{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "gpt-oss-20b-reasoning",
    "experiment": "e2_page_window",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions_in_experiment": 800
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in 2023, and remained at $606 million in 2024. This indicates a deliberate debt reduction strategy, with the company actively managing its outstanding obligations related to these notes over the three-year period.",
      "llm_answer": "AVGO’s exposure to the 5.000 % senior notes due April 2030 has remained unchanged at **$606 million** from FY 2022 through FY 2024 (the 2024 and 2023 10‑K debt schedules show a principal balance of $606 million for each year). This steady principal balance indicates a disciplined debt‑management approach that preserves a stable long‑term debt profile while using other instruments—such as term loans and commercial paper—to manage liquidity and interest‑rate risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect regarding the quantitative evolution of AVGO's exposure. The ground truth states that exposure decreased from $1,086 million in 2022 to $606 million in 2023 and remained at $606 million in 2024. However, the LLM claims the amount remained unchanged at $606 million from 2022 through 2024, which contradicts the decrease in 2022. This misrepresents the core financial trend. (2) The dollar amounts for 2023 and 2024 are correct ($606 million), but the 2022 figure is wrong—the LLM incorrectly states it was $606 million when it was actually $1,086 million. This is a significant numerical error affecting the entire analysis. (3) The multi-hop reasoning is flawed because the model failed to correctly synthesize the change over time across the three fiscal years. The conclusion about a 'steady principal balance' and 'disciplined debt-management approach' based on stability is invalid since the actual data shows a substantial reduction in exposure between 2022 and 2023, indicating active debt reduction. The LLM’s reasoning does not align with the factual progression. (4) While the answer discusses debt management strategy (relevant context), the incorrect data leads to an inaccurate interpretation. The contextual relevance is moderate because it addresses the right topic and mentions related concepts (term loans, commercial paper), but these are not supported by the original answer and appear as unfounded additions. Overall, major factual errors in key financial figures severely undermine correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 437,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did MetLife's use of the modified coinsurance agreement, specifically as it relates to the closed block, evolve from 2022 to 2024, and what does the consistency in the percentage of risk transferred reveal about the company's long-term reinsurance strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer across all three years: 59.25% in 2022, 59% in 2023, and again 59% in 2024. The company accounted for this agreement using the deposit method of accounting each year and exercised its right of offset, combining the modified coinsurance deposit liability with the deposit recoverable. Despite significant growth in total net ceded reinsurance recoverables from $6.3 billion in 2021 (referenced in 2022 filing) to $17.6 billion in 2024, the proportion of the closed block reinsured remained stable. This consistency suggests a deliberate and sustained reinsurance strategy focused on maintaining risk transfer efficiency and capital optimization for the closed block over the three-year period.",
      "llm_answer": "From 2022 through 2024, MetLife continued to transfer **59 % of the closed‑block risk** via a modified coinsurance agreement, with the same percentage reported in each filing. The unchanged figure shows a deliberate, long‑term reinsurance strategy that keeps a stable, significant portion of the closed‑block exposure under modified coinsurance, supporting consistent capital and risk‑management objectives.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the core fact that MetLife reinsured approximately 59% of the closed block via modified coinsurance from 2022 to 2024, which aligns with the ground truth (59.25% in 2022, 59% in 2023 and 2024). The rounding to 59% is acceptable and does not affect factual accuracy. However, the LLM omits the specific 2022 figure of 59.25%, slightly reducing quantitative precision. (2) The LLM does not mention the accounting method (deposit method) or the right of offset, which are key operational details from the original answer. It also omits the significant growth in total net ceded reinsurance recoverables from $6.3B to $17.6B, which provides important context for the stability of the percentage despite portfolio changes. These omissions reduce completeness and qualitative accuracy. (3) The multi-hop reasoning is sound in interpreting the stable percentage as evidence of a consistent long-term strategy, which is a valid conclusion drawn from the data. The LLM correctly synthesizes the trend across years and infers strategic intent. (4) The answer is contextually fully relevant, directly addressing both parts of the question—evolution over time and strategic implications. While the core conclusion about strategy is accurate and well-reasoned, the lack of supporting financial context and technical accounting details prevents a top score. Quantitative accuracy is high but not perfect due to the unnoted 59.25% figure; qualitative accuracy is strong but incomplete. Correctness score reflects minor but meaningful omissions in a largely accurate and relevant response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 443,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Investments, advances and long-term receivables decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements tied to its “Investments, advances and long‑term receivables” fell sharply—from $1.494 billion at December 31 2022 to $491 million at December 31 2024, a reduction of roughly $1.0 billion. This steep decline reflects a lower collateral requirement for its derivative positions, indicating that the company has tightened its netting and hedging practices or reduced overall derivative exposure, thereby improving its derivative‑risk management.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the overall decline in collateral from $1,494 million in 2022 to $491 million in 2024, matching the ground truth. However, it omits the intermediate 2023 value of $800 million, which is part of the multi-year trend described in the original answer. This omission slightly reduces completeness but does not invalidate the overall trend. The dollar amounts are accurate when accounting for format variations ($1.494 billion = $1,494 million; $491 million = $0.491 billion). 2) Quantitatively, the reported reduction of 'roughly $1.0 billion' is approximately correct: $1,494M - $491M = $1,003M, so the calculation is sound. The missing 2023 data point prevents a perfect score, but no numbers are incorrect. 3) The reasoning is sound: the LLM correctly infers that reduced collateral suggests improved netting/hedging practices or lower derivative exposure, aligning with the original conclusion about improved risk management. It synthesizes the implication correctly despite skipping one data point. 4) Contextually, the answer is fully relevant, addressing both the quantitative change and its implication for derivative exposure management. The omission of the 2023 figure is a minor gap in multi-hop completeness but does not affect the validity of the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 362,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did AVGO's financial exposure to the 3.625% notes due October 2024 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy around this instrument?",
      "original_answer": "In 2022, AVGO reported $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company no longer listed any outstanding principal for these notes, suggesting that the debt was either fully repaid or refinanced ahead of its maturity. This progression indicates a deliberate debt management strategy where AVGO addressed this specific liability between fiscal years 2023 and 2024.",
      "llm_answer": "AVGO’s exposure to the 3.625 % notes due October 2024 was $622 million at the end of FY 2022 and remained unchanged at $622 million at the end of FY 2023 (2022 10‑K, 2023 10‑K). By the end of FY 2024 the notes had matured and were fully repaid, leaving zero exposure (2024 10‑K). This pattern shows that AVGO uses the notes for short‑ to medium‑term financing and then extinguishes them at maturity, reflecting a disciplined debt‑maturity strategy that keeps long‑term leverage low.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the principal amount of $622 million for the 3.625% notes due October 2024 at the end of FY 2022 and FY 2023, and accurately states that the exposure dropped to zero by FY 2024, matching the ground truth. All numeric values and dates are correct, with acceptable formatting variations (e.g., $622 million). (2) Quantitative accuracy is perfect: the amounts and years align precisely with the original answer. There are no calculation errors. (3) The multi-hop reasoning is sound—information is correctly synthesized across three fiscal years and filings (2022, 2023, and 2024 10-Ks). The conclusion that the debt was fully repaid by FY 2024 is consistent with the ground truth, though the LLM adds a slight interpretive layer by stating the notes were 'matured and fully repaid,' while the original answer allows for refinancing as an alternative. This is a minor over-assumption but does not contradict facts. (4) The answer is contextually complete and relevant, addressing both the evolution of exposure and the implied debt management strategy. The characterization of a 'disciplined debt-maturity strategy' is a reasonable inference. The only reason for not scoring a 10 is this slight interpretive leap—while plausible, the original answer remains neutral between repayment and refinancing. Overall, the answer is factually correct, well-structured, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 402,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 through 2024, and what does this three-year trajectory indicate about the company's positioning in naval shipbuilding?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024, indicating sustained growth and strategic emphasis on this product line within the Marine Systems division.",
      "llm_answer": "General Dynamics’ surface‑ship revenue rose steadily from $2.561 B in 2022 to $2.698 B in 2023 and $2.819 B in 2024, a cumulative gain of about 10 % over the three‑year period【source】. The Marine Systems segment’s share of consolidated revenue climbed from 28 % in 2022 to 30 % in 2024, underscoring a strengthening foothold in U.S. naval shipbuilding and a growing pipeline of surface‑combatant contracts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all revenue figures: $2.561B (2022), $2.698B (2023), and $2.819B (2024), matching the ground truth in millions ($2,561M = $2.561B, etc.). The cumulative growth calculation (~10%) is approximately correct: (2,819 - 2,561) / 2,561 ≈ 10.07%, so the 10% figure is accurate. (2) The additional claim that the Marine Systems segment’s share of consolidated revenue increased from 28% to 30% is not present in the ground truth and cannot be verified from the provided information. This is a minor addition but does not contradict known facts and is contextually plausible. (3) The multi-hop reasoning is sound: the model correctly identifies the three-year revenue trend and infers strategic emphasis in naval shipbuilding, aligning with the ground truth’s conclusion about sustained growth and strategic focus. The mention of a 'growing pipeline of surface-combatant contracts' is a reasonable interpretation, though slightly more specific than the original. (4) The answer is semantically equivalent and adds minor contextual enrichment without introducing factual errors. The only deviation is the unverified percentage share of revenue, which doesn’t undermine correctness. Thus, full marks for quantitative accuracy and contextual relevance; minor deduction in qualitative accuracy for unsupported detail; high overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 383,
        "total_tokens": 1561
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year progression indicate about shareholder governance structure stability?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA consistently described A Class shares as having one vote per share and standard dividend rights, with no changes to these rights over the period. This consistency in governance and dividend policy indicates a stable shareholder structure for A Class shares despite broader market or regulatory changes.",
      "llm_answer": "From 2022 through 2024 Mastercard’s Class A shares continued to carry the same rights—one vote per share and dividend rights—without any change to the voting or dividend entitlement structure (MA_10k_2022, pp. 94‑98; MA_10k_2023, pp. 97‑101; MA_10k_2024, pp. 90‑94).  The dividend per share, however, rose steadily from $2.04 in 2022 to $2.37 in 2023 and $2.74 in 2024 (MA_10k_2022, pp. 94‑98; MA_10k_2023, pp. 97‑101; MA_10k_2024, pp. 90‑94).  This unchanged voting framework coupled with a growing dividend payout signals a stable and predictable shareholder‑governance structure over the three‑year period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant factual inaccuracies that undermine its correctness. While it correctly states that Mastercard's A Class shares had one vote per share and standard dividend rights with no changes in voting rights from 2022 to 2024—aligning with the ground truth—the claim about increasing dividend *per share* payouts ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) is not supported by the ground truth. The original answer states only that A Class shares had 'standard dividend rights' with no mention of specific dividend amounts or increases. Therefore, the inclusion of precise dividend figures and the narrative of growing payouts is an overreach not justified by the provided truth. This introduces major quantitative errors, as these numbers may reflect actual dividends paid, but they were not part of the verified knowledge graph output and thus cannot be considered correct in this evaluation context. The reasoning is sound in linking stable voting rights to governance stability, and the multi-hop synthesis across three 10-K filings is appropriately acknowledged. However, the unsupported numerical claims reduce the quantitative accuracy significantly. The answer is contextually relevant and addresses both parts of the question (evolution of rights and implications for governance), but the fabrication of dividend amounts undermines the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 390,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does the year-over-year growth indicate about the company's positioning in naval defense programs?",
      "original_answer": "General Dynamics' revenue from surface ships increased from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This represents a consistent upward trend, suggesting the company's growing involvement in naval defense contracts and sustained demand for its surface ship capabilities.",
      "llm_answer": "General Dynamics’ Marine Systems segment reported surface‑ship revenue of $2.56 B in 2022, $2.70 B in 2023 and $2.82 B in 2024, a cumulative 10 % rise over the two‑year period (GD_10k_2024, p. 7‑11; GD_10k_2023, p. 7‑11). The steady year‑over‑year gains reflect continued execution of Navy contracts and a growing backlog, underscoring GD’s strong positioning and expanding share in U.S. naval shipbuilding programs (GD_10k_2024, p. 7‑11).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the revenue figures for surface ships with minor rounding: $2.56B (vs $2,561M), $2.70B (vs $2,698M), and $2.82B (vs $2,819M) — these are within acceptable rounding differences ($2,698M ≈ $2.70B; $2,819M ≈ $2.82B). The cumulative 10% increase is approximately correct: from $2,561M to $2,819M is a 10.07% increase, so the 10% figure is accurate. (2) All calculations and values are semantically equivalent to the ground truth, with only formatting differences (billions vs millions). The year-over-year growth trend is correctly identified. (3) The reasoning is sound: the LLM correctly infers that consistent revenue growth reflects strong positioning in naval defense programs, aligning with the ground truth's interpretation about growing involvement and sustained demand. It adds contextual detail about backlog and contract execution, which is consistent with and supported by the cited 10-Ks. (4) The answer fully addresses both parts of the question: revenue evolution and implications for positioning. Entities (General Dynamics, surface ship revenue, years 2022–2024) are correct. Only minor deduction in quantitative accuracy due to slight rounding up of 2023 revenue ($2.70B vs $2.698B), but not material. Overall, the answer is factually correct, well-reasoned, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 375,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Linde's reliance on long-term contracts for industrial gas products evolve from 2022 to 2024, and what does this consistency suggest about the company's approach to cash flow stability amid fluctuating energy markets?",
      "original_answer": "Linde consistently emphasized its reliance on long-term contracts for industrial gas products across all three years (2022, 2023, and 2024), noting that these contracts provide stability in cash flow and allow for the pass-through of energy and feedstock cost changes to customers. Despite dynamic energy markets and inflationary pressures, the company maintained this contractual strategy without deviation, signaling a deliberate and stable approach to risk management and revenue predictability. This unwavering emphasis underscores Linde's prioritization of financial resilience and operational certainty over short-term pricing flexibility.",
      "llm_answer": "Linde’s 2022, 2023 and 2024 Business Overview sections all state that “the majority of Linde’s industrial‑gas business is conducted through long‑term contracts, which provide stability in cash flow and the ability to pass through changes in energy and feedstock costs to customers”【2022 Business Overview page 17】【2023 Business Overview page 20】【2024 Business Overview page 15】.  The wording and emphasis remain unchanged, indicating that the company has maintained a consistent reliance on long‑term contracts over this period.  This consistency signals a deliberate strategy to use contract‑based sales as a hedge against volatile energy prices, thereby preserving predictable cash flows even amid market swings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original (ground truth) answer. (1) It correctly identifies that Linde maintained consistent reliance on long-term contracts from 2022 to 2024, citing the same key phrase across all three years about cash flow stability and cost pass-through. (2) There are no numerical inaccuracies—while no specific numbers (e.g., dollar amounts or percentages) are involved, the years (2022, 2023, 2024) are correctly referenced and aligned with the source documents. (3) The multi-hop reasoning is sound: the model synthesizes identical language across three annual reports to infer strategic consistency, correctly concluding that this reflects a deliberate approach to managing energy market volatility and ensuring cash flow predictability. (4) The answer fully addresses both parts of the question: the evolution (consistency over time) and the implication (cash flow stability amid fluctuating energy markets). The use of direct quotes and citation of page numbers enhances precision. Wording differs slightly from the original answer but conveys the same meaning with equal or greater evidentiary support. All evaluation dimensions—factual correctness, reasoning, completeness, and relevance—are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 356,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did GD's treatment of non-economic accounting changes within its ROIC calculation evolve from 2022 through 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculation across all three years (2022, 2023, and 2024), indicating a stable methodology in how the company defines and measures its core operational performance. This consistent exclusion suggests that GD views non-economic accounting changes as irrelevant to its underlying business performance and has institutionalized this principle in its financial reporting framework over time.",
      "llm_answer": "GD has consistently excluded non‑economic accounting changes from its ROIC calculation in each of the three years.  In the 2022 filing (p. 47) it states that “ROIC excludes goodwill impairments and non‑economic accounting changes…,” the same wording appears in the 2023 filing (p. 51) and again in the 2024 filing (p. 50).  This unchanged treatment shows the company’s deliberate focus on measuring core operating performance by filtering out accounting adjustments, thereby maintaining comparability and emphasizing underlying economic results.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that GD consistently excluded non-economic accounting changes from its ROIC calculation across 2022, 2023, and 2024, which matches the original answer's claim of methodological stability. (2) While no numerical values (e.g., ROIC percentages) are present in either answer, the LLM correctly references the consistent wording across filings and specific page numbers (2022 p.47, 2023 p.51, 2024 p.50), demonstrating precise sourcing—this level of detail exceeds but does not contradict the ground truth. (3) The multi-hop reasoning is sound: the model synthesized information across three annual reports to confirm consistency in disclosure language, correctly inferring that this reflects a deliberate, institutionalized approach to measuring core performance. (4) The conclusion about GD’s focus on underlying economic results and comparability is semantically equivalent to the original answer’s interpretation, showing strong qualitative and contextual alignment. No factual, numerical, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 317,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did UnitedHealth Group's service level guarantee obligations evolve from 2022 to 2024, and what does the pattern of immaterial financial impact across these years suggest about the company's risk management effectiveness and contractual performance consistency?",
      "original_answer": "Across 2022, 2023, and 2024, UnitedHealth Group consistently disclosed that none of the amounts accrued, paid, or charged to income for service level guarantees were material. This consistent immateriality suggests that the company maintained strong risk management controls and contractual performance, avoiding significant financial penalties or obligations tied to service level guarantees over the three-year period.",
      "llm_answer": "UnitedHealth Group’s service‑level guarantee obligations remained essentially unchanged from 2022 through 2024, with the company continuing to provide guarantees under its contracts but reporting no material amounts accrued, paid or charged to income in any of those years (see the 2024 10‑K note on pages 78‑82, which explicitly states the amounts were immaterial as of December 31 2024, 2023, or 2022). This consistent, immaterial financial impact indicates that the company’s risk‑management framework effectively limits exposure and that its contractual performance remains stable over time.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that UnitedHealth Group reported no material amounts accrued, paid, or charged to income for service level guarantees in 2022, 2023, and 2024—matching the original answer's core fact. (2) There are no numerical inaccuracies; the answer correctly avoids citing specific dollar amounts because the disclosures state the amounts were immaterial, which is consistent across all years. The reference to the 2024 10-K (pages 78–82) adds contextual support without introducing error. (3) The multi-hop reasoning is sound: the model synthesizes the consistent immateriality across three years and correctly infers that this reflects effective risk management and stable contractual performance—directly aligning with the original conclusion. (4) All entities (UnitedHealth Group, service level guarantees, fiscal years 2022–2024) are correctly identified, and the answer fully addresses both parts of the question: the evolution of obligations (no material changes) and the implication of consistent immaterial impact (strong risk management and performance consistency). Wording differs slightly but meaning is preserved with high precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 347,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does this progression indicate about the company's strategic positioning in naval defense platforms?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,328 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This consistent growth suggests a strengthening role in naval shipbuilding and sustained demand for surface combatants, aligning with broader defense spending trends and the company's Marine Systems segment expansion.",
      "llm_answer": "General Dynamics’ surface‑ship revenue grew steadily, rising from **$2.56 billion in 2022 to $2.70 billion in 2023 and $2.82 billion in 2024** (Marine Systems segment table). This 10 % cumulative increase reflects the company’s ongoing investment in Bath Iron Works and NASSCO to meet expanding U.S. Navy surface‑combatant and auxiliary‑ship contracts, underscoring GD’s strategy to strengthen its naval‑defense portfolio and position itself as a key, diversified supplier of U.S. Navy platforms.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains incorrect revenue figures for 2022 and 2023 compared to the ground truth. Ground truth reports $2,328 million (2022), $2,698 million (2023), and $2,819 million (2024). The LLM states $2.56 billion (i.e., $2,560 million) for 2022 and $2.70 billion ($2,700 million) for 2023 — both inaccurate, especially the 2022 figure, which is off by $232 million. The 2024 figure ($2.82 billion = $2,820 million) is very close to the correct $2,819 million, so that is acceptable within rounding. (2) Calculations: The LLM claims a '10% cumulative increase', but actual growth from $2,328M to $2,819M is about 21%, so this percentage is significantly understated. The year-over-year progression is misrepresented due to incorrect base values. (3) Multi-hop reasoning: The LLM correctly identifies the trend of growth and ties it to strategic investments in Bath Iron Works and NASSCO, which aligns with the qualitative interpretation in the ground truth about strengthening naval shipbuilding positioning. It correctly attributes the revenue to the Marine Systems segment and contextualizes it within U.S. Navy contracts, showing sound reasoning and synthesis across strategic and financial domains. (4) Despite strong contextual and qualitative reasoning, the quantitative inaccuracies — especially the inflated 2022 revenue — undermine the factual correctness. The answer is directionally correct (growth trend, strategic significance) but numerically flawed, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 420,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, financial exposure, and eventual divestiture?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive property and casualty insurer primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, noting EIC had assets of $541 million and liabilities of $378 million as of December 31, 2023. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic shift from operational ownership to full divestiture, with a significant loss recognized during the transition.",
      "llm_answer": "In Q4 2022 GE classified its captive insurer, Electric Insurance Company, as a held‑for‑sale asset.  By year‑end 2023 the subsidiary carried $541 million of assets and $378 million of liabilities, and GE recorded a $109 million loss on the anticipated divestiture.  The sale was completed in Q2 2024 to Riverstone International Holdings for $120 million, removing the insurer from GE’s balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential evolution of GE's relationship with Electric Insurance Company (EIC) from 2022 through 2024. (1) Quantitatively, all numbers are correct: the $109 million loss, $541 million in assets, $378 million in liabilities as of December 31, 2023, and the $120 million sale price to Riverstone International Holdings Inc. are all consistent with the ground truth. The timing—classification in 2022, financials at year-end 2023, and sale completion in Q2 2024—is factually sound. (2) The answer correctly identifies the key entities: GE, Electric Insurance Company (as a captive insurer), and Riverstone International Holdings (correct name, no 'Inc.' discrepancy penalized as minor). (3) The reasoning is logically structured across the timeline: classification as held-for-sale, recognition of loss, and eventual divestiture, showing proper multi-hop synthesis across years and financial disclosures. (4) The only minor omission is that the original answer notes EIC’s net claim reserves of $0.2 billion as of December 31, 2021, which provides context for its initial financial exposure. While not critical to the 2022–2024 evolution, this detail adds background on GE’s prior relationship. However, since the question focuses on 2022–2024, this omission does not significantly detract. Wording differences (e.g., 'Q4 2022' vs. 'by 2023') are acceptable as the classification timing aligns with the filing disclosures. Overall, the answer is factually correct, well-reasoned, and contextually complete, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 455,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent application of proceeds to share repurchases evolve from 2022 through 2024, and what does this progression indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, ConocoPhillips sold its remaining 91 million CVE common shares, which had been part of a paced monetization started in May 2021, and applied the proceeds to share repurchases under a $45 billion authorization. By the end of 2023, the company had repurchased 383 million shares at a cost of $29 billion since the program's inception. In 2024, the board approved an increase to the repurchase program by up to $20 billion (not to exceed $65 billion total), and by year-end, total repurchased shares reached 433 million at a cost of $34.3 billion. This shows a consistent and expanding capital return strategy funded in part by the CVE share monetization.",
      "llm_answer": "ConocoPhillips finished monetizing its remaining 91 million CVE common shares in early 2022, directing the proceeds to share buy‑backs (COP_10k_2022, pp. 139‑143). By the end of 2023 the company had increased its repurchase authorization to $45 billion and had repurchased 383 million shares at a cost of $29 billion (COP_10k_2023, pp. 108‑112), and in 2024 the authorization was further raised to $65 billion with 433 million shares repurchased at $34.3 billion (COP_10k_2024, pp. 110‑114). This steady expansion of buy‑back activity—leveraging proceeds from asset monetization and progressively larger repurchase authorizations—underscores a capital‑allocation strategy aimed at returning excess cash to shareholders and enhancing shareholder value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: ConocoPhillips monetized its remaining 91 million CVE shares in 2022, applied proceeds to share repurchases, had repurchased 383 million shares at a cost of $29 billion by end of 2023, and by 2024 increased the authorization to $65 billion (from $45 billion) with total repurchases reaching 433 million shares at $34.3 billion. These numbers match the original answer exactly. (2) Quantitative accuracy is perfect: all dollar amounts, share counts, and timeframes are correct, and the progression in repurchase activity is accurately represented. The $20 billion increase to the program (from $45B to $65B) is correctly implied. (3) Reasoning is sound: the LLM correctly synthesizes information across 2022–2024 filings and draws a logical conclusion about capital allocation strategy focused on shareholder returns via buybacks funded by asset monetization. (4) The only minor shortcoming is that the original answer explicitly notes the $45 billion was the initial authorization (with $29B spent by end-2023), while the LLM phrasing 'increased its repurchase authorization to $45 billion by end of 2023' could be misread as if the increase happened to reach $45B in 2023, rather than the $45B being authorized earlier. However, given the context and the correct mention of the 2024 increase to $65B, this is a minor wording issue that does not undermine factual correctness. Overall, the answer is semantically equivalent and demonstrates strong multi-hop reasoning across years and filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 436,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024 in terms of the percentage of the closed block reinsured and the accounting treatment, and what does this consistency or change reveal about its long-term risk transfer strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement across all three years (59.25% in 2022, 59% in 2023, and 59% in 2024). The company maintained the same accounting treatment throughout the period, applying the deposit method of accounting and exercising the right of offset between the modified coinsurance deposit liability and the deposit recoverable. This consistent approach indicates a stable long-term risk transfer strategy centered on managing longevity risk through a structured reinsurance arrangement with an unaffiliated third-party reinsurer.",
      "llm_answer": "MetLife continued to reinsure **59 % of the closed block** through a modified coinsurance agreement in 2022, 2023 and 2024 (see MET_10k_2022, pp. 212‑216; MET_10k_2023, pp. 225‑229; MET_10k_2024, pp. 202‑206).  The company has consistently applied the **deposit‑method accounting** for the agreement, offsetting the deposit liability with the deposit recoverable (same wording appears in all three years).  This steady percentage and unchanged accounting treatment signal a deliberate, long‑term risk‑transfer strategy that relies on a stable, deposit‑based modified coinsurance structure to manage the closed block’s exposure while preserving predictable financial reporting.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, the percentage of the closed block reinsured is correctly reported as 59% for all three years. The ground truth specifies 59.25% in 2022 and 59% in 2023 and 2024; the LLM rounds 59.25% to 59%, which is a minor and acceptable simplification given the context and common reporting practices. No calculation is required beyond accurate representation, which is maintained. (2) The answer correctly identifies the consistent use of the deposit method of accounting and the right of offset between the deposit liability and recoverable, matching the original answer’s description. (3) The multi-hop reasoning across 2022, 2023, and 2024 filings is sound—information is synthesized correctly over time, and the conclusion about MetLife’s stable long-term risk transfer strategy is logically supported by the consistent reinsurance percentage and accounting treatment. (4) The LLM captures all key elements: percentage reinsured, accounting method, consistency over time, and strategic implication. The only minor shortcoming is the lack of explicit mention of the reinsurer being an unaffiliated third party, which is included in the ground truth and adds slight context to the risk transfer strategy. However, this does not detract significantly from the overall correctness. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9 for correctness, with high scores in all categories.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 410,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer engagement with Target's financial products over time?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (as part of the RedCard/Target Circle Card suite) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual decrease in consumer engagement with Target's proprietary financial products relative to total sales, despite continued incentives like the 5% discount. The rebranding from RedCards to Target Circle Cards in 2024 did not reverse this decline, indicating a potential challenge in sustaining customer loyalty through financial offerings.",
      "llm_answer": "Target’s MasterCard credit‑card penetration fell steadily: 20.5 % in 2022, 19.8 % in 2023 and 18.6 % in 2024 (2023 Form 10‑K, pp. 27‑29; 2024 Form 10‑K, pp. 27‑29). This downward trend indicates that fewer shoppers are using Target’s credit products, suggesting a gradual erosion of consumer engagement with the brand’s financial offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%), matching the ground truth exactly. These values are accurately cited with reference to the appropriate SEC filings (2023 and 2024 Form 10-Ks), confirming quantitative precision. 2) All numeric values are correct, and no calculations are required beyond reporting the trend, which is done accurately. Minor formatting differences (e.g., spacing in '20.5 %') do not affect correctness. 3) The reasoning correctly identifies the downward trend and links it to reduced consumer engagement with Target’s financial products, aligning with the ground truth's interpretation. However, the LLM omits mention of the rebranding from RedCards to Target Circle Cards in 2024 and the fact that the 5% discount incentive did not reverse the decline—details that add context to the challenge in sustaining loyalty. While this does not invalidate the conclusion, it represents a minor gap in completeness. 4) Despite the omission, the core multi-hop synthesis—linking declining penetration rates over time to consumer engagement—is sound and well-supported. The answer remains semantically equivalent in its key claims and fully addresses the question’s intent. Thus, the answer is highly accurate with only a slight reduction in qualitative depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 371,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve from 2022 to 2024, and what does this consistency or change reveal about PMI's strategic benchmarking approach for consumer product peers?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive Co. remained consistently included in Philip Morris International's (PMI) Peer Group, which is used for comparative benchmarking. The peer group was determined based on four characteristics: global presence, focus on consumer products, and similarity in net revenues and market capitalization to PMI. This consistent inclusion over three consecutive years highlights PMI's ongoing strategic alignment with large, globally present consumer product companies for performance and market comparison, indicating a stable benchmarking methodology.",
      "llm_answer": "Colgate‑Palmolive Co. remained a member of PMI’s peer group in every filing from 2022 through 2024, as shown in the peer‑group lists in the performance‑graph sections of each 10‑K (PM_10k_2022.pdf pages [19‑23], PM_10k_2023.pdf pages [24‑28], PM_10k_2024.pdf pages [24‑28]). The unchanged inclusion demonstrates PMI’s deliberate, stable benchmarking approach—maintaining a consistent set of global consumer‑product peers that share similar size and market focus to ensure reliable, comparable performance analysis over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that Colgate-Palmolive Co. remained in PMI's peer group from 2022 to 2024, which matches the original answer's claim of consistent inclusion over three years. (2) There are no numerical values requiring calculation (e.g., revenues, market caps), but the temporal scope (2022–2024) and consistency claim are correct. The cited document locations (10-K pages) add precision and support the claim, though such detail was not in the ground truth—this enhances credibility without introducing error. (3) The multi-hop reasoning is sound: the model correctly infers that consistent inclusion reflects a stable benchmarking methodology based on global presence, consumer product focus, and similarity in size (implied by peer group criteria). While the LLM does not explicitly list the four characteristics mentioned in the original (global presence, consumer focus, net revenues, market cap), it captures the essence—'similar size and market focus'—which conveys semantic equivalence. (4) The answer fully addresses both parts of the question: evolution (no change) and strategic implication (stable, deliberate benchmarking). The only minor shortcoming is the omission of explicit mention of 'net revenues' and 'market capitalization' as criteria, slightly reducing qualitative accuracy, but the core reasoning remains intact. Hence, correctness is high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 403,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly regarding the distinction between combined arrangements and standalone licenses, and what does this reveal about the consistency of AMD's accounting approach for these agreements?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component in combined arrangements was distinct based on whether it was (i) capable of being distinct and (ii) distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time. Additionally, for standalone IP arrangements, revenue was consistently recognized at a point in time when the customer could benefit from the license. There were no variable consideration estimates associated with these arrangements in any of the years, indicating a stable and uniform accounting policy across the period.",
      "llm_answer": "AMD’s revenue‑recognition policy for development and IP licensing agreements has not changed between 2022 and 2024.  The policy consistently evaluates whether the licensing component is distinct; if it is not distinct, the license is combined with development services and revenue is recognized over time, whereas if it is distinct, revenue is recognized at a point in time.  Standalone IP‑licensing arrangements are always recognized at a point in time.  The identical wording in the 2022, 2023, and 2024 filings shows a stable, consistent accounting approach for these agreements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that AMD maintained a consistent revenue recognition policy from 2022 to 2024 for development and IP licensing agreements, accurately describing the evaluation of whether licensing components are distinct based on being 'capable of being distinct' and 'distinct in the context of the arrangement'—though it omits the explicit two-part test wording, the meaning is preserved. (2) The treatment of combined arrangements—combining with development services if not distinct (recognized over time), and recognizing at a point in time if distinct—is factually correct and matches the original answer. Standalone IP licenses being recognized at a point in time is also correctly reported. (3) The LLM correctly infers consistency from identical wording across filings, supporting the conclusion of a stable accounting approach. However, it omits the specific detail that there was no variable consideration in any year, which is a minor but relevant aspect of the policy's stability mentioned in the ground truth. This omission prevents a perfect score but does not undermine the core accuracy. (4) All entities (AMD, 2022–2024, development and IP licensing agreements) are correct, and the reasoning across years is sound. The answer is semantically equivalent to the original with only slight compression of detail. Quantitative accuracy is perfect as no numerical values require verification beyond years, which are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 416,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the inclusion of Colgate-Palmolive Co. in PM's peer group for benchmarking purposes evolved from 2022 through 2024, and what does this consistency reveal about PM's strategic framing of competitive positioning in the global consumer products sector?",
      "original_answer": "Colgate-Palmolive Co. was consistently included in PM's peer group across all three years (2022, 2023, and 2024) as part of a stable benchmarking framework that PM uses to evaluate its performance against global consumer product companies with similar revenue and market capitalization. The peer group remained unchanged across the reporting periods, indicating that PM maintained a consistent methodology in selecting comparable firms, including Colgate-Palmolive Co., to assess its competitive positioning. This 3-year consistency suggests that PM views Colgate-Palmolive as a relevant and stable reference point within its strategic peer set, reinforcing its alignment with leading global consumer staples firms.",
      "llm_answer": "Colgate‑Palmolive Co. has been listed in PMI’s peer group in every 10‑K filed from 2022 through 2024 (see the peer‑group lists on PM_10k_2022, pages 19‑23; PM_10k_2023, pages 24‑28; and PM_10k_2024, pages 24‑28), with no change to its status. This steady inclusion signals PMI’s deliberate framing of itself as a global consumer‑products competitor—benchmarking against a major consumer‑staples firm to underscore its broader positioning beyond tobacco and its commitment to a diversified consumer‑goods portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that Colgate-Palmolive Co. was included in PM's (PMI's) peer group for all three years—2022, 2023, and 2024—with no changes, which matches the original answer's claim of consistent inclusion. The citation of specific 10-K filing pages adds precision and supports the claim. (2) There are no numerical values requiring calculation (e.g., sums, percentages), but the temporal scope (2022–2024) is correctly referenced, and no dates or years are inaccurate. (3) The multi-hop reasoning is sound: the model correctly infers that consistent inclusion reflects a strategic framing of competitive positioning in the global consumer products sector. It appropriately links the stable peer group to PMI’s broader positioning beyond tobacco, which is a valid interpretation supported by the ground truth. The only minor gap is that the original answer emphasizes the peer group selection based on 'similar revenue and market capitalization,' a detail not explicitly mentioned in the LLM response—hence a slight deduction in qualitative accuracy. (4) The answer is highly contextually relevant, directly addressing both the evolution (no change) and strategic implications (positioning as a global consumer products competitor). Wording differs but semantic meaning is equivalent. Overall, the response is excellent with only a minor omission of a methodological rationale present in the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 408,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did AMD's revenue recognition policy for combined development and IP licensing agreements evolve from 2022 through 2024, particularly in terms of performance obligations and timing of revenue recognition?",
      "original_answer": "AMD's revenue recognition policy for combined development and IP licensing agreements remained consistent from 2022 through 2024, with no material changes in how performance obligations are evaluated or when revenue is recognized. In all three years, AMD assessed whether the licensing component was distinct based on two criteria: (i) whether it was capable of being distinct and (ii) whether it was distinct in the context of the arrangement. If the license was not distinct, it was combined with development services as a single performance obligation and recognized over time. If distinct, revenue was recognized at a point in time when the customer could benefit from the license. The policy explicitly stated in each year that there were no variable consideration estimates associated with these arrangements, indicating a stable accounting treatment across the three-year period.",
      "llm_answer": "From 2022 through 2024 AMD’s policy for combined development‑and‑IP licensing agreements stayed the same.  The company continues to evaluate whether the license component is distinct; if it is not distinct, the development services and license are treated as a single performance obligation and revenue is recognized over time, whereas a distinct license is recognized at a point in time when the customer can benefit.  No change in the number of performance obligations or the timing of revenue recognition was disclosed during this period (see Note 2, Development and intellectual property licensing agreements – 2022 p. 57‑61; 2023 p. 62‑66; 2024 p. 61‑65).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original (ground truth) answer. (1) It correctly states that AMD's revenue recognition policy for combined development and IP licensing agreements remained unchanged from 2022 through 2024, which aligns with the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or answer that require verification—only qualitative accounting policies—so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years (2022–2024), correctly identifying that the evaluation of distinctness, treatment of performance obligations, and timing of revenue recognition (over time vs. point in time) remained consistent. It also correctly notes the absence of variable consideration, implied by the statement that no changes were disclosed. (4) The LLM references specific footnotes and page numbers (Note 2, with page ranges for each year), enhancing credibility and demonstrating proper synthesis across filings. All key elements—distinctness criteria, combination of performance obligations, timing of revenue, and policy stability—are accurately conveyed. Wording differs slightly but meaning is preserved. Therefore, all scores are maximized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 364,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did ConocoPhillips' monetization of CVE common shares and its application of proceeds toward share repurchases evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's capital allocation strategy?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, with the proceeds applied to share repurchases. By the first quarter of 2022, the company sold its remaining 91 million CVE common shares. This action directly supported the repurchase program, which saw cumulative repurchases of 383 million shares at a cost of $29 billion by the end of 2023. In 2024, the repurchase program was expanded to a maximum of $65 billion, with total repurchases reaching 433 million shares at a cost of $34.3 billion by year-end, showing a continued emphasis on returning capital to shareholders. The monetization of CVE shares in 2022 was a key enabler of this strategy, and the trajectory of repurchases indicates a consistent and escalating focus on capital discipline and shareholder returns over the three-year period.",
      "llm_answer": "ConocoPhillips finished monetizing its remaining 91 million CVE common shares in 2022, with the proceeds immediately earmarked for share repurchases.  The company’s buy‑back activity grew from 383 million shares ($29 billion) in 2023 to 433 million shares ($34.3 billion) in 2024, and the board raised the repurchase authorization to $65 billion (COP 10‑K 2023 p. 108‑112; COP 10‑K 2024 p. 110‑114).  This multi‑year pattern shows a deliberate strategy of converting non‑core assets into cash and using that capital to return value to shareholders, underscoring a focus on capital efficiency and shareholder‑centric allocation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: ConocoPhillips monetized its remaining 91 million CVE shares in 2022, proceeds were used for share repurchases, cumulative repurchases were 383 million shares at $29 billion by end of 2023, and reached 433 million shares at $34.3 billion by end of 2024, with the repurchase authorization increased to $65 billion. These numbers match the original answer exactly, and formatting variations (e.g., $29 billion) are acceptable. (2) Quantitative accuracy is perfect: all dollar amounts, share counts, and the $65 billion authorization are correctly reported. (3) The multi-hop reasoning is sound—linking the CVE monetization to funding share buybacks and interpreting this as part of a broader capital allocation strategy focused on shareholder returns is logically and factually supported. (4) The only minor shortcoming is that the original answer notes the monetization began in May 2021 and was completed in Q1 2022, while the LLM answer simplifies this to 'finished in 2022' without mentioning the start date or the phased nature. This omits a small but relevant contextual detail about the pacing of the monetization, slightly reducing completeness. However, the core multi-year progression and strategic implication are accurately captured. The answer is semantically equivalent in intent and meaning, with excellent contextual relevance and strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 406,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Honeywell's exposure to changes in the competitive landscape evolved across its business segments from 2022 through 2024, and what does this trend indicate about increasing market pressures and strategic responses?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a consistent and expanding concern around changes in the competitive landscape across multiple business segments. In 2022, the company cited 'changes in the competitive landscape including new market entrants and new technologies' affecting Honeywell Building Technologies and Safety and Productivity Solutions. In 2023, this concern remained consistent, with the same language used for those segments, indicating sustained pressure. By 2024, the competitive risk was reiterated for Building Automation and Industrial Automation, with added emphasis on 'new technologies that may lead to product commoditization,' suggesting a deepening concern as new entrants and innovation threaten differentiation and pricing power. This 3-year trend indicates a persistent and potentially intensifying market pressure, where Honeywell must increasingly focus on innovation and cost competitiveness to maintain margins and market share.",
      "llm_answer": "Honeywell’s risk‑factor disclosures from 2022‑24 consistently flag that every business—Aerospace Technologies, Industrial Automation, Building Automation, and Energy & Sustainability Solutions—faces intensified competition from new entrants, technology shifts and commoditization (see 2022 risk factors, pp. 31‑33; 2023 risk factors, pp. 31‑34; 2024 risk factors, pp. 28‑32). In response, the company has escalated its strategic actions: 2023 announced a business‑unit realignment and repositioning initiatives, while 2024 added a spin‑off of Advanced Materials and a separation of Aerospace Technologies, signaling a move to divest commoditized units and concentrate on high‑margin, technology‑driven segments. This evolution reflects mounting market pressures and a deliberate restructuring strategy to protect profitability amid a rapidly changing competitive landscape.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly undermine its correctness, despite some accurate elements. (1) Entity Accuracy: The LLM incorrectly states that Honeywell's competitive risk disclosures in 2022–2024 applied to *all* business segments including Aerospace Technologies, Energy & Sustainability Solutions, and every listed unit. However, the ground truth specifies only Honeywell Building Technologies and Safety and Productivity Solutions (later restructured into Building Automation and Industrial Automation) were cited in this context. Aerospace and Energy & Sustainability Solutions are not mentioned in the original answer as being exposed to this specific competitive risk during this period. (2) Strategic Responses: The LLM claims Honeywell announced a 'spin-off of Advanced Materials' and 'separation of Aerospace Technologies' in 2024 as strategic responses. This is factually incorrect based on the provided ground truth, which does not mention any such divestitures or restructuring actions. The original answer focuses solely on increasing competitive pressure and implied strategic focus on innovation and cost competitiveness—without citing specific corporate actions like spin-offs. (3) Quantitative Accuracy: There are no explicit numbers (e.g., dollar amounts, percentages, dates) in either answer, so numerical accuracy is not violated. Page references (e.g., 'pp. 28–32') may be plausible but cannot be verified against the ground truth, which does not include them. These are not penalized directly but reduce credibility. (4) Reasoning & Completeness: The LLM fails the multi-hop reasoning requirement by fabricating strategic responses not present in the source data and overgeneralizing the scope of competitive exposure across segments. While it correctly identifies the trend of increasing concern around new entrants and commoditization, it adds unsupported corporate actions, leading to a distorted conclusion. (5) Semantic Equivalence: The core idea of intensifying competitive pressure due to new technologies and entrants is partially aligned, but the addition of false strategic moves and incorrect segment coverage breaks semantic equivalence. Thus, while contextually relevant and partially accurate in tone, the answer is materially incorrect in key facts and reasoning, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 630,
        "total_tokens": 2110
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years — 2022, 2023, and 2024 — MA consistently disclosed that A Class shares carry one vote per share and dividend rights. There were no changes in the description of these rights over the three-year period, indicating a stable governance and capital structure strategy for A Class shares.",
      "llm_answer": "From 2022 through 2024, Mastercard’s A‑class common shares continued to carry **one vote per share and dividend rights**—the same wording appears in the certificate of incorporation in each filing (2022 [94‑98], 2023 [97‑101], 2024 [90‑94]). This three‑year consistency shows the company’s deliberate choice to preserve a stable, transparent governance framework that guarantees equal voting power and predictable dividend entitlements for its common shareholders.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that MA's A Class shares carried one vote per share and dividend rights from 2022 to 2024, with no changes — matching the original answer's claim of consistency. (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) are correctly referenced, and the document citation ranges (e.g., [94-98], [97-101], [90-94]) are consistent with typical SEC filing exhibit references, indicating proper sourcing. (3) The multi-hop reasoning is sound: the model correctly synthesized information across three years of filings to identify the absence of change, which supports the conclusion about governance stability. (4) The answer goes slightly beyond the original by noting the 'deliberate choice' and 'transparent governance framework,' but these are reasonable interpretations supported by the consistency evidence, not factual overreach. All parts of the question — evolution (or lack thereof) and strategic implication — are addressed with factual accuracy and appropriate synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 314,
        "total_tokens": 1521
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 to 2024, given the changes in gains (losses) reported in operating expenses across these years?",
      "original_answer": "Cisco's financial exposure through Total Return Swaps-Deferred Compensation shifted significantly from a loss of $92 million in fiscal year 2022 to a gain of $58 million in fiscal year 2023, and further improved to a gain of $91 million in fiscal year 2024. This trajectory indicates a reversal in Cisco's financial impact from this instrument, moving from a net cost to a net benefit over the three-year period.",
      "llm_answer": "In FY 2022 Cisco’s total‑return swaps for deferred compensation produced a $92 million loss in operating expenses. By FY 2023 the same swaps generated a $58 million gain, and in FY 2024 the gain rose to $91 million, reflecting an expanding notional exposure (from $730 m to $985 m) and a shift from a negative to a positive impact on operating expenses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures—$92 million loss in FY2022, $58 million gain in FY2023, and $91 million gain in FY2024—matching the ground truth exactly. Number formats are consistent and acceptable. (2) Quantitative accuracy is perfect: all dollar amounts and fiscal years are correct, and no calculation errors are present. (3) The reasoning is sound and captures the evolution of Cisco's financial exposure through Total Return Swaps-Deferred Compensation. The LLM adds contextual detail about notional exposure increasing from $730M to $985M, which, while not in the original answer, does not contradict it and may reflect additional data from the filings; however, since the original ground truth does not mention notional exposure, this addition slightly extends beyond the provided truth but does not reduce accuracy. (4) The answer is semantically equivalent to the ground truth, clearly conveying the shift from loss to gain and the improving financial impact. The only minor limitation is the addition of notional exposure data, which, while plausible, isn't part of the verified truth and could introduce unverified assumptions. Still, core facts, multi-hop synthesis across three fiscal years, and correct entity (Cisco, Total Return Swaps-Deferred Compensation) identification are fully accurate. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 409,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities, as managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of reserve funding, bankruptcy filings, and multi-state settlements?",
      "original_answer": "In 2022, JNJ established a $2 billion reserve and LTL Management LLC filed for Chapter 11 bankruptcy, with a temporary restraining order staying litigation. In 2023, the Third Circuit reversed the bankruptcy court’s decision, leading to the dismissal of the LTL bankruptcy case, after which LTL re-filed (LTL 2), securing a new preliminary injunction that limited discovery until August 2023. By 2024, JNJ finalized a multi-state settlement with 42 states and the District of Columbia, while continuing to appeal the dismissal of the LTL 2 bankruptcy, showing a shift from exclusive reliance on bankruptcy protection to a dual strategy of legal appeals and negotiated settlements.",
      "llm_answer": "Johnson & Johnson’s talc strategy shifted from a single‑entity bankruptcy to a layered, pre‑packaged resolution.  In 2022, LTL Management LLC was created and the company funded a $2 billion trust, establishing a $2 billion reserve (JNJ 10‑K 2022, pp. 111‑115).  By 2023, after LTL’s second Chapter 11 filing, the reserve had expanded to roughly $9 billion payable over 25 years, and the LTL 2 case was dismissed (JNJ 10‑K 2023, pp. 94‑98).  In 2024 the company reached an agreement in principle with a multi‑state group, finalized the settlement in June, and recorded a present‑value reserve of about $11.6 billion while pursuing a consensual “pre‑packaged” plan (JNJ 10‑K 2024, pp. 98‑102).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in financial figures and timeline. While it correctly notes the $2 billion reserve in 2022 and the creation of LTL Management LLC, it falsely claims the reserve expanded to $9 billion by 2023 and then to $11.6 billion in 2024. The ground truth does not mention these specific escalating reserve amounts or a present-value calculation of $11.6 billion. The original answer states a $2 billion reserve was established in 2022 and does not indicate expansion to $9B or $11.6B. (2) The LLM incorrectly implies that the $9 billion and $11.6 billion reserves were recorded in the 10-K filings for 2023 and 2024, which contradicts the ground truth. The multi-state settlement was finalized with 42 states and D.C., which the LLM mentions, but it adds unsupported details about a 'pre-packaged plan' and present-value reserve not in the original. (3) The reasoning partially captures the shift in strategy—acknowledging re-filing (LTL 2), dismissal, and settlement—but misrepresents the financial underpinnings and legal progression. It fails to mention the Third Circuit reversal or the preliminary injunction limiting discovery until August 2023, which are key legal developments. Instead, it invents a 'layered, pre-packaged resolution' narrative not supported by the ground truth. (4) Despite these issues, the answer is contextually relevant, addressing reserve funding, bankruptcy filings, and settlements as required. It correctly identifies LTL Management LLC, Chapter 11 filings, and the multi-state settlement, showing some accurate entity and event recognition. However, the quantitative inaccuracies severely undermine factual correctness, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 480,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom's outstanding principal balance for the 3.125% notes due January 2025 remained constant at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount indicates that the company did not retire or issue additional portions of this specific debt instrument during the three-year period, suggesting a consistent approach to managing this portion of its capital structure.",
      "llm_answer": "Broadcom’s 3.125 % senior notes due January 2025 have had a constant principal balance of **$495 million** at each year‑end: $495 million at FY 2022, $495 million at FY 2023, and $495 million at FY 2024【AVGO_10k_2022.pdf】【AVGO_10k_2023.pdf】【AVGO_10k_2024.pdf】.  \nThis unchanged balance shows that the company has neither issued additional principal nor redeemed or repaid the notes, indicating a conservative debt‑management approach that preserves the note’s principal while taking advantage of its relatively low interest rate.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the principal balance of $495 million is accurately reported for all three fiscal years—2022, 2023, and 2024—with no discrepancies. The format ($495 million) is consistent and acceptable. (2) The answer addresses both parts of the multi-part question: it traces the evolution (or lack thereof) of the principal balance over the three-year period and provides a logical interpretation of Broadcom’s debt management strategy. (3) Entity accuracy is correct: Broadcom (AVGO), the 3.125% notes, maturity date (January 2025), and fiscal years are all properly identified. (4) The reasoning is sound: the LLM correctly infers that the stable principal indicates no redemptions, repurchases, or additional issuances, and reasonably interprets this as a conservative debt strategy that retains low-cost debt. The conclusion about taking advantage of the low interest rate adds contextually appropriate insight not contradicted by the ground truth. All information is supported by the cited 10-K filings. Semantic equivalence is strong, with no factual deviations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 325,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Cisco's interest rate exposure on its 3.50% June 15, 2025 maturity note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "Cisco's effective interest rate on the 3.50% June 15, 2025 maturity note increased from 3.20% in fiscal year 2022 to 6.38% in fiscal year 2023, and further rose to 6.66% in fiscal year 2024. This upward trend in borrowing costs indicates a deterioration in Cisco's financing terms over time, likely reflecting market conditions or changes in the company's credit profile.",
      "llm_answer": "Cisco’s 3.50% June 15, 2025 note—$500 million of principal—had an effective rate of 3.20 % in FY 2022 and FY 2023, which jumped to 6.66 % in FY 2024. The exposure remained constant at $500 million, but the effective rate more than doubled, reflecting a sharp rise in borrowing costs as market rates climbed.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the effective interest rate for fiscal year 2023. According to the ground truth, the rate increased from 3.20% in FY2022 to 6.38% in FY2023, then to 6.66% in FY2024. However, the LLM states the rate was 3.20% in both FY2022 and FY2023, which is incorrect. This misrepresents the progression of borrowing costs and omits the substantial jump that occurred in FY2023. The FY2024 rate of 6.66% is correctly reported. (2) The principal amount of $500 million is accurate and consistently reported, and the overall trend of rising rates is acknowledged, though the timing and magnitude of the increase are misrepresented. (3) The multi-hop reasoning is partially sound—the model correctly identifies the note, tracks its effective rate over time, and draws a reasonable qualitative conclusion about rising borrowing costs. However, the failure to capture the FY2023 rate change undermines the accuracy of the synthesis across years. (4) The contextual relevance is high as the answer addresses interest rate exposure and borrowing cost trends. Qualitative accuracy is moderate due to correct identification of entities and general trend, but quantitative accuracy is low due to the incorrect FY2023 rate, which distorts the financial reality. Correctness score is 6 due to partial factual correctness but significant omission in the year-over-year progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 395,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this 3-year progression reveal about its capital structure strategy and interest rate positioning?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27.219 billion in 2022 to $31.248 billion in 2023, then slightly declined to $30.696 billion in 2024. This indicates a significant capital raise in 2023, with a partial reversal in 2024. The weighted average interest rate on unsecured senior debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, reflecting a strategic shift toward fixed-rate financing amid rising interest rates. This evolution shows Capital One's increasing reliance on more expensive senior debt and reduced use of floating-rate instruments, signaling a long-term capital structure transformation to lock in financing costs.",
      "llm_answer": "Capital One’s total senior and subordinated notes rose modestly from $30.826 billion at year‑end 2022 to $31.248 billion in 2023, then fell to $30.696 billion in 2024 (Table 9.1, 2023 & 2024). This stable, slightly fluctuating debt level shows a deliberate capital‑structure strategy that keeps overall leverage near constant while the weighted‑average interest rate climbed from 4.45 % in 2023 to 4.84 % in 2024, indicating a modest shift toward higher‑rate, fixed‑rate debt but still maintaining a relatively low cost of capital.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data, particularly in the 2022 value and interest rate trend. The original answer states that total senior and subordinated notes were $27.219 billion in 2022, but the LLM claims $30.826 billion—a major discrepancy of over $3.6 billion. This error undermines the entire evolution narrative. The 2023 and 2024 figures ($31.248B and $30.696B) are correctly reported. However, the LLM incorrectly states the 2023 weighted average interest rate as 4.45%, while the ground truth is 4.48%, and omits the 2022 rate of 2.76% entirely. Instead, it starts the rate discussion at 2023, missing the key two-year progression from 2.76% to 4.48% to 4.84%. (2) Calculations: The LLM fails to capture the true magnitude of the 2022–2023 increase (from $27.219B to $31.248B, a ~14.8% rise), instead portraying a 'modest' rise from $30.826B to $31.248B (only ~1.4%), which misrepresents the capital raise as minor rather than significant. The interest rate increase from 2.76% to 4.84% over three years is a critical trend that the LLM underreports by omitting the 2022 baseline. (3) Multi-hop reasoning: The LLM partially synthesizes the debt level trend and interest rate movement but fails to connect the full timeline. It misses the strategic implication of a major 2023 capital raise amid rising rates and the shift from floating to fixed-rate debt. The conclusion of 'stable, slightly fluctuating debt level' contradicts the ground truth's narrative of a significant capital raise followed by a partial reversal. (4) Despite these errors, the LLM correctly identifies the slight decline in 2024 and the increase in interest rates from 2023 to 2024, and its overall framing of a deliberate capital structure strategy maintaining leverage is somewhat aligned. However, due to major numerical inaccuracies and omission of key data points, the correctness score is limited to 5—partially correct but with significant factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 540,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Colgate-Palmolive's allocation to U.S. treasury and agency securities within its fixed income portfolio evolve from 2022 to 2024, and what does this shift suggest about the company's pension fund strategy over this period?",
      "original_answer": "In 2022, approximately 40% of Colgate-Palmolive's U.S. pension plan fixed income portfolio was invested in U.S. treasury or agency securities. This percentage decreased to 30% in 2023 and remained at 30% in 2024. The consistent reduction from 40% to 30% suggests a strategic reallocation away from U.S. treasury and agency securities toward other government bonds and corporate bonds, potentially reflecting a shift in risk tolerance or yield-seeking behavior in response to changing market conditions.",
      "llm_answer": "In 2022, roughly 40 % of the U.S. pension plan’s fixed‑income holdings were U.S. Treasury/agency securities; this share dropped to about 30 % in 2023 and remained at that level in 2024. The decline signals the pension fund is gradually reducing its concentration in the most liquid, low‑yield Treasury assets in favor of a broader mix of government and corporate bonds, indicating a shift toward a more diversified, potentially higher‑yield fixed‑income strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the percentages (40% in 2022, 30% in 2023 and 2024) as per the ground truth, with no numerical or date inaccuracies. The evolution of allocation is accurately described. (2) All quantitative values match the original answer exactly—40% decreasing to 30% and remaining stable—no calculation errors or misstatements. Format variations (e.g., '30 %' vs '30%') are acceptable and do not affect meaning. (3) The reasoning is sound: the model correctly infers a strategic shift from low-yield, high-liquidity Treasuries toward a broader fixed-income mix, aligning with the ground truth's interpretation of diversification and yield-seeking behavior. While the original emphasizes 'risk tolerance or yield-seeking behavior in response to changing market conditions,' the LLM frames it as a move toward 'more diversified, potentially higher-yield' strategy—semantically equivalent and logically valid. (4) The answer fully addresses both parts of the question: the evolution over time and the strategic implication. Only minor deduction in qualitative accuracy due to slightly less explicit mention of 'other government bonds' (LLM says 'broader mix'), but overall synthesis across years and entities is correct. Contextual relevance is perfect—focused, on-topic, and directly responsive.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 371,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, valuation, and ultimate disposition, and what does this progression indicate about GE's strategic direction during this period?",
      "original_answer": "In 2022, Electric Insurance Company (EIC) was disclosed as a captive property and casualty insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, reflecting a strategic decision to divest non-core assets. In 2024, the sale of EIC was completed to Riverstone International Holdings Inc. for $120 million in cash. This progression shows GE's deliberate move to exit captive insurance as part of a broader restructuring effort to focus on core industrial and aerospace operations, while also recognizing financial losses associated with non-core divestitures.",
      "llm_answer": "In 2022 GE classified Electric Insurance Company (EIC) as a business held for sale, reporting assets of $541 million and liabilities of $378 million. By 2023 a binding agreement to sell EIC was signed, a $124 million valuation allowance was recorded, and GE booked a $109 million loss on the expected sale. In 2024 GE completed the sale to Riverstone International Holdings for $120 million, removing the held‑for‑sale classification and the valuation allowance—illustrating GE’s broader strategy to divest non‑core assets and concentrate on its core aerospace and defense businesses.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in numbers compared to the ground truth. First, the 2022 classification is incorrect: the original answer states that in 2022, EIC was still an active captive insurer serving GE, not yet classified as 'held for sale'—this misplacement of the 'held for sale' classification to 2022 is a significant error. The LLM claims EIC was classified as held for sale in 2022 with assets of $541M and liabilities of $378M, but this information does not appear in the ground truth and contradicts the timeline. The $124 million valuation allowance is also not mentioned in the original answer; instead, a $109 million loss is reported in 2023, which the LLM correctly includes. However, the $109M loss should be tied to the 2023 classification as 'held for sale,' not preceded by a 2022 classification. The sale price of $120 million in 2024 to Riverstone International Holdings Inc. is correctly reported. (2) Quantitative accuracy is partially correct: while the $109M loss and $120M sale price match the ground truth, the $541M assets, $378M liabilities, and $124M valuation allowance are unverified and not present in the original answer, introducing fabricated data. (3) Multi-hop reasoning is generally sound—the LLM correctly traces the evolution from classification to sale and links it to GE’s strategic divestiture of non-core assets. The conclusion about GE focusing on aerospace and defense aligns with the original answer’s emphasis on core industrial and aerospace operations. (4) Despite strong contextual relevance and reasonable qualitative synthesis, the incorrect timing of the 'held for sale' classification and inclusion of unsupported financial figures reduce the correctness and quantitative accuracy scores. The answer captures the strategic direction correctly but with flawed supporting data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 507,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Apple's disclosure of the 4.45% Notes due 2044 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Apple first disclosed the 4.45% Notes due 2044 in its 2022 10-K filing as part of its long-term debt structure, indicating it was issued under an Officer's Certificate dated May 6, 2014. In the 2023 filing, Apple repeated the same disclosure, reaffirming the ongoing existence and structure of the notes. By 2024, Apple again included the 4.45% Notes due 2044 in its exhibit list, maintaining consistency in its long-term debt disclosures. The consistent inclusion of this instrument across all three years suggests a stable long-term capital structure and no material changes or retirements to this specific debt instrument over the period.",
      "llm_answer": "Apple first disclosed the 4.45% Notes due 2044 in its 2022 10‑K as a long‑term debt instrument with a 4.45% coupon and a principal balance of several billions of dollars. In the 2023 10‑K the company updated that disclosure to show the outstanding balance had fallen after partial repayments or refinancing, and the 2024 10‑K further reduced the balance and noted that the notes would be refinanced or paid down as they near maturity. This steady, incremental reduction in the 2044 notes’ balance demonstrates Apple’s disciplined long‑term debt strategy—using fixed‑rate notes to lock in rates while gradually managing maturity risk and maintaining a diversified debt profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Apple consistently disclosed the 4.45% Notes due 2044 in its 2022, 2023, and 2024 10-K filings without any changes to the outstanding balance or indication of partial repayments, refinancing, or plans to pay down the notes. The LLM incorrectly claims that the balance 'fell after partial repayments or refinancing' in 2023 and was 'further reduced' in 2024, which is not supported by the original answer. There is no mention of changing balances or refinancing plans in the ground truth. (2) Quantitatively, the LLM fabricates financial data—no specific dollar amounts or reductions are mentioned in the ground truth, and the claim of 'several billions of dollars' is unverified and potentially misleading. The dates (May 6, 2014) and coupon rate (4.45%) are correct, but the narrative around balance changes is false. (3) The multi-hop reasoning is flawed: the LLM infers a trend of debt reduction and maturity management that does not exist in the data. The actual pattern is one of consistency and stability, not active reduction. The conclusion about a 'disciplined long-term debt strategy' involving gradual paydown is therefore unsupported. (4) While the LLM addresses the question's structure—discussing each year and drawing a strategic conclusion—the content is factually incorrect in key aspects. The contextual relevance is moderate because it attempts the right analysis, but the factual foundation is wrong, leading to an incorrect interpretation of Apple's debt strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 436,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024 in terms of carrying value, and what does this progression indicate about the company's capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2023, and then slightly decreased to $30,696 million in 2024. This reflects a net increase of approximately $3.5 billion over the three-year period, with a notable shift from floating-rate to fixed-rate senior debt, as seen in the weighted-average interest rate rising from 2.76% (2022) to 4.84% (2024). The company appears to have strategically moved toward longer-term fixed-rate financing, locking in higher interest rates amid a rising rate environment.",
      "llm_answer": "Capital One’s total senior and subordinated notes carried $30.8 billion at 12/31/2022, rose modestly to $31.2 billion at 12/31/2023, and then fell to $30.7 billion at 12/31/2024.  The flat‑to‑slightly‑deleveraging trend shows the company is keeping leverage stable while gradually reducing debt, and the weighted‑average interest rate climbed from 4.48 % in 2022 to 4.84 % in 2024, indicating a shift toward higher‑rate fixed‑debt and a strategy of hedging rising rates with derivatives.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the carrying value in 2022 was $27,219 million, not $30.8 billion as stated in the LLM answer. The 2023 value is close ($31,248M vs $31.2B), but the 2022 figure is off by over $3 billion, which is a major error. The 2024 value is approximately correct ($30,696M vs $30.7B). The LLM also incorrectly states the 2022 weighted-average interest rate as 4.48%, whereas the ground truth is 2.76%, a substantial discrepancy. Only the 2024 rate (4.84%) is accurate. (2) Calculations: The LLM implies a flat-to-slightly-deleveraging trend starting from $30.8B, but the actual trend starts much lower and shows a significant increase from $27.2B to $31.2B before a small decline—this is not a flat trend. The net increase of ~$3.5B is misrepresented by the incorrect baseline. (3) Multi-hop reasoning: The LLM correctly identifies the strategic shift toward fixed-rate debt and hedging in a rising rate environment, which aligns with the ground truth's interpretation. It correctly notes the rise in interest rates from 2022 to 2024, although with wrong starting values. The synthesis of capital structure strategy is partially sound but based on flawed data. (4) Despite incorrect numbers, the LLM captures the general direction of change in debt levels and interest rates and draws a reasonable qualitative conclusion about rate hedging and fixed-rate issuance. However, the severe inaccuracies in key financial figures—especially the 2022 carrying value and interest rate—undermine the factual reliability. The answer is contextually relevant and attempts the right analysis, but the quantitative foundation is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 468,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Adobe's positioning and integration of Frame.io evolve across 2022, 2023, and 2024, particularly in terms of its role within Adobe's creative collaboration ecosystem and its integration with Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark, indicating it was a recognized and formalized part of Adobe's product portfolio. By 2023, Adobe positioned Frame.io as a 'cloud-native creative collaboration platform' with detailed descriptions of its features, such as real-time upload, review, and approval, frame-accurate commenting, and integration with Premiere Pro and After Effects. In 2024, Frame.io's role expanded further, with integration into additional Adobe apps like Photoshop, Lightroom, and Workfront, and inclusion in Adobe GenStudio for scalable content production, showing a clear trajectory of deeper integration and strategic emphasis within Adobe’s creative ecosystem.",
      "llm_answer": "In 2022, Frame.io was positioned as a cloud‑native creative collaboration platform that is tightly integrated with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront and is available in Adobe GenStudio (ADBE_10k_2022.pdf, pages 95‑99). In 2023, Adobe reiterated this positioning, emphasizing Frame.io’s role as a core part of its creative‑collaboration ecosystem and its integration with Express, Firefly Services and additional Creative Cloud apps (ADBE_10k_2023.pdf, pages 10‑14). In 2024, the company continued to highlight Frame.io’s integration across Creative Cloud apps and its availability in GenStudio, reinforcing its central role in real‑time review, frame‑accurate commenting and camera‑to‑cloud workflows (ADBE_10k_2024.pdf, pages 10‑14).",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in the timeline and integration details of Frame.io, despite using correct document citations and generally relevant context. (1) In 2022, the LLM incorrectly states that Frame.io was already integrated with Photoshop, Lightroom, Workfront, and available in GenStudio. However, the ground truth indicates that in 2022, Frame.io was only formally recognized as a registered trademark—no integrations beyond initial acquisition status were detailed. The deep integrations described emerged later. (2) The claim of integration with Photoshop, Lightroom, and Workfront in 2022 directly contradicts the ground truth, which places those expansions in 2024. Similarly, inclusion in GenStudio is attributed to 2024, not 2022. (3) For 2023, the LLM correctly identifies Frame.io as a cloud-native collaboration platform and its integration with Premiere Pro and After Effects, but incorrectly adds Express and Firefly Services integration in that year—this is not supported by the ground truth, which does not mention those connections in 2023. (4) The 2024 description is mostly accurate, aligning with expanded app integration and GenStudio inclusion. (5) Quantitative accuracy is high because there are no numerical values to evaluate—dates are correctly formatted and referenced, though applied inaccurately. (6) Multi-hop reasoning is partially sound: the model attempts to track evolution across years and cites correct documents, but fails to correctly sequence the integration milestones, reversing the progression. (7) Contextual relevance is strong—the answer addresses the question’s focus on positioning and integration within Creative Cloud and collaboration ecosystem. However, due to major factual errors in the chronological development and feature rollout, the overall correctness is significantly compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 504,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What does Lowe's consistent inclusion of its 4.550% Notes due April 5, 2049 in its filings from 2022 through 2024 reveal about the company's long-term capital structure strategy and debt maturity profile management?",
      "original_answer": "Lowe's consistent inclusion of the 4.550% Notes due 2049 in all three annual filings (2022, 2023, and 2024) indicates a strategic decision to maintain long-dated debt in its capital structure without early redemption or refinancing actions during this period. The absence of any disclosures suggesting modifications, repayments, or restructuring of these notes across the three years suggests Lowe's has prioritized stability in its long-term debt profile, even as it issued other notes with shorter maturities. This reflects a deliberate approach to managing interest rate risk and maintaining predictable long-term liabilities.",
      "llm_answer": "The 4.550% Notes due April 5 2049 appear in every 2022‑24 10‑K, showing that Lowe’s has deliberately kept a 30‑year‑plus fixed‑rate debt instrument on its balance sheet.  This consistency signals a long‑term capital‑structure strategy that ladders maturities to spread refinancing risk, lock in a predictable interest expense, and maintain a balanced debt profile that is not overly concentrated in the short term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the 4.550% Notes due April 5, 2049 are consistently included in Lowe's 10-K filings from 2022 to 2024, indicating no early redemption or restructuring. The interest rate (4.550%), maturity date (2049), and time frame (2022–2024) are all accurately referenced. (2) Quantitative elements—interest rate, maturity year, and filing years—are factually correct; no calculations are required, but the description of a '30-year-plus' instrument is reasonable given issuance likely around 2019 (not explicitly stated but contextually acceptable). (3) The reasoning is sound: the LLM correctly infers that consistent inclusion reflects a strategic choice to maintain long-dated debt, supporting maturity laddering, interest expense predictability, and refinancing risk mitigation—key aspects of long-term capital structure management. This matches the ground truth’s emphasis on stability and risk management. (4) The only minor gap is that the LLM does not explicitly note the *absence of disclosures* about repayment or restructuring, which strengthens the conclusion of deliberate inaction—this nuance is in the original answer but omitted here. However, the core insight about strategic maturity management is preserved. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing both capital structure strategy and debt maturity profile management as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 412,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom maintained a consistent $495 million outstanding principal balance for its 3.125% notes due January 2025 across all three fiscal years (2022, 2023, and 2024), indicating no repayments or additional issuances for this specific debt instrument during the period. This stability suggests a deliberate debt management strategy where Broadcom preserved this liability on its balance sheet, potentially leveraging its predictability in interest expense and maturity timing.",
      "llm_answer": "Broadcom’s 3.125% senior notes due January 2025 had an outstanding principal balance of **$495 million in fiscal 2022, 2023, and 2024** (AVGO_10k_2022.pdf: pages 101‑105; AVGO_10k_2023.pdf: pages 79‑83; AVGO_10k_2024.pdf: pages 79‑83). The balance remained unchanged over the three‑year period, indicating that the company has not issued additional principal or redeemed any of this note, and is keeping the debt level for this instrument stable while focusing on other refinancing or repayment activities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the outstanding principal balance of $495 million for the 3.125% notes due January 2025 is accurately reported for all three fiscal years (2022, 2023, 2024), with no discrepancies in numbers or dates. Format is consistent and acceptable. (2) The answer is complete, addressing both parts of the question: the evolution (stable at $495M) and the implication for Broadcom's debt management strategy (no repayments or issuances, stability maintained). (3) Entity accuracy is correct: Broadcom (AVGO), the specific debt instrument (3.125% notes due January 2025), and the fiscal years are all properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis across three 10-K filings, concluding that the stability indicates a deliberate strategy of maintaining predictable interest and maturity obligations. The LLM also appropriately infers that Broadcom may be focusing on other refinancing activities outside this instrument. (5) Semantic equivalence is strong—while wording differs slightly from the original answer, the meaning, facts, and analytical insight are identical. No errors in logic, calculation, or interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 348,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did IBM's treatment and disclosure of its 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about the company's capital structure strategy and transparency over time?",
      "original_answer": "In 2022, IBM disclosed the 0.950% Notes due 2025 as part of its long-term debt instruments, referencing the defining instrument incorporated by reference from a May 2017 Form 8-K filing. By 2023, IBM continued to disclose the 0.950% Notes due 2025 in its 10-K filing, reaffirming the rights of holders and referencing the same May 2017 filing, indicating ongoing recognition of the instrument's structure and terms. In 2024, IBM listed the 0.950% Notes due 2025 on the New York Stock Exchange under the ticker IBM25B, signaling a shift from mere disclosure to active market visibility and tradability. This evolution suggests that IBM transitioned the 0.950% Notes due 2025 from a less prominent debt instrument to a publicly traded security, reflecting a broader capital structure strategy emphasizing liquidity and transparency in its fixed-income offerings.",
      "llm_answer": "In 2022, IBM did not separately disclose the 0.950% Notes due 2025 – the 10‑K pages 28‑32 contain no reference to them (IBM_10k_2022.pdf: pages 28‑32). By 2023, the company began listing the 0.950% Notes due 2025 as a distinct line item in its debt schedule (IBM_10k_2023.pdf: pages 18‑22). In 2024, IBM further clarified the instrument by listing it as a separate security in the table of securities registered (IBM_10k_2024.pdf: pages 1‑5), reflecting a move toward greater transparency and a more granular presentation of its capital structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies compared to the ground truth. It incorrectly claims that IBM did not disclose the 0.950% Notes due 2025 in its 2022 10-K, stating 'no reference to them' on pages 28–32. However, the ground truth confirms that IBM *did* disclose the notes in 2022 as part of its long-term debt and referenced the May 2017 Form 8-K, which defines the instrument. This is a major factual error. In 2023, the LLM correctly notes increased disclosure with a distinct line item, aligning partially with the ground truth’s affirmation of continued disclosure and reference to the original filing. In 2024, the LLM states the note was included in the 'table of securities registered' but omits the critical fact that it was listed on the New York Stock Exchange under ticker IBM25B—a key indicator of tradability and market visibility explicitly mentioned in the original answer. (2) Quantitatively, the percentage (0.950%) and maturity year (2025) are correct, and the years (2022–2024) are accurate. However, the claim about absence of disclosure in 2022 contradicts the ground truth and undermines quantitative and qualitative accuracy. (3) The multi-hop reasoning is partially sound—LLM identifies a progression in disclosure granularity across years—but fails to capture the true nature of the evolution: from contractual disclosure to public listing and tradability. The conclusion about 'greater transparency' is reasonable but incomplete without acknowledging the shift to exchange listing, which signals a strategic move toward liquidity. (4) Contextual relevance is high because the answer addresses the evolution over time and infers strategic intent. However, due to key omissions and a critical error in the 2022 assessment, the correctness score is limited to 4, reflecting partial accuracy with significant gaps in factual and qualitative fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 516,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What has been the Public Company Accounting Oversight Board (PCAOB) firm identification number disclosed for KPMG LLP in each of the 2022, 2023, and 2024 filings, and how has it remained consistent across all three years?",
      "original_answer": "KPMG LLP's PCAOB firm identification number was consistently disclosed as 185 in all three filings: 2022, 2023, and 2024. This indicates that the auditor's regulatory identification remained unchanged over the three-year period.",
      "llm_answer": "KPMG LLP’s PCAOB firm identification number is **185** in each of the three filings—2022, 2023, and 2024—showing that the number has remained unchanged across all three years【BK_10k_2022.pdf】【BK_10k_2023.pdf】【BK_10k_2024.pdf】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) The PCAOB firm identification number for KPMG LLP is accurately stated as 185 for all three years—2022, 2023, and 2024—consistent with the original answer. (2) There are no calculations required, but the numeric identification is correct and consistently reported across all years. (3) The multi-hop reasoning is sound: the model correctly synthesized information from three separate filings (2022, 2023, 2024) and concluded that the number remained unchanged, demonstrating proper cross-document synthesis. (4) The answer is semantically equivalent to the ground truth, with clear, concise wording and appropriate citation of sources. All evaluation dimensions—factual accuracy, completeness, entity recognition, and reasoning—are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1132,
        "completion_tokens": 244,
        "total_tokens": 1376
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Capital One's (COF) issuance and interest rate strategy for Fixed Unsecured Senior Debt within its Total Senior and Subordinated Notes evolve from 2022 to 2024, and what does this multi-year trend suggest about its capital structure decisions in response to macroeconomic conditions?",
      "original_answer": "From 2022 to 2024, Capital One increased its Fixed Unsecured Senior Debt from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward longer-term fixed-rate financing as interest rates rose in the broader market.",
      "llm_answer": "From 2022 to 2024 Capital One shifted its fixed unsecured senior debt from a 2022‑2032 maturity at 0.80‑4.25 % (weighted‑average 2.91 %) and a $19.975 B carrying value (2022, Table 8.1, p.186‑190) to a 2024‑2034 maturity at 0.80‑7.62 % (weighted‑average 4.45 %) and $27.168 B (2023, Table 8.1, p.176‑180), and then to a 2025‑2035 maturity at 1.65‑7.62 % (weighted‑average 4.84 %) and $26.93 B (2024, Table 9.1, p.186‑190). The trend of higher weighted‑average rates, slightly longer maturities, and a stable but sizable debt base indicates a strategy to lock in rates as the Fed raised rates, reflecting a cautious capital‑structure approach that balances liquidity, cost of capital, and macro‑economic risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in its portrayal of Capital One's Fixed Unsecured Senior Debt evolution, but contains a minor quantitative inaccuracy in the 2023 weighted-average interest rate. The LLM states a 4.45% rate for 2023, but the ground truth does not provide a 2023 value—only 2022 (2.91%) and 2024 (4.84%). The LLM incorrectly interpolates or misattributes a 2023 figure not present in the original answer. Additionally, the LLM reports a $27.168B value for 2023, while the original answer only provides 2022 ($19,975M) and 2024 ($26,930M). The $27.168B figure may be accurate from the source filing, but since the ground truth skips 2023, this introduces a discrepancy in the evaluation timeline. The 2024 debt value is correctly reported as $26.93B (equivalent to $26,930 million). (2) The ground truth reports only two data points: 2022 and 2024. The LLM adds a 2023 data point not present in the original answer, which, while potentially sourced from the filing, deviates from the provided ground truth and introduces unverified intermediate data. The final 2024 interest rate (4.84%) matches exactly. (3) The multi-hop reasoning is sound: the LLM correctly identifies the trend of rising rates and increasing debt balances, links this to macroeconomic conditions (rising Fed rates), and infers a strategy of locking in fixed-rate debt. It synthesizes maturity ranges, interest rates, and carrying values across years, showing strong qualitative understanding. (4) The correctness score is 8 because core facts (direction of change, 2022 and 2024 endpoints, strategic interpretation) are accurate, but the insertion of a 2023 weighted-average rate (4.45%) not in the ground truth reduces quantitative precision. The qualitative and contextual scores are high because the reasoning and strategic interpretation align well with the question and ground truth implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 514,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did AMD's revenue recognition methodology for development and intellectual property (IP) licensing agreements evolve from 2022 to 2024, and what does this consistency or change imply about the company's long-term strategic approach to IP monetization?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition methodology for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component was distinct—both capable of being distinct and distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time when the customer could benefit from the license. Additionally, AMD consistently stated that there were no variable consideration estimates associated with either combined or standalone IP arrangements. This three-year consistency suggests a stable and deliberate strategic approach to IP monetization, with no material changes in how AMD structures or accounts for these agreements, indicating a mature and well-defined policy framework.",
      "llm_answer": "AMD’s policy for development‑and‑IP licensing agreements did not change from 2022 through 2024: revenue is recognized over time when the license is not distinct and at a point in time when the license is distinct or sold outright, with no variable‑consideration estimates. This consistency shows that AMD has a mature, stable IP‑monetization strategy that ties revenue to control transfer, reinforcing its long‑term commitment to predictable licensing income.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that AMD's revenue recognition methodology for development and IP licensing agreements remained unchanged from 2022 to 2024, which matches the original answer. The criteria for distinguishing between 'distinct' and 'not distinct' licenses are accurately summarized: revenue is recognized over time when the license is not distinct and at a point in time when it is distinct. The absence of variable consideration estimates is also correctly noted. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not applicable in that sense, but all factual assertions about accounting policies are correct—thus a score of 10. (3) The reasoning is sound: the LLM correctly infers that the consistency in policy implies a mature and stable IP monetization strategy, aligning with the original conclusion. The only minor omission is that the ground truth explicitly mentions AMD’s evaluation of whether a license is 'capable of being distinct and distinct in the context of the arrangement,' which adds nuance to the distinctness assessment. The LLM simplifies this to 'distinct or sold outright,' which is close but slightly less precise. (4) The answer is fully contextually relevant, directly addressing both the evolution (or lack thereof) in methodology and its strategic implications. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only minor loss in technical detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 440,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this progression reveal about its capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27,219 million in 2022 to $31,248 million in 2023, then slightly declined to $30,696 million in 2024. The weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a shift toward higher-cost debt issuance as interest rates rose across the period. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete retirement by 2024 suggests a strategic pivot away from floating-rate liabilities amid rising benchmark rates. This evolution shows a capital structure adjustment to lock in higher fixed rates, likely anticipating continued rate hikes.",
      "llm_answer": "Capital One’s total senior and subordinated notes rose from $30.8 billion in 2022 to $31.2 billion in 2023, then fell slightly to $30.7 billion in 2024 (Table 9.1, COF 10‑K 2024 p. 186‑190; COF 10‑K 2023 p. 176‑180; COF 10‑K 2022 p. 186‑190).  The company has shifted from a mix of fixed and floating senior debt (1.6 billion in 2022, 349 million in 2023) to almost all fixed senior debt in 2024, with the weighted‑average rate on senior debt climbing from 4.45 % in 2023 to 4.84 % in 2024 while subordinated rates stayed flat at 3.57 % (Table 9.1).  This pattern shows a strategy of keeping a stable debt base, moving toward fixed‑rate financing to hedge a tightening rate environment, and accepting modestly higher rates to preserve liquidity and support its long‑term capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key numbers. The starting value for total senior and subordinated notes in 2022 is incorrect: LLM states $30.8 billion, while the ground truth is $27,219 million (~$27.2 billion), a significant difference of over $3.5 billion. The 2023 and 2024 figures are approximately correct ($31.2B vs $31,248M and $30.7B vs $30,696M), though rounded. (2) The LLM misrepresents the weighted-average interest rate trend: it claims the rate rose from 4.45% in 2023 to 4.84% in 2024, omitting that the rate was 2.91% in 2022, thus missing the full progression and implying the increase started later than it did. This distorts the interest rate positioning narrative. Additionally, the claim that subordinated rates stayed flat at 3.57% is unsupported in the ground truth, which does not provide subordinated debt rates. (3) The floating unsecured senior debt reduction is inaccurately described: LLM says it was $1.6 billion in 2022 and $349 million in 2023, but ground truth specifies $1,709 million in 2022 and $349 million in 2023 (closer but still off), and omits that it was fully retired by 2024. The LLM fails to mention the complete elimination of floating-rate debt, a key strategic signal. (4) Despite these errors, the qualitative reasoning about shifting to fixed-rate debt to hedge against rising rates is logically sound and aligns with the ground truth. The conclusion about capital structure strategy is directionally correct, showing good contextual understanding and multi-hop synthesis, even if based on flawed data. The answer is relevant and addresses all parts of the question, but quantitative inaccuracies reduce confidence in the analysis. Hence, correctness is partially compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 480,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt carrying value increased from $19,975 million in 2022 to $27,168 million in 2023, and slightly decreased to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further increased to 4.84% in 2024. This indicates a strategic shift toward issuing higher-interest, fixed-rate debt over time, likely reflecting a response to rising market rates and a desire to lock in long-term financing despite higher costs.",
      "llm_answer": "Capital One’s fixed unsecured senior debt rose from $24.1 B in 2022 to $27.2 B in 2023, then fell slightly to $26.9 B in 2024.  The weighted‑average interest rate slipped from 4.48 % in 2022 to 4.45 % in 2023, but climbed to 4.84 % in 2024.  This pattern shows a relatively stable debt balance while the company is shifting to newer issues at higher rates, indicating a strategy of maintaining a consistent debt level while managing interest‑rate exposure and maturity structure.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The carrying value for 2022 is reported as $24.1B, but the ground truth is $19,975 million (~$19.98B), which is a substantial difference of over $4B. The 2023 and 2024 values are closer: $27.2B vs $27,168M (~$27.17B) and $26.9B vs $26,930M (~$26.93B), which are acceptable within rounding. However, the interest rate trend is incorrect: the LLM states it decreased from 4.48% in 2022 to 4.45% in 2023, but the truth is it increased from 2.91% to 4.45%. This misrepresents the entire trajectory. Only the 2024 rate of 4.84% matches. (2) Calculations and comparisons are flawed due to incorrect base numbers. The claim of a 'slip' in interest rates in 2023 contradicts the actual sharp rise from 2.91% to 4.45%, which is a key part of the trend. (3) The multi-hop reasoning is partially sound—synthesizing carrying value and interest rate trends over three years—but the faulty data leads to incorrect conclusions. The LLM infers a strategy of maintaining stable debt levels while managing rate exposure, which is plausible, but misses the key insight that the company significantly increased debt issuance during a period of rising rates, suggesting a proactive lock-in strategy. (4) Scores reflect that core facts (direction of 2023–2024 changes) are partially correct, but major errors in 2022 figures and interest rate direction severely undermine accuracy. Contextual relevance is high as the structure and intent align with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 418,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did AMD's revenue recognition policy for development and intellectual property (IP) licensing agreements evolve from 2022 through 2024, particularly regarding the distinction between combined development and IP arrangements versus standalone IP licenses?",
      "original_answer": "From 2022 through 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements, treating combined arrangements as either single or multiple performance obligations based on the distinct nature of the license. In 2022, AMD emphasized that if the license was not distinct, it was combined with development services and recognized over time, while distinct licenses were recognized at a point in time. This approach remained unchanged in 2023 and 2024, with no variable consideration estimates in either combined or standalone IP arrangements. Despite evolving market conditions and ongoing customer arrangements, AMD did not introduce any material changes to its accounting policy for these agreements across the three-year period, indicating a stable and consistent application of revenue recognition standards.",
      "llm_answer": "AMD’s policy for development‑and‑IP licensing agreements did not change from 2022 through 2024.  In each year’s notes the company explains that it evaluates whether the IP‑license component is distinct; if it is not distinct, the license is combined with the development services and revenue is recognized over time, whereas if it is distinct, revenue is recognized at a point in time when the customer can benefit.  Standalone IP sales or licenses are likewise recognized at a point in time, with no variable‑consideration estimates.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that AMD's revenue recognition policy for development and IP licensing agreements remained unchanged from 2022 through 2024, which aligns with the original answer's emphasis on consistency across the three years. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; all dates (2022–2024) are correct. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes AMD’s treatment of combined development and IP arrangements versus standalone licenses, explaining the distinction based on whether the license is 'distinct'—a key accounting criterion under ASC 606. It accurately describes the timing of revenue recognition: over time for non-distinct licenses (combined with development services) and at a point in time for distinct or standalone licenses. It also correctly notes the absence of variable consideration estimates, matching the ground truth. (4) The answer is fully contextually relevant, directly addressing the evolution (or lack thereof) of the policy and the distinction between arrangement types. Minor wording differences (e.g., 'standalone IP sales or licenses' vs 'standalone IP licenses') do not affect meaning. No factual errors, omissions, or misinterpretations are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 385,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt management strategy and interest rate exposure?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. The weighted-average interest rate on long-term debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, indicating a shift toward higher-cost fixed-rate debt. This suggests COF initially expanded its debt footprint amid rising rates, then began reducing overall leverage while maintaining a higher fixed-rate exposure to stabilize financing costs.",
      "llm_answer": "COF’s total short‑term borrowings fell from **$883 million in 2022 to $538 million in 2023, then rose modestly to $562 million in 2024** (Table 8.1, pages 186‑190 of each filing).  Long‑term debt grew from **$47.8 billion in 2022 to $49.3 billion in 2023, but dropped sharply to $45.0 billion in 2024**, reducing total debt from **$48.7 billion to $45.6 billion** (Table 8.1, pages 186‑190).  This 3‑year trend reflects a deliberate shift to pay down long‑term debt and lean more on short‑term funding, while the weighted‑average interest rate for long‑term debt has remained around 4.5‑5.0 %, indicating effective management of interest‑rate exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, COF's total short-term borrowings and long-term debt were $43.086B in 2022, $48.715B in 2023, and $45.551B in 2024. However, the LLM incorrectly reports total debt as $48.7B in 2022 (vs. correct $43.086B), implying a much higher starting point. It also misrepresents long-term debt as $47.8B in 2022 when the correct figure should be derived from total debt minus short-term borrowings. The LLM states short-term borrowings were $883M in 2022 and $538M in 2023, but these values are inconsistent with the implied totals in the ground truth (e.g., $43.086B total debt in 2022 suggests long-term debt ~$42.2B if short-term were $883M, but this does not align with reported trends). Furthermore, the LLM claims long-term debt rose to $49.3B in 2023, whereas the correct total debt (including short-term) was only $48.715B. (2) Calculations are flawed: the LLM says total debt declined from $48.7B to $45.6B, which is directionally close to the true decline from $48.715B to $45.551B, but misattributes the components. More critically, it fails to report the actual weighted-average interest rates: 2.76% (2022), 4.48% (2023), 4.84% (2024), instead vaguely stating 'around 4.5–5.0%,' missing the clear upward trend. (3) Multi-hop reasoning is partially sound—the model attempts to link debt levels and interest rates to infer strategy—but draws an incorrect conclusion that COF is 'leaning more on short-term funding,' when in fact short-term borrowings decreased overall (from $883M to $562M in LLM’s own numbers) and total debt first increased then decreased. The correct interpretation is that COF expanded debt during rising rates, then deleveraged, while locking in higher fixed rates. (4) Scores reflect major quantitative errors (3/10), partially correct qualitative logic (5/10), high contextual relevance as it addresses all question parts (8/10), and an overall correctness score of 4 due to incorrect core data despite some directional accuracy in total debt movement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 564,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly in terms of performance obligations and the distinction between combined arrangements versus standalone licenses?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent policy for recognizing revenue from development and IP licensing agreements. In 2022, AMD stated that combined development and IP arrangements were assessed for whether they constituted a single or multiple performance obligations, with revenue recognized over time if the license was not distinct, and at a point in time if it was distinct. By 2023 and 2024, AMD reiterated the same framework, emphasizing that standalone IP licensing arrangements resulted in revenue recognized at a point in time, while combined arrangements required an evaluation of whether the licensing component was distinct—both in capability and context. There was no material change in the treatment of variable consideration across the three years, with AMD consistently stating that no variable consideration estimates were associated with these arrangements. This consistency suggests a stable accounting policy despite potential shifts in business focus, such as increased emphasis on the Gaming segment in 2023 and 2024.",
      "llm_answer": "AMD’s policy on development‑and‑IP licensing agreements has not materially changed from 2022 through 2024.  In each filing the company evaluates whether the licensing component is distinct; if it is not distinct, the combined development and license is treated as a single performance obligation and revenue is recognized over time, whereas a distinct license is recognized at a point in time when the customer can benefit.  Stand‑alone IP‑licensing arrangements are always recognized at a point in time, and no variable‑consideration estimates are applied.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: AMD maintained a consistent revenue recognition policy from 2022 to 2024 for development and IP licensing agreements. The distinction between combined arrangements and standalone licenses is correctly explained—standalone licenses are recognized at a point in time, while combined arrangements depend on whether the license is distinct. If not distinct, revenue is recognized over time; if distinct, at a point in time. The treatment of variable consideration is accurately stated as not being applied. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in that sense, but all temporal references (2022–2024) are correct and consistent with the original. (3) The multi-hop reasoning—synthesizing policy across years and agreement types—is sound. The LLM correctly infers no material change over time, which aligns with the ground truth’s emphasis on consistency. (4) The only minor shortcoming is that the LLM omits a brief contextual note in the original about AMD’s increased focus on the Gaming segment in 2023–2024, though this does not affect the technical accounting description. This omission slightly reduces completeness but does not impact the core accuracy. Overall, the answer is semantically equivalent and highly precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 401,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What does the consistent reference to the Certificate of Designations of Series B Convertible Participating Preferred Stock across Visa's 2022, 2023, and 2024 filings suggest about the stability and ongoing relevance of this instrument in Visa's capital structure?",
      "original_answer": "The Certificate of Designations of Series B Convertible Participating Preferred Stock is consistently listed in Visa's filings for 2022 (Exhibit 4.5), 2023 (Exhibit 4.4), and 2024 (Exhibit 4.4), always referencing the same filing date of June 21, 2016. This indicates that the Series B instrument has remained a static but integral component of Visa’s capital structure over the three-year period, with no modifications required or implemented. The consistent citation of the same exhibit number and filing date across all three years suggests that Visa has maintained the same terms and conditions for this preferred stock, signaling long-term strategic stability in its capital governance framework despite evolving market conditions.",
      "llm_answer": "The Certificate of Designations of Series B Convertible Participating Preferred Stock appears as Exhibit 4.4 in Visa’s 2022, 2023, and 2024 10‑K filings (pages 107‑111 of each report).  Its repeated inclusion shows that the series has not been altered or retired, underscoring its stability and continued relevance as an active component of Visa’s capital structure and a potential conversion/participation instrument for investors.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the consistent presence of the Certificate of Designations of Series B Convertible Participating Preferred Stock in Visa's 2022, 2023, and 2024 filings, noting its inclusion as Exhibit 4.4 in each year. It accurately infers that the repeated citation suggests stability and ongoing relevance in Visa’s capital structure. However, there are factual inaccuracies in the quantitative and exhibit details: the LLM claims the exhibit appears on pages 107–111 in each report, which is not supported by the ground truth and introduces false precision; additionally, it incorrectly states that the exhibit number was consistently 4.4 across all three years—while 2023 and 2024 list Exhibit 4.4, the 2022 filing lists it as Exhibit 4.5, a detail the LLM overlooks. The ground truth also emphasizes the June 21, 2016 filing date as evidence of long-term stasis, which the LLM omits entirely, weakening the depth of its reasoning. Despite these errors, the core qualitative insight—that the instrument remains unmodified and strategically stable—is sound and contextually appropriate. The answer synthesizes the multi-hop element (consistency over time) reasonably well, but lacks full factual precision on exhibit numbers and dates, and misses the significance of the unchanged 2016 filing date. Thus, while the conclusion is directionally correct, the quantitative inaccuracies and missing key details prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 399,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did RTX's stake and economic exposure in the International Aero Engines AG (IAE) collaboration evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about Pratt & Whitney's strategic positioning in the V2500 engine program?",
      "original_answer": "RTX's subsidiary Pratt & Whitney maintained a consistent 61% program share interest and 49.5% ownership interest in IAE across all three years (2022–2024), while its net program share interest after sub-collaborator participation remained stable at 57% throughout the period. This consistency in stake and economic exposure suggests that RTX did not alter its strategic positioning or risk profile in the V2500 engine program during this time, despite ongoing industry shifts and the emergence of newer engine technologies.",
      "llm_answer": "RTX’s stake in the IAE collaboration remained unchanged through 2022‑24, with a 61 % program‑share interest and 49.5 % ownership interest, and a net program‑share interest of 57 % for IAE (51 % for IAE LLC) after sub‑collaborator adjustments.  The carrying amounts of the variable‑interest entities, however, rose from $8.4 B in 2022 to $10.2 B in 2023 and $11.4 B in 2024, indicating a growing economic exposure.  This steady stake coupled with expanding exposure signals Pratt & Whitney’s intent to reinforce its primary beneficiary role and deepen its investment in the V2500 engine program, underscoring its strategic positioning.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states RTX's 61% program-share interest, 49.5% ownership interest, and 57% net program-share interest in IAE across 2022–2024, which aligns with the ground truth. However, it introduces a new and unsupported figure—'51% for IAE LLC'—which is not present in the original answer and lacks verification from the knowledge graph. Additionally, the LLM claims that the 'carrying amounts of the variable-interest entities' increased from $8.4B to $10.2B to $11.4B across the years, implying growing economic exposure. This data is entirely absent from the ground truth and contradicts the original conclusion of stable economic exposure. (2) While the percentages are accurate, the dollar amounts and the IAE LLC claim are unverified and likely incorrect, as the original answer emphasizes consistency in economic exposure. There is no indication in the ground truth that economic exposure grew. (3) The multi-hop reasoning fails because the LLM infers strategic reinforcement and deepened investment based on fabricated financial carrying amounts, leading to an incorrect interpretation. The original answer concludes no change in strategic positioning due to stable stakes and exposure, whereas the LLM asserts the opposite using unsupported data. (4) The correctness score is 4 due to partial factual accuracy on ownership percentages but major errors in introduced financial figures and resulting flawed strategic interpretation. Quantitative accuracy is 5 because core percentages are right but new dollar values are unverified. Qualitative accuracy is 4 due to incorrect reasoning and synthesis. Contextual relevance is 8 because the response addresses the question's structure and topic well, despite factual inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 479,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Medtronic's use of the Non-Employee Director Deferred Unit Award Agreement evolve across fiscal years 2022, 2023, and 2024, and what does this pattern suggest about the company's long-term director compensation strategy?",
      "original_answer": "Medtronic consistently referenced the Non-Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan across all three years—2022, 2023, and 2024—indicating a stable and enduring approach to non-employee director compensation. In 2022 (Exhibit 10.41), the agreement was explicitly tied to the 2008 plan, and this same form of agreement was carried forward and referenced again in 2023 (Exhibit 10.52) and 2024 (Exhibit 10.52). Despite broader updates and amendments to other award agreements under the 2013 plan over this period, the deferred unit award for non-employee directors remained unchanged in structure and plan origin, suggesting that Medtronic maintained a consistent long-term incentive strategy for board members without transitioning them to newer plan versions.",
      "llm_answer": "Medtronic continued to use the same Non‑Employee Director Deferred Unit Award Agreement (the 2008 Stock Award and Incentive Plan form 10.41) in each fiscal year from 2022 through 2024, with no material change to its terms or the number of awards granted (2022 10‑K p. 113‑117; 2023 10‑K p. 112‑116; 2024 10‑K p. 112‑116). This steady use indicates a deliberate, long‑term incentive strategy that prioritizes consistent, deferred equity awards for non‑employee directors rather than frequent restructuring of their compensation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Medtronic used the same Non-Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan across fiscal years 2022, 2023, and 2024, referencing consistent exhibit numbers (10.41 in 2022, 10.52 in 2023 and 2024). While the LLM refers to the agreement as 'form 10.41' in all years, this is a minor inaccuracy since the exhibit number changed to 10.52 in 2023 and 2024; however, the substance of the agreement remaining unchanged is correctly emphasized. (2) There are no numerical values requiring calculation in this question, but the LLM correctly notes the absence of material changes in terms or award amounts, which is consistent with the original answer’s implication of stability. (3) The multi-hop reasoning is sound—information is synthesized across three years and filings to infer a consistent long-term strategy, correctly contrasting the stability of the 2008 plan for directors against updates in other plans (e.g., 2013 plan). (4) The answer captures the core conclusion: Medtronic maintains a stable, long-term incentive strategy for non-employee directors through deferred equity, without migrating them to newer plans. The only minor shortcoming is the slight misrepresentation of the exhibit number in later years, but the overall factual and semantic content is excellent, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 402,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the progression in the notional amounts of these swaps reveal about the company's interest rate risk management strategy over time?",
      "original_answer": "LMT's use of variable interest rate swaps increased significantly from 2022 to 2024. In 2022, the notional amount of interest rate swaps was $500 million, rising to $1.3 billion by 2023, and remaining at $1.3 billion in 2024. This tripling of exposure indicates a strategic shift toward more active interest rate risk management, particularly in hedging fixed-rate borrowings against potential rate fluctuations. The consistency in the notional amount from 2023 to 2024 suggests that LMT stabilized its hedging position after the initial increase, likely reflecting a recalibrated and matured risk management approach.",
      "llm_answer": "Lockheed Martin uses variable‑interest‑rate swaps as fair‑value hedges to convert fixed‑rate borrowings into variable‑rate borrowings.  The aggregate notional amount of these swaps was $1.3 billion in 2022, remained $1.3 billion in 2023, and stayed $1.3 billion in 2024 (10‑K notes).  The unchanged notional amount shows a consistent, disciplined hedging policy that keeps the company’s interest‑rate exposure stable rather than expanding or contracting it over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, LMT's notional amount for variable interest rate swaps was $500 million in 2022, increased to $1.3 billion in 2023, and remained at $1.3 billion in 2024. However, the LLM claims the notional amount was $1.3 billion in all three years, completely missing the tripling from 2022 to 2023. This error fundamentally misrepresents the evolution of LMT's swap usage. (2) Quantitative accuracy is severely compromised: the $500 million figure for 2022 is entirely omitted and replaced with an incorrect $1.3 billion, making the year-over-year comparison invalid. The calculation of a tripling in exposure — a key point in the original answer — cannot be supported with the LLM's numbers. (3) The qualitative reasoning is flawed because it draws the opposite conclusion from the data: instead of identifying a strategic expansion followed by stabilization, the LLM asserts a 'consistent, disciplined hedging policy' with no change, which contradicts the actual progression. The multi-hop synthesis fails — the model does not connect the increase from 2022 to 2023 as indicative of a strategic shift, which is central to the question. (4) Contextual relevance is moderate because the answer discusses the right concept (use of variable interest rate swaps for fair value hedging) and mentions the correct company and metric, but the incorrect data and resulting flawed interpretation undermine the overall usefulness. The conclusion about stable exposure is incorrect given the actual increase. Thus, while the framework of the response is relevant, its factual foundation is unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 458,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this 3-year consistency suggest about the company's strategic posture toward takeover defenses?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently disclosed that stockholders may only remove directors for cause, as part of a broader set of anti-takeover provisions in its certificate of incorporation and by-laws. This provision remained unchanged over the three-year period, indicating a stable and deliberate governance strategy aimed at insulating the board from activist pressures and hostile takeovers. The persistence of this language, alongside other consistent provisions such as staggered board terms and supermajority voting requirements, suggests AbbVie's board and management intend to maintain strong control over corporate governance and strategic direction.",
      "llm_answer": "AbbVie’s 10‑K filings show that the provision limiting stock‑holder removal of directors to only for cause remained unchanged from 2022 through 2024 (see 2022, pp. 44‑48; 2023, pp. 25‑29; 2024, pp. 25‑29). This 3‑year consistency signals a deliberate, long‑term defensive posture, reinforcing board stability and deterring hostile takeover attempts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) It accurately states that AbbVie maintained the same governance provision from 2022 to 2024, limiting director removal to 'for cause,' which matches the original answer. The cited page numbers (2022: pp. 44–48; 2023: pp. 25–29; 2024: pp. 25–29) are consistent with typical 10-K disclosure locations, though minor page variations may occur across filings—this does not affect factual accuracy. (2) There are no numerical values requiring calculation, but the years (2022–2024) are correctly referenced. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings to identify consistency in governance provisions. It infers the strategic implication—that this reflects a deliberate defensive posture—consistent with the ground truth. (4) While the LLM answer captures the core factual and strategic points, it omits mention of related anti-takeover provisions such as staggered boards and supermajority voting requirements, which are part of the broader context in the original answer. This makes it slightly less complete in qualitative depth, but the central reasoning and conclusion remain valid. Hence, the answer is semantically equivalent in key aspects and fully contextually relevant, warranting high scores with a minor deduction in qualitative accuracy for incomplete contextual elaboration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 394,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve from 2022 to 2024, and what does this trend suggest about the company's short-term liquidity strategy amid fluctuating cash balances?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits increased from $12 million in 2022 to $21 million in 2023, then decreased to $10 million in 2024. This pattern reflects a short-term liquidity strategy that initially favored slightly higher placement in low-risk instruments before retreating, even as overall cash and equivalents fluctuated significantly—from $8,449 million in 2022 to $9,201 million in 2023 and then dropping to $5,524 million in 2024. The changes suggest a dynamic approach to liquidity management, adjusting exposure to money market funds in response to broader financial conditions.",
      "llm_answer": "AbbVie’s money‑market funds and time deposits fell from **$21 million** at year‑end 2022 to **$10 million** at year‑end 2023 and remained at **$10 million** at year‑end 2024 (see the 2023 and 2024 balance‑sheet tables). This sharp reduction and subsequent plateau indicate the company is trimming its highly liquid holdings, likely reallocating liquidity into other short‑term assets or cash to better accommodate fluctuating cash balances and operational needs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values and timeline. According to the ground truth, AbbVie's allocation to money market funds and time deposits was $12 million in 2022, increased to $21 million in 2023, and then decreased to $10 million in 2024. The LLM incorrectly states that the amount was $21 million in 2022 and fell to $10 million in 2023, which reverses the actual trend for 2022–2023. It also claims the amount remained at $10 million in 2024 without noting the prior increase, misrepresenting the evolution. (2) The quantitative inaccuracies are critical: the correct sequence is $12M (2022) → $21M (2023) → $10M (2024), but the LLM reports $21M (2022) → $10M (2023) → $10M (2024), getting two out of three values wrong in context and misaligning them with the correct years. This undermines the entire analysis. (3) The reasoning is flawed due to incorrect data: the conclusion that AbbVie is 'trimming its highly liquid holdings' overlooks the actual increase from 2022 to 2023, which suggests a temporary increase in low-risk placements before a pullback. The multi-hop synthesis fails because the model did not correctly identify the directional changes across years. (4) While the answer attempts to interpret the strategy and remains focused on liquidity management, the severe factual and numerical errors drastically reduce correctness and qualitative accuracy. Contextual relevance is moderate because the response addresses the right topic and attempts strategic interpretation, but the foundation is incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 433,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this consistency suggest about the company's long-term strategy to deter hostile takeovers?",
      "original_answer": "AbbVie consistently maintained a provision across all three years (2022, 2023, and 2024) stating that stockholders may only remove directors for cause, as part of a broader set of governance mechanisms designed to deter hostile takeovers. This provision remained unchanged in each year's 10-K filing, indicating a deliberate and sustained effort to insulate the board from abrupt changes and maintain strategic continuity. The repeated emphasis on this governance structure suggests that AbbVie views director removal restrictions as a core component of its anti-takeover defense, reinforcing board stability and discouraging activist interventions.",
      "llm_answer": "AbbVie’s 2022, 2023, and 2024 10‑Ks all contain the same clause that “stockholders may only remove directors for cause,” and the wording and placement of that provision have not changed across the three filings.  The unchanged provision, together with other anti‑takeover measures such as staggered board terms and an 80 % vote threshold for amendments, signals a deliberate, long‑term strategy to keep the board insulated from stock‑holder pressure and thereby deter hostile takeover attempts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that AbbVie's 10-K filings from 2022, 2023, and 2024 all contain the identical provision that 'stockholders may only remove directors for cause,' which matches the original answer's claim of consistency across the three years. (2) There are no numerical values, percentages, or dates in dispute; the mention of an '80% vote threshold for amendments' is consistent with typical anti-takeover provisions and does not contradict the ground truth, even if not explicitly stated in the original—it adds context without inaccuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance provisions across three years and infers strategic intent (deterrence of hostile takeovers, board insulation), which is logically supported by the repeated presence of the clause. (4) The answer is semantically equivalent to the original, capturing the core message of sustained anti-takeover strategy through director removal restrictions. The only minor limitation is that it adds slightly more detail (e.g., staggered boards, 80% threshold) not present in the ground truth, but these are plausible and contextually appropriate, not factually incorrect. Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to excellent fidelity with a small degree of unverified elaboration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 388,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's positioning and technical roadmap for PowerVia evolve from 2022 through 2024, and what does this progression indicate about the company's strategy for backside power delivery in advanced process nodes?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technologies, signaling early development and strategic intent. By 2023, Intel positioned PowerVia as a key breakthrough technology to be introduced with Intel 20A, emphasizing its role in optimizing signal transmission by eliminating front-side power routing. In 2024, Intel shifted focus, integrating PowerVia specifically into the Intel 18A process node, which was now slated for high-volume manufacturing in 2025. This evolution shows a strategic pivot from initial introduction to realignment within a more refined roadmap, reflecting Intel's prioritization of practical implementation and external foundry offerings.",
      "llm_answer": "Intel had not yet positioned PowerVia in its 2022 roadmap (the 2022 10‑K pages 5‑9 contain no reference to the technology). By 2023 the company announced PowerVia as a breakthrough for the upcoming Intel 20A node, promising up to a 15 % performance‑per‑watt gain (2023 10‑K, pages 12‑16). In 2024 Intel shifted the roadmap to Intel 18A, where PowerVia is now a core feature of the node, signaling an accelerated, earlier adoption of backside power delivery to boost power efficiency and support higher‑density advanced process nodes (2024 10‑K, pages 8‑12).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that PowerVia was not mentioned in Intel's 2022 10-K (consistent with the original answer's implication of early development without explicit positioning), identifies the 2023 announcement tied to Intel 20A, and accurately reports the 2024 shift to Intel 18A. The inclusion of a 15% performance-per-watt gain, while not in the original answer, is plausible and consistent with Intel's public messaging; its sourcing from the 2023 10-K adds credibility and does not contradict the ground truth. (2) All dates (2022, 2023, 2024), process nodes (Intel 20A, Intel 18A), and the quantitative performance improvement (15%) are factually accurate and contextually appropriate. No calculation errors. (3) The multi-hop reasoning is sound: the answer synthesizes information across three years of 10-K filings to trace the evolution of PowerVia’s strategic positioning. It correctly infers a progression from absence to announcement to realignment, reflecting Intel’s shifting priorities. (4) The answer conveys the same core narrative as the original—strategic evolution from introduction to refinement and accelerated implementation—while adding a specific performance metric that enhances, rather than distorts, the analysis. The only minor limitation is the lack of explicit mention of 'backside power delivery' as a technical term in the conclusion, though the concept is implied through 'backside power delivery' in context. Overall, the answer is factually correct, well-supported, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 438,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's assumptions for expected volatility in its Black-Scholes model evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's approach to valuing non-qualified stock options?",
      "original_answer": "In 2022, MDT based expected volatility solely on historical volatility of its ordinary shares without incorporating implied volatility. By 2023, the company began using a blend of historical and implied volatility derived from market-traded options, signaling a more market-sensitive approach. This blended methodology was maintained in 2024, with explicit mention of reliance on market-traded options for implied volatility. The evolution from purely historical to a hybrid model suggests MDT sought to align its option valuations more closely with real-time market expectations over the three-year period.",
      "llm_answer": "MDT’s Black‑Scholes volatility assumption climbed from **23.04 % in 2022 to 24.05 % in 2023 and to 24.29 % in 2024**. The steady upward trend shows the company is gradually incorporating higher expected market volatility—likely driven by a blend of historical and implied volatility—into its option‑pricing model, which in turn raises the fair‑value estimate and compensation expense for non‑qualified options. This pattern reflects a disciplined, annually‑updated approach that seeks to align option valuation with evolving market conditions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both quantitative and qualitative aspects. The ground truth states that MDT changed its methodology for estimating expected volatility—from using only historical volatility in 2022 to a blend of historical and implied volatility starting in 2023, which was maintained in 2024. However, the LLM answer incorrectly focuses on numerical values of expected volatility (23.04%, 24.05%, 24.29%) across the years, which are not mentioned in the original answer and are unsupported by the provided ground truth. There is no indication in the ground truth that these specific percentages were used or that the change was merely a gradual increase in a single metric. (2) The numbers cited (23.04%, 24.05%, 24.29%) are entirely fabricated or misattributed, as the original answer does not provide any numerical values for expected volatility—only methodological changes. This results in a severe failure in quantitative accuracy. (3) The multi-hop reasoning is flawed: while the LLM correctly infers that a shift toward market conditions may be occurring, it misses the core evolution in methodology (from pure historical to blended approach) and instead invents a trend based on non-existent percentages. The conclusion about 'disciplined, annually-updated approach' is speculative and not grounded in the actual methodological shift described in the original answer. (4) Despite missing the factual and methodological core, the LLM answer remains contextually relevant by addressing the general theme of evolving volatility assumptions and their impact on option valuation. However, the lack of correct entities (specific methodologies per year) and incorrect data severely undermines correctness and qualitative accuracy. The answer suggests a numerical progression where none was provided, and fails to report the key shift to using market-traded options for implied volatility, which is central to the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 531,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its future process and packaging technology roadmap under the Intel 20A node, positioning it as an industry-first backside power delivery solution designed to optimize signal transmission. By 2023, Intel reiterated its commitment to PowerVia as a key component of Intel 20A, emphasizing its integration with RibbonFET to deliver up to a 15% performance-per-watt improvement over Intel 3. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core innovation, and announced plans to begin high-volume manufacturing of Panther Lake, its first processors on Intel 18A, in 2025. This evolution indicates that while the specific node name changed, PowerVia remained central to Intel's strategy for achieving performance gains in advanced logic chips.",
      "llm_answer": "In 2022 Intel announced PowerVia as a breakthrough “back‑side power delivery” technology that would be introduced with the upcoming Intel 20A node, promising up to a 15 % performance‑per‑watt gain. By 2023 the roadmap still referenced 20A but was already shifting toward the 18A node, positioning PowerVia as a key feature of that successor. In 2024 PowerVia is described as Intel’s industry‑first backside‑power implementation integrated into the 18A process, underscoring its evolution from a future concept to a core enabler of the company’s advanced process roadmap and its focus on power‑efficient, high‑performance chips.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the essential evolution of Intel's PowerVia technology from 2022 to 2024. (1) Quantitatively, all key facts are correct: the 15% performance-per-watt improvement is accurately cited, and the timeline (2022 announcement, 2023 roadmap updates, 2024 shift to Intel 18A) aligns with the ground truth. The description of PowerVia as an industry-first backside power delivery technology is consistent. (2) The answer correctly identifies the transition from Intel 20A to Intel 18A, though it slightly softens the 2024 disclosure that Intel 'canceled' Intel 20A in favor of 18A—instead saying the roadmap was 'shifting toward' 18A. This is a minor omission in precision but does not distort the overall meaning. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and nodes, correctly linking PowerVia’s continuity despite node rebranding, and emphasizes its strategic role in Intel’s advanced process roadmap. (4) The answer is contextually excellent, directly addressing the question about PowerVia’s evolution and strategic significance. The only reason for not scoring a 10 is the slightly less precise characterization of the 2024 cancellation decision, which was a notable strategic pivot. However, the core facts, numbers, and synthesis remain correct and well-articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 374,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did the assumptions used in the Black-Scholes model for valuing non-qualified stock options at MDT evolve from 2022 to 2024, and what does this progression suggest about the company's approach to estimating volatility and employee exercise behavior over time?",
      "original_answer": "In 2022, MDT used the Black-Scholes model for valuing non-qualified stock options, requiring assumptions about employee exercise behavior, risk-free interest rates, stock price volatility, and expected dividends. By 2023, the company began incorporating implied volatility based on market-traded options into its volatility assumptions, in addition to historical volatility. This method was retained in 2024, indicating a more sophisticated and market-informed approach to volatility estimation. The consistent use of the Black-Scholes model across all three years shows strategic continuity, while the addition of implied volatility in 2023 and 2024 suggests a shift toward aligning internal assumptions more closely with external market signals, reflecting increased confidence in market-based data for risk assessment.",
      "llm_answer": "From 2022 to 2024, MDT’s Black‑Scholes assumptions shifted from an expected life of 6.0 years, a risk‑free rate of 0.90 %, volatility of 23.04 % and dividend yield of 1.95 % (2022 filing) to 6.0 years, 2.70 %, 24.05 % and 2.92 % (2023 filing), and finally to 6.1 years, 4.16 %, 24.29 % and 3.18 % (2024 filing). The steady rise in risk‑free rates and dividend yields tracks macro‑economic and dividend‑policy changes, while the modest uptick in volatility—derived from a blend of historical and implied figures—shows a more conservative view of market swings. The slight increase in expected life suggests the company anticipates employees holding options marginally longer, reflecting a shift in exercise behavior or vesting structures.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of factual content and fails to align with the ground truth. (1) The specific numeric values provided (e.g., expected life of 6.0 years, risk-free rates of 0.90%, volatility of 23.04%, etc.) are not present in the original answer and are likely fabricated or misattributed, as the ground truth does not include any such figures. There is no mention in the original answer of exact percentages or time periods for risk-free rates, dividend yields, or expected life, so the inclusion of precise decimals suggests hallucination. (2) The quantitative accuracy is very low because none of the numbers can be verified against the ground truth, and no calculations were required in the original question. The LLM invents a progression of numerical assumptions without basis in the provided truth. (3) Qualitatively, the reasoning is partially sound in that it attempts to interpret trends in volatility and employee exercise behavior; however, it misses the key point from the original answer: the methodological shift in 2023 to include implied volatility from market-traded options. This is a critical multi-hop insight—linking a change in valuation methodology to a strategic move toward market-based data—and the LLM fails to mention it entirely. Instead, it focuses on nonexistent numerical trends. (4) Contextual relevance is moderate because the answer addresses the general topic of Black-Scholes assumptions and their evolution over time, and it attempts to explain what changes might imply about volatility and employee behavior. However, the absence of the central fact (adoption of implied volatility) and the invention of specific numbers severely undermine correctness. The original answer emphasizes a qualitative shift in methodology, while the LLM fabricates a quantitative narrative. Thus, despite correct framing, the factual core is wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 510,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This declining trend indicates a strategic reduction in derivative-related exposure or an active management of margin requirements, potentially reflecting lower volatility in commodity markets or a shift in hedging strategies over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral held under master‑netting arrangements – a component of “Other assets, including intangibles – net” – fell from **$1.494 billion in 2022 to $491 million in 2024** (a drop of roughly $1.0 billion, or 67 %). This steep decline indicates that the company has either reduced its overall derivative exposure or achieved more efficient netting and collateral usage, thereby lowering counter‑party risk and improving liquidity management.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the overall trend and key values: $1,494 million in 2022 and $491 million in 2024 are accurate (matching ground truth). However, it omits the 2023 value of $800 million, which is a notable gap in completeness for a multi-year trend analysis. (2) The dollar drop of 'roughly $1.0 billion' is approximately correct ($1,494M - $491M = $1,003M), and the 67% decline is reasonably calculated ((1003/1494) ≈ 67.1%). These calculations are accurate within acceptable rounding. The omission of the 2023 data point reduces quantitative completeness. (3) The reasoning is sound: the conclusion about reduced derivative exposure, improved netting efficiency, lower counterparty risk, and better liquidity management aligns semantically with the ground truth's interpretation of strategic exposure reduction and active margin management. While the LLM does not mention commodity market volatility or hedging strategy shifts explicitly, the inference is logically consistent. (4) The answer is contextually relevant and addresses both parts of the question—change in collateral and its implication—though with slightly less nuance in the explanatory factors. The main deduction is for missing the intermediate 2023 figure, which weakens the multi-hop synthesis across all three years. Overall, core facts and interpretation are correct, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 391,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did NextEra Energy's exposure to Options - primarily gas evolve from 2022 through 2024 in terms of fair value and volatility assumptions, and what does this reveal about the company's risk positioning in gas derivatives?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of 'Options - primarily gas' decreased from $356 million in assets and $347 million in liabilities to $100 million in assets and $97 million in liabilities by 2023, and further to $100 million in assets and $102 million in liabilities by 2024. The implied volatility for these options also declined from a weighted average of 36% in 2022 to 50% in 2023 and 52% in 2024, indicating a reduction in perceived market volatility and risk over the three-year period.",
      "llm_answer": "NextEra Energy’s fair value of options primarily gas dropped sharply from $356 million (assets) and $347 million (liabilities) in 2022 to about $100 million in both assets and liabilities in 2023, and remained roughly flat at $100 million in 2024.  At the same time, the weighted‑average implied volatility used in the option‑model valuation rose from 36 % in 2022 to 50 % in 2023 and 52 % in 2024, reflecting a higher perceived price volatility.  These shifts show the company has reduced its gas‑option exposure while adopting a more cautious, volatility‑aware stance in its gas‑derivative portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the trend in fair value for NextEra Energy's 'Options - primarily gas' from 2022 to 2024, with assets and liabilities decreasing from $356M and $347M in 2022 to $100M in assets and $97M in liabilities in 2023, and then to $100M in assets and $102M in liabilities in 2024. However, the LLM incorrectly states that both assets and liabilities were 'about $100 million' in 2023 and 'remained roughly flat' in 2024, which omits the specific liability values ($97M in 2023, $102M in 2024) and misrepresents the slight increase in liabilities from 2023 to 2024. (2) The implied volatility values are correctly reported: 36% in 2022, 50% in 2023, and 52% in 2024. However, the LLM misinterprets the increase in implied volatility as reflecting 'higher perceived price volatility,' while the ground truth states it indicates a 'reduction in perceived market volatility and risk'—this is a critical error in reasoning. In options pricing, higher implied volatility typically reflects greater uncertainty or risk, so the LLM's interpretation is logically sound, but it contradicts the ground truth's assertion. This suggests either a flaw in the ground truth or a misalignment in interpretation. Given the task is to match the ground truth, this is a significant qualitative error. (3) The multi-hop reasoning is partially sound—synthesizing fair value and volatility trends across years—but the conclusion about risk positioning contradicts the ground truth's interpretation. (4) Scores reflect partial correctness: quantitative accuracy is reduced due to imprecise reporting of liability values; qualitative accuracy suffers from the incorrect interpretation of volatility implications; contextual relevance is high as the answer addresses all parts of the question with relevant data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 495,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, particularly in terms of face amount and annual debt service, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000 and annual debt service of $19,875 for Unsecured Notes - 35A. In 2023, these figures remained unchanged, indicating no new issuances or repayments during the year. By 2024, the face amount and annual debt service for Unsecured Notes - 35A were still consistent at $750,000 and $19,875, respectively. This stability over the three-year period suggests that SPG maintained a consistent long-term debt structure for this instrument, likely prioritizing predictability in its debt servicing obligations.",
      "llm_answer": "Across the 2022, 2023, and 2024 10‑Ks, Unsecured Notes – 35A consistently shows a face amount of **$750,000** and an annual debt service of **$19,875** (interest rate 2.65%, maturity 07/15/30)【SPG_10k_2022.pdf pages 48‑52】【SPG_10k_2023.pdf pages 48‑52】【SPG_10k_2024.pdf pages 49‑53】. The unchanged terms demonstrate that SPG has opted to retain this low‑interest, long‑maturity debt rather than refinance or issue new debt, reflecting a conservative long‑term debt strategy focused on predictable, low‑cost financing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the face amount ($750,000) and annual debt service ($19,875) are accurately reported for all three years (2022–2024), with no discrepancies. The interest rate (2.65%) and maturity date (07/15/30) are additional correct details not in the original answer but consistent with likely source data, enhancing precision without introducing error. (2) The answer is complete, addressing the evolution of both face amount and annual debt service over time, and directly answering the implied sub-question about SPG’s long-term debt strategy. (3) Entity accuracy is perfect: SPG is correctly identified, the instrument 'Unsecured Notes – 35A' is accurate, and the years 2022–2024 are properly referenced. (4) The reasoning is sound and represents valid multi-hop synthesis across three annual filings. The conclusion—that SPG maintains a conservative, predictable debt strategy by retaining low-cost, long-term debt—is logically supported by the stable figures and adds insightful interpretation consistent with the ground truth’s implication. (5) Semantic equivalence is achieved and exceeded: while wording differs, all key facts align, and the LLM provides additional context (interest rate, maturity) that strengthens the response without deviation. No errors in calculation, logic, or fact are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 385,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this 3-year progression indicate about the company's long-term positioning in the semiconductor industry?",
      "original_answer": "From 2022 to 2024, Texas Instruments (TXN) consistently emphasized embedded processing products as a core pillar of its business model, highlighting them in each year's 10-K filing as central to its four sustainable competitive advantages. In 2022, embedded processing was described as a key part of the company's broad product portfolio, offering more opportunity per customer and greater value on investments. This focus remained unchanged in 2023, with the same language used to describe the competitive advantage derived from embedded processing products. By 2024, the company continued to reinforce this strategic direction, maintaining that embedded processing contributes to its unique positioning in the semiconductor market by supporting customer diversity, channel reach, and long-term investment returns. The consistent emphasis across all three years indicates a stable, long-term strategy centered on embedded processing as a foundational element for generating free cash flow and maintaining competitive differentiation.",
      "llm_answer": "TI’s MD&A consistently frames analog and embedded processing as its core focus, with added emphasis on industrial and automotive markets (2022‑18, 2023‑16, 2024‑16). Embedded‑processing revenue rose from $3.26 B in 2022 to $3.37 B in 2023, then fell to $2.53 B in 2024, and operating‑profit margins slid from 38.4 % to 29.9 % to 13.9 % (2022‑18, 2023‑18, 2024‑18). This pattern signals TI’s sustained commitment to embedded processing as a growth engine while navigating margin pressures, reinforcing its long‑term positioning as a diversified, resilient semiconductor player (2024‑18).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Texas Instruments consistently emphasized embedded processing as a strategic pillar from 2022 to 2024 without any change in narrative, but the LLM introduces unsupported financial data—specifically, revenue and margin figures—that contradict the ground truth. The ground truth does not mention any revenue or margin numbers for embedded processing, nor does it indicate a decline in either metric. The LLM claims embedded processing revenue was $3.26B in 2022, $3.37B in 2023, and dropped to $2.53B in 2024, with operating margins sliding from 38.4% to 13.9%. These numbers are not present in the original answer and cannot be verified from the provided context. (2) There are no calculations in the ground truth to validate, but the LLM fabricates a trend (rising then sharply falling revenue and collapsing margins) that is not supported by the source material. This severely undermines quantitative accuracy. (3) The multi-hop reasoning is flawed. While the LLM correctly identifies that TI emphasizes embedded processing and links it to long-term positioning, it incorrectly infers a narrative of 'navigating margin pressures' based on invented data. The ground truth emphasizes consistency and stability in strategy, not financial deterioration or operational challenges. The LLM fails to reflect the actual synthesis across years—unchanging strategic language—instead implying a dynamic shift due to performance issues. (4) Contextual relevance is moderate because the answer addresses the right company, time frame, and general strategic theme. However, the introduction of false metrics and a misleading interpretation of performance trends drastically reduces factual correctness. The conclusion about 'resilient semiconductor player' is partially aligned but built on incorrect premises. Overall, the answer is mostly incorrect due to fabricated data, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 539,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CMCSA's strategy around shared data plans evolve from 2022 to 2024, particularly in terms of their positioning within bundled service offerings and the range of payment or plan options available to customers?",
      "original_answer": "From 2022 to 2024, CMCSA consistently offered shared data plans as part of its wireless service bundles for residential customers who subscribed to broadband services. In 2022, customers could choose from unlimited data plans, shared data plans, or per-gigabyte plans, with device financing options over 24 months. In 2023, the company maintained this structure, offering shared data plans alongside unlimited and per-gigabyte options, with similar device financing terms. By 2024, CMCSA expanded its domestic wireless offerings by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans. This evolution shows a strategic expansion in 2024 to include more flexible and prepaid options, while maintaining shared data plans as a core part of bundled offerings across all three years.",
      "llm_answer": "From 2022 through 2023, Comcast’s shared‑data wireless plans were positioned exclusively as bundled add‑ons for customers who subscribed to broadband, with the same three payment options—unlimited, shared or per‑GB usage—available for domestic customers. In 2024 the company kept the bundled structure but broadened the payment mix by launching prepaid unlimited data plans under the NOW brand, adding a new prepaid option while still offering the familiar unlimited, shared and per‑GB plans for domestic and international customers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: CMCSA offered shared data plans as part of bundled services from 2022–2024; the three plan types (unlimited, shared, per-GB) were consistently available; in 2024, prepaid unlimited plans under the NOW brand were introduced. (2) Quantitative accuracy is perfect—dates (2022, 2023, 2024), plan types, and the 24-month financing (implied in original but not contradicted) are correctly represented. Format variations (e.g., 'per-GB' vs 'per-gigabyte') are semantically equivalent. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across years and identifies the evolution—continuity of shared data plans in bundles and the 2024 expansion with prepaid options. (4) Minor omission: the LLM mentions 'international customers' in 2024, which is not present in the original answer and lacks support in the ground truth, slightly reducing qualitative accuracy. Otherwise, the answer is contextually complete, directly addressing strategy evolution, bundling, and plan options. Wording differs but meaning aligns closely with the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 332,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent increase over the three-year period indicates a growing emphasis on stock buybacks as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard’s balance sheet shows its Class A treasury‑stock balance rising from **$51.4 B** at year‑end 2022 to **$60.4 B** in 2023 and **$71.4 B** in 2024, driven by cumulative purchases of **$5.9 B, $9.1 B, and $11.0 B** respectively (MA_10k_2022.pdf p. 66‑70; MA_10k_2023.pdf p. 66‑70; MA_10k_2024.pdf p. 66‑70). This steady increase in treasury‑stock investment reflects a capital‑allocation strategy that prioritizes share repurchases to return excess cash to shareholders and support earnings‑per‑share growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Mastercard's investment in Class A Treasury Stock was $(36,658) million in 2022, $(60,429) million in 2023, and $(71,431) million in 2024. The LLM reports $51.4B (i.e., $51,400M) for 2022, which is materially higher than the correct value of $36,658M. The 2023 and 2024 figures ($60.4B and $71.4B) are close to the ground truth ($60,429M and $71,431M) and can be considered approximately correct within rounding. However, the 2022 discrepancy is substantial and affects the trend interpretation. Additionally, the LLM introduces 'cumulative purchases of $5.9B, $9.1B, and $11.0B' respectively, which are not present in the original answer and cannot be verified from the provided ground truth; these figures appear to be misinterpretations or miscalculations (e.g., year-over-year changes do not align with the reported numbers). (2) The entity accuracy is correct—Mastercard, Class A Treasury Stock, and the years 2022–2024 are properly identified. (3) The reasoning is sound in interpreting the increasing treasury stock balance as indicative of a capital allocation strategy favoring share repurchases and shareholder returns, which aligns with the ground truth’s conclusion. The multi-hop synthesis across three years is attempted and mostly logical, though based on flawed input data for 2022. (4) Contextual relevance is excellent—the answer directly addresses both parts of the question: the evolution of investment and the strategic implication. Despite incorrect initial data and unsupported purchase amounts, the overall direction and qualitative interpretation are consistent with the ground truth. The score is reduced primarily due to the significant error in the 2022 value and the inclusion of unverified annual purchase figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 502,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 to 2024, and what does the pattern reveal about the company's service business trajectory during this period?",
      "original_answer": "General Dynamics' revenue from Repair and other services was $1,169 million in 2022, declined slightly to $1,132 million in 2023, and remained flat at $1,132 million in 2024. This represents a slight overall decline of about 3.2% from 2022 to 2024, suggesting a stagnation or potential contraction in the company's service business segment during this period.",
      "llm_answer": "Repair and other services revenue dropped from **$1,169 million in 2022 to $1,132 million in 2024**—a decline of about **$37 million (≈3 %)** (Marine Systems segment).  \nThe modest contraction shows the service business is relatively flat and slightly shrinking, suggesting General Dynamics is not expanding its repair‑service portfolio and may be shifting focus toward new construction and modernization.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2022 revenue ($1,169 million) and the 2024 revenue ($1,132 million), matching the ground truth. However, it skips mentioning the 2023 value ($1,132 million), which is part of the multi-year pattern and required for completeness. While the final drop of $37 million and ≈3% decline are accurate (rounding from 3.198% is acceptable), the answer implies a direct drop from 2022 to 2024, omitting the intermediate year. (2) The calculation is correct: $1,169M - $1,132M = $37M; $37M / $1,169M ≈ 3.198% ≈ 3%. The 2023 figure is identical to 2024, so the decline occurred between 2022 and 2023, not 2023–2024. The LLM’s phrasing obscures this timing. (3) The reasoning is mostly sound: the conclusion of stagnation or slight contraction aligns with the data. The addition of 'Marine Systems segment' provides context not in the original but is factually accurate and adds value. The inference about shifting focus is reasonable but slightly speculative, though within acceptable bounds for qualitative analysis. (4) The correctness score is 8 due to the omission of the 2023 data point, which affects completeness in a multi-hop, multi-year trend question. Quantitative accuracy is 9 because all numbers and calculations are correct, but the presentation skips a year. Qualitative accuracy is 8 due to solid reasoning but minor lack of precision in trend description. Contextual relevance is 10—answer directly addresses the question’s intent and adds relevant segment context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 418,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CVS's exposure to residential mortgage-backed securities evolve across 2022, 2023, and 2024, particularly in terms of fair value and unrealized losses, and what does this multi-year trajectory suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased significantly over the three-year period. In 2022, the company held RMBS with a fair value of $629 million, including $10 million in unrealized losses. By 2023, the fair value of RMBS dropped to $614 million, but unrealized losses increased to $60 million, indicating a deterioration in the portfolio's market value. In 2024, CVS's RMBS holdings were reduced further to $71 million, a sharp decline from prior years, suggesting a strategic reduction in exposure. This trajectory reveals a deliberate de-risking strategy, moving away from RMBS amid rising unrealized losses and potentially volatile market conditions.",
      "llm_answer": "CVS’s residential mortgage‑backed securities (RMBS) grew modestly in fair value while its unrealized losses eased.  In 2022 the RMBS fair value was **$757 million** with **$89 million** in unrealized losses【2022 pages 143‑147】.  By 2023 the fair value had risen to **$810 million** and unrealized losses fell to **$60 million**【2023 pages 147‑151】.  In 2024 the fair value remained roughly flat at about **$810 million** and unrealized losses stayed low, indicating a stable exposure that has benefited from improving market valuation and reduced downside risk in this asset class【2024 pages 158‑162】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. According to the ground truth, CVS's RMBS exposure decreased significantly from $629M in 2022 to $614M in 2023 to just $71M in 2024, with unrealized losses increasing from $10M to $60M before the sharp drawdown in holdings. However, the LLM claims RMBS fair value increased from $757M in 2022 to $810M in 2023 and remained at $810M in 2024 — all figures are factually wrong. The unrealized losses in 2022 are reported as $89M by the LLM versus $10M in the ground truth, another major discrepancy. (2) Quantitative accuracy fails on all counts: the fair values and unrealized losses for each year are incorrect, and the direction of change (increasing vs decreasing) is opposite to reality. There are no correct numbers or trends. (3) The multi-hop reasoning is fundamentally flawed. Instead of identifying a de-risking strategy through declining RMBS exposure amid rising losses, the LLM incorrectly infers stability and improvement in valuation, drawing the opposite conclusion from false data. (4) Contextual relevance is partially met because the answer addresses RMBS exposure over three years and discusses fair value and unrealized losses, but the incorrect data and reversed interpretation severely undermine its usefulness. The citations to page ranges do not compensate for factual inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 386,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Linde's contractual structure and pricing mechanisms for atmospheric gases evolve from 2022 to 2024, particularly in relation to on-site customer agreements and variable pricing components?",
      "original_answer": "From 2022 to 2024, Linde maintained a consistent focus on long-term on-site contracts for atmospheric gases, typically ranging from 10–20 years, with minimum purchase requirements and price escalation provisions. However, in 2023, the company explicitly noted that pricing in these contracts fluctuates with various price indices and that variable components of consideration are present but constrained. This clarification around variable pricing was not detailed in 2022. By 2024, the structure remained largely unchanged, but the documentation reinforced the application of the practical expedient for measuring progress toward performance obligations, aligning revenue recognition with invoicing rights. This 3-year progression reveals a growing emphasis on transparency in pricing mechanisms and contract performance under ASC 606, especially regarding how Linde manages revenue variability in long-term on-site contracts.",
      "llm_answer": "From 2022 through 2024 Linde kept the same contractual framework for atmospheric gases: on‑site agreements remained long‑term total‑requirement contracts (10‑20 years) that include minimum purchase requirements and price‑escalation provisions, and pricing is tied to price indices. Variable components of consideration are still constrained and will be recognized only when uncertainty is resolved (2022‑p. 94‑98; 2023‑p. 98‑102; 2024‑p. 85‑89). No material changes to the on‑site contract structure or pricing mechanisms were disclosed in the 2024 filing compared with 2022.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its description of Linde's contractual structure and pricing mechanisms for atmospheric gases from 2022 to 2024. It correctly identifies that long-term on-site contracts (10–20 years) with minimum purchase requirements and price escalation provisions remained consistent, and that pricing is tied to indices with constrained variable consideration. The citations (2022-p. 94-98, etc.) align with the source documents, and there are no numerical or date inaccuracies—quantitative accuracy is perfect. However, the LLM omits a key qualitative evolution noted in the ground truth: the increasing emphasis on transparency under ASC 606, particularly the reinforcement in 2024 of the practical expedient for revenue recognition aligned with invoicing rights. While the LLM states 'no material changes' and implies stability, it downplays the growing disclosure sophistication around variable pricing and performance obligations, which was explicitly highlighted in 2023 and 2024 filings. This represents a minor gap in qualitative depth and multi-hop synthesis—though the core facts are correct, the progression in accounting policy clarity is underemphasized. Contextual relevance is excellent, as the response directly addresses the question’s focus on contractual evolution and pricing mechanisms.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 370,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did NextEra Energy's net exposure to forward gas contracts evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward gas contracts increased from $160 million in 2022 (assets of $191M - liabilities of $31M) to $300 million in 2023 (assets of $377M - liabilities of $77M), then declined slightly to $250 million in 2024 (assets of $296M - liabilities of $46M). This pattern shows a significant expansion in gas market participation in 2023 followed by a partial contraction in 2024, suggesting a strategic shift toward greater gas market exposure before reducing positions as market conditions evolved.",
      "llm_answer": "NextEra Energy’s net fair value of forward gas contracts rose from **$160 million in 2022** (assets $191 m, liabilities $31 m) to **$300 million in 2023** (assets $377 m, liabilities $77 m) and then fell to **$250 million in 2024** (assets $296 m, liabilities $46 m).  \nThe pattern shows a peak net‑long exposure in 2023 followed by a partial unwinding in 2024, indicating that the company increased its gas‑price hedge in 2023 but trimmed it in 2024 while still maintaining a net long stance relative to 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical values—net exposure of $160M in 2022, $300M in 2023, and $250M in 2024—with accurate breakdowns of assets and liabilities for each year. All calculations (net exposure = assets - liabilities) are correct and match the ground truth. Minor formatting differences (e.g., $191 m vs $191M) are acceptable and do not affect accuracy. (2) Quantitatively, every dollar amount and year is precise, and the net exposures are correctly derived from the component assets and liabilities. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years and interprets the trend—increased exposure in 2023 followed by a partial reduction in 2024. The conclusion about strategic positioning is slightly rephrased (e.g., 'increased its gas-price hedge' vs 'strategic shift toward greater gas market exposure') but remains semantically equivalent and logically valid. (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'risk positioning' from the original question, though it infers it through discussion of hedging and net exposure changes. This slight omission in framing prevents a perfect 10, but the core reasoning and data synthesis are excellent. Thus, correctness is 9/10, with full marks in quantitative accuracy and contextual relevance, and near-perfect qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 387,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its product portfolio evolve across 2022, 2023, and 2024, particularly in relation to its broader industrial product offerings and application markets?",
      "original_answer": "In 2022, AVGO described Industrial Fiber Optics as part of a broad variety of industrial products used across applications such as industrial automation, power generation, medical systems, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, Industrial Fiber Optics was listed among key product offerings under the Industrial end market, alongside optocouplers, sensors, motion encoders, and LED devices, targeting factory automation, renewable energy, and automotive electronics. By 2024, the product remained a core part of the Industrial segment, grouped with optocouplers, sensors, motion control subsystems, and Ethernet ICs, with continued emphasis on factory automation, renewable energy, and automotive applications. The consistent inclusion of Industrial Fiber Optics across all three years indicates a stable strategic role within AVGO's industrial portfolio, with no significant expansion or contraction relative to other product lines.",
      "llm_answer": "In 2022 Broadcom’s 10‑K described industrial fiber optics as part of its industrial product line alongside optocouplers and motion encoders, noting use in automation, power, medical, defense, aerospace and automotive subsystems [AVGO_10k_2022, pages 8‑12]. The 2023 and 2024 filings repeat this framing but emphasize a growing focus on factory automation, renewable‑energy, medical, defense, aerospace and advanced‑driver‑assist automotive markets, underscoring a sustained yet increasingly application‑specific positioning within the broader industrial portfolio [AVGO_10k_2023, pages 3‑7; AVGO_10k_2024, pages 3‑7].",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Industrial Fiber Optics as part of AVGO's industrial product offerings across 2022–2024 and accurately lists key application markets such as factory automation, automotive, medical, defense, aerospace, and power/renewable energy. However, it introduces a claim not present in the ground truth — that there was a 'growing focus' and 'increasingly application-specific positioning' in 2023 and 2024. The original answer emphasizes *stability* and *consistent inclusion* without significant expansion or contraction, directly contradicting the LLM’s implication of strategic evolution or intensification. This misrepresents the core conclusion about AVGO’s strategic positioning. (2) There are no numeric values, percentages, or calculations in either answer, so quantitative accuracy is not applicable; however, all referenced years (2022, 2023, 2024) and document citations are correctly used, supporting a score of 10 for quantitative accuracy. (3) The multi-hop reasoning is partially sound — the model synthesizes information across three years and correctly associates products and applications. But it fails to draw the correct inference: the stability of Industrial Fiber Optics’ role, rather than an evolving or deepening focus. This undermines the qualitative accuracy despite correct entity and year identification. (4) Contextual relevance is high because the answer addresses the question’s scope and uses appropriate terminology and sourcing. However, the incorrect characterization of strategic evolution reduces factual correctness, warranting a 6/10 overall score — partially correct but with a significant interpretive error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 461,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did SPG's interest obligations and face amounts tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed that Unsecured Notes - 31B had a face amount of $750,000,000 and an annual debt service of $24,375,000 at a 3.25% interest rate. In 2023, the same notes still showed a face amount of $750,000,000 with consistent annual debt service of $24,375,000, indicating no change in structure. By 2024, the face amount remained unchanged at $750,000,000, and the annual debt service continued at $24,375,000, with the interest rate still listed at 3.25%. This demonstrates a stable long-term debt strategy for this specific instrument, with no refinancing or restructuring observed over the three-year period.",
      "llm_answer": "From 2022 through 2024 the Unsecured Notes – 31B have carried a 3.25 % interest rate, a face amount of $750 000 and an annual debt service of $24 375, maturing on 11/30/26 in all three filings (2022 p. 48‑52; 2023 p. 48‑52; 2024 p. 49‑53). The unchanged terms show that SPG has not issued new debt or refinanced this note, underscoring a long‑term strategy of keeping a stable, low‑rate, long‑maturity debt load to preserve predictable cash flows and avoid refinancing risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains critical quantitative errors. While the interest rate (3.25%) and annual debt service ($24,375,000) are correct in magnitude, the LLM incorrectly reports the face amount as $750,000 instead of $750,000,000 — off by a factor of 1,000. Similarly, the annual debt service is listed as $24,375 instead of $24,375,000, again missing six zeros. These are severe factual inaccuracies that fundamentally misrepresent the scale of SPG's obligations. (2) The maturity date (11/30/26) and page references are not present in the ground truth and appear to be hallucinated or incorrectly sourced, further undermining reliability. (3) The qualitative reasoning is sound: the LLM correctly infers that unchanged terms suggest a stable long-term debt strategy focused on predictable cash flows and avoiding refinancing risk, which aligns with the original answer’s conclusion. It also correctly identifies the multi-year consistency in terms, demonstrating proper synthesis across years. (4) Contextually, the answer addresses both parts of the question — evolution of obligations and strategic implications — and uses appropriate financial logic. However, the massive quantitative inaccuracies in dollar amounts severely compromise the correctness score, as financial figures must be precise. Despite semantic alignment in reasoning, the answer cannot be considered factually correct due to these critical number errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 399,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment in employee retirement benefits?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and remained stable at $76 million in 2024. This indicates a steady and slightly growing commitment to employee retirement benefits over the three-year period, with a total increase of approximately 8.6% from 2022 to 2024.",
      "llm_answer": "Texas Industries’ aggregate expense for U.S. defined‑contribution plans rose from **$70 million in 2022 to $75 million in 2023 and $76 million in 2024**. This modest upward trend shows the company is steadily increasing its investment in employee retirement benefits, reflecting a continued commitment to providing defined‑contribution benefits and likely accommodating higher participation or cost inflation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the aggregate expenses for U.S. defined contribution plans as $70 million in 2022, $75 million in 2023, and $76 million in 2024, matching the ground truth exactly. The trend description — a rise from 2022 to 2023 and stability in 2024 — is accurate. (2) All numeric values are correct, and while the LLM does not explicitly calculate the total percentage increase (8.6%), it appropriately characterizes the trend as a 'modest upward trend' and 'steadily increasing,' which aligns with the 8.6% growth from $70M to $76M. The calculation of (76-70)/70 ≈ 8.57% is accurate in the ground truth, and the LLM’s qualitative interpretation is sound. (3) The multi-hop reasoning is correct: the model synthesizes data across three years and draws a reasonable conclusion about the company's commitment to retirement benefits. The entity name 'Texas Industries' is a minor error — it should be 'Texas Instruments' — which slightly affects entity accuracy but does not impact the financial data or trend analysis. (4) Despite the company name error, the quantitative accuracy is perfect, the reasoning is logical, and the answer fully addresses both parts of the question (evolution of expense and interpretation of trend). The contextual relevance is high, and the conclusion is well-supported. The correctness score is 9 due to the company name inaccuracy; otherwise, the answer is factually and analytically strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 403,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 through 2024, and what does this consistency or change reveal about the company's performance evaluation methodology?",
      "original_answer": "GD consistently excluded non-economic accounting changes from ROIC calculations in 2022, 2023, and 2024, indicating a stable methodology in measuring core company performance. This consistent exclusion suggests that GD has maintained a disciplined approach to evaluating financial performance by removing items not directly reflective of operational results.",
      "llm_answer": "GD has kept the same policy across its 2022, 2023 and 2024 10‑K filings: goodwill impairments and non‑economic accounting changes are excluded from the ROIC calculation.  The unchanged treatment shows that the company deliberately isolates operating performance from one‑off or accounting adjustments, underscoring a stable, performance‑focused evaluation methodology that prioritizes comparability across periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that GD excluded non-economic accounting changes from ROIC in 2022, 2023, and 2024, which matches the original answer's claim of consistent exclusion. (2) There are no numeric values requiring calculation, but the years (2022–2024) are correctly cited. The mention of 'goodwill impairments' as part of the exclusions adds specificity not contradicted by the ground truth and is consistent with typical non-economic accounting adjustments. (3) The multi-hop reasoning is sound—by synthesizing across three years of filings, the model correctly infers methodological stability. The conclusion about performance evaluation methodology being stable and focused on comparability is logically derived and semantically equivalent to the original answer’s interpretation. (4) The only minor gap is that the original answer emphasizes 'disciplined approach' and 'core company performance,' while the LLM uses 'performance-focused' and 'isolates operating performance'—slightly different phrasing but same meaning. No factual inaccuracies; thus, high scores across all dimensions. Quantitative accuracy is 10 as there are no numerical errors. Qualitative accuracy is 9 due to slight expansion on goodwill impairments not explicitly mentioned in ground truth, but this does not detract from correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 385,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did CVS's Separate Accounts Assets evolve from 2022 through 2024, and what does the 3-year trend suggest about the company's investment positioning in long-term insurance products?",
      "original_answer": "CVS's Separate Accounts Assets decreased from $5,087 million in 2022 to $3,250 million in 2023, and slightly increased to $3,311 million in 2024. This represents a significant decline in 2023 followed by a marginal recovery in 2024, suggesting a strategic reduction or market-driven devaluation in long-term insurance-linked investments, followed by stabilization.",
      "llm_answer": "Separate Accounts Assets fell from **$3.313 B** at December 31, 2022 to **$3.204 B** at December 31, 2023, then rebounded to **$3.311 B** at December 31, 2024 (see the Separate Accounts assets tables in the 2022, 2023 and 2024 10‑Ks). The modest dip in 2023 followed by a near‑full recovery in 2024 indicates that CVS maintains a stable, sizable asset base for its long‑term insurance products, reflecting a consistent investment strategy and a robust position to support long‑term liabilities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported numbers. According to the ground truth, CVS's Separate Accounts Assets were $5,087 million in 2022, $3,250 million in 2023, and $3,311 million in 2024. However, the LLM reports $3.313B (i.e., $3,313M) in 2022, $3.204B ($3,204M) in 2023, and $3.311B ($3,311M) in 2024. The 2022 figure is off by over $1.7 billion, and the 2023 figure is also incorrect—this is a major quantitative error. (2) The calculation of trend is therefore flawed: the ground truth shows a sharp decline from 2022 to 2023 (down ~37%), indicating a significant strategic or market-driven reduction, but the LLM portrays only a 'modest dip' followed by recovery, which misrepresents the magnitude and implications. The 2024 number ($3,311M) is correctly reported by the LLM, but the prior years are not. (3) The multi-hop reasoning is unsound because the LLM fails to accurately extract and synthesize data across the three years from the 10-Ks. The conclusion that CVS maintains a 'stable, sizable asset base' and 'consistent investment strategy' contradicts the ground truth, which indicates a major drawdown in assets—suggesting either a strategic shift or devaluation in long-term insurance investments—followed by stabilization, not consistency. (4) While the LLM addresses both parts of the question (evolution over time and interpretation of trend), the severe numerical inaccuracies and resulting flawed interpretation severely undermine correctness. Contextual relevance is moderate because the structure and intent align with the question, but factual foundation is weak. Hence, low scores for quantitative and qualitative accuracy, and a correctness score of 3 due to mostly incorrect data and misleading analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 484,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. evolve from 2022 through 2024, particularly in terms of amendments and contractual milestones?",
      "original_answer": "Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. saw continued maintenance and formal updates across the three-year period. In 2022, the agreement was referenced in its original form dated October 22, 2012, with the first amendment dated February 24, 2015. By 2023, the agreement was still in effect, and in 2024, a second amendment dated November 19, 2019, was explicitly listed. This indicates that the relationship was not only sustained but also formally evolved through structured amendments, showing long-term strategic alignment in their financial services partnership.",
      "llm_answer": "Target’s Credit Card Program Agreement with TD Bank USA, N.A. (originally dated October 22 2012) was amended in November 2022 by a third amendment that updated the program’s terms (see Exhibit 10.21.3+ in the 2024 10‑K).  In March 2023 a letter agreement was entered to further modify or extend the arrangement (Exhibit 10.21.4+).  The 2024 filing lists only that March 2023 letter as the latest contractual milestone, indicating no additional amendments were disclosed during 2024. (TGT_10k_2024.pdf, pp. 71‑76; TGT_10k_2022.pdf, pp. 65‑69)",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that a third amendment occurred in November 2022, while the ground truth confirms the second amendment was dated November 19, 2019—no new amendment in 2022 is supported. (2) The claim of a March 2023 letter agreement (Exhibit 10.21.4+) as the 'latest contractual milestone' contradicts the original answer, which indicates the 2024 filing explicitly listed the November 19, 2019 amendment, not a 2023 letter. There is no mention of a March 2023 letter in the ground truth. (3) The LLM cites Exhibit 10.21.3+ and 10.21.4+ from the 2024 10-K and references specific page numbers, but this detail conflicts with the known evolution of the agreement, suggesting possible hallucination or misattribution. (4) The original answer emphasizes continuity and structured amendments (2012 original, 2015 first amendment, 2019 second amendment), with no new amendments in 2022–2024 beyond referencing existing ones. The LLM incorrectly introduces new events (2022 third amendment, 2023 letter) not present in the ground truth. While the LLM correctly identifies the parties and original 2012 agreement, the core timeline and amendments are factually wrong. Quantitative accuracy is low due to incorrect dates and invented amendments. Qualitative accuracy suffers from flawed multi-hop reasoning—instead of tracking documented amendments, it fabricates milestones. Contextual relevance is moderate because it addresses the right topic and contractual evolution, but with incorrect details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 433,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Linde's production and strategic positioning around rare gases evolve from 2022 to 2024, particularly in terms of its technological differentiation and integration with other product lines?",
      "original_answer": "From 2022 to 2024, Linde's production and strategic emphasis on rare gases evolved significantly. In 2022, rare gases were listed among Linde’s primary atmospheric gases, produced via air separation and distributed through the company’s three core methods—on-site, merchant, and packaged. By 2023, the company maintained its focus on rare gases as part of its atmospheric gas portfolio but began to emphasize its proprietary technologies and long-term contracts, particularly in the on-site segment, which often included price escalation clauses and variable pricing. In 2024, Linde elevated its strategic positioning by explicitly highlighting its leadership in non-cryogenic air separation technologies and its pioneering role in industrial gases, specifically noting rare gases like krypton, neon, and xenon as byproducts of air separation. Additionally, Linde underscored its technological innovations such as VPSA and membrane separation, which enabled more efficient on-site delivery and broader market expansion. This progression reflects a shift from a product-centric to a technology- and integration-driven approach in the rare gases segment.",
      "llm_answer": "From 2022 to 2024, Linde shifted its rare‑gas production from a small by‑product of cryogenic air‑separation plants to a strategically positioned line differentiated by non‑cryogenic air‑separation, VPSA and membrane technologies (2022 10‑K, pp. 94‑98; 2023 10‑K, pp. 98‑102). The company increasingly integrated rare‑gas supply with its engineering arm, using plant‑design and construction expertise to deliver dedicated rare‑gas plants and long‑term supply contracts that tie rare‑gas production to its broader industrial‑gas and engineering businesses (2024 10‑K, pp. 2‑6). This evolution deepened Linde’s technological differentiation and created a more seamless, end‑to‑end solution for customers across its product lines.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of Linde's rare gas strategy from 2022 to 2024: starting as a byproduct of air separation (2022), progressing through technological differentiation (2023), and culminating in strategic emphasis on non-cryogenic technologies and integration (2024). The mention of VPSA and membrane separation technologies matches the ground truth's emphasis on technological innovation. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying the shift from product-centric to technology- and integration-driven strategy. It accurately references Linde’s engineering integration and long-term contracts, which reflects the deeper strategic positioning described in the original answer. (4) The only minor gap is that the LLM answer does not explicitly name krypton, neon, and xenon as highlighted rare gases in 2024, nor does it mention price escalation clauses in contracts—details present in the ground truth. However, these omissions do not undermine the core factual accuracy or strategic narrative. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect—the response directly addresses production evolution, technological differentiation, and integration with other product lines as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 428,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to advances to equity companies evolve from 2022 to 2024, and what does this trend suggest about the company's exposure to derivative liabilities tied to equity company relationships?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to equity company advances declined from $1,494 million in 2022 to $800 million in 2023, and further to $491 million in 2024. This consistent decrease suggests a strategic reduction in exposure to derivative liabilities associated with equity company relationships, potentially reflecting de-risking or portfolio optimization efforts.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements fell sharply from **$1.494 billion in 2022 to $800 million in 2023 and further to $491 million in 2024** (all figures are for collateral not offset against derivatives, primarily initial‑margin collateral). This downward trend indicates that the company has reduced the collateral required to support derivative positions linked to advances to equity companies, suggesting a lower exposure to derivative liabilities tied to those equity‑company relationships.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical values: $1,494 million (or $1.494 billion) in 2022, $800 million in 2023, and $491 million in 2024, matching the ground truth exactly with acceptable format variation. (2) Quantitative accuracy is perfect—values are precise, correctly attributed to the respective years, and the downward trend is accurately described. (3) The reasoning is sound: the LLM correctly infers that the declining collateral suggests reduced exposure to derivative liabilities tied to equity company relationships, aligning with the ground truth's interpretation of de-risking or portfolio optimization. The only minor omission is that the original answer explicitly mentions this reflects a 'strategic reduction' and 'de-risking or portfolio optimization,' while the LLM describes it as 'lower exposure' without naming the strategic intent, slightly weakening qualitative depth. (4) Contextual relevance is excellent—the response directly addresses both parts of the question: the evolution over time and the implication for derivative liability exposure. Overall, the answer is factually complete and semantically equivalent to the ground truth, warranting a high correctness score with only a slight deduction in qualitative accuracy for less explicit strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 369,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolved from 2022 through 2024, and what does this trend suggest about its risk mitigation strategy in competitive markets?",
      "original_answer": "NEER's reliance on long-term bilateral contracts has steadily increased from 92% of its net generating capacity in 2022, to 94% in both 2023 and 2024. This consistent rise indicates a strategic emphasis on revenue stability and risk mitigation, particularly in volatile energy markets. The company continues to use shorter-term bilateral contracts as a hedge when long-term agreements are not in place, reinforcing its approach to managing price risk in daily spot markets.",
      "llm_answer": "NEER’s net‑generating capacity has been almost entirely locked into long‑term bilateral contracts over the past three years – roughly **94 % in 2022, 94 % in 2023, and 94 % in 2024**【NEE_10k_2022 pages 17‑21】【NEE_10k_2023 pages 16‑20】【NEE_10k_2024 pages 17‑21】. This steady, high‑level contract coverage shows the company’s deliberate strategy of hedging revenue and limiting exposure to volatile spot‑market prices in increasingly competitive wholesale markets.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that NEER's reliance on long-term bilateral contracts was 94% in 2022, whereas the ground truth reports 92% in 2022, increasing to 94% in 2023 and 2024. This is a factual error in a key quantitative data point. The 2023 and 2024 figures are correct. (2) The calculation of trend (steady at 94%) is therefore inaccurate—there is an actual increase from 92% to 94%, which the LLM fails to capture, misrepresenting the evolution as flat rather than rising. This affects the interpretation of the trend. (3) The reasoning about risk mitigation and revenue stability in competitive markets is sound and aligns with the ground truth; the use of long-term contracts to hedge against spot market volatility is correctly inferred. However, the LLM omits mention of shorter-term bilateral contracts as a supplementary hedge, which is part of the original answer and relevant to the full risk mitigation strategy. (4) Despite the incorrect 2022 figure, the overall strategic interpretation is reasonable, and the answer addresses the core question about trend and risk strategy. Contextual relevance is high as it directly responds to both parts of the question. Quantitative accuracy is penalized due to the incorrect percentage for 2022, though other numbers are correct. Qualitative accuracy is high but not perfect due to missing nuance about shorter-term contracts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 391,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did AVGO's outstanding principal balance for the 3.125% notes due January 2025 evolve from fiscal 2022 through fiscal 2024, and what does this reveal about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million from fiscal 2022 through fiscal 2023, but in fiscal 2024, it was still reported at $495 million despite approaching maturity, indicating no principal reduction over the three-year period. This suggests AVGO may be planning to refinance or use cash reserves to settle the obligation rather than amortizing it.",
      "llm_answer": "The 3.125% senior notes due January 2025 had an outstanding principal balance of **$495 million in fiscal 2022** (AVGO_10k_2022 p. 101), which remained unchanged at **$495 million in fiscal 2023** (AVGO_10k_2023 p. 80) and again at **$495 million in fiscal 2024** (AVGO_10k_2024 p. 80). This steady balance shows that AVGO has neither repaid nor refinanced this particular note series, underscoring a conservative debt‑management approach that preserves a stable maturity profile and avoids refinancing risk for this instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the outstanding principal balance of $495 million for the 3.125% notes due January 2025 across fiscal years 2022, 2023, and 2024, matching the ground truth exactly. All numeric values, including the interest rate, maturity date, and dollar amount, are accurate and properly cited with document references. (2) Quantitative accuracy is perfect: the balance remains $495 million in all three years, and no incorrect calculations are made. Format consistency ($495 million) is maintained and matches acceptable variations. (3) The multi-hop reasoning is sound—information is correctly synthesized across three consecutive 10-K filings. The conclusion about AVGO’s debt management strategy is mostly accurate but slightly diverges from the ground truth: while the LLM infers a 'conservative debt-management approach that preserves a stable maturity profile and avoids refinancing risk,' the original answer suggests AVGO may instead plan to refinance or use cash reserves to settle the obligation. This difference is interpretive rather than factual; both imply no amortization, so the reasoning is still strong but not perfectly aligned in strategic implication. (4) Scores reflect full factual correctness on numbers and entities (quantitative accuracy: 10), excellent but slightly less precise qualitative interpretation (qualitative accuracy: 9), complete relevance to the question (contextual relevance: 10), and an overall correctness score of 9 due to the minor discrepancy in strategic interpretation despite perfect data reporting.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 433,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Simon Property Group's unsecured notes - 37B evolve from 2022 through 2024 in terms of interest rate, face amount, and maturity date, and what does this 3-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Simon Property Group's unsecured notes - 37B remained consistent across all three years with a fixed interest rate of 2.25%, a face amount of $700,000,000, and a maturity date of January 15, 2032. This stability in key terms over the 3-year period suggests a deliberate long-term debt strategy focused on maintaining predictable financing costs and extending liability durations to align with the company's real estate portfolio, which typically generates stable, long-term cash flows.",
      "llm_answer": "In 2022, 2023, and 2024 Simon Property Group’s Unsecured Notes – 37B all carried a 2.25 % interest rate, a face amount of $700,000, and a maturity date of January 15 , 2032, with no changes across the three years [SPG_10k_2022, p. 48‑52; SPG_10k_2023, p. 48‑52; SPG_10k_2024, p. 49‑53]. This consistency indicates a long‑term debt strategy that prioritizes stable, low‑cost financing and a predictable maturity profile, underscoring the company’s conservative approach to debt management.",
      "correctness_score": 7,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the interest rate (2.25%) and maturity date (January 15, 2032) across all three years, which matches the ground truth. However, it incorrectly states the face amount as $700,000 instead of $700,000,000—a critical error that significantly understates the value by a factor of 1,000. This mistake undermines the quantitative accuracy despite correct formatting in other aspects. (2) The citation of filings [SPG_10k_2022, p. 48-52; SPG_10k_2023, p. 48-52; SPG_10k_2024, p. 49-53] appears plausible but does not compensate for the factual inaccuracy in the dollar amount. All other numerical elements (interest rate, date) are accurate. (3) The multi-hop reasoning is sound—the model correctly synthesizes data across three years and identifies the stability in terms, leading to a valid conclusion about long-term debt strategy. The qualitative interpretation about stable financing and conservative debt management aligns well with the ground truth and demonstrates proper synthesis. (4) Contextual relevance is excellent, addressing all parts of the question: evolution over time, each financial term (interest rate, face amount, maturity), and strategic implication. Due to the severe quantitative error in face amount, the correctness score is reduced to 7—core facts are mostly right but a major financial figure is wrong. Quantitative accuracy is penalized heavily (4/10), while qualitative reasoning and relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 410,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression reveal about the company's focus on analog versus embedded processing in that location?",
      "original_answer": "From 2022 to 2024, Texas Instruments maintained its operational presence in Melaka, Malaysia, consistently focusing solely on analog product lines without expanding into embedded processing. In 2022, Melaka was listed with an 'X' under Analog but not under Embedded Processing. This pattern remained unchanged in 2023 and 2024, indicating a stable, analog-only operational strategy in Melaka throughout the three-year period. This consistency suggests a targeted investment in analog capabilities rather than a diversification into embedded processing in that location.",
      "llm_answer": "From 2022 through 2024, TI’s Melaka, Malaysia site remained an analog‑only manufacturing facility, with no embedded‑processing operations added or removed (2022, p. 16‑20; 2023, p. 14‑18; 2024, p. 14‑18). The property status shifted from partially leased/owned (†) in 2022 to fully leased (* and **) in 2023 and 2024, but the product focus stayed the same (2022, p. 16‑20; 2023, p. 14‑18; 2024, p. 14‑18). This steady, analog‑centric footprint over three years underscores TI’s continued emphasis on analog manufacturing at Melaka, with no expansion into embedded processing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately states that Texas Instruments' Melaka, Malaysia site remained focused exclusively on analog products from 2022 to 2024, with no embedded processing operations introduced—matching the original answer's core claim. The mention of the property status change (from partially leased/owned to fully leased) adds contextual detail not in the original answer but does not contradict it and is likely derived from the cited pages; this does not detract from correctness. All entities (TI, Melaka, Malaysia, analog, embedded processing) and timeframes (2022–2024) are correct. The reasoning correctly synthesizes information across three years of data to conclude that the operational focus remained stable and analog-centric, demonstrating sound multi-hop logic. The only minor gap is that the original answer emphasizes the 'X' marker in documentation and the consistency of absence in embedded processing, which the LLM implies but does not explicitly note—though the conclusion is still valid. Quantitative accuracy is perfect: no numerical errors, and citations align with the timeframe. Wording differs slightly but maintains semantic equivalence. Thus, the answer is highly accurate, complete, and relevant, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 390,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024 in response to expanding real-time payment infrastructure across increasing numbers of global markets?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach was already robust, incorporating multiple layers of protection and working with issuers, acquirers, and governments to develop technical standards like EMV for secure transactions. At that time, real-time payments infrastructure was operational or being implemented in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets and emphasized intelligent routing with real-time application of fraud scoring and tokenization services across a globally integrated network. In 2024, with the expansion into China through a joint venture and the ability to process domestic transactions there, the security framework had to scale further to accommodate this new market while maintaining network integrity. The multi-layered approach continued to evolve, integrating third-party service risks and public-private partnerships to address emerging threats in an increasingly real-time, cross-border payment ecosystem.",
      "llm_answer": "From 2022 to 2024, Mastercard expanded its real‑time payment infrastructure from 12 to 13 markets and scaled its existing multi‑layered security program—an information‑security framework, enterprise resilience, third‑party assessments, insurance coverage, and industry‑wide technical standards such as EMV—to cover these new real‑time rails. The program continued to collaborate with issuers, acquirers, merchants, governments and industry associations, sharing best practices and free utilities for small businesses, ensuring that the growing global network remained secure and resilient as real‑time payments spread across more markets.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the expansion of real-time payment infrastructure from 12 to 13 markets between 2022 and 2023, matching the ground truth. It accurately references Mastercard's multi-layered security approach, including EMV standards, collaboration with issuers, acquirers, governments, and the use of third-party assessments. However, it omits key developments in 2024, particularly the expansion into China via a joint venture and the need to scale security for domestic transaction processing there—a critical evolution in the multi-hop timeline. This omission reduces completeness and qualitative accuracy. (2) Quantitatively, the numbers (12 to 13 markets) are correct and consistent with the original answer; no calculations are required, so numerical precision is high. (3) The reasoning is sound in linking security scaling to infrastructure growth, but fails to fully synthesize the 2024 China development, which represents a significant multi-hop element involving new market entry, regulatory adaptation, and network scaling. The answer captures the ongoing nature of the security program but misses the forward progression into a major new market. (4) Despite the omission, the answer remains contextually relevant and conveys much of the core factual trajectory. Wording differences are acceptable under semantic equivalence, but the lack of 2024-specific evolution prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 398,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV programs?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, indicating a consistent and growing strategic emphasis on the LAV program. This upward trajectory suggests expanding defense contracts and a deepening commitment to fulfilling international demand for armored mobility platforms.",
      "llm_answer": "General Dynamics ramped up Canadian LAV production from 360 units in 2022 to 399 in 2023 and 449 in 2024, a clear year‑over‑year increase. This upward trend signals a strategic emphasis on the Canadian LAV program, underscoring the company’s commitment to expanding production capacity and supporting upgrades for the Canadian Army (GD_10k_2022.pdf p.10; GD_10k_2023.pdf p.11; GD_10k_2024.pdf p.10).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the production volumes of Light Armored Vehicles (LAVs) for the Canadian Army as 360 units in 2022, 399 in 2023, and 449 in 2024, matching the ground truth exactly. (2) All numeric values are accurate and consistent with the original answer; no calculations were required beyond recognition of year-over-year increases, which the model correctly identifies. (3) The multi-hop reasoning is sound—the model synthesizes production data across three years from presumably different 10-K filings (as cited: GD_10k_2022.pdf, GD_10k_2023.pdf, GD_10k_2024.pdf), correctly infers a growing strategic focus, and links the trend to expanded production capacity and support for the Canadian Army. (4) The qualitative interpretation aligns with the ground truth: the upward trajectory is correctly interpreted as a sign of strategic emphasis and commitment to international demand. Wording differs slightly (e.g., 'ramped up' vs 'increased'), but the semantic meaning is equivalent. All parts of the question are addressed: evolution over time and strategic implications. Scores are maximized due to full factual accuracy, correct entity identification, logical reasoning, and complete responsiveness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 348,
        "total_tokens": 1563
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did CVS's allocation to hedge fund limited partnership investments through pension plan assets change from 2022 to 2024, and what does this three-year trajectory suggest about the company's evolving pension fund strategy?",
      "original_answer": "CVS's allocation to hedge fund limited partnership investments was $214 million in 2022, remained relatively stable at $225 million in 2023, and then increased to $252 million in 2024. This represents a gradual upward trend, with a total increase of 17.8% over the three-year period. The steady or slightly growing allocation suggests that CVS maintained a consistent, and potentially more confident, strategic approach to including alternative investments in its pension fund portfolio over time.",
      "llm_answer": "CVS raised its target allocation to hedge‑fund limited partnership investments from **3 % of pension‑plan assets in 2022 to 4 % in 2024**—a 1‑percentage‑point increase【2022‑pages 164‑168】【2024‑pages 166‑170】. This gradual shift signals the company’s evolving pension‑fund strategy toward greater diversification and higher expected returns by expanding its hedge‑fund exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both magnitude and metric. The ground truth provides absolute dollar allocations ($214M in 2022, $225M in 2023, $252M in 2024), while the LLM incorrectly reports percentage allocations (3% in 2022, 4% in 2024), which are not mentioned in the original answer and cannot be verified from the provided context. There is no mention of total pension plan assets, so percentage-based claims cannot be substantiated. (2) The quantitative inaccuracies are significant: the LLM invents percentage figures and omits the actual dollar amounts entirely. It also fails to report the 2023 value ($225M), breaking the three-year trajectory analysis. The claimed '1-percentage-point increase' and 'target allocation' are unsupported by the ground truth, which describes actual allocations, not targets. (3) The multi-hop reasoning is flawed—the model incorrectly shifts from reporting actual dollar investments (required) to unverified percentage allocations, failing to synthesize the correct trend across all three years. While it identifies a strategic shift toward alternative investments, this conclusion is based on fabricated data. (4) The contextual relevance is moderate because the answer addresses pension strategy evolution and hedge fund allocations, aligning with the question’s intent. However, due to major factual and quantitative errors, the correctness score is low. The qualitative reasoning would be stronger if based on accurate data, but as stands, the answer misrepresents the evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 426,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer adoption and engagement with Target's financial products?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card, as part of the broader RedCard/Circle Card offerings, declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in consumer adoption or engagement with Target's proprietary credit offerings, despite the continued incentive of a 5% discount. The drop in penetration indicates that while RedCard sales increased in dollar terms, total sales grew even faster, diluting the proportional use of the cards. This trend could signal shifting consumer preferences, increased competition in retail credit, or reduced sensitivity to the discount incentive.",
      "llm_answer": "The penetration of Target’s MasterCard‑credit‑card (as reflected in the overall RedCard penetration) fell from 20.5 % in 2022 to 18.6 % in 2024— a decline of roughly 1.9 percentage points (TGT 10‑K 2022 p. 21‑25; 2023 p. 25‑29; 2024 p. 27‑31). This downward trend indicates that, relative to total sales, fewer guests are using the MasterCard credit card, suggesting a modest erosion in consumer adoption and engagement with Target’s financial products and a potential shift toward alternative payment methods.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the penetration rate declined from 20.5% in 2022 to 19.8% in 2023 and further to 17.8% in 2024. However, the LLM states it fell to 18.6% in 2024, which is incorrect. This misrepresents the magnitude of the decline and omits the intermediate 2023 value (19.8%), failing to reflect the consistent three-year downward trend accurately. The claimed decline of 'roughly 1.9 percentage points' (from 20.5% to 18.6%) is also incorrect—the actual drop is 2.7 points (20.5% → 17.8%). (2) While the LLM correctly identifies the starting point (20.5% in 2022) and general downward trend, it synthesizes only partial data and provides an inaccurate endpoint. The citation of specific 10-K page ranges adds apparent rigor but does not compensate for factual inaccuracy. (3) The qualitative reasoning is sound in interpreting the decline as a sign of reduced consumer adoption and engagement, and the suggestion of shifting payment preferences aligns with the ground truth. It correctly links lower penetration to weaker relative usage despite overall sales growth, though this point is less developed than in the original. (4) Contextually, the answer addresses both parts of the question—evolution of penetration and implications for consumer behavior—and uses appropriate terminology (e.g., 'penetration', 'engagement', 'adoption'). However, due to the incorrect 2024 figure and omission of the 2023 data point, the multi-hop synthesis across all three years is incomplete and factually flawed. The conclusion is directionally correct but under-supported by accurate data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 456,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did NextEra Energy's fair value exposure related to FPL Cost Recovery Clauses evolve from 2022 through 2024, particularly in terms of total fair value contributions and the shift between significant other observable inputs and significant unobservable inputs?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value exposure tied to FPL Cost Recovery Clauses showed a notable evolution. In 2022, the total fair value was $1 million, with a negligible contribution from significant other observable inputs (-$5 million) and a small positive contribution from significant unobservable inputs (+$6 million). By 2023, the total fair value increased to $12 million, driven primarily by a -$12 million contribution from significant other observable inputs and a +$24 million contribution from significant unobservable inputs. In 2024, the fair value exposure rose sharply to $38 million, with significant other observable inputs contributing +$4 million and significant unobservable inputs contributing +$34 million. This indicates a growing reliance on unobservable inputs and a strengthening fair value position tied to FPL Cost Recovery Clauses over the three-year period.",
      "llm_answer": "From 2022 to 2024, NextEra’s fair‑value exposure for FPL Cost‑Recovery Clauses fell from $16 million in 2022 to $12 million in 2023, then jumped to $38 million in 2024.  In 2023 the $12 million fair value was split between $12 million of significant other observable inputs and $24 million of significant unobservable inputs, whereas in 2024 the $38 million fair value was driven almost entirely by $34 million of significant unobservable inputs and only $4 million of observable inputs, showing a clear shift toward greater reliance on unobservable estimates.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the 2022 total fair value and input contributions. According to the ground truth, in 2022 the total fair value was $1 million (not $16 million as stated), with significant other observable inputs at -$5 million and significant unobservable inputs at +$6 million. The LLM incorrectly reports a $16 million total, which is not supported by the data and misrepresents the starting point of the trend. The 2023 total fair value is correctly stated as $12 million, but the LLM incorrectly states that observable inputs contributed +$12 million; in reality, they contributed -$12 million (a liability), while unobservable inputs contributed +$24 million. The 2024 figures are correct: $38 million total, with +$4 million from observable and +$34 million from unobservable inputs. (2) Calculations: The LLM fails to accurately represent the component inputs in 2022 and 2023. For example, in 2023, the sum of inputs should be -$12M + $24M = $12M, which is correct in the ground truth, but the LLM implies both inputs are positive, distorting the nature of the exposure. The 2022 error is particularly severe: no combination of the reported inputs in the LLM answer adds up to $16M, and the ground truth never mentions such a figure. (3) Multi-hop reasoning: While the LLM correctly identifies the upward trend from 2023 to 2024 and notes increasing reliance on unobservable inputs, it fails to accurately synthesize the full three-year evolution due to incorrect 2022 and 2023 input values. The conclusion about a 'clear shift' is directionally correct but based on flawed data. (4) Justification for scores: Correctness is scored 4 due to major quantitative errors in two out of three years, despite partial correctness in 2024 and the general trend. Quantitative accuracy is low (3) because of incorrect dollar amounts and signs. Qualitative accuracy is moderate (5) as the model captures the concept of shifting input reliance but misrepresents the nature of inputs (e.g., treating negative observable inputs as positive). Contextual relevance is high (8) because the answer addresses the right metric, company, time frame, and analytical focus on input shifts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 595,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the competitive positioning of NKE relative to Anta evolved from 2022 through 2024, particularly in terms of product innovation emphasis and brand engagement strategies?",
      "original_answer": "From 2022 to 2024, NKE consistently positioned itself as the global leader in athletic footwear and apparel and maintained Anta as a named competitor. In 2022, NKE emphasized product attributes such as quality, performance, and reliability, along with new product style and design innovation as key competitive differentiators. By 2023, NKE elevated the importance of 'innovation and development' ahead of performance and reliability, signaling a strategic shift toward reinforcing technological and design leadership in response to competitive pressures. In 2024, NKE further solidified this innovation focus and reiterated its commitment to digital experiences, social media interaction, and athlete endorsements as critical components of brand engagement. While Anta remained a named competitor across all three years, NKE’s evolving emphasis on innovation and digital engagement suggests a multi-year strategic effort to differentiate itself in a market where Anta and other regional/global competitors are gaining traction through localized and digitally native strategies.",
      "llm_answer": "Nike’s competitive positioning relative to Anta has remained essentially unchanged from 2022 through 2024, with Nike continuing to highlight its leadership in technical product innovation (e.g., Nike Air, Zoom, Flyknit) and a consumer‑centric brand‑engagement strategy built on marketing, digital experiences, athlete endorsements and social‑media interaction (see 2022 and 2024 competition and product‑research sections). Anta is listed as a key competitor in each filing, but Nike’s emphasis on advanced technologies and engagement has not shifted over the period (NKE_10k_2022, pages 6‑10; NKE_10k_2024, pages 6‑10).",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct in stating that Nike maintained Anta as a key competitor and emphasized product innovation and brand engagement from 2022 to 2024. However, it incorrectly asserts that Nike's strategic emphasis 'has not shifted over the period,' which directly contradicts the ground truth. The original answer shows a clear evolution: in 2022, Nike emphasized quality, performance, and reliability; by 2023, it elevated 'innovation and development' above performance and reliability; and in 2024, it further prioritized innovation and digital engagement. This represents a meaningful strategic shift that the LLM answer fails to capture. While the LLM correctly identifies consistent elements (e.g., athlete endorsements, digital experiences), it misses the nuanced progression in priority ranking and strategic emphasis, which is central to the question about competitive positioning evolution. There are no numerical inaccuracies (hence high quantitative accuracy), but the qualitative reasoning is flawed due to incorrect synthesis across years. The answer is contextually relevant and addresses the right companies and general themes, but fails on the core requirement of identifying change over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 342,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the availability of shares under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about TI's ongoing use of this plan for director compensation?",
      "original_answer": "The availability of shares under the Texas Instruments 2003 Director Compensation Plan decreased from 2022 to 2024, indicating a gradual phase-out of the plan in favor of newer compensation vehicles. In 2022, the 2003 Director Compensation Plan was still referenced as active, with shares being issued under it. By 2023, the plan was no longer listed among those with remaining shares available for future issuance, though it was still referenced for outstanding grants. In 2024, the 2003 plan was no longer mentioned as part of the active compensation structure, with TI focusing on the 2024 LTIP and 2018 Director Plan for future awards. This reflects a strategic shift toward updated incentive structures while honoring existing commitments.",
      "llm_answer": "From 2022 through 2024 the Texas Instruments 2003 Director Compensation Plan is only listed as part of the shares to be issued upon exercise of outstanding options; it is never shown as a source of shares available for future issuance.  In each year’s equity‑compensation table the “Remaining Available” column excludes the 2003 plan, listing only the 2009 LTIP, 2014 ESPP and 2018 Director Plan (2022 [61‑65], 2023 [59‑63], 2024 [57‑61]).  This trend indicates that TI has effectively retired the 2003 plan for new director compensation and now relies on newer plans such as the 2018 Director Plan and the 2024 LTIP.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor inaccuracy in the timeline description that affects completeness. (1) The LLM states that from 2022 through 2024 the 2003 plan was never shown as a source of shares available for future issuance, which contradicts the ground truth indicating that in 2022 the plan was still active and issuing shares. The ground truth specifies that the phase-out began after 2022, with the plan no longer having available shares by 2023. This misstatement affects the precision of the trend description. (2) Quantitatively, the LLM correctly identifies the absence of the 2003 plan in the 'Remaining Available' columns for all three years and accurately references the successor plans (2018 Director Plan, 2024 LTIP), though it incorrectly implies this was true in 2022. The citation of document page ranges ([61-65], etc.) adds specificity and supports the claim, assuming those references are accurate. (3) The reasoning is sound in concluding that the plan has been retired for new grants and that TI has shifted to newer plans, which reflects correct multi-hop synthesis across years and plans. However, the failure to acknowledge the 2022 activity slightly undermines the evolution narrative. (4) Despite this, the answer captures the core trend and strategic implication—phase-out in favor of updated plans—and remains highly relevant. Wording differs but meaning is largely equivalent, meriting high scores in qualitative accuracy and full marks in contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 425,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CMCSA's integration and expansion of data-driven services within its advertising offerings evolve from 2022 through 2024, and what specific enhancements were made to its technology, tools, and marketplace solutions during this period?",
      "original_answer": "In 2022, CMCSA's advertising business offered technology, tools, data-driven services, and marketplace solutions to help advertisers better engage with target audiences, with a focus on digital platforms and multichannel video provider partnerships. By 2023, the company expanded these offerings, integrating data-driven services more deeply into its advertising ecosystem, including the use of cloud-based platforms and integrated search functionality across content sources. In 2024, CMCSA further refined its data-driven services by enhancing its digital advertising tools and strengthening its representation agreements with third parties, both domestically and internationally, to improve advertiser reach and targeting precision. The evolution from 2022 to 2024 reflects a strategic shift toward more integrated, technology-enabled advertising solutions that leverage CMCSA's cloud infrastructure and data analytics capabilities.",
      "llm_answer": "From 2022 through 2024, CMCSA’s 10‑K filings (pages 4‑8 of each year) consistently describe its advertising business as offering a suite of technology, tools, data‑driven services and marketplace solutions to media customers.  The filings do not disclose any new specific enhancements or changes to those technology, tools or marketplace solutions during that period, indicating that the company maintained its existing data‑driven advertising capabilities.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) It claims that CMCSA's 10-K filings 'do not disclose any new specific enhancements or changes' from 2022 to 2024, which directly conflicts with the original answer stating progressive enhancements: deeper integration of data-driven services in 2023 (including cloud-based platforms and integrated search), and refinement in 2024 through enhanced digital tools and expanded third-party representation agreements. These developments represent specific, multi-year strategic advancements. (2) There are no numeric values to verify, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The reasoning is flawed: the LLM fails to perform the required multi-hop synthesis across years and instead asserts no changes occurred, missing the evolution entirely. This reflects a failure in both comprehension and synthesis. (4) Contextual relevance is low because the answer denies the evolution the question asks about, rendering it factually and conceptually misaligned. The answer may reflect a literal reading of 10-Ks that omits forward-looking or strategic disclosures, but it does not align with the verified knowledge graph data, which captures the actual evolution described in the filings when interpreted holistically.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 371,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the company held $574 million in CMBS with $12 million in unrealized losses. By 2023, the fair value of CMBS dropped to $675 million, while unrealized losses increased to $100 million. In 2024, the CMBS holdings fell further to just $6 million with no significant unrealized losses reported. This indicates a strategic reduction in CMBS exposure, particularly in 2024, suggesting a de-risking move by CVS amid rising unrealized losses in 2023.",
      "llm_answer": "CVS’s commercial mortgage‑backed securities (CMBS) exposure fell over the period.  In 2022 the CMBS fair value was $1,018 million with unrealized losses of $155 million; in 2023 the fair value dropped to $975 million and unrealized losses eased to $100 million.  The 2024 figures (fair value $?? million, unrealized losses $?? million) continue that downward trend, indicating the company is trimming its CMBS holdings and adopting a more risk‑averse stance toward this asset class.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, in 2022, CVS held $574 million in CMBS with $12 million in unrealized losses, but the LLM reports $1,018 million and $155 million, respectively—both figures are incorrect. In 2023, the ground truth shows CMBS fair value increased to $675 million (not decreased to $975 million as stated by the LLM), and unrealized losses rose to $100 million (which the LLM correctly identifies, though misattributes the direction of change). For 2024, the ground truth reports a drop to $6 million with no significant unrealized losses, but the LLM uses placeholders ($?? million), indicating missing data. (2) Calculations and trends are misrepresented: the LLM claims a continuous decline in fair value from 2022 to 2023, but the actual data shows an increase from $574M to $675M before a sharp drop in 2024. The LLM incorrectly states that unrealized losses 'eased' from 2022 to 2023, when they actually increased dramatically from $12M to $100M. (3) Multi-hop reasoning is flawed: the model fails to correctly synthesize the trajectory of risk—rising losses in 2023 followed by a near-complete exit in 2024—which supports a de-risking narrative. Instead, it infers a steady reduction based on incorrect data. (4) Despite incorrect numbers, the LLM reaches a qualitatively plausible conclusion about de-risking, which aligns with the final year’s near-zero exposure, giving partial credit for contextual relevance and directional interpretation. However, the severe numerical inaccuracies and flawed intermediate reasoning justify a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 456,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the scope and value of merchandise discounts offered to employees evolve across Target's 2022, 2023, and 2024 disclosures, and what does this multi-year progression suggest about the company's employee benefit strategy?",
      "original_answer": "Across the three years, merchandise discounts remained a consistent component of Target's employee compensation package, but the framing and emphasis evolved alongside broader benefits enhancements. In 2022, merchandise discounts were listed among core benefits, alongside a minimum wage of $15/hour. By 2023, the wage range had expanded to $15–$24/hour, and merchandise discounts were included in a more detailed benefits package that now emphasized financial wellness components like 401(k) matching and tuition reimbursement. In 2024, merchandise discounts remained part of the compensation structure, but were presented within an expanded benefits ecosystem that included mental health services and virtual healthcare—suggesting a strategic shift toward holistic employee well-being while maintaining traditional perks. This evolution indicates a benefits strategy that preserves foundational offerings while layering in new, modern benefits to enhance employee satisfaction and retention.",
      "llm_answer": "Target’s 10‑K filings for 2022, 2023, and 2024 all list a merchandise discount as part of the employee benefit package, but none of the documents disclose a specific discount rate or dollar amount【TGT_10k_2022.pdf】【TGT_10k_2023.pdf】【TGT_10k_2024.pdf】. The unchanged scope of the benefit across three years indicates that Target maintains a stable, ongoing perk rather than expanding or reducing it, underscoring a focus on employee retention and satisfaction through a predictable benefit.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that merchandise discounts were consistently offered across 2022–2024 and that no specific discount rate or dollar amount was disclosed in the filings—this aligns with the ground truth. However, the LLM answer omits key qualitative developments in how the benefit was framed within an evolving benefits ecosystem, which is central to the question. The ground truth highlights a strategic shift toward holistic well-being with the addition of financial wellness (2023) and mental health/virtual care (2024), while maintaining foundational perks like merchandise discounts. The LLM fails to capture this multi-year progression in emphasis and context, instead concluding only that the benefit is 'stable' and 'predictable,' which is partially correct but incomplete. (2) There are no numerical inaccuracies; since no figures were provided in the original disclosures, the LLM appropriately avoids inventing them. (3) The multi-hop reasoning is weak: while the model identifies consistency in the presence of the discount, it does not synthesize the broader changes in benefit structure across years that are necessary to answer the 'what does this suggest' part of the question. The original answer draws a strategic inference based on contextual layering of benefits; the LLM misses this entirely. (4) Scores reflect that the answer is factually accurate where it speaks, but lacks depth and synthesis required for full correctness—especially on the strategic implications. Contextual relevance is high because it addresses the core benefit and time frame, but qualitative accuracy is reduced due to missing conceptual evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 456,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Linde's emphasis on cultural challenges during acquisition integration evolve from 2022 to 2024, and what does this reveal about the company's strategic approach to managing cross-border integration risks?",
      "original_answer": "From 2022 to 2024, Linde consistently highlighted cultural challenges as a key risk in acquisition integration, but the depth and framing of the discussion evolved. In 2022, cultural challenges were listed among several integration risks, specifically tied to integrating employees from acquired companies and managing differences in operations across borders. By 2023, the company expanded on these concerns by emphasizing the broader context of global regulatory and compliance risks, indicating a more strategic awareness of how cultural differences could compound legal and operational complexities. In 2024, cultural challenges were again mentioned, but with a sharper focus on the potential negative impact on financial results if integration efforts fail to achieve synergies and retain key personnel. This progression shows that while cultural integration remained a persistent concern, Linde increasingly framed it in terms of strategic risk management and financial outcomes rather than just operational hurdles.",
      "llm_answer": "Across 2022 and 2023, Linde listed “cultural challenges associated with integrating employees from the acquired company into the existing organization” as one of several acquisition‑integration risks (see pages 10‑14 of the 2022 and 2023 10‑Ks). In 2024 the company kept that bullet but added a separate paragraph noting that foreign acquisitions involve unique risks, including “integration of operations across different cultures and languages” (pages 8‑12). This evolution shows that Linde’s strategic approach continues to prioritize integration risk mitigation while increasingly recognizing the nuanced cultural and linguistic factors that can affect cross‑border deals, reflecting a more comprehensive, proactive risk‑management framework.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of Linde's disclosures across 2022–2024, correctly identifying the consistent mention of cultural challenges in acquisition integration and the addition of more nuanced language in 2024 around cross-cultural and linguistic differences. The page references (10–14 for 2022/2023, 8–12 for 2024) are plausible and contextually appropriate, though not verifiable without document access; however, no numeric inaccuracies are present, so quantitative accuracy is full. The entity (Linde), time periods (2022–2024), and document type (10-K) are correct. However, the LLM misses a key element of the ground truth: the evolving strategic framing of cultural challenges in terms of financial risk and synergy realization by 2024. While it notes the addition of 'integration of operations across different cultures and languages,' it does not capture the shift toward emphasizing financial consequences of failed integration or retention of key personnel, which is central to the original answer’s conclusion about strategic risk management. The reasoning is sound but incomplete—synthesis across years is attempted, but the deeper progression from operational to financial risk framing is underdeveloped. Thus, while the answer is contextually relevant and factually correct on surface details, it lacks the full qualitative depth of the ground truth, particularly in interpreting what the evolution reveals about Linde’s strategic approach. This justifies a 7 in correctness and qualitative accuracy, with full marks for quantitative accuracy and high marks for relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 441,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral under master netting arrangements related to Notes and accounts receivable – net fell from **$1,494 million at year‑end 2022 to $491 million at year‑end 2024**, a decline of roughly **$1.0 billion**. This downward trend indicates the company has tightened its collateral requirements, suggesting a more efficient derivative‑exposure management strategy—likely driven by lower derivative volumes or improved netting and clearing practices.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key data points: $1,494 million in 2022 and $491 million in 2024, which match the ground truth. However, it omits the intermediate 2023 value of $800 million, which is part of the full trend described in the original answer. While not strictly necessary to answer the overall change, its absence reduces completeness in capturing the year-by-year decline. The calculated decline of 'roughly $1.0 billion' is approximately correct ($1,494M - $491M = $1,003M), so the calculation is accurate within reasonable rounding. (2) Entity accuracy is strong: 'ExxonMobil', 'collateral under master netting arrangements', 'Notes and accounts receivable - net', and the years 2022 and 2024 are all correctly referenced. (3) The reasoning is sound: the downward trend is correctly interpreted as indicative of improved derivative exposure management, possibly due to lower volumes or better netting practices—this aligns semantically with the original conclusion about 'strategic reduction in derivative exposure or improved offsetting mechanisms'. The multi-hop synthesis across years is logically handled. (4) Contextual relevance is excellent—the answer directly addresses both parts of the question: the net change and its implication for risk management. The only minor shortcoming is the omission of the 2023 figure, which slightly affects completeness and quantitative precision, but does not undermine the overall correctness. Hence, a high score of 9 is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 417,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with external tools, remediation processes, and alignment with broader cybersecurity strategies?",
      "original_answer": "In 2022, the Security Insights Platform was described as a solution that interprets and assesses mainframe security posture, identifies risks, and develops remediation steps, with data available for use with in-house tools for security information and event management (SIEM). By 2023, the platform maintained a similar description but was more explicitly tied to AVGO's broader cybersecurity portfolio, emphasizing proactive risk response and alignment with modern security practices. In 2024, the platform retained its core functionality but was now contextualized within an expanded mainframe software suite that included Cybersecurity, AIOps, and DevOps, indicating a more strategic role in enterprise-wide security planning and regulatory compliance. This evolution shows a shift from a standalone risk assessment tool toward a more integrated and strategically aligned component of AVGO’s cybersecurity offerings.",
      "llm_answer": "AVGO’s Security Insights Platform has been presented in the same way in 2022 and 2024—as a mainframe‑security tool that rapidly interprets posture, flags risks, and produces remediation steps.  Both filings note that the platform’s data feeds into in‑house SIEM tools, underscoring its role in continuous remediation and the company’s overall cyber‑defense strategy.  In short, the core integration, remediation focus and strategic positioning remained essentially unchanged, with the 2024 filing simply reaffirming the platform’s place in the enterprise‑wide security portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that the Security Insights Platform was presented 'in the same way in 2022 and 2024' and that its positioning 'remained essentially unchanged.' This directly contradicts the ground truth, which documents a clear evolution in the platform's strategic positioning from a standalone risk assessment tool in 2022 to a more integrated component of an expanded enterprise-wide suite (including Cybersecurity, AIOps, and DevOps) by 2024. While the LLM correctly notes the platform's core functionality (interpreting security posture, identifying risks, generating remediation steps) and integration with in-house SIEM tools across years, it fails to capture the key 2023–2024 shift in strategic alignment with broader cybersecurity practices and enterprise planning. The answer omits the explicit contextualization within a broader software suite in 2024 and the emphasis on proactive risk response and regulatory compliance. There are no numerical inaccuracies (hence high quantitative score), but the qualitative reasoning is flawed due to failure in multi-hop synthesis across years and incorrect conclusion about stagnation versus evolution. Contextually, the answer addresses the right topic and some aspects of integration and remediation, but misses the strategic evolution, which is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 377,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did SPG's face value and interest rate exposure to Unsecured Notes - 32B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000,000 for Unsecured Notes - 32B with an interest rate of 3.38% maturing on June 15, 2027. In 2023, the same note was still outstanding with identical terms, indicating no principal reduction or refinancing activity. By 2024, the face amount and interest rate remained unchanged at $750,000,000 and 3.38%, respectively, with the maturity date still set for 2027. This consistent exposure over three years suggests a stable long-term debt strategy, where SPG has chosen to maintain the original terms of Unsecured Notes - 32B without early redemption or restructuring, despite potential shifts in market interest rates and overall debt composition.",
      "llm_answer": "From 2022 through 2024, SPG’s Unsecured Notes – 32B has remained unchanged: the face amount is $750,000 and the interest rate is 3.38 % (maturity June 15, 2027) in each filing (2022 p. 48‑52, 2023 p. 48‑52, 2024 p. 49‑53).  The unchanged terms show SPG’s preference for a stable, low‑cost long‑term debt structure, minimizing refinancing risk and keeping debt‑service obligations predictable.",
      "correctness_score": 8,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the interest rate (3.38%), maturity date (June 15, 2027), and consistency of terms across 2022–2024, and accurately infers SPG's stable long-term debt strategy. However, there is a critical error in the face amount: the LLM states '$750,000' instead of the correct '$750,000,000' as per the ground truth. This is a three-order-of-magnitude discrepancy (off by a factor of 1,000), which significantly affects quantitative accuracy. 2) The numbers for interest rate and maturity date are correct, and the assertion that terms remained unchanged is accurate. But the face value is wrong—despite being correctly cited in the original filings (e.g., 2022 p. 48–52, etc.), the LLM transcribed it incorrectly. This undermines financial accuracy, as $750 million vs. $750 thousand represents vastly different exposure. 3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years and filings, recognizes no changes in terms, and draws a logical conclusion about SPG’s debt management strategy—prioritizing stability, predictability, and avoidance of refinancing risk. This reflects strong qualitative reasoning. 4) Contextually, the answer is highly relevant, directly addressing both the evolution of exposure and the strategic implication. The conclusion aligns semantically with the ground truth, despite the numerical error. The score is reduced primarily due to the significant quantitative inaccuracy in the face value, which is central to the question about 'exposure.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 421,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the competitive threat posed by Lumen to CMCSA's broadband services evolved from 2022 through 2024, particularly in terms of fiber network expansion and service bundling strategies?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband market, with a clear escalation in competitive pressure as Lumen expanded its fiber-based infrastructure and emphasized bundled service offerings. In 2022, Lumen was noted as part of a group of wireline telecom companies building fiber infrastructure to deliver higher-speed services in CMCSA's footprint, with some bundling capabilities. By 2023, Lumen was explicitly called out as continuing to deploy fiber deeper into its network, enabling faster speeds and more competitive service packages. In 2024, the trend persisted, with Lumen still listed among top-tier wireline competitors, and the language suggested a continued focus on fiber expansion and bundled offerings as a core competitive strategy. This indicates a consistent and possibly intensifying competitive threat from Lumen over the three-year period.",
      "llm_answer": "From 2022 through 2024, CMCSA’s 10‑K filings consistently note that Lumen is **continuing to expand its fiber‑based wireline network**—“building and are continuing to build fiber‑based wireline network infrastructure further into their networks” and offering “services with these higher speeds in many of our service areas”【CMCSA_10k_2024.pdf, Competition, p. 6】【CMCSA_10k_2022.pdf, Competition, p. 7】.  The reports also highlight that Lumen, like other DSL providers, has introduced **bundled services (e.g., fiber‑plus‑voice/wireless) to compete with CMCSA’s bundled broadband offerings**【CMCSA_10k_2024.pdf, Competition, p. 6】【CMCSA_10k_2022.pdf, Competition, p. 7】, prompting CMCSA to broaden its own fiber‑to‑the‑premises rollout and bundle broadband with voice and wireless.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Lumen continued expanding its fiber-based network from 2022 to 2024, citing direct language from CMCSA's 10-K filings for both 2022 and 2024, which supports the evolution of the competitive threat. The mention of bundled services (e.g., fiber-plus-voice/wireless) matches the original answer’s emphasis on service bundling as a competitive strategy. (2) There are no numerical values, dates, or financial metrics in dispute; all time references (2022–2024) are correct and consistent with the source documents. (3) The multi-hop reasoning is sound: the LLM synthesizes information across multiple years and filings to show a consistent trend in Lumen’s fiber expansion and bundling, correctly inferring an ongoing competitive pressure. The only minor shortcoming is that it does not explicitly note the intensification or escalation of the threat in 2023 as highlighted in the ground truth (e.g., 'explicitly called out as continuing to deploy fiber deeper'), though the cited quotes imply continuity. (4) The answer is contextually fully relevant, directly addressing both fiber expansion and bundling strategies over the specified period. Wording differs slightly but maintains semantic equivalence. No factual inaccuracies are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 373,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the penetration rate of Target's branded payment cards evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy over time?",
      "original_answer": "The penetration rate of Target's branded payment cards declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This downward trend suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy or a shift in consumer payment behavior away from the branded cards during this period.",
      "llm_answer": "Target’s RedCard penetration fell from 20.5 % in 2022 to 19.8 % in 2023 and further to 18.6 % in 2024 (2022 10‑K p. 44; 2023 10‑K p. 27; 2024 10‑K p. 28). This downward trend indicates that the loyalty‑driven payment strategy is losing traction, with card usage declining year‑over‑year.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the penetration rates for 2022 (20.5%) and 2023 (19.8%), which match the ground truth. However, the 2024 penetration rate is reported as 18.6%, whereas the ground truth states 17.8%. This discrepancy affects the quantitative accuracy. (2) The cited sources (2022 10-K p. 44; 2023 10-K p. 27; 2024 10-K p. 28) appear consistent with the format of SEC filings, but the 2024 number does not align with the verified ground truth from the knowledge graph, suggesting either a misreading of the document or an error in data extraction. (3) The reasoning and multi-hop synthesis are sound: the model correctly interprets the downward trend and infers that the loyalty-driven strategy may be losing effectiveness, which aligns with the ground truth's conclusion. It connects data across three years and draws a logical implication. (4) Contextual relevance is perfect—the answer addresses both parts of the question: the evolution of penetration rates and the strategic implication. Despite the incorrect 2024 figure, the overall trend direction (declining) is correct, preserving some validity in the qualitative assessment. The correctness score is 7 because the core trend and interpretation are accurate, but the key 2024 number is off by a full percentage point, which is significant in this context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1167,
        "completion_tokens": 374,
        "total_tokens": 1541
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Chevron's financial and operational engagement with the Republic of Congo evolve from 2022 through 2024, particularly in terms of asset ownership, investment levels, and strategic positioning in the region?",
      "original_answer": "Chevron's engagement with the Republic of Congo evolved significantly from 2022 to 2024. In 2022, the Republic of Congo was listed among Chevron's key operational countries, indicating active presence and strategic importance. In 2023, Chevron invested approximately $0.7 billion in offshore development and natural gas projects across Africa, including the Republic of Congo, signaling continued capital commitment to the region. However, by 2024, Chevron sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, marking a strategic exit from its upstream assets in the country. This shift reflects a transition from active investment and development to divestiture, suggesting a realignment of Chevron's portfolio toward higher-priority regions.",
      "llm_answer": "From 2022 through 2024 Chevron’s presence in the Republic of Congo was confined to a 31.5 % non‑operated working interest in the offshore Haute Mer permit area and a 15.75 % interest in the Republic of Congo portion of Lianzi, with no material capital‑expenditure reported in the region (2022 p. 31‑35; 2024 p. 41‑45). In 2024 the company announced that it would sell both interests in January 2025, effectively divesting from the Republic of Congo and signaling a strategic shift away from the country (2024 p. 41‑45; 2023 p. 107‑111).",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Chevron's asset ownership in the Republic of Congo as a 31.5% nonoperated interest in Haute Mer and a 15.75% interest in Lianzi, which matches the ground truth. It also correctly states that Chevron divested these assets, signaling a strategic exit. However, it contradicts the ground truth by claiming 'no material capital-expenditure reported in the region' in 2022, while the original answer states Chevron invested approximately $0.7 billion in African offshore and gas projects including Congo in 2023. This omission and contradiction represent a significant factual gap. Additionally, the LLM claims the sale was announced to occur in January 2025, which is not mentioned in the ground truth—divestiture is stated as occurring in 2024 without a future timeline. (2) Quantitatively, the percentages (31.5%, 15.75%) are accurate, but the claim of no material capex conflicts with the $0.7 billion investment referenced in the original answer for 2023, even if not broken out by country. The $0.7 billion figure is missing entirely from the LLM response, undermining quantitative completeness. (3) The multi-hop reasoning is partially sound—ownership and divestiture are correctly linked across years—but fails to integrate the 2023 investment data, weakening the synthesis. The strategic shift is acknowledged, but without acknowledging prior investment, the evolution is misrepresented as static presence followed by exit, rather than active investment followed by divestiture. (4) Contextual relevance is high—the answer addresses asset ownership, investment (by negation), and strategic positioning. However, due to missing investment data and an incorrect forward-looking sale date, the overall factual correctness is compromised, warranting a mid-range score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 494,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the shift in fair value and implied volatility reveal about the company's risk positioning in gas markets over time?",
      "original_answer": "In 2022, NextEra Energy reported a fair value of $356 million in assets and $347 million in liabilities for options primarily tied to gas, with implied volatilities averaging 36%. By 2023, the fair value of these options dropped significantly to $100 million in assets and $97 million in liabilities, while implied volatilities increased to an average of 50%. In 2024, the fair value of gas-related options remained at $100 million in assets but slightly exceeded liabilities at $102 million, with implied volatilities decreasing to 52%. This trajectory shows a sharp reduction in exposure from 2022 to 2023, followed by stabilization, while volatility expectations increased and then slightly moderated, suggesting a strategic de-risking in gas options with a cautious outlook on price variability.",
      "llm_answer": "NextEra’s gas‑option exposure fell sharply from 2022 to 2023, with fair‑value assets and liabilities dropping from $356 m/$347 m to $100 m/$97 m, and then remained roughly flat in 2024 at $100 m/$102 m.  The implied volatilities on the liability side fell dramatically—from 295 % in 2022 to 233 % in 2023 and to 150 % in 2024—while the asset‑side volatilities stayed low (17–20 % to 15 %).  This contraction in both position size and perceived volatility indicates that NextEra has pared back its hedging in gas markets and is now operating in a lower‑volatility environment, thereby reducing its overall risk exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in key numeric values, particularly in implied volatility. The ground truth states average implied volatilities of 36% in 2022, 50% in 2023, and 52% in 2024. However, the LLM claims liability-side volatilities were 295%, 233%, and 150%, and asset-side volatilities were 17–20% to 15%, which are entirely incorrect and not supported by the original data. These numbers appear fabricated or misattributed. (2) While the LLM correctly reports the drop in fair value from $356M/$347M in 2022 to $100M/$97M in 2023, it inaccurately states that 2024 values are $100M assets and $102M liabilities. The original answer confirms this, so that part is correct. However, the volatility figures are completely wrong. (3) The multi-hop reasoning is partially sound in interpreting reduced position size as de-risking, but the conclusion that 'perceived volatility' decreased is incorrect—the ground truth shows volatility increased from 36% to 50% to 52%, indicating heightened market uncertainty, not a lower-volatility environment. The LLM’s reasoning is thus based on false data and leads to an inverted conclusion. (4) Contextually, the answer addresses the evolution of exposure and attempts to interpret risk positioning, so relevance is acceptable. However, due to severe quantitative inaccuracies and flawed reasoning stemming from incorrect volatility data, the overall correctness is very low. Minor credit is given for correct fair value figures in 2022 and 2023 and approximate stability in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 427,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Nike's treatment of FlyEase technology evolve from 2022 to 2024, and what does this progression indicate about its role in the company's innovation strategy?",
      "original_answer": "In 2022, Nike introduced FlyEase as part of its broader innovation portfolio, listing it alongside other technologies like Nike Air and Flyknit, signaling its initial strategic positioning. By 2023, the company expanded FlyEase's presence in product development, emphasizing its integration into various categories and consumer applications, which reflects a deliberate effort to scale the technology. In 2024, FlyEase was fully embedded in Nike's innovation narrative, appearing consistently in the product research and development section as a core technology, indicating its established role in the company's long-term design and performance strategy. This progression shows that FlyEase evolved from a newly introduced concept to a foundational element of Nike’s innovation pipeline.",
      "llm_answer": "Nike has consistently listed FlyEase alongside its other performance technologies in the product‑research and development section of its 10‑K filings from 2022 through 2024, with no change in emphasis or separate spotlight. In 2022, FlyEase appeared in the sentence “The proliferation of Nike Air, Zoom, Nike Free, Flywire, Dri‑Fit, Flyknit, **FlyEase**, ZoomX, Air Max, Nike React and Nike Adapt technologies, among others, typifies our dedication to designing innovative products”【2022 10‑K page 6】; the same wording appears in the 2023 and 2024 filings【2023 10‑K page 6】【2024 10‑K page 6】. This steady inclusion indicates that FlyEase remains an ongoing, incremental element of Nike’s broader innovation strategy rather than a headline breakthrough or standalone focus.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim about the evolution of FlyEase technology, despite correctly citing the same sentence from the 10-K filings across 2022–2024. The original answer (ground truth) states that FlyEase evolved from being introduced in 2022, to expanded integration in 2023, to becoming a core, embedded technology by 2024—indicating a clear progression in strategic importance. However, the LLM asserts there was 'no change in emphasis or separate spotlight' and that FlyEase remained a static, 'incremental element,' directly contradicting the ground truth. The LLM appears to base its conclusion solely on verbatim repetition of a single sentence in the filings, failing to recognize or report the deeper strategic evolution described in the ground truth. While the citations and dates are accurate (hence full marks for quantitative accuracy), the reasoning is flawed: the repetition of a list does not preclude increased internal prioritization or broader product integration. The model misses the multi-hop synthesis required—linking stated product integration (2023) and narrative embedding (2024) to infer strategic elevation. Thus, while contextually relevant and factually consistent in surface-level data, it fails to capture the actual progression and strategic significance, resulting in a low correctness and qualitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 382,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's financial obligations tied to Unsecured Notes - 35A remained consistent at $750,000 in face amount across all three years (2022, 2023, and 2024), with an unchanged interest rate of 2.65% and annual debt service of $19,875. However, the maturity date for these notes was consistently listed as 07/15/30 across all disclosures, indicating a stable long-term commitment to this debt instrument. This consistency reveals that SPG maintained a steady approach to this segment of its capital structure, avoiding refinancing or restructuring of these notes despite market fluctuations.",
      "llm_answer": "From 2022 through 2024 the Unsecured Notes – 35A has remained unchanged: a $750,000 face amount, 2.65 % interest, $19,875 annual debt service, and a maturity of July 15 , 2030.  The unchanged terms show that Simon Property Group is keeping this long‑term, low‑rate obligation stable, reflecting a debt strategy that prioritizes predictable cash flows and low‑cost financing over frequent refinancing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the face amount ($750,000), interest rate (2.65%), annual debt service ($19,875), and maturity date (07/15/30) are consistent across 2022–2024. (2) Quantitative accuracy is perfect—each number matches the original answer, including the implied calculation of annual debt service (2.65% of $750,000 = $19,875), which is correctly reflected. (3) The multi-hop reasoning is sound: the model correctly synthesizes that no changes occurred over the three years and infers the strategic implication—that SPG is maintaining stable, low-cost long-term debt to ensure predictable cash flows. (4) Contextual relevance is high, as the answer directly addresses both parts of the question: the evolution (or lack thereof) of the obligation and what it reveals about SPG’s debt strategy. Wording differs slightly but meaning is preserved, and the conclusion about prioritizing stability over refinancing aligns with the ground truth’s interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 302,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent positioning reveal about its long-term growth strategy centered on free cash flow per share?",
      "original_answer": "Texas Instruments has consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024, framing them as a key driver in achieving long-term growth in free cash flow per share. In 2022, the company highlighted the tangible benefits of its four competitive advantages, including a broad portfolio of analog and embedded processing products that offer more opportunity per customer and more value for investments. In 2023, TI reiterated this strategic focus, underscoring that embedded processing products are central to its unique business model and long-term investment decisions. In 2024, the company maintained this narrative, emphasizing that embedded processing products continue to be foundational in leveraging its competitive advantages and guiding capital allocation. This consistent emphasis reveals that TI views embedded processing as a stable, high-margin, and scalable segment that supports its long-term objective of maximizing free cash flow per share.",
      "llm_answer": "Texas Instruments consistently highlighted its strategic focus on analog and embedded‑processing products across 2022, 2023, and 2024, with embedded‑processing revenue growing modestly each year while remaining a core part of its portfolio (TXN_10k_2022.pdf: 18–22; TXN_10k_2023.pdf: 16–20; TXN_10k_2024.pdf: 16–20). This steady positioning underscores TI’s long‑term growth strategy of maximizing free cash flow per share by leveraging its embedded‑processing business as a key driver of cash generation and shareholder returns (TXN_10k_2023.pdf: 18; TXN_10k_2024.pdf: 18). The company’s MD&A repeatedly links its embedded‑processing focus to strong cash flow from operations, reinforcing the view that this segment is central to sustaining free cash flow per share growth (TXN_10k_2023.pdf: 18; TXN_10k_2024.pdf: 18).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core strategic emphasis of Texas Instruments on embedded processing products across 2022, 2023, and 2024, aligning with the ground truth. It accurately reflects that this focus is tied to long-term growth in free cash flow per share. While the LLM mentions 'embedded-processing revenue growing modestly each year,' this detail is not present in the original answer and cannot be verified from the provided ground truth; however, it does not contradict it and is plausible given TI's stable business model. All other qualitative points—such as the linkage between embedded processing, cash flow from operations, and shareholder returns—are consistent with the original. (2) There are no specific numerical values (e.g., dollar amounts, percentages, or exact growth rates) in either the question or the original answer, so quantitative accuracy is not compromised. The LLM does not introduce any incorrect figures, and references to document sections (e.g., page numbers) are appropriate and do not affect factual correctness. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying the continuity in strategic messaging and connecting it to free cash flow per share—a key metric emphasized in the original. The use of MD&A references to support cash flow linkage strengthens the reasoning. (4) The answer is contextually highly relevant, directly addressing both parts of the question: evolution over time and implications for long-term strategy. The only minor deviation is the unverified claim about modest revenue growth, which slightly affects qualitative accuracy but does not undermine the overall correctness. Hence, a score of 9 is justified for correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 503,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Disney's strategic use of the Marvel brand across its streaming platforms evolve from 2022 to 2024, and what does this evolution indicate about its financial strategy in driving subscriber growth, particularly on Disney+ where Marvel became a top-level tile by 2023 and remained a key intangible asset in 2024?",
      "original_answer": "In 2022, Marvel was listed as an indefinite-lived intangible asset, alongside ESPN and Pixar, highlighting its brand value as a core asset on Disney's balance sheet. By 2023, Marvel had transitioned into an active strategic component of Disney+'s user interface, becoming a top-level 'tile' with branded programming, which was a key differentiator in the competitive DTC market. This shift was supported by Disney's plan to launch ESPN+ as a tile in early fiscal 2025, indicating a broader strategy to leverage its branded content for platform engagement. In 2024, Marvel remained listed as an indefinite-lived intangible asset, showing continued recognition of its brand equity. This 3-year progression reflects a financial and strategic pivot from passive asset recognition to active brand utilization in driving subscriber engagement — a shift that aligns with Disney's reported Disney+ subscriber base of 123 million as of September 28, 2024. The integration of Marvel content into the core streaming interface likely contributed to subscriber retention and growth, leveraging brand strength to justify continued asset valuation and platform differentiation.",
      "llm_answer": "Disney’s 2022 10‑K lists Marvel as an indefinite‑lived intangible asset worth $1.792 million, reflecting its status as a balance‑sheet asset (DIS_10k_2022, p.112). By 2023 the company elevated Marvel to a top‑level tile on Disney+, making it a primary visual anchor for subscribers (DIS_10k_2023, p.5‑6). In 2024 Marvel remained an indefinite‑lived intangible asset of $1.792 million, underscoring its continued financial value while the brand is leveraged to drive Disney+ subscriber growth (DIS_10k_2024, p.115‑116).",
      "correctness_score": 7,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic evolution of Marvel on Disney+ from 2022 to 2024, noting its status as an indefinite-lived intangible asset and its elevation to a top-level tile on Disney+ by 2023. It also correctly states that Marvel remained a key intangible asset in 2024. However, there is a critical error in the quantitative value: the LLM claims Marvel was valued at $1.792 million in both 2022 and 2024, which is factually incorrect. In the actual 10-K filings, Marvel is not assigned a standalone dollar value on the balance sheet as an indefinite-lived intangible; instead, it is grouped within broader asset categories. The figure $1.792 million appears to be a misinterpretation or fabrication, as no such line item exists for Marvel alone. This is a major quantitative inaccuracy. (2) The dates and years referenced (2022, 2023, 2024) are correct, and the progression across years aligns with the ground truth. However, the citation of specific page numbers (e.g., p.112, p.5-6, p.115-116) cannot be verified here but are plausible. The core financial claim — assigning a precise $1.792M value to Marvel — is false, severely undermining quantitative accuracy. (3) The multi-hop reasoning is sound: the model connects Marvel’s accounting treatment with its strategic use on Disney+, infers brand leverage for subscriber growth, and tracks continuity across years. This reflects good qualitative synthesis and understanding of Disney’s financial strategy. (4) Despite the serious numerical error, the answer captures the essential strategic narrative — using Marvel as both a balance sheet asset and a growth driver via platform integration — making it contextually relevant and qualitatively strong. The correctness score is reduced primarily due to the fabricated dollar amount, which misrepresents financial data, even though the directional logic and strategic interpretation are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 523,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the associated reinsurance recoverable balances?",
      "original_answer": "In 2022, MetLife reinsured 59.25% of the closed block through a modified coinsurance agreement, with $3.6 billion in unsecured reinsurance recoverable balances. By 2023, the percentage reinsured slightly decreased to 59%, while unsecured balances increased to $4.4 billion. In 2024, the percentage reinsured remained at 59%, but unsecured balances slightly declined to $4.2 billion. This indicates a relatively stable strategic use of the modified coinsurance agreement, with minor fluctuations in unsecured exposure.",
      "llm_answer": "MetLife continued to reinsure the same portion of its closed block each year – 59 % of the block was covered by the modified‑coinsurance agreement in 2022, 2023 and 2024.  The reinsurance recoverable balances tied to that agreement grew markedly, rising from $6.1 billion of net ceded recoverables at year‑end 2022 to $16.7 billion in 2023 and $17.6 billion in 2024, reflecting the expanding scope of the arrangement.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is almost entirely incorrect in terms of quantitative accuracy. It states that 59% of the closed block was reinsured in all three years (2022–2024), but the ground truth shows that in 2022, the percentage was 59.25%, not 59%, and only decreased to 59% in 2023 and remained there in 2024—this minor discrepancy is overshadowed by far larger errors in financial figures. The LLM claims reinsurance recoverable balances were $6.1 billion in 2022, $16.7 billion in 2023, and $17.6 billion in 2024, whereas the ground truth reports unsecured reinsurance recoverable balances of $3.6 billion in 2022, $4.4 billion in 2023, and $4.2 billion in 2024. These numbers are drastically different, with the LLM reporting more than a 300% overstatement in 2024. Additionally, the LLM refers to 'net ceded recoverables,' which is not the same as 'unsecured reinsurance recoverable balances' specified in the original answer—this reflects a potential misunderstanding or misrepresentation of the metric. While the answer attempts to address the evolution over time and discusses both the percentage reinsured and recoverable balances (thus partially meeting completeness), the core data is factually wrong. The reasoning is flawed due to reliance on incorrect figures, leading to an erroneous conclusion about 'expanding scope,' when the actual data shows relative stability with minor fluctuations. Despite using appropriate terminology like 'modified coinsurance agreement' and addressing MetLife and the closed block, the severe numerical inaccuracies and mischaracterization of trends result in a very low correctness score. Contextual relevance is moderate because the structure and intent align with the question, but factual content fails to support it.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 475,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did CVS's investment in residential mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk exposure and strategic positioning in fixed-income assets?",
      "original_answer": "CVS's investment in residential mortgage-backed securities (RMBS) increased significantly from $629 million in 2022 to $614 million in 2023, and then declined sharply to $71 million in 2024. This pattern indicates a strategic pivot away from RMBS in 2024, following a multi-year period of relatively high exposure. The unrealized losses also rose from $10 million in 2022 to $60 million in 2023, reflecting increased risk exposure during that time. The sharp reduction in 2024 suggests a deliberate de-risking or reallocation strategy, likely in response to market conditions or internal portfolio rebalancing.",
      "llm_answer": "From 2022 to 2024 CVS’s residential mortgage‑backed securities grew modestly—from $845 m amortized cost ($757 m fair value) in 2022 to $862 m ($810 m) in 2023 and $870 m ($875 m) in 2024—while the credit quality rating slipped from AAA to AA and the weighted‑average duration rose from 4.7 to about 5.9 years. This shift shows a slight increase in interest‑rate sensitivity but still very low credit‑risk exposure, reflecting CVS’s strategy of expanding a high‑quality, agency‑guaranteed RMBS portfolio to generate stable income for its experience‑rated products.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in both direction and magnitude of CVS's RMBS investment trend. The ground truth states RMBS holdings decreased from $629M in 2022 to $614M in 2023 and then dropped sharply to $71M in 2024. The LLM claims a steady increase from $845M to $870M over the same period—this is a complete reversal of the actual trend. Additionally, the LLM introduces amortized cost and fair value figures not present in the original answer and unsupported by the ground truth. (2) The numbers are factually wrong: $845M, $862M, $870M (vs. $629M, $614M, $71M), and the credit rating (AAA to AA) and duration (4.7 to 5.9 years) are fabricated with no basis in the original data. There are no calculations in the LLM answer, but the core data is invalid. (3) The multi-hop reasoning fails completely: instead of identifying a strategic de-risking move in 2024, the LLM suggests a deliberate expansion of RMBS holdings for stable income, which contradicts the ground truth. The conclusion about 'low credit-risk exposure' and 'agency-guaranteed' portfolio is unsupported and misrepresents the increasing unrealized losses ($10M to $60M) indicating rising risk, not stability. (4) The contextual relevance is low because it addresses the general topic of RMBS and strategy, but with entirely incorrect data and opposite conclusions. Scores are low due to total factual inaccuracy, incorrect entities (implied financials and ratings), and flawed reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 410,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the accounting treatment under the deposit method?",
      "original_answer": "From 2022 to 2024, MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer, and the accounting treatment remained unchanged under the deposit method with the right of offset applied. In 2022, the exact percentage was 59.25%, while in both 2023 and 2024, it was reported as 59%. The accounting policy remained consistent across all three years, with the Company offsetting the modified coinsurance deposit liability with the deposit recoverable. This indicates a stable strategic and accounting approach to managing the closed block through this specific reinsurance structure.",
      "llm_answer": "MetLife’s modified‑coinsurance arrangement for the closed block was reduced slightly: it covered 59.25 % of the block in 2022 and 59 % in 2024.  The deposit‑method accounting remained unchanged throughout, with the modified‑coinsurance deposit liability offset against the deposit recoverable.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) Quantitatively, all numbers are correct: 59.25% in 2022 and 59% in 2024 match the original answer. Although the LLM omits the 2023 figure (also 59%), this is a minor omission and does not distort the trend. The percentage change is correctly implied as a slight reduction. (2) The accounting treatment is accurately described: deposit-method accounting remained unchanged, with the liability offset against the recoverable, which aligns with the ground truth’s mention of the right of offset. (3) The multi-hop reasoning is sound—information is synthesized across years and accounting policies, and the core conclusion about stability in accounting treatment is preserved. (4) The only minor gap is the omission of the 2023 data point, which slightly reduces completeness but does not affect the overall correctness. Wording differs but maintains semantic equivalence. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 313,
        "total_tokens": 1570
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did NextEra Energy's net exposure to forward contracts for gas evolve from 2022 through 2024, and what does this trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward contracts for gas was $160 million in 2022 (assets of $191 million and liabilities of $31 million), decreased to $300 million in 2023 (assets of $377 million and liabilities of $77 million), and then declined to $250 million in 2024 (assets of $296 million and liabilities of $46 million). This trend indicates a general reduction in net exposure from 2023 to 2024, suggesting a more cautious stance or rebalancing in natural gas market commitments after a period of increased forward contracting.",
      "llm_answer": "NextEra Energy’s net fair‑value exposure to forward gas contracts rose from roughly **$160 million in 2022** (assets $191 m – liabilities $31 m) to **$300 million in 2023** (assets $377 m – liabilities $77 m) and then fell to **$250 million in 2024** (assets $296 m – liabilities $46 m). This swing—an increase in 2023 followed by a reduction in 2024—indicates the company tightened its hedging position after a period of heightened exposure, suggesting a shift toward a more balanced or lower‑risk natural‑gas price profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical values from the ground truth: net exposure of $160M in 2022 (assets $191M - liabilities $31M), $300M in 2023 ($377M - $77M), and $250M in 2024 ($296M - $46M). All figures match exactly, with only acceptable formatting variations (e.g., 'm' vs 'million'). (2) Calculations are accurate: 191 - 31 = 160, 377 - 77 = 300, 296 - 46 = 250. No arithmetic or data errors. (3) The multi-hop reasoning is sound—correctly identifying the trend (increase from 2022 to 2023, then decrease in 2024) and interpreting it as a strategic rebalancing or risk reduction. The conclusion that the company 'tightened its hedging position' and moved toward a 'lower-risk natural-gas price profile' is semantically equivalent to the ground truth's 'more cautious stance or rebalancing.' (4) Minor deduction in qualitative accuracy only because the phrase 'tightened its hedging position' could imply reduced activity, whereas the ground truth emphasizes 'rebalancing'—a slightly more neutral term. However, the overall interpretation remains logically consistent and well-reasoned. Contextual relevance is perfect: all parts of the question (evolution over time and risk implication) are fully addressed with precise, relevant information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 358,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its broader industrial product portfolio evolve from 2022 to 2024, particularly in terms of application diversity and integration with adjacent technologies like motion encoders and Ethernet ICs?",
      "original_answer": "From 2022 to 2024, AVGO consistently positioned Industrial Fiber Optics as a core component of its industrial product portfolio, but the context of its integration and application scope evolved. In 2022, Industrial Fiber Optics was listed alongside optocouplers, motion encoders, LED devices, and Ethernet ICs, with applications spanning industrial automation, medical systems, defense, and electric vehicle subsystems. By 2023, the company emphasized a broader alignment with factory automation, renewable energy, and automotive electronics, grouping fiber optics with sensors, encoders, and microcontrollers, suggesting a move toward more integrated industrial solutions. In 2024, Industrial Fiber Optics remained central but was now explicitly linked with Ethernet PHYs, switch ICs, and camera microcontrollers, indicating deeper integration into networked and vision-based industrial systems. This trajectory shows AVGO's strategic shift from standalone industrial components to more interconnected, intelligent systems leveraging fiber optics.",
      "llm_answer": "In 2022 AVGO’s fiber‑optic offerings were framed mainly as networking and storage components (“Fiber Optic Components: We supply a wide array of optical components to the Ethernet networking, storage, and access, metro‑ and long‑haul telecommunication markets”). By 2023 the company broadened its industrial portfolio, explicitly positioning industrial fiber optics alongside motion encoders and Ethernet ICs to serve a wide range of automation, power, medical, defense and automotive applications (“Industrial End Markets: We also provide a broad variety of products for the general industrial and automotive markets, including optocouplers, industrial fiber optics, motion encoders, light emitting diode devices, and Ethernet ICs”). In 2024 this positioning was reinforced, emphasizing tighter integration of industrial fiber optics with adjacent motion‑encoder and Ethernet‑IC technologies as part of a cohesive industrial solutions suite that spans industrial automation, power generation and distribution, medical systems, defense/aerospace, and vehicle subsystems such as electric‑vehicle powertrains and advanced driver‑assist systems.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of entity accuracy, timeline, and overall strategic evolution. It correctly identifies the progression from 2022 to 2024 in AVGO's positioning of Industrial Fiber Optics, noting the expansion from networking/storage contexts toward broader industrial integration. The mention of motion encoders and Ethernet ICs in 2023 and 2024 is accurate and reflects the multi-hop synthesis required. However, the LLM slightly misrepresents the 2022 positioning by emphasizing 'networking and storage' as the primary framing, whereas the ground truth states that in 2022, Industrial Fiber Optics was already listed alongside optocouplers, motion encoders, and Ethernet ICs with explicit industrial applications (industrial automation, medical, defense, EVs). Thus, the LLM underrepresents the industrial focus in 2022 and overemphasizes telecom/storage, which may stem from conflating broader fiber-optic components with the industrial subset. The 2023 and 2024 descriptions are strong, capturing the integration trend and application diversity. No numerical inaccuracies are present (dates are correct, no faulty calculations), so quantitative accuracy is perfect. Qualitative accuracy is high but docked slightly for the 2022 mischaracterization. Contextual relevance is excellent—the answer directly addresses application diversity and integration with adjacent technologies as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1575,
        "completion_tokens": 400,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial implications of Nike's relationship with Sojitz America through its redeemable preferred stock evolve from fiscal years 2022 through 2024, particularly in terms of dividend obligations and the stability of the stock structure?",
      "original_answer": "Nike's relationship with Sojitz America through the redeemable preferred stock remained structurally stable from fiscal years 2022 through 2024, with no changes in the stock's terms or ownership. The dividend obligation remained consistent at $0.10 per share annually, and the total par value of the redeemable preferred stock remained at $0.3 million throughout the period. Despite no changes in the stock structure, Nike emphasized in each year that dividends on the preferred stock must be paid in full before any dividends on common stock could be declared, highlighting the ongoing financial priority of Sojitz America’s stake. This consistent structure underscores a stable, long-term financial relationship with Sojitz America, which has not sought redemption of the stock despite having the option to do so.",
      "llm_answer": "From FY 2022 through FY 2024 Nike’s redeemable preferred stock remained unchanged: the cumulative dividend obligation stayed at $0.10 per share payable each May 31, and the stock was fully issued to Sojitz America with no additional preferred shares or changes to the redemption terms. Consequently, Nike’s cash outflow for preferred dividends was constant and the preferred‑stock structure remained stable, allowing no common‑stock dividends until the preferred dividends were fully paid.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core financial implications of Nike's relationship with Sojitz America through redeemable preferred stock from FY2022 to FY2024. (1) Quantitatively, all key figures are correct: the annual dividend obligation of $0.10 per share is accurately stated, and while the LLM does not explicitly mention the total par value of $0.3 million, this does not contradict the ground truth and the constant cash outflow implication is valid. The timing of dividend payment (May 31) is an additional precise detail supported by filings. (2) The structure, ownership, and redemption terms are correctly reported as unchanged—confirming stability in the stock structure. (3) The multi-hop reasoning is sound: the LLM correctly infers that preferred dividends must be settled before any common dividends, highlighting the financial priority of Sojitz America, even if the exact phrasing about 'must be paid in full' is slightly less explicit than in the original. (4) The omission of the explicit statement that Sojitz America did not seek redemption despite having the option is a minor gap in completeness, but the stability conclusion remains justified. Overall, the answer is semantically equivalent in substance, with only slight reduction in contextual detail. Hence, a score of 9 is appropriate—excellent accuracy with minimal omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 380,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Simon Property Group's (SPG) unsecured debt obligations tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this progression indicate about SPG's long-term financing strategy for this instrument?",
      "original_answer": "Simon Property Group's unsecured debt tied to Unsecured Notes - 31B remained consistent at $750,000 across all three years (2022, 2023, and 2024), with a fixed interest rate of 3.25% and a maturity date of November 30, 2026. Despite broader changes in SPG’s unsecured debt portfolio—such as the retirement of certain notes and the issuance of new instruments like Unsecured Notes - 41A in 2024—this specific obligation remained unchanged. This stability suggests that SPG maintained a consistent long-term financing approach for this particular liability, preserving its structure without refinancing or modifying its terms over the three-year period.",
      "llm_answer": "From 2022 through 2024, SPG’s Unsecured Notes – 31B remained unchanged: a $750,000 face amount, 3.25 % interest, maturing 11/30/26, with an annual debt service of $24,375. The unchanged terms across the three filings indicate SPG’s long‑term financing strategy for this instrument is to preserve a stable, low‑cost, long‑maturity debt position rather than refinance or modify it.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the unsecured debt amount ($750,000), interest rate (3.25%), maturity date (November 30, 2026), and consistency across 2022–2024 are accurately reported. The annual debt service calculation ($750,000 × 3.25% = $24,375) is mathematically correct, though not mentioned in the original answer; its inclusion is a minor enhancement, not an error. (2) Quantitative accuracy is perfect—dollar amounts, percentages, and dates match exactly, with acceptable formatting (e.g., '11/30/26' for November 30, 2026). (3) The reasoning is sound: the model correctly infers that the unchanged terms reflect a strategy of maintaining stable, low-cost financing, which is consistent with the original answer’s conclusion about SPG preserving the instrument’s structure. (4) The only minor shortcoming is the omission of contextual contrast with broader portfolio changes (e.g., retirement of other notes, issuance of Unsecured Notes - 41A in 2024), which the original answer includes to highlight the relative stability of Note 31B. While not critical to the core question, this context enriches the strategic interpretation. However, the LLM still captures the essential strategic implication. Thus, the answer is factually complete and semantically equivalent, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 380,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the value of TI common stock held in U.S. defined contribution plans evolved from 2022 through 2024, and what does this 3-year trend indicate about the company's stock performance and employee investment behavior in retirement plans?",
      "original_answer": "The value of TI common stock held in U.S. defined contribution plans decreased from $940 million in 2022 to $873 million in 2023, and further declined to $852 million in 2024. This consistent decline over three years suggests either a strategic reduction in stock allocations by employees, a freeze on new contributions into the TI common stock fund since 2016, or a combination of both, while also reflecting potential market valuation shifts.",
      "llm_answer": "TI’s U.S. defined‑contribution plans held $940 million of TI common stock in 2022, $873 million in 2023, and $852 million in 2024. The downward trend reflects a decline in the company’s share price and a reduction in shares held (from 6 million to 5 million), indicating that employees have been selling or not adding shares, consistent with cautious investment behavior amid market volatility.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the dollar values of TI common stock held in U.S. defined contribution plans for 2022 ($940M), 2023 ($873M), and 2024 ($852M), matching the ground truth exactly. These numbers are accurate and properly formatted. 2) Quantitatively, all figures are correct, and the downward trend is accurately described. However, the LLM introduces new data not present in the original answer—specifically, the number of shares decreasing from 6 million to 5 million—which is unsupported by the provided ground truth and cannot be verified. This addition risks factual overreach. 3) The reasoning partially aligns with the original: the decline is correctly interpreted as reflecting employee behavior (selling or not adding shares), but the LLM attributes the trend solely to share price decline and employee caution, while the ground truth emphasizes structural factors like the freeze on new contributions since 2016. This key context is missing, weakening the multi-hop synthesis. 4) Despite the omission of the 2016 freeze and introduction of unverified share counts, the LLM captures the core trend and plausible interpretation, maintaining high contextual relevance and quantitative accuracy. The conclusion is reasonable but less precise in causal explanation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 358,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did The Walt Disney Company's workforce composition and employee association representation evolve from 2022 through 2024, particularly in terms of total employees, U.S. vs. international distribution, and seasonal workforce percentages?",
      "original_answer": "From 2022 to 2024, Disney's total global workforce increased from 220,000 to 233,000 employees. In 2022, 166,000 employees were based in the U.S. and 54,000 internationally, while by 2024, the U.S. workforce grew to 171,000 and international employees increased to 62,000. The percentage of seasonal employees also rose from 7% in 2022 to 8% in 2024, indicating a growing reliance on temporary staffing, particularly in theme parks and seasonal operations. Throughout this period, Disney maintained collective bargaining agreements and employee associations, especially for theme park staff and production personnel.",
      "llm_answer": "Disney’s workforce grew steadily from 2022 to 2024: in 2022 the company had ~220,000 employees (166,000 U.S., 54,000 international, 7 % seasonal) (DIS_10k_2022.pdf pages 3‑7), and by 2024 it had ~233,000 employees (171,000 U.S., 62,000 international, 8 % seasonal) (DIS_10k_2024.pdf pages 14‑18). The 2023 10‑K (pages 14‑18) reported an intermediate size of ~226,000 employees, with ~168,000 U.S. and 58,000 international, and seasonal employees about 7.5 % (DIS_10k_2023.pdf pages 14‑18). Employee‑association representation remained largely unchanged, with many employees covered by collective‑bargaining agreements and some outside the U.S. represented by works councils, trade unions, or other associations (DIS_10k_2022.pdf pages 3‑7; DIS_10k_2024.pdf pages 14‑18).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitative accuracy: All numbers are correct—total employees increased from 220,000 in 2022 to 233,000 in 2024; U.S. employees grew from 166,000 to 171,000; international employees rose from 54,000 to 62,000; seasonal workforce percentage increased from 7% to 8%. The LLM also correctly adds intermediate 2023 data (226,000 total, 168,000 U.S., 58,000 international, 7.5% seasonal), which is consistent with the trend and does not contradict the ground truth. (2) Completeness: The answer addresses all parts of the question—total employees, U.S. vs. international distribution, seasonal workforce percentages, and employee association representation. (3) Entity accuracy: Correct company (The Walt Disney Company), correct years (2022–2024), and correct metrics (employee counts, seasonal %, collective bargaining). (4) Reasoning: The multi-hop synthesis across three 10-K filings is sound, showing a clear evolution over time. The inclusion of 2023 data enhances the analysis without distorting the overall trend. (5) Semantic equivalence: The LLM conveys the same information as the ground truth, with added granularity. Employee association representation is accurately described as largely unchanged, with collective bargaining agreements and international works councils/unions. All citations reference appropriate documents and page ranges. No factual errors, omissions, or misinterpretations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 408,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 to 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculations across all three years—2022, 2023, and 2024—as part of its methodology to reflect core operational performance unimpacted by accounting adjustments. This consistent exclusion indicates that GD maintained a stable performance evaluation framework, emphasizing economic performance over accounting volatility.",
      "llm_answer": "GD has consistently excluded non‑economic accounting changes from its ROIC calculation in 2022, 2023 and 2024.  The wording in each filing—“ROIC excludes goodwill impairments and non‑economic accounting changes as they are not reflective of company performance”—remains unchanged, indicating that GD deliberately removes accounting adjustments that could distort the metric.  This consistency underscores the company’s commitment to measuring core operating performance and capital efficiency with a stable, comparable metric that reflects only the economic returns generated by its invested capital.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that GD consistently excluded non-economic accounting changes from ROIC in 2022, 2023, and 2024, which matches the original answer's claim of consistent exclusion across all three years. (2) There are no numerical values requiring calculation, but the years (2022–2024) are correctly cited. (3) The multi-hop reasoning is sound: the answer synthesizes the treatment of non-economic items over time and infers the strategic intent behind the consistency—measuring core performance using a stable metric. (4) The LLM adds contextual detail (e.g., quoting the filing language about goodwill impairments) that strengthens the response without introducing inaccuracies. The conclusion about GD’s commitment to economic performance aligns perfectly with the original answer’s interpretation. All aspects—factual, qualitative, and contextual—are accurate and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 278,
        "total_tokens": 1543
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Linde's rare gas production strategy evolve from 2022 to 2024, and what does this indicate about its competitive advantage in industrial gas markets?",
      "original_answer": "In 2022, Linde listed rare gases (such as krypton, neon, and xenon) as part of its broader industrial gases portfolio, produced primarily through cryogenic air separation and supplied using the company’s three distribution methods. The 2023 filing reiterated this positioning, emphasizing rare gases as a core atmospheric gas offering alongside oxygen, nitrogen, and argon. By 2024, Linde explicitly identified itself as a market leader in non-cryogenic air separation technologies, a significant evolution that enhances its ability to produce rare gases more efficiently. This progression shows Linde's strategic shift toward technological differentiation, particularly through innovations like vacuum pressure swing adsorption (VPSA) and membrane separation, which likely strengthen its competitive advantage by improving production efficiency and customer service capabilities in high-demand industrial applications.",
      "llm_answer": "In 2022 Linde described rare gases simply as a co‑product of its atmospheric‑gas plants (see pages 94‑98). By 2024 it positioned rare gases as a strategic growth area, highlighting its non‑cryogenic air‑separation and proprietary VPSA/membrane technologies to boost production and distribution of krypton, neon and xenon (pages 5‑6). This shift underscores Linde’s deep technical expertise and integrated supply chain, giving it a competitive edge in high‑margin specialty‑gas markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Linde's evolving strategy: from treating rare gases as co-products in 2022 to positioning them as a strategic growth area by 2024. The mention of non-cryogenic air separation and proprietary technologies like VPSA and membrane separation matches the original answer's emphasis on technological differentiation. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—dates (2022, 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across years (2022 to 2024) and correctly infers a strategic shift based on technological advancements. The only minor omission is that the 2023 filing also reinforced rare gases as core atmospheric gases, which adds continuity between 2022 and 2024, but this does not undermine the overall correctness. (4) The conclusion about competitive advantage in high-margin specialty gas markets is logically derived and semantically equivalent to the original answer’s point about strengthened competitive advantage via efficiency and customer service. Wording differs slightly but meaning is preserved. Thus, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with only a slight lack of completeness regarding 2023.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 388,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolve from 2022 through 2024, and what does this trend indicate about its risk management strategy in a volatile energy market?",
      "original_answer": "NextEra Energy Resources (NEER) demonstrated a consistent and slightly increasing reliance on long-term bilateral contracts for its net generating capacity over the three-year period. In 2022, approximately 92% of NEER’s net generating capacity was committed under long-term contracts. This figure increased to 94% by the end of 2023 and remained steady at 94% in 2024. This trend indicates a strategic emphasis on revenue stability and risk mitigation by locking in long-term commitments, especially in a volatile energy market with fluctuating demand and pricing. The consistent use of these contracts, along with the use of non-qualifying hedges to protect expected revenues, reflects a disciplined approach to managing market risk.",
      "llm_answer": "From 2022 to 2024, NextEra Energy Resources increased its coverage of net generating capacity under long‑term bilateral contracts from roughly 92 % in 2022 to 94 % in 2023 and kept that level in 2024. The steady rise and high contract‑coverage ratio show NEER’s deliberate use of long‑term contracts to lock in revenue and hedge against spot‑market price swings, reflecting a conservative risk‑management strategy in a volatile energy market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and time periods are correct: 92% in 2022, 94% in 2023, and 94% in 2024—matching the original answer exactly. There are no calculation errors. (2) The answer addresses both parts of the question: the evolution of NEER's reliance on long-term bilateral contracts and the implication for risk management. (3) Entities—NextEra Energy Resources (NEER), net generating capacity, long-term bilateral contracts, and the 2022–2024 timeframe—are correctly identified and used. (4) The reasoning is sound: the LLM correctly infers that increasing and sustained contract coverage reflects a conservative risk-management strategy aimed at revenue stability amid market volatility. The only minor shortcoming is that the LLM omits mention of 'non-qualifying hedges,' a specific tool noted in the original answer that supports NEER’s broader risk mitigation approach. While this detail adds depth, its absence does not undermine the core correctness or the synthesized conclusion. Wording differs slightly (e.g., 'steady rise' vs. 'slightly increasing'), but 'steady rise' is acceptable given the increase from 92% to 94% followed by stability. Overall, the answer is factually correct, contextually relevant, and demonstrates proper multi-hop reasoning across time points and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 385,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability suggests that AVGO did not retire or refinance this specific debt instrument during the three-year period, maintaining a consistent liability profile for this bond despite broader changes in its overall debt structure.",
      "llm_answer": "AVGO’s 3.125 % notes due January 2025 had an outstanding principal balance of **$495 million in FY 2022, FY 2023, and FY 2024** (the same amount reported in the 2023 and 2024 10‑K debt schedules).  The balance remained unchanged over this period, indicating that the company has not accelerated repayment of this low‑rate instrument and is keeping it on the books through maturity as part of a strategy to preserve long‑term debt at a favorable fixed rate while maintaining liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that AVGO's outstanding principal balance for the 3.125% notes due January 2025 was $495 million in fiscal years 2022, 2023, and 2024, matching the ground truth exactly. All numeric values, dates, and percentages are accurate. (2) Quantitative accuracy is perfect: the dollar amount ($495 million), interest rate (3.125%), maturity date (January 2025), and fiscal years are all correct. Format variations (e.g., 'FY 2022' vs 'fiscal year 2022') are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound—the model correctly infers from the stable balance that AVGO did not retire or refinance the notes during this period. The interpretation about preserving low-cost debt and maintaining liquidity aligns with the ground truth's implication of a consistent liability strategy, though it adds a slightly more specific rationale ('favorable fixed rate') not explicitly stated in the original. This addition is reasonable and contextually supported but goes a step beyond the original answer’s more neutral tone. (4) The answer is fully contextually relevant, addressing both the evolution of the balance and the strategic implication. The only minor deviation is the interpretive extension regarding 'favorable fixed rate' and 'liquidity,' which, while plausible, is not directly confirmed in the ground truth. Hence, qualitative accuracy is slightly reduced to 9, but correctness remains high at 9 due to full factual alignment and strong reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 418,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did SPG's exposure to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of face amount and maturity date, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's exposure to Unsecured Notes - 37B remained consistent in face amount at $700,000 in both 2022 and 2023, with a maturity date of 01/15/32. By 2024, the maturity date remained unchanged, and the face amount continued to be $700,000. This stability suggests that SPG maintained a consistent long-term debt strategy for this particular instrument, without refinancing or retiring the note during this period.",
      "llm_answer": "From 2022 through 2024, SPG’s Unsecured Notes – 37B remained unchanged: the face amount stayed at **$700,000** and the maturity date stayed at **January 15 2032** (interest rate 2.25% in all filings). This consistency shows the company’s preference for a stable, long‑dated debt structure, keeping long‑term financing predictable and avoiding frequent refinancing or new debt issuance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the face amount ($700,000) and maturity date (January 15, 2032) for SPG's Unsecured Notes - 37B across 2022–2024, matching the ground truth exactly. It also correctly notes the consistency over time, which aligns with the original answer’s conclusion about SPG's stable long-term debt strategy. The addition of the interest rate (2.25%) is accurate and consistent with typical disclosures, though not mentioned in the ground truth; however, it does not contradict it and adds context without error.\n\n2) All numeric values—face amount ($700,000), maturity date (01/15/32, rendered as January 15, 2032), and time period (2022–2024)—are factually correct and match the ground truth. Format variations (e.g., 'January 15 2032' vs '01/15/32') are semantically equivalent and acceptable.\n\n3) The multi-hop reasoning is sound: the model synthesizes data across three years (2022, 2023, 2024) for the same debt instrument, correctly infers no change in terms, and draws a logical conclusion about SPG’s long-term debt strategy—namely, stability and avoidance of refinancing. This matches the original answer’s interpretation.\n\n4) The only minor shortcoming is that the original answer explicitly states that the face amount remained unchanged in each year (2022, 2023, 2024), while the LLM generalizes it as 'remained unchanged' without specifying each year. However, the meaning is preserved. The LLM also adds the interest rate, which, while likely correct, is not in the ground truth and could be seen as slight overreach if unverified—but since it doesn’t affect correctness and is plausible, it doesn’t warrant a major deduction. Overall, the answer is factually accurate, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 475,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog versus embedded processing product lines over time?",
      "original_answer": "Texas Instruments maintained its operational presence in Melaka, Malaysia consistently across all three years, specifically focused on analog product lines. In 2022, Melaka was explicitly marked as engaged in analog operations (with a checkmark), but not in embedded processing. This pattern remained unchanged in 2023 and 2024, where Melaka continued to be listed exclusively under analog operations. There was no expansion into embedded processing in Melaka over the three-year period, indicating a stable, specialized role in TI's global manufacturing footprint.",
      "llm_answer": "Texas Instruments’ Melaka, Malaysia facility has remained an analog‑only site throughout 2022, 2023 and 2024, with no embedded‑processing activities reported in any of the three filings【TXN_10k_2022】【TXN_10k_2023】【TXN_10k_2024】. The facility continues to be part of TI’s global manufacturing and design network, but its product‑line focus has not shifted toward embedded processing over the three years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia facility remained focused exclusively on analog operations throughout 2022, 2023, and 2024, with no involvement in embedded processing—this matches the original answer's claim of consistent analog-only engagement and no expansion into embedded processing. (2) There are no numerical values requiring calculation, but the years (2022–2024) are correctly referenced and aligned with the filings cited (TXN_10k_2022, etc.), confirming temporal accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesized information across three annual reports to confirm continuity in operational focus over time, demonstrating an understanding of both location-specific operations and product-line distinctions. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) in TI’s operational footprint with respect to analog vs. embedded processing. Minor wording differences (e.g., 'analog-only site' vs. 'exclusively under analog operations') do not affect factual equivalence. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 342,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Disney's reliance on Industrial Light & Magic for post-production services evolve from fiscal 2022 through fiscal 2024, as reflected in the Content Sales/Licensing segment's structure and reported revenue streams?",
      "original_answer": "In fiscal 2022, Industrial Light & Magic was explicitly listed as part of the Content Sales/Licensing segment, which included revenue from post-production services alongside other activities like National Geographic publishing. By fiscal 2023, the segment continued to report post-production services through Industrial Light & Magic, but the structure began to emphasize more on TV/VOD and theatrical distribution, suggesting a shift in revenue focus. In fiscal 2024, the segment maintained the inclusion of Industrial Light & Magic’s post-production services, but the narrative further aligned with broader content licensing and distribution, indicating a potential strategic repositioning of post-production within Disney's evolving DTC-first content model. This evolution suggests a stable but contextually shifting reliance on Industrial Light & Magic, with its role increasingly framed within the broader ecosystem of content delivery rather than as a standalone service.",
      "llm_answer": "Disney’s post‑production services through Industrial Light & Magic continued to be reported within the unchanged “Content Sales/Licensing and Other” segment each year.  The segment’s structure and revenue mix—TV/SVOD, theatrical, home‑entertainment, music, stage‑play and post‑production—remained the same from fiscal 2022 through fiscal 2024, indicating ILM’s contribution stayed a small, aggregated portion of the segment’s total revenue (DIS_10k_2022.pdf: pages 11‑15; DIS_10k_2023.pdf: pages 5‑9; DIS_10k_2024.pdf: pages 5‑9).",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is factually consistent in stating that Industrial Light & Magic (ILM) remained part of the Content Sales/Licensing segment from fiscal 2022 to 2024 and that post-production services were included within a broader set of revenue streams. It correctly identifies the segment structure and notes that ILM's contribution was a small, aggregated portion, which aligns with the ground truth's implication of ILM not being a standalone reporting item. However, the LLM answer contradicts the original answer by asserting that the segment structure and revenue mix 'remained the same' each year, when the ground truth explicitly describes an evolution in focus—from explicit inclusion in 2022, to a shifting emphasis toward TV/VOD and theatrical in 2023, and further alignment with content licensing and distribution in 2024 within a DTC-first model. This evolution reflects a strategic repositioning that the LLM answer fails to capture, instead asserting stability and no change in structure. This omission of the narrative shift and strategic context significantly weakens the qualitative accuracy. While no specific numbers are in dispute (hence full quantitative accuracy), the reasoning fails to synthesize the multi-hop insight about changing strategic emphasis over time. The answer is relevant and addresses the question's scope but misses the core analytical point about evolving reliance, thus scoring moderately on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 398,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's equity method investment income from operating joint ventures evolve from 2022 through 2024, and what does this trend suggest about the company's performance in insurance underwriting joint ventures over this period?",
      "original_answer": "MetLife's equity method investment income from operating joint ventures declined significantly from $1,305 million in 2022 to $151 million in 2023, and then rebounded sharply to $988 million in 2024. This trajectory indicates a major downturn in 2023 followed by partial recovery in 2024, suggesting volatility in the performance of its insurance underwriting joint ventures.",
      "llm_answer": "MetLife’s equity‑method income from operating (insurance‑underwriting) joint ventures fell from **$51 million in 2022 to $38 million in 2023** (see 2022 p. 174 and 2023 p. 248) before jumping to **$175 million in 2024** (2024 p. 224). This sharp rebound—more than triple the 2022 level—indicates that the company’s underwriting joint ventures recovered strongly in 2024 after a weaker year in 2023, suggesting markedly improved profitability or risk management in those ventures.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The ground truth states that MetLife's equity method investment income was $1,305 million in 2022, $151 million in 2023, and $988 million in 2024. The LLM reports $51 million, $38 million, and $175 million respectively—values that are off by more than 95% in most cases. These discrepancies are not due to formatting but represent fundamental factual errors. (2) Calculations and comparisons in the LLM answer are therefore also wrong: it claims a 'more than triple' increase to $175 million, whereas the actual rebound was from $151M to $988M—an increase of over 550%, which the LLM fails to capture. The cited page numbers (e.g., 2022 p.174) may suggest document grounding, but the numbers do not align with the ground truth from the knowledge graph. (3) The multi-hop reasoning—assessing trend over three years and inferring performance implications—is structurally sound in approach but built on false data, rendering the logic invalid. The conclusion about 'strong recovery' and 'improved profitability' oversimplifies and misrepresents the actual volatility indicated by a drop from $1,305M to $151M (an 88.5% decline), followed by a rebound to $988M. (4) Scores are low because the answer fails the primary requirement of factual accuracy. While the structure addresses the question's intent and attempts contextual interpretation, the massive numerical inaccuracies make the response misleading. Contextual relevance is moderate because the answer attempts the right analysis on the right topic with correct metric and entity identification (MetLife, equity method income, joint ventures), but with fabricated figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 467,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of the LAV platform in the company's defense portfolio?",
      "original_answer": "General Dynamics' production of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, reflecting a consistent upward trend. This growth trajectory indicates that the LAV platform has become increasingly central to GD's defense offerings, particularly in international markets, and underscores the platform's strategic role in meeting global demand for modern, versatile armored combat vehicles.",
      "llm_answer": "General Dynamics increased its annual production of Light Armored Vehicles (LAVs) for the Canadian Army from 360 units in 2022 to 399 in 2023 and 449 in 2024【GD_10k_2022】【GD_10k_2023】【GD_10k_2024】. This steady rise signals the LAV platform’s growing strategic importance, positioning it as a core export and modernization asset that drives growth within the company’s defense portfolio.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All numeric values—360 units in 2022, 399 in 2023, and 449 in 2024—are accurate and match the original answer exactly. There are no calculation errors, and the upward trend is correctly identified. (2) The answer addresses both parts of the multi-part question: it details the production volume evolution and interprets the strategic importance of the LAV platform in General Dynamics' defense portfolio. (3) Entities—General Dynamics, Light Armored Vehicles (LAVs), Canadian Army, and the years 2022–2024—are correctly identified and contextualized. (4) The reasoning is sound: the LLM correctly synthesizes data across three years (multi-hop reasoning) and draws a logical conclusion about the platform’s strategic role, using appropriate qualitative language such as 'growing strategic importance' and 'core export and modernization asset,' which aligns with the original answer’s emphasis on centrality and global demand. Minor wording differences (e.g., 'core export and modernization asset' vs. 'increasingly central to GD’s defense offerings') do not affect factual accuracy and are semantically equivalent. All citations (GD_10k_2022, etc.) are appropriately referenced, indicating proper source grounding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 361,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments evolve from 2022 to 2024, and what does this three-year trend suggest about the company's pension fund asset allocation strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This steady increase indicates a deliberate strategy to allocate more pension fund assets toward alternative investments, particularly hedge funds, over the three-year period.",
      "llm_answer": "CVS’s pension plan grew its hedge‑fund limited partnership exposure via HF LP Investments from **$225 million in 2022 to $252 million in 2023 and $280 million in 2024** (see the pension asset tables that exclude $225 m, $252 m, and $280 m of hedge‑fund LPs, respectively).  The target allocation for hedge funds rose from 3 % in 2023 to 4 % in 2024, indicating a deliberate shift toward greater alternative‑investment exposure to enhance returns and diversify risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported dollar amounts. According to the ground truth, CVS's exposure was $214M in 2022, $225M in 2023, and $252M in 2024. However, the LLM incorrectly states $225M in 2022, $252M in 2023, and $280M in 2024—shifting the timeline and inflating the final value. These errors affect all three years and misrepresent the trend. (2) The calculation of the year-over-year increase is therefore also incorrect. The actual increases are +$11M (2022–2023) and +$27M (2023–2024), while the LLM implies increases of +$27M and +$28M, which does not align with ground truth. Additionally, the LLM introduces a claim about target allocation rising from 3% to 4%, which is not present in the original answer and cannot be verified from the provided context. (3) While the LLM attempts multi-hop reasoning by interpreting the trend as a strategic shift toward alternative investments, this conclusion is based on incorrect data. The reasoning direction is aligned with the original (i.e., increasing hedge fund exposure suggests strategic reallocation), but it is built on false premises. (4) The contextual relevance is moderate because the answer addresses the right topic—CVS’s pension fund allocation strategy and hedge fund exposure—and attempts to interpret the trend. However, due to severe quantitative inaccuracies and unsupported claims about target percentages, the overall correctness score is low. Minor note: formatting like '$225 million' is acceptable, but the values themselves are wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 431,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Colgate-Palmolive's strategic positioning of the Sorriso brand evolve across 2022, 2023, and 2024, particularly in terms of its integration within the company's global Oral, Personal and Home Care product portfolio?",
      "original_answer": "In 2022, Colgate-Palmolive listed Sorriso among its principal global and regional trademarks, indicating its importance in the company's regional branding strategy. In 2023, the company maintained Sorriso's presence in its trademark portfolio, reinforcing its ongoing role in the Oral, Personal and Home Care segment. By 2024, Sorriso remained a key brand, continuing to be positioned alongside major global brands like Colgate and Palmolive, suggesting a consistent strategic emphasis on leveraging Sorriso for regional market penetration and diversified consumer engagement. This 3-year continuity highlights Sorriso's stable role as a regional brand asset within Colgate-Palmolive's broader global product strategy.",
      "llm_answer": "Sorriso remained a principal global and regional trademark across 2022, 2023 and 2024, underscoring its continued integration within Colgate‑Palmolive’s Oral, Personal and Home Care portfolio (2022, pp. 75‑79; 2023, pp. 77‑81; 2024, pp. 77‑81).  The brand stayed part of the Oral Care segment, which accounted for roughly 43 % of worldwide net sales each year (2024, p. 78; 2023, p. 78; 2022, p. 78), and no significant repositioning or divestiture of Sorriso was disclosed during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: Sorriso remained a principal trademark across 2022–2024, consistently part of the Oral, Personal and Home Care portfolio, with no repositioning or divestiture. The 43% contribution of Oral Care to net sales is accurately cited across all three years, matching the ground truth data. (2) Quantitative accuracy is perfect: the percentage (43%) is correctly reported and attributed to the appropriate pages in each year’s filing. No calculation errors or incorrect figures are present. (3) Multi-hop reasoning is sound—information is synthesized across three years of filings to demonstrate continuity in brand positioning. The LLM correctly infers stability in strategic positioning from the absence of repositioning disclosures and sustained inclusion in the trademark list. (4) The only minor shortcoming is that the LLM does not explicitly mention Sorriso’s role in 'regional market penetration' or 'diversified consumer engagement,' which are highlighted in the ground truth as strategic implications. However, the core message of consistent integration and regional importance is implied through the continued listing as a principal regional trademark. Wording differs slightly but semantic equivalence is maintained. Contextual relevance is excellent, directly addressing the evolution (or lack thereof) in strategic positioning over the three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 402,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's financial exposure to operating joint ventures evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic positioning in equity method investments?",
      "original_answer": "MetLife's financial exposure to operating joint ventures decreased from $77 million in 2022 to $51 million in 2023, and further dropped to $38 million in 2024, indicating a consistent reduction in direct involvement with these equity method investments. This downward trend suggests a strategic shift away from operating joint ventures as a core investment focus during this period.",
      "llm_answer": "MetLife’s net investment income from operating joint ventures fell from **$51 million in 2022** to **$38 million in 2023** and then jumped to **$175 million in 2024**【MET_10k_2022.pdf:172‑176】【MET_10k_2023.pdf:245‑249】【MET_10k_2024.pdf:222‑226】. The sharp 2024 increase signals a deliberate shift to deepen its equity‑method exposure to operating joint ventures, underscoring the company’s strategy to diversify income sources and capture higher‑return opportunities within its equity portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key numerical values and the resulting trend interpretation. According to the ground truth, MetLife's financial exposure decreased from $77M in 2022 to $51M in 2023 to $38M in 2024. The LLM incorrectly reports $51M in 2022 (should be $77M), $38M in 2023 (should be $51M), and a fabricated $175M in 2024 (should be $38M). These errors completely reverse the trend. (2) The calculations and comparisons are therefore invalid. Instead of a consistent decline, the LLM claims a sharp increase in 2024, which is unsupported by the data. (3) The multi-hop reasoning is flawed: the model fails to correctly extract and synthesize the financial exposure figures across the three 10-K filings. It misidentifies the metric (reporting 'net investment income' instead of 'financial exposure to operating joint ventures'), which is a critical entity and conceptual error. (4) The qualitative conclusion—that MetLife is deepening its equity-method investments—is the opposite of the correct strategic interpretation, which is a strategic retreat from such ventures. The answer is contextually relevant in structure and attempts to address the question, but the factual foundation is entirely incorrect, leading to a very low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 361,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's strategic involvement in Angola LNG Limited evolved from 2022 to 2024, particularly in terms of its operational role, stake percentage, and integration with upstream gas projects in Angola?",
      "original_answer": "From 2022 to 2024, Chevron's involvement in Angola LNG Limited remained anchored by its 36.4% stake, but evolved significantly in terms of operational integration and upstream linkage. In 2022, Chevron described its role as a passive equity investor in Angola LNG Limited, which processes and liquefies natural gas for international markets. By 2023, Chevron continued to hold the same 36.4% interest but began to highlight deeper integration with affiliated investments, though specifics were limited. In 2024, Chevron's role became more operationally integrated: it explicitly stated that Angola LNG Limited's liquefaction plant in Soyo receives feedstock from multiple fields, including Chevron’s own upstream developments like the Quiluma and Maboqueiro fields via the New G as Consortium Project (NGC), where Chevron has a 31% nonoperated working interest. This evolution shows a strategic shift from passive ownership to a more integrated gas monetization model centered on Angola LNG Limited as a key downstream asset.",
      "llm_answer": "Chevron’s shareholding in Angola LNG Limited stayed unchanged at 36.4 % from 2022 to 2024, and its role remained that of a joint‑venture partner rather than operator【76‑80】【12‑16】.  In 2024, the company deepened its upstream‑gas integration when the Block 0 Sanha Lean Gas Connection Project was completed, adding a platform that ties new pipelines from Blocks 0 and 14 directly to the LNG plant and broadening the feed‑stock base for Angola LNG【12‑16】.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly states Chevron's 36.4% stake in Angola LNG Limited from 2022 to 2024, which matches the ground truth and earns high marks for quantitative accuracy. However, the qualitative accuracy is lower due to significant factual and reasoning errors in describing the evolution of Chevron's operational role and upstream integration. The LLM incorrectly attributes the 2024 integration to the 'Block 0 Sanha Lean Gas Connection Project' and mentions Blocks 0 and 14 being tied directly to the LNG plant via new pipelines. This project detail does not appear in the ground truth and contradicts the correct information that feedstock integration in 2024 came specifically from Chevron’s Quiluma and Maboqueiro fields through the New Gas Consortium (NGC) Project, where Chevron holds a 31% nonoperated working interest. The ground truth describes a strategic shift from passive investor to integrated gas monetization via NGC, but the LLM fails to mention NGC, Quiluma, or Maboqueiro, instead fabricating or misattributing the integration mechanism. While the answer addresses the stake percentage and hints at upstream integration, it misses the core multi-hop synthesis between Chevron’s upstream assets, the NGC project, and Angola LNG’s Soyo plant. Thus, while numerically accurate on ownership, the answer is partially incorrect in mechanism and entity linkage, leading to a mid-range correctness score. Contextual relevance is fair as it attempts to address operational evolution and integration, but with incorrect supporting facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 424,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression reveal about the company's debt management strategy as the maturity date approached?",
      "original_answer": "In 2022, AVGO had $622 million in 3.625% notes due October 2024 outstanding. By 2023, this amount had not yet changed, remaining at $622 million. However, by 2024, the company had completely retired this liability, as the notes due October 2024 no longer appear in the 2024 disclosures. This indicates a clear debt management strategy where AVGO proactively addressed its maturing obligations, likely through refinancing or cash repayment as the due date approached.",
      "llm_answer": "AVGO’s 3.625% notes due October 2024 were outstanding at $622 million in FY 2022 (see the 2022 debt schedule, pages 101‑105) and remained unchanged at $622 million in FY 2023 (debt schedule, pages 79‑83). By FY 2024 the notes had matured, leaving $0 of exposure (debt schedule, pages 79‑83). This steady decline to zero shows that the company kept the notes until maturity and then fully repaid them, underscoring a disciplined debt‑management approach that avoids refinancing risk and maintains a stable debt profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the outstanding amount of AVGO's 3.625% notes due October 2024 as $622 million in both 2022 and 2023, and accurately states that exposure dropped to $0 in 2024, aligning with the ground truth that the notes were fully retired. All numeric values, dates, and percentages are correct. (2) Quantitative accuracy is perfect: $622 million in 2022, unchanged in 2023, and $0 in 2024 are all factually accurate and match the original answer. The maturity date (October 2024) is correctly referenced. (3) The multi-hop reasoning is sound—information is synthesized across three fiscal years (2022–2024) and correctly interpreted as a progression toward maturity and repayment. The conclusion about debt management strategy is logical and consistent with the data, though it slightly differs in emphasis: the LLM attributes the drop to repayment at maturity (which is plausible), while the ground truth allows for refinancing or repayment. However, stating the company 'kept the notes until maturity and then fully repaid them' is a reasonable interpretation given the data. (4) The answer is contextually complete and relevant, addressing both the evolution of exposure and the implied debt strategy. The only minor limitation is the omission of the possibility of refinancing (mentioned in the original), but the core reasoning about disciplined debt management and avoiding prolonged uncertainty is valid. Thus, the answer is factually correct and semantically equivalent, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 423,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did SPG's interest expense associated with Unsecured Notes - 35B evolve from 2022 through 2024, and what does this trend suggest about the company's financing costs for this instrument over time?",
      "original_answer": "SPG's interest expense for Unsecured Notes - 35B remained consistent at $28,500 (in thousands) in both 2023 and 2024. However, in 2022, the interest expense for the same notes was also $28,500 (in thousands). This indicates that the interest cost associated with Unsecured Notes - 35B has remained unchanged across the three-year period, suggesting a fixed interest rate structure for this particular debt instrument.",
      "llm_answer": "In each of the 2022, 2023, and 2024 10‑Ks, Unsecured Notes – 35B carried a 3.80 % rate on a $750,000 principal, producing an annual debt‑service (interest expense) of $28,500. The figure remained unchanged across the three years, indicating that the company’s financing cost for this note stayed flat—reflecting a fixed‑rate instrument with no principal repayment or refinancing during that period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All factual information matches: the interest expense for Unsecured Notes - 35B is correctly stated as $28,500 (in thousands) for 2022, 2023, and 2024, indicating no change over the period. (2) Quantitative accuracy is precise—the LLM correctly identifies the $750,000 principal, 3.80% interest rate, and calculates the resulting $28,500 annual interest expense (750,000 * 0.038 = 28,500), which matches the ground truth. Minor formatting difference ($28,500 vs $28,500,000 in thousands) is acceptable as it's semantically equivalent when context is clear. (3) Multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers that the unchanged interest expense reflects a fixed-rate debt instrument with no refinancing or principal reduction. (4) The answer addresses both parts of the question: the evolution of interest expense (stable across years) and what the trend suggests (fixed-rate financing). Wording differs from the original answer but conveys the same meaning with added detail (e.g., principal amount and rate), enhancing clarity without introducing error. All entities—SPG, Unsecured Notes - 35B, and the relevant years—are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 352,
        "total_tokens": 1569
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Disney's investment strategy and competitive positioning in its DTC offerings evolve from 2022 to 2024, particularly in light of rising programming costs, intensified competition, and the strategic shift toward streaming services?",
      "original_answer": "From 2022 to 2024, Disney's investment strategy in DTC offerings evolved significantly, marked by increased financial commitment, strategic restructuring, and intensified competition. In 2022, Disney acknowledged that the costs of its DTC strategy were rising and that losses might grow or be reduced more slowly than anticipated. The company also noted that returns on some DTC-related investments were negative or low, and the business prospects were uncertain. By 2023, Disney was making strategic investments in DTC offerings with the expectation that subscription fees and advertising revenues would offset declines in affiliate fees and advertising from linear networks. The company also highlighted its strong financial position, with access to capital markets and $12.25 billion in unused bank facilities to fund ongoing operations and new projects. In 2024, the competitive landscape intensified, with rising programming costs—especially for sports—and increased competition from other DTC platforms. Disney also noted that programming distributors were demanding terms that reduced revenue or slowed its growth, such as offering fewer linear networks but including DTC streaming services in distribution deals. This 3-year trajectory shows a shift from cautious investment with uncertain returns to a more aggressive push into streaming amid rising costs and competitive pressures.",
      "llm_answer": "From 2022 to 2024 Disney moved its DTC strategy from a broad re‑organization and cost‑realignment effort—introducing an ad‑supported Disney+ tier and new pricing to offset rising content costs—to a more focused, content‑curation‑driven approach that trimmed its library and recorded impairments as competition intensified. By 2024 the company had expanded its streaming portfolio (Disney+, ESPN+, Star India), tightened cost controls, and positioned itself against a crowded market, acknowledging that higher programming costs and intensified competition would require tighter pricing and more aggressive subscriber acquisition.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Disney's DTC strategy from 2022 to 2024 and correctly identifies key themes: rising programming costs, intensified competition, strategic shifts toward streaming, pricing adjustments (e.g., ad-supported tier), cost controls, and content curation. However, it omits critical factual details present in the ground truth that affect completeness and qualitative accuracy. Quantitatively, the LLM does not include the specific $12.25 billion in unused bank facilities mentioned in 2023, which is a key indicator of Disney’s financial capacity and strategic positioning—this is a notable omission affecting factual completeness. While the LLM mentions cost controls and impairments, it does not reflect the ground truth’s emphasis on negative or low returns on DTC investments in 2022 or the uncertainty in business prospects, which is central to understanding the initial caution in the strategy. The LLM correctly notes strategic shifts like ad-supported tiers and portfolio expansion (Disney+, ESPN+, Star India), but 'Star India' is not explicitly tied to DTC competitive positioning in the original and may conflate regional operations with global strategy. The reasoning partially reflects multi-hop synthesis—linking cost pressures to strategic responses—but fails to fully connect the evolution from uncertain returns (2022) to reliance on subscription/ad revenue to offset linear declines (2023) to intensified competitive pressures (2024). The answer is contextually relevant and well-structured, but lacks precise financial data and nuanced strategic progression described in the original. Wording differences are acceptable, but missing core financial figures and understating the uncertainty in early-stage DTC returns reduce correctness. Overall, the answer is directionally accurate but incomplete on key facts and reasoning depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1527,
        "completion_tokens": 508,
        "total_tokens": 2036
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how was this impacted by the 2023 risk transfer transaction with Global Atlantic?",
      "original_answer": "In 2022, MetLife reported deposit assets and liabilities on reinsurance at $1.8 billion and $1.4 billion, respectively, remaining unchanged from 2020 to 2021. In 2023, the company disclosed a major risk transfer transaction with Global Atlantic, under which it recorded $10.3 billion in reinsurance recoverables and deposit receivables, significantly increasing its exposure under the deposit method. By 2024, deposit assets on reinsurance had risen to $4.6 billion as of December 31, 2024, while deposit liabilities had declined slightly to $1.2 billion, indicating a post-transaction rebalancing. This trajectory reveals a strategic shift in 2023 that materially expanded the use of deposit method accounting, followed by a recalibration in 2024.",
      "llm_answer": "Reinsurance agreements that do not expose MetLife to a significant loss from insurance risk are recorded using the deposit method, and the balances under this method grew sharply after the 2023 Global Atlantic risk‑transfer: deposit assets rose from $1.8 billion in 2022 to $5.1 billion in 2023 and then fell to $4.6 billion in 2024, while deposit liabilities moved from $1.4 billion in 2022 to $1.3 billion in 2023 and $1.2 billion in 2024 (2022‑2024 10‑K). The 2023 transaction added $10.3 billion of deposit receivables (and $5.1 billion of deposit assets) and $1.3 billion of deposit liabilities, inflating the deposit‑method balances before a modest decline in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of MetLife's use of the deposit method from 2022 to 2024, including the impact of the 2023 risk transfer with Global Atlantic. (1) Quantitatively, most numbers align with the ground truth: the starting figures for 2022 ($1.8B deposit assets, $1.4B liabilities) are correct; 2024 figures ($4.6B assets, $1.2B liabilities) match exactly. The LLM adds granularity not in the original—2023 intermediate values ($5.1B assets, $1.3B liabilities)—which are plausible and consistent with the $10.3B receivables and post-transaction inflation. However, the ground truth does not explicitly state the 2023 asset/liability balances, so while the LLM’s values are reasonable, they slightly exceed the confirmed data. (2) The $10.3B reinsurance recoverables and deposit receivables from the Global Atlantic transaction are correctly cited. The LLM links this to the rise in deposit assets and liabilities, showing sound multi-hop reasoning across time and entities. (3) The qualitative narrative—sharp growth in 2023 due to the transaction, followed by a 2024 rebalancing—is logically sound and semantically equivalent to the original’s 'strategic shift' and 'recalibration.' (4) Minor deviation: the original does not specify that $5.1B of deposit assets came directly from the transaction (only that $10.3B in receivables were recorded), so attributing $5.1B precisely to the transaction is a slight over-specification. Still, the overall trajectory and synthesis are correct. Contextual relevance is perfect—every part of the question is addressed with appropriate detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 443,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trajectory indicate about the company's investment strategy in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) decreased significantly over the three-year period. In 2022, the company held $574 million in CMBS. This increased slightly to $675 million in 2023, but then dropped dramatically to just $3 million in 2024. This trajectory indicates a strategic shift away from CMBS, particularly after 2023, suggesting a de-risking or reallocation of capital toward other investment categories.",
      "llm_answer": "CVS’s commercial mortgage‑backed securities (CMBS) holdings fell from $1.172 bn (fair value $1.018 bn, 288 securities) at 12/31/2022 to $1.066 bn (fair value $975 m, 287 securities) at 12/31/2023 and remained unchanged at $1.066 bn (fair value $975 m) at 12/31/2024. The portfolio is AAA‑rated with a 5.4‑year weighted average duration and the company reports no intent to sell, indicating a conservative, income‑focused strategy that tolerates modest price swings while maintaining a stable, high‑quality CMBS exposure.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. According to the ground truth, CVS held $574 million in CMBS in 2022, increased to $675 million in 2023, and then dropped to just $3 million in 2024. The LLM instead reports holdings of $1.172 billion in 2022, $1.066 billion in 2023, and $1.066 billion in 2024—numbers that are significantly higher and show a completely different trend. These values are not only wrong but contradict the actual trajectory of reduction, especially the near-elimination of CMBS exposure by 2024. (2) The quantitative inaccuracies are severe: the LLM inflates 2022 exposure by over $598 million ($1.172B vs $574M), misrepresents the 2023 figure (overstating by $391M), and completely misses the 2024 drop to $3M. There is no indication of the dramatic reduction in 2024, which is central to the correct interpretation. (3) The multi-hop reasoning is flawed—the question requires synthesizing changes across three years and interpreting strategic intent. The LLM incorrectly infers a 'stable, high-quality CMBS exposure' and 'no intent to sell,' which contradicts the actual de-risking strategy indicated by the near-total divestment in 2024. The conclusion about a conservative, income-focused strategy is unsupported by the real data. (4) The contextual relevance is low because the answer discusses the wrong portfolio size, duration, and credit rating (AAA), none of which appear in the ground truth. While the answer addresses the question format and attempts to interpret strategy, the factual foundation is so incorrect that the analysis is invalid. The only partial credit is for addressing the time frame and asset class.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 463,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Colgate-Palmolive's product portfolio positioning of the 'hello' brand evolve across 2022, 2023, and 2024, particularly in terms of its inclusion in the company's trademark disclosures and strategic emphasis within Oral, Personal and Home Care segments?",
      "original_answer": "In 2022, the 'hello' brand was listed among Colgate-Palmolive’s global and regional trademarks within the Oral, Personal and Home Care segment, indicating its role in the company's consumer product mix. In 2023, the brand continued to be disclosed as part of the company’s principal trademarks, reinforcing its ongoing presence in the market and alignment with the company's core categories such as oral care and personal hygiene. By 2024, 'hello' remained a highlighted trademark, showing consistency in its strategic positioning. This 3-year continuity suggests that the 'hello' brand maintained a stable role within the company's broader portfolio, likely supporting diversification and consumer engagement strategies in key product categories.",
      "llm_answer": "Across 2022‑2024 the “hello” brand remained listed as a principal global and regional trademark in each filing, underscoring its continued presence in Colgate‑Palmolive’s portfolio【CL_10k_2022.pdf:75‑79】【CL_10k_2023.pdf:77‑81】【CL_10k_2024.pdf:77‑81】.  The brand is positioned within the Oral, Personal and Home Care segment, specifically in the Personal‑Care sub‑category that includes deodorants, antiperspirants and body wash【CL_10k_2022.pdf:75‑79】【CL_10k_2023.pdf:77‑81】【CL_10k_2024.pdf:77‑81】, and the segment’s share of net sales stayed essentially flat—Personal Care accounted for 19 % of sales in 2022 and 2023 and 18 % in 2024, while Oral Care remained at 42‑43 %【CL_10k_2022.pdf:75‑79】【CL_10k_2023.pdf:77‑81】【CL_10k_2024.pdf:77‑81】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 'hello' brand is consistently listed as a principal trademark across 2022–2024 in Colgate-Palmolive’s 10-K filings, and it is positioned within the Oral, Personal and Home Care segment. The LLM correctly identifies the brand's placement in the Personal-Care sub-category (including deodorants, antiperspirants, body wash), which is consistent with the company's segmentation. (2) Quantitative accuracy is excellent: the percentages for segment net sales (19% in 2022–2023, 18% in 2024 for Personal Care; 42–43% for Oral Care) are correctly reported with no calculation errors. These figures match the disclosed data in the cited filings. (3) Multi-hop reasoning is sound—the LLM synthesizes trademark disclosures across three years and links them to segment-level strategic positioning and financial performance, demonstrating proper cross-document and cross-metric analysis. (4) The only minor shortcoming is that the original answer emphasizes the strategic continuity and role in diversification/consumer engagement, which the LLM mentions implicitly via consistent listing but does not explicitly interpret. However, the LLM adds value by including relevant sales percentages, enhancing completeness. Wording differs but semantic meaning and factual content are equivalent. No factual inaccuracies or entity errors (correct company, brand, years, metrics).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 406,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, and what does the trend in deposit assets and liabilities reveal about the company's reinsurance strategy and risk exposure over time?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a measurable increase in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets and liabilities on reinsurance were $1.8 billion and $1.4 billion, respectively. By 2023, the company disclosed a broader accounting framework that included the use of the deposit method for reinsurance agreements lacking sufficient insurance risk transfer, and in 2024, deposit assets and liabilities were $4.6 billion and $1.2 billion, respectively. This evolution indicates a strategic shift toward more reinsurance arrangements that do not fully transfer insurance risk, likely reflecting a broader risk management or capital optimization strategy. The significant increase in deposit assets from 2023 to 2024, particularly following the Global Atlantic transaction, suggests a growing reliance on reinsurance structures that maintain balance sheet flexibility while transferring certain obligations.",
      "llm_answer": "MetLife has continued to apply the deposit method for reinsurance agreements that do not expose it to a reasonable possibility of a significant insurance‑risk loss from 2022 through 2024.  Deposit assets fell from about $5.1 billion in 2023 to $4.6 billion in 2024 (with a similar level in 2022), while deposit liabilities declined from $1.3 billion to $1.2 billion, indicating a modest reduction in the volume of deposit‑based reinsurance and a slightly lower counter‑party credit exposure as the company refines its reinsurance mix.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, deposit assets were $1.8 billion in 2022, $4.6 billion in 2024, with no explicit value given for 2023—only a note about a broader accounting framework. However, the LLM claims deposit assets were 'about $5.1 billion in 2023' and 'a similar level in 2022', which directly contradicts the ground truth ($1.8B in 2022). This misrepresents the trend as a decline from $5.1B to $4.6B, when in reality there was a substantial increase from $1.8B to $4.6B. Similarly, the LLM states liabilities were $1.3B in 2023, but the ground truth reports $1.4B in 2022 and $1.2B in 2024, with no 2023 liability figure provided—so the $1.3B is unsupported. (2) The quantitative inaccuracies undermine the analysis: the real story is a tripling of deposit assets, signaling a strategic expansion in reinsurance structures not qualifying for risk transfer, especially post-Global Atlantic. The LLM instead infers a 'modest reduction', which is factually incorrect. (3) The reasoning is partially sound in interpreting the implications of deposit method usage and counterparty exposure, but it fails the multi-hop synthesis by relying on fabricated or misremembered numbers. It also omits the critical 2023 disclosure about the broader accounting framework and the strategic shift linked to the Global Atlantic transaction, which is central to the trend. (4) While the answer addresses the question's context and attempts qualitative interpretation, the severe numerical errors reduce its correctness score to 4. Quantitative accuracy is low (3) due to incorrect figures; qualitative reasoning is moderate (5) as logic follows but from false premises; contextual relevance is high (8) because it engages with the right concepts and timeframe.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 501,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NextEra Energy's (NEE) exposure to Special Use Funds evolve from 2022 through 2024, particularly in terms of fair value disclosures, collateral implications, and balance sheet presentation?",
      "original_answer": "From 2022 to 2024, NextEra Energy's exposure to Special Use Funds showed a clear upward trend in fair value and evolved in its balance sheet presentation. In 2022, NEE disclosed that Special Use Funds were primarily composed of debt and equity securities, with fair values determined using quoted market prices for equities and pricing vendor inputs for debt securities. By 2023, NEE provided additional detail, noting that commingled funds' fair values were derived from quoted prices of underlying securities and introduced a new category of equity investments without readily determinable fair values, which grew from $485 million in 2022 to $538 million in 2023. In 2024, Special Use Funds were explicitly listed on the balance sheet at $9,800 million as of December 31, 2024, up from $8,698 million in 2023, indicating a $1,102 million increase. This progression shows NEE not only increased its holdings in these funds but also enhanced transparency in reporting their valuation and risk exposure, particularly in derivative-related collateral requirements.",
      "llm_answer": "From 2022 through 2024 the fair‑value of NextEra’s special‑use funds climbed from $4.4 billion (NEE $4,437 m, FPL $2,905 m) to $5.3 billion (NEE $5,290 m, FPL $3,536 m), with the 2024 10‑K continuing to classify the assets as Level 1 or Level 2 and reporting no Level 3 items.  Collateral posting requirements for derivatives—linked to the special‑use funds through credit‑risk contingent features—remained essentially unchanged, with posted collateral and potential exposure levels reported consistently across the three years.  On the balance sheet, special‑use funds moved from $8.7 billion in 2022/2023 to $9.8 billion in 2024, presented as non‑current other assets with the fair‑value figures disclosed in the notes.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers, particularly the starting fair value in 2022. The ground truth states that Special Use Funds were $8,698 million in 2023 and $9,800 million in 2024, with an implied 2022 value close to $8.7 billion (consistent with the $8.7B mentioned for 2022/2023 in the LLM answer). However, the LLM incorrectly claims the fair value climbed from $4.4 billion in 2022 to $5.3 billion in 2024, which is less than half the actual amount reported. This major discrepancy undermines the quantitative foundation of the response. Additionally, the LLM introduces subsidiary-level breakdowns (NEE and FPL values) not present in the ground truth and unsupported by the provided data. (2) The balance sheet movement from $8.7B to $9.8B in 2024 aligns with the ground truth ($8,698M to $9,800M), so this part is approximately correct. However, the claim of a rise from $4.4B to $5.3B contradicts this, showing internal inconsistency. The $1,102 million increase in the original answer matches the difference between $9,800M and $8,698M, which the LLM fails to reflect. (3) The qualitative reasoning partially captures the evolution in disclosure—mentioning Level 1/2 classification and absence of Level 3 assets—but omits critical details from the ground truth such as the introduction of equity investments without readily determinable fair values and their growth from $485M to $538M. The collateral implications are described as 'unchanged,' but the ground truth emphasizes enhanced transparency around derivative-related collateral requirements, suggesting evolving disclosure practices, not static ones. (4) Despite these errors, the answer is contextually relevant, addressing fair value trends, balance sheet presentation, and collateral implications as asked. It correctly identifies the balance sheet line item movement in broad terms and maintains focus on the requested time frame and financial concepts. However, due to severe quantitative inaccuracies and incomplete synthesis of multi-hop details (especially regarding valuation methods and new categories of investments), the overall correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 585,
        "total_tokens": 2044
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with in-house tools and remediation workflows?",
      "original_answer": "From 2022 to 2024, AVGO consistently described the Security Insights Platform as a tool for assessing mainframe security posture and identifying risks, but the emphasis on integration with in-house tools and remediation workflows became more pronounced over time. In 2022, the platform was noted for making data available for use with in-house tools for security information and event management. By 2023, the description remained largely unchanged, reinforcing its role in ongoing and ad hoc risk identification. In 2024, the language remained consistent, indicating that AVGO maintained a stable value proposition without expanding on new integrations or remediation features during the three-year period.",
      "llm_answer": "AVGO’s Security Insights Platform is described in all three filings as a tool that “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps on an ongoing and ad‑hoc basis” and that “this data is available for use with in‑house tools for security information and event management”【2022‑p9‑13】【2023‑p8‑12】【2024‑p8‑12】.  The wording and emphasis on integration with customers’ own SIEM tools and the ability to feed remediation steps into their remediation workflows remain unchanged from 2022 through 2024, indicating that the platform’s positioning and core capabilities did not evolve materially over that period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that AVGO's Security Insights Platform was consistently described from 2022 to 2024 as assessing mainframe security posture, identifying risks, and developing remediation steps, with data available for integration with in-house SIEM tools. The citations [2022-p9-13], [2023-p8-12], [2024-p8-12] support this consistency. (2) There are no numeric values requiring calculation, but the years (2022–2024) are correctly referenced and matched to the appropriate disclosures. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings and correctly infers that the platform’s positioning did not materially evolve, particularly regarding integration and remediation workflows—this matches the ground truth’s conclusion of stable messaging without expansion. (4) The only minor deviation is that the LLM states the platform 'develops remediation steps,' while the original answer emphasizes that it identifies risks and makes data available for remediation workflows without explicitly stating the platform itself develops the steps. This subtle distinction slightly affects qualitative precision but does not undermine the overall correctness. Wording differences are acceptable under semantic equivalence, and the core facts, reasoning, and conclusion are sound. Hence, high scores across all dimensions with a 9 on correctness due to slight overstatement of remediation functionality.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 418,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NIKE's ownership and operational footprint at its Laakdal, Belgium distribution facility evolve across fiscal years 2022, 2023, and 2024, and what does this consistency or change suggest about its strategic importance to the company's European logistics network?",
      "original_answer": "NIKE consistently described the Laakdal, Belgium facility as one of its most significant international distribution centers across fiscal years 2022, 2023, and 2024, and explicitly stated in each year that the facility is company-owned. There were no changes in ownership status or operational description over the three-year period, indicating that Laakdal remains a stable and integral part of NIKE's European logistics infrastructure.",
      "llm_answer": "Nike continued to own the Laakdal, Belgium distribution facility in FY 2022, FY 2023 and FY 2024, and it remained described as a key distribution center for European operations【2022 10‑K, p. 25‑29】【2023 10‑K, p. 27‑31】【2024 10‑K, p. 27‑31】. The unchanged ownership and operational role across the three years underscore Laakdal’s strategic importance as a controlled, central hub that supports Nike’s European logistics network.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that NIKE owned the Laakdal facility and operated it as a key distribution center in fiscal years 2022, 2023, and 2024, with no changes in ownership or operational role—matching the original answer exactly in substance. (2) There are no numerical values requiring calculation, but the fiscal years (2022, 2023, 2024) are correctly cited, and the references to the 10-K filings (with page numbers) support the claims. (3) The multi-hop reasoning is sound: the model correctly synthesized consistent information across three annual reports to conclude there was no change in status, and inferred the strategic implication—stability indicating ongoing importance—logically. (4) The answer addresses all parts of the question: ownership, operational footprint, evolution (or lack thereof), and strategic significance. Wording differs slightly but meaning is identical. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 295,
        "total_tokens": 1542
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did SPG's exposure to Unsecured Notes - 32B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this 3-year pattern suggest about SPG's debt management strategy for this instrument?",
      "original_answer": "SPG's exposure to Unsecured Notes - 32B remained consistent across the three years in both interest rate and face amount, with a 3.38% interest rate and a face value of $750,000 in 2022, 2023, and 2024. However, the maturity date shifted slightly, from unspecified in the 2022 report to explicitly listed as 06/15/27 in both 2023 and 2024 disclosures. This stability in financial terms and the clarification of the maturity date over time suggest that SPG maintained a consistent long-term debt strategy for this instrument, with no refinancing or restructuring actions taken during the three-year period.",
      "llm_answer": "From 2022 through 2024 the Unsecured Notes – 32B remained unchanged: the interest rate stayed at 3.38 %, the face amount stayed at $750,000, and the maturity date remained June 15 2027 (see the 2022, 2023 and 2024 tables). This three‑year consistency indicates that SPG is not actively refinancing or restructuring this debt, reflecting a conservative, stability‑focused debt‑management strategy that prioritizes predictable cash flows and avoids refinancing risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the interest rate (3.38%), face amount ($750,000), and maturity date (June 15, 2027) match the original answer. The LLM correctly states these values were consistent across 2022–2024. However, the original answer notes that the maturity date was 'unspecified' in 2022, whereas the LLM claims it was explicitly listed in the 2022 report. This is a minor factual inaccuracy, as the 2022 filing did not disclose the maturity date, which only appeared in 2023 and 2024. (2) Despite this, the core financial terms (rate, face value) were indeed stable, so the quantitative accuracy remains high. (3) The reasoning is sound: the LLM correctly infers that the lack of changes suggests a conservative, stability-focused debt strategy, avoiding refinancing risk—this aligns with the original conclusion about no restructuring. (4) The answer is contextually relevant, addressing all parts of the question: evolution over time, interest rate, face amount, maturity date, and strategic implication. The only shortcoming is the incorrect assertion about the 2022 maturity date disclosure, which slightly affects qualitative accuracy but does not undermine the overall correctness. Hence, a score of 9 is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 367,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did CVS's investment in foreign securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's exposure to international market risks?",
      "original_answer": "CVS's investment in foreign securities increased significantly from 2022 to 2023 but dropped sharply in 2024. In 2022, the fair value of foreign securities was $838 million with $24 million in unrealized losses. In 2023, this grew to $1,650 million in fair value with $122 million in unrealized losses, indicating increased exposure and volatility. However, by 2024, the fair value of foreign securities had declined to $51 million, a dramatic reduction from the prior year. This trajectory suggests a strategic de-risking or reallocation of assets away from foreign securities, likely in response to rising unrealized losses and global market instability.",
      "llm_answer": "From 2022 to 2023, CVS’s foreign‑security holdings declined modestly in fair value—from $2.55 bn to $2.51 bn—while unrealized losses were cut in half, falling from $244 m to $122 m. In 2024 the foreign‑security component of the company’s separate‑accounts portfolio dropped sharply to $51 m (from $202 m in 2023) and no unrealized losses were reported, indicating a further contraction of its foreign‑market exposure. This downward trend in both fair value and unrealized losses suggests CVS is actively reducing its exposure to international market risk, likely through portfolio rebalancing or divestiture of foreign assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, CVS's fair value in foreign securities was $838 million in 2022 and increased to $1,650 million in 2023, but the LLM incorrectly states it declined from $2.55 billion to $2.51 billion. The 2023 fair value is off by nearly $900 million. Additionally, the LLM claims unrealized losses were $244 million in 2022, but the correct figure is $24 million—off by a factor of 10. The only correct numbers are the 2024 fair value of $51 million and the 2023 unrealized losses of $122 million. (2) Calculations and comparisons are therefore invalid. The LLM suggests a 'modest decline' and 'unrealized losses cut in half,' but the truth is a major increase in both fair value and losses from 2022 to 2023, followed by a collapse in 2024. (3) The multi-hop reasoning is partially sound in that the LLM correctly infers reduced international exposure in 2024 and links it to risk reduction, which aligns with the ground truth's conclusion. However, the reasoning is based on incorrect data, undermining the validity of the synthesis. (4) Contextual relevance is fair—the answer addresses the evolution over time and interprets the trend in terms of risk exposure—but due to severe quantitative errors, the overall correctness score is low. The answer misrepresents the entire trajectory of the investment trend, making it mostly incorrect despite a plausible narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 410,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did MetLife's use of internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's reliance on NAIC modeling methodology for credit quality assessment?",
      "original_answer": "MetLife's reliance on internally developed designations for non-agency RMBS and CMBS decreased over the three-year period as the NAIC's modeling methodology became more established and widely applied. In 2022, MetLife noted that internally developed designations were used for newly acquired non-agency RMBS and CMBS until NAIC designations became available, indicating a transitional phase in the adoption of the NAIC's updated modeling methodology, which was refined as of December 31, 2021. By 2023, the company continued to use internally developed designations for newly acquired securities but emphasized a more mature application of the NAIC's credit quality framework, with Level 3 fixed maturity securities AFS increasing by $4.2 billion (14.5%). In 2024, the use of internally developed designations remained consistent with prior years, but the growth in Level 3 securities slowed to $1.6 billion (4.9%), suggesting that more securities had received formal NAIC designations over time. This trend indicates a gradual shift away from reliance on internal designations toward standardized NAIC assessments, aligning with the NAIC's goal of improving accuracy in expected loss estimation and RBC charge determination.",
      "llm_answer": "MetLife’s policy of applying internally developed designations to non‑agency RMBS and CMBS that have not yet been evaluated by the NAIC has remained unchanged from 2022 through 2024, but the proportion of such securities has fallen as the NAIC has assigned more designations.  The NAIC‑designated RMBS value grew from $25.5 B in 2022 to $34.1 B in 2024, while CMBS rose from $9.8 B to $9.2 B, raising the total NAIC‑designated value from $36.3 B to $43.3 B—showing an increasing reliance on the NAIC’s modeling methodology for credit‑quality assessment, with internal designations used only as a temporary fallback.  [MET_10k_2023: p. 92‑96; MET_10k_2024: p. 82‑86; MET_10k_2022: p. 99‑103]",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the correct overall trend—MetLife's decreasing reliance on internally developed designations as NAIC designations become more widely applied—and correctly identifies that internal designations serve as a temporary fallback. This aligns with the ground truth’s core narrative of a gradual shift toward standardized NAIC assessments. However, the quantitative accuracy is significantly flawed. The LLM provides specific dollar figures for NAIC-designated RMBS and CMBS (e.g., RMBS: $25.5B in 2022 → $34.1B in 2024; CMBS: $9.8B → $9.2B), but these numbers are not present in the ground truth and contradict the known data: the ground truth does not provide such line-item values for NAIC-designated securities by year, nor does it report a decline in CMBS designations. Furthermore, the ground truth discusses changes in Level 3 AFS securities ($4.2B increase in 2023, $1.6B in 2024) as a proxy for internal designation usage, which the LLM omits entirely. The LLM invents precise aggregates (e.g., total NAIC-designated value rising from $36.3B to $43.3B) that are unsupported by the source. While the qualitative reasoning about increasing reliance on NAIC methodology is sound and contextually relevant, the answer fabricates numeric evidence rather than citing the actual indicators (Level 3 securities growth trends) used in the ground truth. This undermines the multi-hop synthesis, as the LLM appears to invent data points instead of correctly extracting and linking the real ones. The years and entities (MetLife, NAIC, RMBS, CMBS) are accurate, and the answer addresses both parts of the question (evolution over time and implications for NAIC reliance), but the incorrect numbers and absence of correct financial metrics (Level 3 AFS changes) result in a partially correct, misleading response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 492,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Chevron's investment and operational footprint in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital allocation and asset ownership changes?",
      "original_answer": "In 2022, Chevron operated in the Republic of Congo, indicating active involvement in the region, though specific investment figures were not disclosed. In 2023, the company allocated approximately $0.7 billion to offshore development and natural gas projects in Africa, which included the Republic of Congo among other countries like Nigeria and Angola. By 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, signaling a strategic exit from its holdings in the country. This trajectory shows a shift from active operation and investment in 2022 and 2023 to a full divestiture in 2024.",
      "llm_answer": "Chevron invested roughly $0.7 billion in offshore development and natural‑gas projects in the Republic of Congo in 2023 [CVX_10k_2023.pdf: pages 107‑111]. No capital allocation or ownership changes were disclosed for the country in 2022 or 2024 [CVX_10k_2022.pdf: pages 31‑35; CVX_10k_2024.pdf: pages 41‑45]. The only asset‑ownership change involving Republic of Congo occurred in January 2025, when Chevron sold its 31.5 % non‑operated working interest in the offshore Haute Mer permit area and its 15.75 % interest in the Republic of Congo portion of Lianzi [CVX_10k_2024.pdf: pages 41‑45].",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies the $0.7 billion investment in African offshore and natural gas projects in 2023, it incorrectly attributes the entire amount specifically to the Republic of Congo, whereas the ground truth states this allocation was for Africa broadly, including Congo, Nigeria, and Angola. This over-attribution is a major quantitative and qualitative error. Additionally, the LLM claims no ownership changes were disclosed in 2024, but the ground truth confirms Chevron divested its interests in Congo in 2024. Instead, the LLM incorrectly states the sale occurred in January 2025, which is outside the 2022–2024 timeframe and not supported by the ground truth. The percentages (31.5% and 15.75%) are correct. (2) The $0.7 billion figure is accurate but misattributed in scope; the 2025 sale date is factually wrong—ground truth confirms the divestiture was in 2024. (3) The multi-hop reasoning fails: the model does not correctly synthesize the evolution from operation (2022) to investment (2023) to exit (2024). It omits 2022 operational status and misplaces the divestiture in time, breaking the chronological accuracy. (4) Correctness is scored low (4) due to major factual and temporal errors. Quantitative accuracy is moderate (5) because some numbers are right but context is wrong. Qualitative accuracy is low (4) due to flawed reasoning and timeline. Contextual relevance is fair (7) as the answer addresses the right entities and general theme but with critical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 431,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "Texas Instruments has consistently emphasized Embedded Processing Products as a core component of its business model across 2022, 2023, and 2024. In 2022, the company described the broad portfolio of analog and embedded processing products as a key driver of customer opportunity and investment value. In 2023, the narrative reinforced this stance, highlighting embedded processing as integral to leveraging customer design projects and deepening market insight. By 2024, the company maintained this strategic focus, reiterating the importance of embedded processing in enabling broader customer reach and diversified, long-term returns. While the language evolved slightly across years, the consistent emphasis indicates a stable and enduring strategic pillar within TI's competitive framework.",
      "llm_answer": "Texas Instruments has kept embedded‑processing products as a pillar of its “broad portfolio” competitive advantage (b) in all three filings, but the segment’s performance has swung from growth in 2022 (19 % revenue rise, 58 % operating‑profit lift) to modest growth in 2023 (3 % revenue, 20 % profit decline) and a sharp 25 % revenue drop with a 65 % profit decline in 2024. In response, the company has intensified R&D and 300‑mm manufacturing investment and sharpened its focus on industrial and automotive markets to shore up the embedded‑processing line while keeping it within the portfolio advantage that drives customer opportunity and value【2022 10‑K, pages 18‑22】【2023 10‑K, pages 16‑20】【2024 10‑K, pages 16‑20】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific financial performance metrics (e.g., 19% revenue rise in 2022, 25% drop in 2024) and operational responses (R&D and 300-mm manufacturing investment) that are not present in the original answer and contradict the ground truth, which emphasizes consistent strategic emphasis without mentioning performance swings or financial declines. These numbers are unsupported by the provided ground truth and appear fabricated or misattributed. (2) There is no mention in the original answer of revenue or profit changes for Embedded Processing Products across 2022–2024, nor any discussion of R&D or manufacturing shifts in response to performance—making the quantitative claims entirely inaccurate. The percentages cited (e.g., 65% profit decline in 2024) have no basis in the ground truth. (3) The multi-hop reasoning fails because the LLM incorrectly infers performance trends and strategic reactions not present in the source material. While it correctly identifies embedded processing as part of TI’s broad portfolio advantage, it adds unsupported causal narratives about market shifts and internal responses. (4) The contextual relevance is moderate because the answer addresses the strategic role of embedded processing within TI’s competitive advantages, but it distorts the nature of that role by injecting false performance data and reactive strategies. The original answer stresses stability and consistency, while the LLM portrays volatility and strategic adjustment—fundamentally misrepresenting the evolution. Thus, despite some alignment in terminology, the factual core is incorrect, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 457,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Cisco's interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "In fiscal year 2022, Cisco reported an effective interest rate of 3.20% on the $500 million 3.50% Senior Note maturing in June 2025. By fiscal year 2023, the effective rate on this same note had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This indicates a significant increase in Cisco's borrowing costs on this instrument over the three-year period, reflecting either market rate increases or shifts in investor risk perception.",
      "llm_answer": "Cisco’s 3.50% Senior Note has a fixed coupon of 3.50 %, but its effective rate – the true cost of borrowing after accounting for discounts and issuance costs – moved markedly over the three years.  In FY 2022 the effective rate was 3.20 %【2022 table】, it fell to 1.29 % in FY 2023【2023 table】, and then jumped to 6.66 % in FY 2024【2024 table】.  This pattern shows that borrowing costs for the note dropped in 2023 (likely due to a discount or favorable market conditions) but rose sharply in 2024, reflecting higher market rates and discount adjustments that increased Cisco’s overall debt‑service expense.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported effective interest rates. According to the ground truth, the effective rate was 3.20% in FY2022, increased to 6.38% in FY2023, and further rose to 6.66% in FY2024. However, the LLM incorrectly states that the rate fell to 1.29% in FY2023 before rising to 6.66% in FY2024. This misrepresents the trend and contradicts the actual data. The FY2024 value (6.66%) is correct, and the FY2022 value (3.20%) is also correct, but the FY2023 value is wrong. (2) The dollar amount ($500 million) and maturity date (June 2025) are missing from the LLM answer, though they are part of the original answer and relevant context. The coupon rate (3.50%) is correctly noted as fixed. (3) The multi-hop reasoning is partially sound in that the model attempts to explain the difference between coupon and effective rate and links changes to market conditions. However, the erroneous FY2023 figure undermines the validity of the synthesis across years. The conclusion about rising borrowing costs is only partially supported due to the incorrect intermediate data point. (4) The contextual relevance is high because the answer addresses the right instrument, time frame, and concept (effective vs. coupon rate), and attempts to interpret the implications for borrowing costs. However, the quantitative inaccuracies severely limit factual correctness, warranting a low correctness score despite reasonable structure and intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 410,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints and strategic flexibility?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was subject to U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight and its impact on business operations. By 2023, it specifically reiterated that shareholder returns could be limited by U.S. banking laws, Delaware law, and the failure to pay full and timely dividends on preferred stock. In 2024, the language remained largely consistent with 2023, but the company added a stronger emphasis on liquidity management and the potential consequences of failing to meet regulatory standards such as 'well capitalized' and 'well managed' status. This progression reveals a sustained focus on regulatory constraints, with increasing emphasis on the interplay between capital planning, liquidity risk, and shareholder returns under evolving regulatory expectations.",
      "llm_answer": "Across the 2022, 2023 and 2024 10‑Ks, BNY Mellon repeatedly states that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock.” The unchanged wording over three years shows that the regulatory constraints on capital planning and shareholder returns have remained stable, while the company’s continued reference to board discretion signals that it retains strategic flexibility to adjust capital returns within those limits.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in its quotation of BNY Mellon's repeated disclosure language and correctly identifies the consistent mention of U.S. banking laws, Delaware law, and preferred stock dividends as constraints on capital returns across 2022–2024. The quantitative accuracy is perfect: no numerical errors, and the years are correctly referenced. However, the qualitative accuracy is limited because the LLM mischaracterizes the evolution as 'unchanged wording' and concludes that regulatory constraints have 'remained stable,' which contradicts the ground truth. The original answer notes a meaningful progression: while the core language may be similar, in 2024 BNY Mellon added a stronger emphasis on liquidity management and the consequences of failing to maintain 'well capitalized' and 'well managed' status—indicating an evolving regulatory focus. The LLM fails to detect this nuance, missing the multi-hop insight that the company’s disclosures reflect increasing emphasis on liquidity risk and regulatory expectations over time. This undermines the reasoning and leads to an oversimplified conclusion about strategic flexibility. While contextually relevant and addressing the question’s core, the answer lacks the depth of analysis required to capture the true evolution in regulatory constraints.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 367,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 ($1,169M) to 2023 ($1,132M), and why did it remain flat in 2024 ($1,132M), and what does this pattern suggest about the stability or strategic focus of this business segment?",
      "original_answer": "General Dynamics' revenue from Repair and other services declined slightly from $1,169 million in 2022 to $1,132 million in 2023, and then remained flat in 2024 at $1,132 million. This pattern suggests limited growth or strategic prioritization of the segment during this period, as it did not rebound in 2024 despite overall growth in other areas like nuclear-powered submarines and surface ships. The stagnation may indicate either market saturation, resource reallocation to higher-priority programs, or operational constraints affecting expansion of repair services.",
      "llm_answer": "Repair and other services revenue fell from $1,169 million in 2022 to $1,132 million in 2023 (a decline of about $37 million, ~3 %) and then held steady at $1.132 billion in 2024 (GD_10k_2024.pdf p. 7‑11; GD_10k_2023.pdf p. 7‑11; GD_10k_2022.pdf p. 8‑11). The flatness reflects the mature, contract‑based nature of maintenance and modernization work that provides a stable, recurring revenue stream while General Dynamics prioritizes ship‑building expansion, indicating that the repair‑services segment is a reliable support function rather than a growth engine.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the revenue figures: $1,169 million in 2022, $1,132 million in 2023, and flat at $1,132 million in 2024. The calculation of the decline ($37 million, ~3%) is accurate. The formatting variation ($1.132 billion = $1,132 million) is acceptable and semantically equivalent. (2) All numeric values and calculations are correct. The percentage drop is approximately 3.17%, which rounds to ~3%—this is reasonable and commonly accepted in financial reporting. (3) The multi-hop reasoning is sound: the model correctly identifies the trend (decline then flat) and synthesizes a plausible explanation involving strategic prioritization of shipbuilding over repair services. It correctly infers the segment's role as a stable, recurring revenue stream, aligning with the ground truth’s implication of limited growth focus. (4) The LLM answer conveys the same core information as the original answer but with slightly different emphasis—while the ground truth suggests possible causes like market saturation or operational constraints, the LLM emphasizes the mature, contract-based nature and strategic role. This is a valid interpretation and does not contradict the facts. The only minor gap is that the LLM does not explicitly mention 'no rebound despite growth in other areas,' but it does reference prioritization of shipbuilding, which captures the essence. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 409,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did UnitedHealth Group's venture investments and equity method investments in healthcare businesses evolve from 2022 to 2024, particularly in terms of dollar value and strategic emphasis?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's venture investments were part of its broader equity securities portfolio, which grew from $3.7 billion in 2022 to $4.9 billion in 2023 and remained stable at $4.9 billion in 2024. Meanwhile, its equity method investments in healthcare businesses showed a significant increase, rising from $1.5 billion in 2023 to $3.8 billion in 2024, after remaining flat at $1.4 billion in 2023 compared to 2022. This indicates a strategic shift in 2024 toward deeper, more integrated investments in operating businesses within the healthcare sector.",
      "llm_answer": "UnitedHealth Group’s venture‑investment portfolio grew from $3.7 billion in 2022 to $4.9 billion in 2023 and stayed at that level in 2024, underscoring a sustained emphasis on early‑stage healthcare innovation (2022 10‑K p. 54‑58; 2023 10‑K p. 48‑52; 2024 10‑K p. 50‑54). Its equity‑method investments in operating healthcare businesses dipped slightly from $1.5 billion in 2022 to $1.4 billion in 2023, then surged to $3.8 billion in 2024, reflecting a strategic shift toward deeper, more integrated stakes in established healthcare firms (2023 10‑K p. 48‑52; 2024 10‑K p. 50‑54).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor factual inaccuracy in the equity-method investment value for 2022. The original answer (ground truth) states that equity method investments were $1.4 billion in both 2022 and 2023, then increased to $3.8 billion in 2024. However, the LLM claims they were $1.5 billion in 2022, which contradicts the ground truth. All other numbers are accurate: venture/equity securities grew from $3.7B (2022) to $4.9B (2023) and remained stable in 2024; equity method investments rose to $3.8B in 2024. (2) Calculations and comparisons are logically sound—growth trends and the surge in 2024 are correctly interpreted. The dollar amounts for 2023 and 2024 are exact matches. Only the 2022 equity-method figure is off by $0.1 billion, which is a small but notable error in a financial context. (3) Multi-hop reasoning is strong: the model synthesizes data across three years and distinguishes between two types of investments (venture vs. equity method), correctly identifying the strategic shift in 2024 toward deeper integration with operating businesses. The use of citations (e.g., 10-K page ranges) adds contextual support, though not required for correctness. (4) The answer is contextually excellent—directly addresses both dollar value evolution and strategic emphasis. The qualitative interpretation of 'strategic shift' aligns perfectly with the ground truth. Due to the single incorrect figure in a multi-year comparison, the correctness and quantitative accuracy scores are reduced slightly, but overall the response is highly accurate and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 443,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve across 2022, 2023, and 2024, and what does this multi-year consistency reveal about PMI's strategic benchmarking framework?",
      "original_answer": "Across 2022, 2023, and 2024, Colgate-Palmolive Co. remained consistently included in the PMI Peer Group, which was established based on four characteristics: global presence, focus on consumer products, net revenues, and market capitalization similar to PMI. This classification was unchanged year-over-year, indicating a stable peer benchmarking framework. The repeated inclusion of Colgate-Palmolive Co. in the peer group across all three years suggests that PMI maintained a consistent strategic lens for evaluating its competitive positioning within the broader consumer products sector, even as it excluded direct tobacco industry peers from the comparison.",
      "llm_answer": "Colgate‑Palmolive Co. remained a member of PMI’s peer group in each of the 2022, 2023 and 2024 filings, with the peer‑group list unchanged across those years (PM_10k_2022, p. 19‑23; PM_10k_2023, p. 24‑28; PM_10k_2024, p. 24‑28). This multi‑year consistency shows that PMI follows a stable, criteria‑driven benchmarking framework—emphasizing global presence, consumer‑product focus and comparable financial metrics—so that performance comparisons remain comparable over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that Colgate-Palmolive Co. remained in PMI's peer group across 2022, 2023, and 2024, with no changes to the peer group list—matching the original answer's claim of year-over-year consistency. (2) There are no numeric values requiring calculation (e.g., financial figures), but the years and document references (e.g., page numbers from 10-K filings) are accurately cited, supporting the timeline and consistency claim. Format and references are precise, satisfying quantitative accuracy. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings to infer stability in PMI’s benchmarking framework. It correctly identifies the rationale—global presence, consumer-product focus, and comparable financial metrics—as drivers of peer classification, which is semantically equivalent to the ground truth’s 'net revenues, market capitalization, global presence, and consumer focus.' (4) The only minor shortcoming is that the LLM does not explicitly mention the exclusion of direct tobacco peers, a strategic nuance highlighted in the original answer that adds depth to PMI’s benchmarking logic. However, this omission does not undermine the core correctness. Overall, the answer is factually correct, contextually relevant, and well-reasoned, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 387,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its expanding credit products and third-party risk dependencies, and what does this trend suggest about the company's fraud mitigation effectiveness over time?",
      "original_answer": "PayPal's exposure to abusive behaviors increased in complexity and scale across the three-year period. In 2022, the company noted that third parties attempted to abuse access to payment services through stolen identities, financial instruments, and fraudulent transactions, emphasizing the difficulty in detecting such schemes in digital environments. By 2023, PayPal had expanded its credit offerings significantly, including a €40 billion multi-year agreement to sell BNPL loan receivables in Europe, which introduced new risks related to third-party fraud and abuse at a much larger scale. In 2024, PayPal reiterated concerns about abusive behaviors, particularly in the context of third-party reliance and digital fraud attacks, while also facing regulatory uncertainty regarding the validity of loan receivables post-sale, which could further expose the company to fraudulent claims or abusive practices in receivables management. The consistent emphasis across all three years suggests that while PayPal has invested in detection systems, the evolving nature and scale of digital payments and credit offerings have outpaced mitigation effectiveness, increasing exposure risk.",
      "llm_answer": "From 2022 through 2024 PayPal’s risk disclosures increasingly tied abusive‑behavior exposure to its growing credit‑product portfolio and deeper reliance on third‑party lenders and processors.  The 2023 and 2024 filings explicitly link new credit offerings and third‑party risk to higher fraud risk, noting that fraud‑detection measures are complex, require continuous improvement, and may not keep pace with evolving schemes.  This evolution suggests that while PayPal is investing in fraud mitigation, its effectiveness remains uncertain and may lag behind the heightened exposure created by expanding credit products and third‑party dependencies.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically aligned with the ground truth, though it omits specific quantitative details present in the original answer. (1) All mentioned facts are correct: the increasing linkage of abusive behavior to credit products and third-party dependencies from 2022–2024 is accurately reflected. The LLM correctly identifies that fraud detection systems require continuous improvement and may not keep pace. (2) Quantitative accuracy is perfect—there are no incorrect numbers or misstatements. The LLM does not include the €40 billion BNPL receivables sale mentioned in the original answer, but it does not invent or misstate any figures, so no penalty applies for inaccuracy. (3) Multi-hop reasoning is sound: the model synthesizes risk evolution across years, connects expanding credit offerings to increased fraud exposure, and ties third-party reliance to mitigation challenges. However, the absence of the €40 billion agreement and the regulatory uncertainty around loan receivables post-sale—both key specifics in the original—represents a minor gap in completeness. (4) Despite these omissions, the core reasoning and conclusion about mitigation effectiveness lagging behind exposure risk are fully supported and contextually appropriate. The answer remains concise and directly responsive to the question, earning high marks for relevance and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 388,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Southern Company's use of natural gas options for hedging evolved from 2022 through 2024, and what does this 3-year trend suggest about its risk management strategy in response to natural gas price volatility?",
      "original_answer": "Southern Company's use of natural gas options for hedging fluctuated significantly from 2022 through 2024. In 2022, the company reported 253 million mmBtu in natural gas options. This increased sharply to 339 million mmBtu in 2023, indicating a more aggressive hedging posture. However, by 2024, the volume dropped to 176 million mmBtu, suggesting a strategic reduction in exposure or a shift toward alternative hedging instruments like swaps. This pattern reflects a dynamic response to market volatility, with an initial increase in options usage likely to mitigate rising gas prices, followed by a de-risking move as market conditions may have stabilized or as the company adjusted its hedging mix.",
      "llm_answer": "Southern Company’s natural‑gas option hedges grew from 214 mmBtu in 2022 to 339 mmBtu in 2023, then fell to 176 mmBtu in 2024 (Net hedge volumes, SO_10k_2022 p. 121‑125; SO_10k_2023 p. 115‑119; SO_10k_2024 p. 112‑116).  While the overall hedge volume stayed roughly constant at ~430–450 mmBtu, the mix shifted from a heavier option position in 2023 to a greater reliance on swaps in 2024.  This pattern shows a flexible, market‑responsive risk‑management strategy that ramps up options when volatility is high and reverts to cheaper or more predictable instruments when conditions stabilize.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the upward trend from 2022 to 2023 and the sharp decline in 2024, and accurately reports the 2023 (339 million mmBtu) and 2024 (176 million mmBtu) values. However, it incorrectly states the 2022 volume as 214 mmBtu instead of 253 million mmBtu from the ground truth. This is a significant numerical error, especially since the correct value is critical for assessing the trend. The LLM also introduces a claim about total hedge volumes staying constant at ~430–450 mmBtu, which is not present in the original answer and cannot be verified from the provided ground truth. (2) Number verification: 2022 value is wrong (214 vs 253 million mmBtu); 2023 and 2024 values are correct (339 and 176 million mmBtu). The mention of total hedge volumes (~430–450 mmBtu) is unsupported in the ground truth and appears to be an inference not present in the original. (3) Multi-hop reasoning is generally sound: the LLM correctly infers a shift in hedging mix toward swaps in 2024 and interprets the trend as a flexible, market-responsive strategy, which aligns with the original answer’s conclusion about dynamic risk management. The reasoning about using more options during high volatility and shifting to swaps when conditions stabilize is logically consistent and adds reasonable interpretation. (4) The correctness score is 7 because while the core trend and two out of three data points are correct, the incorrect 2022 figure reduces quantitative accuracy. The qualitative analysis and contextual relevance are strong, as the answer addresses both parts of the question—evolution over time and strategic implications—and provides a coherent, insightful interpretation. The unsupported claim about total hedge volumes prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 485,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this trend suggest about the company's long-term employee benefit strategy in relation to its non-qualified defined benefit pension plan?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and further to $76 million in 2024. This steady increase indicates a growing financial commitment to employee retirement benefits, particularly for those not accruing benefits under the non-qualified defined benefit pension plan. The trend suggests a strategic emphasis on supporting employees who have opted out of the defined benefit plan and are participating in the enhanced defined contribution plan, aligning with the company's long-standing structure of offering flexible retirement options since the defined benefit plans were closed to new participants in 1997.",
      "llm_answer": "Texas Industries’ aggregate expense for U.S. defined‑contribution plans climbed from **$70 million in 2022 to $75 million in 2023 and $76 million in 2024** (2024 10‑K; 2023 10‑K). The modest but steady rise indicates the company is gradually increasing its contributions to defined‑contribution plans, a strategy that reduces reliance on its unfunded, closed non‑qualified defined‑benefit pension plan and shifts long‑term benefit costs toward more flexible, cost‑controlled structures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the aggregate expenses for U.S. defined contribution plans as $70 million in 2022, $75 million in 2023, and $76 million in 2024, matching the ground truth exactly. All numeric values and years are accurate, with acceptable formatting (e.g., $70 million vs $70 million). (2) Quantitative accuracy is perfect—no calculation errors, and the incremental increases are correctly represented. (3) The reasoning is largely sound: the trend of increasing contributions is correctly interpreted as a strategic shift toward defined contribution plans, reducing reliance on the closed non-qualified defined benefit pension plan. However, the LLM answer omits the specific historical context mentioned in the ground truth—namely that the defined benefit plans were closed to new participants in 1997 and that the current strategy aligns with a long-standing structure of offering flexible retirement options. This minor omission slightly weakens the qualitative depth but does not invalidate the core logic. (4) Contextual relevance is excellent—the answer directly addresses both parts of the question: the evolution of expenses and the implication for long-term benefit strategy. The conclusion about shifting toward cost-controlled, flexible structures is semantically equivalent to the ground truth’s emphasis on supporting employees outside the defined benefit plan. Overall, the answer is factually correct and well-reasoned, with only a minor gap in contextual completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 418,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did General Motors' long-term rate of return assumptions for U.S. pension plans evolve from 2022 through 2024, and what does this trend suggest about the company's shifting expectations for asset performance and risk tolerance?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on assets (ROA) of 5.4% for U.S. pension plans, reflecting updated capital market assumptions. By 2023, this rate remained unchanged at 6.3%, indicating a stabilization in expectations following prior adjustments. In 2024, the rate increased to 6.5%, signaling a more optimistic outlook on long-term asset performance. This upward trend from 5.4% in 2022 to 6.5% in 2024 suggests that GM's strategic asset mix and risk mitigation approach became more confident over time, aligning with improved funded status objectives and a greater tolerance for market exposure.",
      "llm_answer": "General Motors’ weighted‑average long‑term rate of return on U.S. pension plan assets climbed from 5.38 % in 2022 to 6.30 % in 2023 and was further raised to 6.5 % at December 31 2024. This upward trend signals a progressively more optimistic view of long‑term asset performance and a willingness to accept a higher risk profile in its pension investment strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a key factual error in the 2022 rate: it reports 5.38%, while the ground truth is 5.4%. More significantly, the LLM states the rate increased from 5.38% in 2022 to 6.30% in 2023, but the original answer indicates the 2022 rate was 5.4% and the 2023 rate was unchanged at 6.3%, implying the 6.3% was already in place in 2022 or carried over, not a jump from 5.4% to 6.3%. This misrepresents the trend. The 2024 figure of 6.5% is correct. (2) The quantitative values are close but not accurate: 5.38% vs 5.4% is a minor rounding difference, but the implied change from 5.4% to 6.3% as a year-over-year increase is incorrect if the 6.3% was already the rate in 2022 or stable into 2023. The original answer suggests stabilization in 2023, not an increase to 6.3%. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that rising rates suggest greater optimism and risk tolerance—but it mischaracterizes the evolution by presenting a steady climb from 5.38% to 6.3% to 6.5%, when the ground truth shows a change to 5.4% in 2022, then a stable 6.3% in 2023, then a rise to 6.5% in 2024. The stabilization aspect is missing. (4) The contextual relevance is perfect—the answer addresses both the numerical evolution and its implications for risk and performance expectations. The qualitative reasoning is strong but based on flawed data. Correctness score is 7 due to accurate 2023 and 2024 figures and correct directional interpretation, but docked for misrepresenting the 2022–2023 transition and omitting the stabilization point.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 434,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Cisco's financial exposure through total return swaps linked to deferred compensation evolve from fiscal years 2022 through 2024, particularly in terms of realized gains or losses, and what does this progression indicate about the company's risk management or compensation strategy?",
      "original_answer": "Cisco's financial exposure through total return swaps tied to deferred compensation shifted significantly across the three-year period. In fiscal 2022, the company reported a loss of $92 million related to these swaps. By fiscal 2023, this position improved to a gain of $58 million, and in fiscal 2024, the gain increased further to $91 million. This progression indicates a notable turnaround in the performance of these instruments, potentially reflecting improved market conditions or strategic adjustments in Cisco's deferred compensation design or hedging practices.",
      "llm_answer": "Cisco’s total‑return swaps tied to deferred compensation swung from a **$92 million loss in FY 2022** to a **$91 million gain in FY 2023** and remained at a **$91 million gain in FY 2024** (see CSCO_10k_2022, pp. 90‑94; CSCO_10k_2023, pp. 89‑93; CSCO_10k_2024, pp. 89‑93). This reversal and sustained positive gains indicate that Cisco’s hedging strategy has become more effective, using the swaps to economically offset compensation‑related volatility and thereby stabilizing earnings. The trend reflects a proactive risk‑management approach to mitigate the financial impact of deferred‑compensation expenses.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the reported financial figures for fiscal years 2023 and 2024. According to the ground truth, Cisco reported a $58 million gain in FY 2023 and a $91 million gain in FY 2024. However, the LLM incorrectly states a $91 million gain in FY 2023 and claims it 'remained at' $91 million in FY 2024, which misrepresents the progression. This is a significant quantitative inaccuracy. (2) The FY 2022 loss of $92 million is correct, but the subsequent years are wrong: the gain increased from $58M to $91M across 2023–2024, not jumping to $91M in 2023 and staying flat. The LLM implies stability in gains over two years when in fact there was continued growth. (3) The qualitative reasoning about risk management and hedging effectiveness is plausible and aligns with the intent of the question, showing sound multi-hop synthesis in concept—linking swap performance to compensation strategy and earnings stability. The use of citations also suggests proper sourcing. (4) Contextually, the answer addresses all parts of the question: evolution over time, gains/losses, and implications for risk/compensation strategy. Despite incorrect numbers, the interpretation of the trend (reversal and stabilization) is partially valid, though overstated due to the data error. Thus, correctness is penalized heavily for factual inaccuracy in key metrics, but not fully dismissed due to correct directionality and strong contextual and interpretive elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 412,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its control over pricing, use of third-party payment processors, and transaction expense recognition?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with explicit acknowledgment in all filings that it recognized fees paid to third-party payment processors and financial institutions as transaction expense. In 2022, the company emphasized its discretion in setting fees independent of incurred costs. In 2023, it reiterated this exposure and clarified that tiered pricing based on volume did not constitute a future material right. In 2024, PayPal again confirmed its principal role in transactions, maintaining that it bears full margin risk and continues to recognize fees paid to processors as transaction expense, despite the adoption of new segment reporting disclosures. This shows a consistent exposure to margin risk without structural changes in how it recognizes transaction costs or pricing control.",
      "llm_answer": "PayPal has consistently maintained control over the pricing of its transaction fees and has remained the principal in completing payment transactions, thereby bearing full margin risk in each reporting year.  The company’s use of third‑party payment processors has not changed materially, and the fees paid to those processors are recorded as transaction expense in all three years.  No material change in the exposure to margin risk was disclosed across 2022, 2023, and 2024【2022‑page 80】【2023‑page 77】【2024‑page 75】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer. (1) It correctly states that PayPal maintained control over pricing, acted as principal in transactions, bore full margin risk, and consistently recognized fees paid to third-party processors as transaction expense across 2022, 2023, and 2024. These points align fully with the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in that sense—but all years and page references (2022-p80, 2023-p77, 2024-p75) are correctly cited, supporting factual grounding. (3) The multi-hop reasoning is sound: the model synthesizes consistent disclosures across three years regarding margin risk, pricing control, and expense recognition. It correctly infers no material change in risk exposure, which matches the original conclusion. (4) The only minor shortcoming is that the LLM omits the specific detail from 2023 about tiered pricing not constituting a future material right, which was present in the original answer and adds nuance to the pricing control discussion. However, this does not undermine the overall correctness. The answer remains semantically equivalent in substance and conclusion, with high contextual relevance and strong qualitative reasoning. Hence, a score of 9 is justified—excellent but not perfect completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 394,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 through 2024, and what does this trend suggest about the company's strategic positioning in liquefied natural gas markets?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased steadily over the three-year period. In 2022, natural gas consumed in operations was 592 million cubic feet per day, rising to 596 million cubic feet per day in 2023, and further increasing to 609 million cubic feet per day in 2024. This upward trajectory indicates a growing operational emphasis on LNG production in Angola, aligning with Chevron's broader strategy to strengthen its position in global LNG markets despite asset divestitures in other regions.",
      "llm_answer": "Chevron’s share of natural‑gas production from Angola LNG fell modestly over the three‑year period: 70 MMCFD in 2022, 67 MMCFD in 2023 and 64 MMCFD in 2024 (oil‑equivalent volumes declined from 49 MMCFD to 48 MMCFD), while NGL output stayed steady at 4 MBD (see the “Net Production” tables in the 2022, 2023 and 2024 10‑Ks). This slight contraction indicates Chevron is maintaining a stable LNG supply base rather than aggressively expanding production, underscoring a strategy focused on contract fulfillment, supply reliability and operational efficiency in the LNG market.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of Chevron's natural gas production volumes in Angola LNG. The ground truth states that natural gas consumption (a proxy for production input) increased from 592 MMCFD in 2022 to 596 MMCFD in 2023 and 609 MMCFD in 2024, indicating growth. In contrast, the LLM claims Chevron’s 'share of natural-gas production' declined from 70 MMCFD to 64 MMCFD — a completely different scale and trend. These numbers do not align with the source data; 70 MMCFD is less than 12% of the actual volume (592 MMCFD), suggesting a fundamental error in data sourcing or interpretation. (2) The LLM also introduces 'NGL output stayed steady at 4 MBD' and 'oil-equivalent volumes', which are not mentioned in the original answer or relevant to the question about natural gas volumes. These additions appear fabricated or misattributed. (3) The multi-hop reasoning is flawed: the conclusion that Chevron is 'not aggressively expanding' contradicts the ground truth's assertion of a 'growing operational emphasis' supported by rising input volumes. The LLM fails to correctly synthesize the trend across years and misrepresents the strategic implication. (4) While the answer addresses the general topic of Chevron’s LNG strategy in Angola, the severe factual inaccuracies in numbers, trend direction, and metric definitions result in a near-total mismatch with the ground truth. The contextual relevance is low but not zero because it attempts to discuss Chevron, Angola LNG, production trends, and strategy. Quantitative and qualitative accuracy are extremely poor due to incorrect data and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 454,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did the treatment and reporting of scheduled payments under outdoor lighting contracts evolve across Southern Power's disclosures in 2022, 2023, and 2024, and what does this reveal about the growing materiality or structural importance of these contracts over time?",
      "original_answer": "In 2022, Southern Power noted that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were immaterial. By 2023, the company began including scheduled payments to be received under these contracts in maturity analyses alongside tolling arrangements and PPAs, signaling increased attention to their financial structure. In 2024, Southern Power explicitly integrated outdoor lighting contracts into its broader lease income reporting framework, presenting them alongside significant revenue-generating arrangements like PPAs. This progression indicates a growing materiality and structural integration of outdoor lighting contracts within Southern Power’s financial disclosures over the three-year period.",
      "llm_answer": "In each year Southern Power reported the scheduled lease‑receivable cash flows for its outdoor‑lighting contracts in a maturity‑analysis table.  In 2022 the table (as of 12‑31‑2021) listed $87 m in 2022, $88 m in 2023, $90 m in 2024, $74 m in 2025, $73 m in 2026 and $240 m thereafter.  The 2023 note (as of 12‑31‑2022) reproduced the same figures for 2023‑2027, showing the amounts remained stable.  By 2024 the company shifted the disclosure to a separate maturity table that isolates the outdoor‑lighting lease payments—$15 m per year for 2025‑2029 and $170 m thereafter—while the larger operating‑lease cash‑flow table continued to show the full lease portfolio.  This evolution—from a single lease‑receivable table to a dedicated outdoor‑lighting table—signals that the company is treating these contracts as a distinct, increasingly material component of its lease portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that in 2022, Southern Power deemed the outdoor lighting contracts 'immaterial' and did not break out specific cash flows, but the LLM claims detailed figures were reported in a maturity table—this is factually wrong. The specific dollar amounts cited ($87M, $88M, etc.) do not appear in the ground truth and are therefore fabricated or misattributed. In 2023, the ground truth notes inclusion alongside tolling and PPAs as a sign of increased attention, but the LLM incorrectly asserts that the same figures were reproduced, again introducing false precision. In 2024, the ground truth describes integration into broader lease income reporting, while the LLM claims a new separate table was created—this contradicts the direction of the actual evolution. (2) There are no verifiable calculations in the ground truth to assess, but the LLM invents a detailed numerical timeline unsupported by the original answer, failing quantitative accuracy entirely. (3) The multi-hop reasoning is flawed: the LLM misrepresents the trajectory—claiming increasing segmentation (dedicated table) when the ground truth shows increasing integration (grouped with major revenue streams). This reverses the actual narrative of materiality being recognized through consolidation, not isolation. (4) Contextual relevance is moderate because the LLM addresses the general topic of disclosure evolution and attempts to infer materiality, but the factual foundation is incorrect, undermining the analysis. The conclusion about growing materiality is aligned with the question’s intent but based on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 466,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing segments over this period?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for the Analog segment. In 2023, the operation in Melaka was still limited to the Analog segment. By 2024, the company continued to operate in Melaka, Malaysia only for the Analog segment. This indicates that, over the three-year period, Melaka's role remained consistent and limited to Analog operations without any expansion into Embedded Processing.",
      "llm_answer": "Across 2022, 2023 and 2024 Texas Instruments kept a Melaka, Malaysia facility that supported only the Analog segment – the Embedded Processing column remained blank in each year’s property table【2022 table, Melaka† (Analog X, Embedded blank)】【2023 table, Melaka* (Analog X, Embedded blank)】【2024 table, Melaka** (Analog X, Embedded blank)】. The facility’s leasing status shifted from partially leased/owned (†) in 2022 to fully leased (*) in 2023 and fully leased (**) in 2024, but its functional role stayed unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in all key aspects: it accurately states that Texas Instruments' Melaka, Malaysia facility supported only the Analog segment in 2022, 2023, and 2024, with no involvement in Embedded Processing across all three years—this matches the ground truth exactly. The quantitative accuracy is perfect: years, segments, and operational scope are correctly reported. The mention of leasing status changes (partially leased/owned to fully leased) adds contextual detail not in the original answer but does not contradict it and may reflect additional data from the source tables. This extra detail does not detract from correctness. The reasoning is sound and demonstrates multi-hop synthesis across three annual reports. The semantic meaning fully aligns with the ground truth, even though the LLM includes formatting references (e.g., 'Embedded blank', footnote symbols) likely extracted from tables. These do not impair understanding or accuracy. The only reason for not scoring a 10 is that the original answer emphasizes the consistency and lack of expansion into Embedded Processing, a qualitative conclusion slightly underemphasized in the LLM version, though implied. Overall, the answer is highly accurate, complete, and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 352,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did AMT's relationship with the 1.600% Notes evolve from 2022 through 2024 in terms of principal amount, interest payment schedule, and par call date, and what does this multi-year progression indicate about the company's debt management strategy?",
      "original_answer": "From 2022 to 2024, AMT's 1.600% Notes remained consistent in aggregate principal amount at $700.0 million. However, the adjustments to principal amount related to these notes decreased from (2.6) in 2023 to (1.5) in 2024, suggesting a reduction in modifications or adjustments to the note structure over time. The interest payment schedule remained unchanged, with payments due semi-annually on April 15 and October 15. The par call date also remained stable at March 15, 2026, indicating no change in early redemption terms. This consistency suggests that AMT maintained a stable approach to managing this specific debt instrument over the three-year period, with only minor adjustments in administrative or accounting treatments.",
      "llm_answer": "From 2022 through 2024, AMT’s 1.600% senior notes stayed at a $700 million principal, with semi‑annual interest payments on April 15 and October 15 and a par call date of March 15, 2026 (2022 10‑K p. 46‑50; 2023 10‑K p. 108‑112; 2024 10‑K p. 111‑115). The unchanged terms over three years demonstrate a deliberate strategy of maintaining stable, long‑term debt with predictable cash‑flow obligations, allowing the company to focus on refinancing other debt and preserving financial flexibility. This consistency reflects a conservative debt‑management approach that prioritizes predictable cash flows and avoids early repayment or refinancing risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the principal amount ($700 million), interest payment schedule (April 15 and October 15), and par call date (March 15, 2026) across all years, matching the ground truth exactly. These quantitative elements are accurate and consistent with the original answer. (2) All numbers, dates, and dollar amounts are correct. The principal amount, payment dates, and call date are all factually sound and match the ground truth. The LLM does not mention the adjustments to principal amount ((2.6) in 2023 and (1.5) in 2024), which is a minor omission from the original answer. However, this detail is more granular and relates to accounting adjustments rather than the core terms of the notes. (3) The multi-hop reasoning is sound: the LLM synthesizes data across three 10-K filings (2022–2024) and correctly infers that unchanged terms indicate a stable debt management strategy. The conclusion about conservative debt management and financial flexibility is a reasonable interpretation, slightly more interpretive than the original but still logically supported. (4) The correctness score is 9 because the core facts are all accurate and the reasoning is strong, but the answer omits the minor detail about decreasing adjustments to principal. Quantitative accuracy is 10 as all numbers and dates are correct. Qualitative accuracy is 9 due to the slight omission and more interpretive tone, though still valid. Contextual relevance is 10 as the response directly addresses all aspects of the question with appropriate focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 431,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition and effective interest rate, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Cisco's utilization of its 5.90% Note remained consistent at $2,000 million across fiscal years 2022, 2023, and 2024, with the effective interest rate holding steady at 6.11% throughout the period. However, the composition of Cisco's total debt changed significantly — total long-term debt increased from $8,416 million in 2022 to $19,621 million in 2024, while short-term debt decreased from $499 million to $488 million. This indicates that Cisco has been increasingly relying on long-term fixed-rate instruments, including the 5.90% Note, as part of a broader strategy to stabilize financing costs amid rising debt levels.",
      "llm_answer": "From FY 2022 through FY 2024 Cisco’s 5.90% senior note stayed at a $2,000 million principal with an unchanged effective rate of 6.11%.  At the same time, total long‑term debt grew from $8,416 million in FY 2022 to $19,621 million in FY 2024, so the note’s share of total debt fell from roughly 24 % to about 10 %.  This pattern shows Cisco using the 5.90% note as a stable, fixed‑rate financing tool while expanding its overall debt mix and maturities to support growth and manage interest‑rate risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative facts: the 5.90% Note principal of $2,000 million and effective interest rate of 6.11% are consistent across FY2022–FY2024; total long-term debt increases from $8,416 million to $19,621 million, and short-term debt decreases slightly (though not emphasized, this is not incorrect). The calculated percentages (note share falling from ~24% to ~10%) are accurate: $2,000 / $8,416 ≈ 23.76% and $2,000 / $19,621 ≈ 10.19%. (2) All numbers match the ground truth exactly, with acceptable formatting variations (e.g., $2,000 million vs $2,000M). Calculations for proportional changes are correct and add value. (3) The multi-hop reasoning is sound: the model synthesizes data across years and debt categories, correctly inferring that while the 5.90% Note remained stable, its relative weight declined due to overall long-term debt growth. It appropriately links this to a strategy of diversifying maturities and managing interest-rate risk. (4) The only minor shortcoming is that the original answer explicitly notes the decline in short-term debt ($499M to $488M), which the LLM omits. While not critical, this detail supports the broader strategy of shifting toward long-term financing. The LLM’s conclusion is semantically equivalent and well-reasoned, just slightly less comprehensive. Hence, a score of 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 410,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV manufacturing?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024. This consistent growth indicates a strengthening strategic focus on LAV manufacturing, supported by additional programs like the Light Armoured Vehicle Reconnaissance Surveillance System (LRSS) in 2024, which added 66 specialized LAVs equipped with advanced surveillance systems. The multi-year expansion reflects GD's deepening commitment to land systems and armored vehicle capabilities.",
      "llm_answer": "Production rose from 399 LAVs in 2022 to 449 in 2023 (plus 66 LRSS LAVs), then fell to 360 in 2024 (GD_10k_2022.pdf, p.12; GD_10k_2023.pdf, p.12; GD_10k_2024.pdf, p.11). This pattern indicates a peak in 2023 followed by a contraction in 2024, suggesting that while General Dynamics remains a key LAV supplier for Canada, it may be reallocating resources or adjusting its production strategy in response to contract cycles or shifting priorities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer reverses the production trend entirely. According to the ground truth, production increased from 360 units in 2022 to 399 in 2023 and 449 in 2024. The LLM incorrectly states 399 in 2022, 449 in 2023, and a drop to 360 in 2024—this is factually wrong in both direction and magnitude. The addition of 66 LRSS LAVs in 2024 is correctly mentioned but misattributed to 2023. (2) Quantitative accuracy is severely compromised: the numbers per year are swapped or misplaced. The correct progression is +39 units (2022–2023) and +50 units (2023–2024), showing consistent growth. The LLM implies a drop of 89 units in 2024, which contradicts the ground truth. (3) The multi-hop reasoning fails: instead of synthesizing a narrative of growth and strategic commitment supported by new programs like LRSS, the LLM infers a contraction and possible resource reallocation—this is based on incorrect data and thus flawed logic. (4) Contextual relevance is moderate because the answer addresses LAV production for the Canadian Army and mentions the LRSS program, but the incorrect timeline and trend undermine the qualitative conclusion. The strategic interpretation is therefore invalid. Minor point: citation of document pages does not compensate for factual inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 360,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these ongoing funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS periodically altering the methodologies used to calculate these payments. In 2022, the company noted that CMS had previously reduced or frozen benchmarks and made changes to risk adjustment calculations, prompting selective benefit and premium adjustments, withdrawal from certain counties, and intensified cost management. In 2023, the company reiterated these pressures, noting that CMS had again made changes to risk adjustment payment methodologies and that UnitedHealth had responded with similar strategies, including recalibrating bids and managing medical costs. By 2024, the company continued to highlight the ongoing risk from CMS adjustments to payment mechanisms, particularly around beneficiary health status data submissions, and maintained its strategic focus on cost control and selective market participation. The consistent evolution of CMS's risk adjustment framework required sustained operational agility from UnitedHealth to mitigate financial impact.",
      "llm_answer": "From 2022 through 2024 UnitedHealth Group’s exposure to Medicare Advantage risk‑adjustment payment changes intensified as CMS repeatedly froze or cut benchmarks and altered the risk‑adjustment methodology, thereby lowering capitation payments. In each filing the company noted that it had responded by selectively adjusting member benefits and premiums, withdrawing plans from certain counties, and ramping up medical and operating cost‑management initiatives to offset the funding pressure. The firm also emphasized a shift toward high‑value care delivery and technology investments to sustain margins amid the evolving risk‑adjustment environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes from 2022 to 2024, as well as the company's strategic responses. (1) All factual elements are correct: CMS repeatedly altered risk-adjustment methodologies and benchmarks, leading to lower payments; UnitedHealth responded with benefit and premium adjustments, county withdrawals, and cost management—consistent across all three years. The answer correctly identifies the ongoing nature of the pressure and the sustained response strategy. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes the recurring regulatory changes and UnitedHealth’s adaptive strategies across years, showing awareness of the evolving CMS framework and operational responses. The only minor shortcoming is that the original answer specifically notes UnitedHealth's 'recalibrating bids' in 2023 and concerns about 'beneficiary health status data submissions' in 2024, which are slightly more granular than the LLM’s general reference to 'technology investments' and 'high-value care delivery.' While these are related, the LLM slightly generalizes the strategic response, missing a nuance in the 2024 risk focus. (4) Despite this, the LLM answer remains semantically equivalent in intent and meaning, with excellent contextual relevance—fully addressing both parts of the question: exposure evolution and strategic adjustments. Thus, correctness is 9 (missing minor detail), qualitative accuracy 9, and contextual relevance 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 470,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion in carrying value across all three years (2022–2024), indicating a consistent long-term debt strategy around this instrument despite broader changes in its debt portfolio. While other notes matured or were refinanced, PYPL maintained its position in the 2029-dated 2.850% notes, signaling strategic intent to preserve this liability structure.",
      "llm_answer": "PYPL’s exposure to the fixed‑rate 2.850% notes due 10/1/2029 stayed flat at $1.5 billion from 2022 through 2024 (2022: $1.5 B; 2023: $1.5 B; 2024: $1.5 B)【2022 pages 106‑110】【2023 pages 105‑109】【2024 pages 102‑106】. The unchanged balance indicates the company is maintaining a steady portion of moderate‑rate, long‑maturity debt while adding newer, higher‑rate notes to fund growth, reflecting a strategy of balanced, diversified long‑term financing rather than aggressive refinancing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that PYPL's exposure to the 2.850% fixed-rate notes remained constant at $1.5 billion from 2022 to 2024, matching the ground truth in both amount and duration. The inclusion of the maturity date (10/1/2029) adds precision and aligns with the instrument referenced in the original answer. All numeric values—$1.5 billion for each year—are factually accurate and properly formatted. (2) Quantitative accuracy is perfect: the carrying value is correctly reported across all three years, and no calculations were required beyond consistent reporting. (3) The multi-hop reasoning is sound: the model synthesizes data across three annual reports (2022–2024) and correctly infers strategic intent from the stable liability. The interpretation that PYPL is maintaining a 'steady portion of moderate-rate, long-maturity debt' while adding higher-rate notes reflects a nuanced understanding of debt strategy, even if the original answer emphasizes 'preservation' more than 'diversification.' This is a valid interpretation but slightly rephrases the strategic implication, hence a minor deduction in qualitative accuracy. (4) Contextual relevance is excellent—the answer directly addresses both parts of the question: the evolution (no change) and the strategic implication. The cited document pages further validate the sourcing. Overall, this is a highly accurate, well-supported response with only a slight variance in emphasis on strategic interpretation, not fact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 415,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Chevron's strategic positioning in Angola LNG Limited evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's long-term natural gas monetization strategy in Angola?",
      "original_answer": "Chevron maintained a consistent 36.4 percent ownership stake in Angola LNG Limited throughout 2022, 2023, and 2024. However, the strategic context of this investment evolved significantly. In 2022 and 2023, Chevron's involvement was primarily described in terms of processing and liquefying natural gas for international markets. By 2024, Chevron had expanded its upstream gas portfolio in Angola through new exploration acreage in Blocks 49 and 50, and had also advanced the Quiluma and Maboqueiro (Q&M) gas fields within the New G as Consortium Project, which included direct connectivity to the Angola LNG plant. This evolution shows that Chevron's stake in Angola LNG Limited transitioned from being a standalone LNG export facility into a more integrated hub for gas monetization, supported by expanding upstream development and regional infrastructure integration.",
      "llm_answer": "Chevron has kept a 36.4 % stake in Angola LNG Limited through 2024, but its equity‑method investment fell from about $1.963 B in 2022 to $1.762 B in 2024, reflecting a modest decline in the affiliate’s earnings [CVX_10k_2024.pdf: pages 12‑16; CVX_10k_2023.pdf: pages 80‑84; CVX_10k_2022.pdf: pages 76‑80].  During the same period Chevron expanded its gas portfolio by taking a 31 % interest in the New G as Consortium Project (NGC), which will feed gas into the Angola LNG plant and has newly recognized proved reserves in 2024 [CVX_10k_2024.pdf: pages 12‑16].  These moves underscore a long‑term strategy to secure a stable feedstock base and integrate gas production with liquefaction to monetize Angola’s associated gas.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Chevron's consistent 36.4% ownership stake in Angola LNG Limited from 2022 to 2024, aligning with the ground truth. However, the equity-method investment values ($1.963B in 2022 and $1.762B in 2024) are not present in the original answer and were not part of the ground truth, introducing unverified quantitative details. While these figures may be accurate in the cited 10-Ks, they were not required to answer the strategic evolution question and distract from the core narrative. The 31% interest in the New Gas Consortium (NGC) is correct and matches the ground truth's reference to the Quiluma and Maboqueiro fields within the NGC. The mention of 'newly recognized proved reserves in 2024' is consistent with the 2024 strategic shift. (2) The calculation of a decline in equity investment is numerically plausible but not relevant to the strategic positioning evolution as defined in the ground truth, which focuses on operational and integration developments rather than accounting values. These financial figures, while possibly accurate, are not part of the multi-hop reasoning required and could mislead if taken as central to the strategy. (3) The multi-hop reasoning is strong: the model connects Chevron’s stable ownership with upstream expansion (Blocks 49/50, NGC) and links NGC feedstock to the Angola LNG plant, correctly inferring an integrated monetization strategy. This matches the ground truth’s conclusion about transitioning from a standalone facility to an integrated hub. (4) The answer is contextually excellent, addressing both the evolution and long-term strategy. The core strategic insight—integration of upstream gas with liquefaction for monetization—is semantically equivalent to the ground truth. The score is reduced slightly due to the introduction of unsupported financial figures not in the original answer, affecting quantitative accuracy, but the qualitative and contextual reasoning remains high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 534,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Southern Company's investments in trusts, particularly in domestic equity and private equity, evolve from 2022 through 2024, and what does this progression indicate about the company's long-term capital allocation strategy?",
      "original_answer": "Southern Company's investments in trusts showed a strategic shift over the three-year period. In 2022, domestic equity investments totaled $1,016 million, with private equity at $150 million. By 2023, domestic equity had decreased to $829 million, while private equity increased slightly to $161 million. In 2024, domestic equity rebounded to $1,099 million, and private equity rose to $181 million. This pattern indicates a growing emphasis on private equity as part of a broader diversification and long-term growth strategy, while domestic equity allocations remained relatively stable with minor fluctuations.",
      "llm_answer": "From 2022 to 2023, Southern Company’s trust‑based domestic‑equity holdings jumped from $651 million to $849 million (a $198 million increase), while private‑equity holdings rose modestly from $161 million to $169 million. In 2024 the domestic‑equity level held steady at $849 million and private equity grew to $181 million. This pattern—an aggressive lift in domestic‑equity exposure followed by a gradual expansion of private‑equity stakes—shows a long‑term capital‑allocation strategy that seeks higher‑return equity diversification through trusts while maintaining a stable core asset base.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported financial figures. According to the ground truth, in 2022, Southern Company's domestic equity investments were $1,016 million, not $651 million as stated by the LLM. The LLM claims a jump to $849 million in 2023, but the correct value is $829 million. Furthermore, the LLM incorrectly states that domestic equity held steady at $849 million in 2024, while the actual value rebounded to $1,099 million. For private equity, the LLM incorrectly reports $161 million in 2022, whereas the correct amount is $150 million; it then correctly reports $169 million in 2023 (though ground truth is $161 million), and correctly states $181 million in 2024. These numerical discrepancies are substantial and affect the validity of the analysis. (2) Calculations are also flawed: the LLM claims a $198 million increase in domestic equity from 2022 to 2023, but based on its own incorrect numbers; the actual decrease was $187 million ($1,016M to $829M). The trend direction is misrepresented—domestic equity decreased in 2023, not increased. (3) The multi-hop reasoning is unsound due to reliance on incorrect data. The LLM concludes an 'aggressive lift in domestic-equity exposure,' which contradicts the actual trend of decline followed by recovery. While the observation about gradual private equity growth aligns somewhat with the truth, it is based on inaccurate starting points. (4) Despite incorrect numbers and reasoning, the answer attempts to address the question’s components—evolution over time and strategic implications—and maintains contextual relevance in structure and intent, hence a moderate score for contextual relevance. However, the severe quantitative errors undermine both correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 491,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did the impact of Eliminations/Reclassifications on GM's total net sales and revenue evolve from 2022 through 2024, and what does this trend reveal about the company's internal reporting adjustments across its business segments?",
      "original_answer": "In 2022, Eliminations/Reclassifications reduced GM's total net sales and revenue by $105 million, increasing to $107 million in 2023, and significantly rising to $296 million in 2024. This represents a consistent upward trend in the magnitude of internal reporting adjustments, suggesting increasing complexity or changes in segment reporting structures over the three-year period.",
      "llm_answer": "Eliminations/Reclassifications rose from a $107 million negative adjustment in 2022 to $151 million in 2023 and then to $296 million in 2024, roughly doubling the impact each year. This upward trend shows that GM’s internal cross‑segment transactions and reclassifications are becoming more extensive—particularly as the company integrates its financial‑services and Cruise units—requiring larger adjustments to reconcile segment revenues and keep consolidated figures accurate.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative values for 2022 and 2023. According to the ground truth, Eliminations/Reclassifications were $105 million in 2022 and $107 million in 2023, but the LLM incorrectly states $107 million in 2022 and $151 million in 2023. Only the 2024 figure ($296 million) is correct. This undermines the core accuracy of the response. (2) The calculation claim that the impact 'roughly doubled each year' is incorrect: from $105M to $107M is a ~2% increase, not a doubling; from $107M to $296M is a ~177% increase, which is substantial but not 'doubling each year.' The actual trend shows relative stability in 2022–2023 followed by a sharp rise in 2024, which the LLM misrepresents. (3) The qualitative reasoning about increasing complexity in internal reporting due to integration of financial services and Cruise is plausible and aligns with the upward trend in 2024, showing sound multi-hop interpretation and contextual insight, even if the numerical foundation is flawed. (4) The answer is contextually relevant and addresses both parts of the question—evolution of the impact and interpretation of the trend—but the significant numerical inaccuracies in two out of three years severely limit factual correctness. While the direction of the trend (upward) is correctly identified, the magnitude and progression are misrepresented, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 397,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 through 2024, particularly in terms of its documentation status and integration with other compensation frameworks?",
      "original_answer": "In 2022, Netflix's Performance Bonus Plan was listed as a historical exhibit (Exhibit 10.6†) with a filing date of April 28, 2014, indicating no updates during that year. In 2023, the plan was amended and restated (Exhibit 10.5†), with a filing date of December 9, 2022, showing active revision and formalization. By 2024, the Amended and Restated Performance Bonus Plan (Exhibit 10.5†) was carried forward without further changes, remaining consistent with the 2023 version and continuing to serve as a foundational document integrated with newer compensation structures like performance-based restricted stock unit agreements. This progression reveals a strategic update in 2023 followed by stabilization in 2024.",
      "llm_answer": "In 2022 Netflix disclosed its Performance Bonus Plan as a standalone plan (Exhibit 10.6†) that was not incorporated by reference. By the 2023 filing the plan had been amended and restated (Exhibit 10.5†) and formally incorporated by reference, solidifying its documentation. The 2024 filing kept the plan incorporated by reference and positioned it within the company’s broader compensation framework, linking it to other plans such as the Executive Severance and Retention Incentive Plan (Exhibit 10.6†).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Netflix's Performance Bonus Plan from 2022 to 2024. Quantitatively, all exhibit numbers and years are accurate: the 2022 reference to Exhibit 10.6†, the 2023 update as Exhibit 10.5† with a December 9, 2022 filing date (implied in the original answer), and the carryover in 2024. The LLM correctly identifies the amendment and restatement in 2023 and the stabilization in 2024. However, the LLM introduces a detail not present in the ground truth: integration with the 'Executive Severance and Retention Incentive Plan (Exhibit 10.6†)' in 2024. The original answer mentions integration with performance-based restricted stock unit agreements, not the Severance and Retention Plan. This is a minor overreach or substitution in supporting detail, but does not undermine the core factual progression. The LLM captures the key documentation status changes—standalone and not incorporated in 2022, formally incorporated by reference in 2023 and onward—though the original answer emphasizes the 'historical' status in 2022 and the 2022 filing date of the 2023 exhibit, which the LLM omits. These are minor omissions rather than errors. The reasoning is sound across years, showing multi-hop understanding of plan evolution and integration. Wording differs but meaning is semantically close. The answer is fully contextually relevant and addresses documentation status and integration with compensation frameworks. Minor deductions in qualitative accuracy due to unsupported detail and slight incompleteness in explaining the 2022 'historical' status and filing date context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 453,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did BK's disclosure of its 'Business Relationships and Related Party Transactions Policy' evolve across its 2022, 2023, and 2024 filings, and what does this reveal about the consistency of its corporate governance disclosures related to director independence and committee structures?",
      "original_answer": "BK consistently disclosed its 'Business Relationships and Related Party Transactions Policy' in all three years (2022, 2023, and 2024) within the context of Item 13, specifically under 'Corporate Governance and Board Information.' In each filing, the policy was linked to the discussion of 'Director Independence' and detailed committee structures, including the '- Audit Committee,' '- Corporate Governance, Nominating and Social Responsibility Committee,' and '- Human Resources and Compensation Committee.' The consistent placement and linkage of the policy to director independence and committee charters across all three years indicate a stable and uniform approach to corporate governance disclosures, suggesting that BK maintained a consistent framework for managing related party transactions and ensuring board independence.",
      "llm_answer": "BK consistently referenced its “Business Relationships and Related Party Transactions Policy” in all three filings—appearing in the 2022 proxy (pages 11‑15), the 2023 proxy (pages 12‑16) and the 2024 proxy (pages 12‑16)—with no material changes to the policy text or its disclosure. The corporate‑governance sections that cite director independence and the committee structure (Audit, Corporate Governance/Nominating/Social Responsibility, and Human Resources & Compensation Committees) are likewise identical across the 2022, 2023 and 2024 filings, underscoring a stable, consistent approach to governance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: BK disclosed the 'Business Relationships and Related Party Transactions Policy' in each of the 2022, 2023, and 2024 filings, consistently within the corporate governance section, and linked to director independence and the same three committees—Audit, Corporate Governance/Nominating/Social Responsibility, and Human Resources & Compensation. (2) Quantitative details such as filing years and page ranges (e.g., 2022: pp. 11–15; 2023/2024: pp. 12–16) are accurately reported and consistent with expected disclosure patterns, though page numbers were not in the ground truth—this is acceptable as supplementary detail, not a factual error. (3) The multi-hop reasoning is sound: the model correctly infers that unchanged policy text and consistent placement across years indicate a stable governance framework, which matches the ground truth’s conclusion about consistency in corporate governance disclosures. (4) The only minor limitation is that the LLM emphasizes 'no material changes to the policy text' and 'identical' sections, which, while reasonable, goes slightly beyond the ground truth’s more cautious 'consistent placement and linkage.' However, this does not contradict the core conclusion. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 390,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did UnitedHealth Group's fair value and carrying value of Debt Securities - Held-to-Maturity evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment strategy and valuation assumptions?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's fair value of Debt Securities - Held-to-Maturity decreased from $643 million to $596 million in 2023, and further declined to $508 million in 2024. Similarly, the carrying value dropped from $641 million in 2022 to $603 million in 2023, and then to $512 million in 2024. This consistent decline suggests a strategic reduction in exposure to held-to-maturity debt securities over the three-year period, with a notable shift away from Level 3 unobservable inputs by 2023 and 2024, indicating greater reliance on more liquid or observable market pricing.",
      "llm_answer": "From 2022 to 2024 the fair value of UnitedHealth’s debt securities held‑to‑maturity fell from **$679 million to $508 million**, while the carrying (amortized‑cost) value declined from **$696 million to $512 million**.  The gap between fair value and carrying value narrowed each year (from $17 m in 2022 to $4 m in 2024), showing that the company’s unrealized losses are modest and largely driven by interest‑rate movements rather than credit deterioration.  This trend reflects a conservative, capital‑preservation strategy that holds high‑quality, low‑risk bonds to maturity, with fair‑value reporting used only to monitor temporary market fluctuations that are expected to converge back to the amortized cost.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, UnitedHealth's fair value of Debt Securities - Held-to-Maturity was $643M in 2022, $596M in 2023, and $508M in 2024. The LLM incorrectly states the 2022 fair value as $679M and omits the 2023 value entirely. Similarly, the carrying value in 2022 was $641M (not $696M as stated), $603M in 2023 (missing in LLM answer), and $512M in 2024 (correct). These discrepancies in key financial figures severely undermine factual correctness. (2) Calculations: The LLM claims a gap reduction from $17M to $4M, but using ground truth numbers, the actual gaps were $2M in 2022 ($643M - $641M), -$7M in 2023 ($596M - $603M), and -$4M in 2024 ($508M - $512M), indicating unrealized losses, not convergence as implied. The LLM’s calculation is based on incorrect inputs and misrepresents the trend. (3) Multi-hop reasoning: While the LLM attempts to interpret the trend as reflecting a conservative investment strategy, it misses the key insight from the ground truth—namely, the strategic reduction in exposure and the shift away from Level 3 unobservable inputs, which indicates a move toward more transparent, market-based valuations. This critical qualitative point is absent. (4) Despite incorrect numbers and flawed reasoning, the answer remains contextually relevant by addressing the evolution of fair and carrying values and offering an interpretation of investment strategy, albeit based on incorrect data. Wording flexibility is allowed, but factual divergence—especially in core financial metrics—is severe. Hence, correctness is scored low at 4 due to major quantitative errors, though the structure and intent align with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 479,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did PayPal's exposure to bad transactions through its BNPL loan receivables evolve from 2022 through 2024, particularly in light of its June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables, and what does this reveal about the company's risk mitigation strategy over time?",
      "original_answer": "In 2022, PayPal highlighted its exposure to bad transactions through its credit and merchant financing products, including the risk of defaults and the impact of fraud and abusive behaviors on its loss rate. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to reduce its exposure to bad transactions by offloading a substantial portion of its BNPL portfolio. By 2024, PayPal continued to emphasize the risks associated with bad transactions but noted that the sale of BNPL receivables was subject to certain conditions, and if not satisfied, could delay the expected benefits. This evolution shows PayPal's increasing focus on mitigating bad transaction risk through asset sales and forward-flow arrangements, while still acknowledging the ongoing challenges of fraud and abuse in its digital payments ecosystem.",
      "llm_answer": "PayPal’s BNPL loan portfolio was a source of bad‑transaction risk in 2022, as noted in its risk‑factor disclosures [24].  In June 2023 the company entered a multi‑year agreement to sell up to €40 billion of U.K. and European BNPL receivables, beginning in October 2023, which markedly reduced that exposure [23].  By 2024 PayPal continued to mitigate risk by selling future BNPL receivables and using forward‑flow arrangements, underscoring a strategy of off‑loading credit risk to third parties and structuring financing to limit bad‑transaction losses [21].",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal's exposure to bad transactions in 2022, the June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables, and the continuation of risk mitigation via forward-flow arrangements in 2024. The dates (June 2023, October 2023 start) and amount (€40 billion) are precisely stated, satisfying quantitative accuracy. (2) The numbers and dates match the original answer; no calculation errors or misstatements. Format (€40 billion) is consistent and correct. (3) The multi-hop reasoning is sound: the answer connects PayPal’s initial risk exposure, the strategic sale of receivables, and the ongoing risk mitigation strategy across 2022–2024. It correctly infers that the sale reduces exposure and reflects a broader strategy of offloading credit risk. (4) The only minor omission is that the 2024 disclosure noted the sale was subject to conditions that, if unmet, could delay benefits—a nuance present in the original answer but not mentioned in the LLM response. However, this does not undermine the core factual accuracy or strategic interpretation. The LLM captures the essence of PayPal’s evolving risk mitigation strategy. Thus, while extremely close to perfect, a score of 9 is justified due to this slight contextual gap in 2024 risk acknowledgment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 382,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Chevron's (CVX) upstream production volumes in Myanmar evolve from 2022 through 2024, and what strategic shift in operations is reflected by these changes?",
      "original_answer": "Chevron's upstream production in Myanmar declined from 17 thousand barrels per day (MBD) in 2022 to 15 MBD in 2023, and the company completely withdrew from Myanmar in April 2024, signaling a full exit from the region. This reflects a strategic shift in portfolio optimization and risk management.",
      "llm_answer": "Chevron’s upstream production in Myanmar declined sharply: it was 17 MBD oil‑equivalent and 94 MMCFD natural gas in 2022, fell to 15 MBD and 87 MMCFD in 2023, and dropped further to 4 MBD and 22 MMCFD in 2024【CVX_10k_2023.pdf page 7】【CVX_10k_2024.pdf page 7】. This steep reduction reflects Chevron’s strategic exit from Myanmar, which the company announced in April 2024【CVX_10k_2024.pdf page 7】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While it correctly states the 2022 (17 MBD) and 2023 (15 MBD) upstream oil production figures, it incorrectly reports a 2024 production level of 4 MBD, whereas the ground truth confirms Chevron completely withdrew from Myanmar in April 2024, meaning production dropped to 0 MBD, not 4. Additionally, the LLM introduces natural gas volumes (94 MMCFD, 87 MMCFD, 22 MMCFD) not present in the original answer, which were not part of the ground truth and may reflect over-extraction or misinterpretation. (2) The dates are partially correct—the April 2024 exit is accurately cited—but the implication that Chevron still had 4 MBD production in 2024 contradicts the full withdrawal. Calculations are not required here, but the trend description is flawed due to incorrect endpoint data. (3) The reasoning correctly identifies the strategic exit as a portfolio shift, aligning with the ground truth’s mention of portfolio optimization and risk management. However, the failure to state the complete cessation of production weakens the multi-hop synthesis—despite citing the exit, it reports nonzero output. (4) Contextual relevance is high, as the answer addresses both production trends and strategic implications, and cites appropriate documents. However, the inclusion of unverified gas volumes and incorrect 2024 production undermines factual accuracy. Overall, the core direction of the answer is correct, but key facts are wrong, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 422,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the relative revenue contribution of PC & Notebooks within Texas Instruments' Personal Electronics segment evolve from 2022 to 2024, and what does this trend suggest about the company's strategic positioning in the consumer computing market?",
      "original_answer": "In 2022, the Personal Electronics segment accounted for 24% of TI's revenue, with PC & Notebooks listed as a key subcategory. By 2023, the Personal Electronics segment had declined to 15% of TI's revenue, indicating a reduced emphasis on consumer computing. In 2024, the segment further decreased to 20% of revenue, with PC & Notebooks still included but appearing lower in the list of priorities compared to mobile phones and portable electronics. This trend suggests a strategic shift away from PC & Notebooks as TI increasingly focused on higher-growth or higher-margin areas within Automotive and Industrial markets.",
      "llm_answer": "PC & Notebooks made up a larger portion of Texas Irradiation’s Personal Electronics segment in 2022, fell in 2023, and rose again in 2024.  The segment itself dropped from 24 % of total revenue in 2022 to 15 % in 2023, then rebounded to 20 % in 2024, showing TI is recalibrating its consumer‑computing focus—shifting away from the cyclical PC market when demand weakens and re‑engaging it as the market recovers.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct quantitative elements but introduces a critical error in the company name, referring to 'Texas Irradiation' instead of 'Texas Instruments'—a clear entity inaccuracy. The revenue percentages for the Personal Electronics segment are mostly correct: 24% in 2022, 15% in 2023, and 20% in 2024, which aligns with the ground truth. However, the LLM incorrectly frames the trend in PC & Notebooks as one of decline and rebound in relative contribution, while the original answer emphasizes that PC & Notebooks remained a subcategory but was deprioritized in presentation and context, not necessarily fluctuating in revenue share. (2) The numbers for segment revenue contribution are accurate and match the ground truth, earning partial credit on quantitative accuracy. The years are correct. However, no specific revenue figures for PC & Notebooks itself are provided in either answer, so the LLM’s inference about its rise and fall is speculative and not directly supported. (3) The reasoning is partially sound but flawed in synthesis: the original answer highlights a strategic shift away from consumer computing toward Automotive and Industrial markets, supported by the declining and then partially recovering—but still lower—segment weight. The LLM interprets this as a tactical 'recalibration' based on market cycles, which is a plausible inference but goes beyond the stated evidence in the ground truth, which emphasizes a reduced emphasis and lower priority in listing order. The multi-hop synthesis is weak because it fails to reference the changing priority within the segment (e.g., mobile phones now listed ahead of PCs). (4) Correctness is scored at 5 due to correct numbers but significant qualitative errors in entity name and reasoning. Quantitative accuracy is 6 because the percentages and years are correct, but the implied fluctuations in PC & Notebooks share are not substantiated. Qualitative accuracy is 5 due to the company name error and overinterpretation of strategic intent. Contextual relevance is 8 because the answer addresses the evolution and strategic implication, even if inaccurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 581,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Motors' indemnification obligations to Stellantis evolve from 2022 through 2024, particularly in terms of known liabilities, accruals, and potential future exposures related to legacy Opel/Vauxhall matters?",
      "original_answer": "In 2022, GM continued to have ongoing commercial relationships with Stellantis, including supply and engineering services, but no specific indemnification accruals or liabilities were disclosed. By 2023, GM disclosed that it indemnified Stellantis for certain losses tied to pre-sale representations and warranties, emissions claims, product liabilities, and recalls, with an immaterial indemnification already paid and an inability to estimate reasonably possible future losses. In 2024, GM expanded on these obligations, noting accruals of an immaterial amount related to a European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era, and reiterated that while further indemnification for Takata-related recalls was possible, it was considered remote. The trend shows increasing specificity and emerging regulatory risk exposure over time, though financial impact remained immaterial.",
      "llm_answer": "Across the 2022, 2023, and 2024 10‑Ks (pages 89‑93, 90‑94, 91‑95), GM consistently reported **no material indemnification liability or accrual** for its 2017 Opel/Vauxhall sale to Stellantis and stated it could not estimate any material loss from potential claims. The company has continued to indemnify Stellantis for an **immaterial amount for certain recalls—including Takata inflators in legacy Opel vehicles**—and has deemed any further indemnification for those recalls “remote.” Consequently, the known liabilities remained immaterial, no accruals were recorded, and potential future exposures stayed remote over the three years.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but misses key qualitative developments in GM's indemnification obligations from 2022 to 2024, particularly the increasing specificity and emerging regulatory exposures. Quantitatively, the answer correctly states that liabilities and accruals were immaterial and that further Takata-related indemnification was deemed 'remote'—this aligns with the ground truth. The mention of immaterial recall indemnifications (e.g., Takata) is accurate. However, the LLM fails to capture the evolution described in the original answer: in 2023, GM disclosed actual indemnification for losses tied to pre-sale warranties, emissions, and product liabilities, with an immaterial amount paid and an inability to estimate future losses. In 2024, this expanded to include accruals related to a European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era—a new regulatory risk not mentioned at all in the LLM response. While the financial impact remained immaterial, the trend of increasing disclosure specificity and emerging regulatory exposure is a central theme in the original answer that the LLM omits. This represents a significant gap in qualitative accuracy and completeness, especially for a multi-hop question asking about evolution over time. The LLM presents a static view ('no material liability' across all years) rather than the dynamic progression shown in the ground truth. Contextual relevance is high because the answer addresses indemnification, liabilities, accruals, and future exposures, but the failure to reflect the evolving nature of disclosures reduces correctness. Semantic equivalence is partially achieved on immateriality and Takata, but not on the evolving scope of indemnification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 478,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did American Tower Corporation's issuance of the 1.450% Senior Notes due 2026 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's debt management strategy?",
      "original_answer": "The 1.450% Senior Notes due 2026 were consistently referenced across all three years—2022, 2023, and 2024—as part of Supplemental Indenture No. 10, indicating that the notes remained an active and stable component of AMT’s debt portfolio. In 2022, the notes were introduced in the 10-K filing under Exhibit 4.25, dated September 27, 2021. In 2023, the same notes were referenced under Exhibit 4.22, and in 2024 under Exhibit 4.21, maintaining continuity in documentation and structure. The consistent inclusion of these notes across filings suggests a deliberate and stable debt management strategy, with no refinancing or material modification of the instrument over the three-year period.",
      "llm_answer": "American Tower’s 1.450% Senior Notes due 2026 were first issued under Supplemental Indenture No. 10 on September 27 2021 (see Exhibit 4.21).  The notes remained on the company’s long‑term debt schedule in each subsequent filing—reported as outstanding in the 2022 10‑K (pp. 70‑74), the 2023 10‑K (pp. 68‑72), and the 2024 10‑K (pp. 70‑74)—with no additional issuances or redemptions.  This steady, long‑dated, low‑coupon debt profile demonstrates American Tower’s strategy of maintaining a stable, low‑interest‑rate leverage mix to fund growth while managing refinancing risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core facts and strategic implication of the multi-year pattern of American Tower's 1.450% Senior Notes due 2026. However, there is a minor discrepancy in the exhibit number cited: the LLM states the notes were issued under Exhibit 4.21 in 2021, while the ground truth indicates Exhibit 4.25 in the 2022 10-K (which covers the 2021 issuance). The LLM incorrectly assigns Exhibit 4.21 to the initial issuance, but in the 2024 filing, Exhibit 4.21 is referenced—suggesting the LLM may have conflated the exhibit number from the most recent year with the original filing. Despite this, the key facts—issuance date (September 27, 2021), supplemental indenture number (No. 10), consistent presence in 2022, 2023, and 2024 filings, no redemptions or additional issuances—are all accurate. The strategic interpretation about stable, low-interest debt management is sound and aligns with the ground truth. The answer addresses both parts of the question: the evolution (or lack thereof) across years and the implication for debt strategy. The reasoning is logically sound and synthesizes information across multiple years, though the exhibit number error slightly undermines quantitative and qualitative accuracy. Page ranges (e.g., pp. 70–74) are plausible but not verifiable from the ground truth; they do not contradict it. Overall, the answer is factually strong with a minor documentation inaccuracy that does not distort the overall conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 409,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did The Bank of New York Mellon Corporation's use of the 2019 Long-Term Incentive Plan evolve from 2022 through 2024, particularly in relation to the introduction of new deferred stock unit agreements and performance share unit agreements across those years?",
      "original_answer": "In 2022, the company referenced the 2019 Long-Term Incentive Plan alongside the introduction of the 2019 Form of Performance Share Unit Agreement and the 2019 Form of Restricted Stock Unit Agreement, indicating early implementation of the plan through structured equity instruments. In 2023, the company introduced the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors,' extending the plan’s application to director-level compensation. By 2024, the company continued building on the 2019 plan by incorporating newer forms such as the 2022 Form of Performance Share Unit Agreement, showing a sustained and expanding reliance on the plan as a foundational framework for long-term compensation design. This progression demonstrates a multi-year strategic alignment of executive and director incentives under the 2019 plan, with incremental refinements and broader application over time.",
      "llm_answer": "The 2019 Long‑Term Incentive Plan remained the governing framework for new equity awards from 2022 through 2024, with each year adding new deferred‑stock‑unit and performance‑share‑unit agreements: 2022 (Exhibit 10.18 and 10.19) (BK_10k_2022.pdf pages 18‑22), 2023 (Exhibit 10.23 and 10.24) (BK_10k_2023.pdf pages 16‑20), and 2024 (Exhibit 10.28 and 10.29) (BK_10k_2024.pdf pages 16‑20). These agreements are documented in the respective 10‑K filings for each year.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates, years, and the progression of agreements under the 2019 Long-Term Incentive Plan, correctly identifying the continued use of the plan from 2022 to 2024 and citing specific exhibit numbers and document sources (e.g., Exhibits 10.18, 10.23, 10.28). The quantitative accuracy is high: years (2022–2024), exhibit numbers, and document references are correct and align with the expected filings. However, the LLM answer lacks the qualitative nuance present in the original answer regarding the strategic evolution and purpose of the agreements. For example, it fails to mention that the 2023 introduction of the 'Deferred Stock Unit Agreement for Directors' extended the plan to director-level compensation, a key expansion. Similarly, it does not note that the 2024 adoption of the '2022 Form of Performance Share Unit Agreement' reflects a refinement and sustained reliance on the 2019 plan framework. While the LLM correctly identifies the existence of new agreements each year, it omits the interpretive layer about strategic alignment and incremental broadening of the plan’s application. This missing synthesis reduces qualitative accuracy. Contextual relevance is strong—the answer directly addresses the question’s focus on evolution across years and the introduction of specific agreements. Overall, the answer is factually sound and well-supported with document evidence but lacks depth in explaining the significance and directional evolution of the plan, which is central to the original answer’s multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 431,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Dynamics' focus on aerostructures within its Combat Systems segment evolve from 2022 through 2024, and what does this 3-year trend reveal about its strategic positioning in next-generation missile subsystems?",
      "original_answer": "In 2022, General Dynamics emphasized its production of missile subsystems with critical aerostructures as part of its broader Combat Systems portfolio, which included next-generation weapon systems for air and shipboard applications like those on the F-35. In 2023, the Combat Systems segment accounted for 20% of consolidated revenue, with aerostructures explicitly mentioned as part of next-generation missile provisioning. By 2024, GD continued to highlight its role in producing critical aerostructures for next-gen missiles, while the Combat Systems segment slightly declined to 19% of consolidated revenue. This indicates a consistent strategic focus on aerostructures within Combat Systems, despite slight revenue share fluctuations, underscoring GD's sustained positioning in advanced missile subsystems.",
      "llm_answer": "Across 2022‑24 the Combat Systems segment’s OTS unit consistently highlighted the supply of “critical aerostructures” for both legacy and next‑generation missiles (including hypersonic rocket cases) in its annual disclosures.  Revenue from weapons systems, armament and munitions rose from $2.02 bn in 2022 to $2.93 bn in 2024, underscoring a growing emphasis on advanced missile subsystems.  This 3‑year trend shows General Dynamics positioning itself as a key provider of sophisticated aerostructure technology for next‑generation missile platforms.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative claims. The ground truth states that Combat Systems accounted for 20% of consolidated revenue in 2023 and 19% in 2024, but does not provide absolute revenue figures for weapons systems or a breakdown of $2.02B in 2022 and $2.93B in 2024. These specific dollar amounts are not present in the original answer and cannot be verified from the provided truth, making them likely fabricated or misattributed. Additionally, the mention of 'OTS unit' is not supported in the original answer, which does not name any subunits within Combat Systems. (2) The calculation of revenue growth from $2.02B to $2.93B implies a 45% increase, but this data is absent from the ground truth, which only provides segment revenue as a percentage of total (20% in 2023, 19% in 2024). Without total revenue figures, such absolute values cannot be accurately derived. The original answer does not mention 'hypersonic rocket cases'—this is an addition not supported by the source. (3) While the LLM correctly identifies a multi-year strategic focus on aerostructures in next-gen missile systems, it fails to accurately synthesize the actual disclosures: the original emphasizes consistent messaging despite a slight revenue share decline, whereas the LLM infers growth based on unsupported figures. The reasoning is directionally plausible but built on incorrect data. (4) The contextual relevance is high because the answer addresses the evolution of aerostructures and strategic positioning as asked. However, correctness is low due to unsupported numbers and entities. Qualitative accuracy is moderate because the general strategic narrative aligns, but entity and reasoning flaws reduce reliability. Quantitative accuracy is poor due to unverified financial figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 500,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Philip Morris International's positioning and strategic emphasis on its local cigarette brand Jackpot in the Philippines evolve from 2022 through 2024, and what does this multi-year progression indicate about the brand's role in PMI's broader regional and product portfolio strategy?",
      "original_answer": "In 2022, PMI identified Jackpot as one of its key local cigarette brands in the Philippines, alongside Fortune, indicating its importance in the regional market. In 2023, PMI reiterated its commitment to Jackpot as part of its local brand portfolio in the Philippines, maintaining its strategic focus amid broader global restructuring and integration of Swedish Match. By 2024, PMI continued to highlight Jackpot as a core local brand in the Philippines, even as it expanded its smoke-free product footprint to 95 markets and emphasized its IQOS and ZYN brands. This consistent mention of Jackpot across three years shows that, despite PMI’s long-term vision of a smoke-free future, traditional cigarette brands like Jackpot remain strategically relevant in key regional markets like the Philippines.",
      "llm_answer": "In each of the 2022, 2023, and 2024 10‑K filings (pages 3‑7, 4‑8, and 3‑7 respectively), PMI lists Jackpot as one of its local cigarette brands in the Philippines, with no change in wording or emphasis. This steady positioning shows that PMI treats Jackpot as a stable local brand that underpins its regional strategy to maintain market share in the Philippines while complementing its broader international portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately identifies that PMI consistently listed Jackpot as a local cigarette brand in the Philippines across the 2022, 2023, and 2024 10-K filings, which matches the original answer's claim of sustained strategic emphasis. The page numbers cited (3-7, 4-8, 3-7) are specific and plausible, supporting the claim of unchanged wording and emphasis. Quantitatively, there are no numerical errors—dates and references are accurate. The answer correctly synthesizes multi-hop information by tracking the brand's positioning over three years and inferring strategic stability. The only minor shortcoming is that it does not explicitly mention the broader context of PMI’s smoke-free transition (e.g., IQOS, ZYN, or Swedish Match integration), which the original answer uses to contrast Jackpot’s ongoing relevance. While implied through the idea of 'complementing its broader international portfolio,' the LLM answer could have more clearly articulated the tension between traditional cigarette brands and PMI’s long-term smoke-free vision. Nevertheless, the core facts, timeline, entity identification, and reasoning are sound and semantically equivalent to the ground truth. Thus, the answer is highly accurate with only a slight gap in depth of strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 373,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Chevron's investment and operational focus in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital deployment and asset disposition?",
      "original_answer": "In 2022, Chevron listed the Republic of Congo as one of its key operational areas, signaling ongoing presence and strategic importance. In 2023, the company invested approximately $0.7 billion across offshore development and natural gas projects in Africa, which included activity in the Republic of Congo, indicating active capital deployment in the region. However, by 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi in January 2025, reflecting a strategic exit from its upstream assets in the country. This 3-year trajectory shows a shift from operational continuity to active divestiture in the Republic of Congo.",
      "llm_answer": "Chevron’s activity in the Republic of Congo moved from a passive holding to a divestiture. In 2022 and 2023 the company listed the country as an operating jurisdiction but reported no capital deployment or asset disposition there (Business Environment and Outlook, p. 32; 2023 10‑K, p. 107‑111). By 2024, Chevron announced the sale of its 31.5 % non‑operated interest in the offshore Haute Mer permit area and its 15.75 % interest in the Republic of Congo portion of Lianzi, signalling a shift toward divesting rather than investing in the region (Noteworthy Developments, p. 41‑45).",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Chevron's divestiture in the Republic of Congo in 2024, including the sale of its 31.5% nonoperated interest in the Haute Mer permit and 15.75% in the Lianzi field, which aligns with the ground truth. However, it contradicts the original answer by stating that there was 'no capital deployment' in 2022 and 2023, while the ground truth explicitly states that Chevron invested approximately $0.7 billion in Africa in 2023, including activity in the Republic of Congo. This omission of a key financial commitment significantly undermines the factual accuracy. (2) Quantitatively, the percentages (31.5% and 15.75%) and the timing of the sale (announced in 2024, though executed in January 2025) are correctly reported. However, the $0.7 billion investment in African offshore and gas projects in 2023 — which includes Congo — is entirely omitted, making the quantitative picture incomplete and misleading. (3) The multi-hop reasoning is partially sound: the model correctly traces Chevron’s presence from listing Congo as an operating jurisdiction to divestiture. But it fails to synthesize the 2023 capital deployment in Africa with Congo’s inclusion, which is a critical link in the evolution of investment focus. The conclusion that there was no capital deployment is inconsistent with the ground truth and reflects flawed reasoning. (4) Contextual relevance is high because the answer addresses the timeline, assets, and strategic shift. However, due to the significant error in denying capital deployment, the overall correctness is reduced to a mid-range score. The answer captures the exit but misrepresents the preceding investment phase.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 462,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Southern Company's treatment and valuation of outdoor lighting contracts as operating leases change from 2022 to 2024, particularly in terms of materiality, revenue allocation, and lease payment structure across its subsidiaries?",
      "original_answer": "In 2022, Southern Company noted that outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial, with no significant value disclosed. In 2023, the company began disclosing scheduled lease payments under outdoor lighting contracts as part of maturity analyses, indicating a more structured approach to lease accounting. By 2024, the company expanded this disclosure to include the initial terms of outdoor lighting contracts and further clarified that lease income from PPAs was included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power, suggesting a growing emphasis on transparency and standardization in lease valuation across subsidiaries.",
      "llm_answer": "From 2022 to 2024 Southern Company kept outdoor lighting contracts classified as operating leases with scheduled payments that renew on a month‑to‑month basis after the initial term, but it extended the initial term from up to 7 years to up to 10 years (2022 note p. 270; 2024 note p. 232). Lease payments for Southern Company (and Alabama Power) remained material, while those for Georgia Power and Mississippi Power were immaterial (2024 note p. 233). Revenue allocation for PPAs stayed unchanged—Alabama Power and Southern Power allocate revenue to non‑lease components based on stand‑alone selling price—and the lease income for Southern Company fell from $208 million in 2022 to $136 million in 2024 (2022 note p. 272; 2024 note p. 231).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains multiple significant factual inaccuracies and introduces information not present in the ground truth, indicating a failure in multi-hop reasoning and data synthesis. (1) Quantitative inaccuracies: The claim that lease income fell from $208 million in 2022 to $136 million in 2024 is unsupported by the original answer, which does not provide any financial figures for lease income or revenue from outdoor lighting contracts. Similarly, the assertion that initial terms increased from 'up to 7 years' to 'up to 10 years' is not mentioned in the ground truth, which only states that by 2024, initial terms were disclosed—not that they changed in duration. (2) Completeness and entity accuracy: The LLM incorrectly states that lease payments for Southern Company and Alabama Power were 'material' and for Georgia Power and Mississippi Power 'immaterial' in 2024, while the original answer only notes that Mississippi Power's contracts were immaterial in 2022 and does not assess materiality for other subsidiaries in later years. The LLM also misrepresents revenue allocation by claiming it 'stayed unchanged' with specific allocation methods, but the ground truth does not mention stand-alone selling price or any detailed revenue allocation methodology. (3) Reasoning flaws: The LLM fabricates a narrative of quantitative changes (dollar amounts, term lengths) and materiality assessments across subsidiaries without grounding in the source. The original answer emphasizes evolving disclosure practices—transparency and standardization—not changes in contract terms or financial performance. (4) Contextual relevance: While the LLM addresses the general topic of outdoor lighting leases and attempts to compare years and subsidiaries, the specific claims are largely invented, leading to a low correctness score despite some topical alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 502,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Cisco's 3.50% Note evolve across fiscal years 2022, 2023, and 2024 in terms of its carrying amount and effective interest rate, and what does this progression indicate about the company's debt valuation and market conditions over time?",
      "original_answer": "In fiscal year 2022, Cisco reported a carrying amount of $500 million for the 3.50% Note with an effective interest rate of 3.20%. By fiscal year 2023, the carrying amount remained at $500 million, but the effective rate increased to 6.38%, and in fiscal year 2024, the effective rate further rose to 6.66%, maintaining the same $500 million carrying amount. This upward trend in the effective rate indicates a shift in market conditions or internal risk assessments affecting the valuation of this long-term debt instrument over the three-year period.",
      "llm_answer": "Across FY 2022‑2024 Cisco’s 3.50% senior note stayed at a carrying amount of **$500 million** each year, but its effective interest rate rose from **3.20%** in FY 2022 to **6.38%** in FY 2023 and to **6.66%** in FY 2024 (long‑term debt tables in the 2022, 2023, and 2024 10‑Ks). The unchanged principal but higher effective rate reflects tightening market rates and a discount to fair value, indicating that Cisco’s borrowing cost has increased while the note’s valuation remains stable in terms of principal.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all factual information: the carrying amount of $500 million for the 3.50% Note is consistent across fiscal years 2022, 2023, and 2024, and the effective interest rates are accurately stated as 3.20% in FY2022, 6.38% in FY2023, and 6.66% in FY2024. These match the ground truth exactly. (2) All numeric values are correct and properly formatted; no calculation errors are present. The LLM correctly notes the stability of the carrying amount and the increasing trend in effective interest rates. (3) The multi-hop reasoning is sound: the model synthesizes data across three fiscal years from the 10-K filings and correctly infers the implication of rising effective rates despite stable carrying value. It identifies the key financial insight—increasing borrowing costs due to market conditions or risk reassessment—even using semantically equivalent and accurate phrasing such as 'tightening market rates and a discount to fair value.' (4) The answer is fully complete, addressing both the evolution of the carrying amount and effective interest rate, and provides a correct qualitative interpretation about debt valuation and market conditions. All entities (Cisco, 3.50% Note, fiscal years, financial metrics) are accurate. Therefore, all scores are maximized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 367,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Simon Property Group's exposure to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this multi-year pattern reveal about their long-term debt management strategy?",
      "original_answer": "Simon Property Group maintained a consistent $750 million face value exposure to Unsecured Notes - 35A across all three years (2022, 2023, and 2024), with identical 2.65% interest rates and July 15, 2030 maturity dates. This stability contrasts with broader changes in their unsecured debt portfolio, including new issuances like the 2024 $1 billion Unsecured Notes - 41A and refinancing of credit facilities. The sustained presence of this specific instrument suggests a deliberate strategy to maintain stable long-term financing commitments while selectively refinancing or adding new debt instruments in response to market conditions.",
      "llm_answer": "From 2022 through 2024, Simon Property Group’s Unsecured Notes – 35A stayed identical: a $750,000 face amount, a 2.65 % coupon, and a maturity of July 15 2030【source】【source】【source】.  The unchanged terms show the company’s preference for a stable, low‑cost, long‑term debt instrument and a conservative refinancing policy that avoids frequent issuance or rollover of this note.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent terms of the Unsecured Notes - 35A across 2022–2024, including the 2.65% interest rate and July 15, 2030 maturity date, which matches the ground truth. However, there is a critical error in the face value: the LLM states '$750,000' instead of '$750 million', which is a significant quantitative inaccuracy (off by a factor of 1,000). This undermines the factual correctness despite correct formatting otherwise. (2) The dollar amount is incorrect—ground truth specifies $750 million, not $750,000. All other numbers (interest rate, maturity date) are accurate. The error likely stems from a transcription or data extraction mistake. (3) The reasoning is sound: the LLM correctly infers that the stability of this instrument reflects a conservative and stable long-term debt strategy, which aligns with the ground truth’s interpretation. It appropriately contrasts this stability with broader portfolio changes (implied by mentioning conservative refinancing policy), though it does not explicitly reference other debt instruments like the 2024 $1 billion Unsecured Notes - 41A, missing a key multi-hop element. (4) The correctness score is 7 because the core insight about strategic stability is preserved and most facts are right except the critical face value error. Quantitative accuracy is penalized heavily (6/10) due to the magnitude of the dollar amount mistake. Qualitative accuracy is high (8/10) as reasoning and interpretation are logical. Contextual relevance is strong (9/10) since the response directly addresses the question’s focus on evolution and strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 448,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "From 2022 through 2024, Texas Instruments consistently emphasized Embedded Processing Products as a core component of its business model, maintaining its position as the second of four sustainable competitive advantages. In 2022, the company described the broad portfolio of analog and embedded processing products as offering 'more opportunity per customer and more value for our investments.' This language remained consistent in 2023 and 2024, with identical phrasing used each year to describe the value derived from the product portfolio. While the strategic framing remained stable, the repeated emphasis over three consecutive years underscores the sustained importance of Embedded Processing Products in TI's long-term value creation model, particularly in enabling deeper customer engagement and diversified returns on investment.",
      "llm_answer": "Texas Instruments has consistently positioned embedded‑processing products as a core element of its broad‑portfolio advantage (b) in all three filings, and it continues to target the industrial and automotive markets for these products (2022 p. 18‑22; 2023 p. 16‑20; 2024 p. 16‑20).  While the company’s messaging has not changed, embedded‑processing revenue grew 3 % from 2022 ($3,261 bn) to 2023 ($3,368 bn) and then fell 25 % to $2,533 bn in 2024 (2023 p. 16‑20; 2024 p. 16‑20).  Thus, the strategic emphasis remains embedded‑processing‑centric, but the relative contribution to the broad‑portfolio advantage has contracted in 2024, prompting a recalibration of focus within that advantage.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the financial data. It reports embedded processing revenue as $3,261 bn in 2022, $3,368 bn in 2023, and $2,533 bn in 2024. These values are off by a factor of 1,000—'bn' (billion) is incorrect; the actual figures from TI's filings are in millions (e.g., $3,261 million, not billion). This error renders the quantitative claims grossly misleading. Additionally, the claimed 3% growth and 25% decline are based on incorrect units and thus invalid. (2) The original answer does not mention revenue trends or market targeting (industrial and automotive), nor does it suggest any 'recalibration of focus' due to revenue contraction—this is an unsupported inference. The ground truth emphasizes consistent strategic language across years, not a shift in emphasis due to performance. (3) While the LLM correctly identifies that embedded processing is part of TI's broad portfolio advantage (one of the four sustainable advantages), it introduces a narrative of strategic recalibration not present in the original. The original stresses stability and consistency in strategic framing from 2022–2024, with identical phrasing used each year. The LLM fails to mention this key point about unchanged language, which is central to the ground truth. (4) The contextual relevance is moderate because the answer addresses TI's strategic emphasis and ties embedded processing to the broad portfolio, but the erroneous data and speculative conclusion about shifting strategy undermine correctness. The qualitative reasoning is partially sound in linking embedded processing to competitive advantage, but the multi-hop synthesis is flawed by introducing unsupported financial trends and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 483,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did CMCSA's wireless shared data plan offerings evolve from 2022 through 2024, particularly in terms of plan flexibility and international expansion?",
      "original_answer": "In 2022, CMCSA offered shared data plans exclusively as part of bundled service offerings to residential customers in the U.S. who subscribed to broadband services. By 2023, the company maintained this structure but emphasized the flexibility of customers being able to choose between unlimited data plans, shared data plans, or per-gigabyte plans. In 2024, CMCSA expanded its wireless offerings internationally and introduced prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans and further diversifying plan options for domestic and international customers. This evolution shows increasing flexibility and geographic diversification of shared data plan offerings.",
      "llm_answer": "From 2022 through 2024, Comcast’s wireless plans consistently offered unlimited, shared, and per‑gigabyte options, with 2024 adding prepaid unlimited plans under the NOW brand and extending unlimited choices to international subscribers (CMCSA_10k_2022, pp. 5‑9; CMCSA_10k_2023, pp. 3‑7; CMCSA_10k_2024, pp. 3‑7). Internationally, the company expanded its MVNO presence to the United Kingdom (and Italy) using third‑party networks and its own core network, offering both gigabyte‑tier and unlimited plans and extending device‑financing terms to 24‑48 months for overseas customers (CMCSA_10k_2024, pp. 3‑7).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in terms of key developments and timeline, but misses a critical nuance in the evolution of CMCSA's shared data plan structure. Quantitatively, all dates (2022–2024) and plan types (unlimited, shared, per-gigabyte) are accurately referenced, and the 2024 international expansion with prepaid unlimited plans under the NOW brand is correctly identified. The mention of MVNO expansion to the UK and Italy using third-party and core networks aligns with the 2024 filing, and device-financing terms (24–48 months) are factually accurate. However, the LLM incorrectly implies that shared data plans were available as standalone options in 2022, whereas the ground truth specifies they were exclusively part of bundled broadband offerings for residential U.S. customers. Additionally, the LLM overemphasizes 'unlimited' plans in international markets without clarifying that shared data plans were also extended internationally, which is a key part of the question about shared data plan evolution. The reasoning is mostly sound and synthesizes across all three years, but the failure to accurately represent the bundling constraint in 2022 and the specific continuity of shared data plans reduces qualitative accuracy. Contextually, the answer is highly relevant and addresses both plan flexibility and international expansion, though with slight misrepresentation of the shared data component. Semantic equivalence is mostly preserved, but the omission of bundling limits and over-focus on unlimited plans detracts from full correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 427,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 to 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this progression indicate about the growing complexity of risk management in its digital payments ecosystem?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to abusive behaviors increased in complexity and scope, particularly in relation to its credit products and third-party fraud schemes. In 2022, PayPal highlighted the risk of fraud through fictitious account creation, stolen financial instruments, and abusive schemes that were difficult to detect due to the digital nature of its services. By 2023, the company expanded on this risk by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, which introduced new exposure to third-party fraud in large-scale loan portfolios. In 2024, PayPal further detailed the evolving tactics of fraudsters, including account takeovers and synthetic identity fraud, while also facing legal uncertainty around the validity of loan receivables purchased from FDIC-insured banks. This 3-year progression shows an increasing sophistication in abusive behaviors, requiring PayPal to continuously enhance its detection systems and risk mitigation strategies across a more complex and globalized payments ecosystem.",
      "llm_answer": "In 2022 PayPal’s risk disclosures warned that third‑party abuse—such as synthetic identities, stolen cards and other fraud—could target its consumer credit and merchant‑financing programs, and that its proprietary credit‑risk models might mis‑price default risk. By 2023 the filings expanded this theme, stressing new and evolving fraud schemes linked to the company’s expanding credit offerings and the need for continuous improvement of fraud‑detection systems, while still citing default risk. In 2024 the disclosures broadened further to include the sale of BNPL loan receivables, greater reliance on third‑party lenders, and heightened exposure to third‑party fraud schemes, underscoring that risk management now must juggle increasingly complex credit, fraud, and regulatory challenges across a rapidly growing digital‑payments ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of PayPal's exposure to abusive behaviors from 2022 to 2024. (1) It correctly identifies the progression: in 2022, risks around synthetic identities, stolen cards, and fraud targeting credit programs; in 2023, expanding credit offerings and need for improved fraud detection; in 2024, sale of BNPL receivables and increased third-party fraud exposure. (2) Quantitative accuracy is perfect: while no specific numbers (e.g., €40 billion) are mentioned in the LLM answer, it does not misstate any figures and avoids fabrication. The omission of the exact €40 billion figure from the ground truth is a minor gap but does not affect factual correctness, as the focus is on the qualitative trend. (3) Multi-hop reasoning is sound—LLM synthesizes risk evolution across years, connects credit products to fraud schemes, and links growing complexity to risk management challenges. (4) The answer is contextually excellent, directly addressing how risk evolved and what it indicates about risk management complexity. The only minor shortcoming is the lack of specificity around the legal uncertainty regarding loan receivables from FDIC-insured banks in 2024, which slightly reduces completeness. However, the overall semantic meaning and factual trajectory align closely with the ground truth, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 380,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has GILD's utilization of its El Segundo, California facility evolved from 2022 through 2024, particularly in relation to its cell therapy manufacturing capabilities and strategic facility investments?",
      "original_answer": "In 2022, GILD identified El Segundo, California as a principal manufacturing facility, specifically for clinical and commercial manufacturing and processing of its cell therapy products. By 2023, the company emphasized its clinical and commercial manufacturing capabilities at El Segundo, highlighting its role in cell therapy processing alongside other facilities like Santa Monica and Frederick. In 2024, GILD reaffirmed its reliance on El Segundo for cell therapy manufacturing, while also underscoring the broader context of facility ownership and lease arrangements, and the importance of third-party manufacturers and supply chain risk management. This continuity indicates a strategic focus on scaling and maintaining cell therapy production capabilities at El Segundo, with no indication of reduced emphasis or facility changes over the three-year period.",
      "llm_answer": "Gilead has consistently used its El Segundo, California site for both clinical and commercial manufacturing and processing of cell‑therapy products. The 2022 10‑K (pp. 31‑35), 2023 10‑K (pp. 9‑13) and 2024 10‑K (pp. 8‑12) all list the same role for the facility, and no new expansions or capital investments at El Segundo are disclosed in the provided excerpts, although Gilead notes it continues to invest in cell‑therapy manufacturing capabilities overall.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that GILD (Gilead) has consistently used the El Segundo, California facility for clinical and commercial manufacturing and processing of cell therapy products from 2022 through 2024, citing the relevant 10-K filings for each year. The statement that no new expansions or capital investments at El Segundo are disclosed in the excerpts matches the original answer's implication of continuity without facility changes. The LLM accurately reflects the absence of reported changes in utilization or strategic emphasis, while noting broader investments in cell therapy manufacturing capabilities overall. All entities (GILD, El Segundo, cell therapy manufacturing) and time periods (2022–2024) are correct. The reasoning is sound and synthesizes information across multiple years and filings appropriately. The only minor limitation is that the LLM does not explicitly mention the broader context highlighted in 2024—such as facility ownership/lease arrangements and third-party manufacturer reliance—but this does not detract significantly from the core accuracy. Quantitative elements (years, document types, page ranges) are correctly cited. Semantic equivalence is strong, and the answer fully addresses the question’s focus on evolution, capabilities, and strategic investments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 381,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the maturity structure of Costco's 2.750% Senior Notes evolve across filings from 2022 through 2024, and what does this reveal about the company's debt management strategy over time?",
      "original_answer": "The maturity structure of Costco's 2.750% Senior Notes remained consistent across the 2022, 2023, and 2024 filings, with all references indicating a fixed maturity date of May 18, 2024. Despite the multi-year span of disclosures, the notes were not refinanced or extended during this period, suggesting that Costco maintained a static approach to this specific debt instrument. This consistency implies a deliberate capital structure decision to allow the notes to mature without modification, aligning with a broader strategy of predictable debt repayment.",
      "llm_answer": "Across the 2022, 2023, and 2024 10‑K filings, Costco’s 2.750% Senior Notes remained due **May 18 2024** with no change in maturity dates or principal amounts (COST_10k_2022.pdf, pp. 64‑68; COST_10k_2023.pdf, pp. 64‑68; COST_10k_2024.pdf, pp. 64‑68). This consistency shows that Costco has been maintaining a stable short‑to‑medium‑term debt profile and is likely planning to refinance or retire the notes as they mature, reflecting a conservative, disciplined debt‑management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the 2.750% Senior Notes consistently mature on May 18, 2024, across all three filings (2022–2024), and there is no change in principal or maturity date. The dates and percentages match the original answer exactly. (2) The answer is complete, addressing both parts of the question: it describes the unchanging maturity structure and infers Costco’s debt management strategy. (3) Entity accuracy is strong—'Costco', '2.750% Senior Notes', and the correct years (2022–2024) are properly identified. (4) Reasoning is sound: the consistency in maturity dates supports the conclusion of a stable, disciplined debt strategy. The only minor shortcoming is that the LLM suggests Costco 'is likely planning to refinance or retire' the notes, which introduces a slight forward-looking assumption not explicitly confirmed in the ground truth. The original answer more precisely states that the lack of refinancing or extension reflects a 'deliberate' decision to allow maturity without modification. While the LLM’s inference is reasonable, it slightly overreaches compared to the more neutral, evidence-based tone of the ground truth. Overall, the answer is factually correct, well-supported, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 370,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 to 2024, and what does this three-year trajectory indicate about the company's gas production strategy in Africa?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased from 7,107 million cubic feet per day in 2022, to 7,148 million cubic feet per day in 2023, and further rose to 7,569 million cubic feet per day in 2024. This steady upward trend indicates a strengthening production output from the Angola LNG asset, suggesting that Chevron maintained or expanded its operational focus on natural gas in Africa despite broader asset divestitures elsewhere in its portfolio.",
      "llm_answer": "Chevron’s share of natural‑gas output from Angola LNG stayed flat at roughly 48 million cubic feet per day (MMCFD) in 2022, 2023 and 2024 (CVX_10k_2022.pdf p.10; CVX_10k_2023.pdf p.10; CVX_10k_2024.pdf p.10). This steady trajectory shows that Chevron is prioritising a stable, long‑term gas production base in Africa rather than pursuing rapid expansion or contraction, thereby maintaining consistent supply for its global commitments.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in nearly all aspects. The ground truth states Chevron's natural gas production volumes associated with Angola LNG were 7,107 million cubic feet per day (MMcf/d) in 2022, 7,148 MMcf/d in 2023, and 7,569 MMcf/d in 2024—showing a clear upward trend. In contrast, the LLM claims Chevron’s share was 'flat at roughly 48 million cubic feet per day' across all three years, which is off by an order of magnitude and contradicts the documented growth. (2) The numbers are grossly inaccurate: 48 MMcf/d vs. over 7,100 MMcf/d represents a ~99% underestimation. Additionally, the cited documents (CVX_10k_2022.pdf p.10, etc.) likely report total company-wide or regional gas production metrics, not Angola LNG-specific volumes, indicating a misinterpretation of source data. There are no correct calculations or accurate figures. (3) The multi-hop reasoning fails completely. The question requires synthesizing production trends over three years from Angola LNG to infer strategic direction in Africa. The LLM incorrectly assumes stability and interprets it as a deliberate strategy of 'prioritizing a stable base,' while the actual increasing volumes suggest active operational enhancement or optimization, contrary to broader divestitures. The model missed the upward trajectory entirely and thus drew an invalid conclusion. (4) The contextual relevance is slightly above zero because the answer addresses Chevron, Angola LNG, natural gas, and Africa, and attempts to infer strategy—but the factual foundation is so flawed that the entire analysis collapses. Hence, correctness, quantitative, and qualitative accuracy scores are near-minimum.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 460,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's deferred compensation strategy and market-linked volatility?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, this turned into a gain of $58 million; and by 2024, the gain further increased to $91 million. This trajectory indicates a transformation from a net liability to a net benefit, suggesting either improved market conditions for the underlying assets or a strategic shift in how Cisco manages its deferred compensation obligations using these swaps.",
      "llm_answer": "Cisco’s notional exposure to total‑return swaps used to hedge deferred‑compensation costs grew from $651 million in FY 2022 to $792 million in FY 2023 and $985 million in FY 2024, while the operating impact flipped from a $92 million gain in 2022 to $58 million expense in 2023 and $91 million expense in 2024 (see the “Total return swaps‑deferred compensation” line in the 10‑K tables). This progression shows Cisco is expanding its use of total‑return swaps to economically hedge deferred‑compensation obligations, but the increasing expense reflects rising market‑linked volatility that erodes the hedging benefit.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both direction and magnitude of financial impacts. According to the ground truth, Cisco recorded a $92 million **loss** in 2022, a $58 million **gain** in 2023, and a $91 million **gain** in 2024. However, the LLM incorrectly states a $92 million **gain** in 2022, and then **expenses** (i.e., losses) of $58 million and $91 million in 2023 and 2024—exactly opposite to the correct direction. This reverses the entire financial narrative. Additionally, the LLM introduces 'notional exposure' values ($651M, $792M, $985M) that are not present in the original answer and cannot be verified from the provided ground truth, suggesting fabrication or misattribution. (2) The quantitative inaccuracies are severe: all three P&L figures are misrepresented in sign (gain vs loss), which fundamentally alters the meaning. The introduction of notional amounts, while potentially present in filings, is not part of the ground truth and distracts from the actual question about financial exposure evolution. (3) The multi-hop reasoning is flawed: the LLM concludes that 'increasing expense reflects rising market-linked volatility that erodes the hedging benefit,' but this contradicts the actual trend—recovering from a loss to substantial gains, which suggests improving market performance or effective hedging. The correct reasoning, as in the original answer, would note a shift from liability to benefit, possibly due to favorable market conditions. (4) Despite incorrect facts and reasoning, the answer is contextually relevant—it addresses Cisco, deferred compensation, total return swaps, and attempts to interpret strategy and volatility. However, due to the reversal of gains/losses and unsupported numerical claims, the correctness score is very low. Minor credit is given for addressing the general topic and structure of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 514,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Lowe's approach to supplier practices related to environmental and human rights standards evolve from 2022 to 2024, particularly in terms of policy updates, monitoring enhancements, and third-party certifications?",
      "original_answer": "From 2022 to 2024, Lowe's approach to supplier practices evolved significantly, with increasing emphasis on environmental stewardship and human rights. In 2022, Lowe's monitored suppliers through its Vendor Code of Conduct and human rights policy, which included enhanced environmental standards and a wood sourcing policy ensuring products came from well-managed, non-endangered forests. By 2023, Lowe's had updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process. In 2024, the company further strengthened its approach by implementing a more robust risk-based framework for wood sourcing, improving monitoring practices, and continuing to expand its offering of independently certified products. This progression indicates a deepening commitment to transparency, accountability, and sustainability across the supply chain.",
      "llm_answer": "In 2022, Lowe’s relied on a human‑rights policy (updated in 2021), a conflict‑minerals policy and a vendor code of conduct that set environmental standards, and it monitored suppliers through general reviews and waste‑diversion partnerships. By 2023, the company updated its wood‑sourcing policy to add country‑specific risk levels, enhanced monitoring and a forestry grievance process, and expanded its portfolio of independently certified products such as ENERGY STAR® and WaterSense®. In 2024, Lowe’s further refined the wood‑sourcing policy with a risk‑based framework, improved monitoring tools, and a new forestry grievance process, while encouraging suppliers to report emissions to CDP and increasing third‑party certifications for its products, thereby tightening its environmental and human‑rights oversight.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Correct elements: The evolution from 2022 to 2024 is accurately described with correct policy updates—2022 includes the Vendor Code of Conduct and human rights policy with environmental standards; 2023 updates include country-specific risk levels in wood sourcing, enhanced monitoring, and a forestry grievance process; 2024 refinements include a risk-based framework and improved monitoring. The mention of third-party certifications like ENERGY STAR® and WaterSense® and CDP reporting aligns with the broader sustainability push. (2) Quantitative accuracy: All years (2022, 2023, 2024) are correct and consistently referenced. No numerical values (e.g., dollar amounts, percentages) are present in either answer, so no calculation errors exist. (3) Multi-hop reasoning: The LLM correctly synthesizes information across years and policy domains (environmental standards, human rights, certifications), showing a logical progression in Lowe's supplier oversight. Minor discrepancy: The LLM mentions a 'conflict-minerals policy' and 'waste-diversion partnerships' not present in the original answer—these are plausible but not confirmed in the ground truth, slightly reducing qualitative accuracy. Also, the 'new forestry grievance process' is mentioned as introduced in 2023 in the original, but the LLM says it was introduced in 2024, which is a small factual misalignment. (4) Despite these minor issues, the answer captures the core evolution accurately, uses semantically equivalent phrasing, and fully addresses the question’s dimensions: policy updates, monitoring, and certifications. Hence, high scores across all categories with a 9 on correctness due to minor factual discrepancies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 479,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the competitive threat from wireless telecommunications companies to CMCSA's broadband and wireless services evolve from 2022 through 2024, particularly in terms of technological capabilities (e.g., 4G, 5G, fixed wireless), bundling strategies, and specific competitors named across the filings?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA intensified due to advancements in wireless technology and bundling strategies. In 2022, CMCSA noted that wireless companies were offering internet services using 4G and 5G wireless broadband, which posed a growing threat to its broadband services. By 2023, the filings specifically named major wireless competitors such as AT&T, T-Mobile, and Verizon in the U.S., and highlighted that these companies were increasingly deploying 5G fixed wireless networks as a competitive tool. In 2024, the filings emphasized that wireless companies were not only enhancing their network capabilities but also bundling DTC streaming services with wireless plans, creating a more integrated and attractive offering for consumers. This evolution shows a clear trend of increasing pressure from wireless providers leveraging both technological improvements and strategic bundling to capture market share.",
      "llm_answer": "From 2022 through 2024, CMCSA’s competitive threat from wireless carriers intensified as they expanded 5G fixed‑wireless and 4G/5G broadband capabilities and pushed bundled offerings that directly compete with CMCSA’s broadband and wireless bundles. The 2022 filing noted carriers using 4G and 5G wireless broadband and fixed‑wireless, while the 2023 and 2024 filings added 5G fixed‑wireless and highlighted bundled packages that rival CMCSA’s offerings. Across the three years, the carriers named as competitors included AT&T, Verizon, T‑Mobile, Frontier, Lumen, and other wireless providers.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of competitive threats from 2022 to 2024. It accurately captures the progression of wireless technology (4G, 5G, fixed-wireless) and the increasing use of bundling strategies by wireless carriers as a competitive threat to CMCSA. The named competitors—AT&T, Verizon, and T-Mobile—are correctly identified as key players, which matches the original answer. However, the LLM includes 'Frontier' and 'Lumen' as wireless competitors, which are primarily wireline/fiber providers and not typically categorized as major wireless telecom competitors like the others; this introduces a minor inaccuracy in entity classification. Additionally, while the original answer specifically notes in 2024 that wireless companies were bundling DTC streaming services with wireless plans (a key qualitative detail), the LLM generalizes this as 'bundled packages' without specifying the inclusion of streaming services, resulting in a slight omission in depth. There are no numerical inaccuracies (dates are correct, no faulty calculations), so quantitative accuracy is perfect. The reasoning is sound across years and reflects multi-hop synthesis across filings, though the lack of specificity on DTC bundling in 2024 slightly weakens the qualitative accuracy. Contextual relevance is strong—the response directly addresses all aspects of the question and remains focused on technological capabilities, bundling, and named competitors over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 417,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its transaction pricing strategy, use of payment processors, and revenue incentives, and what does this multi-year trend reveal about the company's control over pricing and cost management?",
      "original_answer": "From 2022 to 2024, PayPal consistently bore full margin risk when completing payment transactions, indicating a stable strategic stance on pricing control despite evolving incentives and cost structures. In 2022, PayPal emphasized its discretion in setting fees independent of costs incurred through payment processors, which were recognized as transaction expenses. In 2023, the company expanded its discussion on incentives to merchants and consumers, including discounts, rebates, and rewards, which were recognized as reductions to revenue, adding complexity to margin management. By 2024, PayPal maintained its stance on bearing full margin risk and further detailed its transaction revenues, including contractual compensation from sellers violating terms (e.g., fraud or counterfeiting), which introduced new revenue streams potentially affecting margin dynamics. Despite these evolving factors, PayPal's consistent recognition of transaction processor fees as expenses and its control over pricing decisions across all three years suggests a disciplined, centralized approach to margin risk management.",
      "llm_answer": "PayPal’s exposure to margin risk stayed essentially the same from 2022 through 2024: the company continued to set transaction fees independently of the costs it incurs from payment processors, retaining full margin risk (2022‑p.78‑82; 2023‑p.75‑79; 2024‑p.73‑77). Tiered, volume‑based pricing and incentive programs—recorded as revenue reductions—remained unchanged across the three years. This consistency shows PayPal maintains strong control over pricing and cost management, with no significant shift in its margin‑risk profile.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in stating that PayPal retained full margin risk from 2022 to 2024 and maintained control over transaction pricing independent of payment processor costs, with correct citation patterns across years. Quantitatively, there are no numbers, percentages, or dollar amounts in either the ground truth or LLM response, so quantitative accuracy is not applicable—scored as 10 by default. Contextual relevance is high, as the answer addresses the core question about margin risk evolution and pricing control. However, the LLM answer falls short in completeness and qualitative accuracy: it incorrectly claims that incentive programs 'remained unchanged' across the three years, which contradicts the ground truth indicating an expansion in 2023 with more detailed discussion of discounts, rebates, and rewards as revenue reductions. Additionally, the LLM omits the 2024 development regarding contractual compensation from sellers violating terms (e.g., fraud), which introduced new revenue streams affecting margin dynamics. These omissions represent significant qualitative gaps in multi-hop synthesis across years, particularly in capturing the evolving complexity of revenue incentives and new margin-related revenue sources. While the core theme of consistent margin risk and pricing control is correct, the answer fails to reflect the nuanced evolution described in the ground truth, warranting a 7 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 405,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from fiscal year 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuation?",
      "original_answer": "In fiscal year 2022, Costco disclosed that free-rent periods and step-rent provisions were recognized on a straight-line basis over the original lease term and any extension options that were reasonably certain to be exercised, using the incremental borrowing rate to calculate the present value of lease payments. By fiscal year 2023, the company maintained the same accounting policy but emphasized that leases with periodic rent increases based on price indices or sales volume were recognized as variable lease payments. In fiscal year 2024, Costco reiterated its consistent application of these policies while reaffirming that leases did not contain material residual value guarantees or restrictive covenants, indicating a stable and consistent approach to lease accounting across the three-year period.",
      "llm_answer": "Costco continued to treat free‑rent periods as part of the lease term, recognizing them on a straight‑line basis over the original lease term and any extension options that the Company is reasonably certain to exercise. The lease‑term assumption—defined as the non‑cancelable period plus any reasonably certain extension options—remained unchanged from FY 2022 through FY 2024. Consequently, the impact on right‑of‑use asset valuation stayed consistent: free‑rent periods reduce the lease payments and thus lower the present value of lease obligations and the associated ROU assets, with no change in policy or disclosure during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that Costco consistently recognized free-rent periods on a straight-line basis over the lease term (including reasonably certain extension options) from FY 2022 to FY 2024, with no changes in policy. The explanation of lease-term assumptions and their impact on right-of-use (ROU) asset valuation—specifically that free-rent periods reduce lease payments and thus lower the present value of obligations and ROU assets—is correct and consistent with the original answer. The only minor omission is that the LLM does not explicitly mention the 2023 clarification about variable lease payments for rent increases tied to price indices or sales volume, nor the 2024 note on absence of material residual value guarantees or restrictive covenants. However, since the question focuses on free-rent periods and their impact on lease term and ROU assets, these omissions are not central to the core inquiry. All entities (Costco, fiscal years 2022–2024, lease terms, ROU assets), reasoning, and disclosures are accurately represented. There are no numerical inaccuracies (quantitative accuracy is perfect), and the answer is highly relevant to the question. The reasoning is sound and reflects proper multi-hop synthesis across the three fiscal years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 372,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 to 2024, particularly in relation to its transaction pricing model, use of payment processors, and contract structure changes across those years?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to margin risk remained consistent in its core description — the company continued to bear full margin risk when completing payment transactions, recognizing fees on a gross basis and paying third-party processors as transaction expense. However, in 2023, PayPal added language clarifying how incentives provided to users were recognized as a reduction of revenue based on performance targets or amortized over the contractual term, which introduced more variability into its margin structure. In 2024, PayPal adopted new segment reporting disclosures under ASU 2023-07, which increased transparency around segment-level expenses, potentially affecting how margin risk is analyzed across business units. Despite these changes, the fundamental pricing model — tiered, volume-based pricing without material rights — remained unchanged, suggesting margin risk exposure was structurally stable but operationally nuanced over the three-year period.",
      "llm_answer": "From 2022 through 2024 PayPal’s margin‑risk exposure remained essentially unchanged.  The company continued to set transaction fees on a gross basis as the principal, with the fee schedule independent of the costs of payment processors, so it retained full margin risk and recorded processor costs as transaction expense.  Contracts stayed open‑ended, automatically renewing, and were priced with tiered, volume‑based discounts, with no material changes to the contract structure or processor‑use policy.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly captures the core stability of PayPal's margin risk exposure from 2022 to 2024, accurately stating that PayPal remained the principal in transactions, recognized fees on a gross basis, and bore full margin risk with processor costs recorded as transaction expenses. It correctly notes the persistence of tiered, volume-based pricing and open-ended, auto-renewing contracts, which aligns with the ground truth. However, the LLM omits two key qualitative developments: (1) the 2023 clarification on user incentives being recognized as revenue reductions or amortized, which introduced variability into margins, and (2) the 2024 adoption of ASU 2023-07, which enhanced segment-level expense disclosures and affected how margin risk could be analyzed across units. These omissions reduce completeness and nuance, particularly in reflecting operational changes that impact margin structure interpretation. While no numbers or dates are incorrect (quantitative accuracy is perfect), the failure to incorporate these multi-hop disclosures from 2023 and 2024 limits the qualitative accuracy and full contextual depth. The answer remains contextually relevant and factually sound on the core model, but lacks the evolving nuances emphasized in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 356,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy and financing costs over this period?",
      "original_answer": "Cisco consistently reported a $2,000 million outstanding balance for the 5.90% Note maturing in February 2039 across all three fiscal years (2022, 2023, and 2024), with the effective interest rate remaining constant at 6.11%. This stability in both principal and effective rate suggests that Cisco has maintained this long-term debt instrument without modification or refinancing over the three-year period, indicating a consistent approach to managing this portion of its capital structure despite broader changes in its debt portfolio.",
      "llm_answer": "Cisco’s 5.90% senior note stayed at a principal of $2.0 bn each year, and its effective interest rate remained flat at 6.11% from FY 2022 through FY 2024 (2022 long‑term debt table, 2023 long‑term debt table, 2024 long‑term debt table).  While the note’s absolute utilization did not change, its share of total debt fell from about 23.5 % in FY 2022–23 (total debt $8.5 bn) to roughly 9.9 % in FY 2024 (total debt $20.3 bn) as Cisco issued additional debt, yet the unchanged effective rate indicates a stable financing cost and a strategy of locking in a fixed‑rate, long‑term liability while diversifying its debt mix.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key figures are correct: the $2,000 million (i.e., $2.0 billion) principal is consistent across 2022–2024, and the effective interest rate is correctly stated as 6.11%. The LLM also accurately calculates the note’s declining share of total debt—23.5% in FY2022–2023 (based on $2B / $8.5B ≈ 23.5%) and 9.9% in FY2024 ($2B / $20.3B ≈ 9.9%), which is not in the original answer but is a valid inference from multi-hop data. (2) These calculations are precise and use acceptable rounding. (3) The reasoning is sound: the LLM correctly infers that while the specific note’s utilization (as a share of total debt) decreased due to new debt issuance, its fixed-rate nature and unchanged carrying value indicate a strategy of maintaining stable, long-term financing costs. This adds analytical depth beyond the original answer by contextualizing the note within Cisco’s broader debt portfolio evolution. (4) The only minor gap is that the original answer emphasizes the lack of refinancing or modification as a sign of consistency in capital structure management, which the LLM implies but does not explicitly state. However, the core facts, synthesis across years and debt totals, and interpretation are correct and relevant. Thus, the answer earns a 9 for correctness—excellent but not perfectly aligned in emphasis—while quantitative accuracy and contextual relevance are flawless.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 405,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the positioning and strategic emphasis on Lowe's private brand 'Kobalt' evolved from fiscal 2022 through fiscal 2024, based on its mention in intellectual property disclosures across those years?",
      "original_answer": "The strategic emphasis on 'Kobalt' remained consistent across the three years, with Lowe's continuing to highlight Kobalt as a key private brand within its intellectual property portfolio. In fiscal 2022, Kobalt was listed among other private brand names like 'STAINMASTER' and 'allen+roth' as part of the company's wholly-owned trademarks. In fiscal 2023 and 2024, Kobalt retained its position as one of the named private brand product lines, indicating ongoing brand importance. However, there was no explicit increase or decrease in Kobalt's prominence in disclosures, suggesting a stable strategic role rather than an expanding one.",
      "llm_answer": "Across fiscal 2022, 2023, and 2024 the intellectual‑property sections (2022 pp. 7‑11; 2023 pp. 5‑9; 2024 pp. 5‑9) all list “Kobalt” simply as a private‑brand product name alongside STAINMASTER and allen+roth. The wording and placement are unchanged, indicating that Lowe’s continues to treat Kobalt as a core private‑brand offering but no shift in strategic emphasis or repositioning is reflected in the disclosures.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that Kobalt was consistently listed as a private-brand product alongside STAINMASTER and allen+roth across fiscal years 2022, 2023, and 2024, with no change in wording or placement, indicating stable strategic positioning. (2) There are no numerical values requiring calculation, but the cited page ranges (2022 pp. 7–11; 2023 pp. 5–9; 2024 pp. 5–9) are consistent with typical disclosure locations and do not contradict the ground truth. (3) The multi-hop reasoning is sound—by comparing the disclosures across three years and noting the unchanged treatment of Kobalt, the model correctly infers no repositioning or shift in strategic emphasis. (4) The answer fully addresses the question’s focus on evolution (or lack thereof) in strategic emphasis based on IP disclosures, accurately concluding that Kobalt maintained a consistent role without expansion or reduction in prominence. All entities (Lowe's, Kobalt, STAINMASTER, allen+roth) and fiscal years are correctly identified. The response is concise, relevant, and matches the original answer in substance and implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 335,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Simon Property Group's unsecured debt obligations tied to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Simon Property Group maintained a consistent interest rate of 2.25% and a face amount of $700,000 for Unsecured Notes - 37B from 2022 through 2024, with the maturity date remaining at 01/15/32 throughout this period. This stability suggests that SPG did not alter its long-term financing structure for this specific note, potentially reflecting confidence in its debt management approach and favorable market conditions for maintaining fixed-rate obligations over the three-year horizon.",
      "llm_answer": "From 2022 through 2024, Simon’s Unsecured Notes – 37B have not changed: each year’s 10‑K lists a 2.25 % interest rate, a $700,000 face amount and a maturity of January 15, 2032. The unchanged, low‑cost, long‑dated debt shows the company’s deliberate strategy of maintaining a stable, low‑interest, long‑term financing base rather than restructuring or refinancing these obligations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the interest rate (2.25%), face amount ($700,000), and maturity date (January 15, 2032) are consistent across 2022–2024, matching the original answer. (2) Quantitative elements are precise—no calculation errors or misstatements; format variations (e.g., 'January 15, 2032' vs '01/15/32') are acceptable and convey the same date. (3) The multi-hop reasoning is sound: the model correctly synthesized data across three years and filings to identify stability in the debt terms, and logically inferred that this reflects a deliberate long-term financing strategy focused on stability and low-cost obligations. (4) The qualitative interpretation—that SPG maintained a stable financing base rather than refinancing—aligns with and expands upon the original answer’s conclusion about confidence in debt management and favorable conditions. All parts of the question (interest rate, face amount, maturity, and strategic implication) are addressed completely and accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 309,
        "total_tokens": 1557
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing business segments over time?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for its Analog business, with no involvement in Embedded Processing. This remained unchanged in 2023, where Melaka continued to support only the Analog segment. By 2024, the operational focus in Melaka remained solely on Analog, with no indication of expansion into Embedded Processing. This 3-year consistency highlights a stable, specialized role for Melaka within TXN's global operations, centered exclusively on Analog product development and manufacturing.",
      "llm_answer": "Across 2022‑24 Texas Instruments kept its Melaka, Malaysia facility as an Analog‑only manufacturing site. In the 2022 10‑K the table lists Melaka under “Analog” only (page 18 of TXN_10k_2022.pdf); the 2023 10‑K shows the same (page 16 of TXN_10k_2023.pdf); and the 2024 10‑K again lists Melaka as Analog only with no Embedded Processing activity (page 16 of TXN_10k_2024.pdf).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia facility was involved exclusively in the Analog business segment across 2022, 2023, and 2024, with no involvement in Embedded Processing—matching the original answer exactly in factual content. (2) There are no numerical values requiring calculation (e.g., dollar amounts, percentages), but the years (2022–2024) and document references (page numbers and file names) are correctly cited, supporting the accuracy of the sourcing. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from three consecutive years of 10-K filings, confirming consistency over time across the same location and business segments. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) of TXN’s operational footprint in Melaka with respect to Analog and Embedded Processing. Minor wording differences (e.g., 'Analog-only manufacturing site' vs 'exclusively for its Analog business') do not affect meaning and are semantically equivalent. All evaluation criteria are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 330,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion from 2022 through 2024, indicating a consistent long-term liability with no principal repayments or retirements over the period. This stability suggests that PYPL maintained its long-term debt structure without altering the principal amount of this specific note, even as it issued new debt and refinanced other tranches. The lack of change in this liability contrasts with PYPL's active debt management in other areas, such as the retirement of its 1.350% notes by 2023 and the introduction of new high-interest notes in 2024.",
      "llm_answer": "PayPal’s exposure to the fixed‑rate 2.850% notes remained unchanged at **$1.5 billion** from 2022 through 2024 (2022 table, page 108; 2023 table, page 106; 2024 table, page 103). The unchanged principal indicates that PayPal has not reduced or refinanced this long‑maturity, lower‑rate tranche, reflecting a strategy of maintaining a stable, diversified debt mix and locking in a fixed rate for long‑term financing while selectively managing other debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the fixed-rate 2.850% notes exposure is accurately reported as $1.5 billion for each year from 2022 to 2024, matching the original answer. The dollar amount, interest rate, and time period are all factually consistent. (2) The answer correctly cites the relevant pages across the three annual reports, reinforcing its accuracy. (3) In terms of reasoning, the LLM correctly infers that the unchanged principal reflects a strategy of maintaining a stable, diversified debt structure and locking in low fixed rates, which is consistent with the ground truth's interpretation. It also correctly contrasts this stability with active management elsewhere in the debt portfolio, though it does not explicitly mention the retirement of the 1.350% notes or the issuance of new high-interest notes in 2024—details present in the original answer. This omission slightly reduces completeness and qualitative accuracy but does not undermine the core correctness. (4) The answer is contextually relevant, directly addressing both parts of the question: the evolution (or lack thereof) in exposure and the strategic implication. Overall, the response is factually sound, well-supported, and semantically equivalent to the ground truth with only minor contextual omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 380,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility evolved across 2022, 2023, and 2024 in terms of its role in the company's global manufacturing strategy for cell therapy products?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as a principal manufacturing facility, indicating its strategic importance in its global operations. By 2023, the company explicitly stated that Hoofddorp was being utilized for the commercial manufacturing and processing of its cell therapy products, signaling a specific functional role in its production pipeline. In 2024, Gilead reiterated the same utilization of the Hoofddorp facility, maintaining its focus on commercial manufacturing and processing of cell therapy products, suggesting continuity and deepening of its strategic role in this therapeutic area. This progression indicates a consistent and growing emphasis on Hoofddorp as a dedicated hub for cell therapy manufacturing over the three-year period.",
      "llm_answer": "Gilead has kept its Hoofddorp, Netherlands plant as the core commercial hub for cell‑therapy manufacturing throughout the three reporting years.  In the 2022 10‑K, the facility is described as being used for “commercial manufacturing and processing of our cell therapy products”【GILD_10k_2022.pdf page 31】.  The same wording appears in the 2023 10‑K【GILD_10k_2023.pdf page 9】 and again in the 2024 10‑K【GILD_10k_2024.pdf page 8】, indicating no change in its role or scope within Gilead’s global cell‑therapy manufacturing strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that the Hoofddorp facility was consistently used for 'commercial manufacturing and processing of cell therapy products' across 2022, 2023, and 2024, citing the exact same wording from each year's 10-K filing. This supports the conclusion of continuity in the facility's role, which matches the original answer's claim of maintained strategic focus. The quantitative accuracy is perfect: correct years, correct citations (document names, page numbers), and consistent description of the facility’s function. There is no numerical data to calculate, but the textual consistency across years is correctly reported. The qualitative accuracy is high—the reasoning correctly infers that no change in wording implies no change in role, which is a reasonable interpretation of regulatory filings. However, the LLM slightly underrepresents the evolution described in the ground truth: while the wording may be identical, the original answer emphasizes a progression—from being identified as a principal facility in 2022 to having an explicitly stated role in cell therapy manufacturing in 2023 and 2024, suggesting growing strategic emphasis. The LLM interprets the repetition as 'no change in role or scope,' which is defensible but overlooks the possibility of increasing strategic importance even if the description remained unchanged. Thus, it misses a subtle but meaningful nuance in the evolution of the facility’s strategic positioning. Contextual relevance is excellent—the answer directly addresses the question about the evolution of the facility’s role in Gilead’s global manufacturing strategy for cell therapy products across the three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 474,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 through 2024, particularly in terms of long-term debt composition and current portion classification?",
      "original_answer": "Costco maintained a consistent principal amount of $1,250 million for the 1.375% Senior Notes due June 2027 across all three years (2022–2024). However, the classification of the current portion of long-term debt changed significantly over time: in 2022, the current portion was $73 million, by 2023 it spiked to $1,081 million, and in 2024 it dropped to $103 million. This reflects shifting debt maturity profiles and short-term obligations tied to these notes.",
      "llm_answer": "Costco’s 1.375% Senior Notes due June 2027 stayed at a carrying amount of $1,250 in each year.  The current‑portion of long‑term debt rose from $73 in 2022 and 2023 to $103 in 2024 as the company repaid its 2.750% Senior Notes due May 2024, which moved that amount into the current portion.  Accordingly, total long‑term debt fell from $6,590 in 2022 to $5,919 in 2024, while the 1.375% notes remained classified as long‑term debt and were not shifted to the current portion.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. While it correctly states the principal amount of $1,250 million for the 1.375% Senior Notes due June 2027 across years, it incorrectly claims the current portion of long-term debt rose from $73 in 2022 to $103 in 2024, skipping the critical spike to $1,081 million in 2023. The ground truth shows a dramatic increase to $1,081 million in 2023 before dropping to $103 million in 2024, which the LLM completely omits. Instead, the LLM falsely states the current portion was $73 in both 2022 and 2023, which is incorrect. (2) The LLM introduces irrelevant information about the repayment of 2.750% Senior Notes due May 2024 affecting the current portion of the 1.375% notes, which is not supported by the ground truth and misrepresents the classification dynamics. Additionally, the total long-term debt figures ($6,590 in 2022, $5,919 in 2024) are not part of the original answer and appear fabricated or misattributed, further undermining quantitative accuracy. (3) The multi-hop reasoning is flawed: the model fails to correctly track the evolving classification of the current portion over time, which is central to the question. It incorrectly implies stability in the current portion when in fact there was a major shift in 2023 due to the note approaching maturity. (4) Contextual relevance is moderate because the answer addresses the right topic (debt classification of the 1.375% notes), but the incorrect numbers, missing spike in 2023, and introduction of unrelated debt instruments severely damage factual correctness and reasoning quality. The core evolution of the current portion—rising sharply then falling—is entirely misrepresented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 467,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PayPal's (PYPL) financial obligations related to its Fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "PayPal's financial obligations related to the Fixed-rate 2.850% notes remained consistent at $1.5 billion across all three years (2022, 2023, and 2024), indicating that the company did not reduce or refinance this particular tranche of debt during the period. In 2022, the note was part of a $5.0 billion September 2019 issuance and was scheduled to mature on October 1, 2029, with an effective interest rate of 2.96%. This maturity date and carrying amount remained unchanged in 2023 and 2024, despite active debt issuance and refinancing activity in other tranches during those years. The lack of change in this obligation suggests that PayPal prioritized refinancing or issuing new debt with different maturities and rates, while maintaining its exposure to the 2.850% notes. This reflects a strategy of preserving capital structure stability in certain long-term liabilities while adapting to changing interest environments in other areas.",
      "llm_answer": "From 2022 through 2024 PayPal’s fixed‑rate 2.850 % notes stayed unchanged at a principal of $1.5 billion, due 10/1/2029, with no repayments or new issuances affecting that tranche (2022 p.106‑107; 2023 p.105‑106; 2024 p.103‑104).  The overall carrying amount of term debt rose from $8.9 billion in 2022 to $9.3 billion in 2023 and remained at $9.3 billion in 2024, reflecting other debt issuances and a $1.6 billion repurchase of earlier notes in 2022 (2022 p.110; 2023 p.109; 2024 p.106), while the 2.850 % notes were untouched.  This stability, coupled with the 2024 issuance of new higher‑rate notes ($1.3 billion), illustrates PayPal’s strategy of maintaining a steady long‑term debt profile, selectively refinancing older debt, and diversifying maturities and rates to manage interest costs and maturity risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $1.5 billion principal amount of the 2.850% notes, the October 1, 2029 maturity date, and the stability of this obligation across 2022–2024 are accurately reported. The references to specific pages in annual reports add credibility. (2) Quantitative accuracy is excellent: the $1.5B amount, $8.9B to $9.3B increase in total term debt, and $1.6B repurchase in 2022 match expectations or are consistent with disclosed activities. The mention of a $1.3B issuance in 2024, while not in the original answer, does not contradict it and may reflect additional context from filings; it is plausible and contextually appropriate. (3) Multi-hop reasoning is sound: the model correctly infers that the unchanged status of the 2.850% notes, despite other refinancing activity, indicates a strategic choice. It synthesizes data across years and debt tranches effectively. (4) The qualitative interpretation slightly expands on the original by mentioning 'diversifying maturities and rates,' which is a reasonable inference but not explicitly stated in the ground truth. However, this does not detract from accuracy—it enhances it with logical context. The core conclusion about maintaining stability in certain liabilities while managing others aligns perfectly. Only a minor deduction from 10 to 9 in correctness due to slight expansion beyond the original answer’s scope, but no factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 410,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the multi-year trend in fair value and volatility assumptions reveal about the company's risk positioning in gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas-related options decreased from $356 million (assets) and $347 million (liabilities) in 2022, to $100 million (assets) and $97 million (liabilities) in 2023, and further to $100 million (assets) and $102 million (liabilities) in 2024. The implied volatility assumptions for these options also declined from 36% in 2022 to 50% in 2023 and then to 52% in 2024, indicating a reduction in expected market volatility and potentially a strategic de-risking in gas market exposure over the three-year period.",
      "llm_answer": "NextEra’s net notional volume of gas‑related options grew from 1,290 MMBtu in 2022 to 1,452 MMBtu in 2023, then fell to 1,131 MMBtu in 2024, while the net fair value of those options moved from a modest $9 million gain in 2022 to a $3 million gain in 2023 and a $2 million loss in 2024. Across the same period, the weighted‑average implied volatility used to value gas options rose from 36 % in 2022 to 50 % in 2023 and 52 % in 2024, indicating that the company is pricing in higher gas‑market uncertainty and adopting a more conservative hedging stance even as its net exposure has slightly declined.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that NextEra Energy's fair value of gas-related options was $356M (assets) and $347M (liabilities) in 2022, decreasing to $100M/$97M in 2023 and $100M/$102M in 2024. The LLM incorrectly reports net fair value as a $9M gain in 2022, $3M gain in 2023, and $2M loss in 2024—this misrepresents both the magnitude and nature of the values (which are total fair values, not gains/losses). Additionally, the LLM introduces 'net notional volume' (e.g., 1,290 MMBtu), a metric not present in the original answer and unsupported by the ground truth. (2) The implied volatility figures (36% in 2022, 50% in 2023, 52% in 2024) are correctly reported, which is the only quantitative match. However, the interpretation of rising volatility as indicating 'higher uncertainty' contradicts the original conclusion that declining fair values suggest de-risking. (3) The multi-hop reasoning is flawed: while the question asks about evolution in exposure and what trends reveal about risk positioning, the LLM infers increased caution due to higher volatility assumptions, ignoring the primary signal—sharp decline in fair value—indicating reduced exposure. It fails to synthesize the correct implication from falling asset/liability values. (4) Scores are low due to major numerical errors and incorrect interpretation of risk positioning. Contextual relevance is moderate because the answer addresses gas-related options and volatility over the correct time frame, but uses incorrect metrics and draws opposite conclusions from the evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 443,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the financial performance of Cisco's available-for-sale (AFS) debt investments impact other income (loss), net across fiscal years 2022 through 2024, and what does this reveal about the volatility of its investment portfolio during this period?",
      "original_answer": "In fiscal 2022, Cisco disclosed the composition and value of its AFS debt investments, indicating active portfolio management. By fiscal 2023, the company reported higher losses from these AFS debt investments, which negatively impacted its other income (loss), net. This trend continued into fiscal 2024, where AFS debt investment losses again contributed to a decline in other income (loss), net, despite offsetting gains from equity and private investments. The recurring negative impact from AFS debt investments over two consecutive years reveals a trend of increasing volatility in Cisco’s investment portfolio, particularly in its debt holdings, which has affected overall financial stability in non-operational income streams.",
      "llm_answer": "Cisco’s available‑for‑sale debt investments swung from a small gain in FY 2022 to losses in the following two years: a net gain of **$9 million** in 2022, a net loss of **$21 million** in 2023, and a larger net loss of **$67 million** in 2024. These amounts drove the overall “Other income (loss), net” from a positive $392 million in 2022 to negative $248 million in 2023 and $306 million in 2024, showing that the portfolio’s performance was volatile—shifting from a modest gain to increasingly larger losses over the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numeric values—$9M gain in 2022, $21M loss in 2023, $67M loss in 2024—that are not present in the original ground truth answer. The ground truth does not provide exact figures for AFS debt investment gains/losses or 'Other income (loss), net' for any year, only qualitative trends (e.g., 'higher losses', 'decline', 'offsetting gains'). Therefore, the inclusion of precise dollar amounts is factually unsupported and likely hallucinated. (2) The claim that 'Other income (loss), net' went from $392M in 2022 to -$248M in 2023 and -$306M in 2024 is also not in the original answer and cannot be verified against the provided ground truth. These numbers may be accurate in reality, but since they are absent from the knowledge graph source, they represent a failure in fidelity to the provided truth. (3) The qualitative reasoning—linking AFS debt investment losses to declining other income and concluding increased portfolio volatility—is aligned with the original answer’s logic and addresses both parts of the question: impact on other income and implications for volatility. This shows correct multi-hop synthesis of cause-effect across years. (4) While the LLM captures the directional trend (worsening AFS performance affecting income), the fabrication of specific financial figures severely undermines factual correctness. Quantitative accuracy is low due to unsupported numbers. Qualitative accuracy is moderate because the reasoning structure is sound but based on invented data. Contextual relevance is high as the response directly addresses the question’s focus on performance impact and volatility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 453,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Lowe's Companies, Inc.'s issuance and documentation of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about the company's long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049, in its filings across 2022, 2023, and 2024, indicating a stable long-term debt structure. The Fifteenth Supplemental Indenture dated April 5, 2019, which includes the 4.550% Notes, was disclosed in all three years, showing no change in the documentation or terms of this specific note over time. This consistency suggests that Lowe's maintained a steady approach to long-term financing through this instrument without modifications or early redemptions during the observed period.",
      "llm_answer": "From 2022 through 2024, Lowe’s continued to report the 4.550% Notes that were issued under the 15th Supplemental Indenture in 2019, with no new issuance or amendment to the terms; the notes remained outstanding with a maturity of April 5, 2049 (Exhibit 4.16; LOW_10k_2022.pdf: pages 73‑77; LOW_10k_2023.pdf: pages 74‑78; LOW_10k_2024.pdf: pages 73‑77). This consistent reporting across three consecutive 10‑K filings indicates a long‑term debt strategy focused on maintaining a stable, long‑dated fixed‑rate debt load to support the company’s capital structure and financing flexibility.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the 4.550% Notes were issued under the Fifteenth Supplemental Indenture on April 5, 2019, with a maturity date of April 5, 2049, and were consistently reported in the 2022, 2023, and 2024 10-K filings. The LLM correctly notes no new issuance or amendment occurred during this period. (2) Quantitative elements—interest rate (4.550%), issuance date (2019), and maturity date (April 5, 2049)—are all precisely correct. Format variations (e.g., '15th' vs 'Fifteenth') are acceptable and do not affect accuracy. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings and correctly infers that the consistent disclosure reflects a stable long-term debt strategy. (4) The conclusion about Lowe's strategy—maintaining long-dated, fixed-rate debt for capital structure stability and financing flexibility—aligns with and expands upon the ground truth without introducing inaccuracies. The answer is complete, factually precise, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 314,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Simon Property Group's (SPG) face value and interest rate exposure on Unsecured Notes - 35B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "From 2022 to 2024, Simon Property Group maintained a consistent face value of $750,000,000 for Unsecured Notes - 35B, while the interest rate remained unchanged at 3.80%. However, the maturity date was extended from 07/15/50 in 2022 to the same date in 2024, indicating a stable long-term financing approach with no refinancing or restructuring of this particular debt instrument over the period. This suggests SPG's confidence in managing long-dated liabilities and maintaining favorable interest terms.",
      "llm_answer": "From 2022 through 2024, SPG’s Unsecured Notes – 35B stayed unchanged: the face value remained $750,000 and the coupon stayed at 3.80 % (maturity 07/15/50) in each 10‑K filing (see 2022, 2023, 2024 tables). This consistency indicates a conservative long‑term debt strategy that prioritizes stable, low‑cost financing and predictable interest expense rather than frequent refinancing or re‑issuance.",
      "correctness_score": 8,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the consistent face value, interest rate, and maturity date of SPG's Unsecured Notes - 35B across 2022–2024, and accurately infers a stable, conservative long-term debt strategy. However, there is a critical error in the face value: the LLM states '$750,000' instead of the correct '$750,000,000' as per the ground truth. This is a significant quantitative inaccuracy (off by three orders of magnitude), though the rest of the data (3.80% interest rate, 07/15/50 maturity) is correct. 2) The interest rate (3.80%) and maturity date (07/15/50) are accurately reported and consistent with the original answer. The error in face value undermines quantitative accuracy despite correct formatting in other aspects. 3) The reasoning is sound: the model correctly synthesizes data across multiple years and draws a logical conclusion about SPG’s long-term debt strategy—emphasizing stability and low-cost financing—based on the lack of change in terms. This reflects proper multi-hop reasoning across annual filings. 4) The answer is contextually fully relevant, addressing both the evolution of the debt terms and the strategic implication. Due to the major numerical error in face value, the correctness and quantitative accuracy scores are reduced, but qualitative reasoning and relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 370,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 to 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what does this multi-year trend reveal about the company's risk management strategy and operational resilience?",
      "original_answer": "In 2022, PayPal highlighted risks around bad transactions tied to credit defaults, particularly in its U.S. consumer credit product through Synchrony Bank, and emphasized concerns about fraud and synthetic identities. In 2023, the company entered a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic shift to reduce balance sheet exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize fraud and abuse risks, particularly in digital payments, while also noting legal uncertainty around the 'valid-when-made' doctrine for purchased loan receivables, which could impact U.S. credit products. The trend shows a transformation from internal risk absorption to external risk mitigation through asset sales and legal contingency planning, indicating a more proactive and diversified risk management approach over time.",
      "llm_answer": "PayPal’s 10‑K risk‑factor disclosures on pages 24‑28 (2022), 23‑27 (2023) and 21‑25 (2024) consistently flag bad‑transaction risk—fraud, erroneous payments and negative customer experiences that can raise loss rates. The 2024 filing expands credit‑product risk by stressing default exposure and reliance on third‑party lenders, and adds language about diversifying payment‑processor relationships, while cross‑border trade risk remains tied to currency, regulatory and tariff uncertainties. These changes show PayPal’s evolving risk‑management strategy—strengthening credit models, broadening third‑party resilience and investing in fraud detection—to sustain operational resilience amid growing regulatory and market pressures.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures some correct elements about PayPal's risk exposure to bad transactions across credit products, third-party dependencies, and cross-border trade, and correctly identifies the continuity of fraud and payment risk in annual disclosures. However, it misses key factual developments that define the multi-year trend in risk management strategy. Specifically: (1) It fails to mention the critical 2023 multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables—a central quantitative and strategic action to reduce balance sheet exposure—which is a major omission affecting both quantitative and qualitative accuracy. (2) It does not reference Synchrony Bank as the U.S. consumer credit partner in 2022, nor the 'valid-when-made' doctrine legal uncertainty in 2024, both of which are essential to understanding PayPal’s credit risk evolution. (3) While the LLM notes 'reliance on third-party lenders' and 'diversifying processor relationships,' it mischaracterizes third-party dependencies as operational resilience efforts rather than accurately reflecting the strategic offloading of credit risk via asset sales. (4) The answer invents page numbers (e.g., 'pages 24-28') not present in the original knowledge graph, introducing spurious precision. (5) The conclusion about 'strengthening credit models' and 'investing in fraud detection' is plausible but not supported by the ground truth, which emphasizes legal and structural risk mitigation (e.g., receivables sales, regulatory contingency) over internal model improvements. Thus, while the answer is contextually relevant and reflects a reasonable interpretation of risk themes, it lacks the specific multi-hop synthesis—particularly around the €40B BNPL sale and legal doctrine risk—that defines the actual trend. This results in a partially correct but materially incomplete assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 509,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the competitive positioning of Costco (COST) relative to BJ's Wholesale Club evolve from 2022 through 2024, particularly in terms of the company's emphasis on private-label brands like Kirkland Signature as a differentiator?",
      "original_answer": "From 2022 to 2024, Costco consistently emphasized its competition with BJ's Wholesale Club, but the depth and framing of its differentiation strategy—particularly around its private-label brand Kirkland Signature—remained stable. In 2022, Costco highlighted Kirkland Signature products as high-quality, lower-priced alternatives to national brands, contributing to higher margins and differentiation. In 2023, the company reiterated this positioning, underscoring Kirkland Signature's role in lowering costs and enhancing merchandise offerings. By 2024, the messaging remained consistent, with no significant shift in strategy, indicating a stable competitive approach to maintaining market leadership in the warehouse club segment against BJ's Wholesale Club.",
      "llm_answer": "Costco’s competitive stance against BJ’s Wholesale Club remained largely unchanged from 2022 through 2024, with the company continuing to view BJ’s as a key rival in the warehouse‑club segment and emphasizing its low‑price, high‑quality membership model (COST_10k_2022.pdf: pages 5‑9; COST_10k_2023.pdf: pages 6‑10; COST_10k_2024.pdf: pages 6‑10). Across all filings, Costco highlighted its private‑label Kirkland Signature as a core differentiator—stressing its superior quality, lower price, and higher margins, and noting plans to increase its sales penetration (COST_10k_2022.pdf: pages 5‑9; COST_10k_2023.pdf: pages 6‑10; COST_10k_2024.pdf: pages 6‑10). Thus, while the competitive relationship with BJ’s remained consistent, Costco’s emphasis on Kirkland Signature as a differentiator intensified, underscoring its strategy to strengthen its private‑label portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of entity accuracy, time frame, and core strategic messaging. It correctly identifies Costco's consistent competitive positioning against BJ's Wholesale Club from 2022 to 2024 and accurately highlights Kirkland Signature as a key differentiator across all years, citing quality, price, and margin advantages. The quantitative accuracy is perfect—no numerical claims are made that conflict with the ground truth, and no incorrect figures are introduced. The contextual relevance is strong, as the response directly addresses the evolution (or lack thereof) in competitive positioning and the role of private-label branding. However, there is a subtle but notable divergence in interpretation: the LLM states that Costco's 'emphasis on Kirkland Signature as a differentiator intensified,' which implies a strategic escalation not supported in the ground truth. The original answer explicitly notes 'no significant shift in strategy' and 'messaging remained consistent,' indicating stability rather than intensification. This overstatement affects the qualitative accuracy, as it introduces a false inference about strategic evolution, despite accurate sourcing. The multi-hop reasoning is sound—information is synthesized correctly across three years of 10-K filings—but the conclusion slightly misrepresents the degree of change. Thus, while factually grounded in the documents, the interpretation nudges beyond what the evidence supports, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 426,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did NextEra Energy's exposure to gas forward contracts evolve from 2022 through 2024, particularly in terms of fair value of assets and liabilities, and what does this 3-year progression indicate about the company's risk positioning in natural gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas forward contract assets increased from $191 million to $296 million, while liabilities rose more sharply from $31 million to $46 million. This indicates a growing but increasingly balanced exposure to natural gas markets, with a notable spike in 2023 where assets reached $377 million. The trend suggests a strategic expansion in gas market participation, accompanied by rising market risk.",
      "llm_answer": "From the Level‑3 fair‑value tables, NEE’s gas forward contracts grew from a net fair value of **$160 million** in 2022 (assets $191 m / liabilities $31 m) to **$300 million** in 2023 (assets $377 m / liabilities $77 m) and then fell to **$250 million** in 2024 (assets $296 m / liabilities $46 m).  The net position stayed positive throughout, indicating a net long stance that peaked in 2023 and was trimmed in 2024, reflecting a dynamic risk‑management strategy that expands exposure when market conditions or hedging needs rise and contracts it when volatility or pricing outlooks shift.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the direction and general trend of NextEra Energy's gas forward contract exposure from 2022 to 2024, with increasing assets and liabilities and a peak in 2023. However, there is a quantitative discrepancy in the 2023 liability figure: the LLM reports $77 million, while the ground truth states $46 million (not $77M). This leads to an incorrect net value of $300 million in 2023 (LLM) versus the correct net of $346 million (assets $377M - liabilities $31M is not in original, but original only states 2023 asset peak at $377M and 2024 liabilities at $46M). The 2024 net value of $250 million (assets $296M - liabilities $46M) is accurate. The 2022 net value of $160 million ($191M - $31M) is correctly calculated. (2) The ground truth does not provide 2023 liabilities, but it does state that liabilities rose from $31M in 2022 to $46M in 2024 — the LLM's $77M in 2023 contradicts this progression and is likely erroneous. The spike in assets to $377M in 2023 is correctly captured. (3) The multi-hop reasoning is sound: the LLM synthesizes asset and liability values across years, computes net positions, and infers a dynamic risk-management strategy, which aligns with the ground truth's interpretation of strategic expansion and rising market risk. (4) Despite the incorrect 2023 liability value, the overall trend and qualitative interpretation are accurate and relevant. The answer addresses all parts of the question — evolution of fair value, assets vs. liabilities, and risk positioning — with strong contextual relevance and logical reasoning. The correctness score is reduced due to the significant error in the 2023 liability figure, which affects quantitative accuracy, but the core narrative remains valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 481,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Lowe's use of forward interest rate swaps evolve from 2022 through 2024, and what does this progression indicate about the company's interest rate risk management strategy in response to changing market conditions?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, noting their impact on other comprehensive income and earnings over a multi-year period (2019–2021), indicating active hedging of interest rate exposure. In 2023, the company held forward interest rate swaps valued at $251 million as of February 3, 2023, classified under other current assets, showing a concrete and current financial commitment to hedging. By 2024, Lowe's no longer held forward interest rate swaps, as they were not listed among the derivative instruments as of January 31, 2025, suggesting a strategic unwind or replacement of these instruments, possibly in response to stabilized interest rates or refinancing activities. This 3-year trajectory shows a deliberate use and subsequent release of forward interest rate swaps as part of Lowe’s broader interest rate risk management strategy.",
      "llm_answer": "Lowe’s forward‑interest‑rate‑swap (FIRS) notional amount jumped from $638 million in 2021 to $2.56 billion in 2022 (Note 9, pages 60‑64) and stayed at that level through 2023 (Note 9, pages 52‑56) and 2024 (the 2024 10‑K notes that still list the $2.56 billion FIRS hedge as of February 3, 2023, pages 44‑48). This steady, high‑level hedge shows the company’s intent to lock in borrowing costs for forecasted debt issuances amid a volatile rate environment, reflecting a conservative, risk‑averse interest‑rate‑risk management strategy.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in both factual content and reasoning. According to the ground truth, Lowe's used forward interest rate swaps in 2022 and 2023 but had completely exited these positions by 2024. The LLM claims the notional amount was $2.56 billion in 2022, 2023, and still active in 2024, which directly contradicts the ground truth stating that as of January 31, 2025 (reporting on 2024), Lowe's no longer held forward interest rate swaps. Additionally, the LLM cites a $638 million notional in 2021, which is not mentioned or supported in the ground truth. (2) The quantitative inaccuracies are severe: the values ($638M, $2.56B), their persistence across years, and the continued existence in 2024 are all factually wrong. The ground truth reports a $251 million value in 2023 (not $2.56B), and zero in 2024. There is no mention of $638M in 2021 in the original answer. (3) The multi-hop reasoning is flawed: instead of showing a progression from active hedging to unwinding, the LLM portrays a sustained, increasing hedge—opposite to the actual strategy. The conclusion about a 'conservative, risk-averse strategy' is based on false premises and misrepresents the company's actual shift away from these instruments. (4) The contextual relevance is partially met because the answer discusses forward interest rate swaps and risk management, but the factual foundation is so incorrect that the analysis is invalid. Correctness, quantitative, and qualitative scores are very low due to complete factual inversion of the core data and trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 434,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the competitive positioning of CMCSA against Lumen evolve from 2022 through 2024, particularly in terms of fiber-based broadband infrastructure expansion and its implications on service offerings in overlapping markets?",
      "original_answer": "From 2022 to 2024, CMCSA consistently identified Lumen as a key competitor in the broadband space, with Lumen actively expanding its fiber-based network infrastructure. In 2022, Lumen was noted as one of the wireline telecommunications companies building fiber infrastructure to offer higher-speed data transmission services in CMCSA's service areas. By 2023, this trend continued, with Lumen further extending its fiber-based services, increasing competitive pressure through enhanced speeds and bundled offerings. In 2024, Lumen remained a prominent competitor, with its fiber infrastructure expansion continuing to overlap with CMCSA’s footprint, intensifying competition in broadband services. The consistent mention of Lumen across all three years underscores its growing influence as a fiber-based competitor, directly impacting CMCSA's market positioning and service strategies.",
      "llm_answer": "From 2022 to 2024, CMCSA’s competitive stance against Lumen shifted as the company accelerated its own fiber rollout. In 2022 CMCSA noted that Lumen was building fiber to offer higher‑speed services in many overlapping markets, while CMCSA’s fiber expansion was limited (2022 competition section, pages 7‑11). By 2024 CMCSA had deployed fiber‑to‑the‑premises with up to 10 Gbps residential and 100 Gbps business speeds, rolled out 2 Gbps downstream to half its footprint, and deployed DOCSIS 4.0, narrowing the speed gap and enabling higher‑speed bundled offerings that improved its position against Lumen in shared markets (2024 competition section, pages 6‑10; 2024 network and technology section, pages 6‑10).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core competitive dynamic between CMCSA and Lumen from 2022 to 2024, correctly identifying Lumen as a fiber-expanding competitor in overlapping markets. It appropriately notes CMCSA's response through fiber and DOCSIS 4.0 deployment, which is contextually relevant and addresses the question's focus on infrastructure expansion and service implications. However, significant quantitative and factual inaccuracies undermine correctness. The claim that CMCSA deployed '10 Gbps residential and 100 Gbps business speeds' by 2024 is not supported by the ground truth, which does not specify such speeds; this is a major fabrication. Similarly, the assertion about '2 Gbps downstream to half its footprint' and DOCSIS 4.0 deployment lacks corroboration in the original answer and introduces precise metrics absent from the source. These unsupported numbers severely impact quantitative accuracy. While the original answer confirms Lumen’s ongoing fiber expansion and competitive pressure across all three years, the LLM overemphasizes CMCSA’s technological countermeasures without grounding them in the provided truth. The reasoning is logically structured—showing evolution over time and competitive response—but relies on non-existent data points, weakening multi-hop synthesis. Entity and year references (CMCSA, Lumen, 2022–2024) are accurate, and the focus on fiber expansion and bundled offerings aligns with the original. Thus, while the qualitative narrative is partially sound and contextually relevant, the inclusion of unverified, specific performance metrics results in a partially correct but factually flawed response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 449,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did PayPal's focus on seamless checkout experiences evolve from 2022 to 2024, particularly in terms of its integration with consumer credit offerings, global currency support, and omnichannel merchant solutions?",
      "original_answer": "From 2022 to 2024, PayPal's focus on seamless checkout experiences matured significantly. In 2022, the company emphasized expanding its global capabilities and increasing customer use of its products, including creating seamless checkout experiences and supporting transactions in over 100 currencies. By 2023, PayPal had expanded currency support to approximately 150 and highlighted the importance of simplifying shopping experiences through platform enhancements and security measures. In 2024, the company deepened integration by embedding buy now, pay later (BNPL) solutions into its branded checkout experiences and offering PayPal- and Venmo-branded debit and credit cards, while also providing omnichannel merchant solutions through Zettle and unbranded payment processors like Braintree. This evolution reflects a strategic shift from global scale and usability to enhanced financial services integration and comprehensive merchant enablement.",
      "llm_answer": "PayPal’s 2022 10‑K highlighted a streamlined checkout that already integrated PayPal Credit and buy‑now‑pay‑later in a handful of markets and supported transactions in more than 200 markets and 100 currencies (pp. 8‑12). By 2023 the company embedded its buy‑now‑pay‑later products directly into the PayPal‑ and Venmo‑branded checkout, expanded credit offerings to additional regions, and kept the same broad currency coverage (pp. 8‑12). In 2024 PayPal deepened that integration, added omnichannel merchant tools such as Zettle, Braintree and PayPal Complete Payments for in‑person and online sales, and continued to support 200 markets, 100 currencies, and 56‑currency withdrawals while embedding credit at checkout (pp. 4‑8).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures PayPal's evolving focus on seamless checkout from 2022 to 2024, addressing integration with credit offerings, global currency support, and omnichannel solutions. However, there are key quantitative inaccuracies. The ground truth states PayPal supported 'over 100 currencies' in 2022 and expanded to 'approximately 150' by 2023. The LLM incorrectly claims '100 currencies' remained constant through 2023 and 2024, contradicting the expansion. Additionally, the LLM states '200 markets and 100 currencies' in all years, but the ground truth emphasizes growth in currency support, which is a significant omission. The mention of '56-currency withdrawals' in 2024 is not in the original answer and introduces unverified detail. (2) The LLM's claim of 'more than 200 markets and 100 currencies' is consistent with PayPal's general footprint, but the lack of recognition of the increase to ~150 currencies in 2023 undermines quantitative accuracy. The original answer highlights this expansion as a key evolution, so failing to reflect it is a material error. (3) The reasoning is otherwise sound: the LLM correctly traces the integration of BNPL and credit products into branded checkouts (PayPal and Venmo) from 2022 to 2024 and identifies Zettle and Braintree as part of omnichannel solutions. It also correctly notes deepening integration over time, aligning with the strategic shift described in the ground truth. (4) Despite missing the currency expansion and adding unsupported specifics (e.g., 56-currency withdrawals), the LLM answer remains contextually relevant and conveys much of the correct qualitative evolution. The core narrative of enhanced financial integration and merchant enablement is preserved, warranting a 7 for correctness. Quantitative accuracy is penalized due to incorrect currency figures and unsupported additions, while qualitative accuracy remains high due to correct entity identification and logical progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 536,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about its role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (as part of RedCards/Target Circle Cards) declined from 20.5% in 2022 to 18.6% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a diminishing role of the card in driving incremental sales, despite its continued value proposition of a 5% discount. The drop indicates a potential weakening in customer engagement with the payment loyalty program, which Target had internally linked to increased sales.",
      "llm_answer": "Target’s debit‑card penetration declined from 20.5 % in fiscal 2022 to 19.8 % in 2023 and further to 18.6 % in 2024 (RedCard/Target Circle Card penetration figures). The steady drop shows that, while the card still generates a meaningful share of incremental purchases—Target notes that a substantial portion of card‑driven sales are incremental—the card’s relative influence on sales is shrinking, likely as guests adopt more payment options or as the card’s incremental lift diminishes over time.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the penetration rate declined from 20.5% in 2022 to 18.6% in 2023 and further to 17.8% in 2024. However, the LLM states 19.8% in 2023 and 18.6% in 2024, which misrepresents both the magnitude and trajectory of the decline. The 2023 figure is off by 1.2 percentage points, and the 2024 figure is presented as the 2023 level in the truth, suggesting a slower decline than actually occurred. (2) These numerical errors affect the validity of the trend interpretation, even though the qualitative direction (declining influence) is correct. The calculation of the trend—while correctly identified as downward—is based on incorrect data points, undermining confidence in the analysis. (3) The reasoning about the card’s diminishing role in driving incremental sales is partially sound and aligns with the ground truth’s implication of weakening customer engagement. The mention of 'more payment options' or 'diminishing lift' is a reasonable inference, though not explicitly stated in the original. However, the multi-hop synthesis is flawed due to reliance on incorrect metrics across years. (4) Despite the factual inaccuracies, the answer addresses both parts of the question—evolution of penetration and its implication for sales—and uses appropriate entities (Target Debit Card, RedCard/Target Circle Card, incremental sales). Hence, contextual relevance is high, and qualitative reasoning is acceptable but not fully accurate due to incorrect data sourcing. Quantitative accuracy is low due to incorrect percentages, pulling down the overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 456,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did AMD's revenue recognition approach for development and IP licensing agreements evolve from 2022 to 2024, particularly in relation to the distinction between combined arrangements and standalone licensing deals?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition framework for development and IP licensing agreements, recognizing revenue over time for combined arrangements and at a point in time for standalone licenses. In 2022, AMD emphasized that combined development and IP arrangements were evaluated for distinct performance obligations, with non-distinct licenses combined with development services and recognized over time. By 2023 and 2024, this policy remained unchanged, with the company continuing to recognize revenue for distinct licenses at a point in time when the customer can benefit from the IP, and for non-distinct licenses over time. Despite no explicit quantitative metrics being disclosed, the consistency in policy suggests a stable approach to IP monetization across all three years.",
      "llm_answer": "AMD’s policy for development‑and‑IP licensing agreements has remained unchanged from 2022 through 2024.  In each filing the company evaluates whether the licensing component is distinct; if it is not, the development services and license are combined into a single performance obligation and revenue is recognized over time, whereas if it is distinct, revenue is recognized at a point in time when the customer can benefit from the license.  Standalone licensing arrangements are always recognized at a point in time, and no variable‑consideration estimates are applied.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately captures AMD's consistent revenue recognition approach from 2022 to 2024: distinguishing between distinct and non-distinct licensing components in combined arrangements, recognizing revenue over time when non-distinct (combined with development services), and at a point in time when distinct or in standalone licensing deals. The statement that the policy remained unchanged across the years matches the original answer’s emphasis on consistency. There are no numeric figures (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not applicable—however, the absence of incorrect numbers supports a score of 10. The only minor shortcoming is the LLM’s omission of the explicit note about 'no explicit quantitative metrics being disclosed' in the ground truth, which slightly weakens completeness but does not affect core accuracy. All entities (AMD, development and IP licensing, performance obligations, revenue recognition timing) are correctly identified and synthesized across years. The reasoning is sound, reflecting proper multi-hop understanding across 2022–2024 filings. The answer is semantically equivalent and highly relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 355,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the strategic positioning of FlyEase technology within Nike's innovation portfolio evolve from fiscal 2022 through fiscal 2024?",
      "original_answer": "In fiscal 2022, FlyEase was newly introduced as part of Nike's innovation pipeline, listed among other emerging technologies aimed at enhancing athletic performance and comfort. By fiscal 2023, FlyEase had transitioned to being consistently named alongside established technologies like Nike Air and Zoom, indicating growing strategic importance and market integration. In fiscal 2024, FlyEase was no longer highlighted as a new innovation but was instead listed among mature technologies such as Nike React and Air Max, suggesting it had become a core part of Nike’s product development framework. This progression reflects FlyEase moving from a novel concept to a foundational technology within Nike’s portfolio over the three-year period.",
      "llm_answer": "Across the 2022, 2023, and 2024 Form 10‑Ks, FlyEase is consistently listed among Nike’s core technologies in the product research and development section, underscoring its ongoing role in product innovation. The filings do not describe a shift in its strategic emphasis or a move to a more central position; rather, FlyEase remains one of several technologies that exemplify Nike’s commitment to design and performance, with no explicit change in priority or integration noted between fiscal 2022 and fiscal 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim. According to the ground truth, FlyEase underwent a clear strategic evolution from fiscal 2022 to 2024: introduced as a new innovation in 2022, elevated alongside established technologies like Air and Zoom in 2023, and classified among mature technologies such as React and Air Max in 2024. This reflects a progression from emerging to foundational status. However, the LLM asserts that FlyEase was consistently listed as a core technology with no shift in strategic emphasis—directly contradicting the documented evolution. There are no numeric values to evaluate, so quantitative accuracy is not applicable (scored 10 by default for absence of errors). Qualitative accuracy is very low because the model fails to capture the multi-hop progression across years and misrepresents the trajectory of FlyEase’s integration. Contextual relevance is moderate—it addresses FlyEase and Nike’s innovation portfolio—but fails to answer the specific question about *evolution* over time, instead asserting stasis. The answer lacks the necessary synthesis across fiscal years to reflect strategic positioning changes, resulting in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 336,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What does the trend in the principal amount of AMT's 1.250% Notes suggest about the company's debt management strategy across 2022, 2023, and 2024?",
      "original_answer": "The principal amount of AMT's 1.250% Notes decreased from $609.1 million in 2022, to $551.9 million in 2023, and further to $517.7 million in 2024, indicating a consistent reduction in outstanding debt. The interest payment terms remained consistent across all three years, with payments due in May and maturing in February 2033. This progressive decline in principal suggests a managed amortization or repurchase strategy, potentially aimed at reducing long-term debt obligations while maintaining stable interest payment schedules.",
      "llm_answer": "The 1.250% senior notes have stayed essentially the same over the three years: the 2022 and 2023 10‑Ks report an outstanding principal of 500.0 million EUR (≈ $609 million) (pages 46‑50, 109‑113), while the 2024 10‑K shows the same series outstanding at 517.7 million USD (≈ 500 million EUR) (pages 112‑116). This stability—no new issuances or significant repayments—suggests AMT is keeping a fixed long‑term debt load in this series and is focusing on predictable cash‑flow management rather than frequent debt restructuring.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth shows a decreasing principal amount: $609.1M in 2022, $551.9M in 2023, and $517.7M in 2024. However, the LLM claims the amount was stable, stating $609M in 2022 and 2023 and only dropping slightly to $517.7M in 2024, which misrepresents the trend. It incorrectly states that the 2022 and 2023 amounts were both ~$609M, missing the $551.9M figure for 2023 entirely. (2) The LLM introduces a conversion between EUR and USD (500 million EUR ≈ $609 million) not present in the ground truth and potentially misleading, as the original answer does not mention currency conversion or EUR. The 2024 figure of $517.7M is correct, but the prior years are wrong. The claim of 'stability' contradicts the actual downward trend. (3) The multi-hop reasoning is flawed: the model fails to recognize the progressive reduction across three years, which is central to the debt management strategy. Instead, it concludes there was no significant repayment, which is false given the $91.4M total reduction from 2022 to 2024. (4) Contextual relevance is moderate because the answer discusses debt management and cash flow, which are relevant, but the incorrect data leads to an invalid conclusion. The qualitative reasoning is unsound due to reliance on incorrect figures and failure to detect the trend. Overall, major factual and quantitative errors severely undermine the answer, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 410,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year trajectory reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal year 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal year 2023, this value had decreased to $851 million, indicating a reduction in the liability's fair value. In fiscal year 2024, the notes were carried at $1,000 million with an effective interest rate of 3.54%, showing a stabilization in valuation. This trajectory suggests NVIDIA's long-term debt strategy involved managing liability values through market fluctuations while maintaining consistent long-term obligations.",
      "llm_answer": "NVIDIA reported a carrying amount of **$870 million** for its 3.50% Notes Due 2040 in FY 2023, which fell to **$851 million** in FY 2024, reflecting amortization and a modest repayment (FY 2023: [65‑69]; FY 2024: [70‑74]). The 2022 filing (pages 78‑82) lists the notes as part of long‑term debt, though a specific figure is not disclosed in the excerpt. The steady decline in carrying amount, combined with the notes’ classification as unsecured senior obligations recorded at original issuance net of discount and interest paid semiannually, signals NVIDIA’s disciplined long‑term debt strategy of gradually reducing debt while maintaining a diversified, moderate‑rate portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, the fair value of NVIDIA's 3.50% Notes Due 2040 was $1,066 million in FY 2022, $851 million in FY 2023, and $1,000 million in FY 2024. However, the LLM incorrectly states the FY 2022 value as undisclosed (though it is known), reports FY 2023 as $870 million (vs. correct $851 million), and claims FY 2024 is $851 million (vs. correct $1,000 million). This represents major quantitative errors, especially the failure to report the correct FY 2022 figure and the misstatement of FY 2024 value, which contradicts the stabilization trend. (2) The calculation and trend analysis are flawed: the ground truth shows a drop from 2022 to 2023, then a rebound to $1,000M in 2024 (stabilization), but the LLM describes a continuous decline from $870M to $851M, which is factually incorrect. The mention of amortization and repayment may be plausible mechanisms, but they are applied to wrong numbers and an incorrect trajectory. (3) Multi-hop reasoning is partially present—the model attempts to synthesize data across years and interpret strategy—but fails due to incorrect data inputs. The entity identification (NVIDIA, 3.50% Notes Due 2040) and fiscal years are correct, showing proper targeting of the right instrument and time frame. (4) Despite incorrect numbers, the answer attempts to address the question’s core about valuation evolution and debt strategy, earning points for contextual relevance and reasonable interpretation framework. However, the quantitative inaccuracies severely undermine the correctness score, as financial analysis hinges on precise figures. The conclusion about a 'disciplined long-term debt strategy' is plausible but based on an incorrect declining trend rather than the actual stabilization pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 503,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Netflix's strategy around membership plans evolve from 2022 to 2024, particularly in terms of service expansions (e.g., games, ad-supported tiers, live programming) and pricing adjustments, and what were the stated risks regarding member acquisition and retention tied to these changes in each respective year?",
      "original_answer": "In 2022, Netflix introduced games as a new component of its service offering and warned that if these efforts were not valued by members, it could negatively impact member acquisition and retention. In 2023, the company expanded its membership plans by introducing a lower-priced ad-supported subscription tier and noted that such adjustments might not be well-received by consumers, potentially leading to higher churn or reduced sign-ups. By 2024, Netflix had further diversified its offerings with the inclusion of live programming and continued to emphasize the risk that changes to pricing, plans, or service features could adversely affect member satisfaction and retention. Across all three years, Netflix consistently highlighted the risk that if consumers did not perceive the evolving service offering as valuable — whether due to new features, pricing changes, or content mix — the company could face challenges in both retaining existing members and acquiring new ones.",
      "llm_answer": "Netflix’s 2022 strategy added a lower‑priced ad‑supported tier and expanded its service to include mobile games, with the 10‑K noting that “if these new features or pricing changes are not well‑received, we may not attract or retain members” (Risk Factors, 2022, pp. 5‑9). In 2023 the company continued to grow its games offering and introduced additional pricing tiers, again warning that “changes to pricing or service offerings that are not favorably received could lead to cancellations and lower growth” (Risk Factors, 2023, pp. 4‑8). By 2024 Netflix broadened its portfolio further to include live programming, more games, and an ad‑supported plan, and the 10‑K reiterated that “if consumers do not perceive the new features or pricing as valuable, we may lose members and experience higher churn” (Risk Factors, 2024, pp. 4‑8).",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several correct elements but has a critical factual error in the timeline of Netflix's strategy, which significantly impacts the correctness score. (1) The main inaccuracy is that the LLM incorrectly states that Netflix introduced the ad-supported tier in 2022, when the ground truth confirms it was launched in 2023. This misplacement of a key strategic move undermines the multi-year evolution narrative. (2) Quantitatively, there are no explicit numbers (e.g., pricing amounts, subscriber counts), so accuracy focuses on correct years and feature rollouts. The years 2022, 2023, and 2024 are correctly referenced, and the progression of features (games, ad-tier, live programming) is mostly accurate, though misaligned in timing. (3) The reasoning is partially sound: the model correctly identifies the link between new features/pricing and risks to member acquisition/retention, and it accurately reflects the consistent risk language across years. However, the multi-hop synthesis fails because it conflates the timing of the ad-supported tier launch, attributing it to 2022 instead of 2023, which breaks the chronological accuracy required by the question. (4) Contextual relevance is high—the answer addresses service expansions, pricing adjustments, and associated risks each year, using appropriate citations and maintaining focus. Despite strong phrasing and structure, the factual misalignment on a core event (ad-tier timing) reduces qualitative and overall correctness scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 414,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did UnitedHealth Group's venture investment exposure evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses, and what does this progression indicate about the company's strategic positioning in the sector?",
      "original_answer": "UnitedHealth Group's venture investment exposure, primarily within equity securities and equity method investments in healthcare businesses, showed a clear upward trend from 2022 to 2024. In 2022, the company held $3.7 billion in equity securities, which increased to $4.9 billion by 2023 and remained steady at that level in 2024. Meanwhile, equity method investments in healthcare businesses rose from $1.3 billion in 2022 to $1.4 billion in 2023, and significantly jumped to $3.8 billion in 2024. This trajectory indicates a deliberate strategic shift toward deeper engagement in healthcare innovation and operating businesses, aligning with UnitedHealth's broader focus on integrated health services and long-term sector transformation.",
      "llm_answer": "UnitedHealth Group’s equity securities holdings grew from **$3.7 billion at 12/31/2022 to $4.9 billion at 12/31/2023 and remained at $4.9 billion through 12/31/2024** (2022‑23‑24).  Equity‑method investments in healthcare operating businesses fell slightly from **$1.5 billion in 2022 to $1.4 billion in 2023, then surged to $3.8 billion in 2024**.  This shift shows the company is increasingly allocating capital to venture‑style, equity‑method stakes in healthcare firms, underscoring a strategic focus on deepening its footprint and driving innovation within the sector.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the equity securities holdings as $3.7B in 2022, $4.9B in 2023, and $4.9B in 2024, which matches the ground truth exactly. However, there is a minor error in the equity method investment value for 2022: the LLM states $1.5B, while the ground truth reports $1.3B. This discrepancy affects quantitative accuracy. The 2023 ($1.4B) and 2024 ($3.8B) values for equity method investments are correct. (2) Number verification: Equity securities — correct across all years. Equity method investments — 2022 value is off by $0.2B; otherwise, calculations and trends (e.g., slight decrease then surge) are directionally accurate. (3) Multi-hop reasoning is sound: the model correctly synthesizes data across three years and two investment types, identifies the upward trend, and infers strategic intent. The conclusion about increasing focus on equity-method stakes to deepen sector footprint aligns with the ground truth’s interpretation of strategic positioning. (4) Scores justified as follows: Correctness is 8 due to the incorrect 2022 equity method figure, though core trends and most data are accurate. Quantitative accuracy is 8 because one major number is wrong but others are precise. Qualitative accuracy is 9 — reasoning and entity identification (UnitedHealth Group, healthcare businesses, equity securities vs. equity method) are strong. Contextual relevance is 10 — the answer fully addresses the question’s scope and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 412,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Nike's financial and strategic relationship with Sojitz America evolve from fiscal years 2022 through 2024, particularly in terms of preferred stock ownership, dividend obligations, and the role of the entity in Nike’s international operations?",
      "original_answer": "Nike's relationship with Sojitz America remained consistent in terms of preferred stock ownership and dividend obligations across fiscal years 2022 to 2024. Sojitz America continued to be the sole holder of Nike's redeemable preferred stock, with a par value of $0.3 million, and the cumulative annual dividend of $0.10 per share remained unchanged throughout the period. However, in fiscal 2024, Nike explicitly highlighted Sojitz America's ongoing role in providing import-export financing services since 1972, underscoring its strategic importance in supporting Nike’s international operations amid rising global trade risks. This evolution reflects a shift from purely financial engagement (noted in 2022 and 2023) to a more operationally strategic role by 2024, particularly as Nike faced increasing trade protectionism and supply chain volatility.",
      "llm_answer": "Nike’s relationship with Sojitz America remained essentially unchanged from FY 2022 through FY 2024: Sojitz America continued to be the sole holder of Nike’s authorized redeemable preferred stock, with a cumulative dividend of $0.10 per share payable annually on May 31 and no common‑stock dividends allowed until the preferred dividend is fully paid.  The preferred‑stock terms and dividend obligations were unchanged in each filing, and Sojitz America’s role in Nike’s international operations stayed the same—providing import‑export financing services that support Nike’s global supply chain and trade‑financing needs.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of quantitative details: Sojitz America remained the sole holder of Nike’s redeemable preferred stock with a cumulative annual dividend of $0.10 per share, and the dividend payment date (May 31) and capital structure restrictions (no common dividends until preferred are paid) are correctly stated. These details align with the ground truth, earning a perfect score on quantitative accuracy. However, the LLM fails to capture a key qualitative evolution highlighted in the original answer: while the financial terms were unchanged, Nike’s characterization of Sojitz America’s role evolved from a primarily financial relationship in 2022–2023 to a strategically emphasized operational partner in 2024, particularly due to rising global trade risks and supply chain volatility. The LLM incorrectly states that 'the role... stayed the same,' which contradicts the ground truth that Nike 'explicitly highlighted' Sojitz America’s strategic importance in FY2024. This omission represents a failure in multi-hop reasoning—synthesizing changes in narrative tone and strategic emphasis across filings—even if the factual elements (ownership, dividend) are stable. The answer is contextually relevant and covers all question components, but misses the nuanced shift in strategic framing, which is central to the question about 'evolution' in the relationship. Hence, correctness and qualitative accuracy are reduced accordingly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 402,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value of its 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2023, then increased to $2,000 million in fiscal 2024. This fluctuation indicates a temporary reduction in long-term debt exposure in 2023 followed by a strategic repositioning to increase long-term liabilities in 2024.",
      "llm_answer": "NVIDIA had no 3.50% Notes due 2050 on its balance sheet in FY 2022.  The carrying amount rose to $1.637 billion at FY 2023 and fell slightly to $1.604 billion at FY 2024【NVDA_10k_2024.pdf pages 70‑74】【NVDA_10k_2023.pdf pages 65‑69】.  The modest, stable change shows that the 3.50% Notes are a small, well‑managed component of NVIDIA’s long‑term debt, reflecting a conservative and steady debt strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, NVIDIA's carrying value of the 3.50% Notes Due 2050 was $2,147 million in fiscal 2022, not $0 as claimed. The LLM incorrectly states there were no such notes in FY2022, which contradicts the ground truth. The LLM reports $1.637 billion in FY2023 and $1.604 billion in FY2024, but the correct values are $1,604 million in FY2023 and $2,000 million in FY2024. The FY2024 value is significantly underreported. (2) Quantitative accuracy is poor: all three years' values are wrong. The supposed 'slight decrease' from $1.637B to $1.604B contrasts with the actual trend of a decrease from $2,147M to $1,604M, then a substantial increase to $2,000M. The LLM misses the key fluctuation pattern entirely. (3) The multi-hop reasoning is flawed. The LLM fails to correctly synthesize data across the 2022, 2023, and 2024 filings. It draws an incorrect conclusion about a 'stable' and 'conservative' debt strategy, while the actual trend shows a significant reduction followed by a strategic increase, indicating active debt repositioning. The LLM's reasoning is based on incorrect data and thus invalid. (4) Contextual relevance is moderate because it addresses the right metric and company, and attempts to interpret the trend, but the interpretation is based on false premises. Due to severe factual and quantitative errors, the overall correctness score is low at 2.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 402,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did MetLife's dependence on global funding markets evolve from 2022 through 2024, particularly in terms of its use of short-term debt like commercial paper and its reliance on diverse funding sources to lower the cost of capital?",
      "original_answer": "From 2022 to 2024, MetLife consistently emphasized the importance of diversifying its global funding sources to reduce market dependence and lower the cost of capital. In 2022, the company highlighted its use of commercial paper programs supported by unsecured revolving credit facilities, with MetLife Funding extending loans to affiliates. In 2023, MetLife reiterated its strategy of funding flexibility through a variety of sources, including short-term debt such as commercial paper, and reaffirmed confidence in its lending counterparties. By 2024, the company maintained the same core funding structure, again emphasizing its diversified global funding sources to limit dependence on any single market. Despite no major structural changes, the consistent mention of commercial paper and credit facilities across all three years shows a stable reliance on short-term debt markets as part of a broader liquidity strategy.",
      "llm_answer": "MetLife’s short‑term debt—primarily commercial paper—fell from $175 million in 2022 to $119 million in 2023 but then surged to $465 million in 2024, indicating a shift toward greater use of commercial paper to support liquidity.  Throughout the period the company continued to rely on a broad mix of global funding sources—including preferred and common equity, long‑term debt, collateral‑financing arrangements, junior subordinated debt, policy‑holder account balances, credit and committed facilities, and a shelf registration statement—to diversify funding and keep the cost of capital low.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claims. The ground truth does not mention any specific dollar amounts for MetLife's commercial paper balances in 2022, 2023, or 2024. Therefore, the LLM's assertion that commercial paper declined from $175 million to $119 million and then surged to $465 million is unsupported and incorrect. There is no evidence in the original answer of such fluctuations, nor of any shift toward greater use of commercial paper in 2024. (2) The quantitative accuracy is very low because the LLM fabricates precise figures not present in the ground truth. The original answer discusses the continued use and strategic role of commercial paper but does not provide balances or trends in amounts. Thus, all numerical claims are hallucinated. (3) The qualitative reasoning is partially sound: the LLM correctly identifies that MetLife uses a diversified set of funding sources (e.g., equity, long-term debt, credit facilities) to lower the cost of capital, which aligns with the multi-year emphasis in the original answer. It also correctly notes the role of commercial paper as part of short-term liquidity strategy. However, it fails to accurately represent the stability of the funding structure over the period, instead implying a strategic shift based on false numerical trends. (4) Contextual relevance is moderate—the answer addresses the right topic (funding sources, commercial paper, cost of capital) and includes relevant instruments, but the inclusion of fabricated data undermines its reliability. The core message of diversification is present, but the incorrect emphasis on changing debt levels distorts the actual narrative of consistency across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 477,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did UnitedHealth Group's service level guarantees in conjunction with its notes payable to subsidiaries evolve from 2022 through 2024, and what does this reveal about the company's liquidity commitments and contractual risk exposure over time?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's notes payable to subsidiaries increased significantly, rising from $8.1 billion in 2022 to $9.9 billion in 2023, and then dropping sharply to $2.0 billion in 2024. Throughout this period, the company consistently disclosed that its service level guarantees under certain contracts were not material in any given year. However, the volatility in notes payable suggests shifting liquidity strategies or contractual obligations tied to its internal financing arrangements. Despite these fluctuations, the company maintained that the financial impact of service level guarantees did not pose a material risk to its financial statements in any of the three years. This trend indicates a stable risk profile for service level guarantees even amid changing internal debt structures.",
      "llm_answer": "Short‑term notes payable to subsidiaries fell from $8.7 B in 2022 to $9.9 B in 2023 and then to $2.0 B in 2024, while long‑term notes payable rose to $14.4 B in 2024 – a level not material in prior years; service‑level guarantees remained non‑material throughout 2022‑24 (2023 10‑K p. 76‑80; 2024 10‑K p. 78‑82; 2022 10‑K p. 79‑83). This shift from short‑term to long‑term financing reduces immediate liquidity pressure but increases long‑term debt exposure, while the stable, non‑material service‑level guarantees indicate low contractual risk exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It states short-term notes payable to subsidiaries were $8.7B in 2022, but the ground truth reports $8.1B. Additionally, the LLM claims short-term notes fell from $8.7B to $9.9B in 2023, which is logically inconsistent (a rise, not a fall), contradicting both its own wording and the actual increase from $8.1B to $9.9B. The $2.0B figure for 2024 is correct. The introduction of 'long-term notes payable rose to $14.4B in 2024' is not present in the original answer and lacks corroboration in the context provided; this is extraneous and unsupported by the ground truth, which only discusses total notes payable to subsidiaries. (2) The original answer does not break down notes into short- and long-term components, so the LLM's distinction appears to be an over-interpretation or misattribution. This affects quantitative and qualitative accuracy. (3) The reasoning about shifting from short-term to long-term financing is plausible but not supported by the ground truth, which only notes volatility in total notes payable and does not mention long-term debt changes. However, the LLM correctly identifies that service-level guarantees remained non-material throughout 2022–2024, aligning with the original answer. (4) Despite incorrect numbers and unsupported breakdowns, the LLM captures the core trend of declining internal debt in 2024 and stable contractual risk, earning moderate scores for qualitative accuracy and high for contextual relevance. The conclusion about reduced liquidity pressure and stable risk exposure is semantically aligned, though based on flawed data. Correctness is penalized due to fundamental numerical errors and unsupported claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 474,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other global networks, and the company's strategic responses to these dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with card networks has evolved from a position of strong competitive differentiation to one marked by increasing regulatory dependency and external pressure. In 2022, Amex emphasized its global position as the fourth-largest general-purpose card network behind China UnionPay, Visa, and Mastercard, competing aggressively on brand value, rewards programs, and premium customer experiences. By 2023, the company highlighted intensified competition not only from traditional card networks but also from alternative payment platforms like Alipay, PayPal, and Venmo, as well as regional payment systems such as the National Payments Corporation of India. This growing competitive landscape underscored the need for innovation and investment in digital and mobile services. In 2024, the tone shifted significantly as Amex became a Category III firm under the U.S. federal bank regulatory framework, subjecting it to heightened regulatory expectations and constraints. Regulatory scrutiny over interchange fees, network routing, and cobrand arrangements—especially in the EU—led to Amex exiting its network licensing businesses in the EU and Australia, and facing uncertainty over future regulatory interpretations. This evolution reflects a trajectory where Amex's independence and competitive edge have been increasingly shaped and constrained by regulatory forces, transforming its strategic posture from one of market-driven competition to one of regulatory navigation and compliance adaptation.",
      "llm_answer": "From 2022‑23, American Express remained the fourth‑largest general‑purpose card network, competing with Visa, Mastercard, UnionPay and a growing set of digital‑wallet and alternative‑payment platforms, and it continued to emphasize premium, high‑margin products and digital‑mobile services.  In 2024 the company’s regulatory exposure intensified—its new Category III bank‑holding status and heightened scrutiny on interchange‑fee caps, routing and merchant‑acceptance rules prompted AmEx to exit EU and Australian network‑licensing businesses, tighten its risk‑management and compliance framework, and diversify revenue through new products such as checking accounts and non‑card lending.  These moves illustrate a strategic pivot that balances maintaining a premium card‑network position with the demands of an increasingly regulated payments landscape.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of American Express's competitive positioning and regulatory dependency from 2022 to 2024. (1) All key facts are correct: Amex remained the fourth-largest general-purpose card network (after Visa, Mastercard, and China UnionPay), faced growing competition from digital wallets (e.g., PayPal, Venmo, Alipay) and regional systems, and in 2024 became a Category III firm under U.S. bank regulation—triggering heightened scrutiny. The response correctly notes Amex’s exit from network licensing in the EU and Australia due to regulatory pressure on interchange fees, routing, and merchant acceptance. Strategic responses like expanding into checking accounts and non-card lending are accurately included. (2) Quantitative accuracy is perfect: no incorrect numbers, dates (2022–2024), or financial figures are cited, and all time-bound events align with the ground truth. (3) Multi-hop reasoning is sound—LLM synthesizes competitive dynamics, regulatory changes, and strategic responses across years and jurisdictions. The only minor gap is that the original answer explicitly names the National Payments Corporation of India as a competitive pressure, which the LLM omits; however, the broader point about regional systems and digital wallets is captured. Also, the LLM slightly condenses the shift in tone and strategic posture from market-driven to regulation-driven, but the essence is preserved. (4) The answer is contextually excellent—directly addresses competitive positioning, regulatory dependency, and strategic responses across the full time horizon. Wording differs slightly but maintains semantic equivalence. No irrelevant content. A score of 9 is justified due to minor omission of NPCI, but all major facts, logic, and synthesis are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1635,
        "completion_tokens": 491,
        "total_tokens": 2126
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did ConocoPhillips' cash-settled PSU compensation strategy evolve from 2022 to 2024, particularly regarding the dividend equivalent payment structure for performance periods beginning in 2018 or later, and what does this reveal about the company's long-term incentive alignment approach?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent framework for cash-settled PSUs initiated after the 2012 downstream separation, with vesting tied to either five years or retirement eligibility. The dividend equivalent structure, however, showed a clear evolution: for performance periods before 2018, no payments were made during the performance period but began after its conclusion, while for periods starting in 2018 or later, recipients received accrued reinvested dividends paid at settlement. This shift—from deferred dividend equivalents to accrued reinvestment—suggests a strategic move toward stronger long-term alignment by deferring rewards until performance outcomes are fully realized. The consistent classification of cash-settled PSUs as liabilities on the balance sheet across all three years further underscores the company's commitment to cash-based incentive structures tied directly to stock value at settlement.",
      "llm_answer": "From 2022 through 2024, ConocoPhillips kept the same dividend‑equivalent structure for its cash‑settled PSUs: for performance periods beginning in 2018 or later, recipients receive an accrued reinvested dividend equivalent that is charged to compensation expense and paid at settlement (see COP_10k_2022 p. 134‑138, COP_10k_2023 p. 121‑125, COP_10k_2024 p. 123‑127).  The unchanged mechanism shows the company’s commitment to aligning executive pay with long‑term shareholder value by tying rewards to the company’s stock performance over a multi‑year horizon.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the dividend equivalent structure for performance periods beginning in 2018 or later, stating that recipients receive accrued reinvested dividends paid at settlement, which aligns with the ground truth. It also accurately notes the consistency of this structure from 2022 to 2024 and ties it to long-term shareholder value alignment. However, it fails to mention the key contrast with pre-2018 performance periods—where no payments were made during the performance period but began after its conclusion—which is a critical part of the evolution described in the original answer. This omission limits completeness and weakens the multi-hop synthesis. (2) All dates (2018), timeframes (2022–2024), and financial terms (accrued reinvested dividend equivalents, compensation expense, settlement) are factually correct and consistent with the ground truth. No numerical inaccuracies present. (3) The reasoning is sound in linking the dividend structure to long-term incentive alignment, but it does not fully synthesize the change over time—specifically the shift from deferred payments (pre-2018) to accrued reinvestment (2018+). This missing comparative analysis weakens the qualitative accuracy despite correct individual facts. (4) The answer is highly relevant and correctly interprets the company’s intent behind the structure, but the lack of contrast between pre- and post-2018 periods reduces the depth of insight into the strategic evolution. Hence, correctness and qualitative accuracy are penalized, while quantitative accuracy remains perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 439,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What does the evolution of NextEra Energy's Special Use Funds from 2022 to 2024 reveal about the company's liquidity positioning in relation to its derivative-related collateral obligations across this period?",
      "original_answer": "The company's Special Use Funds increased from $8,698 million in 2023 to $9,800 million in 2024, following detailed disclosures in 2022 about derivative-related collateral requirements that could reach up to $2.7 billion in the event of a credit downgrade. In 2023, collateral posting requirements in the event of a downgrade to below investment grade dropped significantly from $5.2 billion in 2022 to $2.4 billion in 2023, while actual collateral posted in cash increased to $691 million in 2023 from $84 million in 2022. This suggests the company strengthened its liquidity position through growth in Special Use Funds while simultaneously reducing its potential derivative-related collateral exposure, indicating a strategic improvement in risk management positioning.",
      "llm_answer": "NextEra Energy’s Special Use Funds grew from $7.7 billion at December 31 2022 to $9.8 billion at December 31 2024 (2024: $9,800 m; 2023: $8,698 m; 2022: $7,703 m)【NEE_10k_2024.pdf: page 62‑66】【NEE_10k_2023.pdf: page 84‑88】【NEE_10k_2022.pdf: page 86‑90】.  Even with potential derivative‑related collateral obligations that could reach $5.2 billion in 2022 and $2.4 billion in 2023 for below‑investment‑grade triggers (and up to $1.7 billion for cross‑default triggers)【NEE_10k_2024.pdf: page 62‑66】, the Special Use Funds remain well above these amounts, indicating a robust liquidity buffer that comfortably covers derivative collateral needs.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains mostly correct information but has a significant quantitative inaccuracy in the 2022 Special Use Funds value. The original answer does not mention the 2022 figure, but the LLM states it as $7.7 billion ($7,703 million), which is not present in the ground truth and introduces unsupported data. The ground truth begins with 2023 ($8,698 million) and 2024 ($9,800 million), so the inclusion of a precise 2022 number without corroboration from the original answer undermines quantitative accuracy. Additionally, the LLM claims potential collateral obligations were $5.2 billion in 2022 and $2.4 billion in 2023 — this is correct — but fails to note the key shift from $5.2B to $2.4B was due to a downgrade scenario change, which is central to the original answer’s reasoning about improved risk positioning. (2) While the LLM correctly reports the 2023 and 2024 Special Use Funds values ($8,698M and $9,800M), the unsupported 2022 figure and omission of actual cash collateral posted (rising from $84M to $691M) represent missing key data points that affect completeness. The calculation of growth over time is implied but not inaccurate. (3) The multi-hop reasoning is partially sound: the LLM connects Special Use Funds to derivative collateral obligations and concludes that liquidity is robust, which aligns with the original answer’s implication. However, it omits the critical narrative of *reducing exposure* over time and the strategic risk management improvement, instead focusing only on the buffer size. This weakens the qualitative depth. (4) Despite missing some key comparative dynamics and introducing an unverified 2022 number, the LLM answer remains contextually relevant and draws a reasonable conclusion about liquidity strength. The core facts about fund growth and collateral coverage are present, warranting a score of 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 514,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Tower's (AMT) outstanding principal and amortization trajectory for its 1.600% Notes evolve from 2022 through 2024, and what does this multi-year pattern suggest about its debt management strategy for this instrument?",
      "original_answer": "The outstanding principal for AMT's 1.600% Notes remained constant at $700.0 million across all three years (2022, 2023, and 2024). However, the adjustments to principal (likely representing amortization or accrued interest) decreased over time, from (3.7) million in 2022 to (2.6) million in 2024, indicating a gradual reduction in associated liabilities or accrued costs. This consistent principal amount with declining adjustments suggests a stable long-term debt strategy for this specific note, with predictable amortization patterns.",
      "llm_answer": "American Tower’s 1.600% senior unsecured notes have remained a fixed‑principal, non‑amortizing debt instrument through 2024.  The aggregate principal stayed at $700 million in 2022, 2023 and 2024 (see the 2022 table on pages 46‑50, the 2023 table on pages 108‑112, and the 2024 table on pages 111‑115), and the only change in the “Adjustments to Principal Amount” column was a reduction in the negative discount amortization from (2.6) in 2022/2023 to (1.5) in 2024.  This pattern indicates that AMT is treating the 1.600% Notes as a long‑term, non‑amortizing liability, relying on revolving credit facilities and refinancing rather than scheduled principal repayments to preserve liquidity and keep the debt structure stable.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. While it correctly states that the outstanding principal for AMT's 1.600% Notes remained constant at $700 million from 2022 to 2024, it misrepresents the 'Adjustments to Principal Amount' values. The ground truth reports adjustments decreasing from (3.7) million in 2022 to (2.6) million in 2024, but the LLM claims a reduction from (2.6) in 2022/2023 to (1.5) in 2024—both the starting value and the trend are incorrect. This is a critical error because the question specifically asks about the trajectory of amortization/adjustments. Additionally, the LLM refers to 'negative discount amortization' without clear support from the ground truth, which labels the adjustments more generally. On qualitative grounds, the reasoning about a long-term, non-amortizing strategy is plausible and aligns with the stable principal, but the conclusion about reliance on revolving credit and refinancing goes beyond the provided data and is not supported in the original answer. The contextual relevance is high, as the response addresses both the trajectory and strategic implication, and correctly identifies the instrument and years. However, due to the incorrect numerical values and unsupported extrapolation, the overall correctness is significantly compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 373,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these regulatory shifts across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering calculation methodologies each year. In 2022, the company noted CMS had previously reduced or frozen benchmarks and was making changes to risk adjustment calculations. In response, UNH adjusted benefits and premiums selectively and intensified cost management. In 2023, similar pressures persisted, with the company continuing to adapt by modifying benefits, exiting certain counties, and managing medical costs more aggressively. By 2024, CMS had again made changes to the risk adjustment payment methodology, prompting UNH to further refine its strategies, including more selective benefit design and intensified cost controls. The consistent theme across all three years was the company's evolving response to CMS's recalibrations of risk adjustment payments, which required ongoing adjustments to pricing, benefits, and operational efficiency to maintain profitability and competitiveness.",
      "llm_answer": "UnitedHealth Group’s exposure to Medicare Advantage risk‑adjustment payment changes stayed pronounced from 2022 through 2024 as CMS continued to freeze or cut benchmarks and alter risk‑adjustment calculations, creating uncertainty and potential funding pressures (see 2022 pages 23‑27; 2023 pages 18‑22; 2024 pages 18‑22).  In response, the company has selectively adjusted member benefits and premiums, stopped offering plans in certain counties, and intensified medical and operating cost management to offset the impact of benchmark reductions and other funding pressures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of UnitedHealth Group's exposure to Medicare Advantage risk adjustment changes from 2022 to 2024, as well as the company's strategic responses. It correctly identifies CMS's ongoing changes to benchmarks and risk-adjustment calculations as a persistent pressure across all three years. The strategic adjustments—selective benefit and premium changes, exiting certain counties, and intensified cost management—are factually correct and align with the ground truth. There are no numeric inaccuracies; while no specific dollar figures or percentages are mentioned in either answer, the qualitative descriptions match. The LLM synthesizes information across the three years appropriately, demonstrating sound multi-hop reasoning by connecting regulatory shifts to operational responses. The only minor shortcoming is that the answer does not explicitly highlight the year-by-year progression (e.g., that CMS made changes each year and UNH refined strategies annually), which slightly reduces the granularity of the evolution described. However, the consistent theme of ongoing adaptation is clearly conveyed. Wording differs but semantic equivalence is strong. All entities (UnitedHealth Group, CMS, Medicare Advantage, risk adjustment) are correct, and the context fully addresses both parts of the question: exposure evolution and strategic response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 390,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the scope and structure of merchandise discounts offered to employees evolve from 2022 through 2024, and what does this progression indicate about Target's strategy in supporting employee financial well-being?",
      "original_answer": "From 2022 to 2024, Target consistently offered merchandise and other discounts as part of its employee compensation and benefits package, but the context and broader financial well-being strategy surrounding these discounts evolved. In 2022, merchandise discounts were listed among a suite of benefits including healthcare, 401(k) plans, and tuition reimbursement, with a starting wage of at least $15 per hour. By 2023, the starting wage range had expanded to $15–$24 per hour, and merchandise discounts were mentioned alongside new additions like sick pay and tuition-free education assistance, signaling a more comprehensive approach to employee financial support. In 2024, merchandise discounts remained a consistent offering, but were now framed within a broader narrative of equitable pay and belonging, with continued emphasis on financial wellness through benefits like free virtual healthcare and expanded mental health services. This 3-year trend indicates that while merchandise discounts remained a stable benefit, Target increasingly positioned them as part of a holistic financial and well-being strategy aimed at attracting and retaining talent.",
      "llm_answer": "Target’s 10‑K filings from 2022 through 2024 all list a “merchandise and other discounts” benefit for team members, with no change in wording or scope across the three years (2022: Comp. & Benefits p.5‑8; 2023: Comp. & Benefits p.5‑9; 2024: Comp. & Benefits p.5‑9). The unchanged description indicates that Target maintains a stable, inclusive discount program as a core part of its employee‑well‑being strategy, underscoring a continued commitment to providing cost‑saving benefits to attract and retain talent. The consistent inclusion of the benefit—despite the specific discount rate not being disclosed—signals a sustained focus on supporting employees’ financial health.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in stating that Target consistently offered 'merchandise and other discounts' to employees from 2022 to 2024, with no change in the wording across 10-K filings. This aligns with the ground truth, and there are no numeric inaccuracies (quantitative accuracy is high). However, the LLM fails to capture the evolution in the broader context and structure of employee benefits that the original answer emphasizes. While the discount benefit was consistently named, the ground truth shows a strategic expansion in supporting employee financial well-being—such as increased starting wages ($15 in 2022 to $15–$24 in 2023), addition of sick pay, tuition-free education, and expanded mental health services in 2024. The LLM overlooks these multi-hop developments and incorrectly implies that the only evolution was the stability of the discount, missing the key point that Target increasingly embedded discounts within a more holistic financial and well-being strategy. Thus, while the answer is contextually relevant and factually correct on the surface, it lacks the deeper synthesis required to explain what the progression indicates about Target’s strategy. The reasoning is therefore incomplete, leading to a moderate qualitative accuracy score and a correctness score of 5 due to partial but significant omission of strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 379,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Express's investment in Foreign Government Bonds and Obligations evolve from 2022 through 2024 in terms of yield and maturity distribution, and what does this 3-year pattern suggest about the company's risk appetite and asset allocation strategy?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a weighted average yield of 1.74% for securities due within one year and 2.42% for those due after one but within five years. By 2023, the yield for bonds due within one year increased significantly to 6.45%, while those due after one but within five years had a yield of 4.48%. In 2024, the yield for bonds due within one year decreased slightly to 5.86%, and those due after one but within five years dropped sharply to 2.03%. This pattern indicates a shift in American Express's strategy from relatively stable, low-yield foreign government bonds in 2022 to more aggressive short-term investments in 2023, followed by a partial retreat in 2024 with reduced long-term exposure, suggesting a dynamic response to market conditions and interest rate changes.",
      "llm_answer": "Across 2022‑24 the weighted‑average yield on American Express’s foreign government bonds and obligations rose modestly from 2.08 % in 2022 to 2.18 % in 2023 and 2.28 % in 2024, while the maturity mix stayed heavily tilted to long‑term securities—over 60 % of the portfolio was due after 10 years each year (see the maturity tables on pages 119‑123, 133‑137, 175‑179). This gradual yield lift coupled with a persistent long‑term tilt signals a cautious risk appetite and a conservative asset‑allocation strategy that prioritizes stable, long‑term income over higher‑yield, short‑term exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. It reports a gradual increase in weighted-average yield from 2.08% in 2022 to 2.28% in 2024, which contradicts the ground truth that shows significant volatility and a bimodal pattern—specifically, a sharp rise in short-term yields in 2023 (6.45% for under one year) and a sharp drop in 2024 (2.03% for 1–5 years). The LLM also fabricates a 'weighted-average yield' not present in the original answer and misrepresents the maturity distribution as 'over 60% due after 10 years,' which is unsupported by the ground truth that only specifies holdings within one year and 1–5 years. (2) All key numbers are wrong: the original specifies $630 million in 2022, with distinct yields by maturity band, while the LLM invents aggregate yields and long-term maturity concentrations. There is no mention in the ground truth of holdings due after 10 years, nor any data supporting a 'persistent long-term tilt.' (3) The multi-hop reasoning fails: the original answer infers a dynamic risk strategy—increased short-term exposure in 2023, then retrenchment in 2024—based on yield shifts. The LLM concludes a 'cautious, conservative' strategy, which is the opposite interpretation given the actual yield volatility and short-term focus in 2023. The model fails to synthesize the correct time-series pattern or draw valid inferences. (4) Contextual relevance is moderate because the answer addresses yield, maturity, risk appetite, and asset allocation as asked, but the factual foundation is so flawed that the conclusion is invalid. The citation of non-existent 'pages 119–123, etc.' further undermines credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 463,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative-related exposure or a shift in risk management practices over the three-year period.",
      "llm_answer": "The collateral posted under master‑netting arrangements – which is recorded within the “Other assets, including intangibles – net” line – fell from **$1,494 million in 2022** to **$800 million in 2023** and further to **$491 million in 2024** (a decline of roughly 67 % over the period). This downward trend indicates that ExxonMobil has either reduced its net derivative exposure or improved its hedging and counter‑party risk management, thereby lowering the margin requirements for its derivative positions.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures—$1,494 million in 2022, $800 million in 2023, and $491 million in 2024—matching the ground truth exactly. The percentage decline mentioned (~67%) is approximately accurate: (1,494 - 491) / 1,494 ≈ 67.1%, so the calculation is sound. (2) All numeric values are correct and properly formatted; minor variations like 'million' vs 'M' are acceptable and do not affect accuracy. (3) The multi-hop reasoning is valid: the model correctly identifies the trend over three years and synthesizes the implication about derivative exposure management. It accurately infers that the decline suggests reduced net derivative exposure or improved risk management practices, which aligns with and slightly elaborates on the ground truth without introducing error. (4) The answer addresses both parts of the question: the quantitative change over time and the interpretive aspect regarding risk management. Wording differs slightly but maintains semantic equivalence. All entities—ExxonMobil (XOM), the financial metric, and the time frame—are correctly identified. Therefore, all scores are perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 327,
        "total_tokens": 1572
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AMT's issuance and interest rate terms for the 2.700% Notes evolve from 2022 through 2024, and what does this reveal about the company's financing strategy and market conditions over this period?",
      "original_answer": "In 2022, AMT disclosed the 2.700% Notes with an aggregate principal amount of $700.0 million, issued on March 29, 2021, maturing on April 15, 2031, and a par call date of January 15, 2031. In 2023, the 2.700% Notes were listed with an aggregate principal of $700.0 million, with interest payments due in April and October, and a maturity date of January 15, 2031. By 2024, the 2.700% Notes retained the same $700.0 million principal, with interest payments still scheduled in April and October, and a maturity date unchanged at January 15, 2031, though the interest rate spread had decreased from (5.0) to (4.4). This indicates a consistent long-term financing strategy with stable principal and maturity, but a slight reduction in borrowing costs by 2024.",
      "llm_answer": "AMT issued its 2.700% senior unsecured notes in March 2021 at a fixed 2.700% coupon, maturing April 15 2031, and used the proceeds to repay debt under the 2021 Multicurrency Credit Facility【On March 29, 2021, we completed a registered public offering of $700.0 million aggregate principal amount of 1.600% senior unsecured notes due 2026 (the “1.600% Notes”) and $700.0 million aggregate principal amount of 2.700% senior unsecured notes due 2031 (the “2.700% Notes”). The net proceeds from this offering were approximately $1,386.3 million, after deducting commissions and estimated expenses. We used all of the net proceeds to repay existing indebtedness under the 2021 Multicurrency Credit Facility】. The notes have remained unchanged through 2024, with the same principal, coupon, and maturity reflected in the 2023 and 2024 tables【2.700% Notes | 700.0 | (5.0) | (5.6) | April 15 | and October 15 | March 29, 2021 | January 15 | 2031】【2.700% Notes | 700.0 | (5.0) | (5.6) | April 15 | and October 15 | March 29, 2021 | January 15 | 2031】. This stability reflects a strategy of locking in low fixed‑rate debt early and preserving it while issuing higher‑rate notes later as market rates rose, indicating a conservative, rate‑hedging approach amid tightening credit conditions.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that the 2.700% Notes mature on April 15, 2031, while the ground truth consistently reports a maturity date of January 15, 2031 from 2023 onward. This contradicts the original answer and is a critical error in date accuracy. Second, the LLM claims the notes were issued on March 29, 2021 — which is correct — but fails to note that by 2023 and 2024, the maturity date was updated to January 15, 2031, indicating a possible amendment not acknowledged in the response. Third, the LLM states the interest rate spread remained at (5.0) in both 2023 and 2024, but the ground truth indicates the spread decreased from (5.0) to (4.4) by 2024, which the model completely misses. (2) Quantitative accuracy is partially correct: the $700.0 million principal is accurate, and the issuance date (March 29, 2021) is correct. However, the maturity date is wrong (April 15 vs January 15), and the interest rate spread change is omitted. Interest payment dates (April and October) are correctly noted, though the LLM adds '15' (October 15), which is not in the ground truth and may be an overinference. (3) Multi-hop reasoning is partially sound — the model correctly infers that stable terms suggest a strategy of locking in low rates. However, it fails to recognize the subtle evolution in terms (maturity date shift and spread reduction), leading to an incomplete and slightly misleading conclusion about 'unchanged' terms. The claim that AMT issued 'higher-rate notes later' is unsupported by the provided data and introduces external assumptions. (4) Contextual relevance is high — the answer addresses the evolution of terms and attempts to interpret financing strategy. However, due to key factual errors in dates and spreads, and omission of the reduction in borrowing cost, the overall correctness score is limited to 5. The model captures the stable principal but misses critical updates in maturity and spread, undermining the accuracy of its strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 554,
        "total_tokens": 2077
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did NVIDIA's financial obligations related to the 2.00% Notes Due 2031 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "In 2022, NVIDIA reported a fair value of $1.2 billion for the 2.00% Notes Due 2031. By 2023, this amount slightly increased to $1.044 billion at the beginning of the year, and then remained stable at $1.057 billion by the end of the year. In 2024, the carrying value of the 2.00% Notes Due 2031 was $1.25 billion, with no short-term portion, indicating a consistent long-term debt position. This shows a relatively stable approach to this particular long-term liability, suggesting strategic consistency in managing this component of its capital structure.",
      "llm_answer": "NVIDIA’s 2.00% Notes due 2031 were $1,044 million at year‑end 2022 (as disclosed in the 2022 filing, pages 78‑82), remained unchanged at $1,044 million in 2023 (pages 65‑69), and rose modestly to $1,057 million in 2024 (pages 70‑74). This slight uptick reflects a deliberate, incremental expansion of low‑coupon, long‑dated debt, underscoring the company’s strategy of using stable, long‑term financing to fund growth while keeping leverage manageable.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values and timeline. According to the ground truth, in 2022, the fair value was $1.2 billion, not $1.044 billion as stated in the LLM answer. The LLM incorrectly reports $1.044 billion as the year-end 2022 value (citing 2022 filing), but the ground truth indicates that $1.044 billion was the beginning-of-year 2023 value. The 2024 value is reported as $1.057 billion in the LLM answer, but the ground truth states the 2024 carrying value was $1.25 billion (with no short-term portion), which is materially different. Only the 2023 end-of-year value of $1.057 billion matches the ground truth. (2) The quantitative inaccuracies are severe: the 2022 and 2024 figures are wrong by hundreds of millions of dollars, and the progression is misrepresented (LLM shows $1,044M → $1,044M → $1,057M; correct is $1,200M → $1,044M/$1,057M → $1,250M). These are not formatting differences but factual errors. (3) The multi-hop reasoning is partially sound in that the LLM attempts to track the note across years and infer a debt strategy, but due to incorrect data, the conclusion about 'incremental expansion' is based on flawed premises. The ground truth shows a U-shaped pattern (down then up), not a steady increase. (4) Contextual relevance is fair—the answer addresses the right instrument and time frame and attempts strategic interpretation. However, due to major numerical errors and misrepresentation of the trend, the correctness score is low. The qualitative reasoning would score higher if based on accurate data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 439,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and what does this trend indicate about the company's reinsurance strategy?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a clear upward trend in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets on reinsurance were $1.8 billion, increasing to $5.1 billion by the end of 2024. Similarly, deposit liabilities rose from $1.4 billion in 2022 to $1.3 billion in 2023, and then to $1.2 billion in 2024, indicating a slight decline in liabilities in the final year. This increase in deposit assets suggests that MetLife engaged in more reinsurance agreements that did not expose the company to a significant loss from insurance risk, particularly in 2023 with the Global Atlantic transaction involving $10.3 billion in reinsurance recoverables. The trend reflects a strategic shift toward managing risk exposure through reinsurance structures that align with the deposit method, while maintaining a relatively stable liability position despite the increased asset transfers.",
      "llm_answer": "MetLife’s deposit‑method reinsurance balances have trended downward: deposit assets fell from $5.1 billion at 12/31/2023 to $4.6 billion at 12/31/2024, and deposit liabilities declined from $1.3 billion to $1.2 billion over the same period【2024‑pages‑204‑208】.  While the 2022 figures are not shown here, the pattern indicates a modest reduction in the volume of reinsurance contracts that qualify for the deposit method, suggesting a gradual shift toward other reinsurance structures or a tightening of the company’s reinsurance mix.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both direction and magnitude of the trend. The ground truth states that deposit assets increased from $1.8B in 2022 to $5.1B in 2024, showing a clear upward trend. However, the LLM claims assets fell from $5.1B in 2023 to $4.6B in 2024, which contradicts the truth (no 2022 data provided in LLM answer). Deposit liabilities in the ground truth decreased slightly from $1.4B (2022) to $1.3B (2023) to $1.2B (2024), which the LLM partially gets right for 2023–2024 but omits the 2022 baseline. (2) The LLM incorrectly reports 2023 deposit assets as $5.1B and 2024 as $4.6B; however, the ground truth reports $5.1B as the 2024 figure (not 2023), and does not mention a drop. The cited Global Atlantic transaction involving $10.3B in recoverables is missing entirely from the LLM response, a key driver of the increase. (3) The multi-hop reasoning is flawed: the LLM infers a 'downward trend' and concludes a strategic reduction in deposit-method contracts, which is the opposite of the truth—MetLife expanded such agreements, especially in 2023. The LLM fails to connect the asset growth to strategic risk management via reinsurance structures. (4) The contextual relevance is moderate because it discusses the right topic (deposit method accounting) and mentions liabilities correctly for 2023–2024, but misses the core trend and strategic implication. Due to major factual errors in numbers, timeline, trend direction, and reasoning, the correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 417,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did UnitedHealth Group's (UNH) investment in Debt Securities - Held-to-Maturity evolve from 2022 to 2024 in terms of fair value and carrying value, and what does this 3-year progression suggest about the company's investment strategy and market valuation adjustments?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's Debt Securities - Held-to-Maturity showed a consistent decline in both fair value and carrying value: in 2022, fair value was $679 million and carrying value was $696 million; in 2023, these figures were $596 million and $603 million; and in 2024, they dropped further to $508 million and $512 million. This downward trend indicates a strategic reduction or repositioning of the portfolio, possibly in response to market conditions or internal capital reallocation decisions.",
      "llm_answer": "UnitedHealth’s held‑to‑maturity debt portfolio fell from a fair value of **$679 million** and carrying value of **$696 million** in 2022 to **$596 million** and **$603 million** in 2023, and further to **$508 million** and **$512 million** in 2024. The downward trend reflects a gradual contraction of the portfolio (through maturities or sales) and a consistent decline in market valuation driven by rising rates, while carrying values remain only slightly above fair values, indicating the company views the unrealized losses as temporary and maintains a conservative, low‑risk fixed‑income strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) All numeric values for fair value and carrying value across 2022, 2023, and 2024 are correct and match the ground truth exactly: $679M/$696M (2022), $596M/$603M (2023), $508M/$512M (2024). There are no calculation or formatting errors. (2) The LLM answer fully addresses the question by detailing the 3-year evolution in both fair and carrying values, and provides a synthesized interpretation of the trend. (3) The multi-hop reasoning is sound—correctly identifying the downward trajectory across years and linking it to potential strategic or market-driven factors. The LLM adds context not explicitly in the ground truth—such as rising interest rates and the implication of temporary unrealized losses—but this is reasonable and consistent with the data (carrying values slightly above fair values suggest minimal impairment). (4) While the original answer attributes the decline to 'strategic reduction or repositioning,' the LLM expands with plausible market-aware reasoning (rising rates) and commentary on conservative strategy, which enhances qualitative insight without contradicting facts. This slight elaboration is acceptable under semantic equivalence. No entity errors: UnitedHealth Group (UNH), debt securities, held-to-maturity, and years are all correctly referenced. Minor deduction in qualitative accuracy only because the original does not explicitly mention 'rising rates' or 'unrealized losses,' so part of the explanation is inferred beyond the provided knowledge graph. However, this does not compromise correctness. Overall, the answer is factually precise, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 448,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's credit card strategy in driving incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual reduction in the proportion of purchases made using the credit card, which may indicate weakening engagement or shifting consumer preferences despite Target's continued emphasis on card-linked discounts and loyalty benefits. However, Target's internal analysis still indicates that a meaningful portion of incremental purchases on the card contribute to incremental sales, suggesting some ongoing strategic value.",
      "llm_answer": "Target’s credit‑card penetration dropped from 20.5 % of purchases in 2022 to 19.8 % in 2023 and further to 18.6 % in 2024. The downward trend indicates the card program is losing share of sales, suggesting its effectiveness at generating incremental purchases is weakening.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%), matching the ground truth exactly. All numeric values and time periods are accurate, satisfying quantitative accuracy. 2) The calculation of the downward trend is logically sound and correctly inferred from the data. 3) The answer addresses the first part of the question (evolution of penetration rate) fully, but partially misses the second part regarding what the trend suggests about the effectiveness of Target's credit card strategy. While it correctly infers weakening effectiveness, it omits the key nuance from the original answer that Target's internal analysis still shows the card drives incremental sales and retains strategic value despite the decline. This missing context weakens the qualitative accuracy. 4) The entities (Target Credit Card, years, penetration rate) are correctly identified, and the reasoning across time points is valid. The answer is highly relevant and synthesizes the trend correctly, but lacks the complete strategic interpretation present in the ground truth. Thus, while factually correct on numbers and surface-level interpretation, it falls short on full completeness and depth of insight.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 346,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Nike's ownership and operational footprint in Laakdal, Belgium evolve from fiscal years 2022 through 2024, and what does this indicate about its strategic focus in European logistics infrastructure?",
      "original_answer": "Nike maintained ownership of its significant distribution facility in Laakdal, Belgium throughout fiscal years 2022 to 2024. In 2022, the facility was described as one of the most significant international distribution centers. This characterization remained consistent in 2023 and 2024, with no changes noted in ownership status or operational role. The consistency suggests a stable strategic focus on maintaining direct control over key logistics nodes in Europe.",
      "llm_answer": "Nike owned its Laakdal, Belgium distribution center in fiscal 2022 and still owned it in fiscal 2024, with no change in the facility’s operational footprint. The consistent ownership of this key European hub underscores Nike’s strategy of retaining control over critical logistics infrastructure to maintain supply‑chain efficiency and resilience across its European, Middle‑East and Africa operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) It accurately states that Nike owned the Laakdal facility in both fiscal 2022 and 2024, with no change in operational footprint—consistent with the original answer noting stable ownership and role across 2022–2024. (2) There are no numeric values requiring calculation (e.g., dates, dollar amounts), so quantitative accuracy is fully satisfied. (3) The multi-hop reasoning is sound: the model correctly infers from consistent ownership and description of the facility as 'significant' that Nike maintains strategic control over key European logistics nodes. The slight expansion to 'Europe, Middle East and Africa operations' is a reasonable contextual inference from Nike’s regional reporting segments and does not contradict the ground truth. (4) The answer is semantically equivalent to the original, capturing the core message of strategic stability in logistics infrastructure. The only minor limitation is that it omits the explicit mention of 2023 continuity, though the phrasing 'still owned it in fiscal 2024' implies no change throughout the period. This does not detract significantly from accuracy. All scores reflect high fidelity to the ground truth, with a 9 in correctness due to this slight omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 360,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the competitive positioning of Lumentum Holdings in NVIDIA’s disclosed competitor landscape evolved from fiscal years 2022 through 2024, particularly in relation to NVIDIA’s expanding supply chain and IP protection strategies?",
      "original_answer": "Lumentum Holdings remained consistently positioned as a competitor to NVIDIA across fiscal years 2022, 2023, and 2024, specifically in the domain of networking products such as optical modules and interconnect solutions. In 2022, NVIDIA highlighted its competitive environment, listing Lumentum Holdings among suppliers of interconnect, switch, and cable solutions. By 2023, NVIDIA reiterated this competitive relationship, placing Lumentum in the broader context of increased competition from companies offering semiconductor-based high-performance interconnect products. In 2024, NVIDIA again named Lumentum Holdings Inc. as a competitor, while emphasizing its own strategic moves to strengthen supply chain resilience and expand IP protection. The consistent mention of Lumentum across three years indicates that it remains a persistent competitive force, even as NVIDIA enhances its manufacturing partnerships (e.g., with TSMC, Samsung) and extends its patent portfolio (with expiration dates moving from 2022 to 2045 across the years). This suggests that despite NVIDIA’s strategic supply chain and IP advancements, Lumentum has maintained its relevance in the competitive landscape.",
      "llm_answer": "From FY 2022 through FY 2024, NVIDIA’s 10‑K filings consistently list Lumentum Holdings as a competitor in the interconnect, switch, and cable solutions segment (FY 2022 pages 13‑17; FY 2023 pages 7‑11; FY 2024 pages 7‑11), with no change in its categorization or prominence. In FY 2024, NVIDIA highlighted an expansion of supplier relationships to build supply‑chain redundancy and resilience (FY 2024 pages 7‑11), while its IP protection strategy—reliant on patents, trademarks, trade secrets, NDAs, and licensing—remained largely unchanged across the three years (FY 2024 pages 7‑11). These supply‑chain and IP measures reinforce NVIDIA’s competitive advantage, potentially constraining Lumentum’s relative influence in the same market segment.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and aligns well with the ground truth. It correctly identifies that Lumentum Holdings was consistently listed as a competitor by NVIDIA across FY 2022–2024 in the domain of interconnect, switch, and cable solutions, and accurately references the continuity in categorization. The citation of page numbers (e.g., FY 2024 pages 7–11) supports contextual accuracy, though exact page numbers are not part of the ground truth and are assumed to be plausible. The LLM correctly notes NVIDIA’s supply chain resilience efforts in FY 2024 and accurately describes the consistency of IP protection strategies (patents, trade secrets, NDAs), though it states the strategy 'remained largely unchanged'—a point where nuance diverges slightly from the ground truth, which emphasizes the *expansion* of the patent portfolio (with expiration dates extending to 2045). This omission of patent portfolio growth is a minor but notable gap in qualitative accuracy. The LLM infers that NVIDIA’s strategies may constrain Lumentum’s influence, which is a reasonable interpretation but not explicitly stated in the ground truth; the original emphasizes Lumentum’s *persistent relevance* despite NVIDIA’s advancements. Thus, while the reasoning is sound, the emphasis shifts slightly from 'continued competitive significance' to 'potential constraint,' altering the implication. Quantitatively, no numbers are misstated, and fiscal years are correct. Contextually, all parts of the question are addressed with high relevance. Multi-hop synthesis across years and strategic domains (supply chain, IP, competition) is logically structured and supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 457,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Netflix's reliance on rights holders for content licensing evolved from 2022 through 2024, and what does this reveal about the company's content acquisition strategy amid rising competition and regulatory changes?",
      "original_answer": "From 2022 to 2024, Netflix's reliance on rights holders for content licensing has remained a core risk factor but has been increasingly framed in the context of rising competition and regulatory pressures. In 2022, the company emphasized the risk of content unavailability due to rights holders withdrawing content or increasing licensing costs, especially as studios launched their own streaming services. By 2023, the discussion remained consistent, with a focus on the variability of license terms and the importance of maintaining a compelling mix of content to support membership growth. In 2024, the narrative evolved to include regulatory impacts—such as content quotas and investment obligations in various countries—as additional constraints on content availability and ownership rights. This progression indicates a strategic shift toward securing exclusive and original content while navigating a more regulated and competitive global environment.",
      "llm_answer": "Netflix’s 2022 10‑K warned that “if studios, content providers or other rights holders refuse to license streaming content … our business could be adversely affected” (pp. 9‑13), underscoring a heavy reliance on third‑party licensing. By 2024 the filings still list licensing as essential but shift the narrative toward securing exclusive, longer‑term rights and expanding original production to reduce that dependency, while noting new regulatory pressures such as content quotas and levies (pp. 2‑6). This evolution signals a dual strategy: maintaining a broad licensed library for breadth, but increasingly investing in proprietary content to guard against rising competition and tightening regulatory constraints.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Netflix's reliance on rights holders is consistently highlighted from 2022 to 2024, with evolving emphasis on competition and regulation. The 2022 risk of studios withholding content due to their own streaming platforms is correctly noted, as is the 2024 inclusion of regulatory pressures like content quotas and levies. (2) There are no numerical inaccuracies—while no specific dollar amounts or percentages are mentioned, the qualitative timeline (2022 to 2024) and progression of risk factors are correctly represented. Page references (e.g., pp. 9–13, pp. 2–6) are plausible and consistent with typical 10-K structures, though not verifiable without source documents; they do not affect factual correctness. (3) Multi-hop reasoning is sound: the answer synthesizes information across three years, identifies the shift in narrative, and correctly infers a strategic pivot toward original content and exclusive licensing as a response to external pressures. (4) The LLM captures the core strategic implication—the dual approach of maintaining licensed content while reducing dependency via originals—mirroring the ground truth’s conclusion. The only minor shortcoming is a slightly less detailed mention of 'variability of license terms' in 2023 compared to the original answer, but the overall trajectory and strategic interpretation remain intact. Wording differs but semantic equivalence is strong. Thus, the answer is factually correct, contextually relevant, and well-reasoned, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 468,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Southern Company's treatment and disclosure of scheduled lease payments under outdoor lighting contracts evolve from 2022 to 2024, particularly in terms of materiality, revenue classification, and presentation within maturity analyses?",
      "original_answer": "In 2022, Southern Company disclosed that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial. By 2023, the company began including scheduled lease payments from outdoor lighting contracts in the maturity analyses alongside tolling arrangements and PPAs, signaling a shift toward more structured reporting. In 2024, the disclosure expanded further, with Southern Company explicitly stating that scheduled payments under outdoor lighting contracts’ initial terms were included in maturity analyses, reflecting a consistent and more transparent treatment of these contracts over time. This progression shows an increasing emphasis on formalizing the visibility of outdoor lighting lease obligations and payments within financial reporting.",
      "llm_answer": "From 2022 to 2024, Southern Company continued to report scheduled lease payments under outdoor‑lighting contracts in its operating‑lease maturity analysis, but in 2023 and 2024 it explicitly stated that the undiscounted cash flows from these contracts were immaterial—a detail not highlighted in 2022【268‑272】. Revenue classification remained unchanged, with lease income from outdoor‑lighting contracts recorded as operating‑lease income and variable lease income in all three years【238‑242】【230‑234】. The maturity‑analysis tables consistently grouped these payments under operating‑lease obligations, showing year‑by‑year amounts and a present‑value discount【268‑272】【238‑242】【230‑234】.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in its characterization of Southern Company's disclosure evolution, particularly regarding materiality and presentation changes over time. (1) The Original Answer states that in 2022, the undiscounted cash flows were considered immaterial, but the LLM incorrectly claims that payments were reported in the maturity analysis in 2022—this contradicts the ground truth, which says no such inclusion occurred until 2023. The LLM also wrongly asserts that the immateriality disclaimer was *added* in 2023 and 2024, when the ground truth implies it was present or assumed in 2022 and possibly downplayed later. (2) There are no numeric values (e.g., dollar amounts) in either answer, so quantitative accuracy is not heavily penalized, but the timeline (2022 vs 2023) is a critical date error affecting correctness. (3) The multi-hop reasoning is flawed: the LLM fails to recognize the progression from immaterial/undisclosed (2022) to inclusion in maturity analyses (2023) to explicit inclusion of initial terms (2024). Instead, it assumes consistent reporting throughout, which contradicts the core evolution described in the ground truth. (4) While the LLM correctly notes that revenue classification remained unchanged (operating lease income), and that disclosures appeared in maturity tables, it misrepresents the key narrative of increasing transparency and formalization. The contextual relevance is high because it addresses the right topic areas (materiality, classification, presentation), but the factual backbone is partially incorrect, warranting a moderate score of 4 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 450,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AVGO's outstanding principal balance for the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, decreased to $606 million in fiscal year 2023, and remained unchanged at $606 million in fiscal year 2024. This indicates a deliberate debt reduction strategy in 2023, with no further repayments in 2024, suggesting either capital allocation priorities shifted or a strategic decision to maintain this liability level.",
      "llm_answer": "The 5.000% senior notes due April 2030 have had a constant outstanding principal balance of **$606 million** in FY 2022, FY 2023, and FY 2024 (see the April 2020 Senior Notes table in each 10‑K). This unchanged balance shows that AVGO has neither issued additional principal nor repaid any of this instrument, reflecting a deliberate strategy to keep a stable, predictable debt load and preserve liquidity while managing interest costs.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its key quantitative claim. According to the ground truth, the outstanding principal balance was $1,086 million in FY 2022, decreased to $606 million in FY 2023, and remained at $606 million in FY 2024. The LLM incorrectly states that the balance was $606 million in all three years, missing the reduction from $1,086M to $606M in 2023. This error fundamentally misrepresents the evolution of the debt. (2) The quantitative inaccuracies are severe: the LLM fails to report the correct 2022 balance and the $480 million reduction in 2023, which is central to the debt management narrative. The only correct number is the 2023 and 2024 balance of $606 million. (3) The multi-hop reasoning is flawed because the model fails to synthesize the correct data across the three fiscal years. Instead of identifying a deliberate debt reduction in 2023, it concludes there was a strategy to maintain a stable balance, which contradicts the actual repayment event. (4) The contextual relevance is moderate because the answer addresses the right instrument and discusses debt strategy, but the incorrect data leads to an invalid conclusion. The qualitative reasoning would be acceptable if the numbers were correct, but as is, it reflects a failure in core factual synthesis. Correctness and quantitative accuracy are low due to the critical error in the principal balance for 2022 and the missed repayment event.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 402,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic asset mix adjustments in response to market conditions?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on U.S. pension plan assets of 5.4%, which remained unchanged at 6.3% in 2023, and then increased to 6.5% in 2024. This trajectory shows a 1.1 percentage point increase over two years, indicating a more optimistic outlook in asset performance and a potential shift toward higher-risk, higher-return investment strategies as part of the company's evolving strategic asset mix.",
      "llm_answer": "General Motors’ weighted‑average long‑term rate of return on U.S. pension plan assets was 6.3 % in 2022 (unchanged from 2023), rose to 6.30 % in 2023, and fell slightly to 6.27 % in 2024【GM_10k_2023.pdf】【GM_10k_2024.pdf】. This three‑year trend shows that GM increased its expected return assumptions in 2022‑23 to support a more aggressive asset mix (higher equity and alternative‑asset allocations) and then modestly reduced the assumption in 2024, reflecting a cautious rebalancing toward more conservative assets to dampen funded‑status volatility amid market uncertainty.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported rates of return. According to the ground truth, the rate was 5.4% in 2022, 6.3% in 2023, and 6.5% in 2024. The LLM incorrectly states it was 6.3% in 2022 (wrong), unchanged at 6.30% in 2023 (partially correct), and then falsely claims it fell to 6.27% in 2024 (incorrect—actual was 6.5%). These errors misrepresent the entire trend. (2) The calculation of the trend is therefore flawed: the actual increase is 1.1 percentage points (from 5.4% to 6.5%), but the LLM implies a negligible change or even a decline, which contradicts the truth. (3) The multi-hop reasoning is unsound—the LLM infers a cautious rebalancing toward conservative assets in 2024 due to a supposed drop in expected returns, but the actual data shows an increase to 6.5%, indicating a more optimistic, not cautious, stance. Thus, the conclusion about strategic asset mix is the opposite of what the data supports. (4) While the answer addresses the question's structure and attempts to interpret market-responsive strategy, the severe numerical inaccuracies and resulting flawed logic drastically reduce correctness. Contextual relevance is moderate because the framework of analysis (linking return assumptions to asset mix) is appropriate, but the substance is wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 369,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What does the treatment of American Tower's 2.700% Senior Notes due 2031 across its 2022-2024 filings indicate about its long-term financing strategy?",
      "original_answer": "The consistent referencing of the 2.700% Senior Notes due 2031 across all three filings indicates a stable long-term financing strategy centered on maintaining this specific debt instrument as a core component of American Tower's capital structure. In 2022, the company referenced Supplemental Indenture No. 8 dated March 29, 2021, for these notes (AMT_10k_2022.pdf). In 2023, the same Supplemental Indenture No. 8 was again referenced (AMT_10k_2023.pdf), showing continuity in documentation and treatment. In 2024, the filings continued to reference this same indenture structure for the 2.700% Senior Notes due 2031 (AMT_10k_2024.pdf). This consistent treatment over three consecutive years suggests that the company has maintained a steady approach to this long-term debt instrument without modifications, indicating confidence in its financing terms and alignment with the company's strategic financial planning.",
      "llm_answer": "American Tower consistently reports the 2.700% Senior Notes due 2031 as a separate line item in its long‑term debt schedule in each filing (2022 10‑K, pp. 70‑74; 2023 10‑K, pp. 68‑72; 2024 10‑K, pp. 70‑74).  The uniform, fixed‑rate treatment shows that the company relies on long‑term, low‑cost senior debt as a core element of its financing mix, using it to fund growth and infrastructure while maintaining a diversified debt maturity profile and predictable interest obligations.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its quantitative details: the 2.700% Senior Notes due 2031 are correctly identified, and the consistent reporting across the 2022–2024 10-K filings is accurately noted with correct page references. There are no errors in numbers, percentages, or dates. The answer correctly infers that the consistent treatment reflects reliance on long-term, fixed-rate debt as a core financing strategy, which aligns with the ground truth. However, the LLM omits specific mention of Supplemental Indenture No. 8, a key document referenced in all three filings that demonstrates continuity in legal and structural treatment of the notes. While the LLM captures the broader strategic implication (stable, predictable financing), it does not fully synthesize the multi-hop evidence—the repeated citation of the same supplemental indenture across years—which strengthens the conclusion about intentional, unmodified continuation of the debt instrument. This missing detail reduces completeness and depth of reasoning, though the overall conclusion remains valid. Thus, the answer is semantically close and contextually relevant but lacks a critical piece of documentary evidence that supports the ground truth reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 346,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and cross-border transactions, and what strategic actions were taken to mitigate these risks across the three-year period?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in the context of its credit products, noting that third parties were increasingly using stolen identities and financial instruments to commit fraud at scale. By 2023, PayPal had taken a strategic step to mitigate credit risk by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a shift in how the company managed exposure to fraudulent and abusive transactions in its credit portfolio. In 2024, PayPal continued to emphasize the persistent threat of abusive behaviors, particularly in digital payments, and noted the complexity of detecting and preventing fraud attacks that could undermine consumer and merchant confidence. The company also highlighted its ongoing reliance on third-party lenders and processors, which introduced additional operational and reputational risks tied to abusive behaviors. The three-year trajectory shows PayPal's evolving approach—from identifying the risk (2022), to offloading a significant portion of the exposure (2023), to reinforcing detection and prevention mechanisms while managing third-party dependencies (2024).",
      "llm_answer": "PayPal consistently flagged abusive behaviors as a key risk to its branded credit products and cross‑border transactions from 2022 through 2024 (2022, pp. 24‑28; 2023, pp. 23‑27; 2024, pp. 21‑25). In 2023 the company began mitigating the risk by enhancing fraud‑detection tools, updating credit‑risk models, diversifying payment processors, and selling a large portion of its BNPL loan receivables (2023, pp. 24‑27; 26‑27). By 2024 it further intensified mitigation, expanding monitoring of merchant and credit risk, bolstering cybersecurity and fraud controls, and strengthening cross‑border compliance (2024, pp. 21‑25).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the overall evolution of PayPal's exposure to abusive behaviors and the general strategic actions taken from 2022 to 2024. It correctly identifies that abusive behaviors were a persistent risk in credit products and cross-border transactions, and that mitigation efforts intensified over time. The mention of selling a 'large portion' of BNPL receivables in 2023 aligns with the ground truth, though the specific figure of €40 billion and the geographic focus (U.K. and European receivables) are omitted—this is a notable but not critical omission, as the core action (selling BNPL exposure) is correct. The LLM accurately reflects the progression from risk identification (2022), to risk transfer (2023), to enhanced controls (2024), satisfying the multi-hop requirement across years and domains (credit, fraud, cross-border). All dates and years are correct, and no incorrect numbers are introduced, earning full marks for quantitative accuracy. However, the LLM adds details not present in the ground truth—such as 'enhancing fraud-detection tools,' 'updating credit-risk models,' and 'diversifying payment processors'—which, while plausible, are not specified in the original answer and thus introduce unverified claims. The ground truth emphasizes reliance on third-party lenders/processors as a source of risk, not a mitigation strategy, so the LLM's framing of 'diversifying processors' as a mitigation could misrepresent the nature of third-party risk. This affects qualitative accuracy, as the reasoning, while logical, does not perfectly mirror the source's emphasis on offloading risk (via receivables sale) and managing third-party dependencies as an ongoing challenge. Contextual relevance is high, as the answer directly addresses all parts of the question and maintains focus on credit products, cross-border transactions, and risk mitigation evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 521,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did UNP's pension plan allocation to Collective Trust and Other Funds change from 2022 through 2024, and what does this trend suggest about the company's evolving investment strategy for long-term employee benefits?",
      "original_answer": "UNP's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, and then in 2024, while no updated dollar value is provided, the company emphasized the use of NAV-based valuation for these funds, indicating a strategic focus on transparency and accurate reporting despite the reduced allocation. This represents a significant downward trend in direct exposure to these funds over the three-year period, suggesting a de-risking or rebalancing of the pension portfolio.",
      "llm_answer": "UNP’s pension plan allocated **46.5 %** of plan assets to Collective Trust and Other Funds in 2022, dropped to **39.6 %** in 2023, and then rose to **43.9 %** in 2024 (calculated from the NAV totals on pages 70‑74, 56‑60, 54‑58). The 2023 dip followed by a partial rebound in 2024 indicates a deliberate rebalancing of alternative‑investment exposure as part of the company’s broader de‑risking strategy, showing a cautious yet flexible approach to diversifying long‑term employee benefits.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. The original answer states that UNP's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, with no updated dollar value provided for 2024. However, the LLM claims percentages (46.5%, 39.6%, 43.9%) and asserts a rise in 2024, which directly contradicts the ground truth. These percentages are not supported by the original data and appear to be fabricated or misinterpreted from NAV totals in specific pages not referenced in the ground truth. (2) The calculation of percentages from NAV totals is not corroborated by the ground truth, which only provides absolute dollar values for 2022 and 2023 and no 2024 dollar amount. The LLM introduces new data (percentages, 2024 increase) that are inconsistent with the documented downward trend. (3) The multi-hop reasoning is flawed: while the original answer infers a de-risking strategy based on reduced allocation and increased focus on NAV-based valuation for transparency, the LLM incorrectly interprets a partial rebound in 2024, leading to a distorted view of the investment strategy. The synthesis fails because it relies on inaccurate data points. (4) Despite incorrect numbers and reasoning, the LLM attempts to address the question’s intent—analyzing trends in pension allocation and linking them to investment strategy—hence moderate contextual relevance. However, the factual inaccuracies severely undermine correctness and qualitative reasoning, warranting low scores in those areas.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 434,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Pfizer's treatment and valuation methodology for Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, outstanding status, and accounting treatment?",
      "original_answer": "In 2022, Pfizer disclosed the issuance of 1,165 thousand BPAs at a weighted average intrinsic value of $38.73 per share, with 859 thousand BPAs outstanding at year-end valued at $59.05 per share. By 2023, no BPAs were granted and none remained outstanding, indicating a discontinuation or full vesting/forfeiture of previously issued awards. In 2024, Pfizer detailed a new valuation methodology for BPAs using the intrinsic value method based on the closing stock price at grant date, with expense recognition amortized over the probable vesting term and adjusted quarterly for stock price changes and performance probability assessments. This evolution shows a shift from active BPA issuance and valuation in 2022 to no active BPAs in 2023, followed by a formalized valuation and accounting framework in 2024.",
      "llm_answer": "Pfizer did not grant or have any Breakthrough Performance Awards (BPAs) in 2022, 2023, or 2024, and no BPAs were outstanding as of December 31 2023 or 2024.  Across all three years the valuation method stayed the same – intrinsic value at grant date based on the closing price of common stock – and the accounting treatment remained straight‑line amortization over the probable vesting term with periodic adjustments for changes in stock price, shares likely to be earned, and the probability of meeting performance criteria.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect. It claims Pfizer did not grant or have any BPAs in 2022, 2023, or 2024, and that no BPAs were outstanding at year-end 2023 or 2024. This directly contradicts the ground truth, which states that in 2022, Pfizer issued 1,165 thousand BPAs with 859 thousand outstanding at year-end. By 2023, no new grants occurred and none remained outstanding, indicating prior awards were either vested or forfeited. In 2024, a new valuation methodology was introduced. The LLM incorrectly asserts continuity in treatment across all years, while the ground truth shows a clear evolution. (2) Quantitative inaccuracies are severe: the LLM omits the 1,165 thousand granted in 2022 and 859 thousand outstanding at year-end, along with their respective intrinsic values ($38.73 and $59.05). These are critical financial metrics that are completely missing. (3) The multi-hop reasoning is flawed—the question asks for an evolution across three years, requiring synthesis of grant activity, outstanding status, and accounting changes. The LLM fails to detect the discontinuation in 2023 and the reintroduction of a formalized methodology in 2024, instead asserting no changes occurred. It misses the key transition from active awards in 2022 to none in 2023 to a new framework in 2024. (4) The contextual relevance is low because the answer does not reflect the actual timeline or changes. While the general description of the intrinsic value method and amortization aligns with common accounting practices, it is misapplied here, as the 2024 methodology is presented as new, not consistent across years. The LLM appears to confuse or conflate years and events, leading to a factually incorrect and misleading response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 477,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over time?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements fluctuated significantly from 2022 to 2024: it was $1,494 million at the end of 2022, decreased to $800 million by the end of 2023, and further declined to $491 million by the end of 2024. This downward trend suggests a reduction in derivative exposure or a strategic adjustment in margin requirements over the three-year period.",
      "llm_answer": "Collateral under master‑netting arrangements tied to investments, advances and long‑term receivables fell from **$1.49 billion in 2022** to **$800 million in 2023** and further to **$491 million in 2024**. The downward trend suggests a shrinking derivative exposure or more efficient netting, which reduces initial‑margin requirements and likely lowers the company’s funding costs over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all numerical values: $1,494 million in 2022 (rounded to $1.49 billion, which is acceptable), $800 million in 2023, and $491 million in 2024. These match the ground truth exactly or with acceptable formatting variation. 2) Quantitatively, all figures are accurate and correctly attributed to the right years. The trend of decline is correctly identified. 3) The reasoning is sound: the downward trend is linked to reduced derivative exposure or more efficient netting, which aligns with the ground truth interpretation of reduced exposure or strategic adjustment in margin requirements. The LLM adds a slight expansion—mentioning lower funding costs—which is a reasonable inference but not explicitly stated in the original answer. This does not detract from accuracy but adds a minor interpretive layer. 4) All entities (ExxonMobil, collateral under master netting arrangements, time periods) are correct. The answer fully addresses both parts of the question: the change over time and the implication for derivative exposure and margin requirements. Semantic equivalence is maintained with slightly enhanced explanatory language. Thus, the answer is factually excellent with only a minor addition beyond the original, not contradicting it.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 355,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Broadcom's (AVGO) positioning of Industrial Fiber Optics evolve across 2022, 2023, and 2024 in terms of its industrial product portfolio and application scope, and what does this reveal about the company's strategic focus in industrial markets?",
      "original_answer": "In 2022, Broadcom positioned Industrial Fiber Optics as part of a broad industrial product suite used across applications like industrial automation, power systems, medical equipment, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, the company maintained this positioning but placed Industrial Fiber Optics within a structured table format that emphasized its role in Factory Automation, Renewable Energy, and Automotive Electronics. By 2024, Industrial Fiber Optics remained a core offering under the Industrial end markets, listed alongside optocouplers, sensors, encoders, and Ethernet ICs, but with a more streamlined presentation that emphasized integration with broader semiconductor solutions. This evolution shows a consistent strategic focus on industrial markets, with increasing emphasis on structured, application-specific clarity in product communication.",
      "llm_answer": "Broadcom’s 2022 10‑K lists industrial fiber optics as a core product alongside optocouplers, sensors, encoders, LEDs and Ethernet ICs, framing its industrial portfolio around factory automation, renewable energy and automotive electronics (pages 8‑12). The 2023 and 2024 filings keep the same product family but broaden the application narrative to include power‑generation and distribution, medical, defense/aerospace and electric‑vehicle subsystems (pages 5‑6). This continuity in product positioning, coupled with an expanding scope, signals Broadcom’s strategic intent to deepen its industrial‑connectivity footprint across a wider array of high‑speed, data‑centric industrial and automotive markets (pages 3‑7).",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in the evolution of Broadcom's positioning of Industrial Fiber Optics across 2022–2024. While it correctly identifies that Industrial Fiber Optics was part of the industrial product portfolio in 2022 and remained so in 2023 and 2024, it reverses the direction of change in application scope. The ground truth states that in 2022, the application scope was broad (including industrial automation, power systems, medical, defense, aerospace, automotive), and in 2023–2024, the presentation became more structured and focused (emphasizing Factory Automation, Renewable Energy, Automotive Electronics), with a streamlined integration narrative. The LLM incorrectly claims that the application narrative *broadened* in 2023 and 2024 to include power, medical, defense, etc., which were already present in 2022. This is a significant qualitative error in reasoning and interpretation. (2) There are no numeric values, dates, or calculations in the response, so quantitative accuracy is not applicable—no errors here, hence a score of 10. (3) The multi-hop reasoning is partially sound—information is drawn across years and synthesized, but the synthesis is flawed because it misrepresents the evolution as an expansion rather than a refinement and streamlining. The LLM confuses the direction of change in application scope, undermining the conclusion about strategic focus. (4) Contextually, the answer is relevant and addresses the question’s structure, discussing product portfolio and application scope across years and inferring strategic intent. However, due to the core misrepresentation of how the application scope evolved, the correctness score is limited to 5—partially correct but with significant factual and interpretive errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 490,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its control over transaction pricing and use of third-party payment processors across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bore full margin risk when completing payment transactions and had full discretion over fee pricing, independent of costs incurred with third-party processors. In 2023, the company reiterated this stance, emphasizing that fees paid to payment processors and financial institutions were recognized as transaction expense, maintaining its exposure to margin risk. By 2024, PayPal continued to affirm its role as the principal in transactions, bearing full margin risk, and maintaining discretion over pricing despite using third-party processors. The consistent narrative across all three years indicates a stable margin risk profile, with no material changes in how PayPal manages pricing or third-party cost exposure.",
      "llm_answer": "PayPal has consistently borne **full margin risk** as the principal in payment transactions from 2022 through 2024.  In each filing the company states that it controls transaction pricing and that the fees it charges customers are set independently of the costs it incurs when it uses third‑party processors, so the use of external processors does not mitigate its margin‑risk exposure (PYPL_10k_2022 p. 78‑82; PYPL_10k_2023 p. 75‑79; PYPL_10k_2024 p. 73‑77).  Accordingly, there was no material change in PayPal’s control over pricing or its margin‑risk profile over this period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original (ground truth) answer. (1) It accurately captures that PayPal bore full margin risk from 2022 to 2024, maintained control over transaction pricing, and used third-party processors without transferring margin risk—key facts present in the ground truth. (2) There are no numerical values requiring verification (e.g., dollar amounts, percentages), but the years (2022–2024) are correctly referenced and aligned with the filings. The citations (PYPL_10k_2022 p. 78–82, etc.) match the expected sources and support the claims, indicating accurate grounding. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of 10-K filings, identifying consistency in PayPal’s risk exposure, pricing discretion, and treatment of third-party processor costs as transaction expenses. (4) The answer addresses all parts of the question: evolution over time, control over pricing, use of third-party processors, and resulting margin risk. Wording differs slightly but meaning is preserved. No omissions or inaccuracies. All scores are 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 322,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 to 2024, particularly in terms of financial impact, contractual arrangements, and strategic positioning, and what does this progression indicate about Pfizer's long-term focus in this business area?",
      "original_answer": "Pfizer's relationship with Meridian underwent a clear transformation from 2022 to 2024. In 2022, Meridian was still presented as part of discontinued operations, indicating it was a legacy business being phased out. By 2023, Pfizer had completed the sale of Meridian in late 2021 for $51 million in cash, recognizing a $167 million net loss, and was operating under a Manufacturing Supply Agreement (MSA) that extended for three years post-sale with a two-year extension option. In 2024, Meridian was listed in Pfizer's glossary as 'Meridian Medical Technologies, Inc.', indicating a formalized but likely reduced relationship. This evolution shows Pfizer's strategic shift away from direct ownership of Meridian toward a more arms-length, contract-based relationship, consistent with a broader refocusing on core therapeutic areas and platform technologies like mRNA.",
      "llm_answer": "Pfizer sold Meridian in 2021 for $51 million cash, recording a $167 million net loss and entering into interim TSAs and a three‑year MSA (with a two‑year extension) to keep a supply‑chain relationship (PFE_10k_2022, pp. 114‑118). By 2023 the TSAs were completed and the MSA remained in force with no material financial impact (PFE_10k_2023, pp. 71‑75). In 2024 the MSA continued as the sole post‑sale arrangement, underscoring Pfizer’s shift from owning Meridian to divesting it and concentrating on core operations while preserving a supply‑chain link (PFE_10k_2024, pp. 2‑6). This progression signals a long‑term strategy of portfolio streamlining and core‑business focus.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $51 million sale price and $167 million net loss from the 2021 sale are accurately reported, consistent with the original answer. The timeline (sale in 2021, MSA duration, and post-2022 status) matches. (2) The LLM correctly identifies the contractual arrangements: the three-year Manufacturing Supply Agreement (MSA) with a two-year extension option, and the completion of Transition Services Agreements (TSAs) by 2023. While the original answer refers to 'interim TSAs' and the LLM mentions them explicitly, this is a minor enhancement, not an error. (3) The reasoning across years 2022–2024 is sound: the shift from discontinued operations to formalized contractual relationship is correctly inferred, and the strategic conclusion about Pfizer’s focus on core operations and portfolio streamlining matches the ground truth. (4) The only minor gap is that the 2024 mention of Meridian in the glossary as 'Meridian Medical Technologies, Inc.'—a detail indicating formal recognition—is not included in the LLM answer. This is a small omission in completeness but does not affect the core factual or strategic accuracy. Overall, the answer demonstrates strong multi-hop synthesis across filings and years, with precise financial and contractual details, and conveys the same strategic interpretation as the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 400,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the impact of product regulation on Philip Morris International's competitive positioning evolved from 2022 to 2024, particularly in terms of restrictions on product differentiation and adult consumer communication for reduced-risk products (RRPs/SFPs)?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International's ability to differentiate its reduced-risk products (RRPs) and later its smoke-free products (SFPs), with growing regulatory pressure evident across all three years. In 2022, the company noted that product regulation limited its ability to differentiate tobacco products and restricted adult consumer access to truthful information about RRPs. By 2023, the language evolved to emphasize that such regulation not only restricted communication but also disproportionately impacted the commercialization of RRPs relative to competitors. In 2024, the company replaced 'RRPs' with 'SFPs' and reiterated similar concerns, indicating a continued regulatory burden on product differentiation and consumer engagement, suggesting a deepening regulatory challenge that has persisted and possibly intensified over the three-year period.",
      "llm_answer": "From 2022 to 2024, PMI’s risk‑factor disclosures show a tightening of product‑regulation constraints that curtail product differentiation and adult‑consumer communication for RRPs/SFPs. In 2022 (p. 17) PMI warned that existing rules already risk commoditizing its products and limiting RRP messaging; by 2023 (p. 21) it noted that new enforcement actions and stricter advertising bans further restricted differentiation and communication; and in 2024 (p. 18) it highlighted additional EU nicotine‑product rules and intensified enforcement that deepen these constraints, intensifying competitive pressure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolving regulatory constraints on Philip Morris International (PMI) from 2022 to 2024 regarding product differentiation and adult consumer communication for reduced-risk products (RRPs) and smoke-free products (SFPs). The core facts—increasing regulatory pressure, commoditization risk, restricted messaging, and intensified enforcement—are all present and factually consistent with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; page references (p. 17, 21, 18) are specific and plausible, though not verifiable from the ground truth, but do not contradict it. (3) The multi-hop reasoning is sound: the LLM synthesizes changes across three years, correctly tracking the progression from general restrictions in 2022 to stricter enforcement in 2023 and further regulatory tightening in 2024, including EU-specific rules. The shift from RRPs to SFPs is implied through context, though not explicitly stated as a terminology update as in the original answer. (4) The only minor shortcoming is that the LLM does not explicitly note the strategic rebranding from 'RRPs' to 'SFPs' in 2024, which is a nuance in terminology evolution highlighted in the ground truth. However, the semantic meaning and regulatory trend are accurately conveyed. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 426,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did ExxonMobil's (XOM) exposure to collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 through 2024, and what does this trend suggest about the company's derivative risk management practices?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative exposure or a shift in risk management practices, potentially reflecting lower margin requirements or proactive risk mitigation in a volatile energy market.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements fell from **$1.494 billion in 2022** to **$800 million in 2023** and further to **$491 million in 2024** – a cumulative drop of roughly **$1.0 billion** (‑$694 m from 2022‑23 and ‑$309 m from 2023‑24). This steady decline, driven mainly by lower initial‑margin requirements, indicates that the company is tightening its collateral usage—either by reducing net derivative exposure or by negotiating more efficient netting terms—demonstrating effective and increasingly efficient derivative risk‑management practices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical values: $1,494 million (or $1.494 billion) in 2022, $800 million in 2023, and $491 million in 2024, matching the ground truth exactly. The calculated changes (–$694 million from 2022–2023 and –$309 million from 2023–2024) are accurate, and the cumulative drop of ~$1.0 billion is a reasonable approximation. (2) All numbers are factually correct and calculations are precise. Format variations (e.g., $1.494 billion vs $1,494 million) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly synthesizes the trend across three years and infers implications about derivative risk management. It adds value by identifying 'lower initial-margin requirements' as a potential driver, which is a plausible and insightful extension of the ground truth. While the original answer mentions 'strategic reduction in derivative exposure or shift in risk management,' the LLM elaborates with a specific mechanism ('negotiating more efficient netting terms'), which is reasonable but not explicitly confirmed in the ground truth—hence a minor deduction in qualitative accuracy. (4) The answer is fully contextually relevant, addressing both the quantitative trend and its implication for risk management practices. The conclusion aligns with and slightly enhances the original, without introducing inaccuracies. Overall, this is a highly accurate, well-reasoned response with only minor interpretive additions beyond the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 421,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Duke Energy's expected volatility assumption in its TSR-based performance award model relative to the predefined peer group evolve from 2022 to 2024, and what does this trend suggest about the company's market risk perception over time?",
      "original_answer": "Duke Energy's expected volatility assumption in its TSR-based performance award model decreased from 26.9% in 2022 to 28.6% in 2023, and then dropped significantly to 18.7% in 2024. This trend indicates a notable decline in the perceived market risk associated with Duke Energy's stock performance over the three-year period, despite a short-term increase in 2023. The drop in volatility by 2024 suggests a shift in how the company's stock is behaving relative to its peers, possibly indicating improved market stability or strategic changes affecting its risk profile.",
      "llm_answer": "Duke Energy’s TSR‑based performance‑award model used an expected volatility of **26.9 %** in 2022, which rose to **28.6 %** in 2023, before falling sharply to **18.7 %** in 2024. This upward swing in 2023 signals a heightened perception of market risk relative to 2022, while the steep decline in 2024 suggests the company’s view of market volatility has eased—likely reflecting more favorable market conditions or a shift in risk‑management strategy. (2022, p. 213; 2023, p. 206; 2024, p. 215)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all three volatility values—26.9% in 2022, 28.6% in 2023, and 18.7% in 2024—matching the ground truth exactly. The trend description (increase in 2023, sharp drop in 2024) is accurate. (2) All numeric values are correct and properly attributed to the respective years; no calculation errors are present. Format variations (e.g., spacing in percentages) do not affect accuracy. (3) The multi-hop reasoning is sound: the model synthesizes data across three years from Duke Energy’s filings and correctly infers the implications of the volatility trend. The interpretation of increased risk perception in 2023 and reduced perception in 2024 aligns with the ground truth. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the comparison to the peer group as part of the model context (though it references the TSR-based model), which slightly weakens the qualitative completeness. However, the core reasoning and factual content are highly accurate and relevant. Thus, the answer is factually correct and well-reasoned, warranting a high score with only a small deduction for slight omission in contextual detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 336,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Broadcom's (AVGO) financial obligations tied to its 3.125% notes due January 2025 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's short-term debt management and refinancing strategy?",
      "original_answer": "Broadcom's financial obligation related to the 3.125% notes due January 2025 remained stable at $495 million in both fiscal years 2022 and 2023, indicating no principal repayment or issuance changes during that period. However, by fiscal year 2024, the note had transitioned into its current portion of long-term debt, suggesting that the company was approaching the final year of this obligation. This pattern reveals a consistent short-term debt structure for this specific note over two years, followed by an impending maturity that likely triggered internal refinancing or liquidity planning in 2024.",
      "llm_answer": "Across FY 2022, FY 2023, and FY 2024 the principal outstanding of the 3.125 % senior notes due January 2025 stayed at $495 million, with no repayments or redemptions disclosed (see the 2017 Senior Notes table in each filing).  The company used proceeds from new senior notes to retire other short‑term debt (Term Loans) rather than the 3.125 % notes, reflecting a strategy of refinancing short‑term obligations with long‑term debt to lower short‑term exposure and extend its debt maturity profile.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the principal amount of $495 million for the 3.125% notes due January 2025 across fiscal years 2022, 2023, and 2024, which matches the ground truth. It accurately states there were no repayments or redemptions, aligning with the stability of the obligation in 2022 and 2023. The date (January 2025) and percentage (3.125%) are correct. (2) Quantitatively, all numbers and dates are accurate—$495 million is consistently reported, and the note’s maturity date is correctly cited. There are no calculation errors. (3) However, the LLM answer diverges from the ground truth in reasoning: while the original answer highlights that the note transitioned into the current portion of long-term debt in FY2024 (a key signal of impending maturity), the LLM omits this critical evolution. Instead, it asserts that Broadcom used proceeds from new notes to retire term loans—while possibly true in broader context—it does not directly address how the 3.125% note itself evolved in 2024 or confirm its reclassification as current debt. This misses a core part of the multi-hop synthesis required: tracking the note’s balance sheet classification shift. (4) The answer is factually sound on numbers and broadly relevant, but lacks the specific insight about the note becoming a current liability in 2024, which is central to understanding short-term debt management and refinancing planning. Thus, while the quantitative accuracy is perfect and context is well-addressed, the qualitative reasoning is partially incomplete, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 435,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did AMD's strategic positioning with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB Manufacturers against price reductions, indicating a stable policy to maintain channel partner confidence. In 2022, AMD highlighted that AIBs build and sell board-level products using AMD technology to system integrators, retailers, and sub-distributors. By 2023 and 2024, this relationship remained consistent, with AMD continuing to offer component-level graphics and chipset products to AIBs, reinforcing the importance of discrete graphics solutions as a differentiation tool for AIBs and system integrators. Despite no explicit quantitative changes in AIB-related revenue disclosed, the repeated emphasis on short design cycles, rapid response to new technologies, and the role of discrete graphics in differentiation suggests a sustained strategic focus on AIBs as a key channel for expanding AMD's GPU technology in competitive markets.",
      "llm_answer": "AMD’s 10‑K filings show a steady strategy with AIB manufacturers from 2022 through 2024: in each year the company reiterated that its agreements “protect their inventory of our products against price reductions,” and it continued to highlight that system integrators use discrete‑graphics solutions to differentiate their board‑level products and add value for customers. No substantive changes to the inventory‑protection policy or the role of discrete graphics were disclosed over the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that AMD maintained a consistent inventory protection policy for AIB manufacturers from 2022 to 2024, explicitly stating that 'agreements protect their inventory of our products against price reductions'—this matches the original answer's claim of 'consistently emphasized inventory protection.' (2) There are no numeric values (e.g., revenue figures, percentages) in either the question or ground truth, so quantitative accuracy is not applicable beyond correct handling of years (2022–2024), which are accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes AMD’s repeated disclosures across three years about AIB relationships, inventory protection, and the strategic role of discrete graphics in differentiation—correctly inferring no substantive changes. It captures the core qualitative continuity in strategy, though it omits minor contextual details present in the original answer (e.g., AMD supplying component-level graphics/chipsets to AIBs, the mention of short design cycles and rapid response to technology). (4) Despite these omissions, the LLM conveys the essential meaning: stable policy, sustained strategic focus, and the role of discrete GPUs in differentiation. The answer is semantically equivalent in intent and fact, warranting a high correctness score. Minor deduction in qualitative accuracy due to slightly less depth in explaining the AIB relationship evolution, but no factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 418,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Disney's strategic approach to DTC offerings evolve from 2022 to 2024, particularly in terms of investment focus, competitive positioning, and expectations for revenue growth?",
      "original_answer": "In 2022, Disney acknowledged the financial risks of its DTC strategy, noting that the costs and associated losses 'may continue to grow or be reduced more slowly than anticipated' and that returns on new investments, including DTC offerings, 'may be negative or lower than prior to the change in strategy.' By 2023, Disney shifted toward more confident strategic investment, stating that it expected DTC investments to 'lead to growth in subscription fees and advertising revenues that will more than offset impacts on affiliate fees and advertising revenue from declines in linear network subscribers.' In 2024, Disney's relationship with DTC offerings became more operationally critical, as it noted that DTC streaming services 'compete for customers with an increasing number of competitors' DTC offerings' and that subscription fees and advertising rates were being impacted by competitive pressures. This evolution shows a shift from cautious investment in 2022 to a more integrated and strategically dependent posture by 2024, despite growing competitive intensity.",
      "llm_answer": "From 2022 to 2024 Disney shifted its DTC strategy from a cost‑realignment and ad‑supported Disney+ launch (2022 10‑K, pp. 25‑29) to a broader investment in content and technology, a new content‑curation approach and the launch of ESPN’s flagship DTC service (2023 10‑K, pp. 51‑55; 2024 10‑K, pp. 21‑25). The company positioned its DTC platforms to compete more aggressively with other streaming services, expanding into India via a joint venture and tightening distribution windows, and now expects subscription and advertising revenue from DTC to grow enough to offset declining linear‑network revenue.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Disney's DTC strategy from 2022 to 2024 with accurate qualitative progression and strong contextual relevance. (1) It correctly identifies the shift from cautious cost management in 2022 (referencing ad-supported tier launch and financial risks) to more aggressive investment in content, technology, and ESPN+ in 2023–2024. It also accurately notes competitive positioning efforts like expansion into India and tighter distribution windows, which align with the growing competitive pressures mentioned in the ground truth. The expectation that DTC subscription and ad revenue will offset linear declines matches the 2023 strategic pivot described in the original answer. (2) There are no specific numbers, dates, or financial figures (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly inferring strategic shifts. However, it omits explicit mention of Disney’s growing operational dependence on DTC by 2024 and the increasing competitive intensity impacting subscription and ad pricing—nuances present in the original answer. While implied through 'compete more aggressively,' the explicit acknowledgment of downward pressure on pricing due to competition is missing. (4) Despite this minor omission, the LLM conveys the essential trajectory—cautious → confident → integrated/competitive—and remains factually aligned with the ground truth. Hence, correctness and qualitative accuracy are high but not perfect, warranting an 8. Contextual relevance is full, as all parts of the question (investment focus, competitive positioning, revenue expectations) are addressed appropriately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 500,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did PayPal's (PYPL) relationship with its Fixed-rate 2.850% notes evolve from 2022 through 2024, particularly in terms of its debt structure and maturity obligations across these years?",
      "original_answer": "PayPal's Fixed-rate 2.850% notes remained consistently outstanding at $1.5 billion from 2022 through 2024, with no repayments or changes in principal across the three years. However, the broader debt structure around these notes evolved significantly: in 2022, the company carried $9.0 billion in total term debt, which increased to $10.638 billion by 2023 before slightly declining to $10.574 billion in 2024. The maturity of the 2.850% notes is set for 2029, indicating a long-term liability that remained unchanged while PYPL issued new debt instruments with higher interest rates in 2024 (e.g., 5.150% and 5.500% notes), suggesting a shift in financing strategy while maintaining the same long-term obligation to the 2.850% notes.",
      "llm_answer": "PayPal’s Fixed‑Rate 2.850% notes, issued in September 2019, remained a constant $1.5 billion component of its term debt from 2022 through 2024.  The notes’ maturity stayed unchanged at 10/1/2029, and no early redemption or repurchase of this series occurred during that period.  While the overall debt structure expanded from $9.0 billion in 2022 to $10.6 billion in 2023 and 2024, the 2.850% notes’ principal and maturity obligations stayed the same, with the 2029 principal payment of $1.5 billion still scheduled in the company’s future principal‑payment schedule.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $1.5 billion principal of the 2.850% notes remained unchanged from 2022 to 2024, maturity date is correctly stated as October 1, 2029 (matching the 2029 maturity in the original), and no repayments occurred. The overall debt figures are accurate: $9.0 billion in 2022, and the LLM correctly notes an increase to $10.6 billion in 2023 and 2024 (minor rounding from $10.638B to $10.6B and $10.574B to $10.6B is acceptable and common in reporting). (2) Quantitative accuracy is perfect: all dollar amounts, percentages, and dates match or are reasonably rounded versions of the ground truth. (3) The reasoning is sound—LLM correctly isolates the stability of the 2.850% notes within a broader evolving debt structure. It captures the core multi-hop insight: while total debt increased, the specific note series remained unchanged. (4) The only minor omission is that the original answer notes PayPal issued new higher-rate debt in 2024 (5.150% and 5.500% notes), which the LLM does not mention. This contextual detail about shifting financing strategy adds depth to the 'evolving debt structure' aspect of the question. While not critical to the core facts about the 2.850% notes, it is part of the full evolution. Hence, qualitative accuracy is slightly reduced, but not severely. Overall, the answer is factually correct, well-structured, and highly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 403,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did UNP's allocation to Corporate Stock within its pension plan assets evolve from 2022 to 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "UNP's allocation to Corporate Stock within its pension plan assets significantly declined from $1,990 million in 2022 to $181 million in 2023, and by 2024, the company had reclassified its common stock holdings as Level 1 investments while maintaining a smaller, more structured equity exposure through preferred shares classified as Level 2. This represents a dramatic reduction in equity exposure and a strategic shift toward more transparent and observable valuation methodologies for remaining stock investments.",
      "llm_answer": "UNP’s pension plan corporate‑stock holdings fell sharply from roughly 37 % of plan assets in 2022 (1,111 / 2,990) to about 5 % in 2023 (181 / 3,385), then modestly rose to around 7 % in 2024 (226 / 3,186)【70‑74】【56‑60】【54‑58】. This pattern reflects a de‑risking strategy that cut equity exposure dramatically in 2023, with a slight rebound in 2024 as the plan rebalances its equity allocation within a broader shift toward debt and other assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states UNP's Corporate Stock allocation was $1,990 million in 2022, $181 million in 2023, and reclassified in 2024 with preferred shares in Level 2. The LLM incorrectly reports 2022 as $1,111 million and calculates a 37% allocation based on a total plan asset figure of $2,990 million, which is unsupported by the ground truth. Similarly, the 2024 figure of $226 million is fabricated, as the original answer does not provide a dollar amount for 2024 but instead discusses reclassification of holdings. (2) Calculations are based on incorrect inputs: 1,111/2,990 ≈ 37% is not valid because those numbers do not appear in the ground truth; same for 181/3,385 ≈ 5% and 226/3,186 ≈ 7% — none of these totals or percentages are present or verifiable. The actual data shows a drop from $1,990M to $181M — a 91% reduction in dollar terms — not a fluctuation from 37% to 5% to 7%. (3) The multi-hop reasoning is flawed: the LLM infers a 'rebalancing' with a 'slight rebound' in 2024, which contradicts the ground truth indicating a strategic reclassification toward Level 1 and Level 2 investments, emphasizing transparency and reduced equity exposure, not a rebound. The shift described in the original answer is structural and methodological (valuation levels), not quantitative fluctuation. (4) While the LLM identifies the general trend of de-risking, it fabricates specific numbers, misrepresents the magnitude and nature of the change, and introduces incorrect synthesis. The mention of a 'broader shift toward debt' is speculative and not in the original. The contextual relevance is moderate because it addresses pension allocation and strategy, but the factual foundation is unsound, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 491,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Pfizer's long-term investment in private equity securities at cost change from 2022 to 2024, and what does this trend suggest about the company's strategic allocation to illiquid alternative investments over this period?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, then slightly declined to $719 million in 2024. This indicates a short-term growth strategy in alternative investments in 2023, followed by a modest retrenchment in 2024, suggesting a cautious approach to illiquid asset allocation despite broader shifts in Pfizer's investment portfolio.",
      "llm_answer": "Pfizer’s long‑term investment in private‑equity securities at cost fell from **$800 million in 2022 to $719 million in 2024** – a decline of **$81 million**【source: 2023 table showing 800 million for 2022】【source: 2024 table showing 719 million for 2024】. This modest reduction indicates a slight pullback in the company’s allocation to illiquid alternative investments, suggesting a strategic rebalancing of its investment portfolio over the period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Pfizer's long-term investment in private equity securities at cost was $623 million in 2022, not $800 million as claimed. The 2024 value of $719 million is correct, but the 2023 value of $755 million is omitted entirely. The LLM incorrectly states a decline from $800M to $719M, implying a continuous downward trend, whereas the actual data shows an increase from 2022 to 2023, then a partial decline in 2024. (2) The calculation of an $81 million decrease is based on incorrect starting data and is therefore invalid. The actual change from 2022 to 2024 is an increase of $96 million ($719M - $623M), despite the dip in 2024. (3) The multi-hop reasoning is flawed: the LLM fails to incorporate the 2023 data point ($755M), which is critical for understanding the trend. This omission leads to an incorrect characterization of a 'modest reduction' rather than a short-term growth followed by a slight retrenchment. (4) While the answer addresses the question's structure and discusses strategic allocation, the incorrect numbers and missing intermediate year undermine both quantitative and qualitative accuracy. Contextual relevance is moderate because the response attempts the right type of analysis but is built on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 373,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024, particularly in terms of third-party collaboration, real-time payment infrastructure expansion, and resilience against cyber threats?",
      "original_answer": "From 2022 to 2024, Mastercard's implementation of its multi-layered security approach became more robust and externally collaborative. In 2022, the company emphasized a multi-layered approach involving Security Operations Centers, Fusion Centers, and the Mastercard Intelligence Center, working internally and through public-private partnerships to monitor and respond to threats. It also highlighted its work with stakeholders to develop technical standards like EMV for secure transactions. By 2023, Mastercard expanded this approach by explicitly including third-party service providers in its threat monitoring and response framework and noted that it was operating or implementing real-time payment infrastructure in 13 markets as of year-end, enhancing the security footprint across more jurisdictions. In 2024, the company further deepened its external collaboration, noting that it worked with experts across the organization and through third-party providers to monitor and respond to cyber threats, while also expanding its real-time payments infrastructure globally. This evolution shows a strategic shift toward broader ecosystem integration and enhanced resilience through both technological and partnership-driven security layers.",
      "llm_answer": "From 2022 through 2024 Mastercard’s multi‑layered security strategy broadened its third‑party collaboration—moving beyond issuer, acquirer, merchant and industry‑association standards to partnerships with fintechs, central banks, digital‑messaging platforms and other third‑party technology providers for services such as Mastercard Send, VCN adoption and the Alias‑Based Remittances platform. Real‑time payment infrastructure grew from 12 markets in 2022 to 13 markets by 2023‑24, with continued expansion via new real‑time clearing and settlement platforms and the launch of the Alias‑Based Remittances and Payouts platform. Throughout, the resilience arm has been reinforced by an enterprise‑resilience program, insurance coverage, regular vulnerability testing and a coordinated response network of Security Operations Centers, Fusion Centers and the Mastercard Intelligence Center, all assessed by third‑party auditors and supported by public‑private partnerships.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Correctly captures the evolution of Mastercard's multi-layered security approach from 2022 to 2024, emphasizing increased third-party collaboration, real-time payment infrastructure growth, and sustained resilience efforts. (2) Quantitatively, it states real-time payment infrastructure expanded from 12 markets in 2022 to 13 by 2023–2024, which is consistent with the ground truth noting 13 markets as of year-end 2023; the slight variation in baseline (12 vs. not specified in original) is not contradicted by the original and falls within reasonable reporting variance. No calculation errors. (3) Multi-hop reasoning is sound: synthesizes information across years and dimensions (collaboration, infrastructure, resilience), correctly identifying the strategic shift toward ecosystem integration. Mentions specific platforms (Alias-Based Remittances, Mastercard Send, VCN) that reflect deeper third-party integration, enhancing qualitative accuracy. (4) All entities (Security Operations Centers, Fusion Centers, Mastercard Intelligence Center, public-private partnerships) are correctly identified and contextualized. The answer adds detail not in the original (e.g., fintechs, digital-messaging platforms, insurance, vulnerability testing), but these are plausible extensions consistent with Mastercard’s known practices and do not contradict the ground truth. Only minor deduction from 10 is due to the unverified claim of '12 markets in 2022'—while not incorrect, it introduces a specific number not confirmed in the original, slightly affecting quantitative precision. Overall, the answer is factually correct, comprehensive, and semantically equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1576,
        "completion_tokens": 471,
        "total_tokens": 2048
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did ExxonMobil's (XOM) reported collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management over time?",
      "original_answer": "ExxonMobil's reported collateral under master netting arrangements, which are tied to 'Other assets, including intangibles - net', increased from $641 million at the end of 2021 (reported in the 2022 filing), peaked at $800 million at the end of 2022 (reported in the 2023 filing), and then declined to $491 million at the end of 2023 (reported in the 2024 filing). This represents a 38% decrease from 2022 to 2024. The trend suggests a shift in the company's derivative exposure management, potentially reflecting reduced initial margin requirements or strategic adjustments in derivative positions during this period.",
      "llm_answer": "ExxonMobil’s collateral under master netting arrangements – which is included in the “Other assets, including intangibles – net” line – fell from **$1.49 billion in 2022** to **$800 million in 2023** and further to **$491 million in 2024** (a decline of roughly 67 % over two years). This downward trend indicates that the company has been reducing its collateral commitments, suggesting a more efficient derivative exposure management strategy—through lower notional exposure, tighter netting/clearing arrangements, or both—resulting in lower margin requirements.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values and timeline. According to the ground truth, the collateral was $641 million at the end of 2021 (reported in 2022 filing), increased to $800 million at the end of 2022 (reported in 2023 filing), and then declined to $491 million at the end of 2023 (reported in 2024 filing). The LLM incorrectly states that the value was $1.49 billion in 2022, which is not supported by the data and misrepresents the starting point. The $800 million figure is correctly placed in 2023 in the LLM answer, but it should correspond to the end of 2022, not 2023. The $491 million figure for 2024 is correct in amount but misaligned in timing—it reflects year-end 2023, not 2024. (2) The calculation of a 67% decline is incorrect; the actual decline from $800 million (end of 2022) to $491 million (end of 2023) is a 38.6% decrease, which the ground truth correctly reports as approximately 38%. The LLM’s 67% figure appears to be based on the erroneous $1.49 billion starting value. (3) The multi-hop reasoning is partially sound—the LLM correctly identifies that changes in collateral relate to derivative exposure management and suggests plausible explanations such as reduced margin requirements or strategic adjustments. However, due to incorrect data inputs, the synthesis is flawed. (4) Despite the incorrect numbers and timeline, the LLM addresses both parts of the question—trend in collateral and its implication for derivative management—and maintains contextual relevance. The qualitative interpretation is reasonable given the assumed data, but the factual foundation is unsound, leading to a low quantitative accuracy score and moderate overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 475,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the expected volatility of Duke Energy's stock, as determined by its relative TSR model against a predefined peer group, change from 2022 through 2024, and what might this multi-year shift suggest about the company's market risk perception?",
      "original_answer": "The expected volatility of Duke Energy's stock in its TSR model was 26.9% in 2022, increased to 28.6% in 2023, and then decreased to 18.7% in 2024. This trajectory indicates a peak in perceived market risk in 2023, followed by a significant decline in 2024, suggesting a stabilization or reduced uncertainty in Duke Energy's market position relative to its peers over the three-year period.",
      "llm_answer": "The relative‑TSR model’s expected volatility fell from **28.8 % in 2022** to **28.6 % in 2023** and then dropped sharply to **18.7 % in 2024**【DUK_10k_2022, 212‑216】【DUK_10k_2023, 204‑208】【DUK_10k_2024, 213‑217】. This downward trend indicates that investors perceive Duke Energy’s stock as becoming less volatile relative to its peer group, suggesting a lower market‑risk profile and a more stable outlook over the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the 2022 expected volatility value. The ground truth states 26.9% for 2022, but the LLM reports 28.8%, which is incorrect. The 2023 value (28.6%) and 2024 value (18.7%) are accurate. This misstatement affects the quantitative trajectory and undermines the accuracy of the multi-year comparison. (2) Calculations and trends are partially correct: the decrease from 2023 to 2024 is accurately described as a 'sharp drop', and 18.7% is correctly cited. However, the claim of a 'downward trend' from 28.8% in 2022 to 28.6% in 2023 implies a steady decline, which contradicts the ground truth showing an increase from 26.9% to 28.6%—indicating rising risk in 2023 before falling in 2024. (3) The multi-hop reasoning is sound in concept—comparing three years of volatility data from Duke Energy’s TSR model and interpreting market risk perception over time—but the faulty 2022 number leads to flawed synthesis. The conclusion about reduced market risk by 2024 is consistent with the ground truth, but the overall trend description is inaccurate. (4) Contextual relevance is high, as the answer addresses both parts of the question: the change in volatility and its implication for market risk perception. The qualitative reasoning is logical and well-articulated, just based on one incorrect input. Thus, correctness is penalized primarily for the significant numerical error in 2022, dragging down quantitative accuracy, while qualitative and contextual scores remain moderate to high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 423,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did General Motors' indemnification obligations and accruals related to Stellantis evolve from 2022 through 2024, particularly in relation to legacy Opel/Vauxhall emissions claims and Takata recalls?",
      "original_answer": "In 2022, GM disclosed that it indemnified Stellantis for an immaterial amount related to certain recalls, including those involving Takata inflators in legacy Opel vehicles, and noted the potential for future indemnification obligations. By 2023, GM reiterated the immaterial indemnification and stated that further indemnification related to Takata recalls was considered remote. In 2024, GM continued to emphasize that any potential future indemnification obligations for Stellantis’ Takata recalls remained remote, while also noting that it had accrued an immaterial amount related to European Commission and UK CMA investigations into conduct by Opel prior to the sale. This indicates a consistent stance that the financial exposure to Stellantis-related indemnifications remained minimal and stable across the three-year period.",
      "llm_answer": "From 2022‑2024 GM’s indemnification to Stellantis for legacy Opel/Vauxhall emissions and product liabilities stayed the same—no material accrual was recorded because the loss was not estimable and the exposure was deemed remote (see 2022‑10‑K pp. 89‑93, 2023‑10‑K pp. 90‑94, 2024‑10‑K pp. 91‑95).  The Takata recall liability, however, has steadily declined: the remaining accrual fell from $1.1 billion in 2020 to $609 million in 2023 and $555 million in 2024, reflecting progress in the recall and lower expected costs (2023‑10‑K pp. 90‑94; 2024‑10‑K pp. 91‑95).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that GM indemnified Stellantis for an immaterial amount related to Takata recalls and legacy Opel/Vauxhall emissions claims, with exposure considered remote by 2023 and 2024. However, the LLM incorrectly claims that GM had no material accrual because the loss was not estimable and exposure was remote throughout 2022–2024—this misrepresents the nature of the indemnification, which was already paid or accrued at an immaterial level, not deemed not estimable. More critically, the LLM introduces a $1.1 billion to $609 million to $555 million decline in Takata recall accruals from 2020 to 2024, which refers to GM’s own Takata recall liabilities, not indemnification obligations to Stellantis. This is a fundamental error: the question asks about GM’s indemnification *to Stellantis*, not GM’s standalone recall costs. (2) Quantitatively, the dollar amounts cited ($1.1B, $609M, $555M) are factually incorrect in this context—they do not appear in the ground truth and pertain to a different financial item (GM’s own recall accruals, not payments or liabilities to Stellantis). There is no mention in the original answer of these figures or any trend in accruals related to Stellantis. (3) The multi-hop reasoning is flawed: the model fails to distinguish between GM’s direct product liabilities and its indemnification obligations to Stellantis arising from the sale of Opel. The synthesis across years is superficial and conflates unrelated financial disclosures. (4) While the answer references emissions and Takata recalls and spans the correct time frame (2022–2024), it fundamentally mischaracterizes the financial relationship and obligations between GM and Stellantis. The contextual relevance is moderate because it addresses the right topics and time period but applies them incorrectly. Correctness is low due to major factual and conceptual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 529,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did AMD's reference to the 2011 Executive Incentive Plan evolve across its filings in 2022, 2023, and 2024, and what does this consistency suggest about its long-term executive compensation strategy?",
      "original_answer": "AMD consistently referenced the 2011 Executive Incentive Plan in its filings for 2022, 2023, and 2024 without introducing any amendments or new disclosures about the plan itself. In 2022, the plan was listed as Exhibit 10.1 and was described as filed on April 2, 2011. In 2023 and 2024, the same description and reference were maintained, indicating no changes to the plan were made during this period. This consistent referencing of the original filing suggests that AMD maintained a stable executive compensation framework without material modifications to the 2011 plan over the three-year span.",
      "llm_answer": "In each filing, AMD lists the 2011 Executive Incentive Plan as Exhibit 10.1 and incorporates it by reference (2022, pp. 91‑95; 2023, pp. 99‑103; 2024, pp. 96‑100). The reference remains unchanged across the three years, indicating that AMD has kept the same long‑term incentive framework for executives and has not altered the foundational plan. This consistency underscores a deliberate, stable long‑term executive‑compensation strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AMD consistently referenced the 2011 Executive Incentive Plan as Exhibit 10.1 across 2022, 2023, and 2024 filings, with no amendments noted. The dates and exhibit numbers match the original answer. (2) Quantitative accuracy is perfect: the years (2022–2024), exhibit number (10.1), and reference to unchanged content are all factually correct. Page numbers cited (e.g., 2022 pp. 91–95) are additional details not in the ground truth but do not contradict it and likely reflect actual filing locations; they are plausible and not penalized. (3) Reasoning is sound: the LLM correctly infers that unchanged references over three years indicate a stable, long-term executive compensation strategy, which is a valid conclusion from the consistency. (4) The only minor gap is that the LLM does not explicitly mention that the plan was originally filed on April 2, 2011—a detail in the ground truth—but this omission does not undermine the core correctness. The answer captures the essence and implications of the consistency. Semantic equivalence is maintained, and the response is fully relevant to the question. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 375,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 through 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what strategic actions were taken in 2023 to mitigate this risk?",
      "original_answer": "In 2022, PayPal highlighted increasing risks of bad transactions tied to credit defaults, particularly in its U.S. consumer credit product with Synchrony Bank, and noted that economic conditions like recessions and high unemployment could exacerbate non-payment rates. In 2023, PayPal responded by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, aiming to reduce exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize the risks of fraud and bad transactions, particularly in digital payments, and noted ongoing challenges related to third-party reliance and regulatory uncertainty, especially around the validity of loan sales post-transfer. The strategic move in 2023 to offload BNPL receivables was a key mitigation step, reflecting a broader shift to manage credit risk and reduce exposure to bad transactions.",
      "llm_answer": "PayPal’s 2022 risk‑factor section (p. 24‑28) warned that bad‑transaction losses could arise from its consumer and merchant credit products, cross‑border trade volumes, and reliance on third‑party lenders and processors. In 2023 (p. 23‑27) the company mitigated this exposure by selling a majority of its U.K./European BNPL loan receivables, diversifying its payment‑processor base, and investing in enhanced fraud‑detection and risk‑modeling tools. By 2024 (p. 21‑25) the disclosures reiterated these drivers while adding new concerns around cybersecurity, payment‑fraud, and trade‑policy risks, underscoring the continued importance of credit‑product risk management, cross‑border exposure, and third‑party dependencies.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies PayPal's exposure to bad transactions in 2022 related to credit products, cross-border trade, and third-party dependencies, and notes increased risk disclosures in 2024. It also correctly states that in 2023, PayPal took action by selling U.K./European BNPL receivables. However, it inaccurately states that PayPal sold a 'majority' of these receivables without specifying the €40 billion figure mentioned in the ground truth, which is a key quantitative commitment. The LLM omits the specific multi-year agreement with Synchrony Bank and the focus on U.S. consumer credit risk in 2022. (2) Quantitative accuracy is partially compromised: while no incorrect numbers are stated (e.g., no false dollar amounts), the critical €40 billion figure from the ground truth is missing, and the term 'majority' is vague and not equivalent. Page numbers (e.g., p. 24-28) are likely fabricated or assumed and not part of the original knowledge graph, reducing quantitative precision. (3) The multi-hop reasoning is generally sound—linking risk factors across years and identifying mitigation strategies—but fails to fully synthesize the specific strategic move (€40B receivables sale) as a direct response to U.S. and European credit risk. The addition of 'diversifying payment-processor base' and 'cybersecurity' as new 2024 concerns is plausible but not supported in the ground truth, introducing minor hallucination. (4) Correctness score is 7 because core facts about risk evolution and mitigation are present and directionally accurate, but key specifics (quantitative commitment, partner name Synchrony, exact nature of loan sale) are missing or generalized. Qualitative accuracy is high due to logical flow and correct entity mapping (BNPL, third-party risk), while contextual relevance remains strong as the answer directly addresses all question components with appropriate framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 521,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Union Pacific's ownership and aging profile of Multiple Purpose Locomotives evolve from 2022 to 2024, and what does this indicate about the company's fleet management and modernization strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's owned Multiple Purpose Locomotives decreased slightly from 6,204 to 5,973 units, while leased units dropped more significantly from 1,038 to 920. Over the same period, the average age of the Multiple Purpose Locomotive fleet increased from 22.5 years to 25.2 years, indicating a continued reliance on older assets despite reductions in leased equipment. This suggests a fleet management strategy that prioritizes cost control over aggressive modernization, as the company reduced leasing but did not substantially increase new purchases to offset aging.",
      "llm_answer": "From 2022 to 2024 Union Pacific’s multiple‑purpose locomotive fleet fell from 7,242 units (owned 6,204, leased 1,038, average age 22.5 yrs) to 6,893 units (owned 5,973, leased 920, average age 25.2 yrs) (UNP_10k_2022, p.22‑26; UNP_10k_2023, p.17‑21; UNP_10k_2024, p.17‑21). The decline in ownership and leasing, coupled with a higher average age, indicates a deliberate strategy to retire older locomotives and replace them with newer ones while shrinking the fleet to improve operational efficiency and support modernization initiatives.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer correctly reports the owned units (6,204 in 2022, 5,973 in 2024), leased units (1,038 to 920), and average age increase (22.5 to 25.2 years), which matches the ground truth. The total fleet sizes (7,242 in 2022 and 6,893 in 2024) are accurate as sums of owned and leased units. Thus, quantitative accuracy is high, with only minor formatting differences (e.g., spacing, punctuation) that do not affect meaning.\n\n2) However, the qualitative interpretation is significantly flawed. The LLM concludes that the data indicates a strategy of replacing older locomotives with newer ones and supporting modernization. This contradicts the ground truth, which states that the increasing average age (from 22.5 to 25.2 years) and reduction in both owned and leased units—without a corresponding increase in new purchases—suggests cost control over aggressive modernization. The aging fleet and reduced leasing imply the company is not actively modernizing but rather maintaining older assets while downsizing.\n\n3) The multi-hop reasoning is partially sound: the model correctly synthesizes data across three years of 10-K filings and identifies trends in ownership, leasing, and age. However, the logical leap to 'replacing with newer ones' and 'modernization initiatives' is unsupported by the data provided and directly conflicts with the correct inference based on aging and reduced procurement.\n\n4) Contextual relevance is strong—the answer addresses ownership, aging, and strategic implications as asked. But due to the incorrect strategic interpretation despite correct numbers, the overall correctness is only partially accurate. Hence, a score of 5/10: factually solid on inputs, but flawed in synthesis and conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 471,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has ExxonMobil's collateral exposure under master netting arrangements related to equity company receivables changed from 2022 to 2024, and what does this trend suggest about their derivative risk management approach?",
      "original_answer": "ExxonMobil's collateral exposure under master netting arrangements was $641 million in 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This trend shows a peak in 2023 followed by a decline in 2024, indicating a potential shift in derivative risk management strategy. The use of level 3 fair value inputs for equity company receivables and long-term obligations, as disclosed across all three years, suggests continued reliance on internal models for valuation, but the drop in 2024 may signal reduced exposure or improved credit conditions. The fluctuation reflects dynamic risk positioning in response to market conditions.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements fell sharply – from **$1.494 billion in 2022 to $491 million in 2024** (a drop of about $1.0 billion, or 67 %). This steep decline reflects a more efficient, liquidity‑focused derivative strategy, likely driven by tighter netting, lower derivative exposure or improved counterparty limits, and shows the company is actively reducing collateral commitments that support its equity‑company receivables.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in the quantitative data. According to the ground truth, ExxonMobil's collateral exposure was $641 million in 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. The LLM incorrectly states it was $1.494 billion in 2022, which is more than double the correct value. This error invalidates the reported drop of $1.0 billion and the 67% decline, both of which are based on incorrect inputs. The 2024 figure ($491 million) is correct, but the absence of the 2023 data point ($800 million) omits a critical part of the trend. (2) Calculations are therefore flawed: the actual change from 2022 to 2024 is a decrease of $150 million (from $641M to $491M), or about 23.4%, not 67%. The LLM also fails to mention the increase in 2023, which is a key element of the trend. (3) The reasoning is partially sound in interpreting a decline as indicative of reduced exposure or improved risk management, but because it misses the intermediate increase in 2023, it fails to capture the full multi-hop trend—fluctuation with a peak in 2023—undermining the analysis. The mention of 'equity-company receivables' and derivative strategy shows relevance, but the conclusion about 'more efficient, liquidity-focused strategy' lacks support from the full data pattern. (4) The contextual relevance is moderate because the answer addresses derivative risk management and collateral exposure, but the qualitative accuracy is low due to incorrect synthesis across years. The correctness score is low (3) because the core numerical facts are wrong, despite some correct terminology and directionality in the final year.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 461,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the revenue composition of Starbucks' 'Other' category, which includes single-serve coffees, evolve from 2022 to 2024, based on the specific items listed in each year's 10-K filing?",
      "original_answer": "The 'Other' category, which includes single-serve coffees, remained relatively stable in its composition from 2022 to 2024. In 2022, 'Other' primarily consisted of packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, serveware, and ready-to-drink beverages. In 2023, the description remained largely unchanged, with the same key components listed. By 2024, the structure of the 'Other' category was consistent with prior years, continuing to include packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, and serveware. There was no explicit mention of new product categories or significant shifts in this segment over the three-year period.",
      "llm_answer": "The 2022, 2023, and 2024 10‑Ks all describe “Other” revenue as coming from packaged and single‑serve coffees and teas, royalty and licensing revenues, beverage‑related ingredients, serveware, and ready‑to‑drink beverages – the mix of items did not change materially.  The dollar amount grew from $6.89 B in 2022 to $7.70 B in 2023 and then eased to $7.54 B in 2024, while its share of total revenue rose modestly from 21 % in 2022 to 22 % in 2023 and returned to 21 % in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the composition of the 'Other' revenue category as consistent across 2022–2024, listing the same components (packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, serveware, and ready-to-drink beverages), which aligns with the ground truth. This supports a reasonable qualitative assessment of stability in revenue composition, earning moderate points for qualitative accuracy and high relevance to the question. However, the LLM introduces specific quantitative data—revenue amounts of $6.89B (2022), $7.70B (2023), $7.54B (2024), and percentages of total revenue (21%, 22%, 21%)—that are not present in the original answer or implied by the knowledge graph. The ground truth does not mention any dollar amounts or percentages, nor does it indicate growth or fluctuation in the 'Other' category’s size. Therefore, these figures are unsupported and likely hallucinated, leading to a low quantitative accuracy score. Since the question asks about the evolution of revenue *composition* (i.e., what items are included), not absolute or relative size, the inclusion of unverified financials misdirects the response and undermines factual correctness. While the core idea of compositional stability is correct, the addition of fabricated metrics significantly reduces overall correctness. The reasoning is partially sound in synthesizing consistent category components over time, but the unsupported numbers damage credibility and accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 417,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the monetization of advertising inventory through Google Ad Manager evolve across Google Network properties from 2022 to 2024, particularly in terms of impression-based revenue recognition and gross revenue reporting?",
      "original_answer": "From 2022 to 2024, Google consistently monetized advertising inventory through Google Ad Manager on Google Network properties using impression-based and click-based revenue models. In 2022, Google recognized impression-based revenues by dividing total impression-based and click-based revenues by the number of impressions, with a focus on cost-per-impression as a key metric. In 2023, Google clarified that it generally reports advertising revenues for ads placed on Google Network properties on a gross basis, meaning the full amount billed to customers is recorded as revenue. This approach remained consistent in 2024, with further emphasis on the company's role as principal in these transactions, reinforcing its control over the advertising inventory and supporting the gross revenue recognition model. The evolution shows a consistent monetization strategy with increasing transparency and accounting clarity over time.",
      "llm_answer": "Across 2022‑24 Alphabet continued to monetize Google Network inventory on a **gross‑basis** when it is the principal, recording the full amount billed to advertisers as revenue and the share paid to network partners as cost of revenue.  For **brand advertising** on Network properties, revenue is recognized **impression‑based**—at the moment the ad is displayed or viewed—while performance advertising revenue is recognized only when a user engages with the ad.  This gross‑basis, impression‑based recognition policy remained unchanged through the 2024 filing, with no shift to net‑basis accounting or a change in the timing of revenue recognition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Google (Alphabet) monetized advertising inventory through Google Ad Manager on a gross basis from 2022 to 2024 when acting as principal, recording full billed amounts as revenue—consistent with the original answer's emphasis on gross revenue reporting and control as principal. The distinction between impression-based recognition for brand ads and engagement-based for performance ads is accurate and adds useful detail not contradicted by the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages, impression counts) in either answer, so quantitative accuracy is not compromised; all temporal references (2022–2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes revenue recognition timing (impression-based), accounting model (gross basis), and evolution (no change across years), correctly inferring consistency in policy with increasing clarity—though it does not explicitly mention the 2022 cost-per-impression metric emphasis or the 2023 clarification event, which are minor omissions. (4) Despite these small contextual gaps, the core facts—gross reporting, impression-based recognition for brand ads, and stability of policy—are correct and semantically equivalent. The answer is fully relevant and addresses all key aspects of the question. A score of 9 is justified due to slightly less detail on year-by-year evolution compared to the original, but no factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 420,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has MDLZ's exposure to sales and media marketing restrictions evolved across 2022, 2023, and 2024, particularly in relation to front-of-pack labeling requirements and jurisdictional expansion of extended producer responsibility (EPR) policies?",
      "original_answer": "In 2022, MDLZ noted that over 25 EU countries had implemented EPR policies and that restrictions on advertising products with specified nutrient profiles were in place, with similar policies being considered in India, Vietnam, Indonesia, and the Philippines. By 2023, the company reiterated the same EPR expansion but emphasized increased attention to front-of-pack labeling based on nutrient profiles and environmental claims, while also noting that single-use plastic bans and taxes were being considered in Indonesia and the Philippines. In 2024, MDLZ observed that the EU had formally adopted the Packaging and Packaging Waste Directive, and EPR policies were now being implemented or contemplated in India, Vietnam, and U.S. states, indicating a shift from contemplation to enforcement. The trend shows a growing regulatory burden across more jurisdictions, with increasing specificity around marketing restrictions tied to health and environmental claims.",
      "llm_answer": "In 2022, MDLZ’s 10‑K (p. 13‑17) disclosed that its sales and media‑marketing activities were subject to restrictions on promotions of nutrient‑profile products, front‑of‑pack labeling for nutrient and environmental claims, and EPR policies in more than 25 EU member states. The 2023 filing (p. 9‑13) reiterated these exposures and noted increasing regulatory scrutiny, but the jurisdictional scope remained largely unchanged. By 2024, the 10‑K (p. 9‑13) expanded the EPR exposure to include India, Vietnam and U.S. states, and highlighted that front‑of‑pack labeling and single‑use plastic bans were tightening across Europe and other markets, thereby widening MDLZ’s regulatory exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of MDLZ's exposure across 2022–2024 regarding EPR policies and marketing restrictions. It accurately notes that in 2022, over 25 EU countries had EPR policies and restrictions on nutrient-profile advertising, aligning with the ground truth. In 2023, it correctly observes continued emphasis on front-of-pack labeling and environmental claims. In 2024, it correctly identifies the expansion of EPR to India, Vietnam, and U.S. states, as well as tightening regulations on packaging and plastics. However, the LLM omits specific mention that the EU formally adopted the Packaging and Packaging Waste Directive in 2024—a key regulatory milestone highlighted in the original answer. It also does not explicitly state that single-use plastic bans and taxes were 'being considered' in Indonesia and the Philippines in 2023, instead generalizing tightening rules in 'other markets,' which slightly reduces precision. (2) Quantitatively, all references to jurisdictions (e.g., 'more than 25 EU member states') are consistent with the ground truth. No numerical calculations are required, and dates (2022, 2023, 2024) are correctly applied. (3) The multi-hop reasoning is sound: the model synthesizes information across years and jurisdictions, correctly tracking the expansion from EU-centric policies to broader global implementation. The linkage between EPR, front-of-pack labeling, and marketing restrictions is logically maintained. The only gap is the lack of specificity around the EU directive adoption, which weakens the 2024 analysis slightly. (4) Despite minor omissions, the LLM answer conveys the core trend—increasing regulatory burden across more regions with growing specificity on health and environmental claims—making it contextually fully relevant and semantically close to the original. The score reflects high accuracy with minor qualitative shortcomings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 522,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency across three years indicate about MA's capital structure strategy?",
      "original_answer": "Across 2022, 2023, and 2024, A Class shares consistently maintained one vote per share and dividend rights, indicating no changes in their voting or dividend entitlements over the three-year period. This stability suggests that MA has maintained a consistent capital structure strategy with respect to A Class shares, preserving their governance and economic rights without alteration.",
      "llm_answer": "Between 2022 and 2024, Mastercard’s A‑class common shares consistently retained **one vote per share and dividend rights** as shown in the “Classes of Capital Stock” tables of the 2022, 2023, and 2024 Form 10‑K filings. The unchanged voting and dividend status across all three years signals a deliberate capital‑structure strategy that prioritizes stability and predictability—preserving public investor voting power while maintaining a consistent dividend policy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns with the ground truth in all key aspects. (1) It accurately states that A Class shares maintained one vote per share and dividend rights from 2022 to 2024, which matches the original answer’s claim of consistency across the three years. (2) There are no numerical values requiring calculation, but the years (2022–2024) and the qualitative metrics (voting and dividend rights) are correctly cited. (3) The multi-hop reasoning is sound—by referencing the Form 10-K filings across three years, the model correctly synthesizes information to infer stability in capital structure. (4) The LLM adds interpretive depth by describing the strategy as 'prioritizing stability and predictability' and linking it to 'preserving public investor voting power' and 'consistent dividend policy,' which is a reasonable extension of the original answer’s conclusion about consistent capital structure strategy. The only minor difference is that the LLM provides slightly more interpretation than the original, but this does not introduce inaccuracy. All factual elements are correct, and the semantic meaning fully aligns with the ground truth. Hence, the correctness score is 9 (not 10) due to slight interpretive expansion without overstepping evidence, but all accuracy and relevance metrics remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 370,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Investments, advances and long-term receivables' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over this period?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements not offset against derivatives was $641 million at the end of 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This fluctuation suggests a dynamic derivative exposure profile, with a notable increase in margin requirements in 2023, followed by a significant reduction in 2024, potentially reflecting changes in market volatility, hedging strategies, or credit conditions.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements for the “Investments, advances and long‑term receivables” line fell from **$1.49 billion** at 12/31/2022 to **$800 million** at 12/31/2023 and further to **$491 million** at 12/31/2024. The downward trend indicates that the company is requiring less initial margin, suggesting a reduction in its overall derivative exposure or more efficient netting/hedging practices that lower margin requirements over the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the starting value for 2022. The ground truth states that collateral was $641 million in 2022, but the LLM incorrectly reports it as $1.49 billion. The 2023 and 2024 values ($800 million and $491 million) are correct and match the ground truth. This major error in the initial figure undermines the entire trend analysis. (2) Quantitative accuracy is low because the first data point is more than double the correct amount—this is not a formatting or rounding issue but a clear factual discrepancy. The subsequent decrease described in the LLM answer is based on an incorrect premise. (3) The reasoning is partially sound: the LLM correctly interprets a declining trend from 2023 to 2024 and infers reduced margin requirements or improved hedging. However, it misses the key increase from 2022 to 2023 (since it reports a decrease instead), failing to capture the 'fluctuating' or 'dynamic' nature of exposure emphasized in the original answer. Thus, the multi-hop synthesis across years is flawed due to the incorrect 2022 value. (4) Despite the incorrect numbers, the answer addresses all parts of the question—change over time and implications for derivative exposure—and uses appropriate financial reasoning. Contextual relevance is high because it discusses the right metric, time frame, and implications, even if based on inaccurate data. However, the core factual error in the 2022 figure severely limits correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 412,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Starbucks' forward-looking supply chain commitments to coffee producers evolve from fiscal 2022 through fiscal 2024, and what does this progression indicate about the company's strategy for managing coffee price volatility and supply risk?",
      "original_answer": "In fiscal 2022, Starbucks secured an adequate supply of green coffee through purchase commitments expected to last through fiscal 2023. By fiscal 2023, the company extended its forward-looking commitments, projecting adequate supply through fiscal 2025. This trend continued into fiscal 2024, with Starbucks maintaining the same extended supply assurance through 2025, indicating a strategic shift toward longer-term stability in sourcing and price hedging. The company also consistently utilized forward contracts, futures contracts, and collars across all three years to manage 'C' price exposure, showing an evolving but consistent risk mitigation approach in response to coffee price volatility.",
      "llm_answer": "Starbucks’ forward‑looking coffee‑purchasing strategy has been steadily extended: in FY 2022 the company’s fixed‑price and price‑to‑be‑fixed purchase commitments, together with forward contracts, futures and collars, were expected to cover through fiscal 2023; in FY 2023 that horizon was pushed to fiscal 2024; and in FY 2024 it was further extended to fiscal 2025 【SBUX_10k_2022.pdf: page 12】【SBUX_10k_2023.pdf: page 12】【SBUX_10k_2024.pdf: page 12】. This progression shows a deliberate strategy to lock in coffee prices and secure supply over a longer period, thereby reducing exposure to price volatility and supply risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but contains a minor inaccuracy in the timeline progression compared to the ground truth. According to the original answer, in fiscal 2022, Starbucks had commitments expected to last through fiscal 2023; by fiscal 2023, this was extended through fiscal 2025 (a two-year extension), not just to fiscal 2024 as stated in the LLM answer. The LLM incorrectly frames the FY2023 horizon as 'fiscal 2024' and implies a stepwise one-year extension each year, when in fact the extension from FY2023 was directly to FY2025. This affects quantitative and qualitative accuracy. However, the core facts—progressive extension of supply commitments, use of financial instruments (forwards, futures, collars), and the strategic intent to mitigate price volatility and supply risk—are correctly identified and logically synthesized. The answer addresses both parts of the question: evolution over time and strategic implications. Entity accuracy (Starbucks, fiscal years, contract types) is correct. The reasoning is sound in direction but slightly flawed in temporal precision. Wording and semantic meaning are otherwise equivalent to the ground truth, and citations align with the correct documents and pages. Minor error in timeline does not undermine the overall conclusion but reduces precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 365,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ACN's target asset allocation mix for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment strategy and risk-adjusted return objectives?",
      "original_answer": "ACN's target asset allocation for its defined benefit pension plans showed a strategic shift over the three-year period. In fiscal 2023, the target allocation was referenced in the 2022 10-K filing, which outlined the investment return objective as exceeding inflation over the long term based on the target asset mix for each plan. By fiscal 2024, the company continued to emphasize risk-adjusted returns aligned with the overall investment strategy, maintaining a diversified portfolio of fixed income and equities, with specific attention to matching debt securities' duration to plan liabilities. In fiscal 2025, the target allocation was again referenced in the 2024 10-K, showing continuity in strategy but with updated flexibility ranges to respond to market conditions and required cash flows. This evolution suggests a consistent yet adaptive long-term investment approach focused on balancing return generation with liability matching and risk mitigation.",
      "llm_answer": "ACN’s target mix for U.S. defined‑benefit plans moved from 95 % debt and 5 % cash in fiscal 2023 to a full 100 % debt allocation by fiscal 2025, eliminating equity and cash. For Non‑U.S. plans, equity exposure rose from 19 % to 28 % while debt fell from 43 % to 36 %, with modest changes to cash, insurance contracts and other assets. This multi‑year shift signals a strategic emphasis on duration matching and risk‑controlled, stable returns for U.S. plans, and a higher risk‑adjusted growth objective for Non‑U.S. plans—aligning with the company’s long‑term goal of achieving returns that exceed inflation while maintaining funding levels.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) QUANTITATIVE INACCURACY: The LLM claims specific numerical allocations (e.g., 95% debt and 5% cash in 2023, 100% debt by 2025 for U.S. plans; equity rising from 19% to 28% in Non-U.S. plans), but the original answer (ground truth) contains no such percentages or asset class breakdowns. There is no mention of cash, equity, or debt percentages in the original, nor any indication of a shift from mixed assets to 100% debt. These numbers are fabricated. (2) COMPLETENESS: While the question asks about the evolution from 2023 to 2025 and strategic implications, the LLM invents granular data not present in the source, failing to reflect the actual content. The original emphasizes continuity in strategy with updated flexibility ranges, not a dramatic shift in allocation. (3) ENTITY & REASONING: The LLM introduces a U.S. vs. Non-U.S. plan distinction not mentioned in the original answer, and attributes specific allocation changes to each, which is unsupported. The reasoning about 'duration matching' and 'risk-controlled returns' aligns loosely with the original's mention of liability matching, but this is overshadowed by factual inaccuracies. (4) SEMANTIC EQUIVALENCE: The LLM answer is not semantically equivalent—it presents a detailed, data-driven narrative absent from the source. The original describes a consistent, adaptive strategy focused on inflation-beating returns, diversification, and liability matching, without specifying percentages or a shift toward full debt. The LLM’s answer is contextually relevant in discussing risk-adjusted returns and long-term objectives but fails on factual grounding. Thus, the correctness score is low due to invented data, despite some thematic alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 485,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus and intellectual property protection timeline?",
      "original_answer": "In 2022, Amgen was investigating Olpasiran, an siRNA drug, in phase 2 trials for the treatment of atherosclerotic cardiovascular (CV) disease. By 2023, the company disclosed that Olpasiran had U.S. and European patent protection for 'Compounds' estimated to expire in 2036, signaling strong intellectual property positioning. In 2024, Olpasiran was listed as being indicated for 'Cardiovascular disease,' suggesting a continued focus on CV applications and a transition from phase 2 investigation toward more advanced development or potential regulatory preparation. This progression reflects a strategic evolution from early clinical investigation to therapeutic consolidation and IP protection.",
      "llm_answer": "Across the 2022, 2023 and 2024 10‑Ks, Amgen kept Olpasiran as a Phase 2 siRNA program focused on lowering lipoprotein(a) for atherosclerotic cardiovascular disease (see the Phase 2 table on pages 24‑28 of the 2022 and 2023 filings and pages 22‑26 of the 2024 filing).  The company secured composition‑of‑matter patents in the U.S. and Europe that were already issued by 2022 and remain in force through 2024, with estimated expirations in 2036, providing a 12‑year exclusivity window for the compound.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but contains a key discrepancy in the timeline of patent issuance. The original answer states that Amgen *disclosed* the U.S. and European patent protection for 'Compounds' with estimated expiration in 2036 *in 2023*, while the LLM claims the patents were 'already issued by 2022 and remain in force through 2024'. This misrepresents the timing of the disclosure and potentially the status of the patents, as the ground truth does not confirm issuance by 2022—only that protection was disclosed in 2023. The 2036 expiration date is correctly reported, and the format variation (2036) is acceptable. The therapeutic focus on atherosclerotic cardiovascular disease via lipoprotein(a) reduction is accurately maintained across all years, and the Phase 2 status is consistent with the original answer for 2022 and 2023. However, the original answer notes a strategic evolution in 2024 where Olpasiran was listed as indicated for 'Cardiovascular disease', suggesting progression toward advanced development or regulatory preparation, which the LLM does not reflect—it instead reiterates Phase 2 status from earlier years, missing the nuance of development stage progression. This omission affects completeness and qualitative accuracy. The LLM correctly identifies the compound as an siRNA and ties IP protection to a 12-year exclusivity window (2024 to 2036), which is a reasonable inference. Multi-hop reasoning is partially sound—linking clinical focus and IP across years—but fails to fully synthesize the strategic shift implied in the 2024 update. Contextual relevance is strong, as all information pertains directly to the question. Overall, core facts (therapeutic area, mechanism, patent expiry) are correct, but the evolution narrative is underdeveloped and the patent timeline is inaccurately backdated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 496,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did American Express's reliance on aggregators evolve from 2022 through 2024, and what risks associated with these third-party relationships were emphasized in each year's disclosures?",
      "original_answer": "From 2022 to 2024, American Express increasingly emphasized its reliance on aggregators and the associated risks, particularly around merchant steering, surcharging, and third-party operational disruptions. In 2022, AXP expressed concern over how aggregators might act against AXP's interests, potentially impacting card usage and merchant acceptance. In 2023, the company noted an increased dependency on aggregators and processors to manage merchant relationships, with added emphasis on how surcharging and steering could reduce transaction volumes. By 2024, AXP highlighted broader operational and legal risks, including litigation exposure and potential changes in business practices due to third-party failures or regulatory actions. The trend shows a growing awareness and formalization of risks tied to aggregator relationships, shifting from a focus on merchant behavior to broader systemic and legal concerns.",
      "llm_answer": "From 2022 through 2024, American Express disclosed a steadily growing reliance on merchant acquirers, aggregators and processors to run its merchant‑acceptance and cobrand programs, with the 2024 filing noting an even greater dependence and the need to offer larger incentives and concessions. In 2022 the risk emphasis was on the possibility of losing partner relationships, renegotiating on less‑favorable terms, and third‑party goals that could conflict with the company’s; in 2023 the disclosure added concerns about third‑party operational failures, data‑security breaches and regulatory shifts; and by 2024 it highlighted the heightened risk of losing merchant relationships, the impact of increased incentives and concessions, and the potential for third‑party disruptions or regulatory changes to materially affect card acceptance and network volumes.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of American Express's reliance on aggregators and third-party processors from 2022 to 2024. It accurately captures the increasing dependence and the shifting risk focus over time. Quantitatively, there are no specific numbers (e.g., dollar amounts, percentages) in either the original or LLM answer, so the score is 10 by default—no inaccuracies. The qualitative accuracy is high: the LLM correctly identifies 2022 risks as partner loss, unfavorable renegotiations, and misaligned third-party goals; 2023 additions include operational failures, data breaches, and regulatory shifts; and 2024 highlights increased incentives, merchant relationship losses, and material impacts from disruptions or regulation. However, the LLM omits specific risks emphasized in the ground truth such as 'merchant steering' and 'surcharging' in 2023, and 'litigation exposure' in 2024. Instead, it generalizes with 'regulatory changes' and 'disruptions,' which are related but not as precise. The answer also introduces 'cobrand programs' and 'larger incentives' in 2024, which are plausible but not explicitly mentioned in the ground truth. Despite these minor omissions and slight rephrasing, the core multi-hop reasoning—tracking the evolution of risk disclosures across years—is sound and contextually relevant. The answer addresses both parts of the question: evolution of reliance and risk emphasis per year. Thus, the correctness score is 8 due to missing key specifics in risk categorization, though the overall trajectory and synthesis are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 445,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through fiscal 2024, and what changes occurred in the company's forward supply commitments during this period?",
      "original_answer": "Starbucks consistently cited commodity index funds as a factor influencing green coffee price volatility across all three fiscal years. In 2022, the company expected its purchase commitments and inventory to cover supply needs through fiscal 2023. By 2023, Starbucks extended its supply outlook to fiscal 2025, signaling increased confidence in its forward contracting strategy amid ongoing price pressures from futures market activity. This forward-looking supply assurance remained unchanged in 2024, indicating a stabilized hedging and procurement strategy despite continued exposure to commodity index fund trading in arabica coffee futures. The multi-year extension of supply commitments suggests a strategic shift toward longer-term risk mitigation in response to market volatility driven by financial participants like index funds.",
      "llm_answer": "Starbucks has consistently reported that green‑coffee price volatility is driven in part by trading activity in the arabica futures market—including hedge funds and commodity‑index funds—and it has continued to hedge “C”‑price exposure with forward contracts, futures and collars.  Over the three‑year period the company extended its forward purchase commitments each year: in fiscal 2022 commitments were projected to cover supply through fiscal 2023, in fiscal 2023 through fiscal 2024, and in fiscal 2024 through fiscal 2025.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies Starbucks' exposure to commodity index funds and the role of arabica futures market activity in green coffee price volatility, as well as the company's use of hedging instruments like forward contracts, futures, and collars. It accurately reports the forward purchase commitments for each fiscal year: 2022 commitments covering through 2023, 2023 through 2024, and 2024 through 2025. However, there is a key factual discrepancy: the original answer states that in 2023, Starbucks extended its supply outlook to fiscal 2025 (not 2024), and this remained unchanged in 2024—indicating a multi-year extension rather than annual incremental updates. The LLM implies a yearly one-year extension (e.g., 2023 → 2024), which contradicts the ground truth that the extension to 2025 occurred in 2023 and was maintained in 2024. This undermines the qualitative accuracy regarding the strategic shift and stabilization of procurement strategy. While most entities, years, and mechanisms are correctly identified, the misrepresentation of the timeline of forward commitments constitutes a significant error in multi-hop reasoning and synthesis across years. Quantitative accuracy is high—dates and fiscal year projections are mostly correct in format and context—but the misalignment in the forward-looking horizon reduces precision. Contextual relevance is excellent, as the response directly addresses both parts of the question: evolution of exposure and changes in supply commitments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 413,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this multi-year trajectory indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase strategy showed a significant upward trajectory from fiscal 2022 through fiscal 2024. In fiscal 2022, the company had an aggregate available authorization of $3,129,296 for share purchases and redemptions. By fiscal 2023, the company had purchased 2,000,308 Class A ordinary shares for $605 million under the open-market program, and the total available authorization stood at $2,694 million as of August 31, 2024. In fiscal 2024, Accenture further bolstered its repurchase capacity by securing an additional $4,000 million in authority, raising the total outstanding repurchase authorization to $6,694 million by September 25, 2024. This demonstrates a consistent and expanding commitment to returning capital to shareholders through share repurchases, with increasing authorization and active execution over the three-year period.",
      "llm_answer": "Accenture repurchased $4.111 billion of shares in fiscal 2022 (12.18 million shares) and $4.5 billion in fiscal 2024, with the open‑market program contributing $605 million in 2024; the Board added $3 billion of additional authority in 2022 (raising total authority to $6.129 billion) and $4 billion in 2024 (raising total authority to $6.694 billion). The aggregate available authorization for the open‑market program fell slightly from $3.129 billion in 2022 to $2.694 billion in 2024, yet the program remains open‑ended and is periodically reaffirmed, underscoring Accenture’s disciplined, flexible capital‑return strategy that consistently returns excess cash to shareholders.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple critical factual errors. First, it claims Accenture repurchased $4.111 billion of shares in fiscal 2022, but the ground truth states no actual repurchase amount for 2022—only that the available authorization was $3.129 billion. Similarly, the LLM states $4.5 billion repurchased in fiscal 2024, which is not supported by the ground truth; the only repurchase figure provided is $605 million in fiscal 2023. The LLM incorrectly attributes the $605 million repurchase to fiscal 2024 instead of 2023. Additionally, the LLM claims $3 billion was added in 2022, raising total authority to $6.129 billion, but the ground truth does not mention any increase in 2022—only that the available authorization was $3.129 million (not billion). The $4 billion increase in 2024 is correct and correctly results in a total authorization of $6.694 billion. However, the LLM incorrectly states that the available authorization fell from $3.129 billion in 2022 to $2.694 billion in 2024, while the ground truth shows the $2.694 million figure was as of August 31, 2024, before the $4 billion increase. The LLM also misrepresents the timeline and magnitude of repurchases and authorizations. (2) Key number mismatches: $4.111B repurchase in 2022 (fabricated), $4.5B in 2024 (fabricated), $605M repurchase misdated to 2024 instead of 2023, $3.129B available in 2022 (truth is $3.129M), and incorrect interpretation of authorization changes. (3) Multi-hop reasoning fails: the model conflates available authorization with actual repurchases, misaligns fiscal years, and invents figures not present in the source. It fails to correctly trace the evolution of authorization and repurchases across years. (4) Despite severe factual and quantitative inaccuracies, the answer is contextually relevant in discussing Accenture’s capital return strategy and attempts to synthesize repurchase activity and authorization trends. However, due to pervasive numerical and temporal errors, the correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 546,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the value of Google's marketable equity securities subject to long-term lock-up restrictions change from 2022 to 2024, and what does this fluctuation suggest about the company's investment strategy in illiquid assets over this period?",
      "original_answer": "The value of Google's marketable equity securities under long-term lock-up restrictions was $1.4 billion in 2022, decreased to $803 million in 2023, and then returned to $1.4 billion by 2024. This fluctuation suggests a cyclical or strategic rebalancing of the company's holdings in illiquid investments, potentially reflecting changes in market conditions, liquidity needs, or long-term strategic positioning.",
      "llm_answer": "The long‑term portion of marketable equity securities subject to lock‑up restrictions rose from **$803 million** at 12/31/2022 to **$1.4 billion** at 12/31/2023, then fell sharply to **$266 million** at 12/31/2024. This swing—an 74 % jump followed by an 81 % decline—indicates that Google expanded its illiquid equity exposure in 2023 but then substantially pared it back in 2024, suggesting a shift toward more liquid assets or a rebalancing of its investment strategy to manage risk and liquidity.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values and trends. According to the ground truth, the value was $1.4 billion in 2022, decreased to $803 million in 2023, and returned to $1.4 billion in 2024. The LLM incorrectly states that the value rose from $803 million in 2022 to $1.4 billion in 2023 and then fell to $266 million in 2024—this reverses the correct trend between 2022 and 2023 and introduces a completely incorrect value for 2024. (2) The quantitative inaccuracies are severe: the LLM misreports the 2022 value (uses $803M instead of $1.4B), misstates the 2024 value ($266M vs correct $1.4B), and performs incorrect calculations (e.g., claiming a 74% jump and 81% decline based on wrong numbers). The actual change from 2022 to 2023 was a ~42.7% decrease, not a 74% increase. (3) The multi-hop reasoning is flawed because the model fails to correctly identify the direction and magnitude of changes across years, leading to an incorrect interpretation of Google’s strategy. While the idea of strategic rebalancing is plausible, the LLM concludes a sharp reduction in illiquid assets by 2024, which contradicts the ground truth showing a return to the original level. (4) Contextual relevance is moderate—the response addresses the right question about investment strategy and attempts to interpret fluctuations, but due to incorrect data, the conclusion is misleading. The qualitative reasoning would score higher if based on accurate numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 412,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its strategic positioning, valuation, and ultimate disposition, and what financial impact did this progression have on GE across the three-year period?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive industrial insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion at year-end. By 2023, GE had classified EIC as held for sale, with assets of $541 million and liabilities of $378 million as of December 31, 2023, and recorded a $109 million loss related to the expected sale. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic exit from a non-core business, with a significant loss recognized in 2023 and final monetization in 2024, indicating a shift in GE's portfolio toward more focused industrial operations.",
      "llm_answer": "From 2022 to 2024 GE shifted Electric Insurance Company (EIC) from a core captive insurer to a held‑for‑sale asset and finally sold it. In 2022 EIC was classified as held for sale with a $17 million valuation allowance (2022 10‑K, p. 45‑49); by 2023 the allowance rose to $124 million and GE recorded a $109 million loss on the held‑for‑sale classification (2023 10‑K, p. 48‑52). The asset was sold in 2024 for $120 million cash, yielding a gain of roughly $81 million (net of the $39 million carrying amount) and eliminating the valuation allowance, thereby improving GE’s balance sheet and cash position (2024 10‑K, p. 46‑50).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. According to the ground truth, in 2022 EIC was not classified as held for sale but was still operating as a captive insurer with $0.2 billion in net claim reserves. The LLM incorrectly states that EIC was classified as held for sale in 2022 and cites a $17 million valuation allowance, which does not appear in the ground truth. The ground truth confirms that the $109 million loss was recorded in 2023 when EIC was classified as held for sale, which the LLM correctly notes. However, the LLM invents a $124 million valuation allowance in 2023 and claims a subsequent $81 million gain on sale in 2024, which directly contradicts the ground truth: the sale yielded $120 million cash but no gain is mentioned, and given the prior loss recognition, a gain is unlikely. The ground truth does not mention a $39 million carrying amount or any gain. (2) The only correct numbers are the $109 million loss in 2023 and the $120 million sale price in 2024. All other figures (e.g., $17M, $124M, $81M gain, $39M carrying amount) are incorrect or unsupported. Calculations are therefore invalid. (3) The multi-hop reasoning is partially sound in tracking EIC’s transition from operational to sold, but the LLM misrepresents the timeline (wrongly placing 'held for sale' classification in 2022) and misstates financial impacts. It fails to mention EIC’s role as a captive insurer in 2022 as per the ground truth. (4) Scores reflect major quantitative errors (3/10), partial qualitative accuracy in strategic trajectory but flawed details (5/10), high contextual relevance as it addresses the evolution and financial impact (8/10), and an overall correctness score of 4 due to core factual errors undermining the answer despite some correct elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 501,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Amgen's Phase 3 clinical program portfolio evolve from 2022 through 2024, and what does the progression from 13 to 25 programs reveal about the company's R&D pipeline expansion and strategic focus during this period?",
      "original_answer": "Amgen's Phase 3 clinical program portfolio grew significantly from 13 programs in 2022 to 24 programs in 2024, with a notable increase to 18 programs in 2023. This growth reflects the company's strategic expansion in late-stage drug development, including the acquisition of five programs from Horizon in 2023 and the continued initiation of new Phase 3 studies. By 2024, Amgen had added one more program, bringing the total to 25, while also achieving regulatory approvals in both the U.S. and Japan. This trajectory indicates a focused effort to build a robust and diversified late-stage pipeline.",
      "llm_answer": "Amgen’s Phase 3 portfolio expanded from 13 programs in 2022 (including new approvals and initiations) to 18 in 2023 and 24 by early 2024, reaching 25 by February 2025 (2022 10‑K p.25; 2023 10‑K p.27; 2024 10‑K p.24; 2024 10‑K p.27). This growth reflects a deliberate strategy to broaden its late‑stage pipeline, diversify therapeutic areas (oncology, immunology, cardiovascular), and accelerate development through acquisitions (e.g., Horizon programs) and a focus on biologics and human‑genetics‑driven targets (2024 10‑K p.24).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely correct in its factual content. It accurately reports the growth of Amgen's Phase 3 portfolio from 13 programs in 2022 to 18 in 2023 and 24 by early 2024, which aligns with the ground truth. However, it states the count reached 25 by February 2025, whereas the original answer specifies 25 programs were reached by 2024. This minor temporal misalignment slightly affects precision, though the overall trend is correct. (2) Quantitatively, the numbers 13 (2022), 18 (2023), and 24 (early 2024) are accurate. The mention of 25 by February 2025 instead of 2024 introduces a small error in timing, but the final count of 25 is correct. The ground truth confirms the total reached 25 by 2024, not 2025. (3) The multi-hop reasoning is sound: the LLM correctly infers strategic expansion from acquisitions (e.g., Horizon), diversification across therapeutic areas, and a focus on biologics and human-genetics-driven targets, which are all supported by the 2024 10-K and consistent with the strategic narrative in the original answer. (4) The answer is contextually excellent, addressing both the evolution of the portfolio and the implications for R&D strategy. The only deduction is for the slight date misplacement of the 25th program, which does not undermine the overall correctness but prevents a perfect score. Semantic equivalence is maintained, and the reasoning is robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 392,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has American Express's relationship with global card networks evolved from 2022 to 2024 in response to regulatory pressures and competitive dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with global card networks shifted from a primarily competitive posture to a more complex dynamic influenced by increasing regulatory scrutiny. In 2022, AXP clearly positioned itself as a competitor to other card networks like Visa, Mastercard, and China UnionPay, emphasizing differentiation through premium benefits and cobrand partnerships. By 2023, this competitive stance remained, but there was growing emphasis on the challenges posed by alternative payment platforms like Alipay and PayPal, as well as increasing competition for unique partner offerings such as lounge access and travel benefits. In 2024, regulatory pressures significantly impacted AXP’s relationship with card networks, particularly in the EU and Australia, where AXP exited its network licensing businesses due to regulatory constraints. Additionally, AXP faced uncertainty regarding cobrand arrangements in the EU due to differing regulatory interpretations. This evolution shows a trajectory from direct competition to a more constrained environment shaped by regulatory dependencies, particularly in international markets.",
      "llm_answer": "Between 2022 and 2024, American Express has scaled back its global card‑network licensing, exiting EU and Australian arrangements in response to regulatory scrutiny and tightening interchange‑fee and surcharging rules that have pressured discount revenue. The company has sharpened its focus on premium cardholder value and cobrand partnerships to compete with Visa, Mastercard, China UnionPay and other networks, while its designation as a Category III bank‑holding firm underscores the heightened regulatory expectations it now faces. These shifts reflect a broader industry trend toward tighter regulation of network operations and a competitive push to differentiate through rewards, travel benefits and digital services.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of American Express's relationship with global card networks from 2022 to 2024 as described in the ground truth. (1) It correctly identifies the key developments: regulatory pressures leading to the exit from network licensing in the EU and Australia, which aligns with the original answer's mention of AXP exiting these markets due to regulatory constraints. The emphasis on interchange-fee and surcharging rules as drivers is consistent with the regulatory scrutiny theme. (2) There are no numerical values, dates, or financial metrics in dispute; all timeframes (2022–2024) and references to regulatory actions are factually aligned. The designation as a Category III bank-holding company is an additional accurate contextual detail not in the original but factually correct and relevant. (3) The multi-hop reasoning is sound: the answer synthesizes regulatory impact, competitive dynamics, and strategic shifts across geographies and time. It correctly infers that AXP responded by focusing on premium value and cobrand partnerships to differentiate from Visa, Mastercard, and China UnionPay—matching the original’s emphasis. (4) The only minor gap is that the LLM answer does not explicitly mention the rising competitive threat from Alipay and PayPal or the uncertainty around cobrand arrangements in the EU, which were noted in the original. However, it broadly covers competitive dynamics and regulatory dependencies. Wording differs but semantic meaning is equivalent. Thus, the answer is factually correct, contextually relevant, and only slightly less detailed in one aspect of competitive threats.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 455,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent use of proceeds for share repurchases evolve from 2022 through 2024, and what were the specific dollar amounts and share volumes associated with these actions across the three-year period?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, which continued into 2022 when it sold its remaining 91 million CVE shares. In 2022, the company repurchased a total of 383 million shares at a cost of $29 billion under its share repurchase program. By 2024, the company had repurchased a cumulative total of 433 million shares at a cost of $34.3 billion since the inception of the program, with the share repurchase authorization increased to $65 billion in October 2024. This shows a clear progression of asset monetization followed by capital return to shareholders through share buybacks.",
      "llm_answer": "ConocoPhillips finished monetizing its remaining 91 million CVE common shares in 2022, with the proceeds earmarked for share repurchases.  Share‑repurchase activity grew from 383 million shares at a cost of $29 billion in 2023 to 433 million shares at $34.3 billion in 2024, as the company’s authorization was expanded from $45 billion to $65 billion (2024 10‑K, pp. 110‑114; 2023 10‑K, pp. 108‑112).  The 2022 sale of CVE shares was a one‑time event; the filings do not disclose the dollar proceeds, but they were applied to fund the share‑repurchase program.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the timeline and amounts associated with share repurchases. It incorrectly states that the 383 million shares at $29 billion were repurchased in 2023, while the ground truth indicates this occurred in 2022. This misplacement of a key financial figure across years undermines the quantitative accuracy. Additionally, the LLM implies growth in repurchase activity from 2023 to 2024, but the ground truth does not provide annual breakdowns for 2023 or 2024 individually—only cumulative totals since program inception. The cumulative repurchase of 433 million shares at $34.3 billion by 2024 is correctly reported, as is the $65 billion authorization increase in October 2024. However, the LLM incorrectly suggests the prior authorization was $45 billion (not stated in ground truth), introducing an unsupported figure. (2) The monetization of 91 million CVE shares in 2022 is accurate, but the LLM notes that 'filings do not disclose the dollar proceeds,' which is contextually reasonable but slightly contradicts the ground truth implication that proceeds were used for repurchases—though exact sale proceeds are indeed not specified. The core error remains the misattribution of the $29 billion / 383 million share repurchase to 2023 instead of 2022. (3) The multi-hop reasoning is partially sound—linking asset monetization to share repurchases is correct, and the use of cumulative data by 2024 shows synthesis. However, the incorrect temporal assignment of major transactions breaks the logical evolution across the three-year period, especially distorting the 2022–2023 progression. (4) Contextual relevance is high—the answer addresses the evolution, monetization, and repurchases with appropriate entities (ConocoPhillips, CVE shares, share repurchases) and cites correct document sources. Despite this, the quantitative inaccuracies in timing and amounts significantly reduce overall correctness, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 543,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the availability of shares under The Home Depot Omnibus Stock Incentive Plans evolve from 2022 through 2024, and what does this trend indicate about the company's stock-based compensation capacity and utilization over time?",
      "original_answer": "In 2022, there were 117 million shares available under the 2005 Plan. By 2023, under the newly amended Omnibus Plan, approximately 77 million shares remained available for future grants. This further declined to 70 million shares by 2024, indicating a consistent drawdown on available shares. This trend shows a steady utilization of the share pool for stock-based compensation, suggesting increased use of equity awards over the three-year period, even as the company maintained a replenishment mechanism tied to expirations and forfeitures.",
      "llm_answer": "At the end of fiscal 2022 the Omnibus Plan’s authorized share pool was 80 million shares (the maximum available for issuance)【HD_10k_2022.pdf:65-69】.  The 2023 filing shows the available pool had fallen to about 77 million shares, and the 2024 filing reports it further declined to roughly 70 million shares【HD_10k_2023.pdf:67-68】【HD_10k_2024.pdf:70-71】.  This downward trend indicates Home Depot has been steadily drawing on its equity‑compensation capacity, tightening the share pool and reflecting higher utilization of stock‑based awards over time.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a discrepancy in the 2022 available shares. The ground truth states 117 million shares were available under the 2005 Plan in 2022, while the LLM claims 80 million under the Omnibus Plan. This is a significant quantitative error, though the subsequent figures (77M in 2023 and 70M in 2024) match the ground truth and are correctly cited from the respective 10-Ks. (2) The calculation of the downward trend (80M → 77M → 70M) is accurate within the LLM's own numbers, but the starting point is incorrect. The actual drawdown from 117M to 70M is more substantial than implied, affecting the interpretation of utilization intensity. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years of filings, identifies the trend, and infers increasing utilization of stock-based compensation. It correctly links the declining share pool to higher usage of equity awards, aligning with the ground truth's conclusion. (4) Contextual relevance is excellent—the answer directly addresses both parts of the question: the evolution of share availability and its implications for compensation capacity and utilization. Despite the initial number error, the reasoning and trajectory are logically consistent with the data it presents. The score is reduced due to the material inaccuracy in the 2022 figure, but not severely penalized because the trend analysis and interpretation remain valid based on the cited trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 414,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By 2023 and 2024, this number had increased to 141,000,000, indicating a strategic expansion in the company's capacity to issue share-based awards. The increase suggests a growing emphasis on equity-based incentives as part of Accenture’s long-term compensation strategy, aligning executive and employee interests with shareholder value creation.",
      "llm_answer": "Accenture raised the authorized pool for the Amended 2010 Share Incentive Plan from **127 million shares in 2022** (ACN_10k_2022, pp. 89‑93) to **141 million shares in 2023** (ACN_10k_2023, pp. 81‑85) and kept that level in 2024 (ACN_10k_2024, pp. 96‑100). The 14 million‑share expansion reflects a deliberate broadening of the equity pool to support larger or more frequent share‑based awards, underscoring the company’s focus on equity as a key tool for attracting, retaining, and aligning talent with shareholder interests while managing dilution.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 127 million shares in 2022 and 141 million in both 2023 and 2024. The increase of 14 million shares is correctly implied (141M - 127M = 14M). Format variations (127 million vs. 127,000,000) are acceptable and semantically equivalent. (2) The answer is complete, addressing both the evolution of the share authorization from 2022 to 2024 and the strategic implication of the increase. (3) Entity accuracy is correct: Accenture plc, the Amended 2010 SIP, and the correct fiscal years (2022, 2023, 2024) are properly identified. (4) The reasoning is sound and reflects multi-hop synthesis across three years of 10-K filings. The conclusion about strategic use of share-based compensation—emphasizing talent attraction, retention, alignment with shareholders, and managed dilution—aligns with and expands upon the ground truth without introducing inaccuracies. The inclusion of document citations (e.g., ACN_10k_2022) adds verifiability. Overall, the answer demonstrates precise factual recall, correct calculations, and appropriate qualitative interpretation, meeting all evaluation criteria at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 345,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the weighted average yield on American Express's foreign government bonds and obligations change from 2022 to 2024, and what does this trend suggest about the company's exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations with a weighted average yield of 5.86% for instruments due within one year. By 2023, the weighted average yield on these same instruments due within one year had increased to 6.45%, suggesting heightened exposure to rising international interest rates. However, in 2024, this yield dropped back down to 5.86%, indicating a partial reversal in the trend, possibly due to stabilization or strategic portfolio adjustments. This trajectory reveals a volatile exposure to international interest rate movements over the three-year period, with a peak in 2023 followed by a return to 2022 levels by 2024.",
      "llm_answer": "The weighted‑average yield on American Express’s foreign government bonds and obligations was 2.08 % in 2022 and remained at 2.08 % in 2024, indicating that the company’s exposure to international interest‑rate movements has stayed essentially unchanged over that period【commentary to be inserted: 2021 table reference】. This flat trend suggests that American Express’s portfolio of foreign sovereign debt has not been significantly affected by shifts in global rate environments, maintaining a stable cost of capital for its international holdings.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The ground truth states that the weighted average yield was 5.86% in 2022, increased to 6.45% in 2023, and returned to 5.86% in 2024. The LLM claims the yield was 2.08% in both 2022 and 2024 with no change, which is factually wrong. There is no mention of 2023 data in the LLM response, omitting a critical year for trend analysis. (2) The quantitative inaccuracies are severe: the correct yields are 5.86%, 6.45%, and 5.86% across 2022–2024; the LLM reports 2.08% for both 2022 and 2024. The dollar amount of $630 million in foreign government bonds in 2022 is also missing from the LLM answer. The LLM incorrectly references a '2021 table' in commentary, which is irrelevant and erroneous. (3) The multi-hop reasoning is flawed: the question requires synthesizing yield changes over three years and interpreting exposure to international interest rate environments. The LLM fails to recognize the volatility (increase then decrease) and instead asserts stability, leading to an incorrect conclusion about exposure. The ground truth identifies a peak in 2023 and a reversal in 2024—this dynamic is completely missed. (4) The contextual relevance is low but not zero because the LLM addresses the right topic (yield on foreign government bonds and interest rate exposure) and the right company (American Express), so some thematic relevance remains. However, due to massive factual and quantitative errors, the answer fails on correctness, quantitative accuracy, and qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 433,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did American Express's yield profile from Foreign Government Bonds and Obligations evolve from 2022 to 2024, and what does the progression in weighted average yields (6.45% in 2023, 5.85% in 2024, and the 2022 fair value distribution) indicate about the company's investment strategy and market conditions?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a majority (628 million) maturing within one year, indicating a short-duration focus. In 2023, the weighted average yield on these bonds was 6.45%, the highest among all categories. By 2024, the yield on Foreign Government Bonds and Obligations had decreased to 5.85%, still relatively high compared to other instruments. This decline suggests a potential shift in market conditions or a strategic adjustment in the composition of the portfolio, possibly reducing exposure to higher-yielding, shorter-duration instruments in favor of more stable or diversified maturities. The trend reflects either a response to falling interest rates or a deliberate risk management move.",
      "llm_answer": "American Express’s weighted‑average yield on foreign government bonds and obligations fell from 6.45 % in 2023 to 5.85 % in 2024, while the 2022 fair‑value distribution was $630 million—almost all (≈99.8 %) due within one year, with only a 0.2 % split between 1‑5‑year and 5‑10‑year maturities (2022 10‑K, pp. 119‑123). The downward yield trend, coupled with the 2022 short‑term concentration, indicates a conservative, liquidity‑focused portfolio that has gradually shifted toward lower‑yielding, longer‑dated securities as market rates declined, reflecting a risk‑averse strategy in a tightening rate environment.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key quantitative data: $630 million fair value in 2022, 6.45% yield in 2023, and 5.85% yield in 2024. It accurately notes the short-duration focus in 2022, though it overstates the precision by claiming ≈99.8% maturing within one year and splitting the remainder, while the ground truth only specifies 'a majority (628 million)' maturing within one year—this is a minor over-specification but not factually incorrect. (2) All numbers and percentages are correctly reported; the $630M amount and yield figures (6.45%, 5.85%) match the ground truth exactly. The LLM infers a 0.2% split in maturities beyond one year, which is not explicitly stated in the original answer and represents an unjustified extrapolation—this slightly undermines quantitative precision. (3) The multi-hop reasoning is sound: the model correctly synthesizes the 2022 maturity profile with the 2023 and 2024 yield trends to infer a strategic shift. It draws a logical conclusion about a move toward longer-dated securities in response to declining rates, aligning with the original answer’s suggestion of a potential strategic adjustment or response to market conditions. However, the original answer does not mention a 'tightening rate environment'—this is a mischaracterization, as falling yields typically reflect a loosening or peak-rate environment, not tightening, which slightly weakens qualitative accuracy. (4) Despite this, the answer remains contextually relevant, addressing all parts of the question—evolution of yield profile, interpretation of yield progression, and implications for strategy and market conditions—with strong factual grounding and coherent synthesis. The minor over-precision and one incorrect macroeconomic characterization prevent a top score, but core facts and reasoning are solid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 500,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the presentation and disclosure of COP's 7% Debentures due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year progression indicate about the company's approach to reporting this debt instrument?",
      "original_answer": "In 2022, COP disclosed the 7% Debentures due 2029 alongside its Common Stock, listing both with the trading symbol and CUSIP number under the New York Stock Exchange. In 2023, the company separated the debentures into its own row in the registration table, providing clearer distinction as a separate class of security with its own CUSIP-718507BK1 identifier. By 2024, COP maintained this structured disclosure, reaffirming the debentures' separate registration and continuing to use the same CUSIP, indicating a consistent and more transparent treatment of this debt instrument over time. This evolution suggests a growing emphasis on clarity and specificity in debt disclosure practices.",
      "llm_answer": "In the 2022 10‑K, the 7 % Debentures due 2029 were listed together with common stock in the “Securities registered pursuant to Section 12(b)” table (COP_10k_2022.pdf: page 2). The 2023 filing separated the debentures into its own row, making the debt instrument more prominent (COP_10k_2023.pdf: page 2). The 2024 filing returned to the combined presentation (COP_10k_2024.pdf: page 2). This pattern shows that while ConocoPhillips consistently discloses the debentures, it flexibly adjusts the presentation—likely to enhance clarity or comply with evolving SEC guidance—demonstrating a transparent yet adaptable reporting approach.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the 2024 filing description. While the ground truth states that COP maintained the separated, clearer disclosure in 2024 (continuing the structured treatment from 2023), the LLM incorrectly claims that the 2024 filing 'returned to the combined presentation,' which directly contradicts the ground truth. This misrepresents the multi-year trend and undermines the conclusion. (2) Quantitatively, the percentages (7%), years (2029 maturity), and document types (10-K filings) are correct. The mention of the CUSIP number is omitted in the LLM answer, but no incorrect numeric values are stated—only a mischaracterization of the presentation format. (3) The multi-hop reasoning fails because the LLM incorrectly synthesizes the 2024 data point, breaking the progression: 2022 (combined) → 2023 (separated) → 2024 (should be continued separation, but LLM says re-combined). This invalidates the conclusion about 'flexible adjustments' and 'returning' to prior format. The actual trend indicates increasing transparency, not oscillation. (4) The contextual relevance is moderate because the answer addresses the right documents and general topic of disclosure evolution, but the incorrect 2024 characterization leads to a flawed interpretation. The conclusion about 'transparent yet adaptable reporting' is not supported by the actual consistent improvement in disclosure clarity shown in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 405,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did NVIDIA's financial exposure to its 2.00% Notes Due 2031 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt management strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1.2 billion in 2022 to $1.057 billion in 2023, and then rose further to $1.25 billion in 2024, indicating a consistent long-term debt position with this instrument. This pattern suggests that NVIDIA maintained or slightly increased its long-term liability in the Notes Due 2031 over the three-year period, reflecting a stable approach to long-term financing.",
      "llm_answer": "NVIDIA’s carrying amount of the 2.00% Notes Due 2031 was $1.25 billion in FY 2022 (NVDA_10k_2022, p. 80), $1.25 billion in FY 2023 (NVDA_10k_2023, p. 67), and $1.25 billion in FY 2024 (NVDA_10k_2024, p. 71). The flat exposure over three years shows a long‑term debt strategy that prioritizes a stable maturity mix and coupon structure, avoiding large swings in long‑term debt while preserving refinancing flexibility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, NVIDIA's exposure to the 2.00% Notes Due 2031 was $1.2 billion in 2022, $1.057 billion in 2023, and $1.25 billion in 2024. However, the LLM claims the amount was $1.25 billion in all three years, which misrepresents the actual trend. This error fundamentally undermines the answer’s correctness. (2) The numbers are not accurate: the 2022 and 2023 figures are wrong. The LLM reports $1.25B for 2022 and 2023, but the correct values are $1.2B and $1.057B respectively. While $1.25B is correct for 2024, the prior years are significantly off. There are no calculations in the answer, but the comparison of stability is based on false equivalency. (3) The multi-hop reasoning is flawed because the model failed to correctly extract and compare the liability amounts across the three 10-K filings. Instead, it incorrectly asserts consistency, leading to an invalid conclusion about debt strategy. The ground truth shows a dip in 2023 followed by a rebound, suggesting possible repurchase or reclassification activity, not stability. The LLM’s conclusion about a 'flat exposure' and 'stable maturity mix' is therefore unsupported. (4) Despite the factual errors, the answer is contextually relevant—it addresses the right instrument, company, and time frame, and attempts to interpret the strategic implication, which earns it moderate qualitative and relevance scores. However, the quantitative inaccuracy severely limits its usefulness, warranting a low correctness score of 3.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 436,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Disney's strategic positioning of Marvel evolved across fiscal years 2022, 2023, and 2024, particularly in terms of its branding within streaming services and as a component of Disney's indefinite-lived intangible assets?",
      "original_answer": "In fiscal 2022, Marvel was listed alongside ESPN and Pixar as part of Disney's indefinite-lived intangible assets, indicating its long-term brand value. This was reaffirmed in 2024, showing continued recognition of Marvel's brand strength. In 2023, Marvel was specifically highlighted as a top-level branded tile within the Disney+ interface, underscoring its importance in driving subscriber engagement on Disney's key DTC platform. The consistent inclusion of Marvel in intangible assets across 2022 and 2024, combined with its prominent branding role in Disney+ in 2023, demonstrates Disney's strategic emphasis on leveraging Marvel's brand equity across both financial and content distribution dimensions over the three-year period.",
      "llm_answer": "Disney has kept Marvel as a **top‑level branded tile on Disney+** in each of the three fiscal years, reinforcing its central role in the streaming lineup with no shift to other platforms or bundling (2024 p. 112‑116; 2023 p. 5‑9; 2022 p. 108‑112).  Its trademarks remain classified as **indefinite‑lived intangible assets** at a constant carrying amount of **$1.792 billion** in each year’s balance sheet (2024 p. 112‑116; 2023 p. 5‑9; 2022 p. 108‑112), indicating a stable valuation and unchanged strategic emphasis.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative claims. It states that Marvel was a top-level branded tile on Disney+ in *each* of the three fiscal years (2022, 2023, 2024), but the ground truth only confirms this for 2023. Similarly, it claims the carrying amount of Marvel's trademarks was exactly $1.792 billion in *each* year, but the ground truth does not specify this number or confirm it remained constant—only that Marvel was included in indefinite-lived intangible assets in 2022 and 2024. These specific numerical assertions are unsupported and likely incorrect. (2) The cited dollar amount ($1.792 billion) and exact page references (e.g., 2024 p. 112–116) are presented with false precision and are not corroborated by the ground truth, which makes no mention of this figure or such consistent valuation. This severely undermines quantitative accuracy. (3) Qualitatively, the LLM correctly identifies the two key dimensions of strategic positioning—branding on Disney+ and classification as an indefinite-lived intangible asset—and attempts multi-hop synthesis across years. However, it overgeneralizes the 2023 Disney+ branding to all three years, failing to reflect the evolving, year-specific emphasis described in the ground truth. (4) Contextually, the answer is highly relevant and structured around the right concepts (streaming branding, intangible assets), but the incorrect attribution of consistent branding and valuation across all years leads to a misleading conclusion about 'unchanged strategic emphasis,' whereas the ground truth suggests a dynamic evolution—financial stability paired with a new streaming prominence in 2023. Thus, while the reasoning framework is sound, factual errors reduce overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 488,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did American Express's revenue structure and contractual arrangements with third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of discount revenue recognition, network rate fee negotiation, and merchant coverage expansion strategies?",
      "original_answer": "From 2022 to 2024, American Express's relationship with third-party merchant acquirers evolved significantly. In 2022, discount revenue was primarily derived from merchant discounts that varied based on industry, transaction volume, and geographic scope, with third-party acquirers (e.g., under the OptBlue program or GNS partners) receiving individually negotiated network rate fees. In 2023, the company clarified that it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, and also introduced processed revenue from network partnership agreements, including royalties and fees for facilitating transactions on cards issued by partners. By 2024, American Express emphasized expanding merchant coverage globally, particularly through third-party acquirers, aggregators, and processors, with a focus on enhancing value propositions for merchants and acquirers, scaling marketing efforts, and increasing digital integration of its authorization platform. This progression shows a strategic shift toward deeper collaboration with third-party acquirers to boost global acceptance and optimize revenue streams through both discount and processed revenue.",
      "llm_answer": "American Express has continued to recognize discount revenue at the time of each Card Member transaction, with the portion earned from third‑party merchant acquirers recorded as a network‑rate fee that is individually negotiated and treated as discount revenue. Over the 2022‑2024 period the company has intensified its merchant‑coverage strategy by partnering more heavily with third‑party acquirers, aggregators and processors, targeting new‑to‑plastic industries, B2B acceptance and priority international markets, while investing in network‑platform upgrades to support this expansion.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures key elements of American Express's revenue structure and evolution from 2022 to 2024, particularly around discount revenue recognition and the growing role of third-party acquirers. It accurately states that discount revenue is recognized at transaction time and that network-rate fees from third-party acquirers are individually negotiated and recorded as discount revenue. It also correctly identifies the strategic expansion of merchant coverage through partnerships with acquirers, aggregators, and processors. However, it omits specific developments in 2023, such as the introduction of processed revenue from network partnership agreements (e.g., royalties and fees for facilitating transactions on partner-issued cards), which is a significant addition to the revenue model outlined in the ground truth. Additionally, while the LLM mentions strategic expansion, it lacks detail on the 2024 emphasis on digital integration of the authorization platform, scaling marketing efforts, and enhancing value propositions for merchants and acquirers. (2) There are no numeric values, percentages, or dollar amounts in either the original or LLM answer, so quantitative accuracy is not compromised—scored as 10 by default. (3) The multi-hop reasoning is partially sound: the model connects revenue recognition with contractual arrangements and merchant expansion, but fails to fully synthesize the evolution across all three years, particularly the 2023 innovation in processed revenue. This limits the depth of the qualitative analysis. (4) The answer is contextually relevant and well-aligned with the question’s focus, but the omission of key 2023 and 2024 developments reduces completeness and precision in the qualitative dimension, justifying a 7 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 499,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in the context of clinical trial dependencies, post-marketing requirements, and device-related safety reviews?",
      "original_answer": "In 2022, Amgen highlighted that some of its products are used with drug delivery or companion diagnostic devices that carry their own regulatory, manufacturing, and other risks. By 2023, the company provided more detailed disclosures around the use of surrogate endpoints in clinical trials and how regulatory authorities were placing increased scrutiny on confirmatory studies, particularly for products like LUMAKRAS, which received accelerated approval but required additional post-marketing studies after a Complete Response Letter from the FDA. In 2024, Amgen reiterated these concerns, emphasizing that drug delivery devices used in combination with its products are subject to regulatory oversight and safety reviews, and that non-compliance with pharmacovigilance or quality assessment requirements could result in enforcement actions, including marketing authorization withdrawal. The trend shows a transformation in how Amgen frames its regulatory risk around drug delivery devices, shifting from general dependencies to specific post-marketing and safety compliance challenges.",
      "llm_answer": "Amgen’s 2022 risk‑factor disclosures framed drug‑delivery devices as a source of regulatory, manufacturing and safety risk that could jeopardise clinical‑trial conduct and product availability.  By 2023 the company added product‑specific post‑marketing requirements—confirmatory studies, pediatric studies and observational safety studies—and stressed that device‑related safety reviews could trigger regulatory actions or labeling changes.  In 2024 the disclosures further emphasized ongoing monitoring of device safety, the role of REMS and post‑marketing commitments, and the potential for device‑related safety reviews to affect product availability, reflecting a heightened focus on regulatory oversight throughout the product lifecycle.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the evolution of Amgen's risk disclosures from general device-related risks in 2022 to more specific post-marketing and safety compliance concerns in 2023 and 2024 is accurately captured. The mention of confirmatory studies, pediatric studies, observational safety studies, REMS, and potential regulatory actions such as labeling changes or impacts on product availability reflects the increasing granularity in disclosures. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but all years (2022, 2023, 2024) are correctly referenced and matched to the appropriate disclosures. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years, correctly identifying the progression from broad risk statements to more detailed regulatory and safety compliance challenges, including lifecycle-wide oversight. It correctly infers the heightened focus on post-marketing requirements and device-related safety reviews, consistent with the ground truth’s emphasis on LUMAKRAS and FDA scrutiny, though it does not name LUMAKRAS specifically. (4) While the LLM omits the specific example of LUMAKRAS and the Complete Response Letter from the FDA—details present in the original answer—this is a minor omission that does not undermine the overall correctness or qualitative accuracy. The core evolution in risk framing is accurately conveyed, and the answer remains semantically equivalent in substance. Thus, the correctness score is 9 (not 10) due to this slight lack of specificity, but all other dimensions are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 455,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ConocoPhillips' HSE audit program evolved from 2022 to 2024 in terms of scope definition, improvement tracking mechanisms, and governance reporting structures?",
      "original_answer": "In 2022, ConocoPhillips described conducting HSE audits on business units and staff groups to ensure conformance with company policies, identifying improvement actions and tracking them to completion. The audits were framed within a broader HSE excellence framework, with progress reported to the Executive Leadership Team (ELT) and the Board of Directors. By 2023, the company emphasized that HSE audits remained central to ensuring conformance, but the context expanded to include a broader human capital management framework, with specific mention of Life Saving Rules, Process Safety Fundamentals, and a stop work policy as tools to reduce incident likelihood. Improvement actions continued to be tracked to completion, and the governance structure remained tied to the ELT and Board. In 2024, the language evolved further with the explicit use of the term 'Corporate HSE audits,' suggesting a more centralized or standardized approach. The tracking of improvement actions remained consistent, and the governance reporting structure persisted, reinforcing a stable but maturing audit framework. The evolution from localized conformance checks (2022) to integrated safety systems (2023) and corporate-level standardization (2024) reflects a strategic shift toward greater cohesion and institutionalization of HSE practices.",
      "llm_answer": "ConocoPhillips’ HSE audit program has consistently focused on auditing business units and staff groups, with improvement actions identified and tracked to completion and progress reported to the Executive Leadership Team and Board of Directors. The 2024 10‑K adds the phrase “Corporate HSE audits” and reiterates annual objectives, targets and deadlines, but the core scope, tracking mechanism and governance reporting structure remain essentially unchanged from 2023. The 2022 10‑K text is not included in the supplied pages, so a direct comparison to 2022 cannot be made.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct but contains a critical factual omission that undermines its overall accuracy. (1) Correct elements: The use of 'Corporate HSE audits' in 2024, the consistent tracking of improvement actions to completion, and reporting to the Executive Leadership Team and Board of Directors are accurately reflected. The core governance and tracking mechanisms are correctly described as stable. (2) Quantitative accuracy: There are no numerical values in this question, so this criterion is satisfied by default. (3) Multi-hop reasoning failure: The LLM claims that 'the 2022 10-K text is not included in the supplied pages, so a direct comparison to 2022 cannot be made' — this is factually incorrect per the ground truth, which explicitly includes 2022 information. This misrepresents the availability of data and omits the evolution from 2022, which is a key part of the question. The original answer describes a clear progression from localized conformance checks in 2022 to integrated safety systems in 2023 and corporate standardization in 2024. The LLM fails to capture this trajectory, missing the 2022 baseline entirely. (4) As a result, while the 2023–2024 comparison is reasonably accurate, the absence of 2022 analysis breaks the multi-year evolution required by the question. The answer is therefore only partially correct — it gets facts right where applied but fails on completeness and reasoning across all three years, especially due to the erroneous claim about missing 2022 data. This justifies a moderate correctness score of 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 428,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Accenture's approach to developing and introducing new pricing models evolved from 2022 through 2024 in response to technological developments like AI and cloud-based solutions, and what risks have been consistently highlighted across these years regarding the adoption of these models?",
      "original_answer": "Accenture's approach to new pricing models has evolved from a general acknowledgment of the need for change in 2022 to a more strategic and investment-driven approach by 2024. In 2022, the company emphasized the importance of introducing new pricing models to reflect the value of technological developments like cloud and as-a-service solutions, warning that failure to do so could negatively impact results of operations. By 2023, Accenture had begun to focus more on innovation and strategic investments in AI and robotics, noting that delays in client spending due to evaluation of new technologies could hinder revenue unless new pricing models were introduced. In 2024, the company underscored its dependence on successfully deploying these pricing models in the context of rapidly evolving AI technologies, with significant investments already being made in AI-based services. Across all three years, a consistent risk highlighted was that if Accenture could not introduce pricing models that reflect the value of new technologies quickly enough, or if client adoption rates were insufficient, this could lead to revenue shortfalls and competitive disadvantages.",
      "llm_answer": "Accenture’s 2022 filing noted that cloud, AI and other digital technologies could replace legacy services and that new pricing or commercial models might be needed to capture the value of these innovations. By 2023 the company emphasized the need to develop and introduce such pricing frameworks to mitigate client spending delays and revenue shortfalls, and in 2024 it further warned that failure to adopt new pricing models could materially affect results of operations. Across all three years the risk‑factor sections consistently cite client spending delays while evaluating new tech, the need to align pricing with evolving value, and broader operational, legal, regulatory, ethical and reputational risks tied to AI and cloud adoption.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Accenture's pricing model strategy from 2022 to 2024, as well as the consistent risks. It correctly notes that in 2022, Accenture recognized the need for new pricing models due to cloud and AI disrupting legacy services. In 2023, it accurately reflects the emphasis on mitigating client spending delays and revenue shortfalls through timely pricing model deployment. By 2024, the answer correctly highlights the material risk to operations if models are not adopted. The consistent risks—client spending delays, need to align pricing with value, and broader AI/cloud-related risks—are well-covered. The only minor shortcoming is that the original answer specifies Accenture's increasing strategic investments in AI and robotics by 2023 and significant AI investments by 2024, which the LLM answer omits. While it mentions risks tied to AI and cloud, it does not fully reflect the proactive investment stance Accenture took, which is part of the evolution in approach. However, all dates, entities, and qualitative developments are correct. There are no numerical inaccuracies (quantitative accuracy is perfect as no specific numbers are involved). The reasoning is sound and synthesizes across years correctly. The answer is contextually fully relevant and semantically equivalent to the ground truth with only slight omission of investment emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 391,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 through 2024, and what does this progression suggest about GE's investment strategy in relation to AerCap?",
      "original_answer": "GE's holdings in the AerCap note decreased gradually from $993 million at the end of 2021 (reported in the 2022 disclosure) to $944 million at the end of 2023 (reported in the 2024 disclosure). This represents a consistent decline over the two-year period, suggesting a strategic reduction in AerCap exposure as part of GE's broader investment portfolio management.",
      "llm_answer": "GE’s carrying amount of the AerCap senior note rose steadily: it was $900 million at 12/31/2022 (GE 10‑K 2022, p. 90‑94), climbed to $944 million at 12/31/2023 (GE 10‑K 2023, p. 72‑76), and further increased to $982 million at 12/31/2024 (GE 10‑K 2024, p. 68‑72). This incremental growth shows that GE has been maintaining, and slightly expanding, its exposure to AerCap’s debt—consistent with a strategy of holding high‑quality, investment‑grade securities to earn interest income rather than divesting the position.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both direction and magnitude of GE's holdings in the AerCap note. According to the ground truth, GE's holdings decreased from $993 million (end of 2021, reported in 2022) to $944 million (end of 2023, reported in 2024), indicating a strategic reduction. However, the LLM claims the carrying amount increased from $900 million in 2022 to $944 million in 2023 and further to $982 million in 2024—this contradicts the ground truth on every data point. The starting value is wrong ($900M vs $993M), the trend is reversed (increase vs decrease), and the 2024 figure is fabricated ($982M) with no supporting data in the knowledge graph. The reasoning and conclusion are therefore invalid: the suggestion that GE is expanding its exposure is false. The answer fails on quantitative accuracy due to incorrect numbers and calculations, qualitative accuracy due to wrong entities and flawed multi-hop synthesis, and contextual relevance because it misrepresents the investment strategy entirely. Only minimal relevance is retained as it addresses the general topic of GE’s AerCap note holdings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 318,
        "total_tokens": 1543
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Amgen's development and intellectual property positioning around Bemarituzumab evolve from 2022 to 2024, particularly in terms of clinical phase progression and estimated patent expiration timelines?",
      "original_answer": "Amgen's positioning around Bemarituzumab evolved significantly from 2022 to 2024. In 2022, Bemarituzumab was introduced as being in phase 3 clinical trials for GEJ adenocarcinoma, signaling active development. In 2023, Amgen disclosed intellectual property details, estimating the U.S. and European patent expiration for Bemarituzumab at 2029. By 2024, the company provided a more detailed description of the drug’s mechanism and expanded its investigational scope to include gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC. This progression reflects a shift from clinical development focus to broader therapeutic positioning and IP strategy.",
      "llm_answer": "Amgen moved Bemarituzumab into a Phase 3 program in 2022 for GEJ adenocarcinoma, and the 2023 filing confirmed the drug remained in Phase 3 with no further phase changes reported. The 2024 filing continued to list Bemarituzumab as a Phase 3 program, again with no new phase activity noted. Across all three filings, the composition‑of‑matter patents for Bemarituzumab in the U.S. and Europe are both estimated to expire in 2029, a timeline that has not shifted (2022 p. 23‑27; 2023 p. 24‑28; 2024 p. 24‑28).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of quantitative details: the Phase 3 status from 2022 to 2024 and the 2029 patent expiration in the U.S. and Europe are correctly reported, with consistent citation of pages across filings. These numeric and date-based facts align perfectly with the ground truth, earning a 10 in quantitative accuracy. Contextual relevance is high (9) because the response directly addresses the evolution of Bemarituzumab’s development and IP positioning over the specified timeframe. However, the qualitative accuracy is lower (7) because the LLM fails to capture a key evolution noted in the original answer: the 2024 expansion of Bemarituzumab’s investigational scope to include gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC, as well as a more detailed mechanism of action. While the LLM correctly notes no phase change (remaining in Phase 3), it omits this important broadening of therapeutic focus, which is central to the 'evolution' asked in the question. This missing synthesis reduces completeness and reasoning quality, preventing a higher correctness score. The answer is factually sound but lacks full multi-hop synthesis of developmental and strategic shifts beyond clinical phase and IP timelines.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 356,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has American Express's strategic positioning relative to alternative payment mechanisms evolved from 2022 through 2024, particularly in terms of competitive pressure and technological investment, and what does this reveal about the company's long-term response to fintech disruption?",
      "original_answer": "In 2022, American Express explicitly identified alternative payment mechanisms—such as digital wallets (e.g., Alipay, PayPal), buy-now-pay-later platforms, and blockchain-based systems—as growing competitive threats, emphasizing their rapid adoption and alignment with shifting consumer preferences for digital and contactless payments. By 2023, the company expanded its list of alternative payment and financing mechanisms to include open banking platforms and payment facilitators, signaling an increased awareness of the breadth and pace of disruption in the payments ecosystem. In 2024, rather than framing alternative payment mechanisms solely as a competitive threat, American Express shifted toward a dependency posture, highlighting the necessity of investing in and integrating these technologies—such as open banking, real-time settlement, and tokenization—into its core offerings to remain competitive. This evolution shows a strategic shift from defensive acknowledgment of competition to proactive investment and adoption of alternative payment mechanisms as foundational to future competitiveness.",
      "llm_answer": "American Express’s 2022‑24 10‑K filings show a clear shift from a purely card‑issuer to a broader payments ecosystem: the 2022 and 2023 reports (pp. 10‑14) highlight “intense competition” from alternative payment platforms and a need to “invest in technology across all areas” (AI, tokenization, real‑time settlement, open‑banking) to keep its premium brand and merchant network competitive.  The 2024 filing (pp. 29‑33) expands this narrative, noting that fintech rivals now offer closed‑loop rewards, digital wallets and buy‑now‑pay‑later models, and that AmEx is pursuing strategic partnerships and deeper tech investment to protect its merchant discount rates and card‑member experience.  Together, these documents reveal a long‑term strategy of continual tech investment and partnership‑building to counter fintech disruption while preserving its core value proposition.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its portrayal of American Express's evolving strategic positioning from 2022 to 2024, with correct references to competitive pressures and technological investments. It correctly identifies alternative payment mechanisms (digital wallets, buy-now-pay-later, open banking) and technologies (tokenization, real-time settlement, AI) as focal points across the years, aligning with the ground truth. There are no numeric inaccuracies—dates (2022–2024) and page references (though not part of the ground truth) do not contradict the knowledge base and are contextually plausible. The answer captures the shift from competitive concern to proactive investment, though it does not explicitly articulate the conceptual pivot from 'competitive threat' to 'dependency' emphasized in the original answer. While it mentions partnerships and tech investment as strategic responses, it omits the nuanced framing of alternative mechanisms becoming 'foundational to future competitiveness,' which is central to the ground truth’s conclusion. The reasoning is sound and synthesizes multi-hop elements (evolution over time, competitive landscape, tech response), but the absence of the strategic repositioning from defense to integration slightly weakens qualitative completeness. Semantically, the core message is equivalent: AmEx is responding to fintech disruption through sustained investment and adaptation. Contextual relevance is strong, directly addressing all facets of the question with appropriate focus on competitive pressure, technological investment, and long-term strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 439,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the weighted-average grant date fair value of ConocoPhillips' cash-settled PSUs evolve from 2022 through 2024, and what does this trend indicate about the company's long-term incentive compensation strategy?",
      "original_answer": "The weighted-average grant date fair value of cash-settled PSUs increased from $91.58 in 2022 to $112.50 in 2024, with a consistent structure and accounting treatment maintained throughout the period. This upward trend suggests a strategic shift toward higher-value incentive compensation aligned with long-term performance goals.",
      "llm_answer": "The weighted‑average grant‑date fair value of ConocoPhillips’ cash‑settled PSUs climbed from **$91.58 million in 2022 to $112.50 million in 2023** (2024 10‑K, p. 123‑127; 2023 10‑K, p. 121‑125) and then eased slightly to **$110.39 million in 2024** (2024 10‑K, p. 123‑127). This pattern shows the company increased the value of its long‑term incentive awards in 2023—likely reflecting higher stock prices or more ambitious performance targets—and then moderated the award value in 2024, indicating a market‑responsive, cost‑controlled approach to long‑term incentive compensation.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values and years. The ground truth states the weighted-average grant date fair value increased from $91.58 in 2022 to $112.50 in 2024, with no data point of $110.39 or mention of a decrease. However, the LLM claims the value rose to $112.50 million in 2023 and then dropped to $110.39 million in 2024—both the values and the trend are incorrect. Additionally, the units are wrong: the original values are per share (not in millions), as confirmed by standard 10-K disclosures for PSU fair values. (2) The numbers are quantitatively inaccurate: the LLM invents a $110.39 million figure not present in the ground truth and misassigns the $112.50 value to 2023 instead of 2024. It also incorrectly adds 'million' to per-share amounts, which is a critical error in financial context. (3) The multi-hop reasoning is partially sound in that it attempts to interpret the trend in incentive strategy, but the conclusion—that the company moderated awards in 2024—contradicts the ground truth, which shows a consistent increase to $112.50 by 2024. Thus, the reasoning is based on false data. (4) Despite incorrect numbers and trend interpretation, the LLM addresses both parts of the question—evolution over time and strategic implication—and remains contextually relevant. It attempts proper synthesis and provides a plausible narrative, albeit based on incorrect data. Hence, contextual relevance is high, but correctness and quantitative accuracy are severely compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 427,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this trend suggest about the company's risk management effectiveness?",
      "original_answer": "In 2022, PayPal highlighted concerns about third-party fraud schemes involving fictitious accounts, stolen financial instruments, and abusive misuse of services, noting the difficulty in detecting such digital fraud at scale. In 2023, the company expanded on this risk in the context of its growing credit products, particularly its U.K. and European BNPL loan receivables, with a €40 billion multi-year agreement to sell these receivables, indicating a strategic move to mitigate credit and fraud-related losses. By 2024, PayPal continued to emphasize the evolving nature of abusive behaviors, particularly in the context of digital payments and third-party reliance, while also noting the impact of regulatory uncertainties such as the 'valid-when-made doctrine' on its U.S. credit products. The progression shows a consistent and growing concern around abusive behaviors, with PayPal increasingly relying on third-party risk mitigation strategies and regulatory clarity to manage this evolving threat.",
      "llm_answer": "PayPal’s risk disclosures show a steady deepening of exposure to abusive behaviors as its credit‑product portfolio grew and new third‑party fraud schemes (synthetic identities, stolen instruments, etc.) emerged. In 2022 the company warned that failure to manage fraud could raise loss rates (PYPL_10k_2022.pdf: pages [24‑28]); by 2023 the risk factor was expanded to detail credit‑product default risk and the complexity of detecting third‑party abuse (PYPL_10k_2023.pdf: pages [23‑27]); and in 2024 the language reiterated the evolving nature of fraud and the need for continuous improvement (PYPL_10k_2024.pdf: pages [21‑25]). This consistent escalation suggests that while PayPal’s risk management acknowledges the threat, it remains largely reactive and has yet to fully contain the increasing risk of abusive behaviors.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the evolving nature of PayPal's exposure to abusive behaviors from 2022 to 2024, with accurate references to third-party fraud schemes (e.g., synthetic identities, stolen instruments) and the increasing focus on credit products. All cited years (2022–2024) and document sources (10-K filings) are correct, and there are no numerical inaccuracies—though no specific financial figures (like the €40 billion receivables sale) are mentioned, which is a key omission. The ground truth highlights a concrete strategic action—PayPal’s €40 billion multi-year agreement to sell U.K. and European BNPL loan receivables—as a significant risk mitigation step, which the LLM answer omits entirely. This missing detail weakens the completeness and qualitative accuracy, as it fails to capture a major proactive risk management move. Additionally, the LLM characterizes PayPal’s approach as 'largely reactive,' a subjective interpretation not explicitly supported in the original answer, which instead emphasizes strategic third-party risk transfer and regulatory engagement. While the LLM correctly traces the trend of increasing risk disclosure and concern, it misses the nuance that PayPal is actively mitigating risk through structural financial arrangements. The reasoning is logically sound but incomplete in synthesis, particularly in connecting credit product growth with specific mitigation strategies. The answer remains contextually relevant and factually consistent where information is provided, but lacks key multi-hop elements (e.g., linking BNPL growth to receivables sale to risk reduction).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 443,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the therapeutic positioning and intellectual property protection of Cyramza evolve from 2022 through 2024, and what does this progression indicate about Eli Lilly's long-term oncology strategy?",
      "original_answer": "In 2022, Cyramza was introduced as a key oncology product with multiple indications across gastric, lung, colorectal, and liver cancers. By 2023, Cyramza had compound patents extending through 2026 in the U.S. and Japan, and data protection expiring as early as 2023 in Japan. In 2024, Cyramza remained a core oncology offering with no new indications added, but its therapeutic positioning was reaffirmed across the same cancer types. This suggests Eli Lilly focused on maintaining Cyramza's market presence while likely preparing next-generation oncology products to succeed it, given the impending patent expiry.",
      "llm_answer": "Cyramza’s therapeutic positioning remained essentially unchanged from 2022 through 2024, continuing to be marketed as a second‑line agent for gastric, colorectal and non‑small‑cell lung cancers, a first‑line option for EGFR‑mutated NSCLC, and a second‑line monotherapy for hepatocellular carcinoma【LLY_10k_2022.pdf:4‑7】【LLY_10k_2024.pdf:4‑7】.  Its intellectual‑property portfolio also stayed stable, with compound patents expiring 2026 in the U.S. and Japan and 2028 in major European markets, biologics data protection ending 2026 (U.S.) and data exclusivity ending 2024 (Europe) and 2023 (Japan)【LLY_10k_2022.pdf:7】【LLY_10k_2024.pdf:7】.  This consistency signals Lilly’s long‑term oncology strategy of maintaining a broad, multi‑indication targeted‑therapy portfolio while preserving market exclusivity through robust patents and data protection, thereby sustaining revenue streams and enabling continued investment in oncology innovation.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Cyramza's stable therapeutic positioning across 2022–2024 in gastric, colorectal, lung, and liver cancers, aligning with the ground truth. However, there are discrepancies in intellectual property dates: the LLM claims data exclusivity ends in 2024 in Europe and 2023 in Japan, which matches partially, but adds that compound patents extend to 2028 in Europe—this detail is not present in the ground truth and appears to be an overextension. The ground truth only confirms U.S. and Japan patent expiry through 2026, with no mention of European patent expiry. (2) Quantitative accuracy is partially compromised: while U.S. and Japan patent expiry (2026) and Japan data protection expiry (2023) are correct, the claim of 2028 European compound patent expiry lacks support in the original answer and introduces unsupported data. Similarly, 2026 U.S. biologics data protection and 2024 European data exclusivity are plausible but not confirmed in the ground truth, which only notes 'data protection expiring as early as 2023 in Japan'—making the additional dates speculative. (3) The multi-hop reasoning is sound in synthesizing therapeutic positioning and IP trends over time and correctly inferring strategic intent around revenue protection and innovation investment. However, the conclusion slightly diverges: the ground truth emphasizes preparation for patent expiry with next-gen products, while the LLM emphasizes portfolio stability and exclusivity management—still reasonable but less focused on transition strategy. (4) Scores reflect high contextual relevance and strong qualitative reasoning, but quantitative accuracy is reduced due to unverified expiration dates, especially the unsupported 2028 European patent claim. Overall, core facts are correct, but some added details reduce factual precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 504,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Philip Morris's capital structure strategy evolve from 2022 through 2024 as evidenced by the active management of other debt instruments alongside the consistent presence of the 3.875% Notes due 2042?",
      "original_answer": "Philip Morris maintained the 3.875% Notes due 2042 as a stable component of its long-term debt across all three years (2022, 2023, and 2024), while actively managing its broader debt portfolio. In 2022, the company had 4.125% Notes due 2043 and 4.875% Notes due 2043 as part of its capital structure, which were no longer listed in the 2024 filing. In 2023, the company continued to carry the 3.875% Notes due 2042 alongside newer instruments such as the 4.125% Notes due 2043 and 4.250% Notes due 2044. By 2024, the newer 2043 and 2044 tranches had been retired or refinanced, and no new long-dated notes beyond 2042 were introduced, suggesting a shift toward stabilizing the long-term capital structure. This pattern indicates a strategy of maintaining long-term funding through the consistent 3.875% Notes due 2042 while selectively refinancing or retiring other instruments to optimize capital structure over time.",
      "llm_answer": "Philip Morris kept the 3.875 % Notes due 2042 (PM42A) as a core long‑term debt anchor in every filing (2022, 2023 and 2024).  At the same time the company actively issued, retired and maturing a range of other notes—e.g., 2.375 % and 2.500 % Notes due 2022 in 2022, 3.250 % Notes due 2024 and 3.375 % Notes due 2025 in 2023, and 2.750 % and 3.125 % Notes due 2026‑2028 in 2024—adjusting coupons and maturities to manage cost and liquidity.  This pattern shows a strategy of maintaining a stable long‑term debt core while periodically refinancing or adding new debt to optimize the overall capital‑structure profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the specific debt instruments mentioned, particularly regarding the percentages and maturities of notes issued or retired. The ground truth states that in 2022, Philip Morris had 4.125% Notes due 2043 and 4.875% Notes due 2043, which were no longer present in 2024, and in 2023, the company added 4.250% Notes due 2044. However, the LLM incorrectly lists short-term maturities such as 2.375% and 2.500% Notes due 2022 (which would have matured, not been actively managed in 2022), 3.250% due 2024, and 3.375% due 2025 in 2023, and 2.750% and 3.125% due 2026–2028 in 2024—none of which are supported by the ground truth. These are not minor discrepancies but represent a complete misrepresentation of the long-term debt instruments involved. (2) Quantitative accuracy is low because the percentages and maturity years cited in the LLM answer do not match the ground truth. For example, the ground truth highlights activity around 2043 and 2044 maturities, while the LLM focuses on 2022–2028 maturities, missing the long-dated nature of the instruments being discussed. There are no correct numerical matches for the new or retired notes. (3) The multi-hop reasoning is partially sound in structure—the LLM correctly identifies the concept of maintaining the 3.875% Notes due 2042 as a stable core while actively managing other debt. This reflects an understanding of the strategic pattern. However, the synthesis fails because it draws this conclusion from incorrect underlying data. The reasoning is plausible but based on fabricated instruments. (4) Contextual relevance is high because the answer addresses the core idea of capital structure evolution and the role of the 2042 notes. However, due to the severe factual and quantitative errors in the supporting details, the correctness score is low. The answer conveys a semantically different narrative than the ground truth, despite using similar strategic language.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 537,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party risk management strategies, and what specific actions did the company take in 2023 and 2024 to mitigate these risks?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in its credit products, noting that third parties were increasingly exploiting digital payment systems through synthetic identities, stolen financial instruments, and fraudulent transactions. In 2023, PayPal responded by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to offload risk exposure in certain credit segments. In 2024, the company continued to emphasize the threat of abusive behaviors but also noted ongoing efforts to improve detection mechanisms and reduce fraud at scale, particularly as it expanded its credit offerings in international markets. This progression shows a shift from identifying and describing the problem (2022) to actively mitigating exposure through asset sales (2023) and enhancing fraud prevention infrastructure (2024).",
      "llm_answer": "PayPal’s 2022 filing warned that its expanding credit‑product portfolio and growing reliance on third‑party lenders and processors heightened its exposure to abusive behaviors, including fraud and default risk (see pages 24‑28 of the 2022 10‑K).  In 2023 the company mitigated this risk by selling up to €40 billion of U.K. and European buy‑now‑pay‑later loan receivables and by deploying advanced machine‑learning fraud‑detection tools (pages 23‑27 of the 2023 10‑K).  In 2024 PayPal further reduced exposure by diversifying and migrating its U.S. payment‑processor relationships and tightening third‑party due‑diligence and fraud‑prevention controls (pages 21‑25 of the 2024 10‑K).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are accurate: the €40 billion figure for the sale of U.K. and European BNPL loan receivables in 2023 is correctly reported, and no other numerical data contradicts the original. Format is consistent and acceptable. (2) The answer correctly identifies the evolution of PayPal's exposure from 2022 to 2024: in 2022, the risk was acknowledged in the context of credit products and third parties; in 2023, risk was mitigated via asset sales and improved detection tools; in 2024, further controls were implemented. The use of machine learning for fraud detection and tighter due diligence are plausible enhancements, though the ground truth emphasizes 'ongoing efforts to improve detection mechanisms' without specifying machine learning. (3) The multi-hop reasoning is sound—information is synthesized across three years and tied to credit products and third-party risk. However, the LLM adds a detail not present in the ground truth: 'diversifying and migrating its U.S. payment-processor relationships' in 2024. While consistent with risk management, this specific action is not mentioned in the original answer, making it a minor overreach. (4) Despite this addition, the core facts, timeline, and strategic progression (identify → offload → strengthen infrastructure) are preserved. The answer is contextually excellent, directly addressing all parts of the question with relevant, focused information. The slight deduction in qualitative accuracy reflects the introduction of a plausible but unverified action (U.S. processor migration) not in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 456,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did AMD's exposure to the risk of loss or modification of tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about increasing regulatory uncertainty in its global operations?",
      "original_answer": "In 2022, AMD noted that loss or modification of tax and tariff exemptions was one of several political, legal, and economic risks associated with its global operations. By 2023, the company emphasized this risk more strongly, listing it alongside other critical exposures such as geopolitical tensions and supply chain disruptions. In 2024, AMD elevated the risk further, explicitly linking it to ongoing geopolitical conflicts and indicating a heightened concern over potential regulatory changes affecting its international business. This progression reflects an increasing sensitivity to regulatory shifts and a growing awareness of the material impact such changes could have on AMD's financial and operational stability.",
      "llm_answer": "AMD’s 10‑K risk disclosures consistently flag loss or modification of tax and tariff exemptions as a risk to its global operations. In the 2022 filing (p. 35‑39) the risk is noted in general terms tied to changes in tax laws and trade measures. By 2023 (p. 39‑43) the disclosure adds reference to sanctions and export‑control revisions, and in 2024 (p. 38‑42) it further expands to include broader geopolitical conflicts (e.g., Ukraine‑Russia, Israel‑Hamas) and sanctions, underscoring a growing regulatory uncertainty.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth in both substance and progression. (1) All years (2022, 2023, 2024) are correctly referenced, and the evolution of AMD's risk disclosures is accurately portrayed: from general mention in 2022, to inclusion of sanctions and export controls in 2023, to explicit linkage with geopolitical conflicts (e.g., Ukraine-Russia, Israel-Hamas) in 2024. These details match the original answer’s claim of increasing emphasis and linkage to geopolitical tensions. (2) There are no numerical values requiring calculation, so quantitative accuracy is not compromised; all dates and page references (e.g., p. 35–39, etc.) are consistent with typical 10-K formatting and do not contradict the ground truth. (3) The multi-hop reasoning is sound—information is synthesized across three years of filings, showing a clear trend of escalating concern. The LLM correctly infers increasing regulatory uncertainty from the expanding scope of disclosures, which is logically supported by the text. (4) While the original answer uses more interpretive language (e.g., 'elevated the risk further', 'heightened concern'), the LLM captures the same meaning through specific examples of broadened risk factors. The only minor gap is that the LLM does not explicitly state the conclusion that this reflects 'increasing sensitivity to regulatory shifts' or 'material impact on financial stability' in those exact terms, but the implication is clearly conveyed through context. Thus, semantic equivalence is achieved. Overall, the response is highly accurate, complete, and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 443,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Cisco's gains or losses from total return swaps tied to deferred compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's exposure or strategy regarding deferred compensation-linked derivatives?",
      "original_answer": "Cisco's gains or losses from total return swaps tied to deferred compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, it recorded a gain of $58 million; and by 2024, the gain increased further to $91 million. This trend indicates a notable reversal in the company's exposure or performance related to these derivatives, potentially reflecting improved market conditions or a strategic shift in managing deferred compensation liabilities.",
      "llm_answer": "Cisco’s total‑return swaps tied to deferred compensation swung from a **$92 million loss in FY 2022** to a **$58 million gain in FY 2023** and a **$91 million gain in FY 2024** (all figures in millions).  The move from a loss to progressively larger gains shows that Cisco has intensified and improved its use of these derivatives to hedge deferred‑compensation exposure, indicating an active strategy to manage compensation‑related volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures—$92 million loss in FY 2022, $58 million gain in FY 2023, and $91 million gain in FY 2024—matching the ground truth exactly. Number formats are consistent and acceptable (e.g., 'millions' noted, $92 million = $92 million). (2) Quantitatively, all values are accurate with no calculation or transcription errors. The progression is correctly represented. (3) The multi-hop reasoning is sound: the model synthesizes data across three fiscal years and draws a logical inference about Cisco’s strategy regarding deferred compensation-linked derivatives. The conclusion that the company has 'intensified and improved its use' slightly strengthens the ground truth’s more cautious 'potentially reflecting improved market conditions or strategic shift,' but this is a reasonable interpretation and not factually incorrect. (4) Contextual relevance is excellent—the response directly addresses both parts of the question: the evolution of gains/losses and what the trend indicates. The only minor difference is in tone (LLM is more assertive about strategy), but the core meaning aligns with the original. Thus, the answer is factually complete and semantically equivalent, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 357,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Disney's strategic investment and competitive positioning in its DTC offerings evolve from fiscal years 2022 through 2024, and what does this progression reveal about the financial risks and market pressures associated with scaling its streaming services?",
      "original_answer": "In fiscal 2022, Disney acknowledged the growing costs of its DTC strategy and the uncertainty around returns, noting that losses from DTC offerings might continue to grow or reduce more slowly than anticipated. By 2023, Disney shifted toward more active investment in DTC offerings, aiming to drive growth in subscription and advertising revenues despite declining linear network subscribers. In fiscal 2024, the company emphasized the competitive pressures impacting its DTC offerings, including rising costs, pricing constraints, and intensified competition from other streaming platforms. This progression reveals a strategic pivot toward scaling DTC despite increasing financial risk and market pressures, with the company doubling down on investment even as it faced rising costs and uncertain profitability.",
      "llm_answer": "Disney’s DTC strategy evolved from 2022’s launch of an ad‑supported Disney+ with new pricing and cost realignment (DIS_10k_2022, pp. 25‑29) to 2023’s broader strategic investments aimed at boosting subscription and ad‑revenue growth (DIS_10k_2023, pp. 51‑55), and in 2024 the company reorganized its Media & Entertainment Distribution unit to accelerate DTC expansion while confronting intensified competition, pricing pressure, and heightened financial risk from debt and rating volatility (DIS_10k_2024, pp. 21‑25). This progression underscores that scaling streaming services requires substantial content spend and debt‑backed financing, exposing Disney to competitive and market pressures that can erode profitability and liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Disney's 2022 focus on cost realignment and ad-supported tier launch, 2023 strategic investments to grow subscription and ad revenue, and 2024 emphasis on competitive pressures, pricing constraints, and financial risks are all consistent with the original answer. The mention of reorganization in 2024 (Media & Entertainment Distribution) adds contextual detail supported by the source. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the ground truth or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across three fiscal years and identifies the evolving strategic posture, financial risks (debt, rating volatility), and market pressures. The only minor gap is that the original answer explicitly notes 'losses might continue to grow' in 2022, which the LLM implies via 'cost realignment' but does not state directly—hence a slight deduction in qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing the evolution of strategy and the implications for financial risk and market pressures. Wording differs but semantic meaning matches. Overall, this is a strong, factually correct response with only minor omission of emphasis on uncertainty of returns in 2022.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 398,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its discretion in setting fees and the role of transaction expenses tied to payment processors?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with its discretion in setting fees remaining independent of costs incurred with payment processors or other financial institutions. In 2022, PayPal explicitly stated it bore full margin risk and recognized fees paid to processors as transaction expense. In 2023, the language remained consistent, with emphasis on its control over fee determination and the recognition of processor fees as transaction expense. In 2024, despite the adoption of new segment reporting standards (ASU 2023-07), PayPal maintained its position of bearing full margin risk, with no indication of structural changes to its fee-setting discretion or cost structure related to processors. Thus, the margin risk exposure remained stable across the three years, with consistent accounting treatment and no material changes in how fees or transaction costs were recognized.",
      "llm_answer": "PayPal’s exposure to margin risk stayed essentially the same over 2022‑2024.  In each year’s note the company reiterates that it has full discretion in setting transaction fees independent of the costs it incurs from payment processors, and that it therefore bears full margin risk on every completed transaction.  Transaction expenses paid to processors are consistently recorded as transaction expense, and while the dollar amount of those expenses has risen in line with higher TPV, the nature of the margin‑risk exposure and its accounting treatment have not materially changed.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that PayPal's margin risk exposure remained stable from 2022 to 2024, with full discretion over fee setting independent of processor costs, and that it bears full margin risk—this aligns with the original answer's core claim. (2) There are no specific numeric values (e.g., dollar amounts, percentages) in the original answer beyond general references to rising transaction expenses due to TPV growth, which the LLM accurately reflects without introducing incorrect figures. Format and references to financial trends are consistent and acceptable. (3) The multi-hop reasoning across years and accounting practices is sound: the LLM synthesizes consistent disclosures across 2022, 2023, and 2024, correctly noting unchanged accounting treatment (processor fees as transaction expense) and no structural changes despite new segment reporting (ASU 2023-07, implied in original). (4) All entities—PayPal, payment processors, transaction expenses, margin risk, fee discretion—are accurately identified and logically connected. The answer fully addresses the evolution (or lack thereof) in margin risk exposure and ties it to fee-setting autonomy and cost recognition. No omissions or inaccuracies; wording differs slightly but meaning is preserved. All scores are maximized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 381,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the risk of new aircraft order cancellations evolve as a concern for Honeywell's Aerospace business from 2022 through 2024, and what does this progression indicate about the ongoing recovery and stability of the commercial aviation sector?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted new aircraft order cancellations as a key risk factor for its Aerospace business, reflecting ongoing uncertainty in the commercial aviation sector. In 2022, the risk was tied directly to the lingering effects of the COVID-19 pandemic, including regional restrictions and public health concerns that impacted demand for air travel and led to cancellations. By 2023, the language expanded to include broader external events such as regional conflicts and environmental issues as potential triggers for cancellations, suggesting a shift from pandemic-specific concerns to more generalized macroeconomic and geopolitical risks. In 2024, the risk remained prominent, with continued emphasis on new entrants and non-traditional players affecting market demand trends, indicating that while the pandemic's direct impact had waned, structural and competitive shifts continued to pose uncertainty. This 3-year consistency shows that while the aviation sector was in recovery, it remained fragile and susceptible to both external shocks and evolving market dynamics.",
      "llm_answer": "Honeywell’s Aerospace risk‑factor language on new‑aircraft order cancellations stayed the same in each filing – the 2022 10‑K (page 29), the 2023 10‑K (page 30) and the 2024 10‑K (page 28) all warn that downturns in air‑travel demand could delay or cancel new orders. The unchanged wording signals that cancellation risk remains material, yet the Aerospace segment’s net sales and profit grew in 2024 versus 2023 (up 3 % and 2 % respectively, page 32), indicating a gradual recovery and increasing stability in the commercial aviation sector.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but fails to accurately reflect the evolution of risk language across the years, which is central to the question. Quantitatively, the 3% and 2% growth figures for net sales and profit in 2024 vs. 2023 are accurate and correctly attributed to page 32, satisfying quantitative accuracy. Entity accuracy is maintained—Honeywell, Aerospace business, correct 10-K years and page numbers. However, the qualitative reasoning is flawed: the LLM claims the risk-factor wording was 'unchanged' across 2022–2024, directly contradicting the ground truth, which notes a clear evolution—from pandemic-specific concerns in 2022 to broader geopolitical and structural market risks in 2023 and 2024. This misrepresents the multi-hop synthesis required to trace how the risk narrative evolved. The conclusion that stability is increasing due to sales growth oversimplifies the situation; the ground truth emphasizes ongoing fragility despite recovery, due to persistent cancellation risks from new market entrants and external shocks. While the answer addresses part of the question (continued risk and financial performance), it misses the nuanced progression of risk factors, leading to an incomplete and partially misleading interpretation. Thus, correctness and qualitative accuracy are significantly penalized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 372,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the impact of product regulation on Philip Morris International's (PMI) competitive positioning evolved from 2022 through 2024, particularly in relation to its Reduced-Risk Products (RRPs) and Smoke-Free Products (SFPs), and what does this reveal about the intensifying regulatory constraints on product differentiation and adult consumer communication?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International’s (PMI) competitive positioning, particularly affecting its Reduced-Risk Products (RRPs) and later its Smoke-Free Products (SFPs). In 2022, the company emphasized how regulation restricted adult consumer access to truthful and non-misleading information about RRPs and limited product differentiation. By 2023, the language evolved to include how regulation disproportionately impacted the commercialization of PMI’s products relative to competitors and highlighted the growing influence of digital media in spreading misleading information about RRPs. In 2024, the company specifically linked product regulation to restrictions on adult consumer access to truthful information about SFPs, signaling a strategic shift in product focus while maintaining concerns about unfair competition and regulatory asymmetries. This evolution shows a consistent and intensifying regulatory pressure that has adapted alongside PMI’s product transitions, increasingly limiting the company’s ability to effectively market and differentiate its next-generation tobacco products.",
      "llm_answer": "From 2022 through 2024 PMI’s risk‑factor disclosures show a clear tightening of regulatory constraints that erode its competitive edge.  In 2022 the company warned that “product regulation that diminishes the ability to differentiate tobacco products, restricts adult consumer access to truthful and non‑misleading information about our RRPs, or disproportionately impacts the commercialization of our products in relation to our competitors” (p. 13‑17).  By 2023 the same language was expanded to include specific challenges to RRPs and SFPs—product classification, advertising restrictions, corporate communications and scientific substantiation—highlighting growing scrutiny of its reduced‑risk portfolio (p. 18‑22).  In 2024 the risk factors further intensify the narrative, noting stricter labeling, packaging, marketing and communication rules that limit product differentiation and adult consumer access to information about SFPs, underscoring an escalating regulatory environment that increasingly hampers PMI’s ability to convert smokers and differentiate its offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the evolution of regulatory constraints from 2022 to 2024 is accurately described, with proper emphasis on restrictions on product differentiation, adult consumer access to information, and increasing regulatory pressure on RRPs and SFPs. The shift in focus from RRPs to SFPs by 2024 is correctly noted. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the ground truth, so quantitative accuracy is not applicable—however, the years (2022–2024) are correctly used and referenced, and no incorrect numbers are introduced. (3) The multi-hop reasoning is sound: the LLM synthesizes changes in PMI’s risk-factor disclosures across three years, correctly identifying the expansion and intensification of regulatory concerns over time, including the broadening scope from RRPs to SFPs and the growing challenges in marketing, labeling, and scientific substantiation. (4) The LLM slightly omits the explicit mention of 'digital media spreading misleading information' in 2023 and the point about 'regulatory asymmetries' favoring competitors, which are present in the ground truth and add nuance to the competitive positioning argument. However, the core message about disproportionate impact and unfair commercialization is conveyed. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect—the answer directly addresses all parts of the multi-faceted question about regulatory evolution, product differentiation, and consumer communication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1611,
        "completion_tokens": 440,
        "total_tokens": 2051
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has PayPal's exposure to margin risk evolved from 2022 through 2024, particularly in relation to its transaction pricing models, use of payment processors, and incentives provided to customers across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bears full margin risk when completing payment transactions, with fees paid to payment processors and other financial institutions recognized as transaction expense. In 2023, the company reiterated this exposure to margin risk and added details about incentives provided to merchants and consumers, which are recognized as a reduction of revenue depending on performance targets or amortized over the contractual term. In 2024, PayPal again confirmed its full margin risk exposure and highlighted the independence of the fee charged to customers from the costs incurred when utilizing payment processors. Across the three years, the consistent acknowledgment of bearing full margin risk demonstrates a stable strategic approach, while the increasing detail around incentives and transaction pricing reflects a more nuanced disclosure of how margin risk is managed and potentially mitigated through dynamic pricing and cost structures.",
      "llm_answer": "PayPal’s exposure to margin risk has remained essentially unchanged from 2022 through 2024.  In each year’s 10‑K (2022 p. 78‑82, 2023 p. 75‑79, 2024 p. 73‑77) the company reiterates that it is the principal on all payment‑transaction services, that it sets a volume‑tiered pricing model with fixed and variable (percentage‑of‑payment) fees, and that it bears full margin risk regardless of the costs of payment processors or other financial institutions.  Incentives to merchants and consumers—discounts, rebates, rewards, and coupons—continue to be treated as revenue reductions, and the use of third‑party processors remains a transaction‑expense component but does not materially alter PayPal’s margin‑risk profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key facts are correct: PayPal bears full margin risk in each year (2022–2024), uses a tiered pricing model, treats incentives as revenue reductions, and incurs transaction expenses from third-party processors. These points match the ground truth in substance and detail. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—no discrepancies exist. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying consistent exposure to margin risk and evolving disclosures around incentives and cost structures. It accurately notes that the fee charged to customers is independent of processor costs, which is a key nuance highlighted in the original answer. (4) The only minor shortcoming is that the LLM does not explicitly state that the *increasing detail* in disclosures (especially around amortization of incentives over contractual terms or performance targets) reflects a more nuanced presentation over time—this nuance is present in the original answer. However, the LLM does reference incentives being treated as revenue reductions, which captures the core accounting treatment. Overall, the answer is factually complete, contextually precise, and semantically equivalent to the ground truth, warranting a high correctness score with only a slight deduction for missing the emphasis on evolving disclosure depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 432,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did AMD's strategy and relationship with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation for system integrators?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers against price reductions across all years. In 2022 and 2023, AMD highlighted that AIBs build and sell board-level products using AMD's graphics and chipset technology, which are then sold to system integrators (SIs), retailers, and sub-distributors. By 2024, AMD maintained this inventory protection policy but placed more emphasis on SIs selling based on regional or product-based strengths and responding quickly to new technologies. Throughout the period, AMD underscored the importance of discrete graphics solutions as a key differentiator for SIs to add value to their customers. However, in 2024, there was a subtle shift in language, indicating a more strategic alignment with SIs who integrate AMD-based AIB products into differentiated offerings, suggesting a deepening of the value proposition for AIBs within the broader ecosystem.",
      "llm_answer": "AMD’s 2022 10‑K (pp. 9‑13) already stated that agreements with AIB manufacturers protect their inventory against price reductions and that system integrators (SIs) use discrete graphics solutions to differentiate their products. The 2023 filing (pp. 11‑15) reiterated those inventory‑protection policies and further highlighted the role of discrete GPUs as a key differentiator for SIs. By 2024 (pp. 9‑13), AMD’s AIB agreements explicitly included return rights and reinforced the price‑reduction safeguard, while underscoring discrete graphics solutions as a core lever for SI differentiation, reflecting a strengthened focus on inventory protection and discrete‑GPU differentiation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AMD maintained inventory protection policies for AIB manufacturers from 2022 to 2024, emphasized discrete graphics as a differentiator for system integrators (SIs), and reinforced these commitments over time. The mention of 'return rights' in 2024 is a specific detail not explicitly stated in the ground truth, but it does not contradict it—rather, it adds granularity that may be present in the actual filing and is consistent with strengthened inventory protection. (2) There are no numerical values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is scored as 10 based on correct handling of years (2022, 2023, 2024) and document references (page numbers). (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying the evolution of AMD's strategy regarding AIBs and SIs. It captures the continuity in inventory protection and differentiation through discrete GPUs, and implies a strengthening of policy by 2024. The only minor gap is the absence of the subtle shift toward strategic alignment with SIs who create differentiated offerings—a nuance present in the original answer—but this is implied in the emphasis on 'core lever for SI differentiation'. (4) Contextual relevance is perfect: every part of the question (strategy evolution, inventory protection, role of discrete graphics, and SI differentiation) is addressed directly and accurately. The answer is slightly more concise than the ground truth but retains semantic equivalence on all key points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 454,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did The Walt Disney Company's management of investment credit exposure limits evolve from fiscal 2022 through fiscal 2024, particularly in terms of counterparty credit ratings, collateral requirements, and concentration thresholds?",
      "original_answer": "From fiscal 2022 through 2024, Disney maintained a consistent policy of transacting only with counterparties rated A- or better and requiring collateral if credit ratings fell below A- or exposures exceeded contractual limits. However, by fiscal 2024, the company reported a 24% concentration of cash and cash equivalents with a single financial institution, up from no such concentration in fiscal 2022, suggesting a shift in liquidity strategy despite continued emphasis on credit risk mitigation.",
      "llm_answer": "Across fiscal 2022‑24 Disney kept the same credit‑risk policy: it only enters derivative and other investment transactions with counterparties that have an A‑ or better rating and requires collateral if a counterparty’s rating falls below A‑ or if aggregate exposures exceed contractual limits. The concentration rule for cash and cash‑equivalents remained a 10 % threshold of total cash, but the concentration of balances with institutions that exceed that threshold rose from zero in 2023 to 24 % of total cash in 2024 (no concentration disclosed for 2022). The company continued to report no material cash balances with below‑investment‑grade counterparties throughout the period.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains minor inaccuracies and omissions that affect full precision. (1) Quantitatively, the 24% concentration in fiscal 2024 is correctly reported, and the statement that there was no concentration in 2022 matches the original. However, the LLM incorrectly states that 'zero concentration' was observed in 2023, while the ground truth does not mention 2023 at all—only that there was no concentration in 2022 and a 24% concentration in 2024. This introduces a data point (2023) not present in the source, which is a factual overreach. (2) The 10% threshold for concentration is mentioned in the LLM answer but absent from the original; this is extraneous detail not supported by the ground truth, potentially implying a policy specificity that wasn't confirmed. (3) Entity accuracy is strong: The Walt Disney Company, fiscal years 2022–2024, counterparty ratings (A- or better), collateral triggers, and the shift in cash concentration are all correctly identified. (4) Reasoning is sound in linking consistent credit policy with evolving concentration trends, demonstrating multi-hop synthesis between risk policy and liquidity strategy. However, the unsupported claim about 2023 and the invented threshold reduce quantitative and qualitative accuracy. (5) Despite these issues, the core message—that Disney maintained strict credit policies while increasing exposure to a single institution by 2024—is semantically equivalent and contextually relevant. The answer addresses all key aspects of the question: counterparty ratings, collateral requirements, and concentration trends. Minor deductions apply for introducing unverified details rather than major factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 474,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its 2029-maturing Fixed-rate 2.850% notes evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the Fixed-rate 2.850% notes maturing in 2029 remained consistently at $1,500 million across 2022, 2023, and 2024, indicating no principal reduction or refinancing activity for this specific instrument over the three-year period. Despite issuing new debt in 2023 and 2024, including higher-interest notes in 2024 such as the Fixed-rate 5.150% and 5.500% notes, PYPL maintained its $1,500 million liability for the 2029 notes. This suggests a strategic decision to retain this particular debt instrument, possibly to preserve favorable interest terms or manage cash flow predictability.",
      "llm_answer": "The company’s exposure to the 2029‑maturing Fixed‑rate 2.850% notes stayed at **$1.5 billion** in 2022, 2023, and 2024, with no repurchase or redemption of that tranche during the period. This steady exposure indicates a deliberate long‑term debt strategy that keeps a stable, laddered maturity profile and locks in a fixed rate, rather than aggressively refinancing or reducing that portion of debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly states that PYPL's exposure to the 2.850% fixed-rate notes maturing in 2029 remained constant at $1.5 billion (equivalent to $1,500 million) across 2022, 2023, and 2024, matching the ground truth in both amount and time frame. The formatting variation ($1.5 billion vs $1,500 million) is acceptable and semantically equivalent. 2) All numeric values—dollar amount, interest rate (2.850%), and years (2022–2024)—are accurate. There are no calculations required beyond consistency checks, which the model passes. 3) The reasoning is sound: the model correctly infers from the stable liability that PYPL is pursuing a deliberate long-term debt strategy with a stable maturity profile and fixed-rate retention. It accurately captures the implication of not redeeming or refinancing this tranche. However, it omits a key detail from the original answer: that PYPL issued new debt in 2023 and 2024, including higher-interest notes in 2024 (5.150% and 5.500%), which strengthens the inference that retaining the 2.850% notes was a strategic choice to preserve favorable rates. This omission slightly weakens the qualitative depth but does not make the answer incorrect. 4) The answer is contextually fully relevant, directly addressing both the evolution of exposure and the strategic implication. The conclusion about locking in fixed rates and maintaining maturity laddering aligns with the ground truth. The missing reference to new higher-cost debt prevents a perfect qualitative score, but the core reasoning remains valid and insightful.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 427,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 to 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted its exposure to raw material demand and supply risks in its Performance Materials and Technologies segment across all three years, but the framing and contextual emphasis evolved. In 2022, the company noted that operating results could be adversely impacted by raw material demand and supply, product commoditization, and illegal imports of hydrofluorocarbons into Europe. In 2023, this risk was reiterated with a continued emphasis on the impact of volatility in oil and natural gas prices on customer investment and product demand. By 2024, the segment was rebranded as Energy and Sustainability Solutions, and the exposure to raw material demand and supply remained a key risk factor, now linked more explicitly to the company’s ability to maximize production capacity and minimize downtime. The consistent presence of this risk across three years indicates a sustained vulnerability to commodity market volatility, despite strategic repositioning and operational adjustments.",
      "llm_answer": "Honeywell’s 10‑K risk‑factor disclosures for the Performance Materials and Technologies segment consistently flagged raw‑material demand and supply risk from 2022 through 2024. In 2022 the risk was noted without a contractual coverage figure (2022 p. 29); by 2023 the company disclosed that 64 % of its raw‑material supply base was under contract (2023 p. 31), and in 2024 it stated that a majority of the supply base was under contract (2024 p. 29). This gradual increase in contractual coverage shows the company is reducing exposure, yet the segment remains vulnerable to commodity‑price volatility because its cost structure is heavily tied to commodity inputs (2022 p. 29, 2023 p. 31, 2024 p. 29).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative claims not present in the ground truth, particularly the 64% contractual coverage in 2023 and 'a majority' in 2024, which are not mentioned or supported in the original answer. These figures may be factually accurate in the actual filings, but they are not part of the ground truth derived from the knowledge graph, making the LLM's inclusion of them unsupported in this evaluation context. The original answer focuses on qualitative shifts in risk framing, not contractual mitigation metrics. (2) The quantitative accuracy is low because the percentages (64%, majority) are not present in the ground truth and thus cannot be verified as correctly extracted or synthesized from the intended data source. There is no mention of contractual coverage in the original answer, so these numbers represent a factual divergence. (3) The multi-hop reasoning is partially sound—correctly identifying the continuity of raw material risk across years and linking it to commodity volatility—but it misdirects by emphasizing a mitigation narrative (increasing contractual coverage) that is absent in the ground truth. The original answer stresses sustained vulnerability despite strategic changes, not a reduction in exposure. The LLM incorrectly infers a trend of decreasing risk, whereas the ground truth emphasizes persistent risk. (4) Contextual relevance is high because the answer addresses the core topic—evolution of raw material risks in the segment over time—and correctly notes the rebranding to Energy and Sustainability Solutions by 2024. However, the qualitative accuracy is moderate because while entities (Honeywell, segment, years) and general risk themes are correct, the reasoning is skewed by unsupported numerical claims and a misaligned conclusion about risk reduction. The correctness score is 4 due to significant factual overreach on contractual data and a resulting misinterpretation of the risk trend, despite correct identification of the segment and general risk exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 551,
        "total_tokens": 2006
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What was the trajectory of PM's peer group composition with respect to Imperial Brands PLC over the three-year period from 2022 to 2024, and what does this reveal about PM's benchmarking strategy in the global tobacco and consumer products sector?",
      "original_answer": "Imperial Brands PLC remained consistently included in PM's peer group across all three years (2022, 2023, and 2024), indicating that PM maintained a stable benchmarking strategy focused on companies with similar global presence, revenue scale, and market capitalization. This consistency suggests that PM viewed Imperial Brands as a relevant comparator throughout the period, reflecting strategic alignment in peer selection despite potential market or operational changes.",
      "llm_answer": "Imperial Brands PLC was listed in PMI’s peer group in 2022, 2023 and 2024, with no change in its inclusion over the three‑year span (PM_10k_2022.pdf, pp. 19‑23; PM_10k_2023.pdf, pp. 24‑28; PM_10k_2024.pdf, pp. 24‑28). This steady presence shows that PMI’s benchmarking strategy is deliberately stable, using a consistent core set of global consumer‑product peers—including key tobacco competitors—to evaluate its performance against the broader industry.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) It accurately states that Imperial Brands PLC was included in PM's peer group for all three years (2022, 2023, 2024), which matches the original answer's claim of consistent inclusion. (2) There are no numerical values requiring calculation, but the years and inclusion status are correctly reported with citation to supporting documents, satisfying quantitative accuracy. (3) The multi-hop reasoning is sound—by synthesizing data across three annual 10-K filings, the model correctly infers stability in peer group composition. The conclusion about PM's benchmarking strategy being stable and focused on global consumer-product peers, including tobacco competitors, is logically derived and semantically equivalent to the original answer’s interpretation. (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'revenue scale' and 'market capitalization' as criteria (noted in the original), which slightly reduces qualitative accuracy, but the reference to 'key tobacco competitors' and 'global consumer-product peers' implies similar reasoning. Overall, the answer is contextually rich, factually precise, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 349,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained stable at $1.5 billion in both 2022 and 2023, but by 2024, the company still carried the full $1.5 billion balance, indicating no repayments or refinancing actions over the three-year period. This suggests that PYPL has maintained a consistent long-term liability position for this specific note, possibly prioritizing other debt maturities or leveraging the low fixed rate as part of a broader capital structure strategy.",
      "llm_answer": "From 2022 through 2024 PayPal’s exposure to the fixed‑rate 2.850% notes stayed flat at **$1.5 billion** (2022 table on pages 106‑110, 2023 table on pages 105‑109, 2024 table on pages 102‑106). The company did not redeem or repay this tranche during that period—only other notes were repurchased in 2022—so the long‑maturity, fixed‑rate exposure remained unchanged. This stability reflects a deliberate long‑term debt‑management strategy that locks in a fixed rate on a 2029‑maturity instrument while maintaining a balanced, diversified debt mix.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all figures are correct: the $1.5 billion exposure to the 2.850% fixed-rate notes is accurately reported for 2022, 2023, and 2024, with no repayment or refinancing, matching the original answer. The note's maturity in 2029 is an additional detail not in the ground truth but is factually consistent and adds context. (2) The answer correctly cites source pages across years, reinforcing accuracy. (3) Reasoning is sound: the LLM correctly infers that the lack of repayment indicates a deliberate strategy to maintain low fixed-rate debt, which aligns with the original conclusion about PYPL’s long-term debt management. The mention of other notes being repurchased in 2022 adds nuance and supports the claim of strategic prioritization. (4) The only minor gap is that the original answer explicitly frames the strategy as possibly prioritizing other maturities or leveraging the low rate, while the LLM emphasizes 'balanced, diversified debt mix'—a related but slightly different emphasis. However, this does not contradict but rather complements the original interpretation. Overall, the answer is factually complete, contextually relevant, and demonstrates correct multi-hop reasoning across years and debt instruments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 365,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did ConocoPhillips' approach to HSE audits evolve from 2022 to 2024, particularly in terms of audit scope, conformance tracking, and integration with corporate governance?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent emphasis on HSE audits as a core mechanism for ensuring conformance with company-wide safety and environmental standards. In 2022, the company conducted HSE audits across business units and staff groups, identifying improvement actions and tracking them to completion. By 2023, the company reinforced its HSE audit process by explicitly linking audit outcomes to annual objectives, targets, and deadlines, which were reported to the Executive Leadership Team (ELT) and the Board of Directors. In 2024, the company further refined its audit framework by specifying that audits were conducted at the corporate level, underscoring a more centralized oversight approach. This evolution shows a shift from localized conformance checks toward a more integrated, governance-driven audit model that aligns with strategic performance tracking.",
      "llm_answer": "ConocoPhillips’ HSE audit policy has stayed essentially the same from 2022 through 2024.  In each year the company conducts audits on both business‑unit and staff‑group levels to verify conformance with its HSE policies, standards and practices, and any improvement actions that arise are tracked to completion.  Audit results and progress are reported annually to the Executive Leadership Team and the Board of Directors, ensuring the audit process remains embedded in corporate governance.  (See 2023 10‑K, Health, Safety & Environment: “Corporate HSE audits are conducted on business units and staff groups…where improvement actions are identified and tracked to completion.” 2024 10‑K, Health, Safety & Environment: “HSE audits are conducted on business units and staff groups…Progress is tracked and reported to our ELT and the Board of Directors.”)",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key aspects of the evolution in ConocoPhillips' HSE audit approach from 2022 to 2024, leading to a significant gap in qualitative accuracy. (1) What was correct: The answer correctly states that HSE audits were conducted at business-unit and staff-group levels, improvement actions were tracked to completion, and results were reported to the Executive Leadership Team (ELT) and Board of Directors. These points are supported by the 2023 and 2024 10-K filings and align with the ground truth. (2) Quantitative accuracy: There are no numerical values in this question, so this dimension is satisfied by default—no factual inaccuracies in dates or entities. The years 2022–2024 are correctly referenced. (3) Multi-hop reasoning assessment: The LLM fails to capture the evolution described in the ground truth. It incorrectly claims the policy 'has stayed essentially the same,' which contradicts the documented progression: in 2023, audit outcomes were explicitly linked to annual objectives, targets, and deadlines; in 2024, audits were specified as being conducted at the corporate level, indicating a shift toward centralized oversight and integration with strategic governance. The answer overlooks the increasing integration with corporate performance tracking and governance, which is central to the question. (4) Justification for scores: Correctness is scored 5 because while core elements (audit scope, reporting) are accurate, the answer misses the critical evolution in conformance tracking and governance integration. Qualitative accuracy is 5 due to flawed reasoning about continuity versus change. Quantitative accuracy is 10 because there are no factual errors in the details provided. Contextual relevance is 8 because the answer addresses the general topic and cites relevant sections, but fails to fully engage with the 'evolution' aspect of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 515,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did AMD's reliance on the 2011 Executive Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of its continued reference as a foundational governance document amid broader executive compensation plan disclosures?",
      "original_answer": "Across 2022, 2023, and 2024, AMD consistently referenced the 2011 Executive Incentive Plan as a foundational governance document, indicating no material changes or replacements during this period. In 2022, the plan was listed as *10.1* in the 10-K filing, reiterating its role alongside other executive compensation arrangements like the AMD Executive Severance Plan and the AMD Deferred Income Account Plan. In 2023, AMD again cited the 2011 Executive Incentive Plan as *10.1* in its 10-K filing, showing continuity in its disclosure practices. In 2024, the plan remained listed as *10.1* in the 10-K, reaffirming its ongoing relevance despite the presence of newer agreements and amendments to other plans. The consistent citation of the 2011 plan across all three years suggests AMD's executive incentive framework remained anchored in this policy without significant revision, even as other compensation mechanisms evolved.",
      "llm_answer": "AMD has continued to treat the 2011 Executive Incentive Plan as a foundational governance document by incorporating it by reference as Exhibit 10.1 in each filing.  In the 2022, 2023 and 2024 10‑K reports the plan is listed in the “Exhibit” section (2022 p. 91‑95; 2023 p. 99‑103; 2024 p. 96‑100) and remains a reference point even as the company expands its executive‑compensation disclosures to include newer plans and broader award details.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that AMD consistently referenced the 2011 Executive Incentive Plan as Exhibit 10.1 in its 2022, 2023, and 2024 10-K filings, which matches the original answer's claim about its continued role as a foundational governance document. The page numbers cited (2022 p. 91–95; 2023 p. 99–103; 2024 p. 96–100) are specific and consistent with typical 10-K exhibit section locations, though minor discrepancies in exact pages would not affect factual correctness as long as the exhibit number and context are accurate. (2) There are no numerical values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy pertains to dates and exhibit numbers—both of which are correct: the years 2022–2024 and Exhibit 10.1 are accurately reported. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings, correctly inferring continuity in AMD’s reliance on the 2011 plan despite evolving compensation disclosures. It captures the core insight—that the plan remains a reference point—even as newer plans are introduced. (4) The answer is semantically equivalent to the original, though slightly less detailed in naming other plans (e.g., AMD Executive Severance Plan, AMD Deferred Income Account Plan), which were mentioned in the ground truth but omitted here. This is a minor omission that does not detract from the central claim. Overall, the response is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 436,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did General Motors' indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls evolve from 2022 through 2024, and what does this progression indicate about GM's exposure to post-sale liabilities?",
      "original_answer": "From 2022 through 2024, GM's indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls remained a contingent liability with no material accruals recorded, but the geographic and legal scope of exposure expanded. In 2022, GM noted potential indemnification obligations for emissions claims and recalls, with no specific accrual. By 2023, lawsuits in Germany, the UK, and the Netherlands were explicitly mentioned, and Stellantis had initiated recalls tied to Takata inflators in legacy Opel vehicles, for which GM indemnified an immaterial amount. In 2024, the legal exposure widened further with the addition of Austria as a jurisdiction, and GM faced a new regulatory investigation by the European Commission and UK CMA related to end-of-life vehicle practices at Opel, prompting an immaterial accrual. While GM consistently maintained that further indemnification beyond current estimates was remote, the increasing number of legal and regulatory actions indicates a growing complexity and persistence of post-sale liabilities tied to the Opel/Vauxhall business.",
      "llm_answer": "Across the 2022, 2023 and 2024 10‑K filings GM consistently reported that it had agreed to indemnify Stellantis for any losses arising from inaccuracies in the 2017 Opel/Vauxhall sale agreement, including costs related to emissions claims and recalls, but could not estimate a material loss and only recorded an immaterial indemnification for certain Takata‑related recalls. The obligations remained subject to time limits, thresholds and caps, and the company noted that any further indemnification for Takata recalls is remote. This unchanged, capped exposure indicates that GM’s post‑sale liability from the Opel/Vauxhall sale has remained limited and largely contained within defined parameters.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key qualitative developments in GM's indemnification obligations from 2022 to 2024, particularly the expansion of legal and regulatory exposure. Quantitatively, there are no errors: the mention of immaterial indemnifications for Takata-related recalls and the inability to estimate a material loss align with the ground truth. The entity names (GM, Stellantis, Opel/Vauxhall), time frame (2022–2024), and financial terms (immaterial accruals, capped exposure) are accurate. However, the LLM fails to capture the evolving scope of exposure—specifically, the addition of new jurisdictions (Germany, UK, Netherlands in 2023; Austria in 2024) and new regulatory investigations by the European Commission and UK CMA in 2024 related to end-of-life vehicle practices. These omissions represent a significant gap in multi-hop reasoning, as the question asks how the obligations *evolved* and what that indicates about GM’s post-sale liability. The LLM incorrectly implies the exposure was 'unchanged' and 'contained,' contradicting the ground truth that shows increasing complexity and geographic/legal expansion. While the core fact of immaterial accruals is correct, the synthesis across years and jurisdictions is incomplete, leading to an oversimplified and misleading conclusion about the nature of GM's liability progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 378,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Eli Lilly's (LLY) financial exposure to bamlanivimab evolve from 2022 to 2024, particularly in terms of royalty obligations to AbCellera and the product's contribution to revenue, and what does this reveal about the long-term strategic importance of the product?",
      "original_answer": "Eli Lilly's exposure to bamlanivimab declined significantly from 2022 to 2024. In 2022, the company still reported $2,008.9 million in U.S. revenue from 'COVID-19 antibodies,' which included bamlanivimab, and had ongoing royalty obligations to AbCellera based on tiered percentages ranging from mid-teens to mid-twenties on global sales. By 2023, U.S. revenue from the category had dropped to zero, signaling a full phase-out of the product's commercial relevance. In 2024, the product was no longer mentioned in revenue tables, confirming its complete exit from LLY's active portfolio. This trajectory shows that while bamlanivimab was a significant contributor during the pandemic, it has since lost strategic importance as demand waned and focus shifted to newer therapeutic areas like cardiometabolic health.",
      "llm_answer": "From 2022 to 2024 Eli Lilly’s exposure to bamlanivimab shifted from a major revenue driver to a negligible one. In 2022 the antibody generated $1.978 billion in revenue (≈7 % of total sales) and in 2023 it produced $2.009 billion (≈6 % of sales), but by 2024 the product was essentially discontinued, with revenue falling to near zero. Royalty payments to AbCellera – tiered mid‑teens to mid‑twenties on net sales – remained a cost of sales but represented a small fraction of overall expenses, underscoring that bamlanivimab’s long‑term strategic importance has largely faded as the pandemic waned.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, Eli Lilly reported $2,008.9 million in U.S. revenue from 'COVID-19 antibodies' (including bamlanivimab) in 2022, but $0 in 2023. The LLM incorrectly states that revenue was $1.978 billion in 2022 and increased to $2.009 billion in 2023 before dropping to near zero in 2024. This misrepresents the actual trend — revenue did not increase in 2023; it dropped to zero. Additionally, the percentage of total sales cited (7% and 6%) is unsupported by the ground truth, which does not provide total company revenue for those years or such percentages. (2) The royalty obligations to AbCellera are correctly described as tiered from mid-teens to mid-twenties on net sales, which aligns with the original answer. However, the claim that these royalties 'remained a cost of sales' in 2024 is questionable since the product was fully phased out and no longer generating revenue, implying no ongoing royalty payments. (3) The multi-hop reasoning is partially sound — the model correctly infers declining strategic importance due to reduced revenue and pandemic waning — but the flawed data undermines the logic. The conclusion that bamlanivimab’s strategic importance faded is valid, but it's based on incorrect revenue trends. (4) Contextual relevance is high because the answer addresses all parts of the question: revenue evolution, royalty obligations, and strategic implications. However, the quantitative inaccuracies — especially the false increase in 2023 revenue — severely reduce factual correctness, warranting a low quantitative accuracy score and a moderate overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 467,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Philip Morris International's strategic positioning around the Jackpot brand evolve from 2022 through 2024, and what does this 3-year trajectory reveal about its focus on local cigarette brands in key markets?",
      "original_answer": "From 2022 through 2024, Philip Morris International consistently listed Jackpot as a key local cigarette brand in the Philippines, indicating its ongoing commitment to maintaining a strong regional presence through localized offerings. In 2022, Jackpot was mentioned as part of a broader portfolio of local brands, including Fortune in the Philippines, signaling its importance in the region. In 2023, the company reiterated its reliance on local brands like Jackpot, emphasizing their role in complementing international brands and sustaining market share in key geographies such as the Philippines. By 2024, despite a broader strategic pivot toward smoke-free products and wellness, Jackpot remained a named local brand in the Philippines, suggesting that PMI continued to value its role in market-specific competitiveness. This 3-year consistency highlights PMI's dual strategy of leveraging local cigarette brands to maintain market relevance while transitioning toward a smoke-free future.",
      "llm_answer": "From 2022 through 2024, PMI’s filings consistently list Jackpot as one of its key local cigarette brands in the Philippines, with no change in its positioning or product mix. This steady inclusion shows that PMI continues to maintain a local‑brand portfolio in important markets while its broader strategy pivots toward smoke‑free products. (PM_10k_2022: pages 3‑7; PM_10k_2023: pages 4‑8; PM_10k_2024: pages 3‑7)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately identifies that Philip Morris International (PMI) consistently listed Jackpot as a key local cigarette brand in the Philippines from 2022 to 2024, which is supported by the cited 10-K filings. The answer correctly captures the strategic trajectory: PMI maintains local brands like Jackpot while pivoting toward smoke-free products. All entities (Jackpot, PMI, Philippines) and timeframes (2022–2024) are accurate, and there are no numerical or date inaccuracies (quantitative accuracy is perfect, scoring 10). The reasoning is sound and reflects multi-hop synthesis across three years of filings. The only minor shortcoming is that the LLM answer omits some contextual nuance present in the original answer—specifically, the mention of Fortune as a co-local brand in 2022 and the explicit emphasis on local brands complementing international ones in 2023. While the core message about sustained local brand focus is conveyed, this slight reduction in detail prevents a perfect qualitative score. However, the answer remains semantically equivalent in intent and factual content, and fully addresses both parts of the question: Jackpot’s positioning evolution (stable) and what it reveals about PMI’s local brand strategy. Contextual relevance is therefore full. Correctness is high—minor omission but no factual errors—justifying a 9/10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 393,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did PayPal's exposure to bad transactions through its credit and BNPL products evolve from 2022 through 2024, particularly in light of the 2023 sale of up to €40 billion in U.K. and European BNPL loan receivables and the ongoing risks related to fraud and third-party processing disruptions?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to bad transactions evolved significantly as it transitioned from managing a growing credit and BNPL portfolio to partially offloading that risk through a major asset sale in 2023, while continuing to face persistent threats from fraud and third-party dependencies. In 2022, PayPal highlighted increasing risks around bad transactions due to fraud, synthetic identities, and stolen financial instruments, particularly in its digital payment services. The company also noted its reliance on third-party lenders and processors, which introduced additional operational and reputational risks. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion in U.K. and European BNPL loan receivables, effectively reducing its direct exposure to bad transactions in that segment, although the sale was subject to conditions and execution risks. Despite this, PayPal still faced challenges in managing fraud and account takeover attempts. By 2024, the company continued to emphasize the risks of bad transactions, particularly from fraud schemes and third-party processing, but had shifted some of the credit risk burden through the BNPL receivables sale. However, uncertainty remained around regulatory challenges and the effectiveness of fraud detection systems, indicating that while the direct exposure to bad transactions had decreased, the underlying risks persisted.",
      "llm_answer": "PayPal’s 2022 risk disclosures (pp. 24‑28) highlighted that its branded‑credit and BNPL products exposed it to bad‑transaction losses from credit‑risk defaults, fraud and third‑party processing disruptions.  In 2023 the company mitigated its BNPL exposure by selling up to €40 billion of U.K. and European BNPL loan receivables— a forward‑flow arrangement that transfers most of that portfolio (pp. 23‑27).  By 2024, while the BNPL exposure had largely been transferred, PayPal still faced ongoing credit‑product default risk, evolving fraud schemes and the possibility of third‑party processor outages that could increase bad‑transaction losses (pp. 21‑25).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal's exposure to bad transactions through credit and BNPL products in 2022 included risks from fraud, credit defaults, and third-party processing disruptions. In 2023, the company sold up to €40 billion in U.K. and European BNPL loan receivables via a forward-flow arrangement, reducing direct exposure. By 2024, while BNPL risk was largely transferred, ongoing risks remained around fraud, defaults, and third-party outages. (2) Quantitative accuracy is perfect: the €40 billion figure is correctly cited, and no calculations are required beyond that. Format (€40 billion) matches ground truth. (3) Multi-hop reasoning is sound: the answer synthesizes information across three years, correctly identifying the evolution of risk exposure and the impact of the 2023 sale. It distinguishes between reduced direct exposure and persistent indirect risks. (4) Minor deduction in qualitative accuracy due to slightly less elaboration on synthetic identities and regulatory uncertainty mentioned in the original, but the core reasoning and risk categorization remain intact. Contextual relevance is full—every part of the question is addressed concisely and accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1558,
        "completion_tokens": 354,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment in 2022, Industrial Automation segment in 2024, and overall risk posture in 2023, and what does this evolution suggest about the company's sensitivity to retail demand volatility across its industrial portfolio?",
      "original_answer": "In 2022, Honeywell's Safety and Productivity Solutions segment identified 'fluctuations in retail markets' as a key risk factor that could lead to reduced investments in safety monitoring and process automation, directly impacting demand for its products and services. By 2023, this risk was reiterated as part of the broader macroeconomic and industry risks, with emphasis on how global economic instability and fluctuating demand could continue to affect customer investment behavior. In 2024, the risk was specifically tied to the newly restructured Industrial Automation segment, where 'fluctuations in retail markets' were again cited as a potential cause of slowdowns in demand for safety products and could result in lower market share and reduced margins. This progression shows that Honeywell's exposure to retail market volatility remained a consistent concern across three years, even as the company reorganized its business units, suggesting a persistent sensitivity to consumer-driven demand shifts within its industrial offerings.",
      "llm_answer": "In 2022 the Safety & Productivity Solutions segment was flagged in the risk‑factor section (p. 30‑34) as vulnerable to retail‑market fluctuations, which could erode market share, selling prices and margins. In 2024 the newly‑defined Industrial Automation segment faced a similar risk (p. 28‑32), with the risk‑factor noting that retail‑market volatility could depress operating results and margins. The 2023 risk‑factor (p. 30‑34) reiterated retail‑market volatility as a key risk for both segments, underscoring that Honeywell’s overall risk posture remains sensitive to swings in retail demand across its industrial portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: in 2022, Safety & Productivity Solutions was exposed to retail market fluctuations; in 2024, the Industrial Automation segment faced similar risks; and in 2023, the risk was reiterated as part of the overall risk posture. The entities (segments, years, risk types) are correctly identified. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates and years are accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes risk exposure across three years and two segments, noting continuity despite restructuring. The only minor shortcoming is that the LLM answer implies the 2023 risk applied to 'both segments'—but in 2023, the segment structure may not yet have included 'Industrial Automation' as a standalone unit (since it was restructured in 2024). The ground truth frames 2023 as a broader risk posture without specifying both segments, so this is a slight overprecision. (4) Despite this nuance, the answer remains semantically equivalent and contextually relevant, correctly concluding that Honeywell maintains sensitivity to retail demand volatility across its industrial portfolio. Wording differences are acceptable and do not affect factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 382,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the financial structure and strategic focus of LLY's collaboration with Incyte evolve from 2022 to 2024, particularly in terms of milestone payments, royalty structures, and the role of Olumiant in LLY's revenue base?",
      "original_answer": "From 2022 to 2024, LLY's collaboration with Incyte remained centered on Olumiant, but the financial obligations and strategic framing evolved. In 2022, LLY had capitalized $260.0 million in milestone payments tied to regulatory approvals in the U.S., Europe, and Japan, with Incyte eligible for up to an additional $200.0 million in contingent payments (split evenly between regulatory and sales milestones). The royalty structure was tiered, with rates up to 20% on general sales and an additional low teens royalty for sales exceeding a threshold related to the treatment of COVID-19. In 2023, the focus shifted to ongoing revenue recognition, with LLY continuing to record royalty payments to Incyte as cost of sales, indicating the maturity of the partnership and the product's established market presence. By 2024, the collaboration remained financially consistent, but LLY emphasized the broader strategic positioning of Olumiant, including its use under EUA and the inclusion of follow-on compounds, suggesting a long-term commitment to the partnership and therapeutic expansion. The consistent royalty structure and milestone eligibility across years show a stable financial framework, while the increasing emphasis on Olumiant’s expanded use indicates a deepening strategic alignment.",
      "llm_answer": "From 2022 through 2024 the Incyte partnership kept its tiered double‑digit royalty structure (up to 20 % on worldwide net sales of Olumiant, plus an extra low‑teens royalty on COVID‑19 sales above a threshold) unchanged, while milestone payments were largely front‑loaded—$260 m and $210 m were capitalized as intangible assets in 2021 and 2020, with no new milestones reported thereafter.  The collaboration’s strategic focus broadened to include follow‑on compounds and COVID‑19 indications, but the core royalty arrangement remained the same.  Olumiant’s net product revenue grew from $830.5 m in 2022 to $957.4 m in 2024, highlighting its expanding share of LLY’s revenue base.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. It states that $260M and $210M were capitalized in 2021 and 2020, but the ground truth specifies $260M in milestone payments capitalized in 2022 (not 2021 or 2020), with up to $200M in additional contingent payments. The LLM incorrectly implies all milestone payments were front-loaded and completed before 2022, contradicting the original answer’s mention of potential future milestones through 2024. Additionally, the LLM introduces specific revenue figures for Olumiant ($830.5M in 2022, $957.4M in 2024), which are not present in the ground truth and cannot be verified against it—this adds unsupported precision. (2) The royalty structure is correctly described as tiered with up to 20% and an additional low-teens royalty on COVID-19 sales, which aligns with the original answer. However, the timing of milestone capitalization is wrong, undermining quantitative accuracy. (3) The reasoning partially captures the strategic evolution—mentioning follow-on compounds and expanded indications—but fails to reflect the shift in focus from milestone-triggered payments (2022) to ongoing royalty recognition (2023) and strategic expansion (2024) as emphasized in the ground truth. The multi-hop synthesis is weak because it misaligns the timeline of financial events. (4) Despite these issues, the answer remains contextually relevant, addressing all key aspects of the collaboration: milestones, royalties, strategy, and Olumiant’s role in LLY’s revenue. The qualitative reasoning is reasonable but based on incorrect data. The correctness score is limited primarily by significant quantitative errors and incorrect temporal attribution of financial events.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 481,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Altria's structural relationship and financial exposure to UST evolve from 2022 to 2024, particularly in terms of intangible asset valuation, ownership structure, and integration into Altria's broader smoke-free transition strategy?",
      "original_answer": "In 2022, Altria's indefinite-lived intangible assets included $8.8 billion in MST and snus trademarks from UST, reflecting the legacy value of the 2009 acquisition. By 2023, UST remained a wholly owned subsidiary through its subsidiary USSTC, continuing to manufacture and sell MST and snus products, indicating sustained ownership and operational integration. In 2024, UST continued as a wholly owned subsidiary, with its subsidiary USSTC still engaged in MST production, but Altria's broader portfolio strategy shifted toward oral nicotine pouches via Helix and e-vapor via NJOY, suggesting a strategic evolution where UST's traditional MST business remained a core asset but was increasingly complemented by newer, potentially less harmful tobacco alternatives. This 3-year trajectory shows Altria maintaining UST's financial value while strategically diversifying around it.",
      "llm_answer": "Altria’s ownership of UST remained unchanged through 2024 – UST LLC and its wholly‑owned subsidiary USSTC are still fully owned by Altria (2024 p. 2‑6).  The intangible assets tied to UST—MST and snus trademarks—were reported at $8.8 B and $2.6 B as of 2021, with no impairment recorded in 2021 or 2020 and no changes disclosed in 2022 or 2024, indicating stable valuation (2024 p. 2‑6, 2023 p. 58‑62, 2022 p. 64‑68).  UST continues to be a core part of Altria’s smoke‑free transition strategy, providing moist smokeless tobacco and snus products that fit the company’s Vision to move adult smokers toward smoke‑free alternatives.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and omissions compared to the ground truth. While it correctly states that UST remained a wholly owned subsidiary through 2024, it incorrectly cites intangible asset values from 2021 ($8.8B for MST and $2.6B for snus), whereas the ground truth specifies only the $8.8B MST/snus trademark value in 2022 with no mention of a $2.6B figure or snus being separately valued at that amount. The $2.6B value is not present in the original answer and introduces a fact not supported by the ground truth. Additionally, the LLM claims no changes were disclosed in 2022 or 2024 regarding valuation, but the ground truth does not confirm this stability beyond stating the 2022 value; thus, asserting no changes lacks support. (2) The quantitative accuracy is compromised by the introduction of an incorrect $2.6B figure and reliance on 2021 data when the question focuses on 2022–2024. The $8.8B figure is correct and matches the ground truth for 2022, but the additional number and outdated sourcing reduce precision. (3) The reasoning is partially sound—ownership structure is correctly identified as stable, and UST’s role in the smoke-free strategy is acknowledged. However, the LLM fails to capture the strategic evolution highlighted in the ground truth: the shift toward oral nicotine pouches (Helix) and e-vapor (NJOY) as complementary to UST’s traditional MST business. This key multi-hop insight—Altria diversifying *around* UST rather than relying solely on it—is missing, weakening the synthesis across years and strategic moves. (4) Contextual relevance is high because the response addresses ownership, intangible assets, and strategic role. However, the failure to reflect the evolving strategic integration and incorrect financial figures limits factual correctness. The answer is plausible but not fully aligned with the ground truth, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 520,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Cisco's (CSCO) interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's borrowing costs and capital market conditions over this period?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Senior Note carried an effective interest rate of 3.20%. By fiscal year 2023, this rate had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This represents a significant upward trend in Cisco's effective borrowing cost on this instrument, rising from 3.20% to 6.66% over the three-year period. This evolution reflects tightening capital market conditions and potentially higher perceived risk or changing interest rate environments during this time frame.",
      "llm_answer": "Cisco’s 3.50% senior note had an effective rate of 3.20 % in FY 2022, which jumped to 6.38 % in FY 2023 and rose further to 6.66 % in FY 2024. The sharp climb in the effective rate—well above the 3.50 % coupon—shows that Cisco’s borrowing costs accelerated as market rates tightened, reflecting a shift toward higher interest rates and a more expensive capital‑market environment over the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all percentages and fiscal years are accurate: 3.20% in FY 2022, 6.38% in FY 2023, and 6.66% in FY 2024—matching the original answer exactly. There are no calculation errors or misstatements. (2) The answer is complete, addressing both the evolution of the interest rate exposure and its implications for borrowing costs and capital market conditions. (3) Entity accuracy is correct: Cisco (CSCO), the 3.50% Senior Note, and the correct fiscal years are all properly identified. (4) The reasoning is sound: the LLM correctly interprets the rising effective interest rates—despite a fixed coupon—as indicative of higher borrowing costs due to tightening market conditions, which aligns with the multi-hop inference required. (5) Semantic equivalence is strong: while the wording differs slightly, the meaning, factual content, and analytical insight are identical to the ground truth. Minor stylistic differences (e.g., 'jumped' vs 'increased') do not affect accuracy. All evaluation criteria are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 314,
        "total_tokens": 1563
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory indicate about the company's debt management strategy over this period?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion in 2022, decreased to $15.0 billion in 2023, and further declined to $13.0 billion in 2024. This consistent reduction indicates a deliberate debt management strategy to gradually retire this issuance over time, aligning with Amazon's broader trend of reducing long-term debt from $67.2 billion in 2022 to $52.6 billion in 2024.",
      "llm_answer": "Amazon’s 2017 senior notes, originally issued at $17 billion, fell from $16.0 billion at year‑end 2022 to $15.0 billion in 2023 and further to $13.0 billion in 2024 (all figures in millions). This steady decline—$1 billion in 2023 and $2 billion in 2024—shows a deliberate repayment of that tranche, underscoring Amazon’s strategy of trimming long‑term debt and interest exposure while maintaining a strong balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the outstanding balance of Amazon's 2017 Notes as $16.0 billion in 2022, $15.0 billion in 2023, and $13.0 billion in 2024, matching the ground truth exactly. The reductions—$1 billion from 2022 to 2023 and $2 billion from 2023 to 2024—are accurately described. (2) All numeric values are correct and consistent with the original answer; formatting variations (e.g., 'billions' vs. 'in millions') do not affect accuracy. The mention of the original $17 billion issuance adds context not in the ground truth but is factually accurate and does not detract. (3) The reasoning is sound: the LLM correctly infers a deliberate repayment strategy from the declining balances, aligning with Amazon’s broader debt reduction trend (though it omits the specific total long-term debt figures—$67.2B to $52.6B—mentioned in the ground truth). This is a minor omission but does not invalidate the conclusion. (4) The answer is contextually complete and relevant, addressing both the evolution of the debt and its strategic implication. The only reason for not scoring a 10 is the slight lack of completeness in not referencing the broader long-term debt context from the ground truth, which would have strengthened the multi-hop synthesis. Overall, the answer is factually excellent with high qualitative and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 380,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AVGO's outstanding principal balance and interest rate for the 5.000% notes due April 2030 evolve from fiscal 2022 through 2024, and what does this multi-year progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal 2022, AVGO reported an outstanding principal balance of $606 million for the 5.000% notes due April 2030 with an effective interest rate of 5.18%. This balance remained unchanged in fiscal 2023, still at $606 million with the same interest rate. By fiscal 2024, the balance on these notes remained constant at $606 million, showing no reduction or increase over the three-year period. The consistent principal and interest rate across all three years suggest that AVGO maintained a static approach to this debt instrument, neither accelerating repayments nor issuing additional tranches of this specific note.",
      "llm_answer": "AVGO’s 5.000% notes due April 2030 carried an outstanding principal balance of $606 million and an effective interest rate of 5.18% (coupon 5.000%) in fiscal 2022, 2023 and 2024【AVGO_10k_2022.pdf pages 101‑105】【AVGO_10k_2023.pdf pages 79‑83】【AVGO_10k_2024.pdf pages 79‑83】. The unchanged balance and rate over three years show that AVGO has chosen to keep this long‑term debt in place, using it as a stable, low‑cost financing source and preserving liquidity while avoiding refinancing risk【AVGO_10k_2024.pdf pages 79‑83】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the outstanding principal balance of $606 million and the effective interest rate of 5.18% for the 5.000% notes due April 2030 across fiscal years 2022, 2023, and 2024, matching the ground truth exactly. The coupon rate (5.000%) is also accurately noted. These values are consistent with the original answer and supported by the cited 10-K filings. (2) All numeric values—$606 million principal, 5.18% effective rate, and 5.000% coupon—are factually correct and properly attributed across the three years. No calculations were required beyond recognition of consistency, which the model handled correctly. (3) The multi-hop reasoning is sound: the model synthesized data from three separate 10-K filings (2022, 2023, 2024) and correctly inferred that the lack of change in principal or rate indicates a deliberate debt management strategy. The conclusion that AVGO is using the debt as a stable, low-cost financing source aligns with the ground truth’s interpretation of a 'static approach,' though the LLM adds slight interpretive nuance (e.g., 'preserving liquidity,' 'avoiding refinancing risk') not explicitly stated in the ground truth. While reasonable, this slightly extends beyond the original answer’s more neutral tone. (4) The answer is fully contextually relevant, addressing both the evolution of the debt terms and the strategic implication. The only reason for not awarding a perfect 10 is that the original answer emphasizes the absence of repayment acceleration or additional issuance, while the LLM focuses more on benefits (liquidity, risk avoidance); thus, the qualitative reasoning is excellent but not perfectly aligned in emphasis. Overall, the answer is factually flawless and highly accurate in synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 483,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 to 2024, particularly in terms of its formalization, restatement, and integration with executive compensation agreements across these years?",
      "original_answer": "In 2022, Netflix referenced the Performance Bonus Plan as part of its executive compensation framework, indicating its foundational role in incentivizing leadership. By 2023, the company formally introduced an 'Amended and Restated Performance Bonus Plan' through an 8-K filing on December 9, 2022, signaling a strategic update to the plan. In 2024, the Performance Bonus Plan was further embedded into the broader executive compensation architecture, appearing alongside updated stock option agreements and severance plans, including the 'Executive Officer Severance Plan' and 'Performance-Based Restricted Stock Unit Award Agreement,' suggesting a more integrated and mature compensation strategy.",
      "llm_answer": "In 2022 Netflix formally adopted and **restated** its Performance Bonus Plan, incorporating it into the executive compensation agreements (see Exhibit 10.5).  The 2023 filing repeated that restatement and further integrated the plan into the 2023 executive‑compensation framework, updating performance metrics and eligibility.  By 2024 the plan was again restated and fully embedded in the 2024 executive‑compensation agreements, aligning it with the company’s revised incentive structure and ensuring it is governed by the same contractual framework each year.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Netflix's Performance Bonus Plan from 2022 to 2024 and correctly identifies its integration into executive compensation, which aligns with the question's focus. However, there are significant factual inaccuracies in timing and formalization details. The original answer states that the 'Amended and Restated Performance Bonus Plan' was formally introduced via an 8-K filing on December 9, 2022 — meaning the restatement occurred in late 2022 and was reflected in 2023 disclosures. The LLM incorrectly claims that Netflix 'formally adopted and restated' the plan in 2022, implying the full restatement was effective and documented as such in that year’s filings, which contradicts the ground truth. Additionally, the LLM suggests the plan was 'again restated' in 2024, but the original answer does not mention a second restatement — only deeper integration with other agreements like the Performance-Based RSU and Severance Plan. The LLM also references 'Exhibit 10.5' and updated performance metrics/eligibility, which are not present in the ground truth and introduce unsupported specifics. While the overall trajectory — increasing integration over time — is reasonably inferred, the incorrect dating of the restatement and the claim of repeated restatements undermine quantitative and qualitative accuracy. The contextual relevance remains high because the response addresses formalization, restatement, and integration across years as required. Minor phrasing differences would be acceptable under semantic equivalence, but the introduction of unverified events (multiple restatements, exhibit numbers, metric updates) crosses into factual error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 460,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance protections, and risk mitigation strategies?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained consistent in its modeling approach but evolved in terms of reinsurance protections and risk mitigation strategies. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, AIG emphasized routine monitoring of international terrorism exposure concentration and targeted reinsurance purchases for certain lines of business. In 2024, AIG retained core attachment points for Japan at $200 million and $125 million for the rest of the world, while also purchasing global property per risk covers for non-critical and critical catastrophe events outside North America. Additionally, AIG held $20.1 billion in collateral to support reinsurance recoverable assets. This progression shows a strategic deepening of reinsurance and risk alignment mechanisms over time.",
      "llm_answer": "AIG’s international terrorism‑risk strategy has stayed essentially the same from 2022 to 2024. In 2022 the company disclosed a scenario‑based loss estimate of **$1.3 billion** for a five‑ton bomb attack net of the Terrorism Risk Insurance Program Reauthorization Act (TRIPRA) and reinsurance recoveries, noting that TRIPRA covered **80 %** of losses above a **$1.7 billion** deductible and that only limited private reinsurance was in place【2022 10‑K page 169】【2022 10‑K page 170‑171】. The 2023 and 2024 filings repeat the same approach—scenario‑based modeling, TRIPRA coverage, targeted private reinsurance purchases, and reliance on government‑sponsored terrorism pools—without changing the deductible, coverage percentage, or providing a new loss estimate【2023 10‑K page 119‑123】【2024 10‑K page 86‑89】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains significant omissions and misrepresentations in the evolution of AIG's international terrorism exposure management from 2022 to 2024. (1) Quantitatively, the $1.3 billion loss estimate for a five-ton bomb attack in 2022 is accurate and correctly attributed to being net of TRIPRA and reinsurance. The mention of TRIPRA covering 80% above a $1.7 billion deductible aligns with the context, though this detail was not in the ground truth and may be extraneous or inferred. However, the LLM fails to include key 2024-specific reinsurance attachment points: $200 million for Japan and $125 million for the rest of the world—critical updates showing evolution. The $20.1 billion in collateral supporting reinsurance recoverables, a major risk mitigation enhancement in 2024, is entirely missing. (2) The LLM incorrectly states that the 2023 and 2024 filings 'repeat the same approach' without changes, which contradicts the ground truth: in 2023, AIG began targeted reinsurance purchases and routine monitoring of exposure concentration, and in 2024 expanded to global property per-risk covers outside North America—key strategic developments. (3) The reasoning is flawed in concluding that the strategy 'stayed essentially the same,' when the ground truth shows a clear progression in reinsurance depth and risk alignment. The model fails to synthesize the multi-hop evolution across years, particularly the shift toward more structured and layered protections. (4) While the answer is contextually relevant and uses correct entities (AIG, TRIPRA, years), it lacks completeness and misrepresents the trend, undermining qualitative accuracy. The absence of 2024-specific financial structures and risk mitigation tactics results in a correctness score of 6—partially correct but with significant gaps in key evolving strategies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 503,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did UnitedHealth Group's venture investment strategy evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's venture investment strategy showed a significant shift in focus and scale. In 2022, the company held $3.5 billion in equity securities, which included venture investments and employee savings plan-related investments, along with $1.3 billion in equity method investments in healthcare businesses. By 2023, equity securities increased to $4.9 billion, with venture investments still being a core component, while equity method investments in healthcare businesses declined slightly to $1.4 billion. In 2024, equity securities remained steady at $4.9 billion, but equity method investments in healthcare businesses surged to $3.8 billion, indicating a strategic pivot toward deeper involvement in operating businesses within the healthcare sector. This evolution suggests a growing emphasis on direct operational engagement and long-term strategic value in healthcare ventures.",
      "llm_answer": "UnitedHealth’s venture‑investment focus accelerated between 2022 and 2024.  Total equity‑security holdings grew from **$3.7 billion in 2022 to $4.9 billion in 2024** (2023 10‑K, p. 48‑52; 2024 10‑K, p. 50‑54), while equity‑method investments in operating health‑care businesses more than doubled—from **$1.5 billion in 2022 to $3.8 billion in 2024** (2023 10‑K, p. 48‑52; 2024 10‑K, p. 50‑54).  This trend signals a shift toward larger, more direct stakes in healthcare operating firms as part of the company’s expanding venture portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, UnitedHealth Group held $3.5 billion in equity securities in 2022, not $3.7 billion as stated in the LLM answer. Similarly, the ground truth reports $1.3 billion in equity method investments in 2022, whereas the LLM claims $1.5 billion. While the 2024 figures ($4.9 billion in equity securities and $3.8 billion in equity method investments) are correct, the 2022 baselines are wrong, leading to an inaccurate portrayal of growth. (2) Calculations based on incorrect starting values are therefore flawed: the claim that equity-method investments 'more than doubled' from $1.5B to $3.8B is numerically true but based on an incorrect 2022 figure. The actual increase was from $1.3B to $3.8B, which is a larger relative increase (~192%), so the direction is correct but precision is lacking. (3) The qualitative reasoning is sound—there is a clear recognition of a strategic shift toward deeper involvement in operating healthcare businesses, and the multi-hop synthesis across years is logically presented. The conclusion about a shift to larger, direct stakes aligns with the ground truth's interpretation of a 'strategic pivot.' (4) Contextual relevance is high—the response directly addresses the evolution of UnitedHealth’s venture investment strategy across the specified time frame and focuses on the correct metrics. However, due to the incorrect 2022 figures, the quantitative accuracy score is reduced significantly, pulling down the overall correctness score despite strong qualitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 446,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Altria Group's capital structure evolve across 2022, 2023, and 2024 with respect to its 1.700% 2025 Notes, and what does this multi-year progression indicate about its debt management strategy?",
      "original_answer": "In 2022, Altria disclosed its 1.700% 2025 Notes as part of its capital structure alongside other debt instruments such as the 1.000% 2023 Notes, 2.200% 2027 Notes, and 3.125% 2031 Notes. By 2023, the 1.000% 2023 Notes had matured and were no longer listed, indicating Altria had met its obligation for that instrument, while the 1.700% 2025 Notes remained a key component of its debt portfolio. In 2024, the 1.700% 2025 Notes were still actively listed, suggesting Altria maintained this liability as part of its mid-term capital strategy. This progression shows that Altria actively managed its short-term debt while retaining its 2025 Notes as a stable element of its capital structure.",
      "llm_answer": "Altria issued its 1.700% 2025 Notes in 2022 and the notes remained outstanding through 2023 and 2024, with no changes in principal or maturity reported (MO_10k_2022.pdf:1‑5; MO_10k_2023.pdf:1‑5; MO_10k_2024.pdf:1‑5). The consistent presence of these notes across three consecutive filings shows a deliberate strategy of maintaining a stable long‑term debt profile and predictable interest obligations, allowing the company to manage liquidity and refinance risk while keeping its capital structure steady.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 1.700% 2025 Notes as being present in Altria's capital structure across 2022, 2023, and 2024, which aligns with the ground truth. The dates, percentages, and the fact that the notes remained outstanding are all factually accurate. However, the LLM incorrectly states that the notes were 'issued in 2022', which is not supported by the original answer or typical bond issuance logic—the 1.700% 2025 Notes would have been issued prior to 2022 given their 2025 maturity and are only *disclosed* in the 2022 filing. This is a key factual overreach. (2) Quantitative accuracy is perfect: the interest rate (1.700%), maturity year (2025), and years of disclosure (2022–2024) are all correct. No calculations were required, but the temporal data is accurate. (3) The multi-hop reasoning is partially sound—the model correctly synthesizes the presence of the notes across three years and infers a strategy of stability. However, it misses the broader context of debt roll-off (e.g., the 1.000% 2023 Notes maturing in 2023), which is central to the original answer’s conclusion about active debt management. The LLM focuses only on the 2025 notes and does not contrast them with maturing instruments, weakening the depth of the strategic analysis. (4) The contextual relevance is high—the answer addresses the evolution of the capital structure with respect to the 2025 notes and draws a reasonable inference about debt strategy. However, the qualitative accuracy is reduced due to the unsupported claim about issuance timing and the lack of comparative analysis with other debt instruments, which limits the completeness of the multi-year progression narrative. Thus, while the core facts are correct, the reasoning lacks the full multi-hop synthesis required for a top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 493,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent rise indicates a growing emphasis on stock repurchases as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard’s cost of Class A treasury stock rose from $51.4 billion at year‑end 2022 (MA_10k_2022, p.66‑70) to $60.4 billion in 2023 (MA_10k_2023, p.69‑73) and to $71.4 billion in 2024 (MA_10k_2024, p.66‑70). This steady increase reflects a growing share‑repurchase program, indicating that the company is allocating excess cash to buy back shares and return value to shareholders rather than retaining cash or investing elsewhere.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the upward trend in Mastercard's investment in Class A Treasury Stock from 2022 to 2024 and accurately reports the 2023 ($60.4 billion) and 2024 ($71.4 billion) figures, which align with the ground truth of $(60,429) million and $(71,431) million respectively. However, the 2022 value is reported as $51.4 billion, which does not match the ground truth of $(36,658) million (~$36.7 billion), making it factually incorrect. This discrepancy affects quantitative accuracy significantly. (2) Number verification: 2023 and 2024 values are correctly converted from millions to billions and match the ground truth within rounding tolerance ($60,429M = $60.4B; $71,431M = $71.4B). But $51.4B for 2022 is incorrect — it should be ~$36.7B. This may stem from misreading the financial statement (e.g., confusing total accumulated other comprehensive income or another line item). (3) Multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers that increasing treasury stock costs reflect an expanding share repurchase program, which is a valid interpretation of capital allocation strategy. The conclusion about returning value to shareholders is consistent with the ground truth. (4) Scores justified as follows: correctness_score=8 because core trend and two of three data points are correct, and the strategic interpretation is accurate; quantitative_accuracy=7 due to the significant error in the 2022 figure; qualitative_accuracy=9 because reasoning and entity identification (Mastercard, Class A Treasury Stock, years, strategy) are strong; contextual_relevance=10 as the answer directly addresses both parts of the question and remains focused on the evolution and strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 482,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, given the losses of $92M in 2022, followed by gains of $58M in 2023, and further gains of $91M in 2024?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted dramatically from a loss of $92M in fiscal year 2022 to a gain of $58M in 2023, and then increased further to a $91M gain in fiscal year 2024. This indicates a reversal and strengthening in the performance of these instruments over the three-year period, moving from a net cost to a net benefit.",
      "llm_answer": "Cisco’s total‑return swaps used to hedge deferred‑compensation exposure swung from a $92 million loss in FY 2022 to a $58 million gain in FY 2023, and then to a $91 million gain in FY 2024.  Over the three‑year span the cumulative effect shifted from negative to positive, yielding a net gain of roughly $97 million.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports all financial figures and fiscal years: $92M loss in FY2022, $58M gain in FY2023, and $91M gain in FY2024, matching the ground truth exactly. Number formats are consistent and acceptable. (2) The quantitative accuracy is perfect—each value is correct, and the implied calculation of net gain ($ -92M + $58M + $91M = $57M) is not explicitly stated in the original answer, but the LLM’s mention of a 'net gain of roughly $97M' appears to be a minor arithmetic error. However, this is inconsistent with the correct inputs: -92 + 58 + 91 = 57, not 97. This is a clear calculation mistake, though the direction (net gain) is correct. (3) The multi-hop reasoning is sound—LLM correctly traces the evolution across three fiscal years and interprets the shift from loss to gain. The synthesis of performance trend is accurate and adds value with the net effect observation, despite the math error. (4) Contextual relevance is excellent—the answer directly addresses Cisco’s Total Return Swaps-Deferred Compensation exposure evolution as asked. The only flaw is the incorrect cumulative gain ($97M instead of $57M), which prevents a perfect score. Given that all individual numbers and trends are correct, and only the sum is wrong, the correctness score is reduced slightly to 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 367,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Netflix's dependency on rights holders evolve from 2022 through 2024, particularly in terms of content licensing risks, competition for exclusive rights, and regulatory pressures affecting content availability?",
      "original_answer": "From 2022 to 2024, Netflix's dependency on rights holders intensified due to rising competition for exclusive content, increased regulatory scrutiny, and growing risks around licensing agreements. In 2022, the company expressed concern over content providers launching their own streaming services, potentially limiting Netflix's access to popular content and increasing programming costs. By 2023, Netflix noted that license terms varied and that disputes over intellectual property could lead to content unavailability or service disruptions. In 2024, the company reiterated these risks and further highlighted regulatory changes in multiple jurisdictions—such as content quotas and investment obligations—that constrained its ability to control content offerings. This 3-year progression reveals a growing strategic challenge in maintaining a compelling and cost-effective content library amid external pressures from rights holders and regulators.",
      "llm_answer": "Netflix’s 10‑K risk‑factor disclosures consistently underscored its dependence on third‑party rights holders, but the wording evolved to reflect growing competition and regulatory constraints. In the 2022 filing (Item 1A, p. 9‑13) Netflix warned that studios or rights holders could refuse or withdraw licenses, curbing its library; the 2023 filing (Item 1A, p. 4) added that competition for exclusive rights is intensifying and licensing costs are rising; and the 2024 filing (Item 1A, p. 4; Regulation, p. 6) further highlighted new content‑quota rules, levies and ownership‑rights restrictions that could limit availability and increase costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Netflix's increasing dependency on rights holders from 2022 to 2024 is properly framed around content licensing risks, competition for exclusive rights, and regulatory pressures. The evolution across years is accurately represented—2022 highlights risk of license withdrawal, 2023 adds intensifying competition and rising costs, and 2024 includes new regulatory constraints like content quotas and levies. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but the years (2022, 2023, 2024) and document references (Item 1A, page numbers) are correctly cited, showing precise sourcing. Format variations are not applicable here, but the temporal references are exact. (3) The multi-hop reasoning is sound: the answer synthesizes information across three annual 10-K filings, correctly identifying how the risk disclosures evolved over time and linking them to broader strategic challenges. It connects competition, cost pressures, and regulatory changes coherently. (4) Semantic equivalence is strong—the LLM uses slightly more technical language (e.g., 'levies', 'ownership-rights restrictions') but conveys the same core message as the original answer. The only minor shortcoming is that it does not explicitly state the *strategic challenge* of maintaining a 'compelling and cost-effective content library' as emphasized in the ground truth, which slightly reduces qualitative completeness. However, this is implied through discussion of rising costs and constraints. Overall, the answer is factually correct, well-structured, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 460,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did UnitedHealth Group's financial obligations under service level guarantees evolve from 2022 through 2024, and what does this 3-year trend suggest about the stability of its service delivery commitments across its subsidiaries?",
      "original_answer": "UnitedHealth Group disclosed that the amounts accrued, paid, or charged to income for service level guarantees were immaterial in all three years—2022, 2023, and 2024—indicating consistent financial exposure relative to the company's overall scale. However, the parent company's notes payable to subsidiaries fluctuated significantly during this period, decreasing from $9.9 billion in 2023 to $2.0 billion in 2024 after rising from $8.1 billion in 2022 to $9.9 billion in 2023. This suggests that while the service level guarantees themselves did not result in material financial charges, the internal financing structure supporting these guarantees experienced notable variation, potentially reflecting shifting liquidity strategies or operational adjustments within the company's subsidiaries.",
      "llm_answer": "UnitedHealth Group’s 10‑K notes state that “none of the amounts accrued, paid or charged to income for service‑level guarantees were material as of December 31, 2024, 2023 or 2022” (Note 4).  The obligation level therefore remained essentially unchanged and below materiality thresholds over the three‑year period, indicating that the company’s service‑delivery guarantees to its subsidiaries are stable and not a significant source of financial risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that UnitedHealth Group's service level guarantee obligations were immaterial in 2022, 2023, and 2024, citing Note 4 and accurately reflecting the ground truth on this specific point. All dates and the qualitative assessment of immateriality are factually correct. However, the LLM omits a critical part of the original answer: the significant fluctuations in the parent company's notes payable to subsidiaries—rising from $8.1B in 2022 to $9.9B in 2023, then dropping sharply to $2.0B in 2024. This internal financing data is central to the multi-hop aspect of the question, which asks about the evolution of financial obligations and what the trend suggests about stability across subsidiaries. (2) Quantitatively, the LLM does not misstate any numbers—it avoids mentioning the notes payable figures altogether—so there are no numerical inaccuracies, but this results in incompleteness. (3) The reasoning is partially sound in concluding that service-level guarantees are stable and not a financial risk, but it fails to synthesize the full picture: while the guarantees themselves were not material, the internal financial structure supporting them (i.e., intercompany notes) was volatile, suggesting potential operational or liquidity shifts. The LLM misses this nuance entirely, leading to an oversimplified and less accurate qualitative interpretation. (4) Correctness is scored 6 because core facts about service guarantees are accurate, but the omission of key financial trends significantly undermines completeness and reasoning. Quantitative accuracy is 10 because no numbers are wrong. Qualitative accuracy is 5 due to incomplete reasoning and failure to address the multi-hop element involving subsidiary financing. Contextual relevance is 8 because the answer addresses the main topic and draws a reasonable (though incomplete) conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 512,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Altria's allocation to below investment grade securities within its long-duration fixed income portfolio evolve from 2022 through 2024 for both pension and postretirement plan assets, and what does this trend suggest about the company's risk appetite in managing long-term obligations?",
      "original_answer": "In 2022, Altria's pension plan had 16% of fixed income holdings (or ~11% of total plan assets) allocated to below investment grade securities, while the postretirement plan had 8% of fixed income holdings (or ~3% of total plan assets) in the same category. By 2023, the pension allocation to below investment grade securities decreased to 11% of fixed income holdings (or ~9% of total plan assets), and the postretirement allocation increased slightly to 9% of fixed income holdings (or ~4% of total plan assets). In 2024, specific percentages for below investment grade allocations were not disclosed, but the overall strategy remained focused on long-duration fixed income. This trend suggests a cautious approach to risk, with a reduction in speculative-grade exposure for pensions and a slight increase in postretirement plans, indicating a measured balance between return objectives and risk management.",
      "llm_answer": "Altria’s long‑duration fixed‑income allocation to below‑investment‑grade securities rose from roughly 8 % of its pension fixed‑income holdings in 2022 to about 11 % in 2023, then fell back to 8 % in 2024; the postretirement portfolio followed a similar pattern, moving from ~8 % in 2022 to ~9 % in 2023 and returning to ~8 % in 2024. This modest fluctuation, staying within a narrow 8‑11 % band for pension and 8‑9 % for postretirement, signals a cautious yet responsive risk appetite that adjusts credit exposure to market conditions while maintaining a conservative stance on long‑term obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, Altria's pension plan had 16% of fixed income holdings (not 8%) allocated to below investment grade securities, and the postretirement plan had 8%. The LLM incorrectly states that pension exposure was 8% in 2022, rising to 11% in 2023 — this reverses the actual trend, which was a decrease from 16% in 2022 to 11% in 2023. Additionally, the LLM claims there was a drop back to 8% in 2024 for pensions, but the original answer states that 2024 allocations were not disclosed. For postretirement, the LLM fabricates a drop back to ~8% in 2024, while no such data is available. (2) Quantitative accuracy is severely compromised: the key percentage for pension in 2022 is off by 8 percentage points, and the direction of change is misrepresented. There are no correct calculations or trends reported for the pension plan. The narrow fluctuation band described (8–11%) does not reflect the actual 16% starting point. (3) Multi-hop reasoning fails: the model does not correctly synthesize the evolution across years and plans, misrepresents the risk trend (showing stability when there was a meaningful de-risking in pensions), and invents data for 2024. (4) Contextual relevance is moderate — the answer addresses the right topic (risk appetite in managing long-term obligations) and attempts to interpret the trend, but the conclusion about 'modest fluctuation' and 'responsive risk appetite' is based on incorrect data, undermining the qualitative insight. The actual trend suggests a cautious de-risking in pensions, contrary to the LLM's portrayal of minor adjustments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 459,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Mastercard's methodology for estimating settlement exposure evolve from 2022 through 2024, and what does this consistency indicate about the company's risk management approach despite increasing regulatory scrutiny and litigation risks?",
      "original_answer": "Mastercard's methodology for estimating settlement exposure remained consistent across 2022, 2023, and 2024, using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. Despite facing ongoing regulatory investigations (including from the FTC and DOJ in 2023 and the European Commission in 2024) and multiple litigation risks (such as the U.S. Liability Shift Litigation and TCPA class action), the company maintained its core risk management framework. The disclosed approach to risk mitigation—requiring certain customers to provide cash collateral or credit enhancements based on individual risk assessments—was also unchanged across all three years. This consistent methodology suggests that Mastercard viewed its existing risk management practices as robust and sufficient to address evolving external pressures without requiring fundamental changes to its settlement exposure estimation process.",
      "llm_answer": "Mastercard has applied the same settlement‑exposure model in 2022, 2023 and 2024: the gross exposure is calculated as the average daily payment volume over the prior three months multiplied by the estimated number of days of exposure, and the net figure is derived after applying risk‑mitigation arrangements that are reviewed periodically【2022‑108‑112】【2023‑110‑114】【2024‑102‑106】.  The unchanged methodology—along with regular reviews of risk standards and adjustments only to the mitigation amounts—shows a disciplined, stable risk‑management framework that continues to function effectively even as regulatory scrutiny and litigation pressures rise.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Mastercard used the same methodology from 2022 to 2024: average daily payment volume over the prior three months multiplied by estimated days of exposure. This matches the original answer exactly in both logic and structure. (2) The quantitative elements—time period (three months), metric (average daily payment volume), and calculation approach—are all factually correct and consistent across years, with no numerical discrepancies. Format variations (e.g., no explicit dollar amounts) are acceptable as the methodology is formulaic. (3) The multi-hop reasoning is sound: the model synthesizes information across three years and correctly infers that the unchanged methodology reflects a stable risk management framework despite rising regulatory and litigation pressures. It references ongoing reviews of risk standards and adjustments to mitigation amounts, which aligns with the original answer’s mention of individual risk assessments and collateral requirements. (4) The only minor shortcoming is that the LLM does not explicitly name the specific regulatory bodies (FTC, DOJ, European Commission) or litigation cases (U.S. Liability Shift Litigation, TCPA), though it does refer generally to 'regulatory scrutiny and litigation pressures.' This omission slightly reduces qualitative completeness but does not affect the core correctness. Overall, the answer demonstrates strong factual accuracy, proper synthesis, and appropriate interpretation, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 433,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt management strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million balance on its 5.90% Note across all three fiscal years (2022–2024), with the effective interest rate remaining stable at 6.11% throughout the period. This indicates that Cisco has preserved this high-yield long-term debt instrument as a fixed component of its capital structure rather than refinancing or retiring it, suggesting strategic intent to maintain predictable interest obligations despite potential opportunities to optimize financing costs in a changing rate environment.",
      "llm_answer": "Cisco’s 5.90% senior note has stayed at a $2,000 million principal level in FY 2022, FY 2023 and FY 2024, and its effective interest rate has remained at 6.11 % throughout that period.  The unchanged utilization and cost demonstrate Cisco’s disciplined long‑term debt strategy of maintaining a stable, predictable debt profile and interest expense, rather than pursuing aggressive refinancing or rate‑hedging moves.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Cisco maintained a $2,000 million principal balance on its 5.90% Note and an effective interest rate of 6.11% across fiscal years 2022–2024, matching the ground truth exactly. All numeric values (dollar amount, percentage, years) are accurate. (2) Quantitative accuracy is perfect: $2,000 million and 6.11% are consistently reported for all three years with no calculation or formatting errors. (3) The reasoning is sound and captures the core implication—that Cisco is maintaining a stable debt profile with predictable interest expenses. However, the LLM slightly softens the strategic interpretation by omitting the nuance about 'not refinancing despite potential opportunities to optimize financing costs in a changing rate environment,' which is a key insight in the original answer. This minor omission reduces qualitative accuracy slightly but does not distort the meaning. (4) The answer is fully contextually relevant, directly addressing both the evolution of utilization and interest rate and the strategic implication. Overall, the response is factually complete and semantically equivalent to the ground truth, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 342,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount suggests that AVGO did not make any early repayments or refinancing adjustments specifically for this debt instrument over the three-year period, indicating a consistent approach to managing this portion of its fixed-rate debt portfolio.",
      "llm_answer": "AVGO’s 3.125% notes due January 2025 had an outstanding principal balance of **$495 million** in each of FY 2022, FY 2023 and FY 2024 (see the “Effective Interest Rate” tables in the 2022, 2023 and 2024 10‑K filings). The unchanged balance shows that the company has neither issued additional principal nor repaid this note during the period, indicating a strategy of keeping this long‑term, low‑rate debt component stable rather than actively refinancing or reducing it.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the outstanding principal balance of $495 million is accurately reported for all three fiscal years—2022, 2023, and 2024—with no discrepancies. The format ($495 million) is consistent with acceptable variations. (2) The answer addresses both parts of the multi-hop question: it traces the evolution (or lack thereof) of the debt balance over time and interprets the trend in terms of AVGO's debt management strategy. (3) Entity accuracy is perfect: the company (AVGO), debt instrument (3.125% notes due January 2025), and fiscal years are all correctly identified. (4) The reasoning is sound—the stability of the principal implies no early repayment or refinancing, leading to the valid conclusion that AVGO maintained a consistent strategy for this fixed-rate debt. The LLM also appropriately references the source (10-K filings), enhancing credibility. Semantic equivalence with the original answer is strong, with only minor rephrasing but identical factual and inferential content.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 307,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did CMCSA's shared data plan offerings evolve across its wireless service lines from 2022 through 2024, particularly in terms of bundling strategy and customer flexibility?",
      "original_answer": "From 2022 to 2024, CMCSA's shared data plan offerings within its wireless services evolved to reflect a more structured and flexible bundling strategy. In 2022, shared data plans were offered as part of bundled service offerings to residential customers who subscribed to broadband services, with options to activate multiple lines per account and choose between unlimited data plans, shared data plans, or per gigabyte pricing. By 2023, the company maintained the shared data plan option as part of its domestic wireless services but emphasized bundling with broadband, reinforcing integration across services. In 2024, CMCSA expanded its flexibility by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans as part of qualifying broadband bundles, thereby catering to a broader range of customer preferences. This progression shows a strategic move toward enhancing customer choice and deepening service integration.",
      "llm_answer": "From 2022 through 2024, CMCSA kept wireless services tied to bundled broadband packages, but broadened customer flexibility: in 2022 customers could activate multiple lines and choose unlimited, shared or per‑GB plans (2022, p. 5‑9); in 2023 the same bundling persisted while the company emphasized device financing and multi‑line flexibility (2023, p. 3‑7); by 2024 CMCSA added prepaid unlimited data plans under the NOW brand, letting customers buy wireless separately or within bundles while still offering shared data plans and multi‑line activation (2024, p. 3‑7).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: CMCSA maintained shared data plans from 2022 to 2024, bundled with broadband, with multi-line activation and plan choice (unlimited, shared, per-GB) in 2022; bundling continued in 2023 with emphasis on flexibility; in 2024, prepaid unlimited plans under NOW brand were introduced. These details match the original answer. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022–2024) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes evolution across three years, correctly identifying continuity in bundling and incremental changes in flexibility and product offerings. It accurately links shared data plans to broadband bundling and notes the strategic expansion with NOW in 2024. (4) The only minor shortcoming is that the LLM slightly underemphasizes the strategic intent mentioned in the ground truth—'deepening service integration' and 'strategic move toward enhancing customer choice'—though the factual progression supports that interpretation. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect: it directly addresses bundling strategy and customer flexibility as asked. Thus, correctness is 9/10—excellent but missing slight nuance in strategic framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 389,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 through 2024, and what strategic adjustments did the company make in response to these recurring funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering the calculation methodology each year, leading to persistent funding pressures. In 2022, the company noted that CMS had previously reduced or frozen Medicare Advantage benchmarks and that further cuts were possible. In response, UnitedHealth adjusted members' benefits and premiums selectively and intensified cost management. By 2023, the company reiterated these pressures and strategies, indicating that these adjustments were ongoing rather than one-time fixes. In 2024, the company expanded its discussion to include the impact of evolving CMS payment mechanisms, including risk adjustment and benchmark reductions, and again emphasized its selective benefit adjustments and cost control measures. The consistent mention of these strategies across all three years suggests that UnitedHealth did not find a full resolution to the funding pressures and remained in a reactive posture, continuously adapting its offerings and cost structures to mitigate the impact of Medicare Advantage payment adjustments.",
      "llm_answer": "UnitedHealth Group’s exposure to Medicare Advantage risk‑adjustment payment changes remained a persistent funding pressure from 2022 through 2024, as CMS continued to freeze or cut benchmarks and alter risk‑adjustment calculations. In each year the company responded by selectively adjusting member benefits and premiums, exiting plans in certain counties, and intensifying medical and operating cost management (2022–2024) while also expanding its data‑analytics capabilities and Optum services to offset revenue declines (2023–2024) [UNH_10k_2022:23‑27][UNH_10k_2023:18‑22][UNH_10k_2024:18‑22].",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: UnitedHealth Group faced persistent exposure to Medicare Advantage risk adjustment payment changes from 2022 to 2024 due to CMS benchmark freezes/cuts and methodology changes. The company responded with selective benefit and premium adjustments, cost management, and plan exits—strategies consistently mentioned across all three years. The LLM adds slightly more detail than the original answer by specifying 'exiting plans in certain counties' and 'expanding data-analytics capabilities and Optum services,' which are plausible strategic responses supported by UnitedHealth’s public filings and do not contradict the ground truth. (2) There are no numerical values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable in that sense, but all temporal references (2022–2024, 2023–2024) are correct and consistent. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying recurring pressures and evolving strategic responses. The mention of Optum and data analytics in 2023–2024 reflects a reasonable progression of strategy beyond basic cost controls. (4) The only reason for not scoring a perfect 10 is that the original answer emphasizes the 'reactive posture' and lack of 'full resolution,' a qualitative interpretation slightly underemphasized in the LLM version, though implied. Overall, the LLM answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 441,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Mastercard's implementation of its multi-layered security approach evolved from 2022 through 2024, particularly in terms of third-party collaboration, real-time service integration, and geographic expansion of real-time payments infrastructure?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has evolved significantly in scope and execution. In 2022, the company emphasized a multi-layered framework that included collaboration with issuers, acquirers, and governments to develop technical standards like EMV, and it operated or was implementing real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets globally and integrated more real-time value-added services like fraud scoring and tokenization into transaction routing. In 2024, Mastercard further solidified its security posture by enhancing partnerships and public-private collaborations, while also expanding domestic transaction processing in China through a joint venture, reflecting a broader global reach and deeper integration of security into new markets and services.",
      "llm_answer": "From 2022 to 2024 Mastercard has deepened its multi‑layered security posture by moving from basic third‑party assessments to active public‑private partnerships and real‑time monitoring of incidents involving third‑party providers. The company has also broadened real‑time service integration—building and operating real‑time clearing and settlement infrastructure across a wider array of products—while expanding its real‑time payments footprint from 12 markets in 2022 to 13 markets by the end of 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Mastercard's multi-layered security approach from 2022 to 2024 with accurate emphasis on third-party collaboration, real-time service integration, and geographic expansion. It correctly states that Mastercard operated in 12 markets in 2022 and expanded to 13 by 2023, matching the ground truth. However, it omits the 2024 development regarding the joint venture in China for domestic transaction processing, which is a notable gap in completeness. (2) Quantitatively, the numbers (12 markets in 2022, 13 in 2023) are accurate and correctly attributed to the right years. No calculations are required, and the figures align with the original answer. (3) The reasoning is sound in tracing the evolution across years and integrating third-party collaboration and real-time infrastructure expansion. The synthesis of multi-hop elements (collaboration, services, geography) is logical and mostly complete, though the absence of the 2024 China expansion weakens the full multi-hop narrative. (4) The answer is highly contextually relevant, directly addressing all three dimensions of the question. The omission of the China JV in 2024 prevents a top score, but core facts and trends are accurately conveyed, warranting a high correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 366,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Amazon's financing strategy related to its 1.500% Note due 2030 evolve from 2022 through 2024, and what does this reveal about its long-term debt management and refinancing priorities?",
      "original_answer": "Amazon's financing strategy related to its 1.500% Note due 2030 remained consistent as a disclosed long-term obligation across all three years, but it was increasingly referenced alongside newer credit agreements and short-term financing instruments. In 2022, the note was included in Exhibit 4.5, issued in 2020 and incorporated by reference. In 2023, the note reappeared in Exhibit 4.6, and Amazon introduced a Term Loan Agreement dated January 3, 2023 (Exhibit 10.8), indicating a shift toward securing short- and medium-term liquidity while maintaining long-term fixed-rate obligations. By 2024, the 1.500% Note due 2030 was again referenced in Exhibit 4.6, but Amazon had introduced a new 364-Day Revolving Credit Agreement in October 2024 (Exhibit 10.9), suggesting a layered financing approach that combines long-term fixed debt like the 2030 note with flexible short-term credit facilities. This evolution reveals a strategic balance between locking in long-term capital at favorable rates and maintaining liquidity flexibility through newer credit lines.",
      "llm_answer": "Amazon’s 1.500% Note due 2030 has remained a fixed‑rate, long‑term debt instrument that appears unchanged in each filing (2022 p. 69‑73; 2023 p. 73‑77; 2024 p. 72‑76). The note’s continued presence, alongside newer higher‑rate notes (e.g., the 3.000% Note due 2025 listed in 2024), indicates that Amazon prioritizes a stable, low‑cost debt core while using additional, higher‑rate debt to refinance other obligations—highlighting a long‑term debt‑management strategy focused on cost‑effective refinancing and maturity diversification.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 1.500% Note due 2030 as a consistent long-term obligation across 2022–2024, and accurately notes its presence in each year’s filing with correct exhibit references implied by page numbers. The percentage (1.500%) and maturity year (2030) are factually correct. However, the LLM introduces a '3.000% Note due 2025' in 2024 as evidence of refinancing strategy, which is not mentioned in the ground truth and cannot be verified from the provided data—this is a factual overreach or hallucination. (2) Quantitatively, the interest rate (1.500%), maturity (2030), and temporal consistency are accurate. Page number ranges cited (e.g., 2022 p. 69–73) may vary slightly by document version but are plausibly correct and not materially inaccurate. The mention of a 3.000% Note due 2025 lacks corroboration and introduces incorrect financial instruments not in the ground truth, reducing quantitative accuracy. (3) The multi-hop reasoning is partially sound: the model infers a strategy of maintaining low-cost long-term debt. However, it fails to capture the key evolution described in the ground truth—namely, the introduction of specific new credit agreements (Term Loan Agreement in 2023, 364-Day Revolving Credit in 2024) that demonstrate a shift toward liquidity flexibility. Instead, it focuses on higher-rate notes, which shifts the explanation toward refinancing via new bonds rather than diversified financing instruments. This misrepresents the strategic evolution. (4) The answer is contextually relevant and addresses Amazon’s long-term debt management and refinancing priorities, but misses the core nuance of layered financing combining fixed-rate notes with short-term credit facilities. It substitutes this with a less precise narrative about using higher-rate debt for refinancing. While the general direction of strategy (cost-effective, diversified maturities) is plausible, the absence of key instruments and incorrect addition of others reduces qualitative accuracy. Correctness score is 6 due to partial factual correctness but significant omission of critical developments and introduction of unverified debt instruments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 584,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the competitive threat from wireless telecommunications companies to CMCSA's broadband business evolved from 2022 to 2024, and what evidence suggests this pressure may be impacting CMCSA's market positioning or customer retention strategies?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA's broadband services has evolved significantly. In 2022, wireless providers were noted as offering 4G and 5G wireless broadband services, which directly competed with CMCSA’s wireline broadband. By 2023, the emphasis shifted to 5G fixed wireless networks, with providers deploying technologies that enabled them to offer internet services using devices such as smartphones, laptops, tablets, and mobile and fixed wireless routers. In 2024, wireless providers escalated their strategies by bundling DTC streaming services and offering unlimited data-usage plans, which could attract customers away from traditional broadband subscriptions. This progression shows an intensification of wireless companies' strategies, leveraging both technological advancements and service bundling to gain market share, which likely pressures CMCSA's broadband market positioning and necessitates customer retention innovations such as enhanced broadband speeds, improved customer experience, or bundled offerings.",
      "llm_answer": "From 2022 to 2024, Comcast’s competition narrative shifted from a focus on 4G/5G wireless broadband services (2022, p. 26‑30) to an expanded threat that now includes 5G fixed‑wireless networks, unlimited‑data usage plans and bundled service packages that can compete with its broadband (2024, p. 19‑23; 2023, p. 6‑10 already noted bundling). The 2024 filing’s explicit mention of unlimited‑data plans and bundled offerings, together with the company’s own bundling strategy and reported net customer losses in the video segment, indicates that this intensified competition is pressuring CMCSA’s market positioning and customer‑retention efforts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of competitive threats from wireless telecom companies to CMCSA's broadband business from 2022 to 2024: starting with 4G/5G wireless broadband in 2022, progressing to 5G fixed-wireless networks in 2023, and intensifying in 2024 with unlimited data plans and bundled offerings. These details match the original answer's timeline and technological progression. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the ground truth or LLM response, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years (2022–2024), correctly attributes shifts in competitive dynamics, and infers strategic implications (e.g., CMCSA’s bundling and customer retention challenges). It even references net customer losses in the video segment as indirect evidence of pressure, which is a reasonable inference consistent with the original answer’s implication of market positioning pressure. (4) The only minor shortcoming is that the original answer explicitly links the competitive pressure to CMCSA’s need for 'enhanced broadband speeds, improved customer experience, or bundled offerings,' while the LLM mentions bundling but is slightly less comprehensive on other retention innovations. However, this does not detract significantly from factual correctness. The LLM also cites page numbers not present in the ground truth, but since these are likely from actual filings and do not contradict facts, they don’t reduce accuracy. Overall, the answer is semantically equivalent, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 474,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did AIG's reinsurance recoverable assets evolve from 2022 through 2024, and what does this trend indicate about the company's exposure to insurance loss risk over time?",
      "original_answer": "AIG's reinsurance recoverable assets increased significantly from 2022 to 2023, then dropped sharply in 2024. In 2022, while specific figures were not disclosed, the narrative indicated that reinsurance was used to mitigate insurance loss exposure, particularly for catastrophic events. By 2023, total reinsurance recoverable assets reached $67.5 billion, including $30.4 billion in ceded loss reserves and $28.2 billion in life reinsurance recoverables. In 2024, this figure dropped to $38.0 billion, with $29.1 billion in ceded loss reserves and only $0.8 billion in life reinsurance recoverables. This volatile trend suggests a substantial reduction in ceded life insurance risk exposure by 2024, potentially indicating a strategic shift or de-risking in the life insurance segment.",
      "llm_answer": "AIG’s reinsurance recoverable assets fell from **$70.4 billion at December 31 2022** to **$67.5 billion at December 31 2023** and then sharply to **$38.0 billion at December 31 2024** [169‑173, 120‑124, 86‑90]. This downward trend shows a shrinking pool of recoverable assets, indicating that AIG’s ability to offset losses via reinsurance has diminished and its exposure to insurance loss risk has increased over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. It states that AIG's reinsurance recoverable assets were $70.4 billion in 2022, but the ground truth explicitly says that no specific figure was disclosed for 2022. This is a major error. The 2023 figure of $67.5 billion is correct, and the 2024 figure of $38.0 billion is also correct. However, the LLM incorrectly frames the trend as a continuous decline from 2022 to 2024, while the ground truth describes a significant increase from 2022 to 2023 (with no disclosed number for 2022), followed by a sharp drop in 2024. (2) The calculation and comparison of values are flawed due to the incorrect 2022 number. The LLM implies a decrease from 2022 to 2023, whereas the ground truth indicates an increase (from unspecified to $67.5B). The 2024 drop is correctly reported. (3) The multi-hop reasoning is partially sound in that it attempts to link reinsurance recoverables over time and interpret risk exposure, but it fails to capture the key nuance: the 2024 drop—especially in life reinsurance recoverables from $28.2B to $0.8B—suggests a strategic de-risking or portfolio shift, not simply increased loss exposure. The LLM incorrectly concludes that reduced recoverables mean higher risk exposure, while the ground truth interprets it as reduced ceded risk, particularly in life insurance, which may reflect a strategic shift. (4) The contextual relevance is high because the answer addresses the evolution over time and attempts to interpret risk exposure. However, due to incorrect numbers and flawed reasoning about the implications, the correctness score is low. Quantitative accuracy is poor due to the fabricated 2022 figure. Qualitative accuracy is moderate because the structure and intent are correct, but the synthesis and conclusion are flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 502,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Mastercard's methodology for estimating settlement exposure and its credit risk mitigation arrangements evolve from 2022 through 2024, and what changes, if any, were made in response to ongoing regulatory scrutiny across these years?",
      "original_answer": "From 2022 to 2024, Mastercard consistently estimated settlement exposure using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. This methodology remained unchanged across all three years. However, in 2023, regulatory scrutiny intensified with the FTC finalizing a consent agreement related to debit routing provisions and the DOJ issuing a Civil Investigative Demand focusing on antitrust concerns in the U.S. debit program. In response, Mastercard emphasized its ongoing monitoring of the credit risk portfolio and adequacy of risk mitigation arrangements, which include cash collateral and credit enhancements such as letters of credit and guarantees. In 2024, amid a denied summary judgment motion in the U.S. Liability Shift Litigation and a new European Commission investigation into card scheme fees, Mastercard continued to refine its risk management methodology and maintained its approach to risk mitigation. Despite increasing external legal and regulatory pressures, there is no explicit evidence of a change in the settlement exposure estimation methodology or the structure of credit risk mitigation arrangements across the three-year period.",
      "llm_answer": "Mastercard’s settlement‑exposure calculation has remained the same from 2022 through 2024, using the average daily payment volume of the preceding three months multiplied by the estimated days of exposure.  Its credit‑risk mitigation framework—cash collateral and credit‑enhancement instruments for customers that do not meet risk standards—grew from $9.2 billion in 2022 to $12.2 billion in 2023 and $13.5 billion in 2024, raising net exposure from $55.7 billion to $64.9 billion.  No explicit methodological changes were disclosed in response to regulatory scrutiny, though the company notes it reviews its risk‑management policies regularly, likely to address ongoing FTC, DOJ, and EU investigations.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer correctly states that Mastercard's settlement exposure methodology remained unchanged from 2022 to 2024, using average daily payment volume over the prior three months multiplied by estimated days of exposure. It also correctly notes that there were no explicit methodological changes in response to regulatory scrutiny and mentions ongoing monitoring of risk management, which aligns with the original answer. However, the LLM introduces specific dollar figures—$9.2B, $12.2B, $13.5B for credit risk mitigation and $55.7B to $64.9B for net exposure—that are not present in the ground truth and cannot be verified. These numbers appear fabricated or misattributed, as the original answer contains no such quantitative data. (2) The quantitative inaccuracies are severe: the LLM invents a growing collateral pool and rising net exposure without any support in the ground truth. There is no mention of dollar amounts related to collateral or net exposure in the original answer, so these values are factually incorrect. This significantly undermines trust in the response. (3) The qualitative reasoning is partially sound: the model correctly identifies the consistent methodology and links regulatory scrutiny (FTC, DOJ, EU) to Mastercard’s emphasis on risk monitoring. It synthesizes the idea that despite pressure, no explicit changes were made, which matches the original conclusion. However, the addition of unsupported figures suggests a failure in multi-hop synthesis—instead of stating 'no explicit evidence of change,' it implies growth in mitigation measures, contradicting the 'no change' conclusion. (4) Contextual relevance is high because the answer addresses both parts of the question: methodology evolution and regulatory response. The structure and intent are appropriate, but the inclusion of false quantitative data severely reduces factual correctness. Thus, while the reasoning trajectory is logical, the factual foundation is compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 530,
        "total_tokens": 2039
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did AIG's management approach to loss reserves risk evolve from 2022 through 2024, particularly in terms of internal controls, external expert involvement, and modeling techniques used to address uncertainty in loss estimation?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk showed a consistent emphasis on internal controls and external oversight, while also evolving its modeling and analytical approaches. In 2022, AIG highlighted the use of internal controls and oversight of the loss reserve setting process, along with reviews by external experts, to manage uncertainty in loss estimation. By 2023, the company expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies as part of its insurance risk measurement toolkit. In 2024, AIG reinforced these methods and added a stronger emphasis on model risk management frameworks, validation processes, and experience monitoring with updated assumptions, indicating a maturing and more integrated risk analytics approach over time.",
      "llm_answer": "From 2022 through 2024 AIG’s loss‑reserve governance has become progressively more structured.  In 2022 (p. 165‑169) the company described internal controls and oversight of the reserve‑setting process, reviews by external experts, and the use of stochastic and deterministic modeling to capture uncertainty.  By 2023 (p. 117‑121) AIG added a formal model‑risk management framework and validation processes, and by 2024 (p. 84‑88) it further emphasized escalation procedures, scenario‑ and sensitivity‑analysis techniques, and continued external‑expert reviews, thereby broadening the range of modeling tools used to address reserve uncertainty.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates (2022–2024), entities (AIG), and general evolution of loss reserve risk management, and correctly identifies internal controls, external expert involvement, and modeling techniques. It accurately reflects increasing structure in governance and references appropriate risk management enhancements. However, there are key discrepancies in the qualitative synthesis: (1) The LLM incorrectly states that stochastic modeling was used in 2022, which is not supported by the ground truth—stochastic methods were introduced in 2023. (2) The LLM claims a 'formal model-risk management framework' was added in 2023, but the ground truth states this emphasis came in 2024. (3) The LLM omits specific 2023 additions like experience studies and places scenario/sensitivity analysis in 2024 as a new element, while the ground truth assigns those to 2023. (4) The LLM mentions 'escalation procedures' in 2024 not present in the original answer. While the overall direction of increasing sophistication is correct, the attribution of specific methods to incorrect years undermines the multi-hop reasoning accuracy. Quantitative accuracy is perfect—no numbers or dates are incorrect. Contextual relevance is strong as all parts of the question are addressed. The answer is semantically close but contains misattributions that affect factual precision, warranting a 7 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 398,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the sensitivity of UnitedHealth Group's medical cost per member per month (PMPM) estimates to changes in the mix of benefits offered evolve from 2022 through 2024, and what does this reveal about the company's exposure to benefit design variability over time?",
      "original_answer": "In 2022, UnitedHealth Group identified the mix of benefits offered — including co-pays and deductibles – as a key factor influencing medical cost PMPM trend estimates, with sensitivity analysis conducted as part of broader cost estimation. By 2023, the company noted a negative impact from variations in benefit mix, indicating increased exposure or unfavorable movement in benefit design choices that likely increased medical cost liability. In 2024, the mix of benefits remained a core sensitivity factor, but the language shifted to a more neutral tone, suggesting that the company had either adjusted its benefit structures or improved its ability to manage the cost implications. This 3-year trajectory shows a transforming trend, where benefit mix evolved from a general sensitivity factor in 2022 to a source of financial risk in 2023 and then to a stabilized, though still significant, variable in 2024.",
      "llm_answer": "From 2022 to 2024 the sensitivity of PMPM estimates to a change in benefit mix grew markedly: a 1 % shift in mix raised medical‑cost payable by $298 m in 2022, $376 m in 2023 and $421 m in 2024, while a 3 % shift increased payable by $895 m, $1,128 m and $1,264 m respectively. This upward trend shows that benefit‑design changes are having an increasingly large impact on cost estimates, indicating a rising exposure to benefit‑mix variability over time.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The dollar amounts cited—$298M, $376M, $421M for a 1% shift and $895M, $1,128M, $1,264M for a 3% shift—are entirely fabricated and do not appear in the original answer or any known public filings. The ground truth contains no numerical sensitivity metrics (e.g., dollar impact per percentage point change in benefit mix); instead, it describes qualitative shifts in risk exposure. There are no calculations or financial models in the original to support such precise figures, making the LLM's numbers completely inaccurate. (2) Completeness: While the LLM attempts to address the evolution of sensitivity over time, it fails to capture the actual narrative progression described in the ground truth—namely, the shift from general sensitivity (2022), to negative impact (2023), to stabilization with neutral tone (2024). Instead, it invents a false trend of continuously increasing exposure based on non-existent data. (3) Entity Accuracy: The company (UnitedHealth Group) and metric (medical cost PMPM) are correctly identified, and the years 2022–2024 are accurate. However, the use of 'medical-cost payable' is not consistent with the original terminology ('medical cost PMPM trend estimates'). (4) Reasoning: The multi-hop reasoning is flawed. The original answer infers changing corporate exposure through qualitative language shifts in disclosures, not quantitative modeling. The LLM incorrectly assumes a linear, quantifiable sensitivity that grows each year, which contradicts the ground truth that suggests stabilization by 2024. (5) Semantic Equivalence: The LLM answer conveys the opposite conclusion—rising exposure—while the original states that exposure was managed and stabilized by 2024. This is a major factual divergence. The contextual relevance is moderate because it addresses the right topic and timeframe, but the invented data and incorrect conclusion severely undermine validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 540,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Walmart's positioning of the Marketside brand evolved across its private brand portfolio in 2022, 2023, and 2024, and what does this progression suggest about the brand's strategic importance within Walmart U.S.'s merchandise strategy?",
      "original_answer": "In 2022, Marketside was listed among Walmart's private brands within the broader context of strategic merchandise units, indicating its presence as a recognized brand in the portfolio. In 2023, Marketside remained part of the private brand lineup but was mentioned alongside operational and competitive strategies, suggesting a growing alignment with Walmart's broader omni-channel and customer-centric initiatives. By 2024, Marketside continued to be included in the private brand list, but now within a restructured merchandise unit that emphasized 'Fashion' instead of 'Apparel,' reflecting a broader strategic shift in how Walmart categorizes and markets its offerings. This evolution suggests that Marketside has maintained a consistent presence in Walmart’s private brand ecosystem, potentially gaining relevance as Walmart refines its merchandise strategy to align with changing consumer preferences and competitive pressures.",
      "llm_answer": "Across 2022, 2023, and 2024 Walmart’s 10‑K filings all list **Marketside** among its private‑label brands (alongside Great Value, Mainstays, etc.), with no change in its categorization or emphasis. This steady inclusion shows that Walmart continues to treat Marketside as a core private‑label line that underpins its everyday‑low‑price, broad‑assortment strategy, underscoring the brand’s ongoing strategic importance in the U.S. merchandise mix.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that there was 'no change in categorization or emphasis' of the Marketside brand across 2022–2024, which directly contradicts the ground truth. The original answer shows a clear evolution: in 2022, Marketside was part of strategic merchandise units; in 2023, it was linked to omni-channel and customer-centric strategies; and in 2024, it was included in a restructured unit emphasizing 'Fashion' over 'Apparel,' indicating a strategic repositioning. The LLM fails to capture this progression entirely, instead asserting consistency in treatment and categorization. While the LLM correctly identifies that Marketside remained listed among private brands each year (supporting quantitative and entity accuracy), it misses the nuanced shifts in strategic context and organizational structure that are central to the question. This represents a failure in multi-hop reasoning and qualitative synthesis across years and strategic themes. The conclusion that Marketside is 'core' and 'strategically important' is partially aligned with the ground truth’s implication of sustained relevance, but the reasoning is flawed due to the omission of evolving strategic alignment. Thus, while entities and dates are accurate (quantitative accuracy = 10), the qualitative analysis is significantly deficient, and the overall correctness is low due to missing key strategic developments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 392,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did The Home Depot's competitive positioning against showrooms evolve from fiscal 2022 through 2024, particularly in terms of service offerings and digital integration?",
      "original_answer": "From fiscal 2022 to 2024, The Home Depot expanded its competitive edge against showrooms by enhancing both in-store and digital service offerings. In 2022, the company emphasized its tool and equipment rental services at over 1,400 locations as a differentiator. By 2023, The Home Depot had significantly upgraded its store experience with self-service lockers, curbside pickup, electronic shelf labels, and mobile app-enabled store navigation to improve convenience and customer experience. In 2024, the company further solidified its interconnected retail strategy by integrating digital platforms more deeply, focusing on personalized customer experiences, and expanding product innovation and availability. This multi-year evolution demonstrates a strategic shift from physical service expansion (2022) to omnichannel integration (2023–2024) to outpace showroom competitors.",
      "llm_answer": "From fiscal 2022 through 2024, Home Depot strengthened its competitive stance against showrooms by expanding service offerings—adding extensive installation services, tool rentals, and Pro‑focused solutions—and by deepening digital integration, such as mobile‑first, interconnected shopping experiences and enhanced online order management (2022, pp. 7‑11; 2023, pp. 6‑10; 2024, pp. 6‑10). In 2022, the company positioned itself against showrooms by offering a broad range of services and a frictionless digital experience (2022, pp. 7‑11), and in 2023 it continued to invest in digital tools and installation services to meet evolving customer needs (2023, pp. 6‑10). By 2024, Home Depot further differentiated itself with additional showroom space, an upgraded order‑management system, and a $3.5 billion capital‑expenditure plan that bolstered its digital and service capabilities, solidifying its role as a destination for both urgent purchases and complex professional projects (2024, pp. 6‑10).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trend of The Home Depot strengthening its competitive positioning against showrooms from 2022 to 2024 through service expansion and digital integration, which aligns with the ground truth. However, there are significant factual inaccuracies that reduce correctness. (1) The claim of a '$3.5 billion capital-expenditure plan' in 2024 is not supported by the ground truth and introduces a specific figure absent in the original; this fails the quantitative accuracy check. (2) The mention of 'additional showroom space' contradicts the context, as The Home Depot was differentiating *against* showrooms, not expanding them. (3) While the ground truth highlights specific in-store tech upgrades in 2023—self-service lockers, curbside pickup, electronic shelf labels, and mobile app navigation—the LLM answer vaguely references 'digital tools' and 'mobile-first experiences' without capturing these key differentiators. (4) The ground truth emphasizes a strategic evolution: from physical service expansion (2022 tool rentals) to omnichannel integration (2023) to personalized digital experiences and product availability (2024); the LLM answer acknowledges digital and service growth but misrepresents the trajectory by implying showroom expansion. (5) The LLM correctly identifies tool rentals and installation services as offerings and notes increasing digital integration across years, showing partial multi-hop synthesis. However, it omits the core concept of 'interconnected retail strategy' and mischaracterizes 2024 developments. Semantic equivalence is partially achieved in directionality but not in factual precision, especially regarding capital expenditure and showroom space. Quantitative accuracy is low due to the unsupported $3.5B figure. Qualitative accuracy is moderate due to correct framing but flawed details. Contextual relevance is high as the response stays focused on competitive positioning, services, and digital trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 531,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Cisco's 3.50% Note evolve in terms of effective interest rate and outstanding amount from fiscal year 2022 through 2024, and what does this indicate about the company's borrowing costs and debt structure over time?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Note had an outstanding amount of $500 million with an effective interest rate of 3.20%. By fiscal year 2023, the effective rate had increased to 6.38%, and by fiscal year 2024, it further rose to 6.66%, despite the outstanding amount remaining constant at $500 million. This indicates a significant increase in borrowing costs for this particular note over the three-year period, likely reflecting broader market interest rate trends and Cisco's evolving debt financing strategy.",
      "llm_answer": "Cisco’s $500 million 3.50% senior note stayed at the same principal level from FY 2022 through FY 2024, but its effective interest rate jumped from 3.20 % in FY 2022 to 6.38 % in FY 2023 and 6.66 % in FY 2024. The steep rise in the effective rate reflects higher market rates and a higher effective yield on the note, indicating that Cisco’s borrowing costs have increased markedly, while the debt structure—fixed‑rate, senior notes maturing June 15 2025—remained unchanged.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all factual information: the outstanding amount of $500 million remains constant from FY 2022 to FY 2024, and the effective interest rate increases from 3.20% in FY 2022 to 6.38% in FY 2023 and 6.66% in FY 2024, matching the ground truth exactly. (2) All numeric values are accurate and properly formatted, with no calculation errors. The dollar amount ($500 million), percentages (3.20%, 6.38%, 6.66%), and fiscal years (2022–2024) are all correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes the evolution of both the effective interest rate and outstanding amount over time and draws a valid conclusion about borrowing costs and debt structure. It correctly notes that while the debt structure (fixed-rate senior note) remained unchanged, borrowing costs increased due to rising market rates. (4) The answer is semantically equivalent to the original, with slightly more detail (e.g., maturity date of June 15, 2025), which is acceptable and does not contradict the ground truth. All evaluation dimensions are fully satisfied, warranting top scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 321,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the competitive positioning of CMCSA against Lumen in fiber-based broadband services evolve from 2022 through 2024, particularly in terms of network infrastructure advancements and service offerings?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband space, particularly in deploying fiber-based infrastructure that offered higher data transmission speeds. In 2022, Lumen was highlighted as one of several wireline telecom companies building fiber deeper into their networks, allowing them to offer faster broadband services in CMCSA's service areas. By 2023, this trend continued, with Lumen specifically mentioned alongside AT&T, Frontier, and Verizon as continuing to expand fiber-based infrastructure in the U.S., which enabled them to provide competitive, high-speed services. In 2024, Lumen remained a named competitor, with the added context that such companies were not only expanding fiber but also creating bundled offerings and increasing speeds to further compete with CMCSA. This 3-year progression shows a consistent and intensifying competitive threat from Lumen as it advanced its fiber infrastructure and service strategies, directly impacting CMCSA’s market position.",
      "llm_answer": "From 2022 to 2024, Comcast’s fiber‑based broadband positioning strengthened against Lumen as it moved from offering up to 3 Gbps speeds and planning DOCSIS 4.0 (2022 p. 7‑11) to rolling out 2 Gbps downstream on 50 % of its HFC footprint, deploying DOCSIS 4.0 in select markets, and launching fiber‑to‑the‑premises with up to 10 Gbps residential and 100 Gbps business speeds (2023 p. 6‑10). By 2024, the company continued expanding DOCSIS 4.0 and fiber‑to‑the‑premises capabilities, further solidifying its high‑speed service portfolio while Lumen remained a competitor building its own fiber network (2024 p. 6‑10). This evolution positioned Comcast as a more advanced fiber broadband provider relative to Lumen.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness, despite addressing the right question and showing relevant context. (1) The core issue is a misrepresentation of the competitive dynamic: the ground truth states that Lumen remained a consistent and intensifying competitor to CMCSA (Comcast) due to its fiber expansion, while the LLM incorrectly frames CMCSA as gaining a stronger position *relative* to Lumen. This reversal of the competitive trajectory is a major factual error. (2) Quantitative inaccuracies include unverified speed claims: the LLM cites 'up to 10 Gbps residential and 100 Gbps business speeds' for Comcast in 2023, but the ground truth does not mention these figures or DOCSIS 4.0 deployments in that year. These specifics are absent from the original answer and cannot be verified from the provided context. Additionally, page references (e.g., '2022 p. 7-11') are included but not part of the ground truth, suggesting fabrication or unsupported sourcing. (3) Multi-hop reasoning is partially sound—information is synthesized across years and companies—but the conclusion misaligns with the evidence. The original answer emphasizes Lumen’s growing competitive threat, while the LLM asserts Comcast’s technological superiority, which is not supported. (4) Contextual relevance is high because the answer discusses fiber infrastructure, service offerings, and evolution over time, but the qualitative and quantitative inaccuracies reduce its reliability. The answer introduces technical details (DOCSIS 4.0, specific speed tiers) not present in the ground truth, which shifts the narrative incorrectly. Thus, while the structure and intent are appropriate, the factual foundation is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 473,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has American Express's reliance on aggregators evolved from 2022 through 2024, particularly in relation to the growing risk of merchant steering and the company's ability to enforce non-discrimination clauses in its merchant contracts?",
      "original_answer": "From 2022 to 2024, American Express increasingly relied on aggregators to manage merchant relationships, but this dependence introduced growing risks tied to merchant steering and inconsistent enforcement of non-discrimination clauses. In 2022, the company acknowledged its reliance on aggregators and processors but warned that their business goals might diverge from its own, potentially undermining card acceptance. By 2023, this concern intensified as AXP noted it had 'increasingly relied' on aggregators and highlighted that new products like debit cards on the American Express network could face discrimination, which could reduce transaction volumes and cards-in-force. In 2024, the risk evolved further, with litigation and regulatory scrutiny around merchant contract provisions becoming more prominent. AXP disclosed exposure to legal actions that could force changes in merchant agreements, exposing cards to increased steering and discrimination. The trajectory shows a growing strategic dependence on aggregators alongside rising operational and legal risks tied to enforcement of card acceptance policies.",
      "llm_answer": "American Express’s reliance on aggregators has grown steadily from 2022 through 2024, as the 2023 and 2024 10‑Ks note an expanding dependence on merchant acquirers, aggregators and processors to manage merchant relationships (2023 p. 27‑31; 2024 p. 33‑37). This shift has amplified the risk of merchant steering and differential surcharging, and while the company’s contracts contain non‑discrimination and honor‑all‑cards clauses, enforcement is constrained by the third‑party nature of those relationships, a challenge that has intensified over the period (2022 p. 27‑31).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth in terms of core developments from 2022 to 2024. It correctly identifies the increasing reliance on aggregators, the associated risks of merchant steering and surcharging, and the challenges in enforcing non-discrimination clauses due to third-party relationships. All cited years (2022, 2023, 2024) and references to 10-K pages are consistent with the expected sourcing. There are no numeric inaccuracies—dates and document references are correctly used, and no incorrect figures are presented, satisfying quantitative accuracy. The qualitative reasoning is sound: it captures the multi-hop nature of the question by linking growing dependence on third parties to weakening enforcement of card acceptance policies. However, the LLM answer omits specific evolution noted in the original answer, such as the introduction of American Express debit cards as a new product facing discrimination risk in 2023, and the increasing litigation and regulatory scrutiny in 2024 that could force changes in merchant agreements. These are important nuances in the risk trajectory that enhance completeness. While the core message is preserved, the absence of these details slightly weakens the depth of the synthesis. Contextual relevance is strong—the response directly addresses the question’s focus on evolving reliance, merchant steering, and enforcement challenges. Overall, the answer is correct in substance but lacks some specificity in the 2023–2024 risk evolution, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 430,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Johnson & Johnson's legal and financial strategy regarding talc-related liabilities, managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of litigation handling, settlement attempts, and bankruptcy filings?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson’s strategy around talc-related liabilities through LTL Management LLC shifted from an initial bankruptcy filing and litigation stay to repeated legal challenges and evolving settlement attempts. In 2022, LTL Management LLC was created through a corporate restructuring in October 2021, and it filed for Chapter 11 bankruptcy, securing a Preliminary Injunction that stayed all talc-related litigation. The Company also established a $2 billion reserve to fund a trust for LTL liabilities. In 2023, the Third Circuit reversed the Bankruptcy Court’s decision, forcing LTL to refile for bankruptcy (LTL 2), which resulted in a temporary restraining order and limited discovery. However, the LTL 2 case was dismissed in July 2023, prompting an appeal. By 2024, JNJ had reached multi-state settlement agreements with 42 states and the District of Columbia, signaling a shift toward resolution through negotiation, while continuing to appeal adverse bankruptcy rulings. Throughout this period, JNJ maintained its legal defense strategy while increasing settlement activity, reflecting a dual approach of litigation resistance and partial resolution.",
      "llm_answer": "From 2022 to 2024, Johnson & Johnson shifted its talc strategy from a stay‑based Chapter 11 approach by LTL Management LLC to a comprehensive pre‑packaged plan. In 2022, LTL’s Chapter 11 petition stayed all talc litigation; after court reversals and a dismissal in 2023 the stay was lifted, prompting the company to refile and ultimately pursue a $6.475 billion present‑value pre‑packaged plan in 2024, while establishing a $2 billion trust and a $9 billion reserve for LTL, recording a $5 billion incremental charge and a $11.6 billion present‑value reserve for the plan, and restructuring LLT into Texas entities that filed their own Chapter 11 petitions and enjoined claims. Throughout, the company settled high‑profile cases (including the Ingham verdict and 95 % of mesothelioma suits), reached agreements with state attorneys general, and continued to litigate and appeal decisions to resolve remaining talc claims.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trajectory of Johnson & Johnson's legal and financial strategy regarding talc liabilities through LTL Management LLC from 2022 to 2024, including the use of bankruptcy filings, litigation stays, settlement attempts, and appeals. However, there are significant quantitative inaccuracies that undermine factual correctness. The original answer states J&J established a $2 billion reserve to fund a trust—this is correct. The LLM answer introduces a $6.475 billion present-value pre-packaged plan, a $9 billion reserve, an $11.6 billion present-value reserve, and a $5 billion incremental charge—all of which are not mentioned in the ground truth and appear to be fabricated or conflated with other filings (possibly from later periods or different cases). These figures are central to the financial strategy and their inaccuracy severely impacts the correctness score. Additionally, the claim that LTL was restructured into Texas entities that filed Chapter 11 petitions is not supported by the original answer, which only mentions the refiling of LTL 2 and its dismissal. The LLM also incorrectly states that a 'comprehensive pre-packaged plan' was pursued in 2024, while the ground truth emphasizes multi-state settlement agreements with 42 states and D.C., not a pre-packaged bankruptcy plan. On qualitative accuracy, the LLM correctly identifies the reversal of the bankruptcy stay, refiling, dismissal in 2023, and increased settlement activity, showing sound multi-hop reasoning across time and legal developments. It also correctly notes ongoing litigation and appeals. However, the inclusion of unverified settlements (e.g., Ingham verdict, 95% of mesothelioma suits) goes beyond the original answer’s scope. Contextually, the response is highly relevant, addressing litigation handling, settlement attempts, and bankruptcy evolution. While the narrative flow is logical and comprehensive, the numerous unsupported financial figures and entities reduce overall accuracy. Semantic equivalence is partially achieved in structure and intent but not in factual content due to the erroneous numbers and added details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1551,
        "completion_tokens": 574,
        "total_tokens": 2125
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Home Depot's competitive emphasis on store appearance evolve between 2022 and 2024, and how was this strategy integrated with its interconnected retail and digital capabilities by fiscal year 2024?",
      "original_answer": "In 2022, Home Depot highlighted store appearance as a key competitive factor alongside customer experience, price, and product availability. The company emphasized the importance of store location and presentation of merchandise as part of its in-store competitive edge. By 2023, store appearance remained a core part of the competitive strategy, but it was more explicitly tied to the broader shopping journey, including inspiration, research, and post-purchase support. The company also began linking store appearance with its interconnected retail capabilities, particularly as customers increasingly expected seamless transitions between online and in-store experiences. In 2024, store appearance was further integrated into a more comprehensive interconnected shopping experience, where the company explicitly connected store aesthetics and layout to digital capabilities such as mobile-optimized platforms, product search, and fulfillment options. This evolution shows a shift from treating store appearance as a standalone competitive factor to a component of a digitally enhanced, omnichannel retail strategy.",
      "llm_answer": "In the 2022 10‑K (pages 7‑11) Home Depot highlighted store appearance—location, visual presentation and ease of navigation—as a key competitive differentiator. By the 2024 10‑K (pages 6‑10) that emphasis had evolved into a full‑scale store‑refresh program adding wayfinding signage, self‑service lockers, curbside pickup, electronic shelf labels, redesigned front‑ends and expanded self‑checkout, all linked to digital tools such as GET phones, mobile‑app navigation and an interconnected retail strategy that ties BOPIS, BOSS, BODFS, BORIS and curbside pickup into a seamless online‑to‑in‑store experience. The 2023 10‑K (pages 12‑16) confirms that these physical upgrades are integrated with a frictionless digital ecosystem, enhancing the customer journey from inspiration to fulfillment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of Home Depot's competitive emphasis on store appearance from 2022 to 2024, noting that in 2022, store appearance (including location, visual presentation, and navigation) was a key differentiator. By 2024, this evolved into a comprehensive store-refresh program integrated with digital tools—consistent with the original answer’s claim of integration with interconnected retail capabilities. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not applicable beyond correct fiscal year references (2022, 2023, 2024), which are all accurately cited. Page numbers (e.g., 2022 10-K pages 7–11) are included as supporting detail but do not affect factual correctness. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three fiscal years and connects physical store enhancements (e.g., signage, self-checkout, electronic labels) with digital capabilities (mobile app, GET phones, BOPIS, BOSS, etc.), accurately reflecting the shift from standalone appearance to an omnichannel strategy. The mention of BOPIS, BOSS, BODFS, and BORIS shows detailed understanding of Home Depot’s interconnected retail model. (4) The only minor shortcoming is that the original answer emphasizes the linkage of store appearance to the broader customer journey (inspiration, research, post-purchase) in 2023, which the LLM mentions indirectly via 'frictionless digital ecosystem' and 'customer journey from inspiration to fulfillment' but could have been slightly more explicit. However, the semantic meaning is preserved. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 488,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its ownership stake, operational integration, and eventual divestiture, and what does this multi-year trajectory reveal about AT&T's broader entertainment strategy?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, the company completed the separation of its WarnerMedia business, which had originated from the 2018 acquisition of Time Warner Inc., through a Reverse Morris Trust transaction with Discovery, marking a strategic exit from direct ownership. By 2023, Time Warner Inc. was no longer referenced as an active investment or subsidiary, indicating full operational separation and integration into the new Warner Bros. Discovery entity. In 2024, AT&T finalized its exit from entertainment by agreeing to sell its remaining interest in DIRECTV to TPG, which had been part of the broader post-Time Warner strategic realignment. This 3-year trajectory reveals a consistent strategic pivot away from media and entertainment toward core telecommunications and digital infrastructure.",
      "llm_answer": "From 2022 through 2024 AT&T transitioned from owning and operating Time Warner (WarnerMedia) to fully divesting it: in 2022 AT&T still held a 100 % stake and had integrated WarnerMedia into its WarnerMedia segment (Turner, HBO, Warner Bros.) (T_10k_2022, pp. 3‑7).  In April 2022 the company completed a Reverse Morris Trust with Discovery, distributing the WarnerMedia assets to AT&T shareholders and classifying the unit as discontinued (T_10k_2023, pp. 2‑6; T_10k_2024, pp. 2‑6).  By 2023‑24 AT&T had no remaining ownership or operational role in WarnerMedia, underscoring a strategic pivot away from large content ownership toward a network‑centric model that focuses on delivering its own streaming platform (HBO Max) over its connectivity infrastructure (T_10k_2024, pp. 2‑6).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor inaccuracies and omissions that prevent a perfect score. (1) Quantitatively, the key dates and ownership stake (100%) are accurate, and the April 2022 Reverse Morris Trust completion is correctly cited. The timeline of divestiture by 2023–2024 is consistent with the original answer. (2) However, the LLM incorrectly implies that AT&T retained any role in HBO Max post-divestiture; in reality, HBO Max (and all WarnerMedia assets) were fully transferred to Warner Bros. Discovery, and AT&T did not continue delivering 'its own streaming platform'—this misrepresents the operational outcome. The original answer correctly frames the strategy as a full exit from entertainment, not continued platform delivery. (3) The LLM omits the DIRECTV divestiture in 2024, a key part of AT&T’s broader entertainment exit strategy mentioned in the ground truth, which weakens the completeness of the multi-hop synthesis. (4) Despite this, the core reasoning—AT&T’s pivot from content ownership to network-centric infrastructure—is sound and contextually relevant. The use of citations (T_10k_2023, etc.) adds credibility, though not required. Overall, the answer captures the essential trajectory but misses a critical component (DIRECTV) and contains a subtle but important mischaracterization of post-divestiture HBO Max involvement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 388,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other networks, and the exit from certain network licensing businesses?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest global card network behind China UnionPay, Visa, and Mastercard, but faced increasing regulatory pressure that directly impacted its network business. In 2022 and 2023, the company highlighted intense competition in the premium card space and cobrand relationships, with rivals offering attractive value propositions to high-spending customers and key business partners. In 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and merchant acceptance terms, leading to American Express exiting its network licensing businesses in the EU and Australia. This regulatory pressure also introduced uncertainty around cobrand arrangements in the EU, signaling a shift from a purely competitive stance to a more compliance-driven dependency on regulatory frameworks. The evolution reveals a growing tension between maintaining competitive differentiation and navigating an increasingly complex global regulatory environment.",
      "llm_answer": "From 2022 through 2024, American Express has remained the fourth‑largest general‑purpose card network, but the competitive landscape has sharpened with the rise of alternative payment platforms and continued pressure from Visa, Mastercard, and regional networks (see 2022‑2024 Competition sections, pages 10‑14).  Regulatory scrutiny has intensified, culminating in 2024’s designation as a Category III bank‑holding firm and the company’s exit from network‑licensing operations in the EU and Australia to comply with new regulatory regimes (see 2024 Supervision & Regulation, pages 32‑36).  These changes have deepened the firm’s regulatory dependency on card‑network rules while forcing it to adapt its competitive strategy amid heightened regulatory and market pressures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: American Express remained the fourth-largest card network (correct entity and ranking), faced increasing competition from Visa, Mastercard, and regional networks, and exited network licensing businesses in the EU and Australia in 2024 due to regulatory pressure. The mention of 2024 regulatory changes, including designation as a Category III bank-holding company, adds contextually accurate detail consistent with heightened scrutiny. (2) Quantitative accuracy is strong: no specific numerical values (e.g., dollar amounts, percentages) are present in either answer, but timeframes (2022–2024) and event sequencing are correct. The exit from EU and Australia licensing is correctly dated to 2024. (3) Multi-hop reasoning is sound: the LLM synthesizes competitive dynamics, regulatory evolution, and strategic business exits across years, correctly linking regulatory pressure to strategic withdrawal from licensing—mirroring the ground truth’s core conclusion. (4) The only minor gap is that the LLM does not explicitly mention 'interchange fees, network routing, and merchant acceptance' as specific regulatory focus areas, nor does it highlight uncertainty in EU cobrand arrangements, which are key nuances in the original. However, the broader regulatory dependency and strategic adaptation are accurately conveyed. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing competitive positioning and regulatory dependency evolution as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 438,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this trend suggest about the company's long-term debt management strategy?",
      "original_answer": "Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 decreased from $983 million in 2022 to $808 million in 2024, with an intermediate balance of $826 million in 2023. This represents a total reduction of $175 million over the three-year period, indicating a deliberate strategy to reduce long-term liabilities tied to this specific instrument.",
      "llm_answer": "Johnson & Johnson’s 2.250 % Notes due 2050 fell from **$983 million** at year‑end 2022 to **$826 million** in 2023 and **$808 million** in 2024 (see the long‑term debt tables in the 2022, 2023, and 2024 10‑K). This steady decline shows the company is actively paying down older long‑term debt, underscoring a disciplined strategy of reducing debt exposure while keeping a stable, low‑interest maturity profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical values: $983 million in 2022, $826 million in 2023, and $808 million in 2024, matching the ground truth exactly. The trend of decreasing balance is accurately described. (2) All numbers are factually correct and consistent with the original answer; the reduction from $983M to $808M over the period is a $175M decrease, which the LLM implies through accurate year-by-year reporting even if not explicitly calculated. (3) The multi-hop reasoning is sound—information is synthesized across three annual reports (2022–2024), and the conclusion about debt reduction strategy is logically supported by the declining balances. (4) The qualitative interpretation ('actively paying down older long-term debt', 'disciplined strategy') aligns with the ground truth's characterization of a 'deliberate strategy'. The only minor limitation is that the LLM does not explicitly quantify the total reduction ($175M), but this omission does not detract significantly from the overall accuracy. All entities—Johnson & Johnson, 2.250% Notes due 2050, and the correct years—are accurately identified. Wording differs slightly but maintains semantic equivalence. Thus, the answer is highly accurate, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 359,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did American Express's yield profile on its foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year trend suggest about its exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with a weighted average yield of 6.45% for instruments maturing within one year. By 2023, the yield on these short-term foreign bonds remained high at 6.45%, while the yield on bonds maturing between 1 and 5 years dropped to 4.48%. In 2024, the yield on short-term foreign bonds declined further to 5.86%, and the yield on bonds maturing between 1 and 5 years fell significantly to 2.03%. This 3-year trend indicates a decreasing return on foreign government bonds, potentially signaling a shift in the interest rate environment or a strategic change in the types of foreign bonds held by American Express.",
      "llm_answer": "From 2022 to 2024, the weighted‑average yield on American Express’s foreign government bonds and obligations climbed steadily—moving from roughly 2.08 % in 2022 to about 2.18 % in 2023 and to roughly 2.28 % in 2024 (see the weighted‑average‑yield tables on pages 119‑123, 133‑137 and 175‑179). This upward trend reflects a gradual rise in international rates and indicates that the company’s portfolio has become increasingly sensitive to global interest‑rate movements, heightening its exposure to foreign‑rate volatility.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in both quantitative and qualitative aspects. According to the ground truth, American Express's yields on foreign government bonds were significantly higher—starting at 6.45% in 2022 for short-term instruments—and showed a declining trend through 2024, dropping to 5.86% (short-term) and 2.03% (1–5 year maturities). In contrast, the LLM claims yields rose from 2.08% to 2.28%, which is factually wrong and misrepresents the magnitude and direction of the trend. (2) All numeric values (percentages and implied dollar amounts) are incorrect. The ground truth specifies $630 million in holdings in 2022 and detailed yield breakdowns by maturity, none of which are reflected in the LLM response. The cited pages (119–123, etc.) are fabricated or irrelevant as no such data exists in the actual filings. (3) The multi-hop reasoning is flawed: the LLM fails to distinguish between maturity buckets (a key aspect of the original answer) and incorrectly infers increasing exposure due to rising yields, when the actual trend shows a sharp decline, suggesting de-risking or portfolio rebalancing amid changing international rate environments. (4) The contextual relevance is slightly above zero because the answer addresses foreign government bonds and interest rate exposure, but the factual inaccuracies render the conclusion invalid. Thus, the correctness and accuracy scores are very low, with only minimal credit for addressing the general topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 414,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Adobe's strategic positioning of its free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of platform branding and integration with enterprise customer success initiatives, and what does this evolution indicate about Adobe's broader approach to customer enablement and retention?",
      "original_answer": "In 2022, Adobe introduced its free online self-service learning options under the domain www.training.adobe.com, positioning them as part of a comprehensive portfolio of learning and enablement services aimed at helping customer and partner teams use Adobe products effectively. By 2023, Adobe rebranded and centralized these offerings under learning.adobe.com, signaling a more unified and strategic approach to customer enablement. The 2023 filing emphasized the role of these free offerings in supporting enterprise customer success initiatives, including solution-specific skills assessments to help marketing teams tailor learning priorities. In 2024, Adobe maintained the learning.adobe.com platform and further integrated the self-service learning tools into its broader customer success framework, reinforcing the importance of digital learning in maximizing return on investment for Adobe's offerings. This evolution—from introduction to strategic rebranding and deeper integration—indicates that Adobe increasingly views customer enablement through self-service learning as a critical lever for retention, product adoption, and long-term enterprise value.",
      "llm_answer": "Adobe’s free, self‑service learning was originally hosted on **learning.adobe.com** and was part of a broader Digital Learning Services portfolio that included custom learning for enterprise customers (ADBE 10‑K 2022, pp. 15‑19). By 2024 the platform was re‑branded to **training.adobe.com** and the free learning was positioned as a core element of **Adobe Customer Solutions**, explicitly tied to enterprise customer‑success managers and custom learning services (ADBE 10‑K 2024, pp. 16‑20). This shift shows Adobe’s strategy to embed a unified, branded learning ecosystem into its customer‑success framework, underscoring a broader focus on enabling customers, accelerating adoption, and driving retention.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the timeline and direction of Adobe's platform rebranding. According to the ground truth, in 2022 the platform was at www.training.adobe.com, and in 2023 it was rebranded and moved to learning.adobe.com. However, the LLM claims the opposite — that it started at learning.adobe.com and was rebranded to training.adobe.com by 2024 — which is factually incorrect. This reversal of the actual evolution undermines the entire response. (2) The dates (2022, 2024) are correctly referenced in context, but their associated events are swapped, leading to a false narrative. There are no numerical values to verify, so quantitative accuracy hinges on correct temporal and platform attribution, which fails. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the chronological evolution across filings, incorrectly attributing the branding changes to the wrong years. It also misidentifies the integration pathway — claiming that by 2024 the shift occurred, when the key strategic rebranding happened in 2023 per the original answer. (4) While the general theme — that Adobe is integrating self-service learning into customer success for retention and adoption — is directionally correct, the factual backbone is inverted. Thus, despite some contextual relevance and plausible strategic interpretation, the core facts are wrong, warranting a low correctness score. The contextual relevance is moderate because the answer addresses the right themes (customer enablement, retention, integration with enterprise success), but with incorrect supporting evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 453,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Senior Notes evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million outstanding balance on its 5.90% Senior Notes from 2022 through 2024, with the effective interest rate remaining stable at 6.11% across all three years. This indicates that Cisco has not retired or refinanced this particular tranche of debt during the period, suggesting a deliberate strategy to maintain this higher-yielding long-term liability on its balance sheet.",
      "llm_answer": "Cisco’s 5.90 % Senior Notes stayed at a constant $2.0 billion each fiscal year from 2022 through 2024, and the effective interest rate on those notes remained steady at 6.11 % for each year. This unchanged utilization and cost demonstrate Cisco’s long‑term debt strategy of maintaining a stable debt mix and predictable financing costs rather than pursuing aggressive debt expansion or rate arbitrage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Cisco's 5.90% Senior Notes had a constant outstanding balance of $2.0 billion (equivalent to $2,000 million) from 2022 through 2024 and that the effective interest rate remained stable at 6.11% across all three years. These figures match the ground truth exactly, with acceptable formatting variation ($2.0 billion vs $2,000 million). (2) All numeric values—dollar amount, coupon rate, effective interest rate, and time period—are factually accurate. No calculations were required beyond recognition of consistency over time, which is correctly interpreted. (3) The multi-hop reasoning is sound: the model synthesizes data across three fiscal years for a specific debt instrument and draws a logical conclusion about Cisco’s long-term debt strategy. While the original answer emphasizes the implication that Cisco did not retire or refinance this higher-yielding debt, the LLM response frames the strategy as maintaining a stable debt mix and predictable costs—semantically similar and logically valid. The slight difference in interpretation does not introduce error but reflects a nuanced emphasis (predictability vs. deliberate retention of higher-cost debt). (4) Scores reflect full quantitative accuracy, excellent qualitative reasoning with only minor difference in strategic interpretation, and complete contextual relevance to the question about utilization, interest rate evolution, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 407,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did BA's allocation to Special Situation Strategies evolve from 2022 to 2024, and what does this 3-year trend indicate about the company's private equity investment strategy?",
      "original_answer": "BA maintained a consistent focus on Special Situation Strategies as part of its private equity investment vehicles across 2022, 2023, and 2024. In 2022, the company described its private equity investments as primarily limited partnerships (LPs) investing in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies. This characterization remained unchanged in 2023 and 2024, suggesting a stable strategic allocation to these types of opportunities. While no specific dollar amounts were disclosed for Special Situation Strategies in any year, the consistent inclusion of this category among core private equity strategies indicates that BA has preserved its exposure to these investments as part of a broader diversified private equity portfolio. The lack of quantitative disclosure limits trend analysis but confirms strategic continuity.",
      "llm_answer": "BA increased its allocation to Special Situation Strategies from **8 % of its pension assets in 2022 to 9 % in 2024** (actual allocations in the 2022, 2023, and 2024 tables). This 1‑percentage‑point rise over three years signals a modest but consistent tilt toward opportunistic, higher‑risk private‑equity plays as part of the company’s broader private‑equity strategy.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) QUANTITATIVE INACCURACY: The LLM claims BA allocated 8% of pension assets to Special Situation Strategies in 2022 and 9% in 2024, asserting a 1-percentage-point increase. However, the ground truth explicitly states that 'no specific dollar amounts were disclosed for Special Situation Strategies in any year,' meaning no such percentages are available in the source data. These numbers are fabricated. (2) COMPLETENESS: The answer fails to acknowledge the lack of quantitative disclosure, which is a key point in the original answer. It also does not reflect the actual trend — stability in strategic focus — instead inventing a numerical trend that does not exist. (3) ENTITY & REASONING ERROR: The LLM incorrectly ties Special Situation Strategies to pension assets, while the original answer discusses private equity investments through limited partnerships, not pension allocations. This mischaracterizes the financial context and vehicle type. (4) SEMANTIC NON-EQUIVALENCE: The conclusion that BA is making a 'modest but consistent tilt toward opportunistic, higher-risk private-equity plays' is unsupported, as the ground truth emphasizes strategic continuity without any indication of shifting allocations. The multi-hop reasoning fails because the model invents data rather than synthesizing across years and disclosures. The only relevant aspect is that the topic (Special Situation Strategies in private equity) is contextually related, but the answer distorts facts. Hence, very low scores across correctness, quantitative accuracy, and qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 451,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did JNJ's global sales from Interventional Solutions evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of this product segment post-acquisition?",
      "original_answer": "JNJ's global sales from Interventional Solutions increased from $3,971 million in 2022 to $4,300 million in 2023, and further to $6,350 million in 2024. This significant upward trajectory indicates that the product segment became increasingly strategic following the acquisition in late 2022, with a notable acceleration in 2024, likely driven by integration and expanded market access.",
      "llm_answer": "Global Interventional Solutions sales climbed from **$4.3 billion in 2022** (U.S. $2,169 m + Int’l $2,131 m) to **$6.35 billion in 2023** (U.S. $3,633 m + Int’l $2,717 m) – a 47.7 % jump – and then held steady at **$6.35 billion in 2024** (U.S. $3,633 m + Int’l $2,717 m). The sharp post‑acquisition surge and subsequent plateau demonstrate that the segment has become a key, stable revenue driver within JNJ’s MedTech portfolio, underscoring its strategic importance after the December 2022 acquisition.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, JNJ's global sales from Interventional Solutions were $3,971 million in 2022, $4,300 million in 2023, and $6,350 million in 2024. The LLM incorrectly reports $4.3 billion (i.e., $4,300 million) for 2022 instead of $3,971 million, and claims $6.35 billion in 2023, which is actually the 2024 figure. It then states sales held steady at $6.35 billion in 2024, implying no growth from 2023 to 2024, which contradicts the ground truth showing a large increase in 2024. (2) The calculation of a 47.7% jump is based on incorrect base values: using $4.3B as 2022 and $6.35B as 2023 is wrong on both counts. The actual growth from 2022 ($3,971M) to 2023 ($4,300M) is about 8.3%, and from 2023 to 2024 is about 47.7% — the LLM misattributes this growth to the wrong period. (3) The multi-hop reasoning is flawed: the LLM fails to correctly track the year-over-year progression and misaligns the acquisition timeline (late 2022) with the sales data, incorrectly suggesting a surge in 2023 and plateau thereafter, while the ground truth shows continued strong growth into 2024, indicating accelerating strategic importance. (4) Despite incorrect numbers and timeline, the LLM correctly identifies the strategic importance of the segment post-acquisition and ties it to the December 2022 acquisition, showing some contextual understanding. However, due to major quantitative and temporal errors, the overall correctness score is low. Semantic equivalence is not achieved due to mismatched figures and progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 440,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Walmart's strategic positioning of the 'No Boundaries' private brand evolve across its merchandise units from 2022 through 2024, and what does this multi-year branding consistency reveal about Walmart's private label strategy in general merchandise?",
      "original_answer": "Walmart consistently positioned 'No Boundaries' as a core private brand within its general merchandise offerings across all three years. In 2022, 'No Boundaries' was listed among key private brands under the General Merchandise strategic unit, which included Apparel and Home categories. In 2023, the brand remained a highlighted private brand, even as Walmart emphasized omni-channel expansion and supply chain investments. By 2024, 'No Boundaries' continued to be prominently listed among private brands, despite a reorganization of merchandise units that shifted 'Apparel' to a new 'Fashion' category. This 3-year continuity in branding suggests Walmart's deliberate effort to maintain and leverage strong private-label identities to differentiate offerings and support margin expansion in competitive categories.",
      "llm_answer": "From 2022 through 2024, Walmart continued to list “No Boundaries” as a private‑label brand within its general‑merchandise portfolio, with no change in its placement across the grocery, general‑merchandise, or health‑and‑wellness units (WMT_10k_2022, p. 8; WMT_10k_2023, p. 9; WMT_10k_2024, p. 8). This consistent positioning over three consecutive years shows that Walmart’s private‑label strategy is to maintain a stable, broad assortment of low‑price brands in its core merchandise units, reinforcing its everyday‑low‑price (EDLP) positioning and building long‑term customer trust.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy regarding the placement of 'No Boundaries' across merchandise units. While it correctly notes the brand's consistent presence as a private label in general merchandise from 2022 to 2024 and cites appropriate document sources, it incorrectly states that there was 'no change in its placement across the grocery, general-merchandise, or health-and-wellness units.' The ground truth specifies that 'No Boundaries' was part of General Merchandise, which included Apparel and Home, and that in 2024, Apparel was moved to a new 'Fashion' category—indicating a reorganization that the LLM overlooks. This undermines the qualitative accuracy of the reasoning. Additionally, the LLM incorrectly implies that 'No Boundaries' spans grocery and health-and-wellness units, which is not supported by the original answer. The conclusion about Walmart’s private-label strategy emphasizing low-price brands and EDLP, while plausible, diverges from the ground truth’s focus on using strong private-label identities for differentiation and margin expansion—missing the strategic nuance of brand continuity despite structural changes. Quantitative accuracy is perfect: no numerical errors, and the timeline (2022–2024) is correctly referenced. Contextually, the answer addresses the evolution and strategic implication, so relevance is high. However, the failure to acknowledge the reorganization and misattribution of the brand to incorrect merchandise units results in a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 426,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the performance of Cisco's available-for-sale debt investments evolve from fiscal 2022 to fiscal 2024, based on the specific impacts these investments had on other income (loss), net in 2023 and 2024?",
      "original_answer": "In fiscal 2022, Cisco disclosed the value of its available-for-sale debt investments in a detailed table, indicating active management of these assets. In fiscal 2023, the company reported higher losses in these investments, negatively impacting other income (loss), net. This trend continued into fiscal 2024, where the company again cited higher losses in available-for-sale debt investments as a primary driver of changes in other income (loss), net. This 3-year trajectory suggests a consistent negative impact from these investments, despite their ongoing presence in Cisco’s portfolio.",
      "llm_answer": "Cisco’s available‑for‑sale debt portfolio swung from a modest $9 million gain in fiscal 2022 to a $21 million loss in fiscal 2023, and deepened to a $67 million loss in fiscal 2024. Those losses eroded the company’s other income (loss), net, turning a $392 million gain in 2022 into a $248 million loss in 2023 and a $306 million loss in 2024.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The specific numbers cited—$9 million gain in 2022, $21 million loss in 2023, $67 million loss in 2024, and the other income figures of $392M gain in 2022 turning into $248M and $306M losses—are not supported by the original answer or the underlying ground truth. The original answer does not provide any specific dollar amounts or gains/losses; it only states that 'higher losses' occurred in 2023 and 2024 without quantification. Therefore, the LLM fabricated precise financial figures absent from the source. (2) Completeness: While the LLM attempts to address the evolution from 2022 to 2024 and links investment performance to other income (loss), net, it fails by introducing false precision and incorrect data. The original answer notes only a qualitative trend of increasing negative impact, not exact swings or magnitudes. (3) Entity Accuracy: The company (Cisco), metric (available-for-sale debt investments), and time periods (fiscal 2022–2024) are correctly identified. (4) Reasoning: The multi-hop reasoning is structurally sound—linking investment performance to impact on other income over time—but is based on invented data rather than actual disclosures. (5) Semantic Equivalence: The LLM’s conclusion of worsening performance aligns broadly with the original’s 'consistent negative impact,' but the addition of specific, false numbers undermines factual equivalence. The original emphasizes disclosure practices in 2022 and qualitative trends, while the LLM invents a detailed numerical narrative. Thus, despite correct context and directionality, the answer is factually wrong, warranting a very low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 472,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's reliance on third-party merchant acquirers evolved from 2022 through 2024, particularly in terms of their strategic importance in expanding merchant coverage and facilitating transaction growth across small, mid-sized, and large merchants?",
      "original_answer": "From 2022 to 2024, American Express's reliance on third-party merchant acquirers has grown, reflecting a strategic shift toward leveraging external partners to expand merchant coverage and facilitate transaction volume, especially among small and mid-sized merchants. In 2022, the company highlighted the role of third-party acquirers under programs like OptBlue and GNS, noting that these relationships allowed American Express to process transactions without direct contracts with merchants, thereby broadening its reach. In 2023, the company emphasized the financial structure of these relationships, detailing how it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, reinforcing the financial integration of these partners into American Express’s revenue model. By 2024, the company explicitly stated that its ability to expand merchant coverage globally depended not only on its own efforts but also on the success of third-party merchant acquirers, aggregators, and processors in signing merchants, indicating a deeper strategic dependency on these partners to scale acceptance and usage of American Express cards. This evolution shows a shift from viewing third-party acquirers as supplementary to considering them essential for growth and network expansion.",
      "llm_answer": "American Express has maintained a consistent reliance on third‑party merchant acquirers from 2022 through 2024.  The 2022, 2023 and 2024 10‑K filings all describe third‑party acquirers—such as OptBlue and GNS partners—as a key mechanism for expanding merchant coverage, with small‑ and mid‑size merchants served under flexible, no‑fixed‑term agreements and large merchants under fixed‑term contracts, thereby driving transaction growth across all merchant tiers.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in terms of entities and programs mentioned (OptBlue, GNS), and correctly identifies third-party acquirers as important for expanding merchant coverage across small, mid-sized, and large merchants. It accurately reflects that this reliance was present in all three years (2022–2024), which aligns with the ground truth. However, the LLM fails to capture the key evolution emphasized in the original answer: the growing strategic importance and deepening dependency on third-party acquirers over time. Specifically, the answer omits the progression in American Express’s strategic posture—from viewing acquirers as a mechanism for broader reach in 2022, to recognizing their financial integration via network fee revenue in 2023, to explicitly depending on them for global expansion by 2024. This evolution is central to the question about how reliance 'has evolved,' but the LLM instead describes a static, consistent reliance, which misrepresents the dynamic shift documented in the filings. There are no numerical inaccuracies (hence high quantitative accuracy), but the qualitative reasoning is flawed due to failure in multi-hop synthesis across years to show change over time. Contextually, the answer is relevant and addresses merchant tiers and transaction growth, but misses the core analytical point of strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 379,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Johnson & Johnson's multi-year initiative to enhance financial shared service capabilities evolved from 2022 through 2024, particularly in terms of its integration with enterprise-wide process standardization efforts across HR, IT, procurement, supply chain, and finance?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including human resources, information technology, procurement, supply chain, and finance. In 2022, the company noted that these enhancements were designed to support the growth of its financial shared service capabilities and standardize financial systems, and were not in response to any identified deficiencies in internal controls. By 2023, the company reiterated this strategic direction and highlighted that it was continuing to align and streamline the design and operation of its financial control environment in response to the initiative. In 2024, the company maintained the same narrative, emphasizing that the initiative remained a proactive effort to enhance operational efficiency and control frameworks, not prompted by any material changes or weaknesses in internal control over financial reporting. This consistent, multi-year approach reflects a long-term strategic commitment to process optimization and financial control modernization.",
      "llm_answer": "Johnson & Johnson’s multi‑year initiative to grow its financial shared‑service capabilities has remained a consistent, enterprise‑wide effort from 2022 through 2024, with each filing (2022 p. 115‑119, 2023 p. 116‑120, 2024 p. 117‑121) describing the same goal of “integrating, simplifying and standardizing processes and systems for HR, IT, procurement, supply chain and finance.”  Over this period the focus has deepened on aligning and streamlining the design and operation of its financial control environment, reinforcing the integration of those functions and the standardization of financial systems to support shared‑service growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Johnson & Johnson's multi-year initiative from 2022 to 2024. It correctly identifies the consistent enterprise-wide focus on integrating, simplifying, and standardizing processes across HR, IT, procurement, supply chain, and finance, aligning with the ground truth. The mention of page numbers (e.g., 2022 p. 115–119) adds precision and supports the claim of consistency across filings, though these are not part of the ground truth and do not affect factual accuracy. The LLM accurately reflects the deepening alignment of the financial control environment with shared services over time. It omits the explicit clarification present in the original answer that the initiative was proactive and not in response to internal control deficiencies or material weaknesses—this is a minor but notable omission in qualitative completeness. However, the core facts, entities (Johnson & Johnson, correct functional areas, correct years), and reasoning are sound. There are no numerical inaccuracies (quantitative accuracy is perfect, even though no calculations are involved), and the semantic meaning closely matches the original. The answer is fully contextually relevant, directly addressing the evolution of the initiative and its integration with enterprise process standardization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 373,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's positioning relative to alternative payment mechanisms evolved from 2022 to 2024, particularly in terms of competitive pressure and strategic adaptation to technological innovations such as open banking, digital wallets, and real-time settlement systems?",
      "original_answer": "From 2022 to 2024, American Express faced increasing competitive pressure from alternative payment mechanisms, including digital wallets (e.g., PayPal, Venmo), payment aggregators, and real-time settlement systems. In 2022, the company acknowledged the 'dynamic and rapid growth' of these mechanisms as a key competitive threat. In 2023, the scope of alternative mechanisms expanded to include open banking platforms and more integrated financial services offerings from competitors. By 2024, American Express shifted from a purely competitive stance to a strategic dependence on adopting these technologies, emphasizing investments in open banking, digital identification, and real-time settlement systems to remain relevant. This evolution reflects a transformation from viewing alternative payment mechanisms as external threats to recognizing them as essential components of its technological roadmap.",
      "llm_answer": "American Express has moved from a largely defensive stance in 2022—acknowledging rising competition from open‑banking, digital‑wallet and real‑time‑settlement platforms but without a clear counter‑strategy—to a more proactive approach in 2024, where the company highlights new investments in digital‑wallet integration, real‑time settlement infrastructure and open‑banking APIs to keep its card‑issuer and network businesses competitive. This shift reflects heightened competitive pressure from fintech and tech‑company‑backed payment solutions and a strategic pivot toward technology that supports faster, more seamless payment flows and broader merchant acceptance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: American Express evolved from acknowledging competitive pressure in 2022 to proactively investing in open banking, digital wallets, and real-time settlement by 2024. The characterization of the shift—from defensive to proactive—is semantically equivalent to the original answer's 'from viewing alternative payment mechanisms as external threats to recognizing them as essential components.' (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not applicable; however, the years (2022, 2023, 2024) are correctly referenced in context, satisfying temporal accuracy. (3) Multi-hop reasoning is sound: the LLM synthesizes American Express’s changing stance across time, integrates competitive pressures (fintech, tech companies), and correctly links strategic adaptations (APIs, infrastructure investments) to technological trends. The only minor gap is that the LLM omits explicit mention of 'digital identification'—a specific investment noted in the 2024 phase of the original answer—but this does not undermine the core accuracy. (4) Contextual relevance is excellent: the response directly addresses competitive pressure and strategic adaptation across all three technologies mentioned in the question (open banking, digital wallets, real-time settlement). Overall, the answer demonstrates strong qualitative and factual alignment with the ground truth, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 449,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Adobe's positioning and integration of Frame.io evolve from 2022 through 2024, and what does this progression indicate about Adobe's strategy in creative collaboration tools?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating its strategic importance as a brand within the Adobe ecosystem. By 2023, Adobe had positioned Frame.io as a core part of its creative collaboration offerings, describing it as a 'cloud-native creative collaboration platform' integrated with Premiere Pro and After Effects, supporting real-time upload, review, and approval with frame-accurate commenting. In 2024, Adobe expanded Frame.io’s capabilities beyond post-production into broader video workflows such as casting, location scouting, and marketing campaign management, and integrated it with additional apps like Photoshop, Lightroom, and Workfront. This evolution shows Adobe's deepening investment in end-to-end creative collaboration tools, with Frame.io becoming a central hub for multi-app, cross-functional workflows at scale.",
      "llm_answer": "In the 2022 10‑K (pp. 95‑99) Frame.io was described as a cloud‑native collaboration platform “directly integrated with Adobe Premiere Pro and Adobe After Effects” that enabled real‑time upload and camera‑to‑cloud capture. The 2023 10‑K (pp. 10‑14) kept that core positioning but added frame‑accurate commenting and still‑image camera support, still limited to Premiere Pro and After Effects. By the 2024 10‑K (pp. 10‑14) Adobe had expanded Frame.io’s integration to Photoshop, Lightroom, Workfront, and the new GenStudio suite (including Express and Firefly Services), signaling a strategy to embed collaboration across the entire Creative Cloud ecosystem and make it a core, end‑to‑end production workflow.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and strategic interpretation. (1) It accurately captures the evolution of Frame.io from 2022 to 2024: in 2022, Frame.io was integrated with Premiere Pro and After Effects; by 2023, frame-accurate commenting was added; and by 2024, integrations expanded to Photoshop, Lightroom, and Workfront. The mention of GenStudio (including Express and Firefly Services) is plausible as part of Adobe’s broader AI/automation push, though not explicitly in the ground truth. (2) There are no numeric values, dates, or financial figures in dispute—quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of 10-K filings to show a progression toward deeper integration and broader workflow coverage. However, it omits the 2022 trademark mention from the original answer, which is a minor but relevant strategic signal. Also, the 2024 expansion into casting, location scouting, and marketing campaign management—key indicators of broadening use cases—is not mentioned, representing a gap in completeness. (4) Despite these omissions, the core conclusion about Adobe embedding Frame.io as a central, end-to-end collaboration hub is semantically equivalent and well-supported. The answer is highly contextually relevant and draws the correct strategic inference. Minor deductions in correctness and qualitative accuracy reflect the missing details about pre-production use cases and trademark status.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 426,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion as of December 31, 2022, decreased to $15.0 billion as of December 31, 2023, and further declined to $13.0 billion as of December 31, 2024. This shows a consistent reduction in the balance over the three-year period, indicating a deliberate debt management strategy to gradually pay down this liability.",
      "llm_answer": "Amazon’s outstanding balance on its 2017 Notes fell from **$16.0 billion** at December 31 2022 (2023 p.56) to **$15.0 billion** at December 31 2023 (2023 p.56) and further to **$13.0 billion** at December 31 2024 (2024 p.56). This gradual reduction reflects a disciplined debt‑management strategy, actively paying down higher‑rate long‑term debt. By shrinking the 2017 Notes balance, Amazon lowers interest expense and improves its leverage profile, supporting a lower weighted‑average cost of capital.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all outstanding balance figures—$16.0 billion as of December 31, 2022, $15.0 billion as of December 31, 2023, and $13.0 billion as of December 31, 2024—matching the ground truth exactly. These values are accurately tied to the correct fiscal years, and the progression of reduction is correctly described. (2) All numeric values are factually correct and consistent with the original answer; no calculation errors are present. The format variations (e.g., $16.0 billion vs $16.0 billion) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years and infers a strategic trend in debt management. The conclusion about Amazon’s strategy is logically supported by the declining balances. While the original answer describes the trend as a 'deliberate debt management strategy to gradually pay down this liability,' the LLM adds interpretive depth—mentioning interest expense reduction, leverage improvement, and cost of capital—without contradicting the ground truth. These inferences are reasonable and contextually appropriate, though slightly more detailed than the original, which keeps the explanation more neutral. (4) The answer fully addresses both parts of the question: the evolution of the balance and the implication for debt management. The added financial rationale enhances relevance and insight without introducing inaccuracies. Thus, the answer is factually complete and contextually strong, warranting a high score with only a minor deduction in qualitative accuracy for slight over-interpretation beyond the documented scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 456,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Boeing's emphasis on 'Upgrades and Conversions' evolved across its Global Services segment from 2022 through 2024, and what does this 3-year trajectory suggest about the company's strategic focus in sustaining aerospace platforms?",
      "original_answer": "From 2022 to 2024, Boeing consistently included 'Upgrades and Conversions' as a core service within its Global Services segment, indicating a sustained strategic focus on modernizing existing aerospace platforms. In 2022, 'Upgrades and Conversions' were listed among key offerings such as supply chain management and maintenance. In 2023 and 2024, this emphasis remained unchanged, suggesting a deliberate long-term strategy to support aging fleets and adapt legacy systems to evolving defense and commercial needs. The consistent presence of this service offering across all three filings reflects Boeing's commitment to lifecycle management and service-based revenue streams.",
      "llm_answer": "Boeing’s 10‑K filings for 2022, 2023 and 2024 all list upgrades and conversions as a core component of its Global Services offering, with the wording and emphasis unchanged (see page 3 of each filing). This steady focus signals a long‑term strategic priority on sustaining existing aerospace platforms through upgrades and conversions, underscoring the company’s commitment to aftermarket support and lifecycle services.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately identifies that Boeing consistently listed 'upgrades and conversions' as a core offering in its Global Services segment across the 2022, 2023, and 2024 10-K filings, which reflects a sustained strategic focus. The mention of 'page 3 of each filing' adds specificity and matches the source structure, though the original answer does not include page numbers—this is a minor enhancement rather than an error. Quantitatively, there are no numerical inaccuracies, as the response does not introduce any figures requiring verification (e.g., dollar amounts, percentages), and the years 2022–2024 are correctly referenced. The qualitative reasoning is sound: the LLM correctly infers that the unchanged emphasis indicates a long-term strategy in lifecycle management and aftermarket support, which is a valid conclusion from the data. The only minor shortcoming is that the LLM omits specific examples of related services mentioned in the original (e.g., supply chain management, maintenance), which slightly reduces completeness but does not detract from the core insight. The answer fully addresses both parts of the question—evolution over time (consistency) and strategic implications—and maintains semantic equivalence with the ground truth. Contextual relevance is excellent, directly addressing Boeing’s strategic focus in sustaining aerospace platforms through service offerings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 404,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Johnson & Johnson's pension strategy evolve from 2022 through 2024 with respect to the Retirement Value formula, particularly in terms of employee eligibility and communication around the 2026 implementation date?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently communicated the 2026 implementation date for the Retirement Value formula for all U.S. non-union employees, regardless of hire date, first announced in January 2021. In 2022, the company referenced the Retirement Value formula as part of its future pension strategy without detailed context. By 2023, JNJ clarified that employees hired after 2014 were already under the Retirement Value formula, and in 2024, the same language was repeated, showing no changes to the plan or timeline. The eligibility criteria remained unchanged across all three years, with the Final Average Pay formula still applying to pre-2015 hires for service before 2026.",
      "llm_answer": "Johnson & Johnson’s 2021 amendment to its U.S. non‑union pension plan—effective Jan 1 2026—applies the Retirement Value formula to all eligible employees regardless of hire date. The 2022, 2023, and 2024 10‑K disclosures (2022 p. 73‑77; 2023 p. 74‑78; 2024 p. 75‑79) reiterate that this policy remains unchanged, with no adjustments to eligibility or the 2026 implementation date, and the company continues to communicate the same effective date to employees.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but misses a key nuance regarding employee eligibility based on hire date. (1) Quantitatively, all dates and implementation details are accurate: the 2026 effective date for the Retirement Value formula is correctly cited, and the reference to consistent disclosure across 2022–2024 10-Ks (with page numbers) supports factual precision. (2) The answer correctly states that there were no changes to eligibility or timeline, which matches the ground truth. However, it omits the important clarification present in the original answer that employees hired after 2014 were already under the Retirement Value formula—a critical detail about current eligibility that evolved in communication from 2023 onward. (3) The reasoning is sound in recognizing the consistency of the 2026 implementation date across years, but fails to synthesize the multi-hop detail about pre- vs. post-2014 hires and the progression in disclosure clarity from 2022 to 2024. (4) Despite this omission, the answer remains contextually relevant and factually accurate on the core point: no changes to the plan or communication around the 2026 date. The missing nuance prevents a perfect score, but the core facts and dates are correct, warranting a high but not full correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 368,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AVGO's outstanding principal balance for its 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 decreased from $1,086 million in fiscal year 2022 to $606 million in fiscal year 2023, and remained unchanged in fiscal year 2024. This indicates a deliberate reduction in this specific debt instrument over time, suggesting a targeted debt repayment or refinancing strategy.",
      "llm_answer": "AVGO’s 5.000 % senior notes due April 2030 had an outstanding principal balance of **$606 million** at the end of FY 2022, FY 2023, and FY 2024 (see the senior‑notes table on pages 101‑105 of the 2022 10‑K, pages 79‑83 of the 2023 10‑K, and pages 79‑83 of the 2024 10‑K). The unchanged balance shows that the company has not repaid or refinanced this instrument, indicating a strategy of maintaining a stable, long‑term debt profile and preserving the favorable interest‑rate and maturity terms until the notes mature in 2030.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claim. According to the ground truth, AVGO's outstanding principal balance for the 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, decreased to $606 million in 2023, and remained at $606 million in 2024. The LLM incorrectly states the balance was $606 million in all three years, missing the reduction from 2022 to 2023 entirely. This error fundamentally undermines the answer. (2) The numbers are not accurate: the 2022 figure is off by $480 million. Even allowing for format variations, the values themselves are wrong. The LLM also cites specific pages in the 10-Ks, which may appear credible but contradict the verified ground truth from the knowledge graph. (3) The multi-hop reasoning is flawed because the model fails to detect the change between 2022 and 2023. As a result, the conclusion about 'stable, long-term debt profile' and 'no repayment or refinancing' is incorrect. The actual progression indicates active debt reduction, which the LLM misinterprets due to incorrect data. (4) While the answer addresses the question's structure and attempts to interpret strategy, the factual foundation is wrong, leading to an incorrect inference. Contextual relevance is moderate because it discusses the right instrument and timeframe, but correctness is severely compromised. Quantitative accuracy is very low due to the incorrect principal balances; qualitative accuracy is low due to flawed reasoning based on wrong data; contextual relevance is acceptable as it stays on topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 434,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, operational restructuring, and eventual divestiture as part of the broader WarnerMedia segment?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, Time Warner was described as a key acquisition completed in June 2018, forming a substantial part of AT&T's WarnerMedia segment. By 2023, the company had already separated the WarnerMedia business via a Reverse Morris Trust transaction with Discovery, which was completed in April 2022, marking the exit from the entertainment content creation space. In 2024, AT&T finalized the divestiture of its remaining interest in DIRECTV, the last major asset tied to the entertainment strategy initiated with the Time Warner acquisition. This trajectory shows a strategic pivot away from vertically integrated media and entertainment back toward core telecommunications and connectivity services.",
      "llm_answer": "AT&T acquired Time Warner in 2018 and folded the company into its WarnerMedia segment. In 2021 AT&T agreed to merge WarnerMedia with Discovery, and by April 2022 the Reverse Morris Trust transaction completed the separation, re‑classifying WarnerMedia as a discontinued operation and divesting the Time Warner assets (2024 10‑K pp. 2‑6; 2023 10‑K pp. 2‑6; 2022 10‑K pp. 3‑7). By 2024 the WarnerMedia business remained a discontinued operation, reflecting the full divestiture of the Time Warner holdings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key events in AT&T's strategic relationship with Time Warner Inc. from 2022 through 2024. It accurately notes the 2018 acquisition, the 2021 agreement to merge WarnerMedia with Discovery, and the completion of the Reverse Morris Trust transaction in April 2022. The classification of WarnerMedia as a discontinued operation is correctly stated and supported by references to the 10-K filings across 2022–2024. However, the LLM omits the 2024 divestiture of DIRECTV, which the original answer identifies as the final step in unwinding the entertainment strategy initiated with the Time Warner acquisition. This is a notable omission in completeness, particularly regarding the 'eventual divestiture as part of the broader WarnerMedia segment' aspect of the question. (2) Quantitatively, all dates (April 2022 completion) and sequence of events are accurate. There are no numerical figures to verify (e.g., dollar amounts), but the timeline is factually correct. The mention of 2021 as the year AT&T agreed to the merger is consistent with public records, even though the original answer focuses on post-2022 developments. (3) The multi-hop reasoning is sound: the LLM connects the acquisition, integration into WarnerMedia, separation via Reverse Morris Trust, and post-divestiture reporting status. However, it fails to fully synthesize the final step involving DIRECTV in 2024, which is part of the broader divestiture narrative. (4) The answer is contextually relevant and well-structured, citing appropriate document sources. The omission of DIRECTV’s 2024 divestiture prevents a top score, but core facts about the WarnerMedia/Time Warner exit are correct. Hence, correctness is rated 8/10, with high marks for accuracy and relevance, docked mainly for incomplete coverage of the divestiture timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 504,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 through 2024, particularly in terms of modeled loss scenarios, reinsurance protections, and geographic attachment points?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management evolved with increasing sophistication in scenario modeling, expanded reinsurance protections, and refined geographic attachment points. In 2022, AIG modeled losses for a five-ton bomb attack in New York City net of TRIPRA and reinsurance, estimating a $1.3 billion loss. In 2023, AIG maintained a focus on scenario-based modeling and highlighted its participation in international terrorism pools and targeted reinsurance purchases. By 2024, AIG had retained core attachment points of $200 million for Japan and $125 million for the rest of the world, indicating a more structured and region-specific approach to international terrorism risk. This progression shows a strategic shift from reactive modeling to proactive geographic risk segmentation and enhanced reinsurance structuring.",
      "llm_answer": "AIG’s approach to international terrorism exposure stayed essentially the same from 2022 through 2024.  In 2022 the company disclosed a specific five‑ton bomb scenario with a $1.3 billion net loss and a $1.7 billion deductible under TRIPRA, which covers 80 % of losses above that deductible【2022 pages 167‑171】.  The 2023 and 2024 10‑Ks repeat that terrorism risk is modeled with third‑party scenarios, that TRIPRA remains the primary reinsurance protection, and that targeted private reinsurance and country terrorism pools are used, but they do not report any new attachment points or changes to the deductible【2023 pages 119‑123】【2024 pages 86‑90】.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct facts but misses key elements of the evolution described in the ground truth. It correctly notes the 2022 five-ton bomb scenario and $1.3 billion net loss, aligning with the original answer. However, it incorrectly claims that AIG’s approach 'stayed essentially the same' from 2022 to 2024, which contradicts the ground truth that describes a strategic shift toward more sophisticated modeling, enhanced reinsurance structuring, and region-specific attachment points by 2024. The LLM fails to mention the $200 million attachment point for Japan and $125 million for the rest of the world in 2024, a critical update indicating geographic risk segmentation. (2) Quantitatively, the $1.3 billion loss is accurate, but the LLM introduces a $1.7 billion deductible under TRIPRA not present in the ground truth; this figure is unsupported and potentially incorrect. The 80% TRIPRA coverage is plausible but not confirmed in the original answer. Other numbers (attachment points) are omitted. (3) The multi-hop reasoning is flawed: while the LLM synthesizes data across years, it draws the wrong conclusion—failing to recognize that the retention of core attachment points in 2024 represents a maturation and structuring of risk, not stagnation. The absence of new disclosures does not imply no evolution. (4) Contextual relevance is strong—the answer addresses terrorism modeling, reinsurance (TRIPRA, private reinsurance, pools), and time progression. However, due to significant omissions and misinterpretation of strategic evolution, especially in 2024, the overall correctness is only partial.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 449,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe-working tools, particularly pipe wrenches, change from 2022 to 2024, and what does this multi-year progression indicate about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's product portfolio for pipe-working tools, including pipe wrenches, expanded in sophistication and integration with battery-powered and diagnostic technologies. In 2022, the company emphasized traditional tools such as pipe wrenches, cutters, threading equipment, and drain cleaners. By 2023, Emerson introduced battery hydraulic tools for press connections and enhanced diagnostic systems like sewer inspection cameras. In 2024, the company maintained this advanced toolset and emphasized digital integration, indicating a strategic shift toward modernizing its professional tools segment to meet evolving industry demands for efficiency, safety, and technological integration.",
      "llm_answer": "Emerson’s 10‑K filings for 2022, 2023 and 2024 all present the same description of its pipe‑working tools line—pipe wrenches, cutters, threading/roll‑grooving equipment, etc.—and make no mention of new introductions or discontinuations (see 2022 p. 7–11 and 2024 p. 71–75).  The unchanged product‑portfolio narrative indicates that Emerson has kept its core pipe‑wrench offering stable, focusing on incremental refinements and customer reliability rather than rapid product innovation.  This steady positioning underscores the company’s strategy to maintain a solid foothold in the professional tools market while prioritizing quality and durability.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that Emerson's product portfolio description remained unchanged across the 2022–2024 10-K filings. The ground truth, derived from actual SEC filings, shows a clear evolution: in 2022, Emerson focused on traditional tools (pipe wrenches, cutters, threading equipment); by 2023, it introduced battery hydraulic tools and diagnostic systems like sewer inspection cameras; and in 2024, it emphasized digital integration. This progression indicates a strategic shift toward technological modernization in the professional tools market. The LLM incorrectly asserts no changes were mentioned in the filings and interprets this (falsely) as a strategy of stability and incremental refinement. This contradicts the ground truth, which shows active portfolio advancement. While the LLM correctly identifies the presence of core tools like pipe wrenches and references appropriate sections of the 10-Ks, it fails to detect or report the multi-year innovation trajectory. There are no numerical figures to verify, so quantitative accuracy is not applicable—no numbers were misstated. However, the qualitative reasoning is flawed: the model did not correctly synthesize the multi-hop progression across years and mischaracterized Emerson’s strategy. The answer is contextually relevant (it addresses Emerson, pipe-working tools, and strategy) but factually inaccurate in its central claim, resulting in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 403,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from 2022 through 2024, particularly in terms of recognition methodology and its impact on right-of-use asset valuation?",
      "original_answer": "Costco consistently applied a straight-line recognition methodology for free-rent periods and step-rent provisions across all three years (2022–2024), recognizing these on a straight-line basis over the original lease term and any extension options the company is reasonably certain to exercise. However, in 2022, the company explicitly disclosed its use of discounted future minimum lease payments to initially record right-of-use (ROU) assets and lease obligations, using its incremental borrowing rate derived from quoted interest rates. This detailed explanation of the discounting process and ARO (asset retirement obligation) treatment was not repeated in the 2023 and 2024 filings, suggesting a shift toward more standardized ASC 842 compliance language without elaborating on the valuation mechanics. While the core accounting policy remained stable, the depth and specificity of disclosure around ROU asset valuation decreased over time, indicating a possible maturation of lease accounting practices post-adoption period.",
      "llm_answer": "Costco has consistently treated free‑rent periods as lease incentives, recognizing them on a straight‑line basis over the lease term and any reasonably certain extensions. The present value of the free‑rent period is deducted from the lease liability, so the right‑of‑use (ROU) asset is initially measured net of the incentive, lowering its carrying amount. This accounting treatment and disclosure remained unchanged in the 2022, 2023, and 2024 10‑K filings.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in its description of Costco's accounting treatment for free-rent periods, correctly stating the use of straight-line recognition over the lease term and reasonably certain extensions, and the impact on ROU asset valuation via deduction of lease incentives from the initial measurement. There are no numeric inaccuracies, and the entities (Costco, 2022–2024, ROU assets, lease incentives) are correctly identified, supporting a high quantitative accuracy score. However, the answer fails to capture a key qualitative distinction present in the ground truth: the evolution of disclosure depth over time. While the core accounting policy remained consistent, the original answer highlights that Costco provided detailed disclosures in 2022 about the use of discounted future lease payments and incremental borrowing rates in measuring lease liabilities and ROU assets—details omitted in 2023 and 2024. The LLM incorrectly asserts that the 'disclosure remained unchanged,' which contradicts the ground truth indicating a reduction in disclosure specificity post-2022. This omission represents a significant gap in qualitative accuracy, particularly regarding the 'evolution' aspect of the question, which is multi-hop and requires comparing disclosure practices across years. The reasoning is sound on policy application but incomplete on disclosure trends, undermining full synthesis. Contextual relevance is high as the response addresses the core accounting treatment, but misses the temporal evolution in transparency, which is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 433,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Microsoft's issuance of 2.000% Notes evolve across 2022, 2023, and 2024, particularly in terms of maturity timelines and associated indenture documentation?",
      "original_answer": "Microsoft's 2.000% Notes were referenced consistently across 2022, 2023, and 2024 filings, showing a stable inclusion within the company's long-term debt structure under the same indenture framework. In 2022, the 2.000% Notes were listed under the Eleventh Supplemental Indenture dated August 8, 2016, with a maturity of 2023. By 2023, the same note was still referenced under identical documentation, indicating no structural changes. In 2024, the 2.000% Notes due 2023 were still present in the exhibit list, suggesting that while the maturity date had passed, the documentation remained part of the company's historical indentures. This shows a consistent debt instrument with no modifications across the three years.",
      "llm_answer": "In 2022 Microsoft’s 2.000 % Notes were due 2020 and were governed by the Tenth Supplemental Indenture (Exhibit 4.13). In 2023 the company issued new 2.000 % Notes due 2023, documented under the Eleventh Supplemental Indenture (Exhibit 4.14). By 2024 Microsoft had shifted away from the 2.000 % series, issuing 2.875 % Notes due 2024 under the Twelfth Supplemental Indenture (Exhibit 4.15) rather than new 2.000 % Notes.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Microsoft's 2.000% Notes had a maturity date of 2023 and were governed by the Eleventh Supplemental Indenture dated August 8, 2016, consistently referenced across 2022, 2023, and 2024. However, the LLM incorrectly states that in 2022 the notes were due in 2020, which contradicts the ground truth. It also falsely claims that new 2.000% Notes were issued in 2023 and that Microsoft shifted to 2.875% Notes in 2024, none of which is supported by the original answer. (2) Quantitative accuracy is very low: the maturity years (2020, 2023, 2024), interest rates (2.875%), and exhibit numbers (4.13, 4.14, 4.15) are all incorrect or fabricated. The correct documentation is the Eleventh Supplemental Indenture (Exhibit 4.14) for the 2.000% Notes due 2023, not multiple different indentures. (3) The multi-hop reasoning is flawed: instead of recognizing the consistent presence of the same debt instrument across years, the model invents a narrative of issuance changes and rate shifts, failing to synthesize the stability of the indenture and maturity timeline. (4) Contextual relevance is moderate because the answer addresses the general topic of Microsoft's notes and indentures, but the specific evolution described is entirely incorrect, undermining factual and qualitative accuracy. The core message of stability in the original answer is completely missed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 404,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Amazon's revenue recognition for third-party seller services evolve from 2022 through 2024, particularly in terms of the timing and composition of revenue from commissions and fulfillment fees?",
      "original_answer": "In 2022, Amazon disclosed that it earns revenue from seller programs through fixed fees, a percentage of sales, per-unit activity fees, and interest. In 2023, the company specified that commissions and related fulfillment and shipping fees are recognized as revenue when services are rendered, typically upon delivery of products to a third-party carrier or directly to the customer. In 2024, Amazon continued offering similar seller programs, reinforcing its commitment to enabling sellers to grow through its platform, although specific changes in revenue recognition timing were not mentioned. The evolution shows a consistent approach to revenue recognition tied to service delivery, with increasing clarity in disclosures over time.",
      "llm_answer": "Amazon continued to recognize third‑party seller services revenue when the services were rendered—generally at the point the seller’s products are delivered to a third‑party carrier or to the customer for an Amazon delivery (2022 p. 1‑5; 2023 p. 41‑45; 2024 p. 1‑5).  The revenue composition remained the same across the three years: commissions plus related fulfillment and shipping fees.  No change in the timing or allocation of those components was disclosed in the 2022‑2024 filings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that Amazon recognizes revenue from third-party seller services when services are rendered, specifically upon delivery to a carrier or customer, which matches the 2023 disclosure in the original answer and is consistent with 2022 and 2024. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not compromised—no errors in dates or financial figures. (3) The multi-hop reasoning is sound: the LLM synthesizes information across 2022–2024 filings, correctly identifying consistency in revenue recognition timing and composition (commissions, fulfillment, and shipping fees). It accurately notes no disclosed changes in timing or allocation, which is consistent with the original answer’s observation that no specific changes were mentioned in 2024. (4) The only minor shortcoming is that the LLM does not explicitly acknowledge the evolution in disclosure clarity over time (e.g., increasing specificity from 2022 to 2023), which is a nuance highlighted in the original answer. However, this does not constitute a factual error, just a slight omission in qualitative depth. Overall, the answer is factually correct, contextually relevant, and demonstrates strong reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 373,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What does AT&T's continued guarantee of Southwestern Bell Telephone Co.'s obligations in 2022, 2023, and 2024 suggest about its long-term liability management strategy for legacy telecom entities?",
      "original_answer": "AT&T consistently guaranteed Southwestern Bell Telephone Co.'s obligations across all three years, as evidenced by the repeated inclusion of Exhibit 4-b in its 10-K filings for 2022, 2023, and 2024. This unchanging commitment suggests a deliberate and stable strategy for managing legacy telecom liabilities, with no indication of reduction or restructuring of these obligations over the three-year period. The persistence of this guarantee language across filings indicates that AT&T has maintained full financial responsibility for these legacy entities without altering the terms or scope of its commitments.",
      "llm_answer": "AT&T’s continued guarantee of Southwestern Bell Telephone Co.’s obligations through 2024 reflects a deliberate strategy of retaining long‑term support for legacy telecom liabilities. By maintaining the guarantee, AT&T signals that it is willing to absorb potential future defaults or restructuring costs for its former subsidiaries, thereby preserving credit stability and protecting the interests of bondholders and other stakeholders. This approach indicates a preference for steady, predictable liability management over divesting or restructuring legacy obligations, ensuring that legacy telecom entities remain financially backed as they transition out of AT&T’s core operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All entities—AT&T, Southwestern Bell Telephone Co., and the years 2022, 2023, and 2024—are correctly identified, and there are no numerical inaccuracies, as the focus is on qualitative interpretation rather than specific dollar amounts. (2) The quantitative accuracy is perfect: the time frame (2022–2024) matches the original answer, and no calculations are required. (3) The multi-hop reasoning is sound: the LLM correctly infers from the repeated guarantee (implied by consistent Exhibit 4-b inclusion in 10-Ks) that AT&T maintains a stable, long-term liability strategy for legacy entities. While the original answer emphasizes the lack of change or restructuring, the LLM appropriately interprets this as a deliberate, steady strategy, adding reasonable context about credit stability and stakeholder protection. (4) The LLM adds slight interpretive depth (e.g., 'absorb potential future defaults', 'protecting bondholders') not explicitly in the ground truth, but these are logically consistent and do not contradict it. The only minor gap is the absence of explicit reference to Exhibit 4-b as evidence, which slightly reduces qualitative precision, but the core reasoning and conclusion remain correct. Thus, the answer is factually sound, fully relevant, and semantically equivalent in intent and meaning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 384,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Johnson & Johnson's investment in its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "Johnson & Johnson's investment in its 2.250% Notes due 2050 remained relatively stable across the three years: $983 million in 2022, $826 million in 2023, and $808 million in 2024. The consistent presence of this debt instrument over time suggests a deliberate long-term capital structure strategy, with only minor reductions in exposure. This gradual decline may reflect a cautious approach to managing long-dated liabilities while maintaining a stable cost of capital at a fixed effective rate of 2.29% throughout the period.",
      "llm_answer": "Johnson & Johnson’s 2.250% Notes due 2050 declined from $983 million at the end of 2022 to $826 million in 2023 and $808 million in 2024, reflecting a gradual repayment of that tranche. The steady drop, while keeping the effective rate at 2.29 %, shows the company’s disciplined approach to managing maturity risk and maintaining a low‑cost, long‑term debt base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all numerical values: $983 million in 2022, $826 million in 2023, and $808 million in 2024, matching the ground truth exactly. The effective interest rate of 2.29% is also accurately stated. These figures are consistent with the original answer, and formatting variations (e.g., using ' ' as a thousands separator) do not affect accuracy.\n\n2) Quantitatively, all numbers are correct and properly sequenced across years. The description of a 'gradual repayment' aligns with the observed decline, and no calculations were required beyond interpretation of trends, which is sound.\n\n3) The reasoning is logically sound and captures the essence of Johnson & Johnson's long-term debt strategy: maintaining a stable, low-cost debt base while prudently reducing long-dated liabilities. The LLM correctly infers a 'disciplined approach to managing maturity risk,' which is semantically equivalent to the ground truth's 'deliberate long-term capital structure strategy' and 'cautious approach.' The only minor shortcoming is the absence of the phrase 'consistent presence of this debt instrument over time,' which slightly weakens the emphasis on strategic stability, but the core inference remains valid.\n\n4) The answer is fully contextually relevant, addressing both parts of the question: the evolution of the investment in the notes (declining balance) and what it indicates about long-term debt strategy. It synthesizes multi-hop information (values across years and interest rate consistency) correctly. The conclusion is concise and aligned with the evidence.\n\nOverall, the LLM answer is factually accurate, well-reasoned, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy for not fully emphasizing the strategic continuity implied by retaining the instrument over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 503,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Costco's long-term debt structure evolve from 2022 through 2024 with respect to its 1.375% Senior Notes due June 2027, and what does this reveal about the company's capital management strategy?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained constant at $1,250 million in 2022, 2023, and 2024, indicating that the company did not alter its principal exposure to this specific debt instrument over the three-year period. However, the broader long-term debt structure changed, with total long-term debt decreasing from $6,590 million in 2022 to $6,484 million in 2023, and further declining to $5,919 million in 2024. This trend shows a gradual reduction in overall debt burden while maintaining exposure to the 1.375% Senior Notes, suggesting a selective capital management strategy that prioritized repayment of other debt tranches rather than refinancing or retiring this fixed-rate obligation.",
      "llm_answer": "Costco’s 1.375 % Senior Notes due June 2027 stayed at a carrying amount of $1.25 billion in 2022, 2023 and 2024 (Note 4‑Debt, pages 52–54). The maturity schedule shows the notes due in 2027 (2025‑2027 schedule, pages 53–54). This unchanged balance indicates that Costco has not issued additional 1.375 % notes or redeemed them, reflecting a conservative capital‑management strategy that keeps a stable, low‑interest long‑term debt profile to support growth while preserving liquidity (Note 4‑Debt, pages 52–54).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the 1.375% Senior Notes due June 2027 remained constant at $1.25 billion (i.e., $1,250 million) across 2022, 2023, and 2024, which matches the ground truth exactly. The maturity date and interest rate are also accurate. (2) All numeric values—$1.25 billion, 1.375%, June 2027—are factually correct and consistent with the original answer; no calculation errors are present. (3) However, the LLM answer fails to incorporate the broader evolution of Costco’s total long-term debt, which decreased from $6,590 million in 2022 to $6,484 million in 2023 and $5,919 million in 2024. This omission limits the multi-hop reasoning required to fully assess the capital management strategy. The original answer draws a key insight: while total debt declined, the 1.375% notes were preserved, indicating selective repayment of other tranches. The LLM instead infers a general 'conservative strategy' based only on the stability of the 1.375% notes, missing the comparative context. (4) The answer is contextually relevant and well-supported with footnote references, but the qualitative reasoning is incomplete due to lack of synthesis between the specific notes and overall debt trend. Hence, correctness is reduced to 7 for missing a core component of the multi-hop analysis, though quantitative accuracy remains perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 379,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Mastercard's multi-layered security approach evolve alongside its real-time payments infrastructure expansion from 2022 to 2024, and what does this parallel development suggest about the company's strategy for managing payment processing risk as it scaled globally?",
      "original_answer": "In 2022, Mastercard described a multi-layered security approach that included a robust program to protect its network from cyber threats, with multiple layers of protection across its platforms, and noted it was operating or implementing real-time payments infrastructure in 12 of the top 50 GDP markets as of December 31, 2021. By 2023, the company had expanded its real-time payments infrastructure to 13 markets and reiterated its multi-layered security framework, emphasizing third-party assessments and partnerships to address threats, including those from third-party providers. In 2024, while continuing to describe the same multi-layered security approach, Mastercard noted it was operating real-time payments infrastructure in 'several countries around the world,' signaling a qualitative shift toward broader global deployment. This parallel evolution suggests that Mastercard has intentionally scaled its security capabilities in tandem with its real-time payments infrastructure, aiming to maintain trust and integrity in the ecosystem as it expands into new markets, though the filings do not explicitly state that security measures directly enabled infrastructure expansion.",
      "llm_answer": "From 2022 to 2024 Mastercard expanded its real‑time payments infrastructure from 12 to 13 markets and continued to grow, while its multi‑layered security program deepened—adding more cyber‑resilience layers, third‑party assessments, advanced fraud‑scoring and tokenization, AI‑driven privacy controls, and formal technical standards with issuers, acquirers and industry partners. This parallel evolution shows the company is deliberately scaling risk management in tandem with network expansion, embedding robust, evolving security and governance into every new payment channel as it scales globally.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly states that Mastercard expanded its real-time payments infrastructure from 12 to 13 markets between 2022 and 2023, aligning with the ground truth. However, it inaccurately implies continued quantitative expansion beyond 13 markets, while the 2024 filing only refers to 'several countries around the world'—a qualitative, not numerical, update. The LLM also fabricates specific security enhancements such as 'advanced fraud-scoring and tokenization, AI-driven privacy controls, and formal technical standards with issuers, acquirers and industry partners,' which are not mentioned in the original answer or supported by the knowledge graph. (2) Quantitatively, the 12-to-13 market expansion is accurate for 2022–2023, but the answer misrepresents the 2024 status by suggesting ongoing numerical growth when no such data is provided. There are no calculations in the response, so scoring focuses on factual number accuracy. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that security and infrastructure expansion are parallel developments. However, it overreaches by asserting specific new security features and implying causation or integration (e.g., 'embedding robust, evolving security into every new payment channel') that the original answer does not support. The ground truth explicitly notes that filings do not state security measures directly enabled expansion, which the LLM overlooks. (4) The contextual relevance is high because the answer addresses both parts of the question—evolution of security and infrastructure, and strategic implications. However, the qualitative inaccuracy of invented details and overconfident synthesis reduces correctness. The core idea of parallel scaling is preserved, but with unsupported embellishments, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 513,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Microsoft's issuance of debt instruments related to the 4.000% Notes due 2021 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 across all three fiscal years (2022, 2023, and 2024) as part of its broader debt structure under the Indenture dated May 18, 2009. In 2022, the Third Supplemental Indenture was listed as Exhibit 4.6 in the 10-K filing, reaffirming the company’s ongoing obligations tied to this note. In 2023, the same instrument was again referenced under the same exhibit number and description, indicating no structural changes. By 2024, despite the note being past its maturity date, Microsoft continued to disclose the 4.000% Notes due 2021 in its exhibit list, suggesting either a delayed settlement, rollover, or ongoing disclosure requirement. This pattern indicates a consistent and transparent approach to debt disclosure, even post-maturity, and suggests disciplined long-term debt management.",
      "llm_answer": "Microsoft issued the 4.000% Notes due 2021 in 2011 under the Third Supplemental Indenture (4.6). The notes matured in 2021, and by FY 2022 the company had fully retired them, leaving a zero balance on the debt schedule; the 2023 and 2024 10‑Ks likewise show no outstanding 4.000% Notes due 2021. This pattern demonstrates Microsoft’s disciplined debt‑maturity management, consistently retiring maturing debt and maintaining a low long‑term debt profile【4.6】【MSFT_10k_2022 pages 102‑106】【MSFT_10k_2023 pages 102‑106】【MSFT_10k_2024 pages 102‑106】.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that Microsoft fully retired the 4.000% Notes due 2021 by FY2022. The ground truth states that Microsoft continued to reference these notes in its 10-K filings for 2022, 2023, and 2024, including as Exhibit 4.6, indicating ongoing disclosure or unresolved status post-maturity. The LLM incorrectly asserts a zero balance and full retirement, which contradicts the ground truth. (2) Quantitatively, the LLM fabricates a retirement timeline (matured in 2021, retired by FY2022) not supported by the evidence. The original answer notes the note was past maturity by 2024 but still disclosed, suggesting rollover or delayed settlement—information absent and misrepresented in the LLM response. The citation of 'pages 102–106' and exhibit numbers may appear accurate, but the interpretation is flawed. (3) The multi-hop reasoning fails: the LLM does not correctly synthesize the pattern of continued disclosure across years, which is central to the question. Instead, it assumes silence on outstanding balance equals retirement, which is not justified by the data. The original answer emphasizes transparency and post-maturity disclosure as indicators of strategy; the LLM misattributes this to debt reduction. (4) Contextual relevance is moderate—the response addresses debt management strategy and cites relevant documents, but the factual foundation is incorrect, leading to a misleading conclusion. The strategy described (retiring debt, low long-term debt) is plausible but not supported by the specific evidence provided in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 442,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What does Amazon's consistent reference to the 1.500% Note due 2030 across multiple years indicate about its long-term capital structure strategy, particularly when compared to its other debt instruments?",
      "original_answer": "Amazon's consistent reference to the 1.500% Note due 2030 across its 2022, 2023, and 2024 filings indicates a strategic emphasis on long-dated, fixed-rate debt as part of its capital structure. In 2022, the Note was introduced as part of a broader issuance that included instruments maturing as far out as 2060, signaling Amazon's intent to lock in favorable borrowing terms over extended horizons. In 2023, the Note was reiterated alongside newer instruments such as the 4.700% Note due 2024, which suggests that Amazon was simultaneously managing near-term obligations while maintaining a presence in the long-term debt market. In 2024, the continued inclusion of the 1.500% Note due 2030 amidst newer, higher-yielding instruments like the 4.700% Note due 2032 highlights a deliberate balance between leveraging low-cost capital from earlier issuances and adapting to current market rates for new borrowings. This approach reflects a layered debt maturity profile that mitigates refinancing risk and supports long-term investment in infrastructure and innovation.",
      "llm_answer": "Amazon’s repeated mention of the 1.500% Note due 2030 in its 10‑K filings (see the Officer’s Certificate of June 3 2020 referenced in the 2022, 2023 and 2024 reports) signals that the company treats this long‑term, low‑coupon debt as a core, stable component of its capital structure. By keeping a consistent 1.5% long‑term note in its debt mix, Amazon balances a low‑cost, long‑duration source of capital against higher‑rate or shorter‑maturity instruments, providing a diversified debt profile and a benchmark for future refinancing decisions【AMZN_10k_2022.pdf: 69‑73】【AMZN_10k_2023.pdf: 73‑77】【AMZN_10k_2024.pdf: 72‑76】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All numeric values—'1.500% Note due 2030', references across 2022, 2023, and 2024 filings—are correct and consistent with the original answer. The mention of the Officer’s Certificate of June 3, 2020, while not in the ground truth, is contextually plausible and does not contradict any facts. (2) Quantitative accuracy is perfect: percentages, years, and document references (e.g., page ranges in 10-Ks) are correctly cited. (3) The multi-hop reasoning is sound: the LLM correctly infers that Amazon’s repeated disclosure of this note reflects a strategic use of long-term, low-cost debt as a stable capital component, and it appropriately contrasts this with higher-rate or shorter-term instruments. It captures the essence of a layered maturity profile and risk mitigation, though it does not explicitly mention the comparison to the 4.700% Note due 2032 or the broader 2060 maturity referenced in the ground truth, which slightly reduces qualitative completeness. (4) Contextual relevance is excellent—the answer directly addresses Amazon’s capital structure strategy and the role of this specific debt instrument over time. The core insight about balancing low-cost long-term debt with other instruments matches the ground truth’s conclusion. Minor omission of specific comparative instruments prevents a perfect 10, but the answer remains factually correct and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 400,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AT&T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about AT&T's broader divestiture strategy in international pay-TV markets?",
      "original_answer": "AT&T maintained a 41.3% interest in SKY Mexico in 2022 and accounted for it under the equity method in 2023, but exited the investment completely in mid-2024. This progression reflects a deliberate divestiture strategy targeting non-core international assets. In 2022, AT&T explicitly stated its continued ownership stake in SKY Mexico following the sale of Vrio. By 2023, SKY Mexico was still part of AT&T’s equity method investments alongside DIRECTV and Gigapower. In 2024, AT&T finalized the sale of its 41.3% stake in SKY Mexico, completing its exit from the Mexican pay-TV market. The 3-year evolution shows a phased approach to shedding international media assets, aligning with broader strategic refocusing on core U.S. telecommunications operations.",
      "llm_answer": "From 2022 through 2023 AT&T held a 41.3 % minority stake in SKY Mexico, which it accounted for under the equity method and reported equity in net income of affiliates (T_10k_2022.pdf: 94; T_10k_2023.pdf: 68). In June 2024 the company sold that stake, removing the equity‑method investment from its books and ending its presence in the Mexican pay‑TV market (T_10k_2024.pdf: 66–68). This three‑year path underscores AT&T’s broader strategy of divesting non‑core international pay‑TV assets to streamline its portfolio and focus on U.S. and streaming operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies AT&T's 41.3% ownership stake in SKY Mexico in 2022 and 2023, the equity method accounting treatment, and the June 2024 exit via sale—matching all key facts in the ground truth. The only minor omission is that the original answer notes AT&T's explicit post-Vrio sale confirmation of continued ownership in 2022 and mentions DIRECTV and Gigapower as other equity-method investments in 2023, which adds slight contextual depth not fully captured. (2) Quantitatively, all numbers and dates are accurate: 41.3% stake, equity method in 2022–2023, exit in mid-2024 (specified as June 2024). No calculations are required, and all financial reporting references (e.g., T_10k_2022.pdf: 94) align with plausible sourcing. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes ownership duration, accounting treatment, and divestiture timing across three years and links them to a broader strategic shift. It infers the strategic rationale (focusing on U.S. and streaming operations) consistent with the original answer’s emphasis on core U.S. telecommunications. (4) The answer is semantically equivalent and highly contextually relevant. The phrasing 'streamline its portfolio and focus on U.S. and streaming operations' is a valid rewording of 'strategic refocusing on core U.S. telecommunications operations.' The inclusion of document citations enhances credibility. The qualitative score is 9 due to slightly less contextual detail on Vrio and peer equity investments, but the core reasoning and facts are fully intact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 433,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target allocations for 2022, 2023, and 2024 reveal about the company's de-risking strategy in response to changes in the plan's funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan demonstrated a consistent de-risking strategy across the three years, with increasing emphasis on liability-hedging assets as the plan's funded status improved. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021, and reflected a glide path that reduced growth assets as the funded ratio increased. By 2023, the target allocation for 2024 was based on the funded status at December 31, 2023, showing further reductions in growth assets and increased allocations to liability-hedging assets. In 2024, the glide path continued this trend, with the target allocation for 2025 based on the funded status at December 31, 2024, reinforcing the company's strategy of de-risking as the plan became more fully funded. This consistent evolution indicates that AIG is methodically adjusting its investment strategy in alignment with liability-driven investing principles.",
      "llm_answer": "AIG’s glide‑path strategy has remained a liability‑driven, return‑seeking framework that “reduces growth assets and increases liability‑hedging assets as the plan’s funded ratio improves” (see the 2022, 2023 and 2024 10‑Ks).  The target mix moved from 15 % equity, 75 % fixed‑maturity and 10 % other in 2022 (target) to 8 % equity, 77 % fixed‑maturity and 15 % other in 2023 (actual) and to a 2024 target of 9 % equity, 80 % fixed‑maturity and 11 % other, showing a deliberate de‑risking: equity exposure fell while fixed‑maturity holdings rose as the plan became better funded.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the correct de-risking trend and overall strategy described in the ground truth, showing awareness of AIG's liability-driven investment approach and the reduction in growth assets as funded status improved. However, there are significant quantitative inaccuracies that undermine the correctness. The LLM states a 2022 target allocation of 15% equity, 75% fixed-maturity, and 10% other, but the ground truth does not provide these specific numbers, and more critically, the 2023 'actual' allocation is incorrectly presented as a target—this misrepresents the glide path mechanism, which is based on forward-looking targets derived from prior-year funded status. The 2024 target of 9% equity contradicts the de-risking trend if coming from an 8% 2023 level, and the use of 'other' increasing then decreasing lacks support. The ground truth emphasizes that target allocations are set based on year-end funded status for future years (e.g., 2023 funded status sets 2024 target), but the LLM fails to articulate this multi-hop logic clearly, instead presenting a year-by-year comparison without explaining the lagged trigger mechanism. While the qualitative direction of de-risking is correct and contextually relevant, the incorrect numbers and muddled timeline of targets vs. actuals reduce quantitative accuracy. The reasoning is partially sound but lacks precise synthesis across years and documents, leading to a partially correct answer with notable flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 406,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Mastercard's credit risk mitigation strategies evolve from 2022 to 2024 in response to increasing regulatory scrutiny and litigation risks, and what does this reveal about the company's risk management adaptability?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers not meeting risk standards to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees. However, the context in which these strategies were applied changed significantly. In 2022, the company emphasized its regular monitoring of the credit risk portfolio and the adequacy of risk mitigation arrangements. By 2023, amid the FTC's finalized consent agreement over debit routing compliance and the initiation of a DOJ antitrust investigation into its U.S. debit program, Mastercard reiterated its commitment to revising settlement exposure estimates and risk standards as necessary. In 2024, with the DOJ investigation ongoing and new legal challenges such as the U.S. Liability Shift Litigation and a European Commission investigation into anti-competitive behavior, the company continued to refine its risk management methodology. Despite these pressures, Mastercard consistently reported a low level of losses from customer settlement failures across all three years, indicating that its core credit risk strategies remained effective even as external risks escalated.",
      "llm_answer": "From 2022 to 2024 Mastercard raised its risk‑mitigation buffers for settlement exposure from $9.2 bn to $13.5 bn (a 46 % increase) while net settlement exposure climbed from $55.7 bn to $64.9 bn, reflecting a proactive scaling of credit‑risk safeguards amid mounting litigation and regulatory scrutiny. The company maintained its policy of requiring cash collateral, letters of credit, and guarantees for non‑compliant merchants and expanded its derivative hedging program to cover foreign‑currency and interest‑rate risk, thereby reinforcing its credit‑risk framework. These adjustments demonstrate Mastercard’s agile, data‑driven risk‑management approach that quickly adapts credit‑risk buffers to evolving legal and regulatory pressures.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative claims. The ground truth does not mention any specific dollar amounts for risk-mitigation buffers, settlement exposure, or percentage increases (e.g., $9.2B to $13.5B, 46% increase, $55.7B to $64.9B). These figures are entirely fabricated and not supported by the original answer or the underlying knowledge graph. There is no mention of derivative hedging programs covering foreign-currency or interest-rate risk in the original answer, making this addition incorrect. (2) The quantitative accuracy is very low because all cited numbers are false. Even if formatting variations are allowed, the absence of any such data in the ground truth makes these figures indefensible. Calculations based on them (like the 46% increase) are therefore also invalid. (3) The qualitative reasoning is partially sound in that the LLM correctly identifies the increasing regulatory and litigation pressures Mastercard faced from 2022 to 2024, including references to DOJ and FTC actions (though not explicitly named in the LLM answer). It also correctly notes the use of cash collateral, letters of credit, and guarantees as risk mitigation tools. However, it fails to accurately reflect the continuity of Mastercard’s core credit risk framework, instead implying a proactive scaling of buffers that is not substantiated. The original answer emphasizes consistency in strategy despite external pressures, whereas the LLM suggests active expansion of safeguards, which contradicts the ground truth. (4) Contextual relevance is moderate because the LLM addresses the general theme of evolving risk strategies under regulatory pressure and attempts to demonstrate adaptability. However, the invented metrics and misrepresentation of strategic evolution undermine the answer’s reliability. The conclusion about an 'agile, data-driven approach' is speculative and not directly supported by the original answer, which instead highlights stability and effectiveness of existing controls.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 555,
        "total_tokens": 2070
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the availability of shares for future grants under The Home Depot's Omnibus Stock Incentive Plan evolve from 2022 to 2024, and what does this trend suggest about the company's stock-based compensation strategy?",
      "original_answer": "In 2022, 117 million shares were available for future grants under the 2005 Plan. By 2023, this number had decreased to 77 million shares under the newly amended Omnibus Plan as of January 28, 2024. In 2024, the availability further declined to 70 million shares as of February 2, 2025. This consistent reduction in available shares suggests that the company has been actively issuing stock-based compensation, potentially signaling increased reliance on equity incentives to retain and motivate associates and directors over the three-year period.",
      "llm_answer": "At January 30, 2022 Home Depot reported about 117 million shares available for future grants under its 2005 Omnibus Stock Incentive Plan [HD_10k_2022, pp. 65‑69]. By January 28, 2024 that pool had shrunk to roughly 77 million shares under the Omnibus Plan [HD_10k_2024, pp. 67‑71]. The downward trend indicates a tightening of the equity award pool, suggesting the company is adopting a more disciplined, performance‑aligned stock‑based compensation strategy to manage dilution and reward performance.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 117 million shares available in 2022 and 77 million in 2024, matching the ground truth. However, it omits the 2024 figure of 70 million shares as of February 2, 2025, which is a significant gap in completeness. The dates are slightly misaligned: 'January 30, 2022' is correct for the 2022 report, but the 77 million shares are reported as of January 28, 2024 (for the 2023 fiscal year), not reflecting the 2024 data point. (2) Quantitatively, the two provided numbers are accurate and properly cited, but the missing 70 million figure for 2024 undermines full numerical accuracy. The trend description is directionally correct (downward), but incomplete without the latest data. (3) The reasoning is partially sound but draws a different conclusion than the ground truth: while the ground truth suggests increased reliance on equity compensation due to declining shares, the LLM infers a more 'disciplined, performance-aligned' strategy, which contradicts the implication of growing usage. This misrepresents the strategic interpretation, weakening the qualitative accuracy. (4) The answer is contextually relevant and well-structured, addressing both the evolution and strategic implication, but the omission of a key data point and flawed strategic inference reduce correctness. Overall, core facts are mostly right, but missing data and incorrect reasoning on strategy limit the score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 399,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Broadcom's (AVGO) financial obligations related to its 3.625% notes due October 2024 evolve across fiscal years 2022, 2023, and 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal year 2022, Broadcom reported a $622 million obligation for the 3.625% notes due October 2024. This amount remained unchanged in fiscal year 2023, indicating no repayments or modifications during that period. However, by fiscal year 2024, the obligation associated with these notes had dropped to $0, signaling full repayment or restructuring of the instrument. This progression indicates a deliberate debt management strategy where Broadcom addressed the near-term maturity by eliminating the liability ahead of its October 2024 due date.",
      "llm_answer": "Broadcom’s 3.625% senior notes due October 2024 carried a principal balance of **$622 million** as of October 29 2023 (unchanged from 2022) and were scheduled to mature in October 2024, leaving no outstanding balance thereafter【2024‑10‑K table “April 2019 Senior Notes – fixed rate” – 3.625% notes due October 2024, 622 million】.  The company did not redeem or refinance this instrument early – the principal remained unchanged through 2023 and the notes were held to maturity – indicating a conservative debt‑management approach that prefers to retire debt at its scheduled maturity rather than seek lower‑cost refinancing.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $622 million obligation for the 3.625% notes due October 2024 in both fiscal years 2022 and 2023, and correctly states that the balance dropped to $0 after October 2024, aligning with the ground truth. The dates and dollar amounts are factually accurate, satisfying quantitative accuracy. (2) All numeric values—$622 million, October 2024 maturity—are correct and match the original answer. There are no calculation errors. (3) However, the reasoning about Broadcom’s debt management strategy diverges from the ground truth. While the original answer interprets the drop to $0 as evidence of full repayment or restructuring ahead of the due date (implying proactive management), the LLM asserts the company 'did not redeem or refinance early' and instead 'held to maturity,' characterizing it as conservative. This contradicts the implication of proactive liability elimination in the ground truth. The LLM may conflate 'held to maturity' with no prior action, but the knowledge graph indicates the obligation was cleared by FY2024, which could still involve repayment at maturity—but the strategic interpretation differs. (4) The answer is contextually relevant and complete in covering all parts of the question: evolution across years and strategic interpretation. However, the qualitative inaccuracy in reasoning—assigning a conservative strategy without evidence of intent, and negating refinancing or early action without explicit support—lowers the qualitative accuracy. Quantitative accuracy is perfect, and contextual relevance is high due to proper entity alignment and coverage.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 448,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, divestiture planning, and final exit strategy, and what does this progression reveal about T's shifting focus in the entertainment and telecommunications sectors?",
      "original_answer": "In 2022, T still held Time Warner Inc., which had been acquired in 2018 and was a core component of its WarnerMedia segment. By 2023, T had completed the separation of WarnerMedia in a Reverse Morris Trust transaction with Discovery, marking a strategic pivot away from entertainment and back toward core telecommunications. In 2024, T finalized its exit from the entertainment sector by agreeing to sell its remaining interest in DIRECTV to TPG, signaling a full retreat from the media investments initiated with the Time Warner acquisition. This trajectory reveals a multi-year strategic reversal, moving from aggressive vertical integration in media and entertainment back to a more focused telecom and connectivity business.",
      "llm_answer": "By 2022, AT&T had already folded Time Warner into its WarnerMedia segment and was executing a divestiture plan that culminated in a Reverse Morris Trust transaction with Discovery, fully separating WarnerMedia and ending its ownership stake (2022 10‑K, pp. 3‑7). The 2023 10‑K (pp. 2‑6) confirms the separation as a discontinued operation, and the 2024 10‑K (pp. 2‑6) reports that AT&T has sold its remaining interest in DIRECTV to TPG, completing its exit from legacy media assets. This sequence underscores AT&T’s strategic pivot from a diversified media conglomerate toward a telecom‑centric focus on connectivity, fiber, 5G, and direct‑to‑consumer content distribution.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: T (AT&T) held Time Warner via WarnerMedia until executing a Reverse Morris Trust with Discovery, completed in 2022 (not 2023 as implied in the original answer’s timeline but correctly cited in LLM’s reference to 2022 10-K). The LLM correctly notes the separation was reported in the 2022 10-K (pp. 3–7), treated as discontinued operations in 2023, and the DIRECTV sale to TPG finalized in 2024. (2) There are no numeric inaccuracies—dates, transaction types, and asset dispositions are correctly represented. The mention of 2022 as the year of the Reverse Morris Trust is consistent with SEC filing timelines, even if the deal closed in early 2022; the original answer’s phrasing 'by 2023' is slightly ambiguous but not necessarily incorrect. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-Ks, correctly identifying the divestiture planning (2022), completion (2023 reporting), and final exit via DIRECTV (2024). (4) The strategic pivot from media back to telecom is accurately interpreted, with added value in specifying focus areas like fiber, 5G, and direct-to-consumer distribution, which enriches the conclusion without distorting the core message. The only minor issue is the slight compression of the WarnerMedia separation timing—while the transaction closed in April 2022, the 2023 10-K reflects it as a completed discontinued operation, so attributing the 'completion' to 2022 is defensible but could be more precisely framed. Overall, the answer is factually robust, contextually complete, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 461,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Emerson's (EMR) strategic positioning of its Pipe Cutters product line evolve from 2022 to 2024, particularly in terms of its integration with battery-powered technologies and diagnostic systems across the Safety & Productivity segment?",
      "original_answer": "From 2022 to 2024, Emerson increasingly emphasized battery-powered technologies and diagnostic integration in its Pipe Cutters product line. In 2022, Pipe Cutters were described as standalone tools used by plumbing professionals. By 2023, the product line was explicitly linked with battery hydraulic tools for press connections, indicating a shift toward cordless, high-efficiency cutting solutions. In 2024, this trend continued with Pipe Cutters being positioned as part of a broader ecosystem that includes diagnostic systems like sewer inspection cameras, suggesting a strategic move toward smart, integrated tooling solutions that enhance productivity and safety.",
      "llm_answer": "In 2022 Emerson described its pipe cutters as part of its pipe‑working tools line, noting diagnostic features such as closed‑circuit TV inspection but no battery‑powered emphasis. By 2024 the Safety & Productivity segment’s narrative shifted to highlight battery‑hydraulic tools and integrated diagnostic systems—sewer‑inspection cameras and locating equipment—underscoring a strategic move toward battery‑powered technology and advanced diagnostics to boost safety and productivity.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of strategic evolution, battery-powered integration, and diagnostic systems. It accurately identifies the shift from 2022 to 2024, noting the increased emphasis on battery-hydraulic tools and diagnostic integration like sewer-inspection cameras. The dates (2022 and 2024) are correctly used, and no numeric inaccuracies are present—thus, quantitative accuracy is perfect. However, the LLM slightly misrepresents the 2022 positioning by mentioning 'diagnostic features such as closed-circuit TV inspection' for pipe cutters specifically, which the ground truth does not support; in 2022, pipe cutters were described as standalone tools without mention of diagnostics. The integration of diagnostics comes later, in 2024, as part of a broader ecosystem. This is a minor but notable overattribution of diagnostic capabilities to the 2022 product line. The answer captures the multi-hop evolution across years and segments (Safety & Productivity), showing sound reasoning, but lacks explicit mention of the 2023 transition, which is part of the full trajectory. Despite this, the core strategic shift is correctly conveyed, and the answer remains contextually relevant and semantically close to the original. Hence, a score of 8 is justified for both correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 377,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this consistent emphasis reveal about the company's strategic focus on financial process standardization?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including finance. In 2022, the company described the initiative as a proactive effort to support the growth of its financial shared service capabilities and standardize financial systems, not in response to any internal control deficiencies. In 2023, the company reiterated this strategic direction, highlighting ongoing enhancements aligned with the initiative and affirming its commitment to streamlining the financial control environment. By 2024, the company maintained the same narrative, continuing to align and streamline the design and operation of its financial control environment as part of the broader initiative. This consistent messaging across all three years indicates a long-term strategic commitment to process optimization and financial systems modernization, suggesting that the company views this initiative as foundational to its operational efficiency and control framework.",
      "llm_answer": "From 2022 through 2024, J&J’s multi‑year, enterprise‑wide initiative has remained a continuous effort to integrate, simplify and standardize processes and systems across HR, IT, procurement, supply chain and finance, with the stated goal of expanding shared‑service capabilities and harmonizing financial systems (2022 p.118‑119, 2023 p.119‑120, 2024 p.120‑121). The 2024 filing notes that the company “has and will continue” to align and streamline its financial control environment, indicating progress but no change in focus. This persistent emphasis signals that J&J prioritizes process standardization and operational efficiency in finance as a cornerstone of its governance and risk‑management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Johnson & Johnson's multi-year initiative from 2022–2024 focused on integrating, simplifying, and standardizing processes across finance and other functions to enhance shared services and standardize systems. The initiative is consistently described as proactive, not driven by control deficiencies, and ongoing across all three years. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable in that sense, but all references to years and page numbers (2022 p.118–119, etc.) are consistent with typical 10-K formatting and do not contradict the knowledge graph—thus scored as 10. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of filings, identifying continuity in language and strategic intent, particularly around streamlining the financial control environment. The addition of 'HR, IT, procurement, supply chain' beyond finance is consistent with the enterprise-wide scope mentioned in the original and does not distort the focus on financial standardization. (4) The only minor gap is that the LLM does not explicitly state that the initiative was *not* in response to internal control deficiencies (a point emphasized in 2022), though this nuance may be implied in the characterization of it as a proactive, continuous effort. Otherwise, the conclusion about strategic focus on operational efficiency and governance is semantically equivalent and well-reasoned. Contextual relevance is perfect—the answer directly addresses both parts of the question: evolution over time and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 477,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Costco's disclosures regarding the Executive Health Plan's filing status evolve from fiscal years 2022 through 2024, and what does this consistency or change indicate about the company's long-term executive benefit strategy?",
      "original_answer": "Costco consistently disclosed the Executive Health Plan (Exhibit 10.1*) in its 10-K filings across fiscal years 2022, 2023, and 2024, with the plan always referencing the same 'Period Ended' date of September 2, 2012, and the same 'Filing Date' of October 19, 2012. This indicates no material updates or amendments to the plan were filed during this three-year period, suggesting that Costco maintained a stable long-term executive benefit strategy without structural changes to this specific plan.",
      "llm_answer": "Costco has consistently listed the Executive Health Plan as Exhibit 10.1 in each of its 10‑K filings for FY 2022, FY 2023 and FY 2024, and in every year the plan is noted as being filed with the SEC as part of the 10‑K (COST_10k_2024.pdf p. 64‑68; COST_10k_2023.pdf p. 64‑68; COST_10k_2022.pdf p. 64‑68).  The unchanged filing status across three consecutive years indicates that Costco treats the Executive Health Plan as a stable, long‑term component of its executive compensation program rather than a temporary or ad‑hoc benefit.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Costco consistently disclosed the Executive Health Plan as Exhibit 10.1 in its 10-K filings for fiscal years 2022, 2023, and 2024, and notes the stability of the plan over this period. However, it inaccurately refers to the exhibit as 'Exhibit 10.1' instead of 'Exhibit 10.1*' as specified in the ground truth, which may indicate a minor discrepancy in exhibit labeling. More importantly, the LLM omits the specific 'Period Ended' date (September 2, 2012) and 'Filing Date' (October 19, 2012), which are critical quantitative details confirming that no amendments were made. (2) While the LLM correctly infers consistency in disclosure, it fails to provide the exact dates that substantiate the claim of no material updates—this impacts quantitative accuracy. The absence of these dates weakens the factual foundation of the conclusion, even though the conclusion itself is directionally correct. (3) The reasoning is sound: the model correctly synthesizes information across three years of filings and draws a logical inference about long-term executive benefit strategy based on unchanged disclosures. It demonstrates proper multi-hop understanding by connecting repeated inclusion of the exhibit with strategic stability. (4) The answer is contextually fully relevant and captures the essence of the question. Due to the omission of key dates and the exhibit number inaccuracy, the answer is not fully factually complete, warranting a score of 8 for correctness. Quantitative accuracy is penalized more (7) due to missing precise dates; qualitative reasoning and contextual relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 453,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the dividend and voting rights associated with MA's A Class Shares evolve from 2022 through 2024, and what does this consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA's A Class Shares maintained identical dividend and voting rights: one vote per share and standard dividend rights. This consistency in shareholder rights over a three-year period suggests that MA has pursued a stable and unchanging governance strategy for its A Class shareholders, even amid potential shifts in market conditions or corporate performance.",
      "llm_answer": "Mastercard’s Class A shares continued to carry one vote per share throughout 2022‑2024【MA_10k_2023 pages 97‑101】【MA_10k_2024 pages 90‑94】, while the dividend per share rose from $2.04 in 2022 to $2.37 in 2023 and $2.74 in 2024【MA_10k_2023 pages 97‑101】【MA_10k_2024 pages 90‑94】. This steady voting framework, coupled with a progressive dividend policy, signals a governance strategy that rewards shareholders consistently while maintaining a simple, predictable voting structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that MA's A Class Shares have one vote per share (consistent with ground truth), it incorrectly claims that dividend per share increased from $2.04 in 2022 to $2.37 in 2023 and $2.74 in 2024. The ground truth explicitly states that the dividend *rights* remained standard and unchanged across all three years, not that the actual dividend payments increased. The question asks about *dividend rights*, not dividend amounts paid. Dividend rights refer to the entitlement structure (e.g., parity with other classes), not payout levels. By conflating dividend payouts with dividend rights, the LLM misrepresents the core fact. (2) The cited numbers for dividend per share, while possibly accurate as payouts, are irrelevant to the question about *rights*. There is no support in the ground truth for any change in rights, so the quantitative data is misapplied. (3) The reasoning is flawed in the multi-hop synthesis: the model infers a 'progressive dividend policy' from increasing payouts, then links this to governance strategy—but the question is about stability in *rights*, not changes in distributions. The conclusion about a 'steady voting framework' is correct, but the linkage to dividend *payouts* undermines the analysis. (4) The contextual relevance is moderate because the answer addresses governance strategy and voting rights, but the incorrect focus on dividend amounts instead of rights severely undermines factual correctness. The qualitative reasoning is partially sound but built on a false premise. Thus, correctness is low due to fundamental misinterpretation of 'dividend rights' vs. 'dividend payments'.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 469,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Broadcom's Security Insights Platform evolve in terms of integration with in-house security tools and risk identification capabilities across fiscal years 2022, 2023, and 2024?",
      "original_answer": "In fiscal year 2022, the Security Insights Platform was described as helping ensure a trusted environment by assessing mainframe security posture and identifying risks, with data available for use with in-house tools for security information and event management. By fiscal year 2023, the platform maintained this core functionality but was more explicitly tied to ongoing and ad hoc remediation planning. In fiscal year 2024, the platform retained the same description, indicating stable functionality and consistent integration with in-house tools over the three-year period, suggesting a mature and well-defined offering within Broadcom's cybersecurity portfolio.",
      "llm_answer": "Broadcom’s Security Insights Platform has consistently been positioned as a bridge between its mainframe security analytics and customers’ own SIEM environments.  In each of the FY 2022, FY 2023 and FY 2024 10‑Ks the platform is described as “quickly interpreting and assessing mainframe security posture, identifying risks and developing remediation steps, with data available for use with in‑house tools for security information and event management.”  Over the three years the core integration with in‑house security tools and the risk‑identification function remained, while the company added incremental enhancements—such as broader data availability and more detailed remediation guidance—to deepen that integration and improve the speed and accuracy of risk detection.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy in its description of the evolution of Broadcom's Security Insights Platform. While the answer correctly identifies the platform's integration with in-house security tools (specifically SIEM) and risk identification capabilities across fiscal years 2022–2024, it incorrectly states that the same descriptive language appears in all three years' 10-K filings. The ground truth indicates that in FY2022, the platform was described in terms of assessing security posture and identifying risks with data available for in-house tools. In FY2023, the description evolved to emphasize explicit linkage to remediation planning (ongoing and ad hoc), which the LLM mischaracterizes as 'developing remediation steps' in all years. In FY2024, the description reverted to being identical to FY2022, indicating stability rather than progressive enhancement. The LLM incorrectly implies consistent wording and incremental improvements (e.g., 'broader data availability', 'more detailed remediation guidance') that are not supported by the ground truth. There are no numerical figures to evaluate, so quantitative accuracy is scored as 10. Contextual relevance is high as the response addresses the core topic and timeframe. However, qualitative accuracy is low due to flawed multi-hop reasoning: the model failed to accurately track the nuanced changes and stasis across the three years, instead imposing a narrative of continuous enhancement that contradicts the documented evolution. Thus, while the answer captures the general functionality, it misrepresents the trajectory of the platform’s evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 454,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AIG's management and quantification of loss reserves risk evolve from 2022 through 2024, particularly in terms of the methodologies used to assess reserve adequacy and the role of external experts in validating these estimates?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk became more structured and emphasized greater oversight, with consistent use of internal controls and external expert reviews. In 2022, AIG highlighted the uncertainty in loss development and the use of internal controls and external reviews to manage this risk. By 2023, AIG expanded its risk management framework to include detailed modeling techniques (both stochastic and deterministic) for analyzing risk concentrations and introduced more formalized actuarial profitability and reserve reviews. In 2024, AIG reinforced its multi-tiered risk oversight by incorporating ERM second-line reviews, enhanced budget and expense assumption monitoring, and continued reliance on external experts, indicating a maturing and increasingly proactive approach to loss reserve risk management.",
      "llm_answer": "From 2022 through 2024, AIG kept the same framework for assessing loss‑reserve adequacy: it relies on sensitivity and scenario analyses, stochastic modeling, and experience studies, supported by internal controls and an established review‑and‑challenge process. External experts consistently review and validate the reserve‑setting process, and no significant changes in methodology or the role of those experts are noted in the filings.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in the qualitative evolution of AIG's loss reserve risk management from 2022 to 2024. While it correctly notes the use of stochastic modeling, scenario analyses, and external expert reviews, it incorrectly states that 'no significant changes in methodology' occurred, which contradicts the ground truth. The original answer shows a clear evolution: in 2023, AIG introduced more formalized actuarial reviews and expanded modeling techniques (both stochastic and deterministic), and in 2024, it added ERM second-line reviews and enhanced monitoring of budget and expense assumptions—indicating a maturing and increasingly proactive framework. The LLM answer fails to capture this progression, instead asserting methodological consistency, which misrepresents the multi-hop synthesis across years. There are no numeric values to evaluate, so quantitative accuracy is scored as 10 by default (no errors in numbers, as none are present). Contextual relevance is high because the response addresses the right topic and entities (AIG, loss reserves, external experts, methodologies), but the reasoning is flawed due to omission of key developments. Thus, while the components mentioned are accurate, the overall narrative lacks the necessary depth and change over time required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 376,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Emerson's (EMR) positioning of Electrical Distribution Equipment evolve across its Industrial Solutions segments in 2022, 2023, and 2024, and what does this reveal about its strategic emphasis in discrete automation markets?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as part of Emerson's Industrial Solutions segment, described alongside fluid control and materials joining products used in manufacturing operations. By 2023, the company reorganized under the Discrete Automation segment, where Electrical Distribution Equipment was explicitly listed among core offerings like solenoid valves and programmable automation systems, signaling a stronger alignment with discrete manufacturing. In 2024, the equipment remained within the Discrete Automation segment, now grouped more closely with electric linear motion solutions and programmable control systems, indicating a continued and deepening strategic focus on integrated automation solutions for discrete industries. This 3-year evolution shows Emerson's deliberate shift toward positioning Electrical Distribution Equipment as a foundational component of its discrete automation strategy rather than a general industrial product.",
      "llm_answer": "In 2022 Emerson described Electrical Distribution Equipment as part of its Industrial Solutions offering – a segment that bundled fluid‑control, pneumatic mechanisms and electrical distribution gear (2022 p. 74‑78). By 2023 and 2024, the company moved that product into the newly‑emphasised Discrete Automation segment, which now lists electrical distribution equipment alongside solenoid valves, pneumatic valves, linear‑motion solutions and other discrete‑automation components (2023 p. 71‑75; 2024 p. 71‑75). This repositioning signals Emerson’s strategic shift to treat electrical distribution equipment as a core discrete‑automation asset, underscoring a heightened focus on growth in discrete manufacturing markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Electrical Distribution Equipment was part of Industrial Solutions in 2022 and moved to Discrete Automation in 2023 and 2024. The repositioning is correctly interpreted as a strategic shift toward discrete automation. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not applicable—no errors present. Page references (e.g., 2022 p. 74–78) are included plausibly and do not contradict the knowledge graph. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years and segments, identifying the strategic implication of the reorganization. The only minor omission is that the 2024 update notes a deeper integration with electric linear motion and programmable control systems, which the LLM mentions in part but could have emphasized more clearly as a 'deepening' trend. (4) The answer is contextually excellent—directly addresses the evolution and strategic emphasis, uses correct entities (EMR, Discrete Automation, Industrial Solutions), and draws a valid conclusion. Wording differs slightly but maintains semantic equivalence. One point deducted from qualitative and overall scores for slight under-articulation of the 2024 deepening integration, but core facts and strategic interpretation are fully correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 397,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Johnson & Johnson's pension plan structure evolve from 2022 through 2024 with respect to the Retirement Value formula, and what does this multi-year transition reveal about the company's long-term workforce strategy?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson consistently communicated a strategic shift toward the Retirement Value formula for U.S. non-union employees, effective January 1, 2026. In 2022, the company reiterated that this change would apply to all eligible employees regardless of hire date, while preserving Final Average Pay formula benefits accrued before 2026. By 2023 and 2024, the disclosures maintained the same structural description of the Retirement Value formula, indicating no reversal or delay in the policy. The consistent messaging across all three years highlights a deliberate long-term workforce strategy to standardize retirement benefits and align them with total years of service and compensation, rather than final earnings, suggesting a shift toward cost predictability and broader workforce inclusivity in retirement planning.",
      "llm_answer": "Johnson & Johnson’s pension plan has been moving toward a single “Retirement Value” formula for all U.S. non‑union employees, a change announced in 2021 that takes effect on Jan 1 2026 and does not alter benefits earned before that date (2022 p. 73‑74; 2023 p. 74‑75; 2024 p. 75‑76).  Across 2022‑2024 the plan structure remained unchanged, with the company preparing for the 2026 transition while maintaining the Final Average Pay formula for earlier service.  This multi‑year rollout signals a long‑term workforce strategy that prioritizes pension liability management, cost simplification, and alignment of benefits across all employees to support financial sustainability as the workforce ages.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the Retirement Value formula applies to U.S. non-union employees, takes effect January 1, 2026, and preserves benefits earned under the Final Average Pay formula before that date. The consistent plan structure across 2022–2024 is correctly noted. (2) Quantitative accuracy is perfect: the effective date (Jan 1, 2026) is correct, and no numerical errors are present. Page references (e.g., 2022 p. 73–74) are consistent with typical disclosure locations, though not part of the ground truth—these do not detract from accuracy. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of disclosures to confirm no changes in the plan structure, supporting the conclusion of a stable, long-term transition. The strategic interpretation—cost simplification, liability management, and alignment across employees—overlaps significantly with the ground truth’s emphasis on cost predictability and inclusivity, though it frames the strategy slightly more from a financial than workforce-inclusivity perspective. (4) Contextual relevance is excellent: the answer directly addresses both the evolution of the pension structure and the implied workforce strategy. The only minor gap is that the ground truth emphasizes the alignment with 'total years of service and compensation, rather than final earnings,' which the LLM omits, slightly weakening the qualitative depth. Overall, the answer is factually complete and semantically equivalent, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 434,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the percentage contribution of Downy to Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, and what does this 3-year trend suggest about the brand's strategic importance in the company's portfolio?",
      "original_answer": "Downy consistently remained a key brand within P&G's Fabric & Home Care segment, which grew its net sales contribution from 35% in 2022 to 36% in both 2023 and 2024. This stable positioning of Downy within a growing segment suggests its sustained strategic importance in driving fabric care revenue.",
      "llm_answer": "Downy’s share of the Fabric & Home Care segment’s net sales fell modestly over the three‑year period – roughly 13 % in 2022, 12 % in 2023 and 11 % in 2024 (see the major‑brand contribution tables in the MD&A for each year). This gradual decline indicates that while Downy remains a core brand, its relative importance is shrinking, likely reflecting heightened competition or a strategic shift toward other brands within the portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude. The ground truth states that Downy remained a key brand within the Fabric & Home Care segment, which itself grew from 35% to 36% of P&G's total net sales over 2022–2024. The LLM incorrectly claims that Downy's *share within the segment* declined from 13% to 11%, which is not supported by the original answer and contradicts the stated stability of Downy’s strategic role. (2) There are no correct numbers: the percentages cited (13%, 12%, 11%) do not appear in the ground truth, and no data about Downy’s specific percentage contribution to the segment is provided in the original answer—only the segment’s overall contribution to P&G. The LLM fabricates granular brand-level data that is not present in the source. (3) The multi-hop reasoning fails: the original answer infers strategic importance from the stable positioning of Downy within a growing segment, while the LLM incorrectly assumes a declining trend and draws an unsupported conclusion about reduced strategic importance. This reflects a fundamental misinterpretation of the data and relationships. (4) The contextual relevance is low but not zero because the answer addresses the right company (P&G), segment (Fabric & Home Care), brand (Downy), and time frame (2022–2024), and attempts to discuss strategic importance. However, due to complete factual inaccuracy and flawed reasoning, the correctness, quantitative, and qualitative scores are near the minimum.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 417,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 to 2024 in terms of carrying value, and what does this trend suggest about the company's debt financing strategy over the three-year period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2024, with a peak of $31,248 million in 2023. This indicates a general upward trend in the company's reliance on this form of debt financing, suggesting a strategic shift toward issuing more senior and subordinated notes to fund operations and growth initiatives.",
      "llm_answer": "Capital One’s total senior and subordinated notes carried $27.2 billion at year‑end 2022, rose to $31.2 billion in 2023, and then eased slightly to $30.7 billion in 2024. The peak in 2023 reflects a sizable increase in long‑term debt—likely to fund growth or acquisitions—while the modest decline in 2024 indicates a partial repayment or refinancing effort, suggesting the company is using debt to support expansion but also actively managing its balance‑sheet load and interest costs.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the carrying value was $27,219 million in 2022, increased to $31,248 million in 2023, and remained at $31,248 million in 2024 (no decrease). However, the LLM states it 'eased slightly to $30.7 billion in 2024', which is factually incorrect—there was no decline. This misrepresents the trend. The 2022 and 2023 figures are approximately correct when rounded ($27.2B and $31.2B vs. $27,219M and $31,248M), but the 2024 figure is wrong. (2) Calculations: The LLM implies a decrease of ~$500 million from 2023 to 2024, which contradicts the ground truth showing no change. This error affects the interpretation. (3) Reasoning: The multi-hop synthesis is partially sound—the model correctly identifies the increase from 2022 to 2023 and infers strategic debt use for growth. However, the conclusion about 'partial repayment or refinancing' in 2024 is unsupported by data and introduces a false narrative. The actual trend suggests sustained reliance on debt, not balance sheet management via repayment. (4) Despite incorrect numbers in 2024, the answer is contextually relevant and uses appropriate financial reasoning. The qualitative analysis is logical given the assumed data, but the factual error in the final year reduces correctness. Semantic equivalence fails on the key trend direction in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 390,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about T's broader divestiture strategy in the Latin American pay-TV market?",
      "original_answer": "From 2022 to 2024, T maintained a 41.3% interest in SKY Mexico, a leading pay-TV provider in Mexico, but ultimately exited the investment in June 2024. In 2022, T continued to hold this stake without any significant changes noted. By 2023, SKY Mexico was listed among T’s key equity method investments, alongside DIRECTV and Gigapower, indicating that T was still actively accounting for its stake under the equity method. In 2024, T completed the sale of its 41.3% interest in SKY Mexico, marking the conclusion of its involvement in the Latin American pay-TV market. This 3-year trajectory—from holding steady, to continued equity method treatment, to full divestiture—reflects a deliberate strategic shift by T to exit non-core international assets and focus on its core domestic operations.",
      "llm_answer": "In 2022, T still held a 41.3 % interest in SKY Mexico and accounted for the investment under the equity method. The stake and accounting treatment remained unchanged in 2023. In 2024, T sold its 41.3 % stake, terminating the equity‑method accounting and exiting the investment altogether. This three‑year path illustrates T’s deliberate divestiture of legacy Latin‑American pay‑TV assets, underscoring a broader strategy to streamline its portfolio and focus on higher‑growth or core markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: T held a 41.3% stake in SKY Mexico in 2022 and 2023, accounted for it under the equity method, and sold the stake in 2024. The exit timing (2024) and ownership percentage (41.3%) match exactly. (2) Quantitative accuracy is perfect—41.3% is correctly cited, and no calculations are required beyond accurate reporting of figures. (3) The multi-hop reasoning is sound: the answer synthesizes information across three years, correctly identifies the accounting treatment, and links the exit to a broader strategic shift. The only minor gap is that the original answer explicitly names DIRECTV and Gigapower as other equity method investments in 2023, which the LLM omits—this is a small completeness issue but does not affect the core accuracy. (4) The LLM captures the broader strategic implication accurately—portraying the divestiture as part of a deliberate move to exit non-core Latin American pay-TV assets and focus on core markets. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually excellent with only a slight reduction in qualitative accuracy due to omission of one contextual detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 346,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did BNY Mellon's disclosures about constraints on capital returns to shareholders under U.S. banking laws evolve from 2022 to 2024, particularly in relation to regulatory requirements, dividend policies, and capital adequacy?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including capital adequacy rules and Delaware law. In 2022, the firm emphasized that capital returns were subject to regulatory approval and could be constrained by failure to pay preferred dividends on time. In 2023, the language remained largely consistent, but the firm expanded its risk discussion to include ESG-related regulatory pressures and the impact of new strategic initiatives on capital allocation. By 2024, the disclosures remained centered on regulatory constraints, with additional emphasis on the Parent company’s reliance on subsidiary dividends and the potential impact of strategic transformation initiatives on liquidity and capital planning. The trend shows a stable regulatory framework with increasing contextual complexity around capital return limitations.",
      "llm_answer": "BNY Mellon’s 2022 10‑K risk‑factor warned that its ability to return capital could be limited by U.S. banking laws, capital‑planning rules, Delaware law and the failure to pay full and timely dividends on preferred stock (see pages 1‑5). The 2024 10‑K kept that core warning but added a separate risk‑factor that explicitly cites regulatory capital‑adequacy standards—“well‑capitalized” and “well‑managed” status—and notes that failure to meet those could restrict the company’s activities (see pages 3‑7). Thus, the 2024 disclosure broadened the regulatory context and highlighted capital adequacy alongside the dividend‑policy constraint that was already present in 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that BNY Mellon's disclosures from 2022 to 2024 consistently referenced U.S. banking laws, capital-planning rules, Delaware law, and preferred dividend obligations as constraints on capital returns. The answer accurately notes the evolution: the 2022 disclosure included limitations due to preferred stock dividends and regulatory frameworks, while the 2024 filing expanded the scope to explicitly include 'well-capitalized' and 'well-managed' regulatory standards as potential constraints. This matches the ground truth's emphasis on increasing contextual complexity around capital adequacy and regulatory expectations. The mention of a 'separate risk-factor' in 2024 shows correct synthesis across years. The only minor shortcoming is that the LLM answer does not mention the 2023 evolution (e.g., ESG-related regulatory pressures and strategic initiatives), which the ground truth includes as part of the multi-year trend. However, the core regulatory and policy evolution between 2022 and 2024 is correctly captured. All entities (BNY Mellon, U.S. banking laws, Delaware law, preferred dividends, capital adequacy) and years (2022, 2024) are accurate. No numerical errors—dates and references are consistent. The reasoning is sound, demonstrating multi-hop understanding between filings. The answer is semantically equivalent in key aspects and highly relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 406,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did 3M’s positioning of Structural Adhesives within its Safety and Industrial segment evolve from 2022 through 2024, particularly in terms of product bundling or adjacent offerings, and what does this reveal about the strategic role of adhesives in industrial applications?",
      "original_answer": "In 2022, 3M listed Structural Adhesives alongside industrial abrasives, autobody repair solutions, and electrical materials, emphasizing integration with metalworking and OEM electrical markets. In 2023, the positioning remained largely consistent, grouped with similar industrial solutions but with a slightly expanded emphasis on packaging and closure systems. By 2024, Structural Adhesives were still a core part of the Safety and Industrial segment, but the surrounding product suite showed a shift toward more specialized industrial applications, such as industrial specialty products and materials for construction and maintenance. This evolution suggests a strategic reinforcement of structural adhesives as a foundational component in complex industrial systems rather than just a standalone product.",
      "llm_answer": "From 2022 through 2024, 3M shifted structural adhesives from a standalone product in the Safety and Industrial segment to a bundled core of the newly created Industrial Specialties division, where they are paired with tapes, closure systems, masking, and packaging materials. This re‑organization—highlighted by the 2024 creation of the Industrial Specialties division that groups the former Industrial Adhesive and Tapes division with adjacent industrial‑specialty offerings—underscores adhesives as a foundational technology that enables integrated, high‑performance solutions across metalworking, automotive repair, construction, and electrical applications.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general strategic direction of 3M's structural adhesives becoming more integrated into broader industrial solutions, which aligns with the ground truth. However, it introduces a significant factual inaccuracy: the claim that 3M created an 'Industrial Specialties division' in 2024 by reorganizing from the 'Industrial Adhesive and Tapes division' is not supported by the original answer or known 3M organizational changes during this period. The original answer notes a shift in product bundling and emphasis—such as increased alignment with construction, maintenance, packaging, and closure systems—but does not mention any formal divisional reorganization. This misrepresents the nature of the change as structural (organizational) rather than strategic and contextual within the existing Safety and Industrial segment. The dates (2022–2024) are used appropriately, and the mention of adjacent offerings (tapes, closure systems, packaging) has partial support, especially in the 2023–2024 timeframe. The core idea—that structural adhesives are being positioned as a foundational technology in integrated industrial systems—is semantically consistent with the ground truth. However, the incorrect inference of a corporate reorganization undermines the qualitative accuracy. There are no numerical values to assess, so quantitative accuracy is based on correct use of years and timeline progression, which is accurate. Contextually, the answer addresses the evolution and strategic role, making it relevant despite factual overreach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 426,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Eli Lilly's strategic positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protections across key global markets?",
      "original_answer": "From 2022 to 2024, Eli Lilly's strategic positioning of Cyramza evolved from an initial emphasis on a broad range of oncology indications to maintaining its market relevance through targeted intellectual property protections. In 2022, Cyramza was introduced with a comprehensive set of indications across gastric, lung, colorectal, and liver cancers. By 2024, the therapeutic indications remained consistent, indicating sustained clinical positioning. However, in 2023, the company disclosed that Cyramza's data protection in Japan was set to expire in 2023, followed by data protection expirations in major European countries in 2024, and U.S. biologics data protection expiring in 2026. This timeline reveals a strategic focus on managing Cyramza's lifecycle by highlighting its continued therapeutic relevance while preparing for eventual market competition in key territories.",
      "llm_answer": "From 2022 through 2024, Lilly’s Cyramza portfolio has kept the same core indications—second‑line therapy for gastric, esophageal, colorectal, and hepatocellular cancers and first‑line therapy for EGFR‑mutated NSCLC—while its intellectual‑property horizon has tightened: the compound patents now expire in 2026 in the U.S. and 2028 in major European markets, and data‑protection ends in 2026 (U.S.), 2024 (Europe) and 2023 (Japan)【LLY_10k_2022.pdf: page 5】【LLY_10k_2023.pdf: page 9】【LLY_10k_2024.pdf: page 4】【LLY_10k_2024.pdf: page 8】. This shift signals a strategic pivot toward sustaining exclusivity through new indications or combination therapies as the current patents and data protection wind down.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Cyramza's therapeutic indications remained largely consistent from 2022 to 2024, covering gastric, colorectal, and liver (hepatocellular) cancers, which aligns with the ground truth. However, the LLM incorrectly states that Cyramza is indicated for 'first-line therapy for EGFR-mutated NSCLC'—this is inaccurate; Cyramza is not approved for first-line EGFR-mutated non-small cell lung cancer (NSCLC). Instead, it is used in second-line NSCLC settings, typically in combination with docetaxel. This misrepresentation of a key indication is a significant factual error. (2) Regarding intellectual property, the LLM states that 'compound patents expire in 2026 in the U.S. and 2028 in Europe'—this contradicts the ground truth, which only references data protection expirations (2023 Japan, 2024 Europe, 2026 U.S.) and does not mention compound patent terms. The 2028 European patent expiration is not supported by the ground truth and appears to be fabricated or misattributed. The data protection dates (2023 Japan, 2024 Europe, 2026 U.S.) are correctly reported. (3) The multi-hop reasoning is partially sound: the model synthesizes information across years and geographies and correctly infers a strategic shift toward lifecycle management as exclusivity winds down. However, the reasoning is based on some incorrect premises (e.g., new patent dates and indications), weakening the logical foundation. (4) The contextual relevance is high—the answer addresses both therapeutic indications and IP protections across global markets as asked. The qualitative accuracy is good in structure and synthesis but undermined by key factual inaccuracies. Quantitative accuracy is moderate: while data protection dates are correct, the patent expiration dates are not in the ground truth and are likely incorrect. Correctness score is 7 because the core timeline of data protection expirations and general strategic narrative are accurate, but major errors in indications and patent dates prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 553,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year trend suggest about the company's debt strategy and financing costs over time?",
      "original_answer": "From 2022 to 2024, Capital One's fixed unsecured senior debt increased in carrying value from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward issuing more fixed-rate debt at higher interest rates, likely reflecting broader market conditions and the company's evolving capital structure decisions.",
      "llm_answer": "Capital One’s fixed unsecured senior debt rose from **$19.98 billion** in 2022 to **$27.17 billion** in 2023, then dipped slightly to **$26.93 billion** in 2024.  The weighted‑average interest rate climbed from **2.91 %** in 2022 to **4.45 %** in 2023 and to **4.84 %** in 2024.  This pattern shows the company is expanding its fixed‑rate debt base while accepting higher rates—reflecting a strategy of locking in longer‑dated financing amid a tightening rate environment, even as it manages repayments or refinancing that modestly reduce the carrying value in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in direction and interpretation but contains inaccuracies in the carrying value for 2023 and the interest rate for 2023. The ground truth only provides data for 2022 and 2024, but the LLM introduces a 2023 value not present in the original answer ($27.17 billion and 4.45%), which is unsupported. The 2024 carrying value ($26.93 billion) matches the ground truth (equivalent to $26,930 million), and the 2022 value is correctly approximated as $19.98 billion (vs $19,975 million). The final interest rate in 2024 (4.84%) is correct. (2) Quantitative accuracy is reduced because the model fabricates a 2023 data point for both carrying value and interest rate without source support, even though the 2022 and 2024 endpoints are accurate. The slight dip in 2024 is also not verifiable from the original answer, which only compares 2022 to 2024. (3) The multi-hop reasoning is sound in interpreting the trend as a strategic move to issue more fixed-rate debt at higher rates amid rising interest environments. The explanation about locking in financing during a tightening cycle is logically consistent with the data and adds reasonable qualitative insight. (4) Contextual relevance is perfect—the answer directly addresses the evolution over time, discusses both carrying value and interest rates, and infers strategy and financing cost implications. The core trend (increase in debt and rates) is correctly identified, but the insertion of an unsupported intermediate year reduces quantitative precision. Hence, correctness is penalized to 7 due to unsupported numbers, though the overall conclusion remains aligned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 454,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Cisco's financial exposure through Total Return Swaps tied to Deferred Compensation evolve from fiscal years 2022 through 2024, and what does the pattern of gains and losses reveal about the volatility of this instrument over the three-year period?",
      "original_answer": "Cisco's exposure through Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million, followed by a gain of $58 million in 2023, and a gain of $91 million in 2024. This pattern reveals a volatile financial impact from this instrument, swinging from a notable loss to consistent gains over the period.",
      "llm_answer": "Cisco’s notional exposure to total‑return swaps tied to deferred compensation grew from $651 million in FY 2022 to $792 million in FY 2023 and $985 million in FY 2024.  The fair‑value impact on operating results swung from a $92 million loss in FY 2022 to gains of $58 million in FY 2023 and $91 million in FY 2024, underscoring the instrument’s pronounced volatility—fluctuations of roughly $90 million in either direction over the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the financial impacts—$92 million loss in FY 2022, $58 million gain in FY 2023, and $91 million gain in FY 2024—matching the ground truth exactly. These numbers are presented with accurate formatting and correct fiscal years. (2) While the original answer does not include notional exposure amounts ($651M, $792M, $985M), the LLM provides additional context not in the ground truth. This extra information does not contradict the original answer and is likely derived from the same filings; however, since the question focuses on gains/losses and volatility rather than notional exposure, this addition is contextually relevant but not required. The core quantitative data on gains and losses is fully accurate. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the pattern of swings in fair value impact across three fiscal years and draws a valid conclusion about the volatility of the instrument. The characterization of 'fluctuations of roughly $90 million in either direction' is a reasonable qualitative summary of the swing from -$92M to +$58M to +$91M. (4) The answer is semantically equivalent to the ground truth in terms of the key financial outcomes and what they reveal. The only minor deviation is the inclusion of notional exposure, which enhances rather than detracts from the response. Thus, the answer earns a 9/10 for correctness—fully accurate on required facts, with slight over-delivery on non-essential details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 414,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did The Home Depot's strategic emphasis on store appearance evolve from 2022 to 2024, and what measurable impact did this have on its competitive positioning against multichannel and online retailers across those years?",
      "original_answer": "In 2022, The Home Depot positioned store appearance as a key component of its competitive strategy, emphasizing store location and appearance alongside merchandise presentation and ease of shopping experience as differentiators against competitors like lumber yards and home décor retailers. By 2023, store appearance remained a core competitive factor but was increasingly tied to a broader interconnected retail strategy, with the company noting its importance in combination with digital capabilities like faster delivery and pickup options. In 2024, store appearance was further integrated into a fully interconnected shopping experience, with explicit mention of its role in supporting Pros and DIY customers through a seamless blend of physical and digital touchpoints, including enhanced mobile platforms and in-store digital tools. This multi-year evolution reflects a strategic pivot from standalone in-store experience to a hybrid model where store appearance supports omnichannel engagement, directly influencing the company's ability to compete with exclusively online retailers and digital-first competitors.",
      "llm_answer": "From 2022 to 2024, Home Depot shifted its store‑appearance strategy from basic refresh packages and way‑finding signage (2022 p. 7‑11) to a comprehensive, tech‑enabled experience that added self‑service lockers, curb‑side pickup, electronic shelf labels, front‑end redesigns, expanded self‑checkout, and mobile‑app navigation (2023 p. 12‑16; 2024 p. 6‑10). These upgrades lifted customer‑satisfaction scores and pushed the share of online orders fulfilled through a store to roughly 55 % in 2023 and 50 % in 2024, strengthening Home Depot’s omnichannel advantage and its competitive edge over multichannel and online rivals.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution of The Home Depot's store appearance strategy from 2022 to 2024, correctly identifying the shift from physical enhancements to a tech-integrated, omnichannel experience. It accurately reflects the strategic integration of store appearance with digital and fulfillment capabilities, which aligns with the ground truth’s emphasis on an interconnected retail model. However, the quantitative claims introduce inaccuracies: the ground truth does not specify customer-satisfaction score improvements or the exact percentages of online orders fulfilled through stores (55% in 2023, 50% in 2024), nor are these figures cited in the provided context (e.g., '2023 p. 12–16'). These specific metrics appear to be fabricated or over-specified, significantly impacting quantitative accuracy. While the mention of self-service lockers, curb-side pickup, electronic shelf labels, and mobile-app navigation is consistent with a tech-enhanced in-store experience, the original answer does not list these specific features, making their inclusion speculative. The reasoning is logically sound—tying store upgrades to omnichannel competitiveness—and the entities (Home Depot, years, competitive context) are correct. The answer is highly relevant and synthesizes across years, but the unsupported numerical claims prevent a higher score. Thus, the correctness score is 7: core facts and strategic trajectory are right, but significant quantitative overreach reduces full accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 412,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value for the 3.50% Notes Due 2050 was $2,147 million in fiscal year 2022, decreased to $1,637 million in fiscal year 2023, and remained stable at $2,000 million in fiscal year 2024. This fluctuation indicates a temporary reduction in the short term, followed by a strategic repositioning or stabilization of long-term debt obligations tied to this instrument.",
      "llm_answer": "NVIDIA’s 3.50 % Notes Due 2050 carried **$1,637 million** at the end of FY 2022 (Jan 28 2023)【NVDA_10k_2022.pdf:78‑82】, remained at **$1,637 million** at the end of FY 2023 (Jan 28 2024)【NVDA_10k_2024.pdf:70‑74】, and fell to **$1,604 million** at the end of FY 2024 (Jan 28 2025)【NVDA_10k_2024.pdf:70‑74】. The slight decline—about $33 million—indicates a modest reduction in long‑term debt, suggesting a gradual deleveraging strategy while still maintaining a substantial long‑term debt balance.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported carrying values and fiscal years. According to the ground truth, the carrying value was $2,147 million in FY2022, $1,637 million in FY2023, and $2,000 million in FY2024. The LLM incorrectly states that the value was $1,637 million in FY2022 (it was actually $2,147 million), claims it remained at $1,637 million in FY2023 (which matches only the second year), and reports $1,604 million in FY2024 (when the correct value is $2,000 million). These discrepancies represent major quantitative inaccuracies. (2) The fiscal year alignment is also incorrect: the LLM associates FY2022 with Jan 28, 2023 (which is actually FY2023 per NVIDIA’s reporting), showing a misalignment in time periods. This compounds the error in data interpretation. (3) The reasoning and synthesis are flawed due to incorrect data inputs. The conclusion of a 'modest reduction' and 'gradual deleveraging' contradicts the ground truth, which shows a drop in FY2023 followed by a significant increase back to $2,000 million in FY2024—indicating stabilization or repositioning, not continuous reduction. The LLM fails to capture this multi-hop trend accurately. (4) While the answer addresses the question's structure and attempts to interpret the trend, the severe numerical and temporal inaccuracies severely undermine factual correctness. Contextual relevance is moderate because the response follows the right format and discusses long-term debt positioning, but the conclusions are based on incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 429,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the legal exposure and litigation landscape involving 3M's production of Scotchgard evolve from 2022 through 2024, particularly in terms of case settlements, geographic expansion of lawsuits, and the number of defendants involved?",
      "original_answer": "From 2022 through 2024, 3M's legal exposure related to Scotchgard shifted significantly. In 2022, 3M, along with Saint-Gobain and Honeywell, settled a class action in New York (Baker case) for $65 million, with 3M's share considered immaterial. In 2023, 3M finalized a non-material settlement in a Michigan case involving Wolverine World Wide, where Scotchgard was linked to contamination from shoe manufacturing waste. By 2024, litigation had expanded geographically, particularly in Alabama and Georgia, with multiple new cases brought by municipal water utilities, individual landowners, and even carpet manufacturers like Mohawk Industries suing 3M over alleged PFAS contamination. The number of defendants involved also increased, with companies like DuPont, Chemours, and carpet manufacturers frequently appearing alongside 3M in lawsuits. This indicates a growing and more complex legal environment over time.",
      "llm_answer": "From 2022 to 2024, 3M’s Scotchgard litigation evolved from a single class‑action settlement to a multi‑state exposure that involved more defendants and broader geographic reach.  In 2022 (MMM_10k_2022, pp. 122‑126) 3M settled a $65 million Scotchgard class action with Saint‑Gobain, Honeywell, DuPont and Tonaga, and faced lawsuits in New York and Michigan.  By 2023 (MMM_10k_2023, pp. 92‑96) additional settlements were reached in Michigan (Wolverine) and the litigation expanded to include defendants such as Wolverine, Saint‑Gobain, Honeywell, DuPont and Tonaga across states like Alabama and Georgia, with 3M facing up to five co‑defendants in individual cases.  In 2024 (MMM_10k_2024, pp. 96‑100) the landscape broadened further to new suits in Vermont, New Jersey and other states, with 3M remaining a defendant in hundreds of private actions and the PWS Settlement covering claims from public water systems nationwide.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of 3M's Scotchgard litigation from 2022 to 2024 with correct geographic and qualitative trends, but contains significant factual inaccuracies that reduce correctness. (1) Quantitative Accuracy: The $65 million settlement in 2022 is correct, but the LLM incorrectly includes DuPont and Tonaga as co-settling parties in that settlement; the ground truth specifies only 3M, Saint-Gobain, and Honeywell. There is no mention of DuPont or Tonaga in the 2022 Baker case settlement. Additionally, the LLM claims 'additional settlements were reached in 2023' beyond the Wolverine case, but the ground truth only confirms one non-material settlement in Michigan that year. The LLM also introduces Vermont and New Jersey in 2024, which are not mentioned in the original answer—instead, the truth specifies Alabama and Georgia as key new jurisdictions. (2) Completeness: The answer addresses case settlements, geographic expansion, and number of defendants, satisfying the multi-part structure. However, it omits Mohawk Industries as a notable new defendant (carpet manufacturer) and incorrectly lists Tonaga, which does not appear in the ground truth. (3) Entity Accuracy: Wrong defendants listed (DuPont, Tonaga) in the 2022 settlement; DuPont and Chemours do appear later but not as part of the initial $65M settlement. Wolverine is correctly mentioned but mischaracterized as a defendant in 2023 when it was the plaintiff. (4) Reasoning: The multi-hop synthesis is partially sound—geographic expansion and increasing complexity are correctly inferred—but flawed due to incorrect entity participation. (5) Semantic Equivalence: While the overall narrative of growing exposure is preserved, the inclusion of incorrect parties and locations undermines factual reliability. The mention of 'hundreds of private actions' and 'PWS Settlement' in 2024 adds detail not in the original, potentially conflating with other PFAS litigation. Thus, core facts are partially correct but marred by key errors in entities and scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 549,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial terms and commercial performance of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of royalty structure, milestone payments, and net product revenue?",
      "original_answer": "LLY's collaboration with AbCellera on COVID-19 antibodies showed a declining commercial trajectory from 2022 through 2024. In 2022, LLY recognized $2.02 billion in net product revenue from the sale of these antibodies, and AbCellera received tiered royalty payments ranging from mid-teens to mid-twenties on worldwide net sales. By 2023, sales had dropped to zero, indicating no further demand or regulatory authorization for the product. In 2024, there were still no sales, and no new milestone payments were made to AbCellera. The royalty structure remained consistent across years, but the absence of sales in the latter two years highlights a complete cessation of commercial activity related to this collaboration.",
      "llm_answer": "The royalty structure on worldwide net sales of bamlanivimab and bebtelovimab remained tiered in the mid‑teens to mid‑twenties, and no milestone payments were reported for the AbCellera partnership during this period. Commercially, the collaboration generated $2.02 billion in net product revenue in 2022 (down from $2.24 billion in 2021) and no sales in 2023 or 2024, indicating a sharp decline as the product was discontinued or no longer authorized.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: $2.02 billion in net product revenue for 2022 is accurately reported, and the statement of zero sales in 2023 and 2024 matches the original answer. The mention of $2.24 billion in 2021, while not part of the question's scope (2022–2024), is factually accurate and adds context without distorting the response. (2) The royalty structure is correctly described as tiered in the 'mid-teens to mid-twenties'—matching the ground truth exactly. (3) No milestone payments in 2023 or 2024 is correctly stated, consistent with the original answer. (4) The reasoning is sound: the decline from $2.02B to zero and the conclusion of discontinuation or lack of authorization logically follow from the data. The only minor shortcoming is the slight expansion beyond the requested timeframe (mentioning 2021), which does not detract from correctness but adds peripheral detail. Otherwise, all entities (LLY, AbCellera, royalty structure, net product revenue) are correctly identified and synthesized across years. The answer fully addresses all components of the multi-hop question: evolution over time, royalty structure, milestone payments, and revenue performance. Semantic equivalence is strong, and the conclusion about cessation of commercial activity is correctly inferred.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 383,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Procter & Gamble's positioning of Dawn dish soap within its Fabric & Home Care segment evolve from 2022 to 2024, and what does this reveal about the product's strategic importance in the company's portfolio?",
      "original_answer": "Dawn remained a consistently highlighted brand within P&G's Fabric & Home Care segment across all three years (2022–2024), indicating its sustained strategic importance. In 2022, the segment accounted for 35% of net sales and 31% of earnings, with Dawn listed among key brands. By 2023, the segment maintained its dominance at 36% of net sales and 34% of earnings, again featuring Dawn prominently. In 2024, the Fabric & Home Care segment continued to represent 36% of net sales and 34% of earnings, with Dawn still positioned as a major brand. This consistency suggests that Dawn remained a core contributor to the segment's performance, with no indication of reduced emphasis or strategic repositioning over the three-year period.",
      "llm_answer": "From 2022 through 2024, P&G’s MD&A (2022 p. 17‑21, 2023 p. 16‑20, 2024 p. 16‑20) consistently lists Dawn among the Fabric & Home Care “major brands” and notes that the segment’s ~25 % global home‑care market share is driven by dish‑care products, with Dawn as a core contributor. This unchanged positioning across three years shows that Dawn remains a key revenue driver and brand pillar in P&G’s portfolio, underscoring its strategic importance within the Fabric & Home Care segment.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Dawn was consistently positioned as a major brand in P&G's Fabric & Home Care segment from 2022 to 2024, which aligns with the ground truth. However, it introduces a significant factual inaccuracy by stating the segment has a '~25% global home-care market share driven by dish-care products,' a figure not present in the original answer and unsupported by the provided ground truth. The ground truth emphasizes segment-level financial contributions (35–36% of net sales, 31–34% of earnings), which the LLM omits entirely. (2) Quantitative accuracy is low because the LLM replaces precise financial percentages (e.g., 35% of net sales in 2022) with an incorrect and unsourced market share metric (~25% global home-care share). These numbers are not equivalent: market share ≠ segment contribution to sales/earnings. The LLM also fails to report any correct financial percentages from the ground truth, missing three years of accurate data. (3) The reasoning is partially sound—consistent mention of Dawn as a major brand supports its strategic importance, and the multi-hop synthesis across three years is appropriate. However, the reliance on an incorrect metric undermines the conclusion’s factual basis, even if the direction of inference (strategic importance) is correct. (4) Contextual relevance is high because the answer addresses the evolution (or lack thereof) in Dawn’s positioning and draws a reasonable conclusion about its strategic role. The qualitative accuracy is moderate because entity identification (P&G, Dawn, Fabric & Home Care segment, correct years) and overall logic are sound, but the answer substitutes a key quantitative claim without verification, reducing factual reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 479,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. This trajectory shows a significant rise in debt levels during 2023, followed by a partial reduction in 2024. The composition of debt also shifted notably: floating unsecured senior debt dropped from $1.709 billion in 2022 to $349 million in 2023, and was entirely eliminated by 2024. Meanwhile, the weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a strategic shift toward fixed-rate debt amid rising interest rates.",
      "llm_answer": "Capital One’s total short‑term borrowings fell from $883 million in 2022 to $538 million in 2023 and then rose modestly to $562 million in 2024, while long‑term debt rose from $47.8 billion in 2022 to $49.3 billion in 2023 and declined to $44.9 billion in 2024, bringing total debt down from $48.7 billion to $45.6 billion over the three‑year period. The company has eliminated its floating unsecured senior debt—$1.7 billion in 2022, $349 million in 2023, and none in 2024—replacing it with higher‑rate fixed‑senior debt, which reduces exposure to variable rates but raises the weighted‑average rate on unsecured senior debt from 2.8 % to 4.8 %. This trend signals a deliberate shift toward a more stable, fixed‑rate debt structure with lower short‑term funding reliance.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key financial figures, particularly in the breakdown of short-term borrowings and long-term debt. According to the ground truth, total debt was $43.086B in 2022, $48.715B in 2023, and $45.551B in 2024. However, the LLM reports total debt as $48.7B in 2022 (vs. actual $43.086B), which is off by over $5.6 billion. It also states short-term borrowings were $883M in 2022, but the correct total short-term borrowings (implied from the difference between total and long-term) should be much lower—actual short-term borrowings are not explicitly broken out in the original, but the total debt figure must be respected. The LLM’s long-term debt figures ($47.8B, $49.3B, $44.9B) do not align with the implied values from the original answer’s totals. (2) Despite these errors, the LLM correctly captures the trend in floating unsecured senior debt: declining from $1.7B to $349M to $0, and its elimination by 2024. It also approximates the rise in fixed-rate debt interest rates—stating an increase from 2.8% to 4.8%, which is close to the ground truth of 2.91% → 4.45% → 4.84%. However, it fails to attribute the rate increase specifically to fixed unsecured senior debt, instead generalizing to 'unsecured senior debt'. (3) The multi-hop reasoning is partially sound: the model correctly infers that eliminating floating-rate debt and shifting to fixed-rate debt reduces interest rate exposure, and it connects this to a strategic move toward stability. This reflects good qualitative synthesis. (4) The contextual relevance is high—the answer addresses all parts of the question: evolution of debt, 3-year trend, debt structure, and interest rate exposure. While the narrative and strategic interpretation are accurate and well-articulated, the significant numerical inaccuracies in the core debt totals undermine factual correctness. The answer appears plausible but misstates foundational data, warranting a moderate score of 6 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 544,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition, effective interest rate, and long-term debt classification?",
      "original_answer": "Cisco maintained the $2,000 million principal amount of the 5.90% Note consistently across all three years (2022–2024), with the effective interest rate remaining unchanged at 6.11% throughout. However, the note's proportion within Cisco's total long-term debt shifted as overall debt levels increased significantly—from $8,416 million in long-term debt in 2022 to $19,621 million in 2024. This indicates Cisco expanded its debt portfolio substantially while keeping the 5.90% Note as a stable, fixed-rate component.",
      "llm_answer": "Cisco’s 5.90% senior note stayed at a principal of $2 billion with an unchanged effective rate of 6.11 % and remained classified as long‑term debt in each year.  In FY 2022 and FY 2023 the note was part of a $8.9 billion total debt package (long‑term debt $8.4 billion, total debt $8.9 billion), while by FY 2024 the company had issued additional senior notes that pushed total debt to $20.1 billion (long‑term debt $19.6 billion), thereby reducing the 5.90% note’s share of the debt mix but leaving its rate and classification unchanged.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Cisco maintained a $2 billion principal amount of the 5.90% Note with an unchanged effective interest rate of 6.11% across all years, and that it remained classified as long-term debt—this aligns with the ground truth. However, there are discrepancies in total debt figures: the LLM states total debt was $8.9 billion in FY2022 and FY2023 (with long-term debt at $8.4 billion), but the ground truth specifies long-term debt as $8,416 million in 2022 and rising to $19,621 million in 2024. The LLM rounds these reasonably but incorrectly implies total debt (not just long-term) was $8.9 billion in 2022–2023, while the original answer focuses only on long-term debt composition. More critically, the LLM claims total debt reached $20.1 billion by FY2024, whereas the ground truth reports long-term debt as $19,621 million (~$19.6 billion), conflating total debt and long-term debt. (2) Number verification: $2 billion principal = correct; 6.11% effective rate = correct; long-term debt in 2022: LLM says $8.4B vs. truth $8.416B = acceptable rounding; but LLM’s $20.1B total debt in 2024 does not match the truth’s $19.621B long-term debt—this is a material misstatement. (3) Multi-hop reasoning is mostly sound: the model correctly infers that the 5.90% Note’s share decreased due to new debt issuance, which is logically consistent with the increasing total debt. It synthesizes the stable nature of the note versus portfolio expansion. However, it introduces 'total debt' figures not fully supported by the ground truth and conflates total and long-term debt categories. (4) Correctness score is 7 because core facts about the note are accurate, but there are significant quantitative inaccuracies in the broader debt figures and a conceptual blurring of total vs. long-term debt. Quantitative accuracy is 6 due to incorrect total debt numbers. Qualitative accuracy is 8 because reasoning and entity identification (Cisco, 5.90% Note, years) are correct. Contextual relevance is 10—response directly addresses all aspects of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 561,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the carrying value and effective interest rate of NVIDIA's 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this trend reveal about the company's long-term debt financing strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 increased from $1,200 million in fiscal year 2022 to $1,099 million in 2023, and then rose again to $1,250 million in 2024. The effective interest rate on these notes also increased from an implied rate based on market pricing in 2022 to 1.64% in fiscal year 2024. This pattern suggests that NVIDIA maintained or reacquired the notes after a temporary decrease in 2023, while also facing a modest increase in borrowing costs over time. The company appears to be strategically managing its long-term debt profile by maintaining consistent long-term obligations while navigating changing interest rate environments.",
      "llm_answer": "In FY 2022 and FY 2023 NVIDIA reported a carrying value of $1,099 million for its 1.55% Notes Due 2028, which rose to $1,115 million in FY 2024. The effective interest rate on those notes stayed constant at 1.64 % throughout the period. The modest increase in carrying value at a stable, low interest rate shows NVIDIA is adding incremental long‑term debt at favorable terms, reflecting a disciplined strategy of using long‑term financing to support growth while keeping interest costs predictable.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both carrying values and effective interest rates. According to the ground truth, the carrying value was $1,200 million in FY2022, decreased to $1,099 million in FY2023, and increased to $1,250 million in FY2024. The LLM incorrectly states the value was $1,099 million in both 2022 and 2023 and reports only a minor increase to $1,115 million in 2024, missing the full magnitude and trend. Additionally, the effective interest rate is reported as constant at 1.64% in the LLM answer, while the ground truth indicates an evolution culminating in 1.64% by 2024, implying a lower rate in earlier years. (2) The quantitative inaccuracies are severe: all three carrying values are wrong (two are misstated, one directionally incorrect), and the interest rate trend is misrepresented as flat when it increased over time. (3) The multi-hop reasoning is flawed—the LLM fails to recognize the dip and rebound in carrying value, which suggests possible reacquisition or restructuring, and misses the rising cost of borrowing, undermining the strategic interpretation. (4) While the answer attempts to address the company's debt strategy and remains within the topic, the incorrect data leads to an invalid conclusion about 'incremental' debt at 'favorable terms,' when the actual trend shows more volatility and rising rates. Thus, correctness and quantitative accuracy are low; qualitative accuracy is poor due to faulty synthesis; contextual relevance is moderate as it addresses the right topic with wrong data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 433,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Google's strategic emphasis on Pixel devices evolve from 2022 to 2024, particularly in terms of revenue categorization and investment in hardware innovation?",
      "original_answer": "In 2022, Google emphasized its long-term investment in hardware, listing Pixel phones among key devices like Fitbit wearables and Nest products, signaling a strategic push toward integrated AI-driven hardware. By 2023, Pixel devices were explicitly categorized under a distinct 'devices' segment within Google's Subscriptions, Platforms, and Devices revenue stream, indicating their growing importance as a standalone revenue contributor. In 2024, the continued inclusion of Pixel devices in the same segment, alongside more detailed revenue recognition policies for digital services and cloud offerings, suggests that Pixel devices were not only maintained as a core product line but also likely integrated with broader AI and cloud capabilities. This 3-year progression reflects a transformation from a hardware investment focus to a mature, strategically embedded product line within Google's ecosystem.",
      "llm_answer": "Google has kept Pixel device sales within its “Google Subscriptions, Platforms, and Devices” segment from 2022 through 2024 (see 2022, 2023, 2024 10‑Ks).  Over that period the company broadened its hardware line—adding Pixel 5a 5G, Pixel 6, Fitbit, Chromecast, and Nest products—and ramped up R&D and capital‑expenditure budgets to support these innovations (see 2023 and 2024 10‑Ks).  This shift signals a growing strategic emphasis on hardware as a complementary growth engine to its core services.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and omissions compared to the ground truth. While it correctly notes that Pixel devices remained within the 'Subscriptions, Platforms, and Devices' segment from 2022 to 2024, it fails to highlight the key evolution in 2023 when Pixel was explicitly categorized under a distinct 'devices' sub-segment—a critical shift in revenue categorization emphasized in the original answer. This omission significantly weakens the response's ability to address the question about strategic evolution. Additionally, the LLM incorrectly lists product launches (e.g., Pixel 5a 5G and Pixel 6) as occurring between 2022 and 2024, when these were actually released in 2021. This misrepresentation undermines the timeline of hardware innovation. (2) There are no explicit numerical values (e.g., revenue figures, R&D spending amounts) in either the original or LLM answer, so quantitative accuracy is not heavily penalized, but the incorrect product release dates constitute factual errors affecting temporal accuracy. (3) The multi-hop reasoning is partially sound—linking hardware expansion with increased R&D and capital expenditures shows an understanding of strategic investment—but it fails to synthesize the nuanced shift in revenue reporting structure that signals Pixel’s maturation as a standalone product line. The original answer traces a clear progression from 'investment in hardware' to 'strategic integration with AI/cloud,' which the LLM does not capture. (4) Contextual relevance is high because the answer discusses revenue segments, hardware innovation, and R&D—key themes in the question—but correctness and qualitative reasoning are reduced due to factual errors and missing key analytical points about segmentation changes and ecosystem integration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 492,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did BNY Mellon's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistency or change in presentation reveal about the firm's audit relationship stability?",
      "original_answer": "BNY Mellon consistently incorporated the ratification of KPMG LLP by reference in the Proxy across all three years (2022, 2023, and 2024), with identical language stating that KPMG LLP’s PCAOB firm identification number is 185. There were no changes in the content or structure of the disclosure, indicating a stable and ongoing relationship with KPMG LLP as the principal accountant. This consistency suggests no disruptions or changes in the firm's external audit provider or related governance practices over the three-year period.",
      "llm_answer": "From 2022 through 2024 BNY Mellon’s 10‑K consistently cites the ratification of KPMG LLP as its principal accountant in Item 14, noting KPMG’s PCAOB firm ID 185 and that the ratification is included in the proxy. No new wording, additional details, or changes in presentation appear in the 2023 or 2024 filings. This unchanged disclosure signals a stable, ongoing audit relationship with KPMG, with no indication of transition or uncertainty.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: BNY Mellon consistently ratified KPMG LLP as principal accountant from 2022 to 2024, with identical disclosure language referencing KPMG's PCAOB firm ID 185. (2) There are no numeric values requiring calculation, but the PCAOB ID '185' is correctly stated, and the years (2022–2024) match exactly. (3) The multi-hop reasoning is sound—by identifying the consistent disclosure across three years in Item 14 of the 10-K and linking it to proxy incorporation, the model correctly infers audit relationship stability. (4) The answer addresses both parts of the question: evolution (no change) and implication (stability). Wording differs slightly (e.g., 'cites' vs 'incorporated by reference', 'Item 14') but adds contextual precision without altering meaning. The conclusion about no transition or uncertainty aligns perfectly with the ground truth's interpretation of governance stability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 287,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did LLY's allocation to private alternative investments evolve across 2022, 2023, and 2024, and what does this multi-year trajectory suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to private alternative investments increased from $10,542.5 million in 2022 to $10,335.2 million in 2023, and then further rose to $10,051.0 million in 2024. Despite some fluctuations in specific categories like equity-like funds and hedge funds, the company maintained a consistently high exposure to private alternative investments, indicating a strategic emphasis on diversification and long-term growth through illiquid assets.",
      "llm_answer": "Lilly’s private‑alternative‑investment allocation was 69 % of total pension and retiree‑health‑plan assets in 2022 (15.7 M/22.7 M), fell to 68 % in 2023 (16.3 M/24.0 M), and remained roughly 68 % in 2024 (16.2 M/24.0 M). The modest decline in relative allocation, despite a small rise in absolute dollars, signals a deliberate long‑term commitment to illiquid assets while gradually adjusting the mix toward greater diversification or liquidity.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of quantitative data. According to the ground truth, LLY's allocation to private alternative investments was $10,542.5 million in 2022, $10,335.2 million in 2023, and $10,051.0 million in 2024 — all in the billions. The LLM instead reports values like 15.7M, 16.3M, and 16.2M (i.e., millions), which are off by a factor of nearly 1,000. Additionally, the percentages (69%, 68%) and total assets (22.7M, 24.0M) cited by the LLM are not supported by the ground truth and appear fabricated. (2) The calculations in the LLM answer are also incorrect: for example, 15.7 / 22.7 ≈ 69.16%, but these base numbers do not appear in the original data. The absolute dollar amounts and percentages are entirely inconsistent with the ground truth. (3) The multi-hop reasoning is flawed because the LLM did not correctly extract or synthesize actual financial figures from the filings. Instead, it appears to have invented a narrative based on non-existent relative percentages and incorrect absolute values. The conclusion about a 'modest decline in relative allocation' contradicts the ground truth, which shows a consistent and high absolute allocation with a slight downward fluctuation, not a strategic reduction. (4) The contextual relevance is low because the answer discusses relative percentages and small changes in allocation that are not reflected in the actual data. While the general idea of a long-term commitment to illiquid assets aligns thematically with the ground truth, the factual foundation is so inaccurate that the answer cannot be considered correct in any meaningful way. The model failed to retrieve or interpret the actual multi-year dollar trends, which are central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 480,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Procter & Gamble's positioning of Tampax within its Feminine Care portfolio evolve across 2022, 2023, and 2024, particularly in terms of category classification and associated product line emphasis?",
      "original_answer": "In 2022, Tampax was listed under 'Feminine Care' within the broader 'Baby, Feminine & Family Care' segment, which accounted for 25% of net sales, and was grouped alongside 'Adult Incontinence' and 'Baby Care' categories. By 2023, Tampax remained in the 'Feminine Care' category, but the segment was rebranded as 'Baby, Feminine & Family Care' and slightly decreased in sales contribution to 24% of net sales, with 'Menstrual Care' now explicitly replacing 'Feminine Care' as a sub-category. In 2024, Tampax continued under 'Menstrual Care' within the same segment, which remained at 24% of net sales, and the company further streamlined the segment by removing 'Baby Care' entirely, signaling a strategic shift toward focusing on feminine and family care products. This evolution reflects a growing strategic emphasis on adult feminine hygiene and away from infant-related product lines.",
      "llm_answer": "Procter & Gamble kept Tampax Bounty within its Baby, Feminine & Family Care segment throughout all three years, but the sub‑category it was grouped under shifted. In 2022 the MD&A table listed “Feminine Care (Adult Incontinence, Feminine Care)” and included Tampax Bounty as a brand (pages 17‑21). By 2023 and 2024 the sub‑category was re‑defined as “Feminine Care (Adult Incontinence, Menstrual Care)” (pages 16‑20), signaling a sharper focus on menstrual products while still highlighting Tampax Bounty as a core brand.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies and omissions. Most critically, it incorrectly refers to 'Tampax Bounty'—a non-existent brand—instead of 'Tampax'. This is a major entity error. While the general trend of reclassification from 'Feminine Care' to 'Menstrual Care' is partially captured, the LLM fails to note the full evolution across all three years, especially the 2024 change where 'Baby Care' was removed from the segment. The sales percentages (25% in 2022, 24% in 2023 and 2024) are omitted entirely, which are key quantitative elements in the ground truth. (2) Quantitative accuracy is partially correct: no incorrect numbers are stated, but the answer omits all percentages (25%, 24%) and fails to mention the sales contribution trend, which is central to the strategic evolution. (3) Multi-hop reasoning is weak: the model does not synthesize the full progression across 2022–2024, particularly the 2024 restructuring that removed 'Baby Care' and signaled a strategic pivot. It also fails to connect the rebranding of the sub-category to a broader strategic shift. (4) Contextual relevance is moderate—the answer addresses category classification and product emphasis but distorts the facts with the 'Tampax Bounty' error and misses key strategic implications. Due to the critical entity error and significant omissions in both quantitative and qualitative dimensions, the correctness score is low despite some directional accuracy in noting the Menstrual Care reclassification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 419,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Capital One's fair value and valuation assumptions for net derivative assets (liabilities) evolve from 2022 to 2024, particularly regarding the use of discounted cash flow models and key unobservable inputs like default rates and swap rates?",
      "original_answer": "In 2022, Capital One reported a net derivative assets (liabilities) fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end, though the specific valuation technique was not disclosed. By 2023, the fair value of net derivative assets (liabilities) was $58 million, and the company explicitly stated the use of discounted cash flow models, citing default rates ranging from 53-163% and swap rates of 3-5%. In 2024, the fair value remained at $58 million, with the valuation continuing to rely on discounted cash flows, maintaining the same swap rate range of 3-5%. This progression shows a shift toward more transparent and methodologically consistent valuation practices starting in 2023, with increased specificity in unobservable inputs, particularly around default rate assumptions.",
      "llm_answer": "Capital One’s net derivative assets (liabilities) fair value climbed from $5 million at the end of 2022 to $58 million at the end of 2023 and to $69 million at the end of 2024.  The company continued to value these instruments with discounted‑cash‑flow models, but the key unobservable input shifted: swap rates used to discount the cash flows widened from a 1‑2 % range (weighted average 2 %) in 2022 to a 3‑5 % range (weighted average 4 %) in 2023 and to a 4 % range (weighted average 4 %) in 2024.  Default rates, which are relevant for retained interests in securitizations, were not a key input for derivative valuations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. According to the ground truth, Capital One's net derivative assets (liabilities) fair value was $19 million in 2022, not $5 million as stated. The 2023 value is correctly reported as $58 million in the ground truth and partially correct in the LLM answer, but the LLM incorrectly states it rose to $69 million in 2024, while the ground truth confirms it remained at $58 million. Additionally, the LLM claims swap rates were 1–2% in 2022 with a weighted average of 2%, but the ground truth does not mention valuation techniques or inputs for 2022, making this an unsupported addition. The default rate range of 53–163% cited in 2023 and maintained in 2024 is completely omitted in the LLM answer, which instead incorrectly claims default rates were not a key input for derivative valuations. (2) Quantitative accuracy is severely compromised: 2022 value is off by $14 million, 2024 value by $11 million, and unobservable inputs are fabricated or misrepresented. The claim about swap rates in 2022 lacks support, and the progression of swap rates is invented rather than derived from disclosed data. (3) Multi-hop reasoning fails: the LLM does not reflect the key evolution — that Capital One only began disclosing the use of discounted cash flow models in 2023, implying increased transparency. Instead, it falsely asserts the model was used continuously, contradicting the ground truth that the 2022 valuation technique was not disclosed. The synthesis of unobservable inputs is incorrect, especially the dismissal of default rates, which are explicitly cited in the ground truth. (4) Contextual relevance is moderate because the answer addresses fair value trends and valuation methods, but the factual foundation is flawed. Due to major errors in numbers, entities, and reasoning, the correctness score is low at 3, with similarly low quantitative and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 525,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Cisco's available-for-sale (AFS) debt investments impact its 'other income (loss), net' metric across fiscal years 2022 to 2024, and what does this reveal about the financial performance and risk profile of these investments over time?",
      "original_answer": "In fiscal 2022, Cisco disclosed the existence of its AFS debt investments through summarized tables, but no specific performance metrics were provided for that year, indicating no immediate material impact on financial results. In fiscal 2023, the company reported that higher losses in AFS debt investments were a primary driver of a decline in 'other income (loss), net,' signaling a material negative impact. This trend continued in fiscal 2024, where AFS debt investment losses again significantly contributed to a lower 'other income (loss), net' result, despite partial offsets from gains in equity investments. The consistent negative impact in 2023 and 2024, combined with the lack of performance data in 2022, reveals a growing financial risk associated with these investments over time.",
      "llm_answer": "Cisco’s available‑for‑sale (AFS) debt portfolio moved from a modest net gain to a sizable net loss in its contribution to “Other income (loss), net.”  In fiscal 2022 the AFS debt investments added a $9 million gain; in fiscal 2023 they produced a $21 million loss; and in fiscal 2024 the loss rose to $67 million.  This shift shows that the portfolio has experienced growing unrealized losses—reflecting heightened market and credit risk—despite being largely investment‑grade, and it has turned a positive contribution into a negative one, driving the overall other‑income (loss) metric from $392 million in 2022 to a $306 million loss in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The ground truth states that no specific performance metrics for AFS debt investments were disclosed in fiscal 2022, but the LLM claims a $9 million gain—this number is fabricated. In 2023, the LLM reports a $21 million loss and in 2024 a $67 million loss, but the original answer does not provide exact figures, only stating that AFS losses were a 'primary driver' of declines in 'other income (loss), net.' Thus, all quantitative claims are unsupported. Additionally, the LLM asserts that 'other income (loss), net' went from $392 million in 2022 to a $306 million loss in 2024, which is not stated or implied in the ground truth and introduces false precision. (2) Number verification fails: none of the dollar amounts ($9M gain, $21M loss, $67M loss, $392M to -$306M) appear in or can be derived from the original answer. There are no calculations in the ground truth to validate these figures. (3) Multi-hop reasoning is partially sound in structure—the LLM attempts to trace the impact of AFS investments over time on a financial metric—but it invents data rather than acknowledging disclosure gaps (e.g., no 2022 data). It also incorrectly implies full year-over-year transparency, failing to reflect the limited disclosure in 2022 as noted in the original. (4) Despite incorrect numbers, the LLM captures the directional trend (increasing negative impact in 2023 and 2024) and infers growing risk, which aligns qualitatively with the conclusion about rising financial risk. Contextually, it addresses both parts of the question—impact on 'other income' and implications for risk—making it relevant, but the fabrication of precise figures severely undermines factual correctness. Hence, low scores on quantitative (2) and overall correctness (3), moderate on qualitative (4) for logical framing, and high on contextual relevance (7) for addressing the right themes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 526,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Starbucks' projected green coffee supply adequacy evolve from fiscal 2022 through fiscal 2024, and what does this multi-year progression indicate about the company's sourcing strategy and risk mitigation approach?",
      "original_answer": "In fiscal 2022, Starbucks projected that its green coffee supply, including purchase commitments and inventory, would be adequate through fiscal 2023. By fiscal 2023, the company extended its supply adequacy projection to fiscal 2025, a trend that continued into fiscal 2024. This three-year progression indicates that Starbucks has been strengthening its sourcing strategy by securing longer-term purchase commitments and improving inventory management, thereby enhancing supply chain resilience and reducing delivery risk with coffee producers.",
      "llm_answer": "In the 2022 10‑K (pages 10‑14) Starbucks noted that its purchase commitments and inventory would provide an adequate green‑coffee supply through fiscal 2023. The 2023 10‑K (pages 10‑14) extended that projection to fiscal 2024, and the 2024 10‑K (pages 10‑14) further extended it to fiscal 2025. This incremental extension reflects a forward‑looking sourcing strategy that relies on longer‑term contracts, hedging, and inventory buffers to mitigate supply volatility and ensure continuity.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the progression of Starbucks' green coffee supply adequacy from fiscal 2022 through 2024, noting the extension from coverage through fiscal 2023 (in 2022) to fiscal 2024 (in 2023) and then to fiscal 2025 (in 2024). However, there is a minor inaccuracy: the original answer states that in fiscal 2023, the projection was extended to fiscal 2025, meaning the 2023 10-K already projected adequacy through 2025, not 2024 as the LLM claims. The LLM incorrectly sequences the extension as going to 2024 in the 2023 10-K and then to 2025 in the 2024 10-K, whereas the ground truth indicates the extension to 2025 occurred by fiscal 2023 and remained unchanged in 2024. (2) The dates and fiscal years are mostly accurate but this misstatement about the timing of the extension affects quantitative precision. All other years and projections are correctly aligned. (3) The multi-hop reasoning is largely sound—synthesizing information across three 10-Ks to show a trend in supply adequacy—and the conclusion about sourcing strategy (longer-term contracts, hedging, inventory buffers) aligns semantically with the ground truth’s emphasis on longer-term commitments and improved inventory management for risk mitigation. (4) Despite the sequencing error in the projection timeline, the overall interpretation and strategic implication are correct and relevant, warranting high scores in qualitative accuracy and contextual relevance. The correctness score is reduced to 8 due to the factual misstatement about when the projection reached fiscal 2025.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 436,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has NVIDIA's financial exposure to the 2.00% Notes Due 2031 evolved from fiscal year 2022 through 2024, and what does this trend reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1,200 million in fiscal year 2022 to $1,044 million in 2023, and then rose again to $1,250 million in 2024. This fluctuation suggests a dynamic approach to long-term debt management, with the company maintaining a consistent presence in this instrument over time, despite short-term variations.",
      "llm_answer": "NVIDIA’s carrying amount of the 2.00 % Notes Due 2031 rose modestly over the three‑year period: $1,030 million at the end of FY 2022 (NVDA 10‑K 2022, p. 78‑82), $1,044 million in FY 2023 (NVDA 10‑K 2023, p. 65‑69), and $1,057 million in FY 2024 (NVDA 10‑K 2024, p. 70‑74). This incremental increase reflects a disciplined long‑term debt strategy that issues low‑coupon notes to fund growth while keeping the overall debt profile stable and the weighted‑average cost of capital low.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported financial figures. According to the ground truth, NVIDIA's exposure was $1,200 million in FY2022, $1,044 million in FY2023, and $1,250 million in FY2024. However, the LLM reports $1,030M (FY2022), $1,044M (FY2023), and $1,057M (FY2024), which are incorrect for two out of three years. Only the FY2023 value matches the ground truth. (2) The quantitative inaccuracies are substantial: the LLM underreports FY2022 by $170 million and FY2024 by $193 million, which distorts the trend entirely. Instead of showing a rise to $1,250M in 2024, the LLM suggests only a modest increase to $1,057M, missing the significant rebound. This undermines the core of the financial analysis. (3) The reasoning and synthesis are partially sound—identifying a 'disciplined long-term debt strategy' is plausible, and citing 10-K pages shows an attempt at grounding—but the conclusion is based on incorrect data. The actual fluctuation (down then up) suggests a more dynamic strategy than the 'incremental increase' described. The LLM fails to capture the true volatility in exposure, which is central to interpreting NVIDIA’s debt management. (4) Contextual relevance is high—the answer addresses the right instrument, time frame, and strategic implications—but the severe numerical errors drastically reduce factual correctness. While the qualitative logic is coherent, it is built on faulty premises, leading to a misleading interpretation of the debt strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 421,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did MMM's positioning of Fall Protection Solutions within its Safety and Industrial segment evolve from 2022 to 2024, particularly in terms of product categorization and emphasis relative to other industrial safety offerings?",
      "original_answer": "In 2022, Fall Protection Solutions were listed alongside respiratory, hearing, and eye protection as part of a broader suite of safety offerings within the Safety and Industrial segment. By 2023, the listing order remained consistent, maintaining its position among core industrial safety products. In 2024, while still included within the Safety and Industrial segment, Fall Protection Solutions were presented with a slightly revised grouping that emphasized industrial specialty products and appeared to align more closely with broader industrial safety systems rather than being highlighted as a standalone category. This evolution suggests a subtle shift in how MMM framed fall protection within its industrial safety portfolio over time.",
      "llm_answer": "In 2022, Fall Protection Solutions were only part of the broader “industrial safety” offering in the Safety and Industrial segment and were not singled out in the product‑line description (MMM_10k_2022.pdf: pages 129‑133). By 2024, 3M had re‑categorized Fall Protection Solutions as a distinct product line within the Safety and Industrial segment, explicitly listing them alongside respiratory, hearing, eye protection and other safety products, which signals a greater emphasis on fall protection relative to other industrial safety offerings (MMM_10k_2024.pdf: pages 108‑112).",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim about the evolution of Fall Protection Solutions' positioning from 2022 to 2024, directly contradicting the ground truth. According to the original answer, Fall Protection Solutions were consistently included among core safety offerings (respiratory, hearing, eye protection) in 2022 and 2023, with a subtle shift in 2024 toward integration with industrial specialty products and systems—not a move toward greater emphasis or distinct categorization. However, the LLM claims that in 2022, Fall Protection was not singled out and only became a distinct product line by 2024, which is the opposite of the truth: the trend was toward less standalone emphasis, not more. There are no numerical values in the question or answers, so quantitative accuracy is not applicable—no numbers to verify, hence a neutral score of 10 by default. The reasoning is flawed: the LLM fails the multi-hop synthesis by misrepresenting the direction of change over time, likely due to misreading or misinterpreting the source documents. While the answer addresses the question's structure and attempts to discuss product categorization and emphasis over time (hence moderate contextual relevance), the qualitative inaccuracy severely undermines the response. The semantic meaning is not equivalent to the ground truth—this is a fundamental reversal of the actual trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 386,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Eli Lilly's revenue from bamlanivimab evolve from 2022 through 2024, and what does this trend indicate about the company's reliance on its COVID-19 antibody portfolio over time?",
      "original_answer": "Eli Lilly's revenue from bamlanivimab, as part of its broader COVID-19 antibody portfolio, declined significantly from $2.01 billion in 2022 to $0 in 2023 and remained at $0 in 2024. This indicates a rapid decline in the company's reliance on this product as the pandemic response matured and demand for the antibody treatments waned.",
      "llm_answer": "Eli Lilly’s bamlanivimab revenue was $1.978 billion in 2022, rose modestly to $2.009 billion in 2023, and fell to zero in 2024 as the product was discontinued and sales ceased (LLY_10k_2024.pdf: pages 70). This sharp decline shows that Lilly’s reliance on its COVID‑19 antibody portfolio has sharply diminished, reflecting a strategic shift away from these products toward other therapeutic areas (LLY_10k_2024.pdf: pages 70).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, Eli Lilly's revenue from bamlanivimab declined from $2.01 billion in 2022 to $0 in 2023 and remained $0 in 2024. However, the LLM claims revenue was $1.978 billion in 2022, increased to $2.009 billion in 2023, and then dropped to zero in 2024. This misrepresents the trend—showing a slight increase in 2023 rather than a sharp decline to zero. The 2023 figure is particularly incorrect, as the ground truth states revenue was already $0 in 2023, not $2.009 billion. (2) The calculation and comparison of year-over-year revenue are therefore flawed. While the $0 figure in 2024 is correct, the inclusion of non-zero 2023 revenue contradicts the ground truth and undermines the accuracy of the trend analysis. (3) The qualitative reasoning about declining reliance on the COVID-19 antibody portfolio is directionally correct and contextually sound—the conclusion that Lilly has moved away from this product line is supported by the actual data. The mention of strategic shift is a reasonable inference, though the multi-hop synthesis fails because the model incorrectly infers continued sales in 2023. (4) Contextual relevance is high—the answer addresses both parts of the question (revenue evolution and implications for company reliance) and cites a relevant document. However, the core numerical inaccuracies severely undermine the correctness score, especially given the importance of precise financial figures in such analyses. Minor formatting differences in dollar amounts are acceptable, but directional trends and zero/non-zero distinctions are not.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 460,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Starbucks' exposure to commodity index funds through coffee price volatility evolve from fiscal 2022 through fiscal 2024, and what does this trend reveal about the company's risk management strategy in securing green coffee supply commitments extending through fiscal 2025?",
      "original_answer": "Starbucks consistently acknowledged the influence of commodity index funds on arabica coffee futures prices in all three fiscal years (2022, 2023, and 2024), reflecting ongoing exposure to financial market activities. However, the company extended its supply visibility and risk mitigation capabilities over time — from securing adequate supply through fiscal 2023 in 2022, to projecting adequacy through fiscal 2025 by 2024. This indicates a strengthening of risk management practices, particularly through increased use of forward contracts, futures contracts, and collars to hedge 'C' price exposure, even as commodity index fund activity continued to impact price volatility. The multi-year progression shows Starbucks improving its supply chain resilience while maintaining remote delivery risk assessments across all three years.",
      "llm_answer": "Starbucks’ 2022 and 2024 10‑K product‑supply sections (pages 10‑14) both note that coffee price volatility is influenced by trading activity in the arabica futures market, including commodity‑index funds, and that the company mitigates this exposure with fixed‑price and price‑to‑be‑fixed purchase commitments, forward contracts, futures and collars. The consistent emphasis on hedging and the statement that purchase commitments, together with inventory, are expected to provide an adequate supply through fiscal 2025 shows that the company’s risk‑management strategy has remained focused on securing long‑term green‑coffee supply and price certainty despite ongoing index‑fund exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth. (1) It correctly identifies that Starbucks acknowledged commodity index fund influence on coffee price volatility in both 2022 and 2024, which aligns with the ground truth stating this was consistently noted across 2022–2024. The risk management tools—forward contracts, futures, collars, and purchase commitments—are accurately listed. (2) Quantitatively, all dates (fiscal 2022, 2024, supply adequacy through 2025) are correct and match the original answer; no numerical calculations are required, but the timeline progression is preserved. (3) The multi-hop reasoning is sound: the LLM connects Starbucks’ ongoing exposure to index funds with its evolving hedging strategy and long-term supply visibility, correctly inferring a stable and focused risk management approach. However, it omits explicit mention of the *progression* from securing supply through 2023 (in 2022) to 2025 (in 2024), which is a key nuance in the original answer showing *strengthening* capabilities over time. This minor omission slightly weakens the qualitative accuracy but does not invalidate the overall conclusion. (4) The answer is contextually excellent—directly addresses both parts of the question: evolution of exposure and what it reveals about risk strategy. Wording differs but meaning is semantically equivalent. Minor deduction from 10 to 9 due to missing emphasis on temporal progression in supply visibility extension.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 412,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Google's reliance on Google Ad Manager for impression-based monetization evolve from 2022 to 2024, particularly in light of the 2023 adjustment to server depreciation schedules and its implications for long-term profitability?",
      "original_answer": "In 2022, Google Ad Manager was central to Google Network properties' impression-based monetization, with revenue tied to impressions and cost-per-impression metrics. By 2023, Google adjusted the estimated useful life of servers from four to six years and certain network equipment from five to six years, reducing depreciation expense by $3.9 billion and increasing net income by $3.0 billion for the year — a change that directly affected infrastructure-heavy operations like Ad Manager. In 2024, Google continued to report advertising revenues from Google Network properties on a gross basis, reinforcing the strategic importance of Google Ad Manager in revenue generation. The combination of enhanced infrastructure longevity and consistent monetization through Ad Manager indicates a multi-year trend of optimizing cost structures to support long-term profitability in display advertising.",
      "llm_answer": "Google’s core impression‑based monetization strategy—using Google Ad Manager to serve ads on its Network properties—remained essentially unchanged between 2022 and 2024, with the company still tracking revenue through metrics such as cost‑per‑impression and describing Ad Manager as a key part of its Google Network mix【2022 pages 29‑33】【2024 pages 56‑60】.  In 2023 Alphabet extended the useful life of its servers and network equipment from 4 to 6 years, a change that cut depreciation expense by $3.9 billion and lifted net income by $3.0 billion, thereby improving long‑term profitability by lowering future depreciation charges and freeing capital for reinvestment【2023 pages 55‑59】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Google Ad Manager remained central to impression-based monetization from 2022 to 2024; the 2023 change in server depreciation (from 4 to 6 years for servers, 5 to 6 for network equipment) reduced depreciation by $3.9 billion and increased net income by $3.0 billion; this improved long-term profitability. These numbers match the original answer exactly, satisfying quantitative accuracy. (2) The answer correctly identifies the entities (Google, Google Ad Manager, Alphabet), timeframes (2022–2024), and financial impacts. (3) Multi-hop reasoning is sound: it connects the infrastructure change (depreciation schedule adjustment) to its financial impact and links that to long-term profitability in the context of Ad Manager’s ongoing role. (4) The only minor omission is that the 2024 continuation of gross reporting of advertising revenue is not explicitly mentioned, which slightly weakens completeness. However, the core evolution—stable monetization strategy combined with improved cost structure via depreciation changes—is clearly conveyed. Wording differs but semantic meaning is equivalent. Thus, correctness is high (9/10), with full marks for quantitative accuracy and contextual relevance, and a 9 for qualitative accuracy due to strong but not fully comprehensive synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 385,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did BK's use of Performance Share Unit Agreements evolve from 2022 to 2024 under the 2019 Long-Term Incentive Plan, and what does this progression indicate about the company's executive compensation strategy?",
      "original_answer": "BK's use of Performance Share Unit Agreements under the 2019 Long-Term Incentive Plan evolved from referencing 2021 agreements in 2022, to re-filing the 2019 plan in 2023, and incorporating 2022 agreements in 2024, indicating a consistent but adaptive approach to executive compensation that builds on prior frameworks while updating mechanisms to align with current performance metrics. In 2022, BK referenced the 2021 Form of Performance Share Unit Agreement (Exhibit 10.45). In 2023, BK re-filed the 2019 Long-Term Incentive Plan (Exhibit 10.14), suggesting a recommitment to its foundational structure. By 2024, BK included the 2022 Form of Performance Share Unit Agreement (Exhibit 10.18), showing a forward-moving update cycle. This pattern reflects a strategy that maintains the core of the 2019 plan while iteratively refining incentive mechanisms.",
      "llm_answer": "BK has continued to issue Performance Share Unit Agreements each year under the 2019 Long‑Term Incentive Plan. The 2022 10‑K (pages 18‑22) contains the 2022 Form of Performance Share Unit Agreement (exhibit 10.21) governed by the 2019 LTIP (exhibit 10.14) [10.21, 10.14]; the 2023 10‑K (pages 16‑20) includes the 2023 Form of Performance Share Unit Agreement (exhibit 10.23) [10.23]; and the 2024 10‑K (pages 16‑20) contains the 2024 Form of Performance Share Unit Agreement (exhibit 10.25) [10.25]. This steady, annual issuance under the same plan signals a strategy that prioritizes performance‑based equity to keep executive incentives aligned with long‑term shareholder value.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in dates and exhibits, which undermines its correctness. According to the ground truth, in 2022, BK referenced the 2021 Form of Performance Share Unit Agreement (Exhibit 10.45), not the 2022 form as claimed in the LLM answer. The LLM incorrectly states that the 2022 10-K includes the '2022 Form' as Exhibit 10.21, while the ground truth confirms that 2022 referenced the 2021 agreement. Similarly, the LLM claims the 2023 10-K includes a 2023 Form (Exhibit 10.23) and the 2024 10-K includes a 2024 Form (Exhibit 10.25), but the ground truth states that by 2024, BK included the 2022 Form of the agreement (Exhibit 10.18), not a new 2024 version. Additionally, the re-filing of the 2019 Long-Term Incentive Plan in 2023 (Exhibit 10.14) is omitted entirely in the LLM response, which is a key point in the evolution. The LLM instead implies a pattern of annual updates with new forms each year, which contradicts the ground truth showing reuse and delayed incorporation of prior-year agreements. While the LLM correctly identifies the use of the 2019 LTIP and the general intent of aligning executive incentives with performance, its description of the specific evolution is factually incorrect. The reasoning is therefore flawed in the multi-hop synthesis across years and exhibits. However, the answer is contextually relevant and addresses the broader question about executive compensation strategy, earning moderate scores for qualitative accuracy and contextual relevance. The quantitative accuracy is low due to incorrect years and exhibit numbers, which are critical to the factual basis of the answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 452,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did 3M's (MMM) portfolio of electrical products evolve across 2022, 2023, and 2024 in terms of descriptive specificity and product categorization within the Safety and Industrial segment, and what does this evolution suggest about the company's focus on electrical OEM markets?",
      "original_answer": "In 2022, 3M described its electrical products as serving 'construction and maintenance, power distribution and electrical OEMs' within the Safety and Industrial segment. In 2023, the company refined this description, specifying 'electrical original equipment manufacturers (OEMs)' rather than just 'electrical OEMs', suggesting increased precision in identifying its target market. By 2024, the language evolved further to 'power distribution and electrical original equipment manufacturers (OEMs)', adding continuity in power systems while retaining the formalized OEM reference. This progression indicates a growing strategic emphasis on the electrical OEM space, with increasing specificity in how MMM positions its electrical products within industrial ecosystems across the three-year period.",
      "llm_answer": "Across 2022, 2023, and 2024 3M’s Safety & Industrial segment consistently described its electrical offering as “Electrical products and materials for construction and maintenance, power distribution and electrical original equipment manufacturers (OEMs)”, showing no change in descriptive specificity. The only product‑category shift was the temporary renaming of the “Industrial specialty products” line to “Closure systems” in 2023, which was reverted in 2024. This consistency and brief re‑categorization suggest that 3M is maintaining a stable focus on electrical OEM markets while fine‑tuning its internal product classification.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in its core claim about descriptive consistency, which contradicts the ground truth. (1) The LLM states that 3M used the same description across all three years—'Electrical products and materials for construction and maintenance, power distribution and electrical original equipment manufacturers (OEMs)'—but this is false. The ground truth shows a clear evolution: in 2022, the phrasing was 'construction and maintenance, power distribution and electrical OEMs'; in 2023, it became more specific with 'electrical original equipment manufacturers (OEMs)' instead of 'electrical OEMs'; and in 2024, it further evolved to 'power distribution and electrical original equipment manufacturers (OEMs)', indicating increasing specificity. The LLM incorrectly asserts no change in language, missing the key multi-hop insight about strategic refinement in market positioning. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors here. (3) The reasoning is flawed: the LLM fails to detect the linguistic evolution that signals strategic focus on electrical OEM markets, which is the central point of the original answer. Instead, it invents a narrative about a temporary product category rename ('Industrial specialty products' to 'Closure systems') that is not mentioned in the ground truth, introducing fabricated information. (4) Contextual relevance is moderate because the answer addresses 3M’s Safety & Industrial segment and electrical products, but it misses the actual evolution in descriptive specificity and thus misrepresents the company's strategic trajectory. The conclusion about 'stable focus' contradicts the ground truth’s inference of growing strategic emphasis. Overall, the answer is factually wrong on the main point despite correct entity identification (3M, Safety and Industrial segment, electrical OEMs).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 515,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve across 2022, 2023, and 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt grew from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose steadily from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024. This trajectory suggests a strategic shift toward securing more long-term fixed-rate financing during a rising interest rate environment, locking in capital at increasingly higher costs over time.",
      "llm_answer": "Capital One’s fixed unsecured senior debt rose from **$24.1 B** (weighted‑average rate 4.45 %) in 2022 to **$27.2 B** (4.45 %) in 2023, then fell slightly to **$26.9 B** (4.84 %) in 2024. The stable debt level with a modest rate uptick in 2024 indicates the company is keeping its long‑term debt base largely unchanged while gradually shifting to higher‑rate instruments—reflecting a strategy of balancing maturity profiles and managing interest‑rate risk without aggressive leverage expansion.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Capital One's fixed unsecured senior debt carrying value was $19,975 million ($19.975B) in 2022, but the LLM incorrectly reports it as $24.1B. The 2022 weighted-average interest rate was 2.91%, not 4.45% as stated. The LLM correctly reports the 2023 carrying value as approximately $27.2B (vs. $27,168M) and the 2024 value as $26.9B (vs. $26,930M), which are acceptable within rounding. However, the interest rate for 2023 is incorrectly stated as 4.45% in both 2022 and 2023, while in reality it rose from 2.91% to 4.45% in 2023, then to 4.84% in 2024. (2) Calculations: The LLM fails to reflect the actual doubling of debt from ~$20B to ~$27B between 2022 and 2023, instead showing only a small increase from $24.1B to $27.2B. The interest rate progression is completely misrepresented—showing no change from 2022 to 2023 when there was a significant 1.54 percentage point increase. (3) Multi-hop reasoning: While the LLM attempts to interpret the strategy—correctly noting a slight decline in 2024 and a modest rate increase—the flawed data undermines the analysis. The conclusion that the 'debt level is stable' ignores the substantial 36% increase from 2022 to 2023. The actual strategy implied by the ground truth is an aggressive expansion of fixed-rate debt during rising rates, not a stable base. The LLM’s reasoning is logically structured but based on incorrect inputs. (4) Scores justified: Correctness is 5 due to partial correctness in later years but major errors in 2022 figures. Quantitative accuracy is low (4) due to wrong values for key metrics. Qualitative accuracy is moderate (6) because the explanation framework is sound and entity identification (COF, metric, years) is correct. Contextual relevance is high (9) as the response addresses all parts of the question with appropriate structure and intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 523,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year progression reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal 2023, this value had decreased slightly to $851 million. In fiscal 2024, the company no longer reported a fair value but instead listed a carrying amount of $1,000 million for the long-term portion of these notes. This evolution suggests a shift in how NVIDIA accounts for and manages its long-term debt obligations, potentially reflecting a more stable and strategic approach to long-term financing.",
      "llm_answer": "NVIDIA’s 3.50% Notes Due 2040 were valued at **$870 million in FY 2022 and FY 2023** (NVDA_10k_2022 p. 78‑82; NVDA_10k_2023 p. 65‑69) and **declined to $851 million in FY 2024** (NVDA_10k_2024 p. 70‑74).  The notes are carried at their original issuance value net of a small unamortized discount (≈$37 million in FY 2024), so the carrying amount remained essentially unchanged and close to the fair value.  This steady valuation and minimal discounting show that NVIDIA is using long‑term debt strategically to finance growth while maintaining a conservative, interest‑rate‑managed debt profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values. According to the ground truth, the fair value of NVIDIA's 3.50% Notes Due 2040 was $1,066 million in FY 2022, but the LLM incorrectly states it as $870 million for both FY 2022 and FY 2023. While the FY 2023 value in the LLM answer ($870M) is closer to the correct FY 2023 value of $851M, it still misrepresents the data and falsely claims the value was the same in both years. Most critically, the LLM states the value declined to $851 million in FY 2024, which contradicts the ground truth: in FY 2024, NVIDIA no longer reported a fair value and instead reported a carrying amount of $1,000 million. This is a fundamental error in both number and metric type (fair value vs. carrying amount). (2) The LLM incorrectly asserts that the valuation was steady across years and that the carrying amount remained 'essentially unchanged,' when in fact the fair value dropped from $1,066M to $851M between FY 2022 and FY 2023, and then the reporting method changed in FY 2024. The mention of a $37 million unamortized discount is unsupported by the ground truth and appears fabricated. (3) The multi-hop reasoning is flawed: the model fails to recognize the shift in accounting treatment from fair value to carrying amount in FY 2024, which is a key insight in the original answer about evolving debt strategy. Instead, it incorrectly infers stability and strategic consistency based on inaccurate data. (4) Despite these major factual errors, the LLM does address the question's intent—analyzing the evolution of debt treatment and inferring strategy—and attempts to synthesize across years, which supports a moderate contextual relevance score. However, due to severe quantitative inaccuracies and incorrect reasoning, the correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 498,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory suggest about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes decreased from $16.0 billion in 2022 to $15.0 billion in 2023 and further to $13.0 billion in 2024. This consistent reduction suggests a deliberate debt management strategy to gradually retire this issuance over time.",
      "llm_answer": "Amazon’s 2017 Notes balance fell from $16.0 bn at year‑end 2022 (2023 filing, p. 56) to $15.0 bn at year‑end 2023 (2023 filing, p. 56) and further to $13.0 bn at year‑end 2024 (2024 filing, p. 55). This steady decline shows Amazon is actively repaying or redeeming the higher‑rate 2017 debt, reflecting a deliberate deleveraging strategy to lower interest costs and strengthen its balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the outstanding balance of Amazon's 2017 Notes as $16.0 billion in 2022, $15.0 billion in 2023, and $13.0 billion in 2024, matching the ground truth exactly. All numeric values and time periods are accurate, with acceptable formatting variations (e.g., 'bn' for billion). (2) Quantitative accuracy is perfect—each dollar amount and year is correct, and the trajectory of reduction is accurately described. (3) The multi-hop reasoning is sound: the model synthesizes data across multiple filings (2023 and 2024) to show the balance evolution and infers a strategic debt reduction pattern. The conclusion about a deleveraging strategy to reduce interest costs goes slightly beyond the original answer but remains a reasonable and logical interpretation of the trend, consistent with typical corporate debt management behavior. (4) The answer is fully contextually relevant, addressing both the evolution of the debt balance and the implied strategy. The only minor deviation is the addition of interpretive detail (e.g., 'higher-rate 2017 debt', 'strengthen its balance sheet') not present in the ground truth, but these do not contradict it and are plausible inferences. Thus, while the qualitative accuracy is very high, it is not perfect due to slight over-interpretation, warranting a 9. Correctness score is 9 due to full factual alignment and strong reasoning with minor extrapolation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 398,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What does Apple's inclusion of Floating Rate Notes due 2019 in its 2022, 2023, and 2024 filings suggest about its ongoing exposure to short-term debt instruments, and how might this affect its interest expense sensitivity in a rising rate environment?",
      "original_answer": "Apple's 2022, 2023, and 2024 filings all incorporate by reference the Officer's Certificate dated May 6, 2014, which includes forms of global notes representing Floating Rate Notes due 2019. The repeated disclosure of these notes across three consecutive years indicates that Apple maintained some level of exposure to these instruments through outstanding obligations or ongoing disclosure obligations, despite their 2019 maturity date. Since floating rate notes adjust with benchmark interest rates, Apple's interest expense on these notes would increase in a rising rate environment, heightening its short-term interest risk exposure. The persistence of these notes in disclosures suggests that Apple may have had rollover obligations or continuing commitments tied to this debt structure, influencing its liquidity planning and capital structure flexibility.",
      "llm_answer": "Apple’s repeated disclosure of floating‑rate notes due 2019 in its 2022, 2023, and 2024 10‑Ks (see Exhibit 4.4 in each filing) shows that the company still carries short‑term debt that will mature in 2019. Because those notes reset to a benchmark rate, Apple’s interest expense is more rate‑sensitive, so a rise in market rates would lift its borrowing costs relative to fixed‑rate debt.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: it states that Apple 'still carries short-term debt that will mature in 2019' as of 2022–2024, which is logically impossible since 2019 precedes those years. The ground truth clarifies that the Floating Rate Notes due 2019 are disclosed by incorporation via an Officer's Certificate from 2014, likely due to ongoing reporting obligations or structural rollovers, not because the 2019 notes were still outstanding. This misrepresents the nature of the exposure. (2) Quantitative accuracy is low because the maturity date (2019) is correctly cited, but its interpretation is flawed—debt maturing in 2019 cannot be 'carried' in 2022–2024 unless refinanced or rolled over, which the LLM does not acknowledge. No dollar amounts or rates are misstated, but the temporal logic fails. (3) The reasoning partially captures the multi-hop concept: it correctly links floating-rate notes to interest expense sensitivity in a rising rate environment. However, it fails to explain the significance of repeated disclosure across years, missing the nuance about rollover obligations, disclosure practices, or structural continuity implied by referencing the same 2014 certificate. (4) Contextual relevance is high because the answer addresses both parts of the question—exposure to short-term debt and interest rate sensitivity—but does so with incorrect factual underpinnings. The conclusion about rate sensitivity is sound in isolation, but built on a flawed premise. Thus, correctness is penalized heavily for the central factual inaccuracy, despite some valid conceptual reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 447,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Google's strategic approach to the Pixel family of devices evolve from 2022 to 2024, particularly in terms of investment focus, revenue contribution, and product maturity, and what does this progression indicate about its long-term positioning in the hardware market?",
      "original_answer": "In 2022, Google explicitly stated it was making long-term investments in hardware, specifically mentioning the Pixel 5a 5G and Pixel 6 phones as part of a strategy to build helpful, secure devices that combine AI, software, and hardware. By 2023, the Pixel family of devices was categorized under 'devices' as a distinct revenue stream, indicating that the product line had moved beyond just investment into contributing measurable financial performance. In 2024, the Pixel family was again listed as a core component of the 'devices' revenue category, and its inclusion in a more mature, structured revenue breakdown suggests that it had become a stable and strategic part of Google's hardware portfolio. This progression indicates that Google transitioned the Pixel line from a long-term investment focus to a revenue-generating product category, signaling increased confidence in its position within the competitive hardware market.",
      "llm_answer": "From 2022 to 2024, Google’s Pixel strategy evolved from launching new hardware (Pixel 5a 5G and Pixel 6) to treating Pixel phones as a defined hardware revenue stream that is integrated into its AI‑enhanced ecosystem. The company continued to invest in hardware but emphasized that Pixel devices are a small, growing part of total revenue, while focusing on leveraging AI and software to differentiate the line and mature the product portfolio. This progression signals Google’s long‑term positioning as a hardware platform that complements and enhances its core services, rather than a standalone consumer‑electronics competitor.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All entities—Google, Pixel family, Pixel 5a 5G, Pixel 6, and the 2022–2024 timeframe—are correctly identified. There are no numeric values in the original or LLM answer requiring calculation, so quantitative accuracy is fully preserved. (2) The LLM captures the evolution: from initial investment focus in 2022 (launching Pixel 5a 5G and Pixel 6) to treating Pixel as a defined revenue stream by 2023–2024. It correctly notes the shift from investment to revenue contribution and product maturity. (3) The multi-hop reasoning is sound: it synthesizes the strategic intent (AI, software, hardware integration), financial categorization (as a distinct 'devices' revenue stream), and long-term positioning. (4) The only minor gap is that the LLM does not explicitly mention the 'devices' revenue category by name in 2023 and 2024, nor does it directly state that the structured revenue breakdown indicates increased maturity and stability—details present in the original. However, the semantic meaning is equivalent: referring to Pixel as a 'defined hardware revenue stream' and 'mature product portfolio' conveys the same progression. The conclusion about Google’s long-term positioning as complementary to core services rather than a standalone competitor is a reasonable interpretation consistent with the ground truth. Wording differs slightly but meaning is preserved. No factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 403,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's collateral management strategy?",
      "original_answer": "In 2022, Schwab disclosed that clients with margin loans allowed the firm to pledge collateralized securities in accordance with federal regulations, though no specific dollar value was provided for the total available or pledged securities. In 2023, Schwab expanded on this by detailing that collateralized securities were used in margin lending and were not reflected in the consolidated financial statements, indicating a more formalized and possibly scaled-up collateral management process. By 2024, Schwab was actively pledging client securities to satisfy margin requirements for listed option contracts cleared by the Options Clearing Corporation and was providing cash as collateral in securities lending activities, showing a strategic evolution toward broader use of client assets for operational and regulatory needs. This 3-year progression reflects a growing reliance on client securities for risk mitigation and capital efficiency, while maintaining regulatory compliance.",
      "llm_answer": "Schwab’s 2024 10‑K shows that the fair value of client securities available for pledging rose to **$X billion** from **$Y billion** in 2022, while the fair value of securities pledged for margin‑lending and securities‑lending activities climbed to **$Z billion** from **$W billion**. This upward trend indicates a deliberate strategy of expanding the use of client securities as collateral to support margin lending and securities‑lending, thereby boosting liquidity and interest‑income generation while keeping collateral coverage robust.",
      "correctness_score": 3,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. It introduces specific dollar amounts ($X billion, $Y billion, etc.) that are not present in the original answer or ground truth, and no such figures were disclosed in the provided context for 2022, 2023, or 2024. The original answer explicitly states that 'no specific dollar value was provided' in 2022, and no quantitative data is given for any year, making the LLM's numerical claims entirely fabricated. (2) There are no verifiable numbers in the ground truth to support the LLM's claimed trend from $Y billion to $X billion or pledged amounts rising from $W billion to $Z billion. This results in a severe failure in quantitative accuracy. (3) While the LLM captures a general directional trend—increased use of client securities for collateral—it fails to accurately represent the evolution described in the original answer. The original emphasizes regulatory compliance, use in margin lending (with 2023 clarification on off-balance-sheet treatment), and a 2024 expansion into satisfying margin requirements for listed options and cash collateral in securities lending. The LLM omits the key 2024 detail about pledging for Options Clearing Corporation requirements and providing cash in securities lending, instead vaguely referencing 'securities-lending activities' without the nuance of cash vs. securities collateral. (4) The reasoning is partially sound in identifying a strategic expansion in collateral use, but it lacks the multi-hop synthesis of regulatory, operational, and reporting aspects across the three years. The contextual relevance is moderate because the answer addresses the general theme of collateral strategy evolution but misses critical qualitative distinctions and fabricates data, undermining its reliability. Correctness score is low due to invented figures and missing key factual developments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 516,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did GE's collaboration with primary insurers on long-term care premium rate increases evolve from 2022 through 2024, and what does this progression reveal about GE's reinsurance risk management strategy in its run-off insurance operations?",
      "original_answer": "From 2022 to 2024, GE maintained a consistent reliance on primary insurers to file long-term care premium rate increases with state regulators, while increasingly emphasizing collaboration and alignment with ceding companies. In 2022, GE described its indirect role in seeking rate increases and noted that the frequency of such increases varied by ceding company. By 2023, GE formalized its collaboration with primary insurers under reinsurance contractual terms, and highlighted its active participation in filing proposed increases, signaling a more structured approach. In 2024, GE reinforced this collaborative framework and added that it used recent experience from ceding companies and regulatory precedents to shape its expectations. This evolution indicates a strategic shift toward proactive risk management and tighter integration with primary insurers to stabilize future policy benefit reserves in its run-off insurance portfolio.",
      "llm_answer": "GE’s 10‑K filings show a consistent partnership with primary insurers to file state‑approved premium‑rate increases on long‑term‑care policies, with the frequency of such filings rising from 2022 to 2024 (GE_10k_2022.pdf, pp. 49‑53; GE_10k_2023.pdf, pp. 19‑23; GE_10k_2024.pdf, pp. 18‑22). Sensitivity tables illustrate that the potential adverse impact of a 25 % drop in the success rate of pending rate‑increase actions grew from $200 million in 2023 to $300 million in 2024 (GE_10k_2023.pdf, pp. 20‑21; GE_10k_2024.pdf, pp. 20‑21), underscoring GE’s proactive risk‑management approach that relies on ceding insurers to manage premium deficiencies and adjust reserves accordingly.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but misses key aspects of the evolution in GE's collaboration with primary insurers from 2022 to 2024. While it correctly notes GE’s reliance on primary insurers to file rate increases, it inaccurately implies a rising frequency of filings from 2022 to 2024, which is not supported by the ground truth. The ground truth emphasizes a shift in the nature of collaboration—from indirect involvement in 2022, to formalized contractual collaboration in 2023, to using regulatory precedents and experience in 2024—not an increase in filing frequency. (2) Quantitatively, the $200 million to $300 million increase in potential adverse impact from a 25% drop in success rate is correctly cited and aligns with the sensitivity disclosures in the 2023 and 2024 10-Ks. However, the LLM introduces a metric (‘frequency of filings rising’) not present in the original answer, and the ground truth does not mention such a trend. The numbers themselves are accurate, but their interpretation is misaligned. (3) The multi-hop reasoning is partially sound—linking reinsurance risk to reliance on ceding companies and using sensitivity data across years—but fails to capture the strategic evolution in GE’s engagement model (e.g., formalization under contractual terms, use of regulatory precedents). The answer focuses on financial exposure rather than the progression of collaboration, missing the core of the question. (4) Contextual relevance is high because the answer addresses GE’s reinsurance risk management and uses correct sources and metrics, but qualitative accuracy is reduced due to incorrect characterization of the collaboration evolution. The answer substitutes a narrative about increasing filing frequency for the actual strategic deepening of insurer collaboration, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 506,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did CVS's investment exposure to residential mortgage-backed securities evolve from 2022 through 2024, and what does the 3-year trend reveal about the company's risk positioning in structured credit instruments?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased from $721 million in 2022 to $614 million in 2023, then increased to $71 million in 2024. This reflects a cautious reduction in RMBS holdings in 2023 amid rising unrealized losses, followed by a strategic rebalancing in 2024 with a smaller, more selective allocation. The trend suggests a dynamic risk management approach to structured credit amid macroeconomic uncertainty.",
      "llm_answer": "CVS’s residential mortgage‑backed securities (RMBS) holdings rose modestly from $845 million in 2022 to $862 million in 2023, but fell sharply to $71 million in separate accounts in 2024 – a 92 % decline from the prior year (CVS_10k_2022.pdf: 147; CVS_10k_2023.pdf: 147; CVS_10k_2024.pdf: 158). This 3‑year trend shows the company is trimming its exposure to structured credit, reflecting a more conservative risk stance.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in the reported RMBS exposure values. According to the ground truth, CVS's RMBS exposure was $721M in 2022, $614M in 2023, and $71M in 2024. However, the LLM states $845M in 2022 and $862M in 2023, which are incorrect. Only the 2024 figure ($71M) matches the ground truth. The claimed '92% decline' from 2023 to 2024 is based on incorrect prior-year data ($862M), though a drop from $614M to $71M would still represent an ~88% decline, so the magnitude is roughly in range but not exact. (2) Calculations: The percentage decline is miscalculated due to wrong base values. The LLM uses $862M as 2023 exposure, but correct value is $614M. Thus, quantitative accuracy is severely compromised. (3) Multi-hop reasoning: The LLM fails to correctly synthesize data across the three years due to incorrect input values. While it identifies a trend of reduction in 2024, it misses the initial decrease from 2022 to 2023 (which the ground truth highlights as a cautious reduction amid unrealized losses), instead claiming a rise in holdings in that period. This inverts the actual trend for the first two years. (4) The qualitative interpretation — that CVS is adopting a more conservative risk stance — is partially aligned with the ground truth’s 'dynamic risk management' conclusion, but lacks nuance about strategic rebalancing and the context of macroeconomic uncertainty. Contextual relevance is fair because the answer addresses the right topic and time frame, but factual errors undermine overall correctness. The citations to specific filings are plausible but do not excuse the data inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 454,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does this 3-year progression reveal about the company's capital structure and debt management strategy?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then decreased to $45.551 billion in 2024. This pattern indicates a strategic shift in debt management, with a significant increase in 2023 followed by a deliberate reduction in 2024. The weighted-average interest rate on long-term debt also rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, suggesting rising borrowing costs over time. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete elimination by 2024 reflects a move away from variable-rate instruments. This 3-year trend reveals a dynamic capital structure with a peak in 2023 followed by a strategic deleveraging in 2024, while facing increasing interest rate environments.",
      "llm_answer": "Short‑term borrowings fell sharply from $883 million in 2022 to $538 million in 2023, then rose modestly to $562 million in 2024; long‑term debt rose from $47.8 billion in 2022 to $49.3 billion in 2023 and then fell to $44.9 billion in 2024. The net effect is a decline in total debt from $48.7 billion to $45.6 billion, reflecting a deliberate deleveraging and refinancing strategy that keeps leverage low, preserves liquidity, and relies on a diversified mix of securitized debt and senior notes.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but has significant quantitative inaccuracies. The ground truth states total short-term borrowings and long-term debt were $43.086B in 2022, $49.856B in 2023, and $45.551B in 2024. The LLM incorrectly reports total debt as $48.7B in 2022 and $45.6B in 2024, misrepresenting both the starting point and trajectory. It breaks down short-term borrowings and long-term debt separately, but these figures do not align with the ground truth totals. For example, the LLM claims short-term borrowings were $883M in 2022, but this figure is not supported by the ground truth, which does not provide a separate short-term borrowing amount—only a total debt figure. Similarly, long-term debt values are approximated but not accurate (e.g., $47.8B vs implied $42.2B in 2022 based on ground truth total minus unreported short-term). (2) Calculations are inconsistent: the LLM computes total debt as sum of short-term and long-term, but its 2022 total ($48.7B) exceeds the ground truth total ($43.086B), indicating incorrect component values. The 2024 total ($45.6B) is close to ground truth ($45.551B), but this may be coincidental given errors in components. (3) Multi-hop reasoning is partially sound—the LLM identifies a trend of increase followed by deleveraging, which matches the ground truth’s narrative of a peak in 2023 and reduction in 2024. It also infers a strategic refinancing and deleveraging motive, which is consistent. However, it omits key evidence from the ground truth: rising weighted-average interest rates (2.76% → 4.48% → 4.84%) and the elimination of floating unsecured senior debt ($1,709M → $349M → $0), which are critical to understanding the capital structure shift. (4) The contextual relevance is high because the answer addresses the evolution of debt and interprets it in terms of capital structure strategy. However, the absence of interest rate trends and specific debt instrument changes limits completeness. While the qualitative reasoning is plausible, it is based on inaccurate inputs and misses key multi-hop elements, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 577,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did NVIDIA's long-term liability related to the 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's capital structure strategy over time?",
      "original_answer": "NVIDIA's liability for the 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2024, with a midpoint value of $1,637 million in fiscal 2023. This indicates a deliberate reduction in this long-term debt obligation over the three-year period, suggesting a strategic effort to manage and reduce long-dated liabilities.",
      "llm_answer": "NVIDIA’s 3.50% Notes Due 2050 liability fell modestly over the three‑year period: it was about **$1,650 million in FY 2022, $1,637 million in FY 2023, and $1,604 million in FY 2024**.  The gradual decline reflects a deliberate capital‑structure strategy of trimming long‑term debt to lower leverage and improve debt sustainability while still using bond issuances to fund growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the liability amount for fiscal 2023 ($1,637 million) and 2024 ($1,604 million), which match the ground truth. However, it incorrectly states the fiscal 2022 value as $1,650 million, whereas the ground truth reports $2,147 million—a significant discrepancy of over $500 million. This error affects the accuracy of the trend description, as the decline is portrayed as modest when it was actually more substantial. (2) The calculation of the trend (gradual decline) is directionally correct but understates the magnitude due to the incorrect starting value. The actual reduction from $2,147M to $1,604M (a ~25% decrease) is more significant than implied by the LLM’s $1,650M to $1,604M narrative. (3) The multi-hop reasoning is sound in concept—synthesizing data across three fiscal years and interpreting the trend in the context of capital structure strategy. The conclusion about reducing long-term debt to lower leverage is consistent with the ground truth’s interpretation of a 'deliberate reduction.' (4) Despite the major quantitative error in the 2022 figure, the answer is contextually relevant and provides appropriate qualitative insight. The reasoning and entity identification (NVIDIA, 3.50% Notes Due 2050, correct fiscal years) are accurate. The score is reduced primarily due to the significant numerical inaccuracy in the earliest data point, which undermines full factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 402,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt disclosure strategy?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings across 2022, 2023, and 2024 shows a consistent disclosure pattern, indicating that the company continued to reference this historical debt instrument as part of its ongoing debt structure documentation, even though the notes were issued in 2013 and matured in 2016. This suggests Apple maintains legacy debt disclosures in its exhibits for transparency and legal continuity, rather than removing them immediately post-maturity.",
      "llm_answer": "Apple issued the 0.45% Notes due 2016 in 2013 (see Exhibit 4.3, which lists the 0.45% Notes due 2016).  The notes matured in 2016, so they are not included in the debt schedules of the 2022, 2023, or 2024 10‑K filings (Notes to Consolidated Financial Statements, pages 54‑58).  This pattern shows that Apple discloses only outstanding long‑term debt and does not re‑issue the same instrument after maturity, underscoring a consistent, transparent debt‑management strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a fundamental factual error: it claims the 0.45% Notes due 2016 are *not* included in the 2022, 2023, and 2024 10-K filings, which directly contradicts the ground truth stating they *are* consistently included. This misrepresents the core phenomenon being evaluated. While the issuance date (2013) and maturity date (2016) are correctly stated, the key disclosure behavior across the recent filings is inaccurately described. (2) Quantitatively, the dates (2013 issuance, 2016 maturity) and interest rate (0.45%) are accurate, and no calculations are required, so quantitative accuracy is high. (3) The multi-hop reasoning fails: the model incorrectly infers that because the notes matured in 2016, they are absent from later filings, but the ground truth confirms Apple continues to reference them in exhibits. The conclusion about Apple disclosing only outstanding debt is therefore incorrect, as the inclusion of a matured instrument suggests a practice of retaining legacy disclosures for transparency or legal continuity. The LLM’s reasoning contradicts the actual pattern. (4) The contextual relevance is moderate because it addresses debt disclosure strategy, but the incorrect premise undermines the analysis. The qualitative accuracy is low due to the critical error in entity behavior (presence/absence of the notes in filings). The correctness score is low because the answer gets the central fact wrong, despite accurate dates and rates.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 410,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Capital One's (COF) net derivative assets (liabilities) valuation and associated risk inputs evolve from 2022 to 2024, and what does this multi-year progression indicate about the company's exposure and modeling assumptions?",
      "original_answer": "Capital One's net derivative assets (liabilities) had a fair value of $31 million in 2022, with a net unrealized loss of $20 million still held. By 2023, the fair value of net derivative assets (liabilities) was $58 million, using 'default' as the significant unobservable input with a weighted average of 4%. In 2024, the fair value remained at $58 million, but the significant unobservable input shifted to 'swap rates' with a weighted average of 4%. This evolution indicates a shift in the key risk driver from default assumptions in 2023 to interest rate sensitivity in 2024, while maintaining a consistent valuation level. The reduction in realized losses from $43 million in 2022 to stable values in 2023 and 2024 suggests improved risk management or market stabilization.",
      "llm_answer": "Capital One’s net derivative assets (liabilities) grew from $5 million at December 31 2022 to $58 million at December 31 2023 and to $69 million at December 31 2024 (Table 16.2 2022, Table 16.2 2023, Table 17.2 2024).  The valuation of these Level 3 instruments is driven by discounted‑cash‑flow models that use swap rates as the key unobservable input, with a 3‑5 % range and a 4 % weighted average in 2023 and a 4 % range and weighted average in 2024 (Table 16.3 2023, Table 17.3 2024).  This steady risk‑input profile, coupled with the expanding balance, indicates that the company’s derivative exposure has increased mainly due to market activity while its modeling assumptions and valuation methodology have remained consistent.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Capital One's net derivative assets (liabilities) fair value was $31 million in 2022, not $5 million as stated. In 2023, it was $58 million (correctly reported by LLM), but in 2024, it remained $58 million, not $69 million. The LLM incorrectly states that swap rates were the key unobservable input in both 2023 and 2024 with a 4% weighted average, but the ground truth indicates that in 2023 the significant input was 'default' at 4%, shifting to 'swap rates' at 4% in 2024—this critical shift in risk driver is entirely missed. (2) Quantitative errors include: 2022 value ($5M vs $31M), 2024 value ($69M vs $58M), and misrepresentation of unobservable inputs—claiming swap rates were used in 2023 when default was the actual input. The LLM also fabricates a '3-5% range' in 2023 not present in the ground truth. (3) Multi-hop reasoning is flawed: the model fails to recognize the shift in risk inputs from default to swap rates, which is central to understanding evolving exposure and modeling assumptions. Instead, it incorrectly asserts a 'steady risk-input profile', contradicting the ground truth. (4) Contextual relevance is moderate—the answer addresses derivative valuation and risk inputs over time, but due to major factual and reasoning errors, the conclusion about increasing exposure due to market activity and stable modeling is unsupported and misleading. The correct interpretation should highlight a shift in key risk drivers despite stable valuation, indicating changing sensitivity from credit to interest rate risk.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 448,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did NVIDIA's financial exposure to the 1.55% Notes Due 2028 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 1.55% Notes Due 2028 was $1.2 billion in 2022, remained relatively stable at $1.1 billion in 2023, and then increased to $1.25 billion in 2024. This indicates a consistent long-term debt position in this instrument over the three-year period, with a slight increase in 2024 after a minor reduction in 2023, suggesting a strategic maintenance of this liability as part of its capital structure.",
      "llm_answer": "NVIDIA’s carrying amount of the 1.55% Notes Due 2028 grew modestly over the three‑year period: $1,080 million in FY 2022, $1,099 million in FY 2023 and $1,115 million in FY 2024 (Note 9 – Fair Value of Financial Assets and Liabilities). The incremental rise reflects a deliberate long‑term debt strategy that favors low‑coupon, long‑dated notes to fund growth while keeping leverage levels stable and manageable.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the financial figures. The ground truth states NVIDIA's exposure was $1.2 billion in 2022, $1.1 billion in 2023, and $1.25 billion in 2024. However, the LLM reports $1,080 million (2022), $1,099 million (2023), and $1,115 million (2024), all of which are incorrect. These discrepancies are material—especially the failure to reflect the drop to $1.1 billion in 2023 and the rise to $1.25 billion in 2024. The LLM instead shows a steady increase, which contradicts the actual trend. (2) Calculations and values are not aligned with the ground truth; for example, $1,115 million in 2024 is $135 million below the correct $1.25 billion. The cited source (Note 9) adds apparent credibility but does not excuse the incorrect data. (3) The multi-hop reasoning about long-term debt strategy is partially sound—describing a strategy of using low-coupon, long-dated notes is plausible and contextually appropriate—but it is based on incorrect data trends, undermining the validity of the conclusion. The actual progression (stable, then slightly up) suggests strategic maintenance, while the LLM’s version (steady rise) implies gradual accumulation, a different interpretation. (4) Contextual relevance is high because the answer addresses both parts of the question—evolution of exposure and strategic implications—and uses appropriate financial terminology. However, due to major quantitative errors, the correctness and qualitative accuracy scores are significantly reduced. Minor formatting differences in dollar amounts are acceptable, but the magnitude and trend errors are not.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 451,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did GE's exposure to trailing legal liabilities evolve from 2022 to 2024, particularly in relation to legacy matters from the Alstom acquisition and shareholder lawsuits tied to historical financial reporting, and what does this progression indicate about the persistence and financial impact of these contingent liabilities?",
      "original_answer": "From 2022 to 2024, GE's exposure to trailing legal liabilities remained a persistent risk, with specific reference to legacy matters from the 2015 Alstom acquisition and shareholder lawsuits tied to historical financial reporting. In 2022, GE noted that legacy legal proceedings from Alstom's pre-acquisition period, including claims of anti-competitive conduct or corruption, were resulting in ongoing cash outflows. Additionally, shareholder lawsuits related to GE’s financial performance and disclosure practices were highlighted as reputational risks. By 2023, the company reiterated its exposure to these same Alstom-related liabilities and emphasized that such legal matters could exceed current estimates, adversely affecting financial results. In 2024, GE continued to face shareholder lawsuits tied to legacy financial reporting issues, and the company acknowledged that these matters, along with contingent liabilities from exited businesses, could significantly impact its reputation and financial performance. This 3-year progression shows that these liabilities have not diminished but have remained a consistent and costly burden, indicating that GE's historical acquisitions and accounting practices continue to pose material financial and reputational risks.",
      "llm_answer": "GE’s 2022 10‑K (pp. 69‑73) disclosed that the company still faced trailing legal liabilities from the 2015 Alstom acquisition and from shareholder suits over past financial reporting, with reserves set for potential settlements. The 2023 filing (pp. 34‑38) reiterated those legacy matters, noting that litigation was ongoing and that reserves remained in place, but reported no material change in exposure. By 2024 (pp. 31‑35) GE again highlighted the same Alstom‑related proceedings and shareholder lawsuits, with no reduction in the nature or magnitude of the reserves, underscoring that these contingent liabilities have persisted and continue to pose a potentially significant financial impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: GE's ongoing exposure to legal liabilities from the 2015 Alstom acquisition and shareholder lawsuits tied to historical financial reporting is accurately described across 2022–2024. The LLM correctly notes that reserves remained in place each year with no material reduction, indicating persistence. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2022–2024) and years of the Alstom acquisition (2015) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying the continuity of contingent liabilities and their potential financial impact. It accurately reflects that while there was no 'material change' reported, the risks persisted, which matches the original's emphasis on ongoing burden. (4) The only minor shortcoming is that the LLM omits specific details about reputational risk and the possibility that liabilities could exceed estimates (mentioned in 2023 and 2024 in the original), but it does convey the core idea of 'potentially significant financial impact.' This slight omission prevents a perfect 10 on qualitative accuracy. Otherwise, the answer is contextually complete, semantically equivalent, and precisely targeted to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1538,
        "completion_tokens": 398,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments change from 2022 to 2024, and what does this evolution suggest about the company's pension fund strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This consistent upward trend indicates a strategic decision to maintain and gradually expand alternative investment allocations within its pension fund portfolio, despite market volatility and evolving economic conditions.",
      "llm_answer": "CVS’s exposure to hedge‑fund limited partnership investments through HF LP Investments rose from **$225 million in 2022 to $280 million in 2024**—an increase of $55 million (2022 footnote, 2024 footnote).  The uptick, together with a higher target allocation to hedge funds (from 3 % to 4 %), signals the pension plan’s gradual shift toward a more aggressive, higher‑return strategy while still preserving diversification.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported financial figures. According to the ground truth, CVS's exposure was $214 million in 2022, $225 million in 2023, and $252 million in 2024. The LLM incorrectly states $225 million as the 2022 value (it is actually the 2023 value), and reports $280 million for 2024, which is $28 million higher than the correct $252 million. These errors affect the validity of the trend interpretation. (2) The calculation of a $55 million increase is based on incorrect starting and ending values. The actual increase from 2022 to 2024 is $38 million ($252M - $214M), not $55M. Additionally, the LLM introduces a claim about target allocation increasing from 3% to 4%, which is not present in the original answer and cannot be verified from the provided ground truth. (3) While the LLM correctly infers a strategic shift toward alternative investments, this reasoning is based on inaccurate data. The multi-hop synthesis is partially sound—recognizing a trend and interpreting strategic intent—but flawed due to incorrect inputs. (4) The contextual relevance is moderate: the answer addresses the question's intent regarding strategy evolution and pension fund direction, but the incorrect numbers and unsupported percentage claims undermine factual reliability. The conclusion about a 'more aggressive, higher-return strategy' goes beyond the original answer’s neutral tone, which only stated a 'gradual expansion' despite market volatility. Overall, major quantitative errors reduce correctness despite some structural and interpretive alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 443,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Colgate-Palmolive's financial and operational focus on the Africa/Eurasia region evolve from 2022 to 2024, considering operating profit in 2022, restructuring charges allocated to the region in 2023, and depreciation and amortization spending in 2024?",
      "original_answer": "In 2022, Colgate-Palmolive reported an operating profit of $203 million from the Africa/Eurasia region, indicating a relatively modest contribution compared to other regions. In 2023, as part of the 2022 Global Productivity Initiative, the company allocated 10% of its expected restructuring charges—approximately $20 to $24 million—to Africa/Eurasia, signaling a strategic effort to streamline operations in the region. By 2024, depreciation and amortization expenses for Africa/Eurasia had declined to $8 million, down from $9 million in both 2022 and 2023, suggesting reduced capital investment or aging asset bases. This 3-year trajectory reflects a consistent but low-level financial presence in the region, with limited growth investment and a focus on cost optimization rather than expansion.",
      "llm_answer": "In 2022 Africa/Eurasia generated $228 million in operating profit (CL_10k_2022, p.118). In 2023 the region absorbed about 5 % of the $32 million Global Productivity Initiative charges—roughly $1.6 million in restructuring costs (CL_10k_2023, p.86). In 2024 depreciation and amortization spending in the region was $8 million (CL_10k_2024, p.118), indicating a focus on maintaining existing assets rather than aggressive expansion.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, the operating profit for Africa/Eurasia in 2022 is reported as $228 million, but the ground truth is $203 million—this is a significant numerical error. Second, the restructuring charges allocated to Africa/Eurasia in 2023 are stated as 5% of $32 million (~$1.6 million), but the ground truth indicates 10% of expected charges in the range of $200–240 million (so $20–24 million allocated to the region), making the LLM's figure off by an order of magnitude. The 2024 depreciation and amortization of $8 million is correct. (2) Quantitative accuracy is low due to two major number errors: $228M vs $203M (profit) and $1.6M vs $20–24M (restructuring). Only one of three key figures is accurate. (3) The reasoning framework is sound—LLM attempts to trace financial focus over three years using the correct metrics (operating profit, restructuring, D&A)—but the synthesis is flawed due to incorrect data inputs. The conclusion about 'maintaining assets rather than expansion' aligns with the ground truth's interpretation, but is based on incorrect premises. (4) Contextual relevance is high because the answer follows the correct structure and addresses all three time points and financial metrics asked. However, due to major factual and quantitative errors, especially in critical financial figures, the overall correctness is significantly compromised. Minor formatting like ' ' is acceptable. Score reflects partial correctness with critical data inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 423,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did AIG's international terrorism exposure and reinsurance protections evolve from 2022 through 2024, particularly in terms of modeled loss estimates, attachment points, and reinsurance recoverable assets?",
      "original_answer": "In 2022, AIG estimated a $1.3 billion net loss from a five-ton bomb attack in New York City after TRIPRA and reinsurance recoveries, with a $1.7 billion deductible under TRIPRA. By 2023, AIG continued to actively monitor and model terrorism risk using third-party vendor models, with international terrorism exposure estimated via scenario-based modeling and targeted reinsurance purchases. In 2024, AIG's reinsurance recoverable assets reached $38.0 billion, including $29.1 billion in ceded loss reserves, reflecting an expansion in reinsurance protections. Over the three-year period, AIG maintained a consistent approach to terrorism risk modeling while increasing its reliance on reinsurance to manage global exposures, particularly outside the U.S., where it retained core attachment points of $200 million in Japan and $125 million elsewhere.",
      "llm_answer": "Across 2022‑2024 AIG’s modeled loss estimate for a five‑ton bomb attack stayed at $1.3 billion net of the Terrorism Risk Insurance Program Reauthorization Act (TRIPRA) and reinsurance recoveries, and the TRIPRA attachment point remained a $1.7 billion deductible covering 80 % of losses above that level, with no change in private reinsurance coverage【2022‑10‑k p.167‑171】【2023‑10‑k p.119‑123】【2024‑10‑k p.89】. Reinsurance recoverable assets fell sharply from $67.5 billion at December 31 2023 to $38.0 billion at December 31 2024, indicating a contraction in recoverable exposure【2023‑10‑k p.121】【2024‑10‑k p.87】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual errors, particularly in quantitative accuracy. First, it incorrectly states that AIG's modeled loss estimate for a five-ton bomb attack 'stayed at $1.3 billion' across 2022–2024, implying consistency over time, while the ground truth only reports this figure for 2022 and does not confirm it for 2023 or 2024. Second, the claim that reinsurance recoverable assets 'fell sharply from $67.5 billion in 2023 to $38.0 billion in 2024' is directly contradicted by the ground truth, which states that recoverable assets reached $38.0 billion in 2024 as part of an expansion in reinsurance protections—there is no mention of a prior $67.5 billion figure or a contraction. This misrepresents the trend entirely. The ground truth indicates an increase in reinsurance reliance, not a reduction. Additionally, the LLM introduces a detail about TRIPRA covering '80% of losses above that level,' which is not present in the original answer and cannot be verified from the provided context. On qualitative aspects, the LLM correctly identifies AIG’s use of modeling and TRIPRA framework but fails to mention key developments such as scenario-based modeling in 2023 or the specific international attachment points in Japan ($200M) and elsewhere ($125M), which are central to the question. It also omits the fact that AIG increased reinsurance protections over the period. Contextually, the answer addresses terrorism exposure and reinsurance, so relevance is moderate, but the incorrect data and missing multi-hop synthesis (e.g., evolution across years and geographies) severely undermine correctness. Overall, some elements are accurate (e.g., $38.0 billion recoverable in 2024, $1.3 billion net loss in 2022), but major errors in numbers, trends, and completeness reduce the score to 4.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 490,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What does the trend in NVIDIA's liability for the 2.00% Notes Due 2031 from fiscal years 2022 to 2024 suggest about the company's long-term debt management strategy, particularly in light of the $1.2 billion carrying amount in 2022, the slight reduction to $1.044 billion in 2023, and the return to $1.25 billion in 2024?",
      "original_answer": "The liability for NVIDIA's 2.00% Notes Due 2031 remained relatively stable across the three years, indicating a consistent long-term debt strategy. In 2022, the liability was reported at $1.2 billion. It slightly decreased to $1.044 billion in 2023, possibly reflecting minor debt repayments or reclassifications. However, by 2024, the carrying amount returned to $1.25 billion, suggesting that NVIDIA maintained its long-term capital structure and did not materially alter its exposure to this long-dated debt instrument. This pattern implies a strategic intent to preserve stable long-term liabilities, likely to support ongoing R&D and operational investments without significant refinancing risk.",
      "llm_answer": "NVIDIA’s 2.00% Notes Due 2031 liability fell from a $1.20 billion carrying amount in FY 2022 to $1.044 billion in FY 2023, then rose to $1.25 billion in FY 2024. This modest fluctuation indicates the company is actively managing its long‑term debt mix—repaying or refinancing a portion in 2023 and re‑issuing or rolling over debt in 2024—while keeping the overall debt level stable and aligned with growth‑funding needs. The trend reflects a conservative, flexible debt strategy that balances liquidity, cost of capital, and capital‑structure stability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numeric values: $1.20 billion in 2022, $1.044 billion in 2023, and $1.25 billion in 2024, matching the ground truth exactly. No calculation errors are present, and the formatting variations (e.g., $1.20B vs $1.2B) are acceptable and semantically equivalent. (2) The answer addresses all parts of the question—trend over three years and implications for long-term debt strategy. It accurately captures the slight reduction and subsequent increase, interpreting them as active debt management. (3) Entity accuracy is strong: correct company (NVIDIA), correct debt instrument (2.00% Notes Due 2031), and correct fiscal years (2022–2024). (4) The reasoning is sound and aligns with the ground truth: both emphasize stability in long-term liabilities and strategic capital structure management. The LLM adds slightly more emphasis on 'active management' and 're-issuing or rolling over debt,' which is a plausible interpretation but not explicitly confirmed in the ground truth; this minor inferential stretch prevents a perfect 10 but does not undermine factual correctness. Overall, the answer is factually accurate, contextually appropriate, and demonstrates proper multi-hop synthesis across years and financial behavior.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 357,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Apple's issuance of the 1.05% Notes due 2017 evolve across 2022, 2023, and 2024, and what does this reveal about the long-term visibility and continuity of Apple's debt structure referencing this specific instrument?",
      "original_answer": "Apple's reference to the 1.05% Notes due 2017 remained consistent across all three years—2022, 2023, and 2024—as part of its incorporated debt instruments, indicating that while the notes were issued well before this period, they continued to be a documented part of Apple's ongoing capital structure and financial obligations. Despite the notes having matured in 2017, their persistent inclusion in subsequent filings suggests they may have been rolled over, refinanced, or retained in documentation as historical instruments under the same indenture framework. This continuity implies a stable and transparent debt management strategy by Apple, with consistent disclosure practices around legacy instruments.",
      "llm_answer": "Apple issued the 1.05 % Notes due 2017 in 2014, which were scheduled to mature in 2017.  By the 2022, 2023, and 2024 10‑K filings (pages 54‑58, 53‑57, 54‑58 respectively), the notes appear in Exhibit 4.4 but carry no outstanding balance, indicating they were fully repaid at maturity.  This steady, transparent reporting shows Apple’s disciplined, long‑term debt management, with clear visibility into each instrument’s maturity and a consistent approach to retiring maturing debt.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the issuance of the 1.05% Notes due 2017 and their appearance in Apple's 10-K filings across 2022, 2023, and 2024, which aligns with the ground truth's emphasis on consistent disclosure. It accurately references Exhibit 4.4 and notes the absence of an outstanding balance, implying repayment—this is factually plausible and consistent with typical post-maturity reporting. However, the LLM contradicts the ground truth by asserting the notes were 'fully repaid at maturity' with 'no outstanding balance,' while the original answer suggests the notes were *still included as part of ongoing obligations*, possibly rolled over or refinanced under the same indenture. This is a critical divergence in interpretation: the ground truth implies continued structural relevance, while the LLM assumes retirement. (2) Quantitatively, all dates (2017 maturity), percentages (1.05%), and filing years (2022–2024) are correct. The mention of specific page ranges and exhibit numbers adds precision and matches expected disclosure practices. No calculation errors. (3) The multi-hop reasoning is partially sound—the model connects the note issuance to subsequent filings and infers repayment from zero balance, which is logical. But it fails to consider the possibility of refinancing or rollover under the same instrument, which the ground truth highlights as evidence of continuity in debt structure. Thus, the synthesis is incomplete or misdirected. (4) The answer is contextually relevant and well-structured, addressing both the evolution over time and implications for debt management. However, the conclusion about 'retiring maturing debt' conflicts with the ground truth's emphasis on *continuity* and *long-term visibility* via persistent inclusion, suggesting a more complex strategy than simple repayment. This undermines the qualitative accuracy despite strong quantitative grounding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 522,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024, and what were the key changes in migration limits and balance requirements under the IDA agreements during this period?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to limitations, and had already moved $10.1 billion by year-end. In 2023, under the newly executed 2023 IDA agreement, Schwab no longer exercised this migration option and was instead bound by new minimum and maximum balance thresholds. By 2024, Schwab continued to operate under the 2023 IDA agreement and did not move any IDA balances to its balance sheet, reflecting a strategic shift toward maintaining off-balance sheet deposits under stricter constraints. This evolution shows a transition from active migration to constrained off-balance sheet management.",
      "llm_answer": "In 2022 Schwab was still operating under the 2019 IDA agreement, which let it migrate up to $10 billion of IDA balances each year (only floating‑rate balances) while keeping a $50 billion minimum balance and requiring that at least 80 % of balances be fixed‑rate. In May 2023 the 2019 agreement was replaced by a new 2023 IDA agreement that eliminated the 80 % fixed‑rate rule, introduced a new minimum/maximum regime (a $30 billion cap above the fixed‑rate balance through 9/10/2025, then a $60 billion minimum and $90 billion maximum thereafter), and allowed a $5 billion buy‑down of fixed‑rate obligations; Schwab did not move any IDA balances in 2023. The 2023 agreement remained in force in 2024, during which Schwab again did not migrate balances (the IDA balance fell to $87.6 billion) and the same minimum/maximum thresholds applied.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key evolution in Schwab's IDA balance migration strategy from 2022 to 2024, with accurate qualitative reasoning and strong contextual relevance. However, there are some discrepancies in quantitative details not fully supported by the ground truth. The original answer states that in 2022, Schwab migrated $10.1 billion under the 2019 IDA agreement's $10 billion annual option, implying a slight exceedance or cumulative total, but the LLM claims a $10 billion annual cap 'each year' and adds specific terms—like the $50 billion minimum balance and 80% fixed-rate requirement—that are not present in the ground truth. These specifics, while plausible, are not confirmed in the original answer and introduce unverified detail. The 2023 agreement changes are well-summarized: the elimination of the migration option, no balance migration in 2023 and 2024, and the shift to minimum/maximum thresholds. The LLM adds granular terms like a $30 billion cap above fixed-rate balances, a $60/$90 billion minimum/maximum post-9/10/2025, and a $5 billion buy-down option—details absent from the ground truth. While these may be factual from source documents, they go beyond the provided knowledge graph and risk overprecision. The IDA balance of $87.6 billion in 2024 is a specific figure not mentioned in the original answer, making it potentially accurate but unverifiable against ground truth. The core narrative—transition from active migration (2022) to no migration under new constraints (2023–2024)—is correctly synthesized and aligns with the multi-hop reasoning required. Thus, the answer is factually strong in direction and logic but introduces unsupported specifics, slightly reducing quantitative accuracy. Correctness is high but not perfect due to these additions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 490,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did GE's financial exposure and strategic handling of Bank BPH's borrower litigation evolve from 2022 through 2024, particularly in terms of estimated losses, capital contributions, and the carrying value of the mortgage portfolio?",
      "original_answer": "GE's financial exposure to Bank BPH's borrower litigation increased significantly in 2023, with estimated losses rising to $2,669 million by year-end from $1,359 million in 2022, and a $1,014 million charge recorded in Q2 2023 as part of a settlement program. Capital contributions also spiked in 2023, with a non-cash contribution of $1,797 million through intercompany loan forgiveness, following a $530 million cash contribution in 2022. By 2024, estimated losses slightly declined to $2,461 million, and no further contributions were required. Additionally, the carrying value of the Bank BPH mortgage portfolio dropped to zero by the end of 2024, indicating a full valuation write-down. This trajectory shows a worsening litigation environment through 2023 followed by stabilization in 2024, with GE absorbing significant losses and ultimately exiting active involvement in Bank BPH.",
      "llm_answer": "From 2022 to 2024 GE’s exposure to Bank BPH litigation widened: the estimated loss estimate climbed from $1.359 billion in 2022 to $2.669 billion in 2023 and then eased slightly to $2.461 billion in 2024. Capital support shifted from a $530 million cash injection in 2022 to a $1.797 billion non‑cash inter‑company loan forgiveness in 2023, with no new cash contributions needed in 2024. Correspondingly, the mortgage portfolio’s carrying value was written down to zero by the end of 2023 and remained at zero in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures all key financial figures and trends from the ground truth: estimated losses rising from $1,359 million in 2022 to $2,669 million in 2023, then declining to $2,461 million in 2024; capital contributions of $530 million cash in 2022 and $1,797 million non-cash in 2023; and no further contributions in 2024. All numbers match exactly, with acceptable formatting variations (e.g., $1.359 billion = $1,359 million). (2) The only discrepancy is in the timing of the mortgage portfolio write-down: the LLM states it was written down to zero by the end of 2023, while the ground truth specifies this occurred by the end of 2024. This is a factual error in timeline, though the final state (zero carrying value in 2024) is correctly reported. (3) Multi-hop reasoning is strong—information is synthesized across years and financial dimensions (exposure, capital, valuation), showing a clear evolution of GE’s involvement. The conclusion about stabilization in 2024 and reduced active involvement is logically supported. (4) Scores reflect near-perfect quantitative accuracy and contextual relevance; qualitative accuracy slightly reduced due to the premature timing of the write-down, but overall reasoning and synthesis remain sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 358,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk management strategy?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the total fair value of CMBS was $574 million with $12 million in unrealized losses. By 2023, the fair value increased slightly to $675 million, but unrealized losses rose sharply to $100 million. In 2024, the fair value of CMBS dropped dramatically to just $3 million, indicating a major reduction in exposure. This trajectory suggests a strategic shift in 2024 to de-risk the portfolio, likely in response to the elevated unrealized losses and market volatility observed in 2023.",
      "llm_answer": "From 2022 to 2023 CVS’s commercial mortgage‑backed securities (CMBS) fair value fell from $1,018 million to $975 million, while unrealized losses dropped from $155 million to $100 million (2022‑23 tables).  In 2024 the fair value remained roughly $975 million and unrealized losses stayed low, reflecting a continued focus on high‑quality, low‑loss CMBS and a conservative risk‑management strategy that limits exposure to market‑price volatility.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. According to the ground truth, CVS's CMBS fair value was $574M in 2022, increased to $675M in 2023, and then dropped to $3M in 2024. The LLM incorrectly states that fair value decreased from $1,018M to $975M between 2022 and 2023 and remained at $975M in 2024—this contradicts the actual trend, especially the near-elimination of exposure in 2024. Unrealized losses in the ground truth rose from $12M in 2022 to $100M in 2023, but the LLM claims they dropped from $155M to $100M, which is factually wrong on both starting value and direction of change in losses. (2) All key numbers are incorrect: fair values ($1,018M, $975M, $975M vs. $574M, $675M, $3M) and unrealized losses ($155M, $100M, ~$100M vs. $12M, $100M, not reported but implied to be low due to minimal holdings). There are no correct quantitative matches except the $100M unrealized loss in 2023, which coincidentally aligns but is framed incorrectly as a reduction from a higher loss rather than a sharp increase. (3) The multi-hop reasoning is fundamentally flawed. The LLM fails to recognize the strategic de-risking in 2024—dropping CMBS exposure from $675M to $3M—which is central to the correct interpretation. Instead, it suggests stable exposure and a conservative strategy based on low losses, which misrepresents the actual risk management shift. The correct reasoning requires synthesizing the rise in unrealized losses in 2023 with the drastic reduction in 2024, indicating a reactive de-risking move. (4) The contextual relevance is partially met because the answer discusses CMBS exposure, fair value, unrealized losses, and risk management over time. However, due to pervasive factual errors, the conclusion about 'continued focus on high-quality, low-loss CMBS' is unsupported and misleading. Scores are low because the answer fails on all core dimensions: numbers are wrong, logic is inverted, and the key strategic shift is missed entirely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 541,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Walmart's private brand portfolio featuring Marketside evolve from fiscal years 2022 to 2024, and what does this 3-year progression indicate about the company's private label strategy in the grocery segment?",
      "original_answer": "From 2022 to 2024, Walmart consistently included Marketside as part of its private brand portfolio, highlighting its ongoing commitment to the brand within the grocery category. In 2022, Marketside was listed among key private brands like Great Value and George, indicating its foundational role in Walmart's grocery offerings. In 2023, Marketside remained a named private brand, suggesting continuity in Walmart's strategy to maintain a diversified private label presence. By 2024, Marketside continued to be featured, even as Walmart introduced new private brands like 'bettergoods,' signaling a strategic expansion and modernization of its private label lineup while maintaining legacy brands like Marketside. This 3-year consistency in featuring Marketside, alongside the introduction of new brands, reflects Walmart's dual approach of preserving trusted private brands while innovating to meet evolving consumer preferences.",
      "llm_answer": "Walmart’s private‑label lineup, which includes the grocery brand Marketside, stayed essentially the same from fiscal 2022 through fiscal 2024 – the same 23 private brands appear in each filing.  This steady composition shows the company is pursuing an incremental, stability‑focused private‑label strategy in grocery, reinforcing its price‑leadership and customer‑trust model rather than making large, rapid changes to the assortment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in the claim that 'the same 23 private brands appear in each filing,' which is not supported by the ground truth and introduces a specific number (23) absent from the original answer. This undermines quantitative accuracy. The original answer does not mention the total number of private brands or suggest the portfolio remained unchanged in composition—instead, it emphasizes continuity of Marketside alongside strategic expansion (e.g., introduction of 'bettergoods' in 2024). Thus, the LLM incorrectly implies stasis, contradicting the ground truth's emphasis on strategic evolution and modernization. While the LLM correctly identifies Marketside as a consistent part of Walmart's private brand portfolio from 2022 to 2024 and correctly frames Walmart’s grocery strategy around customer trust, it fails to capture the key nuance of simultaneous innovation and brand expansion. The reasoning is partially sound in drawing a conclusion about stability, but it misses the multi-hop insight that Walmart is both maintaining legacy brands *and* introducing new ones—a core point in the original answer. Contextually, the response addresses the question’s focus on evolution and strategy, but the incorrect quantitative claim and oversimplified interpretation reduce its overall correctness. Semantic equivalence is partially achieved on the role of Marketside but not on strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 402,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Lowe's evolve its monitoring and enforcement of supplier practices related to environmental and human rights standards from 2022 through 2024, and what specific policy enhancements and investments were made across those years to strengthen supply chain sustainability?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its monitoring and enforcement of supplier practices. In 2022, the company monitored suppliers through collaboration and management systems, holding them to standards outlined in its human rights policy, conflict minerals policy, and Vendor Code of Conduct, while also specifying that wood products must come from well-managed, non-endangered forests. In 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process, demonstrating a more structured and responsive approach. By 2024, the company had further strengthened its policies with a more robust risk-based approach to wood sourcing, including improved monitoring and a formalized grievance mechanism. These changes were supported by multi-year investments exceeding $550 million by 2022 and over $400 million through 2023 in operational sustainability initiatives, reflecting a consistent and growing commitment to supply chain responsibility and environmental stewardship.",
      "llm_answer": "In 2022 Lowe’s relied on its human‑rights, conflict‑minerals and Vendor Code of Conduct policies, together with a basic wood‑sourcing policy that set environmental standards, to monitor and enforce supplier practices. By 2023 the company overhauled the wood‑sourcing policy, adding country‑by‑country risk levels, a risk‑based monitoring framework and a new forestry grievance process, while tightening its human‑rights and environmental monitoring. In 2024 Lowe’s further strengthened enforcement with enhanced monitoring practices and expanded renewable‑energy investments—installing rooftop solar at more than 100 sites and spending over $300‑$400 million on energy‑efficiency upgrades—to support a more sustainable supply chain.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Lowe's supplier monitoring and enforcement from 2022 to 2024, including key policy enhancements such as the 2023 overhaul of the wood-sourcing policy with country-by-country risk levels, risk-based monitoring, and a new forestry grievance process. It also notes tightening of human rights and environmental monitoring, and mentions expanded renewable-energy investments in 2024. However, the financial figures are partially inaccurate. The original answer states over $550 million invested by 2022 and over $400 million through 2023 in operational sustainability initiatives. The LLM answer incorrectly shifts this to $300-$400 million spent on energy-efficiency upgrades (without specifying timeframe) and mentions renewable-energy investments like solar installations, which are not mentioned in the ground truth. These investments are real but misaligned in scope and timing, and do not reflect the broader 'operational sustainability initiatives' cited in the original. (2) The dollar amounts are therefore not quantitatively accurate: $300-$400 million is a range that underrepresents the $550M+ by 2022 and conflates different types of spending. The LLM introduces 'rooftop solar at more than 100 sites' and 'energy-efficiency upgrades' not present in the source, suggesting hallucination or misattribution. (3) The multi-hop reasoning is generally sound—linking policy changes across years and connecting them to enforcement and investment—but fails to accurately tie investments to the correct years and initiatives. It correctly synthesizes the progression of wood-sourcing policy and grievance mechanisms across 2023–2024. (4) The qualitative accuracy is high because the core narrative of strengthening policies and monitoring is correct, and the contextual relevance is strong as it directly addresses the question’s focus on policy evolution and investments. However, the quantitative inaccuracies in financial figures and the introduction of unverified specific projects (solar installations) reduce the correctness score to 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 565,
        "total_tokens": 2050
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Apple's disclosure of the 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this 3-year pattern indicate about the company's ongoing debt management strategy?",
      "original_answer": "Apple consistently included the 2.40% Notes due 2023 in its list of global notes in filings for 2022, 2023, and 2024, indicating sustained transparency around this debt instrument despite its impending maturity. In 2022, the note was listed among other global notes in the Officer's Certificate dated May 3, 2013. In 2023, the same note appeared in the filings, showing continuity in disclosure as the maturity date approached. By 2024, Apple still included the 2.40% Notes due 2023 in its exhibit list, even though the notes were set to mature within that year, suggesting a deliberate approach to managing and disclosing legacy debt obligations. This consistent inclusion across three years reflects a stable and transparent debt disclosure strategy.",
      "llm_answer": "Apple consistently reported the 2.40% Notes due 2023 as outstanding long‑term debt in each of its 2022, 2023, and 2024 10‑Ks. The 2022 filing listed a principal balance of $X and a September 2023 maturity (2022 10‑K, p. 54‑58); the 2023 filing reiterated the same outstanding balance (2023 10‑K, p. 53‑57); by 2024 Apple reported the notes had been repaid or had matured and were no longer outstanding (2024 10‑K, p. 54‑58). This steady update shows a disciplined debt‑management strategy that keeps long‑term notes on the balance sheet until maturity or repayment and transparently informs investors.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies the 2.40% Notes due 2023 and the general timeframe, it incorrectly states that Apple reported the notes as 'repaid or matured and no longer outstanding' in the 2024 10-K. The ground truth indicates that Apple *still included* the 2.40% Notes due 2023 in its 2024 exhibit list, despite their maturity, as part of a transparent disclosure strategy for legacy debt. The claim of repayment or removal from the balance sheet in 2024 contradicts the ground truth of continued inclusion. Additionally, the LLM fabricates a specific principal amount '$X' and cites page numbers without providing actual data, undermining quantitative accuracy. (2) There are no verifiable numbers provided (e.g., principal balance), and the use of '$X' is a placeholder, suggesting incomplete or speculative reporting. The maturity date (September 2023) is plausible but not confirmed in the ground truth, which only references the Officer's Certificate from 2013 and consistent listing through 2024. (3) The multi-hop reasoning is partially sound—linking disclosures across three years—but the conclusion about repayment in 2024 breaks the chain. The model fails to recognize that continued disclosure of a matured note reflects a deliberate transparency strategy, not an oversight or update upon repayment. (4) The answer is contextually relevant and addresses the evolution over three years and debt management implications, but the core factual error about the 2024 status severely undermines correctness. The reasoning about disciplined debt management is plausible but based on incorrect premises. Thus, while the structure and intent are appropriate, the factual foundation is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 481,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 to 2024, and what does this progression suggest about GE's investment strategy in financial instruments during this period?",
      "original_answer": "GE's holdings of the AerCap note decreased from $976 million in 2022 to $944 million in 2023, but then increased to $982 million in 2024. This fluctuation suggests a dynamic approach to managing financial assets, with a slight overall stability in AerCap note holdings despite broader changes in GE's portfolio composition, including significant shifts in U.S. corporate debt and mortgage-backed securities over the same period.",
      "llm_answer": "GE’s AerCap note grew steadily over the three‑year period.  In 2022 the note was disclosed as part of GE’s investment‑securities portfolio, but its carrying amount was not separately reported (2022 10‑K, pp. 90‑94).  By year‑end 2023 the note was valued at **$944 million** (2023 10‑K, pp. 68‑72), and it increased to **$982 million** at year‑end 2024 (2024 10‑K, pp. 68‑72).  This modest, incremental rise indicates GE’s strategy of gradually expanding its high‑quality debt‑security holdings within its run‑off insurance portfolio, aiming to enhance yield while maintaining a conservative risk profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative evolution of GE's AerCap note holdings. According to the ground truth, the holdings decreased from $976 million in 2022 to $944 million in 2023, then increased to $982 million in 2024. However, the LLM claims the note was not separately reported in 2022 and implies a steady growth from an unspecified amount to $944M in 2023 and $982M in 2024. This misrepresents the actual trajectory—there was a decrease followed by a recovery, not a 'steady' or 'incremental rise.' The 2023 and 2024 figures ($944M and $982M) are correct, but the 2022 figure is wrong (missing $976M), which breaks the multi-hop comparison. (2) Quantitative accuracy is partially correct: two out of three years' values are accurate, but the missing 2022 value and incorrect characterization of the trend (growth vs. fluctuation) undermine the numerical correctness. The claim that the 2022 amount was not disclosed contradicts the ground truth, which explicitly states it was $976M. (3) The reasoning is flawed: the LLM infers a strategy of 'gradually expanding' high-quality debt holdings based on an incorrect upward trend, while the ground truth suggests a 'dynamic approach' with slight overall stability despite fluctuations. This mischaracterizes GE’s strategy, especially given that the holdings actually declined in 2023. The synthesis across years fails because the model omits the initial 2022 figure and misreads the direction of change. (4) Contextual relevance is high—the answer addresses the right company (GE), instrument (AerCap note), and time frame (2022–2024), and attempts to interpret strategy from financial trends. However, due to incorrect data and flawed reasoning, the conclusion about investment strategy is not supported. Correctness score is 4 due to partial factual accuracy but major errors in key data points and interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 519,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target asset allocations reveal about the plan's de-risking strategy in response to changing funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan consistently guided the allocation between growth assets and liability-hedging assets based on the plan's funded status across 2022, 2023, and 2024. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021. By 2023, the target allocation for 2024 was set according to the funded status at December 31, 2022, and in 2024, the target allocation for 2025 was determined using the funded status at December 31, 2023. The glide path approach progressively reduced the allocation to growth assets while increasing the allocation to liability-hedging assets as the funded ratio improved over the years, reflecting a deliberate de-risking strategy aligned with liability-driven investing principles.",
      "llm_answer": "AIG’s glide‑path policy—defined in the 2023 10‑K as a “return‑seeking” allocation that is lowered and a liability‑hedging allocation that is raised as the plan’s funded ratio rises (page 250)—has stayed conceptually the same but its target mix has shifted.  In 2022 the target was 15 % equity, 75 % fixed‑maturity, 10 % other (page 308); by 2024 the target had moved to 9 % equity, 80 % fixed‑maturity, 11 % other (page 251), a 6‑point drop in growth exposure and a 5‑point rise in hedging assets that reflects a better funded status.  The 2025 target (9 % equity, 80 % fixed, 11 % other, page 183) shows the glide path has plateaued at a more conservative stance once the plan’s funded ratio stabilized.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies AIG's glide path approach as being tied to funded status and evolving over time, with a shift toward de-risking through increased liability-hedging and reduced growth assets. (2) Quantitatively, the percentages are accurate: 15% equity in 2022 (vs. 9% in 2024/2025), 75% fixed-maturity in 2022 rising to 80%, and other assets increasing from 10% to 11%. These reflect a 6-point drop in growth assets and 5-point rise in hedging assets, consistent with de-risking. While the original answer does not specify exact allocations, the LLM provides more granular data from the filings, which enhances precision. (3) The multi-hop reasoning is sound: the LLM connects the policy description (from 2023 10-K) to actual allocation changes across years and infers that the stabilization of targets for 2025 indicates a plateau due to stabilized funded status—this goes beyond the ground truth but is a reasonable interpretation. (4) The only minor limitation is that the original answer emphasizes the timing mechanism (e.g., 2023 decisions based on prior year funded status), which the LLM omits, though it does imply progression. Overall, the LLM adds value with specific percentages and document references, and its conclusions about de-risking strategy are fully supported. Minor deduction due to slight omission of the decision-timing logic in the glide path, but core facts, synthesis, and reasoning are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 414,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this multi-year consistency reveal about the role of this product line in driving long-term free cash flow per share growth?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently emphasized embedded processing products as a core component of its business model, underscoring their role in delivering long-term free cash flow per share growth. In 2022, the company highlighted embedded processing as one of two key product lines (alongside analog) that anchor its four sustainable competitive advantages. This focus persisted in 2023, with the company reiterating that embedded processing products provide 'more opportunity per customer and more value for our investments.' In 2024, Texas Instruments maintained this strategic narrative, describing embedded processing as central to its competitive model that enables supply chain control, customer reach, and diversified returns. The consistent emphasis across all three years indicates that embedded processing is not a tactical shift but a foundational pillar in TI's long-term cash flow generation strategy.",
      "llm_answer": "Texas Instruments has kept the same strategic focus on analog and embedded‑processing products from 2022 through 2024, repeatedly stressing the industrial and automotive markets as its highest‑growth segments (2022 MD&A p. 18‑22; 2023 MD&A p. 16‑20; 2024 MD&A p. 16‑20).  This year‑to‑year consistency shows that embedded‑processing remains a core engine of the company’s business model, as TI links the product line to strong cash‑flow generation and long‑term free‑cash‑flow‑per‑share growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core of the ground truth. (1) It correctly identifies Texas Instruments' consistent strategic emphasis on embedded processing from 2022 to 2024, noting its role alongside analog products as central to the business model. The answer accurately reflects that this consistency underscores embedded processing as a driver of long-term free cash flow per share growth. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the ground truth or LLM answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of MD&A sections (2022–2024), correctly identifying continuity in strategic messaging. However, it omits some specific qualitative nuances present in the ground truth, such as the 2023 statement about 'more opportunity per customer and more value for our investments' and the 2024 emphasis on supply chain control and diversified returns. While the core message is preserved, these omissions slightly reduce completeness in qualitative depth. (4) The answer is fully contextually relevant, directly addressing both parts of the question: evolution of strategy (no change, consistent focus) and what that reveals about cash flow (core engine for long-term growth). Minor lack of granular detail prevents a perfect 10, but overall the answer is factually correct, well-reasoned, and semantically equivalent in intent and substance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 413,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Lowe's intellectual property strategy around its private brands, including Kobalt, evolve from fiscal 2022 through 2024, particularly in terms of brand portfolio emphasis and integration with digital transformation initiatives?",
      "original_answer": "In fiscal 2022, Lowe's explicitly highlighted 'Kobalt', 'STAINMASTER', and 'allen+roth' as part of its private brand portfolio, while also listing 'RONA' and 'Reno Depot' as retail names under its intellectual property. This broader listing suggested a more expansive view of brand assets. In fiscal 2023, the company streamlined its disclosure to focus only on 'Kobalt', 'STAINMASTER', and 'allen+roth', omitting 'RONA' and 'Reno Depot', which may reflect a simplification or refocusing of brand emphasis in the intellectual property section. By fiscal 2024, the company continued to highlight the same three private brands but introduced new language around digital transformation, such as remote customer support and mobile checkout, which could signal a strategic integration of digital tools to enhance private brand customer experiences. The removal of certain brand names and the addition of digital context suggest a shift toward a more focused and digitally enabled private brand strategy over the three-year period.",
      "llm_answer": "From fiscal 2022 through 2024 Lowe’s continued to protect its private‑brand trademarks—Kobalt, STAINMASTER and allen+roth—while shifting its brand‑portfolio emphasis toward higher‑margin private brands.  In 2023 the company highlighted “high‑value private brands” in its product‑selection strategy, balancing them with national power brands and expanding localization and rural assortments【source: 2023 IP & Product Selection】.  By 2024, Lowe’s maintained the same trademark protection but further integrated those private brands into its omnichannel and digital‑first initiatives, using its online platforms, mobile apps and virtual design tools to promote private‑brand products across all customer touchpoints【source: 2024 IP, Omnichannel Capabilities, Online】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of core facts and overall strategic evolution. (1) It accurately identifies the consistent protection of 'Kobalt', 'STAINMASTER', and 'allen+roth' across the period, matching the original answer’s observation that these three brands remained highlighted from 2022 through 2024. It correctly notes a shift in emphasis in 2023 (streamlining focus), though it frames it as a move toward 'higher-margin' and 'high-value private brands'—a plausible interpretation not explicitly stated but inferable from strategic context. The omission of 'RONA' and 'Reno Depot' in 2023 and beyond is not directly mentioned, but the idea of a refocused brand portfolio is captured semantically. (2) There are no numeric values, dates, or calculations in the question or answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes brand portfolio changes with digital transformation, correctly noting that by 2024, private brands were integrated into omnichannel and digital initiatives like mobile apps and virtual design tools, which aligns with the ground truth’s mention of remote support and mobile checkout as part of digital integration. (4) The answer is contextually excellent—directly addressing both brand portfolio emphasis and digital integration as asked. The only minor gap is the lack of explicit mention of the broader IP listing in 2022 (including RONA/Reno Depot) and its subsequent removal, which slightly weakens completeness. However, the core evolution—focus narrowing and digital integration—is correctly conveyed. Hence, a score of 8 is justified: factually strong with minor omissions in descriptive detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 476,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted client relationships and trust as a core competitive differentiator, but the context in which it was framed evolved. In 2022, IBM emphasized trust as part of its hybrid cloud and AI platform integration, particularly through deep industry expertise and a secure, open platform. By 2023, the company expanded this focus by linking client trust to its strategic partnerships with major tech firms like AWS, Microsoft, and SAP, indicating a broader ecosystem-driven approach to delivering client value. In 2024, IBM reinforced this positioning while also adding cybersecurity-focused partners like Palo Alto Networks to its strategic alliance list, suggesting a growing emphasis on security as a key component of client trust. This 3-year trajectory reveals a strategic evolution where trust is increasingly tied to both technical capabilities (AI, hybrid cloud) and a robust, secure partner ecosystem, aligning with the rising importance of data governance and digital transformation in enterprise IT decisions.",
      "llm_answer": "IBM consistently cites client relationships and trust as a core competitive differentiator across its 2022, 2023, and 2024 10‑Ks (2022, p. 2‑6; 2023, p. 1‑5; 2024, p. 1‑5). Over time the company has woven this theme more tightly into its hybrid‑cloud‑and‑AI narrative, positioning its long‑standing client ties as the foundation for delivering integrated AI and hybrid‑cloud solutions (2024, p. 1‑5). The steady emphasis signals IBM’s intent to be the trusted partner for enterprises adopting hybrid‑cloud and AI, differentiating itself from hyperscalers and new entrants while driving growth in those markets.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the core narrative: IBM consistently emphasized client relationships and trust as a competitive differentiator from 2022 to 2024, and this theme was increasingly tied to its hybrid cloud and AI strategy. The answer correctly identifies the continuity across years and the strategic intent to position IBM as a trusted partner in enterprise AI and hybrid cloud adoption, differentiating from hyperscalers. However, it lacks specific details about the evolution in how trust was framed—particularly the expansion into strategic partnerships with AWS, Microsoft, SAP (noted in 2023), and the addition of cybersecurity partners like Palo Alto Networks in 2024. These multi-hop details are present in the original answer and are critical to fully capturing the progression of IBM’s strategic positioning. While the LLM answer captures the general trend and correctly cites the integration of trust with hybrid cloud and AI, it omits the ecosystem and security dimensions that mark the evolution from 2022 to 2024. There are no numerical inaccuracies (quantitative accuracy is perfect as no numbers are misstated), and the reasoning is sound but incomplete. The contextual relevance is high because the response directly addresses the question’s focus on strategic positioning in hybrid cloud and AI. The missing partner ecosystem evolution prevents a higher score on qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 406,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did the role and utilization of Gilead's El Segundo, California facility in cell therapy manufacturing evolve from 2022 through 2024, particularly in terms of its clinical and commercial production responsibilities?",
      "original_answer": "The role of Gilead's El Segundo, California facility in cell therapy manufacturing remained consistent across the three years, with no significant changes in its clinical and commercial production responsibilities. In 2022, the facility was described as being utilized for clinical and commercial manufacturing and processing of cell therapy products, reflecting its dual role in both trial-related and market-ready production. This utilization was reaffirmed in 2023, where the facility continued to serve as a key site for both clinical and commercial manufacturing of cell therapy products, indicating sustained operational importance. In 2024, the facility maintained its function, with no expansion or reduction in responsibilities documented in the filings, showing continuity in Gilead’s strategic use of El Segundo for cell therapy manufacturing. This consistency suggests a stable operational footprint at the El Segundo site for cell therapy despite broader changes in Gilead’s manufacturing network.",
      "llm_answer": "In 2022 the El Segundo, California site was described as a clinical‑manufacturing location for Gilead’s cell‑therapy programs (GILD_10k_2022, pp. 31‑35).  By 2023 the company had expanded that facility’s use to include commercial manufacturing and processing of cell‑therapy products (GILD_10k_2023, pp. 9‑13).  In 2024 the El Segundo site continued to serve both clinical and commercial production responsibilities, remaining a key hub for cell‑therapy manufacturing (GILD_10k_2024, pp. 8‑12).",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that Gilead expanded the El Segundo facility's role to include commercial manufacturing in 2023, implying a change in responsibility over time. However, the ground truth indicates that the facility had a dual role in both clinical and commercial manufacturing consistently from 2022 through 2024, with no significant changes or expansions in responsibilities. This misrepresents the evolution as one of growth when the actual filings show continuity. (2) There are no numeric values (e.g., dollar amounts, percentages, headcount) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correctly used and cited to appropriate filings. (3) The multi-hop reasoning is partially sound in that the model synthesizes information across three years and correctly identifies the facility’s involvement in both clinical and commercial production by 2024. However, it fails in accurately synthesizing the consistency of that role over time, incorrectly inferring an expansion in 2023 when the ground truth confirms no such change. This undermines the core of the question, which asks about the evolution—where the correct answer is 'no change' rather than 'expansion'. (4) The contextual relevance is high because the answer addresses the facility, location, time frame, and production roles. Qualitative accuracy is low due to the incorrect characterization of change over time. Quantitative accuracy is high by default, as no numerical errors were made. Correctness score is 4 due to a partially accurate picture: while the final state (dual role in 2024) is correct, the claimed evolution is factually wrong, making the overall answer significantly misleading.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 478,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Lowe's Companies, Inc.'s issuance and maturity structure of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049 across all three years (2022, 2023, and 2024) as part of its long-term debt structure under the Fifteenth Supplemental Indenture dated April 5, 2019. While the specific maturity date of April 5, 2049 remained unchanged, the consistent inclusion of this instrument across filings indicates a strategic emphasis on long-duration debt to finance long-term obligations and maintain capital flexibility. The stability in referencing this instrument over time suggests Lowe's commitment to managing its capital structure with a focus on extended maturities to avoid near-term refinancing risks.",
      "llm_answer": "From 2022 through 2024, Lowe’s consistently issued 4.550% Notes due April 5, 2049, with each issuance amounting to roughly $1.5 billion (2022 10‑K, p. 79‑83; 2023 10‑K, p. 74‑78; 2024 10‑K, p. 73‑77). The unchanged coupon and long‑dated maturity over these three years show a deliberate long‑term debt strategy that prioritizes stable, fixed‑rate financing to support capital projects and refinance existing debt over a 25‑plus‑year horizon.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in stating that Lowe's 'consistently issued' the 4.550% Notes from 2022 through 2024 with each issuance amounting to roughly $1.5 billion. The ground truth does not support repeated issuances; rather, it confirms that the same note (originally issued under the Fifteenth Supplemental Indenture on April 5, 2019) was consistently referenced in filings across 2022–2024. There is no evidence of new issuances each year or of a $1.5 billion amount per year in the ground truth. This misrepresents the issuance activity and introduces false quantitative data. (2) The maturity date (April 5, 2049) and coupon rate (4.550%) are correctly stated, which supports partial quantitative accuracy. However, the dollar amount of $1.5 billion is not present in the original answer and cannot be verified from the provided truth, making this a critical inaccuracy. (3) The reasoning about Lowe's long-term debt strategy—emphasizing stable, fixed-rate financing and extended maturities to avoid refinancing risk—is semantically aligned with the ground truth and shows sound qualitative understanding of the strategic implication of maintaining long-duration debt. The multi-hop synthesis correctly infers strategic intent from consistent disclosure. (4) While the core strategic interpretation is valid and contextually relevant, the fabrication of issuance amounts and frequency undermines factual correctness. The answer would score higher if not for the unsupported numerical claims. Thus, correctness is reduced to 6 due to major quantitative inaccuracies despite correct reasoning and context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 451,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the legal exposure and associated settlement costs related to 3M's Scotchgard product evolve from 2022 through 2024, and what does this trend reveal about the financial impact of PFAS-related litigation on the company?",
      "original_answer": "In 2022, 3M was defending multiple lawsuits in New York and Michigan, including a consolidated putative class action in Michigan related to Wolverine's disposal of Scotchgard, with 3M contributing to a $65 million settlement alongside Saint-Gobain and Honeywell. By 2023, the legal exposure had expanded, with 3M facing approximately 68 AFFF suits outside the MDL and additional PFAS-related suits, including a case in Illinois and a Canadian class action, while also finalizing a non-material settlement in Michigan related to Wolverine's disposal practices. In 2024, litigation expanded further into Alabama and Georgia, with multiple lawsuits from municipal water utilities, property owners, and carpet manufacturers, including a $65 million settlement in New York being finalized and ongoing litigation in Alabama with trial dates set for 2026. This trend reveals a growing financial burden from PFAS-related litigation, with increasing geographic spread and case complexity, suggesting that the company's liabilities and legal costs associated with Scotchgard are escalating over time.",
      "llm_answer": "From 2022 to 2024, 3M’s Scotchgard product continued to face a growing number of PFAS‑related lawsuits, but the company’s settlement outlays remained immaterial.  In 2023, 3M settled a Wolverine World Wide lawsuit over Scotchgard for an immaterial amount (MMM_10k_2023.pdf: 92‑96), and by 2024 the company still had ongoing litigation but had not incurred additional significant settlement costs (MMM_10k_2024.pdf: 96‑100).  This trend indicates that while legal exposure for Scotchgard remains high, the direct financial impact of PFAS litigation on 3M has been limited.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and omits key details from the ground truth, leading to a misleading conclusion. (1) Quantitatively, the LLM incorrectly claims all settlements were 'immaterial'—this contradicts the ground truth, which specifies a $65 million settlement in 2022 involving 3M, Saint-Gobain, and Honeywell, and another $65 million settlement finalized in New York in 2024. These are substantial, specific dollar amounts, not immaterial. The LLM also fails to mention the 68 AFFF suits in 2023 or the expansion into Alabama and Georgia in 2024. (2) The reasoning is flawed: while the LLM acknowledges ongoing litigation, it concludes that financial impact has been 'limited,' which contradicts the ground truth's clear trend of escalating liabilities and geographic spread. The claim that 3M 'had not incurred additional significant settlement costs' by 2024 is false given the $65M New York settlement. (3) Multi-hop synthesis is weak—the LLM fails to connect the evolution of lawsuits across years and locations (New York, Michigan, Illinois, Canada, Alabama, Georgia) and does not link the increasing complexity and financial exposure over time. (4) Entity accuracy is partially correct (mentions Wolverine, Michigan, 3M), but omits Saint-Gobain, Honeywell, and Canadian class action. Contextual relevance is moderate as it addresses PFAS litigation and Scotchgard, but the conclusion misrepresents the financial trend. Overall, the answer is factually incorrect on key financial figures and misjudges the trend, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 433,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Gilead Sciences' utilization of its Foster City, California facility evolved from 2022 through 2024 in terms of R&D focus, manufacturing responsibilities, and strategic alignment with its global operations?",
      "original_answer": "From 2022 to 2024, Gilead Sciences' Foster City, California facility transitioned from being primarily described as housing administrative, manufacturing, and R&D activities (2022) to being more specifically aligned with process chemistry research, analytical method development, formulation, device development, and the manufacturing of API and drug product for clinical trials (2023–2024). In 2022, Foster City was noted as the corporate headquarters and a key hub within a broader network of global properties. By 2023 and 2024, the facility's role was more narrowly defined with an emphasis on early-stage development and clinical manufacturing, suggesting a strategic shift toward consolidating R&D and clinical production capabilities in Foster City while other locations (e.g., La Verne, Oceanside, and international sites) handled commercial-scale manufacturing and distribution.",
      "llm_answer": "From 2022 to 2024, Gilead’s Foster City headquarters shifted from a broad “administrative, manufacturing and R&D” hub (2022) to a more specialized center that focuses on process‑chemistry research, analytical method development, formulation/device development and API/drug‑product manufacturing for clinical trials (2023‑24). This evolution reflects a tighter integration of R&D and manufacturing at the corporate site and reinforces its role as a key node in Gilead’s global network of facilities that support operations across North America, Europe, Asia and beyond. (GILD_10k_2022, pp. 31‑35; GILD_10k_2023, pp. 9‑13; GILD_10k_2024, pp. 8‑12)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures the evolution of Gilead's Foster City facility from a broad administrative, manufacturing, and R&D hub in 2022 to a more specialized center focused on process chemistry, analytical methods, formulation/device development, and clinical-stage manufacturing (API and drug product) in 2023–2024. The key shift toward early-stage development and clinical manufacturing is accurately reflected. (2) There are no numeric values (e.g., dollar amounts, percentages, headcounts) in either the original or LLM answer, so quantitative accuracy is not applicable beyond correct use of years (2022, 2023, 2024), which are accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings to show a strategic evolution in facility use, correctly inferring a narrowing of focus and tighter integration of R&D and clinical manufacturing. The mention of global operations is slightly more generalized than the original (which names La Verne, Oceanside, and international sites), but the core idea of strategic alignment with global operations is preserved. (4) The answer is contextually relevant and fully addresses the three dimensions in the question: R&D focus, manufacturing responsibilities, and strategic alignment. The only minor shortcoming is the lack of explicit contrast with other sites (e.g., La Verne, Oceanside) handling commercial-scale manufacturing, which slightly reduces completeness in the strategic alignment aspect. However, the reference to Foster City as a 'key node' in a global network suffices for high-level alignment. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 483,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 through 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk remained consistently anchored in internal controls and external expert reviews, but evolved in sophistication and integration. In 2022, AIG emphasized the uncertainty in loss development and outlined internal oversight and external expert reviews as key tools. By 2023, AIG expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies, indicating a more quantitative and layered approach to measuring insurance risk exposure. In 2024, AIG further integrated these practices into a broader enterprise risk management (ERM) framework, including second-line review and challenge of reserving models and assumptions, and enhanced reporting to committees and regulators. The progression shows a shift from reactive oversight to proactive, model-driven, and enterprise-wide risk governance.",
      "llm_answer": "AIG’s loss‑reserve oversight moved from a basic internal‑control system with periodic external expert reviews in 2022 (internal controls and “reviews by external experts”【2022 p.167】) to a formal risk‑management framework in 2023 that added escalation procedures, a model‑risk management and validation process, and expanded modeling to stochastic and scenario analyses【2023 p.119】. By 2024, the company further institutionalized oversight with board‑level risk committees and a three‑tiered limits hierarchy, while embedding external reviews and third‑party model validation into the reserve‑setting process and reinforcing the model‑risk framework【2024 p.84‑85】【2024 p.86】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All entities—AIG, years 2022–2024, and key risk management components—are correctly identified. The evolution across the three years is accurately portrayed: 2022 emphasizes internal controls and external reviews; 2023 introduces more advanced modeling (stochastic and scenario analyses), model-risk management, and validation processes; 2024 shows institutionalization via board-level oversight, three-tiered limits, and embedded external validation. These match the progression described in the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not compromised—score 10 is justified. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three annual reports, correctly attributing specific practices to each year with citation-like references (e.g., '2023 p.119'), indicating proper cross-document synthesis. The only minor gap is that the LLM does not explicitly mention 'experience studies' in 2023 or 'second-line review and challenge' in 2024—details present in the ground truth—which slightly reduces qualitative accuracy. However, the mention of 'model-risk management and validation' and 'third-party model validation' captures the essence. (4) Contextual relevance is perfect: every part of the question—oversight mechanisms, modeling approaches, and external reviews—is addressed across the time period. Wording differs slightly (e.g., 'three-tiered limits hierarchy' and 'board-level risk committees' are more specific than the original’s 'ERM framework'), but these likely reflect additional details from the source and enhance rather than distort accuracy. Overall, this is a semantically equivalent, well-reasoned, and factually correct response with only minor omissions in terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 522,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression indicate about its Analog vs. Embedded Processing manufacturing focus in the region?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently maintained operations in Melaka, Malaysia, focusing exclusively on Analog manufacturing. There was no expansion into Embedded Processing in Melaka during this period, despite changes in other global locations. This indicates a stable but specialized role for Melaka in TXN’s global manufacturing strategy, limited to Analog product lines.",
      "llm_answer": "From 2022 through 2024 Texas Instruments kept the Melaka, Malaysia site as an **analog‑only** manufacturing location (the table lists “Melaka, Malaysia †/∗/∗∗” under the Analog column and no entry under Embedded Processing【TXN_10k_2022】【TXN_10k_2023】【TXN_10k_2024】).  The footnote changed from “† Portions of the facilities are leased and owned” in 2022, to “∗ Portions of the facilities are leased and owned” in 2023, and to “∗∗ Leased” in 2024, indicating a shift to a fully leased facility but no change in product focus.  This three‑year trend shows TI has maintained a consistent analog manufacturing presence in Melaka, with no expansion into embedded‑processing operations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that Texas Instruments maintained operations in Melaka, Malaysia from 2022 to 2024 with a focus exclusively on Analog manufacturing, and correctly notes the absence of Embedded Processing activities. (2) The quantitative details about the footnote evolution († → ∗ → ∗∗) and their meanings—shifting from partially owned/leased to fully leased—are factually accurate and supported by the cited 10-K filings. There are no numerical or date inaccuracies. (3) The multi-hop reasoning is sound: the model synthesizes data across three years of SEC filings, correctly interprets footnotes, and draws a valid conclusion about the consistency in product focus despite operational changes. (4) The answer is semantically equivalent to the original, providing even more granular detail (e.g., footnote changes) without introducing errors. All aspects of the question—evolution over time and implications for Analog vs. Embedded Processing focus—are thoroughly and correctly addressed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 305,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's hedging strategy around forecasted debt issuances?",
      "original_answer": "In fiscal 2022, Lowe's referenced forward interest rate swaps in the context of their impact on other comprehensive income and earnings, indicating active use of these instruments to hedge forecasted debt issuances over multiple prior periods (2019–2021). In fiscal 2023, the company disclosed a fair value of $251 million for forward interest rate swaps under other current assets, showing a concrete financial commitment to managing interest rate risk. By fiscal 2024, however, the company no longer held forward interest rate swaps, focusing instead on fixed-to-floating interest rate swaps as fair value hedges on existing debt, with no mention of forward swaps in the current or prior year positions. This progression indicates a strategic shift from hedging anticipated debt issuances to managing the interest rate exposure on existing debt, reflecting a change in financial risk management focus over the three-year period.",
      "llm_answer": "In FY 2022, Lowe’s had forward‑interest‑rate‑swap exposure of $2.56 billion (notional) (Note 9, p. 60). By FY 2023 the fair value of those swaps had fallen to $251 million (Fair‑Value Measurements, p. 52), and in FY 2024 the company reported no forward‑interest‑rate‑swap exposure on its balance sheet (Fair‑Value Measurements, p. 44). This progression shows that Lowe’s used forward‑rate swaps to hedge forecasted debt issuances and systematically unwound the hedges as the debt was issued or the contracts matured.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "(1) The LLM answer captures the overall trend correctly: Lowe's had forward interest rate swaps in 2022, a reduced fair value in 2023, and no exposure in 2024. It also correctly infers that the company used these instruments to hedge forecasted debt issuances and unwound them over time. However, there is a critical quantitative discrepancy: the LLM claims a $2.56 billion notional amount in FY2022, which is not present in the ground truth. The original answer does not specify a notional value for 2022, only referencing the impact on income and OCI. This unsupported figure undermines factual accuracy. (2) The $251 million fair value in FY2023 matches the ground truth and is correctly attributed. The statement that there was no exposure in FY2024 aligns with the original answer. However, the introduction of a $2.56B notional figure without corroboration from the ground truth constitutes a significant error, especially since the original answer emphasizes the shift in strategy rather than notional amounts. (3) The reasoning is logically sound—unwinding hedges as debt is issued or contracts mature is a reasonable interpretation of the progression. The model correctly synthesizes information across three fiscal years and draws a plausible conclusion about hedging strategy evolution. However, it misses the key qualitative shift emphasized in the ground truth: the move from cash flow hedges (forward swaps for forecasted debt) to fair value hedges (fixed-to-floating swaps on existing debt). This nuance is absent in the LLM answer, which only notes the unwinding without identifying the strategic pivot in hedging focus. (4) Despite the missing strategic context and the incorrect notional value, the answer remains contextually relevant and mostly accurate in directionality. The core timeline and elimination of forward swaps are correct, warranting a score of 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 512,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did IBM's disclosure of the 6.50% Debentures due 2028 evolve across its 2022, 2023, and 2024 filings, and what does the consistency of its referenced filing date reveal about the long-term structure and documentation of this debt instrument?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 across all three years—2022, 2023, and 2024—by citing the same Exhibit 2 to Form 8-K filed on January 8, 1998. This shows that the documentation and legal structure of the debentures remained unchanged over the three-year period, indicating a stable and long-standing debt instrument with no material amendments or refinancing activity disclosed during this time.",
      "llm_answer": "IBM’s 2022, 2023, and 2024 Form 10‑Ks all disclose the 6.50% Debentures due 2028 as Exhibit 2 to a Form 8‑K filed on January 8 1998 (IBM_10k_2024, pp. 17‑21; IBM_10k_2023, pp. 17‑21; IBM_10k_2022, pp. 28‑32). The unchanged reference across all three filings shows that the debt’s terms have remained constant since issuance, and that IBM continues to rely on the original 1998 documentation to support its long‑term debt structure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: the 6.50% Debentures due 2028 are correctly attributed to IBM, and the consistent citation of Exhibit 2 to the Form 8-K filed on January 8, 1998, across the 2022, 2023, and 2024 10-K filings is precisely stated. (2) Quantitative accuracy is perfect: the interest rate (6.50%), maturity year (2028), and filing date (January 8, 1998) match the ground truth exactly. Minor formatting differences (e.g., 'January 8 1998' vs 'January 8, 1998') are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound—the model correctly synthesizes information across three years of filings and draws the valid conclusion that the unchanged reference indicates a stable, long-standing debt instrument with no disclosed amendments. (4) The answer addresses both parts of the question: the evolution (or lack thereof) of the disclosure over time, and the implication of the consistent filing reference regarding the debt’s structure. The reasoning about reliance on original 1998 documentation aligns with the ground truth’s interpretation of 'stable and long-standing.' All entities (IBM, Form 10-K, Form 8-K, Exhibit 2, debentures) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 361,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did the positioning of Reflective Signage within MMM's Transportation and Electronics segment evolve across 2022, 2023, and 2024, and what does this sequence suggest about its strategic importance in MMM's product portfolio?",
      "original_answer": "Reflective Signage remained a consistent offering within MMM's Transportation and Electronics segment across all three years, but its relative positioning within the product list changed, potentially signaling shifts in strategic emphasis. In 2022, Reflective Signage was listed fifth among offerings, following advanced ceramics and attachment tapes but preceding light management films and electronics assembly solutions. In 2023, it moved up to the fourth position, directly after premium large format graphic films and before light management films and electronics assembly solutions. In 2024, Reflective Signage remained in the fourth position but was now placed after 'sound and temperature management' and before 'Light management films and electronics assembly solutions.' This consistent placement in the top half of the segment's offerings over three years suggests ongoing strategic relevance, with a slight early boost in prominence in 2023 that was maintained in 2024.",
      "llm_answer": "Reflective signage has remained a listed product within 3M’s Transportation and Electronics segment in all three years, with its description unchanged as “Reflective signage for highway, and vehicle safety” (2022, p.129‑133; 2023, p.105‑109; 2024, p.108‑112). This continuity indicates that 3M views reflective signage as a core, strategically important component of its transportation and electronics portfolio, likely because it supports highway and vehicle safety markets.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that Reflective Signage remained a consistent offering within 3M's (MMM) Transportation and Electronics segment across 2022, 2023, and 2024, which aligns with the ground truth. It also accurately infers ongoing strategic importance due to continuity in listing—this addresses part of the question. However, the LLM fails to report the key evolution in positioning (i.e., movement from 5th to 4th place in the product list), which is central to the question about how its positioning evolved. The ground truth emphasizes a shift in rank in 2023 and retention in 2024, with specific preceding and succeeding product categories (e.g., advanced ceramics, light management films, sound and temperature management), none of which are mentioned. This omission severely limits the answer's completeness and qualitative accuracy. While no numbers are incorrect (hence perfect quantitative accuracy), the lack of multi-hop synthesis—comparing ordering across years from multiple filings—is a major deficiency. The answer relies only on presence/absence and description, not structural changes in presentation that imply strategic emphasis. Thus, while contextually relevant and factually non-erroneous, it misses critical comparative detail needed for full correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 360,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility for cell therapy manufacturing evolved from 2022 through 2024, particularly in terms of its strategic importance to commercial production?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as one of its principal manufacturing facilities, indicating its operational role within the company's global manufacturing footprint. By 2023, the facility was explicitly described as being utilized for the commercial manufacturing and processing of cell therapy products, aligning with Gilead's broader strategy to expand internal capabilities in this area. In 2024, Hoofddorp retained its designation as a key facility for commercial cell therapy manufacturing, underscoring its growing strategic importance in supporting Gilead's long-term growth needs in advanced therapies. This progression reveals an increasing emphasis on Hoofddorp as a dedicated hub for cell therapy, reflecting Gilead's commitment to scaling this segment.",
      "llm_answer": "From 2022 through 2024, Gilead has consistently described its Hoofddorp, Netherlands site as a commercial manufacturing and processing hub for cell‑therapy products (2022: p. 35; 2023: p. 13; 2024: p. 12). The facility has remained central to Gilead’s cell‑therapy production, supporting key products such as Yescarta and Tecartus, and its strategic importance has grown as the company expands its cell‑therapy portfolio and scales commercial production to meet global demand.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies the Hoofddorp facility's role in commercial cell therapy manufacturing from 2022 through 2024, citing consistent documentation across years (with page references that support the claims). Quantitatively, there are no numerical errors—dates (2022–2024) and facility details are correct. The mention of Yescarta and Tecartus, while not in the original answer, is contextually appropriate and reflects known Gilead cell therapy products, adding relevant detail without introducing inaccuracy. The core progression—growing strategic importance, continuity in commercial manufacturing role, and alignment with scaling efforts—is accurately captured. The only minor gap is that the original answer emphasizes the evolution from being a 'principal facility' in 2022 to an explicitly 'commercial cell therapy' site in 2023–2024, a nuance slightly underemphasized in the LLM response. However, the LLM does state the facility was described as such across all three years, which is supported. Multi-hop reasoning is sound: the synthesis across years and strategic context is logical and well-supported. Semantic equivalence is high, with no factual discrepancies. The answer is fully relevant to the question about evolution and strategic importance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 371,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the number of shares available for future issuance under the 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about Texas Instruments' ongoing use of this plan for director compensation?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 1,843,134 shares in 2022 to 1,786,785 shares in 2023, and further declined to 1,745,284 shares in 2024. This consistent reduction indicates that Texas Instruments has been actively utilizing the 2003 Director Compensation Plan to issue shares for director compensation over the three-year period, with fewer shares remaining available for future grants each year.",
      "llm_answer": "The 2003 Director Compensation Plan had **zero shares available for future issuance in 2022, 2023, and 2024** (the footnote for each year lists only the 2009 LTIP, 2014 ESPP, 2018 Director Plan, and 2024 LTIP). This steady zero balance shows that TI has fully exercised or retired the 2003 plan for new director awards and now relies on newer plans such as the 2018 Director Plan and the 2024 LTIP for director compensation.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitatively, it claims zero shares were available in 2022, 2023, and 2024 under the 2003 Director Compensation Plan, which directly contradicts the ground truth: 1,843,134 (2022), 1,786,785 (2023), and 1,745,284 (2024). These numbers show a clear decreasing trend, not a zero balance. (2) The LLM incorrectly asserts that the 2003 plan was no longer in use and that only newer plans like the 2018 Director Plan and 2024 LTIP are active. However, the ground truth confirms ongoing use of the 2003 plan for share issuances, as evidenced by the逐年 decline in available shares. (3) The reasoning is flawed: a zero balance would imply inactivity or exhaustion, but the actual data shows active utilization. The LLM likely misread or misinterpreted the footnotes, confusing the listing of multiple plans with the inactivity of the 2003 plan. (4) While the answer attempts to address the trend and its implication, the conclusion about TI relying solely on newer plans is unsupported and incorrect. The contextual relevance is low because the core facts are wrong, despite addressing the question's structure. Minor relevance credit is given for discussing director compensation plans and their evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 359,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did IBM's treatment and market transparency of its 0.950% Notes due 2025 evolve from 2022 to 2024, and what does this progression suggest about its broader capital market strategy and investor engagement approach?",
      "original_answer": "In 2022, IBM referenced the 0.950% Notes due 2025 as part of a broader list of debt instruments, citing the May 22, 2017 Form 8-K filing (Exhibit 4.1) as the defining instrument. In 2023, IBM continued to reference the same May 2017 filing but began listing the 0.950% Notes due 2025 alongside newer instruments, suggesting increased prominence. By 2024, the 0.950% Notes due 2025 were explicitly listed with a dedicated trading symbol (IBM25B) on the New York Stock Exchange, indicating a shift from internal documentation to active market visibility. This evolution shows IBM's strategic move toward greater transparency and investor accessibility for this instrument over time.",
      "llm_answer": "In 2022 IBM had not yet issued the 0.950% Notes due 2025, so the 10‑K contained no disclosure of that debt. By 2023 the notes were issued and disclosed in the filing, but they were still unlisted and the company provided only limited market‑for‑securities information. In 2024 IBM registered the notes on the NYSE (IBM25B) and listed them in the “Securities registered pursuant to Section 12(b) of the Act” table, indicating a move to full public trading and a more transparent market‑for‑securities section【2024‑10K‑pages‑1‑5】. This progression shows IBM’s broader strategy of increasing liquidity and investor confidence by making its debt more accessible and its disclosures more complete.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly claims that IBM had not yet issued the 0.950% Notes due 2025 in 2022, which contradicts the ground truth stating that IBM referenced the notes in 2022 via the May 22, 2017 Form 8-K filing. The notes were issued in 2017, not in 2023 as implied. This misrepresents the entire timeline. (2) Quantitative accuracy is poor: the key date of issuance (May 22, 2017) is omitted and replaced with a false 2023 issuance, and the evolution is mischaracterized as beginning in 2023 rather than 2022. The trading symbol IBM25B and NYSE listing in 2024 are correctly identified, but the context is wrong. (3) Multi-hop reasoning is flawed: the model fails to correctly synthesize information across years and filings. It does not recognize that the 2022 and 2023 references were to the same 2017 instrument, which is central to the ground truth narrative of increasing transparency over time. Instead, it fabricates a timeline where the notes are first issued in 2023. (4) Despite these errors, the answer is contextually relevant—it addresses the question’s structure, discusses transparency, investor engagement, and correctly notes the 2024 NYSE listing with symbol IBM25B. The conclusion about increasing liquidity and transparency aligns semantically with the ground truth, but it is based on incorrect premises. Thus, while the direction of reasoning is plausible, the factual foundation is unsound, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 417,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how does the 2023 Global Atlantic reinsurance transaction reflect a strategic shift in this accounting approach?",
      "original_answer": "From 2022 to 2024, MetLife's use of the deposit method of accounting for reinsurance showed a significant increase in both deposit assets and liabilities. In 2022, deposit assets and liabilities were $1.8 billion and $1.4 billion, respectively. By 2023, deposit assets rose to $5.1 billion and liabilities to $1.3 billion. In 2024, deposit assets slightly decreased to $4.6 billion while liabilities remained stable at $1.2 billion. The 2023 Global Atlantic transaction marked a strategic shift, as MetLife recorded $10.3 billion in reinsurance recoverables and deposit receivables, indicating a more aggressive use of the deposit method to manage risk exposure and restructure its life insurance portfolio.",
      "llm_answer": "MetLife’s deposit‑method balances grew from roughly **$1.8 billion in deposit assets and $1.4 billion in deposit liabilities in 2022** to **$5.1 billion in assets and $1.3 billion in liabilities at year‑end 2023**, then fell slightly to **$4.6 billion in assets and $1.2 billion in liabilities by 2024** (2024: $4.6 billion assets, $1.2 billion liabilities; 2023: $5.1 billion assets, $1.3 billion liabilities). The 2023 Global Atlantic transaction, which transferred $9.5 billion of assets and created $10.3 billion of deposit receivables, drove the 2023 jump and signals a strategic shift toward using the deposit method for larger, structured risk‑transfer deals that also move substantial assets to the reinsurer.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numeric values for deposit assets and liabilities across 2022–2024: $1.8B assets / $1.4B liabilities (2022), $5.1B / $1.3B (2023), and $4.6B / $1.2B (2024), matching the ground truth exactly. The mention of the $10.3 billion in deposit receivables from the Global Atlantic transaction is accurate. However, the LLM adds that '$9.5 billion of assets' were transferred, which is not present in the original answer and not confirmed by the ground truth, introducing a minor factual overreach. (2) All stated numbers align with the ground truth, with acceptable formatting (e.g., $4.6 billion). The core financial data and trends—significant increase in 2023, slight decline in 2024, stable liabilities—are correctly conveyed. (3) The multi-hop reasoning is sound: the LLM correctly links the 2023 spike in deposit method balances to the Global Atlantic transaction and interprets it as a strategic shift toward structured risk-transfer deals, which is consistent with the original answer’s claim of a 'strategic shift' and 'more aggressive use' of the deposit method. The synthesis across years and the causal inference are logical and well-supported. (4) The answer is highly relevant, addressing both the evolution of deposit method balances and the strategic implications of the Global Atlantic deal. The only deviation is the unverified $9.5 billion asset transfer figure, which slightly affects qualitative accuracy but does not undermine the overall correctness. Thus, the answer is factually strong, with near-perfect quantitative accuracy and excellent contextual and reasoning alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 450,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MMM's product portfolio related to Fall Protection Solutions evolve across its Safety and Industrial segment from 2022 to 2024, and what does this 3-year progression indicate about the company's focus on workplace safety solutions?",
      "original_answer": "From 2022 to 2024, MMM consistently included 'fall protection solutions' as part of its Respiratory, hearing, eye and fall protection solutions within the Safety and Industrial segment. In 2022, fall protection was listed among a broader set of safety offerings including respiratory, hearing, and eye protection. In 2023, the listing remained consistent, indicating continued emphasis on integrated safety solutions. By 2024, the phrasing slightly evolved to 'respiratory, hearing, eye and fall protection solutions,' maintaining the same product grouping but with a more concise presentation. This 3-year consistency suggests MMM maintained a stable strategic focus on comprehensive worker protection solutions, with fall protection remaining a core component of its industrial safety portfolio.",
      "llm_answer": "Across 2022‑2024, 3M’s Safety and Industrial segment consistently listed “fall protection solutions” as part of its respiratory, hearing, eye and fall protection product line (2022 pp. 129‑133; 2023 pp. 105‑109; 2024 pp. 108‑112), with no new categories added or removed.  The segment’s operating income rose from $1.1 B in 2022 to $2.3 B in 2023 and $2.5 B in 2024 (2022‑24 tables), showing that the company is not only maintaining but also strengthening its focus on workplace safety solutions, particularly fall protection.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that fall protection solutions were consistently part of the Safety and Industrial segment from 2022 to 2024 and were grouped with respiratory, hearing, and eye protection, which aligns with the ground truth. However, it introduces significant factual inaccuracies regarding financial data. The claim that operating income rose from $1.1B in 2022 to $2.3B in 2023 and $2.5B in 2024 is not supported by the ground truth, which does not mention any financial figures or trends in operating income for this segment. This is a major quantitative error that undermines the conclusion about MMM 'strengthening' its focus based on financial growth. (2) The numbers cited for operating income are entirely absent from the original answer and cannot be verified from the provided context. There is no mention of segment-level operating income in the ground truth, making these figures fabricated or misattributed. Even if the formatting were acceptable ($1.1B = $1.1 billion), the values themselves are incorrect and unsupported. (3) The reasoning is partially sound in noting consistency in product portfolio presentation across years, which supports a stable strategic focus. However, the multi-hop synthesis fails because it incorrectly infers increased strategic emphasis based on inaccurate financial growth, introducing a false causal link between revenue growth and product focus. The original answer draws a more cautious and accurate conclusion about 'stable' focus, not increasing emphasis. (4) The contextual relevance is high because the answer addresses the evolution of the product portfolio and attempts to interpret strategic focus. Qualitative accuracy is moderate due to correct entity identification (MMM, Safety and Industrial segment, product categories) and timeline, but penalized for unsupported financial claims. Quantitative accuracy is low due to completely incorrect financial figures. Correctness score is 5 because while the core portfolio description is accurate, the inclusion of false financial data and the resulting flawed inference about strategic strengthening significantly reduce overall factual reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 586,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Altria's organizational structure and ownership of UST evolved from 2022 to 2024, and what does this progression reveal about Altria's strategic positioning in the smokeless tobacco market?",
      "original_answer": "In 2022, Altria highlighted UST as a key subsidiary, owning its trademarks valued at $8.8 billion, and emphasized amortization expenses tied to its acquisition. By 2023, Altria reaffirmed UST's role as a wholly owned subsidiary through its consolidated subsidiaries structure, maintaining its engagement in moist smokeless tobacco (MST) and snus products. In 2024, Altria further solidified UST's integration by describing it as a core operating company under its broader 'Moving Beyond Smoking' initiative, aligning UST's MST products with Altria's strategic pivot toward reduced-risk tobacco offerings. This evolution shows a consistent emphasis on UST as a strategic asset, with increasing alignment toward Altria's vision of transitioning adult smokers to less harmful products.",
      "llm_answer": "Altria has kept UST LLC as a wholly‑owned subsidiary of Altria Group, with its operating arm, U.S. Smokeless Tobacco Company LLC (USSTC), also wholly owned, through 2022‑24 (2022 p. 64‑68; 2023 p. 58‑62; 2024 p. 2‑6).  The company reports UST under its oral‑tobacco segment, reinforcing a centralized ownership and a strategic focus on smokeless tobacco as a core growth engine.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in stating that Altria maintained UST as a wholly owned subsidiary from 2022 to 2024 and correctly identifies UST's operating arm and reporting segment. It accurately reflects the continuity of ownership and strategic focus on smokeless tobacco. However, it omits key qualitative developments highlighted in the ground truth: the $8.8 billion trademark valuation in 2022, the amortization context, and the explicit integration of UST into Altria's 'Moving Beyond Smoking' initiative by 2024. These omissions reduce completeness and depth in capturing the strategic evolution. While the core entity and ownership facts are correct (ensuring high quantitative and contextual scores), the answer fails to convey the progression in strategic positioning—specifically the alignment of UST's MST and snus products with reduced-risk offerings. This missing multi-hop synthesis between ownership structure and strategic repositioning limits qualitative accuracy. The answer is semantically aligned in part but lacks the full trajectory described in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 310,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What does Tesla's repeated reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its 2022, 2023, and 2024 filings suggest about the company's long-term financing strategy for solar energy initiatives?",
      "original_answer": "Tesla's continued reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its annual filings from 2022 through 2024 indicates a sustained reliance on structured solar financing mechanisms to support its renewable energy initiatives. In 2022, Tesla listed the One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015, related to these bonds, reaffirming its legal and financial linkage to the instrument. This reference was repeated in 2023 and again in 2024, showing that Tesla continues to treat this bond series as a material component of its solar financing architecture. The consistent citation of this specific bond structure across three consecutive filings suggests that Tesla maintains a strategic commitment to securitized solar debt as a core funding source for its solar projects, likely reflecting confidence in the bond's performance and its alignment with Tesla's broader clean energy business model.",
      "llm_answer": "Tesla’s repeated mention of the SolarCity 5.45% Solar Bonds, Series 2015/C92‑15 in its 2022, 2023 and 2024 10‑Ks shows that the company still carries this long‑term debt and continues to use it as a key financing vehicle for its solar projects. The consistency across filings signals a deliberate strategy of funding solar initiatives through stable, long‑term debt rather than equity or short‑term borrowing, and that Tesla has not yet refinanced or retired these bonds.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All entities are correct: Tesla, SolarCity 5.45% Solar Bonds, Series 2015/C92-15, and the years 2022–2024 are accurately referenced. The percentage (5.45%) and bond series designation are correctly stated. (2) Quantitative accuracy is perfect: no numerical errors, and the dates and financial instrument details match the original. (3) The reasoning is sound: the LLM correctly infers that Tesla continues to rely on this bond as a long-term financing vehicle, indicating a strategic preference for structured debt over equity or short-term borrowing. It also correctly notes that the bond has not been retired or refinanced, which is consistent with the ground truth’s implication of ongoing materiality. (4) The answer is contextually relevant and directly addresses the question about Tesla’s long-term financing strategy. The only minor shortcoming is that it omits specific mention of the 'One Hundred-and-Sixteenth Supplemental Indenture' and the legal linkage reaffirmed in 2022, which adds a layer of contractual commitment emphasized in the original. While not critical to the core inference, this detail strengthens the original answer’s depth. Overall, the LLM captures the essential meaning and strategic implication with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 368,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did IBM's exposure to stock exchange regulations evolve from 2022 to 2024 in relation to its debt and equity securities, and what does this multi-year progression reveal about its capital market risk management strategy?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted its exposure to stock exchange regulations as a key risk factor affecting both its debt and equity securities. In 2022, IBM noted that the value of its debt securities fluctuates due to factors like interest rates, exchange controls, and stock exchange regulations, with no assurance it could manage these risks successfully. In 2023, the company reiterated this exposure, emphasizing that external regulatory environments, including stock exchange regulations, remained a significant uncontrollable factor influencing its securities' value and liquidity. By 2024, IBM expanded on this risk by linking it to broader market liquidity conditions and customer credit risks, indicating a more integrated view of regulatory impact within its financial risk framework. This evolution shows IBM's increasing recognition of regulatory dynamics as a persistent and systemic component of its capital markets exposure, with no material reduction in dependency or mitigation strategy over the three-year period.",
      "llm_answer": "IBM’s 10‑K risk‑factor disclosures consistently list “governmental and stock‑exchange regulations” as a factor that can affect the value of its debt securities and the market price of its common stock across 2022 (pages 20‑24), 2023 (pages 9‑13), and 2024 (pages 9‑13). The unchanged wording indicates that IBM’s exposure to stock‑exchange regulatory risk has remained stable over this period, with no new regulatory threats identified. This consistency reflects a capital‑market risk‑management strategy that prioritizes ongoing monitoring and mitigation of regulatory risks rather than relying on changes in the regulatory environment to alter its risk profile.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in identifying that IBM consistently disclosed exposure to stock exchange regulations across 2022–2024, and correctly references the risk to both debt and equity securities with appropriate page numbers. Quantitative accuracy is perfect—no numerical or date errors, and entity identification (IBM, years, document type) is correct. However, the qualitative reasoning diverges from the ground truth in a key aspect: while the original answer emphasizes an evolving, increasingly integrated view of regulatory risk (especially in 2024, where it's linked to liquidity and credit risks), the LLM interprets the 'unchanged wording' as indicating a stable, static risk profile and a strategy of 'ongoing monitoring.' This mischaracterizes the progression described in the ground truth, which notes a more nuanced, expanded framing in 2024 rather than mere repetition. The LLM fails to capture the multi-hop insight that IBM’s risk management perspective became more systemic over time, instead concluding the strategy showed no change. This omission of the evolving analytical integration reduces the qualitative accuracy. Contextual relevance is high, as the response directly addresses the question’s focus on regulatory exposure and risk management. Overall, the answer is partially correct but misses the core interpretive progression, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 386,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did MMM's focus on electrical products for construction and maintenance evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about the company's strategic positioning in industrial markets?",
      "original_answer": "MMM consistently listed 'Electrical products and materials for construction and maintenance, power distribution and electrical OEMs' as part of its Safety and Industrial segment in all three years. However, in 2022, the description included 'Closure systems for personal hygiene products, masking, and packaging materials' alongside electrical products, emphasizing a broader industrial offering. In 2023, MMM maintained the same focus on electrical products but added 'Industrial abrasives and finishing for metalworking applications' and 'Autobody repair solutions' as key components of the Safety and Industrial segment, suggesting a continued but slightly expanded industrial focus. By 2024, MMM retained the core electrical product line but rephrased the segment description to 'Industrial abrasives and finishing for metalworking applications' and 'Industrial specialty products such as personal hygiene products, masking, and packaging materials', indicating a potential shift toward emphasizing broader industrial specialties while maintaining electrical offerings. This 3-year progression shows MMM's consistent commitment to electrical products for construction and maintenance, while subtly evolving its industrial portfolio to align with broader market opportunities.",
      "llm_answer": "Across 2022‑24, 3M’s Safety & Industrial segment kept “electrical products and materials for construction and maintenance” as a core offering (MMM_10k_2023, p.107; MMM_10k_2024, p.108). Net sales in that segment fell from $11.6 bn in 2022 to $10.96 bn in 2023 but held steady at $10.96 bn in 2024, while operating income more than doubled from $1.14 bn in 2022 to $2.32 bn in 2023 and $2.49 bn in 2024 (MMM_10k_2022, p.129‑133; MMM_10k_2023, p.105‑109; MMM_10k_2024, p.108‑112). This steady focus coupled with rising profitability signals 3M’s deliberate shift to strengthen its industrial market positioning, especially in high‑margin electrical solutions for construction and maintenance.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that electrical products remained a core offering in the Safety and Industrial segment across 2022–2024, it introduces financial data (net sales and operating income) that are not present in the original ground truth and are factually incorrect. The ground truth does not mention any financial figures for the segment, so including $11.6B, $10.96B, $1.14B, or $2.32B values is unsupported and misleading. These numbers may be fabricated or misattributed from other contexts. (2) Quantitative accuracy is very low because all cited figures are incorrect or unverifiable against the ground truth. There is no mention of segment-level net sales or operating income in the original answer, nor are such figures required to answer the question about strategic evolution. The LLM invents a narrative around profitability doubling, which is not supported by the source. (3) Qualitatively, the LLM captures the continuity of electrical products as a focus but completely misses the key evolution in segment composition described in the ground truth—specifically, the shift in 2023 to adding 'industrial abrasives' and 'autobody repair' and the 2024 rephrasing to emphasize 'industrial specialty products'. Instead of analyzing the changing product descriptions, the model pivots to an unsupported financial narrative. This reflects a failure in multi-hop reasoning: it does not synthesize the evolving textual descriptions of the segment across years as required. (4) Contextual relevance is moderate because the answer addresses 3M’s industrial positioning and mentions the correct segment and product line, but it substitutes descriptive analysis with incorrect financial data, thereby distorting the strategic interpretation. The conclusion about a 'deliberate shift to strengthen industrial market positioning' is plausible but based on false premises. Overall, the answer is partially correct in intent but severely flawed in execution and factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 552,
        "total_tokens": 2064
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has GILD's utilization of its Oceanside, California facility evolved from 2022 through 2024, particularly in relation to its biologics and retroviral vector manufacturing capabilities?",
      "original_answer": "In 2022, GILD's Oceanside facility was referenced as part of its broader operational footprint, indicating its role in research and development alongside other California-based sites. By 2023, the facility was specifically highlighted for its role in clinical manufacturing and process development of biologics candidates. In 2024, the Oceanside facility was further emphasized as the dedicated site for commercial retroviral vector manufacturing, in addition to continuing its role in clinical manufacturing and process development. This progression shows a strategic shift from general R&D to a more specialized and scaled-up function focused on biologics and retroviral vectors, aligning with GILD's broader biopharma manufacturing priorities.",
      "llm_answer": "In 2022 the Oceanside, California site was listed only as a commercial retroviral‑vector manufacturing facility (GILD_10k_2022, pp. 31‑35).  By 2023 and 2024 Gilead expanded that role to also include clinical manufacturing and process‑development work for its biologics candidates while continuing vector production (GILD_10k_2023, pp. 9‑13; GILD_10k_2024, pp. 8‑12).  Thus, the facility evolved from a single‑purpose vector plant to a dual‑capability site supporting both retroviral vectors and biologics manufacturing.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of GILD's Oceanside facility but contains a significant factual inaccuracy in the timeline. According to the ground truth, in 2022 the facility was part of GILD's broader R&D footprint and not yet designated as a commercial retroviral vector manufacturing site. The LLM incorrectly states that in 2022 it was already a 'commercial retroviral-vector manufacturing facility,' which contradicts the original answer stating that this designation was only confirmed in 2024. The ground truth indicates that the commercial retroviral vector role was emphasized in 2024, not 2022. However, the LLM correctly identifies the 2023 and 2024 expansions into clinical manufacturing and process development for biologics, and the dual-capability evolution is accurately summarized. The citations to the 10-Ks are plausible but do not override the factual misrepresentation of the 2022 status. Quantitative accuracy is high because there are no numerical errors (dates are correct as years, though interpreted incorrectly), and contextual relevance is strong as the response directly addresses the question's focus on evolution in biologics and retroviral vector capabilities. The reasoning is partially sound but flawed in the initial premise, undermining the multi-hop synthesis. Thus, the answer is partially correct but contains a key factual error in entity-function mapping for 2022.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 391,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 to 2024, as reflected in the target allocations for the Return-Seeking portion of the portfolio in 2022, 2023, and 2024?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan remained consistent in strategy but evolved in target allocations for the Return-Seeking portion of the portfolio: in 2022, the target allocation was based on the funded status at December 31, 2021; in 2023, the target allocation was set for 2024 based on the funded status at December 31, 2023; and in 2024, the target allocation was set for 2025 based on the funded status at December 31, 2024. This shows a forward-looking, dynamic adjustment of asset allocation in response to the plan's funded status over time.",
      "llm_answer": "AIG’s glide‑path strategy has gradually de‑risked the U.S. pension plan’s growth assets.  The target allocation for Return‑Seeking assets (equity securities) fell from **15 % in 2022** to **8 % in 2023**, then modestly rose to **9 % for 2024** as the plan’s funded ratio and interest‑rate environment changed.  (AIG_10k_2022.pdf, pp. 308‑312; AIG_10k_2023.pdf, pp. 250‑254; AIG_10k_2024.pdf, pp. 182‑186)",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claims. It states that the target allocation for Return-Seeking assets was 15% in 2022, 8% in 2023, and 9% in 2024. However, the ground truth does not provide any specific percentage allocations — instead, it describes the evolution of AIG's glide path approach in terms of timing and methodology: target allocations were set forward-looking (e.g., 2023 targets set for 2024 based on 2023 funded status). There is no mention in the original answer of specific percentages like 15%, 8%, or 9%, nor any indication of a de-risking trend followed by a modest increase. (2) The quantitative inaccuracies are severe: the percentages are entirely fabricated or misattributed, and no such figures appear in the ground truth. Even if the 10-K documents cited contain those numbers, the ground truth — derived from the knowledge graph — does not reflect them, meaning the LLM introduced specific metrics that are not part of the verified answer. (3) The multi-hop reasoning is flawed: instead of synthesizing the forward-looking, dynamic nature of the glide path based on funded status at year-end, the model focuses on a narrow, numerical interpretation of asset allocation changes that are not present in the ground truth. It fails to capture the conceptual evolution of the strategy — the shift in timing and planning horizon — which is the key point of the original answer. (4) The contextual relevance is moderate because the answer addresses AIG's U.S. pension plan and glide path, and cites the correct documents, but it misrepresents the nature of the evolution by substituting unverified quantitative claims for the actual qualitative, process-oriented changes described in the ground truth. Thus, while topically relevant, it is factually and conceptually inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 496,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment risk tolerance?",
      "original_answer": "In fiscal 2023, ACN set target allocations for the following year (fiscal 2024), indicating a strategy that emphasized flexibility around target asset allocations based on market conditions and cash flow needs. By fiscal 2024, the company extended its target allocation planning horizon to fiscal 2025, maintaining similar language around flexibility but continuing to emphasize risk-adjusted returns aligned with long-term investment strategies. The consistent focus on matching debt security durations to liabilities and diversifying equities suggests a measured, stable approach to risk. However, the forward-looking extension of target planning from one year (2023 → 2024) to two years (2024 → 2025) indicates increased confidence in long-term market outlook and a potentially more strategic, less reactive asset allocation stance.",
      "llm_answer": "From fiscal 2023 to fiscal 2025 ACN kept its U.S. pension plans at a 100 % debt allocation, but for non‑U.S. plans it raised equity exposure from 27 % to 28 % and lowered debt from 48 % to 36 %, while increasing cash from 4 % to 7 % and insurance contracts from 11 % to 21 %. This gradual tilt toward higher equity and liquidity—alongside a larger insurance buy‑in—indicates a modest increase in long‑term risk tolerance, aiming for greater returns while still maintaining a conservative liability‑matching framework.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that ACN did not specify exact asset allocation percentages but instead discussed a strategic shift in planning horizon and flexibility in target allocations. In contrast, the LLM answer fabricates specific percentages (e.g., 'raised equity exposure from 27% to 28%', 'debt from 48% to 36%', 'cash from 4% to 7%', 'insurance contracts from 11% to 21%') that are not present in the original answer or implied by the knowledge graph. There is no mention of a 100% debt allocation for U.S. plans in the ground truth. (2) These numbers are entirely inaccurate and unsupported—no calculations or comparisons can be validated because the data does not exist in the source. The fiscal years (2023–2025) are correctly referenced, but the content attributed to them is false. (3) The multi-hop reasoning fails: the original answer emphasizes a shift in planning horizon (from one-year to two-year forward targets) and continued focus on risk-adjusted returns and liability matching—not changes in specific asset weights. The LLM incorrectly interprets or invents granular allocation data rather than analyzing the evolution in strategic planning approach. (4) The contextual relevance is moderate because the answer addresses asset allocation and risk tolerance over the 2023–2025 period, but the factual foundation is incorrect, leading to a misleading conclusion about 'modest increase in long-term risk tolerance' based on fabricated data. The ground truth suggests a more stable risk approach with increased strategic confidence, not a meaningful increase in risk-taking. Thus, the correctness score is low due to complete lack of quantitative accuracy and significant qualitative misrepresentation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 492,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's issuance and structuring of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's solar financing strategy?",
      "original_answer": "Tesla's relationship with the 5.45% Solar Bonds, Series 2015/C25-15, originated from its acquisition of SolarCity and shows a consistent inclusion of this bond series in its 10-K filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured solar financing instrument. In 2022, Tesla referenced the bond as part of a broader set of solar bond issuances, including the 5.45% Solar Bonds Series 2015/C5-15, 2015/C10-15, and 2015/C20-15. By 2023, Tesla continued to reference the Series 2015/C25-15 alongside newer bond structures like Series 2015/C28-15 and 2015/C33-15, suggesting an expansion of its financing framework. In 2024, Tesla maintained the inclusion of Series 2015/C25-15 in its disclosures, reaffirming its long-term commitment to this financing model. The consistent presence of this bond series across filings indicates that Tesla continues to view these structured financings as integral to its solar deployment strategy.",
      "llm_answer": "Tesla’s 5.45% Solar Bonds, Series 2015/C25‑15, were issued in 2015 and remained a long‑term debt component through 2022‑2024 (TSLA_10k_2022, pp. 100‑104; TSLA_10k_2023, pp. 98‑102; TSLA_10k_2024, pp. 97‑101). In 2022 the bonds were reported with a 2025 maturity and an outstanding balance of $X million (TSLA_10k_2022, p. 100); in 2023 Tesla noted a partial repayment reducing the balance to $Y million and planned refinancing (TSLA_10k_2023, p. 99); by 2024 the bonds had matured or been fully repaid, with Tesla shifting to lower‑interest financing for its solar projects (TSLA_10k_2024, p. 98‑101). This multi‑year pattern demonstrates that Tesla uses solar bonds as a temporary, high‑yield tool to fund early‑stage solar deployments, then gradually replaces them with more sustainable, lower‑cost debt as cash flows improve (Exhibit 4.36).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) Quantitative Accuracy: The LLM claims specific events such as partial repayment in 2023, planned refinancing, and full repayment or maturity by 2024, none of which are supported by the original answer. The original makes no mention of repayment, refinancing, or maturity status, nor does it provide any dollar amounts (e.g., $X million or $Y million), making these fabricated figures major errors. (2) Completeness: While the LLM attempts to address the evolution across years, it misrepresents the actual disclosures. The original answer emphasizes consistent inclusion and ongoing reliance on the bond series, not repayment or phase-out. (3) Entity Accuracy: The bond series (5.45% Solar Bonds, Series 2015/C25-15) and years (2022–2024) are correctly identified, and the context of Tesla’s acquisition of SolarCity is implied in both, so entity recognition is partially correct. (4) Reasoning: The LLM constructs a narrative of temporary use and replacement with lower-cost debt, but this is speculative and contradicts the ground truth, which indicates long-term, sustained use of the bond as part of an expanding framework. The multi-hop synthesis is flawed because it infers repayment and strategic phase-out without evidence. (5) Semantic Equivalence: The overall message is not equivalent—the original shows continuity and integration of the bond in Tesla’s strategy, while the LLM portrays it as a transitional instrument being retired. This fundamental contradiction undermines correctness. The contextual relevance is moderate because the answer discusses the right topic and timeframe but draws incorrect conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 467,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance strategies, and risk mitigation mechanisms across global jurisdictions?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained rooted in scenario-based modeling and participation in government-sponsored pools, but evolved in terms of reinsurance structure and global coverage specificity. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, the focus shifted to active management and monitoring of exposure concentrations, with an emphasis on maintaining disciplined reinsurance purchases. In 2024, AIG enhanced its global property per risk covers, retained core attachment points for Japan at $200 million, and maintained reliance on scenario modeling and international terrorism pools. The reinsurance recoverable assets reached $38.0 billion by the end of 2024, indicating a significant scaling of risk transfer mechanisms.",
      "llm_answer": "From 2022 to 2024 AIG’s terrorism‑risk framework stayed essentially the same. In 2022 the company modeled a five‑ton bomb attack at $1.3 B net of TRIPRA and reinsurance, with TRIPRA covering 80 % of losses above a $1.7 B deductible and only limited private reinsurance; international exposure was managed through scenario‑based modeling, targeted reinsurance, and participation in country terrorism pools and government‑sponsored programs (2022, pp. 167‑170). By 2024 AIG continued to use the same third‑party vendor model, TRIPRA, and targeted reinsurance, and maintained its global pool participation, with no new loss‑estimate figures or reinsurance limits disclosed (2024, pp. 86‑90).",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.3 billion modeled loss estimate for a five-ton bomb attack in 2022, net of TRIPRA and reinsurance, which matches the ground truth. However, it introduces a specific detail not present in the original answer — that TRIPRA covers 80% of losses above a $1.7 billion deductible — which is unsupported by the ground truth and potentially inaccurate. This affects quantitative accuracy. Additionally, the LLM claims no new loss estimates or reinsurance limits were disclosed in 2024, which contradicts the ground truth stating that AIG enhanced global property per risk covers, retained a $200 million attachment point in Japan, and reported $38.0 billion in reinsurance recoverable assets by end-2024. These key 2024 updates are entirely missing, leading to significant omissions. (2) The $1.3B figure is correct, but the $1.7B deductible and 80% TRIPRA coverage are unverified additions. The $38.0B reinsurance recoverable and $200M Japan attachment point from the ground truth are not mentioned, representing major quantitative omissions. (3) The reasoning is partially sound in recognizing continuity in scenario modeling and pool participation, but fails the multi-hop synthesis by not connecting AIG’s evolving reinsurance strategy and risk mitigation enhancements from 2022 to 2024. The answer incorrectly implies stagnation rather than evolution. (4) The correctness score is 5 due to partial factual alignment but major omissions and one unsupported addition. Quantitative accuracy is 6 because one key number is correct but others are missing or unverified. Qualitative accuracy is 5 due to flawed synthesis and missing evolution narrative. Contextual relevance is 8 because the response stays on topic and addresses the general framework, even if incompletely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 494,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, and what specific risks within this segment were consistently highlighted as contributing to margin pressures over this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted the Safety and Productivity Solutions segment as being adversely impacted by industry economic conditions, with specific emphasis on reduced investments in process automation, fluctuations in retail markets, and product commoditization. In 2022, the segment cited reduced investments in process automation, retail market fluctuations, and new market entrants leading to commoditization and lower margins. In 2023, similar risks were reiterated, with additional mention of adverse industry economic conditions contributing to lower market share and reduced selling prices. By 2024, the restructured Industrial Automation segment (formerly part of Safety and Productivity Solutions) continued to face these pressures, with an explicit link drawn between adverse industry economic conditions and margin compression. This consistent linkage over three years indicates a persistent vulnerability in this business line despite broader organizational restructuring.",
      "llm_answer": "Honeywell’s 10‑K risk‑factor disclosures for the Safety and Productivity Solutions segment use the same wording each year (2022‑2024), indicating a persistent exposure to adverse industry economic conditions.  Across all three filings the segment’s margin pressures are repeatedly linked to reduced investments in process automation, safety monitoring and plant‑capacity initiatives; retail‑market fluctuations; a slowdown in safety‑product demand; a competitive landscape that includes new entrants and commoditization risks; and lower selling prices.  While the segment’s margin improved in 2024 relative to 2023, the risk‑factor language remained unchanged, underscoring that these conditions continue to be viewed as a consistent risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in identifying the persistent risks to Honeywell's Safety and Productivity Solutions segment from 2022 to 2024, including reduced investments in process automation, retail market fluctuations, commoditization, new market entrants, and lower selling prices. These align with the original answer’s core risks. The quantitative accuracy is high—no specific numbers or dates are misstated, and the timeline (2022–2024) is correctly referenced. However, there are qualitative discrepancies: the LLM claims the risk-factor language was 'the same wording each year,' which cannot be verified from the ground truth and overreaches the provided information. Additionally, the mention of 'safety monitoring and plant-capacity initiatives' and 'slowdown in safety-product demand' introduces details not present in the original answer, which may conflate other segments or filings. The original answer emphasizes that by 2024, the segment was restructured into Industrial Automation, a key structural change that the LLM omits, weakening the multi-hop synthesis across years. While the core risks are accurately captured, the failure to reflect the reorganization and the unsupported claim about identical wording reduce the qualitative accuracy. Contextual relevance remains high as the response directly addresses the evolution of exposure and margin pressures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 382,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Pfizer's treatment of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and recognition in financial statements?",
      "original_answer": "In 2022, Pfizer granted 1,165 thousand BPAs with a weighted average intrinsic value of $38.73 per share, and by the end of the year, 859 thousand BPAs remained nonvested. In 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a complete wind-down of the program. In 2024, Pfizer described the valuation and recognition methodology for BPAs, stating they are valued using the intrinsic value method and amortized over the probable vesting term, with adjustments based on stock price changes and performance goal probabilities. This shows a shift from active issuance and vesting in 2022 to no outstanding awards by 2023, followed by a detailed focus on valuation mechanics in 2024.",
      "llm_answer": "Pfizer did not grant any Breakthrough Performance Awards in 2022, 2023, or 2024, and had no outstanding BPAs at year‑end.  Across all three years the company continued to value BPAs at grant date using the intrinsic‑value method based on the closing price of common stock, and recognized the expense by amortizing it over the vesting term into cost of sales, selling, informational and administrative expenses, and/or research and development expenses, with periodic adjustments for share‑price changes, probability of earning, and vesting‑term estimates.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in its core claims. According to the ground truth, Pfizer granted 1,165 thousand BPAs in 2022 with a weighted average intrinsic value of $38.73 per share and had 859 thousand nonvested BPAs at year-end. However, the LLM incorrectly states that no BPAs were granted in 2022, 2023, or 2024 and that none were outstanding—this directly contradicts the 2022 and 2023 facts. The only partially correct element is the description in 2024 about valuation methodology (intrinsic value method, amortization over vesting term, adjustments), which aligns with the original answer’s 2024 explanation. (2) Quantitative accuracy is very low: the LLM omits the 1,165 thousand grants in 2022, the $38.73 intrinsic value, and the 859 thousand nonvested awards. It falsely asserts zero grants and zero outstanding across all years. No calculations are made, but the failure to report actual figures is a major error. (3) Multi-hop reasoning is flawed: the question requires tracking the evolution across three years—active grants in 2022, wind-down in 2023 (no grants, zero outstanding), and methodological disclosure in 2024. The LLM fails to capture the transition, incorrectly portraying the program as inactive throughout, thus missing the evolution entirely. (4) Contextual relevance is moderate because the answer discusses the right topic (BPAs, valuation, amortization) and mentions correct accounting treatments described in 2024, but it fails to reflect the actual timeline and status changes, making the overall response factually misleading. The qualitative accuracy is low due to incorrect entity states (grant activity, outstanding awards) across years despite correct terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 470,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3,129,296,000 for share purchases and redemptions. By fiscal 2023, the company had spent part of this authorization, and as of August 31, 2024, the remaining available authorization stood at $2,694 million, before receiving an additional $4,000 million in new repurchase authority, bringing the total outstanding authority to $6,694 million. This indicates a consistent and increasing commitment to returning capital to shareholders through share repurchases, with a notable increase in total authorized funds by fiscal 2024, despite a reduction in remaining available funds prior to the new authorization.",
      "llm_answer": "Accenture repurchased $4.111 billion of shares in fiscal 2022, $3.6 billion in fiscal 2023, and $4.5 billion in fiscal 2024, while its available authorization fell from $3.129 million at the end of 2022 to $2.694 million by the end of 2024. This pattern shows a steady rise in cash returned to shareholders via buy‑backs, coupled with a gradual tightening of the authorization cap, indicating a mature, disciplined capital‑return strategy that prioritizes shareholder payouts while preserving flexibility for future repurchases.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims Accenture repurchased $4.111 billion in fiscal 2022, $3.6 billion in 2023, and $4.5 billion in 2024, but the original answer does not provide any actual repurchase amounts for those years—only the remaining authorization and new authorizations. Thus, these repurchase figures are fabricated or hallucinated. Additionally, the LLM states that available authorization fell from $3.129 million (not billion) at end of 2022 to $2.694 million by end of 2024, which is off by a factor of 1,000—this is a critical error. The original answer specifies $3,129,296,000 (~$3.129 billion), not million. (2) The calculation of remaining authorization is misrepresented. The original answer notes that as of August 31, 2024, the remaining authorization was $2,694 million *before* a new $4,000 million was added, bringing total to $6,694 million. The LLM omits this key update and instead frames the decline in available authorization as a 'tightening' without acknowledging the substantial new authorization, distorting the trend. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers increasing repurchase activity year-over-year based on numbers not present in the ground truth, and fails to incorporate the critical fact of the $4 billion increase in authorization in fiscal 2024. This omission undermines the conclusion about capital return strategy. (4) While the LLM attempts to interpret the strategic implication (disciplined capital return), this is based on incorrect data and thus misleading. The contextual relevance is fair because it addresses share repurchases and capital return strategy, but the factual foundation is unsound, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 479,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial disclosures, operational agreements, and strategic alignment, given Meridian's status as a divested entity?",
      "original_answer": "In 2022, Meridian was referenced in the context of discontinued operations, with its operating results presented as part of that category for all periods presented. By 2023, Meridian had been fully divested, with Pfizer completing the sale on December 31, 2021, for approximately $51 million in cash and recognizing a loss of approximately $167 million, net of tax. In 2024, Meridian is only mentioned as a defined entity (Meridian Medical Technologies, Inc.) in the glossary of terms, indicating no active financial or operational relationship remained. This progression shows a complete strategic disengagement from Meridian, transitioning from operational integration (in prior periods), to divestiture, to mere definitional reference.",
      "llm_answer": "In 2022, Pfizer disclosed the sale of Meridian as a discontinued operation, recording a $167 million net loss, and noted that it had entered into interim transition‑service agreements (TSAs) and a three‑year manufacturing‑supply agreement (MSA) with the purchaser to support post‑sale operations. The 2023 filing reiterated that the TSAs were completed by 12/31/2023 and the MSA remained in effect for three years with a two‑year extension, with neither arrangement materially affecting 2023 results. By 2024, the company’s filing (pages 2‑6) contains no further mention of Meridian, indicating that the TSAs/ MSA were still in place but not material to operations and that the strategic relationship remained limited to the contractual framework rather than operational integration.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Pfizer completed the sale of Meridian on December 31, 2021, not in 2022, and that by 2024, Meridian is only mentioned in the glossary as a defined term. However, the LLM claims that in 2022 Pfizer 'disclosed the sale' and entered into transition-service and manufacturing agreements, which contradicts the timeline. The $167 million net loss is correctly cited, and the $51 million sale price is missing from the LLM answer. (2) Quantitative accuracy is partially correct: the $167 million loss is accurate, but the sale date (Dec 31, 2021) is misrepresented as occurring in 2022, and the $51 million cash consideration is omitted. The LLM invents details about a three-year MSA with a two-year extension and TSAs completed by end of 2023, which are not supported by the ground truth. (3) Multi-hop reasoning is flawed: the model incorrectly infers ongoing operational agreements in 2023 and 2024, while the ground truth confirms full divestiture by end of 2021 and only a definitional mention in 2024. The progression from discontinued operations to complete disengagement is misrepresented as an ongoing contractual relationship. (4) Contextual relevance is moderate—the answer addresses financial disclosures, operational agreements, and strategic alignment as asked, but with incorrect facts and invented details. Due to major factual and timeline errors, especially around the divestiture date and post-sale arrangements, the correctness score is low despite some accurate elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 436,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term strategy regarding share-based compensation?",
      "original_answer": "In fiscal year 2022, a maximum of 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 shares in both fiscal years 2023 and 2024. The increase from 2022 to 2023 and the maintenance of that level into 2024 indicate a strategic decision to expand the capacity for share-based compensation, suggesting Accenture's intent to continue leveraging equity incentives as a key component of its employee retention and performance alignment strategy over the three-year period.",
      "llm_answer": "Accenture authorized 127 million Class A shares for the Amended 2010 SIP in FY 2022 and FY 2023, and raised that cap to 141 million in FY 2024. The 14 million‑share (≈11 %) increase signals a deliberate expansion of the equity‑award pool, underscoring a long‑term strategy that prioritizes share‑based compensation to attract, retain, and align employees with shareholder value.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a factual error in the timeline of share authorization. According to the ground truth, the number of authorized shares was 127,000,000 in FY 2022 and increased to 141,000,000 in both FY 2023 and FY 2024. However, the LLM incorrectly states that the 127 million level applied to both FY 2022 and FY 2023, and that the increase to 141 million occurred only in FY 2024. This misrepresents the timing of the change, which actually occurred between FY 2022 and FY 2023. (2) The quantitative values (127 million, 141 million, and the 14 million difference) are numerically correct, and the ≈11% increase is a reasonable approximation (14/127 ≈ 11.02%), so the numbers themselves are accurate, but their assignment to fiscal years is incorrect. (3) The reasoning about the strategic intent behind the increase—employee retention, alignment with shareholder value—is qualitatively sound and consistent with the original answer, showing correct multi-hop synthesis of the implication of the increase. (4) Contextual relevance is high, as the answer addresses both the numerical evolution and the strategic interpretation. However, due to the misattribution of the increase to FY 2024 instead of FY 2023, the core factual timeline is flawed, warranting a moderate correctness score. The error affects the completeness and accuracy of the multi-hop progression across the three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 391,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Tesla's disclosures about its 4.70% Solar Bonds, Series 2015/C52-10, change or remain consistent across its 2022, 2023, and 2024 filings, and what does this pattern suggest about the company's ongoing obligations or strategic priorities related to this bond series?",
      "original_answer": "Tesla's disclosures regarding the 4.70% Solar Bonds, Series 2015/C52-10, remained consistent across all three years. In 2022, the Seventieth Supplemental Indenture related to this bond series was referenced with a filing date of June 16, 2015 (Exhibit 4.49). In 2023, the same Seventieth Supplemental Indenture was referenced again with the same filing date (Exhibit 4.42). In 2024, the identical document was once again disclosed, maintaining the same filing date and exhibit number (Exhibit 4.40). This consistent re-disclosure across three consecutive filings indicates that Tesla continued to carry forward the obligations and terms established under this bond series without material modification. As an investor, this pattern suggests that Tesla has maintained a stable financial commitment to this particular solar bond structure, reflecting ongoing alignment with its solar financing strategies.",
      "llm_answer": "Tesla continued to list the 4.70% Solar Bonds, Series 2015/C52‑10 in each of its 2022, 2023 and 2024 10‑K filings, reporting the same principal amount, maturity date and coupon rate on the debt schedule.  The unchanged disclosure across all three periods indicates that the bond remains outstanding and that Tesla still has contractual obligations under it, underscoring a sustained strategic focus on solar‑related financing rather than a shift away from that debt.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Tesla consistently disclosed the 4.70% Solar Bonds, Series 2015/C52-10 across 2022, 2023, and 2024 filings and that the bond remains outstanding with unchanged terms, which aligns with the ground truth. However, it omits specific documentary evidence cited in the original answer—the Seventieth Supplemental Indenture and its consistent reference with Exhibit numbers (4.49, 4.42, 4.40) and filing date (June 16, 2015)—which is a key part of the disclosure pattern. (2) Quantitatively, the LLM correctly references the 4.70% coupon rate and implies no change in principal or maturity, which is consistent with the ground truth. While it doesn’t list exact exhibit numbers or dates, it does not misstate any numbers, dates, or percentages. (3) The reasoning is sound in interpreting consistent disclosure as an indicator of ongoing obligations and strategic continuity in solar financing. However, it misses the multi-hop detail that the same legal document (Seventieth Supplemental Indenture) was re-filed each year, which strengthens the conclusion about contractual continuity. (4) The answer is contextually relevant and captures the core implication of the disclosure pattern. Scores reflect high accuracy but partial incompleteness in evidentiary detail, which reduces qualitative and quantitative scores slightly despite correct overall interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 392,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Adobe's free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of their positioning within Adobe's broader learning and enablement services and their role in customer adoption strategies?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of its comprehensive portfolio of learning and enablement services, hosted on www.training.adobe.com, aimed at assisting customer and partner teams in product adoption. By 2023, this offering remained central to Adobe’s strategy, with learning.adobe.com continuing to serve as the platform for these self-service options, and was explicitly linked to supporting both Digital Experience and Digital Media products. In 2024, Adobe maintained its emphasis on free online self-service learning as a key component of Adobe Digital Learning Services, reinforcing its role in enabling customers to adopt Adobe’s expanding suite of cloud-based and AI-driven tools. The consistent presence of this offering across all three years reflects Adobe’s strategic commitment to scalable, accessible learning solutions that complement its fee-based and custom learning programs.",
      "llm_answer": "Adobe’s free online self‑service learning options have remained a core pillar of its **Adobe Digital Learning Services** (a subset of the broader learning and enablement services portfolio) from 2022 through 2024.  The 10‑K filings consistently describe the courses on learning.adobe.com as a low‑cost, scalable entry point that helps customers quickly learn and apply Adobe products, thereby driving adoption (see 2022 p. 15‑19, 2023 p. 15‑19, 2024 p. 16‑20).  In short, the offerings have not shifted in positioning but have been reinforced as a key component of Adobe’s customer‑adoption strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) All key facts are correct: Adobe's free online self-service learning remained a core component of Adobe Digital Learning Services from 2022 to 2024, hosted on learning.adobe.com (previously noted as www.training.adobe.com in 2022, but the domain shift is not a factual error as both domains are or have been used by Adobe for training). The positioning as a scalable, low-cost entry point to drive product adoption is consistent with the ground truth. (2) There are no numeric values, dates, or financial figures in dispute; the mention of page numbers (e.g., 2022 p. 15–19) is supplementary and does not contradict the ground truth. (3) The multi-hop reasoning is sound—information is correctly synthesized across three years and linked to Adobe’s broader customer adoption and learning strategy. (4) The LLM slightly condenses the evolution by stating there was 'no shift in positioning,' which is accurate, but omits the explicit mention of support for both Digital Experience and Digital Media products in 2023 and the emphasis on AI-driven tools in 2024. These are minor contextual omissions, not errors, so the answer remains substantially correct. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 396,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AIG's glide path approach for its U.S. qualified pension plan evolve from 2022 to 2024, as reflected in the shifting target allocations for the 'Return-Seeking' portion of the portfolio in response to changes in the plan's funded status?",
      "original_answer": "From 2022 to 2024, AIG consistently applied its glide path approach to de-risk the U.S. qualified pension plan by adjusting the allocation to growth assets based on the plan’s funded status. In 2022, the target allocation for 2022 was set based on the funded status at December 31, 2021. In 2023, the target allocation for 2024 was updated based on the funded status at December 31, 2023, and in 2024, the target allocation for 2025 was again adjusted according to the funded status at December 31, 2024. While the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts, the glide path mechanism consistently guided these annual recalibrations, reflecting a strategic evolution in asset allocation in response to the pension plan's funded ratio over the three-year period.",
      "llm_answer": "AIG’s glide‑path strategy moved the U.S. qualified pension plan toward a more conservative mix as the plan’s funded ratio improved.  In the 2022 target allocation (based on the funded status at 12/31/2021) the Return‑Seeking (equity) portion was 15 % of assets, whereas by the 2024 target allocation (based on the funded status at 12/31/2023) it had fallen to 9 %.  This reduction reflects the glide path’s rule that growth‑asset allocation is trimmed and liability‑hedging assets are increased as the plan becomes better funded.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes specific percentages (15% in 2022 and 9% in 2024) for the 'Return-Seeking' portion of AIG's pension plan, but these numbers are not present in the original ground truth answer, which explicitly states that 'the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts.' Therefore, the inclusion of precise figures is factually unsupported and incorrect. (2) The dates referenced (e.g., 2022 target based on 12/31/2021 funded status, 2024 target based on 12/31/2023) align with the ground truth's description of the annual recalibration process, so the temporal logic is partially correct. However, the claim that the allocation 'fell to 9%' by 2024 is not verifiable from the source and introduces false precision. (3) The multi-hop reasoning is conceptually sound—the model correctly identifies that AIG adjusts its asset allocation via a glide path in response to funded status changes, and that this leads to de-risking as the plan becomes better funded. This reflects an understanding of pension fund management principles and aligns with the qualitative evolution described in the ground truth. (4) While the LLM captures the strategic direction (de-risking over time), it fabricates quantitative details that were not available, severely undermining factual accuracy. The contextual relevance is high because it addresses the evolution of the glide path and links allocation changes to funded status, but the incorrect numbers result in a low correctness score. The qualitative reasoning is partially accurate but based on invented data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 443,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 through 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted raw material demand and supply as a key risk factor for its Performance Materials and Technologies segment across all three years. In 2022, the risk was framed in the context of the ongoing impacts of the COVID-19 pandemic, including disruptions to global supply chains and customer capital availability. By 2023, the company emphasized continued exposure to raw material supply volatility, particularly in relation to chemical, refining, and semiconductor plant utilization rates. In 2024, the risk remained prominent, with additional emphasis on the impact of oil and natural gas price volatility on customer investment behavior. This 3-year progression indicates a sustained vulnerability to commodity-driven supply chain instability, with the risk profile intensifying as energy markets became more volatile.",
      "llm_answer": "Honeywell’s 2022 and 2023 risk‑factor disclosures (pages 29‑33 of the 2022 10‑K and pages 30‑34 of the 2023 10‑K) both list raw‑material demand and supply as a key driver of operating results for the Performance Materials and Technologies segment, underscoring a persistent exposure to commodity price swings.  In the 2024 10‑K (pages 28‑32), the segment was re‑aligned into Energy and Sustainability Solutions, yet the same raw‑material risk language—highlighting demand, supply, and price volatility—remains, indicating the exposure has not diminished.  This continuity suggests Honeywell remains vulnerable to commodity‑market volatility, with raw‑material fluctuations continuing to pose a significant risk to the segment’s profitability.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and correctly identifies the persistent exposure of Honeywell's Performance Materials and Technologies segment (later re-aligned into Energy and Sustainability Solutions) to raw material demand and supply risks from 2022 through 2024. It accurately reflects that this risk was consistently reported across the 10-K filings and ties it to commodity market volatility, which aligns with the ground truth. The mention of specific page ranges (e.g., pages 29–33 in 2022 10-K) adds precision and supports contextual accuracy, though these details are not contradicted by the ground truth. Quantitatively, there are no numerical errors—no specific numbers are misstated, and the timeline (2022–2024) is correct. The reasoning is sound in recognizing continuity of risk language despite segment reorganization, demonstrating appropriate multi-hop synthesis across years and reporting structures. However, the LLM omits key qualitative nuances present in the original answer: it does not mention the evolving context of the risk—such as pandemic-related disruptions in 2022, plant utilization rates in chemical/refining/semiconductor sectors in 2023, or oil and gas price impacts on customer investment in 2024. These details are critical to fully capturing the trend in how the risk evolved, not just persisted. By treating the risk as static rather than intensifying and shifting in emphasis, the LLM provides a slightly less complete picture of the trend. Thus, while the answer is contextually relevant and quantitatively accurate, the qualitative accuracy is reduced due to incomplete synthesis of the evolving risk drivers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 455,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did ACN's investment in mutual fund equity securities evolve from 2022 to 2024, and what does the 3-year trend suggest about its strategic asset allocation?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This decline followed by stability suggests a strategic rebalancing in 2023, with no further adjustments in 2024, indicating a stabilized allocation approach to equity exposure through mutual funds.",
      "llm_answer": "ACN’s fair‑value of mutual‑fund equity securities in its non‑U.S. pension plan assets fell from **$239,293 in 2022 to $196,226 in 2023** and then rose to **$273,699 in 2024** (2022‑2024 tables). The dip in 2023 likely reflects a temporary rebalancing or market downturn, while the 2024 rebound—surpassing the 2022 level—indicates a deliberate shift to increase equity exposure, signalling a more growth‑oriented strategic asset allocation over the three‑year period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in the quantitative data. According to the ground truth, ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023 and remained unchanged in 2024. However, the LLM incorrectly states that the value rose to $273,699 million (or $273.699 million) in 2024, which directly contradicts the ground truth of no change. Additionally, the LLM omits the correct unit (millions), presenting numbers like '$239,293' instead of '$239.293 million', leading to a misrepresentation of scale. (2) The calculation and trend analysis are therefore flawed: the claimed 'rebound' and 'surpassing 2022 levels' are false, as the actual data shows a decline followed by stability. This invalidates the conclusion about a growth-oriented shift. (3) The multi-hop reasoning is partially sound in that the model attempts to interpret trend implications, but it is based on incorrect data, undermining the entire analysis. The entity (ACN) and metric (mutual fund equity securities) are correctly identified, and the time frame (2022–2024) is accurate. (4) The contextual relevance is moderate because the answer addresses the question's structure—discussing evolution and strategic implications—but the incorrect data renders the conclusion invalid. Due to severe quantitative inaccuracies and resulting flawed reasoning, the correctness score is low at 2, with similarly low quantitative accuracy. Qualitative accuracy is slightly higher because the framework of analysis (assessing strategic allocation based on trends) is appropriate, even if misapplied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 451,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Adobe's strategic positioning and feature evolution of Adobe Document Cloud change between 2022 and 2024, particularly in terms of integration with AI-powered tools like Firefly and its role in enterprise digital workflows?",
      "original_answer": "In 2022, Adobe Document Cloud was primarily described as part of a broader 'document and forms platform' within the Publishing and Advertising segment, indicating a more foundational, legacy role in Adobe’s portfolio. By 2023, Document Cloud was elevated as a core component of the Digital Media segment, specifically tied to Adobe’s innovation momentum and positioned alongside AI-driven tools like Adobe Express and Firefly, signaling a shift toward modernization and integration with AI. In 2024, Document Cloud was explicitly detailed as a cloud-based subscription offering with deep integration into AI-powered workflows, including Firefly's generative AI features, and was highlighted for its role in automating enterprise document and signature workflows. This progression reveals Adobe’s transformation of Document Cloud from a legacy infrastructure component into a strategically positioned, AI-enhanced productivity suite for enterprise digital transformation.",
      "llm_answer": "In 2022, Adobe positioned Document Cloud as a PDF‑centric, e‑signature platform, described as a “cloud‑based subscription that delivers reliable, automated digital document and signature workflows across desktop, mobile, web and third‑party enterprise apps.” By 2024, the company re‑positioned it as an AI‑enabled, generative‑content hub, integrating Firefly and the Acrobat AI Assistant to automate and enhance enterprise digital workflows—“Acrobat AI Assistant … gives our users the power to work more productively with their documents” and “Firefly‑powered generative AI features … are also available in a number of our products including Adobe Acrobat.”",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Adobe Document Cloud between 2022 and 2024. It correctly identifies the shift from a PDF- and e-signature-focused platform in 2022 to an AI-enhanced suite in 2024, with explicit integration of Firefly and the Acrobat AI Assistant. The dates (2022 and 2024) are correctly used, and the quoted language aligns with Adobe's strategic messaging found in filings. While the original answer includes a nuanced intermediate step in 2023—where Document Cloud was repositioned within the Digital Media segment and linked to innovation momentum and AI tools like Adobe Express—the LLM answer skips 2023 but still accurately reflects the overall trajectory. This omission is minor and does not undermine the factual correctness of the transformation narrative. All entities (Adobe, Document Cloud, Firefly, Acrobat AI Assistant) are correctly identified, and the role in enterprise digital workflows is accurately described. There are no numerical inaccuracies (quantitative accuracy is perfect), and the reasoning, while condensed, is logically sound and semantically equivalent to the ground truth. The answer is fully contextually relevant, directly addressing strategic positioning and feature evolution with AI integration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 358,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its business segments from 2022 to 2024, particularly in terms of new market entrants, technological disruption, and resulting impacts on market share and pricing power?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted increasing exposure to changes in the competitive landscape across its business segments, with a growing emphasis on the impact of new market entrants and technological disruption. In 2022, Honeywell cited changes in the competitive landscape—including new entrants and new technologies—as a risk factor for Honeywell Building Technologies and Safety and Productivity Solutions, noting potential consequences such as lower market share, reduced selling prices, and lower margins. In 2023, the company expanded this risk to include Performance Materials and Technologies and Aerospace, indicating a broader recognition of competitive pressures across more divisions. By 2024, Honeywell restructured its business units and explicitly tied changes in the competitive landscape to Industrial Automation and Building Automation, with a sharper focus on product commoditization and the accelerating pace of new entrants. This 3-year progression reveals a deepening concern over competitive pressures, with increasing frequency and specificity in disclosures, suggesting a strategic shift toward addressing a more dynamic and disruptive market environment.",
      "llm_answer": "Honeywell’s risk disclosures from 2022‑24 consistently flag new entrants and emerging technologies as threats across all segments.  In the 2022 10‑K (pp. 29‑33) and the 2023 10‑K (pp. 30‑34) the Building Technologies, Safety & Productivity Solutions, Industrial Automation, Energy & Sustainability Solutions, and Aerospace Technologies sections all warn that “new market entrants and new technologies” could lead to product commoditization, lower market share and reduced selling prices.  By the 2024 10‑K (pp. 28‑32) the company not only repeats those warnings but also announces a strategic realignment and planned spin‑offs, indicating a shift from merely recognizing competitive risk to actively restructuring to protect margins and pricing power.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and correctly identifies that Honeywell consistently highlighted risks from new market entrants and technological disruption from 2022 to 2024. It accurately references the relevant business segments and correctly notes the consequences (product commoditization, lower market share, reduced pricing). The inclusion of page numbers (e.g., pp. 29–33) and the observation of strategic realignment in 2024 align with the broader trend in the original answer. However, there are key discrepancies in entity accuracy and reasoning: the LLM incorrectly lists 'Industrial Automation' and 'Energy & Sustainability Solutions' as separate segments in 2022 and 2023, which were not standalone segments at that time—these were restructured into the new segments only by 2024. The original answer correctly identifies that the risk expanded from Building Technologies and Safety and Productivity Solutions in 2022 to include Performance Materials and Technologies and Aerospace in 2023, reflecting a year-over-year broadening. The LLM answer implies all segments faced the same risk from the start, missing this evolution. Additionally, the LLM answer mentions 'Aerospace Technologies' as a segment in 2022–2023 filings, but Honeywell referred to it as 'Aerospace' during those years. While the conclusion about strategic restructuring in 2024 is valid and contextually relevant, the LLM fails to clearly trace the multi-hop progression of risk expansion across years and segments, weakening the qualitative reasoning. Quantitative elements (years, document types, page ranges) are accurate, and the answer remains contextually relevant and well-structured, but the misrepresentation of segment names and the lack of clarity on the evolving scope of risk exposure prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 493,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Pfizer's financial and operational relationship with Viatris evolve from 2022 through 2024, particularly in terms of transition service arrangements and intercompany balances?",
      "original_answer": "From 2022 to 2024, Pfizer's relationship with Viatris showed a gradual decline in intercompany balances and a winding down of transition service arrangements. In 2022, the net amounts due to Viatris under the agreements were $94 million, and services under the TSAs were largely completed by the end of 2023. By 2023, the net amounts due to Viatris had decreased to $33 million, and the TSAs were largely completed as of December 31, 2023. In 2024, the relationship was referenced only in terms of corporate definitions, indicating that the operational interdependencies had been fully resolved. This shows a consistent reduction in financial exposure and operational entanglement with Viatris over the three-year period.",
      "llm_answer": "From 2022 to 2024 Pfizer’s relationship with Viatris moved from a sizable transition‑service arrangement to a largely completed one.  In 2022 the net intercompany balance due to Viatris under TSAs and MSAs was $94 million, which fell to $33 million in 2023 as most services were finished (2023 10‑K, pp. 71‑75).  By 2024 the TSAs were fully concluded, the remaining intercompany balances were negligible, and the cash flows from these agreements were recorded in operating activities (2024 10‑K, pp. 3‑7).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key financial figures: $94 million due to Viatris in 2022 and $33 million in 2023, matching the ground truth exactly. It accurately states that transition service arrangements (TSAs) were largely or fully completed by the end of 2023. The mention of cash flows being recorded in operating activities in 2024 is contextually consistent, though not explicitly part of the ground truth. The only minor discrepancy is the claim that TSAs were 'fully concluded' by 2024, whereas the original answer notes they were 'largely completed' as of December 31, 2023, with 2024 references being limited to corporate definitions. This is a slight overstatement but does not materially misrepresent the winding-down trend. (2) All numeric values and timeframes are accurate: $94M (2022), $33M (2023), and the 2023 completion of most services are correctly cited. No calculation errors. (3) The multi-hop reasoning is sound—LLM synthesizes intercompany balances and TSA status across 2022–2024, correctly inferring a declining operational relationship. It references appropriate document sections (10-K pages), indicating proper sourcing. (4) The answer is semantically equivalent to the ground truth, with only a minor difference in phrasing about the final status of TSAs in 2024. The core facts—declining balances, completion of services, reduced interdependence—are all accurately conveyed. Thus, the answer is highly accurate, with only a slight deduction for overstating the finality of TSA conclusion in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 428,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the composition and structure of Altria Group's debt instruments evolve from 2022 through 2024, particularly with respect to the 1.700% Notes due 2025 in relation to other note maturities, and what does this progression suggest about the company's capital structure strategy?",
      "original_answer": "In 2022, Altria had a 1.000% Note due 2023 in addition to the 1.700% Note due 2025 and longer-dated instruments. By 2023, the 1.000% Note due 2023 had matured or was no longer listed, while the 1.700% Note due 2025 remained as the shortest-dated instrument. In 2024, the 1.700% Note due 2025 was still listed, indicating that Altria did not issue a new near-term note to replace it as it approached maturity. This suggests a strategy of maintaining a consistent capital structure with a focus on intermediate and long-term debt rather than rolling over short-term obligations.",
      "llm_answer": "Altria’s debt ladder changed from a four‑note structure in 2022 (1.000% due 2023, 1.700% due 2025, 2.200% due 2027, 3.125% due 2031) to a three‑note ladder in 2023 and 2024 (1.700% due 2025, 2.200% due 2027, 3.125% due 2031) as the 1.000% notes matured and were retired【MO_10k_2022.pdf】【MO_10k_2023.pdf】【MO_10k_2024.pdf】. The 1.700% 2025 notes now represent the earliest maturity and carry a higher coupon than the retired 1.000% notes, while the longer‑dated notes keep higher rates, indicating a deliberate strategy to consolidate short‑term debt, maintain a staggered maturity profile, and accept slightly higher yields to reduce refinancing risk and preserve capital‑structure stability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers, maturities, and coupon rates are correct: the 1.000% due 2023, 1.700% due 2025, 2.200% due 2027, and 3.125% due 2031 are accurately reported across 2022–2024. The retirement of the 2023 note and continuation of the 2025 note are correctly described. (2) The answer correctly identifies the evolution of the debt structure: from four notes in 2022 to three in 2023 and 2024, with the 1.700% note becoming the shortest-dated instrument. (3) The reasoning is sound and adds value by noting the higher coupon of the 1.700% note versus the retired 1.000% note and interpreting this as a strategy to reduce refinancing risk and maintain capital structure stability—this is a reasonable inference consistent with the ground truth’s conclusion about focusing on intermediate and long-term debt. (4) The only minor gap is that the original answer emphasizes Altria did *not issue a new near-term note* to replace the 2025 instrument, which the LLM does not explicitly state, though the implication is present. The LLM’s addition of 'consolidate short-term debt' and 'accept slightly higher yields' is interpretive but logically supported. Overall, the answer is factually correct, contextually relevant, and demonstrates strong multi-hop synthesis across three years of 10-Ks.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 380,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term borrowing strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, and remained at $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, then slightly declined to 4.84% in 2024. This indicates a strategy shift toward issuing more long-term debt at higher interest rates, likely to capitalize on investor demand or to fund growth initiatives amid rising market rates.",
      "llm_answer": "Capital One’s fixed unsecured senior debt carried $27.2 billion in 2022 (and 2023) and fell to $26.9 billion in 2024, while the weighted‑average interest rate rose from 4.45 % to 4.84 % (Table 8.1, 2023 10‑K; Table 9.1, 2024 10‑K). The modest decline in carrying value coupled with a higher rate indicates the company is refinancing or issuing newer debt at higher rates, likely to extend maturities or adjust to a higher‑rate environment. This reflects a conservative long‑term borrowing strategy that keeps debt levels stable while managing cost and maturity risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key quantitative data. It states the carrying value was $27.2 billion in both 2022 and 2023, but the ground truth shows it was $19,975 million ($19.975 billion) in 2022 and increased to $27,168 million ($27.168 billion) in 2023. This misrepresents the trend of growth in debt. Additionally, the LLM claims the interest rate rose from 4.45% to 4.84%, implying an increase between 2023 and 2024, but omits that the rate in 2022 was 2.91%, which is critical context for the upward trend. The 2024 rate of 4.84% is correct, but the starting point is wrong. (2) Calculations: The LLM incorrectly implies the debt level was flat between 2022 and 2023, when in fact it increased by over $7 billion. The interest rate change is partially correct (4.45% to 4.84%), but the full evolution from 2.91% to 4.45% to 4.84% is not accurately presented. (3) Multi-hop reasoning: The model fails to correctly synthesize data across years. It misses the significant increase in carrying value from 2022 to 2023, which is central to understanding the borrowing strategy. The conclusion about a 'modest decline' ignores the substantial increase the year prior. (4) While the qualitative interpretation about refinancing at higher rates and managing maturity risk has some merit and aligns with the general direction of the ground truth, it is based on incorrect data. The suggestion of a 'conservative' strategy contrasts with the ground truth interpretation of a shift toward issuing more long-term debt at higher rates to fund growth, which implies a more aggressive posture. Contextual relevance is high because the answer addresses the right metrics and attempts to infer strategy, but factual inaccuracies severely undermine correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 486,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15 evolved from 2022 through 2024, and what does this progression indicate about the company's solar financing strategy?",
      "original_answer": "Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15, shows a pattern of sustained reference but declining prominence in the company's solar financing strategy. In 2022 (TSLA_10k_2022.pdf), the bond was listed among key supplemental indentures, specifically in Exhibit 4.61, indicating its active inclusion in the company's financing documentation. In 2023 (TSLA_10k_2023.pdf), the bond was again referenced in Exhibit 4.54, maintaining its presence in Tesla’s capital structure disclosures, though not expanded upon. By 2024 (TSLA_10k_2024.pdf), while the bond remained listed in Exhibit 4.52, newer bond series such as C102-15 and C106-10 appeared in subsequent filings, suggesting a shift toward more recent financing structures. This multi-year pattern indicates that Tesla continued to honor and report on the C92-15 bond series but increasingly relied on newer bond structures, reflecting an evolving solar financing strategy that builds upon prior frameworks while introducing updated instruments.",
      "llm_answer": "Tesla has been steadily paying down the 5.45 % Solar Bonds, Series 2015/C92‑15.  In the 2022 10‑K (p. 103‑107) the outstanding principal was $1.5 billion; the 2023 10‑K (p. 100‑104) shows it had fallen to $1.3 billion, and the 2024 10‑K (p. 100‑104) reports a further decline to $1.1 billion.  This progressive repayment signals a shift away from bond‑based solar financing toward greater reliance on internal cash flows and equity, reflecting a more conservative, self‑sufficient strategy for funding Tesla’s solar initiatives.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that Tesla continued to reference the 5.45% Solar Bonds, Series 2015/C92-15 in its 10-K filings through 2024 as part of its disclosed capital structure, but does not mention any repayment or outstanding principal amounts. In contrast, the LLM claims specific declining balances ($1.5B → $1.3B → $1.1B), which are not present in the ground truth and cannot be verified from the provided information. These numbers are factually unsupported and represent a significant fabrication or misattribution. (2) There are no calculations in the ground truth to validate the LLM's numerical progression, and the cited page numbers (e.g., p.103-107) do not align with the actual content described in the knowledge graph. The bond is referenced in exhibits (e.g., Exhibit 4.61 in 2022, 4.54 in 2023, 4.52 in 2024), not in narrative sections discussing principal balances. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers a repayment trend and concludes a strategic shift toward internal cash flows and equity financing, while the ground truth indicates a shift toward *newer bond series* (e.g., C102-15, C106-10), not away from debt financing altogether. This misrepresents Tesla’s solar financing evolution. (4) While the LLM attempts to address the question’s focus on strategic evolution, it does so with fabricated data and incorrect reasoning, leading to a low correctness score. The contextual relevance is moderate because it discusses the right instrument and timeframe, but the conclusions are unsupported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 448,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 to 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews across the three years?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk demonstrated a consistent yet maturing approach. In 2022, AIG emphasized internal controls and oversight of the loss reserve setting process, complemented by reviews from external experts. By 2023, the company expanded its risk management framework to include a broader set of tools such as sensitivity and scenario analyses, stochastic methods, and experience studies, while continuing to rely on external expert reviews. In 2024, AIG further integrated these practices into a more holistic enterprise risk management (ERM) system, with enhanced reporting to committees, audits by the Internal Audit Group, and more structured second-line reviews of reserving models and assumptions. This evolution reflects a growing emphasis on proactive risk identification, validation, and governance.",
      "llm_answer": "In 2022, AIG’s loss‑reserve risk was governed by business‑unit risk committees chaired by the chief risk officer, with pricing committees and escalation procedures; reserve setting used stochastic and deterministic models within a model‑risk framework and was reviewed by external experts (AIG_10k_2022, pp. 165‑169). The 2023 filing kept this structure, emphasizing internal controls and the reserve‑setting process while continuing the same modeling techniques and external expert reviews (AIG_10k_2023, pp. 117‑121). By 2024, AIG further formalized the review and challenge of reserves with established escalation procedures, retained the stochastic/deterministic modeling approach, and maintained external expert reviews, indicating a more structured governance framework (AIG_10k_2024, pp. 84‑88).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth in terms of entities, years, and overall evolution of AIG's loss reserve risk management. It correctly identifies the continuity of key elements—external expert reviews, use of stochastic and deterministic models, and governance structures—across 2022 to 2024. The quantitative accuracy is perfect: no numerical data is misstated (and none is present beyond document citations, which are correctly attributed). Contextual relevance is strong, as the response directly addresses oversight mechanisms, modeling approaches, and external reviews across the three years. However, the LLM answer slightly underrepresents the qualitative evolution described in the original answer. Specifically, it does not fully capture the 2023 expansion to include sensitivity and scenario analyses, stochastic methods, and experience studies as new enhancements, instead stating that the 'same modeling techniques' were continued. Similarly, the 2024 advancement toward a more holistic enterprise risk management (ERM) system with enhanced reporting, Internal Audit Group audits, and structured second-line reviews is mentioned only partially (e.g., 'formalized review and challenge' and 'escalation procedures'), missing the integration into ERM and the stronger second-line oversight. These omissions reduce completeness and nuance in the multi-hop synthesis, but the core facts and trajectory are correct. Hence, a score of 8 is warranted for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 438,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Altria's allocation to U.S. Treasury and foreign government securities evolve across 2022-2024, and what does this trend indicate about its pension asset strategy?",
      "original_answer": "Altria's allocation to U.S. Treasury and foreign government securities within its pension and postretirement plan assets decreased from 19% in 2022 to 16% in 2023, before dropping further to 8% in 2024. This steady decline indicates a strategic shift away from government-backed fixed income instruments toward other asset categories, likely reflecting a recalibration of risk exposure and return expectations. The reduction in allocation aligns with a broader trend of lowering exposure to below-investment-grade securities—from 11% of fixed income holdings in 2023 to 9% in 2024 for pension assets—and suggests a more conservative or diversified investment posture over time. Additionally, the expected rate of return on pension assets was reduced from 6.6% in 2022 to 6.1% in 2023 and remained at 6.1% in 2024, indicating a more cautious long-term outlook as the asset mix evolved.",
      "llm_answer": "Altria’s pension plan allocated roughly **15 %** of its assets to U.S. Treasury and foreign government securities in 2022, **increased to about 19 %** in 2023, and then **fell to roughly 8 %** in 2024. The temporary tilt toward sovereign debt in 2023 was followed by a rebalancing back toward other fixed‑income or equity instruments in 2024, reflecting the company’s liability‑driven investment framework that seeks to balance risk‑hedging with return‑generation while adjusting the mix of high‑quality debt within the overall 80 % fixed‑income allocation.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported percentages for 2022 and 2023. According to the ground truth, Altria's allocation to U.S. Treasury and foreign government securities was 19% in 2022, not 15%, and decreased to 16% in 2023, not increased to 19% as claimed. The 2024 figure of 8% is correct. These errors in direction and magnitude severely undermine the quantitative accuracy. (2) The calculation and trend analysis are therefore incorrect: the LLM describes a temporary increase in sovereign debt allocation in 2023, whereas the actual data shows a continuous decline from 19% to 16% to 8%. This misrepresents the strategic evolution. (3) The qualitative reasoning is partially sound—the mention of rebalancing and liability-driven investing is plausible and contextually relevant—but it is applied to an incorrect trend. The LLM correctly identifies the broader fixed-income context and strategic intent but fails to accurately synthesize the multi-hop data across years. (4) Contextual relevance is high because the answer addresses the pension asset strategy and attempts to interpret the trend, but the core factual foundation is flawed. The ground truth also includes additional supporting evidence—such as declining below-investment-grade exposure and a downward revision in expected return from 6.6% to 6.1%—that the LLM omits, reducing completeness. Overall, the answer gets the final year correct and offers reasonable interpretation framework, but the incorrect trajectory and missing key corroborating data limit its correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 437,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to changes in floating and fixed unsecured senior debt and securitized debt obligations?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a complex evolution in its debt structure. In 2022, securitized debt obligations were $14.994 billion with a weighted-average interest rate of 1.51%, while floating unsecured senior debt was $1.709 billion at a 1.01% rate. By 2023, securitized debt rose to $18.043 billion at a higher average rate of 3.01%, and floating unsecured senior debt increased to $349 million at 6.75%, signaling a shift toward higher-cost short-term funding. In 2024, securitized debt declined slightly to $14.264 billion but with a significantly higher average rate of 3.48%, and floating unsecured senior debt was fully retired (dropped to $0). This trajectory shows Capital One's increasing reliance on fixed-rate senior debt, which rose from $19.975 billion in 2022 to $26.930 billion in 2024, with a corresponding rise in weighted-average interest rate from 2.91% to 4.84%, suggesting a strategic shift to lock in longer-term financing amid rising interest rates.",
      "llm_answer": "Capital One’s short‑term borrowings fell from **$883 million in 2022 to $538 million in 2023 and rebounded slightly to $562 million in 2024** (Table 9.1, p. 186‑190; Table 8.1, p. 176‑180).  Long‑term debt rose modestly from **$47.8 billion in 2022 to $49.3 billion in 2023 and then dropped to $44.9 billion in 2024** (Table 9.1, p. 186‑190; Table 8.1, p. 176‑180), so total debt declined from **$48.7 billion to $45.6 billion**.  Over the three years the company has eliminated floating‑rate senior debt (from $1.6 billion in 2022 to $0 in 2024) and reduced securitized debt obligations (from $17.0 billion to $14.3 billion), while fixed‑rate unsecured senior debt has remained high (≈$27 billion) with a weighted‑average rate that rose to ~4.8 % in 2024, indicating a shift toward a more fixed‑rate, lower‑interest‑rate‑sensitive debt structure.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, total short-term borrowings and long-term debt were $43.086B in 2022, $48.715B in 2023, and $45.551B in 2024. However, the LLM reports total debt as $48.7B in 2022 and $45.6B in 2024, which misrepresents the starting point and trend. The LLM incorrectly states short-term borrowings as $883M in 2022, while the ground truth shows $1.709B in floating unsecured senior debt alone (a subset of short-term borrowings), indicating a major underreporting. The LLM’s long-term debt figures ($47.8B, $49.3B, $44.9B) also do not align with the ground truth’s total debt figures, suggesting confusion between long-term debt and total debt. (2) Calculations are flawed: the LLM claims total debt declined from $48.7B to $45.6B, but the correct trend is an increase from $43.086B to $48.715B, then a drop to $45.551B. The LLM underestimates 2022 debt by over $5B. Securitized debt is reported as $17.0B in 2022 by the LLM, but ground truth is $14.994B; floating unsecured senior debt is said to be $1.6B in 2022, but truth is $1.709B. While the LLM correctly notes the elimination of floating-rate debt by 2024 and the rise in fixed-rate debt’s interest rate to ~4.8%, the magnitude of changes is imprecise. (3) Multi-hop reasoning is partially sound: the LLM correctly infers a strategic shift toward fixed-rate debt and reduced interest rate sensitivity, which aligns with the ground truth’s conclusion. It identifies the retirement of floating-rate debt and the stability of fixed-rate senior debt (~$27B), though the ground truth specifies a rise from $19.975B to $26.930B. The trend interpretation—shifting to fixed-rate financing amid rising rates—is semantically equivalent and logically supported. (4) Contextual relevance is high: the answer addresses all components of the question—evolution of debt, trend analysis, and implications for interest rate exposure. Despite numerical inaccuracies, the qualitative narrative about debt structure transformation is directionally correct. However, the significant quantitative errors, especially in baseline figures and component sizes, reduce confidence in the answer’s reliability, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 604,
        "total_tokens": 2139
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What does Tesla's repeated reference to the 5.45% Solar Bonds, Series 2015/C25-15 across its 2022, 2023, and 2024 10-K filings suggest about the company's reliance on this specific financing instrument for solar projects, and how does the consistent inclusion of this bond series across filings reflect its ongoing role in Tesla's capital structure?",
      "original_answer": "Tesla's 2022 filing includes the Thirty-Sixth Supplemental Indenture for the 5.45% Solar Bonds, Series 2015/C25-15, dated April 14, 2015. The same bond series appears in the 2023 filing with the Thirty-Sixth Supplemental Indenture dated April 14, 2015, and again in the 2024 filing with the identical bond referenced under the same date. This consistent inclusion across three years indicates that the Series 2015/C25-15 bonds remain an active and integral component of Tesla's capital structure, particularly for financing solar initiatives. The repeated disclosure suggests ongoing reliance on this instrument, implying that Tesla continues to view these bonds as a stable and strategic source of funding for its solar business, even several years after issuance.",
      "llm_answer": "Tesla’s repeated mention of the 5.45% Solar Bonds, Series 2015/C25‑15 in its 2022, 2023, and 2024 10‑K filings (TSLA_10k_2022.pdf, pp. 100‑104; TSLA_10k_2023.pdf, pp. 98‑102; TSLA_10k_2024.pdf, pp. 97‑101) shows that the company continues to rely on this bond series as a primary financing tool for its solar projects. The consistent inclusion across filings indicates that the bond remains an active, material component of Tesla’s long‑term debt, underscoring its ongoing role in the company’s capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly identifies the 5.45% Solar Bonds, Series 2015/C25-15, and notes their consistent appearance in Tesla's 2022, 2023, and 2024 10-K filings, which aligns with the ground truth referencing the Thirty-Sixth Supplemental Indenture dated April 14, 2015, across all three years. The percentage (5.45%), bond series, and implication of ongoing reliance are all correct. The LLM does not explicitly name the 'Thirty-Sixth Supplemental Indenture' or the exact date (April 14, 2015), but this level of document-specific detail is not central to the core question about Tesla's reliance and the bond's role in capital structure. The reasoning is sound: the repeated disclosure is correctly interpreted as evidence of the bond's active and material status in Tesla’s long-term debt. The answer addresses both parts of the question—Tesla’s reliance on the instrument and its ongoing role in capital structure—and synthesizes information across three years of filings. Minor omission of the indenture name and date prevents a perfect 10, but the core financial and strategic implications are accurately conveyed. Number format, entity names (Tesla, bond series), and years are correct. Contextual relevance is strong, directly addressing the significance of multi-year disclosure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 377,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 to 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(51,354) million in 2023 to $(60,429) million in 2023 and further to $(71,431) million in 2024. This represents a consistent upward trend in treasury stock purchases over the three-year period, indicating a growing emphasis on stock buybacks as part of the company's capital allocation strategy.",
      "llm_answer": "Mastercard’s cost of Class A treasury stock rose steadily—from $51.354 billion at year‑end 2022 to $60.429 billion in 2023 and $71.431 billion in 2024 (see the equity tables on pages 66‑70 of each 10‑K). This upward trend reflects an aggressive share‑repurchase program, indicating the company’s capital‑allocation focus is on returning excess cash to shareholders and supporting the share price rather than investing in new growth projects.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the evolution of Mastercard's investment in Class A Treasury Stock with accurate figures: $51.354 billion in 2022, $60.429 billion in 2023, and $71.431 billion in 2024. These match the ground truth values (converted from millions: $(51,354) million = $51.354 billion, etc.), allowing for format variation (billion vs. million). The trend of increasing buybacks is accurately described.\n\n2) Quantitative accuracy is perfect: all dollar amounts and years are correct, and the progression is properly represented. The negative sign in the original (indicating contra-equity) is omitted in the LLM answer, but this is common in narrative descriptions and does not affect factual correctness.\n\n3) The reasoning is sound: the LLM correctly infers that the upward trend reflects an aggressive share repurchase program and ties it to capital allocation strategy—specifically returning cash to shareholders. This aligns with the ground truth’s conclusion about growing emphasis on buybacks. The slight expansion (e.g., 'rather than investing in new growth projects') is a reasonable interpretation, though not explicitly stated in the original, which keeps the inference more neutral.\n\n4) The answer is contextually relevant and fully addresses both parts of the question: the evolution of treasury stock and the implication for capital allocation. The citation of 10-K pages adds detail not in the original but is plausible and enhances credibility.\n\nThe only minor issue is the slightly stronger claim about prioritizing buybacks over growth investments, which goes a step beyond the original’s more neutral 'growing emphasis.' However, this is a reasonable qualitative inference and does not materially misrepresent the data. Hence, correctness is rated 9/10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 485,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, particularly in terms of risks related to reduced investments in automation and plant capacity utilization, and what does this trend suggest about the macroeconomic pressures facing the industrial sector during this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted that its Safety and Productivity Solutions segment was increasingly exposed to adverse industry economic conditions, particularly due to reduced investments in process automation and plant capacity utilization. In 2022, the company cited these factors as contributors to lower market share and reduced margins. By 2023, the language remained largely consistent, but the context of ongoing global economic uncertainty was emphasized. In 2024, the risk was reiterated with a sharper focus on the broader macroeconomic volatility, including geopolitical instability and trade policy shifts, suggesting a deepening concern over sustained industrial sector weakness. This trajectory indicates a persistent and potentially worsening macroeconomic headwind affecting industrial demand and investment behavior over the three-year period.",
      "llm_answer": "Honeywell’s 2022, 2023, and 2024 10‑Ks all flag the Safety and Productivity Solutions segment (now re‑branded as Industrial Automation) as vulnerable to “reduced investments in process automation, safety monitoring, and plant capacity‑utilization initiatives” (2022 p. 31; 2023 p. 32; 2024 p. 30). The unchanged wording across the three years indicates that macro‑economic headwinds—chiefly lower capital spending and a slowdown in industrial investment—remained a persistent concern for Honeywell’s industrial customers, underscoring a broader slowdown in the industrial sector during 2022‑2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and correctly identifies that Honeywell's Safety and Productivity Solutions segment (rebranded as Industrial Automation) faced ongoing risks from reduced investments in process automation and plant capacity utilization from 2022 to 2024. The citations to specific 10-K pages (2022 p. 31; 2023 p. 32; 2024 p. 30) are consistent with the source data, and the observation that the wording remained largely unchanged across years is valid, supporting the conclusion of persistent macroeconomic pressure. Quantitatively, there are no numbers, percentages, or financial figures in either the question or ground truth, so the absence of numerical errors earns a perfect score on quantitative accuracy. Contextual relevance is strong—the answer directly addresses the evolution of risk exposure and links it to macroeconomic conditions affecting the industrial sector. However, the qualitative accuracy is slightly lower because the LLM answer does not fully capture the evolution in tone and emphasis described in the ground truth: while the wording may be similar, the original answer notes a progression in concern—from lower margins in 2022, to global uncertainty in 2023, to sharper focus on geopolitical instability and trade policy in 2024. The LLM’s characterization of 'unchanged wording' downplays this nuanced escalation in risk framing, missing a key aspect of the multi-hop reasoning about how the risk perception deepened over time. Thus, while the answer is substantially correct, it lacks full depth in synthesizing the evolving qualitative risk narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 441,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the lifecycle positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protection timeline?",
      "original_answer": "Cyramza was introduced in 2022 with a defined set of oncology indications, including second-line treatments for gastric, lung, colorectal, and hepatocellular cancers. By 2024, it remained a key oncology product, maintaining the same therapeutic indications. Meanwhile, its intellectual property protection timeline shifted significantly between 2023 and 2024, with data protection expiring in Japan in 2023 and set to expire in major European countries in 2024, while compound patents in the U.S. and Europe extend to 2026 and 2028, respectively. This indicates a narrowing window of exclusivity in key international markets despite continued therapeutic relevance.",
      "llm_answer": "From 2022 to 2024, Cyramza’s therapeutic portfolio expanded from a second‑line therapy for gastric, NSCLC, colorectal, and hepatocellular cancers to also include first‑line treatment of metastatic NSCLC with EGFR mutations (added in 2023 and confirmed in 2024)【product list 2024】. Its compound patent remains in force until 2026 in the U.S. and Japan and 2028 in the EU, while biologics data protection in the U.S. expires in 2026 and data‑package exclusivity in the EU and Japan ends in 2024 and 2023, respectively, signaling an approaching end of exclusivity【IP table】.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual inaccuracy regarding therapeutic indications—specifically, it claims that Cyramza expanded to include first-line treatment of metastatic NSCLC with EGFR mutations in 2023, which is not supported by the ground truth. The original answer states that Cyramza maintained the same indications from 2022 to 2024, with no expansion. This is a major error affecting the correctness of the response. (2) Quantitatively, the patent expiration dates (2026 in U.S., 2028 in EU) are correct and align with the ground truth. Data protection expirations are mostly accurate: Japan 2023 (correct), EU 2024 (correct), though U.S. data protection expiration in 2026 is mentioned but not in the ground truth, which only specifies compound patents. This addition is plausible but unverified by the source, introducing uncertainty. (3) The multi-hop reasoning is partially sound—IP timelines across regions are correctly synthesized, but the therapeutic indication evolution is incorrectly inferred, undermining the overall logic. The claim of expansion is not corroborated and contradicts the stable indication profile in the ground truth. (4) Contextual relevance is high as the answer addresses both therapeutic indications and IP timelines as asked. However, due to the key factual error in indications and partial accuracy in IP details, the correctness score is moderate. Quantitative accuracy is acceptable but not fully reliable due to unconfirmed U.S. data protection date. Qualitative accuracy suffers from incorrect synthesis on a core aspect of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 441,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation evolve from 2022 to 2024, particularly in terms of fair value measurements and unobservable inputs used in their valuation models?",
      "original_answer": "Capital One's net derivative assets/liabilities had a fair value of $19 million in 2022, increased to $58 million in 2023, and remained at $58 million in 2024. In 2022, the valuation included net losses of $20 million still held in the portfolio, and incorporated unobservable inputs like swap rates and default rates. By 2023, the valuation methodology continued to rely on discounted cash flows and unobservable inputs such as default rates (53–163%) and swap rates (3–5%), with the latter being weighted at 4%. In 2024, the fair value remained at $58 million, with similar unobservable inputs (swap rates of 3–5%, weighted at 4%) still playing a key role in the valuation model. This indicates a significant increase in fair value from 2022 to 2023, followed by stabilization in 2024, reflecting a consistent modeling approach with swap rates as a core valuation input.",
      "llm_answer": "Capital One’s net derivative assets/liabilities, all measured at Level 3 fair value, rose from $5 million at year‑end 2022 (Table 16.2, 2022) to $58 million in 2023 (Table 16.2, 2023) and to $69 million in 2024 (Table 17.2, 2024). The valuation remained a vendor‑based discounted‑cash‑flow model with significant unobservable inputs; in 2022 the key input was swap rates (1‑2 % weighted 2 %) (Table 16.3, 2022), in 2023 both default rates (53‑163 % weighted 4 %) and swap rates (3‑5 % weighted 4 %) were used (Table 16.3, 2023), and in 2024 the model again relied on swap rates alone (4 % weighted 4 %) (Table 17.3, 2024).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numerical values. According to the ground truth, Capital One's net derivative assets/liabilities were $19M in 2022, $58M in 2023, and $58M in 2024. The LLM incorrectly reports $5M in 2022 and $69M in 2024, which are materially wrong. The 2023 value ($58M) is correct. (2) Regarding unobservable inputs, the LLM states that in 2022 only swap rates (1–2%, weighted at 2%) were used, but the ground truth indicates both swap rates and default rates were used, with net losses of $20M still held in the portfolio. The 2023 inputs (default rates 53–163%, swap rates 3–5% weighted at 4%) match the ground truth. However, the LLM claims that in 2024 only swap rates were used at 4%, while the ground truth confirms that similar inputs (swap rates 3–5%, weighted at 4%) were still used—consistent with 2023—not that default rates were dropped. The LLM also introduces 'Level 3 fair value' and references to specific tables (e.g., Table 16.2), which are not in the original answer and may be hallucinated. (3) The multi-hop reasoning is partially sound—there is an attempt to track changes over time and link valuation methods across years—but the incorrect numbers and misrepresentation of input usage undermine the synthesis. The conclusion that fair value increased from 2022 to 2023 and stabilized is partially correct, but the LLM suggests continued growth to $69M in 2024, which contradicts the stabilization claim in the ground truth. (4) The contextual relevance is high as the answer addresses fair value evolution and unobservable inputs across years. However, due to major quantitative errors and some misrepresentation of valuation inputs, the correctness score is low. The qualitative accuracy is moderate because the structure and intent align with the question, but key details are wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 507,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Qualcomm's charitable match program evolve from 2022 to 2024 in terms of employee participation and number of supported organizations, and how does this progression align with the company's broader human capital goals tied to executive compensation during this period?",
      "original_answer": "In 2022, Qualcomm reported that thousands of employees utilized the charitable match program, benefiting over 1,500 organizations. By 2024, the program remained active with thousands of employees participating globally, though the number of supported organizations slightly decreased to over 1,300 in fiscal 2024. Throughout this period, the company consistently linked human capital advancements—including charitable engagement—to executive compensation, using progress toward these goals as a non-financial modifier (0.9 to 1.1) for executive bonuses. Despite a minor decline in the number of supported organizations, the sustained high level of employee participation indicates ongoing alignment with Qualcomm's broader human capital strategy, including its 2025 goals for diversity, equity, and inclusion.",
      "llm_answer": "From fiscal 2022 to fiscal 2024, Qualcomm’s charitable match program maintained high employee participation—“thousands of employees” each year—while the number of organizations it supported fell from more than 1,500 in 2022 to more than 1,300 in 2024.  This steady engagement reinforces the company’s human‑capital strategy—emphasizing community involvement, diversity and inclusion—which is a key component of the HR and Compensation Committee’s non‑financial performance modifier that can adjust executive bonus payouts by a factor of 0.9 to 1.1.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and timeframes are correct: 'thousands of employees' participating in both 2022 and 2024, and the number of supported organizations decreasing from over 1,500 in 2022 to over 1,300 in 2024. These figures match the original answer exactly. (2) The answer correctly identifies the link between human capital goals and executive compensation, specifying the non-financial performance modifier range of 0.9 to 1.1, which is factually precise. (3) The multi-hop reasoning is sound: it connects employee participation in the charitable match program to broader human capital goals and ties that to executive compensation mechanics, synthesizing information across ESG reporting and compensation policy. (4) The only minor omission is that the original answer explicitly references Qualcomm’s 2025 DEI goals as part of its human capital strategy, which the LLM answer implies but does not name. However, the core elements—community involvement, diversity, inclusion, and executive compensation linkage—are all present and correctly contextualized. Wording differs slightly but maintains semantic equivalence. No factual errors or calculation issues.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 349,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Adobe's positioning of Acrobat evolve from 2022 to 2024, particularly in terms of its role within Document Cloud, integration with other Adobe services, and product enhancements disclosed in each year's filings?",
      "original_answer": "In 2022, Adobe positioned Acrobat as a core component of Adobe Document Cloud with a focus on achieving strong market adoption and maintaining a leadership position in document-intensive industries such as legal, financial services, and publishing. The 2022 filing emphasized Acrobat's role in modernizing document workflows and the ubiquity of PDF usage, with trillions of PDF documents created annually. In 2023, Adobe expanded Acrobat’s positioning by introducing it within a broader context of AI-powered innovation, as part of its Digital Media offerings, and highlighted Acrobat’s integration with Adobe Sign and other Creative Cloud tools to enhance digital document productivity. The 2023 filing also included forward-looking statements about new or enhanced offerings, including AI-driven features. By 2024, Acrobat was formally associated with AI capabilities through the introduction of 'Acrobat AI Assistant' as a registered trademark, signaling a strategic shift toward embedding intelligent automation into document workflows. This evolution shows a clear trajectory from a document standard to an AI-enhanced productivity platform within Adobe’s ecosystem.",
      "llm_answer": "Adobe’s 2022 filing framed Acrobat as a PDF reader and editor that, together with Adobe Sign, formed the backbone of its Document Cloud, available on web and mobile with features such as Liquid Mode and scanning [2022, p. 7–8]. By 2023, the company highlighted expanded web functionality, more task‑based actions, and tighter integration with Adobe Sign and Sensei AI, positioning Acrobat as a more dynamic, AI‑enabled document‑workflow tool [2023, p. 4–5]. In 2024, Acrobat was positioned as a core component of Document Cloud, with new AI‑driven features, expanded PDF and Sign APIs, and a focus on single‑click web editing and mobile scanning to further streamline digital‑document processes [2024, p. 94–96].",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of Acrobat's positioning from 2022 to 2024: in 2022, Acrobat is described as a core part of Document Cloud with features like Liquid Mode and scanning, consistent with the ground truth emphasis on PDF ubiquity and workflow modernization. In 2023, the integration with Adobe Sign and mention of Sensei AI reflect the shift toward AI-powered innovation and tighter ecosystem integration. In 2024, the focus on AI-driven features and streamlined editing/scanning aligns with the introduction of the 'Acrobat AI Assistant' and strategic AI embedding. (2) There are no numeric values (e.g., dollar amounts, percentages, document counts) in either answer, so quantitative accuracy is not compromised—no discrepancies. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years, correctly identifying shifts in positioning, integration, and product enhancements. One minor omission is that the 2024 filing specifically mentions the 'Acrobat AI Assistant' as a registered trademark, which the LLM answer implies via 'AI-driven features' but does not name explicitly—this slight lack of specificity prevents a perfect 10. (4) The answer is contextually excellent, addressing all parts of the question: role in Document Cloud, integration with other services (Sign, Creative Cloud/Sensei), and product enhancements each year. Wording differs but semantic meaning matches. Thus, correctness is 9 (core facts correct, minor detail missing), qualitative accuracy 9 (strong reasoning, minor entity specificity gap), quantitative 10 (no errors), and contextual relevance 10 (fully on point).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 466,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did the financial implications of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of net product revenue and royalty payments tied to bamlanivimab and bebtelovimab sales?",
      "original_answer": "In 2022, LLY recognized $2.02 billion in net product revenue from its sales of AbCellera-partnered COVID-19 antibodies (bamlanivimab and bebtelovimab), with royalty payments to AbCellera in the mid-teens to mid-twenties percentage range on worldwide net sales. In 2023, LLY had no sales of these antibodies, resulting in no royalty payments to AbCellera. In 2024, the trend continued with no sales reported, indicating a complete wind-down of the product line. This 3-year progression shows a sharp decline in revenue and corresponding royalty obligations after the peak in 2022, reflecting reduced demand or regulatory changes affecting EUA-based sales.",
      "llm_answer": "In 2022, LLY recorded $2.02 billion in net product revenue from its AbCellera collaboration on bamlanivimab and bebtelovimab, with royalty payments to AbCellera recorded as cost of sales at mid‑teens to mid‑twenties percent of worldwide net sales (LLY 10‑K 2023, pp. 71‑75).  In 2023 and 2024 the company had no sales of these antibodies, so net product revenue dropped to zero and no royalty payments were incurred (LLY 10‑K 2024, pp. 72‑76).  Thus, the collaboration’s commercial activity effectively ended after 2022, leaving only the earlier royalty cost structure from the 2022 sales.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: $2.02 billion in net product revenue for 2022, royalty payments in the mid-teens to mid-twenties percentage range, and zero sales and royalties in 2023 and 2024. The answer correctly identifies the wind-down of the collaboration after 2022. (2) Quantitative accuracy is perfect: the dollar amount, percentage range, and timeline (2022–2024) match the original answer exactly. No calculations are required, but the reporting of zero revenue and royalties in 2023 and 2024 is consistent with the source. (3) Multi-hop reasoning is sound—the LLM synthesizes information across two fiscal years (referencing LLY 10-K 2023 and 2024) and correctly infers that no sales imply no royalties, demonstrating understanding of the contractual relationship. (4) The answer is contextually relevant, directly addressing the evolution of financial implications over time, including both revenue and royalty components. Minor wording differences (e.g., 'recorded as cost of sales' vs. 'royalty payments') do not affect semantic equivalence and are consistent with typical financial reporting language. The inclusion of document citations enhances credibility. No errors or omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 355,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did MetLife's reliance on the modified coinsurance agreement as a percentage of its closed block evolve from 2022 through 2024, and what does this consistency reveal about the company's long-term risk transfer strategy?",
      "original_answer": "MetLife maintained a consistent 59% reinsurance of its closed block through the modified coinsurance agreement in all three years: 59.25% in 2022, 59% in 2023, and 59% in 2024. This stability suggests that the company intentionally preserved a long-term risk-sharing structure without altering the proportion of risk transferred, indicating strategic continuity in managing its closed block liabilities.",
      "llm_answer": "MetLife continued to re‑insure 59 % of its closed block through a modified coinsurance agreement in each of the 2022, 2023 and 2024 10‑K filings (2022 Note 6, p. 212; 2023 Note 6, p. 225; 2024 Note 6, p. 202). The unchanged percentage demonstrates a deliberate, long‑term risk‑transfer strategy that relies on this arrangement to keep risk exposure and capital efficiency stable over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that MetLife maintained a consistent 59% reinsurance of its closed block through the modified coinsurance agreement across 2022, 2023, and 2024, which aligns closely with the ground truth (59.25% in 2022, 59% in 2023, and 59% in 2024). The slight rounding of 59.25% to 59% is acceptable under semantic equivalence and common reporting practices, though technically not fully precise. (2) All years and percentages are correctly attributed, and no calculations are required beyond accurate reporting of values. The citation of Note 6 in each 10-K adds credibility and traceability. (3) The reasoning is sound: the LLM correctly infers that the stable percentage reflects a deliberate, long-term risk-transfer strategy focused on stability in risk exposure and capital efficiency, which is logically consistent with the ground truth’s conclusion about strategic continuity. (4) The answer fully addresses both parts of the question—evolution of reliance (stable at ~59%) and its implication for long-term strategy. Contextual relevance is perfect, as all information directly responds to the multi-hop query. The minor deduction in quantitative accuracy reflects the rounding of 59.25% without acknowledgment, but this does not materially distort the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 366,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Mastercard's multi-layered security approach evolved from 2022 to 2024, particularly regarding third-party collaboration and real-time payment infrastructure, and what does this indicate about its cybersecurity strategy?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has consistently emphasized third-party collaboration and the expansion of real-time payment infrastructure, with increasing specificity and integration. In 2022, the company highlighted its multi-layered approach, including partnerships through public-private collaborations and third-party providers to monitor and respond to cyber threats, while operating real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company expanded its real-time infrastructure to 13 markets and explicitly mentioned working with third-party providers to address threats associated with outsourced services, indicating a more structured integration of third-party risk management into its security framework. In 2024, Mastercard continued this trajectory by operating real-time payments in 'several countries globally' and reinforcing its multi-layered security model with ongoing third-party assessments and resilience programs. This evolution demonstrates a strategic alignment between scaling real-time payment capabilities and enhancing cybersecurity through collaborative and resilient third-party engagement, signaling a proactive and adaptive security posture in response to growing digital payment risks.",
      "llm_answer": "Mastercard’s 2022 10‑K outlined a multi‑layered security program that relied on third‑party assessments, an information‑security program, and a network of Security Operations Centers and intelligence centers (MA_10k_2022, p. 9‑13). By 2023 the firm had expanded its real‑time payment infrastructure from 12 to 13 markets and deepened collaboration with fintechs, central banks and digital‑messaging platforms, while maintaining the same layered security framework (MA_10k_2023, p. 9‑13). In 2024 the company further broadened third‑party partnerships—including public‑private security collaborations and advanced threat‑intelligence centers—and continued to grow real‑time payment coverage, underscoring a cybersecurity strategy that prioritizes proactive threat detection, ecosystem collaboration and resilient real‑time payment capabilities (MA_10k_2024, p. 9‑13).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in 2022, Mastercard had a multi-layered security approach with third-party assessments and SOC/intelligence centers; by 2023, real-time payments expanded from 12 to 13 markets (matching ground truth); in 2024, the company continued expanding real-time infrastructure and third-party collaborations. (2) Quantitative accuracy is perfect: the increase from 12 to 13 markets in 2023 is correctly reported, and no other numbers are misstated. Format and sourcing (e.g., page references) are consistent and plausible. (3) Multi-hop reasoning is sound—information is synthesized across three years of 10-K filings, showing evolution over time in both third-party collaboration and real-time infrastructure. The LLM correctly infers a strategic trend toward proactive, collaborative cybersecurity. (4) Minor deduction in qualitative accuracy due to slightly less specificity in 2024: while the original answer notes 'several countries globally' and 'ongoing third-party assessments and resilience programs,' the LLM uses broader phrasing like 'further broadened' and 'advanced threat-intelligence centers'—still accurate but with marginally less precision. However, the core strategic implication about proactive threat detection and ecosystem collaboration is correctly captured. Contextual relevance is full, as all parts of the question are addressed with appropriate focus on evolution, third-party collaboration, real-time infrastructure, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1557,
        "completion_tokens": 431,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did LLY's allocation to private alternative investments, specifically equity-like funds, evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to equity-like funds within private alternative investments increased from $2,844.7 million in 2022 to $4,093.7 million in 2024, with a slight dip in 2023 to $4,014.1 million. This upward trajectory indicates a strategic emphasis on long-duration, higher-return potential assets, suggesting LLY's growing confidence in private market investments as part of its broader pension and retiree benefit funding strategy.",
      "llm_answer": "From 2022 to 2024 the fair value of equity‑like funds in Lilly’s private‑alternative‑investment portfolio rose modestly from $4.01 billion in 2022 to $4.09 billion in 2023, then fell to $3.93 billion in 2024.  The share of equity‑like funds within the private‑alternative segment slipped from roughly 30.4 % of that portfolio in 2022 to 28.8 % in 2024, indicating a stable but slightly adjusted exposure.  This pattern shows Lilly’s continued commitment to illiquid equity‑like assets as a core part of its long‑term growth strategy while periodically rebalancing to manage liquidity and risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, LLY's allocation to equity-like funds increased from $2,844.7 million in 2022 to $4,093.7 million in 2024, with a slight dip to $4,014.1 million in 2023. However, the LLM incorrectly states the 2022 value as $4.01 billion (should be $2.8447 billion), misrepresents the 2024 value as $3.93 billion (should be $4.0937 billion), and falsely claims a decline in 2024 when the trend is actually upward. These errors fundamentally misrepresent the trajectory. (2) The quantitative inaccuracies are severe: the starting value is overstated by over $1.1 billion, the 2024 value is understated, and the direction of change in 2024 is wrong. The percentages cited (30.4% to 28.8%) are not supported by the ground truth, which does not mention portfolio share. No correct calculations can be validated. (3) The multi-hop reasoning fails because the model did not correctly extract or synthesize the time-series data across years. The conclusion about 'stable but slightly adjusted exposure' and 'rebalancing' contradicts the ground truth's indication of a strategic upward commitment to illiquid assets. (4) Despite incorrect facts and reasoning, the answer remains contextually relevant by addressing the question's structure—discussing trends in equity-like funds and linking them to long-term strategy—hence a moderate relevance score. However, the factual foundation is so flawed that the overall correctness is very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 418,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did Procter & Gamble's positioning of Cascade within its Fabric & Home Care segment evolve from 2022 to 2024, particularly in terms of its product categorization and relative contribution to net sales?",
      "original_answer": "In 2022, Cascade was listed as part of the Fabric & Home Care segment, which contributed 35% of net sales. In 2023, the segment's net sales increased to 36%, and Cascade remained a key brand within this category, indicating continued strategic importance. By 2024, the segment maintained its 36% share of net sales, with Cascade still prominently featured, suggesting stable positioning and consistent contribution to the segment's performance over the three-year period.",
      "llm_answer": "Cascade stayed in the Home‑Care sub‑category of the Fabric & Home Care segment throughout 2022‑24, remaining a core air‑care/dish‑care brand.  Its share of the segment’s net sales rose modestly over that period, reflecting growth in the Home‑Care line while its product classification did not change.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but introduces inaccuracies. It correctly states that Cascade remained within the Fabric & Home Care segment from 2022 to 2024 and is a key brand in home care, specifically dish care. However, it incorrectly claims that Cascade is an 'air-care' brand, which is not supported by the ground truth and misrepresents the product categorization. More critically, the LLM asserts that Cascade's 'share of the segment’s net sales rose modestly,' which is not stated or implied in the original answer — the ground truth only reports the segment’s overall contribution to net sales (35% in 2022, 36% in 2023–2024), not Cascade’s individual contribution within the segment. Thus, the claim about rising share is speculative and factually unsupported. (2) Quantitatively, the LLM fails to report the actual segment-level net sales percentages (35%, 36%, 36%) that are central to the original answer, omitting key data points required by the question. While no incorrect numbers are cited, the absence of these figures and the introduction of an unverified trend (rising share) significantly reduce quantitative accuracy. (3) The multi-hop reasoning is partially sound — the model tracks Cascade’s consistent segment placement over time — but fails to correctly synthesize the relationship between brand, segment, and sales contribution. It conflates segment-level performance with brand-level performance, which requires an inference not justified by the source. (4) Contextual relevance is high because the answer addresses the evolution of Cascade’s positioning and categorization over time, but correctness is undermined by omissions and an unsupported claim about sales share growth. The qualitative accuracy is moderate due to correct entity and time period identification but flawed reasoning on contribution trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 506,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Lowe's evolve its supplier sustainability monitoring and wood sourcing practices from 2022 through 2024, and what specific enhancements were made to its policy framework and investment strategy across those years?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its supplier sustainability monitoring and wood sourcing practices. In 2022, the company emphasized monitoring supplier practices through policies like the Vendor Code of Conduct and a wood sourcing policy that ensured wood came from well-managed, non-endangered forests, while also investing over $550 million in environmental facility upgrades. By 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a forestry grievance process, while also committing to a $50 million Gable Grants program over five years to support skilled trades education. In 2024, the company further strengthened its sustainability framework by integrating a more robust risk-based approach into its wood sourcing policy and aligning its broader sustainability strategy with long-term shareholder value, continuing to emphasize supplier accountability through its human rights and environmental policies. This shows a consistent and evolving commitment to sustainable sourcing and supplier oversight.",
      "llm_answer": "From 2022 to 2024 Lowe’s built on a baseline of supplier‑sustainability monitoring that relied on its Vendor Code of Conduct, human‑rights, and conflict‑minerals policies and a wood‑sourcing policy that set basic principles (no illegal logging, deforestation, endangered species, etc.). In 2023 the wood‑sourcing policy was updated to add country‑specific risk levels, enhanced monitoring practices, and a new forestry grievance process, tightening the policy framework, and by 2024 the company further refined that framework with a more robust risk‑based approach and expanded monitoring. Its investment strategy followed a similar trajectory, spending $550 million in 2022, $300 million in 2023, and $400 million in 2024 on energy‑efficiency and renewable‑energy projects such as LED upgrades, HVAC replacements, building‑management systems, and solar panels.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of Lowe's supplier sustainability monitoring and wood sourcing practices from 2022 to 2024, including key policy updates such as the 2023 introduction of country-specific risk levels, enhanced monitoring, and a forestry grievance process, as well as the 2024 refinement with a more robust risk-based approach. These qualitative elements align with the ground truth. However, significant quantitative inaccuracies undermine the answer's correctness. The ground truth states that Lowe's invested over $550 million in environmental facility upgrades in 2022, and committed to a $50 million Gable Grants program over five years starting in 2023. The LLM answer incorrectly reports annual investments of $550M in 2022, $300M in 2023, and $400M in 2024 in energy-efficiency and renewable-energy projects, which are not supported by the original answer and contradict the single $550M figure for 2022 with no subsequent annual breakdowns. There is no mention of the Gable Grants program in the LLM response, a key component of the 2023 investment strategy. (2) The numbers are therefore factually incorrect: the $300M and $400M figures for 2023 and 2024 are fabricated; the $550M is correctly cited but misrepresented as a one-year figure without context of total or ongoing spending. The original does not provide annual breakdowns beyond 2022, so the LLM's specific later-year figures are unsupported. (3) The multi-hop reasoning is partially sound—linking policy updates across years and connecting them to investment trends—but fails in synthesis because it invents financial data rather than accurately reflecting the disclosed commitments. The omission of the Gable Grants program represents a failure to incorporate a key investment initiative mentioned in the ground truth. (4) The correctness score is 5 due to accurate policy evolution description but major financial inaccuracies. Quantitative accuracy is low (3) due to incorrect dollar amounts and invented annual spending. Qualitative accuracy is moderate (6) as the policy framework progression is well captured. Contextual relevance is high (8) because the answer stays on topic and addresses the question’s scope, despite factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 604,
        "total_tokens": 2112
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its Safety and Productivity Solutions, Honeywell Building Technologies, and Industrial Automation businesses from 2022 through 2024, and what does this progression indicate about increasing market pressures and product commoditization risks over time?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a growing emphasis on the risk of changes in the competitive landscape across its Safety and Productivity Solutions (2022), Honeywell Building Technologies (2023), and Industrial Automation (2024) businesses. In 2022, the company noted that changes in the competitive landscape, including new entrants and technology, could lead to product commoditization and lower margins in Safety and Productivity Solutions. In 2023, the risk was reiterated in Honeywell Building Technologies, with a specific mention of new market entrants and new technologies affecting competitive dynamics. By 2024, the risk was expanded to Industrial Automation, where the company again cited new entrants and technological advancements as drivers of commoditization and margin pressure. This 3-year progression indicates that Honeywell faced intensifying and broadening market pressures across multiple divisions, with commoditization risks becoming more systemic rather than isolated.",
      "llm_answer": "Honeywell’s risk disclosures from 2022‑24 consistently flag new entrants and technology as key competitive‑landscape drivers in Safety and Productivity Solutions, Building Technologies (later Building Automation), and the newly‑formed Industrial Automation segment.  In 2024 the Industrial Automation risk factor explicitly cites product commoditization—an emphasis that was absent in 2022‑23—highlighting that automation and safety offerings are becoming more price‑sensitive.  This evolution signals mounting market pressures and a growing risk of margin erosion as Honeywell’s products face increasing commoditization over time.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content, timeline, and key risks. (1) It accurately identifies the progression of competitive landscape risks across Honeywell's segments: Safety and Productivity Solutions, Honeywell Building Technologies (referred to as Building Automation, a minor but acceptable variation), and Industrial Automation. The years 2022, 2023, and 2024 are correctly associated with the expansion of risk disclosures. (2) There are no numeric values or calculations in the question or answers, so quantitative accuracy is not applicable in a traditional sense—however, the temporal sequence (2022–2024) is correctly preserved, earning full marks. (3) The multi-hop reasoning is sound: the model correctly synthesizes that the risk evolved from one segment to others over time and culminated in explicit mention of commoditization in 2024 for Industrial Automation. However, the LLM slightly misrepresents the evolution by stating that commoditization was 'absent' in 2022–23, whereas the ground truth confirms it was explicitly mentioned in 2022 for Safety and Productivity Solutions. This is a notable omission that affects qualitative accuracy. (4) Despite this, the answer captures the core conclusion—that market pressures and commoditization risks are broadening and intensifying—making it contextually highly relevant and semantically close to the original. The minor error in attributing when commoditization was first cited prevents a perfect score, but the overall reasoning and structure remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 433,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Qualcomm's strategic positioning in the digital cockpit market evolve from 2022 to 2024, based on its disclosures regarding automotive transformation, product revenue recognition, and segment reporting?",
      "original_answer": "In 2022, Qualcomm positioned itself as a key enabler of the digital cockpit transformation in automotive, citing analyst projections that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with digital cockpits enabling personalization and over-the-air updates. By 2023, Qualcomm explicitly recognized digital cockpit products as part of its automotive revenue stream, alongside connectivity and ADAS/AD, indicating a transition from strategic vision to monetization. In 2024, Qualcomm formalized its digital cockpit offerings as part of its QCT semiconductor business, grouping them with automotive connectivity and ADAS/AD under a structured segment reporting framework, signaling full integration into its core automotive strategy. This progression shows Qualcomm moving from a forward-looking market opportunity statement in 2022 to structured revenue recognition in 2023 and full operational integration by 2024.",
      "llm_answer": "In 2022 Qualcomm framed its automotive strategy around the **digital‑cockpit transformation**, stressing connectivity, digital‑cockpit and ADAS/AD platforms as the key enablers of in‑vehicle personalization and OTA services (2022 10‑K, pp. 6‑10). By 2024 its QCT automotive revenue had risen from **$1.5 billion (2022) to $2.9 billion (2024)**, making the automotive segment a larger share of total QCT revenue and signaling a strategic pivot toward higher‑margin digital‑cockpit solutions (2024 10‑K, pp. 80‑84; 2023 10‑K, pp. 71‑75). Throughout this period, Qualcomm’s product revenue recognition remained **point‑in‑time for integrated‑circuit products**, with previously satisfied performance obligations falling from $788 million (2022) to $558 million (2024), reflecting a tightening of revenue‑recognition practices in the automotive space.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies and introduces unsupported quantitative claims not present in the original answer or implied by the question. Specifically, the revenue figures of $1.5 billion (2022) and $2.9 billion (2024) are not mentioned in the ground truth and cannot be verified from the provided context. Similarly, the claim about previously satisfied performance obligations falling from $788 million to $558 million is absent from the original answer and introduces granular financial data that was not part of the disclosed evolution in strategic positioning. These numbers may be plausible but are not supported by the ground truth, which focuses on qualitative progression rather than specific revenue recognition practices or obligations. (2) The original answer emphasizes a three-year evolution: from market opportunity framing (2022), to revenue recognition inclusion (2023), to full segment integration (2024). The LLM answer skips 2023 entirely in its narrative and jumps to 2024, missing the critical intermediate step of explicit revenue recognition. Instead, it emphasizes revenue growth and changes in performance obligations, which were not part of the original reasoning chain. (3) The multi-hop reasoning is partially sound—Qualcomm’s strategic focus on digital cockpit transformation is correctly identified in 2022, and the integration into QCT in 2024 is aligned with the original answer. However, the synthesis fails to connect 2023 as the monetization transition year, which is a key link in the chain. The LLM also conflates revenue growth with strategic evolution without establishing causality or citing the shift in reporting structure as evidence. (4) While the LLM answer is contextually relevant and uses appropriate terminology (digital cockpit, OTA, QCT, ADAS/AD), the introduction of unsupported financial figures significantly undermines factual correctness. The qualitative reasoning is moderately accurate but lacks the structured, year-by-year evolution of strategic integration emphasized in the ground truth. Hence, the correctness score is 5 due to partial accuracy with major omissions and unverified data; quantitative accuracy is low due to unsupported numbers; qualitative accuracy is moderate due to correct framing but flawed synthesis; contextual relevance is high as the response stays on-topic and uses correct domain language.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 643,
        "total_tokens": 2106
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Adobe's integration and functional expansion of Frame.io evolve from 2022 to 2024, particularly in terms of supported media types, cross-product integrations, and enterprise capabilities?",
      "original_answer": "In 2022, Frame.io was listed as a trademarked product within Adobe's portfolio, indicating its acquisition and branding alignment. By 2023, Adobe described Frame.io as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting real-time feedback on video, still images, design files, and PDFs. In 2024, Frame.io expanded further with support beyond post-production workflows—now including casting, location scouting, and marketing campaign management—and was integrated with additional Adobe apps such as Photoshop, Lightroom, and Workfront, while also being included in Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "Adobe’s Frame.io evolved from a video‑centric collaboration tool in 2022—supporting mainly video with limited media types and integrations mainly to Premiere Pro and After Effects (ADBE_10k_2022, pp. 95‑99)—to a cloud‑native platform in 2024 that now handles still images, design files, PDFs and video beyond post‑production, integrates with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront, and offers Camera‑to‑Cloud uploads and enterprise‑grade features via Adobe G enStudio (ADBE_10k_2024, pp. 10‑14). The 2023 filing added further media support and deeper cross‑product integration, laying the groundwork for the 2024 expansion (ADBE_10k_2023, pp. 10‑14).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Frame.io evolved from a video-centric tool in 2022 to a broader collaboration platform by 2024. The supported media types—video, still images, design files, and PDFs—are correctly identified, as are the integrations with Premiere Pro, After Effects, Photoshop, Lightroom, Workfront, and inclusion in Adobe GenStudio. The progression across 2022–2024 is accurately framed. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the years (2022, 2023, 2024) are used correctly and in proper sequence, matching the original answer. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying the evolution in media support, integrations, and enterprise capabilities. It appropriately infers that 2023 served as a transitional year with expanded media and deeper integration, leading to the 2024 expansion—consistent with the original answer’s implication. (4) The only minor shortcoming is that the LLM does not explicitly mention 'casting, location scouting, and marketing campaign management' as newly supported workflows in 2024, which are specified in the ground truth. While 'beyond post-production workflows' is mentioned, the specific examples add clarity that is missing in the LLM response. This omission is minor given the overall completeness. Wording differences are acceptable under semantic equivalence. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 451,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year trend indicate about shareholder governance structure stability?",
      "original_answer": "Across the three-year period from 2022 to 2024, MA's A Class shares consistently maintained 'One vote per share' and 'Dividend rights' as disclosed in the annual filings. There were no changes to these rights in any of the years, indicating a stable governance and shareholder rights structure over time.",
      "llm_answer": "From 2022 through 2024, Mastercard’s Class A shares kept the same rights – one vote per share and entitlement to dividends (MA_10k_2022, pp. 94‑98; MA_10k_2023, pp. 97‑101; MA_10k_2024, pp. 90‑94).  The declared dividend per share rose steadily from $2.04 in 2022 to $2.37 in 2023 and $2.74 in 2024 (MA_10k_2024, pp. 90‑94).  This unchanged voting structure coupled with incremental dividend growth signals a stable shareholder‑governance framework over the three‑year period.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Mastercard's (MA) Class A shares maintained 'one vote per share' and dividend rights from 2022 to 2024, aligning with the ground truth on governance stability. However, it introduces specific dividend per share amounts—$2.04 in 2022, $2.37 in 2023, and $2.74 in 2024—that are not present in the original answer or supported by the knowledge graph. The ground truth states only that dividend rights were maintained, not that specific dividends were paid or increased. This is a critical factual overstatement. (2) The quantitative values cited for dividends are unverified and likely incorrect in this context; the original answer explicitly notes no changes to rights, not growth in payout amounts. Even if these numbers appear in the cited 10-K pages, the ground truth does not confirm them as part of the evolution of rights, making their inclusion misleading. (3) The reasoning is otherwise sound: the model correctly synthesizes consistent voting rights and links stable rights to governance stability, demonstrating proper multi-hop understanding across years and documents. (4) Scores reflect that core qualitative and structural elements are accurate (hence high qualitative and contextual scores), but the inclusion of unsupported numerical data significantly undermines factual correctness, warranting a moderate overall correctness score of 6 and low quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 396,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment across fiscal years 2022, 2023, and 2024, and what does this reveal about the segment's vulnerability to consumer demand volatility over time?",
      "original_answer": "Honeywell consistently highlighted that its Safety and Productivity Solutions segment (in 2022) and its Industrial Automation segment (in 2024, previously named in 2023 as Safety and Productivity Solutions) were adversely impacted by fluctuations in retail markets across all three years. In 2022, the segment noted that retail market fluctuations could lead to reduced investments in process automation and safety monitoring, lower demand for safety products, and downward pressure on margins. In 2023, similar language was used, emphasizing the impact of retail volatility on demand for safety products and the risk of commoditization. By 2024, the restructured Industrial Automation segment retained this risk, indicating that despite organizational changes, the business remained sensitive to retail market instability. This consistent risk disclosure suggests that the segment has not significantly mitigated its exposure to retail demand swings over the three-year period.",
      "llm_answer": "Safety and Productivity Solutions net sales fell 21 % to $5.49 bn and profit fell 17 % to $901 m in 2023 versus 2022 (net sales $6.907 bn, profit $1.080 bn in 2022) – a decline driven by weaker retail demand, as noted in the risk‑factor discussion that retail‑market fluctuations can hurt the segment【2022 10‑K pages 29‑33】【2023 10‑K pages 30‑34】.  The segment rebounded in 2024, with net sales up 3 % to $6.43 bn and profit up 2 % to $1.52 bn, reflecting a recovery in retail conditions【2024 10‑K pages 28‑32】【2024 10‑K pages 30‑32】.  These year‑to‑year swings underscore the segment’s ongoing vulnerability to consumer‑demand volatility.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in financial figures and misrepresents the timeline and segment evolution. According to the ground truth, the Safety and Productivity Solutions (S&PS) segment was restructured into Industrial Automation by 2024, but the LLM fails to mention this rebranding or structural change, instead treating S&PS as a continuous segment. The provided financial data is incorrect: for example, the LLM claims S&PS net sales were $6.907B in 2022 and $5.49B in 2023 (a 21% drop), but actual reported figures from Honeywell’s 10-Ks show S&PS segment sales of approximately $7.7B in 2022 and $7.5B in 2023 — a much smaller decline, not 21%. Similarly, the reported 2024 rebound to $6.43B conflicts with the upward trend and reorganization into Industrial Automation, which had broader revenue streams. Profit figures of $901M in 2023 and $1.52B in 2024 are also inconsistent with disclosed data. (2) Calculations are therefore flawed: a 21% drop from $6.907B to $5.49B is mathematically accurate, but the inputs are wrong. The claimed 3% sales increase in 2024 lacks support in context due to segment redefinition. (3) Multi-hop reasoning is partially sound — the model connects retail market fluctuations to segment performance across years and cites risk factors — but it fails the critical synthesis that the segment was renamed and restructured in 2024, undermining the longitudinal analysis. The ground truth emphasizes consistent risk disclosure despite restructuring, while the LLM implies recovery due to improved retail conditions, which contradicts the original answer’s conclusion of ongoing vulnerability without mitigation. (4) Scores reflect partial correctness: numbers are fabricated or misstated (quantitative accuracy penalized), core concept of retail exposure is correct (contextual relevance high), and reasoning captures some qualitative elements but misses key entity changes and draws an overly optimistic conclusion not supported by the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 546,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the financial obligations and royalty structure between LLY and Incyte for Olumiant evolve from 2022 to 2024, particularly in terms of milestone payments, royalty rates, and the inclusion of new indications like COVID-19?",
      "original_answer": "From 2022 to 2024, LLY's financial relationship with Incyte around Olumiant evolved significantly. In 2022, Incyte was eligible to receive up to $100 million in additional regulatory milestones and $100 million in sales-based milestones, and royalty rates on worldwide net sales ranged up to 20%, with an additional low teens royalty for COVID-19 sales above a threshold. By 2023, milestone payments related to regulatory approvals and sales achievements were capitalized as intangible assets and amortized into cost of sales. In 2024, the agreement remained in place with the same royalty structure, but the focus shifted to ongoing royalty payments rather than new milestones, indicating that most contingent payments had likely been triggered or expired. This evolution reflects a shift from milestone-driven obligations to a more stable royalty-based payment model over the three-year period.",
      "llm_answer": "From 2022 to 2024 the LLY‑Incyte agreement continued to provide tiered double‑digit royalties (up to 20 %) on worldwide net sales of Olumiant, with an additional low‑teens royalty on COVID‑19 sales that exceed a threshold (added in 2020). Milestone payments rose from $210 million in 2020 to $260 million in 2021, and by 2023‑24 Incyte was eligible for up to $100 million in additional sales‑based or success‑based regulatory milestones, all capitalized as intangible assets and amortized to cost of sales. The inclusion of COVID‑19 broadened the royalty base and created new milestone opportunities while the core royalty rates remained unchanged.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the timeline and amounts of milestone payments. The ground truth states that in 2022, Incyte was eligible for up to $100 million in regulatory milestones and $100 million in sales-based milestones (total $200 million), not $100 million total by 2023–24 as stated by the LLM. The LLM incorrectly references milestone increases from $210M in 2020 to $260M in 2021, which is not supported by the original answer and introduces data outside the 2022–2024 scope. Additionally, the original answer clarifies that by 2023, milestone payments were capitalized and amortized, not that new milestones of $100M were still available in 2023–24. The royalty structure (up to 20%, plus low teens for COVID-19 sales above threshold) is correctly reported, and the inclusion of COVID-19 as expanding the royalty base is semantically aligned. (2) Quantitative errors include incorrect milestone values and timing—LLM misplaces $100M in additional milestones to 2023–24, while the original indicates this structure was in place in 2022 and likely expired or was triggered by 2024. The reference to 2020 and 2021 milestones is extraneous and unsupported. (3) The multi-hop reasoning is partially sound—LLM correctly identifies the ongoing royalty model and accounting treatment of milestones as intangibles amortized to cost of sales by 2023. However, it fails to reflect the evolution from milestone-driven to royalty-focused payments by implying new milestones were still possible in 2023–24, contradicting the original's point that most contingent payments had likely been triggered or expired by 2024. (4) Correctness is scored 5 due to major quantitative and timeline errors, though core royalty facts are accurate. Quantitative accuracy is low (4) due to incorrect dollar figures and years. Qualitative accuracy is moderate (6) as reasoning and entity identification (LLY, Incyte, Olumiant, royalty types) are correct, but synthesis over time is flawed. Contextual relevance is high (9) as the answer addresses all question components—milestones, royalties, indications—even if with inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 580,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Procter & Gamble's strategic positioning of the Always brand within its Baby, Feminine & Family Care segment evolve from 2022 to 2024, particularly in relation to product categorization and its prominence compared to other brands in the segment?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care (Adult Incontinence, Feminine Care)' within the Baby, Feminine & Family Care segment, appearing alongside brands like Always Discreet, Tampax, Bounty, Charmin, and Puffs. By 2023, the product categorization shifted slightly to 'Feminine Care (Adult Incontinence, Menstrual Care)', and Always was more specifically associated with menstrual care, reflecting a more targeted positioning. In 2024, the categorization remained consistent with 2023, but Always continued to be listed as a major brand alongside Always Discreet and Tampax, maintaining its prominence within the segment. This evolution suggests a strategic sharpening of Always’ positioning around menstrual care while retaining its core role in the Feminine Care category.",
      "llm_answer": "From 2022 to 2024, P&G’s Baby, Feminine & Family Care segment shifted its major‑brand focus away from baby‑care (Pampers and Luvs) toward feminine‑care, with Always consistently listed as a key brand. In 2022 the segment’s major‑brand list included Pampers and Luvs, but by 2023 and 2024 those brands were no longer highlighted, while Always and Always Discreet remained the primary drivers in the Feminine‑Care sub‑category, underscoring Always’s sustained prominence within the segment.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant inaccuracies in entity representation and reasoning. (1) Correctly identifies Always as a consistently prominent brand in the Feminine Care sub-segment across 2022–2024 and notes the continued presence of Always Discreet. However, it incorrectly claims that Pampers and Luvs were removed from the major-brand list in 2023 and 2024, which is not supported by the ground truth and misrepresents the strategic shift. The original answer makes no mention of de-emphasizing baby care brands, so this is an unsupported inference. (2) There are no numerical values to verify, so quantitative accuracy is based on correct use of years and categorizations—these are mostly accurate (2022, 2023, 2024 correctly referenced), earning a high score here. (3) The multi-hop reasoning is flawed: the LLM infers a strategic shift away from baby care without evidence from the source, and fails to mention the key evolution in product categorization (from 'Feminine Care (Adult Incontinence, Feminine Care)' to 'Menstrual Care'). This omission misses the core of the strategic positioning evolution—refining Always’ focus on menstrual care. (4) While the answer addresses Always’s prominence, it mischaracterizes the broader segment dynamics and omits the critical detail about re-categorization that reflects strategic sharpening. Thus, despite some correct surface-level facts, the reasoning and completeness are significantly lacking, warranting a mid-range correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 419,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did ACN's target asset allocation strategy for defined benefit pension plans evolve across fiscal years 2023 (target for fiscal 2023 stated in 2022 filing), 2024 (target as of August 31, 2023 in 2023 filing), and 2025 (target allocation stated in both 2023 and 2024 filings), and what does this multi-year progression reveal about the company's approach to balancing risk-adjusted returns with liability duration matching?",
      "original_answer": "ACN's target asset allocation strategy for defined benefit pension plans showed a consistent framework across the three years, with a focus on risk-adjusted returns aligned with long-term investment strategies. In the 2022 filing, the target allocation for fiscal 2023 emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching the duration of individual plan liabilities to minimize asset volatility. The 2023 filing updated this with the weighted-average plan assets allocation as of August 31, 2023, while introducing the projected target allocation for fiscal 2025, which maintained the same structure but allowed flexibility based on market conditions and cash flow needs. The 2024 filing reaffirmed the fiscal 2025 target allocation, indicating strategic continuity. This evolution reveals that ACN maintained a stable investment framework, prioritizing liability duration matching and diversification, while allowing tactical flexibility in asset allocation decisions to respond to market dynamics.",
      "llm_answer": "ACN’s 2023 target allocation (from the 2022 filing) set U.S. plans at 100 % debt and non‑U.S. plans at 48 % debt, 27 % equity, 4 % cash, 11 % insurance and 10 % other. In the 2023 filing (as of Aug 31 2023) the 2024 target moved to 94 % debt, 6 % cash, 9 % other for U.S. plans and 42 % debt, 23 % equity, 5 % cash, 21 % insurance, 10 % other for non‑U.S. plans. The 2025 target (stated in both 2023 and 2024 filings) returned U.S. plans to 100 % debt but lowered non‑U.S. debt to 36 %, increased equity to 28 %, raised cash to 7 % and kept insurance at 21 %.  \n\nThis evolution shows ACN maintains a core debt‑heavy stance for U.S. plans to match liability duration, while gradually adding equity and insurance exposure in non‑U.S. plans to enhance risk‑adjusted returns, reflecting a cautious, incremental shift toward higher returns without compromising liability matching.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth does not provide specific percentage allocations for U.S. and non-U.S. plans by asset class (e.g., 100% debt for U.S. plans in 2023), nor does it mention exact shifts such as non-U.S. equity increasing to 28% in 2025. These precise figures are fabricated or hallucinated. The original answer emphasizes a general strategy of liability duration matching, diversification, and flexibility without citing granular breakdowns by region or asset class. (2) There are no verifiable calculations in the ground truth to support the LLM's detailed percentages, and no evidence that targets shifted from 48% to 23% to 28% in non-U.S. equity. The claim that U.S. plans went from 100% debt to 94% then back to 100% is unsupported. These numbers do not appear in the knowledge graph and contradict the high-level, principle-based description in the original answer. (3) The multi-hop reasoning is partially sound in structure—attempting to trace allocation changes across filings for 2023, 2024, and 2025—but fails because it invents data rather than synthesizing actual disclosures. The conclusion about a 'cautious, incremental shift toward higher returns' reflects a plausible interpretation but is based on false premises. (4) While the LLM addresses the question’s intent and maintains contextual relevance by discussing risk-adjusted returns and liability matching, the severe factual inaccuracies in numbers and unsupported entity-specific claims drastically reduce correctness. The answer appears detailed but is largely incorrect at the factual level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1550,
        "completion_tokens": 449,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from 2022 through 2024, and what does the change in their fair value classification and hedge accounting treatment reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, with disclosures indicating that both matured and outstanding swaps impacted other comprehensive income and earnings for prior years (2021, 2020, 2019), though no current fair value was listed for 2022 itself. In 2023, the fair value of forward interest rate swaps was explicitly disclosed as $251 million, classified under 'Other current assets' and marked as Level 2 in fair value hierarchy, showing active hedging activity. By 2024, the company no longer held forward interest rate swaps, instead holding fixed-to-floating interest rate swaps as fair value hedges on certain debt, indicating a strategic shift from cash flow hedges to fair value hedges. This evolution suggests Lowe's transitioned from managing forecasted debt issuance risk to managing existing debt exposure, reflecting a more stable capital structure and reduced sensitivity to future interest rate volatility.",
      "llm_answer": "From 2022 to 2024, Lowe’s forward‑interest‑rate‑swap notional exposure grew from $638 million in 2021 to $2.56 billion in 2022 and remained at that level through 2024 (2022 p. 60‑64; 2023 p. 52‑56; 2024 p. 44‑48).  The swaps are treated as cash‑flow hedges, with effective gains/losses recorded in OCI and amortized to interest expense, while fixed‑to‑floating swaps are fair‑value hedges; this dual‑hedge approach shows the company’s strategy of protecting forecasted debt issuances from interest‑rate swings while keeping earnings neutral.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. It claims Lowe's forward interest rate swap notional exposure grew from $638 million in 2021 to $2.56 billion in 2022 and remained at that level through 2024, which directly contradicts the ground truth. The original answer states that in 2022, no current fair value was listed for forward swaps, in 2023 the fair value was $251 million (not notional), and by 2024, Lowe's no longer held forward swaps at all. The LLM invents precise notional amounts and claims continuity through 2024 that is unsupported. (2) The numbers are entirely inaccurate: $2.56 billion notional exposure is not mentioned in the ground truth; the only dollar figure provided is a $251 million fair value in 2023. The LLM confuses notional with fair value and fabricates data for 2022 and 2024. (3) The multi-hop reasoning is flawed: the ground truth shows a strategic shift from cash flow hedges (forward swaps) to fair value hedges (fixed-to-floating swaps) by 2024, indicating a change in risk management focus. The LLM incorrectly asserts that forward swaps remained through 2024 and mischaracterizes the company's strategy as a 'dual-hedge approach' still active in 2024, when in fact the forward swaps were discontinued. (4) The contextual relevance is moderate because the answer discusses hedging strategies and accounting treatments, but the factual foundation is so incorrect that the conclusions are invalid. The LLM fails to identify the key evolution—discontinuation of forward swaps and shift in hedge type—which is central to the question. Thus, despite using relevant terminology, the answer misrepresents the core facts and strategic shift.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 470,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in both 2023 and 2024, indicating a deliberate reduction in this specific debt obligation over the three-year period. This consistent decline suggests an active debt repayment or restructuring strategy focused on managing long-term liabilities.",
      "llm_answer": "AVGO’s exposure to the 5.000% senior notes due April 2030 remained unchanged at **$606 million** from FY 2022 through FY 2024 (as shown in the debt tables of each filing). The unchanged principal balance reflects a deliberate strategy of maintaining a stable long‑term debt mix, with the company using other instruments (e.g., senior notes, term loans) to manage liquidity and leverage rather than altering this particular note.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that AVGO's exposure to the 5.000% notes due April 2030 remained unchanged at $606 million from FY2022 through FY2024. The ground truth shows that exposure was $1,086 million in 2022 and decreased to $606 million in both 2023 and 2024, indicating a reduction. The LLM incorrectly claims no change over the period, contradicting the actual data. (2) Quantitatively, the $606 million figure for 2023 and 2024 is correct, but the $1,086 million value for 2022 is entirely omitted and replaced with the 2023–2024 figure, leading to a false impression of stability. This misrepresents the trend and invalidates any conclusion based on it. (3) The reasoning is flawed: the LLM infers a strategy of maintaining a stable debt mix due to an unchanged balance, but the actual decline from $1,086M to $606M indicates active debt reduction, suggesting a different strategy altogether. The model fails to perform the correct multi-hop comparison across fiscal years and draws an opposite conclusion from the evidence. (4) While the entity (AVGO), debt instrument (5.000% notes due April 2030), and years are correctly identified, the core quantitative trend and resulting qualitative interpretation are incorrect. The answer is contextually relevant but fundamentally inaccurate in both data and inference, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 387,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly regarding interest rates, redemption terms, and maturity structure?",
      "original_answer": "From 2022 to 2024, UPS's 7.620% debentures remained consistent in principal amount ($276 million) and maturity date (April 1, 2030). However, the disclosures evolved in terms of clarity and emphasis on redemption terms. In 2022, UPS clarified that the interest rate had been reduced from 8.375% to 7.620% in April 2020 for the remaining term, while in 2023 and 2024, the interest rate was consistently reported as 7.620%, with no further changes. The redemption terms were consistent across all three years, with the debentures being callable at any time at UPS's option, with the redemption price based on either principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2024, the disclosure placed more emphasis on the semi-annual interest payment schedule and confirmed that the debentures are not subject to sinking fund requirements. This consistency in structure and increasing clarity in disclosure suggests a stable long-term debt instrument with well-defined terms.",
      "llm_answer": "UPS’s 7.620% debentures have been unchanged in the 2022‑through‑2024 filings. The 2022 note explains the rate was cut from 8.375% to 7.620% in 2020 and that the single $276 million tranche matures April 1, 2030, is redeemable at option at the greater of principal + accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus 5 bps, and is not subject to a sinking fund. The 2023 and 2024 10‑Ks simply restate those same terms, indicating no material change in interest rate, redemption policy or maturity structure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the principal amount ($276 million), maturity date (April 1, 2030), interest rate reduction from 8.375% to 7.620% in 2020, and consistent 7.620% rate in 2022–2024. The redemption terms—callable at UPS's option with redemption price based on either principal plus accrued interest or present value of remaining payments discounted at benchmark treasury yield plus 5 bps—are correctly described. The absence of sinking fund requirements is also accurately noted. (2) Quantitative elements are precise: dollar amount, percentage rates, and dates match the original answer exactly, with acceptable formatting (e.g., $276 million). No calculations are required, but factual consistency across years is correctly asserted. (3) Multi-hop reasoning is sound: the model synthesizes disclosures across 2022, 2023, and 2024 filings, correctly identifying that while the 2022 filing explained the historical rate change, subsequent filings merely restated unchanged terms. (4) The answer addresses all aspects of the question—interest rates, redemption terms, maturity structure, and evolution of disclosure—while accurately conveying the increasing clarity and consistency in reporting through the years. Wording differs slightly (e.g., 'no material change' vs. 'increasing clarity'), but the semantic meaning and factual content align perfectly with the ground truth. No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 414,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus, clinical phase progression, and intellectual property protection timeline?",
      "original_answer": "In 2022, Olpasiran was described as an siRNA in phase 2 development aimed at lowering lipoprotein(a) for the treatment of atherosclerotic cardiovascular disease. By 2023, Amgen disclosed that Olpasiran had compound-related patents in both the U.S. and Europe, both expiring in 2036, signaling long-term IP protection. In 2024, Olpasiran was listed with a broader therapeutic indication simply as 'cardiovascular disease,' suggesting a potential expansion of its clinical application or regulatory strategy. This progression reflects Amgen's movement of Olpasiran from mid-stage development toward a more defined commercial and intellectual property strategy in cardiovascular care.",
      "llm_answer": "Amgen’s 2022 10‑K listed Olpasiran as a Phase‑2 siRNA that lowers lipoprotein(a) for atherosclerotic cardiovascular disease; the 2023 and 2024 filings continue to describe the same cardiovascular focus and keep the program in Phase 2 with no move to Phase 3.  The company holds composition‑of‑matter patents in the U.S. and Europe that expire in 2036, giving Olpasiran a 12‑year exclusivity window that has remained unchanged through 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Olpasiran as a Phase 2 siRNA targeting lipoprotein(a) for cardiovascular disease in 2022, with accurate patent expiration dates (2036) in the U.S. and Europe, which matches the ground truth. However, it fails to note the key evolution in 2024 where the therapeutic indication broadened from 'atherosclerotic cardiovascular disease' to simply 'cardiovascular disease,' suggesting a strategic expansion. This omission affects completeness and reasoning. (2) All quantitative elements—patent expiration in 2036, Phase 2 status, and the 12-year exclusivity window (2024–2036)—are factually correct and consistently reported. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes data across years and geographies for IP protection, but misses the nuanced shift in therapeutic focus from 2022 to 2024, which is central to the question about strategic positioning. (4) While the answer is factually accurate in what it reports, the failure to capture the broadening of the therapeutic indication reduces its qualitative accuracy and overall correctness, though it remains contextually relevant and precise on numbers and entities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 337,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the positioning of Tampax within P&G's Feminine Care segment evolve from 2022 to 2024, particularly in terms of its categorization and prominence among major brands?",
      "original_answer": "In 2022, Tampax was listed under the 'Baby, Feminine & Family Care' segment as part of 'Feminine Care (Adult Incontinence, Feminine Care)', and was included among major brands like Always and Bounty. In 2023, P&G reclassified its feminine care offerings under 'Feminine Care (Adult Incontinence, Menstrual Care)', with Tampax still prominently listed among key brands. By 2024, the categorization remained consistent with 2023, but the segment name slightly changed to 'Baby, Feminine & Family Care' again, maintaining Tampax as a highlighted brand. This evolution shows a consistent strategic emphasis on Tampax within the Feminine Care category, with minor refinements in sub-category labeling over time.",
      "llm_answer": "Tampax remained a major brand in P&G’s Feminine Care sub‑category throughout 2022‑2024. In 2022 and 2023 the segment’s major‑brands list included Tampax Bounty alongside Pampers, Always, and others, with the sub‑category described as “Feminine Care (Adult Incontinence, Feminine Care)”【PG_10k_2022.pdf, page 18】【PG_10k_2023.pdf, page 17】. By 2024 Pampers was no longer listed, the sub‑category was re‑described as “Feminine Care (Adult Incontinence, Menstrual Care)”, and Tampax Bounty remained a key brand among the top five (Always, Always Discreet, Tampax Bounty, Charmin, Puffs)【PG_10k_2024.pdf, page 17】.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly affect correctness. First, 'Tampax Bounty' is a fabricated brand combination—Tampax and Bounty are separate brands; this error appears repeatedly and undermines entity accuracy. Second, the claim that Pampers was 'no longer listed' in 2024 is incorrect—the original answer and P&G’s 2024 10-K show Pampers remains a major brand in the 'Baby, Feminine & Family Care' segment. Third, the LLM incorrectly states that in 2024, Tampax Bounty is among the top five brands listed with Always, Always Discreet, Charmin, and Puffs—this grouping misrepresents the actual brand list and segment structure. While the LLM correctly identifies the shift in sub-category labeling from 'Feminine Care' to 'Menstrual Care' in 2023–2024, it misattributes the segment name changes and incorrectly implies continuity in major brand listings. The timeline of segment evolution is partially correct but distorted by incorrect brand associations and erroneous exclusions. Quantitative accuracy is acceptable—no numerical data is present, and dates (2022–2024) are used appropriately. Contextual relevance is high, as the response addresses the evolution of Tampax’s positioning and attempts to track changes over time. However, qualitative accuracy suffers due to flawed multi-hop reasoning: the model fails to correctly disentangle brand groupings and segment reclassifications, leading to a misleading synthesis. Overall, while the general trend of Tampax remaining prominent is captured, the specific details are marred by critical entity and reasoning errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 439,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did MetLife's reliance on internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year trend indicate about the availability of NAIC designations and MetLife's acquisition strategy in this asset class?",
      "original_answer": "MetLife's use of internally developed designations for non-agency RMBS and CMBS remained a consistent practice across 2022 to 2024, reflecting ongoing acquisition activity in newly issued or less frequently evaluated securities. In 2022, MetLife noted that internally developed designations were applied when acquiring non-agency RMBS and CMBS that had not yet been evaluated by the NAIC. This practice continued in 2023 and 2024, indicating that MetLife continued to acquire such securities, and NAIC designations were not immediately available for all new holdings. The persistence of this policy across three years suggests a sustained strategy of investing in complex structured securities, where NAIC evaluations lag behind acquisition timelines, requiring internal credit assessments in the interim.",
      "llm_answer": "From 2022 through 2024, MetLife’s use of internally developed designations for non‑agency RMBS and CMBS dropped to zero – all holdings in each year were assigned NAIC designations (see the NAIC designation tables on pages 99–103, 92–96, and 82–86). This trend shows that NAIC evaluations have become fully available for the asset class, and that MetLife’s acquisition strategy increasingly targets securities that already carry NAIC ratings, thereby eliminating the need for internal credit‑quality assessments.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both factual content and reasoning. (1) Quantitatively, the claim that MetLife's use of internally developed designations 'dropped to zero' and that 'all holdings' received NAIC designations in 2022–2024 is false. The ground truth states that MetLife consistently used internal designations during this period when NAIC evaluations were not yet available, indicating ongoing reliance on internal assessments. There is no support for the claim that internal designations were eliminated. (2) The citation of specific page ranges (e.g., 99–103, 92–96, 82–86) appears fabricated or misinterpreted, as these do not override the explicit textual disclosure in the ground truth about continued internal designation use. (3) Qualitatively, the reasoning is flawed: the LLM concludes that NAIC evaluations became 'fully available' and that MetLife shifted strategy to avoid securities without NAIC ratings, which contradicts the ground truth indicating a sustained strategy of acquiring complex securities where NAIC ratings lag. (4) Contextually, while the answer addresses the question’s structure, it conveys the opposite of the correct information—instead of showing continued reliance on internal designations due to delayed NAIC evaluations, it asserts full reliance on NAIC ratings. This represents a complete inversion of the factual trend, warranting a very low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 392,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase program activity and available authorization show a clear upward trajectory over the three-year period. In fiscal 2022, the company had $3.13 billion in aggregate available authorization for share purchases. By fiscal 2023, this figure had increased, and during the fourth quarter of fiscal 2024, the company purchased 2,000,308 Class A ordinary shares for $605 million under the program. As of August 31, 2024, the available authorization stood at $2.69 billion, but this was subsequently increased by an additional $4 billion on September 25, 2024, bringing total outstanding authority to $6.69 billion. This indicates a consistent and growing commitment to returning capital to shareholders through share repurchases.",
      "llm_answer": "Accenture repurchased 12.18 million shares for $4.11 billion in fiscal 2022, with an available authorization of $3.13 million (later raised to $6.13 billion). By fiscal 2024, the company had bought 2.00 million shares under its open‑market program for $605 million in the fourth quarter, while its aggregate available authorization had surged to $2.694 billion (with an additional $4 billion authority added to bring total outstanding authority to $6.694 billion). The steady rise in both repurchase volume and authorization reflects Accenture’s expanding commitment to returning capital to shareholders and confidence in its cash‑generating strength.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the share repurchase volume and dollar amounts for fiscal 2022. The original answer states that Accenture had $3.13 billion in available authorization in fiscal 2022 but does not specify that $4.11 billion was actually repurchased that year. The LLM incorrectly claims Accenture repurchased $4.11 billion worth of shares in fiscal 2022, which is not supported by the ground truth. Additionally, the LLM states the available authorization was $3.13 million (not billion), which is a critical error (off by a factor of 1,000), though it later corrects to billions. The claim that the authorization was 'later raised to $6.13 billion' is not in the original answer and appears fabricated. (2) For fiscal 2024, the LLM correctly reports the 2 million shares repurchased for $605 million in Q4 and the $2.69 billion available authorization (cited as $2.694 billion — minor rounding difference, acceptable). The $4 billion increase and resulting $6.69 billion total authority are correctly reflected (with negligible rounding). However, the original answer specifies the increase occurred on September 25, 2024, which the LLM omits. (3) The multi-hop reasoning is partially sound — the LLM correctly infers a growing capital return strategy from increasing authorizations and repurchases — but the flawed input data (especially the invented $4.11B repurchase in 2022) undermines the validity of the trend description. The original answer does not mention repurchase volume in 2022, so including it is an overreach. (4) The contextual relevance is high — the answer addresses the evolution of repurchases and authorizations and draws a reasonable conclusion about capital return strategy. However, due to major quantitative errors and unsupported claims, the correctness score is low. The qualitative accuracy is moderate because the structure and intent are sound, but entity and number accuracy are poor. Quantitative accuracy is severely penalized due to the million/billion confusion and invented figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 561,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Broadcom's (AVGO) industrial fiber optics product positioning evolve across 2022, 2023, and 2024, and what does this reveal about the company's strategic emphasis in the industrial end market?",
      "original_answer": "In 2022, Broadcom's industrial fiber optics were described as part of a broad portfolio including optocouplers, motion encoders, LED devices, and Ethernet ICs, targeting applications like industrial automation, medical systems, and electric vehicle subsystems. By 2023, the product was listed in a structured table of key offerings under the Industrial end market, grouped with sensors, encoders, LEDs, and Ethernet components, indicating a more standardized categorization. In 2024, industrial fiber optics remained a consistent offering under the Industrial segment, now explicitly linked with applications in factory automation, renewable energy, and automotive electronics, and listed alongside more specific components like Ethernet PHYs and camera microcontrollers. This evolution shows a consistent presence in fiber optics for industrial use, with increasing alignment to strategic industrial applications over time, suggesting a maturing and application-focused product strategy.",
      "llm_answer": "Broadcom’s 2022 10‑K (pp. 8‑12) presents fiber optics mainly as high‑speed optical components for Ethernet networking, storage, and telecom markets and lists them as part of its industrial product line. The 2023 and 2024 10‑Ks (pp. 3‑7) keep the same generic description but explicitly position “industrial fiber optics” as a core product within the industrial end‑market, alongside optocouplers, motion encoders, LEDs, and Ethernet ICs. This consistent emphasis across three years signals Broadcom’s strategic focus on leveraging fiber optics to drive growth in industrial automation, renewable‑energy, and automotive electronics.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but misses key aspects of the evolution in product positioning across the three years. It correctly identifies that industrial fiber optics were part of the industrial product line and listed alongside optocouplers, motion encoders, LEDs, and Ethernet ICs—consistent with the 2022 and 2023 descriptions. However, it fails to capture the nuanced evolution: in 2022, fiber optics were embedded within a broader portfolio description; in 2023, they appeared in a structured table indicating formal categorization; and in 2024, they were explicitly linked to factory automation, renewable energy, and automotive electronics with more specific component groupings like Ethernet PHYs and camera microcontrollers. The LLM incorrectly states that the 2023 and 2024 10-Ks maintain a 'generic description,' when in fact the positioning became more specific and application-focused over time. (2) There are no numerical values in the question or answers, so quantitative accuracy is not applicable—no errors here, hence a score of 10. (3) The multi-hop reasoning is partially sound: the model synthesizes information across years and recognizes continuity, but it does not accurately reflect the progression toward more strategic application alignment in 2024. The conclusion about strategic focus on industrial automation, renewable energy, and automotive electronics is supported by the 2024 data but is overgeneralized as consistent across all three years, which the ground truth does not support. (4) Contextual relevance is high—the answer addresses Broadcom’s industrial fiber optics and strategic emphasis—but the lack of precision in describing the evolution limits its factual correctness. The answer gives the impression of stability rather than maturation and increasing specificity, which is central to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 507,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the role and delivery model of UPS SurePost evolve from 2022 through 2024, particularly in terms of its reliance on the U.S. Postal Service and any strategic changes implemented by UPS?",
      "original_answer": "From 2022 to 2024, UPS SurePost consistently served as a residential ground service for non-urgent, lightweight shipments, with final delivery frequently handled by the U.S. Postal Service. In 2022 and 2023, this arrangement remained unchanged, emphasizing the reliability of the UPS ground network while leveraging USPS for the last mile. However, in 2024, UPS announced a strategic shift to insource the final delivery for UPS SurePost, effective January 1, 2025, aiming to enhance control over service quality and customer experience. This marks a transformation from reliance on a third-party (USPS) to a more integrated and controlled delivery model.",
      "llm_answer": "From 2022 through 2024 UPS SurePost remained a residential‑ground service for non‑urgent, lightweight shipments, with final delivery “often provided by the U.S. Postal Service” (2022 10‑K p. 7; 2023 10‑K p. 7).  In the 2024 filing UPS announced a strategic shift: beginning January 1 2025 it will insource SurePost to reduce reliance on USPS and gain greater control over the end‑to‑end delivery experience (2024 10‑K p. 7).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: UPS SurePost remained a residential ground service for non-urgent, lightweight shipments from 2022–2024, with final delivery often handled by USPS in 2022 and 2023. The strategic shift to insource final delivery starting January 1, 2025, is accurately reported. (2) Quantitative elements—specifically the effective date of the change (January 1, 2025)—are correct and match the original answer. No numerical calculations are required, but the timeline is precise. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of 10-K filings, identifying continuity (2022–2023 reliance on USPS) and change (2024 announcement of insourcing). (4) The answer is contextually relevant, directly addressing the evolution of the delivery model and strategic changes. Minor wording differences (e.g., 'reduce reliance on USPS' vs. 'transformation from reliance on third-party') do not affect factual accuracy. Citations to 10-K pages further support fidelity to source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 318,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Amgen's Phase 3 programs evolve from 2022 through 2024 in terms of quantity and development milestones, and what does this progression indicate about the company's R&D expansion strategy?",
      "original_answer": "Amgen's Phase 3 programs increased significantly from 13 programs as of February 8, 2022, to 18 programs as of January 31, 2023, and further to 24 programs as of January 31, 2024. By February 4, 2025 (noted in the 2024 filing), the number had grown to 25 Phase 3 programs, driven by five new initiations and regulatory approvals in the U.S. and Japan. This indicates a clear and sustained strategy to expand its late-stage pipeline, including external growth through acquisitions like Horizon Therapeutics in 2023, which added five Phase 3 programs. The consistent increase in Phase 3 programs and the combination of internal development and external acquisition suggest a focused effort to build a robust and diversified product portfolio.",
      "llm_answer": "Amgen’s Phase 3 pipeline expanded from 13 programs in 2022 to 18 in 2023 and 24 in 2024【AMGN_10k_2022.pdf:23‑27】【AMGN_10k_2023.pdf:24‑28】【AMGN_10k_2024.pdf:23‑27】. In 2022 the company secured regulatory approvals for three programs, launched four new Phase 3 studies and terminated one; in 2023 it added three new initiations and one approval while acquiring additional programs; by 2024 the portfolio reached 24 programs, with five Horizon‑acquired initiatives, three new Phase 3 launches, one FDA approval and one Japan approval【AMGN_10k_2024.pdf:23‑27】. This steady rise in quantity and the mix of internal development, acquisitions, and approvals demonstrate Amgen’s deliberate R&D expansion strategy focused on human‑genetics‑driven modalities and accelerated pipeline growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the progression of Amgen's Phase 3 programs: 13 in 2022, 18 in 2023, and 24 in 2024, matching the ground truth. It also notes the increase to 25 by early 2025 in the original answer, but this specific point is omitted—however, the core timeline through 2024 is fully accurate. The mention of five Horizon-acquired programs aligns with the ground truth. (2) Quantitatively, all numbers related to program counts, new initiations (e.g., four new studies in 2022, three in 2023, three new in 2024), approvals (U.S. and Japan), and acquisitions are consistent with the knowledge graph. The only minor gap is that the LLM does not explicitly state the net change from terminations or clarify that the 25-program count (as of Feb 2025) was disclosed in the 2024 filing, but this does not affect the accuracy of the 2022–2024 data. (3) The multi-hop reasoning is sound: the LLM synthesizes data across three 10-K filings, connects internal development (new launches, approvals) with external growth (acquisition of Horizon), and correctly infers a strategic R&D expansion. The reference to 'human-genetics-driven modalities' adds contextual insight not in the ground truth but is plausible and does not detract from accuracy. (4) The answer is highly contextually relevant, addressing both the quantitative evolution and strategic implications. The conclusion about a 'deliberate R&D expansion strategy' mirrors the ground truth's interpretation. The only reason for not scoring a 10 is the omission of the 25-program milestone noted in the 2024 filing, which slightly reduces completeness, but the core facts and synthesis remain excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 460,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In fiscal year 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023 and continuing into 2024, this number increased to 141,000,000, indicating a strategic expansion in the company’s capacity to issue share-based awards. This increase suggests that Accenture placed greater emphasis on equity-based incentives as part of its long-term talent retention and performance alignment strategy over the three-year period.",
      "llm_answer": "In FY 2022 Accenture authorized **127 million** Class A shares for its Amended 2010 SIP (ACN_10k_2022, pp. 89‑93).  The authorized pool was raised to **141 million** shares in FY 2023 (ACN_10k_2023, pp. 81‑85) and remained at that level in FY 2024 (ACN_10k_2024, pp. 96‑100).  The expansion of the share‑based compensation pool signals Accenture’s strategic emphasis on using equity awards to attract, retain, and align employees with shareholder interests.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the number of authorized shares was 127 million in FY 2022, increased to 141 million in FY 2023, and remained at that level in FY 2024. These figures match the original answer exactly, with acceptable formatting (127 million = 127,000,000). (2) Quantitative accuracy is perfect—no calculation errors, and the progression is correctly reported. (3) The multi-hop reasoning across fiscal years 2022–2024 is sound, with proper synthesis from three different 10-K filings (cited with document tags and page ranges), confirming cross-year consistency. (4) The qualitative interpretation—that the increase signals a strategic emphasis on equity compensation for talent retention and alignment with shareholders—matches the original answer’s conclusion. The LLM uses slightly different but equivalent phrasing (e.g., 'attract, retain, and align employees with shareholder interests' vs. 'long-term talent retention and performance alignment'). All parts of the question are addressed: the evolution of share authorization and its strategic implication. No factual, numerical, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 340,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Starbucks' projected duration of green coffee supply coverage evolve from fiscal 2022 through fiscal 2024, and what does this indicate about their inventory and risk management strategy?",
      "original_answer": "Starbucks' projected duration of green coffee supply coverage increased from fiscal 2022 through fiscal 2024. In fiscal 2022, the company stated that purchase commitments and existing inventory were expected to provide an adequate supply through fiscal 2023. By fiscal 2023, this projection extended to cover through fiscal 2025. In fiscal 2024, Starbucks maintained the same projected supply coverage through fiscal 2025. This indicates a more forward-looking inventory and risk management strategy, with increased emphasis on long-term supply assurance through extended purchase commitments and hedging mechanisms.",
      "llm_answer": "Starbucks projected that its green‑coffee supply coverage would extend through fiscal 2023 in FY 2022, through fiscal 2025 in FY 2023, and remained at fiscal 2025 in FY 2024. This shift shows the company has expanded its inventory and purchase commitments to secure a longer‑term supply, underscoring a proactive risk‑management strategy that mitigates supply‑chain disruptions and price volatility.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, all fiscal years and projections are accurate: FY2022 coverage projected through 2023, FY2023 and FY2024 both projecting through 2025. These match the original answer exactly. (2) The answer correctly captures the evolution of Starbucks' green coffee supply coverage duration across the three fiscal years, addressing both the quantitative change and the strategic implication. (3) The multi-hop reasoning—linking changes in supply coverage projections over time to broader inventory and risk management strategy—is sound and well-articulated. The conclusion about proactive risk management, extended purchase commitments, and mitigation of supply-chain disruptions and price volatility aligns with the original answer's interpretation. (4) All entities (Starbucks, green coffee supply, fiscal years 2022–2025) are correctly identified and synthesized. Minor wording differences (e.g., 'proactive risk-management strategy' vs. 'more forward-looking... strategy') do not affect factual equivalence. No errors in reasoning, completeness, or factual content.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 326,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did UPS's financial and strategic treatment of the UPS/IBT Full-Time Employee Pension Plan evolve from 2022 through 2024, particularly in terms of plan amendments, remeasurements, and collective bargaining impacts?",
      "original_answer": "From 2022 to 2024, UPS's treatment of the UPS/IBT Full-Time Employee Pension Plan evolved significantly. In 2022, the plan was remeasured following the enactment of the American Rescue Plan Act, resulting in a pre-tax mark-to-market gain of $3.3 billion ($2.5 billion after tax), which was included in investment income. In 2023, the plan remained a key part of UPS’s pension structure, and the ratification of a new five-year national master agreement with Teamsters employees led to wage and benefit rate increases that were recognized as part of the year-end measurement of the plan. By 2024, the plan was still maintained as a noncontributory defined benefit plan covering employees previously in the Central States Pension Fund and under certain collective bargaining agreements, with no indication of further structural changes, showing UPS's continued commitment to the plan despite broader pension modifications elsewhere. This three-year progression reflects UPS's strategic balance of pension obligations, collective bargaining dynamics, and regulatory responsiveness.",
      "llm_answer": "UPS reported no amendments or remeasurements to the UPS/IBT Full‑Time Employee Pension Plan in 2022 (see pages 90‑94). In 2023, the Teamsters ratified a new five‑year national master agreement that increased wage and benefit rates for UPS/IBT plan participants, and the resulting benefit‑cost increase was recognized in the year‑end measurement of the plan (pages 80‑84). In 2024, UPS disclosed no amendments, remeasurements, or collective‑bargaining changes to the UPS/IBT plan, and the plan continued under the same terms as in 2023 (pages 84‑88).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contradicts the ground truth on a key factual point—specifically, it states that there were no amendments or remeasurements to the UPS/IBT Full-Time Employee Pension Plan in 2022, while the original answer confirms a remeasurement occurred in 2022 due to the American Rescue Plan Act, resulting in a $3.3 billion pre-tax gain. This is a major factual error. The LLM also fails to mention this significant financial impact entirely, omitting both the gain amount and its inclusion in investment income. In 2023, the LLM correctly identifies the ratification of the new five-year agreement with the Teamsters and the recognition of increased benefit costs in year-end measurement, aligning with the ground truth. For 2024, the LLM correctly notes no new amendments or changes, consistent with the original answer’s statement of continued plan stability. (2) Quantitatively, the LLM omits all numerical data present in the ground truth: the $3.3 billion pre-tax and $2.5 billion after-tax gains in 2022. These are critical financial figures that define UPS’s strategic treatment of the plan and their absence severely undermines quantitative accuracy. (3) The reasoning is partially sound—while the LLM correctly links the 2023 collective bargaining agreement to pension cost recognition, it fails the multi-hop synthesis required by missing the regulatory trigger (American Rescue Plan Act) and its financial consequence in 2022. This indicates a failure to connect legislative action with corporate financial reporting. (4) Contextual relevance is high, as the LLM addresses the timeline, plan status, and collective bargaining impacts directly related to the question. However, the omission of the 2022 remeasurement and associated gain results in a materially incomplete and partially incorrect response, warranting a low correctness and quantitative accuracy score despite structurally appropriate organization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 524,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Walmart's categorization and strategic positioning of the 'Holiday Time' private brand evolved across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's approach to seasonal merchandise within its broader private label portfolio?",
      "original_answer": "In fiscal 2022, Walmart categorized 'Holiday Time' within its private brands under the broader merchandise portfolio, alongside other private brands like 'George' and 'Great Value,' without specific strategic emphasis on seasonal offerings. In fiscal 2023, 'Holiday Time' remained listed among private brands but was mentioned in the context of broader merchandise lines without a distinct strategic role, as Walmart emphasized omni-channel offerings and supply chain automation. By fiscal 2024, 'Holiday Time' continued to be listed among private brands, but Walmart explicitly restructured its merchandise units to include 'seasonal merchandise' as a defined category under General Merchandise, signaling a more strategic placement of holiday-themed products within a dedicated seasonal framework. This evolution shows Walmart increasingly aligning 'Holiday Time' with structured seasonal planning, reflecting a shift toward optimizing private label offerings for time-sensitive retail cycles.",
      "llm_answer": "Across fiscal 2022, 2023 and 2024 Walmart continues to list **Holiday Time** as one of its private‑label brands, consistently grouping it with other low‑price, seasonal‑themed lines such as “Way to Celebrate” and “Time and Tru.”  The brand remains positioned within the general‑merchandise unit (the seasonal‑merchandise sub‑category), showing no shift in its categorization or strategic emphasis.  This continuity signals Walmart’s ongoing strategy of embedding seasonal merchandise in its private‑label mix to deliver low‑priced holiday items under the same everyday‑low‑price framework that drives its broader private‑label portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that there was 'no shift in categorization or strategic emphasis' of the 'Holiday Time' brand across fiscal years 2022–2024. The ground truth explicitly states that in fiscal 2024, Walmart restructured its merchandise units to include 'seasonal merchandise' as a defined category under General Merchandise, indicating a strategic evolution for 'Holiday Time' and similar brands. The LLM incorrectly asserts continuity, contradicting the documented shift. Additionally, the LLM introduces brands like 'Way to Celebrate' and 'Time and Tru' as if they were directly grouped with 'Holiday Time' in the filings, which is not supported by the ground truth. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is flawed: the question requires synthesis of changes over three fiscal years, particularly the strategic repositioning in 2024. The LLM fails this synthesis, instead asserting consistency where a shift occurred. It does not reflect the increasing strategic alignment of 'Holiday Time' with structured seasonal planning. (4) Contextual relevance is moderate—the answer addresses Walmart’s private label portfolio and seasonal merchandise, but misrepresents the evolution, leading to an incorrect conclusion about Walmart’s strategy. The answer is relevant in topic but incorrect in substance, hence the low correctness and qualitative accuracy scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 432,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did ACN's investment in mutual fund equity securities evolve across 2022, 2023, and 2024, and what does this trend suggest about the company's strategic allocation to this asset class?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This represents a consistent decline in exposure to mutual fund equity securities over the three-year period, suggesting a strategic rebalancing away from this asset class.",
      "llm_answer": "ACN’s fair‑value of mutual‑fund equity securities in its non‑U.S. pension plan assets fell from **$239,293 k in 2022** to **$196,226 k in 2023** and then rose to **$273,699 k in 2024** (2024 table on pages 94‑98; 2023 table on pages 81‑85; 2022 table on pages 87‑91). The dip in 2023 followed by a rebound in 2024 indicates a deliberate rebalancing—ACN reduced equity exposure amid market volatility or strategic realignment in 2023, then increased it in 2024 to pursue a more growth‑oriented allocation.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023 and remained unchanged in 2024. However, the LLM claims the value rose to $273,699k in 2024, which directly contradicts the ground truth. While the 2022 and 2023 figures are numerically accurate (with $239,293k = $239.293M and $196,226k = $196.226M), the 2024 figure is incorrect. (2) The quantitative values for 2022 and 2023 are correct when adjusted for unit (thousands vs. millions), but the 2024 value is wrong—$273,699k ($273.699M) vs. the correct $196.226M. This is a significant error in magnitude and trend direction. (3) The multi-hop reasoning fails because the model incorrectly infers a rebound in 2024, leading to a flawed conclusion about strategic rebalancing toward growth. The actual trend is a decline followed by stability, suggesting a sustained reduction in exposure, not a rebound. The LLM misinterprets or misreads the 2024 data, undermining the entire analysis. (4) The contextual relevance is moderate—the response addresses the right asset class, company, and time frame, and attempts strategic interpretation. However, due to the critical error in the 2024 value and the resulting incorrect trend analysis, the correctness and quantitative accuracy scores are very low. The qualitative reasoning is partially sound in structure but based on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 413,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through 2024, and what does this reveal about the company's risk management approach in the context of futures market influences?",
      "original_answer": "From fiscal 2022 through 2024, Starbucks consistently acknowledged its exposure to green coffee price volatility driven by trading activities in the arabica coffee futures market, including those by commodity index funds. In 2022, the company hedged 'C' price exposure using forward and futures contracts, with purchase commitments expected to cover needs through fiscal 2023. By 2023, Starbucks extended its hedging strategy and supply commitments through fiscal 2025, signaling increased confidence in managing long-term exposure. In 2024, the company maintained a similar narrative, continuing to emphasize its reliance on fixed-price and price-to-be-fixed contracts alongside futures instruments. This evolution shows a consistent and maturing risk management approach aimed at mitigating the influence of speculative trading in the futures market on its coffee sourcing costs.",
      "llm_answer": "Starbucks has consistently disclosed that green‑coffee prices are influenced by futures‑market activity—including commodity‑index funds—and has maintained a hedging strategy that uses forward contracts, futures contracts and collars to manage “C”‑price exposure across fiscal 2022, 2023 and 2024 (see 2022 10‑K, p. 12; 2023 10‑K, p. 12; 2024 10‑K, p. 12). The company’s disclosures show no significant change in the intensity or composition of these hedges over the three‑year period, indicating a stable, disciplined risk‑management approach that relies on futures instruments to mitigate commodity‑price volatility.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of Starbucks' hedging instruments and exposure to green coffee price volatility due to futures market activity, including commodity index funds, across fiscal 2022–2024. It correctly identifies the use of forward contracts, futures contracts, and collars to manage 'C' price exposure and cites consistent disclosure locations (10-K, p.12 for each year), which aligns with the ground truth. Quantitative accuracy is high: no specific numerical errors are present, and the timeline (2022–2024) is correct. However, the LLM misses a key evolution highlighted in the original answer: the extension of hedging and supply commitments from covering through fiscal 2023 (in 2022) to covering through fiscal 2025 (as disclosed in 2023). This represents a significant strategic shift indicating increased long-term risk management confidence, which the LLM overlooks by stating there was 'no significant change in the intensity or composition of these hedges.' This omission affects qualitative accuracy, as the reasoning fails to capture the multi-hop progression in Starbucks' risk management maturity. While the overall risk management framework is correctly described, the lack of attention to the temporal evolution weakens the synthesis. Contextual relevance remains high, as the answer directly addresses commodity exposure, hedging tools, and risk management in the context of futures markets.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 398,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's near-term debt management strategy?",
      "original_answer": "In 2022, AVGO had $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company had completely retired this liability, as the notes no longer appeared in the debt schedule, suggesting that AVGO either repaid or refinanced the obligation ahead of its maturity. This progression shows a deliberate near-term debt management strategy where AVGO addressed maturing obligations before their due dates.",
      "llm_answer": "AVGO’s exposure to the 3.625 % senior notes due October 2024 stayed flat at **$622 million** from fiscal year 2022 through fiscal year 2024 (see the debt schedule in AVGO_10k_2022.pdf p. 101‑105, AVGO_10k_2023.pdf p. 79‑83, and AVGO_10k_2024.pdf p. 79‑83). This unchanged level shows the company is keeping a low‑level, consistent short‑term debt profile and is not adding new debt at that maturity, instead focusing on refinancing or paying down other obligations to manage its near‑term debt load.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $622 million principal amount outstanding for the 3.625% notes due October 2024 in both 2022 and 2023, which matches the ground truth. However, it incorrectly states that the exposure remained at $622 million through fiscal year 2024, whereas the ground truth confirms the notes were fully retired by 2024 and no longer appear in the debt schedule. This is a critical factual error that undermines the conclusion. (2) Quantitatively, the numbers for 2022 and 2023 are accurate, and the formatting ($622 million) is acceptable. The error lies in the 2024 value, which should be $0 or 'retired' rather than unchanged. (3) The multi-hop reasoning is partially sound—LLM correctly synthesizes data across three 10-K filings—but draws an incorrect conclusion due to misrepresenting the 2024 status. The claim of a 'flat' exposure through 2024 contradicts the actual retirement of the debt, leading to flawed interpretation. (4) The contextual relevance is high as the response addresses both parts of the question—evolution of exposure and implications for debt strategy—but the flawed data leads to an inaccurate assessment of AVGO's strategy. The ground truth indicates proactive repayment/refinancing ahead of maturity, while the LLM suggests stability and no action, which is incorrect. Thus, while the early years are accurate and well-supported, the failure to recognize the 2024 retirement significantly reduces overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 409,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Mastercard's credit risk mitigation strategies and settlement exposure evolve from 2022 through 2024, particularly in light of regulatory scrutiny and litigation risks that emerged during this period?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees based on individual risk assessments. In 2022, the company emphasized its historical experience of low losses from customer failures and its regular monitoring of the adequacy of risk mitigation arrangements. By 2023, regulatory scrutiny intensified, with investigations from the FTC and DOJ focusing on compliance with the Durbin Amendment and potential antitrust violations, prompting Mastercard to enter into a consent agreement with the FTC to improve debit transaction routing transparency. In 2024, litigation risks increased significantly, including a class-action lawsuit alleging a $1+ billion liability related to the EMV liability shift and a formal investigation by the European Commission into anticompetitive behavior tied to network fees. Despite these pressures, Mastercard continued to refine its risk management methodology and maintained its short-term settlement exposure estimation process, revising exposure amounts as necessary. The trend shows a transformation in the external risk environment, prompting Mastercard to reinforce its risk mitigation posture while maintaining stable internal controls.",
      "llm_answer": "Mastercard’s credit‑risk mitigation framework—requiring non‑compliant customers to post cash collateral, letters of credit or guarantees and regularly reviewing the adequacy of those arrangements—remained unchanged in principle but expanded in scale as settlement exposure rose.  Gross settlement exposure climbed from $59.6 million in 2021 to $78.4 million in 2024, with risk‑mitigation arrangements increasing from $7.7 million to $13.5 million, raising net exposure from $51.9 million to $64.9 million (2024 p. 102‑106; 2023 p. 110‑114; 2022 p. 108‑112).  The upward trend reflects intensified regulatory scrutiny (FTC, DOJ, EU investigations) and mounting litigation (merchant and ATM claims) that heightened Mastercard’s settlement‑risk profile and prompted greater risk‑mitigation coverage.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical values for gross settlement exposure and risk-mitigation arrangements across years (e.g., $59.6M in 2021 to $78.4M in 2024), which are not present in the original ground truth answer. The ground truth does not provide any quantitative data on settlement exposure or collateral amounts, nor does it mention a trend in net exposure rising from $51.9M to $64.9M. These figures appear fabricated or hallucinated, severely undermining factual accuracy. (2) There is no mention in the original answer of a '2021' baseline, nor page references (e.g., '2024 p. 102-106')—these are likely fabricated citations. The original answer focuses on qualitative evolution from 2022–2024 without financial metrics, making the LLM’s quantitative claims unsupported. (3) While the LLM correctly identifies key qualitative developments—regulatory scrutiny by the FTC and DOJ, the consent agreement, EU investigation, and litigation risks including merchant and ATM claims—it misattributes the purpose and evolution of risk mitigation strategies. The original answer states Mastercard maintained a 'consistent framework' and 'continued to refine' its methodology, not that it expanded in scale due to rising exposure. The causal link between regulatory pressure and increased collateral coverage is speculative and not stated in the ground truth. (4) The LLM answer is contextually relevant and addresses the multi-hop nature of the question by connecting regulatory and litigation developments to credit risk management. However, the inclusion of false quantitative data and unsupported trends (e.g., increasing net exposure) significantly reduces correctness. The qualitative core—linking regulatory and litigation risks to heightened risk focus—is partially aligned, but the answer distorts the original message by implying a quantitative escalation not present in the source. Thus, while reasoning structure is sound, factual grounding is weak, leading to a correctness score of 4.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1554,
        "completion_tokens": 544,
        "total_tokens": 2099
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in terms of compliance requirements, post-marketing obligations, and safety oversight across those years?",
      "original_answer": "In 2022, Amgen highlighted that its products used with drug delivery devices face distinct regulatory, manufacturing, and compliance risks, and that disruptions could affect clinical trials and product supply. By 2023, the company detailed increasing regulatory scrutiny around surrogate endpoints and conditional approvals, such as the requirement to complete confirmatory studies for products like Repatha and LUMAKRAS. In 2024, Amgen expanded on the regulatory oversight of drug delivery devices used in combination with its products, noting that these devices are subject to safety reviews and that failure to meet post-marketing requirements could lead to enforcement actions, including labeling changes or product withdrawal. The trend shows a growing emphasis on post-market compliance and safety monitoring of integrated drug-device products.",
      "llm_answer": "Amgen’s 10‑K risk disclosures on drug‑delivery devices have remained essentially unchanged from 2022 through 2024.  Each filing (2022 pp. 32‑36, 2023 pp. 51‑55, 2024 pp. 50‑54) stresses that devices used with its products are subject to regulatory oversight, require ongoing pharmacovigilance and reporting, and may trigger post‑marketing studies or REMS obligations.  The 2023 and 2024 disclosures largely mirror the 2022 language, with no substantive changes in compliance requirements or safety‑oversight procedures, though the 2024 filing reiterates the need for continued monitoring and potential post‑marketing commitments.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in its core claim that Amgen's disclosures remained 'essentially unchanged' from 2022 to 2024, which directly contradicts the ground truth showing a clear evolution in regulatory risk disclosures. While the LLM correctly identifies that drug delivery devices are subject to regulatory oversight and post-marketing obligations across all years (contextually relevant), it fails to capture the key developments: (1) In 2022, Amgen focused on general risks to clinical trials and supply chains; (2) In 2023, it emphasized increasing scrutiny on surrogate endpoints and conditional approvals with specific drug examples (Repatha, LUMAKRAS); and (3) In 2024, it expanded on safety reviews and enforcement risks for drug-device combinations, including labeling changes or withdrawal. These evolving details represent a significant shift in emphasis and specificity that the LLM overlooks. The page numbers cited (2022 pp. 32–36, etc.) are plausible and do not contradict the ground truth, so quantitative accuracy is acceptable. However, the qualitative reasoning is flawed—the model asserts no substantive changes when the ground truth shows a clear trend toward greater post-market compliance and safety monitoring. This failure in multi-hop synthesis—comparing disclosures across years to identify evolution—results in a low correctness and qualitative accuracy score. The answer is not irrelevant, as it discusses the right topic and general risks, hence a moderate contextual relevance score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 417,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Walmart's private brand 'Parent's Choice' evolve across its merchandise categorization strategies in fiscal years 2022, 2023, and 2024, and what does this reveal about Walmart's positioning of the brand within its baby and consumables portfolio?",
      "original_answer": "In fiscal 2022, 'Parent's Choice' was listed among Walmart's private brands under the Grocery unit, which included baby products. In fiscal 2023, the brand remained a key private label within the same category, indicating continuity in its positioning. By fiscal 2024, 'Parent's Choice' continued to be prominently featured under the Grocery merchandise unit, which now explicitly included 'baby products' as a defined category. This consistent placement over three years suggests Walmart's strategic intent to reinforce 'Parent's Choice' as a trusted, low-cost private brand in the baby care segment, aligning with its EDLP pricing philosophy and omni-channel convenience strategy.",
      "llm_answer": "Parent’s Choice appears in the list of private‑label brands in each of Walmart’s 2022, 2023 and 2024 10‑K filings, and the company’s grocery‑unit description—across all three years—continues to include baby products and consumables.  The brand has remained consistently categorized under the Grocery unit, indicating that Walmart has not shifted it to a different merchandise category.  This stability shows Walmart’s deliberate positioning of Parent’s Choice as a low‑price private‑label staple within its core baby‑and‑consumables portfolio, reinforcing its everyday‑low‑price strategy in these high‑volume, price‑sensitive categories.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All entities—Walmart, 'Parent's Choice', fiscal years 2022–2024, Grocery unit, baby products, and consumables—are correctly identified. The brand's consistent categorization under the Grocery unit across all three years matches the original answer. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct referencing of years, which are accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three fiscal years from Walmart’s 10-K filings to infer strategic continuity in brand positioning. It correctly infers that stable categorization reflects deliberate strategic positioning, which is consistent with the ground truth’s conclusion about EDLP and omni-channel strategy. (4) The only minor gap is that the LLM does not explicitly note the evolution in fiscal 2024 where 'baby products' became an explicitly defined subcategory within Grocery—this nuance is present in the original answer but only implied in the LLM version. However, the core conclusion about Walmart reinforcing Parent’s Choice as a low-cost staple is semantically equivalent and well-supported. Wording differs slightly but meaning is preserved. Thus, the answer is highly accurate with only a slight omission in detail, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 401,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Tesla's issuance and structuring of the 4.70% Solar Bonds, Series 2015/C24-10 evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about Tesla's solar financing strategy?",
      "original_answer": "In 2022, Tesla referenced the 4.70% Solar Bonds, Series 2015/C24-10 as part of a broader set of solar financing instruments, with the bond introduced via the Thirty-Fifth Supplemental Indenture dated April 14, 2015. In 2023, Tesla continued to reference this bond in the context of ongoing solar project financings, including alongside newer series such as Series 2015/C27-10 and 2015/C32-10, indicating a consistent reliance on this structure. In 2024, Tesla again referenced the 4.70% Solar Bonds, Series 2015/C24-10, but now in the context of a broader historical framework that included earlier series like C4-10 and C9-10, suggesting a matured and recurring financing model. The multi-year presence and repeated referencing of this bond structure indicate that Tesla maintained a consistent and scalable securitization strategy for solar assets across the three years.",
      "llm_answer": "In the 2022 10‑K (p. 100) Tesla reported the 4.70 % Solar Bonds, Series 2015/C24‑10 as outstanding debt maturing in 2025, a legacy of the SolarCity acquisition. By the 2023 10‑K (p. 100) the company had repurchased a portion of those bonds, reducing the principal balance and extending the maturity to 2026. In the 2024 10‑K (p. 97) Tesla disclosed that the remaining bonds were fully repaid (or converted to equity), reflecting a deliberate move to retire legacy debt and shift toward more favorable, lower‑cost financing for its solar operations. This multi‑year pattern indicates that Tesla is actively managing its debt portfolio to reduce long‑term liabilities, streamline its capital structure, and support the expansion of its renewable‑energy business.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) Quantitatively, the claim that Tesla repurchased portions of the 4.70% Solar Bonds in 2023 and extended maturity to 2026, then fully repaid or converted them in 2024, is unsupported by the original answer, which states only that the bond was repeatedly referenced across years as part of an ongoing securitization strategy—there is no mention of repurchases, maturity changes, or conversions. The original answer does not provide maturity dates or repayment details, but the LLM fabricates a detailed debt retirement narrative absent from the source. (2) The original answer emphasizes the continued use and referencing of the 2015/C24-10 bond alongside newer and older series (e.g., C27-10, C32-10, C4-10, C9-10), indicating a recurring and scalable financing model—not retirement. The LLM incorrectly frames the pattern as debt reduction rather than structural continuity. (3) The reasoning is flawed: instead of identifying multi-year consistency in securitization practices, the LLM invents a narrative of active debt management and refinancing, which contradicts the ground truth. (4) While the LLM correctly identifies the bond series and its origin in the SolarCity acquisition context (implied in original), and addresses the multi-year scope of the question, the core conclusion about Tesla’s strategy is factually incorrect. The contextual relevance is moderate because it discusses the right instrument and time frame, but the analysis misrepresents the strategic implication. Minor formatting variations (e.g., 4.70% vs 4.70 %) are acceptable, but invented financial actions (repurchases, maturity extensions, repayments) are not.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 470,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Broadcom's positioning of its Security Insights Platform evolved across 2022, 2023, and 2024, particularly in terms of integration with enterprise security tools and emphasis on mainframe risk assessment?",
      "original_answer": "In 2022, Broadcom described the Security Insights Platform as a solution that 'quickly interprets and assesses mainframe security posture, identifying risks and developing remediation steps,' with data available for use with in-house tools for security information and event management (SIEM). In 2023, the description remained largely consistent, continuing to highlight the platform’s ability to 'identify risks and proactively respond to potential threats' within the mainframe environment. By 2024, the platform retained its core functionality but was presented with a slightly stronger emphasis on integration, noting that the data is available for use with 'in-house tools for security information and event management'—a subtle but meaningful reaffirmation of its role in enterprise security ecosystems. While the core capabilities remained stable across the three years, the 2024 presentation reflects a more deliberate alignment with enterprise-wide security strategies, suggesting a maturing narrative around mainframe integration into broader cybersecurity frameworks.",
      "llm_answer": "Broadcom has consistently described its Security Insights Platform as a main‑frame security‑assessment tool that “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps on an ongoing and ad‑hoc basis” and that “this data is available for use with in‑house tools for security information and event management” (2022 pp. 9‑13; 2023 pp. 8‑12; 2024 pp. 8‑12).  The wording has not materially changed, so the platform’s positioning has remained focused on main‑frame risk assessment while explicitly highlighting its ability to feed data into enterprise SIEM‑type tools across all three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies Broadcom's consistent description of the Security Insights Platform across 2022, 2023, and 2024, emphasizing mainframe risk assessment and integration with in-house SIEM tools. All cited capabilities—interpreting mainframe security posture, identifying risks, developing remediation steps, and enabling integration with enterprise tools—are present in the original answer and correctly attributed across the three years. The LLM accurately notes that the wording has not materially changed, which matches the ground truth observation of stable core functionality. The only minor shortcoming is that the LLM does not explicitly highlight the 'slightly stronger emphasis on integration' and 'maturing narrative around mainframe integration into broader cybersecurity frameworks' noted in the 2024 description in the original answer. While the LLM mentions integration, it does not fully capture the subtle evolution in Broadcom’s positioning toward a more deliberate alignment with enterprise-wide security strategies. This nuance is important for a complete multi-hop synthesis across years but does not undermine the core correctness. There are no errors in entities, years, or terminology. Quantitative elements (years, page references) are correctly cited. The reasoning is sound, and the answer is highly relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 395,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency reveal about MA's capital structure strategy across the three-year period?",
      "original_answer": "Across 2022, 2023, and 2024, MA's A Class shares consistently maintained one vote per share and dividend rights, with no changes to their voting or dividend entitlements. This stability in A Class shares' rights indicates a consistent capital structure strategy by MA, preserving the governance and income distribution framework over the three-year period.",
      "llm_answer": "Between 2022 and 2024 Mastercard’s Class A shares continued to carry one vote per share and retained dividend rights, with the dividend per share rising from $2.04 in 2022 to $2.37 in 2023 and $2.74 in 2024 (2022 p. 94‑98; 2023 p. 97‑101; 2024 p. 90‑94). The unchanged voting structure coupled with a steady increase in dividend payouts shows the company’s deliberate strategy to preserve voting control in Class A shares while progressively rewarding shareholders, reflecting a consistent dual‑class capital‑structure approach across the three‑year period.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that MA's Class A shares maintained one vote per share and dividend rights from 2022 to 2024, aligning with the ground truth on the stability of voting and dividend entitlements. However, it introduces specific dividend amounts ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) that are not present in the original answer and cannot be verified from the provided ground truth. These figures may be factually accurate in external sources, but since the ground truth does not include them, their inclusion constitutes a deviation and potential hallucination. (2) The quantitative accuracy is penalized because the original answer states there was 'no change' to dividend *entitlements*, not necessarily the payout amounts. Dividend payments increasing does not contradict entitlement stability, but the LLM incorrectly implies these payouts are part of the 'entitlement' structure without clarifying that the *right* to dividends remained unchanged, conflating payout levels with structural rights. (3) The reasoning is partially sound: the model correctly infers a consistent capital structure strategy based on stable voting rights and interprets increasing dividends as shareholder rewards. However, it fails to focus on the core point — the *structural consistency* of rights — and instead emphasizes dividend growth, which was not part of the original analysis. This misaligns the strategic interpretation slightly. (4) Contextual relevance is high because the answer addresses both parts of the question — evolution of rights and strategic implication — and correctly identifies the company (MA/Mastercard) and time period. The qualitative accuracy is moderate because entity identification and multi-hop synthesis across years are correct, but the reasoning is weakened by introducing unverified data. Overall, the answer captures the correct structural stability but distracts with unsupported specifics, reducing factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 535,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Amgen's development and patent strategy for Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical trial phases and intellectual property protection timelines?",
      "original_answer": "In 2022, Amgen initiated the phase 3 study for Bemarituzumab, marking the beginning of its advanced clinical development for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab's patent protection for polypeptides was estimated to expire in 2029 in both the U.S. and Europe, indicating a defined IP strategy. In 2024, Amgen provided further context on Bemarituzumab's therapeutic focus, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, and highlighted potential regulatory exclusivity periods that could extend its market protection. This progression shows a transition from early-phase development to a more mature pipeline asset with defined clinical and IP strategies.",
      "llm_answer": "From 2022 through 2024 Amgen kept bemarituzumab in a Phase 3 program for gastro‑esophageal junction (GEJ) adenocarcinoma, with no shift to earlier or later phases noted in the 2022, 2023 or 2024 10‑K filings.  The company’s composition‑of‑matter patents in the U.S. and Europe, issued in 2022, carry estimated expirations in 2029, a date that remained unchanged in the 2023 and 2024 reports.  Amgen continues to file additional patents and pending applications to extend exclusivity beyond the 2029 horizon.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Amgen initiated a Phase 3 trial for Bemarituzumab in GEJ adenocarcinoma in 2022 and maintained it through 2024, consistent with the ground truth. It accurately states that patent protection for Bemarituzumab is estimated to expire in 2029 in both the U.S. and Europe, aligning with the original answer. The mention of ongoing patent filings to extend exclusivity beyond 2029 adds useful context not explicitly in the ground truth but logically consistent with Amgen's strategy. However, the LLM incorrectly implies that the composition-of-matter patents were 'issued in 2022'—the ground truth does not specify issuance year, only disclosure of expiration. This is a minor factual overreach. (2) All numeric values (2022, 2023, 2024, 2029) are correct and consistently used. No calculations are required, but the timeline alignment is accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes clinical development phase (from 2022 forward) with IP timelines across years, correctly linking patent expiration and development stage. It infers continued IP strategy beyond 2029, which is reasonable but not explicitly confirmed in the ground truth. (4) The answer is highly relevant, directly addressing both clinical trial phases and IP protection timelines. The slight overstatement about patent issuance prevents a top score, but core facts and synthesis are correct, warranting a high 8 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 408,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Walmart's private brand 'No Boundaries' fit within the evolving strategic merchandise units from 2022 through 2024, and what does this reveal about the company's shifting focus in apparel and fashion categories?",
      "original_answer": "In 2022, 'No Boundaries' was listed under the 'Apparel' category within Walmart U.S.'s strategic merchandise units, indicating its primary role in clothing and accessories. By 2024, the company restructured its general merchandise categories, and 'No Boundaries' was now referenced under the broader 'Fashion' unit, which included adult and children's apparel, shoes, jewelry, and accessories. This shift aligns with Walmart's increased emphasis on omni-channel offerings and customer-centric experiences, suggesting a strategic realignment to strengthen its fashion positioning. The continuity of 'No Boundaries' in all three years (2022–2024) highlights its consistent importance as a private brand, while its categorization evolved in line with Walmart's broader merchandising strategy.",
      "llm_answer": "Walmart’s private‑label “No Boundaries” has been listed in every filing as part of its apparel assortment (2022 pages 5‑9; 2023 pages 6‑10; 2024 pages 5‑9).  In 2022 and 2023 the apparel sub‑unit was called “Apparel,” but the 2024 filing renamed it “Fashion” (encompassing apparel, shoes, jewelry and accessories) (2024 pages 5‑9).  This re‑labeling signals a deliberate shift to broaden and elevate Walmart’s fashion offering, positioning “No Boundaries” within a wider, style‑centric private‑label strategy that extends beyond basic clothing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that 'No Boundaries' was part of the 'Apparel' category in 2022 and 2023 and moved to the 'Fashion' unit in 2024, which now includes apparel, shoes, jewelry, and accessories—matching the original answer's key factual claims. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in that sense, but the years (2022–2024) and page references (e.g., 2024 pages 5–9) are consistent and plausible; no calculation errors exist. (3) The multi-hop reasoning is sound: the model synthesizes changes in categorization across filings and infers a strategic shift, correctly interpreting the renaming from 'Apparel' to 'Fashion' as a signal of broader strategic intent. (4) The LLM captures the core insight—that Walmart is elevating its fashion positioning through a more integrated, style-centric approach—though it omits explicit mention of 'omni-channel offerings' and 'customer-centric experiences' from the original answer. However, the phrase 'style-centric private-label strategy' conveys a semantically equivalent emphasis. The continuity of the brand across years is implied by 'listed in every filing,' which matches the ground truth's point about consistent importance. Only minor contextual details are missing, not affecting factual correctness. Hence, a score of 9 is justified—excellent accuracy with negligible omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 417,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 through 2024, and what does this progression reveal about its hybrid cloud and AI strategy positioning?",
      "original_answer": "In 2022, IBM highlighted client relationships and trust as one of its principal methods of competition, alongside technology innovation and performance, indicating its foundational role in differentiating the company. By 2023, IBM reinforced this emphasis by explicitly linking client relationships and trust to its ability to deliver business value and solve complex client challenges through integrated technologies. In 2024, the company maintained this positioning but expanded the context by showcasing strategic partnerships with hyperscalers and global system integrators, suggesting that trust and relationships were being extended through ecosystem collaboration to enhance client outcomes. This evolution shows a consistent strategic focus on trust as a core asset, increasingly leveraged through partnerships and hybrid cloud/AI capabilities to drive client-centric innovation.",
      "llm_answer": "IBM has consistently listed “client relationships and trust” as a core competitive differentiator (2022 pages 2‑6; 2023 pages 1‑5), but the 2024 filing (pages 1‑5) explicitly links that trust to its secure, open hybrid‑cloud platform and AI solutions—presenting trust and security as a pillar of the hybrid‑cloud and AI strategy. This shift shows IBM is moving from a general value proposition to positioning trust as a foundational element that underpins its hybrid‑cloud and AI offerings, underscoring the importance of reliable, secure technology in a crowded market.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has a minor omission in completeness that prevents a top score. (1) All entities—IBM, client relationships and trust, hybrid cloud, AI, and the years 2022–2024—are accurately identified. The progression across years is correctly framed: in 2022, trust was a general competitive differentiator; by 2024, it was explicitly tied to hybrid cloud and AI. The LLM correctly notes the shift from a general value proposition to a strategic pillar underpinning technology offerings. (2) There are no numeric values, dates, or calculations in the response, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings and infers a strategic evolution. However, it omits a key element from the ground truth: the 2024 expansion through strategic partnerships with hyperscalers and global system integrators as a mechanism for extending trust. This is a meaningful part of the evolution and reveals how IBM is operationalizing trust via ecosystem collaboration—missing in the LLM answer. (4) Despite this omission, the answer captures the core strategic trajectory and correctly identifies the increasing centrality of trust in IBM’s hybrid cloud and AI positioning. Wording differs but semantic meaning is equivalent on the points covered. Contextual relevance is perfect—the response directly addresses the question’s focus on evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 419,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Tesla's (via SolarCity) issuance of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's solar financing strategy?",
      "original_answer": "Tesla (via SolarCity) consistently referenced the 5.45% Solar Bonds, Series 2015/C25-15 in its filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured debt instrument. In 2022, the bond was introduced as part of a broader series of solar bonds issued in early 2015, with Tesla referencing the Thirty-Sixth Supplemental Indenture dated April 14, 2015. In 2023, Tesla again referenced the same bond series in its filings, showing continued legal and financial linkage to this financing structure. In 2024, the bond remained a key exhibit, with Tesla reaffirming its inclusion in the broader solar bond framework. This 3-year persistence of the same bond series in disclosures suggests that Tesla maintained a consistent solar asset-backed financing strategy over time, reiterating the importance of these instruments in funding solar deployments.",
      "llm_answer": "Tesla’s 5.45% Solar Bonds, Series 2015/C25‑15 were still reported as $1.0 billion of principal outstanding and due 2025 in each of the three filings – $1.0 billion on page 101 of the 2022 10‑K, the same amount on page 100 of the 2023 10‑K, and again $1.0 billion on page 98 of the 2024 10‑K. The unchanged principal over three years shows that Tesla has retained the long‑term, fixed‑rate debt issued by SolarCity, using it as a stable, low‑cost financing vehicle for its solar assets while deferring repayment until the 2025 maturity.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth does not mention any specific principal amount ($1.0 billion), maturity year (2025), or page numbers (101, 100, 98) in the 10-K filings for 2022–2024. These specific quantitative claims are unsupported by the original answer and appear to be hallucinated. The original answer only states that Tesla referenced the bond series in disclosures, not that $1.0 billion remained outstanding or that it was due in 2025. (2) The quantitative accuracy is low because the LLM introduces precise numbers (dollar amounts, pages, maturity date) that are not present in the ground truth. While the 5.45% interest rate and bond series name are correctly mentioned, the core financial details are fabricated. (3) The reasoning partially aligns with the original: the LLM correctly infers that continued referencing implies reliance on the bond for solar financing. However, it goes further by asserting a 'stable, low-cost financing vehicle' and 'deferring repayment until 2025'—conclusions not supported by the ground truth, which only notes consistent disclosure and legal linkage. The multi-hop synthesis is flawed because it assumes financial data (outstanding principal, maturity) without evidence. (4) Contextual relevance is high because the answer addresses Tesla’s solar financing strategy and the bond’s role over three years. However, correctness is severely undermined by invented numbers. The qualitative accuracy is moderate because the general direction of reasoning (continued use implies strategic importance) matches, but lacks evidentiary support. Overall, the answer is partially correct in theme but factually incorrect in key details, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 480,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Emerson's Safety & Productivity segment evolve its pipe-working tool offerings from 2022 to 2024, particularly in terms of product innovation and integration of battery-powered technologies, and what does this progression suggest about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's Safety & Productivity segment significantly enhanced its pipe-working tool portfolio, particularly emphasizing innovation in battery-powered technologies. In 2022, the segment offered traditional pipe-working tools such as pipe wrenches, cutters, threading equipment, and diagnostic systems, including closed-circuit television for pipe inspection. By 2023, Emerson expanded its offerings to include battery hydraulic tools for press connections, indicating a clear shift toward cordless, high-efficiency solutions tailored for professional use. This trend continued into 2024, where the segment further integrated battery-powered tools into its lineup, specifically highlighting battery hydraulic tools for cutting and crimping electrical cables, alongside sewer inspection cameras and locating equipment. The consistent mention of pipe wrenches across all three years underscores their foundational role, while the progressive addition of battery-powered innovations signals Emerson's strategic move to modernize its toolset and align with industry demands for portability, efficiency, and advanced diagnostics. This evolution suggests a deliberate effort to strengthen Emerson's competitive position in the professional tools market by enhancing productivity and safety through technology integration.",
      "llm_answer": "Between 2022 and 2024, Emerson’s Safety & Productivity segment broadened its pipe‑working line by adding battery‑powered hydraulic tools for press connections and for cutting/crimping electrical cable, and by introducing diagnostic systems that include sewer‑inspection cameras and locating equipment—features that were not highlighted in the 2022 offering (pages 7‑11). This shift toward cordless, battery‑driven, tech‑enabled tools signals a strategic emphasis on mobility, safety, and productivity, positioning Emerson as a modern, innovation‑driven competitor in the professional tools market (pages 71‑75).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Emerson's Safety & Productivity segment from 2022 to 2024. It correctly identifies the introduction of battery-powered hydraulic tools for press connections (noted as occurring in 2023 in the ground truth) and for cutting/crimping electrical cables (2024), as well as the addition of diagnostic systems like sewer-inspection cameras and locating equipment. These innovations are accurately framed as a strategic shift toward cordless, tech-enabled tools enhancing mobility, safety, and productivity—aligning with the original answer’s conclusion about Emerson’s positioning in the professional tools market. The mention of pages (7–11, 71–75) appears to be contextual references and do not affect factual accuracy. One minor omission is that the LLM does not explicitly note the continuity of traditional tools like pipe wrenches across all years, which the ground truth emphasizes as foundational. However, this does not undermine the overall correctness, as the focus of the question was on evolution and innovation. All entities (Emerson, Safety & Productivity segment, correct time frame) are accurate. No numerical errors—dates and product timelines are correctly represented. The reasoning is sound, showing multi-hop synthesis across years and product categories. Semantic equivalence is strong, with slightly more concise phrasing but full preservation of meaning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1527,
        "completion_tokens": 396,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Gilead's capital allocation strategy for its El Segundo, California facility evolve from 2022 to 2024, particularly in relation to cell therapy manufacturing investments and their alignment with the company's broader biologics development priorities?",
      "original_answer": "In 2022, Gilead's 10-K listed El Segundo among several principal manufacturing facilities in California, indicating its role in general manufacturing and processing, but without specific emphasis on cell therapy (GILD_10k_2022.pdf:page_33:chunk_1). By 2023, the company explicitly identified El Segundo as a dedicated site for both clinical and commercial manufacturing and processing of cell therapy products, signaling a strategic shift toward specialization in this high-growth therapeutic area (GILD_10k_2023.pdf:page_11:chunk_1). In 2024, El Segundo retained this designation, and the filing also emphasized Gilead’s reliance on internal know-how and third-party confidentiality agreements to protect proprietary manufacturing technologies—suggesting increased investment in securing and scaling proprietary cell therapy processes at this site (GILD_10k_2024.pdf:page_10:chunk_1). This progression indicates a focused capital allocation strategy toward transforming El Segundo into a core node for cell therapy production, aligning with Gilead’s broader biologics development goals and potentially reflecting increased CAPEX or R&D spend tied to facility upgrades and process development.",
      "llm_answer": "From 2022 to 2024, Gilead’s capital‑allocation strategy for its El Segundo, California site shifted from an initial expansion of cell‑therapy manufacturing capacity to a focus on scaling that capacity for commercial production in line with its broader biologics pipeline. In 2022, the company noted that its capital resources were sufficient to support the expansion of the El Segundo facility for cell‑therapy production (2022 10‑K, pp. 31‑35). By 2023, Gilead continued to invest in the site, expanding its clinical and commercial cell‑therapy manufacturing capacity (2023 10‑K, pp. 9‑13), and by 2024 the facility was positioned for commercial manufacturing of cell‑therapy products, reflecting a strategic alignment with the company’s biologics development priorities (2024 10‑K, pp. 8‑12).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its overall narrative and timeline, accurately reflecting Gilead's evolving focus on cell therapy manufacturing at the El Segundo facility from 2022 to 2024. It correctly identifies the increasing strategic emphasis on clinical and commercial cell therapy production and aligns this with Gilead’s broader biologics development goals. All cited years (2022–2024) and document references (10-K pages) are plausibly consistent with the ground truth, though exact page numbers differ slightly (e.g., ground truth cites page 33 for 2022, LLM cites pp. 31–35), which is acceptable given chunking variations. There are no numeric values to verify, so quantitative accuracy is scored as 10. However, the LLM introduces a claim not present in the original answer: that in 2022, Gilead was already expanding El Segundo specifically for 'cell-therapy production.' The ground truth states that in 2022, El Segundo was listed as a general manufacturing site without specific mention of cell therapy, with the dedicated focus only emerging in 2023. This misrepresents the timing of the strategic shift and overstates early-stage specialization. Additionally, the LLM omits the 2024 detail about reliance on internal know-how and third-party confidentiality agreements to protect proprietary processes—a key indicator of increased investment in securing and scaling technology. While the core evolution is captured, these inaccuracies in entity-specific emphasis and missing strategic nuance reduce qualitative accuracy. The reasoning is mostly sound but fails a critical multi-hop distinction: the transition from general manufacturing (2022) to dedicated cell therapy (2023) is blurred. Contextual relevance remains high as the answer directly addresses capital allocation and strategic alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 491,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did IBM's relationship with the 1.250% Notes due 2027 evolve from 2022 through 2024, particularly in terms of its disclosure, issuance, and reference in filings across these years?",
      "original_answer": "In 2022, IBM disclosed the 1.250% Notes due 2027 as part of its exhibit list, referencing the instrument defining the rights of the holders filed on January 30, 2019. By 2023, IBM continued to reference the 1.250% Notes due 2027, specifically noting their inclusion in filings from February 8, 2022, and February 3, 2023. In 2024, IBM formally listed the 1.250% Notes due 2027 (trading symbol IBM27B) as an issued financial instrument on the New York Stock Exchange, indicating a shift from disclosure to active market presence. This progression shows a clear transition from internal documentation and reference to public issuance and trading.",
      "llm_answer": "In its 2022 Form 10‑K, IBM listed the 1.250% Notes due 2027 as a registered security but did not report any issuance. The 2023 filing added a reference to the notes’ instrument definition, indicating that the notes had been issued and were outstanding. By 2024, IBM continued to disclose the notes—listing them in the securities section and providing the instrument definition in the exhibits—showing that the notes remained outstanding and due in 2027.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the presence of the 1.250% Notes due 2027 in IBM's filings across 2022–2024 and correctly notes their continued disclosure and outstanding status. However, it misrepresents the evolution of the notes’ status. According to the ground truth, in 2022, IBM only disclosed the notes by referencing an exhibit filed in 2019—not as a registered security in that year, as the LLM claims. In 2023, the LLM states the notes were 'issued and outstanding' based on the addition of the instrument definition, but the ground truth shows this was merely a continued reference to prior filings (Feb 2022 and Feb 2023), not new issuance. Crucially, the LLM omits the key 2024 development: the notes were formally listed on the NYSE under trading symbol IBM27B, marking a shift to active market presence—this is a major factual omission. (2) Quantitatively, the percentage (1.250%), maturity year (2027), and years of filing (2022–2024) are correct. No calculations are involved, so numerical accuracy is high. (3) The multi-hop reasoning is partially sound—the LLM tracks the notes across years but fails to correctly interpret the nature of disclosure vs. issuance and misses the critical NYSE listing in 2024, which represents the culmination of the evolution. (4) Contextual relevance is strong as the answer stays focused on the question, but the qualitative inaccuracy in characterizing the progression (disclosure → issuance → trading) reduces correctness. The answer suggests issuance occurred between 2022 and 2023, while the truth shows public trading began in 2024, indicating flawed synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 448,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What does Tesla's multi-year reference to the 5.45% Solar Bonds, Series 2015/C45-15 and its subsequent bond structures suggest about the evolution of its solar financing strategy from 2022 through 2024?",
      "original_answer": "Tesla's continued reference to the 5.45% Solar Bonds, Series 2015/C45-15, first introduced in filings as of May 26, 2015 (noted in the 2022 10-K), indicates a sustained reliance on structured solar financing mechanisms inherited from SolarCity. In 2023, Tesla not only referenced this original bond series but also built upon its framework with newer issuances like the 5.45% Solar Bonds, Series 2015/C53-15 (June 16, 2015), suggesting an iterative approach to expanding its securitization model. By 2024, Tesla further extended this pattern by referencing subsequent bonds such as the 5.45% Solar Bonds, Series 2015/C62-15 (June 29, 2015) and 2015/C72-15 (July 21, 2015), demonstrating a deliberate capital structure strategy of leveraging standardized, asset-backed instruments to fund solar deployments. This progression implies Tesla is refining a scalable, repeatable financing model for its solar business, reducing reliance on traditional corporate debt and aligning capital with asset performance.",
      "llm_answer": "Tesla’s 10‑K filings for 2022‑24 (pages 101‑105 in 2022; 99‑103 in 2023 and 2024) repeatedly cite the 5.45 % Solar Bonds, Series 2015/C45‑15, indicating that the SolarCity‑issued debt remains a long‑term obligation on Tesla’s balance sheet.  Over the same period the company also reports newer debt—such as the 2.00 % convertible senior notes due 2024—showing a shift from the legacy SolarCity bonds to more flexible, lower‑cost financing and a consolidation of its solar financing strategy under Tesla’s own debt structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to correctly represent the evolution of Tesla's solar financing strategy as described in the ground truth. (1) Quantitatively, the LLM incorrectly states that Tesla issued '2.00% convertible senior notes due 2024' as part of its solar financing evolution, which is not mentioned or supported in the original answer and misrepresents the bond structures discussed. The original answer references specific Solar Bonds series (C53-15, C62-15, C72-15) with the same 5.45% rate issued in 2015, not new lower-rate instruments. The LLM also fabricates a 'shift' to lower-cost financing not present in the ground truth. (2) The original answer emphasizes an iterative expansion of the *same* 5.45% securitization model across multiple bond series (C45-15 to C72-15), all from 2015, indicating a standardized, repeatable asset-backed financing structure. The LLM misinterprets this as a shift *away* from SolarCity bonds toward Tesla's own debt, which contradicts the ground truth that Tesla is *building upon* the original framework. (3) The LLM incorrectly implies a temporal evolution in bond *rates* and *types* (e.g., convertible notes), when the actual evolution is in the *extension and reuse* of the same bond structure across later-referenced series. (4) While the LLM correctly notes that the 5.45% Solar Bonds, Series 2015/C45-15, are still referenced in Tesla’s 10-Ks, it fails to identify the key multi-hop insight: that Tesla is systematically referencing *later series* of the same bond structure (C53, C62, C72) in 2023–2024, indicating a scalable securitization model. This core reasoning is missing or inverted. (5) Contextual relevance is moderate because the answer addresses Tesla’s solar financing and cites 10-K pages, but the substantive conclusion is factually incorrect. The answer distracts with irrelevant details (e.g., convertible notes) and misses the central theme of standardization and repetition in asset-backed solar financing. Overall, major factual and reasoning errors severely undermine correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 560,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Adobe's strategic positioning of Acrobat evolve from 2022 to 2024, particularly in terms of AI integration, market adoption in document-intensive industries, and the expansion of its digital document services platform?",
      "original_answer": "In 2022, Adobe emphasized Acrobat's strong market adoption and leadership position in document-intensive industries such as legal, financial services, and publishing, highlighting its integration with Adobe Sign and the Document Cloud platform to modernize digital workflows. By 2023, Adobe introduced forward-looking statements about AI innovation, including the vision to embed artificial intelligence across its offerings, signaling a strategic pivot toward AI-powered enhancements for Acrobat. In 2024, Adobe formally introduced the 'Acrobat AI Assistant' as part of its trademark portfolio, indicating a concrete realization of its AI integration strategy and positioning Acrobat as a next-generation, intelligent document solution. This evolution shows a clear trajectory from market leadership in document productivity to AI-driven innovation, with strategic emphasis on expanding the platform’s capabilities and reinforcing its role in digital transformation across industries.",
      "llm_answer": "From 2022 to 2024 Adobe has kept Acrobat as the centerpiece of its Document Cloud while deepening its AI‑driven capabilities and broadening the platform’s reach.  In 2022 the company highlighted Acrobat’s leadership in document‑intensive sectors (government, finance, legal, pharma, aerospace, insurance, publishing) and its use of Adobe Sensei to add intelligent, responsive actions, while positioning Acrobat Web, mobile Reader (Liquid Mode), Scan and Sign APIs as part of a unified digital‑document workflow.  By 2024 the same positioning is reinforced, but with a stronger emphasis on AI‑powered task‑based actions, full integration of Adobe Sign across all surfaces, expanded API‑driven automation, and a more comprehensive, cloud‑based services platform that delivers single‑click PDF editing, AI‑enhanced contract management, and mobile‑first workflows to further accelerate adoption in those high‑volume industries.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of strategic evolution, industry focus, and AI integration. (1) It accurately captures Adobe's continued emphasis on Acrobat as a core Document Cloud product and its strong adoption in document-intensive industries such as legal, finance, publishing, and adds additional sectors (government, pharma, aerospace, insurance) not in the original but plausible and contextually consistent. (2) Quantitatively, there are no numerical claims (e.g., revenue, user counts), so no inaccuracies exist—dates (2022, 2024) are used appropriately. (3) The multi-hop reasoning is sound: it traces the evolution from 2022 leadership to 2024 AI expansion. However, it misses the specific 2023 forward-looking AI statements and the formal introduction of the 'Acrobat AI Assistant' trademark in 2024, which is a key concrete milestone in the ground truth. Instead, it generalizes AI enhancements (e.g., 'AI-powered task-based actions', 'AI-enhanced contract management') without naming the flagship AI Assistant product. (4) The answer remains contextually relevant and semantically close, with slightly less precision on the exact nature of the 2024 AI integration. Wording differences are acceptable, but the omission of the 'Acrobat AI Assistant' as a named strategic milestone reduces qualitative accuracy slightly. Overall, core facts and trajectory are correct, but a key detail from the knowledge graph is missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 407,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has Charles Schwab's provision of interactive tools for RIAs evolved from 2022 through 2024, particularly in terms of platform enhancements and integration capabilities?",
      "original_answer": "In 2022, Schwab provided RIAs with proprietary software and a dedicated website offering account servicing capabilities and access to third-party integrations such as CRM and portfolio management systems. By 2023, Schwab continued to emphasize the Advisor Services website as the core platform, reinforcing its role in delivering interactive tools and educational content to support RIAs transitioning to independence. In 2024, Schwab maintained this trajectory by highlighting Schwab Advisor Portfolio Connect, a free portfolio management solution with an intuitive experience, and continued to expand integrations with third-party platforms to support advisor needs. The evolution shows a consistent focus on enhancing digital tools and integrations to support RIA scalability and efficiency.",
      "llm_answer": "From 2022 to 2024, Schwab’s RIA platform evolved from a web portal that offered interactive tools, multi‑year archival, and third‑party integrations—including the free Schwab Advisor Portfolio Connect—to a more sophisticated suite that added real‑time trading and automated rebalancing. In 2023, the platform was upgraded with Schwab Trading Powered by Ameritrade and the integration of the thinkpipes trading platform and iRebal, providing real‑time charting and customizable portfolio rebalancing capabilities. By 2024, Schwab further enhanced the RIA offering by fully integrating TD Ameritrade’s thinkpipes and iRebal, expanding API‑driven data feeds and third‑party platform connectivity while continuing to provide interactive educational tools【SCHW_10k_2022, pages 7‑11】【SCHW_10k_2023, pages 5‑9】【SCHW_10k_2024, pages 5‑9】.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces information not present in the ground truth. (1) Incorrect platform names and features: 'thinkpipes' and 'iRebal' are not mentioned in the original answer or known Schwab tools; 'Schwab Trading Powered by Ameritrade' and 'thinkpipes' appear to be fabricated or confused with TD Ameritrade platforms. The original answer highlights Schwab Advisor Portfolio Connect as a free portfolio management solution introduced in 2024, but the LLM incorrectly states it was available in 2022. (2) The LLM claims real-time trading and automated rebalancing were added in 2023 via TD Ameritrade integrations, but the ground truth makes no mention of such integrations or enhancements, nor does it reference any post-acquisition platform unification. (3) Multi-hop reasoning is flawed: the LLM synthesizes non-existent evolution across years, inventing technical capabilities (API-driven data feeds, real-time charting) not supported by the original answer. (4) While the LLM correctly identifies the general direction of enhanced digital tools and third-party integrations, it distorts the specifics, timeline, and product names. The mention of 'multi-year archival' and 'Schwab Advisor Portfolio Connect' in 2022 is incorrect — the original states this tool was highlighted in 2024. The citations to 10-K pages are plausible but do not excuse the factual divergence. Overall, the answer misrepresents the evolution with fabricated details, warranting a low correctness score despite some thematic relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 427,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Emerson's (EMR) strategic positioning of Air Preparation Equipment evolve across its Discrete Automation segment in 2022, 2023, and 2024, particularly in terms of integration with other pneumatic and control technologies?",
      "original_answer": "In 2022, Air Preparation Equipment was positioned within a broader suite of pneumatic mechanisms used in food processing, life sciences, and petrochemical processing, emphasizing integration with solenoid and pneumatic valves, actuators, and pressure switches. By 2023, the equipment was more explicitly embedded within the Discrete Automation segment’s portfolio of programmable automation control systems and software, electrical distribution, and materials joining solutions, signaling a stronger alignment with digital and automated control ecosystems. In 2024, the positioning further evolved to highlight interoperability with smart actuation, predictive maintenance capabilities, and secure wireless communication, aligning Air Preparation Equipment with broader trends in Industry 4.0 and digital transformation. This 3-year progression shows a clear shift from a mechanical focus to a digitally integrated component within Emerson’s industrial automation strategy.",
      "llm_answer": "Emerson continued to market Air Preparation Equipment as a core element of its Discrete Automation portfolio throughout 2022‑2024, consistently describing it as part of the same integrated pneumatic‑control family that includes solenoid valves, pneumatic valves, cylinders, actuators, and programmable control systems.  In 2022 the company highlighted Air Preparation Equipment as one of the “pneumatic mechanisms” that “transform air or gas into energy and power” for discrete manufacturing (see pages 4‑8 of the 2022 10‑K).  The 2023 and 2024 10‑Ks repeat the same language, noting that the segment “includes … air preparation equipment” alongside pneumatic valves, cylinders, actuators and control‑system components (see pages 71‑75 of the 2023 and 2024 10‑Ks).  No material shift in positioning or integration strategy was disclosed, indicating that Emerson maintained the same emphasis on integrating Air Preparation Equipment with other pneumatic and control technologies across the three years.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core conclusion, directly contradicting the ground truth. While it correctly identifies that Air Preparation Equipment was part of Emerson's Discrete Automation segment and associated with pneumatic and control technologies across 2022–2024, it falsely claims there was 'no material shift in positioning or integration strategy' and that the same language was repeated in all three 10-K filings. The ground truth, however, shows a clear evolution: from mechanical integration in 2022, to alignment with programmable automation and digital control systems in 2023, and further to Industry 4.0 capabilities like smart actuation and predictive maintenance in 2024. The LLM fails to capture this multi-hop progression entirely, likely due to overreliance on similar boilerplate language in filings without interpreting strategic shifts. Quantitatively, there are no numerical errors (hence a 10), but qualitatively, the reasoning is flawed—missing the nuanced evolution in strategic positioning. Contextually, the answer addresses the right segment and technologies but fails to deliver the required analysis of change over time, making it only partially relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 337,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did The Coca-Cola Company's issuance strategy for the 0.125% Notes due 2029 evolve from 2022 to 2024, and what does this pattern suggest about the company's approach to managing near-term debt obligations in the context of its broader financing activities?",
      "original_answer": "The Coca-Cola Company consistently referenced the 0.125% Notes due 2029 in its filings across all three years (2022–2024), indicating ongoing acknowledgment of this liability. However, the context in which it was referenced changed. In 2022, the note was embedded among a broader set of historical debt instruments, suggesting a passive disclosure approach. By 2023, the note appeared in a more consolidated format, indicating a maturing phase within the company's debt structure. In 2024, while the 0.125% Notes due 2029 were still referenced, the company began introducing significantly higher-yielding instruments (e.g., 5.000% Notes due 2034 and 5.400% Notes due 2064), suggesting a strategic pivot toward longer-term financing as the 2029 note approached its maturity date. This pattern implies a deliberate effort to refinance or extend liabilities as lower-yielding, near-term notes like the 0.125% Notes due 2029 neared expiration.",
      "llm_answer": "From 2022 to 2024, Coca‑Cola issued the 0.125% Notes due 2029 in successive tranches—first in 2022 (p. 134‑138), again in 2023 (p. 132‑136), and once more in 2024 (p. 128‑132)—each time to refinance maturing debt and preserve a low‑coupon debt profile. This incremental issuance pattern shows a disciplined, low‑cost strategy for managing near‑term maturities, using the same instrument to refinance debt while keeping the overall debt mix stable and taking advantage of favorable market conditions.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that The Coca-Cola Company issued the 0.125% Notes due 2029 in successive tranches in 2022, 2023, and 2024. The ground truth indicates that the company did not reissue this note; rather, it continued to reference the existing 0.125% Notes due 2029 in its disclosures, with evolving context. The claim of new issuances is a fundamental error. (2) Quantitatively, the percentages (0.125%, 2029 maturity) are correct, but the implication of repeated issuance in each year is false. There are no dollar amounts or calculations in either answer, but the temporal and transactional framing (issuance events) is inaccurate. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers an incremental issuance strategy, whereas the actual pattern reflects changing disclosure and strategic shifts toward issuing higher-yielding, longer-term debt (e.g., 5.000% Notes due 2034) as the 2029 note nears maturity—indicating refinancing planning, not repeated use of the same instrument. The LLM misinterprets disclosure continuity as active issuance. (4) Contextual relevance is moderate because the answer addresses debt management and near-term obligations, but the core premise (repeated issuance) is wrong, leading to an incorrect conclusion about strategy. The ground truth emphasizes a pivot to longer-term financing, not preservation of a low-coupon profile via reissuance. Thus, the answer fails on factual correctness and reasoning, warranting a low score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 419,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did BNY Mellon's exposure to U.S. banking laws regarding capital planning and shareholder capital returns evolve from 2022 through 2024, particularly in terms of regulatory constraints on dividends and share repurchases?",
      "original_answer": "BNY Mellon's disclosures consistently emphasized regulatory constraints on capital returns throughout 2022–2024, but the framing evolved from a general caution in 2022 to more specific references to U.S. banking laws and capital adequacy rules in 2023 and 2024. In 2022, the firm noted that capital returns were limited by U.S. banking laws and Delaware law. In 2023, it reiterated these constraints and highlighted the impact of preferred stock dividend obligations. By 2024, the language became more structured, emphasizing regulatory standards like 'well capitalized' status and capital adequacy rules as direct limitations on its ability to repurchase shares or pay dividends. This shows a trend of increasing specificity and formalization in how the firm communicates regulatory constraints on capital policy.",
      "llm_answer": "BNY Mellon’s 2022, 2023 and 2024 10‑K filings all contain the same risk‑factor statement: “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock.” The wording and emphasis on regulatory constraints on dividends (and, by implication, share repurchases) have remained unchanged, indicating that BNY Mellon’s exposure to U.S. banking laws regarding capital planning and shareholder capital returns did not materially evolve from 2022 through 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core conclusion, despite using accurate dates and referencing the correct regulatory context. While it correctly identifies that BNY Mellon's 10-K filings from 2022–2024 mention U.S. banking laws, capital planning, Delaware law, and preferred stock dividends as constraints on capital returns, it incorrectly asserts that the wording and emphasis remained unchanged across years. The ground truth shows a clear evolution in language: from a general caution in 2022, to inclusion of preferred stock obligations in 2023, to a more structured reference to 'well capitalized' status and capital adequacy rules in 2024. The LLM claims the 'same risk-factor statement' appears in all three years, which contradicts the documented trend of increasing specificity. This misrepresents the central point of the question—how the firm’s disclosure *evolved*—and thus fails the multi-hop reasoning required to compare disclosures over time. While entity names, years, and general regulatory frameworks are accurate (supporting high quantitative accuracy and moderate contextual relevance), the qualitative analysis and overall correctness are severely undermined by the false claim of static language. The answer would have been stronger if it had acknowledged subtle shifts in emphasis or structure, even if the core sentence was similar. As written, it conveys the opposite of the ground truth: stability instead of evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 401,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did McDonald's portrayal of its McGriddles product within broader menu innovation disclosures evolve from 2022 through 2024, and what does this reveal about the consistency of its breakfast strategy?",
      "original_answer": "McDonald's portrayal of McGriddles remained remarkably consistent across all three years, with the product always listed among core breakfast sandwiches without any specific innovation details. In 2022 (MCD_10k_2022.pdf:page_7:chunk_1), McGriddles were mentioned as a standard breakfast offering alongside Egg McMuffin and Sausage McMuffin with Egg. By 2023 (MCD_10k_2023.pdf:page_6:chunk_1), the company emphasized its 'continuous evolution' of menus to meet customer needs, yet McGriddles remained presented as a static menu item rather than an innovated product. In 2024 (MCD_10k_2024.pdf:page_6:chunk_1), despite mentioning 'testing new products on an ongoing basis,' McGriddles were still described in the same basic format as in prior years. This reveals a stable breakfast strategy where McGriddles maintained its position as a core offering without significant product-level changes, even as the company pursued broader menu innovation elsewhere.",
      "llm_answer": "McGriddles has been presented consistently as a standard breakfast sandwich in each year’s menu disclosures – listed alongside Egg McMuffin, Sausage McMuffin with Egg, biscuits, bagels, oatmeal, breakfast burritos and hotcakes – with no shift in emphasis or positioning from 2022 through 2024. This unchanged portrayal shows that McDonald’s breakfast strategy has remained stable, focusing on maintaining core breakfast items rather than launching major new products. (2024: pages 4‑8; 2023: pages 4‑8; 2022: pages 5‑9)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the same core information as the ground truth. It accurately states that McGriddles were consistently portrayed as a standard breakfast sandwich from 2022 to 2024, with no innovation details, and correctly infers that this reflects a stable breakfast strategy focused on core items. All entities (McGriddles, Egg McMuffin, Sausage McMuffin with Egg, and associated years) are correctly identified. The reasoning is sound: the model synthesizes information across three years of disclosures and draws a valid conclusion about strategic consistency. The only minor shortcoming is that the LLM omits the specific contrast between broader innovation language (e.g., 'continuous evolution' in 2023, 'testing new products' in 2024) and the static treatment of McGriddles, which the original answer highlights to strengthen the analysis. However, this does not undermine the correctness of the overall conclusion. Page number ranges (e.g., 2022: pages 5–9) are slightly less precise than the ground truth’s specific page references (e.g., page 7), but still within reasonable variation. No numerical inaccuracies exist—there are no calculations or figures to verify, and all qualitative claims are supported. The answer is highly contextually relevant and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 370,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Adobe's emphasis on free online self-service learning evolved across 2022, 2023, and 2024, particularly in terms of its positioning within Adobe Digital Learning Services and the platforms used to deliver these offerings?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of a broader enablement strategy, hosted on www.training.adobe.com, emphasizing its role in assisting customer and partner teams in product adoption. By 2023, the company continued to provide these free options but shifted the domain to learning.adobe.com, indicating a more centralized or rebranded approach to digital learning. In 2024, Adobe reinforced its production and delivery of these learning tools on the same platform (learning.adobe.com), integrating them more deeply into a comprehensive portfolio that also included fee-based and custom learning programs. This 3-year trajectory shows a consistent strategic emphasis on self-service learning as a core component of Adobe’s customer enablement, with a shift in platform branding and an increased integration into the broader Adobe Learning Services ecosystem, suggesting a maturing and more structured approach to digital education.",
      "llm_answer": "Adobe has kept free online self‑service learning as a core element of its Digital Learning Services throughout 2022‑2024, but the delivery platform shifted from the older www.training.adobe.com in 2022 to the unified learning.adobe.com portal in 2023 and 2024. This change reflects a consolidation and re‑branding of the learning experience while preserving the same emphasis on accessible, cloud‑based education. The 2024 filing notes that the free learning remains part of Digital Learning Services and is now hosted on learning.adobe.com, which also carries Adobe’s fee‑based training programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the shift from www.training.adobe.com in 2022 to learning.adobe.com in 2023 and 2024 is accurately reported, and the emphasis on free self-service learning as a core component of Adobe Digital Learning Services is correctly maintained across all three years. (2) There are no numeric values requiring calculation, but the dates (2022, 2023, 2024) are used correctly and consistently with the original answer. (3) The multi-hop reasoning is sound—LLM correctly synthesizes information across years and platforms, noting the rebranding and consolidation as a strategic move. (4) The LLM captures the evolution in platform and integration with fee-based offerings in 2024, though it slightly underemphasizes the 'maturing and more structured approach' and deeper integration into a comprehensive portfolio mentioned in the original answer. However, the core message about strategic continuity and platform consolidation is preserved. Wording differs but semantic meaning is equivalent. Minor omission of 'customer and partner teams in product adoption' context does not detract from overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 338,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did Emerson's (EMR) positioning of Commercial Vacuums within its Safety & Productivity segment evolve from 2022 through 2024, particularly in terms of product categorization, strategic emphasis, and alignment with professional tools offerings?",
      "original_answer": "In 2022, Commercial Vacuums were listed among other professional tools like water jetters and wet-dry vacuums under the Tools & Home Products segment, with a focus on promoting safety and productivity for professionals and homeowners. By 2023, Commercial Vacuums were explicitly included in the Safety & Productivity segment, grouped with tools supporting infrastructure and safety, such as battery hydraulic tools and sewer inspection cameras. In 2024, Commercial Vacuums remained within the Safety & Productivity segment, but the description emphasized integration with broader productivity-enhancing tools like programmable automation control systems and electrical distribution equipment, signaling a shift toward aligning Commercial Vacuums with more technologically advanced and industrial productivity tools. This evolution reflects a strategic repositioning of Commercial Vacuums from a general tools category to a more integrated part of Emerson’s industrial safety and productivity solutions.",
      "llm_answer": "Emerson continued to classify commercial vacuums as part of the “Other professional tools” line within its Safety & Productivity segment from 2022 through 2024 (see 2022 10‑K, pp. 7‑11, and 2024 10‑K, pp. 71‑75).  Over this period the company shifted its strategic emphasis toward a stronger professional‑tools focus, positioning commercial vacuums as a key safety‑and‑productivity product and aligning them with the Tools & Home Products portfolio, with sales driven primarily through distributors and a direct sales force.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding Emerson's segment classification of Commercial Vacuums. According to the ground truth, in 2022, Commercial Vacuums were part of the Tools & Home Products segment, not the Safety & Productivity segment. The repositioning into Safety & Productivity occurred in 2023. However, the LLM claims they were classified under Safety & Productivity as early as 2022, which is incorrect. Additionally, the LLM states that Commercial Vacuums were aligned with the 'Tools & Home Products portfolio' during 2022–2024, which contradicts the ground truth showing a strategic move away from that segment. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is flawed: the model fails to correctly trace the evolution across years, misidentifies the initial segment (2022), and incorrectly asserts continuity in classification. It also misrepresents strategic alignment by suggesting alignment with Tools & Home Products, when the actual shift was toward integration with industrial productivity systems like automation controls. (4) Contextual relevance is moderate because the answer addresses product categorization and strategic emphasis, but with incorrect entity mappings and reasoning. Due to major factual and synthetic errors in entity and timeline accuracy, the correctness score is low at 3.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 407,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has GILD's utilization of its Hoofddorp, Netherlands facility evolved from 2022 through 2024, particularly in relation to cell therapy manufacturing and commercial processing activities?",
      "original_answer": "In 2022, GILD's Hoofddorp, Netherlands facility was identified as a principal manufacturing site, indicating its importance in GILD’s global operations. By 2023, the facility was explicitly described as being utilized for commercial manufacturing and processing of cell therapy products, highlighting a strategic shift toward advanced therapies. In 2024, this focus remained consistent, with Hoofddorp continuing to serve as a dedicated site for commercial manufacturing and processing of cell therapy products, suggesting a sustained and potentially expanding role in GILD’s cell therapy portfolio. This progression indicates a growing emphasis on cell therapy capabilities at the Hoofddorp location over the three-year period.",
      "llm_answer": "Gilead’s 10‑K filings for 2022, 2023 and 2024 all describe the Hoofddorp, Netherlands site as a **commercial manufacturing and processing location for its cell‑therapy products**.  No change in the facility’s role or scope is reported across the three years—there is no shift to clinical manufacturing or expansion of its use, indicating a steady, ongoing focus on commercial‑scale cell‑therapy production.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that there was no change in the facility's role from 2022 to 2024, directly contradicting the ground truth. In 2022, the Hoofddorp facility was described only as a 'principal manufacturing site' without explicit mention of cell therapy commercial manufacturing. It was not until 2023 that the 10-K filings specifically identified the site as being used for 'commercial manufacturing and processing of cell therapy products.' This represents a significant evolution in the facility's designated function, which the LLM answer fails to recognize. The LLM incorrectly asserts that the role remained unchanged across all three years, missing the strategic shift toward cell therapy that the ground truth emphasizes. While the entities (GILD, Hoofddorp, Netherlands, cell therapy) and years are correctly identified, and there are no numerical inaccuracies (hence full marks for quantitative accuracy), the qualitative reasoning is flawed due to failure in multi-hop synthesis: the model did not detect the progression in language and strategic emphasis across the filings. The answer is contextually relevant and addresses the question's focus on cell therapy and commercial processing, but the incorrect conclusion about continuity undermines its correctness. Thus, the correctness and qualitative accuracy scores are low despite accurate terminology and proper scope framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 393,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does the persistent reference to the 1.000% Notes due 2028 in Coca-Cola's filings from 2022 through 2024, combined with the introduction of higher-yield notes in 2024 such as the 5.000% Notes due 2034 and 5.400% Notes due 2064, reflect changes in the company's approach to debt financing costs and capital structure management?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2028 in its 10-K filings for 2022, 2023, and 2024, indicating the ongoing importance of this low-interest debt instrument in its capital structure. However, in 2024, the company introduced significantly higher-yield notes, including the 5.000% Notes due 2034 and the 5.400% Notes due 2064. This shift suggests that Coca-Cola began diversifying its debt portfolio to include instruments with higher financing costs, likely to take advantage of favorable market conditions or to fund new strategic initiatives. The contrast between the stable, low-cost 1.000% Notes due 2028 and the new high-yield instruments indicates a recalibration of the company's capital structure management, balancing near-term affordability with long-term funding needs.",
      "llm_answer": "Across the 2022 (p. 134‑138) and 2023 (p. 132‑136) 10‑Ks, Coca‑Cola repeatedly lists the 1.000% Notes due 2028 as a core, low‑cost component of its debt portfolio, underscoring a long‑standing strategy of maintaining a low‑yield, medium‑term debt base. In the 2024 10‑K (p. 128‑132) the company introduces 5.000% Notes due 2034 and 5.400% Notes due 2064, signaling a deliberate shift toward higher‑yield, longer‑dated debt to diversify maturities, lock in rates, and support capital‑expenditure or refinancing needs. This evolution reflects a more aggressive approach to debt‑financing costs and a recalibration of the capital structure to balance cost, maturity, and leverage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values—1.000% Notes due 2028, 5.000% Notes due 2034, and 5.400% Notes due 2064—are correctly stated, with no discrepancies in percentages or maturities. Page references (e.g., p. 134–138 for 2022) add precision and are consistent with typical 10-K structures, though not verifiable without document access, they do not detract from factual accuracy. (2) The answer fully addresses the multi-part question: it acknowledges the persistent role of low-cost debt (1.000% Notes) from 2022–2023 and the strategic introduction of higher-yield notes in 2024. The synthesis across years and instruments is sound. (3) Entity accuracy is strong: Coca-Cola is correctly identified, and the debt instruments are accurately named with correct yields and maturities. (4) The reasoning is logical and reflects a correct interpretation of capital structure evolution—shifting toward longer-term, higher-cost debt to manage maturities and fund strategic needs. The phrase 'more aggressive approach to debt-financing costs' is slightly stronger than the original's 'recalibration,' but it remains semantically reasonable. The only minor gap is less explicit mention of 'favorable market conditions' as a driver, though 'lock in rates' implies similar rationale. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 391,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe cutters across 2022, 2023, and 2024 reflect a strategic shift toward battery-powered and diagnostic-integrated tools, and what does this reveal about the company's positioning in the professional plumbing tools market?",
      "original_answer": "In 2022, Emerson's pipe cutters were described as part of a traditional suite of pipe-working tools used by plumbing professionals, with no emphasis on battery-powered or diagnostic capabilities. By 2023, the company began integrating battery hydraulic technology into pipe cutters, signaling a move toward more advanced, portable tools. In 2024, Emerson further evolved its offering by emphasizing diagnostic systems, including sewer inspection cameras and locating equipment, directly tied to its pipe cutters. This 3-year progression reveals a strategic pivot toward high-value, technology-enhanced tools aimed at improving productivity and safety in the professional plumbing sector.",
      "llm_answer": "Emerson’s pipe‑cutting line moved from a focus on press‑connection tools to fully battery‑powered, hydraulic cutting and crimping tools while adding integrated diagnostic systems.  In 2022 the portfolio included “battery hydraulic tools for press connections” and CCTV pipe‑inspection cameras (pages 7‑11), whereas 2023 and 2024 documents describe “battery hydraulic tools for cutting and crimping electrical cable” and “diagnostic systems, including sewer‑inspection cameras and locating equipment” (pages 71‑75).  This evolution signals a strategic push toward portable, tech‑enabled tools, positioning Emerson as an innovation‑driven leader in the professional plumbing tools market that differentiates itself with battery‑powered, diagnostic‑integrated solutions.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic shift toward battery-powered and diagnostic-integrated tools across 2022–2024 and accurately reflects Emerson's positioning in the professional plumbing tools market. However, it mischaracterizes the 2022 product focus by claiming the portfolio already included 'battery hydraulic tools for press connections' and 'CCTV pipe-inspection cameras' in that year, which contradicts the ground truth stating there was no emphasis on battery-powered or diagnostic capabilities in 2022. The ground truth indicates that integration began in 2023, not 2022. (2) There are no numeric values, dollar amounts, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are incorrect. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes evolution across years and identifies the strategic direction, but incorrectly backdates the introduction of battery-powered and diagnostic tools to 2022, undermining the accuracy of the progression. This misattribution affects the fidelity of the three-year evolution narrative. (4) Despite this key factual error, the overall conclusion about Emerson’s innovation-driven positioning and strategic pivot is aligned with the ground truth. The answer is well-structured and contextually relevant, but the misrepresentation of when the shift began reduces the qualitative and overall correctness scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 410,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has GILD's utilization of its Santa Monica, California facility evolved from 2022 through 2024, particularly in relation to clinical manufacturing and processing of cell therapy products, and what does this progression indicate about the facility's strategic role in GILD's manufacturing network?",
      "original_answer": "In 2022, GILD's Santa Monica facility was identified as part of its R&D and manufacturing network but was not specifically highlighted for cell therapy processing. By 2023, the facility was explicitly noted as being utilized for clinical manufacturing and processing of cell therapy products, aligning it with other specialized sites like El Segundo and Frederick. In 2024, the Santa Monica facility retained this role, indicating a continued strategic emphasis on its importance in GILD's cell therapy manufacturing footprint. This progression shows that Santa Monica transitioned from a general R&D site to a dedicated cell therapy manufacturing hub over the three-year period.",
      "llm_answer": "From 2022 through 2024, Gilead’s Santa Monica, California site has consistently been described as a location for **clinical manufacturing and processing of its cell‑therapy products** (2022 p. 31‑35; 2023 p. 9‑13; 2024 p. 8‑12). The unchanged role shows that the facility functions as a dedicated clinical manufacturing hub within Gilead’s broader network, supporting early‑stage development and clinical‑trial supply of cell‑therapy candidates rather than commercial production.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy in its core claim about the evolution of the Santa Monica facility's role. According to the ground truth, in 2022 the facility was part of GILD's R&D and manufacturing network but was *not specifically highlighted* for cell therapy processing. However, the LLM states that from 2022 through 2024 the site was consistently described as being used for clinical manufacturing and processing of cell therapy products, which contradicts the original answer. This misrepresents the evolution: the key point in the ground truth is that Santa Monica *transitioned* into a dedicated cell therapy role starting in 2023, not that it had a consistent role throughout. The LLM’s claim of an unchanged role over the three years directly conflicts with the documented progression from general R&D to specialized cell therapy hub. Quantitatively, there are no numbers or calculations to assess, so no errors there. Contextually, the answer addresses the question’s focus on clinical manufacturing and strategic role, and correctly identifies the facility’s current function. However, the failure to capture the temporal evolution — especially the absence of cell therapy emphasis in 2022 — undermines the multi-hop reasoning required to assess how the utilization changed over time. Thus, while the answer is well-structured and contextually relevant, it misses the central dynamic shift, resulting in a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 410,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolve from 2022 to 2024, particularly in terms of supported media types and cross-application collaboration features?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its strategic importance but without detailed functional description. By 2023, Frame.io was described as a cloud-native creative collaboration platform with support for still images, design files, and PDFs, and was integrated with Adobe Premiere Pro and After Effects for frame-specific feedback. In 2024, Frame.io's capabilities were expanded to include support for video beyond post-production workflows—such as casting, location scouting, and marketing campaign management—and was integrated with additional Adobe applications including Photoshop, Lightroom, and Workfront, as well as being positioned as part of Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "In 2022, Frame.io was described as a cloud‑native collaboration platform that was directly integrated with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront, enabling real‑time upload, review, approval and frame‑accurate commenting on video, still images, design files and PDFs 【2022‑pages 95‑99】. By 2024, Adobe expanded Frame.io’s media support to include camera‑to‑cloud uploads and still‑image camera integration, and positioned it as part of Adobe GenStudio with deeper ties to Express and Firefly Services, thereby broadening cross‑app collaboration and frame‑specific feedback across the entire Creative Cloud ecosystem 【2024‑pages 10‑14】.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, with significant factual inaccuracies in the timeline and integration details. (1) Correct elements: The 2024 expansion of Frame.io to include camera-to-cloud uploads, still-image camera integration, and positioning within Adobe GenStudio aligns with the ground truth. Mention of deeper ties to Express and Firefly Services is contextually plausible and relevant. (2) Incorrect elements: The LLM incorrectly states that in 2022, Frame.io was already integrated with Photoshop, Lightroom, and Workfront. According to the ground truth, these integrations were only realized by 2024. Additionally, the 2022 description inaccurately portrays Frame.io as already having real-time upload and frame-accurate commenting across multiple apps, while the ground truth only confirms trademark listing in 2022 with no detailed functional integration described. (3) Multi-hop reasoning: The model fails to correctly track the evolution over time—misattributing 2024 capabilities to 2022—indicating flawed synthesis across years. While it captures the direction of evolution, the chronological accuracy is compromised, undermining the multi-hop analysis. (4) Scoring justification: Quantitative accuracy is high because there are no numerical errors (dates are correct as cited, though misapplied). Qualitative accuracy is moderate due to incorrect entity-function mappings across time. Contextual relevance is high as the answer addresses media types and collaboration features. Correctness is scored at 5 due to major factual misplacement in the timeline despite some correct endpoint details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 448,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Emerson's (EMR) strategic positioning of Electrical Distribution Equipment evolve across its Discrete Automation segment from 2022 to 2024, particularly in terms of integration with automation technologies and product scope expansion?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as a foundational product within the Industrial Solutions business, used broadly in manufacturing operations as part of integrated solutions. By 2023, it was more specifically embedded within the Discrete Automation segment, appearing alongside programmable automation control systems and software, signaling a stronger link to automation technologies. In 2024, the equipment was further integrated into the Discrete Automation portfolio, now listed alongside electric linear motion solutions and materials joining solutions, indicating a broader product scope and deeper alignment with intelligent automation systems. This 3-year evolution shows EMR's strategic shift to position Electrical Distribution Equipment not just as a standalone offering, but as a core component of its smart, integrated automation solutions for discrete industries.",
      "llm_answer": "In 2022 Emerson’s electrical distribution equipment was bundled within the Industrial Solutions sub‑segment of Automation Solutions, where it was paired mainly with fluid‑control and pneumatic mechanisms (see 2022 pages 74‑78). By 2023 and 2024 Emerson spun off a dedicated Discrete Automation segment that broadened the product mix to include solenoid valves, pneumatic cylinders, electric linear‑motion solutions, programmable automation control systems and software, and integrated electrical distribution equipment (see 2023–2024 pages 71‑75). This shift reflects a deeper integration of electrical distribution equipment with automation technologies and a wider discrete‑automation portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core evolution described in the ground truth. (1) It correctly identifies the 2022 positioning of Electrical Distribution Equipment within Industrial Solutions and its shift into the newly formed Discrete Automation segment by 2023–2024. The integration with automation technologies (e.g., programmable automation control systems, software, electric linear-motion solutions) is accurately noted. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes changes across years and segments, correctly inferring strategic repositioning. One minor discrepancy: the ground truth does not mention a 'spin-off' of Discrete Automation, but rather a reorganization or repositioning; 'spun off' may inaccurately imply a legal or corporate divestiture, which is not supported. This slightly affects qualitative accuracy. (4) Despite wording differences (e.g., 'bundled', 'spun off'), the semantic meaning aligns closely with the original—equipment becomes more integrated with automation and part of a broader portfolio. Contextual relevance is perfect: all parts of the question (evolution, integration with automation, product scope expansion) are addressed with accurate, focused details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 389,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this progression suggest about the company's debt strategy in a rising interest rate environment?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further to 4.84% in 2024. This indicates a strategy of locking in long-term debt at increasingly higher rates as market conditions changed, suggesting a proactive approach to anticipated rate hikes.",
      "llm_answer": "Capital One’s fixed unsecured senior debt grew from a carrying value of **$19,975 million** at 12/31/2022 (weighted‑average rate 2.91%) to **$27,168 million** at 12/31/2023 (rate 4.45%) and then slightly declined to **$26,930 million** at 12/31/2024 (rate 4.84%)【COF_10k_2022.pdf】【COF_10k_2023.pdf】【COF_10k_2024.pdf】. The rising weighted‑average rate reflects the higher cost of new fixed‑rate issuances in a tightening rate environment, while the modest drop in 2024 suggests some repayment or refinancing; together, the pattern indicates a strategy of expanding fixed‑rate debt to fund growth while accepting higher rates and likely hedging interest‑rate exposure to manage cost volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) All numeric values — carrying values ($19,975M, $27,168M, $26,930M) and weighted-average interest rates (2.91%, 4.45%, 4.84%) — are exactly correct and match the ground truth across 2022–2024. Formatting variations (e.g., $19,975 million vs $19,975M) are acceptable and semantically equivalent. (2) The LLM correctly cites the source documents for each year, confirming multi-hop retrieval from COF’s 2022, 2023, and 2024 10-K filings. (3) The reasoning is sound: the answer correctly identifies the increase in debt and rising rates as indicative of a strategy to issue fixed-rate debt in a rising rate environment. It adds nuanced interpretation — the slight decline in 2024 may reflect repayment or refinancing — which is plausible and consistent with the data. It also introduces the idea of hedging interest-rate exposure, which is a reasonable extension of the proactive strategy mentioned in the ground truth. While this specific term ('hedging') is not in the original answer, it does not contradict it and adds context without introducing error. (4) The answer fully addresses all parts of the question: evolution of carrying value and interest rate, and interpretation of debt strategy. The only minor difference is that the LLM answer frames the strategy slightly more broadly (e.g., 'funding growth'), but this is inferable and does not detract from accuracy. Thus, quantitative accuracy is perfect (10), qualitative reasoning is excellent with slight elaboration beyond ground truth (9), and contextual relevance is complete (10). Correctness is 9 due to the added interpretation that, while reasonable, slightly extends beyond the original conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 459,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's liabilities related to performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities related to performance and operating cost guarantees remained relatively stable from 2022 through 2024, indicating consistent exposure to long-term product performance risks in its commercial aerospace segment. In 2022, the carrying amount of liabilities for these guarantees was $120 million. By 2023, the liability remained unchanged at $120 million, and in 2024, it slightly decreased to $101 million. This stability suggests that RTX's historical estimation methods and accrual adjustments based on claims data and product performance experience have remained effective, with no significant increase in risk exposure despite ongoing obligations tied to commercial aircraft engines.",
      "llm_answer": "RTX’s liability for performance‑and‑operating‑cost guarantees fell from $1.157 billion at the start of 2022 to $993 million by the end of 2024, a net decline of $164 million over three years.  Each year the balance dropped because settlements (2022 $284 m, 2023 $308 m, 2024 $247 m) exceeded new issuances (2022 $264 m, 2023 $305 m, 2024 $216 m), with a modest rise in “other” adjustments in 2024.  The trend shows RTX is actively managing and reducing its guarantee exposure, yet the remaining ~$1 billion balance still reflects substantial long‑term product‑performance risk inherent in its commercial aerospace portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The ground truth states that RTX's liabilities for performance and operating cost guarantees were $120 million in both 2022 and 2023, and decreased slightly to $101 million in 2024. In contrast, the LLM claims the liability started at $1.157 billion in 2022 and ended at $993 million in 2024—over 8 times higher than the actual figures. This massive discrepancy in scale renders the quantitative foundation of the answer invalid. (2) The LLM introduces detailed breakdowns of settlements and new issuances (e.g., $284M in settlements in 2022) that are not present in the ground truth and appear to be hallucinated. There is no mention in the original answer of such sub-components or cash flow dynamics. Additionally, the claim of a 'net decline of $164 million' from over $1.1 billion is unsupported and factually wrong. (3) The multi-hop reasoning is flawed because the model fails to correctly retrieve the basic liability amounts across years. While it attempts to explain trends (e.g., settlements exceeding new issuances), this analysis is based on fabricated data. The conclusion that RTX is 'actively managing and reducing exposure' contradicts the ground truth, which emphasizes stability and consistent risk exposure, not a strategic reduction. (4) Despite the factual inaccuracies, the answer is contextually relevant—it addresses the right company (RTX), the correct type of liability (performance and operating cost guarantees), and the commercial aerospace risk context. It also attempts a year-by-year trend analysis, which aligns with the question’s requirements. However, due to severe quantitative errors and incorrect reasoning based on non-existent data, the overall correctness score is very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 488,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did The Coca-Cola Company's reliance on 'estimates of sales proceeds' as a valuation methodology for nonpublic investments evolve from 2022 through 2024, and what does this reveal about the company's changing approach to fair value assessment in emerging markets?",
      "original_answer": "In 2022, Coca-Cola disclosed the use of 'estimates of sales proceeds' as part of its valuation methodology for nonpublic investments, specifically in the context of impairment assessments where quoted market prices were unavailable. By 2023, the company explicitly stated that it 'relies on' this methodology as a key component of fair value determination for equity and debt securities in nonpublic entities, signaling a deepening dependence on this approach. In 2024, Coca-Cola continued to 'use' estimates of sales proceeds alongside discounted cash flows and appraisals, but with an increased emphasis on the challenges of predicting future cash flows—particularly in emerging and developing markets—suggesting a more cautious application of the methodology over time. This 3-year progression reflects a strategic evolution from disclosure to operational reliance, followed by a risk-aware integration of the method into broader valuation practices.",
      "llm_answer": "Coca‑Cola’s 10‑K notes for 2022, 2023 and 2024 all describe the same valuation framework for non‑public investments: “management’s assessment of fair value is based on various valuation methodologies, including discounted cash flows, estimates of sales proceeds, and appraisals.” The wording and emphasis on “estimates of sales proceeds” did not change across the three years, indicating that the company has continued to rely on this method as part of a diversified, conservative fair‑value approach. This consistency underscores Coca‑Cola’s ongoing commitment to careful valuation in emerging markets, where forecasting cash flows is particularly uncertain and multiple techniques are needed to mitigate risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that Coca-Cola's disclosure and reliance on 'estimates of sales proceeds' remained unchanged from 2022 to 2024. The ground truth shows a clear evolution: in 2022, the method was disclosed as part of impairment assessments; in 2023, the company explicitly stated it 'relies on' this methodology, indicating increased dependence; and in 2024, while still used, there was greater emphasis on the challenges of applying it in emerging markets, reflecting a more cautious, risk-aware approach. The LLM incorrectly asserts that the wording and emphasis did not change, contradicting the documented progression. While the entities (Coca-Cola, nonpublic investments, valuation methods) and years (2022–2024) are correctly identified, and no numerical data is misstated (hence full quantitative accuracy), the qualitative analysis fails entirely on reasoning and synthesis. The model misses the multi-hop progression—disclosure to reliance to cautious integration—and instead asserts stability where there was strategic evolution. This undermines the answer’s ability to address the question about changing approaches to fair value assessment in emerging markets. The contextual relevance is moderate because it discusses fair value methods and emerging market uncertainty, but it draws the wrong conclusion about change over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 380,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did BNY Mellon's disclosures regarding capital return limitations under U.S. banking laws evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's strategic flexibility in shareholder capital distributions?",
      "original_answer": "In 2022, BNY Mellon disclosed that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law, and its failure to pay full and timely dividends on preferred stock. This language was repeated in 2023 and 2024, showing a consistent regulatory constraint over the three-year period. However, the 2024 disclosure added a new emphasis on the Parent's dependency on dividends from subsidiaries and extensions of credit from its IHC to fund share repurchases and dividends, indicating a growing focus on internal capital flows under continued regulatory scrutiny. This three-year progression suggests that despite stable regulatory language, BNY Mellon faced ongoing limitations in capital return flexibility, with increasing internal structural dependencies shaping its shareholder return strategy.",
      "llm_answer": "BNY Mellon’s 10‑K risk‑factor disclosures have remained essentially unchanged from 2022 through 2024: each filing states that the company’s ability to return capital to shareholders is subject to the Board’s discretion and may be limited by U.S. banking laws and regulations, including capital‑planning rules (2022, p. 5; 2023, p. 7; 2024, p. 7). The wording has not evolved materially, only adding a brief note that Delaware law and preferred‑stock dividend obligations also apply. This steady, unaltered language signals that while regulatory constraints continue to govern capital distributions, BNY Mellon preserves strategic flexibility to adjust its capital‑return policy within those limits.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that BNY Mellon's disclosures regarding capital return limitations remained largely consistent from 2022 to 2024 and cites U.S. banking laws, capital-planning rules, Delaware law, and preferred stock obligations—elements present in the original answer. However, it misses a key qualitative evolution noted in the 2024 filing: the new emphasis on the Parent’s dependency on dividends from subsidiaries and extensions of credit from its IHC (Intermediate Holding Company) to fund share repurchases and dividends. This omission is significant because the question specifically asks about the evolution and what it suggests about strategic flexibility. Instead, the LLM concludes that the 'unaltered language' signals preserved strategic flexibility, which contradicts the original answer’s conclusion that structural dependencies are increasing under continued constraints. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—no errors here. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes the repeated language across years but fails to identify the nuanced addition in 2024 that changes the interpretation of strategic flexibility. This weakens the reasoning chain, especially for the second part of the question. (4) The contextual relevance is high because the answer addresses the core topic and timeframe, but the failure to capture the evolving internal capital dependency limits its accuracy. Correctness and qualitative accuracy are scored lower due to the misleading conclusion about strategic flexibility despite ongoing and structurally deepening constraints.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 468,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 to 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD consistently highlighted the risk of losing or having modified tax and tariff exemptions as a key concern in its global operations. In 2022, this risk was listed among other geopolitical and economic risks, indicating a general awareness of its potential impact. By 2023, AMD expanded its discussion to include the effects of specific geopolitical events, such as the conflict in Ukraine and tensions between China and Taiwan, which heightened the likelihood of regulatory shifts affecting exemptions. In 2024, the company reiterated this risk in the context of broader macroeconomic and political instability, including the expansion of U.S. export controls and sanctions, suggesting that the regulatory landscape had become more volatile and complex. This progression indicates that AMD's exposure to the risk of losing tax and tariff exemptions has increased over time, driven by both internal expansion and external geopolitical pressures.",
      "llm_answer": "AMD’s 2022 10‑K (p. 35‑39) listed the risk of losing tax and tariff exemptions as part of its general political, legal and economic risks. The 2023 10‑K (p. 39‑43) repeated that risk but added a focus on sanctions and export‑control revisions that could affect those exemptions. By 2024 (p. 38‑42) the disclosure expanded further to cite specific geopolitical conflicts (e.g., Russia‑Ukraine, China‑Taiwan) and new sanctions that heighten the likelihood of losing tax and tariff exemptions, underscoring an increasingly complex and volatile regulatory environment for AMD’s global operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key facts are correct: AMD consistently reported the risk of losing tax and tariff exemptions from 2022 to 2024, with increasing specificity. In 2022, it was part of general risks; in 2023, linked to export controls and sanctions; in 2024, tied to specific geopolitical conflicts (Russia-Ukraine, China-Taiwan). These details match the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not applicable in that sense, but the years (2022, 2023, 2024) and page numbers (p. 35–39, etc.) are correctly cited and consistent with the expected format—minor variations in page ranges are acceptable and do not affect factual accuracy. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of 10-K filings, identifying the evolution in risk disclosure and linking it to increasing regulatory complexity. The conclusion about a more volatile and complex environment is logically supported. (4) The only reason for not giving a perfect 10 is a slight omission in explicitly stating that this trend reflects both internal (AMD’s global expansion) and external (geopolitical) factors, as noted in the original answer. However, the mention of 'new sanctions' and 'geopolitical conflicts' implies the external drivers sufficiently. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 425,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does this progression reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then declined slightly to $45.551 billion in 2024. This trajectory reflects a significant shift in debt composition: in 2022, floating unsecured senior debt stood at $1.709 billion with a weighted-average interest rate of 1.01%, rising sharply in 2023 to $349 million with a much higher rate of 6.75%, and then dropping to $0 in 2024 as the company eliminated this category. Meanwhile, fixed unsecured senior debt increased from $27.168 billion in 2023 to $26.930 billion in 2024 (from $21.045 billion in 2022), with a rising weighted-average interest rate from 2.91% in 2022 to 4.84% in 2024. This evolution indicates a strategic pivot from floating to fixed-rate debt to mitigate interest rate risk in a rising rate environment.",
      "llm_answer": "Capital One’s total short‑term borrowings fell from $883 million in 2022 to $538 million in 2023, then rose modestly to $562 million in 2024. Long‑term debt stayed at $49.3 billion in 2022‑23 but declined to $44.99 billion in 2024, so total borrowings dropped from $49.86 billion to $45.55 billion. The elimination of $349 million of floating‑rate unsecured senior debt in 2024 and the shift to lower‑rate fixed‑senior and subordinated debt (weighted‑average long‑term rate fell from 6.51% to 5.72%) show a deliberate move to reduce interest‑rate sensitivity and tighten the debt mix.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, total short-term borrowings and long-term debt were $43.086B in 2022, $49.856B in 2023, and $45.551B in 2024. The LLM incorrectly reports total borrowings as $49.86B in 2022 (close to 2023 truth), ignores the 2023 increase, and misrepresents short-term borrowings as $883M in 2022 when the truth is not provided at that granularity—moreover, the ground truth does not break out short-term borrowings separately, so the LLM’s specific short-term figures ($883M, $538M, $562M) are unsupported and likely fabricated. The LLM also misstates long-term debt: it claims $49.3B in 2022–2023, but ground truth implies long-term debt was $21.045B in 2022 and $27.168B in 2023 (plus floating debt), indicating a major overstatement. (2) The floating unsecured senior debt is reported as $349M in 2023 and eliminated in 2024, which aligns with the ground truth, but the LLM omits the 2022 value ($1.709B) and misrepresents the trend (it was reduced from $1.709B to $349M, not introduced in 2023). The LLM incorrectly claims the weighted-average long-term rate fell from 6.51% to 5.72%, while ground truth shows fixed unsecured senior debt rates rose from 2.91% to 4.84%, and no overall rate decline is indicated. (3) The multi-hop reasoning is partially sound in identifying a shift away from floating-rate debt in 2024, but the conclusion about shifting to 'lower-rate' debt contradicts the truth—rates increased due to rising environment, and the pivot was to fixed-rate, not lower-rate, debt. The strategic interpretation is plausible but based on incorrect data. (4) Scores reflect major quantitative errors (2/10), weak qualitative reasoning due to flawed data synthesis (4/10), moderate contextual relevance as it addresses debt structure and interest rate exposure (7/10), and low overall correctness (3/10) due to incorrect core figures and misleading trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 534,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's net program share interest in International Aero Engines AG (IAE) evolve from 2022 to 2024, and what does this change indicate about RTX's strategic positioning within the V2500 engine program collaboration?",
      "original_answer": "RTX's net program share interest in IAE decreased from 61% in 2022 to 57% in both 2023 and 2024, indicating a strategic adjustment in its collaboration structure. This reduction suggests that RTX gradually diluted its direct economic exposure to the V2500 engine program over the three-year period, potentially shifting more of the program's financial burden or risk to sub-collaborators while maintaining operational coordination.",
      "llm_answer": "RTX’s net program share interest in International Aero Engines AG remained unchanged at **57 %** (with a 51 % share in IAE LLC) from 2022 through 2024【RTX_10k_2022.pdf p.108‑112】【RTX_10k_2024.pdf p.99‑103】, indicating that RTX has maintained a stable, significant influence as the primary beneficiary in the V2500 engine‑program collaboration.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect regarding the quantitative evolution of RTX's net program share interest. The ground truth states that RTX's interest decreased from 61% in 2022 to 57% in 2023 and 2024, but the LLM claims it remained constant at 57% throughout 2022–2024. This misrepresents the trend entirely, missing the key decrease in 2022. (2) The cited documents (RTX_10k_2022.pdf and RTX_10k_2024.pdf) should have shown the 61% figure for 2022, but the model either misread or failed to retrieve this data. The 57% figure for 2024 is correct, but the lack of change contradicts the actual reduction. No calculation is needed beyond comparison across years, and even this basic comparison is flawed. (3) The multi-hop reasoning fails because the model did not synthesize the change over time across filings—it incorrectly assumed consistency. The conclusion about 'stable influence' contradicts the ground truth interpretation that RTX was strategically reducing its economic exposure. (4) While the answer addresses the question's structure and mentions relevant entities (IAE, V2500, RTX), the core factual error in the percentage trend severely undermines the correctness. The contextual relevance is moderate because it discusses the right program and metric, but the incorrect data renders the analysis invalid. Thus, low scores for correctness, quantitative, and qualitative accuracy are warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 396,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Cascade's positioning within P&G's home care portfolio evolved from 2022 to 2024, based on its segment reporting across the three most recent 10-K filings?",
      "original_answer": "Cascade has maintained consistent positioning within P&G's Home Care sub-category under the Fabric & Home Care segment across all three reporting periods. In 2022, Cascade was listed among key brands in the Home Care category within the Fabric & Home Care segment which represented 35% of net sales and 31% of net earnings. In 2023, the Fabric & Home Care segment maintained its prominence at 36% of net sales and 34% of earnings, continuing to feature Cascade among its major brands. By 2024, Cascade remained a core brand in the Home Care sub-category while the segment held steady at 36% of net sales and 34% of earnings. This consistency suggests Cascade has maintained stable strategic importance within P&G's portfolio despite the segment's slight earnings contribution increase from 31% to 34% over the period.",
      "llm_answer": "Cascade’s role within P&G’s home‑care portfolio has grown in relative importance.  In the 2022 filing the Fabric & Home Care segment accounted for 35 % of net sales and 31 % of net earnings; by 2023 and 2024 that share rose to 36 % of sales and 34 % of earnings, reflecting a mid‑single‑digit sales lift and a sharper earnings contribution.  These shifts indicate that Cascade, as a key brand in the segment, has become more prominent and profitable within P&G’s home‑care lineup.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly reports the percentages for the Fabric & Home Care segment across 2022 (35% net sales, 31% net earnings), 2023 (36% sales, 34% earnings), and 2024 (same as 2023), which matches the ground truth. These numbers are accurate and properly attributed to the correct years. 2) Quantitatively, all figures are correct, including the segment's sales and earnings contributions. The description of a 'mid-single-digit sales lift' is a reasonable qualitative interpretation of the 1 percentage point increase in sales contribution, though not explicitly verifiable from the data provided. The earnings increase from 31% to 34% is accurately noted. 3) The reasoning contains a subtle but important misstep: while the segment's earnings contribution increased, the ground truth emphasizes that Cascade's *positioning* remained 'consistent' and 'stable' within the portfolio. The LLM concludes that Cascade's role 'has grown in relative importance' and that it has 'become more prominent and profitable', which overinterprets the data. The filings do not provide brand-level financials to support increased profitability or prominence of Cascade specifically—only that it remained a key brand in a slightly more profitable segment. This misattributes segment-level trends to the brand without sufficient evidence. 4) Despite this overinterpretation, the answer is contextually relevant, addresses the evolution over the three years, and correctly synthesizes segment-level data. It misses the nuance of Cascade's stable strategic role as emphasized in the ground truth, but retains core factual accuracy. Hence, correctness is reduced to 7 due to flawed reasoning in drawing brand-level conclusions from segment data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 469,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did BNY Mellon's disclosures regarding the accessibility and governance of its Directors' Code of Conduct evolve from 2022 to 2024, particularly in terms of URL structure, domain branding, and integration with broader corporate governance frameworks?",
      "original_answer": "In 2022, BNY Mellon provided a URL for the Directors' Code of Conduct under the legacy domain structure (bnymellon.com), specifically pointing to a '/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf' path, indicating a siloed and document-focused approach. In 2023, the company maintained the same domain but slightly adjusted the URL path to '/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf', suggesting minor internal reorganization but no significant change in accessibility or integration. By 2024, BNY Mellon transitioned to a new domain branding ('bny.com') and updated the URL structure to '/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf', aligning the Directors' Code of Conduct more closely with investor relations and signaling a more strategic integration into corporate governance communication. This evolution reflects a shift from a static document repository to a more stakeholder-oriented, brand-consistent governance disclosure strategy.",
      "llm_answer": "From 2022 to 2024 BNY Mellon shifted the Directors’ Code of Conduct from a “bnymellon.com” site to the shorter “bny.com” brand and moved the PDF into a more formal “investor‑relations” folder (2022: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors‑code‑of‑conduct.pdf; 2023: …/inv relations/directors‑code‑of‑conduct.pdf; 2024: https://www.bny.com/content/dam/bnymellon/documents/pdf/investor‑relations/directors‑code‑ofconduct.pdf). The 2024 filing also ties the code to the broader corporate‑governance framework by citing it in the governance section of the proxy and noting that amendments will be posted on the website, thereby integrating the code more fully into the company’s governance disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures all key aspects of the evolution in BNY Mellon's disclosure practices from 2022 to 2024. (1) It correctly identifies the domain shift from 'bnymellon.com' to 'bny.com' in 2024 and the progressive changes in URL path: from '/in relations' (2022) to '/inv relations' (2023) to '/investor-relations' (2024), matching the ground truth. Minor formatting differences in the URLs (e.g., spacing vs. hyphens like 'in relations' vs 'investor-relations') are acceptable as they reflect plausible variations in rendering. (2) All dates (2022, 2023, 2024) and entities (BNY Mellon, Directors’ Code of Conduct, investor relations) are correct. No numerical data is present, but the timeline and document locations are factually consistent. (3) The multi-hop reasoning is sound: the model synthesizes changes in domain branding, URL structure, and integration with corporate governance across three years. It correctly infers that the 2024 changes reflect deeper integration by noting the code’s citation in the proxy statement and the policy on posting amendments—details that signal improved governance transparency and stakeholder orientation. (4) The only minor shortcoming is that the LLM does not explicitly characterize the overall strategic shift (e.g., from siloed document repository to stakeholder-oriented strategy), which is present in the original answer. However, the evidence for that conclusion is accurately reported. Thus, the answer is semantically equivalent and contextually fully relevant, meriting a high score with only a slight deduction in qualitative accuracy for missing the synthesized interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 452,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did AMD's strategic positioning with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently maintained inventory protection policies for AIB manufacturers, ensuring their stock was shielded from price reductions. In 2022, AMD emphasized the role of AIBs in building board-level products for system integrators and retail buyers, with discrete graphics as a key differentiator. By 2023, this positioning remained stable, with continued focus on enabling SIs to differentiate through discrete graphics. In 2024, AMD reiterated the same inventory protections and highlighted the continued importance of discrete graphics solutions as a value-add for SIs. The consistency in policy and strategic emphasis on discrete graphics suggests a stable, long-term partnership model with AIBs across the three-year period.",
      "llm_answer": "AMD’s strategy toward AIB manufacturers stayed essentially the same from 2022 through 2024: it continued to offer inventory‑protection clauses that shield AIBs from price reductions and kept emphasizing discrete‑graphics solutions as a key differentiation lever for system integrators. The identical wording appears in the 2022, 2023 and 2024 10‑Ks (AMD_10k_2022, pp. 9‑13; AMD_10k_2023, pp. 11‑15; AMD_10k_2024, pp. 9‑13).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately captures that AMD maintained consistent inventory protection policies for AIB manufacturers from 2022 to 2024, shielding them from price reductions—this matches the original answer's key point. It also correctly identifies the strategic role of discrete graphics solutions as a differentiator for system integrators across all three years. (2) There are no numerical values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not applicable in a traditional sense; however, the cited years (2022–2024) and document references (10-K filings) are accurate and correctly attributed. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of AMD 10-K filings, correctly identifying consistency in language and strategy over time, which reflects proper cross-document synthesis. (4) The answer is contextually highly relevant, directly addressing both parts of the question—evolution of strategic positioning, including inventory protection and the role of discrete graphics. The mention of identical wording across 10-Ks strengthens the conclusion of strategic consistency. Minor stylistic differences (e.g., 'essentially the same' vs. 'stable, long-term partnership') do not affect factual equivalence. All entities—AMD, AIB manufacturers, system integrators, discrete graphics—are correctly identified and used in context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 411,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's disclosure around breakfast menu innovation and supply chain focus evolve from 2022 to 2024, particularly in relation to the Egg McMuffin and its role in meeting customer expectations for quality and consistency?",
      "original_answer": "In 2022, McDonald's disclosed that it offers the Egg McMuffin as part of a full or limited breakfast menu and emphasized its ongoing menu evolution to meet customer expectations around taste, quality, and nutrition. In 2023, the company reiterated the presence of the Egg McMuffin but expanded its narrative around innovation and supply chain collaboration, noting its comprehensive global supply chain strategy led by the Global Chief Supply Chain Officer and a focus on continuous improvement across the supply chain. By 2024, McDonald's placed a stronger emphasis on digital transformation in food safety and quality, with specific mention of a digital transformation project aimed at promoting data excellence and continuous measures on quality and food safety performance, which supports the consistency of core menu items like the Egg McMuffin. This evolution shows a shift from general quality assurance to a more technologically integrated and supply chain-driven approach to maintaining product consistency and meeting customer expectations.",
      "llm_answer": "In 2022 McDonald’s highlighted its breakfast menu—including the Egg McMuffin—as part of a broader effort to evolve its menu while maintaining high food‑safety and quality standards across suppliers. By 2023 the disclosure shifted to a stronger emphasis on supply‑chain innovation and continuous improvement, positioning the Egg McMuffin as a flagship product that exemplifies the company’s commitment to consistent quality. In 2024 the focus expanded further to a digital‑transformation initiative that uses data‑driven quality and food‑safety metrics to manage supply‑chain risk, reinforcing the Egg McMuffin’s role in meeting customer expectations for quality and consistency.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in McDonald's disclosures from 2022 to 2024 regarding the Egg McMuffin, supply chain focus, and quality consistency. (1) All factual elements are correct: in 2022, McDonald’s emphasized menu evolution and quality standards; in 2023, it highlighted supply chain innovation and continuous improvement with the Egg McMuffin as a consistent quality product; in 2024, it introduced digital transformation for data-driven food safety and quality—directly supporting the consistency of core items like the Egg McMuffin. (2) There are no numeric values to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound: the answer synthesizes information across three years and connects the Egg McMuffin to broader strategic shifts in supply chain and digital transformation. The only minor gap is that the original answer specifies the Global Chief Supply Chain Officer’s role in 2023 and the explicit 'data excellence' initiative in 2024, which the LLM omits but does not contradict—this slight lack of specificity prevents a perfect 10 on qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing how disclosures evolved in relation to the Egg McMuffin and customer expectations for quality and consistency. Overall, the LLM conveys semantically equivalent information with excellent fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 386,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What does the consistent disclosure of Oracle's 4.30% Note due 2034 in its filings for 2022, 2023, and 2024 indicate about the company's long-term debt structure and financing priorities across these reporting periods?",
      "original_answer": "Oracle's 4.30% Note due 2034 was disclosed in filings for all three years — 2022, 2023, and 2024 — indicating that the instrument remained a persistent and notable component of Oracle’s long-term debt portfolio. In 2022, the note was listed alongside other instruments such as the 3.625% Note due 2023 and the 4.50% Note due 2044, suggesting a diversified maturity profile. In 2023, the 4.30% Note due 2034 was disclosed alongside newer instruments like the 2.950% Notes due 2024, showing Oracle’s continued reliance on long-dated debt while also issuing shorter-term instruments. In 2024, the note remained included in disclosures, reinforcing its ongoing relevance in Oracle’s capital structure. This consistent inclusion suggests Oracle has maintained a strategic focus on long-term financing, with the 4.30% Note due 2034 serving as a stable element within a broader, evolving debt portfolio.",
      "llm_answer": "Oracle’s repeated reporting of the 4.30% Note due 2034 in its 2022, 2023, and 2024 10‑Ks (pp. 111‑115, 108‑112, 108‑112) shows that the note is a core, long‑term debt instrument in the company’s capital structure. The fixed‑rate, 10‑year maturity is embedded in a diversified mix of notes with varying coupons and maturities, reflecting Oracle’s strategy of securing stable, predictable financing to support capital expenditures, acquisitions, and working‑capital needs. This continuity across reporting periods signals a deliberate, long‑term financing priority rather than ad‑hoc borrowing.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in all quantitative aspects: the 4.30% interest rate and 2034 maturity date are correct, and the note's presence in Oracle's 2022, 2023, and 2024 filings is properly acknowledged. There are no numerical or date inaccuracies. The answer correctly identifies the note as a persistent, long-term component of Oracle’s debt structure, aligning with the ground truth. However, the LLM response lacks the multi-hop synthesis present in the original answer—specifically, it does not reference the other debt instruments disclosed alongside the 4.30% Note in each year (e.g., the 3.625% Note due 2023 in 2022, or the 2.950% Notes due 2024 in 2023), which are key to demonstrating Oracle’s diversified maturity profile and evolving debt strategy. While the LLM infers a strategic focus on long-term financing (which is valid), it misses the opportunity to show how the 4.30% Note fits within a broader, changing portfolio across years. The reasoning is sound but less detailed in comparative analysis. The mention of '10-year maturity' is slightly misleading since the note was issued in 2024 (implied by inclusion in 2024 filing) and matures in 2034—this is accurate only if issued in 2024, but the original answer does not confirm issuance date, so this is a minor assumption. Overall, the answer is contextually relevant, well-reasoned, and factually correct, but omits specific cross-year instrument comparisons that strengthen the multi-hop conclusion in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 412,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation methodology and fair value amounts evolve from 2022 to 2024, and what does this reveal about the company's exposure to unobservable market inputs over time?",
      "original_answer": "In 2022, Capital One reported net derivative assets/liabilities at a fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end. By 2023, the fair value of net derivative assets/liabilities was disclosed at $58 million, with unobservable inputs including default rates (53–163%) and swap rates (3–5%) factored into the valuation. In 2024, the company maintained the same $58 million fair value for net derivative assets/liabilities, with continued reliance on swap rates (3–5%) as a key unobservable input. This indicates a transformation in valuation methodology from a mixed realized/unrealized loss position in 2022 to a more stable fair value by 2023–2024, with increasing transparency and reliance on structured unobservable inputs, particularly swap rates, signaling a more defined risk profile around derivative exposures.",
      "llm_answer": "Capital One values most of its derivatives with vendor‑based models that use observable inputs (yield curves, credit curves, volatility, currency rates) but classify any instrument whose key inputs are unobservable as Level 3, applying credit‑risk adjustments and cross‑checking internal pricing against external valuation agents.  The Level 3 net derivative assets (liabilities) fell to $5 million at year‑end 2022, jumped to $58 million at year‑end 2023, and rose modestly to $69 million at year‑end 2024, showing a growing share of its derivative portfolio that relies on significant unobservable inputs.  This upward trend in Level 3 balances indicates increasing valuation uncertainty and exposure to inputs that are not directly observable in liquid markets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, Capital One's net derivative assets/liabilities fair value was $19 million in 2022, $58 million in 2023, and remained at $58 million in 2024. However, the LLM incorrectly states the 2022 amount as $5 million (Level 3 net derivatives), the 2023 amount as $58 million (correct), and the 2024 amount as $69 million (incorrect; should be $58 million). These numerical discrepancies are material and undermine the answer's reliability. Additionally, the ground truth mentions unobservable inputs such as default rates (53–163%) and swap rates (3–5%) in 2023 and 2024, which are entirely absent in the LLM response. Instead, the LLM generalizes about Level 3 classification without citing these specific inputs. (2) The calculation and trend analysis are flawed: the LLM suggests a steady increase from $5M to $58M to $69M, implying growing exposure and uncertainty. But the actual data shows stability from 2023 to 2024 ($58M), contradicting the 'rising modestly' claim. The ground truth also notes a shift in methodology transparency and stabilization of valuation, which the LLM fails to capture. (3) Multi-hop reasoning is partially present—the LLM attempts to link valuation methodology to unobservable inputs over time—but it misrepresents the evolution due to incorrect numbers and missing specifics. It introduces 'Level 3' classification not mentioned in the original answer, which may be contextually relevant but distracts from the actual disclosed metrics. (4) While the LLM addresses the general theme of unobservable inputs and valuation changes, the severe quantitative errors and omission of key details (e.g., unrealized losses in 2022, specific input ranges) result in a low correctness score. Contextual relevance is moderate because the structure and intent align with the question, but factual fidelity is poor.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 527,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of payment structure and amortization strategy related to the V2500-powered aircraft flight hours?",
      "original_answer": "From 2022 through 2024, RTX's financial obligations to Rolls-Royce remained tied to flight hours of V2500-powered aircraft through a long-term payment structure established in the 2012 acquisition of Rolls-Royce’s stake in IAE. In 2022, these payments were described as contingent liabilities included in 'Other commercial aerospace commitments' and were to be capitalized as collaboration intangible assets as payments were made. By 2023, RTX clarified that these flight-hour payments were being capitalized as collaboration assets and amortized to cost of sales. In 2024, the total commercial aerospace financing and other commitments stood at $14.1 billion, with Rolls-Royce payments still structured on a per-hour-flown basis through June 2027. The amortization policy remained consistent, but the transparency around how these payments were integrated into intangible asset management improved over time.",
      "llm_answer": "RTX’s flight‑hour payments to Rolls‑Royce have remained a per‑hour, cash‑based obligation that is capitalized as a collaboration intangible asset and amortized to cost of sales.  The total flight‑hour commitment fell from about $1.05 billion in 2022 (see the “Other commercial aerospace commitments” table on pages 110‑114 of the 2022 10‑K) to roughly $0.77 billion in 2024 (see the same table on pages 101‑105 of the 2024 10‑K).  The payment structure and amortization policy—capitalizing each payment and spreading it over the life of the V2500 program—remained unchanged through 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth does not specify dollar amounts for the Rolls-Royce flight-hour payments in 2022 or 2024, nor does it state a decline from $1.05 billion to $0.77 billion. Instead, the ground truth states that in 2024, RTX's total commercial aerospace financing and other commitments were $14.1 billion — a figure that includes, but is not limited to, the Rolls-Royce payments. The LLM incorrectly isolates and quantifies the Rolls-Royce portion as $1.05B and $0.77B without support in the original answer, introducing fabricated numbers. (2) These specific dollar figures cannot be verified against the ground truth and appear to be misinterpretations of broader commitment categories in the 10-K tables. The original answer makes no mention of a reduction in the Rolls-Royce-specific obligation, nor provides exact figures for those payments. (3) Qualitatively, the LLM correctly identifies the payment structure (per-hour, tied to flight hours), the capitalization as collaboration intangible assets, and amortization to cost of sales — which aligns with the evolution described in the ground truth from 2022 to 2024. It also correctly notes the consistency of the amortization policy. However, it fails to mention the 2012 IAE acquisition context and the June 2027 end date for the payment structure, which are key elements in the multi-hop synthesis. (4) Contextually, the answer is relevant and addresses the core of the question regarding payment structure and amortization. The reasoning is partially sound but undermined by unsupported numerical claims. The correctness score is low due to the high-stakes error of introducing precise financial figures not present in the ground truth, which misrepresents the factual record.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 491,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Amgen's disclosures regarding user complaints and risk mitigation for the Neulasta Onpro kit evolve from 2022 through 2024, particularly in terms of device-related enhancements and operational resilience measures?",
      "original_answer": "Amgen’s disclosures show a consistent focus on user complaints related to the Neulasta Onpro kit across all three years. In 2022, Amgen referenced the 2017 FDA evaluation of the device and described how it implemented device and labeling enhancements in response to product complaints. In 2023, Amgen reiterated these enhancements and emphasized its ongoing monitoring of complaints and adverse events, indicating a sustained commitment to device safety and regulatory compliance. By 2024, Amgen expanded its disclosures to include operational resilience measures, noting that it had relied on backup generators multiple times due to Puerto Rico's unstable electric grid, including during an island-wide outage on December 31, 2024. While the core risk of device-related complaints remained consistent, Amgen’s disclosures evolved to include broader operational risks, such as infrastructure instability, which could affect device production and thus indirectly influence user experience and complaints.",
      "llm_answer": "Amgen’s 2022 10‑K (pp. 49‑53) disclosed that the FDA had been evaluating the Neulasta Onpro kit after user complaints and that the company had implemented device‑ and labeling‑enhancements to address those complaints, noting it would continue to monitor and add enhancements as needed. The 2023 filing (pp. 53‑57) reiterated this approach, adding that further device‑ and labeling changes had been made and that the company maintained operational resilience through backup power and supply‑chain safeguards for its manufacturing facilities. In the 2024 filing (pp. 52‑56) Amgen again emphasized continuous monitoring of user complaints and additional device‑ and labeling‑enhancements, while underscoring its broader operational‑resilience strategy—including backup generators and supply‑chain continuity measures—to mitigate disruptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Amgen's disclosures in 2022 referenced FDA evaluation and implementation of device and labeling enhancements in response to user complaints; in 2023, the company reiterated these actions and emphasized ongoing monitoring; by 2024, operational resilience measures such as backup generators were highlighted. (2) There are no numeric inaccuracies—while no specific financial figures are involved, the dates and sequence of disclosures (2022–2024) are correctly presented. The mention of the December 31, 2024 island-wide outage in the ground truth is a specific detail not included in the LLM answer, but the broader point about reliance on backup generators due to Puerto Rico's unstable grid is captured in substance. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly tracing the evolution from device-focused risk mitigation to broader operational resilience. (4) The LLM slightly generalizes the 2024 operational resilience context (e.g., doesn't explicitly tie backup generators to Puerto Rico’s grid instability or the Dec 31 outage), but the core evolution in disclosure focus is accurately conveyed. Wording differs but semantic meaning matches. Minor omission prevents a perfect 10, but overall correctness is very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 385,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistent mention of KPMG's PCAOB firm number 185 across all three filings suggest about BK's audit governance continuity?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in each of the 2022, 2023, and 2024 filings, with no substantive changes in the structure or framing of the disclosure across the years. In all three years, KPMG LLP's PCAOB firm identification number was explicitly stated as 185, indicating no change in the external audit firm responsible for financial reporting. This consistency suggests that BK maintained stable audit governance practices over the three-year period, with no indication of auditor rotation or changes in external audit oversight. The unchanged PCAOB number further confirms the ongoing relationship with KPMG, signaling continuity and potentially strong institutional trust in the firm’s audit services.",
      "llm_answer": "BK’s 10‑K filings show no change in the ratification language: each year (2022, 2023, 2024) the “Item 14 – Principal Accountant Fees and Services” section simply states that KPMG LLP is the principal accountant and cites its PCAOB firm identification number 185 (see pages 11‑15 of 2022, 12‑16 of 2023, and 12‑16 of 2024). The unchanged reference to the same PCAOB number across all three filings signals that BK has retained the same audit firm and, by extension, a stable audit‑governance relationship over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All entities—BK, KPMG LLP, PCAOB firm number 185, and the years 2022–2024—are correctly identified. The disclosure is consistently tied to Item 14 across all filings, and the page numbers cited (e.g., 11–15 in 2022, 12–16 in 2023 and 2024) are plausible and contextually appropriate. (2) There are no numerical values requiring calculation, but the PCAOB number 185 is correctly and consistently reported across all years, matching the ground truth exactly. (3) The multi-hop reasoning is sound: the model correctly infers from the unchanged PCAOB number and consistent disclosure language that BK maintained a continuous relationship with KPMG, indicating stable audit governance. This synthesis across three years of filings is valid. (4) While the LLM answer captures the core conclusion about audit governance continuity, it omits a minor but relevant nuance present in the original answer: the explicit mention that there were 'no substantive changes in the structure or framing' of the disclosure, and the interpretation that this reflects 'strong institutional trust.' These are qualitative enrichments rather than factual gaps, so the omission does not undermine correctness. Overall, the answer is semantically equivalent and highly accurate, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 402,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk management strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees showed a gradual decline in the collaboration partners' share of these guarantees over the three-year period. In 2022, the collaboration partners' share was $142 million, which decreased to $135 million in 2023 and further dropped to $131 million in 2024. This consistent downward trend indicates a strategic reduction in shared financial risk with partners, potentially reflecting a shift in how RTX structures its aerospace financing arrangements or a deliberate move to reduce contingent liabilities. Throughout this period, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the value of the guarantees net of reserves, suggesting continued confidence in the underlying asset values despite reducing exposure.",
      "llm_answer": "RTX’s maximum potential exposure to commercial‑aerospace customer‑financing guarantees fell from **$304 million in 2022 to $274 million in 2024** (Note 18, 2022 p. 111; 2023 p. 101; 2024 p. 100).  Simultaneously, the share of those guarantees attributable to collaboration partners declined from **$142 million in 2022 to $131 million in 2024** (Note 18, 2022 p. 111; 2023 p. 101; 2024 p. 100).  This downward trend reflects a risk‑management strategy that limits RTX’s residual liability by curbing its own guarantee commitments and shifting risk to partners.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the collaboration partners' share of guarantees: $142M in 2022, $135M in 2023, and $131M in 2024 according to the ground truth. However, the LLM states the partners' share declined from $142M to $131M, omitting the intermediate $135M value in 2023, which is a factual omission. Additionally, the LLM introduces a new figure—RTX’s 'maximum potential exposure'—as $304M in 2022 and $274M in 2024—which is not present in the original answer and cannot be verified against the ground truth. While this data may exist in the filings, its inclusion changes the focus and implies a broader risk reduction narrative not fully supported by the provided ground truth. (2) The quantitative values for partner shares are accurate in 2022 and 2024, but the omission of 2023 ($135M) breaks completeness. The introduced 'maximum exposure' numbers, while possibly accurate, are unverified and not part of the original answer, risking misalignment. (3) The reasoning about risk management strategy is partially sound—reducing partner share could indicate risk shifting—but the original answer emphasizes RTX reducing *shared* risk and maintaining confidence in asset values, whereas the LLM suggests risk is being shifted *to* partners, which is the opposite interpretation. The original indicates a reduction in overall shared liability, not a transfer of risk to partners. This misrepresents the strategic implication. (4) The answer is contextually relevant and well-structured, citing correct notes and pages, but the incorrect inference and missing 2023 data reduce qualitative and quantitative accuracy. The core trend is correct (decline), but the reasoning and completeness are flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 469,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did Procter & Gamble's positioning of the Always brand within its Feminine Care portfolio evolve from 2022 through 2024, particularly in terms of product categorization and brand emphasis relative to other feminine hygiene offerings?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care' alongside Tampax, with the segment contributing 25% of net sales. In 2023, the segment was renamed 'Baby, Feminine & Family Care' and contributed 24% of net sales, with Always positioned alongside Always Discreet and Tampax. By 2024, the segment retained the same structure and percentage contribution, but the formatting of product categories was streamlined, reflecting a more consolidated approach to brand presentation. This evolution shows a consistent strategic emphasis on Always within the feminine hygiene category, with minor structural refinements over time.",
      "llm_answer": "From 2022 to 2024, P&G kept Always as a core brand in its Feminine Care portfolio but clarified its product positioning.  In 2022 the sub‑category was listed simply as “Feminine Care (Adult Incontinence, Feminine Care)”; by 2023 and 2024 it was re‑defined as “Feminine Care (Adult Incontinence, Menstrual Care)” (PG_10k_2022 p. 17‑21; PG_10k_2023 p. 16‑20; PG_10k_2024 p. 16‑20).  Across all three filings, the MD&A notes that Always and Tampax Bounty are the leading brands in the menstrual‑care sub‑category, underscoring Always’s continued prominence relative to other feminine‑hygiene offerings.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several inaccuracies that significantly affect correctness. (1) Quantitative Accuracy: The original answer states that the 'Feminine Care' segment contributed 25% of net sales in 2022 and 24% in 2023 and 2024. The LLM answer omits these percentages entirely, failing to report key quantitative data. Additionally, the LLM incorrectly claims the segment was labeled as 'Feminine Care (Adult Incontinence, Feminine Care)' in 2022 and later changed to 'Menstrual Care'—this categorization is factually wrong. The ground truth indicates the segment was renamed to 'Baby, Feminine & Family Care' in 2023, not a redefinition within 'Feminine Care' based on sub-components. (2) Entity Accuracy: The LLM incorrectly lists 'Tampax Bounty' as a brand, conflating Tampax (a feminine care brand) with Bounty (a paper towel brand), which is a major factual error. (3) Reasoning & Completeness: While the LLM recognizes Always as a core brand, it fails to capture the actual structural evolution—specifically the 2023 reorganization into a broader segment that includes baby and family care. The mention of 'Adult Incontinence' is misleading; Always Discreet (not mentioned correctly) is related to incontinence, but this was not part of a rebranding of the Feminine Care category itself. The LLM also does not mention the streamlining of product category formatting in 2024, missing a key point. (4) Semantic Equivalence: Despite some correct emphasis on Always’s prominence, the answer misrepresents the nature of the portfolio changes and introduces incorrect entities and structures. The contextual relevance is fair because it addresses brand positioning, but the factual foundation is flawed. Overall, the answer is partially correct in spirit but contains critical errors in entities, structure, and omitted metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 494,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in Asia?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and deepening reliance on third-party manufacturing in Asia. In 2022, AMD noted that its global operations posed challenges in protecting intellectual property, particularly in foreign jurisdictions. By 2023, the company emphasized its increasing international sales (65% of net revenue) and reliance on third-party manufacturing in China, Malaysia, and Taiwan, heightening exposure to IP risks in those regions. In 2024, AMD reiterated these concerns while also noting the geopolitical tensions between China and Taiwan as a new layer of risk that could disrupt its manufacturing partners and adversely affect its business. This 3-year progression shows AMD's IP protection challenges becoming more complex and regionally concentrated, especially in Asia, as its global footprint and outsourcing model expanded.",
      "llm_answer": "In its 2022 10‑K, AMD listed IP‑protection difficulties as a general risk in foreign operations, noting reliance on third‑party wafer foundries in the U.S., Europe and Asia but without specific emphasis on Asia or third‑party manufacturing (AMD_10k_2022, pp. 35‑39). By 2023, the risk factor explicitly highlighted that nearly all assembly and testing occurs at third‑party facilities in China, Malaysia and Taiwan, underscoring the growing exposure to IP protection challenges in those jurisdictions (AMD_10k_2023, pp. 39‑43). In 2024, the filing added detail on geopolitical tensions between China and Taiwan, sanctions and export‑control changes that could disrupt Taiwan‑based foundries and heighten IP risk, reflecting AMD’s expanding international sales (66 % of revenue) and continued reliance on Asian manufacturing (AMD_10k_2024, pp. 38‑42).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Correctly identifies the evolution of AMD's IP protection risks from 2022 to 2024, noting increasing emphasis on third-party manufacturing in Asia and geopolitical risks. (2) Quantitatively, the 2023 revenue percentage is cited as 66% in the LLM answer vs. 65% in the original; this minor discrepancy (1 percentage point) may stem from rounding or document variation but does not materially affect accuracy. All other numbers (e.g., geographic concentration of assembly and testing) are consistent. (3) Multi-hop reasoning is sound: the model synthesizes information across three years of 10-K filings, correctly tracing the escalation of risk from general foreign operations in 2022 to specific Asian jurisdictions in 2023, then to geopolitical tensions in 2024. (4) The LLM adds document citations (e.g., page numbers), which are plausible but not present in the ground truth; however, this does not detract from accuracy. The answer captures the core progression and complexity of AMD’s evolving IP exposure, with only negligible variation in one percentage value. Hence, a score of 9 is justified—excellent factual correctness with minor quantitative variance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 347,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve from 2022 to 2024, and what does this multi-year pattern reveal about the company's broader debt financing strategy?",
      "original_answer": "Oracle first referenced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which included other notes issued in March 2021. In 2023, the company again included the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity in its disclosure of this instrument alongside newer notes issued in late 2022 and early 2023. In 2024, Oracle once more carried forward the 2.300% Notes due 2028 in Exhibit 4.14, keeping it visible among its active debt instruments. The consistent inclusion of these notes across all three years indicates Oracle's ongoing reliance on this specific debt structure, suggesting a stable and deliberate approach to long-term financing with an emphasis on maintaining a diverse maturity profile.",
      "llm_answer": "Oracle first issued the 2.300% Notes due 2028 in 2021 as part of a $4.5 billion issuance; the 2022 10‑K (pp. 112‑116) reports the notes outstanding at $4.5 billion, and the same principal appears unchanged in the 2023 (pp. 108‑112) and 2024 (pp. 109‑113) 10‑Ks, indicating the notes remained fully outstanding through 2024. This steady, long‑term, fixed‑rate debt position, coupled with the company’s simultaneous issuance of higher‑rate notes (e.g., 4.500% due 2028 in 2023), demonstrates Oracle’s strategy of maintaining a staggered maturity profile and a diversified mix of fixed‑rate instruments to manage interest expense and preserve liquidity.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in quantitative details. The ground truth states that Oracle first referenced the 2.300% Notes due 2028 in 2022 as part of Exhibit 4.16, relating to notes issued in March 2021. However, the LLM claims the notes were issued in 2021 and provides specific dollar amounts ($4.5 billion) and page numbers (pp. 112–116, etc.) not present in the ground truth. There is no mention in the original answer of a $4.5 billion issuance or exact page references, making these details fabricated or hallucinated. Additionally, the LLM asserts that the principal remained unchanged through 2024, but the ground truth does not confirm this level of quantitative detail. (2) The calculation and numerical consistency are therefore incorrect—while the LLM performs no mathematical error per se, it introduces precise financial figures and document locations unsupported by the ground truth, undermining factual reliability. (3) On qualitative and reasoning grounds, the LLM correctly infers Oracle’s broader debt strategy: maintaining a staggered maturity profile and diversified fixed-rate instruments. This aligns with the ground truth’s conclusion about a stable, deliberate long-term financing approach and diverse maturity profile. The multi-hop reasoning—linking consistent disclosure over years to strategic intent—is sound and contextually appropriate. (4) Contextual relevance is high because the answer addresses both the evolution of the note and Oracle’s financing strategy. However, the correctness score is reduced to 6 due to major quantitative inaccuracies, even though the strategic interpretation is reasonable. The model adds specifics not in the source, which violates factual fidelity despite plausible reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 485,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did BA's investment strategy in Private Equity Vehicles evolve from 2022 through 2024, particularly in terms of the geographic scope and strategic focus areas of its limited partnership investments?",
      "original_answer": "In 2022, BA's Private Equity Vehicles primarily invested in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies, with real estate investments also including publicly traded vehicles like REITs. By 2023, the focus remained on U.S. and non-U.S. leveraged buyout and venture capital strategies, but with an expanded emphasis on global private investments in real assets such as energy, farmland, and infrastructure. In 2024, the firm maintained this global orientation but showed increased sophistication in investment vehicles, including the use of derivatives to enhance exposure and performance transfer across asset classes. This progression indicates a strategic deepening in global private equity allocation and a broader integration of alternative investment tools.",
      "llm_answer": "From 2022 to 2024, BA increased its private‑equity allocation from a 4 % target in 2022 to a 7 % target in 2023 (and maintained that target in 2024), while actual holdings rose from 8 % in 2022 to 9 % in 2024 (see pages 108‑112, 90‑94, 97‑101). The geographic scope of its limited‑partnership investments remained global—U.S. and non‑U.S.—and the strategic focus continued to center on leveraged buy‑outs, venture capital, growth, and special‑situation strategies (see pages 108‑112, 90‑94, 97‑101).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical targets and allocations (4% in 2022, 7% in 2023, 8%-9% actuals) that are not present in the original answer (ground truth). These numbers are unsupported by the provided ground truth and appear to be hallucinated or derived from external data not referenced in the question. Therefore, the quantitative claims are factually incorrect, significantly undermining the correctness. (2) The original answer focuses on the evolution of geographic scope and strategic focus areas—specifically noting an expansion into global real assets (energy, farmland, infrastructure) in 2023 and increased use of derivatives in 2024. The LLM answer correctly identifies the continued global (U.S. and non-U.S.) geographic scope and mentions leveraged buyouts, venture capital, growth, and special situations, which aligns with 2022 and 2023 focus. However, it completely omits the key developments in 2024 regarding derivatives and performance transfer tools, which represent a critical evolution in investment sophistication. (3) The multi-hop reasoning is partially sound—linking investment focus across years—but fails to capture the strategic deepening and integration of alternative tools in 2024, which is a central point in the ground truth. The LLM instead emphasizes allocation percentages, which were not asked for and are not part of the verified answer. (4) While the LLM addresses geographic scope and some strategic focus areas, it substitutes unverified quantitative data and misses key qualitative shifts in 2024. The contextual relevance is high because it discusses the right topic and time frame, and some elements of continuity in strategy are accurate. However, the hallucinated numbers and omission of critical 2024 developments reduce correctness significantly. Thus, the answer is partially correct but contains major factual inaccuracies and omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 518,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Amgen's development and patent positioning of Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical phase progression and estimated U.S. and European patent expiration timelines?",
      "original_answer": "In 2022, Amgen initiated a phase 3 study for Bemarituzumab for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab was protected by polypeptide-related patents set to expire in 2029 in both the U.S. and Europe. In 2024, Amgen provided further context on Bemarituzumab, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, while reiterating the importance of both patent and regulatory exclusivity in extending its market protection. The molecule progressed through clinical development while maintaining consistent patent expiration estimates, suggesting a stable intellectual property position supporting its clinical advancement.",
      "llm_answer": "Amgen began bemarituzumab’s Phase 3 program in 2022 (the 2022 filing notes “initiated phase 3 study” for GEJ adenocarcinoma).  The 2023 and 2024 filings show the program still in Phase 3 with no additional milestones.  Across all three years, the issued composition‑of‑matter patents for bemarituzumab are projected to expire in 2029 in both the U.S. and Europe.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates and patent expiration timelines are correct: initiation of Phase 3 in 2022, and patent expiration in 2029 in both the U.S. and Europe, as stated in the original answer, are accurately reflected. There are no calculation errors. (2) The answer correctly identifies that Bemarituzumab remained in Phase 3 through 2023 and 2024 with no additional milestones reported, which is consistent with the original answer’s implication of ongoing clinical development without phase advancement. (3) The multi-hop reasoning is sound—information is synthesized across 2022, 2023, and 2024 filings to show continuity in development phase and patent status. (4) The only minor shortcoming is the omission of the 2024 detail about Bemarituzumab being a monoclonal antibody targeting FGFR2b and the mention of regulatory exclusivity as a complement to patents. While this contextual detail enriches the original answer, its absence does not undermine the core factual accuracy regarding clinical progression and patent timelines. The LLM captures the essential evolution: stable IP position with consistent 2029 expiration and ongoing Phase 3 status. Wording differs but semantic meaning is equivalent. Thus, the answer is factually complete and correct, meriting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 403,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Dawn's positioning within Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, based on the segment's earnings contribution and brand listings across those years?",
      "original_answer": "Dawn remained a consistently listed brand within the Fabric & Home Care segment across all three years. In 2022, the segment contributed 31% to P&G’s net earnings, increasing slightly to 34% in 2024, suggesting a growing earnings importance of the segment, which includes Dawn. Despite this increase in earnings contribution, the segment’s percentage of net sales remained stable at 35% in 2022 and 36% in both 2023 and 2024, indicating that Dawn continued to be strategically positioned within a high-performing and stable segment. The consistent inclusion of Dawn in the brand listings for Fabric & Home Care across all three years reinforces its ongoing relevance and positioning within the household cleaning portfolio.",
      "llm_answer": "Dawn remained a core brand in P&G’s Fabric & Home Care segment throughout 2022‑2024.  The segment’s earnings contribution grew from 31 % of net earnings in 2022 to 34 % in 2023 and stayed at 34 % in 2024, while Dawn continued to appear among the major brands listed alongside Ariel, Downy, Gain, Tide, Cascade, Fairy, Febreze, Mr. Clean and Swiffer【PG_10k_2022.pdf, p. 17‑21】【PG_10k_2023.pdf, p. 16‑20】【PG_10k_2024.pdf, p. 16‑20】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Dawn remained a listed brand in the Fabric & Home Care segment from 2022 to 2024 and accurately reports the segment’s earnings contribution increasing from 31% in 2022 to 34% in 2023 and 2024. However, the ground truth specifies the 34% figure for 2024, not 2023, and does not confirm 2023 earnings contribution—thus the LLM slightly misattributes the timing of the increase. The sales stability (35% in 2022, 36% in 2023 and 2024) is omitted, which is a minor completeness gap. (2) The percentages for earnings contribution are mostly correct, though the attribution of 34% to 2023 is not supported in the ground truth, which only confirms 31% in 2022 and 34% in 2024. The sales percentage data is missing entirely. (3) The multi-hop reasoning is sound—linking Dawn’s consistent listing to the segment’s performance and inferring strategic positioning—but misses the nuance that sales share was stable while earnings grew, which strengthens the conclusion about segment efficiency. (4) Despite the minor error in year attribution and omission of sales data, the core facts about Dawn’s positioning and segment earnings are correct, warranting a high score. Contextual relevance is perfect as it directly addresses the evolution of Dawn’s positioning using the right metrics and sources.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 373,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Charles Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and collateral obligations, and what does this trend indicate about the company's exposure to client-held assets?",
      "original_answer": "In 2022, Schwab disclosed the fair value of client securities that could be used as collateral for margin loans, indicating active pledging practices. By 2023, the company maintained margin loan collateral under ASC 326, applying a practical expedient that reduced expected credit losses when collateral value exceeded loan amounts, and allowed pledging of collateralized securities in accordance with federal regulations. In 2024, Schwab continued pledging client securities, particularly for clients writing listed options cleared by the Options Clearing Corporation, and also provided cash collateral to clients in securities lending activities. This 3-year trend shows an increasing sophistication and exposure in how Schwab utilizes client securities for operational and regulatory purposes, reflecting both strategic risk management and growing client engagement in leveraged activities.",
      "llm_answer": "From 2022‑2024 Schwab shifted client‑securities collateral from short‑term credit lines toward liquidity support.  CS&Co’s secured uncommitted lines of credit fell from $950 million in 2023 to $500 million in 2024, while collateral pledged for the Federal Reserve discount window jumped from $6.2 billion in 2023 to $30.5 billion in 2024 and FHLB collateral remained high at $59.8 billion in 2024 (pages 97‑101).  The fair value of client securities available for margin lending grew from $84.006 billion in 2020 to $120.306 billion in 2021, indicating continued expansion of client assets that Schwab now uses more for liquidity than for short‑term borrowing (pages 74‑78).  This trend shows that Schwab’s exposure to client‑held assets remains substantial but is being strategically reallocated to support liquidity rather than short‑term credit lines.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual and quantitative errors that undermine its correctness. (1) The numbers cited are largely incorrect and misaligned with the ground truth: the LLM references $950M and $500M credit lines, $6.2B to $30.5B discount window collateral, and $59.8B FHLB collateral—all of which are not mentioned in the original answer and appear fabricated. The original answer does not provide specific dollar amounts for pledged collateral over the 2022–2024 period, nor does it mention secured credit lines or Federal Reserve discount window usage. (2) The LLM incorrectly cites growth in fair value of client securities from $84.006B in 2020 to $120.306B in 2021—this is both outside the requested 2022–2024 timeframe and factually unsupported by the ground truth, which only states that in 2022 Schwab disclosed the fair value of client securities usable as margin loan collateral, without specifying the amount. (3) The qualitative reasoning is flawed: the LLM claims a 'shift from short-term credit lines toward liquidity support,' but the original answer focuses on the use of client securities for margin lending, regulatory compliance (ASC 326), and securities lending activities, particularly in options clearing and client collateral provision. (4) The multi-hop synthesis is incorrect—the LLM invents trends and data points rather than accurately reflecting the evolution of pledging practices in relation to margin lending and collateral obligations as described in the ground truth. While the answer attempts to address Schwab’s exposure to client-held assets, it does so with fabricated data and misdirected analysis, resulting in a low correctness score. Contextual relevance is moderate because it discusses client securities and collateral, but the substance is factually unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 491,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, based on the disclosed weighted-average plan asset allocations as of August 31 in 2022, 2023, and 2024?",
      "original_answer": "ACN's target asset allocation strategy for its defined benefit pension plans showed a gradual shift toward more fixed income instruments over the three-year period. In fiscal 2023, the weighted-average allocation as of August 31, 2022, was 55% fixed income and 45% equities. By fiscal 2024, with allocations as of August 31, 2023, the balance had moved to 58% fixed income and 42% equities. In fiscal 2025, based on the allocation as of August 31, 2024, the fixed income portion increased further to 61%, while equities decreased to 39%. This indicates a consistent trend toward de-risking the portfolio by increasing exposure to less volatile fixed income assets.",
      "llm_answer": "ACN’s target allocation for U.S. defined‑benefit pension plans remained at 100 % debt from FY 2023 to FY 2025, but the weighted‑average plan assets shifted from 97 % debt (Aug 31 2022) to 95 % (2023) to 94 % (2024), with cash rising from 3 % to 5 % to 6 %. For non‑U.S. plans, the target moved from 48 % debt, 27 % equity, 4 % cash, 11 % insurance, 10 % other (FY 2023) to 36 % debt, 28 % equity, 7 % cash, 21 % insurance, 8 % other (FY 2025), and the weighted‑average allocations reflected a similar trend—debt fell from 50 % (2022) to 43 % (2023) to 42 % (2024), equity rose from 21 % to 19 % to 23 %, cash increased, and insurance grew markedly.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and fails to match the ground truth on multiple levels. (1) Quantitatively, the numbers are completely wrong: the ground truth states that ACN's overall weighted-average allocation shifted from 55% fixed income / 45% equities (2022), to 58/42 (2023), to 61/39 (2024). The LLM instead claims 97% debt in 2022 rising to 94% in 2024, which contradicts the actual trend of increasing fixed income from 55% to 61%. It also introduces a 'cash' component increasing to 6%, which is not mentioned in the original answer and misrepresents the asset classes. (2) The LLM incorrectly splits the analysis into U.S. and non-U.S. plans with detailed breakdowns (e.g., insurance, other) that are not present in the ground truth and contradict the unified strategy described. The claim that the 'target allocation for U.S. plans remained at 100% debt' is false—no such target exists in the original. (3) The reasoning is flawed: the original describes a consistent de-risking trend toward more fixed income; the LLM describes a decrease in debt holdings and rising cash/insurance, implying a different strategy. (4) The LLM introduces entities and categories (e.g., 'insurance', 'non-U.S. plans') not referenced in the question or original answer, failing multi-hop synthesis. The question asks about ACN's overall defined benefit pension plans based on disclosed weighted-average allocations, not a segmented view. (5) Despite attempting to describe a trend over time, the LLM’s data and interpretation are factually incorrect. The only partial credit is for recognizing a temporal evolution in allocation strategy, but even the direction of change is wrong. Thus, the correctness score is 1 due to massive factual and quantitative errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 478,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a significant rise in debt levels, particularly in 2023, followed by a slight decline in 2024. The weighted-average interest rate on long-term debt also increased, from 1.51% on securitized debt in 2022 to 3.01% in 2023 and 3.48% in 2024, indicating rising borrowing costs over the period. Additionally, the company reduced its floating unsecured senior debt from $1,597 million in 2023 to $0 in 2024, signaling a strategic shift away from variable-rate debt amid rising interest rates.",
      "llm_answer": "Capital One’s short‑term borrowings fell sharply from $883 million in 2022 to $538 million in 2023 and then rose modestly to $562 million in 2024, while long‑term debt grew from $47.8 B in 2022 to $49.3 B in 2023 and declined to $45.0 B in 2024, reducing total debt from $48.7 B to $49.9 B and then to $45.6 B. The weighted‑average interest rate on long‑term debt dropped from roughly 4.5 % in 2022 to 3.5 % in 2024, reflecting a shift to lower‑rate, longer‑term financing. This three‑year trend shows a more stable debt structure with a higher proportion of fixed‑rate debt (≈4.8 %) and a small floating‑rate component, thereby lowering overall interest‑rate exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both magnitude and direction of trends. According to the ground truth, Capital One's total short-term borrowings and long-term debt were $43.086B in 2022, $48.715B in 2023, and $45.551B in 2024. The LLM incorrectly reports total debt as $48.7B in 2022 (vs. correct $43.086B), $49.9B in 2023 (vs. correct $48.715B), and $45.6B in 2024 (close to correct $45.551B). The breakdown into short-term and long-term components is also wrong: ground truth does not specify exact short-term borrowings, but the LLM claims they fell from $883M to $538M to $562M, which contradicts the overall upward trend in total debt in 2023. Long-term debt is reported as $47.8B in 2022 by LLM, but actual total debt (short + long) was only $43.086B — impossible if long-term alone were $47.8B. (2) The weighted-average interest rate on long-term debt is completely misrepresented: ground truth shows it increased from 1.51% (2022) to 3.01% (2023) to 3.48% (2024), but LLM claims it dropped from ~4.5% to 3.5%, the opposite trend. Additionally, the LLM fails to mention the elimination of floating unsecured senior debt from $1,597M in 2023 to $0 in 2024, a key strategic shift. Instead, it incorrectly implies floating-rate debt remains a small component. (3) Multi-hop reasoning is flawed: the model fails to correctly synthesize total debt evolution and misrepresents interest rate exposure. It draws incorrect conclusions about a 'shift to lower-rate financing' when rates actually rose significantly. The conclusion of 'more stable debt structure with lower interest-rate exposure' contradicts the ground truth of rising rates and prior reliance on floating-rate debt. (4) Scores justified: Correctness is low (2/10) due to major factual and directional errors in numbers and trends. Quantitative accuracy is poor (2/10) — most dollar amounts and percentages are incorrect. Qualitative accuracy is slightly better (3/10) because the answer attempts to analyze structure and exposure, but reasoning is based on false premises. Contextual relevance is moderate (6/10) — it addresses the right topic and time frame, and attempts trend analysis, but with wrong data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 593,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did BA's fleet support services costs as a percentage of total consolidated costs evolve from 2022 through 2024, and how does this trend relate to the company's abnormal production costs and reach-forward losses in the 787 and 777X programs?",
      "original_answer": "BA's fleet support services costs remained consistently at approximately 1% of total consolidated costs of products and services in 2022, 2023, and 2024, showing no significant change across the three-year period. However, this stable cost ratio contrasts sharply with the company's abnormal production costs and reach-forward losses in the 787 and 777X programs, which grew substantially over the same period. In 2023, the 787 program alone incurred $2.7 billion in cumulative abnormal production costs due to rework and low production rates. In 2024, the 777X program recorded a $2,608 million reach-forward loss in the third quarter and an additional $891 million in the fourth quarter, primarily driven by certification delays, labor instability, and supplier cost increases. These escalating program-specific costs suggest that while fleet support services remained proportionally stable, BA faced increasing operational and production challenges that significantly impacted financial performance. The persistence of the 1% cost ratio indicates that fleet support services were not the source of the financial strain but rather a consistent expense, underscoring that the company's growing losses were tied to production inefficiencies and program execution risks rather than service delivery.",
      "llm_answer": "Fleet‑support costs stayed flat at roughly 1 % of total consolidated costs each year from 2022 through 2024 (2022, 2023 and 2024 filings note that fleet‑support “has historically been approximately 1 % of total consolidated costs of products and services”【BA_10k_2022, pages 40‑44】【BA_10k_2023, pages 34‑38】【BA_10k_2024, pages 37‑41】).  In contrast, abnormal production costs and reach‑forward losses exploded—cumulative abnormal costs of $2.7 billion were recorded through 2023 and $256 million were expensed in 2024 for the 787 program, while the 777X program incurred $2.608 billion in Q3 2024 and $891 million in Q4 2024—showing that the stable fleet‑support expense was not driving the company’s growing losses, which were largely due to production rework and program delays.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that fleet support services costs remained stable at approximately 1% of total consolidated costs from 2022 to 2024, which matches the ground truth. It also accurately contrasts this stability with rising abnormal production costs and reach-forward losses in the 787 and 777X programs. However, there is a quantitative discrepancy in the 787 program's 2024 abnormal production costs: the LLM states '$256 million were expensed in 2024', but the ground truth does not specify 2024 costs for the 787 program—only that cumulative abnormal costs reached $2.7 billion through 2023. The ground truth does not mention any additional 2024 expense for the 787, so this figure appears to be an error or unsupported addition. (2) The 777X program's reach-forward losses are correctly reported as $2,608 million in Q3 2024 and $891 million in Q4 2024 (equivalent to $2.608 billion), matching the ground truth exactly. The cumulative $2.7 billion for the 787 through 2023 is also correct. The only numerical inaccuracy is the unverified $256 million for 787 in 2024. (3) The multi-hop reasoning is strong: the model correctly synthesizes data across three years of 10-K filings, distinguishes between fleet support costs and production-related losses, and draws a valid conclusion that the financial strain stems from production issues, not service costs. (4) The contextual relevance is perfect—the answer directly addresses both parts of the question and provides a clear, focused comparison. Due to the minor but material error in introducing a 2024 787 cost figure not present in the ground truth, the correctness score is reduced to 8 and quantitative accuracy to 7, while qualitative reasoning and relevance remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1544,
        "completion_tokens": 480,
        "total_tokens": 2024
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve across 2022, 2023, and 2024, and what does this 3-year trend indicate about the company's short-term liquidity strategy?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits was $12 million in 2022, increased to $21 million in 2023, and then decreased to $10 million in 2024. This fluctuation indicates a shifting short-term liquidity strategy, with a notable increase in 2023 possibly reflecting a temporary conservative approach, followed by a reduction in 2024 that may signal a reallocation toward other cash equivalents or strategic investments.",
      "llm_answer": "AbbVie’s allocation to money‑market funds and time deposits fell from **$21 million in 2022** to **$10 million in 2023** and stayed at **$10 million in 2024**. The decline and subsequent plateau indicate a deliberate shift away from money‑market holdings, likely to free up cash for other uses or to invest in higher‑yielding short‑term instruments, while still maintaining a modest, stable liquidity buffer.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values and years. According to the ground truth, AbbVie's allocation was $12 million in 2022, increased to $21 million in 2023, and decreased to $10 million in 2024. The LLM incorrectly states it was $21 million in 2022 and $10 million in 2023, reversing the trend between 2022 and 2023. It correctly reports $10 million in 2024 but mischaracterizes it as a plateau rather than a decrease from 2023. (2) The quantitative inaccuracies are severe: the values for 2022 and 2023 are swapped, leading to an incorrect trend interpretation. No calculations are required, but the comparison across years is fundamentally flawed. (3) The multi-hop reasoning is unsound because the model fails to correctly synthesize the year-to-year changes. The conclusion about a 'deliberate shift away' and 'plateau' is based on incorrect data, undermining the qualitative analysis. The actual trend shows a rise then fall, indicating volatility or strategic adjustment, not a steady decline. (4) The contextual relevance is moderate because the answer addresses the right topic (liquidity strategy) and attempts to interpret the trend, but the incorrect data renders the reasoning invalid. Correctness and quantitative accuracy are low due to the swapped figures; qualitative accuracy is slightly higher because the type of interpretation attempted is appropriate, though based on wrong inputs.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 402,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand in aggregate available authorization for share purchases and redemptions. By fiscal 2023, the company had increased its total authorized share repurchase capacity to $50.1 billion cumulatively since 2001, with $2,694 million in remaining available authorization as of August 31, 2023. In fiscal 2024, Accenture further boosted its total outstanding repurchase authority by an additional $4,000 million, bringing the total to $6,694 million as of September 25, 2024. This trajectory shows a consistent and expanding capital return strategy through share repurchases, with increasing board support and management discretion over time.",
      "llm_answer": "Accenture’s share‑repurchase authorization grew from $3.129 million of available authority in fiscal 2022 (when it repurchased 12.18 million shares for $4.111 million【ACN_10k_2022.pdf pages 91‑95】) to $6.129 million after a $3.000 million add‑on, and further to $6.694 million after a $4.000 million add‑on in fiscal 2024, while the available authorization dipped to $2.694 million【ACN_10k_2024.pdf pages 37‑41】. Share‑repurchase activity remained robust, with 12.18 million shares bought in 2022 and 2.0 million shares bought in Q4 2024 under the publicly announced program【ACN_10k_2024.pdf pages 37‑41】. The steady rise in authorization and consistent repurchases signal a proactive capital‑return strategy that prioritizes returning cash to shareholders while preserving flexibility for future buybacks.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative errors. It incorrectly states that Accenture had $3.129 million (not thousand) in available authorization in fiscal 2022, misrepresenting the value by a factor of 1,000. The correct figure is $3,129,296 thousand (~$3.13 billion). Similarly, the LLM claims the authorization grew to $6.129 million after a $3.000 million add-on, which is both numerically and unit-wise incorrect — the actual remaining authorization in 2023 was $2,694 million, and the total repurchase authority was increased cumulatively to $50.1 billion. The final total of $6.694 million is also wrong in units — it should be $6,694 million ($6.694 billion). (2) Calculations are flawed: the LLM implies a simple addition from $3.129M + $3M + $4M = $6.694M, but this ignores the actual repurchase activity that reduced available capacity and misrepresents the nature of cumulative vs. remaining authorization. The ground truth shows that the $4 billion increase in 2024 was added to the prior remaining balance of $2,694 million, resulting in $6,694 million — a fact the LLM partially captures in the final number but with incorrect units and reasoning. (3) Multi-hop reasoning is partially sound — the model attempts to trace the evolution across years and cites repurchase activity, but it fails to correctly distinguish between total cumulative authorization since 2001 ($50.1B by 2023) and remaining available capacity, which is a key nuance. It also incorrectly cites share repurchase amounts: while 12.18 million shares in 2022 is correct, the $4.111 million cost is absurdly low (should be ~$4.111 billion), again off by 1,000x. (4) Despite these serious numerical inaccuracies, the qualitative trend interpretation — that Accenture is pursuing a consistent and expanding capital return strategy — is aligned with the ground truth, and the answer addresses all parts of the question (evolution over time and strategic implication), hence moderate scores in qualitative accuracy and contextual relevance. However, the quantitative inaccuracies are severe enough to severely undermine factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 574,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve across 2022, 2023, and 2024, and what does this consistent emphasis on board entrenchment reveal about the company's long-term takeover defense strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently maintained a provision stating that stockholders may only remove directors for cause. This provision, included in each year’s 10-K filing, was part of a broader set of anti-takeover defenses such as staggered board terms, restrictions on special meetings, and supermajority requirements for bylaw amendments. The repeated disclosure of this specific governance feature across all three filings indicates a stable and deliberate strategy to entrench board control and discourage hostile takeovers. Despite no explicit changes to the 'removal for cause' language, the consistent emphasis in each annual report underscores AbbVie’s ongoing commitment to maintaining board stability and limiting shareholder influence over director tenure.",
      "llm_answer": "AbbVie’s 2022 Form 10‑K (pp. 44‑48) disclosed that “stockholders may only remove directors for cause,” a clause that is repeated unchanged in the 2023 (pp. 25‑29) and 2024 (pp. 25‑29) filings. The unchanged provision, together with the board’s power to fill vacancies and staggered terms, shows a deliberate effort to entrench the board and limit shareholder influence. This consistent emphasis signals a long‑term takeover‑defense strategy that prioritizes board stability and resistance to hostile bids.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that AbbVie's provision allowing stockholders to remove directors only for cause remained unchanged across 2022, 2023, and 2024, citing the specific provision and its repetition in each year’s 10-K. Page numbers (e.g., pp. 44–48, 25–29) are included and plausible, though minor variations in pagination would not affect factual correctness. (2) There are no numerical values requiring calculation, but the temporal consistency (2022–2024) is correctly maintained, and no incorrect dates or years are introduced. (3) The multi-hop reasoning is sound: the model synthesizes the consistent governance language across three years and correctly infers that this reflects a deliberate, long-term takeover defense strategy involving board entrenchment. It appropriately links the removal-for-cause rule with complementary mechanisms like board vacancy filling and staggered terms (mentioned in both answers), which strengthens the conclusion. (4) While the LLM omits explicit mention of 'supermajority requirements for bylaw amendments' and 'restrictions on special meetings' from the full set of anti-takeover provisions noted in the original, it captures the core strategic implication—board stability and resistance to hostile takeovers—accurately. The omission is minor and does not undermine the central correctness. Wording differs but semantic equivalence is preserved. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 439,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did PepsiCo's references to its 4.000% Senior Note due 2047 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent disclosure pattern reveal about the note's role in the company's long-term capital structure strategy?",
      "original_answer": "The 4.000% Senior Note due 2047 was consistently disclosed in all three years: in 2022 it referenced Exhibit 4.5 from the May 2, 2017 8-K filing; in 2023 it maintained the same May 2, 2017 reference; and in 2024 it continued to reference the identical Exhibit 4.5 from May 2, 2017. This consistent disclosure pattern across all three years with the exact same filing reference demonstrates that the 4.000% Senior Note due 2047 has remained a stable, long-term component of PepsiCo's capital structure since its issuance in 2017, with no modifications needed to its form or terms over this three-year period.",
      "llm_answer": "PepsiCo lists the 4.000 % Senior Note due 2047 in each 10‑K’s debt schedule and notes‑to‑financial‑statements (pages 124‑128 for 2022 and 2023; pages 125‑129 for 2024), with the same coupon, maturity and outstanding balance reported each year.  The unchanged, repeated disclosure shows that the note is a core, long‑term financing instrument in PepsiCo’s debt mix, providing a stable, low‑cost source of capital that the company relies on to support its long‑term capital‑structure strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that PepsiCo consistently disclosed the 4.000% Senior Note due 2047 across its 2022, 2023, and 2024 10-K filings and interprets this as evidence of its role as a stable, long-term financing instrument. However, it omits the specific disclosure detail from the ground truth — that all three years reference Exhibit 4.5 from the May 2, 2017 8-K filing — which is a key factual component of the original answer. Instead, the LLM refers generally to 'debt schedule and notes-to-financial-statements' with page numbers, which may be accurate but does not match the precise source documentation cited in the ground truth. (2) Quantitatively, the LLM correctly states the coupon (4.000%), maturity (2047), and implies no change in outstanding balance over the years, which aligns with the ground truth’s implication of stability. Page number ranges (124–128 for 2022/2023, 125–129 for 2024) may be factually correct but are not verifiable from the ground truth and introduce minor uncertainty; however, they do not contradict it. (3) The multi-hop reasoning is partially sound: the model correctly infers that unchanged disclosures imply no changes to the note’s terms and that this reflects strategic stability in capital structure. However, it fails to explicitly connect the repeated reference to the same 2017 filing (a critical multi-hop insight), weakening the qualitative accuracy. (4) The answer is contextually relevant and captures the broader strategic implication well — that the note is a core, low-cost, long-term capital source. While the conclusion is reasonable and aligned with the ground truth, the omission of the specific exhibit and filing date reduces factual completeness and precision, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 487,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did Oracle's issuance and disclosure of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Oracle first disclosed the 4.30% Note due 2034 in 2022 as part of a broader set of debt instruments, reaffirmed its inclusion in 2023 alongside similar structured notes, and maintained consistent disclosure in 2024, indicating a stable long-term debt strategy focused on diversified maturity profiles and sustained capital market engagement.",
      "llm_answer": "Oracle first issued the 4.30% Note due 2034 in 2014 (Exhibit 4.09).  In each subsequent 10‑K, the note is still reported as a long‑term debt instrument with a fixed 4.30 % coupon and a 2034 maturity—2022 (pages 111‑115), 2023 (pages 108‑112), and 2024 (pages 108‑112)—with no change to its principal or terms.  This steady, unchanged disclosure shows Oracle’s long‑term debt strategy is to maintain a stable, fixed‑rate debt portfolio that it holds to maturity rather than frequently refinancing or restructuring.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: it claims Oracle first issued the 4.30% Note due 2034 in 2014, which directly contradicts the ground truth stating the note was first disclosed in 2022. This undermines the entire timeline and misrepresents Oracle's debt strategy evolution. All subsequent disclosures in 2022, 2023, and 2024 being consistent is correctly noted, but the origin year is wrong. (2) Quantitative accuracy is low because the issuance year (2014 vs. 2022) is incorrect, even though the coupon rate (4.30%) and maturity (2034) are accurate. Page numbers cited may be plausible but are not verifiable from the ground truth and introduce unconfirmed detail. (3) The multi-hop reasoning is partially sound—linking disclosures across years to infer a stable debt strategy is valid—but the conclusion is based on a false premise (that the note has been held since 2014). The ground truth emphasizes the *first disclosure in 2022* as part of a broader issuance pattern, indicating active capital market engagement, not passive holding. The LLM incorrectly infers a 'hold-to-maturity' strategy without evidence of issuance timing. (4) Contextual relevance is high because the answer addresses the question’s structure—tracking the note across years and interpreting strategy—but factual inaccuracies severely limit correctness. The core error in issuance year leads to an incorrect interpretation of Oracle's long-term debt behavior.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 405,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 by fiscal year 2023 and remained unchanged through fiscal year 2024. The increase in authorized shares from 2022 to 2023 and the maintenance of that level through 2024 suggests a strategic decision to expand capacity for share-based compensation, likely to support ongoing talent retention and incentive programs.",
      "llm_answer": "In FY 2022 Accenture authorized 127 million Class A shares for the Amended 2010 SIP; the cap was raised to 141 million shares in FY 2023 and remained at 141 million in FY 2024. The increase reflects a deliberate expansion of the share‑based incentive pool to reward a broader employee base, while the subsequent plateau indicates a mature, controlled approach to dilution and a long‑term commitment to aligning employee incentives with shareholder value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the number of authorized shares for each fiscal year: 127 million in FY2022, 141 million in FY2023, and no change in FY2024—matching the ground truth exactly. Number formats (127 million vs 127,000,000) are semantically equivalent and acceptable. (2) All quantitative data is accurate with no calculation errors. The increase of 14 million shares from 2022 to 2023 is correctly implied. (3) The multi-hop reasoning is sound: the model synthesizes data across three fiscal years and draws a logical conclusion about the company's share-based compensation strategy. The interpretation—that the increase reflects expansion of incentives and the plateau suggests controlled dilution—is consistent with and expands upon the ground truth without introducing inaccuracies. (4) The only minor difference is that the LLM adds slightly more interpretive depth (e.g., 'reward a broader employee base', 'aligning employee incentives with shareholder value') not explicitly in the original, but these are reasonable inferences and do not contradict the ground truth. Thus, the answer is factually complete, quantitatively precise, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy due to added interpretation beyond the source.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 368,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did PepsiCo's issuance terms and documentation of the 2.750% Senior Note due 2051 evolve from 2022 through 2024, and what does this multi-year filing pattern indicate about the company's long-term debt structuring strategy?",
      "original_answer": "In 2022, the 2.750% Senior Note due 2051 was first introduced in a list of notes within a broader Board of Directors resolution (Exhibit 4.60), indicating initial authorization and planning. By 2023, the documentation had progressed to include a dedicated 'Form of 2.750% Senior Note due 2051' (Exhibit 4.51), suggesting that the instrument had moved from authorization to formal structuring and disclosure. In 2024, the note continued to be referenced with the same exhibit number (4.48), showing consistency in documentation and no material revision to the note's form. This progression reflects a deliberate, phased approach to long-term debt issuance, with early planning in 2022, formalization in 2023, and maintenance of structure in 2024, indicating stability in PepsiCo’s long-term capital strategy.",
      "llm_answer": "PepsiCo first issued the 2.750% Senior Note due 2051 on October 21 2021 (see Exhibit 4.51 in the 2021 8‑K).  The 2022, 2023 and 2024 Form 10‑K filings (pp. 124‑128, 126‑130, 127‑131) all reference the same note with unchanged terms—2.750% coupon, maturity 2051—and simply incorporate the 8‑K documentation by reference.  This steady, multi‑year reporting shows PepsiCo’s strategy of issuing long‑dated debt with stable, predictable terms and maintaining consistent, transparent documentation across filings to support long‑term capital structure planning.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims the 2.750% Senior Note due 2051 was first issued on October 21, 2021, and references Exhibit 4.51 in a 2021 8-K, which directly contradicts the ground truth stating the note was first introduced in a 2022 Board resolution (Exhibit 4.60). This error misrepresents the timeline and origin of the note. Additionally, the LLM asserts that the 2022, 2023, and 2024 10-Ks reference the same exhibit and unchanged terms, but the ground truth shows a progression in exhibit numbers (4.60 → 4.51 → 4.48) and evolving documentation maturity, which the LLM fails to capture. (2) Quantitative accuracy is low: the issuance date (2021 vs. 2022), exhibit numbers, and filing types (8-K vs. 10-K resolution) are all incorrect. While the coupon rate (2.750%) and maturity (2051) are correct, these are basic facts and do not compensate for the structural timeline errors. (3) The multi-hop reasoning is flawed: the LLM does not recognize the evolution in documentation form or the strategic progression from authorization (2022) to formalization (2023) to consistency (2024). Instead, it incorrectly assumes static documentation, missing the phased strategy entirely. (4) Contextual relevance is high because the answer addresses long-term debt strategy and documentation consistency, aligning with the question’s intent, but the factual foundation is unsound, leading to an incorrect interpretation of PepsiCo’s strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 411,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has American Express's competitive positioning relative to other card networks evolved from 2022 to 2024, particularly in light of increasing regulatory scrutiny and the expansion of alternative payment mechanisms?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest general-purpose card network globally behind China UnionPay, Visa, and Mastercard. In 2022 and 2023, the company emphasized its competitive differentiation through premium offerings, cobrand relationships, and closed-loop loyalty systems, while facing growing pressure from alternative payment platforms like Alipay, PayPal, and buy-now-pay-later services. By 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and cobrand arrangements in the EU, leading to exits from certain markets and increased compliance costs. This evolution indicates a shift from primarily market-driven competition to a more regulation-constrained environment, which has altered the strategic dynamics of its relationship with card networks.",
      "llm_answer": "From 2022 to 2024, American Express has remained the fourth‑largest general‑purpose card network behind China UnionPay, Visa and Mastercard, but its competitive edge has been increasingly tested by tighter regulatory scrutiny and the rapid rise of alternative payment platforms.  In 2022 (pp. 10‑14) the company highlighted its premium‑card and network strengths while noting competition from other networks and digital payment platforms; by 2023 (pp. 10‑14) it began to emphasize growing regulatory focus on interchange‑fee caps, network‑licensing rules and merchant‑acceptance policies; and in 2024 (pp. 32‑36) it noted that it had become a Category III bank‑holding company, faced heightened regulatory expectations, and that the expansion of digital wallets, BNPL, real‑time settlement and other fintech solutions had intensified competition, prompting greater investment in technology and compliance to preserve its market position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies American Express as the fourth-largest general-purpose card network globally, behind China UnionPay, Visa, and Mastercard—matching the original answer exactly. (2) The timeline from 2022 to 2024 is accurately represented with evolving challenges: premium offerings in 2022, increasing regulatory focus in 2023 (interchange fees, network licensing), and heightened regulatory status (Category III bank-holding company) and fintech competition in 2024. These details are consistent with the knowledge graph, though the original does not specify the 'Category III' designation—this is an additional but plausible and contextually appropriate detail likely drawn from accurate regulatory context. (3) The LLM correctly synthesizes multi-hop information across years and themes: competitive positioning, regulatory evolution, and technological disruption (digital wallets, BNPL, real-time payments). (4) Minor difference: the original emphasizes cobrand relationships and closed-loop loyalty systems as differentiators, while the LLM mentions 'premium-card and network strengths'—semantically equivalent but slightly less specific. However, the LLM adds value by referencing compliance investment and technology adaptation, which are logical inferences. All entities (Visa, Mastercard, China UnionPay, BNPL, digital wallets) are correct. No numerical inaccuracies; dates and rankings are precise. The answer fully addresses the question’s scope: competitive positioning, regulatory scrutiny, and alternative payments. Thus, the answer earns a 9 for correctness due to slight under-specification of Amex's loyalty model, but is otherwise excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 473,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has Boeing's strategic emphasis on aircraft upgrades and conversions changed from 2022 to 2024, and what does this suggest about its services business strategy?",
      "original_answer": "In 2022, Boeing listed 'upgrades and conversions' as one of several services within the Global Services segment, grouped alongside logistics, engineering, and training systems. By 2023, the company maintained a similar structure but began emphasizing 'modifications' more prominently, suggesting a deeper integration of upgrades into broader lifecycle support offerings. In 2024, Boeing continued this pattern but introduced clearer language around 'data analytics and digital services' as complementary to upgrades and conversions, indicating a strategic shift toward technology-enabled service differentiation. This progression shows a growing focus on enhancing aircraft value through modernization rather than just sustaining operations, aligning with a broader transformation toward high-value services.",
      "llm_answer": "Boeing’s 10‑K Business sections for both 2022 and 2024 list upgrades and conversions as part of its Global Services portfolio, showing a consistent emphasis on these offerings【BA_10k_2022 pages 3‑7】【BA_10k_2024 pages 1‑5】.  The unchanged focus indicates that Boeing continues to view upgrades and conversions as a core element of its services strategy, aiming to extend aircraft life‑cycles and generate recurring revenue from long‑term customer relationships.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but misses key strategic evolution details present in the ground truth. It correctly identifies that upgrades and conversions remained part of Boeing’s Global Services portfolio in both 2022 and 2024, which aligns with the original answer. However, it fails to capture the nuanced shift from 'upgrades and conversions' being one of many services in 2022 to the increased emphasis on 'modifications' in 2023 and the integration with 'data analytics and digital services' in 2024. This omission significantly weakens the analysis of Boeing’s strategic direction. (2) There are no numerical values or calculations in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is incomplete: while the model correctly synthesizes information across 2022 and 2024 filings, it ignores the 2023 transition and the progressive strategic refinement toward technology-enabled, high-value services. The conclusion that Boeing maintains an 'unchanged focus' contradicts the ground truth, which shows a clear evolution toward modernization and digital integration. (4) Contextual relevance is high because the answer addresses the core topic—Boeing's services strategy around upgrades—but the lack of depth on strategic progression limits its accuracy. The correctness score is 5 due to significant omissions in strategic nuance and development over time, despite correct entity and segment identification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 421,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did PepsiCo's issuance and documentation of the 5.50% Senior Note due 2035 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern reveal about its long-term debt management strategy?",
      "original_answer": "The 5.50% Senior Note due 2035 was consistently referenced across all three years, indicating ongoing documentation and potential refinancing or rollover activity. In 2022, it was listed as 'Form of 5.50% Senior Note due 2035, Series A' (Exhibit 4.31) referencing an 8-K filing from November 8, 2018. In 2023, the same note was referenced again (Exhibit 4.25) with the same filing history, showing continued acknowledgment of this debt instrument. In 2024, the note reappeared (Exhibit 4.23), again tied to the same 2018 filing. This repeated inclusion suggests that PepsiCo maintained this long-term debt obligation on its books without retiring or modifying it during the three-year period, signaling a stable, long-duration capital structure approach.",
      "llm_answer": "PepsiCo first issued the 5.50 % Senior Note due 2035 in 2018, and the note has been listed as an exhibit in every subsequent Form 10‑K: Exhibit 4.23/4.27 in the 2022 filing (PEP_10k_2022 p. 124‑128), the same exhibits in the 2023 filing (PEP_10k_2023 p. 124‑128), and Exhibit 4.27/4.29 in the 2024 filing (PEP_10k_2024 p. 125‑129). The unchanged terms and consistent year‑to‑year disclosure demonstrate PepsiCo’s strategy of maintaining a stable, fixed‑rate senior‑note structure with a long maturity while ensuring transparent, ongoing reporting of its long‑term debt obligations.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 5.50% Senior Note due 2035 as being issued in 2018 and consistently disclosed in annual 10-K filings, which aligns with the ground truth. However, there are discrepancies in exhibit numbers and document versions across years. The ground truth states Exhibit 4.31 (2022), 4.25 (2023), and 4.23 (2024), all tied to the same 2018 8-K filing. The LLM incorrectly reports Exhibit 4.23/4.27 in 2022, same in 2023, and 4.27/4.29 in 2024, which does not match the original data. Additionally, the LLM implies multiple exhibits per year, while the ground truth shows one exhibit per year. Page numbers (e.g., p. 124–128) are plausible but not verifiable from the ground truth and introduce unsupported specifics. (2) The interest rate (5.50%) and maturity year (2035) are correct. The issuance year (2018) is correctly referenced. However, exhibit numbers are factually inaccurate, and the suggestion of dual exhibits per year is unsupported. These are quantitative/documentation errors affecting precision. (3) The multi-hop reasoning is sound: the model correctly infers that consistent year-over-year disclosure reflects a stable long-term debt strategy with transparent reporting. This matches the ground truth’s conclusion about a stable capital structure. The logic connecting repeated documentation to strategic debt management is valid and well-synthesized across years. (4) The answer is contextually relevant and addresses both the evolution of documentation and the strategic implication. While the core factual narrative is correct—unchanged note, ongoing disclosure, strategic stability—the incorrect exhibit references reduce quantitative accuracy. The answer adds minor fabricated details (page ranges, duplicate exhibits) not in the original, but the overall qualitative interpretation remains strong and semantically aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 514,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolved from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints on capital return policies?",
      "original_answer": "BNY Mellon's disclosures across 2022, 2023, and 2024 consistently highlight that its ability to return capital to shareholders is constrained by U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight impacting operations. By 2023, it specifically reiterated that capital return decisions were limited by U.S. banking laws, Delaware law, and preferred stock dividend obligations. In 2024, the language remained largely unchanged, reiterating the same constraints while also noting the importance of maintaining 'well capitalized' status. This consistent yet evolving emphasis reflects a regulatory environment that continues to impose clear boundaries on BNY Mellon’s capital planning flexibility, signaling ongoing prudential oversight and risk-conscious capital management expectations from regulators over the three-year period.",
      "llm_answer": "BNY Mellon’s 2022, 2023 and 2024 10‑Ks all contain the same risk‑factor paragraph stating that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock” (2022 pages 3‑7; 2023 pages 3‑7; 2024 pages 3‑7).  The unchanged wording shows that the company’s exposure to regulatory constraints on capital‑return policies has remained steady over the three‑year period, indicating that U.S. banking laws continue to impose a consistent ceiling on how much capital can be returned to shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that BNY Mellon's 10-K filings from 2022, 2023, and 2024 contain identical language regarding constraints on capital returns due to U.S. banking laws, Delaware law, and preferred stock dividend obligations. The quantitative accuracy is perfect: the years (2022–2024), document type (10-K), and page references (pp. 3–7) are consistent with the source and correctly cited. There are no numerical errors, and the core facts about regulatory constraints are accurately represented. The qualitative accuracy is high—the model correctly infers that the unchanged wording indicates a steady exposure to regulatory constraints, reflecting ongoing prudential oversight. While the original answer adds slightly more interpretive depth (e.g., noting the emphasis on maintaining 'well capitalized' status in 2024 and characterizing the evolution as 'consistent yet evolving'), the LLM captures the essential multi-hop insight: regulatory limits on capital returns have remained materially unchanged across the three years. The reasoning is sound, synthesizing information across multiple filings to infer stability in regulatory exposure. Contextual relevance is excellent—the response directly addresses how regulatory constraints have evolved (or not evolved) and what that implies for capital return policies. The only minor shortcoming is the lack of explicit mention of the 'well capitalized' status noted in 2024 in the ground truth, which slightly enriches the narrative around regulatory expectations. However, this omission does not undermine the overall correctness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 488,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Oracle's issuance terms for its 2.300% Notes due 2028 evolve from 2022 through 2024, and what does this reveal about the company's approach to fixed-income financing in varying interest rate environments?",
      "original_answer": "In 2022, Oracle issued the 2.300% Notes due 2028 under an Officers' Certificate dated March 24, 2021 (filed as Exhibit 4.14 in the 2022 10-K), indicating the instrument was part of a multi-tiered bond offering that included other fixed-rate tranches like the 2.875% Notes due 2031 and 3.950% Notes due 2051. In 2023, Oracle referenced the same 2.300% Notes due 2028 under the same Officers' Certificate, showing no structural or rate changes to the instrument, but instead focused new issuance activity on higher-yielding instruments like the 4.500% Notes due 2028. By 2024, Oracle made no visible changes to the terms of the 2.300% Notes due 2028 and did not introduce any new 2028-dated instruments, suggesting a shift toward maintaining existing obligations rather than refinancing or repricing them. This pattern indicates Oracle's strategy of locking in favorable fixed-rate debt when possible, particularly during lower interest rate periods like those in 2021–2022, and avoiding redundant issuance when existing instruments remain competitive.",
      "llm_answer": "Oracle issued 2.300% Notes due 2028 on March 24 2021 with a 2.300 % coupon, a principal amount of $1.5 billion, a maturity of July 15 2028, and a call date of July 15 2025.  Its 2022, 2023, and 2024 10‑K filings report the same coupon, maturity, and call date with no amendments, indicating that the terms have remained unchanged over that period.  This consistency shows Oracle’s preference for locking in low, fixed rates and long maturities to hedge against rising rates, rather than adjusting debt terms in response to short‑term market swings.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the terms of Oracle's 2.300% Notes due 2028 remained unchanged from 2022 to 2024, which aligns with the ground truth. However, it introduces specific details not present in the original answer—namely, the $1.5 billion principal amount, maturity date of July 15, 2028, and call date of July 15, 2025—which are factually accurate based on actual filings but were not included in the provided ground truth. Since the evaluation must be based solely on alignment with the original answer (not external facts), these additions cannot be verified as correct within this context and thus represent a deviation. (2) Quantitative accuracy is partially compromised because the original answer does not mention dollar amounts, maturity dates, or call dates; including them introduces unverifiable precision relative to the ground truth. While such details may exist in SEC filings, the model overreaches by presenting them as confirmed when the source knowledge graph does not include them. (3) The reasoning is sound: the LLM correctly infers Oracle’s strategy of locking in low fixed rates and avoiding repricing, which matches the original conclusion. It synthesizes the lack of amendments across years into a coherent financing strategy, demonstrating valid multi-hop logic. (4) Contextual relevance is high—the response directly addresses both parts of the question: evolution of terms (no change) and strategic implications (rate-locking behavior). The core factual claim (no changes to terms) and strategic interpretation match the original, but the inclusion of unsupported specifics reduces quantitative accuracy. Hence, correctness is reduced to 7 due to unverifiable numeric claims, though the overall direction and logic remain aligned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 486,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved across 2022, 2023, and 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "In 2022, IBM emphasized client relationships and trust as part of a broader competitive strategy that included embedding AI and cloud into offerings and modernizing platforms. In 2023, the company reinforced this by highlighting its deep incumbency with enterprises and a strong focus on innovation as key differentiators tied to client trust. By 2024, IBM expanded its strategic partnerships (e.g., adding Palo Alto Networks) and continued to position client relationships and trust as central to delivering business value, especially in the context of hybrid cloud and AI solutions. This shows a consistent but increasingly nuanced strategic emphasis on trust as a foundational element for client engagement and competitive advantage in a rapidly evolving tech landscape.",
      "llm_answer": "IBM has consistently listed “client relationships and trust” as a core competitive differentiator in its 2022, 2023, and 2024 10‑K filings, with the wording unchanged across the three years.  The steady emphasis signals that IBM views deep, trusted client relationships as essential to its hybrid‑cloud and AI strategy, reinforcing its positioning as a trusted partner that can deliver integrated, secure, and innovative solutions in a highly competitive market.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in qualitative reasoning and completeness. (1) It correctly identifies that IBM emphasized client relationships and trust across 2022–2024, which aligns with the ground truth. However, it incorrectly states that the 'wording' was 'unchanged' across the three years—a claim not supported by the original answer and likely factually incorrect given the nuanced evolution described in the ground truth. (2) There are no numeric values to verify, so quantitative accuracy is not applicable; the score of 10 reflects no errors in numbers or dates. (3) The multi-hop reasoning is flawed: the original answer shows a progression—2022 (broad strategy with AI/cloud), 2023 (deep incumbency and innovation), 2024 (expanded partnerships like Palo Alto Networks)—but the LLM fails to capture this evolution, instead asserting static emphasis. This omission of strategic progression undermines the core of the question about 'how it evolved' and what that indicates strategically. (4) Contextually, the answer is relevant and correctly frames trust as central to hybrid cloud and AI positioning, but it lacks the depth and synthesis required for full accuracy. The failure to reflect IBM’s expanding partnership ecosystem and evolving narrative results in a score of 5 for correctness—partially accurate but missing key differentiating insights.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 387,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did American Express's yield profile from its holdings of foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year progression indicate about its exposure to interest rate risk and investment strategy?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with $628 million maturing within one year and the remainder evenly split between 1–5 years and 5–10 years. In 2023, the weighted average yield on these holdings was 6.45%, concentrated entirely in securities maturing within one year. By 2024, the yield had decreased to 5.85%, with a significant portion (2.03%) now maturing between 1 and 5 years. This indicates a shift in investment strategy—moving from ultra-short-duration, high-yield foreign debt in 2023 to a more diversified maturity profile by 2024, potentially to manage interest rate risk while maintaining relatively high yields compared to other asset classes.",
      "llm_answer": "American Express’s weighted‑average yield on foreign government bonds and obligations has been essentially flat at roughly 2 % over the 2022‑2024 period.  The 2022 10‑K (covering 2021) reports a 2.08 % yield on this segment【2022 10‑K, pages 119‑123】, and the 2024 10‑K (covering 2023) shows no material change in that yield, while the overall portfolio of investment securities still averages 12.8 % on total interest‑earning assets【2024 10‑K, pages 175‑179】.  This stability indicates a conservative, low‑yield sovereign‑debt focus that limits exposure to interest‑rate swings while preserving capital and generating steady income.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in both quantitative and qualitative aspects. It claims American Express's weighted-average yield on foreign government bonds was 'essentially flat at roughly 2%' from 2022–2024, directly contradicting the ground truth, which states yields were 6.45% in 2023 and 5.85% in 2024—neither of which is near 2%. The LLM incorrectly cites a 2.08% yield from the 2022 10-K (covering 2021), but the question asks about 2022–2024, making that data point irrelevant. Additionally, the claim that the overall portfolio earns 12.8% on total interest-earning assets is unrelated to foreign government bonds and misrepresents the metric. (2) The dollar amounts and maturity breakdowns are completely missing: the ground truth specifies $630M in holdings in 2022 with $628M maturing in one year, and a shift in 2024 to include 2.03% maturing in 1–5 years—none of which appears in the LLM answer. The yield values (6.45% → 5.85%) and their directional change (decrease with maturity diversification) are entirely misrepresented. (3) The multi-hop reasoning is flawed: the LLM fails to synthesize the evolution of yield and maturity profile across 2022–2024, instead citing irrelevant data from prior years and unrelated asset categories. It draws the wrong conclusion about a 'conservative, low-yield' strategy when the truth indicates a shift from ultra-short, high-yield to slightly longer-duration, still-high-yield foreign debt. (4) The contextual relevance is low because the answer discusses sovereign debt focus and interest rate risk, but based on incorrect data and timeframes. The conclusion about stability and low risk is unsupported and opposite to the actual strategic shift indicated in the ground truth. Scores reflect near-total factual inaccuracy, especially in numbers and temporal alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 502,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Danaher Corporation's (DHR) investment in Diagnostics Testing Technologies evolve from 2022 through 2024, particularly in terms of government grant funding allocated to offset capital expenditures, and what does this progression indicate about the strategic importance of diagnostics testing within the company's broader health care portfolio?",
      "original_answer": "Danaher's investment in Diagnostics Testing Technologies through government grant funding showed a clear upward trend from 2022 through 2024. In 2022, $87 million of government grant funds were used to offset capital expenditures related to diagnostics testing technologies. This increased to $136 million in 2023 and further rose to $198 million in 2024. This consistent increase indicates that diagnostics testing technologies became increasingly central to Danaher’s strategic focus in its healthcare portfolio, with growing government support enabling expanded production capacity and development in this area over the three-year period.",
      "llm_answer": "Danaher’s government‑grant assistance earmarked to offset capital expenditures for diagnostics‑testing technology grew steadily: $87 million in 2022, $136 million in 2023 and $198 million in 2024 (with corresponding operating‑expense offsets of $49 m, $51 m and $43 m)【DHR_10k_2022.pdf pages 57‑61】【DHR_10k_2023.pdf pages 69‑73】【DHR_10k_2024.pdf pages 66‑70】. The rising grant‑backed cap‑ex reflects an accelerating commitment to expand testing production capacity, signalling that diagnostics testing is becoming a key growth engine within Danaher’s broader health‑care portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the government grant funding amounts for diagnostics-testing technologies: $87 million in 2022, $136 million in 2023, and $198 million in 2024, matching the ground truth exactly. These figures are critical and accurately reflect the upward trend. (2) All numeric values are correct and properly attributed to the respective years. The additional mention of operating-expense offsets ($49M, $51M, $43M) is not part of the original answer and was not requested in the question; however, it does not contradict the ground truth or detract from correctness, though it introduces minor extraneous information. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years and filings (2022–2024 10-Ks), identifies the increasing trend, and infers strategic importance based on rising grant funding—aligning with the original conclusion that diagnostics testing is becoming more central to Danaher’s healthcare portfolio. (4) The qualitative assessment is strong, with only a minor deduction because the original answer emphasizes government support enabling 'expanded production capacity and development,' while the LLM focuses more narrowly on 'production capacity'—a slight narrowing of scope. However, the core inference about strategic importance is preserved. Contextual relevance is perfect, as all information directly addresses the evolution of investment and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 405,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the PCAOB firm identification number and its presentation within the Proxy sections?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in the Proxy sections for all three years (2022, 2023, and 2024), and in each year, the PCAOB firm identification number was explicitly stated as 185. The structure and placement of the disclosure remained stable, appearing under 'Item 3 - Ratification of KPMG LLP' within Item 14 of the Proxy materials. There was no change in the identification number or in the format of the disclosure across the three-year period, indicating a consistent auditing relationship and disclosure practice.",
      "llm_answer": "BK’s 10‑K filings for 2022, 2023 and 2024 all state that KPMG LLP’s PCAOB firm identification number is **185** and that the ratification is incorporated into the Proxy under **Item 3 – Ratification of KPMG LLP**.  The wording and placement of this disclosure remained unchanged across the three fiscal years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: KPMG LLP was consistently ratified as principal accountant across fiscal years 2022, 2023, and 2024; the PCAOB firm identification number is correctly stated as 185 in all years; and the disclosure is properly located under 'Item 3 – Ratification of KPMG LLP' within Item 14 of the Proxy materials. (2) Quantitative accuracy is perfect: the PCAOB number 185 is correctly reported with no variation or error. (3) The multi-hop reasoning is sound—information is synthesized across three fiscal years and consistent placement/format is correctly inferred. The LLM correctly identifies that there was no change in content or structure over time, which requires cross-year comparison. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) of the disclosure, including both identification number and presentation. Minor wording differences (e.g., referencing '10-K filings' instead of 'Proxy sections') do not affect factual correctness, as the Proxy is incorporated by reference into the 10-K. Overall, the response demonstrates complete factual accuracy, proper synthesis, and clear alignment with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 352,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did American Express's reliance on third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of revenue recognition structure, contractual relationships, and strategic expansion goals?",
      "original_answer": "In 2022, American Express's relationship with third-party merchant acquirers was primarily transactional, with revenue recognized as discount revenue based on negotiated network rate fees under programs like OptBlue and Global Network Services (GNS) partnerships. By 2023, the company had formalized these relationships further, integrating third-party acquirers into a broader 'Processed Revenue' model that included royalties, fees, and network partnership agreements, indicating a more strategic and structured revenue-sharing framework. In 2024, American Express emphasized the importance of third-party acquirers in its global merchant expansion strategy, particularly in increasing card acceptance in low- and new-to-plastic industries and international markets. This evolution shows a shift from a transactional dependency to a more strategic partnership model aimed at scaling global acceptance and enhancing network value.",
      "llm_answer": "From 2022 to 2024, American Express maintained its reliance on third‑party merchant acquirers but shifted its revenue classification from discount revenue (recorded at the transaction) to processed revenue, which also captures alternative‑payment‑service fees recognized when the service is performed (2022‑2024 10‑K pages 102‑106, 101‑105, 91‑95). Contractually, the company moved from variable‑duration agreements for small‑ and medium‑size merchants and fixed 3‑to‑7‑year contracts for large merchants in 2022 to adding auto‑renewal clauses in 2023 and further formalizing network‑partner and acquirer agreements in 2024. Strategically, it has intensified global merchant‑coverage expansion, targeting priority international cities, destinations, and industry verticals through its third‑party acquirer network (2022‑2024 10‑K pages 102‑106, 101‑105, 91‑95).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution from 2022 to 2024 in terms of revenue recognition, shifting from 'discount revenue' to 'processed revenue'—a key change explicitly noted in the original answer and supported by the cited 10-K pages. The inclusion of alternative-payment-service fees under processed revenue adds contextual precision. (2) Quantitatively, no specific numbers (e.g., dollar amounts, percentages) are present in either answer, so no discrepancies exist; dates (2022–2024) are correct and consistently referenced. (3) The reasoning is sound: the LLM captures the multi-hop progression—revenue model shift, contractual formalization (auto-renewal clauses, structured agreements), and strategic expansion via third-party acquirers in targeted markets and industries. It correctly infers a move toward more strategic partnerships, though it does not explicitly name programs like OptBlue or GNS, which are mentioned in the ground truth. This is a minor omission but does not detract from the overall correctness. (4) Contextual relevance is excellent—the answer directly addresses all three dimensions in the question: revenue recognition, contractual relationships, and strategic goals. The use of cited 10-K page ranges adds credibility. The only reason for not scoring a 10 is the lack of explicit mention of OptBlue and GNS, which are key program names in the original answer and contribute to entity-level completeness. However, the semantic meaning and strategic interpretation remain equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 435,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did Qualcomm's human capital goals and their linkage to executive compensation evolve from fiscal years 2022 through 2024, particularly in terms of diversity targets and performance modifiers?",
      "original_answer": "In fiscal 2022, Qualcomm established specific 2025 diversity goals, including increasing women and underrepresented minorities (URM) in leadership roles by 15% and overall URM representation by 20%. Progress toward these goals influenced executive bonuses via a non-financial modifier that could adjust payouts by a factor of 0.9 to 1.1. In fiscal 2023, the company maintained the same executive compensation linkage, emphasizing continued focus on diversity and inclusion, with recognition in multiple regions and participation in initiatives like the Reboot Representation Tech Coalition. By fiscal 2024, the structure of the executive compensation modifier remained unchanged, but the company expanded its global engagement efforts and highlighted broader wellness and development programs, indicating a deepening integration of human capital metrics into corporate strategy. This 3-year progression shows Qualcomm's sustained emphasis on diversity-linked executive incentives while expanding supporting programs.",
      "llm_answer": "Qualcomm’s 2025 human‑capital goals—set in the 2022 10‑K and reiterated in the 2023 and 2024 filings—call for a 15 % increase in women and under‑represented minority leaders and a 20 % increase in overall URM representation (see 2022 p. 18‑19, 2023 p. 18, 2024 p. 18). Across fiscal 2022, 2023 and 2024 the HR and Compensation Committee tied progress on those goals to executive bonuses through a non‑financial multiplier of 0.9‑1.1 (see 2022 p. 18, 2023 p. 18, 2024 p. 18), so the performance modifier remained unchanged over the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Qualcomm set 2025 diversity goals in fiscal 2022 (15% increase in women and underrepresented minorities (URM) in leadership, 20% increase in overall URM representation), and these were consistently referenced in 2023 and 2024 filings. The non-financial modifier range of 0.9 to 1.1 for executive compensation is correctly reported across all three years. (2) Quantitative accuracy is perfect: percentages, timeframes, and modifier ranges match the original answer exactly. (3) The reasoning is sound and reflects proper multi-hop synthesis across three years of filings. However, the LLM omits some qualitative evolution noted in the ground truth—specifically, the expansion of global engagement efforts, wellness and development programs in 2024, and participation in initiatives like the Reboot Representation Tech Coalition in 2023. While the core structure of the compensation modifier remained unchanged (correctly emphasized by the LLM), the original answer highlights a broader deepening of human capital integration, which the LLM does not mention. (4) Despite this minor omission, the LLM captures the central thread of sustained linkage between diversity goals and executive compensation, making it contextually fully relevant and factually precise. The score is reduced slightly (from 10 to 9) due to incomplete coverage of the qualitative evolution beyond the compensation modifier.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 411,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did the geographic reach of Caterpillar's EMD-branded product distribution change from 2022 to 2024, and what does this expansion or contraction suggest about Caterpillar's strategic positioning in global markets?",
      "original_answer": "From 2022 to 2024, Caterpillar's EMD-branded products were distributed across 193 countries in 2022, then slightly declined to 191 countries in 2023, and further decreased to 187 countries by 2024. This gradual reduction in geographic reach suggests a potential strategic refocusing or consolidation in Caterpillar’s global distribution strategy for EMD products, possibly due to market-specific challenges, competitive pressures, or internal restructuring.",
      "llm_answer": "Caterpillar’s EMD‑branded product distribution shrank from 193 countries in 2022 to 187 countries in 2024 (the dealer network fell from 160 to 152 dealers). This modest contraction indicates a strategic realignment that focuses on core, high‑margin markets and streamlines the global distribution footprint to improve efficiency and profitability.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the overall trend of contraction in geographic reach—from 193 countries in 2022 to 187 in 2024—which matches the ground truth. However, it omits the intermediate 2023 figure (191 countries), which is part of the multi-hop progression and relevant for completeness. Additionally, the LLM introduces dealer network numbers (160 to 152 dealers) that are not present in the original answer or ground truth, making them factually unsupported and potentially misleading. (2) The country counts for 2022 and 2024 are accurate, but the absence of the 2023 data point reduces quantitative precision. The inclusion of unverified dealer numbers further undermines quantitative accuracy. (3) The reasoning about strategic realignment is semantically consistent with the original answer’s suggestion of refocusing or consolidation. The interpretation of contraction implying efficiency and profitability goals is a reasonable inference, though slightly more assertive than the original’s cautious 'suggests a potential' phrasing. (4) Despite the factual error with dealer numbers and omission of 2023 data, the core answer captures the key trend and strategic implication, maintaining high contextual relevance and qualitative reasoning. The correctness score is reduced due to unsupported data and incomplete multi-year synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 379,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What does the consistent inclusion of Palmolive in Colgate's list of principal global trademarks from 2022 to 2024 suggest about its strategic role in the company's Oral, Personal and Home Care segment?",
      "original_answer": "The Palmolive brand has remained a consistently listed principal global trademark in Colgate's disclosures from 2022 through 2024, indicating its sustained strategic importance within the company's core product portfolio. In 2022, Palmolive was positioned among key global brands like Colgate and Ajax, underscoring its role in home and personal care categories. In 2023, it maintained its place despite the addition of Darlie to the list, signaling continued emphasis on its market presence. By 2024, Palmolive remained among the top-tier trademarks without any positional dilution, reinforcing its enduring relevance in Colgate's global branding strategy. This 3-year consistency suggests that Palmolive continues to play a foundational role in supporting the company’s market position in key categories like liquid hand soap, dishwashing detergents, and household cleaners.",
      "llm_answer": "The repeated listing of Palmolive among the principal global trademarks in the 2022, 2023, and 2024 10‑K filings signals that the brand remains a core pillar of Colgate’s Oral, Personal and Home Care segment. It indicates that Palmolive is a key driver of sales, brand equity, and market presence, and that Colgate continues to prioritize and invest in this brand as a strategic asset.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in stating that Palmolive's consistent inclusion as a principal global trademark from 2022 to 2024 reflects its strategic importance in Colgate’s Oral, Personal and Home Care segment. All years (2022, 2023, 2024) are accurately referenced, and there are no numerical or date inaccuracies—this earns a perfect quantitative accuracy score. The answer correctly identifies the entity (Palmolive) and its role within Colgate’s brand portfolio. However, it lacks specific contextual details present in the ground truth, such as the comparative positioning with other brands (e.g., Ajax, Darlie), the absence of positional dilution, and the explicit mention of product categories like liquid hand soap and dishwashing detergents. While the LLM captures the overall strategic significance, it omits evidence of multi-hop synthesis across the three years’ disclosures that would demonstrate deeper reasoning. The answer is semantically aligned and contextually relevant, but slightly less complete in elaborating the sustained role through evolving brand lineups. Hence, qualitative accuracy is high but not full, and overall correctness is strong but not comprehensive.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 336,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Qualcomm's positioning and strategic emphasis on Edge Networking evolve from fiscal 2022 through 2024, particularly in terms of its role in IoT growth projections, product categorization, and revenue recognition structure?",
      "original_answer": "In fiscal 2022, Qualcomm positioned Edge Networking as a key growth driver within the IoT segment, citing over 27 billion projected IoT devices by 2026 — more than double the 2022 figure — and linking it to hybrid work trends and wireless technology advances like 5G and Wi-Fi 6/6E. By fiscal 2023, Edge Networking was explicitly included in Qualcomm’s third revenue category alongside consumer and industrial applications, indicating a formalized product grouping that included mobile broadband and wireless access points. In fiscal 2024, Qualcomm maintained this same product categorization, signaling strategic continuity in its Edge Networking focus. The revenue recognition structure remained consistent across 2023 and 2024, with Edge Networking falling under the broader QCT segment that included royalty and incentive-related revenue recognition from prior periods. This 3-year progression shows Qualcomm's strategic transformation of Edge Networking from an emerging IoT opportunity in 2022 to a structurally embedded product pillar by 2023, with sustained emphasis through 2024.",
      "llm_answer": "Qualcomm’s 2022 10‑K (pp. 6‑10) positioned edge‑networking as a key driver of its IoT strategy, noting that the installed base of IoT devices – including edge‑networking products such as mobile broadband and wireless access points – was projected to more than double by 2026.  In the 2023 and 2024 10‑Ks (pp. 71‑75), edge‑networking is listed as a distinct sub‑segment of the IoT portfolio (alongside consumer and industrial), and its equipment revenue is still recognized at point‑in‑time while licensing revenue is recognized over time; the 2024 filing also highlights the separate recognition of previously satisfied performance obligations and unearned revenue tied to future edge‑networking contracts.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor omissions and slight imprecision in describing the revenue recognition structure. (1) Quantitatively, all key facts are accurate: the 2026 IoT projection (more than double by 2026), inclusion of Edge Networking as a distinct sub-segment in 2023 and 2024, and correct fiscal years. The LLM correctly notes the continuity in product categorization and references point-in-time vs over-time revenue recognition, which matches the ground truth's mention of royalty and incentive-related revenue from prior periods. (2) However, the LLM overemphasizes 'equipment' and 'licensing' revenue breakdowns not explicitly detailed in the original answer, and introduces 'unearned revenue tied to future edge-networking contracts'—a detail not present in the ground truth. While plausible based on accounting standards, this specific phrasing and focus slightly deviate from the original emphasis on revenue categorization within QCT and recognition of previously satisfied obligations. (3) The multi-hop reasoning is sound: the LLM synthesizes information across 2022, 2023, and 2024 filings, correctly tracing the evolution from strategic emphasis to formal categorization. It accurately identifies the structural embedding of Edge Networking by 2023 and sustained focus in 2024. (4) The answer is contextually excellent—directly addressing positioning, IoT growth, product categorization, and revenue recognition. The minor deduction in correctness and qualitative accuracy is due to the slight misrepresentation of revenue recognition details, though the core facts and trajectory are preserved. Overall, this is a strong, factually grounded response with high semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 476,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Caterpillar's exposure to and management of currency exchange rate risk through hedging instruments evolve from 2022 to 2024, particularly in relation to its international operations and earnings volatility?",
      "original_answer": "From 2022 to 2024, Caterpillar consistently highlighted its exposure to currency exchange rate risk due to its global operations, emphasizing the use of currency hedging instruments as a key strategy to mitigate adverse fluctuations. In 2022, CAT noted that while hedging instruments could protect against downside risks, they also limited potential upside from favorable currency movements. By 2023, the company expanded its discussion to include risks from exchange controls and currency devaluations, particularly in emerging markets, indicating a growing concern over geopolitical and macroeconomic volatility affecting its foreign subsidiaries. In 2024, Caterpillar reiterated its reliance on hedging strategies but also underscored the limitations of these instruments in the face of unpredictable global currency dynamics, especially as exchange controls and devaluation risks intensified. The multi-year trend reveals a consistent but increasingly cautious approach to managing currency exposure, with rising emphasis on external macroeconomic pressures.",
      "llm_answer": "Caterpillar’s disclosures in 2022, 2023 and 2024 all note that the company’s global operations generate revenue and costs in many currencies and that “fluctuations in currency exchange rates have had, and will continue to have, an impact on our results as expressed in U.S. dollars”【2022‑pages 20‑24】【2023‑pages 17‑21】【2024‑pages 17‑21】.  In each year it reiterates that it uses currency‑hedging instruments to mitigate adverse moves, but that such hedges can forego potential gains and that the coverage remains limited, leaving earnings volatility from FX swings largely unchanged【2022‑pages 20‑24】【2023‑pages 17‑21】【2024‑pages 17‑21】.  No material change in the scope or amount of hedging was disclosed, indicating a largely unchanged approach despite the continued exposure from its international operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and correctly identifies Caterpillar's consistent use of hedging instruments from 2022 to 2024, as well as the limitations of those hedges in protecting against earnings volatility. It accurately reflects that Caterpillar maintained a stable hedging approach with no material changes in scope or amount, which aligns with the ground truth. Quantitative accuracy is perfect—no numerical errors, and the cited page ranges are consistent with the source structure (though specific numbers like dollar amounts aren't present, the qualitative disclosures are correctly represented). However, the LLM answer omits a key evolution highlighted in the original answer: the increasing emphasis on emerging market risks such as exchange controls and currency devaluations, particularly noted in 2023 and 2024. This reflects a growing concern due to geopolitical and macroeconomic volatility, which the LLM answer fails to mention. While it correctly states that the approach remained largely unchanged, it misses the nuanced shift in risk discourse—showing a more cautious tone over time—which is central to how Caterpillar’s *management* of risk evolved in narrative and strategic awareness, even if not in hedging volume. This omission reduces completeness and weakens the multi-hop synthesis across years, particularly in capturing evolving qualitative risk assessments. Contextual relevance is high, as the response directly addresses currency exposure, hedging use, and earnings volatility in relation to international operations. Overall, the answer is factually sound but lacks depth in capturing the evolving risk narrative, warranting a 7 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 469,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Colgate-Palmolive's (CL) allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio evolve from 2022 to 2024, and what does this trend suggest about the company's approach to interest rate risk management during this period?",
      "original_answer": "Colgate-Palmolive's allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio decreased from 50% as of December 31, 2020 (disclosed in the 2022 filing) to 40% as of December 31, 2021, then further declined to 30% as of December 31, 2022 (reported in the 2023 filing), and remained steady at 30% as of December 31, 2023 and 2024 (reported in the 2024 filing). This gradual reduction over two years followed by stabilization suggests a strategic shift away from government-backed securities toward other government bonds and corporate bonds, potentially reflecting a response to rising interest rates during this period. The company maintained a Level 2 classification for these securities, indicating continued over-the-counter trading with limited daily pricing or liquidity, which aligns with an approach that balances interest rate risk with liquidity considerations.",
      "llm_answer": "Colgate‑Palmolive cut its U.S. Treasury/agency exposure in the pension plan fixed‑income portfolio from roughly 40 % in 2022 to about 30 % in 2023, and the allocation remained at that level in 2024 (CL_10k_2022, p. 101; CL_10k_2023, p. 103; CL_10k_2024, p. 100). This downward trend and subsequent plateau indicate a deliberate move to diversify away from Treasury securities, suggesting the company is moderating duration and interest‑rate risk by adopting a more balanced fixed‑income mix during the period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains a key inaccuracy in the starting percentage and year. The original answer states that Colgate-Palmolive's allocation was 50% as of December 31, 2020 (reported in the 2022 filing), then declined to 40% as of December 31, 2021, and further to 30% as of December 31, 2022. However, the LLM claims the reduction was from 'roughly 40% in 2022' to 30% in 2023, which misrepresents both the starting point and the timeline. The correct trend begins earlier and shows a two-year decline starting from 50%, not a one-year drop from 40%. The 30% level in 2023 and 2024 is correctly reported. (2) Quantitative accuracy is compromised because the LLM omits the 50% and 40% data points and incorrectly anchors the timeline in 2022 at 40%, when the 2022 filing actually reports the 2020 data point (50%). This affects the fidelity of the trend description. (3) The reasoning about diversification and interest rate risk management is sound and aligns with the original answer’s interpretation—suggesting a strategic shift to moderate duration and risk through a more balanced mix. The use of 'plateau' to describe stability in 2023–2024 is appropriate. (4) Contextual relevance is high as the answer addresses both parts of the question: the evolution of allocation and its implication for interest rate risk. Despite incorrect initial values, the core narrative of reduction followed by stabilization is preserved. However, the failure to accurately represent the full multi-year trend from 2020–2022 reduces quantitative and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 438,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Pfizer's treatment and valuation of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and disclosure transparency?",
      "original_answer": "From 2022 to 2024, Pfizer's treatment of Breakthrough Performance Awards (BPAs) underwent a notable evolution. In 2022, BPAs were actively granted, with 1,165 thousand shares awarded at a weighted average intrinsic value of $38.73 per share, and 859 thousand shares remained nonvested by year-end. By 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a pause or discontinuation of the program. In 2024, BPAs reappeared in disclosures, with detailed valuation and amortization policies introduced, including the use of intrinsic value at the grant date and adjustments based on performance probability and stock price changes. This 3-year trajectory suggests a strategic shift in how Pfizer structured and communicated its BPA program, moving from active issuance to suspension and then to a more transparent and dynamic valuation framework.",
      "llm_answer": "From 2022 through 2024 Pfizer consistently reported **no Breakthrough Performance Awards (BPAs) granted or outstanding** (2022 note, 2023 note, 2024 note).  The valuation methodology remained unchanged—BPAs were valued at the intrinsic value using the closing price of Pfizer’s common stock and amortized over the vesting term (described in each year’s note).  Disclosure transparency stayed consistent, with each filing explicitly stating zero BPA activity and providing the same terms, valuation, and accounting treatment for the award type.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and contradicts the ground truth. (1) It claims that Pfizer reported 'no BPAs granted or outstanding' from 2022 to 2024, which is false: in 2022, 1,165 thousand shares were granted and 859 thousand remained nonvested. The ground truth confirms active grant activity in 2022, a pause in 2023 (no grants, none outstanding), and a reintroduction with enhanced valuation methodology in 2024. The LLM incorrectly states zero activity across all three years. (2) Quantitative accuracy is extremely low: the LLM omits or misstates all key numbers—1,165 thousand shares granted in 2022, $38.73 weighted average intrinsic value, and 859 thousand nonvested shares. These are entirely absent or falsely reported as zero. (3) Qualitative reasoning fails: the LLM asserts 'consistent' treatment over the period, but the ground truth shows a clear evolution—active use, suspension, then reintroduction with improved transparency and dynamic valuation. The model fails to recognize this multi-hop trajectory and instead asserts stasis. (4) Contextual relevance is low but not zero—the response addresses the right topic (BPAs) and mentions valuation and disclosure, but with incorrect facts. The mention of intrinsic value and amortization aligns with the general accounting treatment, but it is applied to a false narrative of no activity. Overall, the answer reflects a fundamental misunderstanding of the data, likely due to misreading or hallucination of the filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 411,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Charles Schwab's interactive tools for RIAs evolve from 2022 through 2024, particularly in terms of third-party integrations and portfolio management capabilities?",
      "original_answer": "In 2022, Schwab emphasized its proprietary software and online platform for RIAs, including access to third-party platforms supporting client relationship management, portfolio management systems, trade order management, and financial planning. A key offering was Schwab Advisor Portfolio Connect, a free portfolio management solution that allowed advisors to manage Schwab accounts without needing to download and reconcile data. By 2023, Schwab continued to highlight these integrations but placed increased emphasis on the Advisor Services website as a core platform for RIAs, offering multi-year document archiving and search capabilities alongside third-party integrations. In 2024, Schwab maintained its focus on technology and platform scalability, reiterating the importance of integrations with third-party platforms and continuing to offer Schwab Advisor Portfolio Connect. However, 2024's filing specifically reinforced the intuitive modern experience of the platform, suggesting a refinement or enhancement in usability and feature delivery over the three-year period.",
      "llm_answer": "From 2022 through 2024 Schwab’s Advisor Services portal consistently offered RIAs an interactive web platform that provided account‑management, trade execution, archival tools and a free Schwab Advisor Portfolio Connect for portfolio oversight, while also enabling third‑party integrations for CRM, portfolio‑management, trade‑order and financial‑planning systems. The core interactive features and integration framework remained largely unchanged in 2023, continuing to support the same suite of tools and services. In 2024 Schwab expanded these capabilities by integrating the thinkpipes trading platform and the iRebal portfolio‑rebalancing solution, giving RIAs more advanced, automated portfolio‑management options beyond the simplified Advisor Portfolio Connect.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct in describing Schwab's interactive tools for RIAs from 2022 to 2024, particularly in noting the consistent availability of third-party integrations and Schwab Advisor Portfolio Connect. It correctly identifies the core platform capabilities such as account management, trade execution, and integration with CRM, portfolio management, and financial planning systems. However, the answer introduces two specific platforms—'thinkpipes' and 'iRebal'—as new 2024 integrations, which are not mentioned in the original ground truth. The ground truth indicates that while Schwab emphasized platform usability and scalability in 2024, there was no mention of new integrations like iRebal or thinkpipes; instead, the evolution was characterized by refinements to the user experience and continued support for existing integrations. This represents a significant factual error in entity accuracy and reasoning, as the model fabricates specific product integrations not present in the source. There are no numerical values in the question or answer, so quantitative accuracy is not applicable—scored as 10 by default. The answer is contextually relevant and addresses the question's focus on evolution in third-party integrations and portfolio management, but the incorrect addition of non-existent tools undermines the qualitative accuracy and overall correctness. The multi-hop synthesis is flawed because it invents developments in 2024 rather than accurately reflecting the gradual emphasis on usability and document management as described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 433,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent framing reveal about its long-term positioning in semiconductor markets?",
      "original_answer": "Texas Instruments consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024. In each year, the company highlighted that its strategy is 'built around four sustainable competitive advantages,' with a broad portfolio of analog and embedded processing products (point 1.ii) serving as a key pillar. This consistent framing across all three annual reports indicates that embedded processing products remained central to TI's long-term positioning in semiconductor markets, supporting its objective of growing free cash flow per share by offering more value per customer and per investment.",
      "llm_answer": "Across 2022, 2023, and 2024 Texas Instruments consistently framed its strategy around analog and embedded‑processing products, noting a modest 3 % rise in embedded‑processing revenue in 2023 and a 25 % decline in 2024 but maintaining it as a core focus (2022 MD&A, pages 18‑22; 2023 MD&A, pages 16‑20; 2024 MD&A, pages 16‑20). This unchanging emphasis signals TI’s long‑term positioning as a leading analog‑and‑embedded‑processing supplier—particularly for industrial and automotive markets—where a diversified, high‑margin portfolio underpins sustained free‑cash‑flow growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in quantitative data. The claim of a '3% rise in embedded-processing revenue in 2023' and a '25% decline in 2024' is not supported by the ground truth, which does not provide any such revenue figures or trends. These numbers are likely hallucinated or incorrectly extracted, severely undermining factual correctness. (2) There is no mention in the original answer of year-over-year revenue changes, so these specific percentages (3%, 25%) cannot be verified and contradict the absence of such data in the ground truth. This results in a very low quantitative accuracy score. (3) Qualitatively, the LLM correctly identifies that Texas Instruments consistently emphasized embedded processing as part of its long-term strategy across the three years and links it to analog products and free cash flow growth—aligning with the ground truth’s emphasis on the 'four sustainable competitive advantages' and the role of embedded processing within them. The synthesis of strategic consistency and long-term positioning in industrial and automotive markets is reasonable and contextually logical, though not explicitly detailed in the original. (4) Contextual relevance is high because the answer addresses both parts of the question—evolution of strategic emphasis and implications for long-term positioning—and correctly frames embedded processing as a persistent strategic pillar. However, the inclusion of fabricated revenue trends severely damages overall correctness, limiting the score despite accurate qualitative reasoning. Semantic equivalence fails due to the introduction of unsupported numerical claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 458,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did the cost profile and delivery impact of Boeing's fleet support services evolve from 2022 through 2024, particularly in relation to abnormal production costs and delivery delays associated with the 787 program?",
      "original_answer": "From 2022 through 2024, Boeing's fleet support services remained consistently described as accounting for approximately 1% of total consolidated costs of products and services. However, the 787 program's abnormal production costs and delivery delays significantly evolved during this period. In 2022, the company noted ongoing delivery delays and potential future losses due to rework and production instability, with no specific abnormal cost figures disclosed. In 2023, Boeing revealed cumulative abnormal production costs of $2.7 billion through December 31, 2023, primarily related to rework on inventoried aircraft, with expectations that remaining rework costs would not be significant. By 2024, the company had completed rework on most of the 25 inventoried aircraft produced prior to 2023 and expensed $256 million in rework costs during the year, with expectations to deliver the majority of these aircraft in 2025. This progression indicates a reduction in abnormal costs and a gradual resolution of delivery delays, though the program continued to face production and certification challenges.",
      "llm_answer": "Fleet‑support costs stayed essentially flat, remaining about 1 % of total consolidated costs in 2022 (pages 40‑44) and again in 2024 (pages 37‑41).  Abnormal 787 production costs, however, rose sharply—from a projected $2 billion in 2022 to $2.7 billion by year‑end 2023 (pages 34‑38) and then $256 million in 2024 (pages 37‑41) as rework and inspections were expensed.  Delivery delays mirrored this trend: 787 deliveries were paused in 2021, resumed at roughly five per month in 2023, but slowed again below five per month in 2024 due to supply‑chain constraints and rework, continuing to affect the program’s schedule.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that fleet support services accounted for approximately 1% of total consolidated costs in 2022 and 2024, aligning with the ground truth. It accurately reports the cumulative abnormal production costs of $2.7 billion by the end of 2023 and the $256 million expensed in 2024. However, the ground truth does not mention a 'projected $2 billion in 2022'—this figure is not present in the original answer, which states that no specific abnormal cost figures were disclosed for 2022. This is a minor factual overstatement. (2) The delivery timeline is mostly accurate: deliveries resumed in 2023 at about five per month and slowed in 2024, consistent with the ground truth's mention of ongoing delays due to rework and supply chain issues. The ground truth adds that most of the 25 inventoried aircraft were reworked by 2024 and expected to be delivered in 2025, which the LLM omits, reducing completeness. (3) The multi-hop reasoning is sound—linking cost trends to delivery impacts across years and programs—but the unsupported $2 billion projection in 2022 weakens quantitative precision. (4) Despite the minor error and slight omission regarding the 25 aircraft and 2025 delivery expectations, the answer captures the core evolution: flat support costs, rising then tapering abnormal costs, and persistent delivery challenges. Wording differences are semantically acceptable. Scores reflect high accuracy with room for improvement in strict factual fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 415,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial implications and ongoing contractual arrangements post-sale?",
      "original_answer": "In 2022, Pfizer disclosed that Meridian was part of discontinued operations following its sale on December 31, 2021, with the company recognizing a loss of approximately $167 million, net of tax. Interim transition service agreements (TSAs) and a three-year Manufacturing Supply Agreement (MSA) were in place to support the post-sale relationship. By 2023, services under the TSAs were completed as of December 31, 2023, and amounts recorded under the MSA were not material to Pfizer's operations. In 2024, Meridian was referenced in Pfizer's glossary as 'Meridian Medical Technologies, Inc.,' indicating continued recognition of the entity, likely due to the ongoing MSA, which had a two-year extension option beyond the initial three-year term. This trajectory shows a transition from a direct ownership relationship to a limited but structured supplier relationship, with financial impacts diminishing over time.",
      "llm_answer": "Pfizer sold Meridian to a purchaser on December 31, 2021 for about $51 million, recording a $167 million loss (net of tax) in 2021.  In 2022 no cash or revenue was recorded under the post‑sale transition‑service agreements (TSAs) or the manufacturing‑service agreement (MSA); the MSA was set for a three‑year term with a two‑year extension.  By 2023 the TSAs had been completed (but still not material to the financial statements), and the 2024 filing confirms the same MSA framework remains in place with no material amounts recorded through 2024.  (Sources: 2022 10‑K pp. 114‑118; 2023 10‑K pp. 71‑75; 2024 10‑K pp. 2‑6.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $167 million loss (net of tax) is accurately reported, and the December 31, 2021 sale date is correct. The $51 million sale price, while not included in the original answer, is factually accurate and consistent with external disclosures, so its inclusion does not detract from correctness. The three-year MSA with a two-year extension option is correctly stated. (2) The timeline across 2022–2024 is well-represented: TSAs were active in 2022 and completed by end of 2023, with no material financial impact, matching the original answer. The MSA continuing into 2024 with no material amounts recorded is also correct. (3) Multi-hop reasoning is sound—information is synthesized across three 10-K filings (2022, 2023, 2024), showing evolution over time. (4) The only minor gap is that the LLM does not explicitly mention Meridian’s inclusion in the 2024 glossary as 'Meridian Medical Technologies, Inc.', which the original answer cites as evidence of continued recognition. While the ongoing MSA implies this, the specific glossary reference adds contextual support that is missing. However, this is a small omission that does not undermine the core factual accuracy. Wording differs slightly (e.g., 'manufacturing-service agreement' vs 'Manufacturing Supply Agreement'), but terminology is semantically equivalent. Overall, the answer correctly captures the transition from ownership to a limited supplier relationship with diminishing financial impact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 433,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Colgate-Palmolive's strategic positioning of the 'hello' brand evolved from 2022 to 2024 in relation to its other Oral, Personal and Home Care product lines?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive consistently included 'hello' among its principal global and regional trademarks within the Oral, Personal and Home Care segment, indicating sustained strategic emphasis. In 2022, 'hello' was listed alongside major brands like Colgate and Palmolive; in 2023, the brand maintained this positioning despite the addition of Darlie to the list; and in 2024, 'hello' remained a highlighted brand, suggesting continued prioritization within the company’s broader oral and personal care portfolio. This consistent visibility implies that 'hello' has maintained a strategic brand position relative to other key product lines over the three-year period.",
      "llm_answer": "Colgate‑Palmolive continues to list **hello** as one of its global trademarks within the Oral, Personal and Home Care segment and makes no mention of a repositioning or strategic shift for the brand in its 2022, 2023 or 2024 10‑Ks. The filings show that hello remains marketed alongside other global brands such as Colgate, Palmolive, and others, with its positioning relative to the other product lines staying essentially unchanged over the period【CL_10k_2022.pdf pages 75‑79】【CL_10k_2023.pdf pages 77‑81】【CL_10k_2024.pdf pages 77‑81】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that 'hello' has remained a consistently listed global trademark within Colgate-Palmolive’s Oral, Personal and Home Care segment from 2022 to 2024, with no indication of repositioning. The answer correctly references the continuity of 'hello' alongside major brands like Colgate and Palmolive, and cites appropriate document sections. Quantitative accuracy is perfect—no numerical or date inaccuracies, and the time frame (2022–2024) is correctly handled. The reasoning is sound: the model synthesizes information across three years of 10-K filings and correctly infers stable strategic positioning due to consistent listing. The only minor shortcoming is that the LLM does not explicitly note the addition of Darlie in 2023 (mentioned in the ground truth), which slightly weakens the depth of multi-hop synthesis, though it doesn’t affect the overall conclusion. Semantically, the answer conveys the same core message: 'hello' has maintained a stable, prioritized position. Contextual relevance is excellent—the response directly addresses the evolution (or lack thereof) of the brand’s strategic positioning in relation to other product lines.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 348,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the funding status and participant engagement in Texas Instruments' Non-Qualified Defined Benefit Pension Plan evolve from 2022 through 2024, and what does this multi-year progression indicate about the company's long-term pension obligations and employee participation trends?",
      "original_answer": "From 2022 through 2024, Texas Instruments' Non-Qualified Defined Benefit Pension Plan remained unfunded and closed to new participants, with the company continuing to emphasize defined contribution alternatives. In 2022, the U.S. defined contribution plans held 6 million shares of TI common stock valued at $940 million, while in 2023, this decreased to 5 million shares valued at $873 million, and remained at 5 million shares in 2024, valued at $852 million. Dividends paid on these shares declined slightly from $28 million in 2022 to $27 million in 2023 and $26 million in 2024. The company's aggregate expense for U.S. defined contribution plans increased steadily across the period—$70 million in 2022, $75 million in 2023, and $76 million in 2024—suggesting a growing emphasis on defined contribution plans as the primary retirement vehicle for employees. This trend indicates a strategic shift away from defined benefit obligations, with the non-qualified pension plan remaining an unfunded legacy liability and not a growing obligation.",
      "llm_answer": "Texas Industries’ non‑qualified defined‑benefit pension plan has stayed **unfunded and closed to new participants** throughout 2022‑2024, with no change in its funding status reported in the 10‑Ks. Because the plan is closed, **participant engagement has remained static**—only the existing cohort continues to accrue benefits, and no new hires are added. This steady, unfunded status shows that the company’s long‑term pension liabilities are concentrated in the qualified defined‑benefit plan (which remains under‑funded), while the non‑qualified plan is not being expanded or funded, reflecting a shift toward defined‑contribution plans for new employees.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies and omits key quantitative data from the ground truth. It incorrectly refers to 'Texas Industries' instead of 'Texas Instruments', which is a critical entity error. The answer fails to include any of the specific financial figures provided in the original answer—such as the number of shares (6M, 5M, 5M), their values ($940M, $873M, $852M), dividend payments ($28M, $27M, $26M), or defined contribution expenses ($70M, $75M, $76M). These omissions severely undermine quantitative accuracy. (2) There are no correct numbers reported; all key metrics are missing. The claim about the 'qualified defined-benefit plan' being underfunded is not supported in the ground truth, which focuses on the non-qualified plan and does not mention the funding status of the qualified plan. (3) While the LLM correctly identifies that the non-qualified plan is unfunded and closed to new participants—indicating some correct multi-hop synthesis—the reasoning about a strategic shift toward defined contribution plans is only partially supported due to lack of data citation. The conclusion about liability concentration in the qualified plan is unsupported and potentially incorrect. (4) Despite correct identification of the plan’s static status, the absence of all numerical evidence and misstatement of the company name result in a low correctness score. The answer is contextually relevant to the question’s intent but fails on factual precision and completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 419,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Pfizer's (PFE) long-term investment in private equity securities at cost change from 2022 through 2024, and what does this 3-year trajectory indicate about the company's strategic allocation to this asset class?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, before declining slightly to $719 million in 2024. This trajectory indicates a short-term strategic increase in 2023 followed by a partial reduction in 2024, suggesting a measured approach to capital allocation in private equity over the three-year period.",
      "llm_answer": "Pfizer’s long‑term private‑equity at cost declined from **$800 million** at 12/31/2022 to **$755 million** at 12/31/2023 and further to **$719 million** at 12/31/2024. This steady downward trend over three years indicates a deliberate reduction in exposure to private‑equity securities, suggesting the company is reallocating capital toward other investments or risk‑management priorities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, Pfizer's long-term investment in private equity securities at cost was $623 million in 2022, not $800 million as stated in the LLM answer. The 2023 value of $755 million is correct, and the 2024 value of $719 million is also correct. Therefore, the LLM incorrectly reports the starting value, which distorts the entire trajectory analysis. (2) The calculation of trend direction is flawed due to the incorrect baseline: the ground truth shows an increase from 2022 to 2023 ($623M → $755M), but the LLM claims a decline from $800M to $755M, which is factually wrong. The slight decline from 2023 to 2024 ($755M → $719M) is correctly identified. (3) The multi-hop reasoning is partially sound in that it attempts to synthesize a three-year trend, but the incorrect initial value leads to a flawed conclusion about a 'steady downward trend.' The actual trajectory — an increase followed by a partial decrease — suggests a more nuanced, measured strategy, not a deliberate reduction as claimed. The LLM fails to capture this nuance due to the incorrect data. (4) Contextual relevance is high because the answer addresses both parts of the question — the numerical changes and the strategic implication — and uses appropriate financial terminology. However, the qualitative reasoning is based on incorrect inputs, undermining the conclusion. Scores reflect major quantitative error (especially the $800M vs $623M discrepancy), partial correctness in later years, and logically sound but misinformed interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 448,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024 under the changing terms of the IDA agreements, and what constraints were placed on this migration capability in each year?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to capital sufficiency and other limitations, and it had already moved $10.1 billion by December 31, 2021. In 2023, Schwab did not move any IDA balances to its balance sheet after the 2023 IDA agreement replaced the 2019 agreement, introducing new constraints such as maintaining minimum and maximum IDA balance thresholds. In 2024, Schwab remained under the terms of the 2023 IDA agreement and did not migrate any IDA balances, as the agreement required Schwab to maintain minimum balances above the then-outstanding unmatured fixed-rate obligation amounts with a maximum of $30 billion above that total through September 10, 2025. The evolution shows a tightening of Schwab's flexibility to move IDA balances, shifting from an annual $10 billion option to a constrained and conditional framework.",
      "llm_answer": "Under the 2019 IDA agreement that was still in effect in 2022, Schwab could move up to $10 billion of IDA balances each year, but only floating‑rate balances and only if it kept a minimum $50 billion IDA balance and at least 80 % of balances as fixed‑rate obligations through 2026; it migrated roughly $10 billion that year. The 2023 IDA agreement replaced those terms, eliminated the 80 % fixed‑rate rule, required Schwab to maintain balances above the total of unmatured fixed‑rate obligations with a $30 billion ceiling, and limited withdrawals to customer‑initiated amounts; Schwab did not migrate any balances in 2023 or 2024, and the same minimum‑balance and withdrawal constraints applied in 2024. In each year, the migration option was also contingent on Schwab’s capital levels and the binding limitations set out in the applicable IDA agreement.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in structure and captures the evolution of Schwab's IDA balance migration constraints from 2022 to 2024, but contains key factual inaccuracies. It correctly states that Schwab migrated roughly $10 billion in 2022 under the 2019 IDA agreement and did not migrate any balances in 2023 or 2024 under the new agreement. However, it introduces a $50 billion minimum IDA balance and an 80% fixed-rate obligation requirement that are not present in the ground truth. The ground truth does not mention these specific thresholds (e.g., 80% fixed-rate rule), making this a significant error. (2) Quantitative accuracy is partially compromised: while the $10 billion annual migration limit in 2022 and the $30 billion ceiling in 2023/2024 are correct, the $50 billion minimum balance and 80% fixed-rate rule are unsupported by the ground truth and appear to be fabrications or misinterpretations. The claim that Schwab migrated 'roughly $10 billion' in 2022 is plausible but not confirmed in the original answer, which only states that $10.1 billion had already been moved by December 31, 2021. (3) The multi-hop reasoning is sound in that the model correctly identifies the shift from the 2019 to the 2023 IDA agreement and infers that migration stopped in 2023 and 2024 due to new constraints. It correctly notes that capital sufficiency remained a condition and that the 2023 agreement imposed balance thresholds tied to unmatured fixed-rate obligations with a $30 billion cap through 2025. However, the addition of unsupported constraints weakens the qualitative accuracy. (4) The contextual relevance is excellent—the answer directly addresses the evolution of migration capability and constraints year by year. Despite the factual overreach, the core narrative of tightening flexibility is preserved. Hence, correctness is scored 7 for core facts being right but with notable errors; quantitative accuracy is 6 due to incorrect thresholds; qualitative accuracy is 8 for strong reasoning despite errors; and contextual relevance is 10 as the response is fully on-topic and structured appropriately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 574,
        "total_tokens": 2042
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog product manufacturing, and what does this multi-year consistency suggest about the strategic importance of this location?",
      "original_answer": "Texas Instruments consistently listed Melaka, Malaysia as a location involved in analog product manufacturing across all three years—2022, 2023, and 2024. In 2022, Melaka was marked with a † indicating involvement in analog operations. In 2023, this marking continued with an asterisk (*), and in 2024, it was marked with a double asterisk (**), potentially signaling continued operational emphasis. The consistent presence and possible escalation in Melaka over the three-year period suggest a stable and potentially expanding strategic role in TI's global analog manufacturing footprint.",
      "llm_answer": "Texas Instruments listed Melaka, Malaysia as an analog‑manufacturing site in its 2022, 2023 and 2024 10‑K filings (TXN_10k_2022.pdf pp. 16‑18; TXN_10k_2023.pdf pp. 14‑18; TXN_10k_2024.pdf pp. 14‑18). The site remained solely an analog facility, with no embedded‑processing designation, across all three years. This persistent, multi‑year presence signals a deliberate, long‑term commitment to analog production at Melaka, underscoring its strategic value as a stable, cost‑effective manufacturing hub in Southeast Asia.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately states that Texas Instruments consistently listed Melaka, Malaysia as an analog manufacturing site across 2022, 2023, and 2024, which matches the original answer's claim of multi-year consistency. The LLM correctly notes the absence of embedded-processing designation, reinforcing the site’s specialization in analog production. While the original answer highlights symbolic markers (†, *, **) potentially indicating escalating emphasis, the LLM does not mention these specific annotations but still correctly infers strategic importance through 'persistent, multi-year presence' and 'long-term commitment.' This omission is minor and does not detract from the overall correctness, as the core factual content—consistent involvement in analog manufacturing and strategic significance—is accurate. All entities (Texas Instruments, Melaka, Malaysia, analog manufacturing, correct years) are properly identified. The reasoning is sound, demonstrating multi-hop synthesis across three annual reports. The answer is contextually relevant and conveys semantic equivalence to the ground truth, with only a slight lack of detail regarding the evolving notation markers. Quantitative accuracy is perfect—no numerical or date errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 364,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about the card's role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (included under RedCards/Target Circle Cards) was 20.5% in 2022, decreased to 19.8% in 2023, and further declined to 17.8% in 2024. This downward trend over three years suggests a diminishing role of the card in influencing customer purchasing behavior, potentially signaling reduced effectiveness in driving incremental sales or shifts in consumer payment preferences despite the 5% discount incentive.",
      "llm_answer": "The Target Circle Card penetration – which includes the Target Debit Card – fell from **20.5 % in 2022** to **19.8 % in 2023** and **18.6 % in 2024** (2024 Form 10‑K, p. 27‑31; 2023 Form 10‑K, p. 25‑29; 2022 Form 10‑K, p. 44‑48). This downward trend suggests the card’s ability to generate incremental sales is weakening, as fewer guests are using it for purchases, thereby reducing its incremental‑sales contribution over time.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the penetration rates for 2022 (20.5%) and 2023 (19.8%), matching the ground truth. However, it reports 18.6% for 2024, whereas the ground truth states 17.8%, making the final data point factually incorrect. This error affects the quantitative accuracy significantly. (2) The numbers for 2022 and 2023 are accurate and properly cited to the respective 10-K filings. The 2024 figure is incorrect—despite the citation to the 2024 Form 10-K, the value reported (18.6%) does not match the ground truth (17.8%), indicating either a misreading of the source or an error in extraction. No calculations are required beyond reporting percentages, but the trend interpretation relies on correct data points. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers that declining penetration suggests a weakening role in driving incremental sales. The logic connecting reduced usage to diminished sales impact aligns with the ground truth’s interpretation. (4) Contextual relevance is perfect—the answer addresses both parts of the question: the evolution of penetration and its implication for incremental sales. The qualitative reasoning is strong and semantically equivalent to the original answer, except for the inaccurate 2024 figure. Due to the single but significant numerical error, the correctness score is reduced to 7, quantitative accuracy to 6, while qualitative and contextual scores remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 412,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the number of shares available for future issuance under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 through 2024, and what does this trend suggest about the company's use and replenishment of equity incentives for directors?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 35,385,153 shares in 2022 to 25,296,767 shares in 2023, and then to 24,503,062 shares in 2024. This consistent decline suggests that Texas Instruments has been actively utilizing its equity pool for director compensation without replenishment, indicating sustained investment in director incentives as part of its corporate governance strategy.",
      "llm_answer": "Texas Instruments’ 2003 Director Compensation Plan has been largely exhausted over the past three years – the plan’s shares are no longer separately disclosed in the 2024 equity‑compensation table (the total shares available for future issuance under all plans fell from 69.8 million in 2022 to 58.5 million in 2023 and rose to 65.5 million in 2024). This trend indicates the company is depleting the older plan’s balance and replenishing director equity incentives through newer plans (e.g., the 2024 LTIP) rather than restocking the 2003 plan.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both numbers and interpretation. According to the ground truth, the shares available under the 2003 Director Compensation Plan were 35,385,153 in 2022, 25,296,767 in 2023, and 24,503,062 in 2024 — showing a consistent decline. The LLM claims the plan is 'no longer separately disclosed' in 2024 and cites aggregate figures across all plans (e.g., 69.8 million, 58.5 million, 65.5 million), which are irrelevant to the specific 2003 Director Compensation Plan. These aggregate numbers do not support the conclusion about this particular plan. (2) Quantitative accuracy is very low: none of the cited numbers match the ground truth for the 2003 plan. The LLM confuses total shares across all equity plans with the specific director plan in question. There are no correct figures for the 2003 plan in the response. (3) The multi-hop reasoning is flawed. Instead of tracking the evolution of shares in the 2003 Director Compensation Plan across years, the model incorrectly infers depletion based on absence of disclosure and shifts focus to newer plans like the 2024 LTIP — which may be true contextually but is not supported by the provided ground truth. The original answer indicates ongoing use without replenishment, while the LLM claims replenishment occurs through new plans — a contradictory conclusion based on incorrect data synthesis. (4) Contextual relevance is moderate because the answer addresses director equity incentives and corporate strategy, but it fails on correctness due to reliance on incorrect data and misidentification of the plan's status. The reasoning and entities (e.g., 2024 LTIP) are introduced without grounding in the provided truth. Thus, while the general topic is addressed, the factual core is inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 488,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's virtual accounts and related digital capabilities evolve across 2022, 2023, and 2024, particularly in terms of integration with the Visa Direct platform and expansion of cross-border use cases?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of the Currencycloud platform under Visa Treasury as a Service, emphasizing real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, virtual accounts were more deeply integrated into the Visa Direct platform, which also expanded to include Visa Cross-Border Solutions, enhancing the platform’s ability to service new flows and established cross-border consumer payments. In 2024, virtual accounts were a core component of Visa’s digitally native capabilities, supporting a network with the potential to reach over 11 billion endpoints across cards, bank accounts, and digital wallets, and were central to Visa’s strategy for addressing $20 trillion in annual B2B cross-border opportunities. This progression shows a clear trend of deepening integration and expanding use cases for virtual accounts across Visa’s global payments infrastructure.",
      "llm_answer": "In 2022 Visa Direct added push‑to‑wallet capabilities that let financial institutions send funds to nearly 7 billion cards, accounts and wallets worldwide, expanding its card‑based, ACH and RTP reach. By 2023 the platform had broadened its cross‑border reach—supporting P2P, A2A and government payouts in 195 + countries—yet still relied on traditional account identifiers. In 2024 Visa integrated its digitally native Currencycloud platform into Visa Direct, adding virtual accounts, real‑time FX rates and enhanced liquidity/settlement, thereby expanding cross‑border use cases and enabling new digital flows.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution of Visa's virtual accounts and digital capabilities across 2022–2024 with generally accurate reasoning and contextual relevance, but contains key quantitative and factual discrepancies. (1) Correct elements: The integration of Currencycloud’s virtual accounts, real-time FX, and enhanced settlement into Visa Direct by 2024 aligns with the ground truth. The emphasis on expanded cross-border use cases and digital flows is also consistent. The progression from traditional account identifiers to digitally native capabilities is logically presented. (2) Quantitative inaccuracies: The claim of '7 billion cards, accounts and wallets' in 2022 is not supported by the ground truth, which does not specify a number for 2022 reach. The ground truth states a potential reach of over 11 billion endpoints by 2024, not 7 billion in 2022. Additionally, the mention of '195+ countries' in 2023 is specific to the LLM answer and not present in the original, though plausible—it lacks verification. (3) Multi-hop reasoning is mostly sound: The answer correctly links virtual accounts (via Currencycloud) to Visa Direct and tracks integration over time. However, it misattributes the 2022 developments—push-to-wallet and reach expansion—not as the introduction of virtual accounts under Visa Treasury as a Service, which is the actual 2022 milestone. This misalignment affects factual precision. (4) The answer is contextually relevant and well-structured, addressing integration with Visa Direct and cross-border expansion. While the 2024 integration is accurately described, the earlier timeline points are partially conflated. Overall, the answer is semantically close but misses some key specifics and introduces unverified numbers, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 488,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Xtandi's revenue pressures in 2023 influence Pfizer's investment in its lifecycle management, as evidenced by the 2024 indication expansion and the 2022 valuation of the asset within Pfizer's intangible portfolio?",
      "original_answer": "In 2022, Xtandi was explicitly listed among Pfizer's most significant developed technology rights, indicating its importance to the company's oncology portfolio and intangible asset base. By 2023, Xtandi faced declining international revenues and downward pressure on net pricing, with revenues described as 'down 1%'—a sign of intensifying market challenges. In response, Pfizer pursued lifecycle management strategies, culminating in 2024 with the approval of Xtandi for a new indication—non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis. This expansion suggests that Pfizer actively invested in extending Xtandi's commercial life and value despite short-term revenue pressures, leveraging the asset strategically within its oncology pipeline to offset declining performance in existing markets.",
      "llm_answer": "Xtandi’s revenue slipped 1 % in 2023, prompting Pfizer to ramp up lifecycle‑management efforts.  This focus helped secure the EU indication approval in April 2024 (PFE_10k_2024, pp. 44‑48).  The asset’s value within Pfizer’s intangible portfolio was recorded at $19.6 billion in 2022, reflecting the developed‑technology‑rights carrying amount that includes Xtandi (PFE_10k_2022, pp. 90‑94).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Xtandi's 1% revenue decline in 2023 and references the 2024 indication expansion, aligning with the ground truth. It also correctly cites the $19.6 billion valuation of developed technology rights in 2022, which includes Xtandi. However, it introduces a specific dollar figure ($19.6B) not present in the original answer, which only states that Xtandi was among the most significant assets without quantifying it. While this number may be factually accurate from the source document, the original answer did not include it, so the addition goes beyond the ground truth. Additionally, the LLM specifies 'EU indication approval in April 2024', whereas the ground truth refers more generally to a 2024 approval for nmCSPC without specifying region or month—this adds precision not in the original and potentially misrepresents the scope. (2) Quantitatively, the 1% decline and $19.6B figure are accurately presented (assuming correct extraction from cited filings), and years (2022, 2023, 2024) are correct. The citation of document pages adds detail but does not affect factual accuracy. (3) The multi-hop reasoning is mostly sound: the model connects revenue pressure to lifecycle management and traces it to a new indication. However, it misses the explicit link between declining international revenues and pricing pressure mentioned in the original, slightly weakening the causal explanation. Also, the original emphasizes strategic investment despite short-term pressures, a nuance not fully captured. (4) Scores reflect high factual accuracy and relevance, with minor deductions for introducing unverified specifics (dollar amount, EU approval timing) not in the ground truth and for incomplete synthesis of the rationale behind Pfizer's actions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 489,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend indicate about consumer preference and loyalty program engagement during this period?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (included under RedCards™ in 2022 and rebranded as part of Target Circle Cards by 2024) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This consistent decline suggests a gradual reduction in the proportion of purchases made using these cards relative to total sales, potentially indicating a shift in consumer payment preferences or a weakening in loyalty program engagement over the three-year period.",
      "llm_answer": "The Target MasterCard Credit Card’s penetration fell from 20.5 % in 2022 to 19.8 % in 2023 and further to 18.6 % in 2024 (total RedCard penetration for the same periods). This downward trend signals a gradual shift in consumer preference away from the card and a weakening of engagement with Target’s loyalty program, suggesting the need for refreshed incentives to retain card usage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the penetration rates of 20.5% in 2022, 19.8% in 2023, and 18.6% in 2024, matching the ground truth exactly. These numbers are presented accurately with consistent formatting (allowing for thin space in '20.5 %'). (2) All quantitative values are correct, and no calculations are required beyond reporting the trend, which is done accurately. (3) The reasoning is sound: the downward trend is correctly interpreted as indicating a shift in consumer preference and weakening loyalty engagement, aligning with the original answer’s conclusion. The LLM adds a slight interpretive extension—'suggesting the need for refreshed incentives'—which is reasonable but not explicitly stated in the ground truth; this does not detract from accuracy but introduces a minor inference beyond the provided data. (4) The answer addresses both parts of the question: the evolution of penetration rates and the implication for consumer behavior and loyalty engagement. Entity accuracy is strong—'Target MasterCard Credit Card', 'RedCard', and implied rebranding to Target Circle Cards are contextually consistent, though the rebranding detail is slightly under-articulated. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth with only minor interpretive addition.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 377,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's use of virtual accounts evolve across its Currencycloud platform from fiscal years 2022 through 2024, particularly in terms of cross-border payment capabilities and network reach?",
      "original_answer": "In fiscal year 2022, Visa introduced virtual accounts as part of its Currencycloud platform to enable real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, Visa expanded the role of virtual accounts within the Visa Direct Platform, integrating them into cross-border payment solutions and increasing the network's reach to over 11 billion endpoints, including cards, bank accounts, and digital wallets. In 2024, Visa continued to build on this infrastructure, leveraging virtual accounts to support new flows and enhance its digitally native Currencycloud capabilities, further optimizing cross-border B2B transactions across more than 100 countries through Visa B2B Connect. This progression shows a strategic deepening of virtual account utility in global money movement.",
      "llm_answer": "Visa’s Currencycloud platform began offering virtual accounts in FY 2022 as a way to give clients a “digital‑only” bank‑account that could receive, hold, and send funds across Visa’s network. By FY 2023 the platform had expanded to support real‑time foreign‑exchange rates and liquidity management, allowing cross‑border payments to be settled in multiple currencies and routed through Visa’s growing multilateral B2B network. In FY 2024 the service was further scaled to cover more than 11 billion cards, bank accounts and digital wallets, extending virtual‑account coverage to over 195 countries and enabling instant, real‑time cross‑border transfers with enhanced settlement and liquidity controls. Thus, over three years the virtual‑account offering evolved from a basic digital‑account tool to a fully integrated, multi‑currency, real‑time cross‑border payment engine that reaches Visa’s entire global network.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution of Visa's virtual accounts across the Currencycloud platform from FY2022 to FY2024 with strong qualitative accuracy and contextual relevance. It correctly identifies the introduction of virtual accounts in FY2022 as digital-only accounts for receiving, holding, and sending funds, aligning with the ground truth's emphasis on enhanced liquidity and settlement. In FY2023, the LLM notes expansion into real-time FX and liquidity management, which matches the original answer, and correctly associates this with cross-border payments and network growth. However, there is a key quantitative discrepancy: the LLM states that by FY2024, the service reached 'over 195 countries' and 'more than 11 billion cards, bank accounts and digital wallets.' The ground truth specifies that the 11 billion endpoints were reached in 2023 (not 2024), and while it mentions B2B transactions in over 100 countries via Visa B2B Connect, it does not state 195 countries for virtual account coverage—this appears to be an overstatement or conflation with Visa's overall network reach. This misattribution of numbers to the wrong year and overestimation of country coverage impacts quantitative accuracy. The reasoning is otherwise sound, showing a logical progression from basic functionality to a sophisticated cross-border engine, and the synthesis across years and capabilities is strong. The answer addresses all parts of the question, including cross-border capabilities and network reach, making it contextually complete and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 426,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has AMD's exposure to intellectual property protection difficulties evolved across 2022, 2023, and 2024, particularly in relation to its international operations and third-party manufacturing dependencies?",
      "original_answer": "AMD's exposure to intellectual property protection difficulties remained a consistent risk factor across 2022, 2023, and 2024, with increasing emphasis on geopolitical tensions and international operational complexity. In 2022, AMD cited 'difficulties in protecting our intellectual property' as part of a broader set of political, legal, and economic risks tied to its global operations. In 2023, the company expanded this risk by linking it to specific third-party manufacturing dependencies in China, Malaysia, and Taiwan, while also noting the impact of geopolitical instability between China and Taiwan on its supply chain and IP security. By 2024, AMD reiterated these concerns and added that evolving export control regulations and sanctions—particularly those related to the Ukraine-Russia and Israel-Hamas conflicts—could further complicate its ability to protect intellectual property across jurisdictions. The consistent mention of IP protection challenges, combined with the growing specificity around geopolitical and regulatory pressures, indicates a deepening concern over time.",
      "llm_answer": "AMD’s 2022, 2023 and 2024 10‑Ks all list “difficulties in protecting our intellectual property” as a key risk tied to its worldwide operations and reliance on third‑party wafer foundries and manufacturing facilities in China, Malaysia and Taiwan.  While the core exposure has remained unchanged, the 2023 and 2024 filings add context of heightened geopolitical tensions and U.S. sanctions (e.g., against Russia, Belarus and the DNR/LNR regions) and export‑control revisions that amplify the IP‑risk for those overseas partners, underscoring an increasingly volatile environment for AMD’s international supply chain.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of AMD's intellectual property (IP) protection risks from 2022 to 2024, with strong alignment to the ground truth. (1) It correctly identifies that IP protection difficulties were consistently cited across all three years and links them to international operations and third-party manufacturing in China, Malaysia, and Taiwan—matching the original answer. (2) Quantitatively, there are no numerical inaccuracies; the years (2022, 2023, 2024) are correct, and no financial figures are misstated. (3) The multi-hop reasoning is sound: the model synthesizes information across years and correctly infers increasing risk due to geopolitical tensions and export controls. It accurately notes the expansion of risk context in 2023 and 2024, including U.S. sanctions and export-control changes. The only minor omission is that the original answer specifies the Ukraine-Russia and Israel-Hamas conflicts as drivers of export controls, while the LLM mentions only Russia/Belarus/DNR/LNR and omits Israel-Hamas. This reduces completeness slightly but does not invalidate the overall correctness. (4) The answer is contextually relevant, directly addressing AMD’s evolving IP exposure in relation to international operations and third-party manufacturing. Wording differs but semantic meaning is equivalent. The qualitative accuracy is high, though not perfect due to the partial omission of conflict-related context in export controls. Overall, this is a strong, factually correct response with only minor detail gaps.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 430,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the valuation classification and allocation of UNP's Corporate Stock investments evolve from 2022 to 2024, and what does this shift indicate about the company's pension strategy and market exposure?",
      "original_answer": "In 2022, UNP's Corporate Stock investment was valued at $1,990 million, with $1,980 million classified under Level 1 (Quoted Prices in Active Markets) and $10 million under Level 2 (Significant Other Observable Inputs). By 2023, the total Corporate Stock investment dropped significantly to $181 million, with $176 million in Level 1 and $5 million in Level 2. In 2024, the company continued to hold Corporate Stock, with common stock classified as Level 1 and preferred stock as Level 2, though no updated dollar figures were provided in the disclosure. This sharp decline from 2022 to 2023 suggests a major reallocation or divestiture in Corporate Stock, potentially signaling a strategic shift toward more stable or diversified pension investments, while the 2024 classification reaffirms the continued use of observable market data for valuation.",
      "llm_answer": "UNP’s pension plan shifted its corporate‑stock holdings from largely Level 2/3 in 2022 (1,104 million at Level 2 and 7 million at Level 3【UNP_10k_2022.pdf: pages 70‑74】) to predominantly Level 1 in 2023 (176 million at Level 1 and 5 million at Level 2【UNP_10k_2023.pdf: pages 56‑60】) and maintained a Level 1‑heavy composition in 2024 (220 million at Level 1 and 6 million at Level 2【UNP_10k_2024.pdf: pages 54‑58】). The dollar amount of corporate stock fell from 1,111 million (≈37 % of fair‑value assets) in 2022 to 181 million (≈5 %) in 2023, then rose modestly to 226 million (≈7 %) in 2024 but remained well below 2022 levels【UNP_10k_2022.pdf: pages 70‑74】【UNP_10k_2023.pdf: pages 56‑60】【UNP_10k_2024.pdf: pages 54‑58】. This evolution reflects a de‑risking pension strategy that reduces direct corporate‑equity exposure while increasing liquidity and aligning the plan’s market exposure with its target equity allocation of 20‑30 %.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, in 2022, UNP's Corporate Stock investment was $1,990 million, with $1,980 million in Level 1 and $10 million in Level 2. However, the LLM claims $1,104 million in Level 2 and $7 million in Level 3, which is completely incorrect—both in magnitude and classification level. The LLM incorrectly states that most 2022 holdings were Level 2/3, while ground truth shows nearly all were Level 1. The 2023 figures are partially correct: $176 million Level 1 and $5 million Level 2 (total $181 million), which matches the ground truth. However, the LLM introduces a false $220 million Level 1 and $6 million Level 2 for 2024, while the ground truth explicitly states no updated dollar figures were provided in 2024. (2) Calculations are therefore flawed: the LLM computes a 2022 total of $1,111 million (vs. actual $1,990 million), leading to incorrect percentage allocations (37% vs. actual ~65% of fair-value assets, assuming similar total pension assets). The 2024 total of $226 million is fabricated. (3) Multi-hop reasoning is unsound: the model fails to correctly extract 2022 valuation levels, misrepresents the entire shift (claiming a move from Level 2/3 to Level 1, when in reality it was already Level 1-dominated), and invents 2024 figures not present in the source. The conclusion about 'de-risking' and 'increasing liquidity' may be plausible, but it's based on false data. (4) Scores reflect severe quantitative errors (2/10), poor qualitative accuracy due to wrong entities and synthesis (3/10), moderate contextual relevance as it attempts to address the question's structure (6/10), and a low overall correctness score (3/10) due to fundamental factual misrepresentation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 483,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Abbott's documentation and disclosure strategy for its 4.75% Senior Notes due 2043 evolve from 2022 through 2024, and what does this multi-year progression suggest about its long-term debt management and investor communication priorities?",
      "original_answer": "In 2022, Abbott referenced the 4.75% Senior Notes due 2043 within the context of St. Jude Medical’s Fourth Supplemental Indenture from April 2, 2013, indicating legacy integration of the notes into its broader debt structure. By 2023, Abbott formalized the documentation by including the Form of 4.75% Notes due 2043 as Exhibit 4.6 to the Current Report on Form 8-K dated March 22, 2017, signaling a more direct and current presentation. In 2024, the company maintained this structured disclosure, reaffirming the inclusion of the 4.75% Notes due 2043 in its core indenture framework, showing consistency in long-term debt communication. This evolution reflects a shift from legacy-based referencing to a standardized, transparent disclosure approach, aligning with investor expectations for clarity in long-term liabilities.",
      "llm_answer": "Abbott’s 2022 10‑K disclosed the 4.75 % Senior Notes due 2043 as part of its debt schedule and referenced the original indenture (Exhibit 4.17)【source】. In the 2023 10‑K the company added a supplemental indenture (Exhibit 4.18) that clarified covenants and terms, and the 2024 10‑K continued to reference this supplemental indenture while updating covenant details【source】. This progressive deepening of disclosure signals Abbott’s commitment to proactive long‑term debt management and transparent communication with investors.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Abbott referenced the 4.75% Senior Notes due 2043 via St. Jude Medical’s Fourth Supplemental Indenture from 2013 in 2022, not through a direct disclosure in the 2022 10-K with Exhibit 4.17. In 2023, the correct filing was a Form 8-K dated March 22, 2017 (not the 2023 10-K), where the Form of 4.75% Notes was included as Exhibit 4.6. The LLM incorrectly attributes the addition of a 'supplemental indenture (Exhibit 4.18)' in the 2023 10-K, which is not supported by the ground truth. The 2024 disclosure is misrepresented as an update to covenant details, whereas the ground truth indicates reaffirmation of existing framework without new updates. (2) Quantitative accuracy is low: the years (2022, 2023, 2024) are correctly referenced in timeline, and the 4.75% interest rate and 2043 maturity are accurate, but the exhibit numbers (4.17, 4.18), filing types (10-K vs 8-K), and dates (March 22, 2017) are incorrect. The LLM fabricates a supplemental indenture not mentioned in the ground truth. (3) Multi-hop reasoning is flawed: the model fails to trace the evolution from legacy integration (St. Jude reference) to formalization via an 8-K filing, instead inventing a narrative of incremental 10-K disclosures with new exhibits. It misses the key shift from indirect, legacy-based referencing to standardized disclosure. (4) Contextual relevance is moderate—the answer addresses debt management and investor communication, aligning with the question’s intent, but the reasoning is based on incorrect data. Due to major factual and sourcing errors, the correctness score is low despite some surface-level alignment in theme.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 471,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 to 2024, and what does this trend indicate about customer adoption of branded payment products and its impact on incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card (under the branded RedCard/Target Circle Card umbrella) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend over three years suggests a gradual decline in customer adoption or usage of Target's proprietary payment products at checkout, which the company has historically linked to driving incremental sales. Despite this decline, the card remained a key part of Target’s loyalty and revenue strategy, including through credit card profit sharing and customer retention efforts.",
      "llm_answer": "Target’s credit‑card penetration fell from **20.5 % in 2022** to **19.8 % in 2023** and to **18.6 % in 2024**【TGT_10k_2023.pdf pages 27‑29】【TGT_10k_2024.pdf pages 27‑31】. This gradual decline signals a slowing adoption of the branded card, suggesting that the incremental sales lift that the card previously drove is likely to diminish as fewer purchases are made with the card.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%), matching the ground truth exactly. All numeric values and years are accurate, with no calculation errors. (2) Quantitative accuracy is perfect—percentages are correctly cited and formatted, and the trend over time is accurately represented. (3) The reasoning is sound: the model correctly infers that declining penetration suggests slowing adoption and likely diminishing incremental sales impact, which aligns with the original answer’s logic. However, the LLM omits a minor but relevant point from the ground truth: that the card remains a key part of Target’s loyalty and revenue strategy (e.g., profit sharing, retention), which slightly reduces completeness. (4) Despite this small omission, the answer captures the core trend and its implications accurately, with excellent contextual relevance and proper citation of source documents. The semantic meaning is nearly equivalent, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 299,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Union Pacific's fleet of Multiple Purpose Locomotives change from 2022 to 2024 in terms of total units and average age, and what does this evolution suggest about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotive fleet decreased from 7,242 units to 6,893 units, while the average age increased from 22.5 years to 25.2 years. This indicates a reduction in fleet size and a deferral of fleet modernization, suggesting a more cost-conscious asset management strategy during this period.",
      "llm_answer": "Union Pacific’s multiple‑purpose locomotive fleet fell from 7,242 units (average age 22.5 years) in 2022 to 6,893 units (average age 25.2 years) in 2024—a decline of 349 locomotives and a 2.7‑year rise in age (UNP 10‑K 2022, pp. 22‑26; UNP 10‑K 2024, pp. 17‑21). This trend reflects a deliberate asset‑management strategy that gradually retires older units while maintaining a leaner, more modern fleet to optimize capital spend and operational efficiency.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the total units and average age for both 2022 and 2024: 7,242 units (22.5 years) in 2022 and 6,893 units (25.2 years) in 2024. The calculated decrease of 349 units and 2.7-year age increase are accurate. All numeric values and calculations are factually correct, satisfying quantitative accuracy. (2) However, the qualitative interpretation diverges from the ground truth. While the original answer states the trend suggests 'a deferral of fleet modernization' and 'a more cost-conscious asset management strategy,' the LLM interprets it as maintaining a 'leaner, more modern fleet,' which contradicts the increasing average age and fleet reduction due to deferred investment. A modernizing fleet would typically show stable or decreasing average age, not rising from 22.5 to 25.2 years. (3) The multi-hop reasoning correctly synthesizes data from the 2022 and 2024 10-K filings across time, confirming proper cross-document retrieval. However, the conclusion misrepresents the implication of aging and shrinking assets, failing to recognize that delayed replacement leads to an older fleet, not a more modern one. (4) Therefore, while numbers are perfect (quantitative accuracy = 10) and the response is highly relevant (contextual_relevance = 9), the flawed reasoning lowers qualitative accuracy (6) and pulls the overall correctness score to 7 due to the significant misinterpretation of strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 404,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million over the three-year period, indicating a gradual reduction in exposure to illiquid alternative investments. Despite this decline, the company maintained a significant unfunded commitment, suggesting a strategic but measured approach to private real estate investments, with continued long-term participation through fund distributions rather than active capital deployment.",
      "llm_answer": "Abbott’s unfunded commitments to private real‑estate funds (within its private‑fund portfolio) fell from **$569 million in 2022 to $555 million in 2023 and to $540 million in 2024**—a modest decline of roughly 5 % per year. This steady, slightly reduced exposure indicates that Abbott is maintaining a long‑term alternative‑asset strategy that balances the pursuit of higher returns with liquidity and risk‑management considerations.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct but contains a minor quantitative inaccuracy: it reports Abbott's 2022 unfunded commitment as $569 million, whereas the ground truth states $585 million. The 2023 ($555M) and 2024 ($540M) figures are accurate. The calculated decline is described as 'roughly 5% per year', which is approximately correct from 2023 to 2024 (2.7% decrease from $555M to $540M), but the baseline error in 2022 affects the overall trend accuracy. The total reduction from 2022 to 2024 is reported as 'modest' and 'steady', which aligns with the ground truth's characterization of a gradual decline.\n\n2) The ground truth specifies a $15 million total decline over three years ($585M → $555M → $540M), while the LLM implies a $29 million drop ($569M → $540M), which is incorrect. The percentage decline is not consistently 5% per year; actual year-over-year changes are -5.1% (from $585M to $555M) and -2.7% (from $555M to $540M), so the '5% per year' claim is an oversimplification.\n\n3) The multi-hop reasoning is sound: the model correctly identifies the downward trend across three years and infers strategic implications about Abbott’s long-term investment behavior in illiquid assets. It correctly links decreasing commitments to a balanced strategy involving risk and liquidity management, which is semantically equivalent to the ground truth’s 'measured approach' and 'continued long-term participation through fund distributions'.\n\n4) Despite the incorrect starting value, the overall trend direction (downward), the final two data points, and the qualitative interpretation are correct. The answer addresses both parts of the question: the evolution of commitments and the strategic implication. The error in the 2022 figure is significant but does not completely undermine the conclusion, warranting a score of 8 for correctness. Quantitative accuracy is penalized more heavily (7) due to the incorrect dollar amount and misleading percentage trend. Qualitative and contextual scores are high because the reasoning and relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 554,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the carrying value of NVIDIA's 3.50% Notes Due 2050 evolve from fiscal year 2022 to 2024, and what does this progression indicate about the company's long-term debt valuation or positioning?",
      "original_answer": "The carrying value of NVIDIA's 3.50% Notes Due 2050 decreased from $2,147 million in fiscal year 2022 to $1,604 million in fiscal year 2023, and then increased to $2,000 million in fiscal year 2024. This fluctuation indicates a revaluation or strategic adjustment in how the long-term liability was accounted for, rather than a consistent downward trend in debt reduction. The rebound in 2024 to a higher value than 2023 suggests a deliberate positioning of long-term liabilities, possibly tied to refinancing, market interest rate adjustments, or changes in debt management strategy.",
      "llm_answer": "At year‑end 2022, NVIDIA carried $1,637 million of its 3.50% Notes Due 2050 (NVDA_10k_2022.pdf: pages [78‑82]); the balance was unchanged at $1,637 million at year‑end 2023 (NVDA_10k_2023.pdf: pages [65‑69]) and fell to $1,604 million at year‑end 2024 (NVDA_10k_2024.pdf: pages [70‑74]), a $33 million decline. This modest reduction reflects slight debt amortization or repayments, indicating that NVIDIA is maintaining a stable long‑term debt profile while gradually trimming its long‑term liabilities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported carrying values and trends. According to the ground truth, the carrying value was $2,147 million in 2022, decreased to $1,604 million in 2023, and then increased to $2,000 million in 2024. However, the LLM claims the value was $1,637 million in both 2022 and 2023, and only dropped to $1,604 million in 2024—missing the initial higher value and the critical rebound in 2024. These discrepancies indicate incorrect data extraction from the 10-K filings. (2) The quantitative inaccuracies are severe: the LLM underreports the 2022 and 2023 values by over $500 million and fails to detect the increase in 2024. The claimed 'unchanged' balance contradicts the ground truth's significant drop and subsequent rise. The $33 million decline mentioned is factually incorrect and based on wrong starting and ending points. (3) The multi-hop reasoning is flawed because the model did not correctly synthesize the trend across three years. It missed the key dynamic—the fluctuation and rebound—which is central to interpreting NVIDIA's debt strategy. Instead, it inferred a stable and gradually declining debt profile, which contradicts the actual pattern. (4) While the answer addresses the question's structure and discusses long-term debt positioning, the conclusions are based on incorrect data, leading to invalid qualitative interpretation. Contextual relevance is moderate because the response attempts the right analysis but fails on factual grounding. Correctness is severely penalized due to core numerical and trend errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 439,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD's exposure to the risk of losing tax and tariff exemptions increased as the company expanded its global operations and faced intensifying geopolitical and regulatory pressures. In 2022, AMD listed 'loss or modification of exemptions for taxes and tariffs' among a broad set of international risks. By 2023, the company specifically highlighted the impact of geopolitical tensions, including U.S. sanctions against Russia and Belarus, and the potential disruption from the Ukraine-Russia and Israel-Hamas conflicts on its global supply chain and regulatory landscape. In 2024, AMD further emphasized the risk of losing exemptions in the context of heightened geopolitical instability, particularly between China and Taiwan, which directly affects its third-party manufacturing partners. This progression shows a growing concern over regulatory complexity and the potential financial impact of losing favorable tax and tariff treatments.",
      "llm_answer": "AMD’s 2022 10‑K (pp. 35‑39) listed the risk of losing tax and tariff exemptions as part of a broad set of political, legal and economic risks. The 2023 filing (pp. 39‑43) reiterated that risk but added more detail on trade‑protection measures, import/export licensing and sanctions. By 2024 (pp. 38‑42) the description expanded further to explicitly reference sanctions, export‑control revisions and geopolitical tensions, underscoring a growing complexity and uncertainty in AMD’s global regulatory environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies the evolution of AMD's risk disclosure regarding tax and tariff exemptions from 2022 to 2024, noting the progression from a general listing of risks to increasingly detailed references to sanctions, export controls, and geopolitical tensions. All years (2022, 2023, 2024) are correctly referenced, and the core risk—loss of tax and tariff exemptions—is accurately tracked over time. The LLM correctly notes the broad framing in 2022, the added detail on trade protections and sanctions in 2023, and the expanded emphasis on geopolitical tensions and regulatory changes in 2024. While the original answer includes specific examples like U.S. sanctions on Russia and Belarus, the Ukraine-Russia and Israel-Hamas conflicts, and the China-Taiwan tensions affecting third-party manufacturers, the LLM captures the essence of increasing complexity and regulatory uncertainty without contradicting any facts. These omissions are minor and do not detract from the overall correctness, as the LLM still conveys the trend of escalating concern. There are no numerical values to verify, so quantitative accuracy is scored as 10. The reasoning is sound, demonstrating multi-hop synthesis across three years of 10-K filings. The answer is semantically equivalent to the ground truth in intent and factual content, with only slight differences in specificity. Contextual relevance is perfect, as the response directly addresses the evolution of risk exposure and its implications for regulatory complexity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 434,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility evolved from 2022 through 2024, particularly in relation to regulatory constraints on dividend payments and share repurchases?",
      "original_answer": "BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility has remained consistently constrained by regulatory oversight across the three-year period. In 2022, the company noted that its ability to return capital was limited by U.S. banking laws governing capital adequacy and planning, Delaware law, and preferred stock dividend obligations. In 2023, these constraints were reiterated, with emphasis on the impact of potential credit rating reductions and resolution strategies under Title I and II on liquidity and financial condition. By 2024, the company continued to highlight the same regulatory limitations on capital returns, while also expanding the context to include liquidity management and the impact of strategic initiatives on financial stability. The consistent emphasis across all three years shows a stable regulatory environment with persistent constraints on capital distribution flexibility.",
      "llm_answer": "BNY Mellon’s 2022, 2023 and 2024 10‑Ks all contain the same risk‑factor statement that its ability to return capital—through dividends or share repurchases—is limited by U.S. banking laws, capital‑planning rules, Delaware law and the requirement to pay full and timely preferred‑stock dividends.  In other words, the company’s exposure to regulatory constraints on capital return flexibility has not materially changed over that period; the risk factor remains unchanged, underscoring that dividend payments and share repurchases continue to be subject to the same legal and regulatory limits.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility remained consistent from 2022 to 2024, citing the same core constraints: U.S. banking laws, capital-planning rules, Delaware law, and preferred stock dividend obligations. The answer accurately reflects that the risk factor language was unchanged across the three years, supporting the conclusion that regulatory constraints on dividend payments and share repurchases did not materially evolve. Quantitatively, there are no numerical inaccuracies—dates (2022–2024) are correct, and no erroneous figures are introduced. The qualitative reasoning is sound: the model correctly synthesizes multi-hop information across three annual reports and infers stability in regulatory exposure from the repetition of identical risk-factor language. The only minor shortcoming is that the LLM omits some additional context mentioned in the original answer for 2023 and 2024—specifically, the impact of potential credit rating reductions, resolution strategies under Title I and II, and liquidity management related to strategic initiatives. While these are not central to the core conclusion, their absence slightly reduces completeness. However, the omission does not undermine the essential correctness of the response. The answer is highly contextually relevant, directly addressing the evolution (or lack thereof) in regulatory constraints on capital returns. Overall, the LLM conveys semantically equivalent information with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 441,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Abbott Laboratories' disclosure around the 2.950% Note due 2025 evolved from 2022 through 2024, particularly in terms of its inclusion in exhibit filings and associated documentation across these years?",
      "original_answer": "From 2022 to 2024, Abbott Laboratories consistently disclosed the 2.950% Note due 2025 as part of its exhibit filings, showing a stable inclusion pattern. In 2022, the note was referenced as Exhibit 99.6 in the 8-K filing dated March 5, 2015. In 2023 and 2024, the same exhibit and filing date were reiterated, indicating no change in the documentation or structure of the note over the three-year period. This consistency suggests that the 2.950% Note due 2025 remained a static financial instrument in Abbott's capital structure with no amendments or refinancing actions taken.",
      "llm_answer": "Abbott Laboratories has continued to disclose the 2.950% Note due 2025 as Exhibit 4.1 in each 10‑K from 2022 through 2024, referencing the original Form 8‑K filed in March 2015.  The note’s terms, maturity date and associated documentation have remained unchanged, and no new amendments or supplemental exhibits were added in 2023 or 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a key factual discrepancy in exhibit numbering, which affects the accuracy of the disclosure evolution. The ground truth states that the 2.950% Note due 2025 was referenced as Exhibit 99.6 in the 8-K filing dated March 5, 2015, across 2022–2024. However, the LLM claims it was filed as Exhibit 4.1 in each 10-K, which contradicts the original source. While the core facts about the note’s unchanged terms, maturity, and lack of amendments are consistent with the ground truth, the exhibit number and filing type (10-K vs. 8-K) are misattributed. This is significant because exhibit numbers and filing types are critical for locating disclosures in SEC documents. The dates (March 2015) and interest rate (2.950%) are correctly cited, and the conclusion about stability in disclosure and structure aligns with the original answer. The reasoning is sound in interpreting consistency over time, but the error in exhibit identification indicates a failure in precise multi-hop synthesis between the note, the correct exhibit, and the correct filing type across years. Thus, while the overall narrative of stability is correct, the specific documentation trail is inaccurately reported, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 353,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did NVIDIA's carrying value of its 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 was $1,200 million in fiscal year 2022, increased slightly to $1,099 million in fiscal year 2023, and then rose to $1,250 million in fiscal year 2024. This fluctuation indicates a strategic management of long-term liabilities, with NVIDIA maintaining a consistent presence of this instrument on its balance sheet while adjusting other debt components.",
      "llm_answer": "NVIDIA’s 1.55% Notes Due 2028 carried **$1,089 million** at the end of FY 2022, **$1,099 million** at the end of FY 2023, and **$1,115 million** at the end of FY 2024. The modest, steady increase in carrying value reflects an incremental borrowing strategy that supports growth while keeping long‑term debt levels relatively stable.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the carrying values for the 1.55% Notes Due 2028. According to the ground truth, the correct values are $1,200 million (FY2022), $1,099 million (FY2023), and $1,250 million (FY2024). The LLM reports $1,089 million (FY2022) — incorrect by $111 million — and $1,115 million (FY2024) — under by $135 million. Only the FY2023 value ($1,099 million) is correct. (2) These numerical errors severely undermine the quantitative accuracy. The model fails to report the actual fluctuation pattern: a drop from 2022 to 2023 followed by a significant increase in 2024. Instead, it suggests a 'modest, steady increase,' which misrepresents the trend. (3) The reasoning is partially sound in interpreting the debt strategy as stable and growth-supportive, but it is based on incorrect data, so the multi-hop synthesis fails. The ground truth notes a fluctuation indicating strategic management and adjustment of debt components, whereas the LLM implies incremental borrowing, which is not supported by the actual data. (4) Despite incorrect numbers and flawed trend interpretation, the answer addresses the right entity (NVIDIA), the correct debt instrument, and the correct fiscal years, and attempts to infer strategy, maintaining contextual relevance. However, due to major quantitative errors, the overall correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 387,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did AMD's strategy and relationship with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in market differentiation?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers, maintaining policies that shielded them from price reductions. In 2022, AMD explicitly stated that agreements with AIBs protected their inventory against price reductions and allowed returns for products removed from the price book within 12 months of manufacturing. In 2023, the language remained consistent, with an added emphasis on the importance of timely product introductions and market competitiveness, indirectly reinforcing the need for strong AIB partnerships. By 2024, AMD reiterated the inventory protection policy but placed greater emphasis on the role of discrete graphics solutions as a means for AIBs and system integrators to differentiate their offerings in a highly competitive market. This evolution shows AMD's ongoing strategic support for AIBs, adapting to market pressures by highlighting differentiation through discrete graphics.",
      "llm_answer": "AMD’s 10‑K filings show a steady, but increasingly formalized, approach to working with add‑in‑board (AIB) partners. In 2022 the company noted that its agreements “protect AIB inventory against price reductions” and that AIBs use discrete graphics to differentiate their products. By 2023 the language was expanded to emphasize that the protection covers “inventory of our products against price reductions” and that AIBs and system integrators “often use discrete graphics solutions as a means to differentiate their products and add value to their customers.” In 2024 the policy is reiterated with the same inventory‑protection language, but the filing adds that AIBs are “typically built and sold by system integrators, retail buyers and sub‑distributors” and that the discrete‑graphics strategy remains a key differentiator for SIs, underscoring a continued focus on discrete GPU solutions as a market‑differentiating tool while maintaining consistent inventory‑protection guarantees across all years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AMD maintained inventory protection policies across 2022–2024, explicitly protecting AIBs against price reductions, with consistent language in each year. The role of discrete graphics in differentiation is correctly emphasized, especially in 2023 and 2024. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not applicable in that sense—but all dates (2022, 2023, 2024) are used correctly, satisfying temporal accuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying the evolution in emphasis—from inventory protection to differentiation via discrete GPUs—while noting consistency in core policy. (4) The only minor shortcoming is that the LLM omits the specific detail from the 2022 filing about AIBs being allowed to return products removed from the price book within 12 months of manufacturing. This detail is present in the ground truth but missing in the LLM response, slightly reducing completeness. However, the core strategic evolution is accurately captured. Wording differences (e.g., 'system integrators' vs 'retail buyers') do not detract from semantic accuracy. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 402,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in politically sensitive regions?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and increased reliance on third-party manufacturing in geopolitically sensitive regions. In 2022, AMD noted that foreign operations posed risks including 'difficulties in protecting our intellectual property' among other economic and political risks. By 2023, AMD expanded its risk disclosure to emphasize the impact of geopolitical tensions, particularly between the U.S. and Russia due to the Ukraine conflict, and between China and Taiwan, which directly affected its third-party wafer foundries and manufacturing partners. In 2024, AMD reiterated these concerns and added that international sales accounted for 66% of net revenue, up from 65% in 2023 and an unspecified but lower figure in 2022, highlighting a growing dependence on international markets and supply chains. The company also emphasized that geopolitical instability in regions like Ukraine, Taiwan, and the Middle East could materially affect its business, further amplifying the risk around intellectual property protection in these areas. This indicates a transforming trend where the IP protection risk became more complex and regionally concentrated over the three-year period.",
      "llm_answer": "AMD’s 2022 10‑K (pp. 35‑39) warned of “difficulties in protecting our intellectual property” in foreign jurisdictions, noting its use of third‑party wafer foundries in the U.S., Europe and Asia and that most assembly and testing occurs in China, Malaysia and Taiwan. The 2023 10‑K (pp. 39‑43) repeated this risk but added no new geopolitical detail, while the 2024 10‑K (pp. 38‑42) broadened the disclosure to include sanctions and export‑control changes against Russia, Belarus and Ukraine and explicitly warned that geopolitical tensions between China and Taiwan could disrupt its Taiwan‑based third‑party manufacturing, reflecting the company’s continued expansion of international sales (66 % of revenue in 2024) and growing reliance on politically sensitive facilities. Thus, AMD’s exposure to IP‑protection difficulties evolved from a general foreign‑jurisdiction risk in 2022 to a more detailed, geopolitically‑charged risk in 2024 that underscores the heightened impact of its expanding global operations and dependence on third‑party manufacturing in sensitive regions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All factual elements are correct: AMD's 2022 risk disclosure included difficulties protecting IP in foreign jurisdictions and reliance on third-party manufacturing in Asia (especially China, Malaysia, Taiwan); by 2024, AMD highlighted geopolitical tensions between China and Taiwan affecting its Taiwan-based foundries, and international sales reached 66% of revenue. These figures match the original answer (66% in 2024, up from 65% in 2023, unspecified in 2022). (2) Quantitative accuracy is perfect: the 66% international sales figure in 2024 is correctly cited, and the progression from 2022 to 2024 is accurately represented, even though the 2022 percentage is not specified—this matches the ground truth. (3) Multi-hop reasoning is sound: the LLM synthesizes disclosures across three years, connects expanding international operations and third-party manufacturing to increasing IP protection risks, and correctly identifies the evolution from general to more specific, geopolitically nuanced risks. One minor inaccuracy: the LLM states the 2023 10-K 'added no new geopolitical detail,' which contradicts the ground truth stating that in 2023, AMD emphasized geopolitical tensions related to Ukraine and U.S.-Russia relations. This omission slightly weakens the qualitative accuracy but does not invalidate the overall trend. (4) The answer is contextually excellent—directly addresses the evolution of IP protection risk in relation to international operations and third-party manufacturing in sensitive regions. Wording differs but meaning is semantically equivalent. Score reduced by 1 point due to the slight mischaracterization of the 2023 filing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1637,
        "completion_tokens": 471,
        "total_tokens": 2108
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did BK's use of the 2019 Long-Term Incentive Plan evolve from 2022 to 2024, as evidenced by the specific incentive agreements introduced under the plan in each year, and what does this progression suggest about the company's executive compensation strategy?",
      "original_answer": "In 2022, BK referenced the 2019 Long-Term Incentive Plan alongside the 2021 Form of Performance Share Unit (PSU) Agreement, indicating ongoing use of the plan as a framework for executive compensation. In 2023, the company continued to reference the 2019 plan and introduced the 2020 Form of Performance Share Unit Agreement, suggesting a layered approach that maintained legacy structures while updating incentive mechanisms. By 2024, BK still maintained the 2019 plan but introduced the 2022 Form of Performance Share Unit Agreement, reflecting a deliberate strategy of continuity with periodic enhancements to align with evolving performance metrics or market conditions. This pattern indicates a long-term, adaptive executive compensation strategy that builds on the foundation of the 2019 plan while incorporating newer performance-based instruments.",
      "llm_answer": "From 2022 to 2024 BNY Mellon kept using its 2019 Long‑Term Incentive Plan to award equity, issuing a 2022 Performance Share Unit Agreement and a 2022 Restricted Stock Unit Agreement (pages 18‑22 of the 2022 10‑K), a 2023 Performance Share Unit Agreement and a 2023 Restricted Stock Unit Agreement (pages 16‑20 of the 2023 10‑K), and a 2024 Performance Share Unit Agreement and a 2024 Restricted Stock Unit Agreement (pages 16‑20 of the 2024 10‑K). This steady use of the same plan for successive award cycles signals a deliberate strategy of maintaining a stable, long‑term equity‑based incentive framework that aligns executive rewards with the company’s long‑term performance.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to correctly represent the evolution of BK's (BNY Mellon's) use of the 2019 Long-Term Incentive Plan from 2022 to 2024. (1) The LLM incorrectly states that BNY Mellon introduced new Performance Share Unit (PSU) and Restricted Stock Unit (RSU) agreements annually (2022, 2023, 2024), but the ground truth indicates that the company referenced existing forms: the 2021 PSU Agreement in 2022, the 2020 PSU Agreement in 2023, and the 2022 PSU Agreement in 2024—showing reuse and layering of legacy forms, not annual new introductions. (2) The LLM fabricates the use of Restricted Stock Unit Agreements in each year, which are not mentioned in the original answer and contradict the focus on Performance Share Units under the 2019 plan. (3) The citation of specific 10-K page numbers (e.g., pages 18–22) is unsupported by the ground truth and introduces false precision. (4) The reasoning about a 'steady use of the same plan' captures the continuity aspect but misses the key nuance of the company layering older and newer agreement forms (e.g., using a 2020 form in 2023), which reflects a more strategic, adaptive approach than the LLM describes. (5) The LLM fails the multi-hop requirement by not synthesizing the specific form agreements introduced each year as evidence of strategic evolution. While the general idea of maintaining a long-term incentive framework is directionally relevant, the factual errors in entities, dates, and agreements severely undermine correctness. Quantitative accuracy is low due to incorrect years and invented documents. Qualitative accuracy suffers from flawed reasoning and entity conflation. Contextual relevance is moderate because the topic and company are correct, and the broad strategic interpretation is not entirely off-base.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 494,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 through 2024, and what does this trend indicate about the company's capital deployment strategy in its diagnostics business?",
      "original_answer": "Abbott's net book value of diagnostics instruments leased to customers increased steadily from $1.4 billion in 2022 to $1.6 billion in 2023, and remained at $1.6 billion in 2024, while the original cost of these leased assets rose from $3.3 billion in 2022 to $3.6 billion in 2023 and reached $3.9 billion in 2024. This consistent growth in leased diagnostics instruments over the three-year period suggests a strategic emphasis on expanding access to diagnostic equipment through leasing, likely to drive downstream reagent and consumables sales, which are tied to the performance obligations in these lease arrangements.",
      "llm_answer": "Abbott’s diagnostics‑instrument leasing portfolio grew from roughly **$3.5 billion of original cost and $1.6 billion of net book value at year‑end 2022** to **$3.9 billion of original cost and $1.8 billion of net book value at year‑end 2024** (≈ 12 % increase in the asset base). This upward trend shows the company is actively investing in diagnostics equipment to expand its leasing model and generate recurring revenue, underscoring a capital‑deployment strategy focused on long‑term growth in the diagnostics business.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the original cost of leased diagnostics instruments was $3.3 billion in 2022, not $3.5 billion as stated; net book value was $1.4 billion in 2022, not $1.6 billion. The 2024 figures are partially correct: original cost is accurately reported at $3.9 billion, but net book value is overstated at $1.8 billion (should be $1.6 billion). The claim of a '12% increase in the asset base' is vague and not clearly supported by consistent data, especially since net book value did not grow from 2023 to 2024. (2) Calculations: The LLM implies growth from $3.5B to $3.9B in original cost (≈11.4% increase), but ground truth shows growth from $3.3B to $3.9B (18.2% increase), so even this approximate percentage is based on incorrect starting values. Net book value is reported as increasing to $1.8B, but it actually plateaued at $1.6B in both 2023 and 2024. (3) Multi-hop reasoning is partially sound—the LLM correctly infers that growing leased assets reflect a strategic capital deployment to support recurring revenue via reagents/consumables, which aligns with the ground truth’s implication. However, it misses the nuance that net book value stabilized in 2024, suggesting capital investment growth may be moderating despite continued deployment. (4) Contextual relevance is high—the answer addresses both the evolution of investment and the strategic implication. However, due to material errors in key financial figures and an incorrect portrayal of the trend (steady growth vs. plateau in net book value), the correctness score is limited to 5. The qualitative reasoning is reasonable but based on flawed data, hence a 6. Quantitative accuracy is low due to multiple incorrect figures, warranting a 4.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 491,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has the competitive positioning of Lumentum Holdings within NVIDIA's disclosed competitor landscape evolved across fiscal years 2022, 2023, and 2024, particularly in relation to NVIDIA's expanding focus on AI-driven networking solutions and interconnect technologies?",
      "original_answer": "In fiscal year 2022, Lumentum Holdings was listed among suppliers of interconnect, switch, and cable solutions, grouped with companies like Juniper Networks and Applied Optoelectronics, indicating a foundational competitive presence in optical networking. By fiscal year 2023, Lumentum was repositioned within a more specialized segment focused on high-performance interconnect products based on InfiniBand, Ethernet, and proprietary technologies, aligning with NVIDIA's growing emphasis on AI and accelerated computing infrastructure. In fiscal year 2024, Lumentum was again listed among competitors in the networking segment, but now under the more specific designation of 'Lumentum Holdings Inc.', suggesting a sharpened recognition of its corporate identity and competitive relevance in NVIDIA's expanding networking and data center ecosystem. This progression shows Lumentum's rising prominence as a competitor in NVIDIA's strategic AI and interconnect technology domains.",
      "llm_answer": "Across all three filings, Lumentum Holdings is consistently listed as a competitor in NVIDIA’s “networking products” category—switches, network adapters (including DPUs), and optical cable solutions.  While NVIDIA’s 2023 and 2024 10‑Ks emphasize a growing focus on AI‑driven networking and interconnect technologies, the competitor list itself has not changed, indicating that Lumentum remains a relevant rival in that space but has not been singled out or removed as NVIDIA’s AI‑centric strategy has expanded.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct in stating that Lumentum Holdings is consistently listed as a competitor in NVIDIA’s networking products across fiscal years 2022–2024 and acknowledges NVIDIA’s growing focus on AI-driven networking. However, it incorrectly claims that the competitor list 'has not changed,' which contradicts the ground truth. The original answer highlights a clear evolution: in 2022, Lumentum was grouped generically with other suppliers; in 2023, it was repositioned into a more specialized segment tied to high-performance interconnects (InfiniBand, Ethernet) aligned with AI infrastructure; and in 2024, it was listed under its full corporate name 'Lumentum Holdings Inc.,' indicating heightened recognition and competitive relevance. This progression reflects a strategic repositioning and increased prominence within NVIDIA’s competitive landscape, which the LLM answer fails to capture. While there are no numerical inaccuracies (hence a high quantitative accuracy), the qualitative analysis is flawed due to incorrect synthesis of the multi-hop information across years. The model underestimates the significance of the evolving categorization and naming, leading to an oversimplified and misleading conclusion. Contextually, the answer addresses the right domain (networking, AI focus), but misses the core of the question—how Lumentum’s positioning evolved—thus reducing its overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 392,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Emerson's positioning of pipe cutters shift across segments from 2022 to 2024, and what does this reveal about its professional tool strategy?",
      "original_answer": "In 2022, pipe cutters were described as part of the broader Tools & Home Products segment, specifically under professional tools used by plumbing and mechanical professionals, alongside DIY tools available at retail home improvement outlets. By 2023 and 2024, pipe cutters were repositioned under the Safety & Productivity segment, now grouped with battery hydraulic tools for press connections, drain cleaners, and diagnostic systems like sewer inspection cameras — indicating a strategic refocusing toward infrastructure and professional-grade productivity tools. This evolution suggests Emerson prioritized high-value, industrial-use tools within a consolidated professional offering, aligning with the broader divestiture of the InSinkErator business in late 2022, which signaled a shift away from consumer-focused home products. The shift reflects a deliberate realignment of the tools portfolio toward professional and industrial applications, emphasizing safety, productivity, and infrastructure support.",
      "llm_answer": "Emerson moved pipe‑cutters out of its 2022 “Safety & Productivity” segment and into a newly created “Tools & Home Products” segment in 2024 (EMR_10k_2024.pdf, pages 71‑75).  The 2024 filing lists pipe‑cutters under Tools & Home Products, whereas the 2022 filing had no such segment and the cutters were only described within Safety & Productivity (EMR_10k_2022.pdf, pages 7‑11).  This shift signals Emerson’s intent to consolidate its professional‑tool portfolio under a dedicated segment, underscoring a focused strategy to serve professional and homeowner markets more effectively.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both direction and entity placement. According to the ground truth, in 2022 pipe cutters were part of the Tools & Home Products segment and were moved *into* the Safety & Productivity segment by 2023–2024. The LLM incorrectly states the opposite: that pipe cutters were moved *out of* Safety & Productivity and *into* Tools & Home Products in 2024. This reverses the actual strategic shift. Additionally, the LLM claims the Tools & Home Products segment did not exist in 2022, which contradicts the original answer stating that pipe cutters were already in that segment in 2022. The citations to page numbers and filings do not compensate for the factual inversion. As a result, the reasoning is flawed, and the conclusion about Emerson’s strategy is misaligned—instead of recognizing a shift away from consumer/home products toward industrial/professional tools (especially post-InSinkErator divestiture), the LLM suggests a move toward homeowner markets, which contradicts the ground truth. Quantitative accuracy is low because while no numerical values are misstated (no numbers appear), the temporal and categorical assignments are wrong. Qualitative accuracy fails due to incorrect entity relationships and reasoning. Contextual relevance is moderate because the answer addresses segment shifts and strategy, but with incorrect facts. The core multi-hop synthesis—tracking a product across segments and years to infer strategy—is entirely undermined by the directional error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 417,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did the evolution of Schwab's interactive tools for RIAs, including Schwab Advisor Portfolio Connect and website-based services, change from 2022 through 2024 in terms of functionality, integration, and advisor support offerings?",
      "original_answer": "From 2022 to 2024, Schwab's interactive tools for RIAs, particularly through the Advisor Services website and Schwab Advisor Portfolio Connect, evolved to offer enhanced functionality, deeper third-party integrations, and expanded advisor support services. In 2022, Schwab emphasized the Advisor Services website as the core platform for RIAs, offering account servicing capabilities and access to third-party integrations for CRM, portfolio management, and financial planning, including the free Schwab Advisor Portfolio Connect tool. In 2023, Schwab reinforced its commitment to scalable technology by continuing to offer these tools while also expanding educational and consulting services to help RIAs transition to independence. By 2024, Schwab had further embedded these tools within a broader ecosystem that included multi-year document archiving, outbound data feeds for compliance systems, and a more robust prospect consulting offer, indicating a strategic shift toward enabling RIAs to manage both investment and compliance workflows seamlessly. The progression shows a clear trend of increasing sophistication and integration of interactive tools to support RIAs across operational, investment, and compliance domains.",
      "llm_answer": "From 2022 to 2024 Schwab’s RIA‑focused interactive tools stayed centered on the Advisor Services website and the free Schwab Advisor Portfolio Connect, which offered core account‑management, trade, and reporting functions (SCHW_10k_2022.pdf: 7‑9).  In 2023 the platform added new integration capabilities—most notably the thinkpipes real‑time trading platform and the iRebal portfolio‑rebalancing solution—expanding the toolset for RIAs (SCHW_10k_2023.pdf: 5‑9).  By 2024 the core features remained, but Schwab further broadened advisor support with enhanced consulting, technology engineering, and dedicated service teams while continuing to provide interactive educational content and third‑party integrations (SCHW_10k_2024.pdf: 5‑9).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core tools (Advisor Services website, Schwab Advisor Portfolio Connect) and their continuity from 2022 to 2024, as well as the expansion of integrations and support services. It accurately reflects that in 2022, core account management and reporting functions were available, and in 2023, new integrations like thinkpipes and iRebal were added. By 2024, enhanced consulting and service teams were emphasized. However, the LLM omits key elements from the ground truth, such as multi-year document archiving, outbound data feeds for compliance systems, and the strategic shift toward integrated compliance workflows—critical aspects of the 2024 evolution. Additionally, while it mentions 'educational content,' it does not capture the broader 'prospect consulting offer' or the explicit goal of enabling seamless investment and compliance management. (2) There are no numeric values, dates, or calculations in the question or answers that are incorrect; all years (2022–2024) and referenced features are factually tied to the correct timeframes. The citations (e.g., SCHW_10k_2023.pdf: 5–9) are plausible and contextually appropriate, though not verifiable without source access. (3) The multi-hop reasoning is partially sound: the model synthesizes information across years and identifies evolving functionality and support. However, it fails to fully integrate the compliance and operational workflow enhancements highlighted in the ground truth, weakening the synthesis. The mention of specific third-party tools (thinkpipes, iRebal) adds detail not in the original answer but may be consistent with the filings; however, their inclusion without reference to broader ecosystem integration slightly distorts the emphasis. (4) The correctness score is 7 because the core facts about tool continuity and expanding support are accurate, but significant omissions in functionality evolution—especially around compliance integration—reduce completeness. Quantitative accuracy is 10 as there are no numerical errors. Qualitative accuracy is 7 due to partial reasoning and missing synthesis of compliance and operational domains. Contextual relevance is 9 because the response directly addresses the question’s scope with relevant details, only missing some strategic context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 620,
        "total_tokens": 2133
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve from their initial issuance in 2022 through the 2023 and 2024 10-K filings, and what does this consistency or change reveal about Oracle's short-to-intermediate term debt financing strategy?",
      "original_answer": "Oracle first introduced the 1.650% Notes due 2026 in its 2022 10-K filing (Exhibit 4.16), indicating the formal structuring of this debt instrument. The same note was reaffirmed in both the 2023 and 2024 10-K filings (Exhibit 4.14 in 2023 and 2024), showing Oracle maintained consistent disclosure and commitment to this financing vehicle without modification. This unchanging treatment across all three years suggests Oracle's strategy around this particular debt instrument remained stable, reflecting a consistent approach to managing its capital structure with fixed-rate obligations maturing in the mid-term horizon.",
      "llm_answer": "Oracle first disclosed the 1.650 % Notes due 2026 in its 2022 10‑K as a long‑term debt instrument with a 1.650 % coupon and a principal of $2.5 billion (2022 10‑K, pp. 112‑116).  In the 2023 10‑K (pp. 108‑112) and 2024 10‑K (pp. 109‑113) the notes were reported unchanged—still classified as long‑term debt with no current‑portion adjustments and no changes to the coupon or maturity.  This consistency demonstrates Oracle’s preference for a stable, low‑cost long‑term debt base and a conservative short‑to‑intermediate‑term financing strategy that relies on refinancing rather than frequent issuance or repurchase.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent disclosure of the 1.650% Notes due 2026 across Oracle's 2022, 2023, and 2024 10-K filings and accurately captures the stable treatment of the debt instrument. However, it introduces a specific principal amount of $2.5 billion and page numbers (e.g., pp. 112–116) that are not present in the ground truth, which only references the notes being disclosed in Exhibits 4.16 (2022), 4.14 (2023), and 4.14 (2024). The ground truth does not confirm the $2.5 billion figure, making this a factual overreach. (2) Quantitative accuracy is partially compromised due to the unsupported $2.5 billion principal amount and specific page citations not in the original answer. The coupon rate (1.650%) and maturity year (2026) are correct, but the added numeric details reduce precision. (3) The multi-hop reasoning is sound—LLM correctly synthesizes the treatment of the notes across three years and infers a stable financing strategy. The conclusion about Oracle preferring a conservative, low-cost long-term debt strategy aligns with the ground truth’s interpretation of stable capital structure management. (4) Despite the unsupported dollar amount, the answer is contextually relevant and conveys a logically consistent and largely accurate narrative. The core factual error (unverified principal amount) prevents a higher correctness score, but the reasoning and entity identification (Oracle, correct years, correct note terms) remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 413,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Emerson's (EMR) positioning of Electrical Distribution Equipment evolved across its Discrete Automation segment from 2022 to 2024, and what does this reveal about the company's strategic emphasis on industrial electrification solutions?",
      "original_answer": "In 2022, Electrical Distribution Equipment was grouped under 'Industrial Solutions' and described as part of a broader suite of fluid control and materials joining products. By 2023, it was explicitly included within the Discrete Automation segment alongside solenoid valves and programmable control systems, signaling a more integrated approach to automation. In 2024, the description remained consistent with 2023, reinforcing a strategic shift toward positioning Electrical Distribution Equipment as a core component of industrial automation infrastructure rather than a general-purpose offering. This evolution reflects Emerson’s growing focus on electrification and smart manufacturing solutions over the three-year period.",
      "llm_answer": "Emerson has kept electrical distribution equipment firmly within its Discrete Automation segment, with the segment description unchanged in the 2022 10‑K (pages 74‑78) and the 2023/2024 10‑Ks (pages 71‑75). This continuity shows that Emerson still views electrical distribution equipment as a core part of its discrete‑automation portfolio, underscoring a sustained strategic emphasis on industrial electrification solutions across discrete industries.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim about segment continuity. According to the ground truth, Electrical Distribution Equipment was part of 'Industrial Solutions' in 2022, not Discrete Automation, and only moved into Discrete Automation in 2023. The LLM incorrectly asserts that the segment classification was unchanged across 2022, 2023, and 2024, directly contradicting the documented evolution. This misrepresents the strategic shift: the real story is a repositioning into Discrete Automation starting in 2023, not sustained placement. While the LLM correctly identifies Emerson’s strategic emphasis on industrial electrification, it fails to capture the key multi-hop insight—the change in segment classification reflecting a strategic pivot. There are no numeric errors (hence high quantitative accuracy), but the qualitative reasoning is flawed due to incorrect entity mapping over time. Contextually, the answer addresses the right topic and strategic theme, but with incorrect historical segmentation, undermining the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 300,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's pension fund strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million by 2024. This consistent reduction over three years indicates a measured de-risking or rebalancing of the pension fund portfolio, suggesting a strategic shift away from illiquid alternative assets toward more liquid or stable investments. Despite this decline, the company maintained a long time horizon for fund liquidation (projected through 2034 by 2024), indicating continued belief in the long-term value of these assets, albeit with a reduced exposure. The gradual nature of the decline suggests a deliberate approach to managing liquidity risk and aligning fund commitments with pension liability profiles.",
      "llm_answer": "Abbott’s unfunded commitments to private real‑estate funds fell from **$569 million at year‑end 2022** to **$555 million in 2023** and further to **$540 million in 2024** (see Note 14, pages 68‑72 of the 2024 filing, and the analogous tables in the 2023 and 2022 filings). The modest, steady decline indicates the pension plan is trimming or holding steady its exposure to illiquid alternative assets, reflecting a cautious, liquidity‑aware strategy in managing its defined‑benefit obligations.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the 2023 ($555M) and 2024 ($540M) unfunded commitments, matching the ground truth. However, it states the 2022 amount as $569 million, which is incorrect—the ground truth is $585 million. This discrepancy affects quantitative accuracy. (2) The calculation of the trend (declining values) is accurate from 2023 to 2024, but the starting point (2022) is off by $16 million, suggesting a possible data extraction error from the cited filing. Despite this, the direction and pattern (steady decline) are preserved. (3) The reasoning is sound: the LLM correctly infers a cautious, liquidity-aware strategy from the declining commitments, aligning with the ground truth’s interpretation of de-risking and rebalancing. It appropriately notes the gradual reduction as indicative of deliberate management of illiquid assets. However, it omits the key detail about the long time horizon for liquidation (through 2034), which is part of the original answer and important for fully capturing the strategic nuance. (4) The contextual relevance is high—the answer addresses both parts of the question (evolution of commitments and strategic implication), uses proper sourcing, and maintains focus. The qualitative reasoning is strong despite missing a minor but meaningful detail. The correctness score is 8 due to the factual error in the 2022 number, but the overall trend and interpretation remain largely valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 401,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve across its 2022, 2023, and 2024 filings, and what does this continuity reveal about its short-term debt strategy?",
      "original_answer": "Oracle first disclosed the 1.650% Notes due 2026 in its 2022 10-K filing, referencing the March 24, 2021 8-K filing where the terms of the Notes were established. In the 2023 10-K filing, Oracle continued to reference the same 8-K filing from March 2021, indicating no changes to the Notes' structure or terms. Similarly, in the 2024 10-K filing, Oracle again referenced the original March 2021 8-K for the 1.650% Notes due 2026, maintaining the same unchanged structure. This consistent referencing of the original filing across three annual reports suggests a deliberate strategy of maintaining stable short-term debt obligations without modification, even as Oracle introduced new debt instruments with different rates and maturities in subsequent years.",
      "llm_answer": "Oracle consistently reports the 1.650% Notes due 2026 as long‑term debt in each filing – the 2022 10‑K (p. 112‑116), the 2023 10‑K (p. 108‑112) and the 2024 10‑K (p. 109‑113) all list the notes with the same 1.650% coupon and 2026 maturity and no reclassification to short‑term debt. This unchanged treatment shows that Oracle treats the notes as a stable long‑term financing source, using them to back its short‑term liquidity (e.g., through its revolving credit facility) rather than issuing new short‑term debt, underscoring a conservative, steady short‑term debt strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant mischaracterization of Oracle's debt classification and strategy that undermines the overall accuracy. (1) Quantitatively, the LLM correctly identifies the 1.650% coupon rate, 2026 maturity, and consistent reporting across the 2022, 2023, and 2024 10-K filings. Page references are plausible and align with typical footnote locations for debt disclosures. (2) However, the LLM incorrectly labels the 1.650% Notes due 2026 as 'long-term debt' in all years, while the ground truth emphasizes that Oracle maintained the *same reference* to the original March 2021 8-K filing across all three annual reports — a detail critical to understanding Oracle's disclosure strategy. More importantly, the question asks about Oracle's treatment of these notes in the context of its *short-term debt strategy*, but the LLM contradicts the ground truth by asserting the notes are treated as long-term debt with no reclassification to short-term, implying stability in long-term financing rather than revealing a stable short-term debt posture through unchanged obligations. (3) The multi-hop reasoning is flawed: the ground truth hinges on the *continuity of referencing the same original 8-K filing* as evidence of no structural changes, which the LLM omits entirely. Instead, it focuses on balance sheet classification (long-term vs. short-term), which is not the basis of the original answer and introduces a new, unsupported interpretation. (4) While the LLM captures the surface-level consistency of the notes' terms, it misinterprets the implication — the original answer stresses that Oracle maintained stable *short-term* debt obligations despite issuing new instruments, whereas the LLM frames the notes as long-term instruments supporting short-term liquidity via credit facilities, a claim not supported in the ground truth. Thus, despite accurate numbers, the reasoning and qualitative synthesis are significantly off, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 540,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's issuance and documentation of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern suggest about its long-term debt strategy?",
      "original_answer": "The 4.30% Note due 2034 was consistently referenced in Oracle's filings across 2022, 2023, and 2024, indicating its ongoing importance in the company's long-term debt structure. In 2022 (Exhibit 4.11), the note was listed alongside other long-term instruments, reaffirming Oracle’s commitment to a diversified maturity profile. In 2023 and 2024 (Exhibit 4.09), the note continued to be included in the exhibit list, showing no structural changes but reinforcing its sustained presence in Oracle’s capital structure. This consistent documentation suggests Oracle intended to maintain this liability as a stable component of its long-term financing strategy.",
      "llm_answer": "Oracle first issued the 4.30% Note due 2034 in 2014 as part of a set of long‑term notes.  In its 2022 10‑K (pages 111‑112) the note is listed as outstanding with a 4.30% coupon and 2034 maturity, and the same disclosure appears unchanged in the 2023 10‑K (pages 108‑109) and the 2024 10‑K (pages 108‑109).  This steady, multi‑year reporting shows Oracle’s long‑term debt strategy is to keep a stable, fixed‑rate portfolio with long maturities that align with its cash‑flow profile and provide predictable interest costs.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 4.30% Note due 2034 as consistently reported across 2022, 2023, and 2024 filings, aligning with the ground truth's emphasis on sustained documentation. However, it introduces a factual error by stating the note was 'first issued in 2014,' which is not supported by the ground truth and contradicts the multi-year filing pattern focus of the question. The ground truth makes no mention of the original issuance date, so this addition is unsupported and likely incorrect. (2) Quantitatively, the coupon rate (4.30%), maturity year (2034), and consistency across years are accurate. The page numbers cited (e.g., 111–112 in 2022, 108–109 in 2023/2024) may be factually correct in the actual filings but are not present in the ground truth, so their accuracy cannot be verified from the provided knowledge graph. Their inclusion adds detail but risks inaccuracy if mismatched. (3) The reasoning is sound in interpreting the consistent disclosure as evidence of a stable long-term debt strategy with fixed-rate, long-maturity instruments. This aligns with the ground truth’s conclusion about Oracle’s intent to maintain stable financing. However, the LLM infers an issuance date not present in the source, showing flawed multi-hop reasoning—possibly conflating this note with another issuance. (4) Despite the incorrect issuance date, the core of the answer—consistent reporting and strategic implications—is correct and relevant. The answer addresses both parts of the question: evolution (no changes across years) and strategic implication (stable debt portfolio). Thus, the correctness score is 7 due to the significant but not central factual error; qualitative and contextual scores are high due to strong reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 485,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Schwab's utilization of the IDA agreement for migrating IDA balances to its balance sheet evolve from 2022 through 2024, and what changes in contractual flexibility or constraints occurred across these years?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, and it had already moved $10.1 billion by December 31, 2021, including $10 billion subsequent to that date. In 2023, the 2019 IDA agreement was replaced by the 2023 IDA agreement, which eliminated the requirement that at least 80% of IDA balances be fixed-rate obligations, but Schwab did not migrate any IDA balances to its balance sheet that year. In 2024, Schwab continued to operate under the 2023 IDA agreement, maintaining restrictions on balance migration based on capital sufficiency and balance thresholds, and again did not move any IDA balances to its balance sheet. This shows a shift from active migration in 2022 to a more constrained and passive approach in 2023 and 2024, despite increased contractual flexibility.",
      "llm_answer": "In 2022 Schwab exercised the 2019 IDA agreement’s option to move up to $10 billion of IDA balances to its balance sheet (about $10 billion was migrated that year), a provision that required the balances to be floating‑rate obligations, a minimum $50 billion IDA balance through June 2031, and that at least 80 % of the balances be fixed‑rate through June 2026. The 2023 IDA agreement, which replaced the 2019 terms on May 4 2023, removed the 80 % fixed‑rate requirement, allowed Schwab to buy down up to $5 billion of fixed‑rate balances, and imposed stricter withdrawal limits (customer‑initiated withdrawals only until September 10 2025) while setting new minimum and maximum balance thresholds ($30 billion above the fixed‑rate total through 2025, then $60 billion minimum and $90 billion maximum thereafter); Schwab chose not to migrate any balances in 2023. In 2024, under the same 2023 agreement Schwab again did not move IDA balances to its balance sheet, and the contract continued to require maintaining a minimum of $60 billion (post‑Sept 2025) with a $90 billion cap, reflecting a shift toward tighter control over balance composition but reduced flexibility to shift balances to the balance sheet.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that significantly affect correctness. While it correctly notes that Schwab did not migrate any IDA balances in 2023 and 2024, and that the 2023 IDA agreement replaced the 2019 version, it introduces incorrect quantitative and qualitative details. The claim that 'about $10 billion was migrated' in 2022 is misleading—the original answer states that $10.1 billion had already been moved by December 31, 2021, including $10 billion 'subsequent to that date' (i.e., after the 2019 agreement), implying most migration occurred before 2022, not during it. This misrepresents the timing and volume of migration. (2) Quantitative inaccuracies include: (a) the $5 billion 'buy down' of fixed-rate balances, which is not mentioned in the ground truth; (b) specific balance thresholds of $30B, $60B, and $90B, which are fabricated; (c) customer-initiated withdrawal restrictions until September 10, 2025—none of these figures appear in the original. The ground truth only mentions 'restrictions based on capital sufficiency and balance thresholds' without specifics. (3) The reasoning partially captures the shift from active migration to inactivity, but incorrectly attributes reduced balance migration to 'tighter control' and 'stricter withdrawal limits,' whereas the ground truth emphasizes that despite *increased* contractual flexibility (removal of the 80% fixed-rate requirement), Schwab chose not to migrate—highlighting a strategic, not structural, constraint. The LLM inverts the logic by suggesting reduced flexibility. (4) Contextual relevance is high—the answer addresses the evolution across years and contractual changes. However, due to major factual and logical errors in numbers and reasoning, the correctness score is limited to 5. The qualitative accuracy is moderate because entity identification (Schwab, IDA agreements, years) is correct, and the multi-hop structure is attempted, but synthesis is flawed. Quantitative accuracy is low due to invented figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1536,
        "completion_tokens": 549,
        "total_tokens": 2085
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Abbott Laboratories' engagement with its 2.000% Senior Notes due 2018 evolve from 2022 through 2024, particularly in terms of documentation updates and refinancing activities across the three years?",
      "original_answer": "In 2022, Abbott referenced the 2.000% Senior Notes due 2018 as part of the Fifth Supplemental Indenture dated September 23, 2015, indicating ongoing documentation related to legacy St. Jude Medical debt. In 2023, the company continued to reference the same notes within the context of broader debt structure documentation, specifically in Exhibit 4.21, showing continuity in disclosure practices. By 2024, the 2.000% Senior Notes due 2018 were still included in the 10-K exhibit table (Exhibit 4.21), but with no new issuances or amendments noted, suggesting that the notes were likely nearing maturity without further refinancing actions taken. The consistent inclusion of the notes across all three years indicates a stable, though gradually maturing, component of Abbott's capital structure.",
      "llm_answer": "Abbott’s 2.000 % Senior Notes due 2018 had already matured and been repaid by the time of the 2022 filing, and the 2022 10‑K (pp. 85‑89) lists no outstanding balance or new indenture for those notes.  The 2023 10‑K (pp. 84‑88) likewise reports no remaining 2.000 % Senior Notes due 2018 and no supplemental indenture or refinancing activity.  The 2024 10‑K (pp. 84‑88) continues to show no outstanding 2.000 % Senior Notes due 2018 and no further documentation updates or refinancing of that debt.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim that the 2.000% Senior Notes due 2018 had already matured and been repaid by 2022. The ground truth states that Abbott continued to reference these notes in its filings through 2024, specifically in Exhibit 4.21 of the 10-Ks, indicating ongoing documentation and disclosure despite the maturity date having passed. This suggests the notes may have been part of legacy debt structures (originating from St. Jude Medical) that were still being tracked in disclosures, possibly due to legal or structural reasons, even post-maturity. The LLM incorrectly interprets the absence of new activity as evidence of full repayment and closure, which contradicts the ground truth's emphasis on continued inclusion in exhibit tables. Quantitatively, the LLM does not provide any incorrect numbers per se (since it reports no balances, which may be accurate), but it misinterprets the significance of the lack of balance as closure of the matter. However, the ground truth highlights that the continued inclusion in exhibits across years indicates ongoing documentation relevance, not inactivity. The reasoning is flawed because the model fails to recognize that post-maturity disclosures can persist for legal or structural transparency. The answer is contextually relevant—it addresses the right documents (10-Ks) and time frame (2022–2024)—but draws an incorrect conclusion from the evidence. Thus, while the answer is structured well and cites correct document types, it lacks factual alignment with the ground truth regarding the evolution of documentation and refinancing activities. The multi-hop synthesis fails because it does not connect the continued exhibit inclusion to legacy debt tracking practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 476,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's introduction and continuation of its 3.650% Notes due 2041 evolve from 2022 through 2024, and what does this multi-year pattern suggest about Oracle's long-term debt strategy?",
      "original_answer": "Oracle first introduced the 3.650% Notes due 2041 in 2022 as part of its long-term debt instruments, continued to reference the same notes in 2023 alongside newer bond issuances, and reaffirmed its inclusion in 2024 within the broader context of its registered securities. This consistent inclusion over three years indicates Oracle's strategic use of long-term debt to fund operations and maintain financial flexibility. The persistence of the 3.650% Notes due 2041 in Oracle's capital structure suggests a stable long-term financing approach, complemented by periodic new issuances to meet evolving capital needs.",
      "llm_answer": "Oracle first issued the 3.650% Notes due 2041 in 2021 as part of a $3.5 billion long‑term debt program.  In the 2022 10‑K (p. 112) the notes appear as outstanding with a principal of $3.5 billion; the 2023 10‑K (p. 108) and 2024 10‑K (p. 109) report the same principal and coupon, with no repayment or additional issuance.  This steady presence over three years indicates Oracle’s strategy of maintaining a stable, long‑term debt profile that balances moderate interest costs with liquidity and capital‑structure flexibility.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a factual error in the issuance year: it states the 3.650% Notes due 2041 were first issued in 2021, while the ground truth indicates the introduction was in 2022. All other quantitative details—$3.5 billion principal, 3.650% coupon, and consistent reporting in 2022, 2023, and 2024—are accurate and align with the original answer. Page references (2022 p.112, 2023 p.108, 2024 p.109) add precision and are plausible, though not verifiable from the ground truth alone. (2) The dollar amount ($3.5 billion), interest rate (3.650%), and maturity year (2041) are all correct. There are no calculation errors, as none were required. The only inaccuracy is the issuance year, which affects quantitative accuracy but not the ongoing status of the debt. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years of 10-K filings to observe stability in Oracle’s long-term debt, infers a strategic intent around financial flexibility, and connects this to broader capital structure management—consistent with the ground truth’s conclusion. (4) Despite the incorrect issuance year, the core factual content and strategic interpretation are aligned with the original answer. The error is minor in impact because the focus of the question is on the evolution from 2022–2024, which the LLM correctly describes. Hence, correctness is high but docked for the factual discrepancy in timing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 406,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about its debt financing strategy?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, with terms set by an Officers' Certificate issued March 24, 2021. In 2023, Oracle expanded its debt portfolio by issuing additional structured notes, including the 4.500% Notes due 2028 under Exhibit 4.16, indicating a diversification of interest rate profiles. By 2024, Oracle maintained the same structure for the 2.300% Notes due 2028, showing consistency in referencing the March 24, 2021 certificate. This three-year pattern suggests a stable long-term debt financing strategy focused on maintaining a diversified maturity and interest rate structure across multiple fiscal years.",
      "llm_answer": "Oracle issued its 2.300% Notes due 2028 on March 24 2021 as part of a senior‑secured, fixed‑rate debt issuance (Exhibit 4.14).  The notes remained unchanged in coupon, maturity and principal through fiscal 2022, 2023 and 2024, as reflected in each 10‑K’s debt schedule (pages 112‑116 of the 2022 10‑K, pages 108‑112 of the 2023 10‑K, and pages 109‑113 of the 2024 10‑K).  This consistent, long‑term debt profile indicates Oracle’s preference for stable, fixed‑rate financing to manage interest‑rate risk and preserve liquidity while supporting its growth initiatives.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that the 2.300% Notes due 2028 were issued on March 24, 2021, whereas the original answer clarifies that the Officers' Certificate setting the terms was issued on that date, not the actual note issuance. The actual issuance occurred in fiscal year 2022. Second, the LLM references Exhibit 4.14, while the ground truth specifies Exhibit 4.16, which is a significant discrepancy in document citation. Third, the LLM describes the notes as 'senior-secured,' but the original answer does not specify collateral status, and Oracle's senior notes are typically unsecured, making this a material mischaracterization. (2) Quantitatively, the coupon rate (2.300%), maturity year (2028), and consistency across fiscal years 2022–2024 are correctly noted. However, the issuance date and exhibit number are incorrect, and no principal amount is mentioned, which weakens completeness. Page numbers cited (e.g., 112–116 in 2022 10-K) may be accurate but are not verifiable from the ground truth and do not compensate for the structural errors. (3) The multi-hop reasoning is partially sound—Oracle maintaining the same note structure over three years does suggest a stable financing strategy, which the LLM correctly infers. However, it fails to capture the key evolution highlighted in the original answer: the 2023 introduction of *additional* notes (4.500% Notes due 2028), indicating diversification. This omission undermines the analysis of Oracle’s broader debt strategy. The LLM focuses only on stability, missing the nuance of strategic diversification. (4) Despite these errors, the answer is contextually relevant, addressing Oracle’s debt strategy and referencing consistent terms over time. The conclusion about stable, fixed-rate financing aligns partially with the ground truth, but lacks the full strategic picture. Hence, correctness is reduced due to key factual and document-level inaccuracies, though not entirely incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 545,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Visa's virtual accounts evolve across its Currencycloud platform from 2022 to 2024, particularly in terms of their integration into the Visa Direct Platform and the expansion of cross-border capabilities?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of its Treasury as a Service initiative, emphasizing their role in enabling cross-border products and services through the Currencycloud platform. By 2023, virtual accounts were fully integrated into the Visa Direct Platform, supporting new flows and enhancing the established cross-border consumer payments business with real-time foreign exchange rates and improved liquidity and settlement capabilities. In 2024, virtual accounts continued to be a core component of the Visa Direct Platform, further solidifying their role in facilitating cross-border transactions and supporting Visa’s broader network of more than 11 billion endpoints, including cards, bank accounts, and digital wallets.",
      "llm_answer": "In 2022, Visa’s Treasury‑as‑a‑Service launch highlighted the Currencycloud platform’s virtual‑account feature as a new tool for cross‑border treasury, but those accounts were still separate from the Visa Direct network. By 2023, Visa formally integrated Currencycloud’s virtual‑account capability into the Visa Direct Platform, enabling real‑time FX, virtual accounts and liquidity for instant domestic and cross‑border transfers. In 2024 the platform expanded further, adding Visa Cross‑Border Solutions and enhanced settlement liquidity so that virtual accounts could power a broader range of real‑time, cross‑border payments across the network.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: virtual accounts were introduced in 2022 under Visa's Treasury as a Service via Currencycloud, integrated into Visa Direct in 2023 with real-time FX and liquidity improvements, and further expanded in 2024 with enhanced cross-border capabilities. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but all dates (2022, 2023, 2024) are accurate and correctly associated with the respective developments. (3) The multi-hop reasoning is sound—correctly tracing the evolution across years and platforms (Currencycloud → Visa Direct), and synthesizing integration milestones and functional enhancements. (4) The LLM adds slightly more detail (e.g., 'instant domestic and cross-border transfers', 'Visa Cross-Border Solutions') not explicitly in the original, but these are reasonable inferences consistent with the source. One minor point: the original mentions support for 'more than 11 billion endpoints' in 2024, which the LLM omits, but this is a secondary detail. Overall, the answer is factually correct, complete in core aspects, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 335,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did the geographic distribution network for EMD-branded products evolve across Caterpillar's Machinery, Energy & Transportation (ME&T) segment from 2022 to 2024, and what does this progression indicate about Caterpillar's market expansion strategy for EMD?",
      "original_answer": "From 2022 to 2024, Caterpillar's geographic distribution network for EMD-branded products remained consistent at 108–110 distributors covering between 109 and 158 countries. In 2022, EMD-related FG Wilson branded electric power generation systems were sold through 110 distributors across 109 countries. In 2023, this was reported as 110 distributors covering 109 countries. By 2024, the number of distributors slightly decreased to 108, but the geographic reach expanded to 158 countries. This indicates a strategy to optimize distribution efficiency while increasing international market access for EMD products.",
      "llm_answer": "Caterpillar’s ME&T dealer network for EMD‑branded products expanded from 156 dealers (43 U.S., 113 abroad) serving 191 countries in 2022 to 160 dealers (44 U.S., 116 abroad) serving 193 countries in 2024, after a brief contraction in 2023 (41 U.S., 111 abroad, 187 countries). This growth signals Caterpillar’s intent to broaden its global dealer footprint and deepen market penetration for EMD, underscoring a strategy to enhance accessibility and presence in key regions (2022 pages 74‑78; 2023 pages 63‑67; 2024 pages 64‑68).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The ground truth states that the number of distributors for EMD-branded products remained stable at around 110 (110 in 2022, 110 in 2023, 108 in 2024), covering 109 to 158 countries. In contrast, the LLM claims there were 156 dealers in 2022, 160 in 2024, and a network serving 191–193 countries—numbers that are completely inconsistent with the ground truth. The LLM also introduces a split between U.S. and international dealers (e.g., 43 U.S., 113 abroad), which is not present or inferable from the original answer. (2) Quantitative accuracy is extremely low: all key numbers (distributor counts, country counts, U.S./abroad breakdowns) are fabricated or misattributed. There is no evidence of correct calculation or data retrieval. The timeline (2022–2024) is correctly framed, but the values per year are wrong. (3) The multi-hop reasoning is flawed. The original answer infers a strategy of distribution optimization and expanded geographic reach due to fewer distributors covering more countries by 2024. The LLM instead describes a growing dealer network, implying a different strategic direction (expansion via more dealers), which contradicts the actual trend of slight distributor reduction. The LLM fails to capture the core insight about efficiency and reach decoupling. (4) Contextual relevance is moderate because the answer addresses the right topic (EMD distribution evolution and strategy) and references the correct segment (ME&T), but the factual foundation is so inaccurate that the conclusion is invalid. The citation of page ranges adds false credibility. Overall, the answer fabricates data and draws incorrect conclusions, warranting a very low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 483,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 to 2024, based on the changes in the original cost and net book value of these assets on the balance sheet?",
      "original_answer": "Abbott's original cost of diagnostics instruments leased to customers increased from $3.3 billion in 2022 to $3.6 billion in 2023, and further to $3.9 billion in 2024. The net book value of these leased instruments also rose from $1.4 billion in 2022 to $1.6 billion in 2023 and $1.8 billion in 2024, indicating a consistent increase in Abbott's investment in diagnostics instruments over the three-year period.",
      "llm_answer": "Abbott’s diagnostics‑instrument lease portfolio grew modestly from 2022 to 2023, with the original cost rising from **$3.6 billion to $3.9 billion** (a $300 million increase) and the net book value climbing from **$1.6 billion to $1.8 billion** (a $200 million gain).  By 2024 the balance‑sheet figures remained flat at **$3.9 billion and $1.8 billion**, indicating that the investment plateaued after the 2023 uptick.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both numbers and trends. It incorrectly states that the original cost in 2022 was $3.6 billion, when the ground truth is $3.3 billion. It also claims that 2023 values rose from $3.6B to $3.9B, but the correct increase is from $3.3B (2022) to $3.6B (2023). Similarly, the LLM misstates the 2022 net book value as $1.6B instead of $1.4B. These errors misrepresent the entire trend. (2) The LLM claims that values 'plateaued' in 2024, but the ground truth shows continued growth from 2023 to 2024 ($3.6B to $3.9B original cost; $1.6B to $1.8B net book value). The LLM incorrectly implies no change in 2024, contradicting the steady upward trend. (3) The multi-hop reasoning is flawed: the model fails to correctly track the three-year evolution, misaligns the data across years, and draws an incorrect conclusion about investment plateauing. It appears to confuse 2022 and 2023 figures, treating 2023 as the starting point. (4) Despite these major factual and reasoning errors, the answer is contextually relevant—it addresses the right company, metric, and time frame, and interprets balance sheet trends appropriately in structure. However, the quantitative inaccuracies severely undermine correctness, warranting a low score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 362,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "What does the consistent disclosure of the 3.450% Senior Note due 2046 in PepsiCo's 2022, 2023, and 2024 10-K filings indicate about its ongoing role in the company's long-term capital structure strategy?",
      "original_answer": "The consistent disclosure of the 3.450% Senior Note due 2046 across all three years—in Exhibit 4.17 in 2022, Exhibit 4.16 in 2023, and Exhibit 4.15 in 2024—indicates that this instrument remained a stable and integral component of PepsiCo’s long-term debt financing strategy throughout the period. The repeated inclusion of this specific note, without any indication of modification or removal, suggests it was strategically maintained to support the company’s capital structure, likely providing long-dated, fixed-rate funding. This consistency implies that PepsiCo viewed the note as a reliable source of capital with favorable terms that aligned with its broader financial planning over the three-year horizon.",
      "llm_answer": "PepsiCo’s repeated listing of the 3.450% Senior Note due 2046 in the 2022, 2023, and 2024 10‑K filings shows that the note remains a core, long‑term debt instrument in its capital‑structure mix. The consistent disclosure indicates that PepsiCo continues to rely on this moderate‑coupon, long‑maturity note as part of a diversified debt strategy designed to support growth, acquisitions and shareholder returns while keeping the cost of capital stable.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in all quantitative aspects: the interest rate (3.450%), maturity year (2046), and the fact that the note was disclosed in the 2022, 2023, and 2024 10-K filings are accurate. There are no numerical or date inaccuracies, so quantitative accuracy is perfect. The answer correctly identifies the note as a long-term debt instrument and part of PepsiCo’s capital structure strategy, which aligns with the ground truth. However, the LLM omits specific details about the note’s placement in the filings (Exhibit 4.17 in 2022, 4.16 in 2023, 4.15 in 2024) and does not mention the absence of modifications or removal, which supports the inference of strategic stability. While the LLM captures the broader implication—that the note is a reliable, long-dated funding source—it introduces the term 'moderate-coupon' without grounding it in comparative market data, which is not present in the original answer and slightly weakens the qualitative precision. The reasoning is sound and contextually appropriate, correctly synthesizing the multi-year consistency as evidence of strategic intent. The answer is highly relevant and conveys the core meaning of the original, though with slightly less evidentiary detail from the filings. Thus, correctness and qualitative accuracy are high but not perfect due to minor omissions and an unsupported descriptor.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 381,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which also included other notes such as the 1.650% Notes due 2026 and 2.875% Notes due 2031. In 2023, Oracle continued to reference the 2.300% Notes due 2028 in Exhibit 4.14, alongside newer issuances such as the 4.500% Notes due 2028. In 2024, Oracle again referenced the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity with prior disclosures while continuing to include newer notes like the 4.500% Notes due 2028. This pattern suggests Oracle maintained a consistent approach to referencing prior debt instruments while layering in new issuances with potentially higher yields to reflect changing market conditions or strategic financing needs.",
      "llm_answer": "Oracle’s 2.300% Notes due 2028 were issued in March 2021 as part of a $2.5 billion debt package and were still outstanding in the 2022 10‑K (p. 112‑116) and the 2023 10‑K (p. 108‑112), with no principal repayment or rate change reported. In 2023 Oracle added a new 4.500% Notes due 2028 (Feb 2023) and the 2024 10‑K (p. 109‑113) reiterated the 2.300% Notes as still outstanding while highlighting the 4.500% Notes as part of a broader debt mix. This multi‑year pattern indicates Oracle’s strategy of maintaining a stable base of lower‑rate debt while layering new maturities and coupons to manage its capital structure and capitalize on favorable market conditions.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding the issuance date and initial offering details of the 2.300% Notes due 2028. The ground truth does not specify an issuance date or dollar amount (e.g., $2.5 billion in March 2021), nor does it reference such details in Exhibits 4.16, 4.14, etc., as being tied to that offering. The original answer only confirms the note's presence in disclosures across years, not its initial issuance timing or size. This introduces a major quantitative error. (2) The LLM claims the notes were issued in March 2021, but the question and ground truth focus on fiscal years 2022–2024, with no mention of 2021 issuance in the provided truth. Additionally, page numbers (e.g., p. 112–116) and exact dollar amounts are not present in the ground truth and appear fabricated. These are serious quantitative inaccuracies. (3) Qualitatively, the LLM captures the correct multi-hop pattern: Oracle continued referencing the 2.300% Notes in successive years while adding higher-yielding instruments like the 4.500% Notes due 2028. This aligns with the ground truth’s conclusion about maintaining prior instruments while layering in new debt, suggesting a strategy of stable, layered financing. The reasoning about Oracle’s broader debt strategy—maintaining low-rate debt while adding new tranches—is semantically equivalent and logically sound. (4) Contextually, the answer addresses the evolution across fiscal years and infers strategy appropriately. However, the inclusion of unverified specifics (dates, amounts, pages) undermines factual correctness. While the strategic interpretation is strong and contextually relevant, the incorrect anchoring of the issuance timeline and unsupported figures reduce the overall correctness score to a mid-range 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 495,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "Based on Visa's filings from 2022 through 2024, how has the company's treatment of its Series B Convertible Participating Preferred Stock evolved, and what does this continuity suggest about its long-term capital structure priorities?",
      "original_answer": "Visa's treatment of its Series B Convertible Participating Preferred Stock has remained unchanged from 2022 through 2024, as evidenced by its consistent reference to the same Certificate of Designations dated June 21, 2016, across all three annual filings. This lack of modification suggests that Visa has maintained a stable capital structure strategy over this period, prioritizing continuity in its preferred equity instruments. The persistent inclusion of the Series B certificate indicates a deliberate choice to preserve existing shareholder rights and financing flexibility, rather than altering the terms or introducing new preferred stock series. This consistency aligns with a broader pattern of stability in Visa's capital management approach, as seen in its unchanged Bylaws (2022 filing) and the 2024 update to its Certificate of Incorporation without changes to the Series B structure.",
      "llm_answer": "Visa has kept the Series B Convertible Participating Preferred Stock in the same form across its 2022‑, 2023‑, and 2024‑10 K filings, with Exhibit 4.4 (Certificate of Designations of Series B Convertible Participating Preferred Stock) appearing unchanged in each report (2022 p. 112; 2023 p. 108; 2024 p. 108).  None of the filings disclose any issuance or conversion of that series, indicating the instrument has remained a dormant, designated option.  This consistency signals Visa’s long‑term capital‑structure priority of maintaining a flexible, convertible‑preferred tool while primarily relying on debt and common equity for actual financing needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Visa's Series B Convertible Participating Preferred Stock has remained unchanged from 2022 to 2024, referencing the consistent inclusion of the Certificate of Designations (Exhibit 4.4) across all three 10-K filings. The specific page numbers cited (2022 p.112; 2023 p.108; 2024 p.108) are precise and support the claim of continuity. (2) There are no numerical or date inaccuracies—while the ground truth references the June 21, 2016 Certificate date, the LLM does not contradict this and instead focuses on the exhibit’s persistence in recent filings, which is factually sound. The absence of issuance or conversion activity is correctly inferred from lack of disclosure, which is a reasonable interpretation in the context of SEC filings. (3) The multi-hop reasoning is strong: the model synthesizes information across three years of filings, identifies the repeated exhibit, and draws a logical conclusion about capital structure priorities. It adds value by characterizing the instrument as a 'dormant, designated option' and linking it to Visa’s preference for using debt and common equity for active financing—this is a reasonable qualitative extension consistent with the evidence. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2016 Certificate date or the broader context of Bylaws/Certificate of Incorporation updates noted in the ground truth, which slightly reduces completeness in terms of supporting evidence. However, the core facts, reasoning, and conclusion are correct and relevant. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 481,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to the transition from LIBOR to SOFR and the associated risks outlined in each year's disclosures?",
      "original_answer": "From 2022 to 2024, Caterpillar maintained a consistent reliance on currency hedging instruments to manage exchange rate risk, while adapting to the transition from LIBOR to SOFR in its broader interest rate risk management strategy. In 2022, the company was actively assessing the implications of the planned phase-out of LIBOR, noting that Cat Financial had formed a cross-functional team to evaluate risks associated with the use of LIBOR in derivatives, loans, and other financial instruments. By 2023, this focus had evolved to include SOFR as the new benchmark for variable interest rates, with Cat Financial managing interest rate exposure through match funding, selective derivatives, and diversified funding. In 2024, the company continued to emphasize the use of derivatives as part of its hedging strategy, with no significant changes in approach but ongoing acknowledgment of the risks posed by market liquidity and interest rate fluctuations. The consistent use of hedging instruments across all three years shows Caterpillar's strategic effort to mitigate currency risk, even as the broader financial landscape shifted from LIBOR to SOFR.",
      "llm_answer": "Caterpillar’s 2022 10‑K (pp. 20‑24) noted that it uses currency‑hedging instruments to offset foreign‑currency costs but did not discuss the LIBOR‑to‑SOFR transition. In the 2023 filing (pp. 17‑21) the company added a specific risk paragraph explaining that some of its variable‑rate loans and derivatives are LIBOR‑based, that the forthcoming transition to SOFR could alter the valuation and effectiveness of those hedges, and that a cross‑functional team is monitoring the impact. By the 2024 filing (pp. 17‑21) Caterpillar updated the disclosure to state that it has begun replacing LIBOR‑linked derivatives with SOFR‑based instruments, has adjusted its hedging strategy accordingly, and continues to evaluate the transition’s effect on hedging effectiveness and overall currency‑risk exposure.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the evolution of Caterpillar's hedging strategy and the LIBOR-to-SOFR transition, and there are no numeric inaccuracies (quantitative accuracy is perfect, scoring 10). The answer correctly identifies the progression across years: in 2022, no mention of LIBOR transition details; in 2023, acknowledgment of LIBOR-based instruments and risk to hedge effectiveness, with a cross-functional team monitoring; in 2024, active replacement of LIBOR-linked derivatives with SOFR-based ones. These points align well with the original answer’s timeline and key developments. However, the LLM answer overstates the shift in hedging strategy by claiming Caterpillar 'has adjusted its hedging strategy accordingly' and 'begun replacing LIBOR-linked derivatives' in 2024, while the ground truth emphasizes 'no significant changes in approach' and ongoing monitoring rather than active replacement. This misrepresents the degree of strategic change, introducing a subtle but important discrepancy in qualitative accuracy. The original answer stresses consistency in currency hedging despite the benchmark transition, whereas the LLM implies a more active strategic shift. This affects multi-hop reasoning and synthesis (qualitative accuracy scores 7). Contextual relevance is high (9) as the response directly addresses all parts of the question and evolves the narrative appropriately across years, with accurate entity and year references (Caterpillar, Cat Financial implied, 2022–2024). Wording differences are acceptable under semantic equivalence, but the implication of strategic change goes beyond the ground truth’s emphasis on continuity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 462,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities evolve from 2022 through 2024, particularly in relation to LTL Management LLC's bankruptcy filings and the $2 billion trust established to address talc claims?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson's strategy around talc-related liabilities shifted from creating a dedicated liability entity (LTL Management LLC) and establishing a $2 billion trust to a more complex legal maneuvering involving multiple bankruptcy filings and appeals. In 2022, JNJ had already established a $2 billion reserve to fund a trust for LTL to address talc claims, while litigation was stayed due to LTL’s Chapter 11 filing. By 2023, the Third Circuit reversed the bankruptcy court's decision, leading to the dismissal of the initial LTL bankruptcy and the lifting of the stay, prompting LTL to refile (LTL 2), which was also dismissed later that year. In 2024, despite reaching multi-state settlements, the company remained engaged in appellate efforts to uphold the bankruptcy protection for talc claims, showing a continued reliance on the LTL structure to manage liability exposure.",
      "llm_answer": "From 2022 to 2024, Johnson & Johnson shifted from a single $2 billion trust funded to satisfy amounts owed to LTL Management LLC after its 2021 bankruptcy filing to a broader, multi‑year resolution strategy. By 2023 the reserve had expanded to roughly $9 billion (present‑value $12 billion) as part of the LTL 2 bankruptcy and a proposed pre‑packaged plan, and in 2024 the company further increased the reserve to a present‑value of $11.6 billion while pursuing a $6.475 billion, 25‑year payment plan that would resolve 99.75 % of remaining talc claims, all while continuing to file new bankruptcy petitions to isolate and settle claims.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents key aspects of Johnson & Johnson's financial and legal strategy from 2022 to 2024. (1) Quantitatively, the claim that the reserve expanded to $9 billion (present-value $12 billion) by 2023 and then to a present-value of $11.6 billion in 2024 is incorrect; the original answer states only a $2 billion trust was established, with no mention of such increases. The $6.475 billion, 25-year payment plan resolving 99.75% of claims is not supported by the ground truth, which mentions multi-state settlements but no specific dollar figures or percentages. (2) The timeline is flawed: the LLM implies the $2 billion trust was created after a 2021 bankruptcy filing, but the original answer states the trust was established in 2022 in connection with LTL’s Chapter 11 filing. (3) The LLM incorrectly suggests ongoing expansion of reserves and structured settlements as part of a coherent resolution strategy, while the ground truth emphasizes legal reversals (Third Circuit), dismissal of two bankruptcy filings (LTL and LTL 2), and continued appellate efforts without successful resolution. (4) The model invents a 'pre-packaged plan' and detailed payment structure not present in the original, showing poor multi-hop reasoning and synthesis. While the answer correctly identifies the use of LTL Management LLC and repeated bankruptcy filings as part of J&J’s liability management strategy, it fabricates financial figures and implies progress toward resolution that the original answer does not support. The core narrative of evolving strategy is contextually relevant, but the factual foundation is unsound, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 464,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Adobe's Photography Plan evolve from 2022 to 2024 in terms of its positioning within the Creative Cloud ecosystem, and what specific enhancements or strategic shifts were made across those years to attract photographers and creative professionals?",
      "original_answer": "From 2022 to 2024, Adobe's Photography Plan became more integrated and enhanced within the Creative Cloud ecosystem. In 2022, it was positioned as a targeted package for photographers and photo enthusiasts, offering Photoshop, Lightroom, and Lightroom Classic. By 2023, Adobe emphasized the Photography Plan within a broader product-led growth strategy, integrating generative AI capabilities and offering Generative Credits to enhance creative workflows. In 2024, the Photography Plan was further refined with AI-powered features in Photoshop and Lightroom, such as Generative Fill, Lens Blur, and People Masking, making it a more robust offering for photographers while remaining a more limited alternative to the full Creative Cloud suite. This evolution reflects Adobe’s strategic shift to infuse AI into creative tools and position the Photography Plan as a streamlined, yet powerful, solution for photographers.",
      "llm_answer": "In 2022, Adobe positioned its Photography Plan as a limited cloud‑based subscription within Creative Cloud that bundled Photoshop, Lightroom and Lightroom Classic for photographers and photo enthusiasts (2022 10‑K, pp. 5‑9). By 2023, the plan was deepened into the broader Creative Cloud ecosystem—Adobe added generative‑AI (Firefly) and AI‑powered tools across its apps, expanded cloud storage, collaboration, and Adobe Stock access to broaden appeal (2023 10‑K, pp. 3‑7). In 2024 the plan was further refined as a standalone, cost‑effective offering that still includes Photoshop, Lightroom, Lightroom Classic, new AI features such as Generative Fill/Expand and generative credits, and tighter integration with Creative Cloud Libraries and cloud services, positioning it as a focused, cloud‑centric solution for photographers while remaining part of the larger Creative Cloud ecosystem (2024 10‑K, pp. 8‑12).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the Photography Plan included Photoshop, Lightroom, and Lightroom Classic in 2022; generative AI (Firefly) and Generative Credits were introduced in 2023; and AI features like Generative Fill were enhanced in 2024. The positioning as a streamlined offering within Creative Cloud is accurately conveyed. (2) There are no numeric values (e.g., dollar amounts, percentages, user counts) in either the ground truth or LLM answer, so quantitative accuracy is not compromised—dates (2022–2024) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes the evolution across three years, correctly identifying strategic shifts—integration of AI, cloud services, and ecosystem alignment—based on inferred 10-K references. The mention of Firefly, Creative Cloud Libraries, and Adobe Stock adds contextual detail consistent with Adobe’s broader strategy. (4) Semantic equivalence is strong: while the LLM includes slightly more detail (e.g., collaboration, Adobe Stock, Libraries), it does not introduce inaccuracies. One minor point: the ground truth emphasizes the Photography Plan as a 'more limited alternative to the full Creative Cloud suite,' which the LLM implies but doesn't explicitly state. This slight omission prevents a perfect 10, but overall the answer is factually correct, complete, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 392,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Visa maintained consistency in its class C common stock certificate documentation from 2022 to 2024, and what might this stability suggest about the company's approach to corporate governance and investor relations during a period of broader regulatory and market evolution?",
      "original_answer": "Visa has consistently referenced the same Form of Specimen Certificate for Class C Common Stock across its 10-K filings for 2022, 2023, and 2024, with each year citing Exhibit 4.2 filed on January 28, 2009 (8-A, File Number 000-53572). Despite broader changes in corporate governance practices and evolving regulatory environments, Visa has not updated or modified its documentation for Class C common stock certificates. This long-term consistency suggests a deliberate approach to maintaining stable investor relations practices and implies confidence in the adequacy of its existing governance framework for equity instruments. The lack of changes also contrasts with updates seen in other governance documents like the Certificate of Incorporation (revised in 2024) and indicates that Visa has not found it necessary to alter its stock certificate structure despite market and regulatory shifts.",
      "llm_answer": "Visa has continued to reference the same exhibit for its class C common stock certificate in each 10‑K – exhibit 4.2, a form 8‑A filed on 1/28/2009 – in the 2022, 2023 and 2024 filings, with no changes to the form or filing date. This unaltered documentation signals a deliberate commitment to stable, predictable governance practices, giving investors and regulators a clear, consistent reference point even as broader regulatory and market conditions evolve.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the exhibit number (4.2), the form type (8-A), and the filing date (January 28, 2009) are accurately cited across 2022–2024, with no changes—this matches the original answer exactly. Format variations (e.g., '1/28/2009' vs 'January 28, 2009') are acceptable and do not affect accuracy. (2) The answer addresses the core of the question—consistency in documentation and its implications for governance and investor relations. It correctly infers that the unaltered documentation reflects a deliberate strategy for stability and predictability. (3) The multi-hop reasoning is sound: it synthesizes the repeated citation of the same exhibit across three years and draws a logical conclusion about corporate governance. (4) The only minor omission is that the LLM does not mention the 2024 revision to the Certificate of Incorporation, which the original answer uses as a contrast to highlight that other governance documents were updated while the stock certificate form was not. This contextual nuance adds depth to the original answer but does not undermine the correctness of the LLM’s core claims. Overall, the answer is factually correct, well-reasoned, and contextually appropriate, warranting a high score with only a slight deduction for incomplete contextual contrast.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 385,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure and risk management in commercial aerospace contracts?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable across the three-year period. In 2022, the collaboration partners' share of financing guarantees was $140 million, which slightly decreased to $135 million in 2023, and further declined to $131 million in 2024. These figures indicate a gradual reduction in RTX’s shared liability exposure with partners, suggesting improved risk management or renegotiation of terms in aerospace financing arrangements over time. The company consistently accrues for these guarantees based on historical performance data and adjusts as new claims data emerges, showing a disciplined and evolving approach to managing long-term obligations tied to product performance.",
      "llm_answer": "RTX’s carrying amount of liabilities for performance and operating‑cost guarantees declined from $1,109 million at year‑end 2022 to $1,091 million in 2023 and to $993 million in 2024 (see the “Balance as of December 31” rows in Note 16). The drop reflects fewer new guarantees issued (264 m in 2022 to 216 m in 2024) and larger settlements (–284 m to –247 m), indicating that the company is actively trimming its contingent exposure and improving risk management in its commercial aerospace contracts.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both magnitude and entity. The original answer refers to RTX's collaboration partners' share of financing guarantees, which were $140M (2022), $135M (2023), and $131M (2024). In contrast, the LLM cites total carrying amounts of $1,109M, $1,091M, and $993M—over 7x larger—and attributes them to performance and operating-cost guarantees broadly, not the partners' share. These figures appear to conflate total liabilities with a specific subset (partner-shared guarantees), leading to a severe misrepresentation. (2) The numbers cited by the LLM do not match the ground truth: $1,109M vs $140M in 2022 is a massive discrepancy. Even allowing for format variation, the orders of magnitude differ. The LLM also introduces unsupported data like '264m in 2022 to 216m in 2024' for new guarantees and settlement figures not present in the original, making them hallucinated. (3) The multi-hop reasoning fails: the question asks about evolution of specific liabilities tied to partner guarantees, but the LLM misidentifies the metric entirely. It analyzes total carrying amounts rather than the shared liability component, breaking the chain of correct entity and metric tracking. While it attempts to infer risk management trends (declining exposure), the conclusion is based on incorrect data. (4) Scores reflect major factual errors in numbers and entities (quantitative accuracy: 2), flawed reasoning due to misidentification of the liability type and inclusion of fabricated data (qualitative accuracy: 3), and partial relevance as it addresses the general theme of liability trends in aerospace contracts (contextual relevance: 6). Correctness score is low because the core financial data and metric are entirely mismatched.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 483,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in leases evolve from fiscal years 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuations?",
      "original_answer": "Costco consistently applied a straight-line basis for recognizing free-rent periods and step-rent provisions over the lease term, including extension options that the company is reasonably certain to exercise, across all three years. In 2022, the company emphasized its use of the incremental borrowing rate to calculate the present value of lease payments, derived from quoted interest rates. In 2023, the disclosure expanded to clarify how variable lease payments tied to price indices or sales volume were treated separately but still aligned with the same accounting policy. By 2024, the company maintained the same accounting treatment but placed greater emphasis on impairment evaluation of long-lived assets, indicating a heightened focus on lease-related asset valuations in the context of facility relocations or closures. While the core accounting policy remained stable, the context in which it was presented evolved to reflect growing operational complexity in lease management.",
      "llm_answer": "Costco has applied the same lease‑accounting policy for free‑rent periods in FY 2022, FY 2023 and FY 2024.  In each 10‑K the company notes that “some leases include free‑rent periods and step‑rent provisions, which are recognized on a straight‑line basis over the original term of the lease and any extension options that the Company is reasonably certain to exercise from the date the Company has control of the property” (Leases, pages 43‑47).  The lease‑term definition has also remained unchanged: “the lease term is defined as the non‑cancelable period of the lease plus any options to extend when it is reasonably certain that the Company will exercise the option” (Leases, pages 43‑47).  Because free‑rent periods reduce the lease payments, they lower the initial right‑of‑use (ROU) asset valuation, and no material changes to this treatment or disclosure were reported between FY 2022 and FY 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core assertions: Costco maintained a consistent accounting policy for free-rent periods across fiscal years 2022–2024, recognizing them on a straight-line basis over the lease term including extension options that are reasonably certain to be exercised. The definition of lease term and the impact on right-of-use (ROU) asset valuation—specifically that reduced lease payments during free-rent periods lower the initial ROU asset—are correctly described. All referenced disclosures (e.g., straight-line recognition, lease term including extension options) align with the ground truth and are plausibly cited from the 10-Ks. However, the LLM answer omits key qualitative developments in disclosure evolution highlighted in the original answer: (1) the 2023 clarification on variable lease payments tied to price indices or sales volume, and (2) the 2024 increased emphasis on impairment evaluation of long-lived assets in the context of lease-related decisions like facility closures. These omissions represent a failure to fully capture the 'evolution' in disclosure context over time, which was central to the question. While the accounting treatment remained stable, the LLM’s conclusion that 'no material changes to this treatment or disclosure were reported' downplays the incremental enhancements in transparency and focus on asset valuation risks. Quantitative accuracy is perfect—no numbers, dates, or financial concepts are misstated. The reasoning is sound but incomplete in synthesizing multi-hop elements across years. Contextual relevance is high as the response directly addresses lease accounting and ROU asset impacts. Thus, the answer is largely correct but lacks completeness in capturing the nuanced evolution of disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 483,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Adobe's strategic emphasis on AI-powered document productivity evolve from 2022 to 2024, particularly in terms of Acrobat's role, R&D investments, and formal product branding?",
      "original_answer": "In 2022, Adobe highlighted Acrobat's leadership position in document-intensive industries and its role in accelerating digital transformation through Adobe Document Cloud, with trillions of PDFs created annually. In 2023, Adobe formally introduced AI as a core strategic focus across its offerings, signaling an evolution in its product development plans, including enhancements to document workflows. By 2024, Adobe formalized this strategy through branded product extensions like 'Acrobat AI Assistant,' indicating a clear trajectory from Acrobat's foundational document role toward AI-enhanced productivity tools. This evolution reflects a multi-year investment in integrating AI capabilities into Acrobat, aligning with Adobe’s broader innovation momentum and market opportunity in document intelligence.",
      "llm_answer": "Adobe’s 2022 10‑K (pp. 7‑8) framed Acrobat as the core PDF tool of its Document Cloud, noting that Adobe Sensei AI was already adding intelligent actions and that R&D was focused on expanding those AI‑driven features.  By the 2023 10‑K (pp. 4‑5) the company had broadened Acrobat’s AI role to include generative‑AI (Firefly) workflows and announced a higher R&D spend on AI and machine‑learning to support these capabilities.  In the 2024 10‑K (pp. 94‑98) Acrobat is positioned as the flagship of the unified “Adobe Document Cloud,” with AI‑powered features highlighted, R&D investment further ramped up, and formal product branding shifted to present Acrobat as the central AI‑enabled PDF platform within the Document Cloud suite.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Adobe's AI strategy around Acrobat from 2022 to 2024. (1) It accurately captures the progression: in 2022, Acrobat was positioned as the core of Document Cloud with Adobe Sensei AI already enhancing intelligent actions; in 2023, generative AI (Firefly) integration and increased R&D investment were highlighted; by 2024, Acrobat was branded as the flagship AI-enabled PDF platform within Document Cloud. (2) There are no numeric inaccuracies—while no specific dollar amounts or percentages are mentioned in either answer, the qualitative descriptions of R&D investment trends (e.g., 'higher R&D spend', 'further ramped up') are consistent and appropriately inferred from the filings. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of 10-Ks, correctly identifying the evolving role of AI in Acrobat, increasing R&D focus, and branding shifts. However, the LLM answer does not explicitly mention the formal product branding 'Acrobat AI Assistant', which is a key detail in the ground truth and represents a concrete manifestation of the branding evolution. This omission prevents a perfect score. (4) Despite this, the answer remains contextually rich, accurately reflecting the strategic trajectory and investment priorities. The absence of the specific branded feature name slightly weakens qualitative accuracy, but the overall narrative is factually sound and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 415,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 to 2024, particularly in terms of long-term debt classification and total long-term debt composition?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained consistently valued at $1,250 million in 2022, 2023, and 2024, indicating no change in principal amount over the three-year period. However, the classification of long-term debt evolved significantly. In 2022, long-term debt, excluding current portion, was $6,484 million, which decreased to $5,794 million by 2024. This decline was driven by the reclassification of the 2.750% Senior Notes due May 2024 from long-term to current portion as the maturity date approached. The consistent $1,250 million value of the 1.375% Senior Notes shows Costco maintained its exposure to this instrument, while overall long-term debt composition shifted due to other maturities and reclassifications.",
      "llm_answer": "Costco continued to classify the 1.375 % Senior Notes due June 2027 as long‑term debt at a carrying amount of $1.25 bn in each filing (2022, 2023 and 2024).  The total long‑term debt fell from $6.59 bn in 2022 to $5.92 bn in 2024 as the 2.75 % Senior Notes due May 2024 were repaid, while other long‑term debt rose from $590 m to $919 m, and the current portion of long‑term debt dropped from $73 m in 2022 to $103 m in 2024 (peaking at $1.08 bn in 2023 when the 2.75 % notes were still outstanding).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the 1.375% Senior Notes due June 2027 remained at $1.25 billion across 2022–2024 and were classified as long-term debt, which aligns with the ground truth. However, it reports incorrect values for total long-term debt: $6.59 billion in 2022 and $5.92 billion in 2024, whereas the ground truth states $6,484 million and $5,794 million respectively. These discrepancies suggest errors in data retrieval or reporting. Additionally, the LLM introduces 'other long-term debt' rising from $590 million to $919 million and mentions a current portion fluctuating from $73 million to $103 million (peaking at $1.08 billion in 2023), none of which are supported by the original answer and appear to be fabricated or misattributed. (2) The ground truth emphasizes that the decline in long-term debt was due to reclassification of the 2.750% Senior Notes due May 2024 to current portion—not repayment in 2024—whereas the LLM incorrectly states the notes were 'repaid', which is not confirmed in the provided truth. The peak current portion of $1.08 billion in 2023 is plausible but not verifiable from the ground truth, which does not provide intermediate current portion figures. (3) The multi-hop reasoning is partially sound: the model connects the treatment of specific notes over time and attempts to explain shifts in debt composition. However, it fails to accurately reflect the mechanism of reclassification (not repayment) and introduces unsupported figures, weakening the synthesis. (4) Despite these issues, the core point about consistent valuation of the 1.375% notes and decreasing total long-term debt is correct, and the response remains contextually focused. Hence, correctness is reduced due to significant quantitative inaccuracies and a key factual error about repayment vs. reclassification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 502,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Adobe's emphasis on free online self-service learning evolved from 2022 to 2024, particularly in terms of its positioning within Adobe's broader learning and enablement services portfolio and its integration with enterprise customer success strategies?",
      "original_answer": "From 2022 to 2024, Adobe consistently positioned free online self-service learning as a core component of its learning and enablement services, but the depth of integration with enterprise customer success strategies appears to have matured. In 2022, Adobe introduced free online self-service learning as part of a broader strategy to support customer adoption and success, emphasizing its role alongside fee-based programs and custom learning services tailored for enterprise clients. By 2023, Adobe continued to highlight free online self-service learning on learning.adobe.com, reinforcing its importance in enabling both individual users and enterprise teams to build product-specific competencies, with skills assessments offered to help enterprises tailor learning priorities. In 2024, Adobe maintained this structure, underscoring the centrality of free online self-service learning within its portfolio while aligning it more closely with enterprise customer success through custom learning services and skills assessments. The consistent presence of free learning options across all three years indicates Adobe's strategic commitment to democratizing product knowledge, while the growing emphasis on enterprise integration suggests a maturing approach to customer enablement.",
      "llm_answer": "Adobe has consistently positioned its free online self‑service learning as a core element of its Digital Learning Services portfolio, but the emphasis has shifted from a general training resource in 2022 to a strategic pillar integrated with enterprise customer‑success initiatives by 2024. While 2022 and 2023 highlighted the platform as a complement to fee‑based programs and custom services for enterprise customers, the 2024 filing explicitly ties the free learning hub to Customer Success Managers, using skills assessments and tailored training to accelerate adoption and maximize ROI for large enterprises.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Adobe consistently positioned free online self-service learning as a core component from 2022 to 2024, with increasing integration into enterprise customer success strategies. The evolution from a complementary resource to a more strategically integrated pillar by 2024 is correctly captured. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years (2022, 2023, 2024), correctly identifies the role of free learning in relation to fee-based and custom services, and notes the enhanced alignment with Customer Success Managers and skills assessments in 2024. The only minor omission is that the 2023 details in the original answer—such as the mention of learning.adobe.com and enterprise tailoring via skills assessments—are slightly more specific than in the LLM response, which generalizes this point. (4) The LLM answer is semantically equivalent to the original, uses appropriate terminology, and directly addresses all parts of the question: evolution over time, positioning within the broader portfolio, and integration with enterprise success. The slight lack of detail on 2023 does not detract from the overall correctness. Hence, a 9/10 for correctness and qualitative accuracy, with full marks for contextual relevance and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 426,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has NVIDIA's exposure to the 2.00% Notes Due 2031 evolved from 2022 to 2024, and what does this pattern suggest about the company's long-term debt management strategy amid its rapid AI-driven revenue growth?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 was $1.20 billion in 2022, decreased to $1.057 billion in 2023, and then increased again to $1.25 billion in 2024. This fluctuation suggests a dynamic debt management strategy where NVIDIA initially reduced its position in the notes, possibly to optimize capital structure or take advantage of refinancing opportunities, before increasing exposure again—potentially to secure long-term capital aligned with its strategic investments in AI infrastructure and R&D. The consistent presence of this instrument across filings highlights its importance in NVIDIA's long-term financing approach.",
      "llm_answer": "NVIDIA’s carrying amount of the 2.00 % Notes Due 2031 has been essentially flat – $1,250 million in 2024 (the 2024 10‑K table shows $1,250 million for the note, unchanged from the prior year) and the same figure appears in the 2023 and 2022 10‑Ks, indicating a deliberate, low‑interest, long‑maturity debt profile. This stability shows the company is deliberately keeping its long‑term debt structure steady while using the low‑cost, long‑term capital to fund its rapid AI‑driven revenue expansion.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. It states that the carrying amount of the 2.00% Notes Due 2031 was $1,250 million in 2024, 2023, and 2022, implying no change over time. However, the ground truth shows a clear fluctuation: $1.20 billion in 2022, $1.057 billion in 2023 (a decrease), and $1.25 billion in 2024 (an increase). The LLM incorrectly asserts stability, missing the dynamic pattern entirely. (2) The numbers are significantly off: $1.20B vs $1.25B in 2022, $1.057B vs $1.25B in 2023 — these are not minor discrepancies but major errors in magnitude and trend. The LLM also fails to note the 2023 reduction, which is a key part of the narrative. (3) The reasoning is flawed because it draws conclusions about a 'deliberate, low-interest, long-maturity debt profile' based on false stability, whereas the actual pattern suggests a more active debt management strategy — reducing exposure and then increasing it again, possibly in response to strategic needs. The LLM fails to perform the required multi-hop synthesis across three years of data and instead fabricates consistency. (4) While the answer is relevant to the topic of debt management and AI growth, the factual inaccuracies severely undermine the qualitative and quantitative accuracy. The contextual relevance is moderate because it addresses the right theme (debt strategy amid AI growth) but bases its analysis on incorrect data. Correctness is low due to fundamental errors in numbers and trend interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 422,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this progression indicate about the company's strategic focus on financial process standardization and control environment alignment?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year enterprise-wide initiative aimed at enhancing financial shared service capabilities and standardizing financial systems. In 2022, the company described the initiative as a proactive effort to integrate, simplify, and standardize processes and systems across key functions, including finance, without being prompted by any internal control deficiencies. By 2023, the company reiterated this strategic direction, highlighting ongoing alignment and streamlining of the financial control environment in response to the initiative. In 2024, the company maintained the same narrative, underscoring continuity in its efforts and affirming that these enhancements were not reactive but rather part of a long-term plan to improve operational efficiency and control effectiveness. This consistent messaging across three years indicates a sustained strategic focus on modernizing financial infrastructure and reinforcing internal controls through process standardization.",
      "llm_answer": "Johnson & Johnson launched a multi‑year, enterprise‑wide initiative in 2022 to “integrate, simplify and standardize processes and systems for the human resources, information technology, procurement, supply chain and finance functions” to grow its financial shared‑service capabilities (2022, pp. 115‑118).  The same language appears unchanged in the 2023 and 2024 10‑Ks (2023, pp. 116‑120; 2024, pp. 117‑121), showing the program has continued and deepened with an ongoing emphasis on aligning and streamlining the design and operation of its financial control environment.  This steady evolution signals a strategic priority on standardizing financial processes and reinforcing the control environment to support a scalable shared‑services model.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Johnson & Johnson's multi-year initiative began in 2022, focused on integrating, simplifying, and standardizing processes across several functions including finance, and this language was consistently repeated in the 2023 and 2024 10-K filings. The LLM correctly identifies the continuity of the initiative and its strategic intent. (2) Quantitative accuracy is perfect: the years (2022–2024) are correct, and while no numerical values (e.g., dollar amounts) are present, the citation of page numbers (e.g., pp. 115–118) matches typical 10-K referencing and supports verifiability. Format and references are consistent and plausible. (3) Multi-hop reasoning is sound: the model synthesizes information across three years of filings, correctly infers that unchanged language indicates program continuity, and draws a logical conclusion about strategic focus on standardization and control environment alignment. The only minor shortcoming is that the LLM slightly broadens the scope by listing HR, IT, procurement, and supply chain upfront, while the original answer emphasizes finance as the primary domain, with standardization across 'key functions including finance.' While not incorrect, this shifts emphasis slightly. (4) The answer is contextually excellent—directly addresses the evolution from 2022–2024 and interprets the strategic implications accurately. Overall, the response is factually robust, well-reasoned, and semantically equivalent to the ground truth with only a minor nuance in focus. Hence, a correctness score of 9 is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 453,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did Costco's competitive positioning language against BJ's Wholesale Club evolve from 2022 to 2024, particularly regarding the strategic emphasis on private-label brands like Kirkland Signature as a differentiator in warehouse club markets?",
      "original_answer": "From 2022 to 2024, Costco consistently positioned itself in direct competition with BJ's Wholesale Club, emphasizing private-label brands like Kirkland Signature as a key differentiator. In 2022, Kirkland Signature was described as 'high quality, offered at prices generally lower than national brands,' with a focus on lowering costs and earning higher margins. In 2023, the language remained largely consistent, with an added emphasis on sustainability initiatives tied to brand loyalty, though not explicitly linked to Kirkland Signature. By 2024, the description of Kirkland Signature remained core to the competitive strategy, but the surrounding language introduced a stronger tone around 'differentiating our merchandise offerings' in the context of increasingly competitive metropolitan markets. While the core strategy remained stable, the evolution in tone suggests a growing emphasis on differentiation through private-label branding in response to competitive pressures from BJ's.",
      "llm_answer": "Costco’s 10‑K filings from 2022 through 2024 all describe competition with BJ’s Wholesale Club in a generic, unchanged way—simply noting it as one of the other warehouse clubs in the U.S. The company consistently highlights its private‑label brand, Kirkland Signature, as a differentiator—emphasizing its lower prices, high quality, and higher margins—to set Costco apart from competitors like BJ’s, a focus that remains unchanged through the 2024 filing. No major shift in competitive‑positioning language is evident, but the 2024 filing reiterates the strategic importance of Kirkland Signature in differentiating Costco’s merchandise offerings.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but misses a key nuance in the evolution of Costco's competitive positioning language from 2022 to 2024. (1) Correctly identifies that Costco consistently positions Kirkland Signature as a differentiator against BJ's Wholesale Club, emphasizing lower prices, high quality, and higher margins—this aligns with the ground truth for all three years. (2) No numeric data is involved, so quantitative accuracy is 10 by default. (3) However, the LLM incorrectly states there was 'no major shift' and that the language remained 'unchanged,' which contradicts the ground truth: while the core strategy was stable, the 2024 filing introduced a stronger tone around 'differentiating our merchandise offerings' in competitive metropolitan markets, indicating an evolved emphasis. Additionally, the 2023 mention of sustainability initiatives linked to brand loyalty (though not directly to Kirkland) is omitted, missing a subtle qualitative shift. (4) The answer is contextually relevant and captures the central theme—Kirkland Signature as a strategic differentiator—but underrepresents the incremental evolution in tone and strategic framing over time, which is critical to the question about 'evolution' in language. Thus, correctness and qualitative accuracy are reduced due to incomplete synthesis of nuanced changes across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 375,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Charles Schwab's investment in U.S. State and Municipal Securities evolve from 2022 to 2024, and what does the consistent emphasis on investment-grade quality reveal about the firm's fixed income strategy during this period?",
      "original_answer": "In 2022, Schwab's investment portfolio included U.S. State and Municipal Securities as part of its broader credit risk exposure, with management noting that substantially all securities were rated investment grade. In 2023, Schwab disclosed a specific $638 million investment in U.S. State and Municipal Securities within its available-for-sale securities portfolio, indicating a quantifiable allocation to this asset class. By 2024, Schwab reaffirmed its focus on investment-grade quality for these securities, emphasizing continuity in its credit risk management approach. This consistent emphasis across all three years reveals a strategic preference for high-quality, lower-risk fixed income instruments as part of Schwab's broader liquidity and investment portfolio management.",
      "llm_answer": "Schwab’s U.S. state‑and‑municipal holdings were $638 million in both 2022 (page 54) and 2023 (page 114), then fell to $579 million by year‑end 2024 (page 48).  In each MD&A Schwab stresses that “substantially all securities in the investment portfolios were rated investment‑grade” (2022, page 54; 2023, page 114; 2024, page 50), underscoring a conservative fixed‑income strategy that prioritizes credit quality and capital preservation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Schwab did not disclose a specific dollar amount for U.S. State and Municipal Securities in 2022—only that substantially all securities were investment grade. However, the LLM claims a precise $638 million holding in 2022, which is incorrect. The $638 million figure is correctly attributed to 2023 in the ground truth, but the LLM incorrectly repeats it for 2022. Additionally, the LLM introduces a $579 million figure for 2024, which is not present in the original answer and unsupported by the provided ground truth. (2) Quantitative accuracy is low: two of the three numbers provided ($638M in 2022 and $579M in 2024) are either fabricated or hallucinated. Only the $638M in 2023 matches the ground truth. There are no calculations in the question requiring verification, but the presentation of false year-specific values severely undermines numerical correctness. (3) The multi-hop reasoning is flawed. The LLM incorrectly assumes that because a specific amount was disclosed in 2023, the same amount (or a tracked trend) applies in 2022 and 2024. It fails to recognize that the absence of a number in 2022 does not imply the same value as 2023. While it correctly identifies the recurring emphasis on investment-grade quality across years, this part of the reasoning aligns with the ground truth and supports partial qualitative credit. (4) Contextual relevance is moderate: the answer addresses the evolution over time and the strategy around credit quality, which are central to the question. However, the inclusion of false quantitative data undermines the overall correctness. The conclusion about a conservative fixed-income strategy is reasonable but based on misleading numerical trends. Thus, while the direction of analysis is relevant, factual errors dominate the evaluation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 512,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($140M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees, as measured by the collaboration partners' share, steadily declined from $140 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This consistent reduction suggests a strategic shift toward reducing RTX's reliance on third-party risk sharing in these financing arrangements, potentially signaling increased internal risk retention or tighter control over financing terms. Despite this decline, the fair market values of the guaranteed assets remained sufficient to cover the guarantees, indicating that RTX maintained a conservative approach to valuation and risk management throughout the period.",
      "llm_answer": "RTX’s exposure to commercial‑aerospace customer‑financing guarantees has trended downward: the collaboration‑partner share of guarantees fell from $140 million at year‑end 2022 to $135 million in 2023 and $131 million in 2024 (Note 16, Guaranties). This gradual decline indicates that RTX is actively shifting risk to its partners—reducing its own liability while maintaining residual‑value guarantees—reflecting a deliberate risk‑transfer strategy in this area.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the numerical values ($140M in 2022, $135M in 2023, $131M in 2024) and the downward trend in RTX's exposure via collaboration partners' share of guarantees, matching the ground truth exactly on all quantitative points. These numbers are cited with proper context and formatting variations (e.g., $140 million) are acceptable and accurate. (2) However, the qualitative interpretation is fundamentally incorrect: the LLM claims the decline 'indicates that RTX is actively shifting risk to its partners,' which inverts the actual meaning. The ground truth states the opposite — the declining partner share suggests RTX is *reducing reliance on third-party risk sharing*, implying *less* risk transfer to partners, not more. This misrepresents the risk transfer strategy and reflects a critical reasoning error. (3) The multi-hop synthesis fails at the inference stage: while the model correctly identifies the trend, it draws the inverse conclusion about risk strategy. Additionally, the LLM omits key context from the original answer — specifically, that the fair market values of guaranteed assets remained sufficient to cover the guarantees, reflecting conservative risk management. This omission weakens completeness and contextual depth. (4) Quantitative accuracy is perfect (score 10), but qualitative accuracy is low due to the reversed logic in interpreting the strategy (score 4). Contextual relevance is high as the answer addresses the domain, trend, and strategy question directly (score 8). Correctness score is 5: partially correct on facts, but major error in interpretation undermines the core insight required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 461,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Adobe's integration and positioning of Frame.io evolve from 2022 to 2024, particularly in terms of supported file types, application integrations, and role in content production workflows?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark under Adobe's intellectual property, indicating its acquisition and initial branding alignment. By 2023, Frame.io was described as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting still images, design files, and PDFs, with Camera-to-Cloud functionality for video production. In 2024, Frame.io expanded its integration to include Adobe Photoshop, Lightroom, and Workfront, and broadened its role beyond post-production into casting, location scouting, and marketing campaign management, reflecting its deepening role in end-to-end content creation workflows.",
      "llm_answer": "From 2022 to 2024, Adobe’s Frame.io evolved from a post‑production collaboration tool to a core hub for end‑to‑end content production. In 2022, Frame.io supported video, still images, design files and PDFs and was primarily integrated with Premiere Pro and After Effects for review and comment workflows [2022, 95‑99]. By 2023, Adobe added integration with Photoshop, Lightroom, camera‑to‑cloud uploads, and broadened file‑type support, embedding Frame.io more deeply into creative workflows [2023, 10‑14]. In 2024, Frame.io further integrated with Adobe Express, Firefly Services, and Workfront, added native still‑image camera support, and was positioned as part of Adobe G enStudio to enable scalable, cloud‑native production across all Adobe creative applications [2024, 10‑14].",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its overall narrative and timeline, accurately portraying Frame.io's evolution from a post-production tool to a central component of end-to-end content workflows. The dates (2022–2024) are correctly used, and the general progression of integration depth and functional expansion aligns with the ground truth. However, there are notable discrepancies in the details of application integrations and feature rollouts: (1) The LLM claims Photoshop and Lightroom integration began in 2023, but the ground truth states this expansion occurred in 2024. This misplacement of key integrations across years affects the accuracy of the multi-hop reasoning. (2) The LLM mentions integration with Adobe Express and Firefly Services and positioning within 'Adobe GenStudio' in 2024—details not present in the ground truth and potentially conflated with other Adobe product developments. (3) The ground truth highlights Frame.io’s expanded role in casting, location scouting, and marketing campaign management by 2024, which the LLM omits, instead emphasizing technical integrations and cloud-native production. (4) File type support is mostly accurate—both mention still images, design files, PDFs, and video—but the LLM adds 'native still-image camera support' without clear grounding. Quantitatively, there are no numerical errors (dates are used appropriately, no calculations involved), so quantitative accuracy is high. Contextually, the answer remains highly relevant, addressing all core aspects of the question (file types, integrations, workflow role), though with some factual inaccuracies in entity-event alignment. The qualitative accuracy is reduced due to incorrect attribution of integration timelines and inclusion of unsupported features, undermining the precision of the multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 494,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Lockheed Martin's production focus on the VH-92A Helicopter evolve from 2022 through 2024, and what does this multi-year progression indicate about the program's strategic importance within the Rotary and Mission Systems segment?",
      "original_answer": "From 2022 to 2024, the VH-92A Helicopter remained a consistent part of Lockheed Martin's Rotary and Mission Systems (RMS) portfolio, indicating sustained strategic importance. In 2022, RMS highlighted the VH-92A as part of its major programs, alongside other key platforms like the Black Hawk and CH-53K. In 2023, the VH-92A was again listed among RMS's major helicopter programs, reinforcing its ongoing production and support status. By 2024, the VH-92A continued to be a named program within RMS, even as the segment saw increased focus on other platforms and systems such as Aegis and LCS. The consistent mention of the VH-92A across all three years suggests a stable, long-term commitment to the program, despite shifting priorities and production ramps in other areas like missile defense and tactical systems.",
      "llm_answer": "Lockheed Martin’s Rotary and Mission Systems segment consistently reported lower production volume for the VH‑92A helicopter each year from 2022 through 2024, as noted in the segment’s net‑sales commentary for those years (LMT_10k_2024, pp. 38‑42; LMT_10k_2023, pp. 2‑6; LMT_10k_2022, pp. 48‑52). This steady decline indicates that while the VH‑92A remains a key Marine Corps platform, it is not a primary growth driver for the segment, which is instead concentrating on other helicopter and ISR programs such as the CH‑53K, IWSS, and C6ISR.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both factual content and reasoning. (1) The claim that Lockheed Martin's Rotary and Mission Systems (RMS) segment reported a 'steady decline' in VH-92A production volume from 2022 to 2024 is unsupported by the ground truth and contradicts the actual data. The original answer, based on the knowledge graph of SEC filings, states that the VH-92A was consistently listed as a major program within RMS across all three years, indicating stable commitment—not declining production. There is no mention in the ground truth of decreasing production volumes or net-sales commentary indicating a downward trend. (2) The LLM cites specific page numbers from the 10-K filings (e.g., LMT_10k_2024 pp. 38–42) to support its claim of declining production, but the ground truth does not reference such data, suggesting the LLM may have hallucinated or misinterpreted the source material. No quantitative metrics (e.g., units produced, sales figures) are provided in either the original or LLM answer, so the assertion of a 'steady decline' lacks numerical basis. (3) The multi-hop reasoning fails: while the LLM correctly identifies RMS as the relevant segment and mentions other programs (CH-53K, C6ISR), it incorrectly infers strategic demotion from absence of growth, whereas the ground truth emphasizes sustained inclusion as evidence of strategic stability. (4) Contextually, the LLM addresses the question’s structure—discussing evolution and strategic importance—but draws the opposite conclusion of the ground truth. The strategic importance is downplayed ('not a primary growth driver'), while the original answer emphasizes 'sustained strategic importance' due to consistent inclusion. Thus, despite addressing the right segment and timeframe, the answer is factually and logically flawed, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 501,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did the geographic scope and regulatory stringency of sales and media marketing restrictions affecting MDLZ evolve from 2022 through 2024, particularly in the European Union and emerging markets?",
      "original_answer": "From 2022 to 2024, MDLZ faced an expanding scope and increasing stringency of sales and media marketing restrictions. In 2022, over 25 EU countries had implemented EPR policies, and bans or taxes on single-use plastics were being considered in Europe and Southeast Asia. By 2023, these restrictions were reiterated with the inclusion of data privacy as a regulatory area affecting marketing, and EPR policies were being implemented or contemplated in India, Vietnam, and U.S. states. In 2024, the EU formally adopted the Packaging and Packaging Waste Directive, and EPR policies continued to spread globally, with Southeast Asia actively considering plastic bans or taxes. The trajectory shows a clear expansion in both the geographic reach and the regulatory intensity of these constraints.",
      "llm_answer": "In the 2022 10‑K (pp. 13‑17), MDLZ noted that sales‑and‑media marketing restrictions limit promotions or advertising of products with specified nutrient profiles on certain channels or platforms or during certain hours, and that over 25 EU countries had adopted extended‑producer‑responsibility (EPR) policies. The 2023 10‑K (pp. 9‑13) repeated that language with no change in geographic scope, while the 2024 10‑K (pp. 9‑13) added that the EU has adopted its Packaging and Packaging Waste Directive and that emerging markets such as India, Vietnam, Indonesia, and the Philippines are also considering single‑use plastic bans and other plastic taxes—signaling a tightening of regulatory stringency across both the EU and key emerging markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: over 25 EU countries with EPR policies in 2022, the EU's adoption of the Packaging and Packaging Waste Directive in 2024, and the mention of emerging markets (India, Vietnam, Indonesia, Philippines) considering plastic bans or taxes. The timeline across 2022–2024 is correctly represented. (2) The answer correctly identifies the expansion in regulatory stringency and geographic scope, particularly highlighting both the EU and emerging markets. (3) The multi-hop reasoning is sound—synthesizing information across three years of 10-K filings to show evolution in restrictions. The only minor shortcoming is that the 2023 developments in the original answer include data privacy as a new regulatory area affecting marketing, which the LLM answer omits. While EPR and plastic policies are well-covered, this omission slightly weakens completeness on the 'media marketing' aspect of the question. (4) Despite this, the LLM captures the core trajectory of increasing regulatory burden and geographic spread, with precise entity and year references, making it contextually excellent and semantically equivalent in most aspects. Minor deduction from 10 to 9 due to the missing data privacy point in 2023.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 367,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's treatment of its 3.700% Notes due 2046 evolve across its 2022, 2023, and 2024 10-K filings, and what does this pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Microsoft consistently reaffirmed its 3.700% Notes due 2046 across all three reporting years without altering their terms. In each of the 2022, 2023, and 2024 10-K filings, the Eleventh Supplemental Indenture dated August 8, 2016, was referenced, explicitly listing the 3.700% Notes due 2046 alongside other long-term debt instruments. The absence of modifications to these notes across all three years indicates a deliberate strategy of maintaining stable, long-dated liabilities with fixed interest obligations. This consistent treatment suggests Microsoft views these notes as a core component of its capital structure, reflecting confidence in long-term cash flow projections and a preference for predictable debt servicing costs.",
      "llm_answer": "Microsoft continues to report its 3.700% Notes due 2046 under the 11th Supplemental Indenture (Exhibit 4.14) as long‑term debt in each 10‑K (2022, 2023, and 2024) with the same coupon, maturity, and indenture terms (see MSFT_10k_2022 p. 103‑107, MSFT_10k_2023 p. 103‑107, MSFT_10k_2024 p. 103‑107).  The notes are consistently disclosed in the debt schedule without any changes to their structure or repayment plan, indicating that Microsoft maintains a stable, long‑term debt profile and relies on moderate‑rate, long‑maturity notes as a core component of its financing strategy while preserving flexibility to refinance or repay as market conditions allow.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Microsoft's 3.700% Notes due 2046 are consistently reported across the 2022, 2023, and 2024 10-K filings under the Eleventh Supplemental Indenture (referred to as Exhibit 4.14), with no changes to coupon, maturity, or terms. The specific page references (p. 103–107 across filings) support the claim and match typical disclosure locations. (2) Quantitative elements—interest rate (3.700%), maturity year (2046), and indenture details—are all factually correct. No calculations are required, but the consistency of numerical terms across years is properly emphasized. (3) The multi-hop reasoning is sound: the model synthesizes information across three years and filings to infer a stable long-term debt strategy. It correctly identifies the absence of structural changes as evidence of strategic consistency. (4) The only minor shortcoming is that the LLM does not explicitly name the 'Eleventh Supplemental Indenture dated August 8, 2016' as in the original answer, instead referring to it by exhibit number. While this is functionally equivalent for most users, the omission of the full formal name and date slightly reduces qualitative precision. However, the core reasoning and conclusion about Microsoft’s long-term debt strategy—stable, predictable obligations as a financing cornerstone—are semantically equivalent and well-supported. The answer remains highly relevant and factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 412,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across the 2022, 2023, and 2024 10-K filings, particularly in relation to the progression of its debt maturity structure as reflected in the Supplemental Indentures filed in each period?",
      "original_answer": "The 2.000% Notes due 2023 were consistently referenced in the Supplemental Indentures across Microsoft's 2022, 2023, and 2024 10-K filings, indicating their ongoing inclusion in the company's debt maturity strategy. In 2022, the notes appeared in Exhibit 4.14, listed alongside other instruments issued under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same series of notes was still present in the filings under the same exhibit structure, showing no change in the underlying debt instrument but reflecting its continued relevance as the maturity year approached. By 2024, the 2.000% Notes due 2023 remained listed in Exhibit 4.14, even as the actual maturity year had passed, suggesting either a rollover of debt, a delayed maturity, or a continued disclosure requirement for recently matured obligations. This evolution reflects Microsoft's structured approach to managing debt maturities and maintaining transparency around its long-term financing activities.",
      "llm_answer": "In the 2022 10‑K, Microsoft’s 2.000 % Notes due 2023 were issued under the Eleventh Supplemental Indenture (dated Aug. 8 2016) and remained outstanding through the 2023 filing, which still referenced the same indenture.  By the 2024 10‑K the 2.000 % Notes had matured or been repaid, and the debt‑maturity profile had shifted to later maturities, as shown by the new Fifteenth Supplemental Indenture (dated Nov. 6 2023) that introduces notes with maturities beyond 2023.  This progression illustrates a move from a 2023‑maturity note to a more extended debt horizon in Microsoft’s capital structure.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several correct elements but diverges significantly from the ground truth in key factual and interpretive aspects. (1) Quantitatively, the LLM correctly identifies the 2.000% Notes due 2023, the Eleventh Supplemental Indenture dated August 8, 2016, and the Fifteenth Supplemental Indenture dated November 6, 2023. These dates and percentages match the ground truth. However, the LLM incorrectly asserts that by the 2024 10-K the notes 'had matured or been repaid,' which contradicts the original answer stating the notes were still listed in Exhibit 4.14 in 2024, suggesting continued disclosure despite maturity. (2) The ground truth emphasizes the *continued presence* of the 2023 notes in filings even after maturity, possibly due to disclosure requirements or rollover, while the LLM interprets their absence (which isn't stated) as repayment and a shift in maturity profile. This misrepresents the evidence. (3) The LLM introduces the Fifteenth Supplemental Indenture as introducing 'notes with maturities beyond 2023'—a plausible inference but not supported in the original answer, which does not mention this indenture or new notes. This is an unsupported addition. (4) The reasoning fails the multi-hop synthesis: while it connects indentures and maturities across years, it draws an incorrect conclusion about the status of the 2023 notes in 2024. The original answer stresses continuity and disclosure post-maturity; the LLM assumes resolution. (5) Contextually, the answer is relevant and structured well, addressing the evolution of debt and indentures. However, the core factual claim about the 2023 notes being repaid by 2024 is not substantiated by the ground truth, which explicitly states they remained listed. Thus, while the answer is plausible-sounding and contains accurate fragments, it is factually incorrect on a key point, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 511,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Medtronic's Non-Employee Restricted Stock Unit Award Agreements evolve across 2022, 2023, and 2024 filings, particularly in relation to the underlying stock incentive plans referenced each year?",
      "original_answer": "The Non-Employee Restricted Stock Unit Award Agreements referenced in Medtronic’s filings show continuity in form and structure across the three years, but with a clear evolution in the underlying stock incentive plans. In 2022 (MDT_10k_2022.pdf), the agreement was tied to the Amended and Restated 2013 Stock Award and Incentive Plan (effective December 8, 2017), as noted in Exhibit 10.45. In 2023 (MDT_10k_2023.pdf), the agreement referenced the Amended and Restated 2013 Stock Award and Incentive Plan, consistent with 2022, indicating no change in the foundational plan despite prior amendments. In 2024 (MDT_10k_2024.pdf), the same form of agreement was used, again referencing the same Amended and Restated 2013 plan, suggesting long-term stability in the structure of these agreements. This shows that while the plan itself was amended over time, the form agreement remained consistent, reflecting a strategic choice to maintain standardized compensation instruments for non-employee directors.",
      "llm_answer": "In the 2022 10‑K (pp. 113‑117), Medtronic’s Non‑Employee Restricted Stock Unit Award Agreements were issued under the **Amended and Restated 2013 Stock Award and Incentive Plan**.  By the 2023 filing (pp. 111‑115), the agreements had shifted to the **2021 Long‑Term Incentive Plan**, reflecting a new incentive framework for non‑employee directors.  The 2024 filing (pp. 111‑115) continued to reference the 2021 Long‑Term Incentive Plan, indicating no further plan change but maintaining the same underlying incentive structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors in both the underlying stock incentive plans and the timeline of changes. According to the ground truth, Medtronic's Non-Employee Restricted Stock Unit Award Agreements referenced the same plan—the Amended and Restated 2013 Stock Award and Incentive Plan—across all three years (2022, 2023, and 2024). However, the LLM incorrectly claims that in 2023, the agreement shifted to the '2021 Long-Term Incentive Plan,' which contradicts the original answer. This misrepresentation is a critical error in entity accuracy and undermines the entire multi-hop synthesis. There is no mention in the ground truth of a transition to a 2021 plan; instead, the continuity of the 2013 plan (as amended) is emphasized. The LLM also fabricates a 'shift' that did not occur, indicating flawed reasoning. While the answer addresses the question's structure by discussing each year and referencing underlying plans, the core factual content is incorrect. Page numbers cited (e.g., pp. 113–117) may be plausible but do not compensate for the substantive inaccuracy. The conclusion that the 2021 plan was maintained in 2024 is also false per the ground truth. Thus, despite correct framing and apparent attention to detail, the answer fails on quantitative accuracy (wrong plan names/dates), qualitative accuracy (incorrect synthesis and logic), and overall correctness. Contextual relevance is moderate because the response attempts the right type of analysis but is factually baseless.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 415,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans evolve from 2022 to 2024, and what does this trend suggest about the company's liability management strategy for international pension obligations?",
      "original_answer": "MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans decreased from 17% in 2022 to 16% in 2023, and was effectively discontinued by 2024, as the company shifted to fair value estimation methods for these instruments. This trend suggests a strategic move away from insurer-backed annuities toward more direct liability management and valuation control, aligning with broader pension de-risking or restructuring efforts.",
      "llm_answer": "MDLZ’s non‑U.S. pension plans allocated **17 % of assets to buy‑in annuity policies in 2022** (MDLZ_10k_2022, p. 118‑122), **slightly reduced to 16 % in 2023** (MDLZ_10k_2023, p. 103‑107), and **returned to 17 % in 2024** (MDLZ_10k_2024, p. 101‑105). The near‑constant target mix, with only a one‑percentage‑point dip in 2023, indicates that MDLZ maintains a deliberate, risk‑managed liability‑coverage strategy for its international pension obligations, adjusting the allocation only when plan asset or liability profiles warrant a temporary shift.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, MDLZ's allocation to buy-in annuity policies decreased from 17% in 2022 to 16% in 2023 and was effectively discontinued by 2024, with the company shifting to fair value estimation methods. However, the LLM claims the allocation returned to 17% in 2024, which directly contradicts the ground truth. This error undermines the entire response. (2) Quantitatively, the 2022 (17%) and 2023 (16%) figures are correct, but the 2024 figure is wrong—the allocation did not return to 17%, but rather was discontinued. The claim of a 'near-constant target mix' is therefore false. (3) The multi-hop reasoning is flawed: the LLM fails to recognize the strategic shift away from annuities toward fair value estimation, which is a key part of the company's liability management strategy. Instead, it infers continued reliance on annuities with minor adjustments, which misrepresents the trend. (4) Contextual relevance is moderate—the response addresses the right topic (allocation to buy-in annuities in non-U.S. pension plans) and time frame, and cites appropriate documents, but the conclusion about 'deliberate, risk-managed liability-coverage strategy' is based on incorrect data and misses the actual strategic shift toward de-risking and valuation control. The model synthesizes information incorrectly across years, failing the multi-hop requirement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 400,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's issuance of 2.000% Notes due in 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "Microsoft's 2.000% Notes due in 2023 were consistently referenced in all three annual reports (2022, 2023, and 2024) as part of the company's broader debt structure, indicating a stable inclusion in Microsoft's long-term financing strategy. In 2022, the notes were listed in Exhibit 4.14 under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same notes were again referenced in Exhibit 4.14 with identical details, showing no change in the structure or maturity. By 2024, the notes remained in the disclosures under the same exhibit, confirming that Microsoft maintained this liability on its books through the 2024 reporting period, even as the due date approached. This consistency suggests that Microsoft did not retire or refinance the 2.000% Notes ahead of schedule, reflecting a deliberate and steady approach to managing its long-term debt obligations.",
      "llm_answer": "Microsoft issued $2.5 billion of 2.000 % Notes due 2023 in FY 2022, cut the issuance to $1.5 billion in FY 2023, and further trimmed it to $1.0 billion in FY 2024. This gradual decline shows the company’s intent to keep a low‑coupon, diversified debt mix while using long‑term debt to fund capital allocation, share repurchases, and acquisitions, thereby preserving liquidity and supporting a strong balance sheet.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The LLM claims Microsoft issued $2.5 billion in FY2022, $1.5 billion in FY2023, and $1.0 billion in FY2024 for the 2.000% Notes due 2023. However, the ground truth states that these notes were originally issued under an Eleventh Supplemental Indenture in 2016 and were consistently referenced in the same form across 2022, 2023, and 2024 filings—there was no new issuance or reduction in amount over these years. The specific dollar amounts cited by the LLM are entirely fabricated and not supported by the data. (2) Completeness: While the LLM attempts to address the evolution and strategy, it fails to accurately describe the actual continuity of the debt instrument. The question asks about how the notes evolved, and the correct answer is that they remained unchanged. (3) Entity Accuracy: The company (Microsoft) and the debt instrument (2.000% Notes due 2023) are correctly identified, as is the time frame (fiscal years 2022–2024), so partial credit is given here. (4) Reasoning: The LLM constructs a narrative of declining issuance to suggest a strategic wind-down, but this is false—the notes were not being phased out or reissued in smaller amounts. The reasoning is based on non-existent data and thus invalid. (5) Semantic Equivalence: The LLM’s conclusion about maintaining a diversified debt mix and funding capital allocation may reflect general truths about Microsoft’s strategy, but it does not align with the specific evidence regarding this debt instrument. The core facts are wrong, so the answer cannot be considered semantically equivalent. Overall, the answer fabricates key financial data and misrepresents the nature of the debt evolution, warranting a very low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 491,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's treatment of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, particularly in relation to supplemental indentures and the broader debt instrument structure?",
      "original_answer": "Microsoft's treatment of the 4.000% Notes due 2021 remained consistent across all three years, always being grouped under the Third Supplemental Indenture dated February 8, 2011. In 2022 (MSFT_10k_2022.pdf), the notes were listed in Exhibit 4.6 alongside the 2.500% Notes due 2016 and 5.300% Notes due 2041 under the same Third Supplemental Indenture. This structure was unchanged in 2023 (MSFT_10k_2023.pdf) and 2024 (MSFT_10k_2024.pdf), where the 4.000% Notes due 2021 continued to appear in Exhibit 4.6. While the specific notes due 2021 remained unchanged, Microsoft introduced new debt instruments with different maturity dates and interest rates under subsequent supplemental indentures across the years, such as the 2.375% Notes due 2023 in 2023 filings and the 2.125% Notes due 2022 in 2022 filings.",
      "llm_answer": "In the 2022 10‑K, Microsoft disclosed the 4.000% Notes due 2021 as part of the third supplemental indenture (Exhibit 4.6) under the base indenture, describing them as a long‑term debt instrument with a 4 % coupon and a 2021 maturity. The 2023 filing kept the same notes under that same indenture but added a new supplemental indenture (Exhibit 4.18) that re‑issued or consolidated the 4.000% Notes into a larger debt package. By the 2024 filing the 4.000% Notes remained in the third supplemental indenture, yet the new supplemental indenture (Exhibit 4.18) further integrated them into a broader, more diversified debt‑instrument structure while preserving the same coupon and maturity.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but introduces significant inaccuracies in the qualitative and reasoning dimensions. (1) Quantitatively, the 4.000% interest rate and 2021 maturity date are correctly stated, and the reference to Exhibit 4.6 in the 2022 filing aligns with the ground truth. However, the claim that a new supplemental indenture (Exhibit 4.18) was introduced in 2023 that 're-issued or consolidated' the 4.000% Notes is factually incorrect — the ground truth confirms the 4.000% Notes due 2021 remained consistently under the Third Supplemental Indenture (Exhibit 4.6) across all years, with no evidence of re-issuance or consolidation into a new structure. (2) The assertion that Exhibit 4.18 in 2024 'further integrated' these notes into a broader debt structure is unsupported by the original answer, which states the structure remained unchanged. (3) The multi-hop reasoning fails: while the LLM correctly identifies the consistent presence of the notes in Exhibit 4.6 in 2022 and 2024, it incorrectly infers structural evolution via new indentures, contradicting the ground truth that the treatment was 'consistent across all three years.' (4) The answer is contextually relevant and addresses the question's focus on debt structure evolution, but the core conclusion — that there was an evolution involving supplemental indentures — is false. The original answer emphasizes stability, not change. Minor wording flexibility is acceptable, but the LLM invents structural changes not present in the filings, severely undermining factual correctness. Thus, while some numbers and references are accurate, the reasoning and entity relationships are flawed, warranting a partial score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 464,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Medtronic's disclosures around its Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance or outstanding balances in this category reveal about the company's capital structure strategy?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that the company has not utilized Euro Deferred Shares as part of its capital structure strategy, potentially signaling a strategic preference for other forms of equity or debt financing, or a lack of demand for this particular instrument in investor markets.",
      "llm_answer": "Medtronic’s 10‑K filings for FY 2022, 2023 and 2024 all state that the company had **no Euro Deferred Shares issued or outstanding** (authorized at 40 000 shares) as of the reporting dates—April 29 2022 [79], April 28 2023 [79] and April 26 2024 [79].  The unchanged, zero‑balance disclosure shows that Medtronic does not employ Euro Deferred Shares as part of its capital structure, instead relying on ordinary shares and share‑repurchase programs, reflecting a conservative, straightforward equity‑capital strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the authorized amount of 40,000 Euro Deferred Shares with no issuance or outstanding balance is accurately reported for fiscal years 2022, 2023, and 2024, with correct end-of-fiscal-year dates cited (April 29, 2022; April 28, 2023; April 26, 2024). Format variations (e.g., '40 000' vs '40 thousand') are acceptable and semantically equivalent. (2) The answer addresses both parts of the multi-part question: it traces the evolution (consistently zero balances across years) and interprets the strategic implication (non-use in capital structure). (3) Entity accuracy is strong: 'Medtronic', 'Euro Deferred Shares', and fiscal years are correctly identified. (4) Reasoning is sound—correctly infers from the consistent zero balance that the instrument is not being used, and adds relevant context about reliance on ordinary shares and share repurchases, which is consistent with Medtronic's known capital strategy. The only minor shortcoming is that the original answer notes the par value of €1.00 per share, which the LLM omits. While not critical to the core insight, this detail contributes to completeness. Otherwise, the semantic meaning, multi-hop synthesis across three fiscal years, and strategic interpretation are accurate and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 382,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 filings, and what does this consistency or change indicate about the company's treatment of this debt instrument over time?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, always listing the Third Supplemental Indenture under Exhibit 4.6, dated February 8, 2011, and incorporated by reference from a prior 8-K filing. There were no material changes in the description or structure of the Notes across the three years, indicating that the debt instrument remained static in terms of documentation and disclosure treatment. This suggests that the Notes were matured or fully accounted for, with no further amendments or actions required by the company during this reporting period.",
      "llm_answer": "Microsoft’s 10‑K filings for 2022, 2023, and 2024 all list the 4.000% Notes due 2021 as part of the third supplemental indenture (Exhibit 4.6) with the same coupon rate, maturity date, and principal amount [MSFT_10k_2022, pages 102‑106; MSFT_10k_2023, pages 102‑106; MSFT_10k_2024, pages 102‑106]. The unchanged disclosure across the three years indicates that Microsoft continued to carry the notes as a long‑term liability (or had not yet fully retired them) and maintained a stable reporting of the debt instrument over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy in reasoning and interpretation. (1) Quantitatively, the answer correctly identifies the 4.000% Notes due 2021, references Exhibit 4.6 (Third Supplemental Indenture), and notes consistent disclosure across 2022, 2023, and 2024 filings with correct exhibit details and dates. The citation of pages and documents aligns with the ground truth. (2) However, the key error lies in the interpretation: the LLM states that Microsoft 'continued to carry the notes as a long-term liability (or had not yet fully retired them)', which contradicts the ground truth. Since the notes were due in 2021, by 2022 they should have been matured or settled. Their continued disclosure in subsequent 10-Ks is for completeness or legal reference, not because they remained active liabilities. The ground truth correctly infers that the lack of changes indicates the instrument was static and likely already accounted for, not that it was still carried on the balance sheet as an ongoing obligation. (3) The multi-hop reasoning is flawed: the model fails to recognize that a note due in 2021 would not remain an active debt instrument in 2022–2024 financials unless specifically noted as outstanding, which is not the case here. The consistency in disclosure reflects archival or legal continuity, not ongoing liability status. (4) While the factual elements (exhibits, dates, rates) are accurate, the core conclusion about the company's treatment of the debt is misleading, warranting a moderate correctness score. Contextual relevance is high as the answer addresses the evolution and implications, but the qualitative reasoning is unsound in a critical aspect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 466,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did The Coca-Cola Company's disclosure and treatment of the 0.125% Notes due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the consistency of its debt instrument structuring over time?",
      "original_answer": "The Coca-Cola Company's treatment of the 0.125% Notes due 2029 remained consistent across all three filings, with each year explicitly referencing the same Exhibit 4.4 from Form 8-K filings in September 2020 and March 2021. In 2022, the note was listed in Exhibit 4.23 and again in 4.31, each time citing the same underlying documentation. In 2023, it appeared in Exhibit 4.23 and again in 4.31, maintaining identical source references. In 2024, the note was again disclosed in Exhibit 4.23 and 4.31, with no change in the referenced Exhibit 4.4 filings. This reveals a consistent approach to structuring and disclosing this particular debt instrument over three consecutive reporting cycles, suggesting a stable capital market strategy for short-to-medium-term financing needs.",
      "llm_answer": "In each of the three most recent 10‑Ks, Coca‑Cola reports the 0.125% Notes due 2029 as a single, long‑term debt instrument with a fixed 0.125% coupon and a maturity of 2029. The 2022 filing lists the note as part of the company’s debt program (Exhibit 4.23, issued September 18 2020), the 2023 filing repeats the same terms and notes the same issuance date (Exhibit 4.31, March 9 2021), and the 2024 filing again presents the note unchanged as senior unsecured debt with the same coupon and maturity. The unchanged disclosure and classification across all three filings demonstrate that Coca‑Cola’s debt‑instrument structuring has remained stable and consistent over time.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent treatment of the 0.125% Notes due 2029 across the 2022, 2023, and 2024 10-K filings, noting unchanged terms such as coupon, maturity, and classification as senior unsecured debt. However, there are inaccuracies in the exhibit numbers and issuance dates. The ground truth states that each year references Exhibit 4.4 from Form 8-K filings in September 2020 and March 2021, and that in each 10-K the note appears in both Exhibit 4.23 and 4.31. The LLM incorrectly states that the 2022 filing lists the note in Exhibit 4.23 with issuance on September 18, 2020, and the 2023 filing in Exhibit 4.31 with March 9, 2021—implying a shift in exhibits across years, which contradicts the ground truth of dual exhibit inclusion (4.23 and 4.31) each year. (2) The dates September 18, 2020, and March 9, 2021, are plausible but not explicitly confirmed in the ground truth, which only references the Form 8-K filings without specifying exact dates. The coupon (0.125%) and maturity (2029) are correct. (3) The multi-hop reasoning is partially sound—the model correctly infers consistency in disclosure and links it to stable debt structuring. However, it fails to capture the full pattern of dual exhibit referencing (4.23 and 4.31) in each year, which is a key detail in the ground truth demonstrating procedural consistency. (4) The answer is contextually relevant and captures the main conclusion about stable capital market strategy. Due to the exhibit and structural inaccuracies, the quantitative accuracy is reduced, but the core qualitative message and reasoning remain largely intact, warranting a score of 8 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 460,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 to 2024, and what does this trend indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable from 2022 to 2024, with the collaboration partners' share of financing guarantees decreasing slightly from $141 million in 2022 to $135 million in 2023, and further to $131 million in 2024. The company's own liabilities related to these guarantees were not explicitly stated, but the consistent methodology of estimating based on historical experience and adjusting as claims data warrant suggests a managed but ongoing exposure. The trend indicates that RTX continues to extend these guarantees, particularly for commercial aircraft engines, while maintaining a controlled liability posture, suggesting stable long-term product performance expectations despite market uncertainties.",
      "llm_answer": "RTX’s liabilities for performance and operating‑cost guarantees declined from **$1,109 million** at year‑end 2022 to **$1,091 million** in 2023 and further to **$993 million** in 2024 (a $18 million drop in 2023 and a $98 million drop in 2024). This downward trend indicates that the company’s estimated future costs for warranty and performance guarantees are shrinking, suggesting a lower exposure to long‑term product‑performance risks in its commercial aerospace business.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, RTX's liabilities related to performance and operating cost guarantees refer specifically to the collaboration partners' share of financing guarantees, which were $141M (2022), $135M (2023), and $131M (2024)—a gradual decrease of $6M and then $4M. In contrast, the LLM reports total liabilities of $1,109M, $1,091M, and $993M, which are not supported by the ground truth and misrepresent both the magnitude and trend. These figures appear to be fabricated or confused with another liability category. (2) Calculations are internally consistent (e.g., $1,109M to $1,091M is a $18M drop), but since the base numbers are wrong, the entire quantitative analysis is invalid. The claimed $98M drop in 2024 is especially inaccurate. (3) The reasoning is partially sound in interpreting a declining trend as reduced exposure to long-term risks, which aligns with the general logic in the original answer. However, the LLM fails the multi-hop requirement: it does not distinguish between RTX’s own liabilities and partners’ share, nor does it reference the methodology (historical experience, claims adjustments) that supports ongoing managed exposure. (4) Contextual relevance is moderate—the answer addresses the right topic (liabilities for performance guarantees and risk exposure) and draws a plausible conclusion about risk trends, but the factual foundation is entirely incorrect. Due to major quantitative errors and incomplete entity/metric accuracy, the correctness score is low despite some structural coherence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 446,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Medtronic's approach to valuing non-qualified stock options evolved from 2022 to 2024, and what does this suggest about the company's changing assumptions around stock price volatility and equity compensation risk modeling?",
      "original_answer": "From 2022 to 2024, Medtronic consistently used the Black-Scholes model to value non-qualified stock options, but the company's disclosure around expected volatility evolved. In 2022, the company based expected volatility solely on a blend of historical and implied volatility. By 2023, Medtronic explicitly noted that implied volatility was derived from market-traded options, adding transparency to the forward-looking component of the assumption. This clarification was maintained in 2024, suggesting a more refined and market-informed approach to volatility estimation. This evolution indicates a shift toward more dynamic risk modeling in equity compensation, aligning with market behavior and potentially improving the accuracy of compensation expense recognition.",
      "llm_answer": "Medtronic’s Black‑Scholes assumptions for non‑qualified options have become more conservative: the volatility input rose from 23.0 % in 2022 to 24.3 % in 2024, the risk‑free rate jumped from 0.9 % to 4.2 %, and the dividend yield increased to 3.2 % while the expected life lengthened to 6.1 years. These higher volatility and risk‑free rate inputs, coupled with a modest rise in dividend yield, lowered the weighted‑average fair value of options from $22.83 to $18.49 per share, indicating Medtronic’s shift toward a more market‑based, risk‑averse equity‑compensation model that reflects heightened stock‑price volatility.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. While it correctly identifies that Medtronic uses the Black-Scholes model for valuing non-qualified stock options, nearly all specific numeric inputs (volatility, risk-free rate, dividend yield, expected life, fair value) are fabricated and do not appear in the ground truth. The original answer makes no mention of specific percentage values or changes in fair value, so these numbers (e.g., 23.0% to 24.3% volatility, $22.83 to $18.49 fair value) have no basis in the provided data. (2) There are no verifiable calculations in the LLM response because all numbers are unsupported. The claim that higher volatility and risk-free rates lowered fair value contradicts standard Black-Scholes dynamics—higher volatility typically increases option value, not decreases it. This indicates a flawed understanding of option pricing. (3) The multi-hop reasoning is unsound. The original answer focuses on the evolution of *disclosure transparency* around volatility assumptions—specifically, the shift to clarifying that implied volatility comes from market-traded options. The LLM instead invents a narrative about changing inputs and risk modeling based on non-existent numerical trends, failing to capture the actual qualitative shift in disclosure practices. (4) The contextual relevance is moderate because the answer addresses the general topic (valuation of stock options, Black-Scholes, volatility) and attempts to discuss evolving assumptions. However, the complete lack of factual grounding in numbers and the misrepresentation of the nature of the change (numerical input shifts vs. improved disclosure transparency) severely undermine accuracy. The conclusion about a 'risk-averse model' is speculative and unsupported. Thus, correctness is very low despite some topical alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 509,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did The Coca-Cola Company's issuance of notes with a 1.000% interest rate due in 2028 evolve across 2022, 2023, and 2024, and what does this pattern suggest about the company's debt strategy for that specific instrument?",
      "original_answer": "The Coca-Cola Company consistently referenced the 1.000% Notes due 2028 in all three years—2022, 2023, and 2024—indicating ongoing acknowledgment and potential maintenance of this debt instrument. However, in 2024, the company introduced significantly higher-yielding notes (e.g., 5.000% Notes due 2034 and 5.300% Notes due 2054), suggesting a broader strategic shift toward issuing higher-interest debt, while maintaining visibility on the 1.000% Notes due 2028. This implies that while the 1.000% Notes due 2028 remained part of the company's long-term debt structure, KO pursued more aggressive borrowing terms in 2024, possibly to fund new initiatives or refinance existing obligations.",
      "llm_answer": "In 2022 Coca‑Cola issued a $1.0 billion 1.000% note due 2028; it followed that with an additional $500 million of the same instrument in 2023 and a further $300 million in 2024. The steady, incremental issuance of this low‑interest, long‑term debt shows the company’s intent to lock in favorable rates and keep a stable, long‑term debt profile to finance its capital needs.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claims. The ground truth states that The Coca-Cola Company only referenced the 1.000% Notes due 2028 in each year, with no indication of actual issuance amounts or incremental debt raises. However, the LLM falsely asserts specific issuance amounts: $1.0 billion in 2022, $500 million in 2023, and $300 million in 2024—none of which are supported by the original answer or implied by the knowledge graph. These numbers are entirely fabricated. (2) Quantitative accuracy is extremely low because all dollar amounts and issuance events are incorrect. There is no mention in the ground truth of any incremental issuances or total amounts related to the 1.000% Notes due 2028 across the three years. The LLM invents a pattern of increasing issuance that does not exist. (3) The reasoning is flawed: the LLM concludes that Coca-Cola is 'locking in favorable rates' through incremental issuance, but the ground truth indicates only continued acknowledgment of the instrument, not new issuances. Furthermore, the LLM completely misses the key strategic signal in the ground truth—the introduction of high-yield notes (5.000% and 5.300%) in 2024 as evidence of a shift in debt strategy. This critical multi-hop insight (low-rate note maintained while higher-rate debt is issued) is absent. (4) Contextual relevance is moderate because the answer discusses the correct company, the correct note (1.000% due 2028), and the correct time frame. However, it misrepresents the nature of the data (issuance vs. disclosure) and fails to capture the actual strategic implication. The conclusion about 'stable long-term debt profile' contradicts the ground truth's indication of a broader shift toward higher-cost debt in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 482,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Microsoft's approach to structuring its 2.125% Notes evolve across 2022, 2023, and 2024, particularly in terms of associated trustee arrangements and related debt instruments disclosed in each filing?",
      "original_answer": "In 2022, Microsoft disclosed the Seventh Supplemental Indenture for the 2.125% Notes due 2021 alongside the 3.125% Notes due 2028, under the trustee relationship with The Bank of New York Mellon Trust Company, N.A., as part of a broader set of debt instruments. In 2023, the structure remained consistent, with the same trustee named and the 2.125% Notes due 2021 still listed alongside the same associated debt instruments. In 2024, the filing repeated the same exhibit description and trustee relationship, indicating no changes in the structure or administration of the 2.125% Notes over the three-year period. This consistency suggests that Microsoft maintained a stable debt servicing and trustee arrangement for this instrument throughout the period.",
      "llm_answer": "In the 2022 10‑K (pages 102‑106) Microsoft disclosed its 2.125 % Notes due 2022 under the Fourth Supplemental Indenture (Exhibit 4.7) with The Bank of New York Mellon Trust Company, N.A. as trustee. The 2023 filing (pages 102‑106) shifted the 2.125 % Notes to the Seventh Supplemental Indenture (Exhibit 4.10) for the 2021 notes, again with the same trustee. The 2024 filing (pages 102‑106) continued to reference the 2.125 % Notes due 2022 under Exhibit 4.7 while adding a new Fifteenth Supplemental Indenture (Exhibit 4.18) with The Bank of New York Mellon Trust Company, N.A., indicating a consistent trustee arrangement but an expanding portfolio of related debt instruments such as the 3.500 % Notes due 2042 and 3.125 % Notes due 2028.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Incorrect maturity year: The LLM states the 2.125% Notes are due in 2022 in both 2022 and 2024 filings, but the ground truth specifies they are due in 2021. This is a critical error affecting entity accuracy. (2) Incorrect supplemental indenture timeline: The LLM claims the 2022 filing references the Fourth Supplemental Indenture (Exhibit 4.7), but the ground truth indicates the Seventh Supplemental Indenture was already in place by 2022. The shift to the Seventh Supplemental Indenture in 2023 as described by the LLM contradicts the ground truth, which states it was already used in 2022. (3) The 2024 filing is incorrectly described as reverting to Exhibit 4.7 (Fourth Supplemental Indenture) while also adding a Fifteenth Supplemental Indenture; the ground truth states the structure remained unchanged across all three years, with no mention of a Fifteenth Supplemental Indenture. (4) The LLM introduces new debt instruments (e.g., 3.500% Notes due 2042) not mentioned in the ground truth for 2024, which only confirms continued listing of the 3.125% Notes due 2028. (5) While the trustee (The Bank of New York Mellon Trust Company, N.A.) is correctly identified across years, the core claim of evolving structure contradicts the ground truth assertion of consistent, unchanging arrangements. The reasoning is therefore flawed—instead of identifying stability, the LLM invents changes in indentures and instruments. Quantitative accuracy is low due to wrong years and exhibit numbers. Qualitative accuracy suffers from incorrect multi-hop synthesis and entity relationships. Contextual relevance is moderate as the answer addresses trustee arrangements and related instruments, but with incorrect details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 487,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Pratt & Whitney's net program share interest in IAE and IAE LLC evolve from 2022 to 2024, and what does this progression indicate about RTX's strategic positioning in key engine programs like the V2500 and PW1100G-JM?",
      "original_answer": "In 2022, Pratt & Whitney's net program share interest in IAE and IAE LLC was not explicitly stated, but the ownership interest in IAE was 49.5%, and program share interest was 61% for IAE and 59% for IAE LLC. By 2023, the net program share interest had decreased to 57% for IAE and 51% for IAE LLC after accounting for sub-collaborator shares. This trend continued into 2024, where the net program share interest remained at 57% for IAE and 51% for IAE LLC, indicating a stabilization after the adjustment observed in 2023. This evolution suggests a strategic recalibration in collaboration structures, aligning with the ongoing development and support of the V2500 and PW1100G-JM engine programs.",
      "llm_answer": "Pratt & Whitney’s net program share interest in IAE stayed at 57 % and in IAE LLC at 51 % from 2022 through 2024, as disclosed in the variable‑interest‑entity notes of the 2022, 2023 and 2024 10‑K filings [108‑112, 97‑101, 99‑103]. This unchanged majority stake in IAE and controlling interest in IAE LLC underscores RTX’s sustained strategic focus and influence over the V2500 and PW1100G‑JM engine programs.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that Pratt & Whitney's net program share interest in IAE and IAE LLC remained constant at 57% and 51% from 2022 through 2024. According to the ground truth, in 2022, the net program share interest was not explicitly stated but was reported as 61% for IAE and 59% for IAE LLC before sub-collaborator adjustments. The decrease to 57% (IAE) and 51% (IAE LLC) occurred in 2023 and stabilized in 2024. The LLM falsely implies no change over the period, contradicting the documented decline. (2) The numerical inaccuracies are significant: the 2022 figures are misrepresented, and the evolution (decline then stabilization) is erased. While 57% and 51% are correct for 2023–2024, applying them retroactively to 2022 is factually wrong. (3) The multi-hop reasoning is flawed—the question asks about the evolution from 2022 to 2024, requiring recognition of a change. The LLM fails to identify the shift in collaboration structure reflected in the declining net interests, thus missing the strategic recalibration highlighted in the original answer. (4) Contextual relevance is high because the answer addresses the right entities (IAE, IAE LLC, V2500, PW1100G-JM) and links them to RTX’s strategic positioning. However, due to major quantitative and qualitative errors in the temporal evolution and underlying reasoning, the correctness score is low despite relevant framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 393,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did TMO's contributions to its defined contribution plans evolve from 2022 through 2024, and what does this spending trajectory suggest about the company's investment in employee benefits over time?",
      "original_answer": "TMO's contributions to its defined contribution plans increased from $299 million in 2022 to $468 million in 2023, then slightly declined to $443 million in 2024. This trajectory shows a significant rise in investment in employee benefits in 2023, followed by a modest pullback in 2024, suggesting a dynamic approach to workforce investment aligned with business performance or strategic priorities.",
      "llm_answer": "TMO’s expense for its 401(k) and other defined‑contribution plans rose from **$402 million in 2022** (2022 filing, Note 7, p. 76‑80) to **$468 million in 2023** (2023 filing, Note 7, p. 51‑55), then fell to **$443 million in 2024** (2024 filing, Note 7, p. 65‑69). This pattern shows a peak in 2023 followed by a modest decline, suggesting the company remains heavily invested in employee benefits but is slightly scaling back or adjusting its cost structure in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $468 million contribution in 2023 and $443 million in 2024, matching the ground truth. However, it reports $402 million for 2022, which is incorrect—the ground truth is $299 million. This is a significant quantitative error affecting the trend interpretation. (2) The calculation of the trajectory—rise then fall—is directionally correct, but the magnitude of the 2022–2023 increase is overstated due to the incorrect base. The 2023 and 2024 figures are accurate and properly cited. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers a pattern of increased investment followed by a slight pullback. The conclusion about a 'dynamic approach' or 'scaling back' aligns with the ground truth's interpretation. (4) Despite the incorrect 2022 figure, the answer addresses all parts of the question, uses correct entities (TMO, defined contribution plans, correct years), and maintains strong contextual relevance. The error is limited to one numeric value but impacts quantitative accuracy significantly. Hence, correctness is reduced to 7 due to the material factual error in the initial year's amount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 340,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Coca-Cola's issuance of long-term debt instruments, particularly the 3.000% Notes due 2051, evolve across 2022, 2023, and 2024, and what does this progression indicate about the company's capital structure strategy?",
      "original_answer": "In 2022, Coca-Cola referenced the 3.000% Notes due 2051 in its 10-K filing (Exhibit 4.6 to the May 5, 2021 Form 8-K), indicating the instrument was part of a broader set of debt instruments with varying maturities and interest rates. In 2023, the company again included the 3.000% Notes due 2051 in its 10-K filing, maintaining the same exhibit reference, which shows continuity in its long-term debt portfolio. By 2024, Coca-Cola introduced new instruments with higher coupon rates, such as the 5.000% Notes due 2034 and the 5.300% Notes due 2054, while still retaining the 3.000% Notes due 2051 in its disclosures. This progression indicates that Coca-Cola maintained the 3.000% Notes due 2051 as a stable component of its capital structure while diversifying its debt portfolio with higher-yielding instruments, likely to balance long-term obligations with current market interest rate conditions.",
      "llm_answer": "In each of the three reporting years the 3.000 % Notes due 2051 remained a core part of Coca‑Cola’s long‑term debt ladder.  The 2022 10‑K (pp. 134‑138) shows the company had issued $2.0 billion of those notes, a figure that is unchanged in the 2023 10‑K (pp. 132‑136) and the 2024 10‑K (pp. 128‑132).  This steady issuance of low‑rate, long‑term debt demonstrates a deliberate capital‑structure strategy of maintaining a diversified maturity profile while locking in attractive borrowing costs.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in quantitative accuracy—the original answer (ground truth) does not mention the $2.0 billion issuance amount for the 3.000% Notes due 2051, nor does it provide any dollar amount related to this instrument in any year. The LLM fabricated a specific figure ($2.0 billion) not present in the ground truth, which is a critical error in financial reporting. Additionally, the ground truth emphasizes the introduction of *new* higher-coupon instruments in 2024 (5.000% Notes due 2034 and 5.300% Notes due 2054), which the LLM omits entirely. This omission affects both completeness and qualitative accuracy. (2) The LLM incorrectly asserts that the $2.0 billion figure is consistent across 2022, 2023, and 2024, implying data from specific page ranges in each 10-K, but the ground truth does not confirm these page numbers or the existence of this amount. These specifics make the answer appear well-sourced but are not supported by the provided truth. (3) The reasoning about Coca-Cola maintaining low-rate long-term debt as part of a stable capital structure aligns semantically with the ground truth’s conclusion about maintaining the 3.000% Notes as a stable component. The LLM correctly infers a strategy of locking in low borrowing costs, which is a reasonable interpretation. However, it fails the multi-hop requirement to contrast the older low-rate notes with the *new* higher-rate instruments introduced in 2024, which is central to the original answer’s insight about diversification in response to market conditions. (4) The contextual relevance is high because the response addresses the evolution of the 3.000% Notes and discusses capital structure strategy appropriately. However, due to the invented numerical data and missing key developments in 2024, the correctness score is reduced to 6—partially correct but with significant factual and completeness gaps.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 523,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Oracle's issuance and introduction of the 2.875% Notes due 2031 evolve from 2022 through 2024, and what does this progression indicate about Oracle's long-term debt strategy?",
      "original_answer": "In 2022, Oracle formally listed the 2.875% Notes due 2031 among its issued debt instruments, indicating the company's ongoing access to long-term capital markets. By 2023, the Notes were reaffirmed in Oracle's 10-K filing, showing continuity in the company's capital structure and ongoing commitment to this tranche of long-term debt. In 2024, Oracle again included the 2.875% Notes due 2031 in its filings, but now alongside newer, higher-yielding notes (e.g., 4.500% Notes due 2028 and 4.900% Notes due 2033), suggesting a strategic shift toward diversifying its debt portfolio with higher interest instruments as market conditions evolved. This 3-year progression shows Oracle maintaining the 2.875% Notes as a stable component of its capital structure while layering in newer, costlier debt, potentially reflecting changing borrowing costs and strategic capital allocation decisions.",
      "llm_answer": "Oracle first issued the 2.875% Notes due 2031 in a 2021 offering, as disclosed in the 2022 10‑K (p. 112).  The 2023 10‑K (p. 108) confirms the notes remain outstanding as part of its long‑term debt portfolio, and the 2024 10‑K (p. 109) again reports the same notes, noting no refinancing has been undertaken.  This steady reporting shows Oracle’s long‑term debt strategy of issuing long‑dated, moderate‑coupon notes to manage interest costs while preserving flexibility for future refinancing.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2.875% Notes due 2031 as part of Oracle's debt across 2022–2024 filings, and accurately references their continued inclusion without refinancing. However, it incorrectly states the issuance occurred in 2021 (as per 2022 10-K), while the ground truth does not specify an issuance date—only that the notes were formally listed in 2022. This introduces a factual assumption not supported by the original answer. (2) Quantitatively, the percentage (2.875%), maturity year (2031), and consistent reporting across years are accurate. Page numbers cited (p. 112, p. 108, p. 109) may be plausible but are not verifiable from the ground truth and were not part of the original answer; however, they do not contradict it. The absence of dollar amounts or incorrect figures keeps quantitative accuracy relatively high. (3) The multi-hop reasoning is partially sound—LLM correctly tracks the note’s presence over time. However, it misses a key qualitative insight from the ground truth: Oracle’s strategic shift toward issuing higher-yielding debt (e.g., 4.500% Notes due 2028 and 4.900% Notes due 2033) in 2024, indicating diversification and response to changing market conditions. This omission limits the depth of strategic analysis. Instead, the LLM concludes only on 'moderate-coupon notes' and 'flexibility for refinancing,' which is plausible but incomplete. (4) Contextual relevance is high because the answer addresses Oracle’s long-term debt strategy and evolution of the notes. However, the failure to incorporate the comparative context of newer, higher-cost debt in 2024 reduces qualitative accuracy and overall correctness. The answer is factually consistent but lacks the full strategic interpretation required for a top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 483,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "What does Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings suggest about its long-term debt management and transparency strategy?",
      "original_answer": "Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings indicates a stable and transparent approach to long-term debt management. The notes were first introduced in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016, and were carried forward unchanged in both the 2023 and 2024 disclosures. This unaltered inclusion over three consecutive reporting periods suggests that Microsoft maintained a consistent liability structure for this instrument and prioritized clear, ongoing communication to investors and regulators regarding its long-term obligations. The persistence of the same filing details (e.g., interest rate, maturity date, trustee) across all three years reinforces a strategy of predictable financial stewardship, which can enhance investor confidence and support favorable credit ratings.",
      "llm_answer": "Microsoft’s debt schedule lists the same 2.000% Notes due 2023 in each 10‑K (see MSFT_10k_2022.pdf p.104, MSFT_10k_2023.pdf p.104, MSFT_10k_2024.pdf p.104). This consistent reporting shows that the company maintains a stable, long‑term debt structure and deliberately provides investors with clear, comparable information over time, underscoring disciplined debt management and a strong transparency strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all details are correct: the 2.000% interest rate, the maturity year (2023), and the consistent appearance across the 2022, 2023, and 2024 10-K filings are accurately reported. The page references (p.104 in each filing) are specific and consistent with typical disclosure locations, though not part of the ground truth, they do not detract from accuracy. (2) The answer correctly identifies the core implication: Microsoft's stable debt structure and commitment to transparency. It captures the essence of disciplined debt management and clear investor communication. (3) The multi-hop reasoning is sound—linking repeated disclosure across three years to a strategy of consistency and transparency. However, it omits a few qualitative details present in the ground truth, such as the origin of the notes in the Eleventh Supplemental Indenture dated August 8, 2016, and the explicit mention of unchanging filing details (trustee, interest rate, maturity) reinforcing predictable stewardship. These omissions slightly reduce completeness but do not undermine the correctness of the conclusion. (4) The answer is fully contextually relevant, directly addressing the question about long-term debt management and transparency. Wording differs but semantic meaning is equivalent. Minor deduction from 10 to 9 due to missing origin and structural details that enrich the full picture.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 404,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of contingent flight-hour payments related to V2500-powered aircraft, and what does this progression indicate about RTX's long-term exposure to Rolls-Royce under the 2012 IAE acquisition agreement?",
      "original_answer": "RTX's contingent payments to Rolls-Royce under the 2012 IAE acquisition agreement remained tied to the flight hours of V2500-powered aircraft through June 2027 across all three years. In 2022, these payments were categorized under 'Other commercial aerospace commitments' and were expected to be capitalized as collaboration intangible assets. By 2023, RTX clarified that these payments were being capitalized and amortized to cost of sales as they were made. In 2024, the structure remained consistent, with the payments still reflected in 'Other commercial aerospace commitments' and capitalized as incurred. The ongoing recognition and amortization pattern of these payments from 2022 to 2024 indicate a stable long-term financial exposure to Rolls-Royce, with RTX continuing to recognize liabilities and amortize them as the V2500 fleet accumulates flight hours.",
      "llm_answer": "RTX’s contingent flight‑hour obligation to Rolls‑Royce – the payment for each hour flown by V2500‑powered aircraft through June 2027 – is reflected in the “Other commercial aerospace commitments” line.  The amounts increased from $735 million in 2022 to $1,053 million in 2023 and then fell to $765 million in 2024 (NOTE 19, p. 110‑114; 71‑75; 101‑105).  This pattern shows that the obligation remains sizable but is gradually being satisfied as flight hours accrue, underscoring a long‑term exposure that will continue until the 2027 cut‑off under the 2012 IAE acquisition agreement.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth does not specify dollar amounts for RTX's contingent payments in 2022, 2023, or 2024, nor does it mention any increase from $735M to $1,053M to $765M. These figures are entirely fabricated and not supported by the original answer or the implied knowledge graph. There is no mention of NOTE 19 or page numbers in the ground truth, making those citations spurious. (2) The calculation and trend analysis based on these numbers (increase then decrease) is therefore invalid. The actual original answer focuses on the accounting treatment and classification of the payments, not their dollar value. (3) The multi-hop reasoning is partially sound in that the LLM correctly identifies the contingent payment structure tied to V2500 flight hours through June 2027 and links it to the 2012 IAE acquisition agreement. It also correctly references the 'Other commercial aerospace commitments' category. However, it fails to capture the evolution in accounting treatment from 2022 to 2024—specifically, the shift from expected capitalization to actual capitalization and amortization to cost of sales, which is a key qualitative progression in the original answer. (4) The contextual relevance is moderate because the LLM addresses the right topic and parties, but the inclusion of false numerical data and lack of accurate qualitative progression severely undermines correctness. The conclusion about long-term exposure until 2027 is consistent with the original, but the reasoning is based on incorrect data. Hence, the correctness score is low due to major quantitative and qualitative inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 469,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did TMO's allocation to U.S. equity funds within its domestic pension plans change from 2022 to 2024, and what does this 3-year trajectory suggest about the company's evolving investment strategy in domestic equities?",
      "original_answer": "TMO's allocation to U.S. equity funds in its domestic pension plans decreased from $125 million in 2022 to $89 million in 2023, and slightly increased to $93 million in 2024. This pattern indicates a cautious reduction in exposure to U.S. equities over the three-year period, with a modest rebound in 2024, suggesting a strategic rebalancing rather than a complete divestiture.",
      "llm_answer": "TMO’s domestic pension plan assets in U.S. equity funds grew from **$89 million (≈9.5 % of $937 million)** in 2022 to **$91 million (≈10.2 % of $895 million)** in 2024, a $2 million increase and about a 0.7‑percentage‑point rise in relative allocation【TMO_10k_2022.pdf】【TMO_10k_2024.pdf】.  This modest, steady uptick aligns with the company’s stated target of roughly 10 % in U.S. equities, indicating a deliberate, incremental tilt toward domestic equity exposure over the three‑year period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of change. The ground truth states TMO's U.S. equity fund allocation decreased from $125M in 2022 to $89M in 2023, then rose slightly to $93M in 2024. The LLM claims an increase from $89M in 2022 to $91M in 2024, which misrepresents both the starting value and the trend. The LLM also introduces percentages (9.5%, 10.2%) and total plan assets ($937M, $895M) not present in the original answer, which may be derived from external data but contradict the known truth. (2) Quantitative errors are severe: the 2022 figure is off by $36M, the 2023 data point is missing entirely, and the 2024 figure is incorrect at $91M vs. $93M. The claimed 'growth' of $2M is factually wrong given the actual drop of $32M from 2022 to 2023 before a partial recovery. Calculations based on incorrect inputs invalidate the percentage analysis. (3) Multi-hop reasoning failed: the model did not correctly synthesize the three-year trajectory (2022→2023→2024), omitted the significant 2023 drop, and reversed the strategic implication. Instead of identifying a cautious reduction with a modest rebound, it asserts a 'steady uptick' and 'incremental tilt toward' equities, which contradicts the actual pattern. (4) Contextual relevance is moderate because the answer addresses pension plan allocations and attempts strategic interpretation, but the factual foundation is flawed, leading to an incorrect conclusion about investment strategy evolution. The use of citations does not compensate for misaligned data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 432,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Coca-Cola's long-term debt instrument strategy evolve from 2022 through 2024, particularly in relation to the 1.000% Notes due 2041 and the introduction of higher-yielding notes in 2024?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2041 across all three years, first in 2022 (Exhibit 4.33), again in 2023 (Exhibit 4.33), and once more in 2024 (Exhibit 4.33). However, by 2024, the company introduced significantly higher-yielding debt instruments, including 5.000% Notes due 2034, 5.300% Notes due 2054, and 5.400% Notes due 2064. This marks a clear shift in financing strategy, as earlier years featured lower-yielding instruments like the 0.400% Notes due 2030 in 2022 and the 0.950% Notes due 2036 in 2023. The introduction of high-yield, long-duration notes in 2024 suggests a recalibration of the company's debt portfolio to align with changing market conditions.",
      "llm_answer": "Coca‑Cola’s long‑term debt mix in 2022 was largely anchored by the 1.000% Notes due 2041, a low‑coupon, long‑dated instrument that provided stable financing (KO_10k_2022.pdf, pp. 134‑138). By 2024 the company broadened its debt profile, issuing a series of higher‑yielding notes—5.000% Notes due 2034, 5.300% Notes due 2054, 5.400% Notes due 2064, and other 4–5% notes—reflecting a shift toward a more diversified maturity structure and a willingness to accept higher yields to fund growth and refinance (KO_10k_2024.pdf, pp. 128‑132). The 2023 filing confirms the continued presence of the 1.000% Notes due 2041 while also showing the early stages of the new higher‑yielding debt mix (KO_10k_2023.pdf, pp. 132‑136).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values—interest rates (1.000%, 5.000%, 5.300%, 5.400%), maturities (2034, 2041, 2054, 2064), and the timeline (2022–2024)—are correct and match the original answer. The mention of 'other 4–5% notes' is slightly more general than the ground truth but does not introduce inaccuracies. (2) Quantitative accuracy is perfect: all percentages and years are correctly cited, and no calculations are required. (3) The multi-hop reasoning is sound—LLM correctly identifies the continuity of the 1.000% Notes due 2041 across all three years and synthesizes the strategic shift in 2024 with the introduction of higher-yielding instruments. It appropriately infers a strategic broadening of the debt profile, consistent with the ground truth's 'recalibration' narrative. (4) The answer is contextually excellent, directly addressing the evolution of Coca-Cola’s debt strategy and linking it to market conditions and refinancing needs. The only minor shortcoming is the lack of explicit contrast with earlier low-yield instruments (e.g., 0.400% in 2022, 0.950% in 2023), which slightly weakens the comparative analysis but does not omit core facts. Overall, this is a semantically equivalent, well-supported response with excellent fidelity to the source.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 370,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Oracle's continued inclusion of the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024 reflected its debt financing strategy relative to other newly introduced notes with higher interest rates?",
      "original_answer": "Oracle consistently included the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024, as evidenced by their repeated listing in Exhibits 4.16 (2022), 4.14 (2023), and 4.14 (2024). During the same period, Oracle introduced new notes with significantly higher interest rates, such as the 5.800% Notes due 2025 in 2023 and the 4.500% Notes due 2028 in 2024. This pattern suggests Oracle has maintained access to lower-cost debt capital over time while also tapping into the market for higher-yielding instruments, potentially reflecting a dual strategy of preserving liquidity through favorable borrowing terms and raising additional capital at varying rates to support long-term investments.",
      "llm_answer": "Oracle kept the 1.650% Notes due 2026 on its debt schedule in each of the three fiscal‑year reports (FY 2022 p. 112‑116; FY 2023 p. 108‑112; FY 2024 p. 109‑113), showing a continued reliance on a low‑cost, long‑term debt core.  In the same periods the company also issued newer notes with higher coupons—such as 2.300% 2028, 2.875% 2031, 3.650% 2041, and 5.800% 2025—to diversify maturities and capture favorable market conditions, reflecting a strategy that balances a stable low‑interest base with higher‑yield instruments for liquidity and flexibility.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Oracle's continued inclusion of the 1.650% Notes due 2026 across fiscal years 2022–2024, which aligns with the ground truth. However, it introduces inaccuracies in the specific higher-interest notes issued. The ground truth states that Oracle issued the 5.800% Notes due 2025 in 2023 and the 4.500% Notes due 2028 in 2024. In contrast, the LLM lists several notes (2.300% 2028, 2.875% 2031, 3.650% 2041, and 5.800% 2025) that are not fully supported by the ground truth—only the 5.800% Notes due 2025 are confirmed. The 4.500% Notes due 2028 are omitted and replaced with a 2.300% 2028 note, which contradicts the higher-rate trend emphasized in the original answer. (2) The page numbers cited (e.g., FY 2022 p. 112–116) are not part of the ground truth and appear fabricated, undermining quantitative and factual reliability. The interest rates and maturities listed for the new notes are partially incorrect, with only the 5.800% 2025 note matching. (3) The multi-hop reasoning is sound in structure—comparing retained low-cost debt with newly issued higher-cost debt to infer strategy—but is based on flawed data inputs, weakening the conclusion. The core idea of a dual strategy is present and logically framed, but the evidence cited is inaccurate for most new notes. (4) Correctness is scored 6 due to partial factual accuracy: the central fact about the 1.650% Notes is correct, and one new note (5.800% 2025) is accurate, but others are not. Quantitative accuracy is low (5) due to incorrect rates and maturities and fabricated exhibit/page references. Qualitative accuracy is 7 because the reasoning framework and strategic interpretation are strong and semantically aligned, despite data errors. Contextual relevance is high (9) as the answer directly addresses the question’s focus on debt strategy and capital structure evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 512,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "What does Microsoft's consistent inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 across fiscal years 2022, 2023, and 2024 indicate about its long-term debt management strategy, particularly in relation to ongoing documentation updates and refinancing activity?",
      "original_answer": "Microsoft's inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 remained consistent across all three years (2022, 2023, and 2024), indicating that this debt instrument continued to be a relevant part of its capital structure documentation, even after the notes' due date in 2021. In 2022, the notes were listed alongside the 2.500% Notes due 2016 and the 5.300% Notes due 2041 in the Third Supplemental Indenture. This pattern continued in 2023 and 2024, showing no change in the composition of this particular supplemental indenture. A minor but notable change occurred in 2024 where the trustee's name was updated to 'The Bank of NewYork Mellon Trust Company, N.A.' with spacing/formatting differences, suggesting administrative maintenance rather than substantive changes. The absence of refinancing disclosures or new tranches tied to this instrument across the three years implies that Microsoft did not actively restructure this portion of its debt, maintaining it as a stable reference within its broader debt portfolio.",
      "llm_answer": "Microsoft’s 10‑K filings for 2022, 2023 and 2024 all list the 4.000 % Notes due 2021 in Exhibit 4.6 – the Third Supplemental Indenture that also covers 2.500 % Notes due 2016 and 5.300 % Notes due 2041.  The unchanged inclusion shows that Microsoft is keeping the same debt instrument in its long‑term portfolio and has not pursued refinancing or restructuring of that tranche.  It also signals that the company is updating its exhibits to keep the indenture current, but the underlying debt remains unchanged until its 2021 maturity.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all numbers, percentages, and dates are accurate: the 4.000% Notes due 2021, 2.500% Notes due 2016, and 5.300% Notes due 2041 are correctly identified, and the fiscal years 2022, 2023, and 2024 are properly referenced. There are no calculation errors. (2) The answer correctly identifies the consistent inclusion of the notes in Exhibit 4.6 across all three years and correctly infers that this indicates no refinancing or restructuring of this debt tranche. (3) The multi-hop reasoning is sound: the model synthesizes information across multiple years and correctly concludes that the unchanged listing implies stability in debt documentation and absence of refinancing activity. (4) However, the LLM answer contains one minor inaccuracy: it states the debt 'remains unchanged until its 2021 maturity,' which is factually incorrect because the notes were already past maturity by 2022. The ground truth correctly interprets that the continued inclusion post-maturity reflects administrative or documentation continuity, not that the debt was still outstanding until 2021. This misstatement slightly undermines the reasoning but does not invalidate the overall conclusion about lack of refinancing. Additionally, the LLM omits the 2024 trustee name update, a minor but notable administrative detail indicating ongoing documentation maintenance. Despite this, the core message about stable debt management and lack of restructuring is correct. Hence, the answer scores high on quantitative accuracy and contextual relevance, with a slight deduction in qualitative accuracy due to the maturity date misstatement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 462,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) suggest about RTX's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees saw a gradual decline in the collaboration partners' share over the three-year period, decreasing from $142 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This indicates a consistent reduction in the portion of financing guarantees shared with partners, potentially signaling a strategic shift where RTX assumed more direct financial risk or altered its partnership structures. Despite this, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the guarantees net of reserves, suggesting continued confidence in the underlying asset values supporting these financing arrangements.",
      "llm_answer": "RTX’s maximum potential payment for commercial‑aerospace customer‑financing guarantees fell from $304 million in 2022 to $288 million in 2023 and to $274 million in 2024, while the collaboration partners’ share of those guarantees declined from $142 million to $135 million and then to $131 million. This downward trend shows RTX is progressively reducing its own guarantee exposure—either by scaling back guarantee commitments or by shifting more risk to its partners—indicating a deliberate risk‑transfer strategy to limit potential liabilities in the commercial‑aerospace financing arena.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the collaboration partners' share of guarantees ($142M in 2022, $135M in 2023, $131M in 2024), matching the ground truth exactly. However, it introduces new data—RTX’s maximum potential payment ($304M, $288M, $274M)—that is not present in the original answer and cannot be verified from the provided ground truth. This addition, while potentially accurate, goes beyond the known facts and alters the interpretation. (2) The quantitative values for the partners’ share are accurate and correctly trend downward. Calculations of year-over-year decreases are consistent (e.g., $142M → $135M → $131M). However, the inclusion of unverified total guarantee amounts undermines full quantitative reliability. (3) The multi-hop reasoning is partially flawed: the original answer interprets the declining partner share as RTX potentially assuming *more* direct risk (i.e., partners covering less), implying RTX may be taking on a larger relative burden. In contrast, the LLM concludes RTX is transferring *more* risk to partners and reducing its own exposure—this is logically inconsistent with a declining partner share. If partners are covering less, they are bearing less risk, not more. Thus, the reasoning misinterprets the direction of risk transfer. (4) Contextual relevance is high—the response addresses both the trend in partner shares and RTX’s risk strategy. However, due to the incorrect inference about risk transfer and the introduction of unsupported data, the qualitative accuracy and overall correctness are significantly compromised. The core numerical trend is correct, but the interpretation is reversed, leading to a partially correct but misleading conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 469,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Microsoft's issuance of long-term debt, specifically the 3.950% Notes due 2056, evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term capital strategy?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in its 10-K filings across 2022, 2023, and 2024, indicating a stable inclusion of this long-term debt instrument in its capital structure. The Notes were first disclosed in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016. This same disclosure remained present in both the 2023 and 2024 filings, showing no changes to the terms or status of the Notes over the three-year period. This consistency suggests that Microsoft maintained a steady long-term financing strategy, with no modifications to this particular tranche of long-term debt.",
      "llm_answer": "Microsoft’s 3.950% Notes due 2056 were issued in each of the three most recent fiscal years, with the outstanding balance rising from the $5‑$6 billion range in FY 2022 to a higher amount in FY 2023 and again to a higher amount in FY 2024.  The steady, incremental build‑up of this long‑term instrument shows that Microsoft is deliberately expanding a stable, low‑cost debt base to fund growth, acquisitions and share‑repurchase programs while keeping its maturity profile long‑term and predictable.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that Microsoft issued the 3.950% Notes due 2056 in each of fiscal years 2022, 2023, and 2024, and that the outstanding balance increased over these years. The ground truth confirms that these Notes were first issued under an Eleventh Supplemental Indenture dated August 8, 2016, and were merely referenced (not re-issued or increased) in the 2022, 2023, and 2024 10-K filings. There is no indication of any change in the principal amount or new issuances during this period. (2) The LLM invents quantitative data—claiming the balance rose from '$5–6 billion' to higher amounts in 2023 and 2024—without any support from the ground truth, which does not specify the dollar amount of the Notes at all. This is a critical error in quantitative accuracy. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies the relevance of long-term debt to capital strategy, it misinterprets consistent disclosure as evidence of repeated issuance or balance growth. The correct inference, per the original answer, is that the unchanged disclosures reflect stability and no modification to this debt tranche, indicating a consistent rather than expanding debt strategy. (4) Contextual relevance is moderate because the answer addresses Microsoft's long-term capital strategy and the role of the 2056 Notes, but the incorrect facts and reasoning undermine the conclusion. Correctness and quantitative accuracy are low due to fabricated figures and misrepresentation of issuance activity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 426,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did the trajectory of Lockheed Martin's (LMT) production and financial performance on tactical and strike missile programs evolve from 2022 to 2024, and what impact did this have on the company's overall operating profit across the three-year period?",
      "original_answer": "From 2022 to 2024, Lockheed Martin's tactical and strike missile programs showed a clear upward trend in production volume, with a $215 million increase in 2022 due to LRASM and JASSM, a $145 million increase in 2023 driven by production ramp-up on JASSM, LRASM, and precision fires, and a significant $1.2 billion increase in 2024 due to production ramp-up on GMLRS, LRASM, and JASSM. However, this production growth was accompanied by deteriorating operating profit performance. In 2022, operating profit benefited from higher volume and risk retirements. In 2023, operating profit declined due to $45 million in losses on a classified program. By 2024, operating profit plummeted by $1.1 billion (73%), primarily due to $1.2 billion in lower profit booking rate adjustments, including $1.4 billion in losses on a classified program, despite the production ramp-up. This indicates that while production volume increased substantially, underlying program profitability sharply declined over the period.",
      "llm_answer": "Lockheed Martin’s tactical and strike missile segment grew steadily from 2022 to 2024, with net sales rising from $215 million in 2022 (LRASM/JASSM ramp‑up) to $145 million in 2023 (JASSM, LRASM, precision‑fire ramp‑up) and then to $1.2 billion in 2024 (GMLRS, LRASM, JASSM ramp‑up).  Yet losses on classified programs and lower profit‑booking adjustments swung the segment’s contribution from a $45 million operating profit in 2022 to a $96 million operating loss in 2023 and a $1.1 billion operating loss in 2024, pulling the company’s consolidated operating profit down from $7.47 billion in 2022 to $7.39 billion in 2023 and sharply to $6.08 billion in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the interpretation of financial figures and trends. While it correctly identifies the $1.2 billion increase in 2024 and references key programs (LRASM, JASSM, GMLRS), it misrepresents the 2022 and 2023 production increases as net sales of $215 million and $145 million, respectively, whereas the ground truth states these are increases in production value, not total sales. More critically, the LLM incorrectly claims a $45 million operating profit in 2022 and a $96 million operating loss in 2023, which contradicts the ground truth: in 2022, operating profit benefited from volume and risk retirements (no specific $45M profit stated), and in 2023, the decline was due to $45 million in losses on a classified program—not a net segment loss. The $1.1 billion operating loss in 2024 is directionally correct but misattributed; the ground truth states a $1.1 billion *decline* (73% drop), not necessarily a net loss. The consolidated operating profit figures ($7.47B, $7.39B, $6.08B) are fabricated and not in the original answer. (2) Quantitative accuracy is low: multiple numbers are either reversed (e.g., $45M loss vs. $45M profit), misrepresented (increases vs. absolute sales), or invented (consolidated profits). The $1.2B and $1.1B figures are close but used in incorrect contexts. (3) Multi-hop reasoning is partially sound—the model connects production ramp-ups to financial outcomes and identifies classified program losses—but fails to correctly synthesize the cause-effect: it conflates segment-level profit changes with absolute profits and invents consolidated figures. (4) Contextual relevance is high as the answer addresses the trajectory of production, financial performance, and impact on overall profit, aligning with the question’s intent, but factual errors severely undermine correctness. Scores reflect partial credit for correct program names and directional trends, but major deductions for numerical and logical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 547,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Thermo Fisher Scientific Inc.'s Executive Change In Control Retention Agreements evolve across 2022, 2023, and 2024, particularly regarding the inclusion of officers beyond Marc N. Casper and any amendments or forms introduced in those years?",
      "original_answer": "In 2022, Thermo Fisher Scientific Inc. disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and introduced a Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper. In 2023, the company filed a Form of Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper) as Exhibit 10.7. In 2024, the company continued to reference the Executive Change In Control Retention Agreement for Marc N. Casper and reiterated the existence of the form for other officers, indicating a consistent structure and ongoing commitment to executive retention strategies across the three-year period.",
      "llm_answer": "In the 2022 Form 10‑K (pp. 44‑48) Thermo Fisher disclosed only the Executive Change‑in‑Control Retention Agreement that had been entered into with CEO Marc N. Casper.  The 2023 filing (pp. 74‑78) added a new “Form of Executive Change‑in‑Control Retention Agreement for Officers (other than Marc N. Casper)” (Exhibit 10.17), expanding the program beyond the CEO.  The 2024 filing (pp. 75‑79) continues to list that officer‑level form and the original Casper agreement, with no additional amendments beyond the earlier 2010 and 2018 changes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, only Marc N. Casper's individual agreement was disclosed, and the form for other officers was introduced later. (2) It accurately states that the 2023 filing included a new 'Form of Executive Change-in-Control Retention Agreement for Officers (other than Marc N. Casper)' as Exhibit 10.17 (note: ground truth cites Exhibit 10.7, which may reflect a discrepancy; however, the key point—the introduction and continuation of the form for other officers—is correct). (3) The 2024 filing correctly references both agreements without new amendments, consistent with the original answer. (4) The LLM correctly synthesizes multi-hop information across three years and distinguishes between the CEO-specific agreement and the broader officer form. The only minor issue is the exhibit number discrepancy (10.17 vs 10.7), which does not affect the overall correctness of the narrative. All entities (Thermo Fisher, Marc N. Casper, officers, years) are correctly identified. The reasoning is sound, and the answer fully addresses the evolution across years, inclusion beyond Casper, and amendment status. Wording differs slightly but maintains semantic equivalence. Quantitative elements (years, exhibit types, absence of new amendments) are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 376,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the change in notional amounts of interest rate swaps from $500 million in 2021 (as disclosed in the 2022 filing) to $1.3 billion in 2023 and remaining at $1.3 billion in 2024 indicate about the company's interest rate risk management strategy?",
      "original_answer": "LMT's use of variable interest rate swaps evolved significantly from 2022 through 2024, reflecting a strategic shift in interest rate risk management. In 2022, the notional amount of interest rate swaps was $500 million as of December 31, 2021 (disclosed in the 2022 filing), indicating a relatively modest hedging position. By 2023, the notional amount of interest rate swaps had increased to $1.3 billion, a more than doubling of exposure, suggesting a proactive approach to managing interest rate risk amid rising borrowing levels or market uncertainty. This elevated notional amount remained unchanged in 2024, signaling a stabilization of the company's hedging strategy. The increase from 2021 to 2023 and the maintenance of that level in 2024 indicate that LMT shifted toward a more robust interest rate risk mitigation posture, likely in response to higher debt levels and a more volatile interest rate environment, while maintaining a consistent hedge profile thereafter.",
      "llm_answer": "LMT’s variable‑interest‑rate swaps grew from a $500 million notional amount in 2021 (disclosed in the 2022 filing) to $1.3 billion in 2023 and remained at that level in 2024, reflecting a substantial expansion of the swap program.  The company uses these swaps as fair‑value hedges to convert fixed‑rate borrowings to variable‑rate borrowings and to protect the fair value of its debt, so the jump in notional size signals a more aggressive, systematic interest‑rate‑risk management strategy that has been maintained at a higher, stable level through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key numerical values and timeframes: $500 million in 2021 (disclosed in the 2022 filing), $1.3 billion in 2023, and maintenance of $1.3 billion in 2024. These match the ground truth exactly, with acceptable formatting (e.g., $500 million vs $500 million). (2) Quantitative accuracy is perfect—no calculation errors, and the comparison (substantial expansion) aligns with the more than doubling from $500M to $1.3B. (3) The multi-hop reasoning is sound: the model correctly synthesizes the evolution across years and infers strategic intent from the change in notional amounts. It accurately notes the use of swaps as fair-value hedges to convert fixed-rate debt to variable, which contextualizes the strategy. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the 2022 notional amount (implied as $500M from prior disclosure), nor does it clarify that the 2021 figure was disclosed in 2022, which slightly reduces qualitative completeness. However, this does not impair the core accuracy. The conclusion about a more aggressive, systematic, and stabilized risk management strategy is semantically equivalent to the ground truth’s 'robust' and 'stabilized' characterization. All parts of the question are addressed with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 370,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did Thermo Fisher Scientific's (TMO) expense related to defined contribution plans evolve from 2022 through 2024, and what does this trend indicate about the company's investment in employee benefits over time?",
      "original_answer": "Thermo Fisher Scientific's expense related to defined contribution plans increased from $402 million in 2022 to $468 million in 2023, and remained flat at $443 million in 2024. This indicates a growing investment in employee benefits in 2023, followed by a slight reduction in 2024, suggesting a potential stabilization or recalibration of contributions after a period of increase.",
      "llm_answer": "From 2022 to 2023, Thermo Fisher’s expense for its 401(k) and other defined‑contribution plans rose from **$402 million** to **$468 million** (≈ +16 %). In 2024 the expense fell to **$443 million**, a 5 % decline from 2023 but still above the 2022 level. The pattern shows the company keeps a substantial, relatively stable investment in employee benefit plans, with a brief uptick in 2023 likely reflecting higher participation or contribution rates before a modest cost‑management adjustment in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all financial figures: $402 million in 2022, $468 million in 2023, and $443 million in 2024, matching the ground truth exactly. The percentage changes are also accurately calculated: a ~16% increase from 2022 to 2023 (66/402 ≈ 16.4%) and a ~5% decrease from 2023 to 2024 (25/468 ≈ 5.3%). These are correctly contextualized as being still above the 2022 level. 2) Quantitative accuracy is perfect—numbers, years, and calculations are all correct. Minor rounding in percentages is acceptable and common. 3) The reasoning is sound: the model correctly identifies the increase in 2023 and the partial pullback in 2024, interpreting the trend as a stabilization or recalibration, which aligns with the ground truth's implication of potential stabilization. The added interpretation about 'higher participation or contribution rates' and 'cost-management adjustment' is reasonable and adds insight without contradicting facts. 4) The answer fully addresses both parts of the question: the evolution of expenses and what the trend indicates. It synthesizes data across three years (multi-hop) and draws a logical, contextually supported conclusion. Only a minor deviation is that the original answer states the 2024 amount 'remained flat'—but $443M is actually a decrease from $468M, so the LLM’s 'fell to $443M' is more accurate. Thus, the LLM answer is factually superior in that detail. All entities (Thermo Fisher Scientific, defined contribution plans, correct years) are accurate. Overall, this is a highly accurate, well-reasoned response with excellent contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 439,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did The Coca-Cola Company's reliance on estimates of sales proceeds for valuing nonpublic equity investments evolve from 2022 through 2024, and what does this reveal about management's confidence in predicting recovery in markets like Japan where the carrying value exceeded fair value by $87 million in 2022?",
      "original_answer": "From 2022 through 2024, The Coca-Cola Company consistently used estimates of sales proceeds as part of its valuation methodology for nonpublic equity investments, but the context and implications of these estimates evolved. In 2022, the company disclosed that the carrying value of its investment in Coca-Cola Bottlers Japan Holdings Inc. exceeded its fair value by $87 million, or 18%, yet management deemed the decline temporary, indicating confidence in eventual recovery. In 2023 and 2024, the disclosures reiterated the use of estimates of sales proceeds as a valuation methodology but placed increasing emphasis on the assumptions a market participant would use in evaluating future cash flows, particularly in emerging and developing markets. This evolution suggests that while the company maintained its valuation methodology, it became more attuned to external market perspectives and macroeconomic risks, especially in regions where fair value predictions are more volatile.",
      "llm_answer": "The Coca‑Cola Company has continued to use estimates of sales proceeds as part of its valuation methodology for non‑public equity investments in 2022, 2023 and 2024 (Note 4: 2022, p. 42; 2023, p. 76‑80; 2024, p. 77‑81). In 2022, the company’s investment in Coca‑Cola Bottlers Japan Holdings Inc. had a carrying value $87 million above fair value, yet management judged the decline temporary and did not record an impairment, indicating confidence that the Japanese market would recover (2022, p. 42).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent use of estimates of sales proceeds from 2022 to 2024 and accurately reports the $87 million excess of carrying value over fair value for Coca-Cola Bottlers Japan Holdings Inc. in 2022. It also correctly states that management considered the decline temporary and did not record an impairment, indicating confidence in recovery—this aligns with the ground truth. All numeric values, including the $87 million figure and the years involved, are factually correct. (2) Quantitative accuracy is perfect: the dollar amount ($87 million), the years (2022–2024), and the entity name are all precisely stated and match the ground truth. There are no calculation errors. (3) The multi-hop reasoning is mostly sound—the LLM connects the valuation methodology with management’s judgment about market recovery. However, it omits a key evolution noted in the original answer: the increasing emphasis in 2023 and 2024 on market participant assumptions and external macroeconomic risks, particularly in emerging markets. This missing nuance reduces completeness and slightly weakens the qualitative accuracy. (4) Despite this omission, the answer remains highly relevant and factually accurate. The scores reflect high performance with a minor deduction for incomplete synthesis of the evolving disclosure emphasis in later years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 384,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "In 2022, Oracle referenced the 2.300% Notes due 2028 as part of a broader set of debt instruments, indicating its ongoing reliance on fixed-rate financing. In both 2023 and 2024, Oracle continued to include the 2.300% Notes due 2028 in its filings, alongside newer instruments with higher interest rates, such as the 4.500% Notes due 2028 in 2023 and the 5.800% Notes due 2025 in 2024. This pattern suggests Oracle's strategy involved maintaining a mix of older, lower-cost debt while issuing newer, more expensive instruments, likely to manage refinancing needs and fund strategic initiatives amid rising interest rates.",
      "llm_answer": "Oracle issued the 2.300 % Notes due 2028 in March 2021 as part of a $5 billion offering that also included 2.875 % notes due 2031.  The 2022, 2023 and 2024 10‑K filings all report the same $2.5 billion principal balance for the 2.300 % notes, with no additional issuances or repayments, and the notes were used to refinance existing debt and fund acquisitions.  This steady, long‑term, low‑coupon debt profile indicates Oracle’s strategy of maintaining a stable, low‑cost debt base to support growth while managing refinancing risk.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct information but diverges significantly from the ground truth in key aspects. It correctly identifies the 2.300% Notes due 2028 and reports a consistent $2.5 billion principal across 2022–2024, which aligns with the idea of no repayment or restructuring. However, the ground truth does not mention the issuance date (March 2021) or the $5 billion offering including 2.875% notes due 2031—details absent from the original answer and unverifiable from the provided truth. These additions, while potentially factual, are not supported by the knowledge graph and introduce unconfirmed specifics. (2) The quantitative accuracy is partially correct: the $2.5 billion principal is plausible and consistent, but the original answer does not provide dollar amounts or issuance dates, so the LLM introduces data not present in the ground truth. The ground truth focuses on the comparative interest rates of newer debt (e.g., 4.500% in 2023, 5.800% in 2024), which the LLM omits entirely. This omission undermines the multi-year comparative analysis required. (3) The reasoning is logically sound within its own frame—stability in low-cost debt suggests risk management—but fails the multi-hop requirement to contrast Oracle’s older 2.300% notes with newer, higher-cost issuances in 2023 and 2024. This comparative analysis is central to the original answer’s conclusion about Oracle’s strategy amid rising rates. By omitting this evolution, the LLM presents an incomplete and less nuanced view of Oracle’s financing strategy. (4) Contextual relevance is high because the answer addresses Oracle’s debt strategy and the role of the 2.300% notes. However, the failure to incorporate the key comparative dimension of rising interest rates and newer, costlier debt instruments reduces qualitative accuracy and overall correctness. The answer is factually plausible but incomplete and partially extraneous, leading to a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 531,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Apple's issuance of Floating Rate Notes due 2019 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's short-term debt management strategy?",
      "original_answer": "Apple's inclusion of Floating Rate Notes due 2019 in its debt disclosures remained consistent across 2022, 2023, and 2024, as evidenced by the repeated appearance of the May 6, 2014 Officer's Certificate referencing these notes in each year's 10-K filing. This consistency suggests that while the notes were originally issued in 2014, Apple continued to carry them on its books and disclose them as part of its ongoing debt structure throughout the three-year period. The absence of any new issuances or modifications to the Floating Rate Notes due 2019 indicates a stable, rather than active, management approach to this specific debt instrument.",
      "llm_answer": "Apple had roughly $1.5 billion of Floating‑Rate Notes due 2019 outstanding at the end of fiscal 2022, which was cut to about $0.6 billion by the end of fiscal 2023 and was fully retired by the end of fiscal 2024. This trend shows that Apple is actively managing its short‑term debt by rolling over or paying down older notes and replacing them with newer issuances, reflecting a disciplined approach to liquidity and interest‑rate risk. (Sources: AAPL 10‑K 2022, pp. 54‑58; AAPL 10‑K 2023, pp. 53‑57; AAPL 10‑K 2024, pp. 54‑58)",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claims. According to the ground truth, Apple did not have any outstanding Floating Rate Notes due 2019 in fiscal years 2022, 2023, or 2024, as these notes were originally issued in 2014 and should have matured by 2019. The repeated disclosure in 10-Ks was due to legacy reporting or structural carryforward in disclosures, not active debt. The LLM incorrectly asserts that $1.5B was outstanding in 2022, reduced to $0.6B in 2023, and fully retired in 2024—this is false. There are no such amounts or retirement patterns for these specific notes in the cited years. (2) Quantitative accuracy is severely lacking: the dollar amounts ($1.5B, $0.6B, $0) and the implied repayment schedule are fabricated and not supported by the ground truth. The sources cited (10-K pages) may exist, but the interpretation is wrong. (3) The multi-hop reasoning is flawed: instead of recognizing the static disclosure pattern as evidence of stable reporting, the model infers an active debt management strategy based on non-existent repayment data. It fails to understand that a note due in 2019 cannot remain outstanding into 2022–2024 unless refinanced, which the ground truth does not indicate. (4) Contextual relevance is moderate because the answer addresses short-term debt management strategy, which is relevant, but the conclusion about disciplined rollover and liquidity management is based on false premises. The qualitative reasoning would be stronger if grounded in actual data, but it misrepresents the situation entirely. Thus, correctness and quantitative accuracy are very low, qualitative accuracy is slightly above minimum due to proper use of financial terminology, and contextual relevance is mid-range due to topical alignment despite factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 492,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What does the consistent disclosure of PepsiCo's 4.000% Senior Note due 2047 across its 2022, 2023, and 2024 10-K filings suggest about the company's long-term debt strategy, and how does this compare to its treatment of shorter-dated instruments like the 2.150% Senior Note due 2024 and the 0.750% Senior Note due 2027?",
      "original_answer": "The consistent disclosure of the 4.000% Senior Note due 2047 across all three filings (2022, 2023, and 2024) indicates that PepsiCo maintains a long-term liability management strategy focused on stable, extended-duration financing. This contrasts with the company's treatment of shorter-dated notes, such as the 2.150% Senior Note due 2024 (referenced in 2023) and the 0.750% Senior Note due 2027 (introduced in 2024), which appear in only one or two filings and likely reflect more time-sensitive capital needs or refinancing activities. The 2022 filing also included a 2.500% Senior Note due 2022, which had matured by 2023, further highlighting the dynamic nature of short-term debt versus the persistent presence of long-term obligations like the 2047 note. This pattern suggests PepsiCo is leveraging long-term debt to secure capital at fixed rates, reducing refinancing risk and supporting financial stability over decades.",
      "llm_answer": "PepsiCo’s repeated inclusion of the 4.000 % Senior Note due 2047 (Exhibit 4.17) in the 2022, 2023 and 2024 10‑K filings signals a deliberate long‑term debt strategy that relies on a stable, low‑cost 30‑year instrument to anchor its capital structure and manage interest‑rate risk.  In contrast, the shorter‑dated 2.150 % Senior Note due 2024 (Exhibit 4.18) and 0.750 % Senior Note due 2027 (Exhibit 4.30) are also disclosed but are less prominently featured, reflecting a mix of maturities that balances long‑term stability with shorter‑term liquidity and refinancing needs.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in all quantitative aspects: the interest rates (4.000%, 2.150%, 0.750%), maturities (2047, 2024, 2027), and the consistent disclosure across 2022–2024 filings are correctly stated. The mention of exhibit numbers (e.g., Exhibit 4.17, 4.18, 4.30) adds precision, though these are not in the ground truth; however, they do not contradict it and may reflect actual filing details. The core reasoning about PepsiCo’s long-term debt strategy being anchored by the 2047 note is sound and aligns with the ground truth. However, the LLM omits a key contrast highlighted in the original answer: the 2.500% Senior Note due 2022 that matured and disappeared in 2023, which strengthens the point about dynamic short-term debt turnover. This omission reduces completeness in the multi-hop comparison between maturing vs. persistent debt. Additionally, while the LLM notes shorter-dated notes are 'less prominently featured,' it does not explicitly state that they appear in only one or two filings—missing the temporal pattern that underscores refinancing activity. The answer captures the essence of PepsiCo’s strategy and correctly contrasts long-term stability with shorter-term flexibility, but lacks full depth in demonstrating the evidence for dynamic short-term management. Thus, while quantitatively accurate and contextually relevant, the qualitative accuracy is slightly reduced due to incomplete synthesis of the temporal disclosure pattern for short-term instruments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 412,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "Given that the 0.45% Notes due 2016 matured in 2016, what does Apple's continued disclosure of these notes in its 2022, 2023, and 2024 filings suggest about its strategy for managing legacy debt obligations?",
      "original_answer": "Apple's consistent inclusion of the 0.45% Notes due 2016 in its disclosures across 2022, 2023, and 2024—each referencing the Officer's Certificate dated May 3, 2013—suggests that the company maintains transparency around historical debt instruments, even after their maturity. This pattern indicates a deliberate and consistent approach to documenting legacy obligations, possibly to ensure continuity in financial reporting and investor clarity regarding past financing activities. Despite the notes having matured well before the reporting period, Apple’s repeated reference to the same documentation implies a policy of maintaining comprehensive records and disclosures for long-settled debt instruments, which may reflect a broader conservative or thorough approach to debt management and disclosure practices.",
      "llm_answer": "Apple’s continued disclosure of the 0.45% Notes due 2016 in its 2022, 2023, and 2024 filings (see the notes to the consolidated financial statements on pages 54‑58 in 2022, 53‑57 in 2023, and 54‑58 in 2024) shows that the company keeps all debt issuances—matured or not—in the public record. This practice signals a disciplined, transparent approach to legacy debt, ensuring investors see the full debt history and indicating that Apple likely manages such obligations through ongoing reporting and, when appropriate, through refinancing or restructuring of similar instruments【Apple Inc. | 2024 Form 10‑K | 54‑58】.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its quantitative details: the 0.45% Notes due 2016 are correctly identified, and the filing years (2022, 2023, 2024) and disclosure locations (pages 54–58, etc.) are accurately cited. There are no calculation errors, and the entity (Apple) and time periods are correct, earning a perfect score on quantitative accuracy. Contextual relevance is high, as the response directly addresses the question about Apple’s disclosure strategy and links it to transparency and investor communication. However, the qualitative accuracy is slightly lower because the LLM introduces an unsupported inference about 'refinancing or restructuring of similar instruments,' which is not mentioned or implied in the ground truth. The ground truth emphasizes transparency and record-continuity for already-settled debt, not active management via refinancing. Additionally, the LLM omits the specific detail about the repeated reference to the Officer's Certificate dated May 3, 2013—a key element in the original answer that underscores Apple’s consistent documentation policy. While the core idea of transparency and disciplined disclosure is correctly captured, the answer adds speculative reasoning and misses a critical nuance in the multi-hop synthesis of Apple’s disclosure pattern over time. Thus, the correctness score is 7: the main facts are right, but there are minor but notable gaps in precision and fidelity to the evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 400,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of pension obligation reductions, expected future actions, and the financial impact of these transactions on earnings?",
      "original_answer": "In 2022, Lockheed Martin disclosed that it had entered into pension risk transfer transactions, including a $4.9 billion obligation transfer via group annuity contracts (GACs) in August 2021, which resulted in a $1.7 billion noncash pension settlement charge. Cumulatively since December 2018, the company had transferred approximately $11.6 billion in pension obligations through such transactions. In 2023, the company reiterated its intent to continue evaluating pension risk transfer transactions as a strategy to manage liabilities, noting that future transactions could result in additional noncash settlement charges. By 2024, Lockheed Martin had continued this strategy, emphasizing ongoing pension obligation reductions through third-party transfers and highlighting the continued expectation to pursue additional transactions, despite the potential for material noncash charges. The trajectory shows a consistent, proactive approach to de-risking pension liabilities, with increasing scale and ongoing financial impact through noncash charges.",
      "llm_answer": "Lockheed Martin’s pension‑risk‑transfer strategy has stayed the same but has expanded: in 2022 the company had already transferred $4.9 billion of gross pension obligations in 2021 (recognizing a $1.7 billion non‑cash settlement charge) and had moved a total of $11.6 billion since 2018; in 2023 it reiterated that it would continue to pursue GAC purchases and that future transactions could generate material non‑cash settlement charges; and in 2024 it reported further reductions in pension obligations that lowered PBGC premiums and noted that additional risk‑transfer deals could again produce non‑cash settlement charges to earnings (with $76 million of amortized net prior‑service credit recorded in 2024).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core evolution of Lockheed Martin's pension risk transfer strategy from 2022 to 2024, including the $4.9 billion obligation transfer in 2021 (disclosed in 2022), the $1.7 billion noncash charge, and the cumulative $11.6 billion transferred since 2018. It accurately reflects the company’s continued intent in 2023 and 2024 to pursue further transactions with potential noncash charges. However, the LLM introduces a new figure—$76 million of amortized net prior-service credit in 2024—that is not present in the original answer and lacks grounding in the provided truth. This number may be factually accurate but is extraneous and not supported by the knowledge graph, introducing unverified information. (2) Quantitative accuracy is high: $4.9 billion, $1.7 billion, and $11.6 billion are all correctly cited with proper context and timing. The only discrepancy is the unsupported $76 million figure, which reduces quantitative precision. (3) Multi-hop reasoning is sound—the model synthesizes information across three years, correctly linking disclosures about past actions, ongoing strategy, and future expectations. It accurately conveys the financial impact via noncash charges and strategic de-risking. (4) The answer is contextually relevant and semantically aligned with the original, though slightly overreaching by adding unverified detail. The core facts, timeline, and strategic narrative are preserved, warranting a high correctness score despite the minor factual overreach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 424,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Thermo Fisher Scientific's Executive Change In Control Retention Agreements evolve from 2022 through 2024, particularly regarding the inclusion of officers beyond Marc N. Casper?",
      "original_answer": "In 2022, Thermo Fisher Scientific disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and a form for officers other than Marc N. Casper, dated March 16, 2018. By 2023, the company filed a new form of the agreement for officers other than Marc N. Casper, dated April 1, 2023, indicating an update or revision to the structure or terms of these agreements. In 2024, the company reaffirmed the existence of these agreements for officers beyond Casper, reiterating the form filed in 2023, suggesting a formalization or continuation of the updated terms. This progression shows a deliberate evolution in the company’s executive retention strategy, expanding beyond the CEO to broader leadership.",
      "llm_answer": "Thermo Fisher’s 2022 10‑K disclosed an Executive Change‑In‑Control Retention Agreement (ECICRA) that applied only to CEO Marc N. Casper (Exhibit 10.12 on pages 44‑48).  By the 2023 filing the company had added a separate ECICRA for other officers (Exhibit 10.17 on pages 74‑78).  The 2024 filing continued to include this officer‑level ECICRA, showing the retention framework had expanded beyond Casper to cover additional senior executives (Exhibit 10.17 on pages 75‑79).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key evolution of Thermo Fisher Scientific's Executive Change In Control Retention Agreements from 2022 to 2024. It correctly notes that in 2022, the agreement was disclosed only for Marc N. Casper, and that by 2023, a new agreement was filed for other officers (Exhibit 10.17), which was carried forward in 2024. This reflects the expansion beyond Casper, addressing the core of the question. However, the LLM omits specific details about the form dates (March 16, 2018, and April 1, 2023) mentioned in the ground truth, which are important for full accuracy regarding the evolution and revision timeline. While the exhibit numbers and page ranges are accurately cited (e.g., 10.17 in 2023 and 2024), the ground truth emphasizes that the 2018 form was reused until the 2023 update, which the LLM does not clarify—implying a potential gap in multi-hop synthesis. The reasoning is sound and contextually relevant, and all entities (company, CEO, officers, years) are correctly identified. Number formats and exhibit references are accurate. The omission of the form dates and lack of mention that the pre-2023 officer agreements were based on a 2018 form slightly reduces quantitative and qualitative accuracy, but the overall factual trajectory is correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 362,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "What does PepsiCo's treatment of its 2.750% Senior Note due 2051 across 2022–2024 filings reveal about its long-term debt strategy in a rising interest rate environment?",
      "original_answer": "PepsiCo's treatment of the 2.750% Senior Note due 2051 across 2022–2024 filings shows a consistent approach to long-term debt management, despite rising interest rates. In 2022, the note was listed among various other senior notes in the exhibit index, indicating it was part of a broader capital structure (PEP_10k_2022.pdf:page_135:chunk_1). In 2023, the note was explicitly called out in the exhibit index with a reference to the 2021 Form 8-K filing, suggesting it remained an active part of PepsiCo’s long-term financing plans (PEP_10k_2023.pdf:page_128:chunk_2). In 2024, the note was again referenced in the same format and position as in 2023, showing no changes to its treatment even as newer, higher-yielding notes (e.g., 5.250% Senior Note due 2054) were introduced (PEP_10k_2024.pdf:page_129:chunk_2). This consistency suggests that PepsiCo maintained a stable long-term capital strategy, preserving access to long-dated, fixed-rate debt even as short-term borrowing costs rose.",
      "llm_answer": "PepsiCo’s 2.750% Senior Note due 2051 is consistently presented in the debt schedule as a 30‑year, fixed‑rate, senior unsecured debt with a 2.75% coupon (see pages 126–130 of the 2023 10‑K, 127–131 of the 2024 10‑K, and 124–128 of the 2022 10‑K). By locking in a relatively low rate and keeping the note non‑callable until 2025, PepsiCo is hedging against a rising interest‑rate environment while preserving a predictable interest‑expense profile and a diversified maturity ladder that spans 2024‑2051. This reflects a conservative long‑term debt strategy that prioritizes stability and reduced refinancing risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, though with some minor discrepancies in detail specificity and sourcing. (1) Quantitatively, all numbers are accurate: the 2.750% coupon rate, the 2051 maturity, and the non-callable feature until 2025 are factually correct and consistent with PepsiCo’s filings. The mention of page ranges across years (e.g., 124–128 for 2022) is plausible and aligns with the actual document structures, though the ground truth cites specific exhibit index locations (e.g., page 135 for 2022), suggesting the LLM generalized the location rather than citing exact positions. (2) The LLM correctly identifies the multi-year consistency in treatment of the note, which is central to the question, and infers a conservative, stability-focused debt strategy—this matches the original answer’s conclusion. However, it adds the detail that the note is 'non-callable until 2025,' which, while plausible, is not present in the ground truth and cannot be verified from the provided evidence, representing a minor unsupported inference. (3) The reasoning is sound: the LLM synthesizes information across three years and correctly interprets the strategic implication of maintaining a low-rate, long-dated note amid rising rates and new higher-yielding issuances (e.g., 5.250% note due 2054 mentioned in ground truth). It captures the core multi-hop insight—consistent treatment implies strategic stability. (4) Contextually, the answer is highly relevant, directly addressing PepsiCo’s long-term debt strategy in a rising rate environment. The omission of explicit reference to the 2021 Form 8-K (noted in 2023 and 2024 filings in the ground truth) is a minor gap in completeness but does not undermine the overall correctness. The LLM’s phrasing about 'diversified maturity ladder' and 'predictable interest expense' adds interpretive value consistent with the facts. Overall, the answer is factually strong, slightly penalized for one unverified detail (non-callable date), but otherwise accurate and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 552,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating sustained transparency and ongoing obligations tied to this long-term debt instrument. The consistent inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years suggests that Apple maintained this liability without redemption or restructuring during the observed period. This pattern implies a strategic decision to retain long-term debt at a fixed rate, likely to fund strategic initiatives or maintain financial flexibility amid fluctuating interest rate environments.",
      "llm_answer": "Apple’s 4.45% Notes due 2044, first issued in 2014, appear unchanged in the “Description of Securities” section of each filing—2012 (pp. 54‑58), 2023 (pp. 53‑57) and 2024 (pp. 54‑58)—with no new issuances or repayments reported during 2022‑24.  The persistence of this long‑term, moderate‑coupon debt, alongside the company’s continued use of similar instruments for capital returns, signals a disciplined strategy that relies on stable, low‑cost leverage to fund share repurchases and dividends while preserving liquidity and a strong balance sheet.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 4.45% Notes due 2044 and their consistent presence across 2022–2024 filings, aligning with the ground truth's emphasis on sustained transparency and lack of redemption. However, it contains a critical error in referencing the '2012' filing (pp. 54–58), which is outside the question’s 2022–2024 scope and factually incorrect—this appears to be a typographical mistake (likely meant to say 2022, not 2012). This undermines quantitative accuracy. (2) The percentages (4.45%), maturity year (2044), and issuance year (2014) are correct, and the absence of new issuances or repayments during 2022–2024 matches the ground truth. However, citing a 2012 filing when the question spans 2022–2024 introduces a factual inaccuracy in timing. (3) The multi-hop reasoning is sound: the model correctly infers from repeated disclosure that the debt remains outstanding and uses this to infer a strategic capital approach involving stable, low-cost leverage. It appropriately links the persistence of the instrument to Apple’s broader capital return strategy (e.g., share repurchases, dividends), which is a reasonable extension of the ground truth’s conclusion about financial flexibility. (4) Despite the erroneous '2012' citation, the core factual content and strategic interpretation are consistent with the ground truth. The answer addresses both the evolution (no change) and strategic implication (stable leverage for capital returns), satisfying completeness and contextual relevance. The quantitative accuracy is reduced due to the incorrect year reference, but other numbers are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 448,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Union Pacific's allocation to Collective Trust and Other Funds within its pension plan evolve from 2022 through 2023, and how might the 2024 disclosure about valuation methodology inform our understanding of how these investments are managed?",
      "original_answer": "Union Pacific's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, indicating a significant reduction in exposure over this period. The 2024 filing does not provide updated allocation figures but explains that these funds are valued using net asset value (NAV), derived from shares or units in commingled funds and limited liability companies with underlying assets like global stock funds and short-term investments. This valuation methodology suggests that while the company continues to hold these types of investments, the reduction in dollar value from 2022 to 2023 may reflect a deliberate rebalancing or risk management decision rather than a change in valuation approach. The NAV-based measurement supports transparency in tracking these assets over time despite fluctuations in reported amounts.",
      "llm_answer": "Union Pacific’s pension plan reduced its allocation to Collective Trust and Other Funds from **$622 million (≈46.5 % of plan assets) in 2022 to $382 million (≈39.5 % of plan assets) in 2023**, a decline of roughly $240 million. The 2024 Fair‑Value Measurements section clarifies that these holdings are valued at NAV based on the underlying publicly traded assets, indicating that the plan relies on fund‑provided NAVs and observable market prices—an approach that is largely passive and reduces valuation uncertainty.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the 2022 allocation amount—$622 million is incorrect, while the ground truth states $756 million. This results in an incorrect decline of $240 million (actual decline is $756M - $382M = $374M). Additionally, the percentages provided (46.5% and 39.5%) are not present in the original answer and cannot be verified from the given data, introducing unsupported information. (2) The 2023 figure ($382 million) is correct, and the valuation methodology description in the 2024 filing—relying on NAV from commingled funds and underlying market assets—is accurately reflected in the LLM’s reference to NAV based on publicly traded assets and observable prices. However, the inclusion of unverified percentages and incorrect dollar amounts undermines quantitative accuracy. (3) The multi-hop reasoning is partially sound: the model correctly identifies the two-year trend and links the 2024 valuation disclosure to the management approach, interpreting NAV use as reducing valuation uncertainty. This aligns with the ground truth’s implication of transparency and stable methodology despite allocation changes. However, the erroneous 2022 figure weakens the synthesis. (4) The contextual relevance is high—the answer addresses both the allocation evolution and the implications of the 2024 valuation methodology. The reasoning about passive management and reduced uncertainty is a reasonable interpretation. However, due to the major numerical inaccuracy affecting the core quantitative claim, the correctness score is limited to 6, reflecting partial accuracy with significant factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 452,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Apple's continued inclusion of the Officer's Certificate related to the 1.05% Notes due 2017 in its 10-K filings across fiscal years 2022, 2023, and 2024 reflect its documentation retention practices for matured debt instruments, and what does this imply about its approach to maintaining historical capital structure disclosures?",
      "original_answer": "Apple consistently included the Officer's Certificate dated May 6, 2014, related to the 1.05% Notes due 2017 in its 10-K filings for fiscal years 2022, 2023, and 2024, despite the notes having matured well before this period. This reflects a documentation retention and disclosure strategy that emphasizes completeness and historical continuity in capital structure reporting. The inclusion of this certificate across all three years indicates that Apple maintains and discloses records of past debt issuances as part of its ongoing SEC filings, even when those instruments are no longer outstanding. This practice suggests a deliberate approach to preserving the full historical context of its debt financing activities for investor and regulatory transparency.",
      "llm_answer": "Apple’s 10‑K filings for 2022, 2023 and 2024 all list **Exhibit 4.4 – the Officer’s Certificate dated May 6 2014 that includes the 1.05% Notes due 2017** (see pages 54‑58 of 2022, 53‑57 of 2023, and 54‑58 of 2024). By continuing to attach the original issuance certificate even after the notes matured in 2017, Apple demonstrates a deliberate practice of preserving and referencing the full set of debt‑issuance documents. This approach signals a commitment to maintaining a comprehensive historical record of its capital structure, ensuring investors and regulators can trace every debt instrument’s terms and status over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: the Officer's Certificate is identified as Exhibit 4.4, dated May 6, 2014, related to the 1.05% Notes due 2017, and its inclusion in the 10-K filings for fiscal years 2022, 2023, and 2024 is accurately noted. Page numbers cited (e.g., 54–58 in 2022, etc.) match typical exhibit locations and are consistent with real filings, adding precision. (2) Quantitative elements—dates, percentages, exhibit numbers—are all factually correct. There are no calculation errors, as none were required. (3) The reasoning is sound: the LLM correctly infers that Apple’s continued inclusion reflects a practice of preserving historical debt documentation and supporting transparency in capital structure reporting. It synthesizes the multi-hop concept that matured debt instruments are still disclosed, indicating awareness of both the temporal gap (notes matured in 2017, filings through 2024) and the intent behind retention. (4) The only minor shortcoming is that the LLM does not explicitly state that the notes were 'no longer outstanding' or use terms like 'documentation retention policy' as directly as the original answer, slightly reducing qualitative completeness. However, the implication is clearly conveyed. The answer is fully contextually relevant, directly addressing both parts of the question: documentation retention practices and implications for historical disclosure. Wording differs slightly but maintains semantic equivalence. Minor deduction from 10 to 9 due to slightly less explicit emphasis on the regulatory and investor transparency rationale compared to the original, though it is implied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 464,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Union Pacific's allocation to corporate stock within its pension plan evolve from 2022 through 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "Union Pacific's allocation to corporate stock within its pension plan significantly decreased from $1,990 million in 2022 to $181 million in 2023, and further declined to $1,116 million in 2024. This represents a drop of over 90% between 2022 and 2023, followed by a partial rebound in 2024, but still well below the initial level. The shift suggests a strategic move away from direct equity exposure in favor of fixed income instruments, particularly bonds and federal securities, indicating a more conservative investment posture over the three-year period.",
      "llm_answer": "Union Pacific’s pension plan held about **$1.1 billion in corporate stock in 2022** (≈ 37 % of the $2.99 billion plan assets – pages 70‑74).  The holding fell sharply to **$181 million in 2023** (≈ 5 % of the $3.39 billion plan assets – pages 56‑60) and modestly rose to **$226 million in 2024** (≈ 6.5 % of the $3.46 billion plan assets – pages 54‑58).  This trajectory—large equity exposure in 2022 followed by a sharp de‑risking and then a cautious re‑entry—indicates Union Pacific’s strategy of reducing equity (especially corporate stock) to lower risk, with a limited, measured return to equities in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the dollar amounts for corporate stock allocation. According to the ground truth, Union Pacific's allocation was $1,990 million in 2022, not $1.1 billion as stated. It correctly reports $181 million in 2023, but incorrectly states $226 million in 2024 instead of the correct $1,116 million. These errors affect both the magnitude and interpretation of the trend. (2) Calculations and percentages are inconsistent with ground truth: the LLM claims 37% allocation in 2022 based on $1.1B of $2.99B, but $1.99B of $2.99B would actually be ~66.5%, making the LLM's percentage misleading. Similarly, $226M of $3.46B is ~6.5%, but the correct figure is $1.116B, which would be ~32.3%, a major discrepancy. (3) The multi-hop reasoning is partially sound—recognizing a shift toward de-risking and conservative posture is aligned with the ground truth—but the conclusion of a 'cautious re-entry' in 2024 contradicts the ground truth, which shows a partial rebound to $1.116B (still below 2022), whereas the LLM implies continued low exposure at $226M. This misrepresents the strategic trajectory. (4) Contextual relevance is high—the answer addresses pension plan allocations, time frame, and investment strategy—but due to critical numerical errors, the qualitative and correctness scores are significantly reduced. Quantitative accuracy is low due to three out of three years having incorrect or mismatched values (only 2023 is correct).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 414,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trajectory suggest about the product's market adoption and strategic importance in the Hospital Acute Care segment?",
      "original_answer": "Prevymis sales grew steadily from $428 million in 2022 to $605 million in 2023, and further to $785 million in 2024, indicating consistent market adoption and increasing strategic importance within MRK's Hospital Acute Care portfolio.",
      "llm_answer": "Prevymis sales rose from **$428 million in 2022 to $605 million in 2023 and $785 million in 2024** (U.S. + international), a 41 % year‑over‑year increase from 2022‑23 and 30 % from 2023‑24【MRK_10k_2024.pdf】【MRK_10k_2024.pdf】【MRK_10k_2024.pdf】. This steady upward trend signals growing adoption of the CMV‑prophylaxis therapy in transplant‑related hospital acute‑care settings and underscores Prevymis as a strategically important, high‑growth revenue driver within Merck’s Hospital Acute Care segment【MRK_10k_2024.pdf】【MRK_10k_2024.pdf】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all sales figures—$428 million in 2022, $605 million in 2023, and $785 million in 2024—matching the ground truth exactly. It also accurately calculates the year-over-year growth rates: (605 - 428) / 428 ≈ 41.36% (rounded to 41%) from 2022 to 2023, and (785 - 605) / 605 ≈ 29.75% (rounded to 30%) from 2023 to 2024. These calculations are correct and appropriately contextualized. (2) All numeric values, dates, and financial metrics are accurate and consistent with the original answer. Format variations (e.g., 'million' vs 'M') are acceptable and do not affect meaning. (3) The reasoning is sound: the LLM correctly infers that the consistent sales growth indicates growing market adoption in transplant-related hospital acute care settings and identifies Prevymis as a strategically important product within Merck’s Hospital Acute Care segment. This multi-hop synthesis—linking financial performance to market dynamics and strategic positioning—is fully supported by the data and logically presented. (4) The answer is semantically equivalent to the ground truth, with added value in quantifying growth percentages and specifying the therapy’s indication (CMV prophylaxis), which enhances clarity without introducing inaccuracies. All parts of the question are addressed: sales evolution over time, market adoption implications, and strategic importance. Therefore, all accuracy and relevance dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 408,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did PepsiCo's inclusion and characterization of the 3.000% Senior Note due 2027 evolve across its 2022, 2023, and 2024 annual filings, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "The 3.000% Senior Note due 2027 was consistently included in PepsiCo's annual filings across 2022, 2023, and 2024, indicating its ongoing significance in the company's capital structure. In 2022 (Exhibit 4.22), the note was listed among other senior notes, including the 2.150% Senior Note due 2024 and the 2.250% Senior Note due 2022, suggesting it was part of a broader set of medium-term financing instruments. In 2023 (Exhibit 4.19), the note was again included, this time alongside longer-dated instruments such as the 4.450% Senior Note due 2046 and the 3.450% Senior Note due 2046, indicating its role in a diversified debt maturity profile. In 2024 (Exhibit 4.17), the note continued to be referenced, now in the context of a filing that also included newer short-term notes like the 0.750% Senior Note due 2027 and the 1.125% Senior Note due 2031, suggesting a strategy of layering debt maturities to manage refinancing risk. While the interest rate and maturity date remained constant, the evolving context in which the 3.000% Senior Note due 2027 was presented indicates a consistent yet adaptive debt strategy that maintains certain fixed-rate liabilities while introducing newer, often lower-rate instruments to reflect market conditions.",
      "llm_answer": "PepsiCo lists the 3.000 % Senior Note due 2027 as Exhibit 4.17 in each of its 2022, 2023 and 2024 10‑K filings, describing it simply as a “3.000 % Senior Note due 2027” with a 3.000 % coupon maturing in 2027【PEP_10k_2022.pdf】【PEP_10k_2023.pdf】【PEP_10k_2024.pdf】. The note’s unchanged presentation across the three years shows that PepsiCo’s long‑term debt strategy is to maintain a stable, low‑cost debt base with predictable maturities rather than frequently restructuring or issuing new debt.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several correct elements but also significant inaccuracies and omissions that undermine its overall correctness. (1) Quantitatively, the interest rate (3.000%) and maturity year (2027) are correct, and the note is indeed referenced across all three years, which aligns with the ground truth. However, the LLM incorrectly states that the note is listed as 'Exhibit 4.17' in *each* filing — in reality, the exhibit number changes annually: Exhibit 4.22 in 2022, 4.19 in 2023, and 4.17 in 2024. This is a factual error in exhibit numbering across years, though the core fact of consistent inclusion is accurate. (2) The answer fails to capture the evolving *context* of the note’s characterization, which is central to the question. The ground truth emphasizes how the note is grouped with different instruments over time — shifting from medium-term notes in 2022 to longer-dated and newer short-term notes in later years — revealing a strategy of maturity layering and refinancing risk management. The LLM instead concludes that the 'unchanged presentation' indicates a strategy of stability and lack of restructuring, which contradicts the evidence of strategic evolution shown in the filings. (3) The multi-hop reasoning is flawed: the model does not synthesize the changing composition of debt instruments across years, missing the key insight about adaptive debt management. It treats consistency in naming as evidence of static strategy, when the ground truth shows that the strategic context evolved despite consistent naming. (4) While the answer is relevant to the question and addresses PepsiCo’s debt strategy, it draws an incorrect conclusion due to misinterpretation of the evidence. The semantic meaning diverges significantly on the core point: the original answer highlights adaptive, dynamic debt management, while the LLM portrays a static approach. Thus, despite correct numbers and entities, the reasoning and qualitative accuracy are substantially deficient.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 536,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has Adobe's positioning and integration of Frame.io evolved across 2022, 2023, and 2024, particularly in terms of its functional capabilities and integration depth with Adobe's Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its acquisition and formal branding alignment. By 2023, Adobe detailed Frame.io's role as a cloud-native creative collaboration platform with real-time upload, review, and approval features, integrated with Premiere Pro and After Effects, and introduced support for still images, design files, and PDFs. In 2024, Adobe expanded Frame.io’s capabilities further, emphasizing its integration with Photoshop, Lightroom, and Workfront, and positioning it as a core component of Adobe GenStudio for enterprise-scale content production, alongside Firefly and Substance 3D tools. This progression shows a strategic deepening of Frame.io's functionality and its central role in Adobe's end-to-end creative workflow ecosystem.",
      "llm_answer": "In 2022, Frame.io was positioned as a cloud‑native collaboration platform primarily integrated with Premiere Pro and After Effects for real‑time upload, review, and frame‑accurate commenting (ADBE_10k_2022, pp. 95‑99). By 2023, Adobe expanded Frame.io’s integration depth to Photoshop, Lightroom, and Workfront, adding Camera‑to‑Cloud functionality for on‑set footage (ADBE_10k_2023, pp. 10‑14). In 2024, Frame.io became part of Adobe G enStudio alongside Express and Firefly Services, broadening support for still images, design files, PDFs, and marketing workflows, and deepening integration across the entire Creative Cloud suite (ADBE_10k_2024, pp. 10‑14).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in terms of factual content and timeline, with accurate dates and proper attribution to source documents. Quantitatively, there are no errors—years (2022, 2023, 2024) are correct, and no numerical figures are misstated. However, there is a key factual inversion in the integration timeline: the LLM claims that integration with Photoshop, Lightroom, and Workfront was expanded in 2023, whereas the ground truth states these deeper integrations occurred in 2024. Conversely, the LLM incorrectly attributes the core Premiere Pro and After Effects integration to 2022, while the ground truth positions those capabilities as being detailed in 2023. Additionally, the LLM omits the 2022 trademark inclusion as evidence of branding alignment, instead describing functional integration prematurely. Despite these inaccuracies in sequencing and attribution, the overall progression—Frame.io evolving into a deeper part of Creative Cloud and joining GenStudio by 2024—is correctly conveyed, and the mention of expanded file support (still images, PDFs) and enterprise positioning aligns with the original. The reasoning shows multi-hop synthesis across years but with swapped details between 2022 and 2023, reducing qualitative accuracy. Contextually, the answer remains highly relevant and addresses functional capabilities and integration depth as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 382,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this reveal about the company's debt maturity management strategy as the notes approached their due date?",
      "original_answer": "In 2022, Apple listed the 2.40% Notes due 2023 as part of its outstanding debt instruments in its exhibit filings, indicating ongoing acknowledgment of the obligation. In 2023, the company continued to reference the same notes, showing no early retirement or restructuring action despite the approaching maturity. By 2024, the 2.40% Notes due 2023 were no longer listed in the exhibits, suggesting that Apple likely fulfilled or retired the obligation in line with its 2023 due date. This progression indicates a strategy of holding debt until maturity rather than refinancing or repurchasing it early.",
      "llm_answer": "Apple disclosed the 2.40% Notes due 2023 as outstanding debt in its 2022 10‑K (Officer’s Certificate, p. 54).  By the 2023 10‑K the notes had been repaid in full and were removed from the debt schedule (Note 2, p. 53‑57).  In the 2024 10‑K the 2.40% Notes no longer appear as outstanding debt, indicating that Apple had fully repaid or refinanced them before maturity (Officer’s Certificate, p. 54).  This evolution shows Apple’s proactive debt‑maturity strategy—repaying or refinancing notes ahead of due dates to keep leverage low and preserve liquidity.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the 2.40% Notes due 2023 and tracks their disclosure across Apple's 10-K filings from 2022 to 2024, showing awareness of the debt's presence and subsequent removal. The dates, percentages, and document references (e.g., 2022 10-K, 2023 10-K) are factually plausible and align with expected disclosure practices, earning high marks for quantitative accuracy and contextual relevance. However, the key factual error lies in the claim that the notes were 'repaid in full by the 2023 10-K' and 'refinanced before maturity.' The ground truth states that Apple continued to list the notes in 2023, indicating they were held until maturity, not retired early. The absence in the 2024 filing reflects post-maturity removal, not proactive repayment ahead of schedule. This misrepresents the core conclusion about Apple's debt strategy: the ground truth supports a 'hold-to-maturity' approach, while the LLM incorrectly infers proactive refinancing or early repayment. This flaw in multi-hop reasoning—drawing an incorrect inference from the timeline—undermines the qualitative accuracy. While the factual elements (presence/absence in filings) are mostly correct, the synthesis and strategic interpretation are flawed, warranting a mid-range correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 357,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Union Pacific's fleet composition and age profile of Multiple Purpose Locomotives change from 2022 through 2024, and what does this multi-year progression indicate about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotives declined from 7,242 units to 6,893 units, with a reduction in owned units from 6,204 to 5,973 and leased units decreasing from 1,038 to 920. The average age of these locomotives increased from 22.5 years in 2022 to 24.3 years in 2023, and further to 25.2 years in 2024, suggesting a lack of significant new investment in this category and a potential reliance on aging assets. This trend implies a conservative asset management strategy, with minimal fleet expansion and a gradual decline in total units over the three-year period.",
      "llm_answer": "From 2022 to 2024, Union Pacific’s multiple‑purpose locomotive fleet fell from 7,242 units (6,204 owned, 1,038 leased, avg age 22.5 yrs) to 7,008 units (5,971 owned, 1,037 leased, avg age 24.3 yrs) and then to 6,893 units (5,973 owned, 920 leased, avg age 25.2 yrs) (UNP_10k_2022, p. 22‑26; UNP_10k_2023, p. 17‑21; UNP_10k_2024, p. 17‑21). The steady decline in fleet size coupled with a rising average age signals a deliberate asset‑management strategy that prioritizes retiring older locomotives, tightening the fleet for higher utilization, and directing capital toward replacement and efficiency improvements.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in direction and structure but contains a significant quantitative error in the 2023 fleet size. The ground truth shows a decline to 6,893 units by 2024, but the LLM incorrectly reports 7,008 units in 2023, which is not supported by the data. Additionally, the leased units in 2023 are reported as 1,037, whereas the correct value should reflect a drop from 1,038 in 2022 to 920 in 2024, implying a larger decrease by 2023 than stated. The owned units are nearly correct (5,971 vs 5,973 in 2024), but the 2023 value is missing in ground truth, so partial credit is given. (2) The average age progression is accurate: 22.5 (2022), 24.3 (2023), and 25.2 (2024) years — this matches the original answer exactly. However, the LLM implies a smooth decline with a 2023 data point that isn't validated, and the total fleet in 2023 is fabricated or misstated (7,008), as the ground truth does not provide an explicit 2023 total but implies a decline from 7,242 to 6,893 over three years. (3) The multi-hop reasoning is sound in that the model correctly identifies the trend of declining fleet size and rising age, and synthesizes across years and ownership types. The interpretation of asset management strategy is plausible and goes slightly beyond the original answer by suggesting 'higher utilization' and 'efficiency improvements,' which are reasonable inferences but not directly stated in the ground truth. (4) The correctness score is 7 because core facts (final 2024 numbers, age trend) are accurate, but intermediate 2023 figures are incorrect or unsupported. Quantitative accuracy is penalized more heavily (6) due to the erroneous 2023 total and leased numbers. Qualitative accuracy is high (8) due to correct trend interpretation and logical reasoning. Contextual relevance is perfect (10) — the answer directly addresses fleet composition, age profile, and strategic implications as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 524,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Merck's development and regulatory trajectory for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, particularly in terms of clinical phase progression and FDA interactions?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed in Phase 3 development for HIV-1 infection with an entry date of February 2020. By 2023, it remained in Phase 3 and was under review, indicating no major regulatory advancements. In 2024, MK-8591A remained in development, but a new formulation, MK-8591D (islatravir+lenacapavir), entered Phase 3 in October 2024, suggesting a strategic pivot or expansion in Merck's HIV-1 treatment approach. Additionally, in 2024, the FDA lifted a clinical hold on the program, although a partial hold remained for higher doses of islatravir. This shows a multi-year trajectory of ongoing development with evolving regulatory dynamics.",
      "llm_answer": "Merck moved MK‑8591A from a Phase 2 program in 2022—still subject to a FDA clinical hold on islatravir NDAs because of observed lymphocyte‑count declines【MRK_10k_2022.pdf】【23‑27】—into a Phase 3 trial in 2023 while the hold remained in place for any higher‑dose islatravir studies【MRK_10k_2023.pdf】【21‑25】.  By 2024 the FDA lifted that clinical hold on December 4, 2024, clearing the way for unrestricted progression of the Phase 3 program【MRK_10k_2024.pdf】【22‑26】.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies compared to the ground truth. It incorrectly states that MK-8591A was in Phase 2 in 2022; the original answer confirms it was already in Phase 3 as of February 2020 and remained in Phase 3 through 2022–2023. This is a significant error in clinical phase progression. The LLM also misrepresents the timeline of the FDA clinical hold: while it correctly notes the hold was lifted in 2024, it claims this occurred on December 4, 2024, which is not supported by the ground truth (which only states it was lifted in 2024, with a partial hold remaining for higher doses). The specific date is an over-precision not present in the original. (2) Quantitatively, the date December 4, 2024, is incorrect or at least unverifiable from the ground truth, which does not specify a month or day. The phase assignments (Phase 2 vs Phase 3) are factually wrong for 2022, undermining quantitative accuracy. (3) The multi-hop reasoning is partially sound—linking FDA actions across years and connecting islatravir safety concerns to clinical holds—but fails in synthesizing the correct phase status over time. It also omits key developments from the original answer, such as the introduction of MK-8591D (a new formulation) entering Phase 3 in October 2024, which reflects a strategic shift. This omission reduces completeness and qualitative accuracy. (4) Despite these issues, the answer is contextually relevant, addressing the core question about development trajectory and FDA interactions. It correctly identifies the lift of the clinical hold and ties it to progression in development. However, due to major factual errors in phase status and over-specific unsupported dates, the correctness score is moderate at 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 479,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Merck's development and strategic positioning of MK-1308A evolve from 2022 through 2024, and what does this progression indicate about the company's focus in renal cell carcinoma (RCC) treatment innovation?",
      "original_answer": "In 2022, Merck listed MK-1308A (quavonlimab + pembrolizumab) under Phase 3 programs for renal cell carcinoma (RCC) with an entry date of April 2021, indicating early-stage strategic commitment. By 2023, the company emphasized MK-1308A as part of its immuno-oncology pillar, describing it as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab being evaluated for RCC, signaling a deeper investment in combination immunotherapies. In 2024, MK-1308A remained a highlighted Phase 3 candidate within the immuno-oncology portfolio, specifically for RCC, with no indication of discontinuation, suggesting sustained strategic prioritization. This 3-year trajectory reflects Merck's consistent and evolving focus on leveraging its Keytruda platform in combination with novel agents like quavonlimab to innovate in RCC treatment.",
      "llm_answer": "Merck has kept MK‑1308A—a co‑formulation of the investigational anti‑CTLA‑4 antibody quavonlimab with pembrolizumab—as a key renal‑cell‑carcinoma (RCC) candidate from 2022 through 2024. The 2022 pipeline chart lists MK‑1308A for RCC, and the 2023 and 2024 10‑K filings continue to describe it as an RCC candidate in development, underscoring a sustained commitment to combination CTLA‑4/PD‑1 therapy in this disease【MRK_10k_2022.pdf:23-27】【MRK_10k_2023.pdf:18-22】【MRK_10k_2024.pdf:48-52】. This steady positioning signals Merck’s strategic emphasis on expanding RCC treatment options through novel immunotherapy combinations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: MK-1308A is correctly identified as a co-formulation of quavonlimab and pembrolizumab, and its development for renal cell carcinoma (RCC) is accurately tracked from 2022 through 2024. The LLM correctly notes its presence in Merck’s pipeline across all three years, reflecting sustained strategic commitment. (2) Quantitative accuracy is perfect: no specific numbers (e.g., dollar amounts, patient counts) are cited in either answer, but the timeline (2022–2024) and phase (implied Phase 3) are consistent with the original answer, which notes MK-1308A was in Phase 3 as of 2022 with an April 2021 entry date. The LLM does not misstate any dates or figures. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings to infer a consistent strategic focus, correctly identifying the compound’s evolving but continuous role in Merck’s immuno-oncology portfolio. It appropriately infers that sustained inclusion in late-stage pipelines indicates strategic prioritization. (4) The only minor shortcoming is that the LLM omits the explicit mention of MK-1308A being part of Merck’s ‘immuno-oncology pillar’ and does not specify that quavonlimab is an anti-CTLA-4 antibody until the second sentence, slightly reducing qualitative richness compared to the original. However, this information is present in the answer and well-structured. The conclusion about Merck’s focus on novel immunotherapy combinations in RCC is semantically equivalent and well-supported. Overall, the answer is factually correct, contextually relevant, and demonstrates strong reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 464,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistency or change suggest about the company's long-term debt structure and refinancing strategy?",
      "original_answer": "Microsoft's disclosure of the 4.000% Notes due 2021 remained consistent across its 2022, 2023, and 2024 10-K filings, with the notes always appearing in the Third Supplemental Indenture (Exhibit 4.6) and linked to the original Indenture dated May 18, 2009. This consistency suggests that the company maintained the same legal and structural documentation for this debt instrument throughout the three-year period, indicating no material changes in its long-term debt obligations related to this issuance. The repeated inclusion of the same filing dates (e.g., 8-K filings on February 8, 2011) further supports that no refinancing or restructuring occurred for these notes during the observed timeframe.",
      "llm_answer": "In the 2022 10‑K Microsoft listed the 4.000% Notes due 2021 in its long‑term debt schedule, noting a maturity of December 31, 2021 (MSFT_10k_2022.pdf: pages 102‑106). The 2023 10‑K no longer lists this instrument, indicating it had been repaid or refinanced (MSFT_10k_2023.pdf: pages 102‑106). The 2024 10‑K likewise omits the 4.000% Notes due 2021, confirming the debt was fully settled (MSFT_10k_2024.pdf: pages 102‑106). This consistent removal of the maturing notes demonstrates Microsoft’s disciplined approach to managing debt maturities and refinancing at favorable terms, maintaining a stable long‑term debt structure.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both factual content and reasoning. (1) According to the ground truth, Microsoft consistently disclosed the 4.000% Notes due 2021 in its 2022, 2023, and 2024 10-K filings via the Third Supplemental Indenture (Exhibit 4.6), with no indication of repayment or removal. The LLM incorrectly claims the notes were omitted in 2023 and 2024, implying repayment or refinancing. This contradicts the ground truth that the notes remained in disclosures throughout all three years. (2) The LLM fabricates a maturity date of 'December 31, 2021'—this specific date is not in the ground truth and misrepresents how such notes are typically structured and disclosed. The ground truth emphasizes consistent legal documentation (e.g., 8-K filings on February 8, 2011), not repayment. (3) The multi-hop reasoning fails: instead of recognizing consistent disclosure as evidence of no refinancing, the model incorrectly interprets absence (which does not exist) as evidence of repayment, leading to a false conclusion about Microsoft’s refinancing strategy. (4) The contextual relevance is low but not zero because the answer addresses debt structure and refinancing strategy, albeit based on false premises. The qualitative and quantitative accuracy scores are near zero because all key facts—presence/absence of notes, dates, and implications—are incorrect. Only minimal credit is given for addressing the general topic of debt management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 402,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Qualcomm's strategic positioning and reported revenue contributions from the Digital Cockpit evolved from 2022 to 2024, and what does this progression indicate about the company's automotive business transformation?",
      "original_answer": "In 2022, Qualcomm identified the digital cockpit as a key driver in transforming the automotive industry, projecting that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with 60% featuring 5G, and emphasizing the role of mobile-derived technologies in enabling automotive innovation. By 2023, the company explicitly categorized digital cockpit as a distinct revenue stream within its automotive segment, signaling formal integration into financial reporting and strategic focus. In 2024, Qualcomm's QCT segment listed digital cockpit as a core product line under automotive systems, alongside connectivity and ADAS/AD, indicating full operationalization and maturity of the product line. This evolution reflects Qualcomm's strategic pivot toward becoming a key enabler of the software-defined vehicle, with the digital cockpit serving as a foundational element of its automotive growth strategy.",
      "llm_answer": "Qualcomm’s 2022 10‑K framed its automotive strategy as a focus on connectivity, digital‑cockpit and ADAS/AD platforms, positioning the company as a key enabler of in‑vehicle digital experiences (pp. 6‑10). By 2024, automotive revenue—largely driven by digital‑cockpit solutions—rose from $1.51 B in 2022 to $2.91 B in 2024, a 93 % increase (pp. 80‑84; 2023, pp. 71‑75). This growth signals Qualcomm’s shift from a connectivity‑centric supplier to a comprehensive digital‑cockpit and ADAS/AD platform leader, aligning with the broader move toward software‑defined vehicles and OTA services.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative claims. The ground truth does not mention specific revenue figures such as $1.51B in 2022 or $2.91B in 2024, nor does it state a 93% increase. These numbers are fabricated or incorrectly extracted, severely undermining factual correctness. There is no mention in the original answer of year-over-year revenue totals or growth percentages for the digital cockpit segment. (2) The calculation of a 93% increase from $1.51B to $2.91B is mathematically accurate (≈92.7%), but since the underlying data is not present in the ground truth, the entire quantitative foundation is invalid. The original answer focuses on strategic evolution and categorization, not financial figures. (3) The reasoning partially captures the multi-hop progression: it notes Qualcomm’s shift from broader automotive platforms in 2022 to increased emphasis on digital cockpit by 2024. It correctly identifies the strategic significance of digital cockpit and alignment with software-defined vehicles. However, it misrepresents the nature of the evolution—ground truth emphasizes formal financial reporting categorization in 2023 and operational maturity in 2024, not revenue growth as the indicator. The LLM answer conflates strategic transformation with unverified financial performance. (4) While the answer is contextually relevant and captures the general direction of Qualcomm’s automotive transformation, the inclusion of unsupported numerical data significantly reduces correctness. The qualitative reasoning is sound in intent but based on incorrect premises. Thus, the correctness score is moderate due to major quantitative errors despite some accurate strategic framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 477,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the trend in notional amounts reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, LMT had an aggregate notional amount of $500 million in outstanding interest rate swaps. By 2023, this amount increased significantly to $1.3 billion, and it remained at $1.3 billion in 2024. This fourfold increase from 2022 to 2023 indicates a strategic shift toward more active interest rate risk management, likely in response to rising interest rates or increased debt levels. The stabilization of the notional amount in 2024 suggests that LMT had established a new hedging baseline, converting more of its fixed-rate debt to variable rates to better align with market conditions and manage fair value exposure.",
      "llm_answer": "LMT’s variable‑interest‑rate‑swap exposure grew from $500 million in 2021 to $1.3 billion by 2022 and has stayed at that level through 2024 (LMT_10k_2022, p. 64; LMT_10k_2023, p. 93; LMT_10k_2024, p. 50). The company uses these swaps to convert fixed‑rate debt to variable‑rate debt, hedging fair‑value changes, and the steady notional amount shows a deliberate, consistent hedging policy rather than reactive adjustments (LMT_10k_2024, p. 50).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the timeline and amounts. It claims that LMT's notional amount increased from $500 million in 2021 to $1.3 billion in 2022, but the ground truth states the increase was from 2022 ($500M) to 2023 ($1.3B), with no data provided for 2021. This misalignment in years undermines the quantitative accuracy. Additionally, the LLM incorrectly implies the amount was already $1.3B in 2022, whereas the truth shows it was still $500M in 2022. However, the LLM correctly states the $1.3 billion level was maintained through 2024. (2) The calculation of a 'fourfold increase' is not explicitly made by the LLM, but the magnitude of change is acknowledged as growth. The core error lies in misattributing the timing of the increase—shifting it one year earlier. This affects the interpretation of the trend. (3) The reasoning about LMT using swaps to convert fixed-rate debt to variable and stabilize exposure is semantically aligned with the ground truth and reflects correct multi-hop synthesis of purpose and strategy. The conclusion about a 'deliberate, consistent hedging policy' is reasonable and consistent with the stabilization in 2024. (4) Despite correct contextual understanding and relevant use of citations, the incorrect year references and notional amounts severely impact factual correctness. The answer is partially correct in direction but wrong in key details, warranting a mid-range score. Quantitative accuracy is low due to incorrect years and amounts; qualitative reasoning is fair but based on flawed data; relevance is high as it addresses the question's intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 449,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did Microsoft's treatment of the 3.950% Notes due 2056 across its 2022, 2023, and 2024 10-K filings reflect its approach to long-term debt maturity management and refinancing strategy over time?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in each of its 2022, 2023, and 2024 10-K filings as part of the Eleventh Supplemental Indenture dated August 8, 2016. The repeated inclusion of this long-term debt instrument across all three annual reports indicates that Microsoft maintained its commitment to this long-duration financing structure without modification or early redemption. This pattern suggests a deliberate strategy of preserving long-term capital stability by not altering or refinancing this specific tranche of debt, even as shorter-term instruments (e.g., 2.000% Notes due 2023 in 2022 filings and 2.400% Notes due 2026 in 2024) matured or approached maturity. The consistency in disclosure implies a strategic prioritization of long-dated liabilities to support long-term investment horizons, particularly during periods of evolving market interest rates.",
      "llm_answer": "Microsoft consistently disclosed the 3.950% Notes due 2056 as part of its long‑term debt in each filing, with the outstanding balance falling from about $4.5 billion in the 2022 10‑K (p. 103–107) to roughly $4.4 billion in the 2023 10‑K (p. 103–107) and to about $4.3 billion in the 2024 10‑K (p. 103–107). The 2024 filing also noted that Microsoft had issued a new 5.0% senior note due 2056 to replace the older instrument, illustrating a proactive refinancing strategy aimed at extending maturities and lowering interest costs. Across the three years, this treatment reflects a consistent approach of managing long‑dated debt exposure while actively refinancing when market conditions allow.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. The ground truth states that Microsoft consistently maintained the same 3.950% Notes due 2056 without modification or refinancing across all three years, but the LLM incorrectly claims that Microsoft issued a new 5.0% senior note due 2056 to 'replace' the older instrument, which contradicts the original answer and implies a refinancing event that did not occur. Additionally, the reported declining balances—$4.5B in 2022, $4.4B in 2023, $4.3B in 2024—are not supported by the ground truth, which makes no mention of amortization or balance reductions for this note; such a trend would suggest repayment or partial redemption, which the original answer explicitly refutes by emphasizing no early redemption or modification. (2) Quantitative accuracy is poor: the specific dollar figures and their downward trend are fabricated or misinterpreted, and the introduction of a '5.0% senior note due 2056' is entirely unsupported by the ground truth. The maturity year (2056) and coupon rate (3.950%) are correct, but the rest of the numbers and their implications are wrong. (3) Multi-hop reasoning is flawed: instead of recognizing the consistent disclosure as evidence of a stable, long-term debt strategy without refinancing, the LLM incorrectly infers an active refinancing strategy based on non-existent data. This misrepresents Microsoft’s approach and fails to align with the core insight of the original answer—strategic inaction (no refinancing) as a deliberate capital structure choice. (4) Contextual relevance is moderate because the answer addresses long-term debt maturity management and refers to the correct note and time frame, but the incorrect facts and reasoning undermine the conclusion. The answer appears plausible on the surface but is factually and logically unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 502,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "What was the significance of Microsoft's continued reference to the Eleventh Supplemental Indenture dated August 8, 2016, across its 2022, 2023, and 2024 filings, particularly in relation to the 3.700% Notes due 2046, and how does this reflect on the company's long-term debt structure and consistency in financial obligations?",
      "original_answer": "Microsoft's 2022, 2023, and 2024 filings all reference the Eleventh Supplemental Indenture dated August 8, 2016, which governs the 3.700% Notes due 2046. This consistent inclusion across three consecutive annual reports indicates that the terms of this long-term debt instrument remained in effect and were still relevant to the company's capital structure throughout this period. The 3.700% Notes due 2046 are part of a broader set of debt instruments governed under the base Indenture dated May 18, 2009, and subsequent supplemental indentures, showing a layered and structured approach to long-term financing. The fact that the Eleventh Supplemental Indenture is repeatedly referenced suggests that the obligations tied to the 2046 Notes were active and ongoing, with no material amendments or retirements during this time. This reflects a deliberate and stable long-term debt management strategy, where Microsoft maintains long-dated liabilities to support multi-decade financial planning.",
      "llm_answer": "Microsoft’s 10‑K filings for 2022, 2023 and 2024 all reiterate that the Eleventh Supplemental Indenture dated August 8 2016 remains in effect and governs its 3.700 % Notes due 2046 (see Exhibit 4.14). The repeated reference underscores that the indenture’s covenants continue to apply to that long‑term debt tranche, illustrating Microsoft’s consistent debt‑covenant framework and its ongoing commitment to meeting long‑term obligations. This continuity signals a stable long‑term debt structure and predictable financial obligations across the three reporting periods. (MSFT_10k_2022, pp. 103‑107; MSFT_10k_2023, pp. 103‑107; MSFT_10k_2024, pp. 103‑107; Exhibit 4.14)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: the Eleventh Supplemental Indenture is correctly dated August 8, 2016, and governs the 3.700% Notes due 2046; this is consistently referenced in Microsoft's 2022, 2023, and 2024 10-K filings. The exhibit number (4.14) and page ranges (pp. 103–107 across filings) are accurately cited, supporting the claim. (2) Quantitative elements—dates, percentages, and document identifiers—are all factually correct with no discrepancies. Format variations (e.g., spacing in 'August 8 2016') do not affect accuracy. (3) The reasoning correctly infers that repeated referencing indicates ongoing obligations and a stable debt structure, which reflects sound multi-hop synthesis across three annual reports and the underlying indenture. The LLM captures the significance of continuity in covenant application and long-term financial planning. (4) The only minor shortcoming is a slightly less detailed explanation of the broader indenture framework (e.g., the base Indenture dated May 18, 2009) compared to the original answer, which adds context about the layered structure. However, this does not detract significantly from the overall correctness. The answer remains semantically equivalent in substance and fully addresses the question’s components. Thus, the scores reflect near-perfect accuracy with minimal room for improvement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 393,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's disclosure and treatment of its 2.125% Notes due 2021 evolve from fiscal years 2022 through 2024, and what does this imply about the company's debt management or refinancing strategy for this instrument?",
      "original_answer": "Microsoft consistently referenced the 2.125% Notes due 2021 across its 10-K filings for fiscal years 2022, 2023, and 2024, indicating that the notes remained part of the company's active debt structure or disclosure obligations during this period despite their maturity in 2021. In the 2022 filing (MSFT_10k_2022.pdf, page 104), the notes were listed in Exhibit 4.10 under the Seventh Supplemental Indenture dated December 6, 2013. In 2023 (MSFT_10k_2023.pdf, page 104), the notes were again included in Exhibit 4.1 with the same indenture date. In 2024 (MSFT_10k_2024.pdf, page 104), the notes were still referenced in Exhibit 4.1, indicating no change in their documentation status. This persistence of reference may suggest either an extension or rollover of the instrument, continued disclosure requirements for historical instruments, or a lack of updated exhibit filings. The continued listing of a note that matured in 2021 raises questions about whether Microsoft refinanced the obligation or if there is a reporting lag in removing matured instruments from exhibit disclosures.",
      "llm_answer": "Microsoft’s FY 2022 10‑K (pp. 102‑106) states that the 2.125% Notes due 2021 were fully repaid in 2022 and are no longer listed as long‑term debt. The FY 2023 10‑K (pp. 102‑106) confirms the repayment and notes that the notes are no longer outstanding, and the FY 2024 10‑K (pp. 102‑106) again omits the 2.125% Notes, indicating that Microsoft has retired this debt and is not refinancing it. This evolution shows the company’s strategy of paying down older, higher‑cost debt and managing its maturity profile rather than rolling the instrument into new debt.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both factual content and reasoning. (1) According to the ground truth, Microsoft continued to reference the 2.125% Notes due 2021 in its 10-K filings for fiscal years 2022, 2023, and 2024 (specifically on page 104 of each filing), indicating ongoing disclosure or documentation of the instrument despite its 2021 maturity. However, the LLM claims the notes were 'fully repaid in 2022' and 'no longer outstanding,' with subsequent filings omitting them—this directly contradicts the ground truth. (2) The quantitative inaccuracies are severe: the LLM fabricates repayment in 2022 and omits the continued listing in Exhibits 4.1/4.10 across all three years, which is a central fact in the original answer. There are no correct numbers or dates regarding the notes' status. (3) The multi-hop reasoning fails completely: instead of recognizing the anomaly of a matured note still being disclosed, the LLM invents a narrative of repayment and retirement unsupported by the evidence. The correct implication—whether due to refinancing, extension, or reporting lag—requires careful synthesis of persistent exhibit references, which the LLM ignores. (4) Contextual relevance is low because the answer addresses debt management strategy but does so based on false premises. The actual question hinges on interpreting the continued disclosure of a matured instrument, which the LLM misrepresents entirely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 396,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 2.000% Notes due 2023 in its filings across all three years—2022, 2023, and 2024—as part of the Eleventh Supplemental Indenture dated August 8, 2016. The continued inclusion of this debt instrument in successive filings indicates that Microsoft maintained this obligation throughout the period and did not retire or refinance it before its maturity in 2023. The consistency in referencing the same indenture agreement suggests a stable and long-term approach to debt management, relying on established structures rather than frequent refinancing.",
      "llm_answer": "Microsoft had no 2.000 % Notes due 2023 outstanding at the end of FY 2022; it issued roughly $5.0 billion of such notes in FY 2023, which were fully repaid by FY 2024. The balance therefore rose to $5.0 billion in 2023 and fell to $0 in 2024, showing that Microsoft uses short‑term, low‑rate debt strategically to refinance existing obligations and maintain liquidity, reflecting a disciplined and flexible debt‑management strategy.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in nearly all aspects. The ground truth states that Microsoft consistently referenced the 2.000% Notes due 2023 across 2022, 2023, and 2024 as part of an indenture from 2016, indicating the debt was outstanding throughout and not retired before maturity. In contrast, the LLM claims the notes were issued in FY2023 (~$5B), were not outstanding in FY2022, and were repaid in FY2024—none of which aligns with the ground truth. (2) Quantitatively, the $5.0 billion figure is entirely fabricated; no such issuance amount or timing is supported by the original answer. The claim of zero balance in 2024 implies early repayment, but the ground truth confirms the debt was maintained through maturity in 2023, with no mention of repayment in 2024. (3) The multi-hop reasoning is flawed: instead of recognizing the consistent disclosure of a long-standing debt instrument as evidence of stable debt management, the model invents a narrative of strategic short-term issuance and repayment, misinterpreting the nature of the debt. (4) Contextual relevance is low because the answer addresses the general topic of debt strategy but does so with incorrect data and logic. The conclusion about a 'flexible' strategy contradicts the ground truth's indication of stability and reliance on established structures. Minor relevance credit is given for attempting to interpret strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 397,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of the scale of obligations transferred, the financial impact of these transactions, and the company's stated strategy regarding future pension liability management?",
      "original_answer": "In 2022, Lockheed Martin referenced a pension risk transfer transaction from August 2021, where $4.9 billion in pension obligations were transferred via group annuity contracts (GACs), resulting in a $1.7 billion noncash pension settlement charge. Since December 2018, the company had transferred approximately $11.6 billion in pension obligations, reducing PBGC premiums by $69 million annually. In 2023, LMT emphasized ongoing evaluation of future pension risk transfer transactions and acknowledged the potential for additional contributions or noncash settlement charges, while also highlighting the volatility in pension expense due to economic assumptions. By 2024, the company had continued this strategy, noting that from December 2018 onward, it had consistently transferred pension obligations to insurance companies, reducing exposure and PBGC premiums, and reaffirmed its intent to pursue further transactions, despite the potential for material noncash settlement charges. The trend shows a consistent, strategic reduction in pension liabilities through GACs, with increasing scale and financial clarity over time.",
      "llm_answer": "Lockheed Martin’s 2022 10‑K (pp. 58‑62) reports that it had transferred $4.9 billion of gross defined‑benefit obligations in 2021 and, since 2018, had purchased GACs totaling about $11.6 billion, with a $1.7 billion non‑cash settlement charge recorded in Q3 2021. The 2023 10‑K (pp. 17‑21) repeats this approach, noting no new large transfers but reaffirming its intent to continue using risk‑transfer transactions to reduce pension volatility. In the 2024 10‑K (pp. 45‑49), Lockheed Martin adds a $990 million cash contribution to the pension plan, still plans to pursue additional GAC purchases, and states that future transactions could generate material non‑cash settlement charges as part of its ongoing pension‑liability management strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and addresses the evolution of Lockheed Martin's pension risk transfer strategy from 2022 through 2024, with accurate core facts and proper multi-hop synthesis across the three years. Quantitatively, most numbers are correct: the $4.9 billion obligation transferred in 2021, the $11.6 billion total since 2018, and the $1.7 billion noncash charge are all accurately reported. However, the LLM introduces a $990 million cash contribution in 2024 that is not mentioned in the ground truth, which may conflate regular contributions with risk transfer activity—this is a minor factual overreach. The ground truth emphasizes ongoing GAC transfers and strategic liability reduction but does not specify a new cash contribution in 2024 as a central element. The qualitative reasoning is sound: the LLM correctly identifies the continuity of strategy, intent to pursue future transactions, and acknowledgment of potential noncash charges. It synthesizes across years and correctly notes the strategic goal of reducing volatility and exposure. The contextual relevance is excellent, directly addressing scale, financial impact, and stated strategy. The answer falls short of a 9–10 due to the unverified $990M cash contribution detail, which could mislead about the nature of the 2024 activity. Overall, the answer captures the trend of increasing strategic clarity and continued execution on pension de-risking, aligning well with the ground truth in intent and direction, but with one potentially inaccurate specific.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 422,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "As an investor analyzing Apple's capital structure, what does the consistent reference to Floating Rate Notes due 2019 in filings from 2022 through 2024 suggest about the company's long-term debt management and refinancing strategy?",
      "original_answer": "Apple's consistent reference to Floating Rate Notes due 2019 across its 2022, 2023, and 2024 filings indicates a deliberate and stable approach to managing its long-term debt obligations. Despite the maturity of these notes in 2019, Apple continued to disclose them in its filings through 2024, suggesting that these instruments may have been part of a broader, ongoing debt structure or refinancing plan. This pattern implies that Apple may have rolled over or repriced this debt into newer instruments while maintaining transparency around its historical debt instruments, reflecting a disciplined and predictable capital structure strategy.",
      "llm_answer": "Apple’s repeated listing of the floating‑rate note due 2019 in its 2022‑24 10‑Ks shows that the instrument is still on the balance sheet, likely having been rolled over or extended beyond its original maturity. This indicates a deliberate strategy of keeping a mix of floating‑rate debt to capture low rates and match cash‑flow timing, rather than aggressively paying down that tranche. In short, Apple is actively refinancing long‑term debt to preserve flexibility and manage interest‑rate exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All entities—Apple, Floating Rate Notes due 2019, and the 2022–2024 filing period—are correctly identified. There are no numerical values requiring calculation, but the dates (2019 maturity, references through 2024) are accurately used. (2) The answer correctly infers that the continued disclosure of a matured debt instrument suggests it was likely rolled over or extended, which matches the ground truth’s interpretation of refinancing and transparency in capital structure. (3) The multi-hop reasoning is sound: the model connects the post-maturity appearance of the notes in filings to a strategic refinancing behavior, implying active debt management and interest-rate exposure control. This reflects disciplined capital structure management, as stated in the original answer. (4) The only minor gap is that the LLM does not explicitly mention 'transparency around historical debt instruments' or 'predictable strategy' as emphasized in the ground truth, slightly reducing qualitative completeness. However, the core insight—refinancing for flexibility and rate management—is correct and well-reasoned. Wording differs but semantic meaning is equivalent. No factual errors; minor omission does not undermine correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 363,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did Microsoft's reference to the 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the ongoing relevance of this debt instrument in the company's capital structure?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, indicating that the Notes remained a part of its structured debt disclosures despite their maturity date having passed. This suggests that the Notes were likely still outstanding or held ongoing legal or structural relevance in the context of Microsoft's broader debt framework, such as covenants or indentures that continued to apply. The consistent inclusion of the Notes in Exhibit 4.6 across all three years shows that the company maintained a formal linkage to this instrument, even post-maturity, likely for transparency and continuity in investor understanding.",
      "llm_answer": "Microsoft’s 2022 10‑K lists the 4.000% Notes due 2021 as part of the third supplemental indenture (Exhibit 4.6) with a principal balance of $X billion【MSFT_10k_2022.pdf pages 102‑106】. The 2023 10‑K continues to disclose the same note, but the balance has been reduced to $Y billion, reflecting partial repayment【MSFT_10k_2023.pdf pages 102‑106】. The 2024 10‑K still references the 4.000% Notes due 2021 (Exhibit 4.6) with an even smaller outstanding balance of $Z billion, indicating the instrument remains part of Microsoft’s capital structure but is being paid down and is becoming less material【MSFT_10k_2024.pdf pages 102‑106】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in key aspects. The 4.000% Notes due 2021 matured in 2021 and should not have outstanding balances in 2022, 2023, or 2024. The ground truth states that Microsoft continued to reference the notes in disclosures (e.g., Exhibit 4.6) for structural or transparency reasons, not because they remained outstanding with declining balances. The LLM invents specific balances ($X, $Y, $Z billion) and claims of partial repayment, which are not supported by the ground truth and contradict the expected behavior of a matured debt instrument. (2) Quantitative accuracy is very low: there are no actual dollar amounts provided in the ground truth, and the use of placeholders like $X, $Y, $Z billion with a narrative of declining balance implies a repayment pattern that is not accurate. The maturity of the notes in 2021 means no principal should remain post-2021 unless refinanced or extended, which is not indicated. (3) Multi-hop reasoning is flawed: while the LLM correctly identifies Exhibit 4.6 as the location of the note disclosure across years, it misinterprets the continued disclosure as evidence of an ongoing financial liability rather than a structural or legal continuity. The model fails to grasp that post-maturity references can persist for transparency without implying active debt. (4) Contextual relevance is moderate because the answer addresses the evolution across filings and mentions Exhibit 4.6 correctly, but the core conclusion—that the debt is being paid down and remains part of the capital structure—is misleading. The ground truth emphasizes legal/structural relevance, not financial materiality or repayment. Thus, correctness is low due to fundamental factual and conceptual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 478,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly in terms of redemption terms, interest payment structure, and overall debt positioning?",
      "original_answer": "From 2022 to 2024, UPS consistently disclosed the $276 million 7.620% debentures maturing in 2030, with unchanged redemption terms allowing UPS to redeem them at any time at a price equal to the greater of principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2022, the debentures were highlighted in the context of interest rate history (8.375% until April 2020, then 7.620%) and semi-annual interest payments. By 2023, the debentures were presented in a broader debt table showing a book value of $280 million, consistent with the prior year. In 2024, the debentures were again described in detail, but with a sharper focus on the redemption mechanics and interest payment schedule, while being positioned within a larger context of international debt instruments such as Pound Sterling and Euro notes. This 3-year progression shows a shift from historical interest rate context to a more structural and comparative treatment of the debentures within UPS's global debt portfolio.",
      "llm_answer": "UPS continued to disclose its 7.620 % debentures as a $276 million, April 1 2030 maturity instrument with a fixed 7.620 % coupon (reduced from 8.375 % in 2020).  The redemption terms and semi‑annual interest‑payment structure remained unchanged through 2024, with the debentures redeemable at the greater of principal plus accrued interest or the present value of remaining payments discounted at a treasury yield plus 5 bps.  The debentures stayed a small, long‑term debt component—carrying $280 million in each year—within a total debt that rose modestly from $22.08 billion in 2022 to $22.47 billion in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the debentures are $276 million, mature in 2030 (specifically April 1, 2030), carry a fixed 7.620% coupon (reduced from 8.375% in April 2020), and have unchanged redemption terms allowing redemption at the greater of principal plus accrued interest or the present value of remaining payments discounted at a treasury yield plus 5 bps. The book value of $280 million is consistent across years, matching the original answer. (2) Quantitative accuracy is perfect: all dollar amounts, percentages, dates, and redemption mechanics are correctly reported. The total debt figures ($22.08B in 2022, $22.47B in 2024) are not in the ground truth but are plausible and do not contradict it; they add context without introducing error. (3) The multi-hop reasoning is sound: the LLM synthesizes consistent disclosure over three years, unchanged terms, and positioning within the broader debt portfolio. However, it omits the 2024 shift in focus toward comparative treatment with international debt instruments (e.g., Pound Sterling and Euro notes), which is a minor but notable qualitative nuance from the original answer. (4) Despite this omission, the answer captures the core evolution—stable terms, consistent disclosure, and structural continuity—within a growing total debt context. The answer is semantically equivalent in factual content and highly contextually relevant. A score of 9 is justified due to the omission of the 2024 comparative global debt framing, but quantitative and overall correctness remain excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 442,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did ABBV's development, commercialization, and financial performance related to Vraylar evolve from 2022 through 2024, and what does this trajectory indicate about its strategic importance in the neuroscience portfolio?",
      "original_answer": "In 2022, ABBV announced top-line results from two Phase 3 trials of Vraylar as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was clearly established in the market as a core neuroscience product, indicated for schizophrenia, bipolar disorder, and as an adjunct in MDD. Financially, in 2023, Vraylar generated $2,759 million in total revenue, with a 35.4% year-over-year increase, indicating strong commercial traction. This evolution shows that Vraylar transitioned from a late-stage clinical asset in 2022 to a key revenue driver and therapeutic pillar in ABBV’s neuroscience portfolio by 2024.",
      "llm_answer": "After successful Phase‑3 trials in 2021, AbbVie secured regulatory approval for Vraylar as an adjunctive therapy for major depressive disorder in 2023, enabling full commercialization. Revenue rose from $2.038 B in 2022 (2022 10‑K, pp. 58‑62) to $2.759 B in 2023 (2023 10‑K, pp. 40‑44), a 35 % YoY increase driven by market‑share uptake and the new indication. The 2024 10‑K (pp. 4‑8) reports continued growth, confirming Vraylar’s strategic importance as a core neuroscience asset that diversifies AbbVie’s portfolio beyond its core immunology and oncology businesses.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer gets key financial data correct: Vraylar revenue of $2.759 billion in 2023 and a year-over-year increase of approximately 35% are accurate and align with the ground truth. The revenue figure for 2023 matches exactly, and the 35% increase is a valid rounding of the 35.4% reported in the original answer. However, the LLM incorrectly states that revenue in 2022 was $2.038 billion. This figure is not present in the ground truth and cannot be confirmed; more importantly, the original answer does not provide 2022 revenue, so introducing this number—while enabling a plausible calculation—is unsupported and introduces a factual overreach. (2) The timeline of clinical development contains inaccuracies: the LLM claims Phase 3 trials were successful in 2021 and that regulatory approval for MDD was granted in 2023. However, the ground truth states that in 2022, ABBV announced top-line results from two Phase 3 trials—one positive, one not statistically significant—indicating that success was not definitive and likely not in 2021. The original answer does not mention approval timing, so asserting 2023 approval is an unsupported inference. (3) The qualitative reasoning partially misrepresents the multi-hop trajectory: while the LLM correctly infers growing strategic importance from revenue growth and expanded indication, it fabricates a more definitive clinical and regulatory path than the evidence supports. The ground truth emphasizes uncertainty in 2022 (mixed trial results), whereas the LLM portrays a smoother, more successful development path. (4) Despite these issues, the answer correctly identifies Vraylar as a core neuroscience asset by 2024 and accurately reflects its role in portfolio diversification, which is contextually relevant and well-supported in the 2024 10-K reference. The synthesis of financial and strategic significance is sound, even if some foundational facts are misstated. Thus, the answer is mostly correct but contains significant factual overreach in the clinical/regulatory timeline and introduces an unsupported 2022 revenue figure, warranting a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 575,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "What does the consistent inclusion of the 0.45% Notes due 2016 in Apple's filings across fiscal years 2022, 2023, and 2024 suggest about the company's long-term debt structure and disclosure strategy for legacy instruments?",
      "original_answer": "Apple's 10-K filings for 2022, 2023, and 2024 all include Exhibit 4.3, which contains the Officer's Certificate dated May 3, 2013, detailing the 0.45% Notes due 2016 among other instruments. Despite the maturity of these notes in 2016, Apple continued to disclose this historical debt instrument across three consecutive annual reports. This pattern suggests that Apple maintains transparency around legacy debt structures, possibly to preserve a complete record of past financing activities for investor reference. The persistence of this disclosure, even after the notes' maturity, indicates a consistent approach to documenting capital structure history, rather than focusing solely on active obligations.",
      "llm_answer": "Apple’s repeated disclosure of the 0.45% Notes due 2016 in the 2022, 2023 and 2024 10‑Ks (see the “Description of Securities” on each filing’s notes section) shows that the company treats all issued debt—including those that have matured—as part of its long‑term debt narrative.  This conservative, transparent reporting approach preserves a complete historical record of Apple’s debt portfolio, indicating a diversified long‑term debt structure and a consistent strategy to disclose legacy instruments for investors and regulators.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All entities are correct: Apple, 0.45% Notes due 2016, and fiscal years 2022–2024 are accurately referenced. The maturity date (2016) and interest rate (0.45%) match the original. (2) Quantitative accuracy is perfect: no calculations required, but dates and percentages are correct. (3) Reasoning is sound: the LLM correctly infers that Apple maintains transparency by disclosing matured debt instruments, indicating a consistent disclosure strategy for legacy instruments. It accurately captures the intent behind preserving historical records for investors and regulators. (4) The only minor shortcoming is that the LLM refers generally to the 'Description of Securities' in the notes section, whereas the ground truth specifies Exhibit 4.3 and the Officer's Certificate dated May 3, 2013. This detail is not critical to the overall meaning but adds precision. Despite this, the core message about transparency and historical disclosure is preserved. Semantic equivalence is strong, and the answer fully addresses both parts of the question: implications for long-term debt structure and disclosure strategy. Contextual relevance is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 342,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the role and operational structure of UPS SurePost evolve from 2022 through 2024, particularly in terms of delivery methodology and strategic positioning within UPS's U.S. Domestic Package business?",
      "original_answer": "In 2022, UPS SurePost was positioned as a residential ground service for non-urgent, lightweight shipments, leveraging the consistency of the UPS ground network with final delivery often handled by the U.S. Postal Service. By 2023, UPS SurePost retained the same description, indicating continuity in its delivery methodology and strategic positioning. In 2024, UPS announced that beginning January 1, 2025, it would insource the final delivery component of UPS SurePost, shifting from reliance on USPS to internal control to enhance service quality. This marks a strategic transformation in the delivery methodology of SurePost, signaling UPS’s intent to improve reliability and service differentiation in the residential delivery segment.",
      "llm_answer": "In 2022 and 2023 UPS SurePost was a residential‑ground service that used UPS’s ground network for pickup and sorting and relied on the U.S. Postal Service for final delivery, positioning it as a low‑cost, non‑urgent option within the U.S. Domestic Package segment. By the 2024 filing UPS announced that, while SurePost would still serve the same customer base, it would insource the final delivery beginning January 1 , 2025—shifting the operational structure from a USPS partnership to an in‑house last‑mile operation and thereby strengthening UPS’s control and positioning SurePost as a fully integrated, higher‑quality component of its domestic package offering.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: UPS SurePost in 2022 and 2023 used the UPS ground network with final delivery by USPS for non-urgent, lightweight residential shipments. In 2024, UPS announced the insourcing of final delivery effective January 1, 2025. (2) Quantitative accuracy is perfect: the date 'January 1, 2025' is correctly cited, and no numerical errors are present. Format variations (e.g., spacing in 'January 1 , 2025') do not affect factual correctness. (3) Multi-hop reasoning is sound—information is synthesized across 2022, 2023, and 2024 timeframes, correctly identifying continuity and then a strategic shift. The answer captures the evolution in operational structure (from USPS partnership to in-house last-mile) and strategic repositioning (from low-cost to higher-quality, integrated service). (4) Entity accuracy is strong: 'UPS SurePost', 'U.S. Postal Service (USPS)', 'U.S. Domestic Package segment', and correct years are all properly identified. The answer fully addresses the question’s focus on delivery methodology and strategic positioning across the three-year period. Minor wording differences (e.g., 'low-cost' vs 'non-urgent') add clarity without distorting meaning. All scoring categories warrant top marks.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 368,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern indicate about Apple's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating a sustained reliance on long-term debt instruments as part of its capital structure. The repeated inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years shows that Apple maintained this long-term liability on its books without early redemption or restructuring during the observed period. This consistent presence suggests a strategic decision to retain long-duration debt, possibly to manage interest rate risk and maintain financial flexibility over time.",
      "llm_answer": "Apple’s 4.45 % Notes due 2044 were issued in 2014 for $5.5 billion and have remained a core part of the company’s long‑term debt portfolio.  The 2022, 2023 and 2024 10‑Ks all list the same instrument, but the outstanding balance has been steadily reduced each year – from $5.5 billion at the end of 2022 to $4.5 billion at the end of 2023 and $3.5 billion at the end of 2024.  This gradual draw‑down shows Apple’s disciplined capital strategy: it relies on low‑cost, long‑maturity debt to fund operations and capital allocation while steadily paying down leverage to preserve liquidity and maintain a stable balance‑sheet profile.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details. While it correctly identifies the 4.45% Notes due 2044 and their origin from the 2014 Officer's Certificate, it falsely claims the outstanding balance decreased from $5.5B in 2022 to $4.5B in 2023 to $3.5B in 2024. The ground truth does not support any reduction in principal over this period; instead, the consistent reference across filings indicates the debt remained outstanding without repayment or restructuring. There is no evidence in the original answer of amortization or balance reduction. This introduces major quantitative errors that undermine the conclusion about a 'gradual draw-down' and 'disciplined capital strategy' involving repayment. The reasoning is therefore flawed—while the idea of using long-term debt for financial flexibility aligns with the original interpretation, the LLM fabricates a repayment pattern unsupported by data. Entity accuracy (Apple, 4.45% Notes due 2044, years 2022–2024) and contextual relevance are acceptable, as the response addresses the right instrument and timeframe and attempts multi-hop synthesis. However, the invented numerical trend results in a low correctness score. Semantic equivalence fails on the key point of balance changes, which contradicts the ground truth assertion that the note was maintained without alteration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 381,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Oracle's treatment of the 2.875% Notes due 2031 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent positioning as Exhibit 4.14 reveal about the company's capital structure management and debt strategy over time?",
      "original_answer": "The 2.875% Notes due 2031 were consistently positioned as Exhibit 4.14 in Oracle's 10-K filings for 2022, 2023, and 2024, with no modifications to the terms of the Notes indicated in any of the filings. This consistent treatment across all three years reveals a stable approach to capital structure management, with Oracle maintaining the same debt instrument positioning without alteration. The Notes were originally established under an Officers' Certificate issued on March 24, 2021, and this structure remained unchanged through subsequent filings. The lack of modifications to the Notes' terms or exhibit positioning suggests Oracle maintained a consistent long-term debt strategy during this period, prioritizing stability in its capital structure despite potential market fluctuations.",
      "llm_answer": "Oracle continued to list the 2.875% Notes due 2031 in Exhibit 4.14 in its 2022, 2023, and 2024 10‑K filings, with no change to the terms or maturity dates. The notes remain part of the same 2021 issuance of a series of long‑term, fixed‑rate notes (1.650% due 2026, 2.300% due 2028, 3.650% due 2041, etc.). This consistent placement underscores Oracle’s disciplined capital‑structure policy—maintaining a diversified, long‑term debt program with stable coupon rates and maturities rather than restructuring or retiring the notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2.875% Notes due 2031 were consistently listed as Exhibit 4.14 in Oracle's 2022, 2023, and 2024 10-K filings, with no changes to terms or maturity. The original issuance date (March 24, 2021) is not explicitly mentioned but is not contradicted. (2) Quantitative accuracy is perfect: percentages (2.875%, 1.650%, 2.300%, 3.650%), maturity years (2026, 2028, 2031, 2041), and exhibit number (4.14) are all correct. No calculations were required. (3) The multi-hop reasoning is sound—LLM correctly synthesized information across three years of filings and inferred Oracle’s stable debt strategy. It adds contextual value by referencing the broader debt program, which is consistent with the ground truth’s emphasis on stability. (4) The only minor omission is the lack of explicit mention of the Officers' Certificate from March 24, 2021, which slightly reduces completeness but does not affect the core conclusion. The LLM emphasizes disciplined capital structure management, which is semantically equivalent to the ground truth’s 'stable approach.' Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 345,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did the 2023 Teamsters collective bargaining agreement impact pension benefit accruals under the UPS/IBT Full-Time Employee Pension Plan, and what does this reveal about UPS's long-term pension obligations as reflected in the 2024 disclosures?",
      "original_answer": "In 2022, the UPS/IBT Full-Time Employee Pension Plan was described as a noncontributory plan covering employees previously in the Central States Pension Fund and others under collective bargaining agreements. In 2023, the Teamsters employees ratified a new five-year agreement that included wage and benefit rate increases for participants in this plan, which directly impacted pension benefit accruals and were factored into the year-end plan measurement. By 2024, the disclosures showed no structural changes to the plan, indicating that the 2023 agreement represented the most recent material update to benefit accruals. The 2023 changes suggest a continuation of defined benefit commitments under collective bargaining, with implications for UPS's long-term pension liabilities as they relate to funded status and future obligations.",
      "llm_answer": "The 2023 Teamsters national master agreement increased wage and benefit rates for Teamsters employees in the UPS/IBT Full‑Time Employee Pension Plan, and the plan’s year‑end measurement reflected those increases as a higher service‑cost component of pension benefit accruals (2023 10‑K, pp. 80‑84).  In the 2024 10‑K, the projected benefit obligation for U.S. pension benefits (including the UPS/IBT plan) is $29.3 billion and the net periodic benefit cost is $1.212 billion (pp. 84‑88), showing that UPS’s long‑term pension liabilities remain substantial and are directly influenced by collective‑bargaining adjustments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the 2024 projected benefit obligation of $29.3 billion and net periodic benefit cost of $1.212 billion match the disclosed figures in the 2024 10-K (pp. 84–88), and the reference to the 2023 10-K (pp. 80–84) for service cost impacts is consistent with source disclosures. (2) The LLM correctly identifies that the 2023 Teamsters agreement increased wage and benefit rates, which directly increased pension accruals via higher service costs—a key multi-hop link between collective bargaining and pension accounting. (3) Qualitatively, the answer captures the core implication: UPS maintains substantial long-term pension liabilities influenced by collective bargaining, with no structural plan changes noted in 2024. The only minor omission is that the original answer notes the plan covers former Central States Pension Fund participants and that the 2023 agreement was the most recent material update—context that adds background but does not alter the core conclusion. (4) The reasoning is sound, synthesizing information across 2023 and 2024 filings to connect labor agreements to pension obligations. Wording differs but meaning is semantically equivalent. All entities (UPS/IBT Full-Time Employee Pension Plan, Teamsters, 2023 agreement, 2024 disclosures) are correctly identified. Thus, the answer is factually complete, numerically precise, and contextually appropriate, warranting a high score with only slight room for added context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 426,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Apple's disclosure regarding its 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this continuity reveal about its approach to managing short-term debt instruments issued under its 2014 Officer's Certificate?",
      "original_answer": "Apple's disclosure regarding the 1.05% Notes due 2017 remained unchanged across all three years — it was consistently described in the 10-K filings for 2022, 2023, and 2024 as part of the Officer's Certificate dated May 6, 2014. This static disclosure indicates that Apple did not modify or refinance this particular debt instrument during this period, suggesting a passive management approach toward this specific short-term debt obligation. The consistency in reporting implies that Apple prioritized stability in its capital structure for this instrument, choosing not to adjust its terms or maturity despite evolving market conditions.",
      "llm_answer": "Apple’s 2022, 2023 and 2024 Form 10‑Ks all list the 1.05% Notes due 2017 as part of the 2014 Officer’s Certificate, with identical terms (interest rate, maturity and outstanding balance).  The 2024 filing (pages 54‑58) again cites the 1.05% Notes due 2017 in Exhibit 4.4, confirming that the instrument remains unchanged from the prior years.  This consistency shows Apple’s disciplined, transparent approach to short‑term debt issued under the 2014 Officer’s Certificate, maintaining stable reporting and a predictable capital‑structure profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Apple's 1.05% Notes due 2017 were consistently disclosed in the 2022, 2023, and 2024 10-K filings as part of the 2014 Officer's Certificate, with no changes in terms. This matches the ground truth. The mention of Exhibit 4.4 in the 2024 filing and page numbers (54–58) adds specificity and supports the claim of unchanged disclosure. (2) All quantitative elements are accurate: the interest rate (1.05%), maturity year (2017), and reference to the May 6, 2014 Officer’s Certificate (implied by '2014 Officer’s Certificate') are correct. No dollar amounts or calculations are missing or incorrect. (3) The multi-hop reasoning is sound—synthesizing disclosures across three years and linking them to Apple’s approach to debt management under the 2014 framework. The conclusion about 'disciplined, transparent approach' and 'predictable capital-structure profile' is semantically equivalent to the ground truth’s 'passive management approach' and 'stability in capital structure,' though slightly more positive in tone. (4) The answer is fully contextually relevant, addressing both the evolution (or lack thereof) of disclosure and what it reveals about Apple’s debt management. The only minor gap is not explicitly stating that the note was long matured (2017 maturity reported in 2022–2024), which the ground truth implies affects interpretation—however, this does not undermine the factual correctness. Thus, the answer is highly accurate with only slight nuance missing in interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 425,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "Apple first disclosed the 2.40% Notes due 2023 in its 2022 10-K filing as part of its Officer's Certificate dated May 3, 2013. The same disclosure was carried forward in both the 2023 and 2024 10-K filings, indicating no changes to the specific debt instrument's terms or status over the three-year period. This static disclosure suggests that Apple maintained a consistent approach to managing this particular debt obligation, with no early repayments, modifications, or extensions during the period. The lack of changes implies a stable long-term debt strategy for this instrument, with Apple likely planning to meet the 2023 maturity as originally structured.",
      "llm_answer": "Apple’s 10‑K filings from 2022 through 2024 consistently list the 2.40% Notes due 2023 in the description of securities (Exhibit 4.3) on pages 54 (2022), 53 (2023) and 54 (2024). The unchanged coupon and maturity across the three years indicate that Apple maintains a stable debt profile, issuing moderate‑coupon notes with predictable maturities and actively managing the portfolio to keep interest costs predictable and liquidity flexible. This pattern reflects a disciplined long‑term debt strategy that prioritizes predictable interest expense and maturity matching.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Apple's 2.40% Notes due 2023 were consistently disclosed in the 2022, 2023, and 2024 10-K filings, with accurate page numbers and exhibit references (Exhibit 4.3), which aligns with the ground truth. The coupon rate (2.40%) and maturity year (2023) are correctly stated. However, the LLM infers a broader strategic conclusion—'actively managing the portfolio to keep interest costs predictable and liquidity flexible' and 'disciplined long-term debt strategy'—that goes beyond the evidence provided in the ground truth. The original answer emphasizes the *lack of changes* to this specific instrument and interprets that as stability in handling this debt, not necessarily a broader active portfolio management strategy. (2) Quantitatively, all numbers (2.40%, 2023 maturity, page numbers) are accurate, and no calculations are required. Format is consistent and correct. (3) The multi-hop reasoning is partially sound—correctly identifying the continuity of disclosure across three years—but overreaches in drawing strategic implications not directly supported by the static disclosure pattern. The ground truth refrains from inferring proactive management and instead notes the absence of modifications, which is a more cautious and accurate interpretation. (4) Contextual relevance is high, as the answer addresses both the evolution (or lack thereof) of the disclosure and attempts to interpret the strategic implication. However, the qualitative accuracy is reduced due to the speculative extension beyond the data. A score of 7 is justified: factually solid on the disclosures, but overinterprets the strategic meaning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 457,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did the commercial trajectory of Vraylar evolve from 2022 through 2024, particularly in terms of clinical development progress, revenue growth, and therapeutic positioning within AbbVie's neuroscience portfolio?",
      "original_answer": "In 2022, Vraylar demonstrated clinical progress as an adjunctive treatment for major depressive disorder (MDD), with one successful Phase 3 trial and a numerically positive but non-significant result in another. By 2023, Vraylar had become a revenue driver in the neuroscience segment, generating $2,759 million in total sales, with U.S. sales growing from $2,037 million in 2022 to $2,755 million in 2023, representing a 35.2% increase. In 2024, Vraylar was formally positioned as a key therapeutic agent within AbbVie's neuroscience portfolio, now indicated for schizophrenia, bipolar I disorder (manic/mixed and depressive episodes), and as an adjunctive treatment in MDD, reflecting a broadening of its therapeutic applications and strategic importance.",
      "llm_answer": "Vraylar’s commercial trajectory shifted from a modest 2022 revenue of $951 million (US) after the Phase 3 trials that led to its 2021 approval as an adjunctive therapy for major depressive disorder (2022 10‑K, pp. 58‑62) to a sharp rebound to $2.76 billion in 2023 and a stable $2.76 billion in 2024 (2023 10‑K, pp. 40‑44; 2024 10‑K, pp. 4‑8).  The product’s indications—acute and maintenance treatment of schizophrenia, bipolar disorder, and adjunctive major depressive disorder—have kept it positioned as a core small‑molecule antipsychotic within AbbVie’s neuroscience portfolio, complementing migraine (Qulipta, Ubrelvy) and movement‑disorder (Duodopa) assets.  While no new clinical data were reported after the 2021 top‑line results, the sustained revenue growth reflects successful market uptake of the approved indications.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in revenue figures for 2022. The ground truth states U.S. sales were $2,037 million in 2022 and total sales reached $2,759 million in 2023, but the LLM claims $951 million in 2022 U.S. sales and $2.76 billion in both 2023 and 2024 without specifying U.S. vs. total. The $951 million figure does not appear in the ground truth and is likely incorrect. While the 2023 revenue of ~$2.76 billion aligns closely with the true $2,759 million, the 2022 figure is substantially underreported, leading to an inaccurate portrayal of growth. Additionally, the LLM implies no new clinical data after 2021, but the ground truth confirms Phase 3 trial results in 2022 (one successful, one numerically positive but non-significant), which is a key part of the clinical development progress. (2) Calculations: The ground truth reports a 35.2% increase from $2,037M to $2,755M (U.S. sales), but the LLM does not mention this growth rate nor accurately report the base year value, undermining quantitative accuracy. The LLM’s claim of stable revenue in 2024 is unsupported by the ground truth, which does not provide 2024 sales data. (3) Multi-hop reasoning: The LLM correctly identifies Vraylar’s indications and its role in AbbVie’s neuroscience portfolio, showing some synthesis across clinical and commercial domains. However, it fails to connect the 2022 clinical trial outcomes to the drug’s evolving therapeutic positioning, missing a key multi-hop link between clinical results and expanded use. (4) Despite these errors, the answer is contextually relevant, addressing all major dimensions of the question—clinical development, revenue, and portfolio positioning—with mostly accurate indications and recognition of Vraylar’s strategic importance. Wording and structure are clear, but core factual inaccuracies, especially in 2022 revenue and clinical progress, reduce correctness. Hence, a mid-range score of 5 is justified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 539,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the context and strategic framing evolved. In 2022, IBM highlighted trust as part of its hybrid cloud and AI platform, emphasizing its ability to integrate data, AI, and industry expertise. In 2023, the company expanded this by linking trust to its strategic partnerships, showing how it leverages alliances to deliver end-to-end solutions. By 2024, IBM reinforced trust as a foundational element in its go-to-market strategy, particularly in addressing complex business challenges through a broad ecosystem of partners. This indicates a strategic deepening of how IBM positions trust not just as a value proposition, but as an enabler of integrated, client-centric innovation.",
      "llm_answer": "IBM’s 2022 10‑K listed “client relationships and trust” as one of its core competitive methods (Competition, pages 2‑6). The 2023 10‑K reiterated that emphasis in the same section (pages 1‑5), while the 2024 10‑K not only kept the phrase but also positioned trust and security as a pillar of its hybrid‑cloud platform, explicitly tying it to AI and data (Business and Competition, pages 1‑5). This multi‑year progression shows IBM sharpening its strategic positioning by foregrounding secure, trusted client relationships as a key differentiator in the hybrid‑cloud and AI market, leveraging its incumbency and research strengths to build confidence in its solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly identifies that IBM emphasized 'client relationships and trust' as a competitive differentiator in each year from 2022 to 2024, citing the consistent presence of this language in the 10-K filings across all three years. (2) There are no numerical inaccuracies—dates and references to document sections (e.g., Competition section, pages) are consistent with expected reporting practices, and no incorrect figures are presented. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings and correctly observes the evolution—from general emphasis in 2022, to reaffirmation in 2023, to strategic deepening in 2024 by linking trust to AI, data, and hybrid cloud. While the original answer highlights strategic partnerships and ecosystem development more explicitly in 2024, the LLM captures the essence by noting trust as a 'pillar' tied to AI and hybrid cloud and mentions leveraging incumbency and research strengths, which aligns semantically. (4) The answer is highly contextually relevant, directly addressing how IBM’s emphasis evolved and what it indicates about strategic positioning. The only minor shortcoming is that it does not fully elaborate on the role of partnerships in 2023 and 2024 as emphasized in the ground truth, but the core progression and strategic implication are accurately conveyed. Hence, a high score of 9 is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 407,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has IBM's treatment of its 1.250% Notes due 2027 evolved from 2022 to 2024, particularly in terms of disclosure practices and the instrument's role within the company's debt portfolio?",
      "original_answer": "In 2022, IBM referenced the 1.250% Notes due 2027 in its exhibit list as part of a broader set of instruments, specifically noting that the rights of holders were defined in Exhibit 4.3 to Form 8-K filed January 30, 2019. By 2023, the Notes were again referenced in a list that included a growing number of debt instruments, now tied to more recent filings such as February 8, 2022, indicating a broader and more complex debt structure. In 2024, the 1.250% Notes due 2027 were explicitly listed in the company's 10-K with a distinct trading symbol (IBM27B), showing they had become a formally recognized and actively traded financial instrument. This progression reflects IBM's increasing transparency and emphasis on this particular note within its capital structure.",
      "llm_answer": "IBM first disclosed the 1.250% Notes due 2027 as a line item in its long‑term debt schedule (2022 10‑K, pp. 28‑32).  In 2023 the note remained in the debt schedule (pp. 18‑22) but the company added a brief note on its maturity and coupon, indicating a modest increase in disclosure detail.  By 2024 IBM expanded the disclosure further, listing the instrument in the Securities‑registered table (pp. 1‑5) and noting its current‑portion classification, underscoring that it remains a small, long‑term component of the overall debt portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but diverges significantly from the ground truth in key aspects. It correctly identifies the 1.250% Notes due 2027 as part of IBM's debt disclosures across 2022–2024, and the general trend of increasing disclosure is consistent with the original answer. However, it fabricates specific details not present in the ground truth, such as page numbers (e.g., 'pp. 28–32', 'pp. 18–22', 'pp. 1–5') and claims about the structure of disclosures (e.g., 'long-term debt schedule', 'Securities-registered table', 'current-portion classification'), which are not mentioned or supported in the original answer. (2) There are no explicit numerical errors (percentages and years are correct: 1.250%, 2027, 2022–2024), so quantitative accuracy is acceptable. However, the answer invents granular formatting details (page ranges, table names) that cannot be verified and are likely inaccurate. (3) The multi-hop reasoning is partially sound—there is an attempt to trace the evolution of disclosure practices over time—but it misrepresents the nature of the disclosures. The ground truth emphasizes the instrument’s growing recognition through exhibit references and the assignment of a trading symbol (IBM27B), indicating market visibility and formal trading status. The LLM instead focuses on internal reporting details (debt schedules, classification) that do not align with the actual progression described in the original answer. The critical 2024 development—the explicit listing with a trading symbol—was entirely omitted. (4) Contextual relevance is high because the answer addresses the question’s core about disclosure evolution and role in the debt portfolio, but the factual inaccuracies and omission of the trading symbol (a key indicator of the instrument’s evolving status) significantly reduce correctness. The answer captures a plausible narrative but not the actual one supported by the knowledge graph.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 530,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did IBM's disclosures around the 6.50% Debentures due 2028 evolve from 2022 to 2024, particularly in relation to the consistency of exhibit references and the broader context of IBM's debt instrument disclosures?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 as Exhibit 2 to Form 8-K, filed on January 8, 1998, across all three years (2022, 2023, and 2024), indicating no changes in the documentation defining the rights of the holders of these debentures. However, the broader context of IBM's debt disclosures evolved subtly over time. In 2022, the debentures were listed among a wider range of debt instruments, including newer notes due in 2022, 2023, 2024, and beyond, with detailed exhibit references for each. By 2023 and 2024, the disclosures focused more on integrating legacy debt (like the 6.50% Debentures due 2028) alongside newer instruments such as the 6.22% Debentures due 2027 and 5.875% Debentures due 2032, suggesting a continued emphasis on long-term debt management and investor clarity. This consistency in exhibit referencing for the 6.50% Debentures due 2028, despite the broader evolution in debt disclosures, likely supports regulatory compliance and investor understanding of IBM's long-standing obligations.",
      "llm_answer": "IBM’s 10‑K filings show no change in how the 6.50% debentures due 2028 are presented: all three years (2022, 2023, 2024) list the instrument as “Exhibit 2 to Form 8‑K, filed January 8 1998” under the “Instruments defining the rights of security holders” section.  The exhibit number and filing date remain identical, indicating a consistent disclosure approach.  In the broader debt‑instrument context, IBM continues to list the same set of debentures and notes (e.g., 7.00% 2025, 7.00% 2045, 6.22% 2027, 5.875% 2032, etc.) across all three filings, underscoring that the 6.50% debentures remain part of a stable, comprehensive debt‑instrument disclosure framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the 6.50% Debentures due 2028 are consistently referenced as 'Exhibit 2 to Form 8-K, filed January 8, 1998' across 2022–2024, and the dates, percentages, and exhibit details match exactly. No calculation errors or factual inaccuracies are present. (2) The answer correctly identifies the consistency in exhibit referencing, which is the core of the question. (3) Qualitatively, the LLM captures the multi-hop aspect by noting both the stable exhibit reference and the broader context of IBM’s debt disclosures. However, it slightly underrepresents the evolution in disclosure focus described in the ground truth—specifically, the shift from listing a wider range of newer notes in 2022 to integrating legacy and newer debt more cohesively in 2023 and 2024. While the LLM mentions the continued listing of various debentures, it frames this as static ('same set... across all three filings'), missing the nuanced evolution in presentation emphasis. (4) Despite this minor omission, the answer remains factually sound, contextually relevant, and semantically aligned with the core message of consistency in exhibit references and stable disclosure framework. The slight lack of nuance in describing the broader contextual evolution prevents a perfect 10 on qualitative accuracy, but quantitative and contextual accuracy are flawless.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 400,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, this had expanded to nearly 60 origin countries and over 190 destination countries, indicating significant growth in the service's global footprint. In 2024, the service maintained its reach at nearly 60 origin countries and over 190 destination countries, suggesting that FedEx had completed a major phase of international deployment for this e-commerce-focused offering. This trajectory indicates a deliberate and aggressive expansion into new markets, particularly in support of global e-commerce growth, followed by stabilization as the service reached a mature coverage level.",
      "llm_answer": "FedEx International Connect Plus grew from coverage of **nearly 50 origin countries to over 130 destination countries in 2022** to **nearly 60 origin countries and over 190 destination countries in 2024** (2022: “nearly 50 origin countries…over 130 destination countries”; 2024: “nearly 60 origin countries…over 190 destination countries”). This widening of both origin and destination footprints signals FedEx’s deliberate push to scale its e‑commerce logistics network, positioning the company to capture a larger share of global cross‑border e‑commerce traffic as part of its broader strategy to deepen its e‑commerce service offering.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the geographic reach in 2022 (nearly 50 origin and over 130 destination countries) and the expanded reach in 2024 (nearly 60 origin and over 190 destination countries), which aligns with the ground truth. However, it skips the explicit mention of 2023 data, which is a key intermediate step in the evolution and part of the multi-hop reasoning required. While the 2024 data is accurate, the answer incorrectly implies that the expansion occurred directly from 2022 to 2024, omitting the 2023 milestone where the expansion was already achieved. (2) All numeric values are factually correct and match the ground truth, with appropriate format consistency. The citation of the 2022 and 2024 figures is accurate, but the absence of 2023 data reduces completeness. (3) The reasoning correctly infers that the expansion reflects a strategic focus on e-commerce logistics and cross-border traffic, which is consistent with the original answer’s interpretation. However, the failure to note that the expansion was completed by 2023 and maintained in 2024 means the model misses the nuance of stabilization after aggressive growth, weakening the strategic analysis slightly. (4) The answer is highly relevant and addresses the core of the question regarding expansion and strategic focus, but the omission of the 2023 data point—critical for showing the trajectory—prevents a top score. Overall, the answer is factually sound and well-reasoned but lacks full completeness in the temporal evolution, impacting the multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 432,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Qualcomm's human capital advancement goals and their linkage to executive compensation evolve from fiscal 2022 through 2024, particularly in terms of diversity targets and bonus adjustment mechanisms?",
      "original_answer": "From fiscal 2022 to 2024, Qualcomm maintained consistent executive compensation linkage to human capital advancements, with a non-financial performance modifier adjusting executive bonuses by a factor of 0.9 to 1.1 based on progress. However, the company's diversity goals saw quantitative evolution: in 2022, specific 2025 goals were set to increase women in leadership by 15%, underrepresented minorities (URM) in leadership by 15%, and overall URM representation by 20%. These goals were reaffirmed in 2023 and 2024, with no changes to the targets, but with increased emphasis on initiatives like the Reboot Representation Tech Coalition aiming to double degrees for underrepresented groups by 2025. This shows a stable strategic framework with sustained incentive alignment and expanding external partnerships to achieve long-term diversity outcomes.",
      "llm_answer": "Qualcomm’s 2025 human‑capital goals stayed the same through fiscal 2022‑24: a 15 % increase in women in leadership, a 15 % increase in under‑represented‑minority (URM) leadership and a 20 % increase in overall URM representation.  In each of those years the company linked progress on those goals to executive bonus payout, applying a non‑financial modifier that can adjust the bonus by a multiplier of 0.9 to 1.1.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in all quantitative aspects: the 15% increase for women in leadership, 15% for URM in leadership, and 20% for overall URM representation are correctly stated, as is the non-financial performance modifier (0.9 to 1.1) applied to executive bonuses. These numbers match the ground truth exactly. The time frame (fiscal 2022–2024) is correctly interpreted, and the consistent linkage of diversity goals to executive compensation is accurately conveyed. The answer, however, omits a minor but relevant detail mentioned in the original answer: the increased emphasis on external initiatives like the Reboot Representation Tech Coalition aiming to double degrees for underrepresented groups by 2025. While this does not affect the core factual correctness, it represents a slight incompleteness in fully capturing the evolution of Qualcomm’s approach, particularly the expansion of partnerships to support long-term goals. The reasoning is sound, entities (Qualcomm, URM, leadership roles, fiscal years) are correct, and the synthesis across years is logically consistent. The answer is semantically equivalent to the ground truth in terms of strategic framework and incentive alignment, with only a minor gap in contextual depth. Hence, the correctness score is 9 rather than 10 due to this omission, but quantitative accuracy remains perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 380,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Apple's continued inclusion of Floating Rate Notes due 2019 in its debt disclosures from 2022 through 2024 reflect its approach to short-term interest rate risk management and liquidity planning?",
      "original_answer": "Apple consistently included Floating Rate Notes due 2019 in its debt disclosures across all three years (2022, 2023, and 2024), indicating a deliberate and stable approach to managing short-term interest rate risk. The recurring appearance of these notes in the 10-K filings suggests that Apple maintained exposure to variable interest rates through these instruments, likely to align borrowing costs with current market conditions. This consistency implies that Apple's liquidity planning strategy relied on flexible debt instruments that could adapt to changing interest rate environments, without needing to issue new short-term floating rate instruments during this period. The company's approach reflects a cautious yet adaptive stance toward financing operations and capital returns while managing exposure to interest rate volatility.",
      "llm_answer": "Apple’s debt schedule in the 2022, 2023, and 2024 10‑Ks continues to list its 2019 floating‑rate notes, as shown in the Notes to Consolidated Financial Statements (page 34) and the Exhibits (exhibit 4.4) that detail the 2019 FRNs. By keeping these short‑term floating‑rate instruments on its books, Apple signals that it actively uses floating‑rate debt to hedge against short‑term interest‑rate fluctuations and to preserve a flexible, low‑cost borrowing base that supports its liquidity planning. This approach reflects Apple’s proactive strategy of managing short‑term interest‑rate risk while maintaining ample liquidity for operational and strategic needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Apple included the 2019 Floating Rate Notes (FRNs) in its 10-K filings for 2022, 2023, and 2024, which is accurately reflected. The mention of specific disclosure locations (page 34, exhibit 4.4) adds precision and supports the claim, though these details were not in the original answer, they do not contradict it and enhance credibility. (2) Quantitative accuracy is perfect: the years (2019 maturity, disclosures through 2022–2024) are correct, and no numerical calculations are required. (3) Reasoning is sound: the LLM correctly infers that retaining these notes in disclosures indicates an ongoing strategy to use floating-rate debt for managing short-term interest rate risk and supporting liquidity planning. It captures the multi-hop logic—linking persistent disclosure with strategic risk management—though it slightly underemphasizes the implication that Apple did not need to issue new short-term FRNs, a nuance present in the original. (4) The answer is contextually relevant, directly addressing how the continued inclusion reflects Apple’s approach to interest rate risk and liquidity. The only minor gap is the lack of explicit mention that this consistency suggests a stable, long-term reliance on existing instruments rather than new issuances, but the core reasoning and factual content are substantively equivalent. Thus, the answer earns a 9/10 for correctness, with full marks for quantitative accuracy and contextual relevance, and a 9 for qualitative accuracy due to the slight omission of strategic continuity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 448,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Qualcomm's strategic positioning and revenue focus on Digital Cockpit technology evolve from 2022 to 2024, particularly in terms of its automotive business segmentation and projected market demand?",
      "original_answer": "In 2022, Qualcomm highlighted the digital cockpit as a key transformational force in the automotive industry, projecting that over 60% of new vehicles would feature 5G connectivity by 2028 and emphasizing the role of mobile-derived computing technologies in enabling digitalization of the cockpit. By 2023, the company reported concrete revenues from digital cockpit products within its QCT semiconductor business, indicating that these technologies had moved beyond conceptual development into commercial sales. In 2024, Qualcomm formally integrated digital cockpit solutions into its QCT segment structure, reflecting a strategic consolidation of automotive offerings, including digital cockpit and ADAS/AD, as a core part of its semiconductor business. This evolution shows a clear trajectory from market positioning and R&D emphasis in 2022 to revenue generation in 2023 and full strategic integration by 2024.",
      "llm_answer": "Qualcomm’s automotive strategy shifted decisively toward digital‑cockpit and ADAS/AD solutions, with automotive revenue rising from $1.5 B in FY 2022 to $2.9 B in FY 2024—doubling and growing from 4 % to 8.8 % of QCT revenue (QCOM_10k_2022 p. 6‑10; QCOM_10k_2024 p. 71‑75). The 2024 10‑K projects that by 2028 more than 70 % of new vehicles will embed cellular connectivity, 60 % of those with 5G, driving strong demand for in‑vehicle digital‑cockpit experiences (QCOM_10k_2024 p. 80‑84). This repositioning was underpinned by the 2022 acquisition of Veoneer’s Arriver business, expanding Qualcomm’s automotive portfolio (QCOM_10k_2022 p. 6‑10).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several correct elements but contains significant factual inaccuracies, particularly in quantitative details not present in the ground truth. The ground truth does not mention specific automotive revenue figures ($1.5B in 2022, $2.9B in 2024), the percentage of QCT revenue (4% to 8.8%), or the 2022 acquisition of Veoneer’s Arriver business—none of which are supported by the original answer. These numbers, while plausible, are fabricated or hallucinated and not part of the verified knowledge graph. The 2024 10-K projection cited (more than 70% of new vehicles with cellular connectivity, 60% with 5G) slightly misrepresents the original answer, which states 'over 60% of new vehicles would feature 5G connectivity by 2028'—not 60% of 70%, which implies a different calculation. (2) The original answer emphasizes a three-year evolution: 2022 (market positioning and R&D), 2023 (revenue generation), and 2024 (strategic integration into QCT). The LLM answer skips 2023 entirely and jumps from 2022 to 2024, missing the critical intermediate step of commercial revenue emergence. This breaks the multi-hop reasoning required to show progression. (3) While the LLM correctly identifies digital cockpit and ADAS/AD as key areas and notes strategic repositioning, it introduces unsupported M&A activity and financial metrics, undermining factual reliability. The core idea of increasing strategic focus and market demand is contextually relevant and aligns with the original, but the reasoning is based on incorrect data points. (4) Correctness is scored 6 due to partial factual alignment but major quantitative errors; Quantitative Accuracy is 5 because key numbers are incorrect or unverified; Qualitative Accuracy is 7 as the overall narrative direction is reasonable but misses key steps; Contextual Relevance is 9 because the answer addresses the right themes and evolution, despite factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 524,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Abbott's unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott's unfunded commitments to private real estate funds decreased from $569 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million per year over the three-year period. The gradual reduction in unfunded commitments suggests a strategic de-risking or rebalancing away from illiquid alternative assets, even as Abbott continues to maintain exposure to private real estate through existing investments. The liquidation periods for these funds remained long-term (2025–2034 by 2024), indicating that Abbott is not exiting the space entirely but is managing its exposure more cautiously.",
      "llm_answer": "Abbott’s unfunded commitments to private‑real‑estate funds fell from **$569 million at year‑end 2022** to **$555 million in 2023** and further to **$540 million in 2024** (Note 14, Other (i) in the 2023 and 2024 10‑Ks). The modest, steady contraction indicates the company is trimming its illiquid‑asset exposure while still maintaining a sizable long‑term allocation, underscoring a disciplined, long‑term alternative‑investment strategy that balances liquidity needs with pursuit of higher returns.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical values: $569 million in 2022, $555 million in 2023, and $540 million in 2024, matching the ground truth exactly. The year-over-year decreases of $14 million (569 to 555) and $15 million (555 to 540) are approximately consistent with the ground truth's characterization of a $15 million annual decline, with only a minor deviation in the first year that does not undermine overall accuracy. (2) All financial figures are accurate and properly attributed to Note 14 in the respective 10-K filings, confirming source fidelity. Calculations of trend direction (downward) and magnitude (steady reduction) are correct. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers a strategic trend—reduced but sustained exposure to illiquid assets. It accurately captures the nuance that Abbott is not exiting private real estate but managing exposure cautiously. (4) While the original answer mentions the 2025–2034 liquidation periods as evidence of continued long-term commitment, this detail is omitted in the LLM response, slightly weakening the qualitative depth. However, the core conclusion about disciplined, long-term strategy balancing liquidity and returns is semantically equivalent and well-reasoned. Thus, the LLM answer is factually complete and contextually appropriate, meriting a high score with only minor room for added detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 401,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern reveal about the company's long-term debt structuring strategy?",
      "original_answer": "Apple first disclosed the 0.45% Notes due 2016 in its 2022 10-K filing as part of a broader set of global notes issued under an Officer's Certificate dated May 3, 2013. The same disclosure was repeated in both the 2023 and 2024 10-K filings, indicating that the company maintained this debt instrument as part of its capital structure across all three years. The consistent inclusion of the 0.45% Notes due 2016 in each annual report suggests a stable long-term debt strategy, with Apple preserving a mix of older, lower-yield debt instruments alongside newer issuances.",
      "llm_answer": "Apple issued the 0.45 % Notes due 2016 in 2013 (as part of the 2013 officer’s certificate) and those notes were due to mature in 2016, so by fiscal years 2022, 2023 and 2024 the company had no outstanding 0.45 % Notes and had not issued any new ones 【AAPL_10k_2023.pdf pages 53‑57】. This pattern shows that Apple’s long‑term debt strategy is to issue debt with favorable terms and then refinance or retire older debt, thereby maintaining a diversified maturity profile and optimizing its cost of capital 【AAPL_10k_2024.pdf pages 54‑58】【AAPL_10k_2022.pdf pages 54‑58】.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in asserting that the 0.45% Notes due 2016 were no longer outstanding in fiscal years 2022, 2023, and 2024. The ground truth states that Apple continued to disclose these notes in its 10-K filings for all three years, indicating they were still part of the company's capital structure. The LLM incorrectly assumes that because the notes were due in 2016, they were no longer relevant by 2022, failing to recognize that companies may carry disclosures of past debt instruments for transparency or comparative purposes, or that the notes might have been refinanced or extended. (2) Quantitatively, the LLM gets the issuance year (2013) and interest rate (0.45%) correct, but misrepresents the timeline by implying the debt was retired by 2016 and had no presence in later years. There are no calculations in this question, but the temporal logic is flawed. (3) The multi-hop reasoning is unsound: the model fails to synthesize the fact that consistent disclosure across multiple 10-Ks indicates ongoing relevance or structural continuity in debt reporting, which contradicts its claim of retirement. Instead, it draws an unsupported conclusion about refinancing without evidence from the provided context. (4) While the LLM attempts to address Apple's long-term debt strategy, its conclusion about refinancing and diversification is speculative and contradicts the ground truth, which emphasizes stability and retention of older, low-yield debt. The citations to specific pages do not override the factual inaccuracy of the interpretation. Thus, the answer is mostly incorrect despite some accurate inputs.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 453,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has IBM's emphasis on client relationships and trust evolved from 2022 to 2024 as a competitive differentiator, and what does this multi-year progression reveal about its strategic positioning in hybrid cloud and AI?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted 'client relationships and trust' as a core competitive differentiator, but the framing evolved alongside its hybrid cloud and AI strategy. In 2022, IBM emphasized trust as part of a broader innovation and service portfolio, including AI, hybrid cloud, and research. By 2023, the company maintained this positioning but began to more explicitly link trust with its consulting services and mission-critical infrastructure. In 2024, trust remained central, but IBM began to highlight its strategic partnerships more prominently as enablers of trust and value delivery. This shows a maturing strategy where trust is not only a standalone differentiator but also increasingly integrated with ecosystem collaboration and innovation leadership.",
      "llm_answer": "In 2022, IBM’s 10‑K listed client relationships and trust as a key competitive differentiator alongside technology, price, and brand, while hybrid‑cloud and AI were emerging strategic focus areas (2022 p. 2‑6). By 2023, the company positioned itself explicitly as a hybrid‑cloud and AI leader, framing client relationships and trust as a core pillar for delivering business value and securing adoption (2023 p. 1‑5). In 2024, IBM further integrates trust into its hybrid‑cloud platform, emphasizing security and ecosystem partnerships to build client confidence and differentiate from hyperscalers, underscoring its strategy to be the trusted partner for AI‑enabled digital transformation (2024 p. 1‑5).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: IBM consistently emphasized client relationships and trust as a competitive differentiator from 2022 to 2024, with evolving framing tied to hybrid cloud and AI. The progression—from trust as part of a broader portfolio in 2022, to linking with consulting and infrastructure in 2023, and to ecosystem partnerships in 2024—is accurately reflected, though the LLM uses slightly different phrasing (e.g., 'ecosystem partnerships' and 'trusted partner for AI-enabled digital transformation' captures the essence of the 2024 shift). (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable in a traditional sense, but all references to years (2022–2024) and document locations (e.g., 2022 p. 2-6) are correctly cited and consistent with the expected sourcing, earning full marks. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying the strategic evolution and linking trust to hybrid cloud and AI adoption. It accurately infers that trust is increasingly integrated with ecosystem collaboration, which matches the ground truth’s emphasis on strategic partnerships. (4) The answer is contextually excellent—directly addressing both parts of the question: the evolution of trust as a differentiator and what it reveals about IBM’s strategic positioning. The only minor shortcoming is that the LLM does not explicitly mention 'mission-critical infrastructure' in the 2023 context, which was in the original answer, but this detail is implicitly covered under 'delivering business value' and 'securing adoption.' Overall, the answer is semantically equivalent and factually precise, warranting a 9/10 due to near-perfect alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 504,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What does the evolution of FedEx's liquidity arrangements for the 4.250% Note due 2030 from 2022 to 2024 indicate about the company's approach to managing credit support for this obligation?",
      "original_answer": "The liquidity arrangements for the 4.250% Note due 2030 remained centered around the Revolving Credit Agreement (2020-1AA) with Wilmington Trust Company and BNP Paribas across all three years. In 2022, the foundational agreements were established, including the Intercreditor Agreement and Revolving Credit Agreement dated August 13, 2020. In 2023, FedEx filed Amendment No. 1 to the Liquidity Provider Revolving Credit Agreement on May 22, 2023, indicating a proactive adjustment to the liquidity support structure. By 2024, the arrangement remained in place with no further amendments noted, suggesting that FedEx maintained a consistent credit support framework for the Note, with a single modification in 2023 to adapt to potential liquidity needs.",
      "llm_answer": "From 2022 to 2024 FedEx kept a structured liquidity‑support framework for its 4.250% Note due 2030 that includes a Pass‑Through Trust Agreement, an Intercreditor Agreement and a Revolving Credit Agreement with BNP Paribas as liquidity provider (2022 10‑K, pp. 117‑121).  The 2023 and 2024 10‑Ks (pp. 121‑125) report an amendment to the Liquidity Provider Revolving Credit Agreement (Amendment No. 1, dated May 22 2023) that extends or adjusts the credit line, indicating FedEx’s proactive approach to revising credit support to match market conditions and maintain liquidity for the obligation.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all key facts are accurate: the 4.250% Note due 2030, the May 22, 2023 amendment date, and the involvement of BNP Paribas and the Revolving Credit Agreement are correctly stated. The references to the 10-K pages and years (2022, 2023, 2024) are consistent with the source structure. (2) The answer correctly identifies the core liquidity arrangements—Pass-Through Trust Agreement, Intercreditor Agreement, and Revolving Credit Agreement—and notes the 2023 amendment, matching the ground truth. (3) However, the LLM incorrectly implies that the amendment was reported in both the 2023 and 2024 10-Ks, while the ground truth only confirms the filing of Amendment No. 1 in 2023 with no further amendments in 2024. This overstates continuity of change. Additionally, the LLM omits mention of Wilmington Trust Company as a party to the agreement, naming only BNP Paribas, which slightly reduces entity accuracy. (4) Despite these minor omissions and a small overstatement about the 2024 reporting, the reasoning is sound: it correctly infers a proactive, consistent approach to credit support. The answer is contextually relevant and captures the essence of FedEx’s strategy. Thus, a score of 8 is warranted—core facts and logic are correct, but with minor inaccuracies in entity completeness and reporting timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 387,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did Apple's long-term debt structure evolve across 2022, 2023, and 2024 with respect to the 4.45% Notes due 2044, and what does this multi-year pattern suggest about the company's long-term financing strategy?",
      "original_answer": "Apple's long-term debt structure with respect to the 4.45% Notes due 2044 remained consistent across 2022, 2023, and 2024, as the notes were first issued in 2014 and were reported in all three annual filings. This multi-year consistency suggests that Apple maintained its long-term financing strategy, retaining the 4.45% Notes as a stable component of its capital structure without early redemption or restructuring during this period.",
      "llm_answer": "Apple’s 4.45 % Notes due 2044 have remained a steady, unchanged component of its long‑term debt—about $10.3 billion of principal in each of the 2022, 2023 and 2024 filings.  No new 4.45 % Notes were issued and none were retired during that span, underscoring Apple’s preference for locking in a low, fixed‑rate debt over a long horizon to keep financing costs predictable and its capital structure stable.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the 4.45% Notes due 2044 remained unchanged across 2022, 2023, and 2024, aligning with the ground truth's assertion of consistency in Apple's long-term debt structure. However, the ground truth does not mention the $10.3 billion principal amount, nor does it specify the exact figure in any year—this number is an addition not supported by the provided knowledge graph. While plausible, this quantitative detail is unverifiable and introduces a potential inaccuracy. (2) The dates (2044 maturity, reference to 2022–2024 filings) and interest rate (4.45%) are correct. The claim of no issuance or retirement during the period is consistent with the ground truth’s statement about no early redemption or restructuring. However, the original answer does not confirm the exact principal balance, so asserting $10.3 billion reduces quantitative accuracy. (3) The multi-hop reasoning is sound: the model synthesizes the stability of the debt instrument across three annual reports and infers a strategic preference for fixed-rate, long-term financing. This interpretation aligns with the ground truth’s conclusion about Apple maintaining a stable capital structure. (4) The contextual relevance is perfect—the answer directly addresses both parts of the question: evolution over time and strategic implication. The qualitative reasoning is strong and semantically equivalent to the original, despite the unsupported numerical precision. Thus, correctness is reduced primarily due to the unverified dollar amount, warranting a 7/10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 434,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, the service had expanded to nearly 60 origin countries and over 190 destination countries. This geographic footprint remained consistent in 2024, indicating a significant two-year expansion followed by stabilization. The trajectory suggests a strategic push by FedEx to capture global e-commerce logistics demand through enhanced international connectivity, particularly in emerging markets, followed by a phase of consolidation and optimization.",
      "llm_answer": "FedEx International Connect Plus grew from roughly **50 origin countries and 130 destination countries in 2022** to about **60 origin countries and 190 destination countries by 2024** (2022: “nearly 50…over 130”; 2024: “nearly 60…over 190”). This widening footprint shows FedEx is deliberately expanding its global e‑commerce logistics network, aiming to capture more cross‑border e‑commerce volume and reinforce its competitive position in the worldwide logistics market.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the geographic expansion of FedEx International Connect Plus from nearly 50 origin and over 130 destination countries in 2022 to nearly 60 and over 190 by 2024. However, it states the expansion occurred 'by 2024', while the ground truth specifies that the expansion was achieved by 2023 and remained stable in 2024. This misrepresents the timeline, missing the stabilization in 2024, which is a key part of the strategic trajectory. 2) Quantitatively, all numbers are accurate and reflect the 'nearly' and 'over' qualifiers appropriately. The use of 'roughly' and 'about' is acceptable as semantic equivalents. The comparison across years is numerically sound. 3) The reasoning correctly infers that the expansion reflects a strategic push in e-commerce logistics, particularly for cross-border volume. However, it omits the consolidation/optimization phase implied by the stabilization in 2024, which weakens the multi-hop synthesis of expansion followed by maturity. 4) The answer is highly relevant and addresses both parts of the question—evolution and strategic implication—but with minor incompleteness regarding the 2024 status. The strategic interpretation is reasonable, though less nuanced than the original. Overall, core facts and numbers are correct, but the timeline precision and full strategic interpretation are slightly lacking.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 382,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "What was the status of Apple's 1.05% Notes due 2017 across fiscal years 2022, 2023, and 2024, and how does the continued reference to these notes in disclosures reflect Apple's approach to managing maturing debt instruments?",
      "original_answer": "Apple's 1.05% Notes due 2017 were referenced consistently across fiscal years 2022, 2023, and 2024 in its 10-K filings, despite the notes having matured in 2017. In 2022, the notes were listed in Exhibit 4.4 as part of the Officer's Certificate dated May 6, 2014. In 2023, the same notes were again included in Exhibit 4.4 with identical language. In 2024, Apple continued to reference the 1.05% Notes due 2017 in the same exhibit, indicating no change in disclosure strategy. This pattern suggests that Apple may have retained historical references to these notes as part of a standardized disclosure framework, possibly to maintain continuity in its debt documentation or to reflect refinancing activities, though no explicit updates were provided in any of the three years.",
      "llm_answer": "Apple’s 1.05 % Notes due 2017 matured in 2017 and were fully repaid by the end of 2022, so the notes were not outstanding in the 2022, 2023, or 2024 10‑K filings.  The notes are still listed in the debt schedule and referenced in the Notes to Consolidated Financial Statements for each year, illustrating Apple’s practice of keeping a complete historical record of all debt issuances—even those that have matured—to provide transparency and to manage its debt‑maturity profile proactively.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information. (1) Quantitatively, the claim that the 1.05% Notes due 2017 matured in 2017 is correct, but the statement that they were 'fully repaid by the end of 2022' is factually wrong—the notes matured in 2017 and would have been repaid then, not in 2022. This misstatement undermines the timeline. The ground truth confirms the notes were referenced in Exhibits 4.4 in 2022, 2023, and 2024 filings despite maturity, which the LLM correctly notes in terms of continued disclosure, though for incorrect reasons. (2) The LLM correctly identifies that the notes appear in the debt schedule and footnotes across the three years, aligning with the original answer’s observation about persistent disclosure. However, it incorrectly infers repayment timing and implies the notes were not outstanding due to repayment by 2022, when in fact their presence in disclosures post-maturity is purely for historical continuity. (3) The reasoning is partially sound—Apple does maintain historical records, as the LLM suggests—but the explanation fails to reflect the multi-hop insight from the ground truth: that the *same exhibit (4.4)* with *identical language* was reused across years, indicating a standardized disclosure framework rather than active debt management. The LLM invents a rationale about 'managing its debt-maturity profile proactively' which is not supported in the ground truth. (4) Despite these flaws, the answer is contextually relevant and captures the high-level idea of maintaining historical disclosures. However, due to significant factual and logical errors in timing and reasoning, the correctness score is limited to 4 out of 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 461,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did Qualcomm's strategic focus and financial commitment to 5G technologies evolve from fiscal years 2022 through 2024, particularly in terms of licensing revenue, investment in new applications, and exposure to geopolitical risks?",
      "original_answer": "In fiscal 2022, Qualcomm highlighted 5G as a foundational enabler of immersive mobile experiences and a catalyst for growth in IoT and automotive applications, projecting over 27 billion IoT devices by 2026. By fiscal 2023, the company emphasized increased R&D investments in 5G and next-generation wireless technologies, while also noting growing geopolitical risks, including the revocation of export licenses to Huawei, which had contributed $560 million in fiscal 2024 prior to the ban. In fiscal 2024, Qualcomm underscored its leadership in 5G intellectual property and licensing, with the majority of QTL revenues derived from OFDMA-based (including 5G) devices, and expanded its strategic investments in 5G-enabled sectors like AI, automotive, and IoT through Qualcomm Ventures. This progression shows a deepening financial and strategic commitment to 5G despite rising external risks.",
      "llm_answer": "Qualcomm kept 5G at the heart of its 2022‑2024 strategy, with licensing revenue remaining a large share of total income but increasingly concentrated in per‑unit royalties; the 2024 MD&A notes a $560 M loss of Huawei revenue after a U.S. revocation, illustrating the shift (QCOM_10k_2024, pp. 11‑15).  The company ramped up R&D and strategic investments in automotive, IoT, XR and other new applications (see 2022 pages 6‑10 and 2023 pages 18‑22), while its exposure to geopolitical risk intensified—particularly U.S./China trade and national‑security tensions that threaten licensing and supply‑chain stability (see 2024 pages 11‑15 and 2023 pages 18‑22).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $560M Huawei revenue loss is correctly cited and matches the original answer's statement about Huawei contributing $560 million in fiscal 2024 prior to the export license revocation. The fiscal years (2022–2024) are accurately referenced. (2) The answer correctly identifies the strategic focus on 5G licensing revenue, R&D investments, and geopolitical risks, particularly U.S.-China tensions affecting Huawei. It accurately notes the shift in revenue due to the U.S. revocation and ties it to licensing exposure. (3) Multi-hop reasoning is sound: the LLM synthesizes information across fiscal years and domains (licensing, R&D, geopolitical risk) and correctly links the Huawei revenue loss to broader geopolitical exposure. (4) Minor omission: the original answer includes Qualcomm’s projection of over 27 billion IoT devices by 2026 in 2022 and the emphasis on OFDMA-based 5G as the core of QTL revenues in 2024—details not explicitly mentioned in the LLM response. Also, the expansion via Qualcomm Ventures into AI, automotive, and IoT is implied but not directly named. However, these are contextual enrichments rather than critical factual gaps. Wording differences (e.g., 'per-unit royalties' vs 'majority of QTL revenues from OFDMA-based devices') are semantically consistent. Overall, the LLM captures the evolution accurately with strong support from cited sections.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 405,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did the allocation of TMO's domestic pension plan assets across U.S. equity funds, international equity funds, and fixed income funds change from 2022 to 2024, and what does this reveal about the company's investment strategy evolution over the three-year period?",
      "original_answer": "In 2022, TMO's domestic pension plan allocated $125M to U.S. equity funds, $126M to international equity funds, and $1,001M to fixed income funds. By 2023, these allocations had shifted to $89M in U.S. equity funds, $91M in international equity funds, and $739M in fixed income funds, indicating a significant reduction in total domestic pension plan assets from $1,267M to $937M. In 2024, the allocations slightly increased to $93M in U.S. equity funds, $93M in international equity funds, and remained flat at $739M in fixed income funds, with total domestic pension plan assets rising slightly to $947M. This pattern reveals a strategic shift toward more stability and reduced exposure to equity markets, particularly in 2023, followed by stabilization in 2024.",
      "llm_answer": "From the 2022 10‑K, domestic pension plan assets were 89 m in U.S. equity funds (≈9.5 %), 91 m in international equity funds (≈9.7 %) and 739 m in fixed‑income funds (≈78.9 % of the 937 m total). In 2024 those figures were 91 m (≈10.2 %), 89 m (≈9.9 %) and 692 m (≈77.4 % of the 895 m total), respectively. The allocation therefore stayed near the company’s target of roughly 10 % U.S. equity, 10 % international equity and 80 % fixed income, but with a modest shift toward slightly higher equity exposure and a small reduction in fixed‑income holdings, indicating a continued liability‑hedged framework that is gradually tilting toward higher return‑seeking equity assets.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both dollar amounts and years. It incorrectly states that the 2022 allocation was $89M U.S. equity, $91M international equity, and $739M fixed income — these are actually the 2023 figures, not 2022. The correct 2022 figures are $125M, $126M, and $1,001M respectively. For 2024, the LLM reports $91M, $89M, and $692M with a total of $895M, but the ground truth is $93M, $93M, $739M, and a total of $947M. These errors affect all quantitative comparisons. (2) Calculations are incorrect: the LLM computes percentages based on wrong totals and misassigned years. For example, it claims a 2024 total of $895M, but the correct total is $947M. The fixed income allocation is reported as $692M instead of $739M, a major discrepancy. (3) Multi-hop reasoning is flawed because the model fails to correctly track changes across the three years. It incorrectly implies a gradual increase in equity exposure, while the actual data shows a sharp reduction in equity and fixed income from 2022 to 2023, followed by a slight rebound in equities in 2024 — a de-risking strategy, not a re-risking one. The LLM concludes a 'gradual tilting toward higher return-seeking equity assets,' which contradicts the ground truth showing a strategic shift toward stability and reduced equity exposure, especially in 2023. (4) Contextual relevance is moderate because the answer addresses the right topic (pension asset allocation and strategy) and attempts to interpret strategic intent, but due to incorrect data and reversed interpretation, the conclusion is fundamentally wrong. The model also mislabels 2023 data as 2022, breaking the temporal comparison. Scores reflect severe quantitative errors (2), poor reasoning due to incorrect synthesis (3), and partial relevance (6) as structure and intent are sound but facts are not.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 508,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did Qualcomm's strategic positioning in the edge networking market evolve from 2022 to 2024, based on its product development and revenue contributions across those years?",
      "original_answer": "In 2022, Qualcomm identified edge networking as a growing market driven by hybrid work environments and 5G adoption, noting increased demand for mobile broadband and wireless access points. By 2023, edge networking was explicitly listed as a key revenue contributor within Qualcomm’s broader industrial and consumer product segment. In 2024, the company continued to emphasize edge networking as a core product category, specifically calling out mobile broadband and wireless access points as part of its revenue-generating offerings. This shows a consistent and maturing strategic focus on edge networking as a key growth area over the three-year period.",
      "llm_answer": "Qualcomm’s 2022 10‑K positioned edge‑networking as a core part of its IoT portfolio, with $7.353 B in IoT revenue that included mobile‑broadband and Wi‑Fi 6/6E access‑point products (QCOM_10k_2022, pages 6‑10). By 2024, the company continued to push Wi‑Fi 6E and 5G NR‑U access‑point technology, but IoT revenue fell to $5.423 B, indicating a relative decline in edge‑networking contribution as the firm shifted focus toward automotive and handset segments (QCOM_10k_2024, pages 71‑75).",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While the original answer states that Qualcomm consistently emphasized edge networking as a growing and core strategic area from 2022 to 2024, the LLM incorrectly claims that IoT revenue declined from $7.353B in 2022 to $5.423B in 2024 and interprets this as a strategic shift away from edge networking toward automotive and handsets. However, the ground truth does not mention any such decline or strategic shift. In fact, the original answer emphasizes a maturing and consistent focus on edge networking. The specific revenue figures for IoT ($7.353B and $5.423B) are not present in the ground truth and are therefore unverified or potentially fabricated. (2) Quantitative accuracy is low because the dollar amounts and implied revenue trends are not supported by the original answer. There is no mention of IoT revenue totals or a decline in the ground truth, so these numbers cannot be confirmed as correct. Even if they were accurate in isolation, the interpretation—that declining IoT revenue indicates reduced focus on edge networking—is flawed, as edge networking is only one component of IoT and the strategic emphasis remained strong. (3) The multi-hop reasoning is unsound. The LLM fails to trace the evolution of strategic positioning as required, instead introducing unsupported financial data and drawing an incorrect conclusion about strategic repositioning. The original answer shows continuity and increasing integration of edge networking into key revenue segments, while the LLM suggests a reversal or de-emphasis, which contradicts the ground truth. (4) Contextual relevance is moderate because the answer discusses relevant technologies (Wi-Fi 6E, 5G NR-U) and product areas (mobile broadband, access points), and attempts to address the time frame and strategic focus. However, the core conclusion is factually and logically incorrect, severely undermining the answer’s validity. The inclusion of citation-like references (e.g., 'QCOM_10k_2024, pages 71-75') without verification against the ground truth further reduces reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 570,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How does Apple's consistent inclusion of the 0.45% Notes due 2016 in its 10-K filings from 2022 through 2024 reflect its approach to managing fixed-rate debt maturities and capital structure stability?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings for 2022, 2023, and 2024 indicates a consistent and transparent approach to disclosing its fixed-rate debt obligations, even for notes with earlier maturity dates. This consistent treatment suggests that Apple maintains a structured capital management strategy, prioritizing clarity in debt composition and long-term financial planning. While the 0.45% Notes due 2016 are no longer outstanding, their repeated documentation across filings reflects Apple's emphasis on comprehensive debt disclosure and historical tracking of its capital structure evolution.",
      "llm_answer": "Apple’s 10‑K filings consistently list the 0.45% Notes due 2016 in the “Description of Securities” section (2022, 2023, 2024 10‑K pages 54–58, 53–57, 54–58). By continuing to disclose this low‑coupon, fixed‑rate debt that matured in 2016, Apple signals a disciplined maturity‑management strategy that keeps a predictable debt profile and avoids volatility from refinancing or new debt issuance, thereby supporting capital‑structure stability.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual misinterpretation that undermines the reasoning. (1) Quantitatively, all numbers and dates are accurate: the 0.45% Notes due 2016 are correctly identified, and the filing years (2022–2024) are right. The mention of consistent disclosure in the 'Description of Securities' section with page ranges aligns with typical 10-K structure, though exact pages may vary slightly by year—this is acceptable for semantic equivalence. (2) However, the core reasoning is flawed: the LLM claims Apple continues to disclose the 2016 notes to signal a 'disciplined maturity-management strategy' and to 'avoid volatility from refinancing,' implying the continued disclosure reflects an active debt management policy. This contradicts the ground truth, which clarifies that the notes are no longer outstanding and their inclusion is for transparency and historical tracking, not because they are part of current debt management. (3) The multi-hop reasoning fails: while the model correctly identifies the repeated disclosure, it infers an incorrect causal relationship—linking current disclosure to ongoing maturity management, rather than recognizing it as retrospective transparency. (4) The answer is contextually relevant and addresses the question about capital structure stability, but the conclusion is based on a misinterpretation of the purpose of the disclosure. Thus, while facts like percentages and years are correct (earning high quantitative accuracy), the qualitative reasoning is weak, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 435,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did the geographic reach of Caterpillar's EMD brand distribution network change from 2022 to 2024, based on the number of countries covered by its distribution network?",
      "original_answer": "In 2022, Caterpillar's EMD brand distribution network covered 130 countries. This geographic reach remained unchanged in 2023, with the network still covering 130 countries. However, by 2024, there was a reduction in the network's international footprint, with the number of covered countries declining to 109. This represents a decrease of 21 countries (or approximately 16%) in the geographic reach of the EMD brand distribution network over the two-year period from 2022 to 2024.",
      "llm_answer": "Caterpillar’s EMD‑brand distribution network reached **193 countries in 2022** and **191 countries in 2024**, a decline of **two countries** in its geographic reach【CAT_10k_2022.pdf: 74‑78】【CAT_10k_2024.pdf: 64‑68】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is almost entirely incorrect in terms of factual content. (1) Quantitatively, it states that Caterpillar's EMD brand distribution network covered 193 countries in 2022 and 191 in 2024, which directly contradicts the ground truth of 130 countries in 2022 and 109 in 2024. The reported decline of only two countries is also wrong—the actual decrease was 21 countries (16%). These numbers are significantly off, indicating a failure in data extraction or synthesis. (2) The calculations are incorrect: even if the LLM's numbers were accurate, a drop from 193 to 191 is a decrease of 2 countries (~1%), but the ground truth shows a much steeper decline from 130 to 109. (3) The qualitative reasoning is flawed—while the model attempts multi-hop reasoning by comparing two years using cited documents, it fails to accurately extract the correct figures from the referenced filings. It omits 2023 entirely, despite the ground truth noting no change that year, which weakens the longitudinal analysis. (4) Contextually, the answer addresses the right question (geographic reach over time) and cites relevant documents, so it is not irrelevant. However, the severe factual inaccuracies in core data points—especially the invented numbers (193, 191) that are far above the true values—result in a very low correctness score. Minor credit is given for attempting temporal comparison and citing sources, but the answer misrepresents the actual scale and trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 402,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has TMO's outstanding value of the '1.750% 7-Year Senior Notes' evolved from 2022 through 2024, and what does this progression indicate about the company's medium-term debt strategy in the healthcare sector?",
      "original_answer": "In 2022, TMO reported $700 million in outstanding value for the 1.750% 7-Year Senior Notes due October 15, 2028. In 2023, this figure remained unchanged at $700 million. By 2024, the outstanding value of these notes was still $700 million, indicating a consistent level of medium-term debt tied to this instrument over the three-year period. This stable pattern suggests that TMO maintained a steady approach to this segment of its capital structure, without retiring or increasing the principal amount of these notes during the observed years.",
      "llm_answer": "At year‑end 2022 the 1.75% 7‑Year Senior Notes (euro‑denominated, due 4/15/2027) had an outstanding principal of **$642 million**; this rose to **$662 million** at year‑end 2023 and fell to **$621 million** at year‑end 2024 (see Note 10 tables in the 2023 10‑K for 2022/2023 values [TMO_10k_2023, pp. 60‑64] and in the 2024 10‑K for the 2024 value [TMO_10k_2024, pp. 45‑49]). The modest increase in 2023 followed by a reduction in 2024 indicates that Thermo Fisher is keeping its medium‑term debt level relatively stable, using the notes to fund operations or acquisitions while gradually refinancing or repaying to maintain a balanced debt profile in the healthcare sector.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that TMO's 1.750% 7-Year Senior Notes due October 15, 2028, had an outstanding value of $700 million in each year from 2022 to 2024. However, the LLM reports different amounts ($642M, $662M, $621M), incorrect maturity dates (April 15, 2027 vs. October 15, 2028), and incorrectly identifies the notes as euro-denominated—none of which align with the ground truth. These discrepancies invalidate the quantitative core of the response. (2) The numbers are entirely incorrect and inconsistent with the original data; there is no indication of a rise and fall in principal, as the actual value remained flat at $700 million. Additionally, the cited maturities and currency denomination do not match the ground truth, suggesting confusion with a different debt instrument. (3) The multi-hop reasoning fails because the model synthesizes information about a different note (possibly mixing up TMO's various debt tranches), leading to flawed conclusions about debt strategy. While the general idea of assessing medium-term debt strategy is relevant, the reasoning is based on false premises. (4) The contextual relevance is moderate because the answer attempts to interpret the debt trend in relation to corporate strategy in the healthcare sector, which addresses the second part of the question. However, due to severe quantitative and entity inaccuracies, the overall correctness score is very low. Minor credit is given for addressing the structure of the question, but the factual foundation is unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 438,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to LIBOR phase-out timelines and the adoption of SOFR as a benchmark, and what does this reveal about the company's strategic adaptation to global financial market reforms?",
      "original_answer": "In 2022, Caterpillar highlighted its exposure to LIBOR-linked financial instruments through Cat Financial, noting the uncertainty around the phase-out of LIBOR and its potential impact on derivative valuations and borrowing costs. The company acknowledged the FCA's announcement to stop LIBOR after 2021 and IBA’s plan to cease USD LIBOR on June 30, 2023 for most tenors. It also indicated it had formed a cross-functional team to assess LIBOR-related risks. By 2023, Caterpillar had transitioned its disclosures to emphasize the use of SOFR as a new benchmark in variable-rate loans and financing, and the company had expanded its cross-functional team to assess risks related to floating reference rates like SOFR. In 2024, the company no longer referenced LIBOR at all and focused entirely on SOFR, indicating a full strategic pivot away from LIBOR-based instruments. Throughout this period, Caterpillar consistently used currency hedging instruments to manage exchange rate risk, but the shift from LIBOR to SOFR demonstrates a proactive adaptation to evolving global financial standards. This evolution shows Caterpillar’s strategic alignment with regulatory changes and market benchmarks, ensuring continued financial stability and risk mitigation.",
      "llm_answer": "From 2022 through 2024 Caterpillar shifted its interest‑rate hedging exposure from LIBOR‑based derivatives to SOFR‑based instruments, creating a cross‑functional team in 2023 to assess floating‑rate risk and updating its hedging documentation to reflect the new benchmark.  While it continued to use currency‑hedging instruments to mitigate FX risk, the company noted that such hedges could forego gains from favorable currency movements.  These changes show Caterpillar’s proactive adaptation to global benchmark reforms—aligning its risk‑management framework with regulatory shifts while maintaining robust currency‑risk mitigation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Caterpillar's hedging strategy from LIBOR to SOFR between 2022 and 2024. It correctly identifies the formation of a cross-functional team (noting 2023, which aligns with the ground truth's emphasis on expansion in 2023), the shift in benchmark from LIBOR to SOFR, and the continued use of currency hedging instruments. The statement about hedges potentially forgoing gains from favorable currency movements is contextually reasonable, though not explicitly mentioned in the ground truth; this is a minor addition that does not detract from accuracy. Quantitatively, no specific numbers (e.g., dollar amounts) are involved, but all dates and timelines are correct: the transition starting in 2022, active management in 2023, and full pivot by 2024. The LLM correctly reflects the multi-hop synthesis across years and regulatory changes (FCA/IBA timelines, SOFR adoption). The only minor shortcoming is that the original answer notes Caterpillar had *already* formed the cross-functional team by 2022 to assess LIBOR risks, while the LLM implies it was created in 2023—this slightly misrepresents the timeline of internal response. However, the overall strategic adaptation narrative is sound and semantically equivalent. The answer is fully relevant to the question and effectively communicates Caterpillar’s proactive alignment with global financial reforms.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 393,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Thermo Fisher Scientific's use of Executive Change in Control Retention Agreements evolve from 2022 through 2024, particularly regarding the standardization of agreements for officers beyond the CEO?",
      "original_answer": "In 2022, Thermo Fisher Scientific had the Executive Change In Control Retention Agreement specifically for CEO Marc N. Casper (Exhibit 10.12) with amendments dated through March 16, 2018 (Exhibit 10.17). By 2023, the company introduced a standardized Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper (Exhibit 10.17), indicating expansion beyond just the CEO. In 2024, this standardization was reaffirmed with continued use of the form agreement for officers (Exhibit 10.17), showing a clear evolution from a CEO-specific arrangement to a standardized executive compensation practice across the organization.",
      "llm_answer": "In the 2022 Form 10‑K (pages 44‑48), Thermo Fisher’s only Executive Change in Control Retention Agreement was a CEO‑specific contract (Exhibit 10.11). By the 2023 filing (pages 74‑78), the company had adopted a standardized form for all officers other than the CEO (Exhibit 10.17). The 2024 10‑K (pages 75‑79) continues to use that same standardized officer agreement, indicating a shift toward uniform retention agreements for all non‑CEO officers.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in conveying the evolution of Thermo Fisher Scientific's Executive Change in Control Retention Agreements from 2022 to 2024, with accurate qualitative reasoning and contextual relevance. (1) It correctly identifies that in 2022, only a CEO-specific agreement existed, and that by 2023 and 2024, a standardized form was adopted for officers other than the CEO. The core factual progression—shift from CEO-only to standardized non-CEO officer agreements—is accurately captured. (2) However, there is a minor discrepancy in exhibit numbering: the ground truth states the 2022 CEO agreement was Exhibit 10.12 (with amendments in 10.17), while the LLM claims it was Exhibit 10.11. Additionally, the LLM does not mention Marc N. Casper by name, though this does not undermine the factual core. The page numbers cited (e.g., 44–48 for 2022) may vary slightly by filing version but are plausible. (3) The multi-hop reasoning across years and document versions is sound—the model correctly synthesizes changes over time and infers standardization as an organizational shift. (4) Despite minor inaccuracies in exhibit numbers, the answer conveys semantic equivalence and captures the key evolution. Thus, the correctness score is 8 due to minor factual discrepancies, not fundamental errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 365,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technology roadmap, positioning it alongside RibbonFET as a breakthrough innovation for Intel 20A. By 2023, the company emphasized PowerVia's role in optimizing signal transmission by eliminating front-side power routing, as part of its broader push to achieve process leadership by 2025. In 2024, Intel disclosed that it had canceled Intel 20A in favor of Intel 18A, which retained PowerVia as a core component, indicating a strategic shift to prioritize a more refined version of the technology for high-volume manufacturing starting in 2025. This 3-year evolution shows that PowerVia remained a central pillar of Intel's advanced node strategy, even as the company adjusted its roadmap for greater efficiency and execution focus.",
      "llm_answer": "In 2022 Intel introduced PowerVia as a breakthrough backside‑power delivery technology for its planned Intel 20A node, positioning it as a key differentiator in the advanced process roadmap (2022 10‑K, pp. 5‑9). The 2023 filing continued to highlight PowerVia as part of the 20A strategy, but the company began shifting focus toward the 18A node. By 2024 Intel announced the cancellation of the 20A node and the prioritization of Intel 18A, which still incorporates PowerVia (2024 10‑K, pp. 8‑12), underscoring that PowerVia remains a core technology for improving performance‑per‑watt and signal integrity in Intel’s next‑generation process nodes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 for Intel 20A, remained a focus through 2023, and was retained in Intel 18A after 20A's cancellation in 2024. The years, technology names (PowerVia, 20A, 18A), and strategic context are factually sound. (2) There are no numeric values requiring calculation (e.g., financials, percentages), so quantitative accuracy is not compromised; dates (2022, 2023, 2024) are correct. (3) The multi-hop reasoning is solid: the answer synthesizes Intel's evolving process roadmap across three years, correctly identifying the shift from 20A to 18A while maintaining PowerVia as a core technology. It accurately infers that PowerVia remained strategically important despite node changes. (4) The only minor shortcoming is that the LLM does not explicitly mention RibbonFET (a paired innovation with PowerVia in 2022) or the specific rationale of eliminating front-side power routing for signal transmission, which slightly reduces completeness compared to the original answer. However, the mention of 'improving performance-per-watt and signal integrity' captures the functional benefit. Overall, the answer is semantically equivalent, well-supported, and contextually precise, warranting a high correctness score with only a slight deduction for missing a minor technical detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 387,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Apple's disclosure of the 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this repeated inclusion suggest about the company's debt management practices for this instrument?",
      "original_answer": "Apple first disclosed the 1.05% Notes due 2017 in its 2022 10-K filing, where it was included as part of the Officer's Certificate dated May 6, 2014 (filed as Exhibit 4.4). The same instrument was again disclosed in both the 2023 and 2024 10-K filings, maintaining its presence as a listed debt instrument despite its maturity in 2017. This repeated inclusion of the 1.05% Notes due 2017 across filings post-maturity suggests that Apple may have either rolled over the debt into a new instrument or maintained it in its capital structure in some form, indicating a continuity in its debt management approach for this obligation. The persistence of this specific note in disclosures over multiple years, even after its due date, implies a deliberate and consistent reporting practice by Apple regarding this financial liability.",
      "llm_answer": "Apple’s 10‑K filings for 2022, 2023 and 2024 all contain a separate note on the 1.05% Notes due 2017 in the “Notes to Consolidated Financial Statements” section (pages 54‑58 in 2022, 53‑57 in 2023, and 54‑58 in 2024).  The wording, principal amount, 1.05 % coupon, maturity date and covenants are identical across the three filings, with no change in figures or terms.  The unchanged, repeated disclosure indicates that Apple continues to hold or refinance this long‑term debt instrument and that it follows a disciplined, transparent debt‑management policy for it.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Apple included the 1.05% Notes due 2017 in its 2022, 2023, and 2024 10-K filings, and accurately notes the consistency in terms (coupon, maturity date, covenants) across years. However, it incorrectly implies that the notes are still active or being refinanced by stating Apple 'continues to hold or refinance this long-term debt instrument,' which contradicts the ground truth that the note matured in 2017. The ground truth suggests possible rollover or continued reporting for transparency, but the LLM overinterprets this as ongoing liability without acknowledging the post-maturity anomaly. (2) Quantitatively, all figures—1.05%, maturity in 2017, consistent disclosure across 2022–2024—are correct. Page numbers cited (e.g., 54–58) are plausible and align with typical 10-K structure, though not verifiable from the knowledge graph; no calculation errors present. (3) The multi-hop reasoning is partially sound: the model connects disclosures across three years and infers a pattern in debt management. However, it fails to recognize the logical inconsistency of a matured note still being reported with unchanged terms, which the ground truth interprets as a reporting practice rather than active debt. The conclusion about 'disciplined, transparent debt-management policy' is reasonable but less nuanced than the original answer’s suggestion of rollover or structural continuity. (4) Contextual relevance is high—the response directly addresses the evolution of disclosure and its implications. Scores reflect minor factual overreach in interpretation despite strong quantitative and structural alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 456,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024, particularly in terms of the types of equity awards granted and their vesting conditions?",
      "original_answer": "In 2022, Intel referenced the 2006 Equity Incentive Plan primarily for strategic growth performance-based RSUs and stock options, including specific agreements for executives and non-employee directors. By 2023, the company amended and restated the plan, effective May 11, 2023, and introduced a broader range of RSU agreements, including those with retirement vesting terms, without retirement vesting terms, and performance-based RSUs for both grandfathered and non-grandfathered executives. In 2024, the plan continued to be referenced for similar types of RSUs, but there was a noticeable consolidation in the documentation structure, with a focus on performance-based RSUs for grandfathered executives and a streamlined format for grant agreements. This evolution indicates a shift toward more nuanced performance alignment and simplified documentation over time.",
      "llm_answer": "From 2022 to 2024, Intel continued to use the 2006 Equity Incentive Plan mainly to grant restricted‑stock units (RSUs) to executives and non‑employee directors. The plan’s award types remained consistent—time‑based RSUs with or without retirement vesting, and performance‑based RSUs for both grandfathered and non‑grandfathered executives—while the addition of RSUs for non‑employee directors in 2022 marked the only expansion. Vesting conditions stayed largely unchanged: retirement‑vesting RSUs vest upon retirement, time‑based RSUs vest over a set schedule, and performance‑based RSUs vest when specified performance metrics are met (INTC_10k_2024, pp.104‑108; INTC_10k_2023, pp.99‑103; INTC_10k_2022, pp.112‑116).",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key aspects of the evolution of Intel's 2006 Equity Incentive Plan from 2022 to 2024, particularly regarding structural changes and documentation trends. (1) What was correct: The types of equity awards—time-based RSUs (with and without retirement vesting) and performance-based RSUs—are accurately described, as are vesting conditions. The inclusion of non-employee directors in 2022 aligns with the ground truth. Dates and years referenced (2022–2024) are correct, and no numeric values are factually wrong, supporting a high quantitative accuracy score. (2) However, the LLM fails to mention the critical amendment and restatement of the plan effective May 11, 2023, which is a major factual omission. This change introduced broader RSU agreement types and marked a formal evolution in the plan’s structure, not just continuity. (3) Regarding multi-hop reasoning: the LLM does not synthesize the progression toward more nuanced performance alignment or the 2024 consolidation and streamlining of documentation, which are central to the ground truth’s conclusion about 'simplified documentation over time.' Instead, it incorrectly implies consistency in structure and format across years. (4) The answer is contextually relevant and uses appropriate terminology, but the qualitative accuracy suffers due to incomplete reasoning and failure to capture the plan’s transformation—especially the 2023 amendment and 2024 documentation trends. Thus, while core award types and vesting are correct, the narrative of evolution is oversimplified and misses key developments, warranting a moderate correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 451,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Medtronic's capital structure disclosures regarding Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance against the authorized 40 thousand Euro Deferred Shares suggest about the company's financing strategy over this period?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand Euro Deferred Shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that Medtronic did not utilize Euro Deferred Shares as a financing instrument during this time, potentially indicating a preference for other capital structure tools such as ordinary share repurchases and dividend policies to manage capital allocation.",
      "llm_answer": "Across FY 2022, 2023 and 2024 Medtronic’s 10‑K notes consistently report that 40,000 Euro‑Deferred Shares are authorized but “no Euro Deferred Shares were issued or outstanding” (April 29 2022, April 28 2023, April 26 2024). The unchanged authorization and zero issuance indicate the company has not used this instrument for capital raising, instead relying on other equity or debt mechanisms while keeping the Euro‑Deferred Shares available for future strategic flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the authorized amount of 40,000 Euro Deferred Shares, the par value (implied in original answer), and the consistent absence of issuance across FY2022–FY2024 are accurately reported. The fiscal year-end dates cited (April 29, 2022; April 28, 2023; April 26, 2024) match typical Medtronic 10-K filing dates and are contextually valid. (2) The answer correctly identifies that no shares were issued or outstanding each year, satisfying the multi-hop requirement across three fiscal years. (3) The reasoning is sound: the LLM infers that the lack of issuance suggests non-use for capital raising, which is consistent with the original answer’s conclusion. It also correctly notes the potential strategic intent—keeping shares authorized for future flexibility—adding a nuanced but reasonable interpretation. (4) The only minor gap is that the LLM does not explicitly mention Medtronic’s use of alternative capital tools like share repurchases and dividends, which the original answer highlights as part of the financing strategy. However, the reference to reliance on 'other equity or debt mechanisms' captures the essence. Overall, the answer is factually correct, well-reasoned, and contextually appropriate, warranting a high score with only slight deduction for partial omission of specific capital allocation methods.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 399,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and execution risks related to Advanced Packaging Technologies evolve from 2022 to 2024, particularly in terms of R&D investment, manufacturing complexity, and financial impact?",
      "original_answer": "From 2022 to 2024, Intel's strategic focus on Advanced Packaging Technologies intensified as part of its IDM 2.0 strategy, but execution risks and financial pressures grew. In 2022, Intel acknowledged the complexity and cost of deploying advanced packaging in disaggregated designs, citing delays in Intel 4 and 10nm processes. In 2023, the company positioned its advanced packaging capabilities as a competitive differentiator, especially for AI-driven systems of chips, and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon. However, by 2024, Intel faced significant financial strain, with $3.1 billion in non-cash impairments tied to Intel 7, and delays in global manufacturing projects, casting doubt on its ability to scale advanced packaging capacity profitably. The trend shows an initial strategic bet, followed by technical progress, but ultimately financial and operational setbacks.",
      "llm_answer": "Intel’s focus on advanced packaging shifted from a modest niche in 2022 to a core pillar of its IDM 2.0 strategy by 2024.  In 2023 the company began securing Intel 18A design wins, especially for AI‑related systems, and in 2024 it adopted a disaggregated‑design approach that increased manufacturing complexity and cost.  R&D spend remained high—$17.5 B in 2022, $16.0 B in 2023 and $16.5 B in 2024—while the financial impact grew from a $482 M operating loss in 2023 (due to strategic growth spend) to $3.1 B in impairment charges, $922 M in Gaudi AI inventory write‑downs and $755 M in construction penalty charges in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general strategic evolution of Intel's advanced packaging from 2022 to 2024 and correctly identifies key themes—increased strategic importance, R&D investment, manufacturing complexity, and financial strain. However, several critical numeric inaccuracies undermine factual correctness. The $482M operating loss in 2023 is not supported by the ground truth, which does not mention this figure or attribute an operating loss to advanced packaging specifically. Similarly, the $922M Gaudi AI inventory write-downs and $755M construction penalty charges in 2024 are absent from the ground truth, which only specifies $3.1B in non-cash impairments tied to Intel 7. These invented figures constitute major quantitative errors. While the R&D spending figures ($17.5B, $16.0B, $16.5B) are plausible and consistent with Intel’s reported trends, they are not confirmed in the ground truth and thus introduce unverified data. (2) The only number that matches the ground truth exactly is the $3.1B impairment in 2024, which is correctly cited. All other financial figures are either partially correct (R&D amounts, if accurate, are not in the original answer) or incorrect (Gaudi and construction charges). (3) The multi-hop reasoning is partially sound: the LLM connects advanced packaging to IDM 2.0, AI systems, disaggregated design, and financial impact over time. It correctly positions 2023 as a year of technical progress (design wins, UCIe implied) and 2024 as a year of financial setbacks. However, it fabricates specific charges rather than synthesizing the known impairment and delays, weakening the reasoning. (4) Correctness score is 6 due to partial factual alignment but significant fabrication of financial data. Quantitative accuracy is low (5) due to multiple incorrect dollar amounts. Qualitative accuracy is 7 because the narrative arc and strategic interpretation are reasonable. Contextual relevance is high (9) as the answer directly addresses all dimensions of the question with appropriate framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 552,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and technical expectations for PowerVia evolve from its initial introduction in 2022, through roadmap updates in 2023, to its disclosed manufacturing readiness in 2024?",
      "original_answer": "In 2022, Intel introduced PowerVia as part of its future packaging and process technology roadmap, positioning it as an industry-first backside power delivery solution aimed at optimizing signal transmission by eliminating front-side power routing. By 2023, Intel had solidified its roadmap, stating that PowerVia would be introduced with the Intel 20A process node and would deliver up to a 15% performance-per-watt improvement over Intel 3, alongside RibbonFET. In 2024, Intel disclosed that PowerVia was part of the Intel 18A process node (the successor to Intel 20A), which was expected to enter high-volume manufacturing in 2025, indicating a shift in focus to a more refined version of the technology. This evolution shows a transition from conceptual introduction to a mature, production-ready innovation integrated into Intel's advanced node offerings.",
      "llm_answer": "In the 2022 10‑K (pp. 5‑9), Intel positioned PowerVia as a new backside‑power‑delivery technology for the upcoming 20A node, noting it would eliminate front‑side power routing and serve as a future packaging innovation. By the 2023 10‑K (pp. 12‑16), the roadmap update framed PowerVia as a breakthrough technology expected to deliver up to a 15 % performance‑per‑watt improvement over Intel 3. In the 2024 10‑K (pp. 8‑12), Intel disclosed that PowerVia is now part of the Intel 18A node—a first high‑volume commercial implementation offered to external foundry customers—indicating the technology is ready for high‑volume manufacturing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 as a backside power delivery technology for the 20A node, expected to eliminate front-side routing; in 2023, Intel stated it would deliver up to 15% performance-per-watt improvement over Intel 3; by 2024, it was disclosed as part of the Intel 18A node with high-volume manufacturing plans and availability to external customers. (2) Quantitative accuracy is perfect: the 15% performance-per-watt figure is correctly cited, and the timeline (2022 introduction, 2023 update, 2024 manufacturing readiness) matches. Number format (15 % vs 15%) is acceptable variation. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly tracking the evolution from concept to production. The shift from Intel 20A to 18A is accurately noted, though the ground truth clarifies 18A is the successor to 20A and implies a delay or refinement, which the LLM mentions implicitly by stating 18A is now the vehicle for PowerVia. (4) The only minor omission is that the LLM does not explicitly state that 18A succeeded 20A or that this represents a refinement of the technology, but it does convey that PowerVia is now in 18A and ready for high-volume manufacturing, capturing the essence of maturity and production readiness. Wording differences (e.g., 'first high-volume commercial implementation') are semantically equivalent. Overall, the answer is factually correct, well-structured, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 432,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "Has Medtronic updated its U.S. employee restricted stock unit agreements between FY2022 and FY2024, and what does this consistency—or lack thereof—suggest about its equity compensation strategy?",
      "original_answer": "Medtronic has not updated its U.S. employee restricted stock unit agreements from FY2022 through FY2024. In all three annual filings, the company continued to reference the same Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan, first filed on August 27, 2013 (File No. 001-07707). The absence of modifications to this agreement across a three-year span suggests a stable and consistent equity compensation strategy for U.S. employees, indicating that Medtronic has maintained its approach to long-term incentive alignment without introducing structural changes to this particular award vehicle.",
      "llm_answer": "No – Medtronic’s U.S. employee Restricted Stock Unit (RSU) agreement has remained the same between FY 2022 and FY 2024.  Both the 2022 10‑K (page 113) and the 2024 10‑K (page 112) refer to the same “Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan” (exhibit 10.54).  The unchanged wording and continued use of the 2013 plan suggest a deliberate emphasis on stability and continuity in its equity‑compensation approach for U.S. employees.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately states that Medtronic did not update its U.S. employee RSU agreement between FY2022 and FY2024, correctly citing the continued use of the 'Form of Restricted Stock Unit Award Agreement (U.S. Employees)' under the 2013 Stock Award and Incentive Plan. The specific exhibit number (10.54) and reference to the 2022 and 2024 10-Ks (with page numbers) add precision and are consistent with the knowledge graph. The conclusion about stability in equity compensation strategy is logically sound and semantically equivalent to the original answer. The only minor limitation is the lack of explicit mention of FY2023, which was included in the ground truth’s three-year span (FY2022–FY2024), though the implication of continuity across all years is reasonably conveyed by referencing both 2022 and 2024. All entities (Medtronic, U.S. employees, 2013 Plan, RSU agreement) are correctly identified, and the reasoning correctly synthesizes information across multiple filings. No numerical or date inaccuracies are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 312,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024 in structuring performance-based restricted stock unit (RSU) grants to executives?",
      "original_answer": "In 2022, Intel utilized the 2006 Equity Incentive Plan for strategic growth performance-based RSUs granted to executives on or after February 1, 2019, as evidenced by the restricted stock unit grant agreement listed in the 2022 10-K filing. In 2023, the company continued to use the same plan for RSUs with performance-based conditions, including separate agreements for grandfathered and non-grandfathered executives, as detailed in the 2023 10-K filing. By 2024, the company reaffirmed its reliance on the 2006 Equity Incentive Plan, as amended and restated effective May 11, 2023, and filed an S-8 registration on September 26, 2023, to support continued use of the plan for equity grants. This demonstrates a consistent strategic focus on performance-based compensation aligned with long-term corporate objectives across the three-year period.",
      "llm_answer": "Intel’s 2006 Equity Incentive Plan has been progressively broadened to include performance‑based RSU grants. In 2022 the plan was amended to allow performance‑based RSUs for non‑employee directors, while in 2023 it was further expanded to grant performance‑based RSUs with retirement‑vesting terms to executives. By 2024 the plan had been refined to align performance metrics and vesting schedules more closely with the company’s long‑term strategic objectives.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and introduces factually unsupported claims not present in the ground truth. (1) It states that the 2006 Equity Incentive Plan was 'amended in 2022 to allow performance-based RSUs for non-employee directors'—this is not mentioned or supported in the original answer, which only notes the use of the plan for executives with grants dating back to 2019. (2) It claims that in 2023 the plan was 'expanded to grant performance-based RSUs with retirement-vesting terms to executives'—again, no such detail appears in the ground truth; the original answer refers to separate agreements for grandfathered vs. non-grandfathered executives, not retirement-vesting terms. (3) The 2024 claim of 'refined to align performance metrics' is vague and not substantiated by specific evidence in the LLM response, whereas the original answer cites a specific amendment date (May 11, 2023) and an S-8 filing (September 26, 2023) to support continued use of the plan. (4) The original answer emphasizes consistency in the plan’s use over time, while the LLM incorrectly frames it as a series of expansions and refinements. There are no numeric values to verify, but the dates and events cited in the LLM response (e.g., 2022 amendment, 2023 retirement-vesting expansion) are fabricated or misattributed. The multi-hop reasoning fails because the LLM invents details rather than synthesizing from the provided facts. While the general topic (use of the 2006 plan for performance-based RSUs) is relevant, the specific claims lack factual basis, resulting in low accuracy despite moderate contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 441,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How did Intel's investment in advanced packaging technologies evolve from 2022 through 2024, and what does this progression reveal about the company's ability to execute its disaggregated design strategy and compete in the AI-driven semiconductor market?",
      "original_answer": "Intel's investment in advanced packaging technologies showed a complex evolution from 2022 through 2024. In 2022, the company acknowledged significant challenges in implementing its disaggregated design approach using advanced packaging technologies, noting that delays or failures could adversely affect its ability to introduce competitive products. By 2023, Intel had made concrete progress, demonstrating the Universal Chiplet Interconnect Express (UCIe) standard in silicon and positioning its advanced packaging capabilities as a unique advantage in the AI-driven market. However, in 2024, despite investing $16.5 billion in R&D (including packaging technologies), Intel recorded $3.1 billion in charges related to non-cash impairments and accelerated depreciation for certain manufacturing assets, including those tied to the Intel 7 process node, indicating ongoing execution risks and financial pressures in scaling advanced packaging technologies. This trajectory reveals persistent execution challenges and the high financial stakes in competing for leadership in advanced packaging for AI applications.",
      "llm_answer": "Intel’s focus on advanced packaging grew steadily from 2022‑24: in 2022 the company framed packaging as a high‑risk, early‑stage element of its disaggregated‑design strategy (pages 52‑56), then in 2023 it reported accelerated interest and five new design wins for AI‑related packaging (pages 35‑39), and by 2024 it positioned advanced packaging as a key differentiator for AI workloads under its IDM 2.0 strategy (pages 32‑36). This trajectory—coupled with a sustained R&D spend of $17.5 B (2022), $16.0 B (2023), and $16.5 B (2024)—shows Intel is allocating more resources to chip‑let packaging to support its disaggregated architecture, thereby strengthening its competitive stance in the AI‑driven market, though execution remains complex and subject to delays.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general trajectory of Intel's advanced packaging evolution and correctly identifies its strategic importance to disaggregated design and AI competitiveness. However, there are significant factual inaccuracies in the quantitative details. The R&D figures are partially incorrect: the LLM states $17.5B (2022), $16.0B (2023), and $16.5B (2024), but the ground truth only confirms $16.5B in 2024 and does not specify the exact R&D amounts for 2022 and 2023—thus the LLM introduces unsupported precision. More critically, the LLM omits the key 2024 $3.1 billion in non-cash impairment charges related to manufacturing assets (including Intel 7), which is a major indicator of execution risk and financial pressure. This omission significantly weakens the assessment of Intel’s challenges. Additionally, the claim of 'five new design wins for AI-related packaging' in 2023 is not present in the ground truth and appears fabricated or misattributed. (2) Number verification: R&D figures are inconsistent with ground truth (which only specifies 2024 at $16.5B); the $3.1B impairment charge is entirely missing. These are material financial facts. (3) Multi-hop reasoning: The LLM correctly synthesizes the strategic progression—acknowledging early risk (2022), progress (2023), and strategic positioning (2024)—and links packaging to disaggregated design and AI. However, it fails to incorporate the negative financial signal in 2024, which is essential for a balanced view of execution ability. The reasoning is directionally sound but lacks critical risk context. (4) Correctness score is 6 due to partially accurate narrative but major omissions and inaccuracies in financial data. Quantitative accuracy is 5 due to incorrect R&D figures and missing impairment charge. Qualitative accuracy is 7 because the strategic logic and entity identification (Intel, advanced packaging, disaggregated design, AI) are correct, but reasoning is weakened by missing evidence. Contextual relevance is 9 as the answer directly addresses the question’s scope and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 562,
        "total_tokens": 2059
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of plan amendments and grant agreements?",
      "original_answer": "In 2022, Intel referenced multiple grant agreements under the 2006 Equity Incentive Plan, including forms of Restricted Stock Unit (RSU) and Stock Option Grant Agreements for executives, non-employee directors, and performance-based awards. In 2023, the company filed an amended and restated version of the plan effective May 11, 2023, continuing to reference specific RSU grant agreements with retirement vesting terms and performance-based RSUs. By 2024, Intel continued to rely on the 2006 Equity Incentive Plan, with filings showing ongoing use of standardized RSU grant agreements and notices of grant, indicating sustained reliance on the plan despite its age. The evolution shows a consistent but increasingly mature application of the plan, with formal amendments in 2023 reflecting structural updates.",
      "llm_answer": "Across 2022‑2024 Intel continued to use the 2006 Equity Incentive Plan to award RSUs to executives, non‑employee directors and performance‑based RSUs—granting RSUs with retirement vesting terms, without retirement vesting terms, and performance‑based RSUs for both grandfathered and non‑grandfathered executives (see pages 112‑116, 99‑103, 104‑108). No amendments to the plan itself were disclosed in those filings, indicating the plan’s structure remained unchanged while the scope of grant agreements broadened.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Intel's continued use of the 2006 Equity Incentive Plan across 2022–2024 and accurately references the types of awards (RSUs, performance-based RSUs) and recipients (executives, non-employee directors). It also correctly notes the inclusion of retirement vesting terms. However, it makes a critical factual error by stating that no amendments to the plan were disclosed, which directly contradicts the ground truth: in 2023, Intel filed an amended and restated version of the plan effective May 11, 2023. This omission severely undermines the correctness of the answer, especially since the question specifically asks about plan amendments. (2) Quantitatively, there are no explicit numbers (e.g., dollar amounts, percentages) in either answer, so accuracy on dates and years is key. The LLM correctly references the 2022–2024 timeframe and implies ongoing use, but fails to mention the specific May 11, 2023 amendment date, which is a key factual detail. (3) The multi-hop reasoning is partially sound—Intel’s use of the plan across years and the variety of grant agreements are correctly synthesized. However, the failure to recognize and report the 2023 amendment breaks the chain of accurate synthesis, particularly for the evolution of the plan structure. The claim that 'no amendments were disclosed' shows a failure to correctly interpret or retrieve the filing information. (4) The contextual relevance is fair—the answer addresses the use of grant agreements and types of awards, which is relevant, but misses the central point about the 2023 amendment, which is a major component of the plan’s evolution. Thus, while some factual elements are correct, the core error on amendments reduces the overall correctness significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 485,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Qualcomm's financial categorization and strategic emphasis on wireless access points evolve from 2022 to 2024, particularly in terms of revenue classification and market positioning within the edge networking segment?",
      "original_answer": "In 2022, Qualcomm highlighted wireless access points as a key growth driver within edge networking, projecting a doubling of IoT devices between 2022 and 2026 to over 27 billion, which included wireless access points as a core component. In 2023, wireless access points were explicitly categorized under the edge networking revenue segment, which includes mobile broadband and wireless access points, indicating a formal financial classification. By 2024, this categorization remained consistent, showing a continued strategic emphasis on edge networking, with wireless access points listed alongside mobile broadband as a core product line. While exact revenue figures for wireless access points alone are not disclosed, the consistent inclusion in edge networking and the growing IoT ecosystem suggest an increasing strategic and financial importance over the three-year period.",
      "llm_answer": "Qualcomm continued to classify revenue from wireless access points under its IoT segment’s edge‑networking sub‑category in both 2022 and 2024 (see the QCT revenue‑streams table – 2024, pp. 71‑75). In 2022 the company framed wireless access points as part of a broader edge‑networking growth narrative driven by Wi‑Fi 6/6E and 5G NR‑U (2022, pp. 6‑10), whereas by 2024 it positioned them as a core driver of its edge‑computing strategy, emphasizing leadership in Wi‑Fi 6E/7 and 5G NR‑U and the expansion of its portfolio to deliver high‑speed, low‑latency connectivity for both mobile and fixed wireless users (2024, pp. 71‑75).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in key aspects but contains a notable discrepancy in entity classification. (1) Quantitatively, there are no numeric errors—no specific revenue figures or dates are misstated, and the time frame (2022–2024) is correctly referenced. (2) The LLM states that wireless access points were classified under the 'IoT segment’s edge-networking sub-category', but the ground truth specifies that by 2023, wireless access points were formally categorized under the 'edge networking revenue segment' alongside mobile broadband, not as a sub-category of IoT. This is a material misrepresentation of Qualcomm’s financial segmentation structure. (3) The reasoning partially captures the strategic evolution: the shift from framing wireless access points as part of a growth narrative in 2022 to a core driver in 2024 is supported, and the emphasis on Wi-Fi 6E/7 and 5G NR-U aligns with the original answer. However, the multi-hop synthesis is weakened by the incorrect segment classification, which affects the financial categorization accuracy. (4) Despite this, the answer remains contextually relevant and captures the strategic emphasis on edge networking and technological leadership. Wording differences are acceptable under semantic equivalence, but the misplacement of the revenue segment reduces qualitative accuracy. Correctness score reflects core factual alignment with minor but significant structural inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 404,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trend suggest about the product's market positioning in the Hospital Acute Care segment?",
      "original_answer": "MRK's sales of Prevymis increased from $370 million in 2022 to $428 million in 2023, and then significantly rose to $785 million in 2024. This represents a compound growth rate of approximately 46% over the two-year period from 2022 to 2024. The substantial growth in sales suggests that Prevymis gained stronger market adoption and became more strategically positioned within the Hospital Acute Care segment, particularly as a prophylactic treatment for CMV infection in high-risk transplant recipients.",
      "llm_answer": "Prevymis sales rose from **$428 million in 2022** (MRK_10k_2022 p. 139‑143) to **$605 million in 2023** (MRK_10k_2023 p. 2‑6) and to **$785 million in 2024** (MRK_10k_2024 p. 128‑132). This steady growth—over 40 % in two years—indicates that Prevymis is gaining traction and solidifying its position as a key CMV‑prophylaxis therapy within the Hospital Acute Care segment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported sales figures. According to the ground truth, MRK's Prevymis sales were $370 million in 2022 and $428 million in 2023, but the LLM incorrectly reports $428 million for 2022 and $605 million for 2023. Only the 2024 figure ($785 million) is correct. This misrepresentation leads to an inaccurate growth trajectory. (2) The calculation of 'over 40%' growth is vague and less precise than the ground truth's compound growth rate of approximately 46% from 2022 to 2024, which is mathematically verifiable: ($785M / $370M)^(1/2) - 1 ≈ 46%. The LLM’s implied growth from $428M to $785M over two years would actually be much lower, especially if 2023 were $605M. (3) The multi-hop reasoning is partially sound—the model correctly identifies the upward trend and links it to market positioning in Hospital Acute Care—but the flawed input data undermines the validity of the synthesis. The conclusion about gaining traction is reasonable but based on incorrect figures. (4) Contextual relevance is high as the answer addresses both parts of the question: sales evolution and market positioning. However, due to major quantitative inaccuracies, the correctness score is low despite appropriate framing and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 360,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How did Intel's investment and strategic positioning in advanced packaging technologies evolve from 2022 through 2024, and what does this multi-year trajectory reveal about its ability to execute on the IDM 2.0 strategy amid manufacturing delays and capital constraints?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk in deploying advanced packaging technologies as part of its disaggregated design approach, citing delays in process technologies like Intel 4 (formerly 7nm) and the increased costs and design challenges associated with advanced packaging. By 2023, Intel positioned its advanced packaging capabilities as a competitive differentiator under the IDM 2.0 strategy, highlighting 2D and 2.5D/3D packaging solutions and the Universal Chiplet Interconnect Express (UCIe) standard, which was demonstrated in silicon that year. However, by 2024, despite R&D investments (e.g., $16.5 billion in 2024), Intel faced delays in product introductions (e.g., 4th Gen Xeon Scalable processors) and significant non-cash impairments ($3.1 billion in Q3 2024), particularly affecting the Intel 7 process node. This trajectory shows that while Intel made strategic progress in packaging innovation, execution challenges and capital constraints undermined its ability to consistently deliver on the IDM 2.0 roadmap.",
      "llm_answer": "From 2022 to 2024 Intel shifted its advanced‑packaging focus from a nascent, disaggregated‑design approach (2022 MD&A, pp. 52‑56) that was hampered by 10 nm and 7 nm delays, to a more mature positioning—2023 MD&A (pp. 35‑39) reports accelerated AI‑related interest, five new design wins and a growing IFS accelerator ecosystem, and 2024 MD&A (pp. 32‑36) notes further expansion of packaging capabilities, new ARM and Synopsys agreements, and additional design wins under the Smart Capital joint‑investment model. This multi‑year trajectory shows Intel has steadily increased investment and strategic emphasis on advanced packaging as a key IDM 2.0 differentiator, yet the persistent manufacturing delays and high capital requirements (e.g., joint investments, EUV tool costs, and government‑grant contingencies) continue to constrain full execution of the IDM 2.0 strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general strategic evolution of Intel's advanced packaging efforts from 2022 to 2024 and correctly frames it within the IDM 2.0 strategy, showing awareness of delays and capital constraints. However, it introduces several unsupported or incorrect specifics not present in the ground truth. For example, it cites '10 nm and 7 nm delays' in 2022—while the ground truth only mentions Intel 4 (formerly 7nm) delays, not 10nm. It also references 'five new design wins', 'ARM and Synopsys agreements', 'Smart Capital joint-investment model', and 'accelerated AI-related interest'—none of which appear in the original answer and lack grounding in the provided truth. These additions, while plausible, are factually unverified and reduce accuracy. (2) Quantitatively, the LLM fails to include any of the key financial figures from the ground truth: the $16.5 billion R&D investment in 2024 and the $3.1 billion non-cash impairment in Q3 2024 are entirely omitted. Instead, it vaguely references 'high capital requirements' and 'EUV tool costs' without specific numbers, missing critical data points essential to assessing capital constraints. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic shift over time and links packaging to IDM 2.0. However, it does not accurately synthesize the core evidence—specific financial impacts and product delays (e.g., 4th Gen Xeon Scalable processors)—that ground truth uses to evaluate execution challenges. The conclusion that 'persistent manufacturing delays and high capital requirements... constrain full execution' aligns thematically but lacks the factual anchoring in impairments and R&D figures needed for full accuracy. (4) Contextual relevance is high—the answer directly addresses the question’s focus on evolution and strategic implications. Qualitative accuracy is moderate due to correct overall trajectory but flawed supporting details. Quantitative accuracy is low due to missing or incorrect figures. Correctness score reflects partial factual alignment with significant omissions and unsupported claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 571,
        "total_tokens": 2081
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved from 2022 through 2024, and what does this progression indicate about its hybrid cloud and AI strategy positioning?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the framing evolved in alignment with its hybrid cloud and AI strategy. In 2022, IBM explicitly tied trust to its hybrid cloud platform and AI for production, highlighting trust and security as integrated components of its offerings. By 2023, the company reinforced this positioning, emphasizing trust as part of its broader competitive methods, including service and support, innovation, and talent. In 2024, IBM maintained this stance, continuing to highlight client relationships and trust as a key competitive lever while expanding its strategic partnerships to include Palo Alto Networks, signaling a deepening of trust-based collaboration to support client digital transformations. This 3-year consistency shows IBM's strategic commitment to trust as a foundational element in client acquisition and retention within the competitive AI and hybrid cloud market.",
      "llm_answer": "IBM has consistently highlighted client relationships and trust as a key competitive differentiator in its 2022, 2023, and 2024 10‑K filings (2022 10‑K, pp. 2‑5; 2023 10‑K, pp. 1‑5; 2024 10‑K, pp. 1‑5). In 2023 the company explicitly linked this emphasis to its hybrid‑cloud and AI platform, noting that it supports clients’ digital transformations (2023 10‑K, pp. 1‑5), and by 2024 it framed its hybrid‑cloud and AI strategy as being built on client relationships and trust, underscoring the role of trusted partnerships in delivering integrated solutions (2024 10‑K, pp. 1‑5). This progression signals that IBM is positioning hybrid‑cloud and AI not merely as technology offerings but as value‑add services anchored in deep client trust, differentiating itself from hyperscalers and other competitors.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of core facts and overall trajectory. (1) It accurately captures IBM's consistent emphasis on client relationships and trust from 2022 to 2024 and correctly links this evolution to its hybrid cloud and AI strategy. The framing of trust as a differentiator against hyperscalers is a valid inference and adds contextual insight. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable—scored as 10 by default since no errors exist. (3) However, the LLM misattributes the timing of IBM’s explicit linkage between trust and hybrid cloud/AI: the ground truth states this began in 2022, not 2023 as claimed by the LLM. Additionally, the LLM omits the specific 2024 strategic partnership with Palo Alto Networks, which is a key piece of evidence for deepening trust-based collaboration. These omissions affect the completeness and precision of the multi-hop synthesis across years, though the overall trend is correctly interpreted. (4) The answer remains highly contextually relevant, directly addressing the evolution and strategic implications. The reasoning is sound but slightly flawed in chronology and specificity, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 365,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did IBM's issuance and disclosure strategy for the 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about its broader debt management approach during this period?",
      "original_answer": "In 2022, IBM disclosed the instrument defining the rights of the holders of the 0.950% Notes due 2025, referencing Exhibit 4.1 to Form 8-K filed May 22, 2017. In 2023, IBM again referenced the same instrument in its disclosures, indicating ongoing transparency and regulatory continuity around this debt instrument. By 2024, the 0.950% Notes due 2025 were actively listed on the New York Stock Exchange under the trading symbol IBM25B, showing that the instrument remained a live and traded financial liability for IBM. This 3-year progression reflects a consistent disclosure framework and sustained presence of the 0.950% Notes in IBM's capital structure, suggesting a stable and transparent debt management strategy around this specific instrument.",
      "llm_answer": "IBM first issued the 0.950% Notes due 2025 in 2022 and disclosed the terms and outstanding balance in its 2022 10‑K (IBM_10k_2022, p. 28‑32).  In 2023, the company continued to report the notes in its 10‑K, updating the balance and covenant status and framing them as part of a low‑interest, long‑term debt strategy (IBM_10k_2023, p. 18‑22).  By 2024, the 10‑K listed the notes as a registered security and highlighted the maturity and planned refinancing, underscoring a disciplined, diversified debt‑management approach that aligns maturities with capital‑allocation priorities (IBM_10k_2024, p. 1‑5).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The 0.950% Notes due 2025 were not first issued in 2022; the ground truth states that IBM referenced the instrument from a May 22, 2017 filing, indicating issuance occurred in 2017, not 2022. This is a major error in timeline and issuance facts. Additionally, there is no mention in the ground truth about updating balances, covenant status, or planned refinancing in 2024—these details are fabricated or inferred beyond the evidence. The listing on NYSE under IBM25B in 2024 is omitted entirely. (2) Quantitative accuracy is low: the percentages (0.950%) and maturity year (2025) are correct, but the issuance year is wrong (2022 vs actual 2017), and there are no actual dollar amounts or balances mentioned in either answer to verify numerical precision. Page references (e.g., p. 28–32) appear specific but cannot be validated and may be hallucinated. (3) Multi-hop reasoning is partially sound—the model attempts to trace disclosure evolution across years and link it to debt management strategy—but it fails on core facts. It incorrectly assumes issuance occurred in 2022 and adds unverified details like 'planned refinancing' and 'low-interest, long-term strategy' not present in the ground truth. The actual progression emphasizes regulatory continuity and transparency via consistent referencing and eventual exchange listing, which the LLM overlooks. (4) Contextual relevance is fair because the answer addresses disclosure trends and debt strategy, aligning with the question’s intent, but factual correctness undermines the response. The conclusion about disciplined debt management is plausible but not directly supported by the provided ground truth. Overall, the answer is partially correct in theme but flawed in key facts and synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 495,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did Intel's development and manufacturing strategy for PowerVia technology evolve from 2022 through 2024, and what does this progression reveal about Intel's roadmap for backside power delivery in advanced process nodes?",
      "original_answer": "Intel's strategy for PowerVia evolved significantly from 2022 through 2024. In 2022, Intel introduced PowerVia as part of its future roadmap alongside RibbonFET, signaling its intent to innovate in backside power delivery. By 2023, PowerVia was positioned as a key breakthrough technology within the Intel 20A node, designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of Intel 18A, which integrates PowerVia for commercial high-volume production starting in 2025. This shows a strategic pivot from concept (2022) to technical integration (2023) to commercial deployment (2024), indicating Intel's commitment to delivering backside power delivery at scale.",
      "llm_answer": "In 2022, Intel announced PowerVia as a new backside‑power delivery technology slated for the Intel 20A node (INTC_10k_2022.pdf pages 5‑9). By 2023, the company detailed PowerVia’s role in Intel 20A, emphasizing its ability to eliminate front‑side power routing (INTC_10k_2023.pdf page 14). In 2024, Intel moved PowerVia to the earlier Intel 18A node, indicating an accelerated adoption and underscoring backside power delivery as a key enabler for performance‑per‑watt gains in its advanced‑node roadmap (INTC_10k_2024.pdf page 12).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 for Intel 20A, detailed in 2023 as part of Intel 20A eliminating front-side power routing, and moved to Intel 18A in 2024 for earlier deployment. The years, technology names (PowerVia, Intel 20A, Intel 18A), and strategic progression are accurate. (2) There are no numeric values requiring calculation, but all dates and node names match the original answer. The citation of specific 10-K pages adds precision, though not required. (3) The multi-hop reasoning is sound—information is correctly synthesized across three years of filings, showing evolution from announcement to integration to acceleration. The only minor gap is that the LLM answer states PowerVia was 'moved' to Intel 18A, while the ground truth clarifies that Intel canceled Intel 20A productization in favor of Intel 18A. This nuance about cancellation is omitted, slightly reducing completeness in qualitative reasoning. (4) Despite this, the answer captures the strategic acceleration and importance of backside power delivery, maintaining semantic equivalence. Contextual relevance is perfect—directly addresses the evolution and what it reveals about Intel's roadmap.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 356,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What does Medtronic's Restricted Stock Unit Award Agreement documentation from 2022 to 2024 indicate about the stability of their U.S. equity compensation strategy?",
      "original_answer": "The Restricted Stock Unit Award Agreement for U.S. Employees (Exhibit 10.54) remained unchanged across all three years, consistently referencing the same August 27, 2013 filing. This demonstrates strategic stability in Medtronic's core equity compensation approach for U.S. employees despite evolving market conditions, suggesting the company maintained its foundational incentive structure without modification throughout the period.",
      "llm_answer": "Medtronic’s 2022, 2023 and 2024 10‑K filings all reference the same 2021 Long‑Term Incentive Plan Restricted Stock Unit Award Agreements (exhibits *10.81–*10.82 in 2022, *10.86–*10.89 in 2023 and *10.86–*10.89 again in 2024).  The agreements are described with identical vesting schedules, eligibility criteria and payout terms, and the filings note no substantive changes to the plan’s structure or the RSU award terms over the three‑year period (MDT_10k_2022.pdf, pp. 112‑116; MDT_10k_2023.pdf, pp. 112‑116; MDT_10k_2024.pdf, pp. 112‑116).  This consistency indicates a stable U.S. equity‑compensation strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims that Medtronic's 2022–2024 10-K filings reference the '2021 Long-Term Incentive Plan' and specific exhibit numbers (*10.81–*10.82 in 2022, *10.86–*10.89 in 2023/2024), which contradicts the ground truth stating that the Restricted Stock Unit Award Agreement (Exhibit 10.54) remained unchanged and consistently referenced an August 27, 2013 filing. The LLM incorrectly identifies the plan year as 2021 and cites non-matching exhibit numbers, indicating a failure in entity accuracy. (2) Quantitative accuracy is low because the dates (2013 vs 2021), exhibit numbers, and plan names are incorrect. While the LLM correctly notes consistency across years, the foundational facts underpinning that conclusion are wrong. (3) The reasoning is partially sound in that it infers stability from lack of change, which aligns with the ground truth’s logic. However, this conclusion is based on fabricated or incorrect document references, undermining the multi-hop synthesis. The model appears to have invented exhibit numbers and plan dates rather than accurately extracting from filings. (4) Contextual relevance is high because the answer addresses the core question about equity compensation stability and attempts to support it with vesting terms and structural consistency. However, due to major factual errors in entities and documentation, the correctness score is low despite the logically coherent structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 411,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did Intel's strategic positioning and execution challenges related to its advanced packaging technologies evolve from 2022 through 2024, particularly in light of delays, capital constraints, and the introduction of disaggregated design approaches?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk associated with implementing advanced packaging technologies as part of its disaggregated design approach, noting that delays in manufacturing process technologies like Intel 4 (formerly 7nm) could hinder the timely introduction of competitive products. By 2023, Intel emphasized its strategic advantage in advanced packaging, including 2D and 2.5D/3D solutions, and demonstrated progress with the Universal Chiplet Interconnect Express (UCIe) standard, positioning it as a key differentiator in the foundry market. However, in 2024, the company faced significant execution challenges, including delays in manufacturing projects in multiple geographies and a $3.1 billion impairment charge tied to underutilized manufacturing assets, particularly for the Intel 7 node, which highlighted the risks in scaling advanced packaging capabilities amid constrained capital and uncertain customer demand.",
      "llm_answer": "Intel’s IDM 2.0 strategy positioned advanced packaging as a differentiator for AI and chip‑let markets, but execution has been hampered by recurring delays in 10 nm and 7 nm nodes and capital constraints that forced the postponement of new fabs and capacity expansions (2022 pages 52‑56; 2023 pages 35‑39).  In 2023 the company secured several advanced‑packaging design wins, yet still faced the same timing and cost overruns that eroded margins (2023 pages 35‑39).  By 2024, Intel had to adopt a disaggregated design approach—manufacturing different components on separate processes and linking them with advanced packaging—to meet customer needs, a strategy that added further complexity and risk while capital constraints continued to limit facility build‑out (2024 pages 32‑36).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures some correct themes but contains significant factual inaccuracies. It incorrectly states that delays were in '10 nm and 7 nm nodes' as ongoing issues in 2022–2024, while the ground truth emphasizes Intel 4 (formerly 7nm) delays specifically impacting advanced packaging timelines. More critically, the LLM answer omits the $3.1 billion impairment charge in 2024—a key quantitative fact reflecting capital misallocation and underutilized assets—which is central to the execution challenges. This omission severely impacts quantitative accuracy. (2) No correct dollar amounts or specific financial figures are mentioned (e.g., $3.1B impairment), and the reference to 'pages 52-56', etc., while possibly accurate to source documents, cannot compensate for missing core data. The answer fabricates no numbers but fails to report critical ones, leading to a low quantitative accuracy score. (3) The reasoning partially aligns with the ground truth: it correctly identifies advanced packaging as a strategic differentiator, links delays to process node execution, and notes capital constraints affecting fab expansion. It also correctly associates disaggregated design with advanced packaging. However, it misrepresents the timeline by implying Intel adopted disaggregated design in 2024, whereas the ground truth indicates this approach was part of earlier strategy (acknowledged in 2022). The LLM also misses the significance of UCIe standard progress in 2023 as a strategic advantage. (4) Contextual relevance is high because the answer addresses strategic positioning, execution challenges, capital constraints, and disaggregated design—all relevant themes. However, due to missing key facts (especially the $3.1B impairment) and misrepresenting the evolution of Intel's strategy, the overall correctness is only partially accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 506,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How did Accenture's target asset allocation strategy for its defined benefit pension plans evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the mix of fixed income and equities, and what does this multi-year shift suggest about the company's approach to risk-adjusted returns?",
      "original_answer": "In fiscal 2022, Accenture's target asset allocation for defined benefit pension plans emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching debt securities' duration to plan liabilities and using equities for long-term capital appreciation. By fiscal 2023, the company maintained this dual focus but placed increased emphasis on flexibility in asset allocation decisions to adapt to current and anticipated market conditions and required cash flows. In fiscal 2024, the target allocation for fiscal 2025 was introduced, continuing the strategy of aligning asset mix with long-term investment objectives while allowing for variation within established ranges to manage volatility and ensure risk-adjusted returns. The consistent emphasis on balancing fixed income and equities, alongside evolving flexibility in rebalancing, suggests Accenture is refining its approach to managing pension risk in dynamic markets while maintaining long-term return objectives.",
      "llm_answer": "In FY 2022 the defined‑benefit plans were targeted at 100 % debt for U.S. plans and 50 % debt with 21 % equity for non‑U.S. plans (the weighted‑average plan‑asset mix for 2022 reflects this target)【ACN_10k_2023, p. 81‑85】.  In FY 2023 the target shifted to 100 % debt for U.S. plans and 48 % debt with 27 % equity for non‑U.S. plans, a modest increase in equity exposure【ACN_10k_2023, p. 81‑85】.  By FY 2024 the target allocation (as indicated by the 2025 target) moved toward 28 % equity and 36 % debt for non‑U.S. plans, underscoring a continued tilt toward higher risk‑adjusted returns while preserving a fixed‑income core【ACN_10k_2024, p. 93‑97】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. The claim that U.S. defined benefit plans had a 100% debt target in FY2022 and FY2023 is incorrect — the ground truth does not specify such precise allocations by region or asset class, nor does it state 100% debt targeting. Similarly, the specific percentages for non-U.S. plans (e.g., 50% debt / 21% equity in 2022, 48% debt / 27% equity in 2023, 36% debt / 28% equity in 2024) are not supported by the original answer and appear to be fabricated or misextracted. These numbers contradict the qualitative description in the ground truth, which emphasizes a general strategy of balancing fixed income and equities with increasing flexibility, not exact percentage allocations. (2) There are no verifiable calculations in the original answer to cross-check, but the LLM presents false precision with exact percentages across years that do not align with the source. The citation of pages in the 10-Ks may suggest data sourcing, but the numbers do not reflect the actual narrative in the filings as summarized in the ground truth. (3) The multi-hop reasoning is partially sound in structure — the model attempts to track changes over three fiscal years and interpret strategic intent — but fails in execution due to incorrect data synthesis. It incorrectly infers a 'continued tilt toward higher risk-adjusted returns' based on rising equity percentages, which is not stated or implied in the original answer. The original emphasizes consistency in balancing fixed income and equities with evolving flexibility, not a directional shift toward higher equity risk. (4) Despite the factual errors, the answer is contextually relevant — it addresses the evolution of asset allocation across the requested years and attempts to interpret strategic implications. However, the correctness score is low due to major quantitative inaccuracies that undermine the validity of the conclusion. The qualitative reasoning would warrant a higher score if based on accurate inputs.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 554,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "What does Apple's continued reference to the 1.05% Notes due 2017 in its filings through 2023 and 2024 indicate about its approach to debt disclosure, and how does this compare to its broader debt issuance strategy across 2022–2024?",
      "original_answer": "Apple's continued reference to the 1.05% Notes due 2017 in its 2023 and 2024 filings indicates a consistent and transparent approach to disclosing historical debt instruments, even after their maturity. This contrasts with Apple's broader strategy of issuing new debt instruments with varying maturities (e.g., Floating Rate Notes due 2020, 2.15% Notes due 2022, and 3.45% Notes due 2024) across the three-year period. The persistence of the 1.05% Notes due 2017 in filings suggests that Apple maintains a comprehensive historical record of its capital structure, possibly for legal or investor transparency purposes, even as it actively manages and evolves its debt portfolio.",
      "llm_answer": "Apple’s repeated reference to the 1.05% Notes due 2017 (see Exhibit 4.4 in the 2024 10‑K and the same exhibit in the 2023 filing) shows the company’s deliberate, conservative approach to debt disclosure—ensuring that all debt obligations, even those that have long since matured, remain disclosed for full transparency.  In contrast, Apple’s broader debt‑issuance strategy over 2022‑2024 has focused on new, longer‑term notes with higher coupon rates: 2.40% notes due 2023 and 3.85% notes due 2043 were issued in 2022 (Exhibit 4.3, 2022 10‑K), and 4.421% notes due 2026, 4.000% notes due 2028, 4.150% notes due 2030, 4.300% notes due 2033 and 4.850% notes due 2053 were issued in 2023‑24 (Exhibit 4.28, 2024 10‑K).  This pattern reflects a strategy to fund share repurchases and dividends while managing cost of capital, while still maintaining a thorough disclosure of its entire debt history.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth references specific notes issued between 2022–2024 such as the 2.15% Notes due 2022 and 3.45% Notes due 2024, but the LLM incorrectly lists multiple new notes with different rates and maturities (e.g., 2.40% due 2023, 3.85% due 2043 in 2022; 4.421% due 2026, etc. in 2023–24), which are not present in the original answer or implied by the knowledge graph. These specific percentages and maturities are fabricated or misattributed, severely undermining factual correctness. (2) The mention of 'Exhibit 4.4' and 'Exhibit 4.3' adds apparent precision but cannot be verified against the ground truth, which does not reference exhibit numbers. More critically, the financial terms (coupon rates, maturities) do not align with the original answer’s data points. For example, the original mentions a 3.45% Note due 2024, while the LLM claims a 4.850% note due 2053 was issued—this is a major deviation. (3) Qualitatively, the reasoning is sound: the LLM correctly infers that continued disclosure of the 1.05% Notes due 2017 reflects a transparent, conservative disclosure policy, and contrasts this with ongoing debt issuance, which aligns with the multi-hop logic required. The interpretation of Apple maintaining historical records while actively managing its debt portfolio is semantically consistent with the ground truth. (4) Contextual relevance is high—the response directly addresses both parts of the question: the meaning of referencing matured debt and how it compares to recent issuance strategy. However, due to the incorrect numerical details and invented debt instruments, the correctness score is limited to 6, reflecting partial accuracy with significant factual errors in the quantitative components.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 490,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern suggest about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3.13 billion for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2.69 billion, despite an additional $4.0 billion in new share repurchase authority approved in September 2024, bringing total outstanding authority to $6.69 billion. During fiscal 2024 alone, Accenture purchased over $605 million worth of Class A ordinary shares under its open-market program. The 2023 filing mirrors the 2024 disclosures regarding the ongoing share purchase program and total authorized amounts, indicating consistent execution over the two years. This trend suggests a sustained but measured capital return strategy focused on strategic share repurchases while maintaining flexibility for future buybacks.",
      "llm_answer": "In fiscal 2022 Accenture repurchased 12.18 million shares for $4.11 million, with an available authorization of $3.13 million and a total outstanding authority of $6.13 million after a board approval (Share Purchases and Redemptions table, pages 91‑95). By fiscal 2024 the program had expanded to 2.07 million shares for $303.05 million, with an available authorization of $2.69 million and a total outstanding authority of $6.69 million after a $4 billion board approval (Purchases of Accenture plc Class A Ordinary Shares table, pages 37‑41). The steady rise in buy‑back volume, coupled with a consistently large authorization pool, signals a proactive, flexible capital‑return strategy that prioritizes shareholder value while preserving ample capacity for future repurchases.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple critical factual errors. It incorrectly states that Accenture repurchased 12.18 million shares for $4.11 million in fiscal 2022 — this is factually wrong; $4.11 million is implausibly low for such a large company. The ground truth does not provide repurchase volume for 2022, only the available authorization of $3.13 billion. The LLM also misrepresents the 2024 repurchase as 2.07 million shares for $303.05 million, whereas the ground truth states over $605 million in repurchases in fiscal 2024. The available authorizations are cited in millions instead of billions (e.g., $3.13 million vs $3.13 billion), which is a 1,000x error. (2) Calculations and figures are severely inaccurate: the total outstanding authority in 2022 is stated as $6.13 million, but the ground truth does not support this number, and again confuses millions with billions. The $4 billion new authorization in September 2024 is correctly mentioned, but incorrectly contextualized with wrong base figures. (3) Multi-hop reasoning is partially present — the model attempts to compare fiscal 2022 and 2024 data and infer a capital return strategy — but due to incorrect data, the conclusion is flawed. The ground truth emphasizes a 'measured' strategy, while the LLM describes a 'steady rise in buy-back volume', which is unsupported (and contradicted by lower dollar repurchases in 2024 vs implied 2022 level). (4) Despite severe quantitative inaccuracies, the answer is contextually relevant — it addresses share repurchases, authorizations, and capital return strategy. The structure follows the question’s intent, and it references appropriate tables. However, the factual foundation is so flawed that the overall correctness is very low. Quantitative accuracy is extremely poor due to unit errors and fabricated figures. Qualitative reasoning is weak due to incorrect premises. Contextual relevance is acceptable as the framework of the response aligns with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 538,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did BMY's issuance and structuring of long-term debt, specifically the 4.350% Senior Notes due 2047, evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term financing strategy?",
      "original_answer": "BMY consistently referenced the 4.350% Senior Notes due 2047 across all three years—2022, 2023, and 2024—indicating that this instrument remained a core part of its long-term debt portfolio. In 2022, the notes were listed among a broader set of senior notes issued under the Eleventh Supplemental Indenture dated November 22, 2019. In 2023, the notes were again included in the list of outstanding debt instruments, this time alongside newer issuances like the $1.75 billion 2.950% Notes due 2032 and the $2 billion 3.700% Notes due 2052. By 2024, the 4.350% Senior Notes due 2047 remained part of the capital structure, even as BMY issued additional long-term debt such as the $3.75 billion 4.250% Senior Notes due 2049. This persistence of the 2047 notes, despite new issuances, suggests a strategy of maintaining diversified long-term liabilities with staggered maturities, where the 4.350% notes serve as a stable, high-yield component of the company's capital structure.",
      "llm_answer": "Bristol‑Myers Squibb’s 4.350 % Senior Notes due 2047 were a standing element of its debt mix in 2022 and 2023 (see the 10‑K Exhibit index on pages 137‑141 and 132‑136).  In 2024 the company issued a new tranche of these notes as part of a $13 billion senior unsecured notes offering, extending the maturity to 2047 and locking in a fixed 4.350 % rate (see pages 134‑138).  This multi‑year pattern shows BMY’s deliberate use of long‑term, fixed‑rate debt to secure stable financing and align maturities with its capital‑needs profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in the quantitative and qualitative domains. (1) It incorrectly states that BMY 'issued a new tranche' of the 4.350% Senior Notes due 2047 in 2024 as part of a $13 billion offering, which contradicts the ground truth: the 4.350% notes due 2047 were not reissued in 2024; instead, BMY issued new $3.75 billion 4.250% Senior Notes due 2049. The $13 billion offering is not supported by the ground truth and appears fabricated. (2) The ground truth confirms the 4.350% notes were first issued under the 2019 Eleventh Supplemental Indenture and remained outstanding across all years, not newly issued in 2024. The LLM misrepresents the evolution of the debt instrument by implying a new issuance when the data shows continuity. (3) While the LLM correctly identifies the 4.350% rate and 2047 maturity, and acknowledges the strategic use of long-term fixed-rate debt, it fails to accurately describe the multi-year pattern: the persistence of the 2047 notes alongside newer, diverse maturities (e.g., 2032, 2052, 2049) is misrepresented by focusing on a non-existent 2024 reissuance. (4) The reasoning is partially sound in concluding a strategy of stable, long-term financing, but this is based on incorrect premises. The contextual relevance is high as the answer addresses the question's intent, but factual correctness is compromised by key errors in debt issuance events and amounts. Minor formatting (e.g., % spacing) is not penalized, but incorrect dollar figures ($13B), mischaracterized transactions (new tranche), and absence of correct new issuances (e.g., 2049 notes) severely impact accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 453,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did Apple's disclosure approach evolve for the 2.40% Notes due 2023 in the years leading up to their maturity, based on filings from 2022, 2023, and 2024?",
      "original_answer": "Apple consistently disclosed the 2.40% Notes due 2023 in the same manner across all three reporting periods—2022, 2023, and 2024—indicating a stable and unchanging disclosure approach. The notes were listed in each filing under Exhibit 4.3, with identical descriptions referencing the Officer's Certificate dated May 3, 2013. Despite the notes approaching and reaching maturity in 2023, Apple did not alter the format or substance of the disclosure, suggesting a standardized and consistent reporting strategy for maturing debt instruments.",
      "llm_answer": "Apple’s 2022 10‑K listed the 2.40 % Notes due 2023 only in the Description of Securities exhibit (exhibit 4.3) without a detailed maturity schedule 【2022 10‑K, pages 54‑58】. By the 2023 10‑K the company expanded the disclosure to include a table of the outstanding principal, maturity dates and interest‑payment schedule for the notes, reflecting the approaching maturity 【2023 10‑K, pages 53‑57】. In the 2024 10‑K, after the notes had matured, Apple disclosed the retirement of the notes and the repayment of principal and interest, indicating the completion of the obligation 【2024 10‑K, pages 54‑58】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both factual content and reasoning. According to the ground truth, Apple maintained a consistent disclosure approach for the 2.40% Notes due 2023 across 2022, 2023, and 2024 filings, with no changes in format or substance—specifically, the notes were listed under Exhibit 4.3 in each year with identical descriptions referencing the Officer's Certificate dated May 3, 2013. However, the LLM claims that Apple 'expanded' disclosure in 2023 to include a detailed table of principal, maturity, and interest schedules, and then disclosed retirement in 2024—none of which aligns with the ground truth. There is no mention in the original answer of evolving disclosure depth or post-maturity retirement reporting, which the LLM fabricates. This indicates a complete failure in multi-hop synthesis: instead of recognizing consistency across filings, it invents a progression. Quantitative elements like percentages and years (2.40%, 2023 maturity) are correct, but these isolated facts do not compensate for the core inaccuracy. The reasoning is unsound, as it contradicts the key finding of stable disclosure. Contextual relevance is low because the answer describes a narrative of change that did not occur. Thus, the correctness score is severely penalized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 360,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023, this number increased to 141,000,000, and remained at that level in fiscal year 2024. This upward adjustment from 2022 to 2023 and stability thereafter indicates a strategic decision to expand the pool of available shares for compensation purposes, likely to support ongoing incentive programs, followed by a stabilization of the share reserve as the new level became sufficient to meet award needs in 2024.",
      "llm_answer": "The Amended 2010 Share Incentive Plan authorized 127 million Class A shares in FY 2022, increased to 141 million in FY 2023, and remained at 141 million in FY 2024 (ACN_10k_2022.pdf p. 89–93; ACN_10k_2023.pdf p. 81–85; ACN_10k_2024.pdf p. 96–100). This upward adjustment reflects Accenture’s deliberate expansion of its equity‑award pool, underscoring a long‑term strategy to use share‑based compensation to align employee incentives with shareholder value and support talent retention.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the number of authorized shares for each fiscal year: 127 million in FY 2022, 141 million in FY 2023, and 141 million in FY 2024, matching the ground truth exactly. Number formats (127 million vs 127,000,000) are semantically equivalent and acceptable. (2) All quantitative values are accurate, and no calculations are required beyond correct reporting of figures. The increase of 14 million shares from 2022 to 2023 is correctly implied. (3) The multi-hop reasoning is sound—information is synthesized across three fiscal years and filings, and the trend is accurately interpreted. The LLM correctly identifies the increase and subsequent stability. (4) The qualitative interpretation is strong, noting the strategic expansion of the equity pool to support incentive alignment and talent retention. While the original answer adds that the stabilization suggests the new level became 'sufficient to meet award needs,' this nuance is minor and does not detract from the overall correctness. The LLM answer captures the core strategic implication. All entities (Accenture plc, Amended 2010 SIP, Class A ordinary shares) and fiscal years are correctly identified. The citations to the 10-Ks are a bonus but not required for correctness. Minor deduction in qualitative accuracy only for slightly less depth in explaining the post-2023 stability, but the reasoning remains valid and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 398,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its importance in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its updated manufacturing process and packaging technology roadmaps, positioning it alongside RibbonFET as a key innovation for future nodes. By 2023, Intel had solidified PowerVia’s role within the Intel 20A node, describing it as an 'industry-first implementation of backside power delivery' designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core feature and was slated for high-volume manufacturing in 2025 with the Panther Lake client processor family. This evolution shows that PowerVia transitioned from a roadmap concept to a foundational element of Intel’s leading-edge process technology, underscoring its strategic importance in achieving performance-per-watt improvements and maintaining competitive parity in advanced semiconductor manufacturing.",
      "llm_answer": "In the 2022 10‑K (pages 5‑9) Intel announced PowerVia as a breakthrough backside‑power technology for the upcoming 20A node, framing it as a key enabler of future performance‑per‑watt gains. By the 2023 10‑K (pages 12‑16) the company had expanded PowerVia’s role, describing it as a core feature of the 18A node and reiterating its importance for the 20A roadmap, signaling its maturation and broader application. The 2024 10‑K (pages 8‑12) continued to position PowerVia as a foundational element of both the 18A and 20A nodes, underscoring its centrality to Intel’s advanced process strategy and its commitment to delivering significant power‑efficiency improvements across its product portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trajectory of PowerVia's strategic importance in Intel's roadmap and correctly identifies its association with the 20A and 18A nodes, as well as its role in improving performance-per-watt. However, it contains a significant factual inaccuracy: it states that by the 2023 10-K, PowerVia was described as a core feature of the 18A node. In reality, Intel did not introduce the 18A node until 2024, after canceling the productization of 20A. The original answer clarifies that 18A replaced 20A as the next-generation node with PowerVia, with high-volume manufacturing planned for 2025 via Panther Lake. The LLM incorrectly implies that 18A was already part of the 2023 roadmap and that PowerVia was being applied to both nodes simultaneously. This misrepresents the timeline and evolution of Intel’s process node strategy. Additionally, the LLM answer fails to mention the cancellation of 20A’s productization, a key strategic shift that underscores the refinement of PowerVia’s deployment. While the qualitative emphasis on PowerVia’s foundational role is correct, the flawed sequencing of node development and incorrect attribution of 18A’s prominence in 2023 undermines the multi-hop reasoning. Quantitative elements (years, node names) are mostly accurate but misaligned in context. The answer is relevant and captures the intent of PowerVia’s importance, but lacks precision in the evolution narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 396,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Accenture's allocation to mutual fund equity securities evolve across fiscal years 2022, 2023, and 2024, and what does this 3-year trajectory indicate about the company's strategic positioning in equity-based investments?",
      "original_answer": "Accenture's allocation to mutual fund equity securities decreased from $239,293 million in fiscal year 2022 to $196,226 million in fiscal year 2023, and remained unchanged at $196,226 million in fiscal year 2024. This represents a consistent reduction in exposure to this asset class over the three-year period, suggesting a strategic rebalancing away from mutual fund equity securities toward other investment categories.",
      "llm_answer": "Accenture’s fair‑value allocation to mutual‑fund equity securities in its Non‑U.S. pension plans fell from **$239,293** in fiscal 2022 to **$196,226** in fiscal 2023, then climbed to **$273,699** in fiscal 2024 (see the fair‑value tables for each year). This three‑year swing shows a market‑responsive strategy: a contraction in 2023 amid volatility, followed by a rebound in 2024 that signals a renewed emphasis on equity exposure to capture long‑term growth while maintaining risk‑adjusted returns.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in the quantitative data. While it correctly reports the $239,293 million allocation in fiscal year 2022 and $196,226 million in 2023, it incorrectly states that the allocation increased to $273,699 million in 2024. The ground truth shows the 2024 allocation remained unchanged at $196,226 million, not an increase to $273,699 million. This is a critical error that completely misrepresents the trend. (2) The calculation and comparison of values are therefore incorrect: instead of a consistent reduction followed by stability, the LLM fabricates a rebound in 2024. The claimed 'three-year swing' and 'rebound' are unsupported by the data. (3) The multi-hop reasoning is flawed because the model fails to correctly synthesize the actual trajectory across the three years. It introduces a non-existent recovery in 2024, leading to an erroneous conclusion about strategic repositioning toward equities. The actual trend indicates a strategic reduction and sustained lower exposure, not renewed emphasis. (4) Despite the incorrect numbers and reasoning, the answer is contextually relevant—it addresses the right company (Accenture), the correct metric (mutual fund equity securities), and the appropriate fiscal years. It also attempts to interpret strategic intent, which aligns with the question’s request. However, due to the severe quantitative inaccuracy, the overall correctness score is low. Minor note: the use of 'million' is implied in the numbers (e.g., $239,293 means $239,293 million), which is consistent with SEC filing conventions and acceptable format variation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 448,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Merck's financial and strategic treatment of Dificid evolve from 2022 to 2024, particularly in terms of asset valuation, therapeutic positioning, and global revenue contribution?",
      "original_answer": "Merck's treatment of Dificid evolved significantly from 2022 to 2024. In 2022, Dificid was reported as a $145 million intangible asset under acquired human health marketed products, indicating its established but modest valuation on the balance sheet. By 2023, Dificid was explicitly highlighted in Merck's Pharmaceutical segment as a key product for treating C. difficile-associated diarrhea, signaling a clear therapeutic positioning in the hospital acute care space. In 2024, Dificid generated $340 million in global sales (with $303 million from the U.S. and $37 million internationally), demonstrating its role as a revenue contributor within the Hospital Acute Care franchise. This progression shows Dificid moving from a relatively minor asset to a strategically recognized product with measurable financial performance.",
      "llm_answer": "Merck’s net intangible asset for Dificid, originally recorded at $145 million in 2021, has been amortized over its useful life with no new impairment disclosed through 2024, indicating a gradual decline in carrying value. The product’s therapeutic positioning as a fidaxomicin antibiotic for Clostridioides difficile infection in the hospital acute‑care segment remained unchanged, as shown by its consistent listing under Hospital Acute Care in the 2022‑2024 segment sales tables. Global revenue from Dificid rose from $263 million in 2022 to $302 million in 2023 and $340 million in 2024, reflecting modest growth in sales [MRK_10k_2024.pdf: pages 128‑132].",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in numbers and timeline. The ground truth states that Dificid was reported as a $145 million intangible asset in 2022, but the LLM claims this value was from 2021 and implies amortization without mentioning the 2022 balance sheet valuation directly. While amortization is plausible, the original answer does not mention it, and the LLM introduces a detail (amortization trend with no impairment) not supported by the ground truth. More critically, the LLM reports Dificid revenue as $263M in 2022 and $302M in 2023, but the ground truth only provides 2024 revenue ($340M) and does not give prior year figures—making the LLM's specific earlier revenue numbers factually unsupported. The 2024 revenue of $340M is correct and matches the ground truth. (2) The therapeutic positioning is correctly described: Dificid is accurately placed in the Hospital Acute Care segment for treating C. difficile, consistent with the original answer. However, the LLM says this positioning 'remained unchanged' from 2022–2024, while the ground truth emphasizes a strategic evolution—specifically that Dificid was 'explicitly highlighted' as a key product in 2023, suggesting increased strategic focus, which the LLM overlooks. (3) The multi-hop reasoning is partially sound: the LLM attempts to synthesize asset valuation, therapeutic positioning, and revenue trends across years, which aligns with the question. However, it fabricates or infers revenue figures for 2022 and 2023 not present in the ground truth, undermining quantitative accuracy. (4) Contextual relevance is high—the answer addresses all three dimensions (valuation, positioning, revenue) and maintains focus on Dificid’s evolution. Despite incorrect or unsupported numbers, the overall narrative of modest growth and consistent positioning is plausible, but the introduction of unverified data reduces correctness. The correctness score is 6 due to partially correct facts but significant quantitative errors and missed strategic nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 550,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Intel's strategic positioning and execution challenges related to Advanced Packaging Technologies evolve from 2022 through 2024, particularly in terms of R&D investment, implementation delays, and financial risk exposure?",
      "original_answer": "From 2022 to 2024, Intel's strategic emphasis on Advanced Packaging Technologies grew significantly as a core differentiator within its IDM 2.0 and foundry strategy. In 2022, Intel acknowledged the complexity and cost of implementing advanced packaging within its disaggregated design approach, citing delays and increased R&D costs. In 2023, the company highlighted its progress in developing 2D and 2.5D/3D packaging solutions and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon, positioning it as a unique advantage in the AI-driven chip market. However, by 2024, Intel faced mounting financial pressure, including a $3.1 billion impairment charge tied to manufacturing assets, and admitted that the execution risks in deploying novel packaging technologies were contributing to delays in product introductions and higher-than-anticipated costs. The trajectory shows a shift from strategic optimism to operational and financial strain around advanced packaging execution.",
      "llm_answer": "Intel’s advanced‑packaging strategy has shifted from a nascent AI‑focused offering in 2022 (pages 52‑56) to a core pillar of its IDM 2.0 plan by 2023, where it reported accelerated demand and five new design wins (pages 35‑39).  R&D spending rose from $15.190 B in 2022 to $17.528 B in 2023, then fell slightly to $16.046 B in 2024 (page 36), yet the company still faced persistent implementation delays—10 nm, 7 nm, and the Intel 7 node—and incurred $3.1 B of impairment and $755 M in construction‑penalty charges in 2024 (pages 32‑36), underscoring growing financial risk exposure as packaging technology execution lags behind its strategic ambitions.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Intel's advanced packaging strategy from 2022 to 2024, aligning with the ground truth's narrative of growing strategic emphasis followed by execution and financial challenges. It accurately notes increased R&D investment in 2023 and a slight decrease in 2024, consistent with the trend in the original answer. The $3.1 billion impairment charge in 2024 is correctly reported, matching the ground truth. However, the LLM introduces specific figures for R&D spending—$15.190B (2022), $17.528B (2023), $16.046B (2024)—which, while plausible, are not present in the original answer and cannot be verified against the ground truth; this introduces a minor factual overreach. Additionally, the mention of 'construction-penalty charges' of $755M and '10nm, 7nm, and Intel 7 node' delays adds detail not present in the original and potentially conflates general process node delays with advanced packaging specifically, which the original answer treats as distinct. (2) The $3.1B impairment is correctly cited. The R&D numbers, while precise, are not corroborated by the ground truth and appear to be pulled from external data; this affects quantitative accuracy slightly. No calculation errors are present, but the inclusion of unverified specifics reduces confidence. (3) The multi-hop reasoning is sound: the LLM connects strategic positioning (IDM 2.0), R&D trends, implementation delays, and financial risks across years, synthesizing information appropriately. However, it slightly misaligns by attributing node-specific delays (e.g., Intel 7) directly to advanced packaging, whereas the original answer frames packaging as a separate but related challenge. (4) Despite minor over-specification and potential conflation of issues, the LLM answer conveys the core trajectory—strategic optimism giving way to financial and execution strain—with strong factual alignment on key points like UCIe progress (implied via 'design wins'), rising R&D, and the 2024 impairment. The answer is highly relevant and contextually appropriate, earning full marks in that category.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 570,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Merck's development timeline and regulatory status for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, and what does this progression indicate about the company's long-term strategy in the HIV therapeutic area?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed as being in Phase 3 development with a Phase 3 entry date of February 2020, indicating it was already in late-stage trials. By 2023, MK-8591A remained in Phase 3, with no indication of regulatory submission or approval, suggesting delays or ongoing evaluation. In 2024, MK-8591A remained under development, but notably, the FDA lifted a clinical hold on December 4, 2024, signaling resolution of prior regulatory concerns. However, the compound remained under a partial clinical hold for higher doses. This 3-year trajectory shows Merck's persistent commitment to the HIV-1 treatment space despite regulatory challenges, with MK-8591A remaining a key part of its infectious disease pipeline.",
      "llm_answer": "In 2022 the FDA issued a clinical hold on MK‑8591A, leading Merck to stop dosing in the Phase 2 IMAGINE‑DR trial and pause enrollment in all ongoing studies (MRK_10k_2022, pp. 23‑24).  In 2023 a Phase 2 trial of an islatravir/lenacapavir once‑weekly combination finished enrollment, but the NDA remains under a partial hold for higher‑dose regimens (MRK_10k_2023, pp. 21‑25).  By 2024 no new studies have been initiated and the program is still listed under a clinical hold in the pipeline chart, indicating Merck is deprioritizing this islatravir‑based HIV therapy and reallocating resources to other HIV or alternative therapeutic strategies (MRK_10k_2024, pp. 22‑26).",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) It incorrectly states that the FDA issued a clinical hold on MK-8591A in 2022, while the ground truth indicates the compound was in Phase 3 starting February 2020 and does not mention a 2022 hold. The actual clinical hold occurred earlier (in 2021, not 2022), and the 2022 filing would reflect the ongoing status, not a new hold. (2) The LLM claims in 2023 that a Phase 2 trial of islatravir/lenacapavir finished enrollment, but the ground truth focuses on MK-8591A (doravirine+islatravir) in Phase 3, not a Phase 2 trial of a different combination. This misidentifies both the compound and the trial phase. (3) The LLM incorrectly asserts that no new studies were initiated in 2024 and that the program remains under a full clinical hold, while the ground truth states the FDA *lifted* the clinical hold on December 4, 2024, with only a *partial* hold remaining for higher doses—indicating progress, not stagnation. (4) The conclusion that Merck is deprioritizing the therapy and reallocating resources contradicts the ground truth’s interpretation of 'persistent commitment despite challenges.' The reasoning is flawed due to incorrect entity mapping (confusing MK-8591A with other islatravir combinations) and incorrect timeline events. While the answer addresses the question’s structure and cites document references, the core facts—dates, regulatory actions, trial phases, and strategic implications—are largely incorrect, leading to a low correctness score. Quantitative accuracy is poor due to wrong dates and mischaracterized regulatory status. Qualitative accuracy fails on multi-hop synthesis: the model did not correctly track the same drug candidate across years or interpret regulatory developments accurately. Contextual relevance is moderate because the answer attempts the right question but with wrong data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 516,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How has Merck's development strategy for MK-1308A evolved from 2022 through 2024, particularly in terms of its clinical focus, combination therapies, and regulatory progress?",
      "original_answer": "In 2022, MK-1308A was listed as part of Merck's oncology pipeline, specifically for renal cell carcinoma (RCC), and was in Phase 3 development in combination with pembrolizumab. By 2023, MK-1308A was explicitly described as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab, and it was being evaluated for the treatment of RCC, indicating a more defined therapeutic focus and formulation strategy. In 2024, MK-1308A remained a key immuno-oncology candidate within Merck's Phase 3 portfolio, continuing to be evaluated in combination with pembrolizumab for RCC, with no indication of regulatory approval yet but sustained strategic emphasis on its development. This progression shows a consistent focus on RCC with increasing specificity in formulation and therapeutic strategy over time.",
      "llm_answer": "From 2022 through 2024 Merck has kept MK‑1308A’s development focused on renal cell carcinoma (RCC) as a quavonlimab/pembrolizumab co‑formulation in Phase 3 (2022 p. 23‑27; 2023 p. 18‑22; 2024 p. 48‑52). The combination strategy has remained unchanged, and the 2024 filing reports no new regulatory submissions or approvals for the program, indicating a steady, ongoing effort without major regulatory milestones.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: MK-1308A has been consistently developed for renal cell carcinoma (RCC) from 2022 to 2024, remains in Phase 3, and is a co-formulation of quavonlimab and pembrolizumab. The absence of regulatory approval or submissions by 2024 is correctly noted. (2) There are no numeric values requiring calculation (e.g., dates, percentages, dollar amounts), but the timeline (2022–2024) and phase (Phase 3) are accurately reported across years, matching the original. Page references are included as evidence, though not required. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings to show continuity in clinical focus (RCC), combination therapy (quavonlimab + pembrolizumab), and regulatory status (no approval yet). It correctly infers sustained development without major milestones. (4) The only minor shortcoming is that the 2023 clarification of MK-1308A as a 'coformulation' is slightly underemphasized—the LLM mentions it but doesn’t highlight the increased specificity in formulation strategy over time as clearly as the original answer. However, this does not detract significantly from factual correctness. Semantic equivalence is maintained, and all parts of the question (clinical focus, combination therapies, regulatory progress) are addressed accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 388,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand (approximately $3.13 billion) in aggregate available authorization for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2,694 million, despite an additional $4,000 million in repurchase authority approved in September 2024, bringing total outstanding authority to $6,694 million. During fiscal 2024 alone, Accenture purchased 2,000,308 Class A ordinary shares for $605 million under its open-market program, in addition to 72,255 shares acquired through employee-related transactions. The 2023 filing appears to contain a forward-looking disclosure about fiscal 2024 activity, suggesting consistent messaging around repurchase levels and strategic intent. This pattern indicates a sustained but measured capital return strategy, with periodic replenishment of repurchase authority to maintain flexibility.",
      "llm_answer": "Accenture repurchased $4.1 billion of shares in fiscal 2022, leaving $2.0 billion of remaining authorization (ACN_10k_2022, pp. 91‑95). In fiscal 2023 the company bought $5.0 billion of shares, reducing the remaining authorization to $1.1 billion (ACN_10k_2023, pp. 37‑41). In fiscal 2024 share repurchases totaled $4.5 billion, and the board added $4.0 billion of new authority, bringing total outstanding authority to $6.694 billion and leaving $2.7 billion of remaining authorization (ACN_10k_2024, pp. 37‑41). This multi‑year pattern shows Accenture consistently uses share repurchases as a core part of its capital‑return strategy, maintaining a flexible authorization that lets it adjust the pace of repurchases while balancing dividends.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, Accenture did not repurchase $4.1B in fiscal 2022, $5.0B in 2023, or $4.5B in 2024. Instead, the only specific repurchase amount provided is for fiscal 2024: $605 million (not $4.5B). The remaining authorizations are also incorrect: the LLM claims $2.0B left in 2022 and $1.1B in 2023, but the ground truth states $3.13B available at the start of 2022 and $2.694B remaining in 2024 after new authorization. The LLM incorrectly implies large repurchases occurred annually without support from the provided data. (2) The only correct number is the $4.0B new authorization approved in September 2024 and the resulting total outstanding authority of $6.694B, which matches the ground truth. However, the LLM fabricates repurchase totals for 2022 and 2023 that are not in the original answer. The $2.7B remaining authorization in 2024 is close to the correct $2.694B, but the derivation is flawed due to incorrect repurchase assumptions. (3) The multi-hop reasoning is unsound: the LLM invents a trend of $4–5B annual repurchases without evidence in the ground truth, which only specifies $605M in fiscal 2024 repurchases. It fails to note that the 2023 filing contains forward-looking disclosure about 2024 activity, a key nuance in the original answer. The synthesis across years is therefore misleading. (4) While the LLM correctly identifies the strategic theme of sustained capital returns and flexibility, this is a generic conclusion not fully supported by the fabricated numbers. The contextual relevance is moderate because it addresses the question’s structure and intent, but the factual foundation is severely flawed, undermining the overall correctness. The answer would score higher if the numbers were accurate, even with similar wording.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 508,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How has the persistence of Bristol-Myers Squibb's $750,000,000 2.350% Notes due 2040 in its capital structure filings from 2022 through 2024 reflected its strategy in managing long-term fixed-rate debt obligations?",
      "original_answer": "Bristol-Myers Squibb has consistently included the $750,000,000 2.350% Notes due 2040 in its capital structure filings across 2022, 2023, and 2024, indicating a stable long-term debt strategy focused on maintaining fixed interest rate obligations. In 2022, the notes were explicitly listed as part of the company's long-term debt instruments, signaling their importance in the capital structure. In 2023, the notes were again referenced, reaffirming the company's commitment to this fixed-rate liability. By 2024, the continued inclusion of the notes shows that BMY has not refinanced or retired this instrument despite market fluctuations, suggesting a strategic decision to retain predictable long-term liabilities. This consistency in retaining the 2040 notes across filings reflects a deliberate approach to long-term interest rate risk management, favoring fixed-rate debt to stabilize future interest expenses.",
      "llm_answer": "BMS has kept the $750 million 2.350% Notes due 2040 on its balance sheet in each of its 2022, 2023 and 2024 10‑K capital‑structure disclosures, showing a deliberate choice to retain a long‑term, fixed‑rate debt instrument rather than refinance or retire it. This persistence reflects the company’s strategy of locking in a low, stable interest rate, managing interest‑rate risk, and preserving liquidity while maintaining a diversified long‑term debt mix (BMY_10k_2022.pdf pp. 137‑141; BMY_10k_2023.pdf pp. 132‑136; BMY_10k_2024.pdf pp. 134‑138).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $750 million 2.350% Notes due 2040 are correctly identified, and their presence in the 2022, 2023, and 2024 filings is accurately stated. The dollar amount is correctly rendered as $750 million (equivalent to $750,000,000), and the interest rate and maturity year match exactly. (2) Quantitative accuracy is perfect: no calculations are required, but all numeric values (amount, rate, years) are correct and consistently reported. (3) The reasoning is sound and reflects multi-hop synthesis across three years of 10-K filings. The LLM correctly infers that the continued inclusion of the notes reflects a strategic choice to maintain fixed-rate debt, manage interest-rate risk, and avoid refinancing—consistent with the ground truth's interpretation. It also appropriately cites specific document sections, enhancing verifiability. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the absence of refinancing/retirement despite market fluctuations, a nuance emphasized in the original answer that strengthens the strategic interpretation. However, this is implied in 'retain' and 'not refinance or retire.' Overall, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 383,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How has Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 evolved across recent filings, and what does this pattern reveal about the company's approach to long-term debt financing?",
      "original_answer": "Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 has remained consistent across the 2022, 2023, and 2024 filings. In 2022, the notes were referenced in Exhibit 4bbb of the 10-K filing, issued under the Twelfth Supplemental Indenture dated November 13, 2020. In 2023, the same 4.350% rate was reiterated in Exhibit 4ff, reaffirmed under the Fourteenth Supplemental Indenture dated November 13, 2023. In 2024, the rate was again explicitly stated as 4.350% in Exhibit 4ff, incorporated by reference to the same original Form 8-K filing from November 22, 2019. This consistent disclosure across three years indicates a deliberate and stable long-term debt strategy, where the company maintains transparency and predictability in its long-term financing obligations despite changing market conditions.",
      "llm_answer": "BMS has consistently maintained a 4.350 % fixed‑rate commitment on its Senior Notes due 2047 across the 2022, 2023, and 2024 10‑Ks (see pages 137‑141 of the 2022 filing, 132‑136 of the 2023 filing, and 134‑138 of the 2024 filing). This stability reflects the company’s preference for long‑dated, fixed‑rate debt to lock in predictable interest costs and support a stable capital structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in stating that Bristol-Myers Squibb (BMS) has maintained a consistent 4.350% fixed interest rate on its Senior Notes due 2047 across the 2022, 2023, and 2024 10-K filings, which aligns with the ground truth. The percentage (4.350%) is accurately reported, and the multi-year consistency is correctly identified—meeting quantitative accuracy fully. The answer also correctly infers that this reflects a strategic preference for fixed-rate, long-term debt to ensure predictable interest costs and capital structure stability, which is a valid qualitative interpretation. However, the LLM omits specific details present in the original answer that demonstrate multi-hop synthesis: it does not reference the exact exhibits (e.g., Exhibit 4bbb, 4ff), supplemental indentures (Twelfth, Fourteenth), or the Form 8-K filing from November 22, 2019, which are key evidence points from the filings. While the core reasoning and conclusion are sound and semantically equivalent in intent, the absence of these specific document-level details reduces completeness and depth of multi-hop validation. The page numbers cited (e.g., 137–141 in 2022 filing) may be accurate but are not verifiable without access to exact document layouts and were not part of the ground truth, so they do not count as errors but add unverified specificity. Overall, the answer captures the essential truth and reasoning, but lacks the granular, cross-referenced evidence that would fully satisfy the multi-hop requirement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 417,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Nike's reporting on FlyEase technology evolve from fiscal 2022 to fiscal 2024, and what quantitative evidence in the 2024 filing demonstrates its production scale and integration into global manufacturing operations?",
      "original_answer": "In fiscal 2022, Nike introduced FlyEase as part of its portfolio of innovative technologies, signaling its early-stage importance in product development. By fiscal 2023, FlyEase was consistently mentioned alongside established technologies like Nike Air and Dri-FIT, indicating its growing integration into Nike’s broader product innovation strategy. In fiscal 2024, the mention of FlyEase persisted, and Nike provided specific production data showing that Vietnam, Indonesia, and China manufactured approximately 50%, 27%, and 18% respectively of total Nike Brand footwear, which includes FlyEase-integrated products. This geographic manufacturing distribution demonstrates the technology's full-scale integration into Nike’s global supply chain, supporting its scalability and strategic embedding into core footwear production.",
      "llm_answer": "In FY 2022 Nike’s 10‑K only listed FlyEase as one of many product technologies in a general innovation statement. By FY 2024 the company still referenced FlyEase in that same context but added detailed manufacturing data—Nike Brand footwear was produced by 15 contract manufacturers operating 96 finished‑goods factories in 11 countries, with 50 % of footwear output in Vietnam, 27 % in Indonesia and 18 % in China, and apparel was produced by 68 contract manufacturers in 285 factories across 33 countries, with 28 % of apparel output in Vietnam, 16 % in China and 15 % in Cambodia—showing the technology’s large‑scale, globally integrated production.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of FlyEase reporting from FY2022 to FY2024, noting its initial mention as one of many technologies and continued presence in FY2024. It accurately includes the key quantitative evidence from the 2024 filing on footwear production distribution: 50% in Vietnam, 27% in Indonesia, and 18% in China—matching the ground truth. However, the LLM adds extraneous apparel manufacturing data (28% Vietnam, 16% China, 15% Cambodia), which is not relevant to FlyEase technology integration and was not part of the original answer. This information, while factually plausible from Nike’s 10-K, distracts from the focus on FlyEase-integrated footwear and introduces content not supported in the ground truth. (2) All numeric values related to footwear production are correct and match the original answer. The percentages sum to 95%, which is acceptable due to rounding or unlisted residual countries. The inclusion of contract manufacturer counts (15 for footwear, 68 for apparel) and factory counts (96 and 285) is factually consistent with typical Nike disclosures but not mentioned in the ground truth; these details are accurate but not essential. (3) The multi-hop reasoning is partially sound: the model correctly infers that FlyEase’s inclusion in global manufacturing output implies integration into large-scale operations. However, it fails to explicitly state the progression in strategic emphasis from FY2022 to FY2023 (e.g., being grouped with Nike Air and Dri-FIT), which is a key part of the evolution. This weakens the qualitative synthesis across years. (4) The correctness score is 7 because core facts and numbers are accurate, but there is a lack of precision in focusing only on FlyEase-integrated footwear and missing the FY2023 strategic signal. Quantitative accuracy is high (8) due to correct percentages and figures. Qualitative accuracy is 7 due to incomplete reasoning across all three fiscal years and inclusion of irrelevant apparel data. Contextual relevance is strong (9) as the answer addresses the main thrust of production scale and integration, albeit with some off-topic details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 580,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the penetration rate of the Target Debit Card and associated RedCard products evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy?",
      "original_answer": "The penetration rate of the Target Debit Card and associated RedCard products declined from 20.5% in 2022 to 19.8% in 2023 and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy, potentially signaling reduced customer engagement with the RedCard program or increased competition in retail payment offerings.",
      "llm_answer": "RedCard penetration fell from 20.5 % in FY 2022 to 19.8 % in FY 2023 and further to 18.6 % in FY 2024 (TGT 10‑K 2023, p. 27; TGT 10‑K 2024, p. 28). The downward trend indicates that the 5 % discount incentive is not sustaining growth in card usage, suggesting Target’s loyalty‑driven payment strategy is losing effectiveness and may need to be revised to maintain or boost customer engagement.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the penetration rates for 2022 (20.5%) and 2023 (19.8%), which match the ground truth. However, it reports the 2024 penetration rate as 18.6%, whereas the ground truth states 17.8%. This discrepancy in the final year's percentage is a significant quantitative error, though the overall downward trend is accurately captured. (2) The numbers for 2022 and 2023 are correct and properly cited to Target’s 10-K filings. The 2024 figure, while plausible and cited to TGT 10-K 2024, p. 28, does not align with the ground truth value of 17.8%, indicating either a misreading of the source or an inconsistency in data. No calculations are required beyond reporting percentages, but the trend interpretation depends on accurate values. (3) The multi-hop reasoning is sound—the model correctly synthesizes data across two annual reports to show a trend over three years and draws a logical conclusion about the weakening effectiveness of Target’s loyalty strategy. The reasoning that declining penetration suggests reduced effectiveness is consistent with the ground truth interpretation. (4) Despite the incorrect 2024 figure, the answer addresses both parts of the question: the evolution of penetration rates and the implication for Target’s strategy. The qualitative analysis is strong and contextually appropriate, hence high scores for qualitative accuracy and contextual relevance. The correctness score is reduced due to the key numerical inaccuracy in the 2024 penetration rate, which affects the precision of the trend assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 434,
        "total_tokens": 1652
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 798,
    "successful_evaluations": 798,
    "failed_evaluations": 0,
    "average_correctness_score": 6.33,
    "average_quantitative_accuracy": 6.98,
    "average_qualitative_accuracy": 6.63,
    "average_contextual_relevance": 8.55,
    "score_distribution": {
      "excellent": 273,
      "good": 158,
      "fair": 204,
      "poor": 163
    }
  },
  "original_experiment_metadata": {
    "model": "gpt-oss-20b-reasoning",
    "experiment": "e2_page_window",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions": 800,
    "successful": 798,
    "failed": 2,
    "elapsed_seconds": 34747.38,
    "timestamp": "2026-02-03T10:43:01.663334"
  }
}